,claim,keyword,mask,fake_claim,source,evidence
0,"100 percent of regular ICU beds in Texas Medical Center occupied , but hospitals have space for surge",100,"_ percent of regular icu beds in texas medical center occupied , but hospitals have space for surge","One percent of regular icu beds in texas medical center occupied, but hospitals have space for surge",https://www.khou.com/article/news/health/coronavirus/houston-hospitals-ceo-provide-update-on-bed-capacity-amid-surge-in-covid-19-cases/285-a5178aa2-a710-49db-a107-1fd36cdf4cf3,"[(""Abbott pauses reopening The average ICU occupancy rate at the world's largest medical center is 70 to 80 percent, but higher rates aren't unheard of."", 0.537752), (""That's bad news for hospitals that have already taken a huge financial hit because elective surgeries are where they make the most money."", 0.49323714), (""Hospitals in Houston's Medical Center will now move some ICU patients to beds not normally used for critical care."", 0.4900035), ('The governor’s order suspends elective surgeries at hospitals in Harris, Bexar, Dallas and Travis counties.', 0.48053145), ('Despite reaching surge capacity, four hospital CEOs said Thursday there\'s no cause for ""unwarranted alarm.""', 0.4609822)]"
3,Reinfection could not occur in SARS-CoV-2 infected rhesus macaques,not,reinfection could _ occur in sars-cov-2 infected rhesus macaques,reinfection could still occur in sars-cov-2 infected rhesus macaques,https://www.biorxiv.org/content/10.1101/2020.03.13.990226v1,"[('Notably, neither viral loads in nasopharyngeal and anal swabs along timeline nor viral replication in all primary tissue compartments at 5 days post- reinfection (dpr) was found in re-exposed monkeys.', 0.38662422), ('Combined with the follow-up virologic, radiological and pathological findings, the monkeys with re- exposure showed no recurrence of COVID-19, similarly to the infected monkey without rechallenge.', 0.38401353), ('However, it remains unclear whether the convalescing patients have a risk of “relapse” or “reinfection”.', 0.3357618), ('The longitudinal tracking of re-exposure after the disappeared symptoms of the SARS-CoV-2-infected monkeys was performed in this study.', 0.31735477), ('Taken together, our results indicated that the primary SARS-CoV-2 infection could protect from subsequent exposures, which have the reference of prognosis of the disease and vital implications for vaccine design.', 0.3020938)]"
10,Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralisation and commercial assays,six,_-month antibody response to sars-cov-2 in healthcare workers assessed by virus neutralisation and commercial assays,One-month antibody response to sars-cov-2 in healthcare workers assessed by virus neutralisation and commercial assays,https://www.medrxiv.org/content/10.1101/2020.12.08.20245811v1,"[('The neutralising antibody (NAb) titre was also determined for all samples with a virus neutralisation assay (VNA) using live virus.', 0.67424726), ('VNA should remain the gold standard to assess the protective antibody response, but some commercial assays could be used as first-line screening of long-term presence of NAb.', 0.628521), ('Serum samples (n=296) collected six months after disease onset were tested using three commercial assays: the Wantai Ab assay detecting total antibodies against the receptor binding domain (RBD) of the S protein, the bioMerieux Vidas assay detecting IgG to the RBD and the Abbott Architect assay detecting IgG to the N protein.', 0.6004276), ('The data presented herein suggest that commercial assays detecting antibodies against the N protein must not be used in long-term seroprevalence surveys while the Wantai assay could be useful for this purpose.', 0.55982345), ('Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Written informed consent was obtained from all participants; ethics approval was obtained from the national review board for biomedical research in April 2020 (Comite de Protection des Personnes Sud Mediterranee I, Marseille, France; ID RCB 2020-A00932-37), and the study was registered on ClinicalTrials.gov (NCT04341142).', 0.45805043)]"
15,Closed environments facilitate secondary transmission of coronavirus disease 2019,facilitate,closed environments _ secondary transmission of coronavirus disease 2019,closed environments prevent secondary transmission of coronavirus disease 2019,https://www.medrxiv.org/content/10.1101/2020.02.28.20029272v2,"[('Conclusions It is plausible that closed environments contribute to secondary transmission of COVID-19 and promote superspreading events.', 0.5333812), ('Our findings are also consistent with the declining incidence of COVID-19 cases in China, as gathering in closed environments was prohibited in the wake of the rapid spread of the disease.', 0.42006314), ('Methods A total of 110 cases were examined among eleven clusters and sporadic cases, and investigated who acquired infection from whom.', 0.30897248), ('Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search ', 0.28805), ('Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.', 0.28333235)]"
16,Moderna Receives Confirmation of Eligibility for Submission of Marketing Authorization Application to the European Medicines Agency for mRNA Vaccine Against COVID-19,confirmation,moderna receives _ of eligibility for submission of marketing authorization application to the european medicines agency for mrna vaccine against covid-19,moderna receives loss of eligibility for submission of marketing authorization application to the european medicines agency for mrna vaccine against covid-19,https://investors.modernatx.com/news-releases/news-release-details/moderna-receives-confirmation-eligibility-submission-marketing,"[('Confirmation of eligibility was given in response to the submission of a letter of intent enabling Moderna to evaluate the opportunity for submitting a Marketing Authorization Application (MAA) for mRNA-1273 with the EMA.', 0.69724464), ('Moderna’s investigational Zika vaccine (mRNA-1893), currently in a Phase 1 study, was granted FDA Fast Track designation in August 2019.', 0.6878668), ('This submission follows positive results from a preclinical viral challenge study and the positive interim analysis of the Phase 1 study of mRNA-1273 in healthy adults (ages 18-55 years) and older adults (ages 56-70 and 71+) published in the New England Journal of Medicine.', 0.6444942), ('The potential advantages of an mRNA approach to prophylactic vaccines include the ability to combine multiple mRNAs into a single vaccine, rapid discovery to respond to emerging pandemic threats and manufacturing agility derived from the platform nature of mRNA vaccine design and production.', 0.6414437), ('About Moderna Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients.', 0.64075387)]"
17,Lipid droplets fuels SARS-CoV-2 replication and inflammatory response,fuels,lipid droplets _ sars-cov-2 replication and inflammatory response,lipid droplets inhibit sars-cov-2 replication and inflammatory response,https://www.biorxiv.org/content/10.1101/2020.08.22.262733v1,"[('In vitro, SARS-CoV-2 infection modulates pathways of lipid synthesis and uptake, as CD36, SREBP-1, PPARÎ³ and DGAT-1 in human monocytes and triggered LD formation in different human cells.', 0.71544987), ('Lipid droplets (LD) are organelles with major functions in lipid metabolism and energy homeostasis, and have multiple roles in infections and inflammation.', 0.6835966), ('Use of a lipophilic vital-stain, BODIPY TR methyl ester, could help visualize the entire complement of endomembraneous-organelles in Covid-Infected Cells.', 0.62266976), ('Associations of Covid ROs with Lipid Droplets could also be examined in combinations with other vital-stains (e.g.', 0.60160697), ('It was hypothesized that the virus induces these changes to promote viral replication and that lipid droplets play an important in viral replication.', 0.60145843)]"
20,Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity,facilitates,neuropilin-1 _ sars-cov-2 cell entry and infectivity,neuropilin-1 blocks sars-cov-2 cell entry and infectivity,https://science.sciencemag.org/content/early/2020/10/19/science.abd2985,"[('now show that neuropilin-1 (NRP1), which is known to bind furin-cleaved substrates, potentiates SARS-CoV-2 infectivity.', 0.8183976), ('1 NRP1 facilitates the cellular entry of SARS-CoV-2 pseudotyped particles.', 0.80146575), ('Data are normalized to SARS-2 infectivity in cells expressing ACE2 and TMPRSS2.', 0.7831179), ('Data are normalized to the respective infectivity of SARS-2 and VSV-G pseudotype in ACE2-expressing cells.', 0.7718859), ('Data are normalized to the respective infectivity of SARS-2 and VSV-G pseudotype in control cells.', 0.7472832)]"
23,Thrombotic microvascular injury is not mediated by thrombotic microangiopathy despite systemic complement activation in Covid-19 patients,not,thrombotic microvascular injury is _ mediated by thrombotic microangiopathy despite systemic complement activation in covid-19 patients,thrombotic microvascular injury is mostly mediated by thrombotic microangiopathy despite systemic complement activation in covid-19 patients,https://www.medrxiv.org/content/10.1101/2020.06.18.20115873v1,"[('No sign of Thrombotic microangiopathy is found in severe covid-19 patients ', 0.70288646), ('In summary, this study show moderate activation of complement and coagulation with presence of thrombotic microvascular injury in patients with severe COVID-19 without evidence of systemic thrombotic microangiopathy.', 0.632899), ('Severe covid-19 patients show moderate elevation of final activation of complement 2.', 0.4952858), ('We research sign of complement activation and presence of thrombotic microangiopathy in 8 severe patients.', 0.4822709), ('Interestingly, none the 8 patients had signs of mechanical hemolytic anemia (median value of hemoglobin : 10,5 gr/dL[IQR : 8,1 - 11,9], median value of haptoglobuline 4,49 [IQR 3,55-4,66], none of the patients has schistocyte) and thrombocytopenia (median value: 348000/mL [IQR : 266 000 - 401 000).', 0.44953966)]"
24,Sixty-Day Outcomes Among Patients Hospitalized With COVID-19,sixty,_-day outcomes among patients hospitalized with covid-19,Up-day outcomes among patients hospitalized with covid-19,https://www.acpjournals.org/doi/10.7326/M20-5661,"[('O bjective: To describe 60-day postdischarge clinical, financial, and mental health outcomes of patients with COVID-19.', 0.789892), ('Persistent symptoms in patients after acute COVID-19.', 0.7888394), ('Despite these limitations, our study conveys that adverse events after COVID-19 hospitalization are common.', 0.67234516), ('F indings: Of 1648 patients with COVID-19 admitted to 38 hospitals, 398 (24.2%) died during hospitalization and 1250 (75.8%) survived.', 0.6307819), ('The aim of MI-COVID19, a Michigan statewide collaboration sponsored by Blue Cross Blue Shield of Michigan (BCBSM) and Blue Care Network, is to improve care for patients hospitalized with COVID-19.', 0.6122281)]"
25,Two dogs tested positive of SARS-CoV-2 .,dogs,two _ tested positive of sars-cov-2 .,two children tested positive of sars-cov-2.,https://www.oie.int/wahis_2/public/wahid.php/Reviewreport/Review?page_refer=MapFullEventReport&reportid=33684,"[('However, only two dogs and one cat have tested positive for SARS-CoV-2 infection.', 0.789484), ('The evidence suggests that these are instances of human-to-animal transmission of SARS-CoV-2.', 0.77054095), ('Information about testing for SARS-CoV-2 in animals is available here.', 0.76710665), ('Infection of dogs with SARS- CoV-2.', 0.76700544), ('Oral and nasal swabs tested positive for SARS- CoV-2 RNA on the first two occasions (Table 1).', 0.7337092)]"
26,Convalescent plasma is ineffective for covid-19,ineffective,convalescent plasma is _ for covid-19,convalescent plasma is suitable for covid-19,https://www.bmj.com/content/371/bmj.m4072,"[('In prespecified, intention-to-treat analyses, the PLACID Trial investigators found no net benefit associated with convalescent plasma in patients admitted to hospital with moderate covid-19.', 0.6499312), ('Convalescent plasma for covid-19.', 0.62569153), ('Endotheliopathy is induced by plasma from critically-ill patients and associated with organ failure in severe COVID-19.', 0.59455705), ('Convalescent plasma in Covid-19: Possible mechanisms of action.', 0.5393086), ('Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients.', 0.5317118)]"
29,Covid-19 is Transmitted Through Aerosols .,aero,covid-19 is transmitted through _ .,covid-19 is transmitted through Torsols.,https://time.com/5883081/covid-19-transmitted-aerosols/,"[('The second possibility for how COVID-19 spreads is through droplets, small bits of saliva or respiratory fluid that infected individuals expel when they cough, sneeze, or talk.', 0.66808534), ('Fomites and droplets have dominated our everyday understanding of COVID-19 transmission.', 0.63090146), ('Everything you need to know about the global spread of COVID-19 Please enter a valid email address.', 0.6141399), ('Read More: A New Study Suggests COVID-19 Reinfection Is Possible.', 0.55157757), ('Many diseases, including COVID-19, infect most effectively at close proximity.', 0.54320705)]"
33,Biolidics to launch ten-minute rapid test kits for COVID-19,ten,biolidics to launch _-minute rapid test kits for covid-19,biolidics to launch 2-minute rapid test kits for covid-19,https://www.mobihealthnews.com/news/asia-pacific/biolidics-launch-ten-minute-rapid-test-kits-covid-19,"[('Using serum, plasma or whole blood samples, Biolidics’ rapid test kit can detect COVID-19 with an accuracy of more than 95% in ten minutes.', 0.76832736), ('By Dean Koh March 31, 2020 03:17 am Share Credit: Biolidics Singapore-listed medtech company Biolidics recently launched its rapid test kit for COVID-19 and has entered into a manufacturer agreement with a diagnostic kit manufacturer to customize and manufacture the rapid test kits.', 0.71567136), ('Ltd. Singapore medtech company develops portable genetic test for COVID-19 ', 0.6927688), ('THE LARGER PICTURE The tiny nation-state of Singapore has developed (or is developing) a number of test kits for COVID-19, such as the Veredus Laboratories’ VereCoV detection kit, ASTAR and TTSH’s Fortitude Kit 2.0, and the ongoing development of a COVID-19 detection kit by iHealthTech researchers.', 0.6347787), ('The first batch of Biolidics’ rapid test kits is expected to be available in April 2020.', 0.6253416)]"
34,The disease-induced herd immunity level for Covid-19 is substantially lower than the classical herd immunity level,lower,the disease-induced herd immunity level for covid-19 is substantially _ than the classical herd immunity level,the disease-induced herd immunity level for covid-19 is substantially greater than the classical herd immunity level,https://arxiv.org/abs/2005.03085,"[('The classical > herd immunity level $hC$ is defined as $hC=1-1/R0$, where $R0$ is the > basic reproduction number, for covid-19 estimated to lie somewhere in the > range 2.2-3.5 depending on country and region.', 0.595113), ('It is shown here that the > disease-induced herd immunity level $hD$, after an outbreak has taken place > in a country/region with a set of preventive measures put in place, is > actually substantially smaller than $hC$.', 0.5730394), ('Consequently, disease- > induced immunity is stronger than when immunity is uniformly distributed in > the community as in the classical herd immunity level.', 0.5677), ('> Consequently, a lower fraction infected is required for herd immunity to > appear.', 0.5175097), ('A common question is > if and when a country or region will reach herd immunity $h$.', 0.40180254)]"
35,"99.9 % of SARS-CoV-2 Gets Destroyed After Gargling Betadine , Claims Study",destroyed,"99.9 % of sars-cov-2 gets _ after gargling betadine , claims study","99.9 % of sars-cov-2 gets stable after gargling betadine, claims study",https://www.techtimes.com/articles/251563/20200804/covid-19-new-cure-gargling-betadine-kills-99-9-of-coronavirus-in-30-seconds-says-study.htm,"[('A study claims that gargling betadine substance for 15 to 30 seconds may destroy 99.9% of the SARS-CoV-2 in a human body.', 0.68238497), ('Preliminary results show Betadine Gargle killed 99.9 percent of the virus within 15 seconds.', 0.65581346), ('In this study, results showed a 99.9 percent reduction of SARS- CoV-2 viral load starting at 15 seconds and at all subsequent time points in the study (30 seconds, 60 seconds and 5 minutes).', 0.592484), ('A scientific study claims that gargling betadine can destroy SARS-CoV-2, which has been infecting the human body into Coronavirus.', 0.5812502), ('Based on the study, antiseptic products like betadine, namely Solution (10% PVP-I), Skin Cleanser (7.5% PVP-I), Gargle, and Mouthwash (1.0% PVP-I) and Throat Spray (0.45% PVP-I) can destroy 99.9% of Coronavirus for as fast as 30 seconds.', 0.5185672)]"
37,"Finding suggests technology can be installed in air conditioning , vacuum , and water systems",can,"finding suggests technology _ be installed in air conditioning , vacuum , and water systems","finding suggests technology cannot be installed in air conditioning, vacuum, and water systems",https://www.sciencedaily.com/releases/2020/12/201214164328.htm,"[('Disinfection systems based on LED bulbs, however, can be installed in the ventilation system and air conditioner, for example, and sterilize the air sucked in and then emitted into the room.', 0.56467795), ('Eventually, as the science develops, the industry will be able to make the necessary adjustments and install the bulbs in robotic systems or air conditioning, vacuum, and water systems, and thereby be able to efficiently disinfect large surfaces and spaces.', 0.53528404), ('Our research has commercial and societal implications, given the possibility of using such LED bulbs in all areas of our lives, safely and quickly.""', 0.44547635), ('In the future, the researchers will test their unique combination of integrated damage mechanisms and more ideas they recently developed on combined efficient direct and indirect damage to bacteria and viruses on different surfaces, air, and water.', 0.4327197), ('This is the first study conducted on the disinfection efficiency of UV-LED irradiation at different wavelengths or frequencies on a virus from the family of coronaviruses.', 0.3319974)]"
38,"Global partnership to make available 120 million affordable , quality COVID-19 rapid tests for low- and middle-income countries",120,"global partnership to make available _ million affordable , quality covid-19 rapid tests for low- and middle-income countries","global partnership to make available 1 million affordable, quality covid-19 rapid tests for low- and middle-income countries",https://www.who.int/news-room/detail/28-09-2020-global-partnership-to-make-available-120-million-affordable-quality-covid-19-rapid-tests-for-low--and-middle-income-countries,"[('These two arrangements will make available to LMICs 120 million antigen rapid diagnostic tests (Ag RDTs) - priced at a maximum of US$5 per unit - over a period of six months.', 0.645281), ('Overall, the ACT-Accelerator Diagnostic Pillar aims to facilitate the supply of 500 million tests to LMICs within 12 months.', 0.6236857), ('These agreements are critical to fulfil the key objective of the ACT- Accelerator: to ensure all countries, regardless of income, have fair access to new tests and tools to fight COVID-19.', 0.6137465), (""It draws on the experience of leading global health organizations which are tackling the world's toughest health challenges, and who, by working together, are able to unlock new and more ambitious results against COVID-19."", 0.6099576), (""Both companies' tests are faster and cheaper than laboratory-based tests, enabling countries to increase the pace of testing, tracing and treating people for COVID-19 at the point of care particularly in areas with under-resourced health systems."", 0.58284736)]"
40,SARS-CoV-2 Is Not Detectable in the Vaginal Fluid of Women With Severe COVID-19 Infection,not,sars-cov-2 is _ detectable in the vaginal fluid of women with severe covid-19 infection,sars-cov-2 is still detectable in the vaginal fluid of women with severe covid-19 infection,https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa375/5815295,"[('Conclusions: Findings from this small group of cases suggest that SARS- CoV-2 virus does not exist in the vaginal fluids of severe COVID-19 patients.', 0.82600677), ('Our aim in this study was to determine if SARS-CoV-2 is present in the vaginal fluid of women with coronavirus disease 2019 (COVID-19).', 0.5869014), ('The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients.', 0.49048495), ('All 10 patients were tested for SARS-CoV-2 in vaginal fluid, and all samples tested negative for the virus.', 0.48134446), ('Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection.', 0.47605723)]"
42,Nasal-Swab Testing Misses Patients with Low SARS-CoV-2 Viral Loads,misses,nasal-swab testing _ patients with low sars-cov-2 viral loads,nasal-swab testing confirmed patients with low sars-cov-2 viral loads,https://www.medrxiv.org/content/10.1101/2020.06.12.20128736v1,"[('Those with viral loads below 1,000 copies/mL, the majority in our cohort, exhibited low concordance (Cohen’s kappa = 0.49); most of these would have been missed by nasal testing alone.', 0.69961053), ('These findings counsel caution in use of nasal testing in healthcare settings and contact-tracing efforts, as opposed to screening of asymptomatic, low-prevalence, low-risk populations.', 0.58639336), ('Among these alternatives is collection of nasal-swab samples, which can be performed by the patient, avoiding the need for healthcare personnel and personal protective equipment.', 0.5661129), ('To resolve this disagreement, we compared nasal and NP specimens collected by healthcare workers in a cohort consisting of individuals clinically suspected of COVID-19 and outpatients known to be SARS-CoV-2 RT-PCR positive undergoing follow-up.', 0.48946786), ('We found high concordance (Cohen’s kappa >0.8) only for patients with viral loads above 1,000 copies/mL.', 0.43823326)]"
43,"Scientists See Signs of Lasting Immunity , Even After Mild Infections",see,"scientists _ signs of lasting immunity , even after mild infections","scientists no signs of lasting immunity, even after mild infections",https://www.nytimes.com/2020/08/16/world/coronavirus-covid-19.html,"[('Scientists see signs of lasting immunity to COVID-19, even after mild infections Share: August 18, 2020 ', 0.7287549), ('Disease-fighting antibodies, as well as immune cells called B cells and T cells that are capable of recognizing the virus, appear to persist months after infections have resolved — an encouraging echo of the body’s enduring response to other viruses.', 0.6045396), ('Scientists who have been monitoring immune responses to the virus are now starting to see encouraging signs of strong, lasting immunity, even in people who developed only mild symptoms of Covid-19, a flurry of new studies suggests.', 0.6024011), ('Scientists who have been monitoring immune responses to the virus are now starting to see encouraging signs of strong, lasting immunity, even in people who developed only mild symptoms of COVID-19, a flurry of new studies suggests.', 0.6024011), ('Disease-fighting antibodies, as well as immune cells called B cells and T cells capable of recognizing the virus, appear to persist months after infections have resolved — an encouraging echo of the body’s robust immune response to other viruses.', 0.59969807)]"
45,Sorrento IDs Antibody Against COVID-19 That Appears 100 % Effective,100,sorrento ids antibody against covid-19 that appears _ % effective,sorrento ids antibody against covid-19 that appears 70 % effective,https://www.biospace.com/article/sorrento-ids-antibody-against-covid-19-that-appears-100-percent-effective/,"[(""Skip to main content \\--> <!-- <div id='div-gpt-ad-1488483363281-0'> <script type='text/javascript'> googletag.cmd.push(function() { googletag.display('div-gpt-ad-1488483363281-0'); }); [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number"", 0.08222965)]"
46,The Man Who Saw The Pandemic Coming,man,the _ who saw the pandemic coming,the child who saw the pandemic coming,http://m.nautil.us/issue/83/intelligence/the-man-who-saw-the-pandemic-coming,"[('He sounds sympathetic to people frightened by the outbreak.', 0.5171192), ('Do you think the current outbreak was inevitable?', 0.50305074), ('I began by asking about the source of the outbreak.', 0.48139936), ('He has been an eyewitness to people around the world suffering from similar viruses.', 0.46838087), ('By the time it’s cooked and prepared, the virus would have been dead.', 0.4604147)]"
47,Rapid Recovery from COVID-19 Respiratory Failure with Comorbidity in 21 Patients Treated with Vasoactive Intestinal Peptide,rapid,_ recovery from covid-19 respiratory failure with comorbidity in 21 patients treated with vasoactive intestinal peptide,No recovery from covid-19 respiratory failure with comorbidity in 21 patients treated with vasoactive intestinal peptide,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3665228,"[('Rapid Recovery in Six Patients with COVID-19 Respiratory Failure after Treatment with Vasoactive Intestinal Peptide.', 0.7324826), ('Methods: Case series of 21 consecutive with Critical COVID-19 and multiple co-morbidities, treated with intravenous aviptadil (synthetic VIP).', 0.6595352), ('Comment: The short term survival of 6/6 patients with respiratory failure in the setting of COVID-19 and major comorbidity is the most dramatic response ever seen with an antiviral agent.', 0.64161587), ('Methods: This report describes the first 6 patients with Acute Respiratory Failure in Critical COVID-19, enrolled under Emergency Use IND were treated with three successive 12-hour infusions of intravenous Aviptadil at 50/100/150 pmol/kg/hr, while continuing to receive maximal ICU care.', 0.5905177), ('Comment: The short term outcome in these 21 patients represent a dramatic response in patients whose comorbidities precluded their randomization in all other trials of COVID therapeutics and who were previously treated with remdesivir, tocilizumab, or convalescent plasma.', 0.5844494)]"
48,Closed environments facilitate secondary transmission of COVID-19,facilitate,closed environments _ secondary transmission of covid-19,closed environments prevent secondary transmission of covid-19,https://www.medrxiv.org/content/10.1101/2020.02.28.20029272v1,"[('Conclusions It is plausible that closed environments contribute to secondary transmission of COVID-19 and promote superspreading events.', 0.7621442), ('Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19).', 0.6904061), ('It is time to address airborne transmission of COVID-19.', 0.6129341), ('Temporal dynamics in viral shedding and transmissibility of COVID-19.', 0.6111732), ('COVID-19 may transmit through aerosol.', 0.5928322)]"
49,The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19,not,the approved dose of ivermectin alone is _ the ideal dose for the treatment of covid-19,the approved dose of ivermectin alone is still the ideal dose for the treatment of covid-19,https://www.medrxiv.org/content/10.1101/2020.04.21.20073262v1,"[('Bias Possibility in a Retrospective Study of Ivermectin for COVID-19.', 0.6028772), ('In summary, the likelihood of a successful clinical trial using the approved dose of ivermectin is low.', 0.52980095), ('Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.', 0.4760707), ('Repurposing drugs for use in coronavirus disease 2019 (COVID-19) treatment is an ideal strategy but is only feasible when product safety has been established and experiments of repurposed drugs are conducted at clinically relevant concentrations.', 0.47350264), ('The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.', 0.43967295)]"
53,COVID-19 attack rate increases with city size,increases,covid-19 attack rate _ with city size,covid-19 attack rate decreased with city size,https://www.medrxiv.org/content/10.1101/2020.03.22.20041004v1,"[('This means that COVID-19 is spreading faster on average in larger cities with the additional implication that, in an uncontrolled outbreak, larger fractions of the population are expected to become infected in more populous urban areas.', 0.8107019), ('Here, we estimate the growth rates and reproductive numbers of COVID-19 in US cities from March 14th through March 19th to reveal a power-law scaling relationship to city population size.', 0.7033268), ('We discuss the implications of these observations for controlling the COVID-19 outbreak, emphasizing the need to implement more aggressive distancing policies in larger cities while also preserving socioeconomic activity.', 0.5562089), ('Yes All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.', 0.22192183), ('Back to top PreviousNext Posted April 03, 2020.', 0.20071405)]"
56,Gilead has suspended access to Remdesivir,suspended,gilead has _ access to remdesivir,gilead has allowed access to remdesivir,https://www.statnews.com/2020/03/22/gilead-suspends-access-to-experimental-covid-19-drug-remdesivir/,"[('Skip to main content ', 0.46015918), ('Before the suspension, Gilead’s remdesivir appeared to be offered to individual patients for emergency use.', 0.442002), ('To stem demand, Gilead will pivot from accepting compassionate- use requests to only providing treatment through expanded access programs.', 0.39587063), ('These include AbbVie’s HIV combo therapy Kaletra (Aluvia), which just failed a clinical study in China in critically ill patients.', 0.375209), ('“We have heard zero.', 0.36152732)]"
58,Gilead data suggests coronavirus patients are responding to treatment,responding,gilead data suggests coronavirus patients are _ to treatment,gilead data suggests coronavirus patients are resistant to treatment,https://www.statnews.com/2020/04/16/early-peek-at-data-on-gilead-coronavirus-drug-suggests-patients-are-responding-to-treatment/,"[('Remdesivir was one of the first medicines identified as having the potential to impact SARS-CoV-2, the novel coronavirus that causes Covid-19, in lab tests.', 0.5777765), ('Support STAT: If you value our coronavirus coverage, please consider making a one-time contribution to support our journalism.', 0.5122564), ('The primary goal is a statistical comparison of patient improvement between the two treatment arms.', 0.5041005), ('The trial is investigating five- and 10-day treatment courses of remdesivir.', 0.48284826), ('Is this what Covid-19 has in… A side-by-side comparison of the Pfizer/BioNTech and Moderna vaccines A side-by-side comparison of the Pfizer/BioNTech and Moderna vaccines CDC says people with history of severe allergic reactions… CDC says people with history of severe allergic reactions can get Covid-19 vaccine Recommended Biden will mobilize FEMA, the National Guard, and pharmacies… Biden will mobilize FEMA, the National Guard, and pharmacies to ramp up vaccine distribution Genome-sequencing pioneer Eric Lander to lead science policy for… Genome-sequencing pioneer Eric Lander to lead science policy for Biden New coronavirus variant could become dominant strain in March,… New coronavirus variant could become dominant strain in March, CDC warns ', 0.47921103)]"
59,A 67-Year-Old Woman with Sudden Hearing Loss Associated with SARS-CoV-2 Infection,with,a 67-year-old woman _ sudden hearing loss associated _ sars-cov-2 infection,a 67-year-old man with sudden hearing loss associated with sars-cov-2 infection,https://www.amjcaserep.com/abstract/index/idArt/927519,"[('CASE REPORT A 67-year-old woman with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as confirmed by reverse transcription-polymerase chain reaction (RT-PCR) testing from nasopharyngeal and oropharyngeal swabs, was examined.', 0.61226916), ('An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss.', 0.60480285), ('She experienced sudden hearing loss in her right ear and disabling tinnitus.', 0.53921485), ('This report describes a case of sudden hearing loss in a patient with COVID-19 pneumonia due to SARS-CoV-2 infection.', 0.53682697), ('CONCLUSIONS Although rare, hearing loss appears to be a possible sequela to SARS-CoV-2 infection and deserves attention because it is a medical emergency requiring immediate clinical treatment.', 0.5047302)]"
60,"Ohio health official estimates 100,000 people in state have coronavirus",100,"ohio health official estimates _,000 people in state have coronavirus","ohio health official estimates 1,000 people in state have coronavirus",https://thehill.com/policy/healthcare/487329-ohio-health-official-estimates-100000-people-in-state-have-coronavirus,"[('Mike DeWineMike DeWineRepublicans eye primaries in impeachment vote Shellshocked GOP ponders future with Trump Governors respond to violence at Capitol MORE (R) that given that the virus is spreading in the community in Ohio, she estimates at least 1 percent of the population in the state has the virus.', 0.47598296), ('""We know now, just the fact of community spread, says that at least 1 percent, at the very least, 1 percent of our population is carrying this virus in Ohio today,"" Acton said.', 0.45920885), ('More than 1,300 people in the U.S. have currently tested positive for the illness, according to data from Johns Hopkins University, while about three dozen people in the country have died.', 0.44122463), ('So the math is over 100,000.', 0.42952353), ('Ohio Department of Health Director Amy Acton said at a press conference alongside Gov.', 0.36151323)]"
62,Assessment of 135 794 Pediatric Patients Tested for SARS-CoV-2 Across the United States,135,assessment of _ 794 pediatric patients tested for sars-cov-2 across the united states,assessment of 10 794 pediatric patients tested for sars-cov-2 across the united states,https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.5052,"[('Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States.', 0.7701194), ('Results: A total of 135 794 pediatric patients (53% male; mean [SD] age, 8.8 [6.7] years; 3% Asian patients, 15% Black patients, 11% Hispanic patients, and 59% White patients; 290 per 10 000 population [range, 155-395 per 10 000 population across health systems]) were tested for SARS-CoV-2, and 5374 (4%) were infected with the virus (12 per 10 000 population [range, 7-16 per 10 000 population]).', 0.69005084), ('Objective: To describe testing for SARS-CoV-2 and the epidemiology of infected patients.', 0.5470134), ('Conclusions and relevance: In this large cohort study of US pediatric patients, SARS-CoV-2 infection rates were low, and clinical manifestations were typically mild.', 0.5209596), ('Design, setting, and participants: A retrospective cohort study was conducted using electronic health record data from 135 794 patients younger than 25 years who were tested for SARS-CoV-2 from January 1 through September 8, 2020.', 0.51688564)]"
63,Nitric Oxide May Slow Progression of COVID-19,slow,nitric oxide may _ progression of covid-19,nitric oxide may promote progression of covid-19,https://smhs.gwu.edu/news/nitric-oxide-may-slow-progression-covid-19,"[('The authors suggest that if nitric oxide’s efficacy is illustrated for COVID-19, its use as a treatment can be pivotal in the fight against the pandemic.', 0.6848109), ('The authors highlight the potential for inhaled nitric oxide contributing to better clinical outcomes and alleviating the rapidly rising strain on health care capacity due to COVID-19.', 0.5700632), ('“With the emergence of COVID-19 as a pandemic with the ability to overwhelm the body and our health care infrastructure, patients have a pressing need for effective agents that can slow the disease in their bodies and in their communities,” Friedman said.', 0.50583667), ('“Harnessing nitric oxide for preventing, limiting, and treating the severe pulmonary consequences of COVID-19” can be found at www.sciencedirect.com/science/article/pii/S1089860320301701.', 0.47423512), ('There is currently no registered treatment or vaccine for COVID-19.', 0.4431927)]"
66,A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate,single,a _-dose live-attenuated yf17d-vectored sars-cov-2 vaccine candidate,a multi-dose live-attenuated yf17d-vectored sars-cov-2 vaccine candidate,https://www.nature.com/articles/s41586-020-3035-9,"[('Here we describe the development of a candidate vaccine (YF-S0) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that uses live-attenuated yellow fever 17D (YF17D) vaccine as a vector to express a noncleavable prefusion form of the SARS-CoV-2 spike antigen.', 0.7600609), ('17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study.', 0.7239109), ('Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.', 0.70679456), ('Using an advanced reverse genetics system, we generated a panel of YF17D-based candidate vaccines (YF-S) that express the S protein of SARS-CoV-2 in its native cleavable S1 and S2 subunits (hereafter, S1/2) form, its noncleavable S0 version or its S1 subdomain as in-frame fusions within the E and NS1 intergenic region of YF17D (which we termed YF-S1/2, YF-S0 and YF-S1, respectively) (Fig.', 0.6689322), ('A panel of several SARS-CoV-2 vaccine candidates was engineered by inserting a codon-optimized sequence of either the SARS-CoV-2 S protein (GenBank: MN908947.3) or variants thereof into the full-length genome of YF17D (GenBank: X03700) as translational in-frame fusion within the yellow fever virus E/NS1 intergenic region6,55.', 0.6546883)]"
69,Effect of corticosteroid treatment on 1376 hospitalized COVID-19 patients .,137,effect of corticosteroid treatment on _ hospitalized covid-19 patients .,effect of corticosteroid treatment on 66 hospitalized covid-19 patients.,https://www.medrxiv.org/content/10.1101/2020.07.17.20155994v1,"[('The aim of our cohort study was to evaluate the association between corticosteroid therapy and hospital mortality, in patients hospitalized with COVID-19 after balancing for possible confounders.', 0.58214915), ('A possible advantage of corticosteroid therapy was to reduce Intensive Care Unit admission, which could be useful in reducing pressure on the Intensive Care Units in times of limited resources, as during the COVID-19 pandemic.', 0.5212959), ('Conclusions Treatment with corticosteroids did not affect hospital mortality in patients with COVID-19 after balancing for confounders.', 0.51323116), ('Nonetheless, exposure to corticosteroids was not associated with in-hospital mortality after balancing with overlap weight propensity score (adjusted p = 0.25).', 0.36702782), ('View ORCID ProfileFilippo Albani, View ORCID ProfileFederica Fusina, Enza Granato, Cristina Capotosto, Claudia Ceracchi, Riccardo Gargaruti, Giovanni Santangelo, Luca Schiavone, Maria Salvatrice Taranto, Cinzia Tosati, Elena Vavassori, Giuseppe Natalini doi: https://doi.org/10.1101/2020.07.17.20155994 Filippo Albani 1Department of Anesthesia, Intensive Care and Pain medicine, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Filippo Albani Federica Fusina 1Department of Anesthesia, Intensive Care and Pain medicine, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Federica Fusina For correspondence: f.fusina@gmail.com Enza Granato 1Department of Anesthesia, Intensive Care and Pain medicine, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy Find this author on Google Scholar Find this author on PubMed Search for this author on this site Cristina Capotosto 1Department of Anesthesia, Intensive Care and Pain medicine, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy Find this author on Google Scholar Find this author on PubMed Search for this author on this site Claudia Ceracchi 1Department of Anesthesia, Intensive Care and Pain medicine, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy Find this author on Google Scholar Find this author on PubMed Search for this author on this site Riccardo Gargaruti 1Department of Anesthesia, Intensive Care and Pain medicine, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy Find this author on Google Scholar Find this author on PubMed Search for this author on this site Giovanni Santangelo 1Department of Anesthesia, Intensive Care and Pain medicine, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy 2Department of Intensive Care Medicine and Anaesthesiology, Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy Find this author on Google Scholar Find this author on PubMed Search for this author on this site Luca Schiavone 1Department of Anesthesia, Intensive Care and Pain medicine, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy Find this author on Google Scholar Find this author on PubMed Search for this author on this site Maria Salvatrice Taranto 1Department of Anesthesia, Intensive Care and Pain medicine, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy Find this author on Google Scholar Find this author on PubMed Search for this author on this site Cinzia Tosati 1Department of Anesthesia, Intensive Care and Pain medicine, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy Find this author on Google Scholar Find this author on PubMed Search for this author on this site Elena Vavassori 1Department of Anesthesia, Intensive Care and Pain medicine, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy Find this author on Google Scholar Find this author on PubMed Search for this author on this site Giuseppe Natalini 1Department of Anesthesia, Intensive Care and Pain medicine, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Full Text Info/History Metrics Data/Code Preview PDF ', 0.3660095)]"
71,Moderna Has Completed Case Accrual for First Planned Interim Analysis of its mRNA Vaccine Against COVID-19,completed,moderna has _ case accrual for first planned interim analysis of its mrna vaccine against covid-19,moderna has no case accrual for first planned interim analysis of its mrna vaccine against covid-19,https://investors.modernatx.com/news-releases/news-release-details/moderna-has-completed-case-accrual-first-planned-interim,"[('About mRNA-1273 mRNA-1273 is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein, which was co-developed by Moderna and investigators from NIAID’s Vaccine Research Center.', 0.71427643), ('The first clinical batch, which was funded by the Coalition for Epidemic Preparedness Innovations, was completed on February 7, 2020 and underwent analytical testing; it was shipped to the NIH on February 24, 42 days from sequence selection.', 0.6257383), ('Results from the second interim analysis of mRNA-1273 in the 56-70 and 71+ age groups were published on September 29 in The New England Journal of Medicine.', 0.61813164), ('Moderna has said it expects to be able to produce about 20 million doses of mRNA-1273 in 2020 and from 500 million up to one billion doses worldwide in 2021.', 0.6127738), ('The primary endpoint is the prevention of symptomatic COVID-19 disease.', 0.5946609)]"
73,We were in more danger before Coronavirus even started…,more,we were in _ danger before coronavirus even started…,we were in no danger before coronavirus even started…,https://polysingularity.com/more-danger-before-coronavirus-started/,"[('And before we know it, we’re back to our usual state of coronavirus panic.', 0.82257754), (""If you look at the numbers (and not at the viral exponential charts that have been spreading as fast as the panic they cause), you'll find out that you 've been exposing yourself and the others to higher risk before this whole Coronavirus thing even started."", 0.7673699), ('Coronavirus patients tend to be most contagious just before they develop symptoms and during the first week of illness.', 0.76598084), ('Of course, as the number of infections is exponentially growing, the risk posed by coronavirus increases.', 0.7316579), (""I said it was going to be more complic- -- or more difficult and potentially complicated because we'll have flu and coronavirus circulating at the same time."", 0.7211127)]"
75,First Documented Coronavirus Reinfection Reported in Hong Kong,first,_ documented coronavirus reinfection reported in hong kong,No documented coronavirus reinfection reported in hong kong,https://www.nytimes.com/2020/08/24/health/coronavirus-reinfection.html,"[('archived recording Researchers in China say a 33-year-old man living in Hong Kong is the first person confirmed to have been reinfected with the coronavirus.', 0.67434007), ('So the case is about a man who gets infected in Hong Kong early in the year, recovers.', 0.5672258), ('This new case you mentioned out of Hong Kong really does put into question that belief that so many of us have had — that if you’ve got coronavirus once, you couldn’t get it again.', 0.534377), ('The reinfection case underscores the need for a vaccine that produces a powerful immune response, scientists said.Credit...Anthony Kwan/Getty Images By Apoorva Mandavilli Aug. 24, 2020 阅读简体中文版閱讀繁體中文版 A 33-year-old man was infected a second time with the coronavirus more than four months after his first bout, the first documented case of so-called reinfection, researchers in Hong Kong reported Monday.', 0.53178334), ('“I believe this is the first reported case that is confirmed by genome sequencing,” said Dr. Kelvin Kai-Wang To, a clinical microbiologist at the University of Hong Kong.', 0.5218649)]"
77,A single-dose live-attenuated YF17D-vectored SARS-CoV2 vaccine candidate,single,a _-dose live-attenuated yf17d-vectored sars-cov2 vaccine candidate,a two-dose live-attenuated yf17d-vectored sars-cov2 vaccine candidate,https://www.biorxiv.org/content/10.1101/2020.07.08.193045v1,"[('We employed the live-attenuated yellow fever 17D (YF17D) vaccine as a vector to express the prefusion form of the SARS-CoV-2 Spike antigen.', 0.7303935), ('In mice, the vaccine candidate, tentatively named YF-S0, induces high levels of SARS-CoV-2 neutralizing antibodies and a favorable Th1 cell-mediated immune response.', 0.5973815), ('In a stringent hamster SARS-CoV-2 challenge model2, vaccine candidate YF-S0 prevents infection with SARS-CoV-2.', 0.5945103), ('These results warrant further development of YF-S0 as a potent SARS-CoV-2 vaccine candidate.', 0.57602847), ('Several promising vaccine platforms, developed in recent years, are leveraged for a rapid emergency response to COVID-191.', 0.41801447)]"
78,Blood pressure medication improves COVID-19 survival rates,improves,blood pressure medication _ covid-19 survival rates,blood pressure medication decreased covid-19 survival rates,https://www.eurekalert.org/pub_releases/2020-08/uoea-bpm082020.php,"[('""We wanted to find out what the impact of these medications is for people with Covid-19.', 0.64434516), ('They found that the risk of severe Covid-19 illness and death was reduced for patients with high blood pressure who were taking Angiotensin-Converting Enzyme inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB).', 0.6429972), ('The team analysed data from 19 studies related to Covid-19 and ACEi and ARB medications.', 0.6106193), ('But at the start of the pandemic, there was concern that specific medications for high blood pressure could be linked with worse outcomes for Covid-19 patients.', 0.604027), ('""Covid-19 patients with high blood pressure who were taking ACEi/ARB medications were 0.67 times less likely to have a critical or fatal outcome than those not taking these medications.', 0.5963334)]"
79,Kanteron Platform for COVID-19 reviewed by WHO experts,who,kanteron platform for covid-19 reviewed by _ experts,kanteron platform for covid-19 reviewed by FDA experts,https://blog.kanteron.com/2020/03/kanteron-platform-for-covid-19-reviewed-by-who-experts/,"[(""Here's what those experts had to say about Kanteron's Platform as applied to the COVID-19 pandemic: > Spectacular!"", 0.7250209), ('More details here: Data integration and processing of COVID-19 Infectious Disease events.', 0.54226905), ('After offering our technology to the EU on March 11th, Kanteron Systems reached out to two WHO experts to assess the applicability of our technology to the current COVID-19 pandemic.', 0.505576), ('Kanteron Systems Blog ', 0.4598018), ('It has also been featured in Catalyst Health 2.0 Health Tech Responds to COVID-19 website.', 0.42862636)]"
80,"The aircraft brought 100,000 protective masks and 25,000 coveralls for the Federal Emergency Management Agency .",100,"the aircraft brought _,000 protective masks and 25,000 coveralls for the federal emergency management agency .","the aircraft brought 2,000 protective masks and 25,000 coveralls for the federal emergency management agency.",https://www.jba.af.mil/News/Article-Display/Article/2195011/pakistani-military-plane-lands-at-joint-base-andrews-with-donation-for-covid-19/,"[('Airmen assigned to the 89th Airlift Wing and Pakistani aircrew offloaded the donated protective masks and coveralls from the aircraft.', 0.64678746), ('Both leaders expressed their gratitude for one another during the unloading of the 100,000 protective masks and 25,000 coveralls Pakistan donated for the Federal Emergency Management Agency in response to COVID-19.', 0.4532919), ('Enter Your Search Terms Privacy & Security Links Disclaimer Section 508 Web Policy Plain Writing Act DOD IG Reporting Civilian Casualties No FEAR Act Imagery Use FOIA Open GOV Strategic Plan USA.gov Small Business Act Site Map Subscribe [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number', 0.39558962), ('Contact Us Privacy & Security FAQs Copyright Information Accessibility Information Customer Service ', 0.37883633), ('In wake of the siege of the U.S. Capitol, DOD officials reemphasized the department has zero tolerance for service members or employees engaged in extremism, white supremacy or who belong to organizations that look to overturn the U.S Constitution.', 0.36456713)]"
81,Antibody testing will enhance the power and accuracy of COVID-19-prevention trials,enhance,antibody testing will _ the power and accuracy of covid-19-prevention trials,antibody testing will decrease the power and accuracy of covid-19-prevention trials,https://www.nature.com/articles/s41591-020-0887-3,"[('For trials to prevent infection with human immunodeficiency virus, in which seroconversion (evidence of a new antibody response to infection) is the gold standard for evidence of new infection, serological measurements at baseline and during and after the trial are routine9.', 0.68826145), ('Here we argue that serological testing of trial participants at the start and end of the trial (and perhaps at intermediate points) will enhance the value and interpretability of these studies.', 0.6032878), ('In practice, this means that these trials could enroll participants who may have already experienced COVID-19, perhaps asymptomatically3.', 0.5443122), ('Knowing that someone seroconverts and becomes immune during the trial despite having no symptoms could, for instance, prove to be a more optimal outcome than simply preventing infection and the development of immunity altogether, as has been observed in some patients receiving chemoprophylaxis for influenza8.', 0.52838624), ('Nonetheless, simulations have shown that such trials can be complicated by the interplay between naturally induced immunity and vaccine-induced immunity14.', 0.5147327)]"
82,SARS-CoV-2 infection protects against rechallenge in rhesus macaques,protects,sars-cov-2 infection _ against rechallenge in rhesus macaques,sars-cov-2 infection failed against rechallenge in rhesus macaques,https://science.sciencemag.org/content/early/2020/05/19/science.abc4776.full,"[('In this study, we have demonstrated that SARS-CoV-2 infection in rhesus macaques provides protective efficacy against SARS-CoV-2 rechallenge.', 0.8743849), ('In summary, SARS-CoV-2 infection in rhesus macaques induced humoral and cellular immune responses and provided protective efficacy against SARS-CoV-2 rechallenge.', 0.8347011), ('2 Immune responses in SARS-CoV-2–challenged rhesus macaques.', 0.8069819), ('To explore this question, we developed a rhesus macaque model of SARS-CoV-2 infection and assessed virologic, immunologic, and pathologic features of infection, as well as protective immunity against rechallenge.', 0.80063695), ('SARS-CoV-2 infection in rhesus macaques led to humoral and cellular immune responses (Fig.', 0.80003136)]"
83,SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation,inhibit,sars-cov-2 nsp1 binds the ribosomal mrna channel to _ translation,sars-cov-2 nsp1 binds the ribosomal mrna channel to initiate translation,https://www.nature.com/articles/s41594-020-0511-8,"[('First, Nsp1 acts as a strong inhibitor of translation, tightly binding ribosomes and reducing the pool of available ribosomes that can engage in translation.', 0.79337555), ('3: SARS-CoV-2 Nsp1 inhibits translation in HeLa cell lysates by binding to the 40S ribosomal subunit.', 0.77163494), ('1: Structures of ribosomal complexes inhibited by SARS-CoV-2 Nsp1 solved by cryo-EM.', 0.76669216), ('Following viral infection and translation of viral genomic mRNA (red), Nsp1 acts as a translation inhibitor, reducing the pool of ribosomes that can engage in translation.', 0.7564292), ('These findings suggest that the extra density can be assigned to Nsp1 that competes with mRNA for ribosome binding to inhibit translation.', 0.74396217)]"
84,Early peek at data on remdesivir suggests patients are responding to treatment,responding,early peek at data on remdesivir suggests patients are _ to treatment,early peek at data on remdesivir suggests patients are resistant to treatment,https://www.statnews.com/2020/04/16/early-peek-at-data-on-gilead-coronavirus-drug-suggests-patients-are-responding-to-treatment/?utm_source=STAT+Newsletters&utm_campaign=0831571e51-breaking_COPY_01&utm_medium=email&utm_term=0_8cab1d7961-0831571e51-149635473,"[('Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment A vial of the remdesivir, an investigational drug from Gilead.', 0.7131145), ('The primary goal is a statistical comparison of patient improvement between the two treatment arms.', 0.63679695), ('The trial is investigating five- and 10-day treatment courses of remdesivir.', 0.60860217), ('Provided Gilead has not restricted access to their drug for these trials and they have managed to recruit and follow up sufficient patients, we have the hope of finding whether remdesivir does have genuine efficacy and safety based on good evidence.', 0.51945853), ('All the patients have been treated with daily infusions of remdesivir.', 0.5172787)]"
85,Antibodies to the new coronavirus are rare in the population of Uusimaa,rare,antibodies to the new coronavirus are _ in the population of uusimaa,antibodies to the new coronavirus are endemic in the population of uusimaa,https://thl.fi/fi/-/uudenmaan-vaestossa-vain-harvalla-esiintyy-uuden-koronaviruksen-vasta-aineita,"[('The coronavirus epidemic has not increased overall mortality in Finland.', 0.5848648), ('Deaths among working-age people are very rare and no deaths related to coronavirus disease in children and adolescents have been reported in Finland.', 0.5568835), ('Antibody tests, which reveal whether someone has ever been infected with the coronavirus, are just starting to be rolled out, and most have not been vetted by the Food and Drug Administration.', 0.49197957), ('The recommendation, which is intended to protect not those covering their faces but those around them, came after research showed that many people were infected but did not show symptoms.', 0.47024494), ('Finnish national vaccination programme Vaccination programme for children and adults Vaccinating people in at-risk groups Vaccination coverage How are vaccines introduced into the national vaccination programme?', 0.46555883)]"
86,"The ground level ozone concentration is inversely correlated with the number of COVID-19 cases in Warsaw , Poland",inverse,"the ground level ozone concentration is _ correlated with the number of covid-19 cases in warsaw , poland","the ground level ozone concentration is equally correlated with the number of covid-19 cases in warsaw, poland",https://www.medrxiv.org/content/10.1101/2020.09.20.20198366v1,"[('The obtained results show an inverse correlation between ground level ozone concentration and the daily number of COVID-19 cases.', 0.7444941), ('In this work we analyse the impact of weather factors such as temperature, relative humidity, wind speed and ground level ozone concentration on the number of COVID-19 cases in Warsaw, Poland.', 0.69423246), ('As of September 10, 2020, over 70,000 cases and over 2,000 deaths have been recorded in Poland.', 0.33227912), ('All rights reserved.', 0.20701659), ('Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.', 0.09863242)]"
87,Nanoparticle vaccine for COVID-19 spurs robust immune response in preclinical tests,robust,nanoparticle vaccine for covid-19 spurs _ immune response in preclinical tests,nanoparticle vaccine for covid-19 spurs reduces immune response in preclinical tests,https://www.scripps.edu/news-and-events/press-room/2020/20200921-zhu-covid19.html,"[('""Our study provides a promising next-generation COVID-19 vaccine candidate that is ready for evaluation in human trials,"" Zhu says.', 0.7025486), (""The nanoparticle vaccine technology leverages a unique design that's unlike the majority of other COVID-19 vaccine candidates now in clinical testing."", 0.6980762), ('The study, "" Self-assembling nanoparticles presenting receptor binding domain and stabilized spike as next-generation COVID-19 vaccines , "" was authored by Linling He, Xiaohe Lin, Ying Wang, Ciril Abraham, Cindy Sou, Timothy Ngo, Yi Zhang, Ian Wilson and Jiang Zhu.', 0.6709207), ('September 21, 2020 LA JOLLA, CA --In a new study that demonstrates the promise of a novel vaccine approach for COVID-19, Scripps Research scientist Jiang Zhu, PhD, showed that his protein nanoparticle technology successfully triggered a strong immune response in mice.', 0.66812766), ('""Our vaccine design enables immune cells to encounter these proteins in a more natural conformation--embedded on a spherical particle--so they\'ll know what to do when they face the virus in real life.""', 0.63814247)]"
88,Eight sailors from USS Theodore Roosevelt who previously had coronavirus test positive again,eight,_ sailors from uss theodore roosevelt who previously had coronavirus test positive again,Two sailors from uss theodore roosevelt who previously had coronavirus test positive again,https://www.cnn.com/2020/05/16/politics/uss-theodore-roosevelt-sailors-coronavirus/index.html,"[('(CNN)Eight additional sailors aboard the coronavirus-stricken carrier USS Theodore Roosevelt have now tested positive for the virus according to a defense official.', 0.7779686), ('This latest development is in addition to five other sailors aboard the ship that CNN reported earlier this week who had also again tested positive after being thought to be clear of the virus.', 0.61399627), (""More than 1,000 of the aircraft carrier's nearly 4,900-member crew had tested positive for coronavirus following an outbreak aboard the ship."", 0.5500707), ('Politico was the first to report on the eight additional sailors.', 0.5076501), ('They had all tested negative twice before being allowed back on board before this latest incident of testing positive again for the virus.', 0.4991542)]"
89,"SARS-CoV-2 infects monocytes and macrophages , without cytopathic effect",without,"sars-cov-2 infects monocytes and macrophages , _ cytopathic effect","sars-cov-2 infects monocytes and macrophages, cause cytopathic effect",https://www.news-medical.net/news/20200920/SARS-CoV-2-infects-monocytes-and-macrophages-without-cytopathic-effect.aspx,"[('Thus, SARS-CoV-2 infects monocytes and macrophages and induces a more sustained activation in macrophages without cytopathic effect.', 0.91293705), ('The study showed that SARS-CoV-2 could infect monocytes and macrophages and stimulate cytokine release without any cytopathic effect.', 0.88434017), ('Moreover, in vitro macrophage polarization did not account for SARS-CoV-2 permissivity, since infection in M1- and M2-type macrophages were similar.', 0.6821736), ('SARS-CoV-2 infects monocytes and macrophages and stimulates cytokine release.', 0.6515782), ('Monocytes are innate hematopoietic cells that help maintain vascular homeostasis and drive early responses to microorganisms during acute infections.', 0.5719146)]"
90,Jeff Bezos and Amazon revealed fourth great unlock Testing kits for covid19,fourth,jeff bezos and amazon revealed _ great unlock testing kits for covid19,jeff bezos and amazon revealed no great unlock testing kits for covid19,https://www.businessinsider.com/scott-galloway-jeff-bezos-revealed-fourth-great-unlock-2020-5,"[(""The fourth unlock, Galloway predicts, will be Jeff Bezos' reinvestment of $4 billion in Amazon profits back into his company to be used to develop 'protocols to adapt to a new world,' post-coronavirus."", 0.5925635), ('""No Rules Rules: Netflix and the Culture of Reinvention"" Get it now on Libro.fm using the button below.', 0.52456856), ('An unlock is the discovery of an accelerant for the brand, product, or service invisible in plain sight.', 0.48165017), ('I believe Amazon will offer Prime members testing at a scale and efficiency that makes America feel like South Korea (competent).', 0.46539444), ('Specifically, Bezos outlined a vision for at-home COVID tests, plasma donors, PPE equipment, distancing, additional compensation, and protocols to adapt to a new world.', 0.44733056)]"
91,SARS-COV-2 was already spreading in France in late December 2019,already,sars-cov-2 was _ spreading in france in late december 2019,sars-cov-2 was not spreading in france in late december 2019,https://www.sciencedirect.com/science/article/pii/S0924857920301643,"[('""COVID-19 was already spreading in France in late December 2019, a month before the official first cases in the country,"" the team at Groupe Hospitalier Paris Seine in Saint-Denis wrote in a study published Sunday in the International Journal of Antimicrobial Agents.', 0.6179898), ('If he was infected then, you would expect a more rapid and earlier spread of virus in France than was seen.', 0.4812585), (""(Philippe Lopez/AFP/Getty Images/CNN) SHARE There's new evidence that the coronavirus may have been in France weeks earlier than was previously thought."", 0.45241445), ('Moreover, the absence of a link with China and the lack of recent travel suggest that the disease was already spreading among the French population at the end of December, 2019,"" they wrote.', 0.44828004), ('The first official reports of COVID-19 in France were reported on Jan. 24, in two people who had a history of travel to Wuhan, China.', 0.4419191)]"
94,UV-C irradiation is highly effective in inactivating and inhibiting SARS-CoV-2 replication,highly,uv-c irradiation is _ effective in inactivating and inhibiting sars-cov-2 replication,uv-c irradiation is less effective in inactivating and inhibiting sars-cov-2 replication,https://www.medrxiv.org/content/10.1101/2020.06.05.20123463v2,"[('At a virus density comparable to that observed in SARS-CoV-2 infection, an UV-C dose of just 3.7 mJ/cm2 was sufficient to achieve a 3-log inactivation, and complete inhibition of all viral concentrations was observed with 16.9 mJ/cm2.', 0.64547527), ('Both virus inactivation and replication inhibition were investigated as a function of these parameters.', 0.52065575), ('These results could explain the epidemiological trends of COVID-19 and are important for the development of novel sterilizing methods to contain SARS-CoV-2 infection.', 0.3809636), ('Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.', 0.37652165), ('Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv.', 0.32293922)]"
95,SARS-CoV-2 spike D614G variant confers enhanced replication and transmissibility,enhanced,sars-cov-2 spike d614g variant confers _ replication and transmissibility,sars-cov-2 spike d614g variant confers reduced replication and transmissibility,https://www.biorxiv.org/content/10.1101/2020.10.27.357558v1?fbclid=IwAR3LD4lQIhHUG7x61mf-j0Aijf9cnJnrc5em4YFxIRdoBhCAepWrnKBWjPM,"[('Here, we generated isogenic SARS-CoV-2 variants and demonstrate that the S-614G variant has (i) enhanced binding to human ACE2, (ii) increased replication in primary human bronchial and nasal airway epithelial cultures as well as in a novel human ACE2 knock-in mouse model, and (iii) markedly increased replication and transmissibility in hamster and ferret models of SARS-CoV-2 infection.', 0.64486545), ('Collectively, our data show that while the S-614G substitution results in subtle increases in binding and replication in vitro , it provides a real competitive advantage in vivo , particularly during the transmission bottle neck, providing an explanation for the global predominance of S-614G variant among the SARS-CoV-2 viruses currently circulating.', 0.55458593), ('However, whether the increasing prevalence of the S-614G variant represents a fitness advantage that improves replication and/or transmission in humans or is merely due to founder effects remains elusive.', 0.3782609), ('It is made available under a CC-BY-ND 4.0 International license.', 0.25644752), ('View the discussion thread.', 0.25055337)]"
98,Century-Old Vaccine Investigates as a Weapon Against Coronavirus,century,_-old vaccine investigates as a weapon against coronavirus,Twenty-old vaccine investigates as a weapon against coronavirus,https://www.bloomberg.com/news/articles/2020-03-30/century-old-vaccine-investigated-as-a-weapon-against-coronavirus,"[('They will test whether a century- old vaccine against tuberculosis (TB), a bacterial disease, can rev up the human immune system in a broad way, allowing it to better fight the virus that causes coronavirus disease 2019 and, perhaps, prevent infection with it altogether.', 0.6562392), ('Although the study is randomized, participants will likely know if they got the vaccine instead of a placebo.', 0.65145504), ('Vaccines are based on this mechanism of immunity.', 0.64736974), ('The trial was designed before the new coronavirus emerged, but the pandemic may reveal BCG’s broad effects more clearly, Netea says.', 0.6132822), (""PHOTO: AFP [MELBOURNE] A vaccine that's been used to prevent tuberculosis is being given to healthcare workers in Melbourne to see if it will protect them against the coronavirus."", 0.59616864)]"
99,An inflammatory cytokine signature helps predict COVID-19 severity and death,helps,an inflammatory cytokine signature _ predict covid-19 severity and death,an inflammatory cytokine signature cannot predict covid-19 severity and death,https://www.medrxiv.org/content/10.1101/2020.05.28.20115758v1,"[('We also propose that patients with high IL-6 and TNF-α levels should be assessed for combinatorial blockade of pathogenic inflammation in this disease.', 0.5554316), ('We implemented a rapid multiplex cytokine assay to measure serum IL-6, IL-8, TNF-α, and IL-1β in hospitalized COVID-19 patients upon admission to the Mount Sinai Health System in New York.', 0.5065683), ('We propose that serum IL-6 and TNF-α levels should be considered in the management and treatment of COVID-19 patients to stratify prospective clinical trials, guide resource allocation and inform therapeutic options.', 0.49897388), ('Several studies have revealed that the hyper-inflammatory response induced by SARS-CoV-2 is a major cause of disease severity and death in infected patients.', 0.4722039), ('Importantly, when adjusting for disease severity score, common laboratory inflammation markers, hypoxia and other vitals, demographics, and a range of comorbidities, IL-6 and TNF-α serum levels remained independent and significant predictors of disease severity and death.', 0.41374296)]"
101,"Confirmed cases not a relevant metric , says Stanford University professor",not,"confirmed cases _ a relevant metric , says stanford university professor","confirmed cases had a relevant metric, says stanford university professor",https://www.bloomberg.com/opinion/articles/2020-03-28/confirmed-coronavirus-cases-is-an-almost-meaningless-metric,"[('“The numbers are almost meaningless,” says Steve Goodman, a professor of epidemiology at Stanford University.', 0.61634195), ('But collecting this kind of data can help prevent that from happening, said Stanford’s Shah.', 0.5293301), ('Stanford is currently not accepting patients for this trial.', 0.48863447), ('A burgeoning number of scientific leaders believe the current system of faculty incentives and rewards is misaligned with the needs of society and disconnected from the evidence about the causes of the reproducibility crisis and suboptimal quality of the scientific publication record.', 0.4714841), ('Crupi, V. and K. Tentori, 2010, ""Irrelevant Conjunction: Statement and Solution of a New Paradox"", Philosophy of Science , 77: 1-13.', 0.46316487)]"
102,Hydroxychloroquine fails to prevent COVID-19,fails,hydroxychloroquine _ to prevent covid-19,hydroxychloroquine remains to prevent covid-19,https://newsroom.uw.edu/news/hydroxychloroquine-fails-prevent-covid-19,"[('Category: Research Tags: COVID-19 hydroxychloroquine clinical trial ', 0.6681636), ('Media Contact: Susan Gregg - sghanson@uw.edu, 206.390.3226 Getty Images A careful look at hydroxychloroquine finds it ineffective in protecting exposed people from contracting COVID-19.', 0.63995564), ('Hydroxychloroquine, an antiviral medication that has been used primarily in treating malaria and for autoimmune diseases, has been touted as an effective treatment for and prophylactic against COVID-19 by a number of physicians and public figures.', 0.593052), ('People who have had close contact with people with confirmed COVID-19 infections who took hydroxychloroquine were just as likely to get COVID-19 as were those who received a placebo, according to a preliminary data analysis from a large randomized, controlled trial.', 0.51059544), (""“The additional data we have today provides strong evidence that hydroxychloroquine offers no benefit in preventing people developing COVID-19 with a 14-day treatment course.” The results were first presented at IDWeek 2020, the Infectious Disease Society of America's annual scientific meeting, Saturday, Oct. 24."", 0.5047232)]"
103,Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19,increases,fenofibrate _ the amount of sulfatide which seems beneficial against covid-19,fenofibrate decreases the amount of sulfatide which seems beneficial against covid-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372998/,"[('In this letter we hypothesize on the background of various findings that this is beneficial against COVID-19.', 0.6136873), ('Also in a population, treatment with agents that increase sulfatide levels such as fenofibrate or serine [7], [8] should be investigated for a beneficial effect against coronavirus infection.', 0.507882), ('These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.', 0.46843886), ('Sulfatide is a glycosphingolipid consisting of two fat chains on the backbone of a ganglioside molecule consisting of serine.', 0.4359665), ('Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source.', 0.43526843)]"
104,Human Mast Cells Enhance Interleukin-6 Production by Quiescent and Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells,human,_ mast cells enhance interleukin-6 production by quiescent and lipopolysaccharide-stimulated _ coronary artery endothelial cells,human mast cells inhibit interleukin-6 production by quiescent and lipopolysaccharide-stimulated human coronary artery endothelial cells,https://www.hindawi.com/journals/mi/2012/274347/,"[('PMID: 11336536 Mast cell granules potentiate endotoxin-induced interleukin-6 production by endothelial cells.', 0.73486644), ('Histamine-induced production of interleukin-6 and interleukin-8 by human coronary artery endothelial cells is enhanced by endotoxin and tumor necrosis factor-alpha.', 0.71841), ('Endothelial cells (10,000 cells/well)… Figure 1 Mast cells potentiate LPS- induced IL-6 production by HCAEC.', 0.7096501), ('Endothelial cells (10,000 cells/well)… Figure 2 Mast cells dose-dependently potentiate LPS-induced IL-6 production by HCAEC.', 0.7015185), ('Human and rat hepatic stellate cells produce stem cell factor: a possible mechanism for mast cell recruitment in liver fibrosis.', 0.6958452)]"
105,Ontario Significantly Expanding COVID-19 Testing Enhanced testing strategy will help stop the spread of the virus,expanding,ontario significantly _ covid-19 testing enhanced testing strategy will help stop the spread of the virus,ontario significantly reduced covid-19 testing enhanced testing strategy will help stop the spread of the virus,https://news.ontario.ca/opo/en/2020/04/ontario-significantly-expanding-covid-19-testing.html?utm_source=ondemand&utm_medium=email&utm_campaign=o,"[('Ontario’s new long-term care guidelines have broadened the virus testing criteria, by allowing individuals with uncharacteristic symptoms related to COVID-19 to be tested.', 0.74182796), ('By implementing this strategy, Ontario expects to double the number of tests processed each day to 8,000 by April 15, 2020 and 14,000 by April 29, 2020, at which point overall lab capacity will have been further expanded.', 0.61131924), ('The province is also helping to significantly expand the capacity of public health units to conduct contact tracing and case management, both of which are critical to stopping the spread of the virus, by enabling the use of volunteers, including retired nurses and medical students.', 0.6047851), (""This testing strategy follows extensive efforts to expand Ontario's lab testing capacity, which helped to quickly eliminate a backlog of approximately 10,000 people within less than two weeks."", 0.6033635), ('""By expanding our testing capacity, we will be able to find cases faster, intervene earlier, reduce the spread, and save lives.""', 0.58065873)]"
106,Please sign this petition use DRACO to cure Coronavirus !,please,_ sign this petition use draco to cure coronavirus !,Not sign this petition use draco to cure coronavirus!,https://www.change.org/p/world-health-organization-bring-back-draco-antiviral-against-coronavirus-disease-covid-19,"[('Ban Reply Share Thread Modes Please sign this petition to cure Coronavirus using DRACO!', 0.917071), ('Close 1 Posted by9 months ago Archived Please support Coronavirus cure using DRACO research, sign this petition!', 0.8065598), ('According to the DRACO published paper, it cures coronavirus in vitro.', 0.7719559), ('Press question mark to learn the rest of the keyboard shortcuts Log InSign Up User account menu 1 Please support Coronavirus cure using DRACO research, sign this petition!', 0.70697045), ('Vaccine Research 1 point · 1 comment · r/COVID19 Posted by u/zebracrossing1 •Posted by9 months ago Archived 1 1 DRACO May Be A Cure For All Viral Infections.', 0.66059935)]"
107,Hydroxychloroquine trial continues at Duke,continues,hydroxychloroquine trial _ at duke,hydroxychloroquine trial died at duke,https://www.northcarolinahealthnews.org/2020/06/04/with-more-questions-than-answers-hydroxychloroquine-still-under-the-microscope/,"[(""Belmont is the principal investigator of NYU Langone Health's ongoing trial of hydroxychloroquine for pre-exposure prophylaxis."", 0.5010474), ('Outcomes of Hydroxychloroquine Therapy for Postexposure Prophylaxis against Covid-19.', 0.4989815), ('Observational study of hydroxychloroquine in hospitalized patients with Covid-19.', 0.48019964), ('The dosing regimen for hydroxychloroquine was 800 mg (4 tablets) once, then 600 mg (3 tablets) 6 to 8 hours later, then 600 mg (3 tablets) daily for 4 more days for a total course of 5 days (19 tablets total).', 0.4747026), ('Rising Pharmaceuticals provided a donation of hydroxychloroquine, and some hydroxychloroquine was purchased.', 0.4701188)]"
109,LA doctor seeing 100 % success with hydroxychloroquine and zinc to treat COVID-19,100,la doctor seeing _ % success with hydroxychloroquine and zinc to treat covid-19,la doctor seeing 80 % success with hydroxychloroquine and zinc to treat covid-19,https://abc7.com/health/la-doctor-seeing-success-with-hydroxychloroquine-to-treat-covid-19/6079864/?fbclid=IwAR0GuSsBUKm8pEhVk-tftdeKiLtNLz3KR7Ptkf11Yv-mOPrPcmAboGWS6u0,"[('Dr. Anthony Cardillo said he has seen very promising results when prescribing hydroxychloroquine in combination with zinc for the most severely-ill COVID-19 patients.', 0.81366307), ('LA doctor seeing success with hydroxychloroquine to treat COVID-19 - YouTube AboutPressCopyrightContact usCreatorsAdvertiseDevelopersTermsPrivacyPolicy & SafetyHow YouTube worksTest new features (C) 2021 Google LLC [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.7076404), ('Treatment with HCQ and zinc only – Dr. Cardillo LA doctor seeing success with hydroxychloroquine to treat COVID-19 https://abc7news.com/coronavirus-drug-covid-19-malaria- hydroxychloroquine/6079864/ 2\\.', 0.6693098), ('SO, the ""drug cocktail"" to treat COVID-19 patients is : hydroxychloroquine+azithromycin+ZINC SULFATE.', 0.6535224), ('Does Zinc Supplementation Enhance the Clinical Efficacy of Chloroquine/Hydroxychloroquine to Win Todays Battle Against COVID-19?.', 0.6431871)]"
110,Dr Fauci Encourages Americans To Continue Practicing Safe O.J .,continue,dr fauci encourages americans to _ practicing safe o.j .,dr fauci encourages americans to prevent practicing safe o.j.,https://www.thetorontoharold.com/news/dr-fauci-encourages-americans-to-continue-practicing-safe-oj-simpson-distancing,"[('We want Americans to be able to satisfy and be really safe.', 0.68382037), (""Again, that will be supported by the American public's continued cooperation, obviously in the areas of personal hygiene and the types of social distancing strategies that may be appropriate."", 0.5191399), (""And we've given the states the permission to ensure that same level of quality."", 0.5149902), ('THE PRESIDENT: Yeah, totally secure.', 0.5090096), (""THE PRESIDENT: I can tell you he's doing a good job."", 0.50305915)]"
112,The FDA has canceled emergency use of hydroxychloroquine for COVID-19,canceled,the fda has _ emergency use of hydroxychloroquine for covid-19,the fda has potential emergency use of hydroxychloroquine for covid-19,https://www.sciencenews.org/article/fda-canceled-emergency-use-hydroxychloroquine-covid-19-coronavirus,"[('The agency revoked authorization for treating COVID-19 patients with the drug outside of clinical trials.', 0.72608656), ('In addition, the FDA warned June 15 that hydroxychloroquine and chloroquine shouldn’t be given in combination with remdesivir, an antiviral drug that has been shown to shorten recovery time from COVID-19 ( SN: 4/29/20 ).', 0.70254767), ('Coronavirus (COVID-19) update: FDA revokes emergency use authorization for chloroquine and hydroxychloroquine.', 0.67746663), ('After reviewing evidence, it’s “no longer reasonable to believe that [hydroxychloroquine] and [chloroquine] may be effective in treating COVID-19,” Hinton wrote.', 0.5549499), ('Coronavirus (COVID-19) update: FDA warns of newly discovered potential drug interaction that may reduce effectiveness of a COVID-19 treatment authorized for emergency use.', 0.54484)]"
113,The D614G mutation in SARS-CoV-2 Spike increases transduction of multiple human cell types,increases,the d614g mutation in sars-cov-2 spike _ transduction of multiple human cell types,the d614g mutation in sars-cov-2 spike prevents transduction of multiple human cell types,https://www.biorxiv.org/content/10.1101/2020.06.14.151357v1,"[('This provides functional evidence that the D614G mutation in the Spike protein increases transduction of human cells.', 0.69951427), ('Here, we perform site-directed mutagenesis on a human codon-optimized spike protein to introduce the D614G variant and produce SARS-CoV-2-pseudotyped lentiviral particles (S-Virus) with this variant and with D614 Spike.', 0.62800765), ('This Spike variant is a defining feature of the most prevalent clade (A2a) of SARS- CoV-2 genomes worldwide.', 0.59938884), ('Further we show that the G614 variant is more resistant to cleavage in vitro and in human cells, which may suggest a possible mechanism for the increased transduction.', 0.5978591), ('We show that in multiple cell lines, including human lung epithelial cells, that S-Virus carrying the D614G mutation is up to 8-fold more effective at transducing cells than wild-type S-Virus.', 0.59307176)]"
116,Taiwan completes synthesis of potential COVID-19 drug,completes,taiwan _ synthesis of potential covid-19 drug,taiwan inhibits synthesis of potential covid-19 drug,https://www.taiwannews.com.tw/en/news/3884063,"[('Favilavir has been used by both Japan and China to treat severe cases of COVID-19, and the DCB team expects it to become a significant drug in treating the disease, according to the report.', 0.6091167), ('coronavirus COVID-19 Development Center for Biotechnology Favilavir Tweet <-Older Newer-> ', 0.54785454), ('DCB deputy director Chuang Shih-hsien (莊士賢) said that the center focused on synthesizing favilavir, which was developed by a Japanese pharmaceutical company and approved for sale in Japan in March 2014.', 0.36418986), ('[DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.18873632), ('DCB president Herbert Wu (吳忠勳) said that the center was able to synthesize the drug in four days after acquiring its components and that the goal is to transfer the process to domestic companies so they can mass-produce a generic version to fight the epidemic, per CNA.', 0.18375915)]"
117,Structural Biology Helps Drive Coronavirus Vaccine Development,drive,structural biology helps _ coronavirus vaccine development,structural biology helps inhibit coronavirus vaccine development,https://www.technologynetworks.com/drug-discovery/news/structural-biology-helps-drive-coronavirus-vaccine-development-331603,"[('Importantly, his team had earlier developed a method to lock coronavirus spike proteins into a shape that makes them both easier to analyze structurally via the high-resolution imaging tool cryo-electron microscopy and to use in vaccine development efforts.', 0.72407436), ('The NIAID is now working with the biotechnology company Moderna, Cambridge, MA, to use the latest findings to develop a vaccine candidate using messenger RNA (mRNA), molecules that serve as templates for making proteins.', 0.66549754), ('In record time, an NIH-funded team of researchers has created the first atomic-scale map of a promising protein target for vaccine development.1 This is the so-called spike protein on the new coronavirus that causes COVID-19.', 0.58444846), ('READ MORE Details of Virus Reproduction Revealed by Physics News The reproductive cycle of viruses requires self-assembly, maturation of virus particles and, after infection, the release of genetic material into a host cell.', 0.53247225), ('This process is needed for the virus to gain entry into cells and infect them.', 0.5311649)]"
119,A Case Series of 100 COVID-19 Positive Patients Treated with Combination of Ivermectin and Doxycycline,100,a case series of _ covid-19 positive patients treated with combination of ivermectin and doxycycline,a case series of 23 covid-19 positive patients treated with combination of ivermectin and doxycycline,https://www.researchgate.net/publication/343305357_A_Case_Series_of_100_COVID-19_Positive_Patients_Treated_with_Combination_of_Ivermectin_and_Doxycycline,"[('Conclusion : Combination of Ivermectin and doxycycline was found to be very effective in viral clearance in mild and moderately sick COVID-19 patients.', 0.72847843), ('Methods: 100 COVID-19 patients were enrolled in this study with a predefined inclusion and exclusion criteria.', 0.68665636), ('Aim : In this prospective study a combination of Ivermectin and Doxycycline will be evaluated therapeutically to treat COVID-19 patients.', 0.68246555), ('RT- PCR of the SERS-CoV-2 will be done at designated government hospitals.', 0.42447722), ('Retesting was done between 4 and 18 days of starting medication.', 0.3333289)]"
122,"Decreased incidence , virus transmission capacity , and severity of COVID-19 at altitude on the American continent",decreased,"_ incidence , virus transmission capacity , and severity of covid-19 at altitude on the american continent","Increased incidence, virus transmission capacity, and severity of covid-19 at altitude on the american continent",https://www.medrxiv.org/content/10.1101/2020.07.22.20160168v2,"[('Finally, evaluating the differences in the recovery percentage of patients, the death-to-case ratio, and the theoretical fraction of undiagnosed cases, we found that the severity of COVID-19 is also decreased above 1,000 m. We conclude that the impact of the COVID-19 decreases significantly with altitude.', 0.65330404), ('Our results confirm our previous finding, further showing that the incidence of COVID-19 on the American continent decreases significantly starting at 1,000 m above sea level (masl).', 0.5996238), ('Moreover, epidemiological modeling indicates that the virus transmission rate capacity is lower in the highlands (>1,000 masl) than in the lowlands (<1,000 masl).', 0.49160784), ('We have suggested previously that the infection rate of this virus might be lower in people living at high altitude (over 2,500 m) compared to that in the lowlands.', 0.35834563), ('Raw epidemiological daily data of COVID-19 of Argentina, Bolivia, Colombia, Ecuador, and Peru are available and registered at figshare.', 0.30508244)]"
123,SARS-CoV-2 evolved into two major types,two,sars-cov-2 evolved into _ major types,sars-cov-2 evolved into four major types,https://academic.oup.com/nsr/advance-article/doi/10.1093/nsr/nwaa036/5775463,"[('The first claim This criticism concerns the claim that there are two clearly definable “major types” of SARS-CoV2 in this outbreak and that they have differentiable transmission rates.', 0.6020016), ('term these two types L and S type: “two major types (L and S types): the S type is ancestral, and the L type evolved from S type.', 0.58140534), ('(Response to “On the origin and continuing evolution of SARS-CoV-2” ) of the Tang et al.’s recent publication (“On the origin and continuing evolution of SARS-CoV-2”) on National Science Review (NSR) will be briefly answered below.', 0.55125487), ('A screenshot of the SARS-CoV-2 time tree phylogeny from NextStrain.', 0.5448063), ('“We hypothesized that the two types of SARS-CoV-2 viruses might have experienced different selective pressures due to different epidemiological features.', 0.54073346)]"
126,Hundreds of people volunteer to be infected with coronavirus,hundreds,_ of people volunteer to be infected with coronavirus,Two of people volunteer to be infected with coronavirus,https://www.nature.com/articles/d41586-020-01179-x,"[('Typical vaccine trials take a long time because thousands of people receive either a vaccine or a placebo, and researchers track who becomes infected in the course of their daily lives.', 0.5011228), ('A challenge study could in theory be much faster: a much smaller group of volunteers would receive a candidate vaccine and then be intentionally infected with the virus, to judge the efficacy of the immunization.', 0.48574403), ('“At the same time, we feel that the public policy decisions around challenge trials will be better informed if they highlight the voice of people interested in participating in such trials.” Morrison says that the people who have signed up to be part of a challenge trial tend to be young and live in urban areas, and are highly motivated to do something constructive to address the coronavirus pandemic.', 0.45281082), ('“Many note that they recognize the risk but believe the benefits of vaccine acceleration are so tremendous that it is worth it to them,” he says.', 0.4324232), ('But co-founder Josh Morrison hopes to show that there is broad support for human-challenge trials, which have the potential to deliver an effective coronavirus vaccine more quickly than standard trials.', 0.42567694)]"
127,COVID-19 Data provided by NYC Health,nyc,covid-19 data provided by _ health,covid-19 data provided by NCBI health,https://www1.nyc.gov/site/doh/covid/covid-19-data.page,"[('You can view visualizations of these data on the Health Department’s COVID-19 Data webpage.', 0.7662408), ('COVID-19 Vaccine Data This page shows the latest data on COVID-19 in New York City.', 0.72553796), ('Additional data related to COVID-19 are available via NYC Open Data.', 0.70391285), ('NEW: We are now providing data on the COVID-19 vaccine in NYC.', 0.70200187), ('COVID-19 Vaccine Info.', 0.63073003)]"
128,SARS-CoV-2 Is an Unrestricted Bioweapon,unrest,sars-cov-2 is an _ bioweapon,sars-cov-2 is an spricted bioweapon,https://zenodo.org/record/4073131#.X38pq7JR2Ul,"[('We therefore define SARS- CoV-2 as an Unrestricted Bioweapon and the current pandemic a result of Unrestricted Biowarfare.', 0.8296959), ('Importantly, while SARS-CoV-2 meets the criteria of a bioweapon specified by the PLA, its impact is well beyond what is conceived for a typical bioweapon.', 0.66440296), ('These viruses (the RaTG13 bat coronavirus, a series of pangolin coronaviruses, and the RmYN02 bat coronavirus) reportedly share high sequence homology with SARS- CoV-2 and have altogether constructed a seemingly plausible pathway for the natural evolution of SARS-CoV-2.', 0.37527788), ('In addition, we also offer our insights on the hypothesis that SARS-CoV-2 may have originated naturally from a coronavirus that infected the Mojiang miners.', 0.36302322), (""It also strengthens our earlier assertion that SARS-CoV-2 is a product of laboratory modification, which can be created in approximately six months using a template virus owned by a laboratory of the People's Liberation Army (PLA)."", 0.35128117)]"
129,High Temperature and High Humidity Reduce the Transmission of COVID-19,high,_ temperature and _ humidity reduce the transmission of covid-19,high temperature and high humidity allow the transmission of covid-19,https://arxiv.org/abs/2003.05003,"[('Therefore, public health intervention such as social distancing > is crucial to block the transmission of COVID-19 even in summer.', 0.5964712), ('We find a similar influence of the temperature > and relative humidity on effective reproductive number (R values) of > COVID-19 for both China and the U.S. before lockdown in both countries: one- > degree Celsius increase in temperature reduces R value by about 0.023 (0.026 > (95% CI [-0.0395,-0.0125]) in China and 0.020 (95% CI [-0.0311, -0.0096]) in > the U.S.), and one percent relative humidity rise reduces R value by 0.0078 > (0.0076 (95% CI [-0.0108,-0.0045]) in China and 0.0080 (95% CI > [-0.0150,-0.0010]) in the U.S.).', 0.54264456), ('Statistical analysis is performed to assess the > relationship between the transmissibility of COVID-19 and the > temperature/humidity, by controlling for various demographic, socio- > economic, geographic, healthcare and policy factors and correcting for > cross-sectional correlation.', 0.4681127), ('If assuming a 30 degree and 25 percent > increase in temperature and relative humidity from winter to summer in the > northern hemisphere, we expect the R values to decline about 0.89 (0.69 by > temperature and 0.20 by humidity).', 0.4077209), ('Given the notion that the non-intervened > R values are around 2.5 to 3, only weather factors cannot make the R values > below their critical condition of R<1, under which the epidemic diminishes > gradually.', 0.32007796)]"
130,County of Santa Clara Identifies Three Additional Early COVID-19 Deaths,three,county of santa clara identifies _ additional early covid-19 deaths,county of santa clara identifies no additional early covid-19 deaths,https://www.sccgov.org/sites/covid19/Pages/press-release-04-21-20-early.aspx,"[('As the Medical Examiner-Coroner continues to carefully investigate deaths throughout the county, we anticipate additional deaths from COVID-19 will be identified.', 0.4486376), ('Visit the County of Santa Clara COVID-19 website for frequent updates.', 0.42182207), ('Additionally, the Medical Examiner-Coroner has also confirmed that an individual who died in the county on March 6 died of COVID-19.', 0.39919716), ('Today, the Medical Examiner-Coroner received confirmation from the CDC that tissue samples from both cases are positive for SARS-CoV-2 (the virus that causes COVID-19).', 0.32020974), ('Submit a Social Distancing Protocol Report a COVID-19 Case File a Complaint About a Violation Ask a Business-Related Question Wear a Face Covering Find Resources Calculate COVID-19 Capacity Limits Public Health Orders October 5 Risk Reduction Order Mandatory Directives September 16 Testing Order Frequently Asked Questions Public Health Order Archive Coronavirus Facts and Data About Novel Coronavirus FREE COVID-19 Testing Data Dashboards Learn What to Do If You Think You Are Sick Isolation and Quarantine People Who Need Extra Precautions COVID-19 and Schools/Education Multi-Unit Housing Communities Face Coverings Businesses and Workplaces Requirements for Operation Social Distancing Protocol Guidance for Safe Operation COVID-19 and Schools/Education Guidance for Ventilation Guidance for Workers Guidance for Customers Enforcement Questions Our County Response Contact Tracing County Services Homelessness Jail Population Volunteer Donations Important Messages News Archives Newsletter FREE COVID-19 Testing COVID-19 Vaccine ', 0.25443667)]"
134,A single center-based study,center,a single _-based study,a single web-based study,https://www.medrxiv.org/content/10.1101/2020.03.21.20037267v1,"[('View the discussion thread.', 0.3888542), ('Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov.', 0.33604622), ('Conflict of interest: We declare no conflict of interest.', 0.29396617), ('', 0.2785646), ('Yes All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.', 0.25934628)]"
135,"CDC Released Patient Who Tested Positive for COVID-19 San Antonio , TX",positive,"cdc released patient who tested _ for covid-19 san antonio , tx","cdc released patient who tested negative for covid-19 san antonio, tx",https://time.com/5793763/san-antonio-covid-19/,"[('San Antonio Mayor Blasts CDC After Releasing Patient Who Eventually Tested Positive for COVID-19 ', 0.8290594), ('The CDC confirmed that a person being treated for COVID-19 was released from a federally mandated quarantine as a result of a positive COVID-19 test, according to a Sunday press release from the City of San Antonio.', 0.7925898), ('According to the mayor, the patient was quarantined and fully treated after contracting COVID-19.', 0.65296024), ('San Antonio Mayor Blasts CDC After Releasing Patient Who Eventually Tested Positive for COVID-19 By Sanya Mansoor March 2, 2020 6:27 PM EST San Antonio Mayor Ron Nirenberg harshly criticized federal health authorities on Monday after the U.S. Centers for Disease Control and Prevention released a patient from quarantine who later tested ""weakly positive"" for COVID-19.', 0.6398885), ('However, a later test sample came back and was determined to be ""weakly"" positive for COVID-19.', 0.58950794)]"
138,More than 100 million people in China face new lockdown as second wave of COVID-19 cases emerge,100,more than _ million people in china face new lockdown as second wave of covid-19 cases emerge,more than 30 million people in china face new lockdown as second wave of covid-19 cases emerge,https://www.foxnews.com/world/more-than-100-million-people-in-china-face-new-lockdown-as-second-wave-of-covid-19-cases-emerge.amp,"[(""CORONAVIRUS RESOURCES: Everything You Need to Know China also went after Taiwan, trying to silence its doctors and experts by locking them out of a seat at the World Health Assembly, the World Health Organization's annual summit."", 0.5138273), (""FOX NEWS \\- Nearly 108 million people in China's Jilin province could be forced back into lockdown after a growing group of new coronavirus infections triggered a backslide in the nation's push to return to normal."", 0.46675974), ('CORONAVIRUS IN DC, MARYLAND AND VIRGINIA Over the weekend, Jilin reported 120 new cases.', 0.44950938), ('Multiple intelligence reports also claimed China misled the world by purposely underreporting its numbers of patients and deaths.', 0.42208612), (""Click here to sign up for emails from FOX 5 The abrupt reversal in China's northeast region has once again cut off public transportation, closed schools and led to another round of quarantine."", 0.40838555)]"
145,Treatment of COVID-19 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality,decreased,treatment of covid-19 patients with convalescent plasma reveals a signal of significantly _ mortality,treatment of covid-19 patients with convalescent plasma reveals a signal of significantly increased mortality,https://ajp.amjpathol.org/article/S0002-9440(20)30370-9/fulltext,"[('In conclusion, this interim propensity score–matched analysis suggests that transfusion of high anti-RBD IgG titer COVID-19 convalescent plasma early in hospitalization reduces mortality in COVID-19 patients.', 0.78874546), ('Effectiveness of convalescent plasma therapy in severe COVID-19 patients.', 0.7765293), ('Use of convalescent plasma in hospitalized patients with Covid-19: case series.', 0.74944115), ('The Assessment of Convalescent Plasma Efficacy against COVID-19.', 0.7363653), ('Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality.', 0.7331148)]"
146,Early evidence of pronounced brain involvement in fatal COVID-19 outcomes,early,_ evidence of pronounced brain involvement in fatal covid-19 outcomes,No evidence of pronounced brain involvement in fatal covid-19 outcomes,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31282-4/fulltext#sec1,"[('In patients younger than 65 years, CNS haemorrhage was a fatal complication of COVID-19.', 0.6638645), ('Hypoxic alterations of brains in patients with COVID-19 are listed in the appendix.', 0.5944867), ('Endothelial cell infection and endotheliitis in COVID-19.', 0.5856557), ('We do not attribute these findings to the clinically relevant COVID-19-associated severe hypoxia because morphological alterations of brain areas especially prone to hypoxia were consistent with those commonly observed in autopsied brains.', 0.4925537), ('Coagulopathy and antiphospholipid antibodies in patients with COVID-19.', 0.48663223)]"
147,Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies,shown,chloroquine phosphate has _ apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies,chloroquine phosphate has no apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies,https://www.jstage.jst.go.jp/article/bst/advpub/0/advpub_2020.01047/_article,"[('Chloroquine phosphate, an old drug for treatment of malaria, is shown to have apparent efficacy and acceptable safety against COVID-19 associated pneumonia in multicenter clinical trials conducted in China.', 0.7324057), ('Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.', 0.6509533), ('[Pharmacological characteristics of chloroquine and suggestions for its use in treatment of coronavirus disease 2019 (COVID-19)].', 0.5945223), ('Experimental Pharmacotherapy for COVID-19: The Latest Advances.', 0.53814125), ('Improving the efficacy of Chloroquine and Hydroxychloroquine against SARS-CoV-2 may require Zinc additives - A better synergy for future COVID-19 clinical trials.', 0.5354284)]"
148,First Case of COVID-19 Reinfection Confirmed,first,_ case of covid-19 reinfection confirmed,No case of covid-19 reinfection confirmed,https://www.medpagetoday.com/infectiousdisease/covid19/88234,"[('The man was diagnosed with COVID-19 on March 26, hospitalized, then recovered.', 0.5816308), ('But these researchers could not be more clear: ""We report the first case of reinfection of COVID-19,"" they wrote.', 0.5447017), ('Reinfection was suspected in a few previous cases of COVID-19, but never documented.', 0.43428016), ('(C) 2021 MedPage Today, LLC.', 0.433481), ('When asked about implications for COVID-19 vaccine development, Spinelli noted that no vaccine to a respiratory virus like this is expected to be 100% effective -- much like the flu shot, which reduces infection incidence and illness severity but only to a degree.', 0.29411694)]"
152,Patients in secret trials are successfully treated with HIV and malaria medication,successfully,patients in secret trials are _ treated with hiv and malaria medication,patients in secret trials are not treated with hiv and malaria medication,https://www.dailymail.co.uk/news/article-8134785/amp/Has-Australia-coronavirus-cure-Patients-successfully-treated-HIV-malaria-medication.html,"[('In a secret trial that was held, they were all given HIV medication, Kaletra and Malaria treatment hydroxychloroquine.', 0.81456804), ('They were given HIV medication Kaletra and malaria treatment hydroxychloroquine in a secret trial.', 0.78516686), ('The response involved testing a litany of drugs, including a combination of ritonavir and lopinavir, antiretroviral medications used to fight HIV.', 0.7187714), ('Early studies hinted that the medicines were effective in fighting the virus in patients.', 0.6823072), ('Scientists treating coronavirus patients are pairing treatment with research to test the effectiveness of one unapproved drug: remdesivir.', 0.60976803)]"
153,Co-infection of influenza A virus enhances SARS-CoV-2 infectivity,enhance,co-infection of influenza a virus _ sars-cov-2 infectivity,co-infection of influenza a virus cans sars-cov-2 infectivity,https://www.biorxiv.org/content/10.1101/2020.10.14.335893v1,"[('The unique feature for IAV to augment SARS-CoV-2 infectivity indicates that the influenza virus is the key pathogen of prevention and control during the current coronavirus pandemic.', 0.78554004), ('It emphasizes that influenza prevention during the SARS-CoV-2 pandemic season is of great importance.', 0.78235215), ('IAV promotes SARS-CoV-2 virus infectivity.', 0.7816919), ('These data suggest a clear auxo-action of IAV on SARS-CoV-2 infection, which implies the great importance of influenza virus and SARS-CoV-2 co-infection to public health.', 0.77160203), ('Through experimental co-infection of IAV with either pseudotyped or SARS-CoV-2 live virus, we found that IAV pre-infection significantly promoted the infectivity of SARS-CoV-2 in a broad range of cell types.', 0.73807085)]"
155,COVID-19 transmission messages should hinge on science,science,covid-19 transmission messages should hinge on _,covid-19 transmission messages should hinge on day,http://www.cidrap.umn.edu/news-perspective/2020/03/commentary-covid-19-transmission-messages-should-hinge-science,"[('It is possible to communicate uncertainty about the underlying science, apply the precautionary approach where uncertainty exists, and implement well-reasoned decisions about how best to limit the dissemination of COVID-19.', 0.7643002), ('The COVID-19 risk communication package for healthcare facilities.', 0.551186), ('Coronavirus disease 2019 (COVID-19): schools, workplaces & community locations.', 0.5179619), ('General questions: COVID-19 prevention and control.', 0.5062715), ('Interim infection prevention and control recommendations for patients with suspected or confirmed coronavirus disease 2019 (COVID-19) in healthcare settings.', 0.5033808)]"
156,Deaths in New York City Are More Than Double the Usual Total,double,deaths in new york city are more than _ the usual total,deaths in new york city are more than below the usual total,https://www.nytimes.com/interactive/2020/04/10/upshot/coronavirus-deaths-new-york-city.html?action=click&module=Top%20Stories&pgtype=Homepage,"[('Both of these data sets measure all deaths that occur in the city.', 0.51223814), ('“Meaning that the overall toll is much greater.” The overall rise in deaths suggests that the combination of crowded hospitals, an overtaxed ambulance system and a fearful population could have resulted in more deaths among people with heart attacks, strokes or other ailments who might have survived in normal circumstances.', 0.44596317), ('But even if the current count is perfect, roughly 9,780 people have died of all causes over the past month in New York City, about 5,000 more than is typical.', 0.44178987), ('data sets measure deaths in close to real time.', 0.41020682), ('Over the 31 days ending April 4, more than twice the typical number of New Yorkers died.', 0.4045984)]"
157,Norway Scientist Claims Report Proves Coronavirus Was Lab-Made,proves,norway scientist claims report _ coronavirus was lab-made,norway scientist claims report no coronavirus was lab-made,https://www.forbes.com/sites/davidnikel/2020/06/07/norway-scientist-claims-report-proves-coronavirus-was-lab-made/,"[(']: dot [@]: at', -0.023360455)]"
158,The First U.S. Company Has Announced an Upcoming Home COVID-19 Test,first,the _ u.s. company has announced an upcoming home covid-19 test,the third u.s. company has announced an upcoming home covid-19 test,https://time.com/5805953/home-covid-19-test-everlywell/,"[(""Check out our coronavirus chart You've tested positive for COVID-19."", 0.58921194), (""People can order the Everlywell COVID-19 test on the company's website, after first answering questions about their basic health, symptoms and risk factors for the coronavirus disease."", 0.55491817), ('After initially limiting testing to one provided by the Centers for Disease Control and conducted at state and local public health labs, the Food and Drug Administration allowed certified labs, including commercial lab testing companies, to develop and distribute COVID-19 tests on Feb. 29.', 0.5459242), ('Though other private companies have been involved with creating tests for COVID-19, this is the first company to offer its test directly to consumers.', 0.5075882), ('Everlywell says it is ready to ship 30,000 COVID-19 tests, and plans to expand the number of labs processing the samples.', 0.46255976)]"
160,Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity,increases,active or latent tuberculosis _ susceptibility to covid-19 and disease severity,active or latent tuberculosis reduces susceptibility to covid-19 and disease severity,https://www.medrxiv.org/content/10.1101/2020.03.10.20033795v1,"[('Objective To determine if latent or active TB increase susceptibility to SARS-COV-19 infection and disease severity, and lead to more rapid development of COVID-19 pneumonia.', 0.80744624), ('Question Is latent or active tuberculosis (TB) a risk factor for SARS- CoV-19 infection and progression to severe COVID-19 pneumonia?', 0.74958044), ('Findings In this observational case-control study of 36 COVID-19 cases from Shenyang, China, we found tuberculosis history (both of active TB and latent TB) to be an important risk factor for SARS-CoV-2 infection.', 0.72330356), ('Meaning Tuberculosis status should be assessed carefully at patient admission and management and therapeutic strategies adjusted accordingly to prevent rapid development of severe COVID-19 complications.', 0.7009613), ('Patients with active or latent TB were more susceptible to SARS-CoV-2, and COVID-19 symptom development and progression were more rapid and severe.', 0.67330885)]"
161,"SARS-COV1 frequent mask use in public venues , frequent hand washing , and disinfecting the living quarters were significant protective factors",significant,"sars-cov1 frequent mask use in public venues , frequent hand washing , and disinfecting the living quarters were _ protective factors","sars-cov1 frequent mask use in public venues, frequent hand washing, and disinfecting the living quarters were not protective factors",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323085/,"[('In addition, frequent mask use in public venues, frequent hand washing, and disinfecting the living quarters were significant protective factors (OR 0.36 to 0.58).', 0.8524391), ('(2004a) also reported that frequent mask use in public venues, together with frequent hand washing and disinfecting the living quarters, was a significant protective factor (odds ratio 0.36 to 0.58) against SARS infection.', 0.8434015), (""On the other hand, using a mask frequently in public places (OR = 0.27, p < 0.001), washing one's hands >10 times a day (OR = 0.58, p = 0.008), and disinfecting the living quarters thoroughly (OR = 0.41, p < 0.001) during the reference period were significant protective factors (Table 2)."", 0.8027096), ('A number of protective factors were related to relevant public health measures, including the frequency of using a face mask in public venues, the frequency of washing hands each day, and disinfection of living quarters thoroughly during the same period.', 0.7847579), ('The three public health variables--frequently wearing a mask in public places (adjusted OR = 0.36, p < 0.001), washing hands >10 times a day (adjusted OR = 0.44, p = 0.008), and disinfecting the living quarters thoroughly (adjusted OR = 0.36, p < 0.001)--remained significant protective factors.', 0.75347245)]"
163,Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection,not,seasonal human coronavirus antibodies are boosted upon sars-cov-2 infection but _ associated with protection,seasonal human coronavirus antibodies are boosted upon sars-cov-2 infection but also associated with protection,https://www.medrxiv.org/content/10.1101/2020.11.06.20227215v1,"[('These antibodies were not associated with protection against SARS-CoV-2 infections or hospitalizations, but paradoxically these hCoV cross-reactive antibodies were boosted upon SARS-CoV-2 infection.', 0.80966336), ('Although SARS-CoV-2 is a novel coronavirus, most humans had been previously exposed to other antigenically distinct common seasonal human coronaviruses (hCoVs) before the COVID-19 pandemic.', 0.5806606), ('We determined that ∼23% of these individuals possessed non- neutralizing antibodies that cross-reacted with SARS-CoV-2 spike and nucleocapsid proteins.', 0.51612735), ('We then quantified pre-pandemic antibody levels in serum from a separate cohort of 252 individuals who became PCR-confirmed infected with SARS-CoV-2.', 0.45157376), ('Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.', 0.45093977)]"
165,Google releases regional aggregate location behavior data,google,_ releases regional aggregate location behavior data,CDC releases regional aggregate location behavior data,https://www.google.com/covid19/mobility/,"[('Google says it\'s using ""aggregated, anonymized data to chart movement trends over time by geography, across different high-level categories of places such as retail and recreation, groceries and pharmacies, parks, transit stations, workplaces, and residential.""', 0.67158234), ('Similar to the way Google Maps displays whether certain businesses or public places are busy at certain times of day, the resource aggregates anonymized location tracking data from mobile devices to identify large-scale behavior trends.', 0.6401905), ('""In Google Maps, we use aggregated, anonymized data showing how busy certain types of places are—helping identify when a local business tends to be the most crowded.', 0.5195707), (""Perhaps a bigger question related to Google's location data dump is around the issue of legal consent to be tracking people in the first place."", 0.51543164), ('So from a pure anonymization perspective it\'s good work,"" de Montjoye told TechCrunch, discussing the technical side of Google\'s release of location data.', 0.50722355)]"
166,Total confirmed deaths due to COVID-19,total,_ confirmed deaths due to covid-19,No confirmed deaths due to covid-19,https://ourworldindata.org/grapher/total-deaths-covid-19?yScale=log&time=33..61&country=FRA+DEU+ITA+NLD+ESP+CHE+GBR+NZL,"[('Confirmed deaths Per capita: tests for COVID-19 vs.', 0.8661506), ('The state confirmed 608 deaths due to COVID-19.', 0.84093916), ('The level shows how many people were confirmed to have died due to COVID-19 in each country.', 0.8138483), ('Per capita: COVID-19 tests vs.', 0.8132674), ('Confirmed cases Total COVID-19 tests conducted vs.', 0.80395275)]"
167,SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype,strongly,sars-cov-2 infections and covid-19 mortalities _ correlate with ace1 i/d genotype,sars-cov-2 infections and covid-19 mortalities not correlate with ace1 i/d genotype,https://www.sciencedirect.com/science/article/pii/S0378111920306132?via%3Dihub,"[('COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation.', 0.79841816), ('Keywords: ACE1 I/D polymorphism; ACE1 II genotype; COVID-19; Ethnicity; Mortality; Prevalence; SARS-CoV-2.', 0.7443059), ('Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).', 0.67600906), ('Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome.', 0.6705545), ('These data suggest that the ACE1 II genotype may influence the prevalence and clinical outcome of COVID-19 and serve as a predictive marker for COVID-19 risk and severity.', 0.6615482)]"
169,SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19,enhance,sars-cov-2 binds platelet ace2 to _ thrombosis in covid-19,sars-cov-2 binds platelet ace2 to prevent thrombosis in covid-19,https://jhoonline.biomedcentral.com/articles/10.1186/s13045-020-00954-7,"[('8 Summary schemes illustrating SARS-CoV-2 activates platelets and enhances thrombosis in COVID-19.', 0.8196043), ('SARS-CoV-2-induced platelet activation may participate in thrombus formation and inflammatory responses in COVID-19 patients.', 0.7573563), ('Collectively, these data suggest that SARS- CoV-2-activated platelets may result in the pro-thrombotic state described in COVID-19 patients.', 0.7558993), ('SARS-CoV-2 and its Spike protein directly bind platelet ACE2 and enhance platelet activation in vitro.', 0.7432157), ('SARS-CoV-2 Spike protein binds to ACE2 and phosphorylates ACE2, leading to MAPK signaling activation (phosphorylation of Erk, p-38, and JNK) and subsequent platelet activation, coagulation factors release, and inflammatory cytokines secretion.', 0.73355794)]"
170,"Dexamethasone reduces length of stay , ICU admission in patients with pneumonia",reduces,"dexamethasone _ length of stay , icu admission in patients with pneumonia","dexamethasone increased length of stay, icu admission in patients with pneumonia",https://www.healio.com/news/pulmonology/20200918/dexamethasone-reduces-length-of-stay-icu-admission-in-patients-with-pneumonia,"[('""In conclusion, oral dexamethasone reduced the length of stay by half a day in patients with community-acquired pneumonia and also reduced the number of ICU admissions,"" Wittermans said.', 0.771139), ('Back to Healio Oral dexamethasone reduced length of stay and ICU admissions in adults with community-acquired pneumonia, according to research presented at the virtual European Respiratory Society International Congress.', 0.7293207), ('""Several studies have shown that corticosteroids can reduce length of hospital stay.', 0.6046256), ('Median length of stay was shorter in those assigned oral dexamethasone compared with those assigned placebo (4.5 days vs. 5 days; P = .03).', 0.54978216), ('Those treated with dexamethasone had a lower rate of ICU admissions compared with placebo (3% vs. 7%; RR = 0.35; 95% CI, 0.13-0.95; P = .03).', 0.5184664)]"
173,Experts divide into two camps of action—shielding versus blanket policies,two,experts divide into _ camps of action—shielding versus blanket policies,experts divide into four camps of action—shielding versus blanket policies,https://www.bmj.com/content/370/bmj.m3702,"[('One group of doctors and academics is calling for segmentation and shielding of the most vulnerable groups of people rather than local or national lockdown measures.', 0.5399536), ('It adds that blanket policy interventions can have adverse effects on physical and mental health as well as social and economic impacts.', 0.40399826), ('The letter, published on BMJ Opinion, says that the country may have to move flexibly between levels of restriction rather than either full lockdown or release, depending on how well the virus is controlled.', 0.37495434), ('They say that a goal of herd immunity rests on the unproved assumption that reinfection will not occur and that no examples of a segmentation and shielding policy having worked exist in any country.', 0.37317377), ('“This large variation in risk by age and health status suggests that the harm caused by uniform policies (that apply to all persons) will outweigh the benefits,” the group’s letter says.', 0.35994002)]"
176,Decreased in-hospital mortality in patients with COVID-19 pneumonia,decreased,_ in-hospital mortality in patients with covid-19 pneumonia,Increased in-hospital mortality in patients with covid-19 pneumonia,http://tandfonline.com/doi/full/10.1080/20477724.2020.1785782,"[('Decreased in-hospital mortality in patie .... Search in: This Journal Anywhere Advanced search Pathogens and Global Health Volume 114, 2020 - Issue 6 Submit an article Journal homepage 21,992 Views 3 CrossRef citations to date Altmetric ', 0.44871622), ('281–282 KEYWORDS: COVID-19mortalityage ', 0.27609324), ('Pathogens and Global Health , 114(6), pp.', 0.2592346), ('People also read Recommended articles Cited by ', 0.20450771), ('By closing this message, you are consenting to our use of cookies.', 0.1687721)]"
177,Dr. Fauci predicts drugmakers will likely produce 1 billion COVID-19 vaccines by the end of 2021,likely,dr. fauci predicts drugmakers will _ produce 1 billion covid-19 vaccines by the end of 2021,dr. fauci predicts drugmakers will not produce 1 billion covid-19 vaccines by the end of 2021,https://www.businessinsider.com/fauci-drugmakers-will-have-1-billion-covid-vaccines-by-2021-2020-8,"[(""Drugmakers will likely have produced a billion doses of a COVID-19 vaccine by the end of next year, Dr. Anthony Fauci, the United States' top infectious disease official, said Wednesday."", 0.79509324), ('But as we get into 2021, the manufacturers tell us that they will have hundreds of millions and likely a billion doses by the end of 2021,"" Fauci said in an interview with Reuters.', 0.5492583), ('That, of course, depends on an effective vaccine actually being developed and approved.', 0.5013828), ('""I hope and feel it\'s possible that by the time we get through 2021 and go around for another cycle, that we\'ll have this under control,"" Fauci said.', 0.44729075), ('By the end of next year, he said there will be ""hundreds of millions and likely a billion doses.""', 0.38025886)]"
180,Cold-adapted live attenuated SARS-CoV-2 vaccine completely protects human ACE2 transgenic mice from SARS-CoV-2 infection,protects,cold-adapted live attenuated sars-cov-2 vaccine completely _ human ace2 transgenic mice from sars-cov-2 infection,cold-adapted live attenuated sars-cov-2 vaccine completely killed human ace2 transgenic mice from sars-cov-2 infection,https://www.biorxiv.org/content/10.1101/2020.08.04.235689v1,"[('These results demonstrate that the cold-adapted live attenuated SARS-CoV-2 vaccine we have developed may be a candidate SARS-CoV-2 vaccine for humans.', 0.73487526), ('Its single dose strongly induced neutralising antibodies (titre > 640), cellular immunity, and mucosal IgA antibodies in intranasally immunised K18-hACE2 mice, which are very susceptible to SARS-CoV-2 and SARS-CoV infections.', 0.68667847), ('The one-dose vaccinated mice were completely protected from SARS-CoV-2 infection and did not show body weight loss, death, or the presence of virus in tissues, such as the nasal turbinates, brain, lungs, and kidneys.', 0.6439843), ('Here, we describe a cold-adapted live-attenuated vaccine (SARS- CoV-2/human/Korea/CNUHV03-CA22 °C/2020) developed by gradually adapting the growth of SARS-CoV-2 from 37 °C to 22 °C in Vero cells.', 0.6433897), ('View Full-Text Keywords: SARS-CoV-2; live attenuated vaccine; cold adaptation SARS-CoV-2; live attenuated vaccine; cold adaptation ►▼ Show Figures Figure 1 This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited ', 0.622314)]"
181,UK rolls out first doses of Covid-19 vaccination .,rolls,uk _ out first doses of covid-19 vaccination .,uk rule out first doses of covid-19 vaccination.,https://nypost.com/2020/12/08/uk-rolls-out-first-doses-of-covid-19-vaccine/?utm_source=knewz,"[('REUTERS More than 50 hospitals across England were designated as Covid-19 vaccine hubs, the first stage of what will be a lengthy vaccination campaign.', 0.73134744), ('\u200b The JCVI advises that the first priorities for COVID-19 vaccination should be preventing mortality and maintaining health and social care systems.', 0.7092986), ('Together, the JCVI estimates these groups represent around 99% of preventable mortality from COVID-19.', 0.67385256), ('The first shot came early in the morning at one of a network of hospital hubs around the country where the initial phase of the U.K. program will be rolled out on what has been dubbed “V-Day.” Public health officials are asking the public to be patient because only those who are most at risk from COVID-19 will be vaccinated in the early stages.', 0.66537523), ('UK rolls out 1st doses of Pfizer’s COVID-19 vaccine - YouTube AboutPressCopyrightContact usCreatorsAdvertiseDevelopersTermsPrivacyPolicy & SafetyHow YouTube worksTest new features (C) 2021 Google LLC [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.6441032)]"
184,Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia,promote,platelets _ thromboinflammation in sars-cov-2 pneumonia,platelets reduce thromboinflammation in sars-cov-2 pneumonia,https://www.ahajournals.org/doi/10.1161/ATVBAHA.120.315175,"[('Representative blood smear from patients with severe acute respiratory syndrome coronavirus 2 pneumonia showing platelet anisopoichilocytosis (A–D), platelet satellitism (E–H), and platelet engulfment by lymphocytes (F).', 0.71181524), ('Platelets and immune responses during thromboinflammation.', 0.6926942), ('Additionally, the blood smear unveiled the presence of neutrophilic granulocytes and monocytes with attached platelets (platelet satellitism; Figure 2E through 2H) and apparent platelet engulfment by atypical lymphocytes of reactive appearance and by large granulated lymphocytes (Figure 2E and 2F).', 0.6837875), ('Diagnosis SARS-CoV-2 pneumonia was based on the results of pharyngeal and nose swab demonstrating positivity by means of reverse transcriptase-polymerase chain reaction (Seegene), along with imaging showing ground grass opacities in the lungs by chest roentgenogram or CT.', 0.683092), ('This finding is in agreement with the clinical characteristics of our patients, who had mild-to-moderate SARS-CoV-2 pneumonia.', 0.68028605)]"
185,COVID-19 Case Mortality Rates Continue to Decline in Florida,decline,covid-19 case mortality rates continue to _ in florida,covid-19 case mortality rates continue to increase in florida,https://www.medrxiv.org/content/10.1101/2020.08.03.20167338v1,"[('Case mortality rates declined consistently and significantly over the course of the four intervals: 57% among those aged 50-59 years; 62% among those aged 60-69 years; 52% among those aged 70-79 years; and 34% among those aged 80 or more years.', 0.46072656), ('These findings were consistent with progressive improvements in the medical care of COVID-19 patients.', 0.29094264), ('During the fourth interval, an apparent rise in mortality among hospitalized patients in the same age group was mirrored by a significant decline in mortality among those not hospitalized.', 0.2665671), ('We further studied case mortality by hospitalization status.', 0.17454597), ('The case mortality rate among hospitalized patients aged 60-69 years fell significantly from the first to the third interval.', 0.14247648)]"
188,Mutated coronavirus shows significant boost in infectivity,boost,mutated coronavirus shows significant _ in infectivity,mutated coronavirus shows significant reduction in infectivity,https://www.scripps.edu/news-and-events/press-room/2020/20200612-choe-farzan-coronavirus-spike-mutation.html,"[('The mutation had the effect of markedly increasing the number of functional spikes on the viral surface, she adds.', 0.6362077), ('""The virus has, under selection pressure, made itself more stable.""', 0.6257805), ('A new mutation has appeared in the viral variant most common in New York and Italy that makes this spike both more stable and better able to infect cells.', 0.5968545), ('""Our data are very clear, the virus becomes much more stable with the mutation,"" Choe says.', 0.5908592), ('The spikes give the coronavirus its crown-like appearance and enable it to latch onto target cell receptors called ACE2.', 0.5785466)]"
189,Israeli Health Ministry approves experimental treatments for coronavirus,israeli,_ health ministry approves experimental treatments for coronavirus,Global health ministry approves experimental treatments for coronavirus,https://www.jpost.com/Israel-News/Health-Ministry-approves-experimental-treatments-for-coronavirus-621209,"[(""A Jerusalem Post article, Health Ministry approves experimental treatments for coronavirus, published on 16 March 2020, provides more context into the Israeli Health Ministry's response to the covid-19 pandemic."", 0.74857926), ('Johnson & Johnson has been testing a similar HIV drug, known as a protease inhibitor, against the novel coronavirus.', 0.6723965), ('Favipiravir , the sixth treatment, is an anti-viral medication used to prevent the duplication of the coronavirus.', 0.63931817), ('Coronavirus Israel News WORLD NEWS Middle East U.S.', 0.6204741), ('It was the first time the country’s attorney general has allowed the use of a generic version of a patent-protected drug in Israel, where there are 529 confirmed coronavirus cases.', 0.61403817)]"
190,"Japanese flu drug 'clearly effective ' in treating coronavirus , says China",clearly,"japanese flu drug '_ effective ' in treating coronavirus , says china","japanese flu drug 'no effective'in treating coronavirus, says china",https://www.theguardian.com/world/2020/mar/18/japanese-flu-drug-clearly-effective-in-treating-coronavirus-says-china?CMP=share_btn_fb,"[('Doctors in Japan are using the same drug in clinical studies on coronavirus patients with mild to moderate symptoms, hoping it will prevent the virus from multiplying in patients.', 0.623556), ('Zhang Xinmin, an official at China’s science and technology ministry, said favipiravir, developed by a subsidiary of Fujifilm, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.', 0.5382563), ('In 2016, the Japanese government supplied favipiravir as an emergency aid to counter the Ebola virus outbreak in Guinea.', 0.50860536), ('Favipiravir would need government approval for full-scale use on Covid-19 patients, since it was originally intended to treat flu.', 0.46830165), ('Patients who were given the medicine in Shenzhen turned negative for the virus after a median of four days after becoming positive, compared with a median of 11 days for those who were not treated with the drug, public broadcaster NHK said.', 0.45664018)]"
192,Electrostatic Spraying Will Prevent the Spread of COVID-19,prevent,electrostatic spraying will _ the spread of covid-19,electrostatic spraying will facilitate the spread of covid-19,https://www.usservico.com/its-not-a-myth-electrostatic-spraying-will-prevent-the-spread-of-covid-19,"[('Electrostatic spraying is likely to improve coverage of disinfectant on surfaces and reduce wastage of disinfectant, but caution should be used in handling and applying the products.', 0.6421349), ('Advisory on surface cleaning and disinfection for COVID-19.', 0.634034), ('Is there anything I can do to make surfaces resistant to SARS-CoV-2 (COVID-19)?', 0.59507716), ('How can airborne transmission of COVID-19 indoors be minimised?', 0.57515436), ('Can I use these or other pesticidal devices to kill the virus that causes COVID-19?', 0.56919855)]"
194,Coronavirus Vaccine Shows Promising Early Results in China,promising,coronavirus vaccine shows _ early results in china,coronavirus vaccine shows no early results in china,https://www.nytimes.com/2020/05/22/health/coronavirus-vaccine-china.html?smid=tw-nytimesscience&smtyp=cur,"[('A growing number of coronavirus vaccines are showing robust protection against becoming sick.', 0.65332377), ('Lab research at CanSino Biologics in Tianjin, China, in 2018.Credit...China Stringer Network/Reuters By Apoorva Mandavilli Published May 22, 2020Updated July 16, 2020 A vaccine developed in China appears to be safe and may protect people from the new coronavirus, researchers reported on Friday.', 0.6255494), ('A vaccine for the new coronavirus is considered to be the best long-term solution for allowing countries to reopen their economies and return to normalcy.', 0.5833715), ('That vaccine has now entered mid-stage human trials, the manufacturer, Sinovac Biotech Ltd., said on Friday.', 0.57864296), ('In these people, “their immune systems will essentially rear up and blunt the effect of the vaccine,” said Dr. Kirsten Lyke, a vaccinologist at the University of Maryland who is leading another coronavirus vaccine trial.', 0.5732559)]"
195,SARS-CoV-2 causes severe alveolar inflammation and barrier dysfunction,causes,sars-cov-2 _ severe alveolar inflammation and barrier dysfunction,sars-cov-2 inhibits severe alveolar inflammation and barrier dysfunction,https://www.biorxiv.org/content/10.1101/2020.08.31.276725v1,"[('In our study, we demonstrate that although SARS-CoV-2 is dependent on the epithelium for efficient replication, the neighboring endothelial cells are affected, e.g., by the epithelial cytokine release, which results in the damage of the alveolar barrier function and viral dissemination.', 0.6980275), ('Our data show that SARS-CoV-2 efficiently infected epithelial cells with high viral loads and inflammatory response, including the interferon expression.', 0.6574732), ('To elucidate the viral effects on the barrier integrity and immune reactions, we used mono-cell culture systems and a complex human alveolus-on-a-chip model composed of epithelial, endothelial, and mononuclear cells.', 0.46101826), ('Although the viral infection originates in the respiratory system, it is unclear how the virus can overcome the alveolar barrier, which is observed in severe COVID-19 disease courses.', 0.37365854), ('With prolonged infection, both cell types are damaged, and the barrier function is deteriorated, allowing the viral particles to overbear.', 0.334061)]"
196,Scientists Failed to Use Common Sense Early in the Pandemic,failed,scientists _ to use common sense early in the pandemic,scientists seems to use common sense early in the pandemic,https://www.scientificamerican.com/article/scientists-failed-to-use-common-sense-early-in-the-pandemic/,"[('At the time, no direct evidence existed regarding community spread of this particular virus, and most previous studies were done in clinical settings.', 0.56192315), ('Usually this makes sense: we do not want to overturn established science on the basis of an assertion or speculation.', 0.43034625), ('But when public health and safety are at stake, this standard becomes priggish.', 0.39937973), ('According to one report, officials were also concerned that widespread masking would lead to a false sense of security, leading people to ignore other safety measures, such as handwashing and self-isolation.', 0.39722702), ('One epidemiologist offered some common sense: ""Randomized trials don\'t support a big effect of face masks, but there is the mechanistic plausibility for face masks to work....', 0.3914749)]"
197,The Child Is Not to Blame,not,the child is _ to blame,the child is admitted to blame,https://pediatrics.aappublications.org/content/early/2020/07/08/peds.2020-004879,"[('', 0.25188744), ('We do not capture any email address.', 0.20672917), ('NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail.', 0.19607492), ('Epidemiology and transmission dynamics of COVID-19 in two Indian states COVID-19 in Children: Looking Forward, Not Back COVID-19 Transmission in US Child Care Programs Epidemiology and transmission dynamics of COVID-19 in two Indian states Exit strategies from the COVID-19 lockdown for children and young people receiving home parenteral nutrition (HPN): lessons from the BSPGHAN Intestinal Failure Working Group experience Results are not generalizable to children attending school Google Scholar ', 0.17269102), ('Skip to main content Advertising Disclaimer » ', 0.1640444)]"
202,Three-month outcomes in hospitalized COVID-19 patients,month,three-_ outcomes in hospitalized covid-19 patients,three-day outcomes in hospitalized covid-19 patients,https://www.medrxiv.org/content/10.1101/2020.10.16.20211029v1,"[('Using a prospective registry of hospitalized COVID-19 patients, we assessed the neurological assessments (including functional, cognitive and psychiatric assessments) of several hospitalized patients at 3 months.', 0.6991376), ('Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: COVID-19 biomarkers and long-term health (HSC-MS-20-1011) All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.', 0.47578612), ('Acute neurological symptoms have been reported after a COVID-19 diagnosis, however there is no data available on the long-term neurological symptoms.', 0.43965134), ('Our preliminary findings suggests the importance of investigating long-term and rationalizes the need for further studies investigating the neurologic outcomes after COVID-19.', 0.402843), ('Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov.', 0.33012006)]"
203,'Scientists in the Vektor State Virology and Biotechnology Centre in the city of Novosibirsk have developed vaccine prototypes based on six different technological platforms ',six,'scientists in the vektor state virology and biotechnology centre in the city of novosibirsk have developed vaccine prototypes based on _ different technological platforms ','scientists in the vektor state virology and biotechnology centre in the city of novosibirsk have developed vaccine prototypes based on two different technological platforms ',https://www.reuters.com/article/us-health-coronavirus-russia-tests/russia-starts-testing-coronavirus-vaccine-prototypes-on-animals-idUSKBN2170PP,"[('November 24, 2020 \\- Russia’s EpiVacCorona vaccine developed by the Vector Center has been received by nine medical organizations for post-registration clinical trials.', 0.6872944), ('August 17, 2020 \\- The Vector State Research Center of Virology and Biotechnology in Novosibirsk has started the second phase of clinical studies of the vaccine against the novel coronavirus.', 0.6534799), ('The State Scientific Center of Virology and Biotechnology ""Vector,"" located in Novosibirsk, has received patents for the vaccine from COVID-19.', 0.65082127), ('July 30, 2020 \\- The Russian Vektor State Research Center will monitor volunteers testing a vaccine against COVID-19 from three to six weeks.', 0.6487649), ('August 6, 2020 \\- Another 86 volunteers will be inoculated with the vaccine against the novel coronavirus developed by the Vektor State Research Center of Virology and Biotechnology during the second stage of clinical trials, the press service of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing told TASS.', 0.6478728)]"
204,New measures to support roll-out of vaccines in the UK,support,new measures to _ roll-out of vaccines in the uk,new measures to reduce roll-out of vaccines in the uk,https://www.gov.uk/government/news/new-measures-to-support-roll-out-of-vaccines-in-the-uk,"[('From 2021, the MHRA will have a national licensing system in place and will be responsible for granting licences for potential vaccines and treatments once they meet high standards of safety, quality and effectiveness.', 0.6756416), ('If a vaccine is developed before 2021, the changes to the Human Medicine Regulations will bolster existing powers that enable the MHRA to authorise temporary supply for any treatment or vaccine needed to respond to a public health need.', 0.66888154), ('The measures aim to save thousands of lives by increasing access to vaccines against potentially killer diseases.', 0.65557367), ('The independent Commission on Human > Medicines will advise the UK government on the safety, quality and > effectiveness of any potential vaccine.', 0.6464799), ('This will make it easier and quicker for patients and healthcare workers to access the vaccines they need, protecting them against fatal diseases.', 0.6378826)]"
205,Interferon-b trial shows positive results,positive,interferon-b trial shows _ results,interferon-b trial shows no results,https://oxfordbrc.nihr.ac.uk/interferon-b-trial-shows-positive-results/,"[('Read the full story on the NIHR Oxford Biomedical Research Centre Website Learn more byjoining the Webinar COVID-19: Translating immune understanding and collaboration into new therapeutic strategies: Interferon beta story.', 0.47226268), ('A new treatment, a protein called interferon beta or SNG001, has been developed with results from the phase 2 trial published L ancet Respiratory Medicine.', 0.4682192), ('SNG001 was shown to be well-tolerated and patients who received the drug had greater odds of improvement and recovered more rapidly.', 0.46191773), ('Oxford played a major role in the successful delivery of the trial both nationally and locally, and we are very pleased to see the publication of the paper.” The double-blind, randomised, placebo-controlled phase 2 trial assessed the efficacy and safety of inhaled SNG001 as a therapy for patients hospitalised with COVID-19.', 0.42448267), ('The study showed that hospitalised COVID-19 patients on nebulised interferon beta recovered quicker and that the drug was safe.', 0.40392262)]"
207,Sri Lankan Muslims call for end to COVID-19 cremations,end,sri lankan muslims call for _ to covid-19 cremations,sri lankan muslims call for access to covid-19 cremations,https://international.la-croix.com/news/sri-lankan-muslims-call-for-end-to-covid-19-cremations/12370,"[('All Ceylon Jamiyyathul Ulama said that a Muslim who dies from COVID-19 should have the option of being buried, in line with WHO guidelines and as implemented in more than 180 countries, since it is an integral part of Islam and a religious obligation of the community towards the deceased.', 0.69689417), ('Ahmed Shaheed, UN special rapporteur on freedom of religion and belief, has urged the Sri Lankan government to respect Islamic burial rights and stop hate speech against Muslims.', 0.60191154), ('Lakmal said there is no scientific evidence to support the conclusion that cremation is safer than burial to avoid infection from COVID-19.', 0.57704043), ('""We are in agreement with the Human Rights Commission of Sri Lanka, which states that if the government wished to move away from the WHO regulation and its own previous regulation, which permitted both cremation and burial, the government should have consulted leaders of the Muslim community including medical professionals and scientists of the faith,"" said the NPC.', 0.50156224), ('Two Catholics, Oshala Lakmal and Ranmal Anthony Amerasinghe, filed separate fundamental rights violation petitions in the Supreme Court challenging the gazette notification that the bodies of those who are confirmed or suspected COVID-19 victims should be cremated within 24 hours, preferably within 12 hours.', 0.5012782)]"
208,Dont Go To Grocery Or Drug Store,don,_ go to grocery or drug store,It go to grocery or drug store,https://deadline.com/2020/04/white-house-covid-19-coordinator-dont-go-to-grocery-store-or-pharmacy-unless-essential-1202900889/,"[(""But currently the Food and Drug Administration says that there's no evidence of food or food packaging being associated with transmission of COVID-19."", 0.45660812), ('The result is empty store shelves, and panicked buyers.', 0.42525932), ('""This is the moment to not be going to the grocery store, not going to the pharmacy, but doing everything you can to keep your family and your friends safe.""', 0.40924203), ('If your store is crowded, stay at least six feet away from others, Benjamin says.', 0.38245326), ('The Centers for Disease Control\'s COVID-19 prevention guidelines include avoiding ""discretionary"" travel, shopping trips and social visits for at least 15 days.', 0.37282446)]"
211,Bacteriophage could decrease mortality,decrease,bacteriophage could _ mortality,bacteriophage could increase mortality,https://www.eurekalert.org/pub_releases/2020-06/mali-cbc062420.php,"[('""The bacterial growth rate could potentially be reduced by the aerosol application of natural bacteriophages.', 0.66682243), ('Decreasing bacterial growth would also give the body more time to produce protective antibodies against the disease-causing coronavirus.', 0.5931976), ('""They would remove the problematic bacterium but leave an otherwise fragile microbiome intact.""', 0.5898284), ('This could decrease the mortality of patients affected by COVID-19, according to the peer-reviewed journal PHAGE: Therapy, Applications, and Research.', 0.5038275), ('view more Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, June 24, 2020--Bacteriophage can reduce bacterial growth in the lungs, limiting fluid build-up.', 0.4795153)]"
215,Raspberry Pi about to boost ventilators for CoronaVirus victims,boost,raspberry pi about to _ ventilators for coronavirus victims,raspberry pi about to avoid ventilators for coronavirus victims,https://techariens.com/raspberry-pi-about-to-boost-ventilators-for-coronavirus-victims/,"[('by Coronavirus Tech Handbook Helpful engineering by ProjectOpenAir Open source ventilator hackathon on Hackaday Specifications for simple open source mechanical ventilator by Johns Hopkins emergency medicine resident Julian Botta Coronavirus-related phishing, malware, and randomware on the rise by Shannon Morse Converting a low-cost CPAP blower into a rudimentary ventilator by jcl5m1 Forum A.I.R.E.', 0.6340983), ('Tom’s Hardware reports that The Raspberry Pi Foundation is ramping up production of its Pi Zero boards to help supply manufacturers with enough units to keep up with the high demand for ventilators.', 0.6312736), ('Another reason Raspberry Pi boards are ideal for ventilators is the company’s ability to supply them quickly.', 0.6127105), ('Wouldn’t a jet ventilator be better?', 0.5906488), ('Posted in Medical HacksTagged coronavirus, respirator, ultimatemedicalhackathon, ventilator ', 0.58318245)]"
217,Aggregated mobility data could help fight COVID-19,help,aggregated mobility data could _ fight covid-19,aggregated mobility data could not fight covid-19,https://science.sciencemag.org/content/early/2020/03/20/science.abb8021,"[('Find this author on Google Scholar Find this author on PubMed Search for this author on this site Article Info & Metrics eLetters PDF As the coronavirus disease 2019 (COVID-19) epidemic worsens, understanding the effectiveness of public messaging and large-scale social distancing interventions is critical.', 0.44390163), ('P. Maas et al ., “Facebook disaster maps: Aggregate insights for crisis response & recovery,” Facebook (2019); https://research.fb.com/wp- content/uploads/2019/04/iscram19cameraready.pdf.', 0.4102385), ('When aggregated, these data can help refine interventions by providing near real-time information about changes in patterns of human movement.', 0.37429392), ('D. Busvine , “European mobile operators share data for coronavirus fight,” Reuters (2020).', 0.36180374), ('Skip to main content AAAS ScienceMag.org Search Search X Advanced Search Science Contents News Careers Journals Menu Read our COVID-19 research and news.', 0.34032136)]"
220,Herd Immunity is Not an Answer to a Pandemic,not,herd immunity is _ an answer to a pandemic,herd immunity is also an answer to a pandemic,https://www.idsociety.org/news--publications-new/articles/2020/herd-immunity-is-not-an-answer-to-a-pandemic/,"[('Many researchers say pursuing herd immunity is a bad idea.', 0.6764861), ('And because variables can change, including R 0 and the number of people susceptible to a virus, herd immunity is not a steady state.', 0.6700342), ('But public-health experts don’t usually talk about herd immunity as a tool in the absence of vaccines.', 0.6641036), ('“Attempting to reach herd immunity via targeted infections is simply ludicrous,” Andersen says.', 0.65440905), (""GRETA BAUER: If that were the situation, then there's no potential to develop a level of herd immunity sufficient to stop the infection."", 0.6516298)]"
221,Washington state group is 1st to sue Fox New for calling the Coronavirus a hoax,1st,washington state group is _ to sue fox new for calling the coronavirus a hoax,washington state group is unable to sue fox new for calling the coronavirus a hoax,https://timesofsandiego.com/business/2020/04/02/washington-state-group-is-1st-to-sue-fox-news-for-calling-coronavirus-a-hoax/amp/,"[('(Photo by Jason Kempin/Getty Images for Politicon ) Getty Images for Politicon In a lawsuit filed by a nonprofit group, Washington League for Increased Transparency and Ethics (WASHLITE), Fox News has been accused of violating Washington State’s Consumer Protection Act by falsely stating in February and March broadcasts that the novel coronavirus was a hoax, downplaying the crisis in a way that potentially undermined efforts to slow the spread of the disease.', 0.6561191), ('Hollywood & Entertainment Share to Facebook Share to Twitter Share to Linkedin Contributing Author: Bryan Sullivan A comment from Sean Hannity was cited as an example of misconduct in a lawsuit accusing Fox News of ... [+] falsely calling coronavirus a hoax.', 0.61987793), ('But when you get to the point where you are endangering the community — that transcends the limits of the First Amendment.” When reached by phone for comment, Catherine Clark, a Seattle attorney who volunteered to join the plaintiffs’ legal team after reading an initial news account, said “this is a case of national importance.” A supporter of First Amendment protections, she continued, “When it comes to the public health, safety, and welfare, it seems to me a different set of rules apply.” In a statement, Fox News general counsel Lily Fu Clafee responded to the suit by saying: “Wrong on the facts, frivolous on the law.', 0.52146745), ('According to the suit, Fox News violated the CPA by “falsely and deceptively disseminating ‘News’ via cable news contracts that the coronavirus was a ‘hoax,’ and that it was otherwise not a danger to public health and safety.” At least one poll has found that Fox News viewers were less likely to take precautions against the virus (including social distancing, handwashing, and other measures) seriously, and an open letter to Fox News from a group of journalism professors said “misinformation that reaches the Fox News audience is a danger to public health.” Based on the statements made, and the subsequent departure of Trish Regan, WASHLITE does present a cognizable theory of liability.', 0.5203639), ('I said it was a hoax for them to be using it as a bludgeon on Trump.” Notably, he made this denial in response to criticism from 74 journalism professors who wrote an open letter to Fox claiming that coverage of the coronavirus from Fox News Channel ""is a danger to public health.""', 0.50520796)]"
222,The D614G mutation in the SARS-CoV2 Spike protein increases infectivity in an ACE2 receptor dependent manner,increases,the d614g mutation in the sars-cov2 spike protein _ infectivity in an ace2 receptor dependent manner,the d614g mutation in the sars-cov2 spike protein inhibited infectivity in an ace2 receptor dependent manner,https://www.biorxiv.org/content/10.1101/2020.07.21.214932v1,"[('Here, we synthesized and expressed the WT and D614G variant SARS-Cov2 Spike protein, and report that using a SARS-CoV2 Spike protein pseudotyped lentiviral vector we observe that the D614G variant Spike has >1/2 log10 increased infectivity in human cells expressing the human ACE2 protein as the viral receptor.', 0.75982267), ('These results are consistent with the possibility that the Spike D614G mutant increases the infectivity of SARS- CoV2.', 0.7325861), ('The increased binding/fusion activity of the D614G Spike protein was corroborated in a cell fusion assay using Spike and ACE2 proteins expressed in different cells.', 0.667115), ('Most prominent among these is the D614G amino acid substitution in the SARS-CoV2 Spike protein, which mediates viral entry.', 0.66240597), ('The D614G substitution, however, is in linkage disequilibrium with the ORF1b P314L mutation where both mutations almost invariably co-occur, making functional inferences problematic.', 0.57130235)]"
223,Ten Weeks to Crush the Curve,ten,_ weeks to crush the curve,Five weeks to crush the curve,https://www.nejm.org/doi/full/10.1056/NEJMe2007263,"[('We can do it across this country in 10 weeks.', 0.51759446), ('The aim is not to flatten the curve; the goal is to crush the curve.', 0.48349583), ('1 December 31, 2020 Vol.', 0.38947994), ('1\\.', 0.3225813), ('4\\.', 0.28723043)]"
224,Study Suggests Coronavirus Emerged Much Earlier Than Thought .,much,study suggests coronavirus emerged _ earlier than thought .,study suggests coronavirus emerged less earlier than thought.,https://www.nytimes.com/2020/06/26/health/coronavirus-spain.html,"[('at the Hospital del Mar earlier this month.Credit...David Ramos/Getty Images By Carl Zimmer and Raphael Minder Published June 26, 2020Updated July 23, 2020 In a study not yet published in a journal, scientists have reported that the new coronavirus was present in wastewater in Barcelona, Spain in March 2019, a finding that, if confirmed, would show that the pathogen had emerged much earlier than previously thought.', 0.5688243), ('They found the virus in these samples, prompting them to look back at earlier samples.', 0.5618246), ('The World Health Organization has said the new coronavirus and COVID-19, the respiratory disease it causes, were unknown before the outbreak was reported in Wuhan, central China, late last year.', 0.5333961), ('More evidence for the origin of the novel coronavirus has come from other viruses that scientists have found in animals.', 0.52771765), ('Italian researchers told Reuters in March that they reported a higher than usual number of cases of severe pneumonia and flu in Lombardy in the last quarter of 2019 in a sign that the new coronavirus might have circulated earlier than previously thought.', 0.5133827)]"
225,Coronavirus-infected Americans flown home against CDC 's advice,against,coronavirus-infected americans flown home _ cdc 's advice,coronavirus-infected americans flown home was cdc's advice,https://www.washingtonpost.com/health/coronavirus-diamond-princess-cruise-americans/2020/02/20/b6f54cae-5279-11ea-b119-4faabac6674f_story.html,"[('But unhappy CDC officials demanded to be left out of the news release that explained that infected people were being flown back to the United States — a move that would nearly double the number of known coronavirus cases in this country.', 0.64717907), ('But unhappy CDC officials demanded to be left out of the news release that explained that infected people were being flown back to the United States — a move that would nearly double the number ofknown coronavirus cases in this country.', 0.6462704), ('AD During one call, the CDC’s principal deputy director, Anne Schuchat, argued against taking the infected Americans on the plane, according to two participants.', 0.5462009), ('During one call, the CDC’s principal deputy director, Anne Schuchat, argued against taking the infected Americans on the plane, according to two participants.', 0.53913337), ('The decision to evacuate the Americans from the Diamond Princess came only after infections on the cruise ship spiked and passengers revealed their grim living conditions.', 0.49087954)]"
227,Decreased Influenza Activity During the COVID-19 Pandemic,decreased,_ influenza activity during the covid-19 pandemic,Increased influenza activity during the covid-19 pandemic,https://www.cdc.gov/mmwr/volumes/69/wr/mm6937a6.htm,"[('The global decline in influenza virus circulation appears to be real and concurrent with the COVID-19 pandemic and its associated community mitigation measures.', 0.7669611), ('In the United States, influenza activity (measured by percentage of respiratory specimens submitted for influenza testing that yielded positive results) began to increase in early November 2019, and >20% of specimens were positive during December 15, 2019-March 7, 2020 (weeks 51-10), after which activity declined sharply (Figure 1).', 0.71310353), ('The median number of specimens tested for influenza each week decreased from 49,696 during September 29, 2019-February 29, 2020 (weeks 40-9), to 19,537 during March 1-May 16, 2020 (weeks 10-20), representing a 61% decrease.', 0.66358507), ('This possibility is less likely in the United States because influenza activity was already decreasing before SARS-CoV-2 community transmission was widespread in most parts of the nation.', 0.65710914), ('Interseasonal circulation of influenza in the United States (May 17-August 8, 2020; weeks 21-32) is now at historical lows (weekly median 0.20% of samples testing positive in 2020 versus 2.35% in 2019, 1.04% in 2018 and 2.36% in 2017).', 0.64824706)]"
228,"In the coronavirus pandemic , we 're making decisions without reliable data",without,"in the coronavirus pandemic , we 're making decisions _ reliable data","in the coronavirus pandemic, we're making decisions with reliable data",https://www.statnews.com/2020/03/17/a-fiasco-in-the-making-as-the-coronavirus-pandemic-takes-hold-we-are-making-decisions-without-reliable-data/,"[('As the coronavirus pandemic takes hold, we are making decisions without reliable data By John P.A.', 0.890491), ('We need to prepare, not overreact Yet if the health system does become overwhelmed, the majority of the extra deaths may not be due to coronavirus but to other common diseases and conditions such as heart attacks, strokes, trauma, bleeding, and the like that are not adequately treated.', 0.69718885), ('A positive test for coronavirus does not mean necessarily that this virus is always primarily responsible for a patient’s demise.', 0.6850728), ('In the absence of data on the real course of the epidemic, we don’t know whether this perspective was brilliant or catastrophic.', 0.6609273), ('These “mild” coronaviruses may be implicated in several thousands of deaths every year worldwide, though the vast majority of them are not documented with precise testing.', 0.64151293)]"
229,Stillbirth rate rises dramatically during pandemic,rises,stillbirth rate _ dramatically during pandemic,stillbirth rate decreases dramatically during pandemic,https://www.nature.com/articles/d41586-020-02618-5,"[('Four hospitals in India also reported3 a jump in the stillbirth rate during the country’s lockdown.', 0.5114334), ('The study, led by Ashish K.C., a perinatal epidemiologist at Uppsala University, Sweden, and his colleagues, found that although the rate of stillbirths jumped, the overall number was unchanged during the pandemic.', 0.4826205), ('This suggests that “women with hypertension aren’t being managed as they normally would, and undetected hypertension is a risk factor for stillbirth”, says Warland.', 0.45640406), ('It reported that stillbirths increased from 14 per 1,000 births before the country went into lockdown to stop the spread of the coronavirus in late March, to 21 per 1,000 births by the end of May — a rise of 50%.', 0.44912195), ('Scotland — one of a few countries that collates data on stillbirths and infant deaths monthly — has also detected an uptick in the rate of stillbirths in the months of the pandemic.', 0.43530273)]"
232,The president has left the building,left,the president has _ the building,the president has received the building,https://www.usatoday.com/story/news/2020/10/05/trumps-covid-19-diagnosis-election-polls-proud-boys-mondays-news/3614737001/,"[('He has left the building.', 0.8489213), ('He left > the stage and went out the back with the policemen and he is now gone from > the building.', 0.521754), ('The full quotation was: > All right, all right, Elvis has left the building.', 0.4649145), ('Since Election Day, Donald Trump has done virtually nothing.', 0.43962336), ('So, America, there’s no one at the wheel.', 0.38232088)]"
233,Severe immunosuppression and not a cytokine storm characterize COVID-19 infections,not,severe immunosuppression and _ a cytokine storm characterize covid-19 infections,severe immunosuppression and also a cytokine storm characterize covid-19 infections,https://insight.jci.org/articles/view/140329,"[('Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections.', 0.9891231), ('Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.', 0.7618035), ('We conclude that the major immunologic abnormality in COVID-19 is a profound defect in host immunity and not hypercytokinemia-induced organ injury.', 0.75828195), ('In contrast, non-specific inflammatory markers appeared to be relatively comparable between COVID-19 and non-COVID-19 illnesses.', 0.7000823), ('The results from the present study strongly suggest that the primary endotype of COVID-19 is one of immunosuppression rather than hyperinflammation.', 0.6923779)]"
236,Treatment with ACE-inhibitors is not associated with early severe SARS-Covid-19 infection in a multi-site UK acute Hospital Trust,not,treatment with ace-inhibitors is _ associated with early severe sars-covid-19 infection in a multi-site uk acute hospital trust,treatment with ace-inhibitors is also associated with early severe sars-covid-19 infection in a multi-site uk acute hospital trust,https://www.researchgate.net/publication/340261837_Treatment_with_ACE-inhibitors_is_not_associated_with_early_severe_SARS-Covid-19_infection_in_a_multi-site_UK_acute_Hospital_Trust,"[('Share ACE-inhibitors and Angiotensin-2 Receptor Blockers are not associated with severe SARS-COVID19 infection in a multi-site UK acute Hospital Trust Daniel M Bean, Zeljko Kraljevic, Thomas Searle, Rebecca Bendayan, Kevin O’Gallagher, Andrew Pickles, Amos Folarin, Lukasz Roguski, Kawsar Noor, Anthony Shek, Rosita Zakeri, Ajay M Shah, James TH Teo, Richard JB Dobson medRxiv 2020.04.07.20056788; doi: https://doi.org/10.1101/2020.04.07.20056788 Share This Article: Copy Citation Tools ACE-inhibitors and Angiotensin-2 Receptor Blockers are not associated with severe SARS-COVID19 infection in a multi-site UK acute Hospital Trust Daniel M Bean, Zeljko Kraljevic, Thomas Searle, Rebecca Bendayan, Kevin O’Gallagher, Andrew Pickles, Amos Folarin, Lukasz Roguski, Kawsar Noor, Anthony Shek, Rosita Zakeri, Ajay M Shah, James TH Teo, Richard JB Dobson medRxiv 2020.04.07.20056788; doi: https://doi.org/10.1101/2020.04.07.20056788 ', 0.72872657), ('You are going to email the following ACE-inhibitors and Angiotensin-2 Receptor Blockers are not associated with severe SARS-COVID19 infection in a multi-site UK acute Hospital Trust Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website.', 0.650255), ('Conclusions There was no evidence for increased severity of COVID19 disease in hospitalised patients on chronic treatment with ACEi or ARB.', 0.5758574), ('The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.', 0.4199497), ('This paper represents independent research part funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London.', 0.38081306)]"
237,Melatonin is significantly associated with survival of intubated COVID-19 patients,significantly,melatonin is _ associated with survival of intubated covid-19 patients,melatonin is not associated with survival of intubated covid-19 patients,https://www.medrxiv.org/content/10.1101/2020.10.15.20213546v1,"[('Conclusions Melatonin exposure after intubation is significantly associated with a positive outcome in COVID-19 and non-COVID-19 patients.', 0.8548639), ('Additionally, melatonin exposure after intubation was statically associated with a positive outcome in COVID-19 patients (demographics and comorbidities adjusted HR: 0.127, 95% CI: 6.01E-02 - 0.269, p-value = 7.15E-08).', 0.79401016), ('Melatonin exposure after intubation was statistically associated with a positive outcome in COVID-19 (demographics and comorbidities adjusted HR: 0.131, 95% CI: 7.76E-02 - 0.223, p-value = 8.19E-14) and non-COVID-19 (demographics and comorbidities adjusted HR: 0.278, 95% CI: 0.142 - 0.542, p-value = 1.72E-04) intubated patients.', 0.7465127), ('Additionally, melatonin exposure after intubation is significantly associated with a positive outcome in COVID-19 patients requiring mechanical ventilation.', 0.7425933), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template', 0.38284928)]"
238,The effectiveness of interventions to reduce COVID-19 transmission in a large urban jail,reduce,the effectiveness of interventions to _ covid-19 transmission in a large urban jail,the effectiveness of interventions to enhance covid-19 transmission in a large urban jail,https://www.medrxiv.org/content/10.1101/2020.06.16.20133280v1,"[('Policy Implications Decision-makers should prioritize reductions in the jail population, single celling, and testing asymptomatic populations, as additional measures to manage COVID-19 within correctional settings.', 0.77477276), ('Conclusions Depopulation, single celling, and asymptomatic testing within jails can be effective strategies to mitigate COVID-19 transmission in addition to standard public health measures.', 0.70288783), ('Methods We developed a stochastic dynamic transmission model of COVID-19 in one large urban U.S. jail among staff and incarcerated individuals.', 0.6423021), ('We estimated the fraction of new cases, hospitalizations, and deaths averted by these interventions along with the standard measures of sanitization, masking, and social distancing interventions.', 0.34102315), ('Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study was deemed exempt from IRB review by the Yale Human Investigation Committee as we received completely anonymized data from the jail.', 0.33372223)]"
239,Trial of Oxford COVID-19 vaccine in South Africa begins,africa,trial of oxford covid-19 vaccine in south _ begins,trial of oxford covid-19 vaccine in south Taiwan begins,http://www.ox.ac.uk/news/2020-06-23-trial-oxford-covid-19-vaccine-south-africa-begins,"[('“We began screening participants for the South African Oxford 1 Covid-19 vaccine trial last week and the first participants will be vaccinated this week,” says Madhi, who is also the National Research Foundation/Department of Science and Innovation SARChI (South African Research Chairs Initiative) Chair in Vaccine Preventable Diseases, based at the University of the Witwatersrand.', 0.8189014), ('The South African Ox1Cov-19 Vaccine VIDA-Trial aims to find a vaccine that will prevent infection by SARS-CoV-2, the virus that causes COVID-19.', 0.8097763), ('Shabir Madhi, Professor of Vaccinology at Wits University and Director of the South Africa Medical Research Council (SAMRC) Vaccines and Infectious Diseases Analytics Research Unit (VIDA), leads the South African Ox1Cov-19 Vaccine VIDA-Trial.', 0.7594257), ('About the South African vaccine trial The technical name of the vaccine is ChAdOx1 nCoV-19, as it is made from a virus called ChAdOx1, which is a weakened and non-replicating version of a common cold virus (adenovirus).', 0.73270726), ('The first clinical trial in South Africa and on the continent for a COVID-19 vaccine was announced today, 23 June, at a virtual press conference hosted by the University of the Witwatersrand, Johannesburg (Wits).', 0.7221588)]"
240,Landmark legal ruling finds that Covid tests are not fit for purpose .,not,landmark legal ruling finds that covid tests are _ fit for purpose .,landmark legal ruling finds that covid tests are good fit for purpose.,https://www.rt.com/op-ed/507937-covid-pcr-test-fail/?fbclid=IwAR2mCEgNpvToyMmKHfcAcmyuC1Wwmhgk3tLQu9r6vWo5qGC7ymy1cAWofm4,"[('In the eyes of this court, then, a positive test does not correspond to a Covid case.', 0.6181195), ('The implication was that the results could not be trusted.', 0.4549304), ('Read more Immunity for YEARS or DECADES: Covid resistance may last much longer than previously thought, says new research They were also scathing about the reliability of the PCR (polymerase chain reaction) test, the most commonly used check for Covid.', 0.45330507), ('It showed that if someone tested positive for Covid at a cycle threshold of 35 or higher, the chances of that person actually being infected is less than three percent, and that "" the probability of… receiving a false positive is 97% or higher.""', 0.40755284), ('And it is not the only country whose institutions are clashing with received wisdom on Covid.', 0.40734392)]"
246,"'In a few weeks , we will have coronavirus vaccine '",weeks,"'in a few _ , we will have coronavirus vaccine '","'in a few years, we will have coronavirus vaccine '",https://www.jpost.com/HEALTH-SCIENCE/Israeli-scientists-In-three-weeks-we-will-have-coronavirus-vaccine-619101,"[('Yes, in a few weeks, if it all works, we would have a vaccine to prevent coronavirus.""', 0.84254616), ('""We are in the middle of this process, and hopefully in a few weeks we will have the vaccine in our hands.', 0.68590903), ('""Given the urgent global need for a human coronavirus vaccine, we are doing everything we can to accelerate development,"" MIGAL CEO David Zigdon said.', 0.54303473), ('The vaccine could ""achieve safety approval in 90 days,"" he said.', 0.52349544), ('Coronavirus Israel News WORLD NEWS Middle East U.S.', 0.5108677)]"
250,Co-author of controversial hydroxychloroquine study has 2018 paper corrected for unintentional mistake,2018,co-author of controversial hydroxychloroquine study has _ paper corrected for unintentional mistake,co-author of controversial hydroxychloroquine study has no paper corrected for unintentional mistake,https://retractionwatch.com/2020/07/23/co-author-of-controversial-hydroxychloroquine-study-has-2018-paper-corrected-for-unintentional-mistake/,"[('Here’s the correction for “Identification of rickettsial immunoreactive proteins using a proximity ligation assay Western blotting and the traditional immunoproteomic approach,” which came four months after scientific sleuth Elisabeth Bik pointed out potential issues in Figure 2 on PubPeer: > The authors regret to have made an unintentional mistake during the > conception of Figure 2.', 0.41905087), ('One of the institution’s deans and star researchers, Chen-Yu Zhang, had arranged the section and written an article for it as well -- a piece Witwer described as essentially an advertorial for Zhang’s questionable research.', 0.40956873), ('That victory... Nick Brown Interesting piece by @BenNHWalker, but this chart looks a lot like the ecological fallacy.', 0.39639562), (""Central to the concerns is that the authors s… Nick Brown The comments on @RetractionWatch's coverage of the expression of concern on the @PLOSONE COVID/Vitamin D article are every bit as sober, dispassionate, and nuanced as you would expect."", 0.392756), ('8 Paper suggesting vitamin D might protect against COVID-19 earns an expression of concern Ivan Oransky \\- Retraction Watch 84d 5 tweets PLOS ONE has issued an expression of concern for a paper it published last month suggesting that vitamin D might protect against severe COVID-19.', 0.3618169)]"
251,Droplets and Aerosols generated by singing and the risk of COVID-19 for choirs,singing,droplets and aerosols generated by _ and the risk of covid-19 for choirs,droplets and aerosols generated by coughing and the risk of covid-19 for choirs,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1241/5908276,"[('These results points toward the possibility of COVID-19 spread by small airborne droplets during singing.', 0.7593425), ('Our visualisation and velocimetry results reveal that majority of droplets expelled during singing follow the ambient airflow pattern.', 0.5409215), (""PMID: 23855264 'Singing has empowered, enchanted and enthralled me'-choirs for wellbeing?"", 0.5186678), ('PMID: 30715392 The Effects of Three Physical and Vocal Warm-Up Procedures on Acoustic and Perceptual Measures of Choral Sound.', 0.51296556), ('Protection for Otolaryngologic Surgery in the COVID-19 Pandemic.', 0.40047583)]"
255,The papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy,disrupt,the papain-like protease of coronaviruses cleaves ulk1 to _ host autophagy,the papain-like protease of coronaviruses cleaves ulk1 to facilitate host autophagy,https://www.biorxiv.org/content/10.1101/2020.10.23.353219v1,"[('Using murine hepatitis virus-A59 (MHV-A59) as a model betacoronavirus , time-course infections revealed a significant loss in the protein level of ULK1, a canonical autophagy regulating serine-threonine kinase, and the concomitant appearance of a possible cleavage fragment.', 0.60911345), ('Autophagy modulators have emerged as potential therapeutic candidates against SARS-CoV-2 but recent clinical setbacks underline the urgent need for better understanding the mechanism of viral subversion of autophagy.', 0.5690323), ('Consistent with this, over-expression of SARS-CoV-2 PLpro is sufficient to impair starvation-induced canonical autophagy and disrupt formation of ULK1-ATG13 complex.', 0.5325678), ('In conclusion, our study identified a new mechanism by which PLpro of betacoronaviruses induces viral pathogenesis by targeting cellular autophagic pathway (Word count=250) IMPORTANCE The recent COVID-19 global pandemic alongside the 2003 SARS and 2012 MERS outbreaks underscore an urgent need to better understand betacoronaviruses as pathogens that pose global challenge to human health.', 0.52418923), ('To investigate whether virus-encoded proteases target this protein, we conducted in vitro and cellular cleavage assays and identified ULK1 as a novel bona fide substrate of SARS-CoV-2 papain-like protease (PLpro).', 0.5021715)]"
260,"Dr. Vladimir Zelenko has now treated 699 coronavirus patients with 100 % success using Hydroxychloroquine Sulfate , Zinc and Z-Pak",100,"dr. vladimir zelenko has now treated 699 coronavirus patients with _ % success using hydroxychloroquine sulfate , zinc and z-pak","dr. vladimir zelenko has now treated 699 coronavirus patients with 5 % success using hydroxychloroquine sulfate, zinc and z-pak",https://techstartups.com/2020/03/28/dr-vladimir-zelenko-now-treated-699-coronavirus-patients-100-success-using-hydroxychloroquine-sulfate-zinc-z-pak-update/,"[('March 31 Update : Dr. Vladimir Zelenkoprovides important update on three drug regimen of Hydroxychloroquine Sulfate, Zinc and Azithromycin (Z-Pak) he used to effectively treat 699 coronavirus patients with 100% success 0 Shares Share On Facebook Tweet It ', 0.67348087), ('April 5 Update : Dr. Vladimir Zelenko said in a video interview that acocktail of Hydroxychloroquine, Zinc Sulfate and Azithromycin are showing phenomenon results with 900 coronavirus patients treated.', 0.60314214), ('Last Wednesday, we published the success story from Dr. Vladimir Zelenko, a board-certified family practitioner in New York, after he successfully treated 350 coronavirus patients with 100 percent success using a cocktail of drugs: hydroxychloroquine, in combination with azithromycin (Z-Pak), an antibiotic to treat secondary infections, and zinc sulfate.', 0.5859068), ('Now, Dr. Zelenko provides updates on the treatment after he successfully treated 699 COVID-19 patients in New York.', 0.58346707), ('In an exclusive interview with former New York Mayor, Rudy Giuliani, Dr. Vladmir Zelenko shares the results of his latest study, which showed that out of his 699 patients treated, zero patients died, zero patients intubated, and four hospitalizations.', 0.5320546)]"
262,Causal empirical estimates suggest COVID-19 transmission rates are highly seasonal,highly,causal empirical estimates suggest covid-19 transmission rates are _ seasonal,causal empirical estimates suggest covid-19 transmission rates are low seasonal,https://www.medrxiv.org/content/10.1101/2020.03.26.20044420v1,"[('It has been hypothesized that if COVID-19 exhibits seasonality, changing temperatures in the coming months will shift transmission patterns around the world.', 0.7178088), ('However, these patterns reverse as the boreal winter approaches, with seasonal temperatures in January 2021 increasing average COVID-19 transmission by 59% relative to March 2020 in northern countries and lowering transmission by 2% in southern countries.', 0.4879082), ('Moreover, Northern Hemisphere countries face a crucial window of opportunity: if contagion-containing policy interventions can dramatically reduce COVID-19 cases with the aid of the approaching warmer months, it may be possible to avoid a second wave of COVID-19 next winter.', 0.47722894), ('Using constructions of expected seasonal temperatures, we project that changing temperatures between March 2020 and July 2020 will cause COVID-19 transmission to fall by 43% on average for Northern Hemisphere countries and to rise by 71% on average for Southern Hemisphere countries.', 0.4646781), ('Our statistical approach separates effects of climate variation on COVID-19 transmission from other potentially correlated factors, such as differences in public health responses across countries and heterogeneous population densities.', 0.45092404)]"
263,A man in Hong Kong is the first confirmed case of coronavirus reinfection,man,a _ in hong kong is the first confirmed case of coronavirus reinfection,a gift in hong kong is the first confirmed case of coronavirus reinfection,https://www.sciencenews.org/article/coronavirus-covid-19-first-case-reinfection-man-hong-kong,"[('archived recording Researchers in China say a 33-year-old man living in Hong Kong is the first person confirmed to have been reinfected with the coronavirus.', 0.72246456), ('So the case is about a man who gets infected in Hong Kong early in the year, recovers.', 0.6838639), ('He tested positive for the coronavirus on March 26 and was admitted to a hospital in Hong Kong three days later.', 0.6073277), ('Hamilton, Ontario A 33 year old man from Hong Kong is reported to have the first confirmed case of covid reinfection.', 0.60108376), ('The reinfection case underscores the need for a vaccine that produces a powerful immune response, scientists said.Credit...Anthony Kwan/Getty Images By Apoorva Mandavilli Aug. 24, 2020 阅读简体中文版閱讀繁體中文版 A 33-year-old man was infected a second time with the coronavirus more than four months after his first bout, the first documented case of so-called reinfection, researchers in Hong Kong reported Monday.', 0.5915431)]"
265,Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19,drives,imbalanced host response to sars-cov-2 _ development of covid-19,imbalanced host response to sars-cov-2 prevents development of covid-19,https://www.cell.com/cell/fulltext/S0092-8674(20)30489-X?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS009286742030489X%3Fshowall%3Dtrue,"[('Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications.', 0.6224082), ('Keywords: COVID-19; Coronavirus; IL6; SARS-CoV-2; chemokines; ferret; interferon; transcriptomics; virus-host interactions.', 0.5779335), ('Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response.', 0.5366145), ('We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19.', 0.5263524), ('(B and C) Cytokine profiles of COVID-19 patients.', 0.5176859)]"
266,"Largest Statistically Significant Study by 6,200 Multi-Country Physicians on COVID-19 Uncovers Treatment Patterns and Puts Pandemic in Context",largest,"_ statistically significant study by 6,200 multi-country physicians on covid-19 uncovers treatment patterns and puts pandemic in context","No statistically significant study by 6,200 multi-country physicians on covid-19 uncovers treatment patterns and puts pandemic in context",https://www.sermo.com/press-releases/largest-statistically-significant-study-by-6200-multi-country-physicians-on-covid-19-uncovers-treatment-patterns-and-puts-pandemic-in-context/,"[('To create a centralized and dynamic knowledge base, Sermo, the largest global healthcare polling company and social platform for physicians, leveraged its capabilities to publish results of a COVID-19 study with more than 6,200 physicians in 30 countries.', 0.73951316), ('Key findings; Sermo Real Time Barometer : Treatments & Efficacy The three most commonly prescribed treatments amongst COVID-19 treaters are 56% analgesics, 41% Azithromycin, and 33% Hydroxychloroquine Hydroxychloroquine usage amongst COVID-19 treaters is 72% in Spain, 49% in Italy, 41% in Brazil, 39% in Mexico, 28% in France, 23% in the U.S., 17% in Germany, 16% in Canada, 13% in the UK, and 7% in Japan Hydroxychloroquine was overall chosen as the most effective therapy amongst COVID-19 treaters from a list of 15 options.', 0.619321), ('(37% of COVID-19 treaters) 75% in Spain, 53% Italy, 44% in China, 43% in Brazil, 29% in France, 23% in the U.S., and 13% in the UK The two most common treatment regimens for Hydroxychloroquine were: (38%) 400mg twice daily on day one; 400 mg daily for five days (26%) 400mg twice daily on day one; 200mg twice daily for four days Outside the U.S., Hydroxychloroquine was equally used for diagnosed patients with mild to severe symptoms whereas in the U.S. it was most commonly used for high risk diagnosed patients Globally, 19% of physicians prescribed or have seen Hydroxychloroquine prophylactically used for high risk patients, and 8% for low risk patients Second Wave of Outbreak Story continues The second global outbreak is anticipated by 83% of global physicians, 90% of U.S. physicians but only 50% of Chinese physicians Average Testing Time On average tests in the U.S. take 4-5 days, and in 10% of cases the wait is more than 7 days 14% of U.S. physicians and over 50% in all of Europe and Japan report getting test results in 24 hours; in China 73% of doctors get tests back in 24 hours, while 8% get tests back within the hour Prioritizing Treatment if Ventilator Shortage In all countries except China, the top criteria for deciding who should receive a ventilator first was patients with the highest chance of recovery (47%) followed by those most ill and at highest risk of death (21%), then first responders (15%) In China the priorities were reversed as the most ill and highest risk of death received ventilators First responders were more important in the U.S. France, Japan, and Italy prioritized age Brazil and Russia prioritized higher risk patients Peak Timing & Restrictions In the U.S., 63% of physicians recommend restrictions be lifted six or more weeks from now and 66% believe the peak is at least 3-4 weeks away For the full methodology click here.', 0.5741984), ('During the quarter, the company passed 50,000 iFuse procedures, handled by 2,200 surgeons around the world.', 0.53006285), ('Data covers current treatment and prophylaxis options, timing to the outbreak peak, ethical choices, effectiveness of government responses, and much more.', 0.47064248)]"
268,We Had the COVID-19 Vaccine the Whole Time,whole,we had the covid-19 vaccine the _ time,we had the covid-19 vaccine the next time,https://nymag.com/intelligencer/2020/12/moderna-covid-19-vaccine-design.html,"[('The whole time, we also knew that the Moderna vaccine was essentially safe.', 0.6085763), ('And then we formulate that into a vaccine using essentially the same technology platform that all the other influenza vaccines are based on.” The whole process takes a few months, and utilizes a “platform” that we already know is basically safe.', 0.58291054), ('This is — as the country and the world are rightly celebrating — the fastest timeline of development in the history of vaccines.', 0.5571372), ('More precisely, they thought it would be possible to do all the research, development, preclinical testing, and Phase I trials for new viral pandemics before those new viruses had even emerged — to have those vaccines sitting on the shelf and ready to go when they did.', 0.49080205), ('Just one drug, the steroid dexamethasone, has proven to be a worthwhile treatment for COVID-19 in a randomized control trial — though given too early, it too can be dangerous.', 0.4894282)]"
269,"Sleep quality has declined since COVID-19 lockdown , particularly among those working from home",declined,"sleep quality has _ since covid-19 lockdown , particularly among those working from home","sleep quality has increased since covid-19 lockdown, particularly among those working from home",https://www.psypost.org/2020/09/sleep-quality-has-declined-since-covid-19-lockdown-particularly-among-those-working-from-home-57863,"[('Interestingly, those who reported ‘smart working’ — using technology to work from home —showed a greater loss in sleep quality than those who did not.', 0.6514543), ('When it came to specific aspects of sleep, participants showed increased sleep disturbance and daytime dysfunction, less efficient sleep, and an increase in the time it took them to fall asleep.', 0.6352695), ('Working from home may lead to increased screen time, including time spent in front of the computer or television screen late at night, which can impact sleep quality.', 0.6269637), ('The researchers address how stress related to the pandemic likely affected participants’ sleep, creating a destructive cycle.', 0.5776669), ('Unsurprisingly, participants also reported reduced physical activity during the lockdown.', 0.4919433)]"
270,We Made One Gram of Remdesivir !,one,we made _ gram of remdesivir !,we made no gram of remdesivir!,https://www.acsh.org/news/2020/03/26/problem-remdesivir-making-it-14665,"[('This... Scheme 1.', 0.53313047), ('The weight of the isolated product that was obtained in this way ranged from 10-61 mg (!).', 0.4776491), (""Gilead's first generation synthetic scheme for remdesivir."", 0.4622951), ('This is one of them.', 0.45583802), (""Yes, you're getting about 1/200th of the theoretical amount!"", 0.4490372)]"
271,Two Case Reports,two,_ case reports,One case reports,https://pubmed.ncbi.nlm.nih.gov/32574433/,"[('2.', 0.62117), ('Full size table This paper reports two cases of TPP, one of which was associated with blunt trauma and the other, with penetrating trauma.', 0.5339528), ('In the two cases presented here, TPP was not diagnosed with chest x-ray imaging on the first day.', 0.43440017), ('Report of three cases.', 0.4180883), ('CAS Article PubMed Google Scholar 2.', 0.4091791)]"
278,ESC Council on Hypertension Says ACE-I and ARBs Do Not Increase COVID-19 Mortality,not,esc council on hypertension says ace-i and arbs do _ increase covid-19 mortality,esc council on hypertension says ace-i and arbs do also increase covid-19 mortality,https://www.dicardiology.com/content/esc-council-hypertension-says-ace-i-and-arbs-do-not-increase-covid-19-mortality,"[('Despite some early report theorizing these drugs might play a role to increase COVID-19 mortality, the Council on Hypertension of the ESC pointed out the lack of any evidence supporting harmful effect of ACE-I and ARB in the context of the pandemic COVID-19 outbreak.', 0.6279534), ('Watch the VIDEO: Cancelling Non-essential Cardiac Procedures During the COVID-19 Outbreak — an interview with SCCT President Ehtisham Mahmud, M.D., For more information: https://www.escardio.org/Councils/Council-on- Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension- on-ace-inhibitors-and-ang ', 0.5925301), ('""This speculation about the safety of ACE-i or ARB treatment in relation to COVID-19 does not have a sound scientific basis or evidence to support it.', 0.52648413), ('The Council on Hypertension strongly recommends that physicians and patients should continue treatment with their usual anti-hypertensive therapy because there is no clinical or scientific evidence to suggest they cause any harm in COVID-19 infections.', 0.52556014), ('Read more on ACC COVID-19 recommendations for the cardiovascular care team.', 0.45729673)]"
279,SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus,induce,sars-cov-2 proteins and anti-covid-19 drugs _ lytic reactivation of an oncogenic virus,sars-cov-2 proteins and anti-covid-19 drugs prevent lytic reactivation of an oncogenic virus,https://www.biorxiv.org/content/10.1101/2020.10.02.324228v1,"[('In the current study, we have reported that SARS-CoV-2 encoded proteins and some anti-COVID-19 drugs currently used are able to induce lytic reactivation of Kaposi’s sarcoma- associated herpesvirus (KSHV), one of major human oncogenic viruses through manipulation of intracellular signaling pathways.', 0.8569343), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.53823453), ('Therefore, it is required to investigate the impacts of COVID-19 on pre-existing diseases of patients, such as cancer and other infectious diseases.', 0.499025), ('Our data indicate that those KSHV+ patients especially in endemic areas exposure to COVID-19 or undergoing the treatment may have increased risks to develop virus-associated cancers, even after they have fully recovered from COVID-19.', 0.48424262), ('Due to the mechanisms of SARS-CoV-2 infection to host cells and its pathogenesis remain largely unclear, there are currently no antiviral drugs with proven efficacy nor are there vaccines for its prevention.', 0.45502752)]"
281,NEW CAR SALES RISE AFTER COVID-19 LOCK-DOWN DECLINE,rise,new car sales _ after covid-19 lock-down decline,new car sales decreased after covid-19 lock-down decline,https://industryglobalnews24.com/united-kingdom-new-car-sales-rise-after-covid19-lockdown-decline,"[('The new car registrations in United Kingdom.... Click here to read more Tags : Car Sales, SHARE THIS ARTICLE ', 0.32635757), ('Create Account Click here to go back × ', 0.22850806), ('Login to your Industry Global News24 account Sign in ', 0.2234697), ('☰ Menu Business Healthcare Markets Fashion Entertainment Technology Industry Chemicals Sports Politics and Nation Services Energy and Power Press Release Economy Corporate Trends Innovations Deals Company Results and Outlook Disease Pharmaceuticals Biotechnology Research & Discovery Wellness Products & Health Commodities IPO Forex Stocks Bonds India Market US Market Currencies Cosmetic & Beauty Fashion Tech Design Mens Fashion Womens Fashion Celebrity Movies Art & Media Music Dance Gadgets Emerging Technologies IT/Services Hardware Software Automobile Banking/Finance Consumer Goods Agriculture Education Logistic and Transport Construction Food Manufacturing Telecom News Bio Chemicals Specialty Chemicals Chemical Tech Plastics Petro Chemicals Cricket Football Others Atheletics National International Press Conferences & Submits Announcements Market Intelligence Analytics Specialist Serivces Retail Travel Advertising consultancy Oil and Gas Renewable Energy Environment Conventional energy Fuel Logistic System Clean Energy Geo Thermal Energy Healthcare Technology Services SIGN IN 3 Home About Us Authors Contact Us VideoGraphics United States India Japan South Korea European Union China Worldwide ', 0.18025409), ('Sign Up Industry Global New 24 LLC, 25110 Sundance park lane, Katy TX 77494 © 2019-2020 Industry Global News 24, All rights reserved Business Healthcare Markets Fashion Entertainment Technology Industry Chemicals Sports Services Sign In About Us Authors Contacts Terms & Condition Privacy Policy ', 0.17853953)]"
282,"The newly introduced SARS-CoV-2 variant A222V is rapidly spreading in Lazio region , Italy",rapidly,"the newly introduced sars-cov-2 variant a222v is _ spreading in lazio region , italy","the newly introduced sars-cov-2 variant a222v is not spreading in lazio region, italy",https://www.medrxiv.org/content/10.1101/2020.11.28.20237016v1,"[('A222V, first recognized in August, represents 11.2% of sequences in this period, reaching 100% of autochthonous sequences in October, supporting increased GV circulation in Italy.', 0.6554965), ('To establish the A222V variant involvement in the infection rise in Italy, all GISAID sequences from Italy and those from our Laboratory (Lazio) in the period June- October were analysed.', 0.5692322), ('Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This work was performed within the framework of the COVID-19 outbreak response and surveillance program, and has been approved by the INMI Ethical Committee (Comitato Etico INMI Lazzaro Spallanzani IRCCS/Comitato Etico Unico Nazionale Covid-19; issue n. 214/20-11-2020).', 0.28007665), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.23430301), ('871029).', 0.23183438)]"
283,Pandemic infection rates are deterministic but can not be modeled,not,pandemic infection rates are deterministic but can _ be modeled,pandemic infection rates are deterministic but can then be modeled,https://aip.scitation.org/doi/10.1063/5.0015303,"[('Model predictions fail because the observed infection rates are beyond modeling: any model that uses fixed rates or uses memory or averages of past rates cannot reproduce the data on active infections.', 0.72672975), ('Second, model building does not and cannot reflect real epidemic data because the only correct rates emerge day by day in the daily data, cannot be usefully forecast for more than a few days in advance, and cannot be forecast at all correctly near a peak.', 0.7201314), ('SUMMARYREFERENCES The pandemic infection rates to two to three decimal places are an example of complexity: the infection rates can be calculated daily from the infections but they cannot be modeled and predicted from fixed initial conditions.', 0.7133857), ('However, there is no such relationship between a past average and future rate jumps in real infection data.', 0.6563421), ('However, since the real, observed data do not obey (24), this ansatz unfortunately does not inform us about epidemics.', 0.6442734)]"
286,Herd immunity is not a realistic exit strategy during a COVID-19 outbreak,not,herd immunity is _ a realistic exit strategy during a covid-19 outbreak,herd immunity is also a realistic exit strategy during a covid-19 outbreak,https://www.researchsquare.com/article/rs-25862/v1,"[('Therefore, reported COVID-19 cases do not reflect the true scale of outbreak5-9.', 0.65783596), ('The ""herd immunity"" in the case of an epidemic with a pathogen with potential fatal outcome is not achievable because it\'s essential mechanism, randomisation of immunised (R) within a society is not achievable.', 0.62489796), ('This study provides vital information on the extent of virus spread in a country where social distancing is in place, concluding that herd immunity to SARS-CoV-2 is not a realistic short-term exit strategy option.', 0.60697716), ('Natural herd immunity has been suggested as a potential exit strategy during COVID-19 outbreaks, which may arise when 50-67% of a community has been infected10.', 0.5906813), ('Before anybody thinks that ""herd immunity"" is a possibility in real world, this assumption should be tested.', 0.48453337)]"
292,Fauci says he wears a mask to be a symbol of what 'you should be doing ',mask,fauci says he wears a _ to be a symbol of what 'you should be doing ',fauci says he wears a point to be a symbol of what 'you should be doing ',https://edition.cnn.com/2020/05/27/politics/fauci-coronavirus-wear-masks-cnntv/index.html,"[('Fauci said he believes that while wearing a mask is not ""100% effective,"" it is a valuable safeguard and shows ""respect for another person.""', 0.63547194), ('The wearing of masks while out in public has emerged as a politically charged issue as Trump has called for a return to pre-pandemic life in the hopes of revitalizing the US economy.', 0.40098068), ('He has repeatedly declined opportunities to wear a mask in public, telling reporters at a Ford plant in Michigan last week that he ""didn\'t want to give the press the pleasure of seeing it,"" though he did wear a mask while touring parts of the plant.', 0.37428892), ('""I want to protect myself and protect others, and also because I want to make it be a symbol for people to see that that\'s the kind of thing you should be doing,"" Fauci, the nation\'s top infectious disease expert and a member of the White House\'s coronavirus task force, told CNN\'s Jim Sciutto on ""Newsroom.""', 0.33895668), ('This week, Trump shared a tweet that mocked former Vice President Joe Biden for wearing a mask Monday at a Memorial Day ceremony, prompting the presumptive 2020 Democratic presidential nominee to call Trump ""an absolute fool.""', 0.25053585)]"
293,The first case of documented Covid-19 reinfection in Israel,first,the _ case of documented covid-19 reinfection in israel,the latter case of documented covid-19 reinfection in israel,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528892/,"[('We describe a case of confirmed Covid -19 reinfection in Israel, where the infection rates have been among the highest worldwide [6].', 0.7697332), ('CGTN: Ecuador confirms first case of COVID-19 reinfection.', 0.63141906), ('Two cases of Covid -19 reinfection reported in Europe.', 0.6021601), ('Keywords: COVID 19, Reinfection, Israel, Immunity, Antibodies ', 0.5716007), ('He made a full recovery with negative viral tests, but again tested positive for COVID-19 while traveling home from Europe in mid-August.', 0.43258575)]"
294,Comparative genomics suggests limited variability and similar evolutionary patterns between major clades of SARS-Cov-2,limited,comparative genomics suggests _ variability and similar evolutionary patterns between major clades of sars-cov-2,comparative genomics suggests wide variability and similar evolutionary patterns between major clades of sars-cov-2,https://www.biorxiv.org/content/10.1101/2020.03.30.016790v1,"[('Additional comparative genomics analyses between non SARS-CoV-2 like CoVs.', 0.7881597), ('While levels of genomic variability between SARS-CoV-2 isolates are limited, to our knowledge, it is not clear whether the observed patterns of variability in viral super-clades reflect ongoing adaptation of SARS-CoV-2, or merely genetic drift and founder effects.', 0.64641225), ('Here, we analyze more than 1100 complete, high quality SARS-CoV-2 genome sequences, and provide evidence for the absence of distinct evolutionary patterns/signatures in the genomes of the currently known major clades of SARS-CoV-2.', 0.5970616), ('Although this study can not be conclusive, we believe that the evidence presented here is strongly consistent with the notion that the biased geographic distribution of SARS- CoV-2 isolates should not be associated with adaptive evolution of this novel pathogen.', 0.596205), ('We observe that while cross species adaptation of the virus is associated with hypervariability of specific protein coding regions (including the RDB domain of the spike protein), the more variable genomic regions between extant SARS- CoV-2 episomes correspond with the 3’ and 5’ UTRs, suggesting that at present viral protein coding genes should not be subjected to different adaptive evolutionary pressures in different viral strains.', 0.5875536)]"
295,Coronavirus Case Counts Are Meaningless*,meaningless,coronavirus case counts are _*,coronavirus case counts are defined*,https://fivethirtyeight.com/features/coronavirus-case-counts-are-meaningless/,"[('CORRECTION (April 13, 2020, 1:47 p.m.): In describing what it would take for the new coronavirus to begin to die out, a previous version of this story incorrectly referred to the R value falling below zero, which is not possible.', 0.537192), ('But, as in the case of real coronavirus models, there are an awful lot of messy, real-world problems we need to consider, too.', 0.4580645), ('At the same time, the parameters in each scenario reflect what I hope are semi-realistic assumptions that at least loosely approximate the coronavirus situation in different groups of countries.', 0.4549964), (""By a generation, I don't mean the Baby Boomers or something like that -- I mean one round of infections."", 0.43697143), (""Given that includes people who probably do have the coronavirus (since asymptomatic cases are fairly common), we can assume the rate of false positives is even lower -- for the purpose of the scenarios, we'll guess that it's 0.2 percent."", 0.43610513)]"
299,ACE2 exhibits protective action against thrombosis,protective,ace2 exhibits _ action against thrombosis,ace2 exhibits no action against thrombosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811560/,"[('Does this affect the protective effect of ACE2?', 0.70567334), ('Taken together, ACE2 plays a protective role in both cardiovascular diseases and acute lung injury.', 0.7041128), ('Summary In clinical practice the protective effects of ARBs and ACEIs are thought to be associated with an increase in ACE2 expression and their inhibition of the overactive renin-angiotensin system through reduction of Ang II effects.', 0.6744284), ('Therefore, induction of the downstream pathway of ACE2, by activating the ACE2/Ang1-7/MAS axis may prove a useful strategy in preventing lung and cardiovascular damage associated with SARS-CoV-2 infections.', 0.6610242), ('Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease.', 0.6609944)]"
301,Do Lockdowns Bring about Additional Mortality Benefits or Costs ?,mortality,do lockdowns bring about additional _ benefits or costs ?,do lockdowns bring about additional economic benefits or costs?,https://www.medrxiv.org/content/10.1101/2020.08.28.20183699v1,"[('Employing a difference-in-differences method, we find that lockdowns reduced the number of non-COVID-19 deaths by 4.9% (cardiovascular deaths by 6.2%, injuries by 9.2%, and non-COVID-19 pneumonia deaths by 14.3%).', 0.44535306), ('These findings can help better inform policymakers around the world about the benefits and costs of city and community lockdowns policies in dealing with the COVID-19 pandemic.', 0.43957537), ('A back-of-the-envelope calculation shows that more than 32,000 lives could have been saved from non-COVID-19 diseases/causes during the 40 days of the lockdown on which we focus.', 0.38434595), ('The health benefits are likely driven by significant reductions in air pollution, traffic, and human interactions.', 0.31867415), ('The codes necessary to re-produce all the tables in the paper are ready to submit to the journal as supplementary materials or to post on a public repository.', 0.31043154)]"
302,CDC releases new resources and tools to support opening schools,support,cdc releases new resources and tools to _ opening schools,cdc releases new resources and tools to prevent opening schools,https://www.cdc.gov/media/releases/2020/p0723-new-resources-tools-schools.html,"[('""The CDC resources released today will help parents, teachers and administrators make practical, safety-focused decisions as this school year begins.', 0.6636101), ('CDC will host a media telebriefing tomorrow with Dr. Redfield to discuss the new resources: What CDC provide an update to media on the COVID-19 response, including school reopening guidance Who Robert Redfield, M.D., CDC Director Mitchell Zais, Ph.D., Deputy Secretary of Education Erin K. Sauber-Schatz, Ph.D., Lead, CDC Community Interventions and Critical Populations Task Force for the COVID-19 response When 12:30 p.m.', 0.6491252), ('CDC is prepared to work with K-12 schools to safely reopen while protecting the most vulnerable.""', 0.5915253), ('The resources, available at https://www.cdc.gov/coronavirus/2019-ncov/community/schools- childcare/index.html, also provide students, school administrators, parents, guardians, or caregivers the information they need to guide their decision- making on attending in-person curriculum and how to adapt to local conditions.', 0.5721174), ('The resources and tools made available today support how to open schools safely by promoting behaviors that prevent spread, altering how a school and school day is structured, and outlining how to keep the school environment healthy through cleaning, proper ventilation, and other practices.', 0.57202923)]"
303,Mylan to restart production of hydroxychloroquine,restart,mylan to _ production of hydroxychloroquine,mylan to prevent production of hydroxychloroquine,https://www.marketwatch.com/story/mylan-to-restart-production-of-hydroxychloroquine-2020-03-19,"[(""Mylan's hydroxychloroquine-sulfate tablets currently have FDA approval for malaria, lupus erythematosus and rheumatoid arthritis."", 0.34851533), ('The company said it may have a supply in place by mid-April, with the bandwidth to make 50 million tablets, which could treat about 1.5 million patients.', 0.26838526), ('Intraday data delayed at least 15 minutes or per exchange requirements.', 0.22281621), ('Pharmaceuticals ', 0.21866253), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.21688613)]"
305,Use of antiviral drugs to reduce COVID-19 transmission .,reduce,use of antiviral drugs to _ covid-19 transmission .,use of antiviral drugs to enhance covid-19 transmission.,https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30114-5/fulltext,"[('We here assume that an antiviral drug will reduce the viral load of an infected individual with COVID-19.', 0.8781712), ('A prospect on the use of antiviral drugs to control local outbreaks of COVID-19.', 0.7558056), ('Therefore, in the absence of a vaccine, an antiviral drug in addition to isolation could be used to contain the current COVID-19 epidemic.', 0.7377199), ('We investigate the use of contact tracing and isolation in combination with an antiviral compound to control local outbreaks of COVID-19, to avoid such invasive social measures, and to preemptively reduce the burden of the epidemic.', 0.71018016), ('This control measure could be an effective strategy to control local and re-emerging outbreaks of COVID-19.', 0.68853045)]"
306,Adiposity is the Crucial Enhancer of COVID-19,enhance,adiposity is the crucial _ of covid-19,adiposity is the crucial decr of covid-19,https://cardiologyres.org/index.php/Cardiologyres/article/view/1118/1127,"[('Hypercoagulability of COVID-19 patients in intensive care unit.', 0.6512245), ('Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19.', 0.6071896), ('Potential risks for severe COVID-19 in obesity before SARS-CoV-2 infection and the mechanisms for adiposity-mediated exacerbation of COVID-19 were shown in Figure 1.', 0.55064756), ('In conclusion, obese people have various factors including high likelihood of entry of SARS-CoV-2 into human vital tissues, elevated cytokines, endothelial dysfunction and procoagulant state, which may enhance the severity of COVID-19.', 0.5292305), ('Potential risks for severe COVID-19 in obesity before SARS-CoV-2 infection (a) and the mechanisms for adiposity- mediated exacerbation of COVID-19 (b).', 0.5142312)]"
307,New 100 % accurate COVID-19 antibody test approved for use in UK,100,new _ % accurate covid-19 antibody test approved for use in uk,new 50 % accurate covid-19 antibody test approved for use in uk,https://news.sky.com/story/coronavirus-new-100-accurate-covid-19-antibody-test-approved-for-use-in-uk-11987924,"[('The BMJ An antibody blood test for covid-19, which the manufacturer Abbott claims is 99% accurate, has been certified for use by the European Union.', 0.81438506), ('Covid-19: Antibody test that claims to be 99% accurate is certified by EU News ', 0.8054471), ('Covid-19: Antibody test that claims to be 99% accurate is certified by EU BMJ 2020; 369 :m1742 ', 0.76821476), ('The test—which has received its CE mark, meaning that it complies with EU safety rules—detects the antibody IgG to identify whether a person has had covid-19.', 0.7599174), ('The test is designed to help determine if a patient has had COVID-19 and whether they have developed antibodies against it.', 0.66030645)]"
308,Severity of COVID-19 is inversely correlated with increased number counts of non-synonymous mutations in Tokyo,inverse,severity of covid-19 is _ correlated with increased number counts of non-synonymous mutations in tokyo,severity of covid-19 is equally correlated with increased number counts of non-synonymous mutations in tokyo,https://www.medrxiv.org/content/10.1101/2020.11.24.20235952v1,"[('Conclusion Viral genome sequencing in 90 patients treated in the Tokyo Metropolitan area showed that the accumulation of point mutations, including Pro108Ser in 3CLpro and Pro151Leu in nucleocapsid protein, was inversely correlated with COVID-19 severity.', 0.63612926), ('Whether the accumulation of point mutations is correlated with milder manifestations of COVID-19 remains unknown.', 0.55071497), ('Results The number of non-synonymous mutations was inversely correlated with COVID-19 severity, as defined by requiring oxygen supplementation.', 0.5001088), ('Methods We performed SARS-CoV-2 genome sequencing in 90 patients with COVID-19 infection treated at a tertiary medical center in Tokyo between March and August 2020.', 0.34409732), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.26317045)]"
312,Survey suggests aerosol is significant form of COVID-19 transmission,significant,survey suggests aerosol is _ form of covid-19 transmission,survey suggests aerosol is no form of covid-19 transmission,https://www.manchester.ac.uk/discover/news/survey-suggests-aerosol-is-significant-form-of-covid-19-transmission,"[('Taking both samples together, being tall more than doubled the probability of having a COVID 19 medical diagnosis or positive test for people over 6ft.', 0.43559837), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.4092322), ('The data in both countries, argue the researchers, could suggest that aerosol transmission is very likely, with taller individuals at higher risk - something that would not be expected if transmission was exclusively through droplets.', 0.39494634), ('Aerosols can accumulate in poorly ventilated areas and are carried by air currents.', 0.37114084), ('> The results of this survey in terms of associations between height and > diagnosis suggest downward droplet transmission is not the only transmission > mechanism and aerosol transmission is possible Professor Evan Kontopantelis „ Follow me on Twitter (opens in new window) Professor Evan Kontopantelis, from The University of Manchester, said: ""The results of this survey in terms of associations between height and diagnosis suggest downward droplet transmission is not the only transmission mechanism and aerosol transmission is possible.', 0.31335947)]"
313,Saliva sampling is an excellent option to increase the number of SARS CoV2 diagnostic tests in settings with supplies shortages,increase,saliva sampling is an excellent option to _ the number of sars cov2 diagnostic tests in settings with supplies shortages,saliva sampling is an excellent option to reduce the number of sars cov2 diagnostic tests in settings with supplies shortages,https://www.biorxiv.org/content/10.1101/2020.06.24.170324v1,"[('Here, we show that saliva samples treated with a lysis buffer can serve as a suitable source for viral RNA detection, that is cheaper and can be as efficient as the classical protocol that involves column purification of the viral RNA.', 0.60603136), ('Detection of the viral genome through RT-qPCR is the golden standard for this test, however, the high demand of the materials and reagents needed to sample individuals, purify the viral RNA, and perform the RT-qPCR test has resulted in a worldwide shortage of several of these supplies.', 0.5515063), ('Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.', 0.32037267), ('Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search New Results ', 0.3078701), ('In addition, it skips the need for swab sampling, decreases the risk of the healthcare personnel involved in this process, and accelerates the diagnostic procedure.', 0.28826484)]"
316,The Return to the Office Will Only Succeed Through Radical Transparency,only,the return to the office will _ succeed through radical transparency,the return to the office will not succeed through radical transparency,https://forge.medium.com/the-return-to-the-office-will-only-succeed-through-radical-transparency-69821b3c2707?source=grid_home---------0-74-----------------18---0ae11d26_0115_43fb_84f2_c57693fcf4df--,"[('What I realized is that a return to the office will only succeed through radical transparency.', 0.9330367), ('We won’t get it all right, but if we commit to having important conversations using radical transparency, we’ll learn and we’ll grow as we head back to a world very different from the one we left.', 0.5403768), ('For workers making a safe transition back to the office — a situation that I acknowledge is an extremely fortunate one to be in right now — there may be a lot of mixed feelings and anxieties.', 0.4852581), ('Here’s how to help make the process easier — and less anxiety-inducing.', 0.4225205), ('As the journalist Shane Snow writes on Forge: “If you want to be helpful and maintain your healthy boundaries, continually ask yourself this question: What action will help the whole team the most in the long run?” Are there any valuable lessons you learned while working from home that you can bring back to the office?', 0.38201624)]"
318,Phytochemical in Ashwagandha may disrupt Covid-19 's entry on spike protein receptor binding domain,disrupt,phytochemical in ashwagandha may _ covid-19 's entry on spike protein receptor binding domain,phytochemical in ashwagandha may promote covid-19's entry on spike protein receptor binding domain,https://www.researchsquare.com/article/rs-17806/v1,"[('Acharya Balkrishna, Subarna Pokhrel, Jagdeep Singh, Anurag Varshney (2020) Withanone from Withania somnifera May Inhibit Novel Coronavirus (COVID-19) Entry by Disrupting Interactions between Viral S-Protein Receptor Binding Domain and Host ACE2 Receptor.', 0.6613618), ('Withanone from Withania somnifera may inhibit novel coronavirus (COVID-19) entry by disrupting interactions between viral S-protein receptor binding domain and host ACE2 receptor.', 0.63835), ('Potential therapeutic agents for COVID-19 based on the analysis of protease and RNA polymerase potential therapeutic agents for COVID-19 based on the analysis of protease and RNA polymerase docking.', 0.59950763), ('Peptide-like and small-molecule inhibitors against Covid-19.', 0.5696176), ('In these premises, TMPRSS2 has emerged as an attractive therapeutic target against COVID-19.', 0.55384636)]"
321,U.S. to suspend visa services in virus-hit countries including Japan,suspend,u.s. to _ visa services in virus-hit countries including japan,u.s. to provide visa services in virus-hit countries including japan,https://english.kyodonews.net/news/2020/03/ad7b673aa857-us-canada-border-to-be-temporarily-closed-to-non-essential-traffic.html,"[('(File photo) [Getty/Kyodo] Beginning Thursday, the U.S. Embassy in Tokyo and all consulates in Japan will suspend routine nonimmigrant visa appointments, while most services for U.S. citizens will continue.', 0.55316323), ('The State Department decided to suspend visa services in ""response to worldwide challenges related to the outbreak of COVID-19,"" with countries subject to travel advisories higher than level 1 set to be affected, the U.S. Embassy in South Korea said in a statement.', 0.5078207), ('In South Korea, the U.S. embassy said it will cancel all routine immigrant and nonimmigrant visa appointments as of Thursday.', 0.40504003), (""Related coverage: Japan to ask 14-day self-quarantine for travelers from Europe China reports 1 locally transmitted coronavirus case, 12 imported ones Malaysia lockdown over coronavirus spurs workers' rush to Singapore Mar 19, 2020 "", 0.39836112), ('The travel advisory for Japan is at level 2, which calls for U.S. citizens to ""exercise increased caution,"" while that for South Korea is at level 3, or ""reconsider travel.""', 0.35345253)]"
324,Sauna use reduces pneumonia risk,reduces,sauna use _ pneumonia risk,sauna use increased pneumonia risk,https://www.telegraph.co.uk/science/2017/10/09/saunas-cut-pneumonia-risk/,"[('Conclusions: Frequent sauna baths is associated with reduced pneumonia risk in a middle-aged male Caucasian population.', 0.75623745), ('Having frequent sauna baths has been found to be associated with reduced risk of acute and chronic disease conditions.', 0.7384587), ('Frequent sauna baths may be associated with a reduced risk of acute and chronic respiratory conditions in a middle-aged male Caucasian population.', 0.72683054), ('Benefits and risks of sauna bathing.', 0.7110733), ('Still, it’s possible that regular sauna bathing helps reduce blood pressure, inflammation, oxidative stress, circulation of bad cholesterol and stiffness in the arteries, the authors note.', 0.6994466)]"
325,New Method to Reduce COVID-19 Transmission,reduce,new method to _ covid-19 transmission,new method to generate covid-19 transmission,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241285/,"[('Our proposal is to use a circulating wind ultraviolet air disinfector as an additional indoor protection measure, to reduce the risk of airborne transmission of the COVID-19.', 0.5302317), ('These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.', 0.49055278), ('The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1].', 0.42720973), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.3356073), ('Although it cannot be proven to have the effect of killing SARS-CoV-2 and reducing proliferation.', 0.31885996)]"
326,Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs,more,saliva is _ sensitive for sars-cov-2 detection in covid-19 patients than nasopharyngeal swabs,saliva is less sensitive for sars-cov-2 detection in covid-19 patients than nasopharyngeal swabs,https://www.medrxiv.org/content/10.1101/2020.04.16.20067835v1,"[('To validate the use of saliva for SARS-CoV-2 detection, we tested nasopharyngeal and saliva samples from confirmed COVID-19 patients and self-collected samples from healthcare workers on COVID-19 wards.', 0.7620356), ('Taken together, our findings demonstrate that saliva is a viable and more sensitive alternative to nasopharyngeal swabs and could enable at-home self-administered sample collection for accurate large- scale SARS-CoV-2 testing.', 0.74613595), ('Saliva is a promising candidate for SARS-CoV-2 diagnostics because (1) collection is minimally invasive and can reliably be self-administered and (2) saliva has exhibited comparable sensitivity to nasopharyngeal swabs in detection of other respiratory pathogens, including endemic human coronaviruses, in previous studies.', 0.7057436), ('When we compared SARS-CoV-2 detection from patient-matched nasopharyngeal and saliva samples, we found that saliva yielded greater detection sensitivity and consistency throughout the course of infection.', 0.6993059), ('Furthermore, we report less variability in self- sample collection of saliva.', 0.6080961)]"
328,Ten areas of uncertainty waiting to be resolved,ten,_ areas of uncertainty waiting to be resolved,Two areas of uncertainty waiting to be resolved,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235473/,"[('10.', 0.46671844), ('Uncertainty is therefore rife.', 0.42087412), ('These proportions may furthermore change with time.', 0.35065544), ('Both the onset of infectiousness and the interval of 14 days adopted by many countries as the period of continuing infectivity need to be examined critically.', 0.31800097), ('These expectations are mostly unrealistic.', 0.30486262)]"
330,O-GlcNAc transferase promotes influenza A virus–induced cytokine storm by targeting interferon regulatory factor–5,promotes,o-glcnac transferase _ influenza a virus–induced cytokine storm by targeting interferon regulatory factor–5,o-glcnac transferase inhibits influenza a virus–induced cytokine storm by targeting interferon regulatory factor–5,https://advances.sciencemag.org/content/6/16/eaaz7086,"[('5 IAV-induced inflammatory cytokine expression through OGT/IRF5.', 0.7308874), ('These results suggest that IRF5 is at least the major, if not the only, functional OGT target that promotes IAV- regulated cytokine storm.', 0.72131324), ('We hypothesized that OGT regulated IAV-induced cytokine storm via interacting with IRF5.', 0.70388854), ('Furthermore, we characterized OGT-mediated IRF5 O -GlcNAcylation on S430, induced by IAV, as a key mechanism for IRF5 ubiquitination and activation of inflammatory cytokine expression.', 0.7029425), ('S. Liu , MicroRNA-302a suppresses influenza A virus-stimulated interferon regulatory factor-5 expression and cytokine storm induction.', 0.70004696)]"
333,Early intervention is the key to success in COVID-19 control,key,early intervention is the _ to success in covid-19 control,early intervention is the risk to success in covid-19 control,https://www.medrxiv.org/content/10.1101/2020.10.20.20216457v1,"[('We assess the importance of early implementation of interventions for controlling COVID-19.', 0.80137503), ('The timing of interventions is crucial to their success.', 0.62518126), ('Executive Summary Evaluating the effectiveness of New Zealand’s COVID-19 response, relative to hypothetical response scenarios, is important for guiding future response strategies.', 0.5614448), ('These interventions were successful in containing the outbreak and ultimately eliminating community transmission of COVID-19.', 0.4949783), ('Key measures describing the dynamics of a COVID-19 outbreak (notably peak load on the contact tracing system, the total number of reported COVID-19 cases and deaths, and the probability of elimination within a specified time frame), are used to compare outcomes from each scenario with New Zealand’s actual outcomes.', 0.39448494)]"
336,Israel is arresting Palestine 's Doctors fighting COVID-19,israel,_ is arresting palestine 's doctors fighting covid-19,China is arresting palestine's doctors fighting covid-19,https://www.haaretz.com/amp/israel-news/.premium-israeli-police-raid-palestinian-coronavirus-testing-clinic-in-east-jerusalem-1.8767788,"[('The U.S. Food and Drug Administration has authorized emergency use of both chloroquine and hydroxychloroquine for COVID-19 patients.', 0.5615204), ('Turning to COVID-19, he emphasized that there is no alternative to cooperation in fighting the pandemic.', 0.54789996), ('Treating COVID-19 patents with hydroxychloroquine, a derivative of chloroquine generally thought to have less severe side effects, has become standard at many hospitals.', 0.53113437), ('On the radio, they heard medical experts discussing chloroquine and hydroxychloroquine, two antimalarial drugs that President Donald Trump had just touted at a press briefing, despite no conclusive evidence that they can treat COVID-19.', 0.5244771), ('Outlining Israel’s work to mitigate the impact of COVID-19 across the region, he said it is providing resources to the United Nations response, facilitating the flow of medical supplies and food into Gaza and conducting medical trainings for Palestinian health workers.', 0.4786644)]"
338,EagleFeel is a project that attempts to minimize Covid-19 Spread,minimize,eaglefeel is a project that attempts to _ covid-19 spread,eaglefeel is a project that attempts to develop covid-19 spread,https://i.eaglefeel.com/,"[('If you’re reading this, Screaming Eagle, feel free to send me one.', 0.35179162), (""The benchmarks had rallied in recent weeks, buoyed by the start of COVID-19 vaccine rollouts and a surprise cut of crude output by the world's biggest oil exporter, Saudi Arabia."", 0.32315934), ('At a December meeting to lay out economic goals for 2021, the ruling Communist Party signaled that stimulus would be gradually withdrawn, although it would avoid any “sharp turns” in policy.', 0.31800458), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.3098179), ('If you ever have a chance to go drinking with Sam, do that.', 0.3001002)]"
339,EPA Proposes Broad Science Restrictions in Midst of Coronavirus Pandemic,restrictions,epa proposes broad science _ in midst of coronavirus pandemic,epa proposes broad science support in midst of coronavirus pandemic,https://blog.ucsusa.org/michael-halpern/epa-proposes-broad-science-restrictions-in-midst-of-coronavirus-pandemic?utm_source=facebook&utm_medium=social&utm_campaign=fb&fbclid=IwAR08i87W6M4y7cQIOWaaLYw837Dm8P2LgCiHA7OmFZo6oL1eKAuqy70kE24,"[('According to EPA, it would apply not only to studies behind EPA decisions about vehicle emissions, clean air standards, and clean water protections, but also EPA’s own “state-of-science reports, technology assessments, weight-of-evidence analyses, meta-analyses, risk assessments, toxicological profiles of substances, integrated assessment models, hazard determinations, exposure assessments, or health, ecological, or safety assessments.” The EPA has not articulated a problem it wants to solve.', 0.658638), ('The EPA’s Science Advisory Board initially called it a “license to politicize” science and said that it would compromise the agency’s decision-making process.', 0.65486777), ('Photo: EPA Posted in: Science and Democracy Tags: COVID-19, restricted science Support from UCS members make work like this possible.', 0.6465658), ('What EPA is saying here is that it wants political control over what research is used in any of the agency’s work.', 0.60029304), ('The overreach of the EPA has went to far all, ready Caroline Lindley We must have public hearings.', 0.57761574)]"
340,"Millions of women lose contraceptives , abortions in COVID-19",millions,"_ of women lose contraceptives , abortions in covid-19","None of women lose contraceptives, abortions in covid-19",https://apnews.com/4f3f067fa843de8d3d6cec5a74581fe5,"[('Millions of women and girls globally have lost access to contraceptives, abortion services and related care because of the coronavirus pandemic.', 0.66821325), ('(AP Photo/Themba Hadebe) NEW DELHI (AP) — Millions of women and girls globally have lost access to contraceptives and abortion services because of the coronavirus pandemic.', 0.60812247), (""More Stories: – Pharmacists can give childhood shots, U.S. officials say – Pope: Rich can't get priority for vaccine, poor need help – Mosquitoes carrying West Nile virus found in E. Washington Lockdowns, travel restrictions, supply chain disruptions, the massive shift of health resources to combat COVID-19 and fear of infection continue to prevent many women and girls from care."", 0.55176747), ('Now many women face second-trimester abortions, which are more expensive and complicated, especially “because everyone who is involved needs to wear PPE.” Abortion access has improved in India, but the pandemic resulted in abortion pill shortages in several states surveyed by Foundation for Reproductive Health Services India.', 0.5320123), ('The World Health Organization this month said two-thirds of 103 countries surveyed between mid-May and early July reported disruptions to family planning and contraception services.', 0.4979401)]"
343,Brazilian President Jair Bolsonaro tests positive for coronavirus,positive,brazilian president jair bolsonaro tests _ for coronavirus,brazilian president jair bolsonaro tests negative for coronavirus,https://edition.cnn.com/2020/07/07/americas/brazil-bolsonaro-positive-coronavirus-intl/index.html,"[('Play Video 4:15 Why has Brazil been so badly hit by coronavirus?', 0.63238513), ('Topics Brazil Jair Bolsonaro Americas Coronavirus news Share on Facebook Share on Twitter Share via Email Share on LinkedIn Share on Pinterest Share on WhatsApp Share on Messenger Reuse this content ', 0.50678015), ('“Going around Brasília, without a mask, hugging people … he was flirting with infection – and he was infected,” he said.', 0.44139794), ('But speaking to the Brazilian broadcaster GloboNews, Bolsonaro’s former health minster Luiz Henrique Mandetta said the news raised questions over the president’s behaviour.', 0.42871878), ('– video explainer Another prominent politician, the mayor of the biggest city in the Amazon, Manaus, was flown to hospital in São Paulo on Monday after also falling ill with coronavirus last week.', 0.41457748)]"
344,NYC map shows patients testing positive for coronavirus,testing,nyc map shows patients _ positive for coronavirus,nyc map shows patients not positive for coronavirus,https://nypost.com/2020/04/01/nyc-map-shows-percentage-of-patients-with-coronavirus-by-zip-code/,"[('Wealthier parts of the city, including much of Manhattan, waterfront sections of Queens and brownstone Brooklyn, have the fewest number of coronavirus cases, according to the map released by the city Department of Health.', 0.51442635), ('Data scientist Michael Donnelly, who’s been crunching the city’s coronavirus numbers since the start of the outbreak, noted the new map tracks with earlier MTA turnstile data.', 0.43035993), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.36345506), ('Another version of the map showing percent of patients testing positive for COVID-19 by zip code was flawed because it was a depiction of which neighborhoods had the most access to testing, not the prevalence of the disease.', 0.31178245), ('Back to Reading Sections News Metro Page Six Sports Business Opinion Entertainment Fashion NY Post Shopping Living Media Tech Real Estate Video Photos Sub Menu 1 Covers Columnists Horoscopes Sports Odds Podcasts Email Newsletters Store Home Delivery Sign in Search Type to Search Search Tips Sign Up New York Post New York Post ', 0.3067997)]"
347,"The differing immune system responses of patients with COVID-19 can help predict who will experience moderate and severe consequences of disease , according to a new study",can,"the differing immune system responses of patients with covid-19 _ help predict who will experience moderate and severe consequences of disease , according to a new study","the differing immune system responses of patients with covid-19 cannot help predict who will experience moderate and severe consequences of disease, according to a new study",https://news.yale.edu/2020/07/27/immune-system-variation-can-predict-severe-covid-19-outcomes,"[('(Express Photo: Amit Chakravarty) A new study suggests that the differing immune system responses of Covid-19 patients can help predict who will experience moderate and severe consequences of disease.', 0.83531725), ('They also said drugs that target specific causes of inflammation identified in the study could help treat patients at risk of developing severe cases of COVID-19.', 0.7756703), ('More carefully defining distinct classes of T cell response types in COVID-19 and delineating how pre-existing conditions, co-morbidities, race, ‘immune health’ status and other variables influence T cell responses should reveal novel opportunities for treatment and prevention.', 0.76804805), ('The findings may help identify individuals at high risk of severe illness early in their hospitalization and suggest drugs to treat COVID-19.', 0.758478), ('Tables show the immune parameters that have been reported to differ between mild and severe COVID-19.', 0.72888577)]"
348,"D614G Spike Variant Does Not Alter IgG , IgM , or IgA Spike Seroassay Performance",not,"d614g spike variant does _ alter igg , igm , or iga spike seroassay performance","d614g spike variant does also alter igg, igm, or iga spike seroassay performance",https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaa743/6013009,"[('Accordingly, we analyzed the serologic reactivity of D614 (original) and G614 variant spike proteins.', 0.46848398), ('It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.', 0.42597097), ('We found that antibodies from a high-incidence population in New York City reacted both toward the original D614 spike and the G614 spike variant.', 0.34755588), ('This project has been funded in part with Federal funds from the National Cancer Institute, National Institutes of Health, under contract number HHSN261200800001E.', 0.31319672), ('Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The negative controls were collected under an approved NIH protocol listed on ClinicalTrials.gov NCT01386424.', 0.2650997)]"
349,SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation,triggers,sars-cov-2 _ inflammatory responses and cell death through caspase-8 activation,sars-cov-2 suppress inflammatory responses and cell death through caspase-8 activation,https://www.nature.com/articles/s41392-020-00334-0,"[('SARS-CoV-2 infection induces the cell death through the activation of caspase-8.', 0.92262197), ('2 SARS-CoV-2 infection induces caspase-8 activation to mediate pro-IL-1β processing.', 0.8544095), ('2 SARS-CoV-2 infection induces caspase-8 activation… Fig.', 0.8466822), ('4 SARS-CoV-2 infection triggers apoptosis through caspase-8 activation.', 0.8000057), ('Here we report that SARS-CoV-2 infection activates caspase-8 to trigger cell apoptosis and inflammatory cytokine processing in the lung epithelial cells.', 0.77681804)]"
350,SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is further increased by a naturally occurring elongation variant,increased,sars-cov-2 orf3b is a potent interferon antagonist whose activity is further _ by a naturally occurring elongation variant,sars-cov-2 orf3b is a potent interferon antagonist whose activity is further inhibited by a naturally occurring elongation variant,http://biorxiv.org/content/10.1101/2020.05.11.088179v1,"[('A natural elongation variant of SARS-CoV-2 ORF3b isolated from two patients showed a stronger suppression of interferon induction than wildtype SARS-CoV-2 ORF3b.', 0.766943), ('Interestingly, extension of SARS-CoV2 ORF3b by removal of a premature stop codon enhances its ability to antagonise IFN-β induction.', 0.74891376), ('Finally, SARS-CoV2 isolates from two severe COVID-19 cases were shown to express the extended ORF3b which shows increased IFN-β antagonism.', 0.60784733), ('They find the truncated ORF3b encoded by SARS-CoV-2 (22 aa) suppresses IFN-β induction more efficiently than the full-length SARS-CoV ortholog (~153 aa).', 0.5946613), ('AB855654) Translatability: Strains of SARS-CoV2 with ORF3b mutation could potentially be an indicator of disease severity.', 0.59431595)]"
355,Colchicine Reduces Lung Injury in Experimental Acute Respiratory Distress Syndrome,reduces,colchicine _ lung injury in experimental acute respiratory distress syndrome,colchicine increases lung injury in experimental acute respiratory distress syndrome,https://www.researchsquare.com/article/rs-43204/v1,"[('This study strongly supports the clinical development of colchicine, a widely available low-cost drug, for the prevention of ARDS in conditions causing acute lung injury.', 0.7280174), ('Colchicine reduced histological lung injury by 61%, reduced lung edema, and markedly improved blood oxygenation by increasing PaO2/FiO2 from 66 ± 13 mmHg (mean ± SEM) to 246 ± 45 mmHg.', 0.6814557), ('Lung neutrophil recruitment was reduced by colchicine with evidence for reduced neutrophils activation, as assessed by flow cytometry.', 0.6571249), ('We studied the effects of colchicine pre-treatment on oleic acid-induced ARDS in rats.', 0.44537127), ('Effects of colchicine therapy on plasma cytokines and NETs 4 hours after oleic acid ALI.', 0.3808251)]"
356,Top 10 Countries Compared,countries,top 10 _ compared,top 10 days compared,https://www.forbes.com/sites/trevornace/2020/03/22/population-adjusted-coronavirus-cases-top-10-countries-compared/#56c7a7da974f,"[('self Each figure we’ll look at compares the top 10 countries with the most confirmed coronavirus cases to date.', 0.60877633), ('The big question is which figure is a more realistic representation of today’s picture of each country?', 0.34040904), ('If you have a scenario where there are 10,000 coronavirus cases in a country with 300 million residents and one with 30 million residents, the virus will grow the same all other factors being equal.', 0.33566493), ('Thus, the raw numbers of cases are more telling on the current situation of a country.', 0.25532705), ('Here Are The Deadliest (And Least Deadly) Coronavirus States Here we compare confirmed coronavirus cases with confirmed coronavirus cases adjusted to the population of each country.', 0.23483968)]"
358,Vitamin D status and seroconversion for COVID-19 in UK healthcare workers who isolated for COVID-19 like symptoms during the 2020 pandemic .,2020,vitamin d status and seroconversion for covid-19 in uk healthcare workers who isolated for covid-19 like symptoms during the _ pandemic .,vitamin d status and seroconversion for covid-19 in uk healthcare workers who isolated for covid-19 like symptoms during the 2003 pandemic.,https://www.medrxiv.org/content/10.1101/2020.10.05.20206706v1,"[('We aimed to determine the prevalence of vitamin D deficiency in NHS staff who have isolated with symptoms suggestive of COVID-19 and relate this to vitamin D status.', 0.72117126), ('Added value of this study In this study of healthcare workers who had isolated for COVID-19 symptoms towards the end of UK surge within a large UK NHS trust, 15.6% were vitamin D deficient.', 0.71477646), ('Therefore, we suggest future high-dose vitamin D treatment trials should target such at risk groups within healthcare workers with aim of potentially preventing or alleviating COVID-19.', 0.6987033), ('Vitamin D status and outcomes for hospitalised older patients with COVID-19.', 0.6806816), ('Vitamin D deficiency is a risk factor for COVID-19 seroconversion for NHS healthcare workers especially in BAME male staff.', 0.6517489)]"
359,Eli Lilly can produce up to one million doses of Covid-19 Antibody Drug this year if allowed by FDA,one,eli lilly can produce up to _ million doses of covid-19 antibody drug this year if allowed by fda,eli lilly can produce up to 50 million doses of covid-19 antibody drug this year if allowed by fda,https://www.wsj.com/articles/eli-lilly-asks-fda-to-authorize-covid-19-antibody-drug-11602074998?mod=e2tw,"[(""Eli Lilly via AP hide caption toggle caption Eli Lilly via AP The Food and Drug Administration has authorized Eli Lilly's antibody-based drug bamlanivimab for emergency use as a treatment for COVID-19."", 0.8015189), (""Enlarge this image The Food and Drug Administration has authorized Eli Lilly's antibody-based drug bamlanivimab for emergency use as a treatment for COVID-19."", 0.74937916), ('Lilly is testing both single antibody therapy as well as combinations of antibodies as potential therapeutics for COVID-19.', 0.7382045), ('Lilly has successfully completed a Phase 1 study of bamlanivimab in hospitalized patients with COVID-19 (NCT04411628).', 0.72242904), ('Existing Lilly medicines are being studied to understand their potential in treating complications of COVID-19, and the company is collaborating with partner companies to discover novel antibody treatments for COVID-19.', 0.708874)]"
361,Ecuador sees massive surge in deaths in April,deaths,ecuador sees massive surge in _ in april,ecuador sees massive surge in investment in april,https://www.bbc.com/news/world-latin-america-52324218,"[(""Ecuador's coronavirus nightmare in pictures They said authorities had been unable to keep up with the huge rise in deaths, leaving corpses wrapped in sheets in family homes and even in the streets."", 0.4916233), ('While Ecuador is not the worst offender in the region, low testing rates have made it very difficult to understand how the virus has moved through communities, some of which have been devastated by the high death toll.', 0.42683905), ('Ecuador as a whole has had 8,225 confirmed cases of coronavirus to date, according to Johns Hopkins University, though a lack of widespread testing means this is likely a significant undercount.', 0.42431414), ('Indeed, the first recorded case was of an Ecuadorean woman returning from Spain.', 0.4128387), ('The government said 6,700 people died in Guayas province in the first two weeks of April, far more than the usual 1,000 deaths there in the same period.', 0.40848494)]"
363,Erythrocytes Reveal Complement Activation in Patients with COVID-19,reveal,erythrocytes _ complement activation in patients with covid-19,erythrocytes suppress complement activation in patients with covid-19,https://www.medrxiv.org/content/10.1101/2020.05.20.20104398v1,"[('Here we report the presence of complement activation products on circulating erythrocytes from hospitalized COVID-19 patients using flow cytometry.', 0.8280222), ('These findings suggest that novel erythrocyte- based diagnostics provide a method to identify patients with dysregulated complement activation.', 0.5763198), ('The mortality of patients hospitalized with COVID-19 is unacceptably high and new strategies are urgently needed to rapidly identify and treat patients at risk for organ failure.', 0.49075958), ('is the founder of Amyndas Pharmaceuticals, which is developing complement inhibitors for therapeutic purposes and is the inventor of patents or patent applications that describe the use of complement inhibitors for therapeutic purposes some of which are developed by Amyndas.', 0.36771774), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.34620744)]"
365,"Among 6 mothers with confirmed COVID-19 , SARS-CoV-2 was not detected in the serum or throat swab in any of their newborns .",not,"among 6 mothers with confirmed covid-19 , sars-cov-2 was _ detected in the serum or throat swab in any of their newborns .","among 6 mothers with confirmed covid-19, sars-cov-2 was also detected in the serum or throat swab in any of their newborns.",https://jamanetwork.com/journals/jama/fullarticle/2763854,"[('Discussion Among 6 mothers with confirmed COVID-19, SARS-CoV-19 was not detected in the serum or throat swab by RT-PCR in any of their newborns.', 0.935356), ('In a study by Dr. Hui Zeng published in Lancet on March 26, 2020, among six mothers with confirmed COVID-19, SARS-CoV-19 was not detected in the serum or throat swab in any of their newborns.', 0.7757417), ('SARS-CoV-2 nucleic acids were not detected in 12 breast milk samples of mothers with COVID-19 in various stages of disease.', 0.7380136), ('In our findings, SARS-CoV-2 was not detected in breast milk, and the mothers who continued breastfeeding had no breast lesions.', 0.6783343), ('SARS-CoV-2 nucleic acids were not detected in maternal breast milk ( n = 12), vaginal secretions ( n = 10), neonatal oropharyngeal swabs ( n = 12) or meconium specimens ( n = 6).', 0.6735212)]"
368,High-Dose Corticosteroid Pulse Therapy Increases the Survival Rate in COVID-19 Patients at Risk of Cytokine Storm,increases,high-dose corticosteroid pulse therapy _ the survival rate in covid-19 patients at risk of cytokine storm,high-dose corticosteroid pulse therapy reduces the survival rate in covid-19 patients at risk of cytokine storm,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3633168,"[('Corticosteroids have primarily been thought about in COVID-19 as a means to stave off the \'cytokine storm"" and its consequences like ARDS, disseminated intravascular coagulation, hypotension, shock and death.', 0.74170613), ('Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis.', 0.72358257), ('Nevertheless, the Randomized Evaluation of COVid-19 thERapY (RECOVERY Trial) conducted in patients with COVID-19 has shown a significantly improved the outcome with dexamethasone, a corticosteroid, in the treatment of severe COVID-19 requiring oxygen therapy or on mechanical ventilator [14].', 0.71890724), ('Cytokine storm induction by SARS-CoV-2 was confirmed in COVID-19 patients at the intensive care unit (ICU), and elevated plasma levels of inflammatory cytokines have been associated with disease severity and prognosis [7, 8].', 0.7030628), ('Another target of therapies that are currently being trialled in COVID-19 is the complement system, activation of which might contribute to the secondary inflammatory response and microvascular injury in patients with severe COVID-19 (ref.132).', 0.69196916)]"
369,"McConnell declares war on blue states , dismisses more COVID-19 aid",dismiss,"mcconnell declares war on blue states , _ more covid-19 aid","mcconnell declares war on blue states, enteres more covid-19 aid",https://www.dailykos.com/stories/2020/4/22/1939474/--Let-them-go-bankrupt-McConnell-declares-war-on-blue-states-dismisses-more-COVID-19-aid,"[(""Well, here's a hearty fuck you, McConnell, from all the blue states that have been paying Kentucky's goddamned bills."", 0.54492354), ('So, again, a resounding fuck you to McConnell on that one.', 0.52224183), (""Turn it into the CARES 2 bill McConnell's now throwing cold water on."", 0.49651664), ('Rather than the big rescue fund for states and local governments that even Trump has acknowledged is necessary, McConnell says the states should just go bankrupt.', 0.44213468), ('Immediately following the bill\'s Senate passage Tuesday, McConnell pulled out the ""deficit"" card.', 0.38565847)]"
371,"Symptom-based screening process was ineffective in detecting SARS-CoV-2 infection during evacuation of 126 people from Wuhan , China .",ineffective,"symptom-based screening process was _ in detecting sars-cov-2 infection during evacuation of 126 people from wuhan , china .","symptom-based screening process was successful in detecting sars-cov-2 infection during evacuation of 126 people from wuhan, china.",https://www.nejm.org/doi/full/10.1056/NEJMc2001899?query=RP,"[('In this effort to evacuate 126 people from Wuhan to Frankfurt, a symptom-based screening process was ineffective in detecting SARS-CoV-2 infection in 2 persons who later were found to have evidence of SARS-CoV-2 in a throat swab.', 0.84112334), ('Nevertheless, the researchers concluded that the symptom-based screening process was ""ineffective"" at detecting cases of SARS-CoV2 infection.', 0.6495564), ('In fact, the researchers noted ""epidemiologic uncertainty regarding possible transmission of the virus by asymptomatic or subclinically symptomatic infected persons"" and that it is also not clear ""whether persons who show no signs or symptoms of respiratory infections shed SARS-CoV2.""', 0.5789629), ('STR/AFP/Getty Images With a majority of some US medical supplies coming from or originating in China, coronavirus could hold ""chilling implications"" by hindering that pipeline, according to Robert P. Kadlec, assistant secretary for preparedness and response at the US Department of Health and Human Services.', 0.53114194), ('Aside from the ineffectiveness of the screening process, the authors found that the virus could potentially be spread by those who exhibited mild symptoms: “Shedding of potentially infectious virus may occur in persons who have no fever and no signs or only minor signs of infection.” Over 73,000 people around the world have been infected with the coronavirus, most of those cases in mainland China.', 0.516821)]"
373,It will never be controlled by a vaccine,never,it will _ be controlled by a vaccine,it will potentially be controlled by a vaccine,https://www.cnn.com/2020/09/18/opinions/reinfection-covid-19-prevention-herd-immunity-haseltine/index.html,"[('But there is another, worst-case possibility: that no vaccine is ever developed.', 0.826836), (""There's just one vaccine to prevent two strains of adenovirus, and it's not commercially available."", 0.70637524), ('""We can\'t make an absolute assumption that a vaccine will appear at all, or if it does appear, whether it will pass all the tests of efficacy and safety.', 0.69176584), ('Inadequate systems to track vaccine side effects.', 0.6838692), ('""I don\'t think any vaccine has been developed quickly,"" Offit cautions.', 0.67191327)]"
375,Decontaminate Your N95 Mask Within Just 3 Minutes !,minutes,decontaminate your n95 mask within just 3 _ !,decontaminate your n95 mask within just 3 days!,https://www.hayvine.com/tech/decontaminate-your-n95-mask-within-just-3-minutes,"[('Home Tech Science Sports Entertainment Social COVID-19 Quiz try { window.mNHandle.queue.push(function (){ window.mNDetails.loadTag(""431642074"", ""300x250"", ""431642074""); }); } catch (error) {} .detial-comment-section h4 { font-family: Nunito; font-size: 35px; font- weight: 700; } .detial-comment-section h4 span { font-weight: 500; margin- left: 26px; } .detial-comment-section .write-comment { font-family: Nunito; color: ', 0.19620983), (""'); } }); } if($(this).val() == 'recent'){ var div = $('.comment-single').length; $('.all-comments').addClass('selected-comments'); } }); $(document).on('click', '"", 0.13875908), ('\'); } }); }); $(document).on(\'click\',\'.commentreply\',function(){ commentreplyid = $(this).attr(\'data-comment-id\'); // alert(commentreplyid) that = $(this); $.ajax({ url: ""https://www.hayvine.com/replylike"", type: ""get"", data: { commentreplyid: commentreplyid }, success: function(data){ console.log(data) if(data.status == 2){ // alert(\'already liked\'); } else{ console.log(that); //alert(data.data); getparent = that.parents(\'.left\'); getparent.find(\'.likecountreply\').html(data.data) getparent.find(\'.commentreply\').html(\'LIKED\'); } }, errors: function(data){ alert(\'Error!!!', 0.13057205), ('\'); } }); }); $(document).on(\'click\',\'.commentdislikereply\',function(){ var commentreplyid = $(this).attr(\'data-comment-id\'); var that = $(this); $.ajax({ url: ""https://www.hayvine.com/replydislike"", type: ""get"", data: { commentreplyid: commentreplyid }, success: function(data){ if(data.status == 2){ // alert(\'already disliked\'); } else{ var getparent = that.parents(\'.left\'); console.log(getparent.find(\'.dislikecountreply\')); getparent.find(\'.dislikecountreply\').html(data.data) getparent.find(\'.commentdislikereply\').html(\'DISLIKED\'); } }, errors: function(data){ alert(\'Error!!!', 0.12937385), (""'); } }); }); $(document).on('click', '"", 0.08078695)]"
377,Mexico finds a COVID-19 villain in big soda,villain,mexico finds a covid-19 _ in big soda,mexico finds a covid-19 population in big soda,https://www.usatoday.com/story/news/world/2020/08/23/coca-cola-bottled-poison-mexico-finds-covid-19-villain-soda/5607741002/,"[('As COVID-19 cases mount in Mexico and the death toll soars – Mexico only trails Brazil and the United States in total pandemic fatalities – López- Gatell and President Andrés Manuel López Obrador have increasingly pinned Mexico’s pandemic problems on its poor nutrition habits — soda consumption chief among them.', 0.5891098), ('Health undersecretary Hugo López-Gatell connected soda consumption with COVID-19 deaths, blaming sugar for causing comorbidities such as obesity, diabetes and hypertension – maladies common in Mexico, where almost three- quarters of the population is overweight, according to a study by the Organisation for Economic Cooperation and Development.', 0.57984215), ('In Mexico City’s southern Xochimilco borough, stricken with COVID-19 cases, locals purchasing sodas spoke of potential risks – and difficulties of kicking the habit.', 0.5693061), ('The soda habit starts young in Mexico.', 0.52420795), ('“It’s a pretext because the fact is that sugary drinks contribute to gaining weight and obesity in Mexico is nothing new.” Mexico’s beverage industry shot back at López-Gatell, saying Mexicans consume less than 6% of their daily calories from sugary drinks and alleging his comments “show the need to find a public enemy to hold responsible for the health crisis the country confronts due to the COVID-19 pandemic.” Public health proponents, however, call the castigation of big soda long overdue.', 0.47606248)]"
378,Latin America 's embrace of an unproven COVID treatment is hindering drug trials,hind,latin america 's embrace of an unproven covid treatment is _ drug trials,latin america's embrace of an unproven covid treatment is benefitering drug trials,https://www.nature.com/articles/d41586-020-02958-2,"[('Exploring the Impact of COVID-19 in Latin America.', 0.4008218), ('COVID-19 in Latin America.', 0.37155503), ('Skip to main page content COVID-19 is an emerging, rapidly evolving situation.', 0.3292222), ('SARS-CoV-2 diagnostic testing alternatives for Latin America.', 0.30499926), ('Clipboard, Search History, and several other advanced features are temporarily unavailable.', 0.20548779)]"
379,COVID-19 Map Was Found to be Malware,mal,covid-19 map was found to be _,covid-19 map was found to be stableware,https://blog.reasonsecurity.com/2020/03/09/covid-19-info-stealer-the-map-of-threats-threat-analysis-report/,"[('It contained recommendations on how to prevent infection and came with an attachment that supposedly contains the latest updates on COVID-19 but actually carried malware.', 0.7162632), ('The emails had attachments that contain malware, which executes a PowerShell command that will download a file from a URL related to COVID-19.', 0.680785), ('COVID-19 being used for extortion ', 0.5951507), ('Early COVID-19 related malicious email Now there are ongoing business email compromise (BEC) scams that use the disease as a hook.', 0.59234905), ('The URL is hxxps://recoverrryasitalycovid-19.xyz/over Upon further investigation, it was found that the malware used Evil Clippy, a tool for creating malicious MS Office Documents, to hide its macro.', 0.59086263)]"
383,Confirmed Case in the Dominican Republic,confirmed,_ case in the dominican republic,No case in the dominican republic,https://www.miamiherald.com/news/nation-world/world/americas/article240781521.html,"[('Coronavirus Population World / Countries / Dominican Republic Last updated: January 18, 2021, 01:51 GMT ', 0.4963063), ('Health officials in the Dominican Republic on Sunday reported the first confirmed case of the new coronavirus in the tourist-rich Caribbean, a 62-year-old Italian citizen.', 0.42089218), ('©2021 FOX News Network, LLC.', 0.3222125), ('Fox News U.S.', 0.29009277), ('Legal Statement.', 0.289112)]"
384,"Risk of COVID-19 hospitalisation rises exponentially with age , inversely proportional to T-cell production",rises,"risk of covid-19 hospitalisation _ exponentially with age , inversely proportional to t-cell production","risk of covid-19 hospitalisation decreased exponentially with age, inversely proportional to t-cell production",https://www.medrxiv.org/content/10.1101/2020.08.25.20181487v1,"[('In addition, incidence of severe disease and mortality due to COVID-19 are both higher in men, consistent with the degree to which thymic involution (and the decrease in T-cell production with age) is more severe in men compared to women.', 0.7784301), ('The strikingly simple inverse relationship between COVID-19 risk and thymic T-cell output reported here begs a mechanistic understanding and suggests that T-cell based therapies may be a promising target.', 0.5180614), ('COVID-19 can therefore be added to the list of other diseases with this property, including those caused by MRSA, West Nile virus, Streptococcus Pneumonia and certain cancers, such as chronic myeloid leukemia and brain cancers.', 0.47965702), ('This mirrors the well studied exponential decline of both thymus volume and T-cell production, which halve every 16 years.', 0.43086326), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.43046147)]"
385,10 July 2020 Retraction Note to : SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion,july,10 _ 2020 retraction note to : sars-cov-2 infects t lymphocytes through its spike protein-mediated membrane fusion,10 February 2020 retraction note to : sars-cov-2 infects t lymphocytes through its spike protein-mediated membrane fusion,https://www.nature.com/articles/s41423-020-0498-4?fbclid=IwAR3AeCrTsdAj4aah9hKLNIjW1tdPLg_w3pfxXZ0wBa2o0sZa87fcXbG4epg,"[('Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion.', 0.80255413), ('This retracts the article ""SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion"" in Cell Mol Immunol on page 1.', 0.75699985), ('""SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion.""', 0.7479956), ('SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion.', 0.73993057), ('Inhibition of SARS-CoV-2 infection (previously 2019-nCoV) by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.', 0.65829206)]"
386,A Spanish Medical Dictionary and Guide Mastered for the Professional Interpreter,guide,a spanish medical dictionary and _ mastered for the professional interpreter,a spanish medical dictionary and not mastered for the professional interpreter,https://www.amazon.com/dp/B08JF5KTRG,"[(': Intuitive Interpreting : A Spanish Medical Dictionary Mastered for the Professional Interpreter by Annalisa Nash Fernandez (2015, Trade Paperback, Abridged edition) ', 0.8516457), (': Intuitive Interpreting : A Spanish Medical Dictionary Mastered for the Professional Interpreter by Annalisa Nash Fernandez (2015, Trade Paperback, Abridged edition) Be the first towrite a reviewAbout this product Pre-owned: Lowest price ', 0.8127694), (': Intuitive Interpreting : A Spanish Medical Dictionary Mastered for the Professional Interpreter by Annalisa Nash Fernandez (2015, Trade Paperback, Abridged edition) Be the first towrite a review About this product Current slide {CURRENTSLIDE} of {TOTALSLIDES}- Top picked items Pre-owned $15.68 Make an offer: Pre-owned ', 0.78859216), ('See details \\- Intuitive Interpreting: A Spanish Medical Dictionary Mastered for the Profession Watch Sold bybilzebrauska0 (100)100.0% Positive feedbackContact seller ', 0.76443267), ('This is the only terminology resource a professional medical interpreter needs to work effectively in English<>Spanish.', 0.73419094)]"
389,Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions,shortened,serial interval of sars-cov-2 was _ over time by nonpharmaceutical interventions,serial interval of sars-cov-2 was increased over time by nonpharmaceutical interventions,https://science.sciencemag.org/content/early/2020/07/20/science.abc9004,"[('1 Serial intervals of SARS-CoV-2 substantially shortened over time in mainland China.', 0.67684287), ('Empirical serial interval distributions for transmission pairs, counting from symptom onsets of the infectors during each period, indicate that the serial intervals shortened over time (Fig.', 0.6286478), ('In contrast to the use of a constant distribution of serial intervals, our analysis suggests that serial intervals were gradually shortened over the study period (Fig.', 0.615736), ('noticed that the average serial interval changed as nonpharmaceutical interventions were introduced.', 0.5532688), ('After the peak, these estimates further shortened to 2.6 (1.9, 3.2) days and 4.6 (4.2, 5.1) days, respectively (table S2).', 0.53424907)]"
390,SARS-CoV-2 in human milk is inactivated by Holder pasteurization but not cold storage,not,sars-cov-2 in human milk is inactivated by holder pasteurization but _ cold storage,sars-cov-2 in human milk is inactivated by holder pasteurization but also cold storage,https://www.medrxiv.org/content/10.1101/2020.06.18.20134395v1,"[('Here, we investigate the inactivation of SARS-CoV-2 in human milk by pasteurisation, and the stability of SARS-CoV-2 in human milk under cold storage (freezing or refrigeration).', 0.7858252), ('Our findings demonstrate that SARS-CoV-2 can be effectively inactivated by Holder pasteurisation, and confirm that existing milk bank processes will effectively mitigate the risk of transmission of SARS-COV-2 to vulnerable infants through pasteurised donor human milk.', 0.76674414), ('Cold storage of SARS-CoV-2 in human milk (either at 4°C or - 30°C) did not significantly impact infectious viral load over a 48 hour period.', 0.6821904), ('live) virus was undetected in both human milk and the control medium.', 0.6614282), ('Under these circumstances, ensuring the safety of donor human milk is paramount, as the risk of vertical transmission of SARS-CoV-2 is not well understood.', 0.58254266)]"
391,Four volunteers who got Pfizer 's vaccine developed Bell 's palsy,four,_ volunteers who got pfizer 's vaccine developed bell 's palsy,Two volunteers who got pfizer's vaccine developed bell's palsy,https://www.dailymail.co.uk/health/article-9030943/Four-volunteers-got-Pfizers-vaccine-developed-Bells-palsy.html,"[('In Pfizer’s trial, all four participants who experienced Bell’s palsy received the vaccine.', 0.8752633), ('""Four Pfizer vaccine volunteers (for COVID-19) develop Bell\'s palsy,"" claims a Dec. 12 Facebook post.', 0.78872705), ('These are 3 of the 4 volunteers who developed Bells palsy after being vaccinated with the Pfizer (SIC) covid experimental vaccine.', 0.7844628), (""As the United Kingdom began administering people with the Pfizer-BioNTech vaccine, four people who got Pfizer's coronavirus vaccine in the firm's trial developed Bell's palsy, a form of temporary facial paralysis, according to US regulators' report on the shot."", 0.7435976), ('I’ll go on to say there we’re deaths in the trial and none of them we’re linked to the vaccine.” To be clear, four participants in the Pfizer vaccine trial and four participants in Moderna’s trial did experience Bell’s palsy.', 0.6892805)]"
392,Delayed Thrombocytopenia in Patients of CoVID-19,delayed,_ thrombocytopenia in patients of covid-19,Acute thrombocytopenia in patients of covid-19,https://www.medrxiv.org/content/10.1101/2020.04.11.20059170v1,"[('Mechanisms involved in the development of thrombocytopenia in patients with COVID-19.', 0.8584615), ('Thrombocytopenia and thrombosis in hospitalized patients with COVID-19.', 0.84300894), ('Thrombocytopenia as an initial manifestation of COVID-19; case series and literature review.', 0.8249277), ('The delayed-phase thrombocytopenia in COVID-19 is prone to develop in elderly patients or patients with low lymphocyte count on admission.', 0.820169), ('Hematopoietic system can also be affected by COVID-19.', 0.7236005)]"
395,"In the lab , St. Jude scientists identify possible COVID-19 treatment",jude,"in the lab , st. _ scientists identify possible covid-19 treatment","in the lab, st. Chinese scientists identify possible covid-19 treatment",https://www.stjude.org/media-resources/news-releases/2020-medicine-science-news/in-the-lab-st-jude-scientists-identify-possible-covid-19-treatment.html,"[('St. Jude Children’s Research Hospital scientists have discovered a potential strategy to prevent life-threatening inflammation, lung damage and organ failure in patients with COVID-19.', 0.72040355), ('Kanneganti’s team focused on a select set of the most elevated cytokines in COVID-19 patients.', 0.67460954), ('History Careers Our Stories Visit St. Jude For updates to our current visitor policy regarding COVID-19, please read.', 0.5805487), (""Memphis, Tennessee, November 18, 2020 Thirumala-Devi Kanneganti, Ph.D., vice chair of St. Jude Immunology (center); and Bhesh Raj Sharma, PhD (left), and Rajendra Karki, PhD (right), both of Kanneganti's lab, contributed to research that helps increase understanding of the pathways and mechanism that drives COVID-19 inflammation so researchers can develop effective treatment strategies."", 0.55351365), ('“The findings link inflammatory cell death induced by TNF-alpha and IFN-gamma to COVID-19,” Kanneganti said.', 0.5358271)]"
398,Trump extends restrictions beyond Easter,trump,_ extends restrictions beyond easter,China extends restrictions beyond easter,https://www.bbc.co.uk/news/world-us-canada-52087113,"[('Mr Trump had previously said that Easter - 10-13 April - would be a ""beautiful time"" to be able to open at least some sections of the country.', 0.6372862), ('The extension would leave the federal recommendations in place beyond Easter, April 12, by which time Trump had hoped the country and its economy could start to rev up again.', 0.57946014), ('Trump’s decision to extend the guidelines reflected a recognition that the struggle will take place over the longer haul and the risk of deaths spiraling into the hundreds of thousands is real.', 0.550492), ('Advertisement Trump on Sunday extended the voluntary shutdown for a month.', 0.54119205), ('“So yes, Easter will still be here in 2020, just the celebration will be different.', 0.528702)]"
401,Cyclosporin A inhibits the replication of diverse coronaviruses,inhibit,cyclosporin a _ the replication of diverse coronaviruses,cyclosporin a hosts the replication of diverse coronaviruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352363/,"[('CsA inhibits the replication of GFP-expressing recombinant coronaviruses.', 0.7221639), ('Cyclophilin inhibitors block arterivirus replication by interfering with viral RNA synthesis.', 0.6824429), ('CsA treatment inhibits coronavirus protein and RNA synthesis, and the production of infectious… Fig.', 0.65698504), ('Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506.', 0.6415344), ('CsA treatment inhibits coronavirus protein and RNA synthesis, and the production of infectious progeny.', 0.63493085)]"
403,Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63,lack,older adults _ sars cov-2 cross-reactive t lymphocytes directed to human coronaviruses oc43 and nl63,older adults have sars cov-2 cross-reactive t lymphocytes directed to human coronaviruses oc43 and nl63,https://www.nature.com/articles/s41598-020-78506-9,"[('One subject in the older adults group, who did not respond to stimulation with the HCoVs NL63 and OC43, had a high frequency of T cells to the SARS CoV-2 M protein, (1000 SFC/106 PBMCs).', 0.70923877), ('Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals.', 0.6890985), ('Full size image Our data confirm the presence of cross-reactive T cells to SARS-CoV-2 in study subjects unexposed to the newly emerging coronavirus but with pre-existing immunity to the HCoVs NL63 and OC43.', 0.687853), ('Second, we demonstrated that T cell memory lymphocytes to HCoVs OC43 and NL63 were virtually absent in the group of older adults and that accordingly SARS- CoV-2 cross-reactive T cells were absent.', 0.6774276), ('T cell responses to whole SARS coronavirus in humans.', 0.65631783)]"
404,"In the lab , St. Jude researchers uncover origins of deadly inflammation caused by the novel coronavirus",jude,"in the lab , st. _ researchers uncover origins of deadly inflammation caused by the novel coronavirus","in the lab, st. Chinese researchers uncover origins of deadly inflammation caused by the novel coronavirus",https://www.stjude.org/inspire/news/st-jude-scientists-make-advance-in-covid-19.html?linkId=104985052&fbclid=IwAR0u2T5CwuBn8axV3JHr2FnnzJSepFBfsIuaZ52Wr8rnvEDhOALr9WSmlNs,"[('A team led by Thirumala-Devi Kanneganti, PhD, vice chair of the St. Jude Department of Immunology, identified a previously unknown interaction between two messenger proteins that can unleash a cascade of inflammatory cell death, leading to tissue damage and multiple organ failure.', 0.6118648), ('The study, published online in the journal Cell , comes as researchers around the globe race to develop therapies and vaccines to staunch a pandemic that, in less than one year, has killed some 1.2 million people and sickened millions more.', 0.47774228), ('Researchers further concluded that existing drugs, Remicade and Gamifant, which are used to treat such inflammatory diseases as Crohn’s disease and colitis prevented COVID-19 complications in laboratory models.', 0.4623735), ('“This research provides that understanding.” The work by Kanneganti’s team focused on cytokines, tiny proteins secreted primarily by immune cells.', 0.4370594), ('The team also reported that two existing drugs based on neutralizing antibodies appear to disrupt this deadly process.', 0.4367329)]"
405,"Antibody Test For COVID-19 Could Help To Control Virus Spread , Says Singapore Medtech Firm",could,"antibody test for covid-19 _ help to control virus spread , says singapore medtech firm","antibody test for covid-19 cannot help to control virus spread, says singapore medtech firm",https://www.forbes.com/sites/pamelaambler/2020/04/09/antibody-test-for-covid-19-could-help-to-control-virus-spread-says-singapore-medtech-firm/#22f7c0402514,"[('Yee estimates commissioning roughly two million COVID-19 test kits in the next two months from Nanjing-based Vazyme Biotech, a Chinese producer of enzymes and antibodies.', 0.6570475), ('The medtech company, which specializes in cancer treatment equipment and applications, has created a test kit that detects antibodies directed against the coronavirus that’s sweeping the world.', 0.6514514), ('Meanwhile, Singapore’s Ministry of Health issued a document released to all registered medical practitioners on April 3 stating, “There is currently no role for COVID-19 serology rapid test kits in the diagnosis of COVID-19 infections.” The Biolidics test checks the blood for antibodies and can identify who was previously infected and may have already developed immunity to the virus.', 0.5855746), ('The following day, the Department of Health in the Philippines authorized the use of the company’s rapid test kit for the detection of COVID-19.', 0.5375955), ('In the meantime, Biolidics is working to gain approval to sell its infectious disease diagnostic kits in other countries in Asia, and with the U.S. Food and Drug Administration’s Emergency Use Authorization.', 0.52351844)]"
407,Our main findings are that cardiac involvement may occur with COVID-19 even without respiratory tract signs and symptoms of infection .,may,our main findings are that cardiac involvement _ occur with covid-19 even without respiratory tract signs and symptoms of infection .,our main findings are that cardiac involvement cannot occur with covid-19 even without respiratory tract signs and symptoms of infection.,https://jamanetwork.com/journals/jamacardiology/fullarticle/2763843,"[('Patients with COVID-19 infection can present with symptoms mimicking CV events, including chest pain, dyspnoea, and shock, even in the absence of cardiac injury.', 0.80847895), ('Heart palpitations have been reported to be the main presenting symptom of COVID-19 in patients without a fever or cough82.', 0.793736), ('Some patients who present without the typical symptoms of fever or cough have cardiac symptoms as the first clinical manifestation of COVID-19 (refs52,53).', 0.78216016), ('These observations suggest that COVID-19 can cause ACS even in the absence of substantial systemic inflammation.', 0.768455), ('An autopsy of a patient with COVID-19 and ARDS who died of a sudden cardiac arrest showed no evidence of myocardial structural involvement, suggesting that COVID-19 did not directly impair the heart57.', 0.7564876)]"
408,A simple tip to boost your immunity,boost,a simple tip to _ your immunity,a simple tip to prevent your immunity,https://www.cnbc.com/2020/04/22/coronavirus-tip-to-boost-immunity-especially-on-lockdown.html,"[('Getting adequate rest may strengthen your natural immunity.', 0.6848247), ('Here are 9 tips to strengthen your immunity naturally.', 0.6571593), ('Immunity in action.', 0.63430244), ('Engage in moderate exercise Although prolonged intense exercise can suppress your immune system, moderate exercise can give it a boost.', 0.56965315), (""But don't worry about immunity."", 0.56948525)]"
409,"Keep staying home , you are saving lives —Inder Singh , Kinsa",saving,"keep staying home , you are _ lives —inder singh , kinsa","keep staying home, you are no lives —inder singh, kinsa",https://medium.com/@inders/your-sacrifices-are-saving-lives-3c80d88cea39,"[('""Keep staying home.', 0.61071134), ('“People need to know their sacrifices are helping,” said Inder Singh, founder of Kinsa.', 0.5128415), ('They did not go into lockdown.', 0.39798015), ('We must continue to stay home and distance ourselves from each other.', 0.39275566), ('We are working with all of our Kinsa users to ensure that they are doing their part to keep their families, communities and their country safe.', 0.38676593)]"
410,IL-6 inhibition could be key to COVID-19,key,il-6 inhibition could be _ to covid-19,il-6 inhibition could be resistant to covid-19,https://www.fiercepharma.com/pharma/are-il-6-inhibitors-key-to-covid19-eusa-pharma-joins-sanofi-regeneron-rolling-out-trials,"[('If it is possible to block the signal transduction pathway of IL-6, it is expected to become a new method for the treatment of severe COVID-19 patients.', 0.7286221), ('Tocilizumab is an IL-6 receptor (IL-6R) blocker that can effectively block the IL-6 signal transduction pathway and thus is likely to become an effective drug for patients with severe COVID-19.', 0.6918692), ('Keywords: COVID-19; Cytokine release syndrome; IL-6; IL-6R; Tocilizumab.', 0.63428104), (""One possibility is tocilizumab, an antibody that binds to receptors for IL-6, inhibiting that cytokine's action."", 0.6199281), ('Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions.', 0.61059105)]"
413,Synthesis of Lipid Prodrugs that Substantially Enhance Anti-Coronavirus Activity,enhance,synthesis of lipid prodrugs that substantially _ anti-coronavirus activity,synthesis of lipid prodrugs that substantially decrease anti-coronavirus activity,https://www.biorxiv.org/content/10.1101/2020.08.26.269159v1?rss=1%22,"[('Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro.', 0.6970612), ('In addition to likely improved oral bioavailability and simpler metabolic activation, two of the three new lipid prodrugs of RVn had anti-SARS-CoV-2 activity 9 to 24 times greater than that of RDV in Vero E6 cells Keywords: SARS-CoV-2, Remdesivir, Remdesivir nucleoside, antiviral agents, lipid prodrugs, Vero E6 cells ', 0.6798138), ('Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn- glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro.', 0.6666467), ('Oral treatment of murine cytomegalovirus infections with ether lipid esters of cidofovir.', 0.6426841), ('The lipid prodrugs were more active with EC50s ranging from 0.19 ± 0.023 to 0.96 ± 0.17.', 0.6382581)]"
414,Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 infection,improves,human soluble ace2 _ the effect of remdesivir in sars-cov-2 infection,human soluble ace2 inhibits the effect of remdesivir in sars-cov-2 infection,https://www.embopress.org/doi/abs/10.15252/emmm.202013426,"[('ACE2 is the critical cell surface receptor for SARS-CoV-2.', 0.7381263), ('A Treatment of SARS‐CoV‐2 (106 PFU) infected Vero‐E6 cells with human recombinant soluble ACE 2 (hrsACE2) (200 µg/ml) and remdesivir (Remd.', 0.69229275), ('A, B (A) Remdesivir and (B) hrsACE2 inhibition of SARS‐CoV‐2 infections of Vero E6 cells.', 0.6375001), ('This combination treatment markedly improved their therapeutic windows against SARS-CoV-2 in both models.', 0.63283867), ('C Treatment of SARS‐CoV‐2 (106 PFU) infected Vero‐E6 cells with clinical doses of hrsACE2 (5 and 10 µg/ml) and remdesivir (Remd.', 0.6194155)]"
415,FDA authorizes two-minute antibody testing kit to detect coronavirus,two,fda authorizes _-minute antibody testing kit to detect coronavirus,fda authorizes 15-minute antibody testing kit to detect coronavirus,https://www.axios.com/fda-coronavirus-two-minute-testing-kit-bodysphere-a665429d-488d-4edf-bd36-9180e2a06e4c.html,"[('What happened: A medical distribution company called Bodysphere said in a press release that the FDA had granted an “emergency use authorization” that could allow patients to get a diagnosis in only about two minutes.', 0.6444828), (""In its press release Tuesday, Bodysphere claimed its test had already been “used successfully in several states.” It was published a day after President Donald Trump touted the FDA's approval last week of a swab test that can detect the illness in five minutes."", 0.5444374), ('REUTERS/Jeenah Moon Reuters - The March 31 story on BodySphere receiving FDA authorization for a rapid antibody test for coronavirus has been withdrawn.', 0.5348087), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.5306776), ('Due to a press release being issued about a two-minute COVID-19 test being granted Emergency Use Authorization (EUA) from the FDA, the story was shared with MPO readers.', 0.51383233)]"
419,Vitamin K2 deficiency link to COVID-19 mortality explained in new paper,mortality,vitamin k2 deficiency link to covid-19 _ explained in new paper,vitamin k2 deficiency link to covid-19 not explained in new paper,https://www.nutraceuticalbusinessreview.com/news/article_page/Vitamin_K2_deficiency_link_to_COVID-19_mortality_explained_in_new_paper/170281,"[('According to the authors, a “profound increase” in inactive matrix Gla protein (MGP) levels were observed in COVID-19 patients, indicating a poor K2 status and associated increased risk of mortality from comorbidities (such as obesity, diabetes, hypertension and cardiovascular diseases).', 0.6355169), ('The researchers write: “Therefore, MK-7 deficiency can be a risk factor for increasing the severity of the COVID-19 disease and SARS-CoV-2 infected patients with comorbid conditions tend to develop acute manifestations.” This paper strengthens the concept that vitamin K2 as MK-7 is a nutrient with substantial ability to protect pulmonary function during an active virus.', 0.55284363), ('This is the second study that associates K2 status with outcomes in COVID-19 patients.', 0.55278325), ('It supports an earlier study published in April that evaluated MK-7 in 123 patients with COVID-19 and 184 controls, revealing a link between vitamin K2 deficiency and disease severity.', 0.48064578), ('“Of course, a dietary supplement is not a cure or a treatment but, with time, MK-7 can fortify the body’s resilience to age-related conditions and viral infection.', 0.3855374)]"
422,COVID-19 outbreak and decreased hospitalisation of pregnant women in labour .,decreased,covid-19 outbreak and _ hospitalisation of pregnant women in labour .,covid-19 outbreak and rapid hospitalisation of pregnant women in labour.,https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30319-3/fulltext,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.3927667), ('Main content 1 Search 2 Footer 3 +A A -A High contrast COVID-19 Global literature on coronavirus disease العربية 中文 (中国) english français Русский español português Advanced Search Title, abstract, subject Title Author Abstract Search 1.', 0.2059989), ('Lancet Glob Health ; 8(9): e1116-e1117, 2020 09.', 0.17828004), ('Kumari, Vimla; Mehta, Kalpana; Choudhary, Rahul.', 0.13999882), ('Article in English ', -0.061896253)]"
424,"Kids Rarely Transmit Covid-19 , Say UVM Docs in Top Journal",rarely,"kids _ transmit covid-19 , say uvm docs in top journal","kids all transmit covid-19, say uvm docs in top journal",https://www.uvm.edu/uvmnews/news/kids-rarely-transmit-covid-19-say-uvm-docs-top-journal?fbclid=IwAR1WCSc7fpPEQnKlSrW5NUIVkn2EgDCN0DF3xkoT5TI3GUqt1zogM9ECzpM,"[('In a French study, a boy with Covid-19 exposed over 80 classmates at three schools to the disease.', 0.5586021), ('A commentary published in the journal Pediatrics , the official peer- reviewed journal of the American Academy of Pediatrics, concludes that children infrequently transmit Covid-19 to each other or to adults and that many schools, provided they follow appropriate social distancing guidelines and take into account rates of transmission in their community, can and should reopen in the fall.', 0.5119198), ('The authors of the commentary, titled “COVID-19 Transmission and Children: The Child Is Not to Blame,” base their conclusions on a new study published in the current issue of Pediatrics , “COVID-19 in Children and the Dynamics of Infection in Families,” and four other recent studies that examine Covid-19 transmission by and among children.', 0.5010517), ('In a study in New South Wales, nine infected students and nine staff across 15 schools exposed a total of 735 students and 128 staff to Covid-19.', 0.47001454), ('In the new Pediatrics study, Klara M. Posfay-Barbe, M.D., a faculty member at University of Geneva’s medical school, and her colleagues studied the households of 39 Swiss children infected with Covid-19.', 0.46611023)]"
425,"68 per cent of patients hospitalized for severe Covid-19 , who were treated with compassionate-use remdesivir , showed clinical improvement",showed,"68 per cent of patients hospitalized for severe covid-19 , who were treated with compassionate-use remdesivir , _ clinical improvement","68 per cent of patients hospitalized for severe covid-19, who were treated with compassionate-use remdesivir, without clinical improvement",https://www.nejm.org/doi/full/10.1056/NEJMoa2007016,"[('In this report, we describe outcomes in a cohort of patients hospitalized for severe Covid-19 who were treated with remdesivir on a compassionate-use basis.', 0.756088), ('A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19.', 0.6709371), ('This preliminary report describes the clinical outcomes in a small cohort of patients who were severely ill with Covid-19 and were treated with remdesivir.', 0.6674084), ('Although the latter precludes definitive conclusions, comparisons with contemporaneous cohorts from the literature, in whom general care is expected to be consistent with that of our cohort, suggest that remdesivir may have clinical benefit in patients with severe Covid-19.', 0.66082567), ('Although data from several ongoing randomized, controlled trials will soon provide more informative evidence regarding the safety and efficacy of remdesivir for Covid-19, the outcomes observed in this compassionate-use program are the best currently available data.', 0.6601423)]"
427,Scientists are Turning to Existing Drugs to Combat COVID-19,existing,scientists are turning to _ drugs to combat covid-19,scientists are turning to new drugs to combat covid-19,https://blog.labtag.com/scientists-are-turning-to-existing-drugs-to-combat-covid-19/,"[('To expediate the development and approval process, many are looking at repurposing drugs to combat COVID-19.', 0.74365765), ('First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients.', 0.5247072), ('Tags COVID-19 Facebook Twitter Pinterest WhatsApp Linkedin ReddIt Email Print Tumblr Telegram Mix VK Digg LINE Viber Naver Previous article9 Tips for Working from Home Next articleThe Ins and Outs of Labeling your SDS-PAGE and Western Blot Alexander Goldberg, Ph.D.', 0.5076935), ('Yuen K, Ye Z, Fung S, Chan C, Jin D. SARS-CoV-2 and COVID-19: The most important research questions.', 0.49040857), ('This means that it could potentially be tested sooner rather than later for patients with COVID-19.9 Other protease inhibitors that are currently being tested include the combination of ritonavir and lopinavir, drugs that were originally used for patients with HIV.', 0.47384995)]"
429,Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structures,inhibit,amilorides _ sars-cov-2 replication in vitro by targeting rna structures,amilorides promote sars-cov-2 replication in vitro by targeting rna structures,https://www.biorxiv.org/content/10.1101/2020.12.05.409821v1,"[('The RNA-biased amiloride scaffold was recently tuned to target a viral RNA structure critical for translation in enterovirus 71, ultimately uncovering a novel mechanism to modulate positive-sense RNA viral translation and replication.', 0.66621625), ('Select amilorides also potently inhibited replication competent SARS-CoV-2 as evident in the decreased levels of cell free virions in cell culture supernatants of treated cells.', 0.6585071), ('These molecules will serve as chemical probes to further understand CoV RNA biology and can pave the way for the development of specific CoV RNA-targeted antivirals.', 0.648643), ('Taken together, the use of multiple orthogonal approaches allowed us to identify the first small molecules aimed at targeting RNA structures within the 5’-UTR and proximal region of the CoV genome.', 0.6240398), ('Amilorides inhibited OC43 replication as seen in viral plaque assays.', 0.6233461)]"
430,FDA approves expanded access to Wilmington company 's experimental Covid-19 therapy,expanded,fda approves _ access to wilmington company 's experimental covid-19 therapy,fda approves no access to wilmington company's experimental covid-19 therapy,https://www.neurorxpharma.com/news/fda-approves-expanded-access-to-wilmington-companys-experimental-covid-19-therapy/,"[(""Dr. Jonathan Javitt, chairman and CEO of NeuroRx, said the company's application covers the same type of coronavirus patients whom the FDA has already allowed to receive treatment under an expanded access protocol authorized by the federal agency in July."", 0.5692587), ('The action means Covid-19 patients who are not eligible to enroll in the ongoing phase-II/III clinical trials for the therapy because of […] Read more Press releases ', 0.56511694), ('What To Know About The Fast- Tracked Drug Aviptadil A drug that mimics a peptide produced by the bowel has been fast-tracked by the Food and Drug Administration to treat COVID-19 lung inflammation, NeuroRx Inc. announced Wednesday.', 0.5636139), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.5332397), ('The protocol specifically makes the treatment available to pregnant women.', 0.5065892)]"
432,Air quality influences the pandemic - Communiqués de presse,air,_ quality influences the pandemic - communiqués de presse,Virus quality influences the pandemic - communiqués de presse,https://www.unige.ch/communication/communiques/en/2020/covid-19-la-qualite-de-lair-influence-la-pandemie/,"[('The increase in fine particles is generally favored by air temperature inversions, characterized by fog situations, or by Saharan dust intrusions.', 0.5425736), ('In these situations, emissions accumulate in the layer of air underneath the fog.', 0.5250803), ('Epidemiologists widely agree that there is a correlation between acute and locally elevated concentrations of fine particles and the severity of influenza waves.', 0.5160514), ('The study provides preventive measures related to air pollution to limit future outbreaks of morbidity and mortality due to the coronavirus.', 0.4497149), ('A multifactorial pandemic Nonetheless, the researchers also emphasize that, although particulate matter pollution can influence the virulence of the virus and possible severe disease progression, physiological, social or economic factors will clearly also influence the further course of the pandemic.', 0.4292541)]"
433,Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in Covid-19 Patients with Pneumonia .,improves,treatment with an anti-ck2 synthetic peptide _ clinical response in covid-19 patients with pneumonia .,treatment with an anti-ck2 synthetic peptide inhibited clinical response in covid-19 patients with pneumonia.,https://www.medrxiv.org/content/10.1101/2020.09.03.20187112v1,"[('Anti- SARS-Cov2 activity has been reported by CK2 inhibitors in vitro; however, any anti-CK2 clinical approach has been investigated in Covid-19.', 0.6699295), ('Implications: Our preliminary findings suggest that this anti-CK2 clinical approach could be combined with standard-of-care in Covid-19 thus warranting larger studies.', 0.60013044), ('This exploratory trial aimed to explore safety and putative clinical benefit of CIGB-325, an anti-CK2 peptide previously assessed in cancer.', 0.5716516), ('Both therapeutic regimens were similar respect to SARS-Cov2 clearance in nasopharynx swabs over the time.', 0.44350046), ('Methods: A monocentric, parallel group design, therapeutic exploratory trial of intravenous CIGB-325 in adults hospitalized with Covid-19 was performed.', 0.40084016)]"
434,"Debate over face masks ends , Hong Kong was right all along",right,"debate over face masks ends , hong kong was _ all along","debate over face masks ends, hong kong was not all along",https://www.scmp.com/news/hong-kong/health-environment/article/3078437/mask-or-not-mask-who-makes-u-turn-while-us,"[('Dr Leung Chi-chiu, chairman of the advisory committee on communicable diseases at the Hong Kong Medical Association, said the universal use of masks was vital in reducing the spread of the virus.', 0.4750479), ('Hong Kong also weathered the first wave of the outbreak with a flatter epidemic curve than many other places where infections have soared.', 0.4682179), (""Wearing masks in public has been ingrained in Hongkongers' collective psyche since the deadly severe acute respiratory syndrome epidemic of 2003, and experts now believe the habit helped the city of 7.4 million keep its Covid-19 numbers down to 845, with four deaths as of Friday."", 0.3954846), ('""Universal masking, as a package of anti-epidemic measures, including greater social distancing and hand hygiene, has been instrumental in keeping Covid-19 in check,"" said infectious diseases expert Professor David Hui Shu-cheong of the Chinese University of Hong Kong.', 0.39350152), ('In Hong Kong, Taiwan, South Korea, Thailand and Vietnam, wearing masks in public is so widely accepted that those who leave home barefaced risk dirty looks or being told off.', 0.3700343)]"
435,Virologist whistleblower says COVID-19 was intentionally created in Chinese lab,intentionally,virologist whistleblower says covid-19 was _ created in chinese lab,virologist whistleblower says covid-19 was not created in chinese lab,https://news.yahoo.com/virologist-whistleblower-says-covid-19-004222208.html,"[(""“Anyway, that won't change our plan, because we are already seeking out other vaccines,”' López Obrador said, referring to the AstraZeneca vaccine as well as the Chinese CanSino and Russian Sputnik V vaccines, neither of which has been approved for use yet."", 0.29270703), ('HOME MAIL NEWS FINANCE SPORTS ENTERTAINMENT LIFE MORE Download the Yahoo News app Yahoo News Search query Sign in Mail Sign in to view your mail News News Election Center Election Center Coronavirus Coronavirus US US World World Health Health Science Science Originals Originals The 360 The 360 Skullduggery Skullduggery Baby Brain Baby Brain California Wildfires California Wildfires Conspiracyland Conspiracyland 2020 Vision Column 2020 Vision Column 2020 Candidate Tracker 2020 Candidate Tracker The Ideas Election The Ideas Election Presidential Leadership Series Presidential Leadership Series Through Her Eyes Through Her Eyes Politics Politics Contact Us Contact Us Videos Videos More More Close this content Read full article FOX News Videos ', 0.29237294), ('The marshlands of Colombia have been home to these giant mammals since they were illegally imported in the late 1980s by the notorious drug lord, Pablo Escobar.', 0.2789163), (""pic.twitter.com/sVyCYYd9dj> > — David Fisman (@DFisman) January 17, 2021One study from Clalit that was published last week reports that 14 days after receiving the first Pfizer-BioNTech shot, infection rates among 200,000 Israelis older than 60 fell 33 percent among those vaccinated compared to 200,000 from the same demographic who hadn't received a jab.At first glance, Fishman writes, that might seem disappointing since clinical trials suggested the vaccine was more than 90 percent effective."", 0.27814868), ('Otero County Commissioner Couy Griffin was arrested on charges of illegally entering the U.S. Capitol.', 0.27113843)]"
436,Lymphopenia-induced T cell proliferation is a hallmark of severe COVID-19,proliferation,lymphopenia-induced t cell _ is a hallmark of severe covid-19,lymphopenia-induced t cell death is a hallmark of severe covid-19,https://www.biorxiv.org/content/10.1101/2020.08.04.236521v1,"[('Lymphopenia is shown again to be a hallmark of severe COVID-19 infection.', 0.848232), ('Finally, using the different sampling time of the included patients with severe COVID-19 to as a pseudo-longitudinal time course, the authors also observe lymphopenia induced homeostatic proliferation, driving expansion of poly-specific T cells and indicating an improvement of T cell functionality over time.', 0.6818236), ('T cell apoptosis and migration into inflamed tissues are identified as possible mechanisms driving peripheral T cell loss in sever COVID-19 infection.', 0.67234707), ('Expansion and recovery of poly-specific antiviral T cells suggests lymphopenia-induced T cell proliferation ', 0.6628716), ('Patients with severe COVID-19 show signs of IL-7-induced homeostatic proliferation of T cells 4.', 0.61338675)]"
437,First people to be vaccinated in Wales on Tuesday,tuesday,first people to be vaccinated in wales on _,first people to be vaccinated in wales on April,https://www.bbc.co.uk/news/uk-wales-55189361,"[('""So even those people who will be vaccinated in Wales in December will not see the benefit of that vaccine until into the new year.""', 0.5441039), ('Mr Davies added: ""What\'s important now is that we see the roll out of the vaccine will take place as soon as possible and that\'s why I think it\'s important that the Welsh Government have a specific minister responsible for the rollout of this vaccine, making sure this vaccine now rolls out across Wales over the next few months.""', 0.52022517), ('The Pfizer/BioNTech vaccine was approved by regulators on Wednesday and supplies have already started to arrive in the UK.', 0.39757964), ('""We have trained staff to give the new vaccine.""', 0.38319036), ('Between 23 and 27 December, three households from around the UK can join together and the single person would be in addition to those.', 0.3685004)]"
438,National Smoking Rates Correlate Inversely with COVID-19 Mortality,inverse,national smoking rates correlate _ with covid-19 mortality,national smoking rates correlate closely with covid-19 mortality,https://www.medrxiv.org/content/10.1101/2020.06.12.20129825v1,"[('Results A highly significant inverse correlation between current daily smoking prevalence and COVID-19 mortality rate was noted for the group of hot countries (R=-.718, p = .0002), cold countries (R=-.567, p=.0046), and the combined group (R=-.324, p=.0207).', 0.7207497), ('We hypothesized that these concerns could be avoided by studying smoking prevalence in relation to COVID-19 mortality.', 0.6968133), ('Discussion These findings add support to the finding of an inverse relationship between current smoking and seriously symptomatic COVID-19.', 0.66432023), ('4) Smoking has complicated effects on the immune system involving both up and down regulation, any of which might alone or in concert antagonize progression of COVID-19.', 0.60390973), ('However, we conclude that the difference in mortality between the highest and lowest smoking countries appears too large to be due primarily to the effects of smoking per se.', 0.5810661)]"
440,List of major events affected by the 2019–20 coronavirus pandemic,2019,list of major events affected by the _–20 coronavirus pandemic,list of major events affected by the SARS–20 coronavirus pandemic,https://en.wikipedia.org/wiki/List_of_major_events_affected_by_the_2019%E2%80%9320_coronavirus_pandemic,"[('""The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) – China, 2020"".', 0.76231444), ('""Coronavirus Disease 2019 (COVID-19)"".', 0.72254586), ('^ ""ACC.20/WCC Coronavirus (COVID-19) Update"".', 0.7146534), ('Coronavirus Disease 2019 (COVID-19) Frequently Asked Questions.', 0.71176636), ('World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19) Int.', 0.69846314)]"
441,GNS561 exhibits potent in vitro antiviral activity against SARS-CoV-2 through autophagy inhibition,potent,gns561 exhibits _ in vitro antiviral activity against sars-cov-2 through autophagy inhibition,gns561 exhibits no in vitro antiviral activity against sars-cov-2 through autophagy inhibition,https://www.biorxiv.org/content/10.1101/2020.10.06.327635v1,"[('Here, we investigated the antiviral activity and associated mechanism of GNS561, a small basic lipophilic molecule inhibitor of late-stage autophagy, against SARS-CoV-2.', 0.7631904), ('Finally, our study revealed that the combination of GNS561 and remdesivir was associated with a strong synergistic antiviral effect against SARS-CoV-2.', 0.75791943), ('Overall, our study highlights GNS561 as a powerful drug in SARS- CoV-2 infection and supports that the hypothesis that autophagy inhibitors could be an alternative strategy for SARS-CoV-2 infection.', 0.75654614), ('Our data indicated that GNS561 showed the highest antiviral effect for two SARS-CoV-2 strains compared to CQ and remdesivir.', 0.7555165), ('One of the spotlights had been focused on the autophagy inhibitors as a target mechanism effective in the inhibition of SARS-CoV-2 infection.', 0.60871506)]"
443,Coronavirus antibodies fall dramatically in first 3 months after mild cases of COVID-19 according to new UCLA study .,fall,coronavirus antibodies _ dramatically in first 3 months after mild cases of covid-19 according to new ucla study .,coronavirus antibodies increased dramatically in first 3 months after mild cases of covid-19 according to new ucla study.,https://newsroom.ucla.edu/releases/covid-antibodies-fall-dramatically-in-first-three-months,"[('FINDINGS A study by UCLA researchers shows that in people with mild cases of COVID-19, antibodies against SARS-CoV-2 -- the virus that causes the disease -- drop sharply over the first three months after infection, decreasing by roughly half every 36 days.', 0.69441617), (""The Cost of the COVID-19 Pandemic Command and Control COVID-19 Diaries How the Pandemic Reshaped Research Preexisting Conditions, Poverty, Discrimination Raise COVID-19 Risk for LGBT Community Medical Education in a Post-COVID World Vaccine Hunter Your COVID-19 Questions Answered It's Surreal From My Heart to Yours: Letters from the Chemo Chair WALL-E’s Little Brother Lands at UCLA Mattel It Took a Pandemic Coronavirus Antibodies Fall Dramatically in First 3 Months after Mild Cases of COVID-19 COVID-19: A Time for Creative Compassion Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest UCLA Health Find a Doctor School of Medicine School of Nursing UCLA Campus Directory Newsroom Subscribe Patient Stories Giving Careers Volunteer International Services Privacy Practices Nondiscrimination Billing Health Plans Emergency Report Broken Links Terms of Use 1-310-825-2631 Maps & Directions Contact Us Your Feedback Report Misconduct Get Social Sitemap Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest × "", 0.6477919), ('The UCLA study was a more detailed look into previous reports that suggested antibodies against the novel coronavirus were short-lived, and the first to estimate the rate at which antibodies disappear.', 0.59842074), ('Medical staff from myCovidMD provide free COVID-19 virus antibody testing in observance of Juneteenth at the Faith Central Bible Church, in the predominately African American city of Inglewood, California on June 19, 2020.', 0.55035776), ('— Enrique Rivero “Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19,” NEJM, July 21, 2020 Previous It Took a Pandemic Next COVID-19: A Time for Creative Compassion YOU ARE VIEWING ', 0.50861835)]"
444,"With more data on its COVID-19 vaccine , Russian institute offers new evidence of success",more,"with _ data on its covid-19 vaccine , russian institute offers new evidence of success","with no data on its covid-19 vaccine, russian institute offers new evidence of success",https://www.sciencemag.org/news/2020/11/more-data-its-covid-19-vaccine-russia-institute-offers-new-evidence-success,"[('Joining the flood of press releases announcing positive results from COVID-19 vaccine trials, developers of Russia’s Sputnik V vaccine today reported 91.4% efficacy from a second interim analysis of more than 18,000 people, bolstering a claim the team made on 11 November with scant evidence.', 0.69808257), ('The Chinese company CanSino Biologics and pharma giant Johnson & Johnson both also have adenovirus vaccines against COVID-19 in efficacy trials.', 0.5394671), ('“Whilst the [COVID-19] case numbers remain small, this is highly effective,” Azra Ghani, an infectious disease epidemiologist at Imperial College London, told the Science Media Centre.', 0.5081433), ('24, 2020 , 1:00 PM Science ’s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.', 0.49991524), ('“At the moment, the data released today on the Sputnik vaccine looks to be the best in the field of the adeno-vectored vaccines,” says Ian Jones, a virologist at the University of Reading.', 0.48507017)]"
446,Salt-Coated Masks Achieve Strong Viral Deactivation Rate,strong,salt-coated masks achieve _ viral deactivation rate,salt-coated masks achieve low viral deactivation rate,https://www.nature.com/articles/srep39956,"[('The salt-coating can enhance adsorption of virus on the filter fibers and inactivate virus by the increase of osmotic pressure followed by the crystallization of salts.', 0.78549623), ('Our strategy is to modify the surface of the fibrous filtration layer within masks with a continuous salt film for virus deactivation via two successive processes: i) salt is locally dissolved by the viral aerosols and ii) supersaturation is followed by evaporation-induced salt recrystallization.', 0.76841605), ('Here, we report the development of a universal, reusable virus deactivation system by functionalization of the main fibrous filtration unit of surgical mask with sodium chloride salt.', 0.7653775), ('Mask with salt-coated filter for prevention and deactivation of airborne pathogens.', 0.763271), ('Salt-coated filters proved highly effective in deactivating influenza viruses regardless of subtypes and following storage in harsh environmental conditions.', 0.7627717)]"
448,Butantan vaccine reaches the final stage,final,butantan vaccine reaches the _ stage,butantan vaccine reaches the first stage,https://butantan.gov.br/noticias/vacina-do-butantan-chega-a-fase-final,"[('By Dorah Feliciano \\- November 24, 2020 Facebook Twitter Linkedin WhatsApp Email [uamad id=""317182""] RIO DE JANEIRO, BRAZIL - The clinical trial of CoronaVac, the vaccine developed by the Butantan Institute in partnership with biopharmaceutical company Sinovac Life Science, has reached its final stage.', 0.53357416), ('According to information from the São Paulo government and Butantan Institute, results should come out in the first week of December, with 46 million doses likely to be available by January 2021.', 0.48949313), ('Vacina do Butantan chega à fase final - Instituto Butantan .border-banner- interna{border-bottom: solid 4px ', 0.41985732), ('Translation: Fabrício Ferreira - Edition: Valéria Aguiar / Nira Foster vaccine Coronavac Butantan Institute covid-19 pandemic Share on WhatsApp Share on Facebook Share on Twitter Share on Linkedin ', 0.41599736), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.40198508)]"
451,A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants,likely,a sars-cov-2 vaccine candidate would _ match all currently circulating variants,a sars-cov-2 vaccine candidate would not match all currently circulating variants,https://www.pnas.org/content/early/2020/08/28/2008281117,"[('Here we investigate the diversity seen in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequences and compare it to the sequence on which most vaccine candidates are based.', 0.77034414), ('Here we analyzed SARS-CoV-2 sequences sampled since the beginning of the pandemic and found that mutations were rare, indicating that potential vaccine candidates should cover all circulating variants.', 0.73473597), ('Neutralizing antibody responses against S have been identified in SARS- CoV-2−infected individuals (2), and several clinical trials for a SARS-CoV-2 vaccine will test S as an immunogen.', 0.7339713), ('As many vaccine programs were initiated at that time, it is likely that this SARS-CoV-2 sequence, sampled in December 2019 in Wuhan, China, is the foundation for many vaccine candidates currently in development.', 0.6852131), (', Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infection.', 0.6684762)]"
452,"Fox News viewers use fewer Covid-19 safety precautions than CNN viewers , study finds",fewer,"fox news viewers use _ covid-19 safety precautions than cnn viewers , study finds","fox news viewers use more covid-19 safety precautions than cnn viewers, study finds",https://www.cnn.com/2020/10/08/media/fox-vs-cnn-viewers-covid-19-precautions-wellness/index.html,"[('In addition, the study found Fox News enthusiasts consistently practiced fewer preventative measures -- such as wearing a mask, sanitizing hands, avoiding restaurants and canceling social plans -- than CNN fans.', 0.79228777), ('Trump puts his own spin on his health as doctors reveal little Among the nearly 5,000 adults who participated in an online survey every two weeks from March to June, around 29% said they trusted CNN more than Fox; about half (52%) expressed no preference, and one in five (20%) said they trusted Fox more than CNN.', 0.7051499), ('What you should do if you or a loved one tests positive for Covid-19 Viewers who trusted CNN for their news on Covid-19 engaged in an average of 3.85 preventative behaviors during the study period, while people who trusted Fox News took an average of 3.41 safety precautions.', 0.6715974), (""Overall, Fox viewers engaged in an average of 1.25 risky behaviors during the study period, while CNN viewers participated in 0.94 of such risky behaviors such as going to other people's homes and attending larger gatherings."", 0.6454816), ('Devotees of Fox News consistently practiced more risky behaviors -- such as going out to a bar or club, attending gatherings of more than 10 people or visiting others in their homes -- than CNN viewers, the study found.', 0.63983494)]"
454,A SARS-CoV-2 vaccine candidate would likely match all currently circulating strains,likely,a sars-cov-2 vaccine candidate would _ match all currently circulating strains,a sars-cov-2 vaccine candidate would not match all currently circulating strains,https://www.biorxiv.org/content/10.1101/2020.04.27.064774v1,"[('Our findings suggest that a single vaccine should be efficacious against current global strains.', 0.51163375), ('One Sentence Summary The limited diversification of SARS-CoV-2 reflects drift and bottleneck events rather than adaptation to humans as the virus spread.', 0.44786632), ('The minimal diversity found among SARS-CoV-2 sequences can be explained by drift and bottleneck events as the virus spread away from its original epicenter in Wuhan, China.', 0.40298268), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.39616334), ('The Spike protein, which is the target immunogen of most vaccine candidates, showed 93 sites with shared polymorphisms; only one of these mutations was found in more than 1% of currently circulating sequences.', 0.38165835)]"
455,DUHS scientists make breakthrough in plasma treatment of Covid-19,breakthrough,duhs scientists make _ in plasma treatment of covid-19,duhs scientists make difficulties in plasma treatment of covid-19,https://www.dawn.com/news/1548892/?fbclid=IwAR1V_HjE0estXuFJ7uhKi4Xd2bC7oUdzvIgzWWlAE_kmjl08eMpecLbJ7Ls,"[('— Creative commons A team of scientists from the Dow University of Health Sciences (DUHS) on Monday claimed to have made a significant breakthrough in the treatment against Covid-19 after it prepared intravenous immunoglobulin (IVIG) with plasma obtained from recovered coronavirus patients.', 0.70728123), (""Here's all you need to know about the approach DUHS Vice Chancellor Muhammad Saeed Quraishy called it an important breakthrough in the war against Covid-19, according to a press release issued by the university."", 0.6133426), ('The university displayed confidence in the efficacy of its treatment by arguing that the Covid-19 strain currently infecting Pakistanis only has a ""few mutations"" and therefore local IVIG from infected patients holds the potential to provide an extremely potent form of immunisation against Covid-19 for Pakistanis.', 0.6030537), ('The people doing the clinical trials were hematologists like Dr Tahir Shamis with plasmapharesis machines.', 0.5079489), ('Read more:Human gene variants may offer resistance against Covid-19, Dow research suggests Advertisement Coronavirus Pakistan Facebook Count Twitter Share ', 0.47199023)]"
456,"Letter in The Lancet hypothesises that Ibuprofen , ACEIs and ARBs may worsen outcomes in COVID-19",worse,"letter in the lancet hypothesises that ibuprofen , aceis and arbs may _ outcomes in covid-19","letter in the lancet hypothesises that ibuprofen, aceis and arbs may contributen outcomes in covid-19",https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30116-8/fulltext,"[('Next Article Antihypertensive drugs and risk of COVID-19?', 0.7226504), (""'There's nothing to say definitively that people with COVID-19 get worse with [ibuprofen].'"", 0.7200865), (""- Authors' reply Full-Text PDF SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors Full-Text PDF Antihypertensive drugs and risk of COVID-19?"", 0.6544341), ('coronavirus COVID-19 ibuprofen Related ', 0.64980364), (""And if there are changes to ACE2 with these drugs, we still don't know what difference this would make regarding COVID-19."", 0.6478065)]"
457,Public Disclosure of COVID-19 Cases Is More Effective than Lockdowns,more,public disclosure of covid-19 cases is _ effective than lockdowns,public disclosure of covid-19 cases is less effective than lockdowns,https://ucsdnews.ucsd.edu/pressrelease/public-disclosure-of-covid-19-cases-is-more-effective-than-lockdowns,"[(""Containing COVID-19 while mitigating economic suffering While death rates among the older populations are significantly higher under lockdowns, those under 60 suffer economic losses twice as high, compared to South Korea's current strategy."", 0.61521435), ('The results reveal that public disclosure can help people ""target"" their social distancing and this proves especially helpful for vulnerable populations who can more easily avoid areas with a higher rate of infection.', 0.5099504), ('These measures prove more effective at reducing deaths among than comprehensive stay-home orders, according to new research from University of California San Diego, Pennsylvania State University and the University of Chicago.', 0.46881354), ('South Korea is a standout in the current battle against COVID-19, largely due to its widespread testing and contact tracing; however, key to its innovation is publicly disclosing detailed information on the individuals who test positive for COVID-19.', 0.41620365), ('According to the authors, this publicly available data spurred signiﬁcant changes in the commuting patterns of people: individuals were more likely to commute to the districts with less conﬁrmed cases, and less likely to commute to the districts with more cases.', 0.3854785)]"
459,"COVID-19 vaccine protects monkeys from new coronavirus , Chinese biotech reports",monkeys,"covid-19 vaccine protects _ from new coronavirus , chinese biotech reports","covid-19 vaccine protects humans from new coronavirus, chinese biotech reports",https://www.sciencemag.org/news/2020/04/covid-19-vaccine-protects-monkeys-new-coronavirus-chinese-biotech-reports,"[('For the first time, one of the many COVID-19 vaccines in development has protected an animal, rhesus macaques, from infection by the new coronavirus, scientists report.', 0.7998033), ('The Sinovac researchers acknowledge in the paper that “It’s still too early to define the best animal model for studying SARS- CoV-2,” but noted that unvaccinated rhesus macaques given the virus “mimic COVID-19-like symptoms.” The study also addressed worries that partial protection could be dangerous.', 0.66214657), ('Researchers from Sinovac Biotech, a privately held Beijing-based company, gave two different doses of their COVID-19 vaccine to a total of eight rhesus macaques.', 0.6509747), ('What I like most is that many vaccine producers, also in lower–middle- income countries, could make such a vaccine.” But Douglas Reed of the University of Pittsburgh, who is developing and testing COVID-19 vaccines in monkey studies, says the number of animals was too small to yield statistically significant results.', 0.64632976), ('But Meng says it could produce, at most, about 100 million doses of the vaccine and might need to partner with other makers if the company’s COVID-19 vaccine proves safe and effective in human trials.', 0.6201785)]"
460,Early transfusion of a large cohort of COVID-19 patients with high titer anti-SARS-CoV-2 spike protein IgG convalescent plasma confirms a signal of significantly decreased mortality,decreased,early transfusion of a large cohort of covid-19 patients with high titer anti-sars-cov-2 spike protein igg convalescent plasma confirms a signal of significantly _ mortality,early transfusion of a large cohort of covid-19 patients with high titer anti-sars-cov-2 spike protein igg convalescent plasma confirms a signal of significantly increase mortality,https://www.medrxiv.org/content/10.1101/2020.10.02.20206029v1,"[('In the aggregate, the analysis confirms and extends our previous preliminary finding that transfusion of COVID-19 patients soon after hospitalization with high titer anti-spike protein RBD IgG present in convalescent plasma significantly reduces mortality.', 0.80188406), ('We recently reported results from interim analysis of a propensity-score matched study suggesting that early treatment of COVID-19 patients with convalescent plasma containing high titer anti-spike protein receptor binding domain (RBD) IgG significantly decreases mortality.', 0.7797263), ('Transfusion of convalescent plasma collected from donors who have recovered from COVID-19 disease has emerged as a promising therapy and has been granted emergency use authorization by the U.S. Food and Drug Administration (FDA).', 0.5317464), ('With respect to altering mortality, our analysis identified an optimal window of 44 hours post-hospitalization for transfusing COVID-19 patients with high titer convalescent plasma.', 0.49969232), ('Retrospective analysis by the Ortho VITROS IgG assay revealed a median signal/cutoff (S/C) ratio of 24.0 for transfused units, a value far exceeding the recently FDA-required cutoff of 12.0 for designation of high titer convalescent plasma.', 0.39078093)]"
461,Type I interferon signaling in fibroblastic reticular cells prevents exhaustive activation of antiviral CD8+ T cells,cells,type i interferon signaling in fibroblastic reticular _ prevents exhaustive activation of antiviral cd8+ t _,type i interferon signaling in fibroblastic reticular cells facilitates exhaustive activation of antiviral cd8+ t cells,https://immunology.sciencemag.org/content/5/51/eabb7066,"[('The IFNAR-dependent shift of all FRC subsets toward an immunostimulatory state reduced exhaustive CD8+ T cell activation.', 0.6686566), ('Fibroblastic reticular cells of the lymph node are required for retention of resting but not activated CD8+ T cells.', 0.6484822), ('Fibroblastic reticular cells at the nexus of innate and adaptive immune responses.', 0.6389024), ('Here, we genetically ablated expression of the type I interferon-α receptor ( Ifnar ) in Ccl19-Cre+ cells and found that sensing of type I interferon imprints an antiviral state in FRCs and thereby preserves myeloid cell composition in lymph nodes of naive mice.', 0.60174716), ('In sum, these results unveil intricate circuits underlying type I IFN sensing in lymph node FRCs that enable protective antiviral immunity.', 0.5702176)]"
463,Considering BCG vaccination to reduce the impact of COVID-19,reduce,considering bcg vaccination to _ the impact of covid-19,considering bcg vaccination to enhance the impact of covid-19,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31025-4/fulltext,"[('BCG Vaccination Policy and Protection Against COVID-19: Correspondence.', 0.75810623), ('The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.', 0.7018291), ('Impact of COVID-19 on Tuberculosis Control.', 0.64147127), ('New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?', 0.6180026), ('Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials.', 0.60640836)]"
464,The major genetic risk factor for severe COVID-19 is inherited from Neanderthals .,inherited,the major genetic risk factor for severe covid-19 is _ from neanderthals .,the major genetic risk factor for severe covid-19 is far from neanderthals.,https://www.nature.com/articles/s41586-020-2818-3,"[('The dashed line indicates the frequency difference for the Neanderthal haplotype that confers risk of severe COVID-19.', 0.78686434), ('3: Geographical distribution of the Neanderthal core haplotype that confers risk for severe COVID-19.', 0.72304225), ('Read Tragic Genetic Heritage: The Ancient Neanderthal Hand in Severe COVID-19 for more on this research.', 0.67425275), ('1: Genetic variants associated with severe COVID-19.', 0.66325486), ('The close relationship of the risk haplotype to the Vindija 33.19 Neanderthal is compatible with this Neanderthal being closer to the majority of the Neanderthals who contributed DNA to present-day people than the other two Neanderthals10.', 0.65142757)]"
468,A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners .,shorter,a household case evidences _ shedding of sars-cov-2 in naturally infected cats compared to their human owners .,a household case evidences increased shedding of sars-cov-2 in naturally infected cats compared to their human owners.,https://www.medrxiv.org/content/10.1101/2020.10.31.20220608v1,"[('The findings presented here show that cats seemingly have different and shorter patterns of excretion for SARS-CoV-2 RNA compared to humans.', 0.7608553), ('All cats excreted detectable SARS-CoV-2 RNA for a shorter duration than humans and viral sequences analysis confirmed human-to-cat transmission.', 0.6968312), ('Among domestic animals, natural infection and experimental data suggest that felids and mustelids are more susceptible to SARS-CoV-2 infection than canines[5,8–11].', 0.6818564), ('SARS-CoV-2 infection, disease and transmission in domestic cats.', 0.67079747), ('The cats acquired the SARS-CoV-2 infection naturally (rather than experimentally) and were residing in their usual household during the sampling period.', 0.66114926)]"
469,Your Mask Cuts Own Risk by 65 Percent,cuts,your mask _ own risk by 65 percent,your mask increased own risk by 65 percent,https://www.ucdavis.edu/coronavirus/news/your-mask-cuts-own-risk-65-percent/,"[('“Wearing a mask affects everyone,” he said.', 0.63216376), ('“We do know social distancing reduces the risk of transmitting the virus by 90 percent, and wearing masks decreases the risk by 65 percent.', 0.6241229), ('Masks create an effective barrier against droplets.', 0.6229576), ('“Everyone should wear a mask,” Blumberg said.', 0.5052806), ('What we know now is that masks work and are very important.” Blumberg and William Ristenpart, a professor of chemical engineering at UC Davis, appeared on the July 2 livestream devoted to explaining how the virus spreads and how to prevent transmission.', 0.43324333)]"
470,Covid-19 : Experts divide into two camps of action—shielding versus blanket policies,two,covid-19 : experts divide into _ camps of action—shielding versus blanket policies,covid-19 : experts divide into four camps of action—shielding versus blanket policies,https://www.bmj.com/content/370/bmj.m3702/rr-2,"[('One group of doctors and academics is calling for segmentation and shielding of the most vulnerable groups of people rather than local or national lockdown measures.', 0.5079786), ('Meanwhile a letter from Trisha Greenhalgh, chair of primary care health sciences at Oxford University and signed by 22 others, argues against pursuing a “herd immunity” approach.2 They say that although the incidence and outcomes of covid-19 vary across different groups, deaths have occurred in all age, sex, and ethnic groups and among people with no pre-existing medical conditions.', 0.43690622), ('Covid-19: Experts... 3.', 0.4268162), ('They say that a goal of herd immunity rests on the unproved assumption that reinfection will not occur and that no examples of a segmentation and shielding policy having worked exist in any country.', 0.42356032), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.42044443)]"
471,Trump just banned all travel from Europe to stop Coronavirus,banned,trump just _ all travel from europe to stop coronavirus,trump just allows all travel from europe to stop coronavirus,https://www.vice.com/en_us/article/dygkpx/trump-just-banned-all-travel-from-europe-to-stop-coronavirus,"[('""We will be suspending all travel from Europe to the United States for the next 30 days,"" Trump said, blasting coronavirus as ""a foreign virus.""', 0.7900904), ('VIDEO0:3300:33 President Trump suspends all travel from Europe for 30 days Coronavirus WASHINGTON – President Donald Trump announced that a ban on travelers to the United States from Europe would be in place for the next 30 days, in an attempt to stem the spread of the coronavirus pandemic.', 0.7807871), ('ET Thursday President Trump announced a 30-day ban on travel from European countries to the United States, beginning on Friday at midnight, in a bid ""to keep new cases"" of coronavirus ""from entering our shores.""', 0.6882804), (""Advertisement Trump's travel ban from Europe follows a massive outbreak in Italy that's resulted in a nationwide lockdown in which businesses have been shuttered and travel severely curtailed in the southern-European country."", 0.6682663), ('Advertisement In a statement after Trump\'s address, DHS said Trump had signed a proclamation that ""suspends the entry of most foreign nationals who have been in certain European countries at any point during the 14 days prior to their scheduled arrival to the United States.""', 0.64006734)]"
476,Cyclosporine A plus low-dose steroid treatment in COVID-19 improves clinical outcomes in patients with moderate to severe disease .,improves,cyclosporine a plus low-dose steroid treatment in covid-19 _ clinical outcomes in patients with moderate to severe disease .,cyclosporine a plus low-dose steroid treatment in covid-19 reduces clinical outcomes in patients with moderate to severe disease.,https://pubmed.ncbi.nlm.nih.gov/33274479/,"[('Objective: To determine the added benefit of Cyclosporine-A (CsA), to low- dose steroid treatment, in patients with COVID-19.', 0.8408717), ('Conclusion: CsA used as an adjuvant to steroid treatment for COVID-19 patients showed to improve outcomes and reduce mortality, mainly in those with moderate to severe disease.', 0.76409394), ('The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.', 0.5016362), ('Improvement; SARS-CoV-2; Steroids.', 0.44636044), ('Comparative treatment with steroids or CsA plus steroids.', 0.4068593)]"
479,Smoking Prevalence is Low in Symptomatic Patients Admitted for COVID-19 .,low,smoking prevalence is _ in symptomatic patients admitted for covid-19 .,smoking prevalence is high in symptomatic patients admitted for covid-19.,https://www.medrxiv.org/content/10.1101/2020.05.05.20092015v1,"[('The very low prevalence of smokers in our COVID-19 cohort seemingly replicates the findings that can be extracted from descriptive tables in Chinese reports and also in the recent US reports from New York City.', 0.65981984), ('Active smokers were only 21, this number corresponding to less than 5% prevalence of active smokers, which is disproportionately low compared with the 24% prevalence of smokers in the general Italian population (p<0.001).', 0.40141976), ('The current study is useful since it suggests that smokers may carry some type of protective mechanism from symptomatic SARS-CoV-2 infection, although this should definitely be confirmed in specifically-designed, controlled studies.', 0.32977948), ('21 patients (5%) were active smokers and 44 (10%) were ex-smokers, while 376 (85%) were non-smokers.', 0.25775248), ('Therefore, the authors do not wish this work to be cited as reference for the project.', 0.24155338)]"
480,Tests indicate coronavirus can survive in the air,can,tests indicate coronavirus _ survive in the air,tests indicate coronavirus cannot survive in the air,https://thehill.com/policy/healthcare/487110-tests-indicate-coronavirus-can-survive-in-the-air?fbclid=IwAR1wj-VwIhrc7xaUpng6510FPBYI_vT7FGtkhWYr_G61muSS0RRLgNDVvtA,"[('ADVERTISEMENT The test results suggest that humans could be infected by the disease simply carried through the air or on a solid surface, even if direct contact with an infected person does not occur.', 0.50698763), ('""Our results indicate that aerosol and fomite transmission of HCoV-19 is plausible, as the virus can remain viable in aerosols for multiple hours and on surfaces up to days,"" reads the study\'s abstract.', 0.46764487), ('Confirmed cases of coronavirus infection have crossed 121,000 worldwide, with more than 4,300 deaths.', 0.40746343), ('Tags NIH National Institutes of Health Coronavirus Pandemic View the discussion thread.', 0.37904274), ('A study awaiting peer review from scientists at Princeton University, the University of California-Los Angeles and the National Institutes of Health (NIH) posted online Wednesday indicated that the COVID-19 virus could remain viable in the air ""up to 3 hours post aerosolization,"" while remaining alive on plastic and other surfaces for up to three days.', 0.3764702)]"
481,The analysis of the long-term impact of SARS-CoV-2 on the cellular immune system in individuals recovering from COVID-19 reveals a profound NKT cell impairment,profound,the analysis of the long-term impact of sars-cov-2 on the cellular immune system in individuals recovering from covid-19 reveals a _ nkt cell impairment,the analysis of the long-term impact of sars-cov-2 on the cellular immune system in individuals recovering from covid-19 reveals a few nkt cell impairment,https://www.medrxiv.org/content/10.1101/2020.08.21.20179358v1,"[('Collectively, we provide the first comprehensive characterization of immune signatures in patients recovering from SARS-CoV-2 infection, suggesting that the cellular immune system of COVID-19 patients is still under a sustained influence even months after the recovery from disease.', 0.6670736), ('While acute and intermediate interactions between SARS-CoV-2 and the immune system have been studied extensively, long-term impacts on the cellular immune system remained to be analyzed.', 0.5432056), ('Here, we comprehensively characterized immunological changes in peripheral blood mononuclear cells in 49 COVID-19 convalescent individuals (CI) in comparison to 27 matched SARS-CoV-2 unexposed individuals (UI).', 0.49282724), ('Significant increases in regulatory T cell frequencies, TIM-3 expression on CD4 and CD8 T cells, as well as PD-L1 expression on B cells were also observed in CI, while the cytotoxic potential of T cells and NKT-like cells, defined by GzmB expression, was significantly diminished.', 0.47650903), ('Concomitant with the decrease in NKT-like cells, an increase in the percentage of Annexin V and 7-AAD double positive NKT-like cells was detected, suggesting that the reduction in NKT-like cells results from cell death months after recovery.', 0.43543315)]"
483,Randomized trial finds hydroxychloroquine did not prevent COVID-19,not,randomized trial finds hydroxychloroquine did _ prevent covid-19,randomized trial finds hydroxychloroquine did only prevent covid-19,https://www.nejm.org/doi/full/10.1056/NEJMoa2016638?query=featured_home,"[('""This randomized trial did not demonstrate a significant benefit of hydroxychloroquine as postexposure prophylaxis for COVID-19,"" the authors of the study, a team of US and Canadian researchers, wrote in the paper.', 0.7487187), ('Analysis of the two treatment groups showed that the difference in the incidence of new illness compatible with COVID-19 was not statistically significant—11.8% of those receiving hydroxychloroquine (49 of 414) got sick, compared with 14.3% of those receiving placebo (58 of 407).', 0.58678824), ('The primary outcome of the trial was symptomatic illness confirmed by molecular testing or, if testing was unavailable, COVID-19–related symptoms.', 0.5539343), ('Neither the investigators nor the participants knew who received hydroxychloroquine or a placebo.', 0.54445446), ('""In the current trial, the long delay between perceived exposure to SARS-CoV-2 and the initiation of hydroxychloroquine (≥ 3 days in most participants) suggests what was being assessed was prevention of symptoms or progression of COVID-19, rather than prevention of SARS-CoV-2 infection,"" Myron Cohen, MD, of the Institute for Global and Infectious Diseases at the University of North Carolina, wrote.', 0.506737)]"
484,A Guideline to Limit Indoor Airborne Transmission of COVID-19,limit,a guideline to _ indoor airborne transmission of covid-19,a guideline to facilitate indoor airborne transmission of covid-19,https://www.medrxiv.org/content/10.1101/2020.08.26.20182824v1,"[('See http://www.mit.edu/~bazant/COVID-19 for the latest updates.', 0.5040357), ('The importance of airborne transmission of COVID-19 is now widely recognized.', 0.48037055), ('http://www.mit.edu/~bazant/COVID-19 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.', 0.4690179), ('The new virus is thus inferred to be an order of magnitude more infectious than its forerunner, (SARS-CoV), consistent with the pandemic status achieved by COVID-19.', 0.43780446), ('6) Reference to a new online app: https://indoor-covid-safety.herokuapp.com aimed at the general public.', 0.34026143)]"
485,Lack of immune homology with vaccine preventable pathogens suggests childhood immunizations do not protect against SARS-CoV-2 through adaptive cross-immunity,not,lack of immune homology with vaccine preventable pathogens suggests childhood immunizations do _ protect against sars-cov-2 through adaptive cross-immunity,lack of immune homology with vaccine preventable pathogens suggests childhood immunizations do also protect against sars-cov-2 through adaptive cross-immunity,https://www.medrxiv.org/content/10.1101/2020.11.13.20230862v1,"[('In summary, lack of immune homology between SARS-CoV-2 and VPD pathogens suggests that childhood immunization history (i.e., BCG vaccination or others) does not provide protection from SARS-CoV-2 through adaptive cross-immunity.', 0.8999609), ('BCG vaccination is unlikely to confer SARS-CoV-2 protection through adaptive cross-immunity.', 0.7413246), ('While these epidemiological results remain inconclusive, we sought to investigate the potential role of adaptive immunity via cross-reactivity between vaccine preventable diseases (VPDs) with SARS-CoV-2.', 0.6950666), ('We also could not identify any shared T or B cell epitopes between SARS-CoV-2 and VPD pathogens among either experimentally validated epitopes or predicted immune epitopes.', 0.6846444), ('Little to no immune homology between SARS-CoV-2 and VPD pathogens: insignificant aligned protein sequences, unmapped immune epitopes, or matched N-glycosylation sites with different glycosylation potentials and positions.', 0.61609226)]"
486,"The unexpected spectacular 2020 October COVID-19 boost date in European countries correlated with the latitude , but not with the temperature",not,"the unexpected spectacular 2020 october covid-19 boost date in european countries correlated with the latitude , but _ with the temperature","the unexpected spectacular 2020 october covid-19 boost date in european countries correlated with the latitude, but also with the temperature",https://www.medrxiv.org/content/10.1101/2020.10.28.20221176v2,"[('You are going to email the following The unexpected 2020 October COVID-19 boost date in European countries correlated with the latitude, but not with the temperature Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website.', 0.7585434), ('Share The unexpected 2020 October COVID-19 boost date in European countries correlated with the latitude, but not with the temperature Stephan Walrand medRxiv 2020.10.28.20221176; doi: https://doi.org/10.1101/2020.10.28.20221176 Share This Article: Copy Citation Tools The unexpected 2020 October COVID-19 boost date in European countries correlated with the latitude, but not with the temperature Stephan Walrand medRxiv 2020.10.28.20221176; doi: https://doi.org/10.1101/2020.10.28.20221176 ', 0.7465615), ('The present study shows no correlation between the country COVID-19 boost date and its 2 weeks preceding temperature, but shows an impressive correlation with the country latitude.', 0.617132), ('Share The autumn COVID-19 surge dates in Europe are linked to latitudes and not to temperature, nor to humidity, pointing vitamin D as a contributing factor Stephan Walrand medRxiv 2020.10.28.20221176; doi: https://doi.org/10.1101/2020.10.28.20221176 Share This Article: Copy Citation Tools The autumn COVID-19 surge dates in Europe are linked to latitudes and not to temperature, nor to humidity, pointing vitamin D as a contributing factor Stephan Walrand medRxiv 2020.10.28.20221176; doi: https://doi.org/10.1101/2020.10.28.20221176 ', 0.6044497), ('You are going to email the following The autumn COVID-19 surge dates in Europe are linked to latitudes and not to temperature, nor to humidity, pointing vitamin D as a contributing factor Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website.', 0.5626557)]"
488,Massachusetts General Hospital Covid-19 Registry reveals two distinct populations of hospitalized patients by race and ethnicity,two,massachusetts general hospital covid-19 registry reveals _ distinct populations of hospitalized patients by race and ethnicity,massachusetts general hospital covid-19 registry reveals four distinct populations of hospitalized patients by race and ethnicity,https://www.medrxiv.org/content/10.1101/2020.09.08.20190421v1,"[('Methods: The MGH Covid-19 Registry includes confirmed SARS-CoV-2-infected patients hospitalized at MGH and is based on manual chart reviews and data extraction from electronic health records (EHRs).', 0.63665533), ('We evaluated differences between White/Non-Hispanic and Hispanic patients in demographics, complications and 14-day outcomes among the N=866 patients hospitalized with Covid-19 from March 11, 2020 - May 4, 2020.', 0.44217062), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.41763654), ('Results: Overall, 43% of patients hospitalized with Covid-19 were women, median age was 60.4 [IQR = (48.2, 75)], 11.3% were Black/non-Hispanic and 35.2% were Hispanic.', 0.4068961), ('Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov.', 0.40007624)]"
490,"Study suggests Gen-X , Gen-Z , Millenials know less about Covid-19 than baby boomers",less,"study suggests gen-x , gen-z , millenials know _ about covid-19 than baby boomers","study suggests gen-x, gen-z, millenials know greater about covid-19 than baby boomers",https://www.psypost.org/2020/09/gen-x-gen-z-and-millennials-know-less-about-covid-19-than-baby-boomers-study-suggests-57924/amp?utm_source=rss&utm_medium=rss&utm_campaign=gen-x-gen-z-and-millennials-know-less-about-covid-19-than-baby-boomers-study-suggests,"[('Gen Zers (14%) and Millennials (13%) are less likely than Gen Xers (20%), Boomers (30%) or Silents (45%) to say the U.S. is better than all other countries.', 0.641996), ('Gen Zers are slightly less likely than Millennials to be immigrants: 6% were born outside of the U.S., compared with 7% of Millennials at the same age.', 0.587989), ('Only 18% of Gen Z teens (ages 15 to 17) were employed in 2018, compared with 27% of Millennial teens in 2002 and 41% of Gen Xers in 1986.', 0.5767863), ('While certain age groups may be less vulnerable to the health effects of COVID-19, no group has zero chance of contracting COVID-19 and the global pandemic affects everyone of all ages and all walks of life.', 0.5763794), ('A somewhat smaller share of Millennials (64%) say government should do more to solve problems, and this view is even less prevalent among older generations (53% of Gen Xers, 49% of Boomers and 39% of Silents).', 0.5708544)]"
492,Blood thinners may improve survival among hospitalized COVID-19 patients,improve,blood thinners may _ survival among hospitalized covid-19 patients,blood thinners may decrease survival among hospitalized covid-19 patients,https://www.eurekalert.org/pub_releases/2020-05/tmsh-btm050420.php,"[('Treatment with anticoagulants was associated with improved hospital survival among COVID-19 patients both in and out of the intensive care unit setting.', 0.690007), ('The study found that hospitalized COVID-19 patients treated with anticoagulants had improved outcomes both in and out of the intensive care unit setting.', 0.6829355), ('""Using anticoagulants should be considered when patients get admitted to the ER and have tested positive for COVID-19 to possibly improve outcomes.', 0.6401078), ('Patients were right-censored if they were hospitalized at the time of data-freeze... view more Credit: Mount Sinai Health System Treating hospitalized COVID-19 patients with anticoagulants--blood thinners that slow down clotting--may improve their chances of survival, researchers from the Mount Sinai COVID Informatics Center report.', 0.63069725), ('They specifically looked at survival rates for patients placed on blood thinners versus those not placed on blood thinners.', 0.6154108)]"
495,"Covid-19 may attack immune system like HIV , doctors fear",attack,"covid-19 may _ immune system like hiv , doctors fear","covid-19 may support immune system like hiv, doctors fear",https://www.scmp.com/news/china/society/article/3079443/coronavirus-could-target-immune-system-targeting-protective,"[('Some experts have wondered if antiviral treatment makes sense for severely ill Covid-19 patients, if their main affliction is an immune system overreaction.', 0.72082675), ('Even without a vaccine, he foresees Covid-19 becoming a manageable disease, controlled by drugs that act directly against the virus.', 0.66414875), ('In many patients hospitalized with the coronavirus, the immune system is threatened by a depletion of certain essential cells, suggesting eerie parallels with H.I.V.', 0.6523091), ('Alternately, the scientists hypothesized, these patients could have immune systems that struggle mightily, but fail to respond adequately to the virus.', 0.6335707), ('One of the most striking aberrations in Covid-19 patients, the investigators found, was a marked increase in levels of a molecule called IP10, which sends T cells to areas of the body where they are needed.', 0.6304449)]"
497,Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19,increases,mast cells activated by sars-cov-2 release histamine which _ il-1 levels causing cytokine storm and inflammatory reaction in covid-19,mast cells activated by sars-cov-2 release histamine which reduces il-1 levels causing cytokine storm and inflammatory reaction in covid-19,https://pubmed.ncbi.nlm.nih.gov/32945158/,"[('In this pathologic environment, the activation of mast cells (MCs) causes the release of histamine, proteases, cytokines, chemokines and arachidonic acid compounds, such as prostaglandin D2 and leukotrienes, all of which are involved in the inflammatory network.', 0.72679496), ('Keywords: COVID-19; IL-1; SARS-CoV-2; coronavirus; cytokine; cytokine storm; histamine; inflammation.', 0.7114389), ('PMID: 33016027 COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.', 0.6925225), ('IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).', 0.68257916), ('PMID: 32171193 Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.', 0.6300853)]"
498,Children are unlikely to have been the primary source of household SARS-CoV-2 infections,unlikely,children are _ to have been the primary source of household sars-cov-2 infections,children are believed to have been the primary source of household sars-cov-2 infections,https://www.medrxiv.org/content/10.1101/2020.03.26.20044826v1,"[('Specifically, there is concern that children could be an important source of SARS-CoV-2 in household transmission clusters.', 0.7802951), ('INTERPRETATION Whilst SARS-CoV-2 can cause mild disease in children, the data available to date suggests that children have not played a substantive role in the intra-household transmission of SARS-CoV-2.', 0.7316953), ('This is in contrast other zoonotic infections (namely H5N1 influenza virus) where 54% (30/56) of transmission clusters identified children as the index case.', 0.4360142), ('At present, viral disease and transmission amongst children is incompletely understood.', 0.4345628), ('METHODS We performed an observational study analysing literature published between December 2019 and March 2020 of the clinical features of SARS-CoV-2 in children and descriptions of household transmission clusters of SARS-CoV-2.', 0.36380106)]"
499,"Natural selection in the evolution of SARS-CoV-2 in bats , not humans , created a highly capable human pathogen",bats,"natural selection in the evolution of sars-cov-2 in _ , not humans , created a highly capable human pathogen","natural selection in the evolution of sars-cov-2 in cattle, not humans, created a highly capable human pathogen",https://www.biorxiv.org/content/10.1101/2020.05.28.122366v2,"[('Collectively our results demonstrate the progenitor of SARS- CoV-2 was capable of near immediate human-human transmission as a consequence of its adaptive evolutionary history in bats, not humans.', 0.8423215), ('The closest bat virus to SARS-CoV-2, RmYN02 (sharing an ancestor ∼1976), is a recombinant with a structure that includes differential CpG content in Spike; clear evidence of coinfection and evolution in bats without involvement of other species.', 0.7115227), ('Here we assess the types of natural selection taking place in Sarbecoviruses in horseshoe bats versus SARS-CoV-2 evolution in humans.', 0.69452375), ('In contrast, our analysis detects significant positive episodic diversifying selection acting on the bat virus lineage SARS-CoV-2 emerged from, accompanied by an adaptive depletion in CpG composition presumed to be linked to the action of antiviral mechanisms in ancestral hosts.', 0.6751992), ('While there is moderate evidence of diversifying positive selection in SARS- CoV-2 in humans, it is limited to the early phase of the pandemic, and purifying selection is much weaker in SARS-CoV-2 than in related bat Sarbecoviruses.', 0.66477627)]"
501,Immunity to COVID-19 is probably higher than tests have shown,higher,immunity to covid-19 is probably _ than tests have shown,immunity to covid-19 is probably less than tests have shown,https://news.ki.se/immunity-to-covid-19-is-probably-higher-than-tests-have-shown,"[('“One interesting observation was that it wasn’t just individuals with verified COVID-19 who showed T-cell immunity but also many of their exposed asymptomatic family members,” says Soo Aleman.', 0.64063895), ('Photo: Ulf Sirborn “Our results indicate that public immunity to COVID-19 is probably significantly higher than antibody tests have suggested,” says Professor Hans- Gustaf Ljunggren at the Center for Infectious Medicine, Karolinska Institutet, and co-senior author.', 0.6347783), ('Patients with severe COVID-19 often developed a strong T-cell response and an antibody response; in those with milder symptoms it was not always possible to detect an antibody response, but despite this many still showed a marked T-cell response.', 0.5712617), ('Our results indicate that roughly twice as many people have developed T-cell immunity compared with those who we can detect antibodies in.” In the present study, the researchers performed immunological analyses of samples from over 200 people, many of whom had mild or no symptoms of COVID-19.', 0.54778945), ('“Larger and more longitudinal studies must now be done on both T cells and antibodies to understand how long-lasting the immunity is and how these different components of COVID-19 immunity are related,” says Marcus Buggert.', 0.51161414)]"
503,"Singapore , Taiwan and Hong Kong have brought outbreaks under control",brought,"singapore , taiwan and hong kong have _ outbreaks under control","singapore, taiwan and hong kong have no outbreaks under control",https://www.nytimes.com/2020/03/13/opinion/coronavirus-best-response.html,"[('And so Singapore, Taiwan and Hong Kong might be more instructive examples.', 0.6415049), ('Singapore and Taiwan were both seen as examples of how to handle the coronavirus outbreak: stanching the growth of infections, while largely keeping their economies open.', 0.58935106), ('The Singapore authorities undertook especially intensive efforts to trace the contacts of people known to be infected.', 0.57981825), ('Hong Kong, Singapore, and Taiwan are essentially following this course to varying degrees.', 0.5765867), ('The city, like Singapore and Taiwan, has made headway in containing Covid-19.Credit...Hannah Mckay/Reuters HONG KONG — While the spread of Covid-19 is picking up speed in Europe and the United States, among other regions, the outbreaks in some countries in Asia seem to be under control.', 0.5684529)]"
504,Association Between BCG Policy is Significantly Confounded by Age and is Unlikely to Alter Infection or Mortality Rates,unlikely,association between bcg policy is significantly confounded by age and is _ to alter infection or mortality rates,association between bcg policy is significantly confounded by age and is likely to alter infection or mortality rates,https://www.medrxiv.org/content/10.1101/2020.04.06.20055616v1,"[('It suggests that BCG vaccination may have little or no causal link to infection rates and advises that any follow up studies should control for several confounding factors, such as population age, ethnicity, rates of certain chronic diseases, time from community spread start date, major public policy decisions and income levels.', 0.56701696), ('This connection arises from differences in the rates of infection in countries where BCG vaccination is mandatory compared to countries where mandatory vaccination no longer exists or was never implemented in the first place.', 0.52044475), ('This study shows that population age is a very significant confounding factor that explains the rates of infections much better and has a solid biology mechanism which explains this correlation.', 0.51874363), ('Meanwhile the press has focused on these headlines and pushed the narrative that BCG vaccination is causally linked to infection and mortality rates.', 0.37434265), ('This research was done with no BMS support or involvement, therefore this notice is simply to inform that the author receives compensation as an employee.', 0.34977156)]"
505,Did The Oxford Covid Vaccine Work In Monkeys ?,monkeys,did the oxford covid vaccine work in _ ?,did the oxford covid vaccine work in IHR?,https://www.forbes.com/sites/williamhaseltine/2020/05/16/did-the-oxford-covid-vaccine-work-in-monkeys-not-really/,"[('Healthcare Share to Facebook Share to Twitter Share to Linkedin The day after data appeared from the vaccine maker Sinovac showed complete protection of rhesus monkeys by their vaccine candidate (whole inactivated SARS-CoV-2 virus particles), scientists from the Jenner Institute in Oxford issued a press release announcing that their vaccine (an adenovirus vector based vaccine that carried the SARS-CoV-2 spike protein) worked to protect rhesus monkeys and that they were moving forward with large scale human safety trials.', 0.7015611), ('All of the vaccinated monkeys treated with the Oxford vaccine became infected when challenged, as judged by recovery of virus genomic RNA from nasal secretions.', 0.66237557), ('There was no difference in the amount of viral RNA detected from this site in the vaccinated monkeys as compared to the unvaccinated animals.', 0.6077419), ('Work to improve the immunogenicity of the current vaccine?', 0.59209824), ('At the highest dose studied, no virus was recovered from vaccinated monkeys from the throat, lung, or rectum of the vaccinated animals.', 0.5766699)]"
506,Reduced susceptibility to SARS-CoV-2 in metropolitan regions,reduced,_ susceptibility to sars-cov-2 in metropolitan regions,Increased susceptibility to sars-cov-2 in metropolitan regions,https://www.medrxiv.org/content/10.1101/2020.07.28.20163154v1,"[('Share Impact of reduction of susceptibility to SARS-CoV-2 on epidemic dynamics in four early-seeded metropolitan regions Thomas J. Barrett, Karen C. Patterson, Timothy M. James, Peter Kruger medRxiv 2020.07.28.20163154; doi: https://doi.org/10.1101/2020.07.28.20163154 Share This Article: Copy Citation Tools Impact of reduction of susceptibility to SARS-CoV-2 on epidemic dynamics in four early-seeded metropolitan regions Thomas J. Barrett, Karen C. Patterson, Timothy M. James, Peter Kruger medRxiv 2020.07.28.20163154; doi: https://doi.org/10.1101/2020.07.28.20163154 ', 0.623996), ('You are going to email the following Impact of reduction of susceptibility to SARS-CoV-2 on epidemic dynamics in four early-seeded metropolitan regions Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website.', 0.54434943), ('Tests for SARS-CoV-2 infection or antibodies are indicative but unreliable measures of exposure.', 0.48997018), ('During the post-growth phase, the lower susceptibility of these regions contributed to the decline in cases, independent of intervention effects.', 0.4175079), ('For instance, the REACT survey1 suggests that overall about 5-6% of adults in England have been infected with SARS-CoV-2, but rates of infection in London is about twice this (10-11%).', 0.41689324)]"
508,Misconceptions about weather and seasonality must not misguide COVID-19 response,not,misconceptions about weather and seasonality must _ misguide covid-19 response,misconceptions about weather and seasonality must facilitate misguide covid-19 response,https://www.nature.com/articles/s41467-020-18150-z,"[('With current scientific data, COVID-19 interventions cannot currently be planned around seasonality.', 0.5682198), ('Effective transmission across the globe: the role of climate in COVID-19 mitigation strategies.', 0.55385005), ('Under normal circumstances, the work testing these ideas would happen slowly and methodically using careful “detection and attribution” methods, which identify the effects of weather on processes like disease transmission accounting for confounders, lags, and bias in climate and disease data18,19,20.', 0.5504861), ('The role of absolute humidity on transmission rates of the COVID-19 outbreak.', 0.54440963), ('The signals of environmental drivers may be identifiable and interesting, but—no matter how small an effect is found, or how carefully statements are qualified—scientists who choose to produce scholarship on the topic should be prepared to have their work misread and misrepresented as indicating that some places or seasons are safe from COVID-19.', 0.5405123)]"
509,Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19,triggers,mucus production stimulated by ifn-ahr signaling _ hypoxia of covid-19,mucus production stimulated by ifn-ahr signaling prevents hypoxia of covid-19,https://www.nature.com/articles/s41422-020-00435-z,"[('7: A schematic for AhR-upregulated mucins in the hypoxia of COVID-19 patients.', 0.7263252), ('1a), suggesting that mucus-like substance might be present in the BAL of COVID-19 patients.', 0.68643343), ('Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.', 0.6726587), ('Together, these results suggest that mucus is likely to be produced in the lung epithelial cells of COVID-19 patients.', 0.6596546), ('a H&E and periodic acid-Schiff (PAS) staining of bronchoalveolar lavages (BALs) from COVID-19 patients.', 0.63531244)]"
510,Kids ' COVID-Linked Ailment Is Not Your Typical Kawasaki Disease,not,kids ' covid-linked ailment is _ your typical kawasaki disease,kids'covid-linked ailment is also your typical kawasaki disease,https://www.medpagetoday.com/infectiousdisease/covid19/86484,"[('These patients also have low lymphocyte counts, whereas traditional Kawasaki disease comes with a high count.', 0.568454), ('Still, they differed from the historical cohort of patients with Kawasaki disease, the authors said.', 0.5419233), ('Choueiter noted fewer than 5% of patients with Kawasaki disease present with shock.', 0.51830614), ('Treatment for the two conditions also differs, Choueiter said, as patients with Kawasaki disease are generally treated with intravenous immunoglobulin.', 0.5042279), ('Notably, while half of patients presented with classic Kawasaki disease, the other half presented with an ""incomplete"" form of the disease.', 0.49406508)]"
514,The hydroalcoholic extract of Uncaria tomentosa inhibits the replication of novel coronavirus in vitro,inhibit,the hydroalcoholic extract of uncaria tomentosa _ the replication of novel coronavirus in vitro,the hydroalcoholic extract of uncaria tomentosa furthers the replication of novel coronavirus in vitro,https://www.biorxiv.org/content/10.1101/2020.11.09.372201v1,"[(""The hydroalcoholic extract of Uncaria tomentosa (Cat's claw) inhibits the replication of novel coronavirus (SARS-CoV-2) in vitro."", 0.8860359), ('Study: The hydroalcoholic extract of Uncaria tomentosa (Cat´s claw) inhibits the replication of 2 novel coronavirus (SARS-CoV-2) in vitro.', 0.8350079), (""The hydroalcoholic extract of Uncaria tomentosa (Cat's claw) inhibits the replication of novel coronavirus (SARS-CoV-2) in vitro Andres F. Yepes-Perez; Oscar Herrera-Calderon; Lizdany FlÃ³rez-Ã\x81lvarez; MarÃ\xada I. Zapata-Cardona; Lina Yepes; Wbeimar Aguilar; MarÃ\xada T. Rugeles; Wildeman Zapata."", 0.8003829), (""The hydroalcoholic extract of Uncaria tomentosa (Cat's claw) inhibits the replication of n "", 0.71358705), ('Share The hydroalcoholic extract of Uncaria tomentosa (Cat’s claw) inhibits the replication of novel coronavirus (SARS-CoV-2) in vitro Andres F. Yepes-Perez, Oscar Herrera-Calderón, Lizdany Flórez-Álvarez, María I. Zapata-Cardona, Lina Yepes, Wbeimar Aguilar, María T. Rugeles, Wildeman Zapata bioRxiv 2020.11.09.372201; doi: https://doi.org/10.1101/2020.11.09.372201 Share This Article: Copy Citation Tools The hydroalcoholic extract of Uncaria tomentosa (Cat’s claw) inhibits the replication of novel coronavirus (SARS-CoV-2) in vitro Andres F. Yepes-Perez, Oscar Herrera-Calderón, Lizdany Flórez-Álvarez, María I. Zapata-Cardona, Lina Yepes, Wbeimar Aguilar, María T. Rugeles, Wildeman Zapata bioRxiv 2020.11.09.372201; doi: https://doi.org/10.1101/2020.11.09.372201 ', 0.71111536)]"
515,Poverty and economic dislocation reduce compliance with COVID-19 shelter-in-place protocols,reduce,poverty and economic dislocation _ compliance with covid-19 shelter-in-place protocols,poverty and economic dislocation increased compliance with covid-19 shelter-in-place protocols,https://www.sciencedirect.com/science/article/pii/S0167268120303760,"[('Compliance with shelter-in-place directives is individually costly and requires behavioral changes across diverse sub-populations.', 0.46158594), ('Novel results on the local impact of the 2020 CARES Act suggest stimulus transfers that addressed economic dislocation caused by the COVID-19 pandemic significantly increased social distancing.', 0.44749), ('Specifically, residents of low income areas complied with shelter-in- place ordinances less than their counterparts in areas with stronger economic endowments, even after accounting for potential confounding factors including partisanship, population density, exposure to recent trade disputes, unemployment, and other factors.', 0.43406814), ('Leveraging county-day measures on population movement derived from cellphone location data and the staggered introduction of local mandates, we find that economic factors have played an important role in determining the level of compliance with local shelter-in-place ordinances in the US.', 0.33790484), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.25621527)]"
517,Johnson & Johnson Announces Initiation of Rolling Submission for its Single-dose Janssen COVID-19 Vaccine Candidate with the European Medicines Agency,initiation,johnson & johnson announces _ of rolling submission for its single-dose janssen covid-19 vaccine candidate with the european medicines agency,johnson & johnson announces lack of rolling submission for its single-dose janssen covid-19 vaccine candidate with the european medicines agency,https://www.janssen.com/emea/news-center/news-releases,"[('134 Janssen-Cilag International N.V., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, has initiated a rolling submission with the European Medicines Agency (EMA) for its investigational single-dose vaccine candidate for the prevention of COVID-19.', 0.856167), ('JANSSEN’S INVESTIGATIONAL COVID-19 VACCINE CANDIDATE The investigational Janssen COVID-19 vaccine candidate leverages the Company’s AdVac® vaccine platform, which was also used to develop and manufacture Janssen’s European Commission-approved Ebola vaccine regimen and construct its Zika, RSV, and HIV investigational vaccine candidates.', 0.7067535), ('The EMA’s Committee for Medicinal Products for Human Use (CHMP) enabled a rolling review of the investigational single-dose Janssen COVID-19 vaccine candidate based principally on positive non-clinical data showing that the vaccine candidate elicits a robust immune response, as demonstrated by neutralizing antibodies.', 0.6718149), ('The safety data profile from an interim analysis of the ongoing Phase 1/2a clinical trial of the investigational Janssen COVID-19 vaccine candidate – studying the safety profile and immunogenicity of both a single-dose and two- dose vaccination – is supportive of further development of the vaccine candidate.', 0.61942196), ('In addition to the EMA, Janssen is in discussions with other regulatory authorities worldwide, as it prepares to initiate regulatory review processes for use of its investigational single-dose COVID-19 vaccine candidate during the pandemic response period.', 0.6141796)]"
518,Reduced prevalence of SARS-CoV-2 infection in ABO blood group O,reduced,_ prevalence of sars-cov-2 infection in abo blood group o,Increased prevalence of sars-cov-2 infection in abo blood group o,https://ashpublications.org/bloodadvances/article/4/20/4990/463793,"[('PMID: 32562665 Association between ABO blood groups and risk of SARS-CoV-2 pneumonia.', 0.5039109), ('Current understanding of the influence of environmental factors on SARS-CoV-2 transmission, persistence, and infectivity.', 0.4678735), ('This study identifies ABO blood group as a risk factor for SARS-CoV-2 infection but not for hospitalization or death from COVID-19.', 0.43602276), ('Eur J Prev Cardiol.', 0.3935619), ('Dai X. Dai X. Eur J Prev Cardiol.', 0.36055946)]"
519,Pet dog further tests positive for antibodies for COVID-19 virus,positive,pet dog further tests _ for antibodies for covid-19 virus,pet dog further tests negative for antibodies for covid-19 virus,https://www.info.gov.hk/gia/general/202003/26/P2020032600756.htm?fontSize=1,"[('As at yesterday (March 25), the AFCD has conducted tests on 17 dogs and eight cats from households with confirmed COVID-19 cases or persons in close contact with confirmed patients, and only two dogs had tested positive for the COVID-19 virus.', 0.61778855), ('Nevertheless, as COVID-19 is a newly emerged disease and the situation is still evolving, the AFCD is taking a precautionary approach in quarantining animals (mammals, including cats and dogs) from households with confirmed COVID-19 human cases.', 0.61311257), ('Veterinary experts and scientists from the Jockey Club College of Veterinary Medicine and Life Sciences of City University of Hong Kong, as well as the School of Public Health of the HKU, have concluded that the result further supported that the Pomeranian has been infected with the COVID-19 virus.', 0.5691273), ('These findings indicate that dogs and cats are not infected easily with this virus, and there is no evidence that they play a role in the spread of the virus.', 0.50198495), ('This indicates that the Pomeranian had developed an immune response to the viral infection with antibodies found in the blood.', 0.4940322)]"
521,"China 's changing coronavirus case count is not unusual in an outbreak , health official says",unusual,"china 's changing coronavirus case count is not _ in an outbreak , health official says","china's changing coronavirus case count is not available in an outbreak, health official says",https://edition.cnn.com/asia/live-news/coronavirus-outbreak-02-21-20-intl-hnk/h_b3eeaa213531fb22d521744dd365e24f,"[('“It’s not unusual to count things in different ways as the epidemic evolves,” said Sylvie Briand, WHO director of the infectious hazards management department.', 0.63847697), ('""“It’s not unusual to count things in different ways as the epidemic evolves,” said Sylvie Briand, WHO director of the infectious hazards management department.""', 0.63737416), ('Confusion over how China is counting cases of infections is making it harder to know how coronavirus is spreading, even as China is officially reporting that the numbers of new cases reported in recent days have fallen sharply.', 0.60008776), ('AFP via Getty Images Infectious diseases experts are losing confidence in the accuracy of China’s count of cases of the novel coronavirus, pointing toward health officials’ shifting definition of cases over time.', 0.5830729), ('Asked by reporters about the potential impact of the coronavirus on the economy and whether he anticipates it being similar to the effect of SARS, Kudlow said, “I understand the risks, and I understand these things could change quickly, but right now what we know is there’s barely any impact here at home.” ""“The human toll in my opinion is more important than the statistics… [China’s] getting hurt very badly,” he added. ""', 0.5829398)]"
523,Anakinra To Prevent Respiratory Failure In COVID-19,respiratory,anakinra to prevent _ failure in covid-19,anakinra to prevent neurological failure in covid-19,https://www.medrxiv.org/content/10.1101/2020.10.28.20217455v1,"[('We investigated if early suPAR (soluble urokinase plasminogen activator receptor)-guided anakinra treatment could prevent COVID-19-assocated SRF.', 0.5756018), ('Conclusions Early suPAR-guided anakinra treatment is associated with decrease of the risk for SRF and restoration of the pro- /anti-inflammatory balance.', 0.42972004), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.3706965), ('Anakinra treatment was associated with decrease in SOFA score and in circulating interleukin (IL)-6, sCD163 and sIL2-R; the serum IL-10/IL-6 ratio on day 7 was inversely associated with the change in SOFA score.', 0.34803557), ('Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv.', 0.31472898)]"
524,Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease,eliminate,harnessing innate immunity to _ sars-cov-2 and ameliorate covid-19 disease,harnessing innate immunity to complement sars-cov-2 and ameliorate covid-19 disease,https://journals.physiology.org/doi/full/10.1152/physiolgenomics.00033.2020,"[('The fact that many people infected with SARS-CoV-2 will clear the virus without even developing symptoms suggests that the immune system may hold the key to defeat this virus.', 0.6760696), ('Innate immunity may be the key to defeat severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).', 0.6758938), ('Overall, our “2 cents” to fight against the enemy of SARS-CoV-2 and, thus, COVID-19 disease, is immunomodulation of hijacked host innate immunity (as summarized in Fig.', 0.6494876), ('While surely this involves adaptive immunity and suggests vaccination will play a central role in ameliorating this pandemic, we would like to propose harnessing innate immunity as a potential approach to immediately combat COVID-19.', 0.635715), ('Hence, it is plausible that TLR5 signaling could advance SARS-CoV-2 virulence, and TLR5-mediated proinflammatory responses could inflict unwarranted damage.', 0.6299644)]"
525,Oxford vaccine triggers immune response,triggers,oxford vaccine _ immune response,oxford vaccine inhibits immune response,https://www.bbc.com/news/uk-53469839,"[('They are injecting coronavirus RNA (its genetic code), which then starts making viral proteins in order to trigger an immune response.', 0.60982704), ('Neutralising antibodies can disable the coronavirus.', 0.5916848), ('This means the vaccine resembles the coronavirus and the immune system can learn how to attack it.', 0.56859994), ('The US company Moderna was first out of the blocks and its vaccine can produce neutralising antibodies.', 0.5469104), ('Scientists did this by transferring the genetic instructions for the coronavirus\'s ""spike protein"" \\- the crucial tool it uses to invade our cells - to the vaccine they were developing.', 0.5335728)]"
528,96 % of Covid-19 patients recover in Beacon pharma 's Favipira trial,recover,96 % of covid-19 patients _ in beacon pharma 's favipira trial,96 % of covid-19 patients died in beacon pharma's favipira trial,https://tbsnews.net/coronavirus-chronicle/covid-19-bangladesh/96-covid-19-patients-recover-beacon-pharmas-favipira-trial,"[('The Business Standard : https://tbsnews.net/coronavirus- chronicle/covid-19-bangladesh/96-covid-19-patients-recover-beacon-pharmas- favipira-trial By BPL', 0.666242), ('Our Time: http://www.ourtimebd.com/beta/2020/07/08/96-covid-19-infected-patients- recovered-in-dhaka-by-taking-beacon-pharmas-favipira/ 7.', 0.5721022), ('Daily Star Link : https://www.thedailystar.net/backpage/news/covid-19-patients-favipiravir- effective-dhaka-trial-1927321 3.', 0.41069296), ('Daily Sun : https://www.daily-sun.com/printversion/details/492324/Favipiravir-recommended- for-Covid19-treatment 5.', 0.39558902), ('Speakers at the seminar said those who did not test positive for Covid-19 or do not have symptoms should not take Favipira.', 0.39058927)]"
529,3Blue1Brown Provided Detailed Simulations of an Epidemic,epidemic,3blue1brown provided detailed simulations of an _,3blue1brown provided detailed simulations of an algorithm,https://www.3blue1brown.com/,"[('Epidemic Simulation An interactive inspired by 3Blue1Brown\'s ""Simulating an Epidemic"" video.', 0.84350765), ('For other interactives, visit prajwalsouza.github.io --- Simple Case Please watch the 3b1b video to understand what is presented here.', 0.5746144), ('Simulating an epidemic - YouTube AboutPressCopyrightContact usCreatorsAdvertiseDevelopersTermsPrivacyPolicy & SafetyHow YouTube worksTest new features (C) 2021 Google LLC [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.34652257), (""Please zoom in/out of simulation/graph if it doesn't fit into your screen."", 0.2790632), ('Make great charts.', 0.27458385)]"
536,"Most New York Coronavirus Cases Came From Europe , Genomes Show",most,"_ new york coronavirus cases came from europe , genomes show","No new york coronavirus cases came from europe, genomes show",https://www.nytimes.com/2020/04/08/science/new-york-coronavirus-cases-europe-genomes.html,"[('Since the first genome of the coronavirus was sequenced in January, researchers around the world have sequenced over 3,000 more, some of which are genetically identical while others carry distinctive mutations.Credit...National Institutes of Health/EPA, via Shutterstock By Carl Zimmer April 8, 2020 New research indicates that the coronavirus began to circulate in the New York area by mid-February, weeks before the first confirmed case, and that travelers brought in the virus mainly from Europe, not Asia.', 0.5483069), ('“The majority is clearly European,” said Harm van Bakel, a geneticist at Icahn School of Medicine at Mount Sinai, who co-wrote a study awaiting peer review.', 0.5452051), ('Dr. Gonzalez-Reiche and her colleagues found that these viruses were practically identical to viruses found around Europe.', 0.53015065), ('But they write that the viruses reveal “a period of untracked global transmission between late January to mid-February.” So far, the Mount Sinai researchers have identified seven separate lineages of viruses that entered New York and began circulating.', 0.43580338), ('Dr. Heguy and her colleagues found some New York viruses that shared unique mutations not found elsewhere.', 0.42755824)]"
537,Poor correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects,poor,_ correlation between antibody titers and neutralizing activity in sera from sars-cov-2 infected subjects,Significant correlation between antibody titers and neutralizing activity in sera from sars-cov-2 infected subjects,https://www.medrxiv.org/content/10.1101/2020.07.10.20150375v1,"[('Importantly, a poor direct correlation between antibody titers and neutralizing activity levels was evidenced in the present study.', 0.67557555), ('Thirdly, possible correlations between antibody levels and the resulting neutralizing activity against a clinical isolate of SARS-CoV-2 were evaluated.', 0.58700395), ('Amongst them, LIAISON® SARS-CoV-2 S1/S2 IgG by DiaSorin and Elecsys Anti-SARS-CoV-2 cobas® by Roche are currently used by laboratory medicine hospital departments in Italy and many other countries.', 0.39639235), ('Secondly, eighty-five negative serum samples collected before the SARS-CoV-2 pandemic were analyzed.', 0.38757896), ('Results revealed that both tests are endowed with low sensitivity on the day of hospital admission, which increased to 97.8 and 100% for samples collected after 15 days for DiaSorin and Roche tests, respectively.', 0.31350404)]"
538,Performance of VivaDiagTM COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department,inadequate,performance of vivadiagtm covid-19 igm/igg rapid test is _ for diagnosis of covid-19 in acute patients referring to emergency room department,performance of vivadiagtm covid-19 igm/igg rapid test is useful for diagnosis of covid-19 in acute patients referring to emergency room department,https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.25800,"[('Such low sensitivity leads to non-diagnosis of most patients, which is why the authors do not recommend the use of the COVID-19 IgM/IgG VivaDiagTM rapid test for triage of patients with suspected COVID-19 in emergency department.', 0.69252986), ('We herein report results of a real‐life study performed in an emergency room department of a tertiary hospital in Northern Italy to validate VivaDiag COVID‐19 IgM/IgG Rapid Test lateral flow immunoassay (LFIA) for the rapid diagnosis of COVID‐19.', 0.6422769), ('On the basis of our results, VivaDiag COVID‐19 IgM/IgG Rapid Test LFIA is not recommended for triage of patients with suspected COVID‐19.', 0.6365622), ('As expected, all 30 COVID‐19 negative volunteers were negative for both immunoglobulin G (IgG) and immunoglobulin M (IgM) using the VivaDiag COVID‐19 IgM/IgG Rapid Test.', 0.63608193), ('Indeed, the majority of patients that tested positive for COVID‐19 by real‐time RT‐PCR would have been identified as negative using only the rapid serological assay, leading to a misdiagnosis of COVID‐19 disease in the vast majority of patients.', 0.6269549)]"
540,"A Chicago hospital treating severe COVID-19 patients with Gilead Sciences ' antiviral medication remdesivir is seeing recoveries in patients ' symptoms , Stat News reports .",seeing,"a chicago hospital treating severe covid-19 patients with gilead sciences ' antiviral medication remdesivir is _ recoveries in patients ' symptoms , stat news reports .","a chicago hospital treating severe covid-19 patients with gilead sciences'antiviral medication remdesivir is no recoveries in patients'symptoms, stat news reports.",https://www.businessinsider.com/stat-news-gileads-remdesivir-treats-coronavirus-patients-2020-4,"[('Gilead Sciences via AP A Chicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned.', 0.86141247), (""A Chicago hospital treating severe Covid-19 patients with Gilead Sciences' antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned."", 0.86065555), ('A Chicago hospital treating severe Covid-19 patients with remdesivir, the Gilead Sciences (GILD) antiviral, in a clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned.', 0.8578827), ('Is this what Covid-19 has in… A side-by-side comparison of the Pfizer/BioNTech and Moderna vaccines A side-by-side comparison of the Pfizer/BioNTech and Moderna vaccines CDC says people with history of severe allergic reactions… CDC says people with history of severe allergic reactions can get Covid-19 vaccine Recommended Biden will mobilize FEMA, the National Guard, and pharmacies… Biden will mobilize FEMA, the National Guard, and pharmacies to ramp up vaccine distribution Genome-sequencing pioneer Eric Lander to lead science policy for… Genome-sequencing pioneer Eric Lander to lead science policy for Biden New coronavirus variant could become dominant strain in March,… New coronavirus variant could become dominant strain in March, CDC warns ', 0.5894916), ('Remdesivir was one of the first medicines identified as having the potential to impact SARS-CoV-2, the novel coronavirus that causes Covid-19, in lab tests.', 0.5778176)]"
542,Robust ACE2 protein expression localizes to the motile cilia of the respiratory tract epithelia and is not increased by ACE inhibitors or angiotensin receptor blockers,not,robust ace2 protein expression localizes to the motile cilia of the respiratory tract epithelia and is _ increased by ace inhibitors or angiotensin receptor blockers,robust ace2 protein expression localizes to the motile cilia of the respiratory tract epithelia and is significantly increased by ace inhibitors or angiotensin receptor blockers,https://www.medrxiv.org/content/10.1101/2020.05.08.20092866v1,"[('ACE2 mRNA and protein expression are not found in goblet cells of the respiratory tract.', 0.76385283), ('We further determined whether ACE2 expression in the cilia of upper respiratory cells was influenced by patient demographics, clinical characteristics, co-morbidities, or medication use, and found no evidence that the use of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARBs) increases ACE2 protein expression.', 0.71221364), ('ACE2 expression in the nasal cilia is not increased in patients taking angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARBs), but potentially decreased in ACEI patients.', 0.69435126), ('ACE2 mRNA and protein expression are not found in goblet… Extended Data Fig.', 0.6763218), ('ACE2 mRNA expression (red dots) was not noted within goblet cells marked by MUC5AC in the nasal turbinate, uncinate process, and trachea.', 0.6624664)]"
543,Lower incidence associated with prophylactic administration of Ivermectin,lower,_ incidence associated with prophylactic administration of ivermectin,Increased incidence associated with prophylactic administration of ivermectin,https://www.sciencedirect.com/science/article/pii/S0924857920304684,"[('risk of COVID-19 case, 78.0% lower, RR 0.22, p < 0.02, African countries.', 0.38758597), ('risk of COVID-19 case, 80.0% lower, RR 0.20, p < 0.001, worldwide.', 0.35835087), ('COVID-19 studies: C19 studies: C19: IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I REGNREGN LY-CoVLY RemdesivirRMD IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I REGNREGN LY-CoVLY RemdesivirRMD Ivermectin study ', 0.18723157), ('[c.]: circa', 0.17480001), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.11349386)]"
545,SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling,block,sars-cov-2 orf6 hijacks nup98 to _ stat nuclear import and antagonize interferon signaling,sars-cov-2 orf6 hijacks nup98 to promote stat nuclear import and antagonize interferon signaling,https://www.pnas.org/content/early/2020/10/22/2016650117,"[('Keywords: Nup98; ORF6; SARS-CoV-2; STATs; interferon signaling antagonism.', 0.79290867), ('We found that SARS-CoV-2 Orf6 localizes at the nuclear pore complex (NPC) and directly interacts with Nup98-Rae1 via its C-terminal domain to impair docking of cargo-receptor (karyopherin/importin) complex and disrupt nuclear import.', 0.7794806), ('In this study, we show that SARS-CoV-2 is able to efficiently block STAT1 and STAT2 nuclear translocation in order to impair transcriptional induction of IFN-stimulated genes (ISGs).', 0.7557535), ('The Orf6-Nup98 interaction is critical to block STAT nuclear translocation and IFN signaling.', 0.7546239), ('The Orf6-Nup98 interaction is critical to block STAT nuclear translocation and IFN signaling.… Fig.', 0.7523083)]"
546,Face Masks Considerably Reduce Covid-19 Cases in Germany,reduce,face masks considerably _ covid-19 cases in germany,face masks considerably increase covid-19 cases in germany,https://www.medrxiv.org/content/10.1101/2020.06.21.20128181v1,"[('There is a general perception in Germany that the mandatory use of face masks in public reduces COVID-19 incidences considerably.', 0.83250135), ('As Heinsberg is one of the German regions that was significantly affected by the COVID-19 pandemic during the Carnival season, one may expect that this leads to an overestimation of the effects of face masks.', 0.69758785), ('As face masks became mandatory at different points in time across German regions, we can compare the rise in infections in regions with masks and regions without masks.', 0.66777164), ('2 E and F. The latter indicate the probability that the reduction in the number of COVID-19 cases was observed by chance given the distribution of pseudo-treatment effects in the other German regions (see ref.', 0.65965426), ('Such latent factors may, for instance, be related to the macroregional dynamics of COVID-19 in Germany.', 0.6523659)]"
548,A neutrophil activation signature predicts critical illness and mortality in COVID-19,critical,a neutrophil activation signature predicts _ illness and mortality in covid-19,a neutrophil activation signature predicts mild illness and mortality in covid-19,https://www.medrxiv.org/content/10.1101/2020.09.01.20183897v1,"[('Altogether, we define an essential role for neutrophil activation in the pathogenesis of severe COVID-19 and identify molecular neutrophil markers that distinguish patients at risk of future clinical decompensation.', 0.6169786), ('Neutrophil activation was present on the first day of hospitalization in patients who would only later require transfer to the intensive care unit, thus preceding the onset of critical illness and predicting increased mortality.', 0.4825474), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.44490492), ('In the health system database, early elevations in developing and mature neutrophil counts also predicted higher mortality rates.', 0.41569155), ('We carried out proteomic profiling of plasma from cross-sectional and longitudinal cohorts of hospitalized patients with COVID-19 and analyzed clinical data from our health system database of over 3,300 patients.', 0.3863573)]"
549,Raoult 's Hydroxychloroquine-COVID-19 study did not meet publishing society 's expected standard,not,raoult 's hydroxychloroquine-covid-19 study did _ meet publishing society 's expected standard,raoult's hydroxychloroquine-covid-19 study did indeed meet publishing society's expected standard,https://www.isac.world/news-and-publications/official-isac-statement,"[(""Another preprint by Raoult's group of 80 COVID-19 patients who received hydroxychloroquine and the antibiotic azithromycin similarly received criticism for a lack of control group, the inclusion of asymptomatic carriers, and questionable results."", 0.6347017), (""Chronic treatment with hydroxychloroquine didn't seem to exert a protective effect."", 0.60321355), ('The April 3, 2020, notice, from the International Journal of Antimicrobial Agents , states that the March 20 article, “Hydroxychloroquine and azithromycin as a treatment of Covid-19: results of an open-label non- randomized clinical trial” > does not meet the [International Society of Antimicrobial Chemotherapy’s] > expected standard, especially relating to the lack of better explanations of > the inclusion criteria and the triage of patients to ensure patient safety.', 0.5929811), ('With little evidence to back him, President Donald Trump has championed an anti-malarial drug called hydroxychloroquine as a treatment for COVID-19.', 0.57598674), ('on a different group of patients, found ""No Evidence of Rapid Antiviral Clearance or Clinical Benefit with the Combination of Hydroxychloroquine and Azithromycin in Patients with Severe COVID-19 Infection"": https://www.sciencedirect.com/science/article/pii/S0399077X20300858 Reply 1.', 0.5748147)]"
551,"Four minutes of your time can save thousands , if not millions , of lives !",save,"four minutes of your time can _ thousands , if not millions , of lives !","four minutes of your time can infect thousands, if not millions, of lives!",https://www.linkedin.com/pulse/calling-all-humans-marc-banoub/?trackingId=JmsPfSgPTTOEhF4S99%2Bw%2Fg%3D%3D,"[('Under this plan, the average worker who has lost his or her job will receive 100 percent of their salary for up to four full months.', 0.5697681), ('All we are asking for is four minutes of your time to share this post and fill out this simple, completely anonymous survey that can save thousands, if not millions of lives, as well as the livelihoods of most small business owners and day laborers.', 0.51683176), ('They did it in less than four days.', 0.5105735), (""So they'll be getting a check for $3,400 for the typical family of four."", 0.48589325), ('We think, by June 1st, a lot of great things will be happening.', 0.44242465)]"
552,"UCI develops low-cost , accurate COVID-19 antibody detection platform",uci,"_ develops low-cost , accurate covid-19 antibody detection platform","RSV develops low-cost, accurate covid-19 antibody detection platform",https://news.uci.edu/2020/08/19/uci-develops-low-cost-accurate-covid-19-antibody-detection-platform/,"[('Timothy Abram Irvine, Calif., Aug. 19, 2020 — A robust, low-cost imaging platform utilizing lab-on-a-chip technology created by University of California, Irvine scientists may be available for rapid coronavirus diagnostic and antibody testing throughout the nation by the end of the year.', 0.60403204), ('“Because the device’s materials are cheap and easy to obtain, the platform is easy to manufacture and use in low-resource areas, making testing accessible on a world scale.” Aarti Jain, Rie Nakajima, Rafael Ramiro de Assis, Trevor Pearce, Algis Jasinskas and Saahir Khan of UCI along with Timothy Abram and Melody Toosky of Velox Biosystems participated in the study, which was supported by the National Institutes of Health (grants P41 GM103540 and R01 AI117061) and a UCI CRAFT-COVID grant.', 0.5861263), ('The TinyArray imager combines a 3D-printed prototype with an off-the-shelf LED and a small 5-megapixel camera to find markers for many antibodies simultaneously.', 0.51257014), ('The same device can also process the results of commonly used nose swab tests for SARS-CoV-2 so that patients can be tested for COVID-19 and its antibodies on a single platform.', 0.48759955), ('This ensures accuracy equal to that of expensive imaging systems but makes the platform portable enough to deploy anywhere – at a cost of only $200.', 0.4538607)]"
553,Poop tests stop COVID-19 outbreak at University of Arizona,arizona,poop tests stop covid-19 outbreak at university of _,poop tests stop covid-19 outbreak at university of March,https://www.sciencemag.org/news/2020/08/poop-tests-stop-covid-19-outbreak-university-arizona,"[('28, 2020 , 2:40 PM By testing dorm wastewater for the coronavirus, the University of Arizona may have stomped out a potential outbreak before it could spread, The Washington Post reports.', 0.5089549), ('In Arizona, wastewater from a student dormitory contained viral RNA just days after students—who had all tested negative for COVID-19—moved into their rooms this month.', 0.48737648), ('The university retested all 311 residents and dorm workers and found two students who were asymptomatic but positive for the virus; they were then quarantined, officials explained in a press conference.', 0.45187625), ('Skip to main content AAAS ScienceMag.org Search Search X Advanced Search Science Contents News Careers Journals Menu Read our COVID-19 research and news.', 0.41792467), ('Several countries and some U.S. universities have been checking sewage for RNA from SARS-CoV-2 in people’s poop, which can signal infections shortly before clinical cases and deaths appear.', 0.3759541)]"
556,Blood Samples of 7 Severely Ill COVID-19 Patients Indicate Leronlimab Has Reduced the Cytokine Storm in All Patients,reduced,blood samples of 7 severely ill covid-19 patients indicate leronlimab has _ the cytokine storm in all patients,blood samples of 7 severely ill covid-19 patients indicate leronlimab has increased the cytokine storm in all patients,https://www.cytodyn.com/newsroom/press-releases/detail/413/blood-samples-at-day-0-3-and-7-for-severely-ill-covid-19,"[('Blood samples fromdays 0, 3, and 7demonstrated that leronlimab induced significant reductions in the cytokine storm among all 7 severely ill patients with coronavirus disease 2019 (COVID-19) under evaluation in the phase IIb/III study.', 0.8103437), ('Blood Samples at Day 0, 3 and 7 for Severely Ill COVID-19 Patients Clearly Indicate Leronlimab Has Significantly Reduced the Cytokine Storm in All (7) Patients and All Patients Demonstrated Immunological Benefit at Both Day 3 and Day 7 [news release].', 0.8054491), ('The blood samples confirmed immunological benefit at day 3 and 7 in all patients, according to a press release from CytoDyn, Inc.1 “The day 7 results from these patients demonstrates even more dramatic immune restoration especially in the CD8 T-lymphocyte population, the major immune cell responsible for eliminating virally infected cells,” Bruce Patterson, MD, chief executive office, founder, IncellDx, stated in a press release.', 0.6748811), ('The blood samples confirmed immunological benefit at day 3 and 7 in all patients, according to a press release from CytoDyn, Inc.', 0.6007378), ('Critically ill patients are experiencing the benefit of extubating within 7 days of treatment with leronlimab.” Following recent clearance by the U.S. Food and Drug Administration (FDA), the Company is enrolling patients in two clinical trials, a Phase 2 trial for mild-to-moderate COVID-19 patients, and a Phase 2b/3 trial for severe and critically ill COVID-19 patients.', 0.5836892)]"
557,Fewer coronavirus deaths seen in countries that mandate tuberculosis vaccine,fewer,_ coronavirus deaths seen in countries that mandate tuberculosis vaccine,Many coronavirus deaths seen in countries that mandate tuberculosis vaccine,https://www.japantimes.co.jp/news/2020/04/09/world/science-health-world/fewer-coronavirus-deaths-seen-countries-mandate-tuberculosis-vaccine/#.XpQd7kD7TIV,"[('Netea’s decadelong work shows that BCG vaccine sensitizes the immune system in such a way that, whenever any pathogen that relies on the same attack strategy as the tuberculosis bacteria attacks, it is ready to respond in a better way than the immune system of those who haven’t received the vaccine.', 0.63172716), ('Other trials are taking place in Australia, Denmark, Germany, the U.K. and the U.S. Scientists are still working to better understand why the BCG vaccine may be effective against not just tuberculosis but other disease microbes.', 0.61616933), ('The preliminary study posted on medRxiv, a site for unpublished medical research, finds a correlation between countries that require citizens to get the bacillus Calmette-Guerin (BCG) vaccine and those showing fewer number of confirmed cases and deaths from COVID-19.', 0.59068173), ('Otazu said he knew about studies showing the BCG vaccine provided protection against not just tuberculosis bacteria but also other types of contagions.', 0.5887078), (""If you're not sure how to activate it, please refer to this site: https://www.enable- javascript.com/ A preliminary study posted on medRxiv, a site for unpublished medical research, foudn a correlation between countries that require citizens to get the bacillus Calmette-Guerin (BCG) vaccine and those showing fewer number of confirmed cases and deaths from COVID-19."", 0.54798305)]"
558,Epidemiological analysis of an outbreak in Hong Kong revealed that blood group O was associated with a lower risk of SARS-COV-2 infection .,lower,epidemiological analysis of an outbreak in hong kong revealed that blood group o was associated with a _ risk of sars-cov-2 infection .,epidemiological analysis of an outbreak in hong kong revealed that blood group o was associated with a increased risk of sars-cov-2 infection.,https://pubmed.ncbi.nlm.nih.gov/18818423-inhibition-of-the-interaction-between-the-sars-cov-spike-protein-and-its-cellular-receptor-by-anti-histo-blood-group-antibodies/?from_single_result=coronavirus+abo+blood,"[('Epidemiological analysis of a hospital outbreak in Hong Kong revealed that blood group O was associated with a low risk of infection.', 0.87407833), ('Yet, it is precisely what was observed in the case of a hospital outbreak of SARS in Hong Kong, where O blood group individuals appeared at a much lower risk of being infected by SARS-CoV than subjects of other blood types (Cheng et al.', 0.82313514), ('The findings revealed that the person having O blood type were less susceptible towards SARS-CoV infection in comparison with those having other blood types.', 0.74692225), ('The ABO gene stands out among the genes involved since O blood group individuals were shown to have very low odds of infection compared to non-O individuals in a hospital outbreak that occurred in March 2003 in Hong Kong (Cheng et al.', 0.667975), ('The blood group type of the index case in the Hong Kong outbreak was not provided (Cheng et al.', 0.6135208)]"
562,Three Ways to Make Coronavirus Drugs in a Hurry,three,_ ways to make coronavirus drugs in a hurry,Two ways to make coronavirus drugs in a hurry,https://www.scientificamerican.com/article/three-ways-to-make-coronavirus-drugs-in-a-hurry1/,"[('Because of this work, three main strategies for impeding the virus have emerged as the labs have turned to the current threat.', 0.5341697), ('EMERGING from a cell, SARS-CoV-2 virus particles ( red circles ) will create a wider infection unless drugmakers find ways to block them.', 0.4843556), ('This article was originally published with the title ""Fast-Track Drugs"" in Scientific American 322, 6, 32-35 (June 2020) doi:10.1038/scientificamerican0620-32 Rights & Permissions ', 0.478091), ('By the time the new coronavirus was genetically sequenced and its structure revealed, scientists already had identified the enzymes and proteins that most coronaviruses use to spread from one infected human cell to another and also understood that the body could create an overly aggressive inflammatory response when the virus infected lung airway cells.', 0.47254533), ('Read more about the coronavirus outbreakfrom Scientific American here.', 0.47243822)]"
564,It is Time to Address Airborne Transmission of COVID-19,airborne,it is time to address _ transmission of covid-19,it is time to address human transmission of covid-19,https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa939/5867798,"[('These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing.', 0.48293614), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.3598653), ('[c.]: circa', 0.32617098), ('2020 Jul 6 : ciaa939.', 0.28460214), ('Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.', 0.22461292)]"
565,"U.K. Approves Pfizer Coronavirus Vaccine , a First in the West",first,"u.k. approves pfizer coronavirus vaccine , a _ in the west","u.k. approves pfizer coronavirus vaccine, a third in the west",https://www.nytimes.com/2020/12/02/world/europe/pfizer-coronavirus-vaccine-approved-uk.html?smtyp=cur&smid=tw-nytimes,"[('Approves Pfizer Coronavirus Vaccine, a First in the West https://nyti.ms/3qj8Mue ', 0.8561046), ('For Britain, which has suffered one of Europe’s highest per capita death tolls from the virus, the decision by its drug regulator was the latest evidence of a vaccination strategy that has been the most aggressive in the West.', 0.5561086), ('The U.S. Food and Drug Administration plans to decide on emergency authorization for the Pfizer vaccine shortly after a meeting of an advisory panel on Dec. 10.', 0.5216346), ('The Pfizer and BioNTech vaccine is delivered as a shot in the arm, like other typical vaccines.', 0.5042188), ('The vaccines from Moderna and Pfizer use a genetic molecule to prime the immune system.', 0.5007272)]"
566,2019 novel coronavirus is undergoing active recombination,undergoing,2019 novel coronavirus is _ active recombination,2019 novel coronavirus is not active recombination,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa219/5781085,"[('Origin and Evolution of the 2019 Novel Coronavirus.', 0.8725395), ('[Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].', 0.5701902), ('Betacoronavirus Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic.', 0.5107651), ('2020 Nov 18;16(11):e1009175.', 0.47730973), ('2020 May 18;94(11):e00543-20.', 0.45582604)]"
567,Coronial autopsies identify the indirect effects of COVID-19,indirect,coronial autopsies identify the _ effects of covid-19,coronial autopsies identify the therapeutic effects of covid-19,https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(20)30180-8/fulltext,"[('Review of autopsy reports enabled the determination of the relative contributions of undiagnosed COVID-19 and lockdown restrictions on deaths.', 0.5929835), ('We believe direct collaboration between autopsy pathologists and public health clinicians can improve evaluation of deaths indirectly caused by COVID-19 at the national level.', 0.57749665), ('https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases Date accessed: June 9, 2020 Google Scholar Confirmed COVID-19 accounted for the majority of deaths; the remaining excess deaths ( >12 000) could reflect undiagnosed COVID-19 or alternatively, deaths from unrelated conditions.', 0.5548459), ('Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study.', 0.52156204), ('Deaths from drug and alcohol misuse significantly increased during the lockdown period in comparison to the same period in 2018 (appendix), but it was not possible to identify whether individual cases were influenced by COVID-19 movement restrictions.', 0.48774856)]"
568,Horror fans and morbidly curious individuals are more psychologically resilient during the COVID-19 pandemic,more,horror fans and morbidly curious individuals are _ psychologically resilient during the covid-19 pandemic,horror fans and morbidly curious individuals are less psychologically resilient during the covid-19 pandemic,https://www.sciencedirect.com/science/article/pii/S0191886920305882,"[('We predicted that 1) horror fans would be more psychologically resilient during the COVID-19 pandemic, 2) those who score high in trait morbid curiosity would be more psychologically resilient during the pandemic, and 3) watching more pandemic films would be associated with greater preparedness and psychological resilience during the COVID-19 pandemic.', 0.89374346), ('In this study, we show that people who engaged more frequently with frightening fictional phenomena, such as horror fans and the morbidly curious, displayed more robust psychological resilience during the COVID-19 pandemic.', 0.8683141), ('In this study, we tested the hypothesis that morbidly curious individuals and horror fans exhibit greater psychological resilience during the COVID-19 pandemic.', 0.82180953), ('We also found that morbid curiosity, a personality trait that has been previously associated with interest in horror (Scrivner, in press), was associated with greater positive resilience during the COVID-19 pandemic.', 0.7843191), ('Although our study does show that horror and prepper genre fans display better psychological resilience in the face of the pandemic, it is still a correlational study.', 0.78252304)]"
572,Significant expression of FURIN and ACE2 on oral epithelial cells may facilitate the efficiency of 2019-nCov entry,facilitate,significant expression of furin and ace2 on oral epithelial cells may _ the efficiency of 2019-ncov entry,significant expression of furin and ace2 on oral epithelial cells may reduce the efficiency of 2019-ncov entry,https://www.biorxiv.org/content/10.1101/2020.04.18.047951v1,"[('Conclusions Based on these findings, we speculated that 2019-nCov could effectively invade oral mucosal cells though two possible routes: binding to the ACE2 receptor and fusion with cell membrane activated by FURIN protease.', 0.8247001), ('Our results indicated that oral mucosa tissues are susceptible to 2019-nCov, which provides valuable information for virus-prevention strategy in clinical care as well as daily life.', 0.7060272), ('Results The bioinformatics results indicated the differential expression of ACE2 and FURIN on epithelial cells of different oral mucosal tissues and the proportion of FURIN-positive cells was obviously higher than that of ACE2-positive cells.', 0.7058995), ('Furthermore, immunohistochemical staining experiment was performed to confirm the expression of ACE2 and FURIN in the protein level.', 0.64052355), ('The S-glycoprotein, which recognized as the key factor for the entry of 2019-nCov into the cell, contains two functional domains: an ACE2 receptor binding domain and a second domain necessary for fusion of the coronavirus and cell membranes.', 0.63093054)]"
575,Blacks/African Americans are 5 Times More Likely to Develop COVID-19,more,blacks/african americans are 5 times _ likely to develop covid-19,blacks/african americans are 5 times less likely to develop covid-19,https://www.medrxiv.org/content/10.1101/2020.05.14.20101691v1,"[('There was a nearly five-fold increase in the risk of a positive COVID-19 test.', 0.6889525), ('During the early months of the pandemic, the report asserts that blacks were more likely to have preexisting conditions that predispose them to COVID-19 infection, less likely to have health insurance, and more likely to work in jobs that do not accommodate remote work.', 0.52527535), ('In a multivariable model including estimates for age, COPD, heart disease, housing density and Black/African American race, the only variables that remained associated with positive COVID-19 testing with a probability greater than chance were the proportion of Black/African American residents and proportion of older persons.', 0.51841843), ('The five largest known clusters of COVID-19 virus are inside corrections institutions.', 0.5183464), ('African Americans are incarcerated at more than 5 times the rate of whites.', 0.48936984)]"
576,Reappearance of Effector T Cells Predicts Successful Recovery from COVID-19,predict,reappearance of effector t cells _ successful recovery from covid-19,reappearance of effector t cells cannots successful recovery from covid-19,https://www.medrxiv.org/content/10.1101/2020.05.11.20096263v1,"[('Interpretation Our data suggest that activation and expansion of innate and adaptive lymphocytes play a major role in COVID-19.', 0.67993176), ('Understanding T cell-responses in the context of clinical severity might serve as foundation to overcome the lack of effective anti-viral immune response in severely affected COVID-19 patients and can offer prognostic value as biomarker for disease outcome and control.', 0.5750282), ('We used two comprehensive 11-color flow cytometric panels conforming to Good Laboratory Practice and approved for clinical diagnostics.', 0.4317943), ('Follow up samples revealed a marked increase in effector T cells and memory subsets in convalescing but not in non-convalescing patients.', 0.40398157), ('Findings Absolute numbers of lymphocyte subsets were differentially decreased in COVID-19 patients according to clinical severity.', 0.39946878)]"
577,SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo,exhibits,sars-cov-2 d614g variant _ efficient replication ex vivo and transmission in vivo,sars-cov-2 d614g variant inhibits efficient replication ex vivo and transmission in vivo,https://science.sciencemag.org/content/early/2020/11/11/science.abe8499.full,"[('These data show that the D614G substitution enhances SARS-CoV-2 infectivity, competitive fitness, and transmission in primary human cells and animal models.', 0.6939653), ('SARS-CoV-2 S pseudotyped viruses encoding the D614G substitution were reported to exhibit increased infectivity in continuous cell lines and increased sensitivity to neutralization ( 4, 5).', 0.64627635), ('1 SARS-CoV-2 D614G variant shows enhanced infectivity in immortalized cell lines and replication fitness in upper human respiratory epithelia compared with the ancestral WT virus.', 0.6413933), ('Using authentic SARS-CoV-2 isogenic variants, we show the role of the D614G substitution in enhancing viral infectivity in immortalized cell lines, growth, and fitness in primary human airway epithelial cells and hamsters, yet it marginally alters viral pathogenesis in hamster and hACE2 mouse models.', 0.63274926), ('2 D614G substitution does not alter SARS-CoV-2 virion morphology, S protein cleavage patterns, and sensitivity to neutralizing Abs.', 0.62760556)]"
578,DARPA Races to Create Firebreak Treatment for the Coronavirus,create,darpa races to _ firebreak treatment for the coronavirus,darpa races to receive firebreak treatment for the coronavirus,https://spectrum.ieee.org/the-human-os/biomedical/bionics/darpas-firebreak-treatment-for-the-coronavirus,"[('Now, DARPA is racing against time as experts warn of a likely second wave of the coronavirus this fall.', 0.63256776), ('Once those antibodies are identified, there are two paths forward in producing this ""firebreak"" treatment.', 0.52478516), ('Dr. Jenkins stressed that this would not replace a vaccine, but would be meant as a firebreak.', 0.49198827), ('Researchers working under the program sought ways to confer instant (but short-term) protection from a dangerous virus or bacteria.', 0.47896868), ('Read Full Article Â» Related Topics:DARPA, Coronavirus, COVID-19 Comment Show comments Hide Comments Log In with your RCMG Account Register report this ad ', 0.46628058)]"
579,"Synergism of TNF-α and IFN-γ triggers inflammatory cell death , tissue damage , and mortality in SARS-CoV-2 infection and cytokine shock syndromes",triggers,"synergism of tnf-α and ifn-γ _ inflammatory cell death , tissue damage , and mortality in sars-cov-2 infection and cytokine shock syndromes","synergism of tnf-α and ifn-γ reduces inflammatory cell death, tissue damage, and mortality in sars-cov-2 infection and cytokine shock syndromes",https://www.cell.com/cell/fulltext/S0092-8674(20)31542-7?rss=yes,"[('Of the multiple inflammatory cytokines produced by innate immune cells during SARS-CoV-2 infection, we found that the combined production of TNF-α and IFN-γ specifically induced inflammatory cell death, PANoptosis, characterized by gasdermin-mediated pyroptosis, caspase-8-mediated apoptosis, and MLKL-mediated necroptosis.', 0.76713943), ('In vivo neutralization of both TNF-α and IFN-γ in multiple disease models associated with cytokine storm showed that this treatment provided substantial protection against not only SARS-CoV-2 infection, but also sepsis, hemophagocytic lymphohistiocytosis, and cytokine shock models, demonstrating the broad physiological relevance of this mechanism.', 0.7272574), ('Additionally, these results open new avenues for the treatment of other infectious and autoinflammatory diseases and cancers where TNF-α and IFN-γ synergism play key pathological roles.', 0.64272654), ('Collectively, our findings suggest that blocking the cytokine- mediated inflammatory cell death signaling pathway identified here may benefit patients with COVID-19 or other cytokine storm-driven syndromes by limiting inflammation and tissue damage.', 0.5941967), ('However, cells deficient in both RIPK3 and caspase-8 or RIPK3 and FADD were resistant to this cell death.', 0.5119059)]"
580,Infectious diseases expert warns of second corona wave after fall,second,infectious diseases expert warns of _ corona wave after fall,infectious diseases expert warns of one corona wave after fall,https://asia.nikkei.com/Spotlight/Caixin/Infectious-diseases-expert-warns-of-second-corona-wave-after-fall,"[(""He said it's unlikely that the outbreak will end this summer, and it's very likely that a second wave will take place after the fall."", 0.58849025), ('But after the fall, the second wave could come.', 0.5075986), (""I said repeatedly two weeks ago that it's unlikely the pandemic will be over by the summer, that it will largely last till the next year."", 0.48898095), ('There is a high probability of a second international outbreak.', 0.48456845), ('Once detecting local patients with Covid-19 symptoms, the hospital and the disease control system will quickly move to put off any potential threat.', 0.45590648)]"
581,"Repurposing existing drugs for COVID-19 a more rapid alternative to a vaccine , say researchers",more,"repurposing existing drugs for covid-19 a _ rapid alternative to a vaccine , say researchers","repurposing existing drugs for covid-19 a less rapid alternative to a vaccine, say researchers",https://www.cam.ac.uk/research/news/repurposing-existing-drugs-for-covid-19-a-more-rapid-alternative-to-a-vaccine-say-researchers,"[('The race is on to find new drugs to treat COVID-19 patients and to develop a vaccine to prevent infection in the first place.', 0.821957), (""“While we're waiting for a vaccine, drugs currently being used to treat other illnesses can be investigated as treatments for COVID-19 – in other words repurposed,” said Dr Steve Alexander from the University of Nottingham."", 0.78823715), ('“These treatments will have already been shown to be safe and so, if they can now be shown to be effective in COVID-19, they could be brought to clinical use relatively quickly.” One promising candidate is remdesivir, a drug originally developed for Ebola.', 0.6642377), ('Although clinical trials found it to be insufficiently effective at treating Ebola, clinical trials in the USA have suggested the drug may be beneficial for treating patients hospitalised with COVID-19, and the FDA has now approved it for emergency use.', 0.65512884), ('> ""[Repurposed drugs] will have already been shown to be safe and so, if they > can now be shown to be effective in COVID-19, they could be brought to > clinical use relatively quickly"" > > Anthony Davenport Since the emergence of the SARS-CoV-2 virus in late 2019, more than 3.5 million people are known to have been infected, leading to over 240,000 deaths worldwide from COVID-19, the disease caused by the novel coronavirus.', 0.62086034)]"
582,The ARDSnet protocol may be detrimental in COVID-19,detrimental,the ardsnet protocol may be _ in covid-19,the ardsnet protocol may be useful in covid-19,https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03081-4,"[('Heart-lung interactions may play a crucial role, especially in the management of COVID-19 patients.', 0.5576251), ('Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: ARDS or not?', 0.5435786), ('If we had followed the suggested protocols, we should have applied a PEEP of 18 cmH2O.', 0.4298635), ('However, COVID-19 ARDS does not seem to be “typical” [4].', 0.40726405), ('Jamil S, Mark N, Carlos G, Dela Cruz C, Gross J, Pasnick S. Diagnosis and management of COVID-19 disease.', 0.4071044)]"
584,Two Huge Covid-19 Studies Are Retracted After Scientists Sound Alarms,two,_ huge covid-19 studies are retracted after scientists sound alarms,No huge covid-19 studies are retracted after scientists sound alarms,https://www.nytimes.com/2020/06/04/health/coronavirus-hydroxychloroquine.html,"[('The retractions may breathe new life into the antimalarial drugs hydroxychloroquine and chloroquine, relentlessly promoted by Mr. Trump as a remedy for Covid-19 despite a lack of evidence.', 0.53345037), ('One undercut President Trump’s claim that certain antimalarial drugs cure Covid-19, the illness caused by the virus, concluding that the medications in fact were dangerous to patients.', 0.48934093), ('Two prominent studies on the drugs chloroquine and hydroxychloroquine that used the same dataset from a company called Surgisphere were retracted on Thursday.Credit...John Locher/Associated Press By Roni Caryn Rabin and Ellen Gabler Published June 4, 2020Updated June 20, 2020 The studies, published in renowned scientific journals, produced astounding results and altered the course of research into the coronavirus pandemic.', 0.48106307), ('Critics were quick to point out anomalies in both pieces of research, including implausible findings that should have been detected during the peer review process — like the registry’s apparent inclusion of a large number of Covid-19 cases very early on in the pandemic, even in Africa, where few hospitals have electronic health records.', 0.47752804), ('Though there had been other hints of side effects associated with the drugs, clinical trials were halted worldwide while alarmed investigators began safety reviews.', 0.47625107)]"
585,Early Hydroxychloroquine but not Chloroquine use reduces ICU admission in COVID-19 patients,not,early hydroxychloroquine but _ chloroquine use reduces icu admission in covid-19 patients,early hydroxychloroquine but also chloroquine use reduces icu admission in covid-19 patients,https://www.sciencedirect.com/science/article/pii/S1201971220321755#ec-research-data,"[('Comparison of hospital treatment strategy or of actually received treatment with hydroxychloroquine in COVID-19?', 0.6981492), ('Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.', 0.6839516), ('Chen Z., Hu J., Zhang Z. Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial.', 0.6660195), ('Boulware D.R., Pullen M.F., Bangdiwala A.S. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19.', 0.6511271), ('Is Machine Learning a Better Way to Identify COVID-19 Patients Who Might Benefit from Hydroxychloroquine Treatment?-The IDENTIFY Trial.', 0.6501876)]"
587,Active compound in WP1122 reduces in vitro replication of SARS-CoV-2 by 100 %,100,active compound in wp1122 reduces in vitro replication of sars-cov-2 by _ %,active compound in wp1122 reduces in vitro replication of sars-cov-2 by 10 %,https://ir.moleculin.com/press-releases/detail/165/moleculin-to-host-investor-conference-call-to-discuss,"[('The authors reported that inhibiting glycolysis with non-toxic concentrations of 2-DG completely prevented SARS-CoV–2 replication in Caco–2 cells.', 0.63630617), ('WP1122 is referred to as a “prodrug” of 2-DG whereby chemical elements are added to 2-DG to improve its delivery in vivo.', 0.48108748), (""WP1122 appears to solve this problem because it is a 'prodrug' of 2-DG."", 0.45746365), ('Once administered, these added elements are removed by normal metabolic processes and what remains is 2-DG.', 0.45630136), (""Therefore, even though 2-DG is active against a range of viruses, including SARS-CoV-2, it isn't useful as a clinical therapy because it's too rapidly metabolized."", 0.4541393)]"
588,Combined metabolic cofactor supplementation accelerates recovery in mild-to-moderate COVID-19,recovery,combined metabolic cofactor supplementation accelerates _ in mild-to-moderate covid-19,combined metabolic cofactor supplementation accelerates death in mild-to-moderate covid-19,https://www.medrxiv.org/content/10.1101/2020.10.02.20202614v1,"[('Combined metabolic cofactors supplementation (CMCS) consisting of L-serine, N-acetyl-L-cysteine (NAC), nicotinamide riboside (NR), and L-carnitine tartrate is being studied for the treatment of patients with COVID-19.', 0.7266227), ('CONCLUSIONS In patients with mild-to-moderate COVID-19, CMCS resulted in a significant reduction in recovery time and liver enzymes associated with hepatic function compared to placebo.', 0.55625486), ('METHODS We conducted a placebo-controlled, phase-2 clinical trial involving ambulatory COVID-19 patients.', 0.5060583), ('Clinical status was evaluated daily by phone, using a binomial scale for subject reported presence or absence for multiple COVID-19 related symptoms.', 0.3960014), ('Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.', 0.36404556)]"
589,Germany shuts down daily life,germany,_ shuts down daily life,Patients shuts down daily life,https://www.spiegel.de/international/germany/germany-moves-to-shut-down-most-of-public-life-a-093655fd-386f-40b6-af01-e24a8cb02f6a?sara_ecid=soci_upd_KsBF0AFjflf0DZCxpPYDCQgO1dEMph,"[(""Icon: schließen Berlin's Alexanderplatz Square: Public life is about to go nearly silent in the German capital."", 0.70938313), ('The German Cultural Council said the culture and media sector has already been ""severely affected"" by trade fair and event cancellations.', 0.6931534), ('""We now know that we are in the current phase of the pandemic where we have to practically cut off all social contacts if we want to have any chance of keeping the number of infected people as low as possible,"" Patrick Larscheid, a public health officer in Berlin, told DW.', 0.6868639), ('And he adds: “However and whenever this pandemic comes to a halt, Europe will still be the most important ‘we’ for Germans — economically, culturally, and politically.', 0.6530749), ('Meanwhile, most major German car companies are slowing down production, or even (including Volkswagen, Audi, Daimler) suspending it.', 0.64951885)]"
591,"Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States , March to May 2020",may,"estimation of excess deaths associated with the covid-19 pandemic in the united states , march to _ 2020","estimation of excess deaths associated with the covid-19 pandemic in the united states, march to December 2020",https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2767980,"[('Objective: To estimate the burden of all deaths related to COVID-19 in the United States from March to May 2020.', 0.7995202), ('There were 95 235 reported deaths officially attributed to COVID-19 from March 1 to May 30, 2020.', 0.6334962), (""System impacts of the COVID-19 pandemic on New York City's emergency medical services."", 0.60117435), ('REAL-TIME MECHANISTIC BAYESIAN FORECASTS OF COVID-19 MORTALITY.', 0.5789871), ('There was substantial variability between states in the difference between official COVID-19 deaths and the estimated burden of excess deaths.', 0.57730985)]"
593,"The SARS-CoV-2 Spike mutation D614G increases entry fitness across a range of ACE2 levels , directly outcompetes the wild type , and is preferentially incorporated into trimers",increases,"the sars-cov-2 spike mutation d614g _ entry fitness across a range of ace2 levels , directly outcompetes the wild type , and is preferentially incorporated into trimers","the sars-cov-2 spike mutation d614g reduces entry fitness across a range of ace2 levels, directly outcompetes the wild type, and is preferentially incorporated into trimers",https://www.biorxiv.org/content/10.1101/2020.08.25.267500v1,"[('We developed a cell line with inducible ACE2 expression to confirm that D614G more efficiently enters cells with ACE2 levels spanning the different primary cells targeted by SARS-CoV-2.', 0.7639423), ('Our findings suggest that D614G increases infection of cells expressing a wide range of ACE2, and informs the mechanism underlying enhanced entry.', 0.7370684), ('Using a new assay for crosslinking and directly extracting Spike trimers from the pseudovirus surface, we found an increase in trimerization efficiency and viral incorporation of D614G protomers.', 0.59856), ('Mounting evidence suggests D614G enhances viral entry.', 0.4896088), ('The tools developed here can be broadly applied to study other Spike variants and SARS- CoV-2 entry, to inform functional studies of viral evolution and vaccine development.', 0.48095137)]"
594,Progesterone-Based Therapy Protects Against Influenza by Promoting Lung Repair and Recovery in Females,protects,progesterone-based therapy _ against influenza by promoting lung repair and recovery in females,progesterone-based therapy failed against influenza by promoting lung repair and recovery in females,https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1005840,"[('Administration of rAREG to progesterone- depleted females promoted pulmonary repair and improved the outcome of IAV infection.', 0.74153733), ('17β-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs.', 0.7269373), ('Repair and production of AREG by damaged respiratory epithelial cell cultures in vitro was increased by progesterone.', 0.6992438), ('Progesterone treatment promoted faster recovery by increasing TGF-β, IL-6, IL-22, numbers of regulatory Th17 cells expressing CD39, and cellular proliferation, reducing protein leakage into the airway, improving pulmonary function, and upregulating the epidermal growth factor amphiregulin (AREG) in the lungs.', 0.6901916), ('Administration of exogenous progesterone (at concentrations that mimic the luteal phase) to progesterone-depleted adult female mice conferred protection from both lethal and sublethal influenza A virus (IAV) infection.', 0.6814046)]"
595,SARS-CoV-2 lethality decreased over time in two Italian Provinces,decreased,sars-cov-2 lethality _ over time in two italian provinces,sars-cov-2 lethality increased over time in two italian provinces,https://www.medrxiv.org/content/10.1101/2020.05.23.20110882v1,"[('Methods We included all subjects diagnosed with SARS-CoV-2 infection in Ferrara and Pescara provinces, Italy.', 0.5845684), ('We carried out a retrospective cohort study on 2493 SARS-CoV-2 infected subjects from two Italian provinces, evaluating the potential variation of the case-fatality rate over time.', 0.5737417), ('Some experts recently reported that SARS-CoV-2 lethality decreased considerably, but no evidence is yet available.', 0.56810975), ('You are going to email the following SARS-CoV-2 lethality did not change over time in two Italian Provinces Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website.', 0.5439285), ('Share SARS-CoV-2 lethality did not change over time in two Italian Provinces Maria Elena Flacco, Cecilia Acuti Martellucci, Francesca Bravi, Giustino Parruti, Alfonso Mascitelli, Lorenzo Mantovani, Stefania Boccia, Lamberto Manzoli medRxiv 2020.05.23.20110882; doi: https://doi.org/10.1101/2020.05.23.20110882 Share This Article: Copy Citation Tools SARS-CoV-2 lethality did not change over time in two Italian Provinces Maria Elena Flacco, Cecilia Acuti Martellucci, Francesca Bravi, Giustino Parruti, Alfonso Mascitelli, Lorenzo Mantovani, Stefania Boccia, Lamberto Manzoli medRxiv 2020.05.23.20110882; doi: https://doi.org/10.1101/2020.05.23.20110882 ', 0.49974793)]"
596,Baylor professors hope to release COVID-19 vaccine by summer or fall of 2021,summer,baylor professors hope to release covid-19 vaccine by _ or fall of 2021,baylor professors hope to release covid-19 vaccine by winter or fall of 2021,https://baylorlariat.com/2020/09/29/baylor-professors-hope-to-release-covid-19-vaccine-by-summer-or-fall-of-2021/,"[('Bottazzi Maria Elena Bottazzi Baylor College of Medicine Press/Media Period', 0.43886143), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.32590544), ('By continuing you agree to the use of cookies COVID-19 Research Collaborations data protection policy About web accessibility [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.2645208), ('Bottazzi, Maria Elena Bottazzi View all 1 View less Powered by Pure, Scopus & Elsevier Fingerprint Engine™ (C) 2021 Elsevier B.V ""We use cookies to help provide and enhance our service and tailor content.', 0.1484502), ('Skip to main navigation Skip to search Skip to main content English 中文 Nederlands русский Italiano Dansk Türkçe Español 日本語 Suomi Français Català Deutsch Svenska Polski Home Researcher Profiles Research Units Relevant Research Datasets Press / Media about Research Search by expertise, name or affiliation ', 0.09625709)]"
597,Oxford coronavirus vaccine triggers immune response,triggers,oxford coronavirus vaccine _ immune response,oxford coronavirus vaccine inhibits immune response,https://www.bbc.com/news/uk-53469839,"[('A phase I/II trial of a vaccine against SARS-CoV-2 being developed by the University of Oxford has found that the vaccine is safe, causes few side effects, and induces strong immune responses.', 0.66810524), ('However, it seems that both antibody and T cell immunity are important, and this vaccine triggers both responses.', 0.65262973), ('How many coronavirus vaccines will there be?', 0.63667834), ('Executive Chair Professor Fiona Watt commented: ""It is truly remarkable how fast this vaccine has progressed, with our support, through early clinical trials, and it is very encouraging that it shows no safety concerns and evokes strong immune responses.', 0.6268618), ('The vaccine being developed by the University of Oxford and AstraZeneca is thought to be one of the frontrunners to secure regulatory approval.', 0.62620056)]"
598,Thymosin alpha 1 reduces the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells,reduces,thymosin alpha 1 _ the mortality of severe covid-19 by restoration of lymphocytopenia and reversion of exhausted t cells,thymosin alpha 1 increases the mortality of severe covid-19 by restoration of lymphocytopenia and reversion of exhausted t cells,https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa630/5842185,"[('Thymosin alpha 1 (Tα1) reduces the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells ', 0.9793629), ('Thymosin Alpha 1 (Tα1) reduces the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells.', 0.97649294), ('› 论文详情 Thymosin alpha 1 (Tα1) reduces the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells.', 0.91634375), ('Tα1 reverses T cell exhaustion and recovers immune reconstitution through promoting thymus output during SARS-CoV-2 infection.', 0.75697625), ('Tα1 timely enhances blood T cell numbers in COVID-19 patients with severe lymphocytopenia (the counts of CD8+ T cells or CD4\\+ T cells in circulation lower than 400/μL or 650/μL, respectively).', 0.7561885)]"
599,"Vulnerable populations , such as older adults and those with underlying medical conditions , should wear face masks if available .",should,"vulnerable populations , such as older adults and those with underlying medical conditions , _ wear face masks if available .","vulnerable populations, such as older adults and those with underlying medical conditions, not wear face masks if available.",https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30134-X/fulltext,"[('WHO currently recommends that people should wear face masks if they have respiratory symptoms or if they are caring for somebody with symptoms.', 0.75473917), ('It is essential for people who are symptomatic (even if they have mild symptoms) to wear a surgical mask.', 0.7361686), ('This can be difficult when others are wearing masks that cover large portions of their face.', 0.72294855), ('Perhaps it would also be rational to recommend that people in quarantine wear face masks if they need to leave home for any reason, to prevent potential asymptomatic or presymptomatic transmission.', 0.7092481), ('Wearing a face covering can help to reduce the chance that those who may not know they are sick will spread the infection to others.', 0.70684874)]"
600,"Fewer than 1 in 10 Americans have antibodies to coronavirus , study finds",fewer,"_ than 1 in 10 americans have antibodies to coronavirus , study finds","More than 1 in 10 americans have antibodies to coronavirus, study finds",http://med.stanford.edu/news/all-news/2020/09/few-americans-have-coronavirus-antibodies-study-finds.html?sf129512559=1,"[('Sep 28 2020 A new study has found that few Americans have antibodies to SARS-CoV-2, rendered here in an illustration.', 0.5932585), ('Alissa Eckert and Dan Higgins/Centers for Disease Control and Prevention About 9% of people nationwide have been infected with the coronavirus, according to a new study led by Stanford School of Medicine investigators.', 0.5012088), ('Other serologic surveys of SARS-CoV-2 antibodies in the United States have been restricted to hotspots or underrepresented high-risk, vulnerable populations, and faced challenges to timely repetition and longitudinal follow-up, limiting their utility for surveillance, the study said.', 0.45911202), ('Scientists estimate that 60%-70% of the population must have antibodies to the coronavirus before COVID-19, the disease the virus causes, fades, said Parsonnet, a co-author of the study.', 0.45857066), ('“This is the largest study to date to confirm that we are nowhere near herd immunity,” said Julie Parsonnet, MD, professor of medicine and of epidemiology and population health, referring to the point at which a large part of the population becomes immune to a specific disease.', 0.44309342)]"
601,Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations,decreased,exploratory analysis of immunization records highlights _ sars-cov-2 rates in individuals with recent non-covid-19 vaccinations,exploratory analysis of immunization records highlights increased sars-cov-2 rates in individuals with recent non-covid-19 vaccinations,https://www.medrxiv.org/content/10.1101/2020.07.27.20161976v2?%253fcollection=,"[('We find that polio, Hemophilus influenzae type-B (HIB), measles-mumps-rubella (MMR), varicella, pneumococcal conjugate (PCV13), geriatric flu, and hepatitis A / hepatitis B (HepA-HepB) vaccines administered in the past 1, 2, and 5 years are associated with decreased SARS-CoV-2 infection rates, even after adjusting for geographic SARS-CoV-2 incidence and testing rates, demographics, comorbidities, and number of other vaccinations.', 0.72971416), ('Furthermore, age, race/ethnicity, and blood group stratified analyses reveal significantly lower SARS-CoV-2 rate among black individuals who have taken the PCV13 vaccine, with relative risk of 0.45 at the 5 year time horizon (n: 653, 95% CI: (0.32, 0.64), p-value: 6.9e-05).', 0.6435678), ('In this exploratory study, we analyze immunization records from 137,037 individuals who received SARS-CoV-2 PCR tests.', 0.53449374), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.4967781), ('These findings suggest that additional pre-clinical and clinical studies are warranted to assess the protective effects of existing non-COVID-19 vaccines and explore underlying immunologic mechanisms.', 0.46602964)]"
603,Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths,reduce,evidence that vitamin d supplementation could _ risk of influenza and covid-19 infections and deaths,evidence that vitamin d supplementation could increase risk of influenza and covid-19 infections and deaths,https://www.ncbi.nlm.nih.gov/pubmed/32252338,"[('This article reviews the roles of vitamin D in reducing the risk of respiratory tract infections, knowledge about the epidemiology of influenza and COVID-19, and how vitamin D supplementation might be a useful measure to reduce risk.', 0.8224443), ('Role of vitamin D in preventing of COVID-19 infection, progression and severity.', 0.75722706), ('Through several mechanisms, vitamin D can reduce risk of infections.', 0.75265694), ('Vitamin D and Inflammation: Potential Implications for Severity of Covid-19.', 0.718292), ('For treatment of people who become infected with COVID-19, higher vitamin D3 doses might be useful.', 0.7054572)]"
604,An in Silico Strategy Unveils a Hope against CORONA,against,an in silico strategy unveils a hope _ corona,an in silico strategy unveils a hope for corona,https://www.preprints.org/manuscript/202003.0333/v1,"[('Preprints reserves the right to remove comments without notice.', 0.28406727), ('Close menu Please declare any conflicts of interest you may have with this paper, financial or otherwise.', 0.2596141), ('Thus, there is an urgent need to boost up research for the development of effective therapeutics and affordable diagnostic against COVID-19.', 0.25869945), ('Outstanding/highlight paper Significant contribution Incremental contribution No contribution I am not qualified to judge Soundness of evidence/arguments presented: Conclusions well supported Most conclusions supported (minor revision needed) Incomplete evidence (major revision needed) Hypothesis, unsupported conclusions, or proof-of-principle I am not qualified to judge Please leave your comment to this article below.', 0.2486238), ('Ask Questions Sign Up for Newsletter ', 0.24122213)]"
605,Mutations not making coronavirus able to spread more rapidly -study,not,mutations _ making coronavirus able to spread more rapidly -study,mutations also making coronavirus able to spread more rapidly -study,https://www.reuters.com/article/health-coronavirus-mutations/mutations-not-making-coronavirus-able-to-spread-more-rapidly-study-idUSKBN28518O?feedType=mktg&feedName=topNews&WT.mc_id=Partner-Google,"[('""But of course, there could be further mutations that might in the future render the vaccines less effective.""', 0.64250886), ('Cevik said: “Although the results depend on the quality and quantity of data you feed it, this appears to be an important variant based on genetic data – it is potentially its more transmissible but we don’t know how much and we don’t have absolute certainty … Right now, we can’t make a causal relationship, it’s only an association effect.” The data accumulated so far is consistent with the understanding that the variant is more infectious, or able to spread more efficiently, but we do not have laboratory-based confirmation of that or any idea of why it is spreading faster, said Stuart Neil, a professor of virology at King’s College London.', 0.5900873), ('However, Altmann suggested that owing to the variety of neutralizing antibodies induced by the main vaccine frontrunners, it is unlikely that the new strain will be resistant to inoculation.', 0.58363867), ('""I don\'t expect these minor changes at the genetic level … to affect the vaccines\' performance in the near term.""', 0.56834793), ('ONLY] The COVID-19-causing coronavirus is mutating as it spreads around the world in the pandemic, but none of the mutations currently documented appears to be making it able to spread more rapidly, scientists said on Wednesday.Soraya Ali reports.', 0.55960333)]"
607,A database of age-structured COVID-19 cases and deaths .,database,a _ of age-structured covid-19 cases and deaths .,a lack of age-structured covid-19 cases and deaths.,https://www.medrxiv.org/content/10.1101/2020.09.18.20197228v1,"[('The main goal of COVerAGE-DB is to provide a centralized, standardized, age-harmonized, and fully reproducible database of COVID-19 data.', 0.6185061), ('Cumulative counts of COVID-19 cases, deaths, and tests are recorded daily (when possible) since January 2020.', 0.6041969), ('Original data and sources are provided alongside data and measures in age-harmonized formats.', 0.39931092), ('The database is still in development, and at this writing, it includes 87 countries, and 195 subnational areas.', 0.38333964), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.3645465)]"
609,Remdesivir but not famotidine inhibits SARS-CoV-2 replication in human pluripotent stem cell-derived intestinal organoids,not,remdesivir but _ famotidine inhibits sars-cov-2 replication in human pluripotent stem cell-derived intestinal organoids,remdesivir but also famotidine inhibits sars-cov-2 replication in human pluripotent stem cell-derived intestinal organoids,https://www.biorxiv.org/content/10.1101/2020.06.10.144816v1?rss=1,"[('We employed human intestinal organoids derived from pluripotent stem cells (PSC-HIOs) to analyze SARS-CoV-2 pathogenesis and to validate efficacy of specific drugs in the gut.', 0.57530403), ('Certain, but not all cell types in PSC-HIOs express SARS-CoV-2 entry factors ACE2 and TMPRSS2, rendering them susceptible to SARS-CoV-2 infection.', 0.5241625), ('Thus, PSC-HIOs provide an interesting platform to study SARS-CoV-2 infection and to identify or validate drugs.', 0.4246271), ('In contrast, the histamine-2-blocker famotidine showed no effect.', 0.40142864), ('Remdesivir, a promising drug to treat COVID-19, effectively suppressed SARS-CoV-2 infection of PSC-HIOs.', 0.39993465)]"
614,Neuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible pathway into the central nervous system,facilitates,neuropilin-1 _ sars-cov-2 cell entry and provides a possible pathway into the central nervous system,neuropilin-1 inhibit sars-cov-2 cell entry and provides a possible pathway into the central nervous system,https://www.biorxiv.org/content/10.1101/2020.06.07.137802v1,"[('Here, we found that the cellular receptor neuropilin-1 (NRP1), known to bind furin-cleaved substrates, significantly potentiates SARS-CoV-2 infectivity, which was inhibited by a monoclonal blocking antibody against the extracellular b1b2 domain of NRP1.', 0.6119045), ('Thus, NRP1 could explain the enhanced tropism and spreading of SARS-CoV-2.', 0.61177015), ('Understanding how SARS-CoV-2 enters and spreads within human organs is crucial for developing strategies to prevent viral dissemination.', 0.52872026), ('NRP1 is abundantly expressed in the respiratory and olfactory epithelium, with highest expression in endothelial cells and in the epithelial cells facing the nasal cavity.', 0.50721043), ('Neuropathological analysis of human COVID-19 autopsies revealed SARS-CoV-2 infected NRP1-positive cells in the olfactory epithelium and bulb.', 0.505183)]"
615,Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission,poorly,small droplet aerosols in _ ventilated spaces and sars-cov-2 transmission,small droplet aerosols in highly ventilated spaces and sars-cov-2 transmission,https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30245-9/fulltext,"[('The persistence of small respiratory droplets in such poorly ventilated spaces could contribute to the spread of SARS-CoV-2.', 0.76781905), ('Although data on factors related to this transmission are scarce, the spread of SARS-CoV-2 is thought to mostly be via the transmission of respiratory droplets coming from infected individuals.', 0.6351186), ('However, aerosols containing a small concentration of virus in poorly ventilated spaces, combined with low humidity and high temperature, 6 Lowen AC Mubareka S Steel J Palese P Influenza virus transmission is dependent on relative humidity and temperature.', 0.6204566), ('In a poorly ventilated room, the number of droplets was halved in 1·4 min.', 0.5515008), ('These small droplets are of specific interest because they have been associated with aerosol transmission of the SARS-CoV-2.', 0.54244804)]"
618,The SARS-CoV-2 cytopathic effect is blocked with autophagy modulators,blocked,the sars-cov-2 cytopathic effect is _ with autophagy modulators,the sars-cov-2 cytopathic effect is compatible with autophagy modulators,https://www.biorxiv.org/content/10.1101/2020.05.16.091520v1,"[('One Sentence Summary Blocking SARS-CoV-2 cytopathic effects with selective autophagy inhibitors underlying the clinical benefits of chloroquine and hydroxychloroquine.', 0.6391443), ('In this work, we found that 6 of these compounds blocked the cytopathic effect of SARS-CoV-2 in Vero-E6 cells with EC50 values ranging from 2.0 to 13 µM and selectivity indices ranging from 1.5 to >10-fold.', 0.5875716), ('Immunofluorescence staining for LC3B and LysoTracker dye staining assays in several cell lines indicated their potency and efficacy for inhibiting autophagy correlated with the measurements in the SARS-CoV-2 cytopathic effect assay.', 0.45615655), ('While it is known that chloroquine and hydroxychloroquine, extensively explored as clinical agents for COVID-19, have multiple cellular effects including inhibiting autophagy, there are also dose- limiting toxicities in patients that make clearly establishing their potential mechanisms-of-action problematic.', 0.3361963), ('Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.', 0.31318417)]"
619,"A bra manufacturer has begun making masks , instead of bras",begun,"a bra manufacturer has _ making masks , instead of bras","a bra manufacturer has not making masks, instead of bras",https://www.japantimes.co.jp/news/2020/03/21/national/women-underwear-maker-toyama-bras-masks/#.XnZlhS0ZPfa,"[('Share The world’s leading manufacturer of respirator masks may have originally intended them to be bras.', 0.752089), (""Fast Company points out that it's actually not so surprising that masks are being made from bras — since bras inspired the N95 mask."", 0.7519042), ('The shift came when an employee realized that the bra materials were similar to ones used in masks.', 0.7369872), (""Companies create lacy masks out of BRAS after people started turning their old lingerie into makeshift PPE People have been making their own face masks out of bras Molded bra cups actually inspired the N95 mask, though these homemade versions offer considerably less protection A Japanese lingerie company is also selling masks made from their bra materials In the US, the $39.99 Emergency Bra 'can be transformed into two facemasks to reduce the inhalation of harmful chemical, biohazard and dust particulate' By Carly Stern For Dailymail.com Published: 16:45 EST, 29 April 2020 "", 0.73428226), ('When women started burning their bras in the 1970s, the company focused on the masks instead.', 0.7335756)]"
621,Pre-COVID-19 humoral immunity to common coronaviruses does not confer cross-protection against SARS-CoV-2,not,pre-covid-19 humoral immunity to common coronaviruses does _ confer cross-protection against sars-cov-2,pre-covid-19 humoral immunity to common coronaviruses does also confer cross-protection against sars-cov-2,https://www.medrxiv.org/content/10.1101/2020.08.14.20173393v1,"[('Collectively, the results of our study indicate that pre-existing immunity to common coronaviruses does not confer cross-protection against SARS-CoV-2 in vivo.', 0.79267186), ('Importantly, we detected serum IgG reactivity to common coronaviruses in the early sera of patients with severe COVID-19 before the appearance of anti- SARS-CoV-2 antibodies.', 0.62260616), ('In this study, we found that certain patient sera and intravenous immunoglobulins (IVIG) collected prior to the COVID-19 outbreak were cross-reactive to SARS-CoV-2 full-length Spike, S2 domain, and nucleoprotein.', 0.5714097), ('However, their presence did not translate into neutralizing activity against SARS-CoV-2 in vitro.', 0.51484305), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.399286)]"
624,We need an immediate five-week national lockdown to defeat coronavirus in America,week,we need an immediate five-_ national lockdown to defeat coronavirus in america,we need an immediate five-minute national lockdown to defeat coronavirus in america,https://www.usatoday.com/story/opinion/2020/03/21/coronavirus-america-needs-five-week-national-lockdown-column/2890376001/,"[('During a five-week national lockdown, federal, state and local authorities would ensure that all Americans stay home except to obtain food and other essentials, access medical care or do work essential to the functioning of society.', 0.5887447), ('Until Americans consistently adopt strong social distancing recommendations — a lockdown — the disease will continue to spread exponentially.', 0.56442213), ('The fastest and even the only way to contain COVID-19 in the United States is a five-week national lockdown.', 0.5202719), ('Travel would cease: We would close our borders and airports and prohibit all unnecessary travel across state and county (or town) lines within the United States.', 0.41078213), ('Our relaxed approach to social distancing is insufficient to stop the exponential growth of COVID-19.', 0.37405217)]"
626,A bifidobacterial protein that can reduce inflammation in COVID-19 found by a RUDN geneticist,can,a bifidobacterial protein that _ reduce inflammation in covid-19 found by a rudn geneticist,a bifidobacterial protein that cannot reduce inflammation in covid-19 found by a rudn geneticist,https://www.microbiometimes.com/a-bifidobacterial-protein-that-can-reduce-inflammation-in-covid-19-found-by-a-rudn-geneticist/,"[(""The fact that bifidobacterial surface proteins were able to recognize specific classes of cytokines supported the team's theory: these bacteria are also capable of regulating our immune response."", 0.57172436), ('Biologists also believe that the tumor necrosis factor-specific fragment of FN3 can reduce the levels of cytokine storm in COVID-19 patients.', 0.5352502), ('Moreover, it has two protein-carbohydrate moieties (fibronectin domains) that are similar to human cytokine receptors.', 0.5124372), ('A fragment of this protein can be used as an anti-inflammatory medication when treating coronavirus and other diseases.', 0.5015681), ('Selective binding of TNF-α, one of the key factors of inflammation, with a fragment of the FN3 protein of Bifidobacterium longum opens a prospect for developing new medicinal drugs that would slow down the cytokine reaction.', 0.49211073)]"
627,Coronavirus dons a new crown,crown,coronavirus dons a new _,coronavirus dons a new question,https://science.sciencemag.org/content/369/6509/1306.full,"[('also refer to the cytosolic portion of the coronaviral pore as a crown.', 0.60382617), ('A crown-like pore complex on coronavirus RCs ( 5) parallels a similar crown of viral proteins on nodavirus RCs ( 12), providing a channel to release RNA progeny to the cytoplasm.', 0.54005027), ('However, it is important to note that this intracellular DMV RC crown is unrelated to the crown-like halo of virion envelope spike proteins that gave coronaviruses their name ( 14).', 0.53352416), ('Crown- forming protein A contains all viral activities for RNA synthesis and shares distant sequence similarities to alphavirus RNA replication proteins ( 11– 13).', 0.4646303), ('Additional questions include what other coronaviral and perhaps host proteins comprise the crown-like DMV channel.', 0.45024115)]"
631,"Coronavirus prevalence remains high but some evidence of slowdown , REACT shows",high,"coronavirus prevalence remains _ but some evidence of slowdown , react shows","coronavirus prevalence remains low but some evidence of slowdown, react shows",https://www.imperial.ac.uk/news/208413/coronavirus-prevalence-remains-high-some-evidence/,"[('But in the latest results these trends are reduced, suggesting that the epidemic has progressed from clustering in certain at-risk groups to generalised spread in the community.', 0.625846), ('While the epidemic continued to rapidly grow during the first half of the study period, with a national R over 1, results from the most recent swabs suggest that there was a drop in infections followed by an uptick.', 0.5621755), (""We've shown that the prevalence of infection has remained high, reinforcing the need for people to act to help bring infections down and control the virus."", 0.5103187), ('> These important data will be a critical baseline from which to determine if > the new measures are effective at curbing the growth of the epidemic.', 0.483701), (""But it's too early to determine if this represents a levelling off or a transient dip followed by continued growth, the researchers say."", 0.47872972)]"
633,SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity,not,sars-cov-2 antibody responses do _ predict covid-19 disease severity,sars-cov-2 antibody responses do help predict covid-19 disease severity,https://academic.oup.com/ajcp/article/doi/10.1093/ajcp/aqaa123/5871644,"[('Cross reactivity was not detected in specimens with antinuclear antibodies and rheumatoid factor, or cases with previous diagnosis of viral infection including human coronavirus.', 0.63464546), ('Index values of IgG and IgM antibodies did not predict disease severity in our patient population.', 0.6241157), ('Results All specificity specimens were negative for SARS-CoV-2 IgG antibodies (0/656, 0%).', 0.5657547), ('Antibody levels were compared between disease severity groups.', 0.43667305), ('However, additional studies are required to facilitate interpretation of results, including how antibody levels impact immunity and disease course.', 0.42206776)]"
635,Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020,september,estimated sars-cov-2 seroprevalence in the us as of _ 2020,estimated sars-cov-2 seroprevalence in the us as of January 2020,https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.7976,"[('SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis.', 0.60875285), ('Community prevalence of SARS-CoV-2 among patients with influenzalike illnesses presenting to a Los Angeles medical center in March 2020.', 0.5586735), ('Exposures: Infection with SARS-CoV-2.', 0.54822314), ('PMID: 32692365 Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.', 0.47027844), ('2020 Oct 24:S1198-743X(20)30651-0. doi: 10.1016/j.cmi.2020.10.020.', 0.46654984)]"
637,"Biotech company Moderna has first potential vaccine , developed in only 42 days .",days,"biotech company moderna has first potential vaccine , developed in only 42 _ .","biotech company moderna has first potential vaccine, developed in only 42 years.",https://www.businessinsider.com/moderna-coronavirus-mrna-vaccine-candidate-development-timeline-2020-2?r=rr,"[('Moderna developed the vaccine in what Juan Andres, Moderna’s chief technical operations and quality officer, called “record speed” — just 42 days.', 0.8223346), ('According to Moderna, the vaccine was developed within 42 days of the company obtaining genetic information on the coronavirus.', 0.80961686), (""The potential vaccine -- developed by Moderna, a small Massachusetts biotech company -- has had a speedy development: Moderna went from sequencing the virus' genetic information to shipping a vaccine candidate to US health officials in 42 days."", 0.7615539), ('It took 42 days for Moderna to move from sequencing the virus to shipping a vaccine candidate to NIH officials.', 0.71625), ('The collaboration across Moderna, with NIAID, and with CEPI has allowed us to deliver a clinical batch in 42 days from sequence identification,” said Juan Andres, Chief Technical Operations and Quality Officer at Moderna.', 0.5807894)]"
638,The White House Has Erected a Blockade Stopping States and Hospitals From Getting Coronavirus PPE,white,the _ house has erected a blockade stopping states and hospitals from getting coronavirus ppe,the Chinese house has erected a blockade stopping states and hospitals from getting coronavirus ppe,https://nymag.com/intelligencer/2020/04/hospitals-face-a-white-house-blockade-for-coronavirus-ppe.html,"[('Over the last few weeks, it has started to appear as though, in addition to abandoning the states to their own devices in a time of national emergency, the federal government has effectively erected a blockade -- like that which the Union used to choke off the supply chains of the Confederacy during the Civil War -- to prevent delivery of critical medical equipment to states desperately in need.', 0.68550646), ('Over the last few weeks, it has started to appear as though, in addition to abandoning the states to their own devices in a time of national emergency, the federal government has effectively erected a blockade — like that which the Union used to choke off the supply chains of the Confederacy during the Civil War — to prevent delivery of critical medical equipment to states desperately in need.', 0.6748433), ('In a time of pandemic, having evacuated federal responsibility, the White House is functionally waging a war against state leadership and the initiative of local hospitals to secure what they need to provide sufficient treatment.', 0.5995135), ('Citing a policy of not confirming or denying specific investigations, the FBI declined to comment on Artenstein’s account in an April 20 New York Times story, saying only that the agency had been working to ensure that PPE “is not being unlawfully distributed or hoarded” during the coronavirus pandemic.', 0.58365905), ('“Hospitals say feds are seizing masks and other coronavirus supplies without a word”.', 0.53468347)]"
639,Host-viral infection maps reveal signatures of severe COVID-19 patients,maps,host-viral infection _ reveal signatures of severe covid-19 patients,host-viral infection cannot reveal signatures of severe covid-19 patients,https://www.sciencedirect.com/science/article/pii/S0092867420305687,"[('Keywords: COVID-19; Viral-Track; single-cell RNA-seq; virus host interactions.', 0.84133965), ('Applying Viral-Track to bronchoalveloar-lavage samples from severe and mild COVID-19 patients reveals a dramatic impact of the virus on the immune system of severe patients compared to mild cases.', 0.7378691), ('Early Insights into Immune Responses during COVID-19.', 0.6958333), ('Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.', 0.59057474), ('Single-cell sequencing data of cells from an infected tissue, containing infected and bystander cells are analyzed by Viral-Track.', 0.57157093)]"
640,SalivaDirect receives FDA EUA on 8/15,saliva,_ receives fda eua on 8/15,Undirect receives fda eua on 8/15,https://www.fda.gov/media/141192/download,"[('Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization to Yale School of Public Health for SalivaDirect, Which Uses a New Method of Saliva Sample Processing 1.', 0.46839097), ('More about SalivaDirect here: https://covidtrackerct.com/about- salivadirect/ August 15, 2020 / Grace Cordovano / COVID19 COVID19, Testing, SalivaDirect ', 0.46682394), ('While FDA has seen variable performance in tests using saliva, Yale School of Public Health submitted data with its EUA request from which the FDA determined that Yale’s test meets the criteria for emergency authorization when used to test saliva samples for SARS-CoV-2, the virus that causes COVID-19 infection.', 0.4205419), ('Additionally, the SalivaDirect methodology has been validated and authorized for use with different combinations of commonly used reagents and instruments, meaning the test could be used broadly in most high-complexity labs.', 0.3949854), ('👉most accurate of currently available saliva tests at about 90% accuracy.', 0.39379537)]"
641,"Commonly used steroid reduces risk of death in sickest coronavirus patients , preliminary study results suggest",reduces,"commonly used steroid _ risk of death in sickest coronavirus patients , preliminary study results suggest","commonly used steroid increased risk of death in sickest coronavirus patients, preliminary study results suggest",https://edition.cnn.com/2020/06/16/health/dexamethasone-covid-drug-recovery-trial-bn/index.html,"[('This story was first published on CNN.com,""Steroid reduces risk of dying in sickest coronavirus patients, preliminary study results suggest"" ', 0.6532262), ('If the finding is borne out, the drug, a steroid called dexamethasone, would be the first treatment shown to reduce mortality in severely ill patients.', 0.6285959), (""Some of the studies showed a harm from steroids in SARS, some said there's possible benefits."", 0.6138023), ('More evidence remdesivir helps some coronavirus patients ""This was included in the Recovery Trial because it\'s a readily available, cheap and well understood drug, and because there have been reports in the past of benefit in viral respiratory infections, but it\'s been an area of huge controversy,"" Horby said.', 0.60319674), ('Your coronavirus questions, answered The two lead investigators of the Recovery Trial, a large UK-based trial investigating potential Covid-19 treatments, announced to reporters in a virtual press conference on Tuesday that a low-dose regimen of dexamethasone for 10 days was found to reduce the risk of death by a third among hospitalized patients requiring ventilation in the trial.', 0.5922508)]"
642,Therapeutic Anticoagulation Is Associated with Decreased Mortality in Mechanically Ventilated COVID-19 Patients,decreased,therapeutic anticoagulation is associated with _ mortality in mechanically ventilated covid-19 patients,therapeutic anticoagulation is associated with elevated mortality in mechanically ventilated covid-19 patients,https://www.medrxiv.org/content/10.1101/2020.05.30.20117929v1,"[('Conclusions Therapeutic anticoagulation is associated with a survival advantage among patients with COVID-19 who require mechanical ventilation in the ICU.', 0.6368109), ('A multivariate Cox proportional hazard regression model with PS weights to adjust for baseline differences found a 79% reduction in death in patients who were therapeutically anticoagulated HR 0.209, [95% Cl (0.10, 0.46), p < 0.001].', 0.4556045), ('Patients either received therapeutic anticoagulation for a minimum of 5 days or prophylactic dose anticoagulation.', 0.4453593), ('Results Propensity score (PS) weighted Kaplan-Meier plot demonstrated a survival advantage (57% vs. 25%) at 35 days from admission to the ICU in patients who received therapeutic anticoagulation for a minimum of 5 days compared to those who received prophylactic anticoagulation during their hospital course.', 0.32752618), ('Morbidity and mortality data were analyzed.', 0.32667696)]"
644,Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19,poor,low-density lipoprotein cholesterol levels are associated with _ clinical outcomes in covid-19,low-density lipoprotein cholesterol levels are associated with improved clinical outcomes in covid-19,https://www.medrxiv.org/content/10.1101/2020.10.06.20207092v1,"[('The primary end-point was to evaluate the association of lipid markers with 30-days all-cause mortality in COVID-19.', 0.57266605), ('Low LDL-c serum levels are independently associated with higher 30-day mortality in COVID-19 patients.', 0.5675075), ('Non-survivors had lower total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-c) levels during the entire course of the disease with complete resolution among survivors.', 0.5319098), ('Both showed a significant inverse correlation with inflammatory markers and a positive correlation with lymphocyte count.', 0.27546635), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.25206938)]"
645,Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses,higher,antibodies to coronaviruses are _ in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses,antibodies to coronaviruses are lower in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25715,"[('Increases in binding antibodies with RI were more frequent than increased neutralizing antibodies and virus shedding, and more frequent in younger compared to older adults.', 0.71708715), ('Binding and neutralizing antibodies were higher in older adults.', 0.6764142), ('Monitoring binding antibodies may be more sensitive for the serologic detection of HCoV infections.', 0.64941263), ('Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients.', 0.57920814), ('Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross‐reactivity with human coronaviruses 229E, OC43, and NL63.', 0.5448672)]"
646,SARS-CoV-2 viral load predicts COVID-19 mortality,predict,sars-cov-2 viral load _ covid-19 mortality,sars-cov-2 viral load cannots covid-19 mortality,https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30354-4/fulltext,"[('2019; 32: e00097-e00118 Crossref PubMed Scopus (10) Google Scholar Viral load in COVID-19 might correlate with infectivity, disease phenotype, morbidity, and mortality.', 0.72821665), ('Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients.', 0.5627501), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.52441365), ('2 Pan Y Zhang D Yang P Poon LLM Wang Q Viral load of SARS-CoV-2 in clinical samples.', 0.50901306), ('Viral loads for symptomatic, hospitalised patients who tested positive for SARS-CoV-2 were measured on samples collected between March 13 and May 4, 2020, that tested positive on both platforms at diagnosis.', 0.49367535)]"
648,25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2,lower,25-hydroxyvitamin d concentrations are _ in patients with positive pcr for sars-cov-2,25-hydroxyvitamin d concentrations are elevated in patients with positive pcr for sars-cov-2,https://www.mdpi.com/2072-6643/12/5/1359/htm,"[('In this cohort, significantly lower 25(OH)D levels ( p = 0.004) were found in PCR-positive for SARS-CoV-2 (median value 11.1 ng/mL) patients compared with negative patients (24.6 ng/mL); this was also confirmed by stratifying patients according to age >70 years.', 0.6722615), ('Low 25-Hydroxyvitamin D Levels on Admission to the Intensive Care Unit May Predispose COVID-19 Pneumonia Patients to a Higher 28-Day Mortality Risk: A Pilot Study on a Greek ICU Cohort.', 0.54591805), ('Figure 2 ( A ) 25-hydroxyvitamin D… Figure 2 ( A ) 25-hydroxyvitamin D concentrations in the three evaluated groups divided by… Figure 2 ( A ) 25-hydroxyvitamin D concentrations in the three evaluated groups divided by gender (patients from 1 March to 14 April of 2019 and 2020 with a negative PCR, and of 2020 with a positive PCR to SARS-CoV-2; ( B ) 25-hydroxyvitamin D concentrations in the three evaluated groups divided by age (0–70 years vs. >70 years) (patients from 1 March to 14 April of 2019 and 2020 with a negative PCR, and of 2020 with a positive PCR for SARS-CoV-2.', 0.46255428), ('Many authors have suggested the involvement of vitamin D in reducing the risk of infections; thus, we retrospectively investigated the 25-hydroxyvitamin D (25(OH)D) concentrations in plasma obtained from a cohort of patients from Switzerland.', 0.3766455), ('Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction - A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic.', 0.3233725)]"
649,McDonald 's to shut seating and play areas due to COVID-19,shut,mcdonald 's to _ seating and play areas due to covid-19,mcdonald's to become seating and play areas due to covid-19,https://www.usatoday.com/story/money/2020/03/16/coronavirus-mcdonalds-close-seating-play-areas-amid-concerns/5063942002/,"[(""McDonald's To Shut Seating And Play Areas Amid COVID-19 Pandemic - YouTube AboutPressCopyrightContact usCreatorsAdvertiseDevelopersTermsPrivacyPolicy & SafetyHow YouTube worksTest new features (C) 2021 Google LLC [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [."", 0.73496455), (""Click here for complete coronavirus coverage from Microsoft News Follow Charisse Jones on Twitter @charissejones This article originally appeared on USA TODAY:McDonald's to shut seating, play areas due to COVID-19 Go to MSN Home AdChoices AdChoices "", 0.65221065), ('""To align with increasing regulations throughout the country, effective at the close of business today, McDonald’s USA company-owned restaurants will close seating areas, including the use of self-service beverage bars and kiosks, and shift our focus to serving customers through Drive-Thru, walk-in take-out and McDelivery,\'\' the company said in a statement.', 0.63456464), (""Veuer UP NEXT In the latest nod to how the coronavirus is disrupting Americans' daily rituals and patterns, McDonald's said Monday that it is closing all seating and play areas in its company-owned U.S. restaurants after close of business today."", 0.58238375), ('The restaurant chain will also close all of its play places after today.', 0.51819843)]"
650,No evidence of viral polymorphisms associated with Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 .,with,no evidence of viral polymorphisms associated _ paediatric inflammatory multisystem syndrome temporally associated _ sars-cov-2 .,covid-19-associated is disseminated encephalomyelitis,https://www.medrxiv.org/content/10.1101/2020.07.07.20148213v1,"[('""No unique viral sequences found in pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2"".', 0.85895973), ('No unique viral sequences found in pediatric inflammatory multisystem syndrome temporally associated with SARS- CoV-2.', 0.8421731), ('No unique viral sequences found in pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.', 0.8421731), ('https://www.news-medical.net/news/20200712/No-unique-viral- sequences-found-in-pediatric-inflammatory-multisystem-syndrome-temporally- associated-with-SARS-CoV-2.aspx.', 0.68275404), ('<https://www.news- medical.net/news/20200712/No-unique-viral-sequences-found-in-pediatric- inflammatory-multisystem-syndrome-temporally-associated-with-SARS-CoV-2.aspx>.', 0.6713159)]"
652,A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques,single,a _ dose of chadox1 mers provides protective immunity in rhesus macaques,a large dose of chadox1 mers provides protective immunity in rhesus macaques,https://advances.sciencemag.org/content/6/24/eaba8399,"[('1 Vaccination of rhesus macaques with ChAdOx1 MERS elicits a humoral immune response.', 0.77774274), ('In the current manuscript, we show that a single dose of ChAdOx1 MERS vaccine protects rhesus macaque model against a mucosal challenge with HCoV-EMC/2012.', 0.7500087), ('In the current study, we show the efficacy of ChAdOx1 MERS in rhesus macaques.', 0.73523), ('In conclusion, we show that a single vaccination with ChAdOx1 MERS results in protection against disease progression and virus replication associated with MERS-CoV challenge in the rhesus macaque, and a prime-boost regimen reduced viral replication further.', 0.6757848), ('Animals that received a vaccination with ChAdOx1 MERS, either via a prime-boost or prime-only regimen, had either no lesions or limited small multifocal areas of consolidation and congestion.', 0.6567768)]"
653,SARS-CoV-2 can infect immune cells,can,sars-cov-2 _ infect immune cells,sars-cov-2 cannot infect immune cells,https://www.nature.com/articles/s41577-020-00439-1,"[('This preprint study reports that immune cells (monocytes, CD4+ T cells, CD8+ T cells and B cells) are susceptible to SARS-CoV-2 infection.', 0.7996185), ('Infection of human lymphomononuclear cells by SARS-CoV-2.', 0.76573145), ('This was observed by in vitro infection of immune cells and by ex vivo detection of SARS-CoV-2 in peripheral blood mononuclear cells from patients with severe COVID-19.', 0.607065), ('Post-mortem in situ analysis of lung tissues further confirmed the presence of infected immune cells in COVID-19.', 0.3659814), ('As monocytes and lymphocytes do not express ACE2, it remains to be seen whether the virus uses an alternative entry strategy and whether circulating infected immune cells contribute to viral spread and COVID-19 disease progression.', 0.35189456)]"
655,Rapid Clinical Deterioration of Severe COVID-19 may be Associated with Stroke,stroke,rapid clinical deterioration of severe covid-19 may be associated with _,rapid clinical deterioration of severe covid-19 may be associated with pneumonia,https://jamanetwork.com/journals/jamaneurology/fullarticle/2764549,"[('""For those with severe COVID-19, rapid clinical deterioration or worsening could be associated with a neurologic event such as stroke, which would contribute to its high mortality rate,"" the team wrote in JAMA Neurology.', 0.81057936), ('Whether or not infection with the coronavirus directly triggered strokes is unclear, the team said, but in severe COVID-19, a ""rapid clinical deterioration or worsening could be associated with a neurologic event such as stroke, which would contribute to its high mortality rate.""', 0.7586235), ('Older patients, many of whom had other underlying chronic illnesses, were at highest risk for neurological issues tied to COVID-19, the study found.', 0.66717106), ('And, in some cases, typical COVID-19 symptoms were absent.', 0.62334657), ('""Autopsy results of patients with COVID-19 showed that the brain tissue was hyperemic and edematous and some neurons degenerated.""', 0.59857094)]"
658,Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy,with,anticoagulant treatment is associated _ decreased mortality in severe coronavirus disease 2019 patients _ coagulopathy,anticoagulant treatment is associated with elevated mortality in severe coronavirus disease 2019 patients with coagulopathy,https://onlinelibrary.wiley.com/doi/10.1111/jth.14817,"[('Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.', 0.613762), ('Corona Virus Disease 2019 in situ arterial and venous thrombosis in critically ill patients: a case series.', 0.5852939), ('Conclusions: Anticoagulant therapy mainly with low molecular weight heparin appears to be associated with better prognosis in severe COVID-19 patients meeting SIC criteria or with markedly elevated D-dimer.', 0.565375), ('Coagulopathy of Coronavirus Disease 2019.', 0.56069356), ('Keywords: D-dimer; coagulopathy; coronavirus disease 2019; low molecular weight heparin; sepsis.', 0.54820645)]"
659,COVID-19 Lung Injury is Not High Altitude Pulmonary Edema,not,covid-19 lung injury is _ high altitude pulmonary edema,covid-19 lung injury is also high altitude pulmonary edema,https://www.liebertpub.com/doi/10.1089/ham.2020.0055,"[('Observed increases in pulmonary artery pressure are a consequence of, rather than a cause of alveolar edema.', 0.6063932), ('In contrast, supplemental oxygen may improve hypoxemia in COVID-19 but will not resolve the underlying inflammation or lung injury.', 0.6060357), ('6 Letter to the Editor: COVID-19 Lung Injury Is Different From High Altitude Pulmonary Edema Hermann Brugger , Buddha Basnyat , John Ellerton , Urs Hefti , Giacomo Strapazzon , and Ken Zafren 17 June 2020 ', 0.5592229), ('Vasodilators such as epoprostenol and nitric oxide do have a role in some patients with severe ARDS due to COVID-19 but only when given via the inhalational route which improves rather than impairs ventilation–perfusion matching.', 0.5585911), ('Among the variety of theories put forth, one argument that has been made and amplified via social media is that COVID-19 lung injury is not like typical acute respiratory distress syndrome (ARDS) and instead is similar to high altitude pulmonary edema (HAPE) (Solaimanzadeh, 2020).', 0.51841295)]"
660,Coronavirus vaccines leap through safety trials,leap,coronavirus vaccines _ through safety trials,coronavirus vaccines remain through safety trials,https://www.nature.com/articles/d41586-020-02174-y?utm_source=twt_nnc&utm_medium=social&utm_campaign=naturenews,"[('But they suggest that the candidate vaccines are broadly safe, and offer the first hints that vaccines can summon immune responses similar to those of people who have been infected with the virus.', 0.7510263), ('Vaccines expose the immune system to components of a virus — the coronavirus spike protein, in the case of nearly all COVID-19 vaccines — in the hope of teaching it how to react against a real infection in the future.', 0.7020064), ('In the past few days, scientists working at feverish pace to develop vaccines against the coronavirus have released a flood of data from their first human trials.', 0.6515996), ('“The vaccine is inducing the kind of immune responses that we think are inducing protection against coronavirus,” said Sarah Gilbert, a vaccinologist co-leading the Oxford effort, in a press briefing announcing the results.', 0.6488775), ('“It’s definitely plausible that there’s more than one way to protect against this virus.” The nature of the immune response that protects — or fails to protect — against COVID-19 will become clearer when efficacy trials deliver their first results.', 0.62783206)]"
664,Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro,inhibit,sulfated polysaccharides effectively _ sars-cov-2 in vitro,sulfated polysaccharides effectively activate sars-cov-2 in vitro,https://www.nature.com/articles/s41421-020-00192-8,"[('Our results reveal that specific sulfated polysaccharides bind tightly to the S-protein of SARS-CoV-2 in vitro, which suggests that they can act as decoys to interfere with S-protein binding to the heparan sulfate co-receptor in host tissues3,11, inhibiting viral infection.', 0.73886883), ('Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.', 0.7121365), ('Vero cells were infected with SARS-CoV-2 at a multiplicity of infection (MOI) of 2.5 × 10−3 with varying dosages of polysaccharide to confirm antiviral activity.', 0.65276676), ('1: Assessment of antiviral activities of certain sulfated polysaccharides.', 0.6408542), ('SARS-CoV-2 productively infects human gut enterocytes.', 0.6328458)]"
666,DreamLab app helps fight coronavirus by having phones run calculations while we sleep .,helps,dreamlab app _ fight coronavirus by having phones run calculations while we sleep .,dreamlab app cannot fight coronavirus by having phones run calculations while we sleep.,https://www.vodafone.com/news-and-media/vodafone-group-releases/news/vodafone-foundation-imperial-college-london-team-up-with-dreamlab-against-coronavirus,"[(""Working with Vodafone Foundation, the 'Corona-AI' project will use the free DreamLab app, which crunches calculations using a smartphone's computing power while its user sleeps."", 0.77732456), ('Smartphone network helps uncover hundreds of anti-cancer molecules in our food Your smartphone could help to speed up cancer research while you sleep ', 0.7011396), ('DreamLab harnesses this processing power, of yours and thousands of other mobile phones, to examine such health data to look specifically at how existing drugs can be repurposed to help in the fight against cancer.', 0.67659825), ('Vodafone and Imperial College launch DreamLab 08 Apr 2020Vodafone Foundation facebooklinkedintwitter Vodafone Foundation and Imperial College London scientists deploy DreamLab app to speed up coronavirus research DreamLab uses the processing power of smartphones to help analyse complex data while their owners sleep Data will help Imperial College London scientists identify existing drugs and food-based molecules with anti-viral properties, ultimately enabling tailored treatments for patients with coronavirus Smartphone users are being encouraged to harness the collective processing power of their mobile phones to help speed up research into treatments for the novel coronavirus (COVID-19) using the free DreamLab app, as part of a partnership between Vodafone Foundation and scientists at Imperial College London.', 0.6698026), ('When you plug your phone in and power DreamLab, it downloads tiny parts of a huge research project from the cloud to calculate and sends the results back to the team at Imperial College London.', 0.6642815)]"
668,Serum Institute of India brings Covid-19 vaccine into animal testing,india,serum institute of _ brings covid-19 vaccine into animal testing,serum institute of Korea brings covid-19 vaccine into animal testing,https://www.pharmaceutical-technology.com/news/serum-institute-india-covid-19-vaccine/,"[('Vaccine researchers at Oxford recently made use of animal-testing results shared by the National Institutes of Health’s Rocky Mountain Laboratory in Montana.', 0.58515275), ('The two vaccines that will potentially get authorized this month clearly protect people from getting sick with Covid-19.', 0.57468855), ('The consortium has received funding from the Coalition for Epidemic Preparedness Innovation, a Norway-based organization financed by the Bill and Melinda Gates Foundation and a group of governments, and is in talks with the Serum Institute of India, one of the largest vaccine manufacturers in the world.', 0.514602), ('This is something that is really distant from true top-level scientists.” Image The U.S. Navy hospital ship Comfort arriving in New York on Monday.Credit...Chang W. Lee/The New York Times On a recent morning, for example, scientists at the University of Pittsburgh discovered that a ferret exposed to Covid-19 particles had developed a high fever — a potential advance toward animal vaccine testing.', 0.5047896), ('Researchers will be intensely studying this question as the vaccines roll out.', 0.4489718)]"
669,Prior infection by seasonal coronaviruses does not prevent SARS-CoV-2 infection and associated Multisystem Inflammatory Syndrome in children,not,prior infection by seasonal coronaviruses does _ prevent sars-cov-2 infection and associated multisystem inflammatory syndrome in children,prior infection by seasonal coronaviruses does also prevent sars-cov-2 infection and associated multisystem inflammatory syndrome in children,https://www.medrxiv.org/content/10.1101/2020.06.29.20142596v1,"[('We tested if prior infections with seasonal coronaviruses impacted SARS-CoV-2 infections and related Multisystem Inflammatory Syndrome (MIS).', 0.739908), ('Interpretation Prior infection with HCoVs does not prevent SARS-CoV-2 infection and related MIS in children.', 0.7340321), ('The level of anti-SARS-CoV-2 antibodies was not significantly different in children who had prior seasonal coronavirus infection.', 0.680798), ('COVID-19 and MIS attack rates, and anti-SARS-CoV-2 antibodies titres were not significantly impacted by prior seasonal coronavirus infection.', 0.671504), ('Evidence before this study Children seem to be less likely affected by SARS-CoV-2 infection and clinical course of COVID-19 is less severe than in adults.', 0.61758155)]"
670,FDA authorizes 15-minute coronavirus test,minute,fda authorizes 15-_ coronavirus test,fda authorizes 15-year coronavirus test,https://www.cnn.com/world/live-news/coronavirus-outbreak-03-27-20-intl-hnk/h_2e02561c478f5a183cb25568a66722b5,"[('Tags FDA Coronavirus COVID-19 cases Pandemic testing Test Food and Drug Administration View the discussion thread.', 0.52908146), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.44390544), ('The U.S. is now adding more than 14,000 new cases per day.', 0.40789592), ('ADVERTISEMENT It marks one of the fastest tests for COVID-19 available and comes just a week after the FDA approved another 45-minute rapid point-of-care test.', 0.35960352), ('The approval comes as cities across the nation scramble to get testing done and prevent the spread of the coronavirus.', 0.3471209)]"
671,Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi—challenges in acquiring herd immunity for COVID 19,challenges,seroprevalence of anti-sars-cov-2 antibodies in residents of karachi—_ in acquiring herd immunity for covid 19,seroprevalence of anti-sars-cov-2 antibodies in residents of karachi— help in acquiring herd immunity for covid 19,https://academic.oup.com/jpubhealth/advance-article/doi/10.1093/pubmed/fdaa170/5906459,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.40630054), ('Log in Create account Ray ID: 61352b6dd9672605 Client IP: 34.86.133.111 © ResearchGate GmbH.', 0.16223316), ('Sign in or create an account https://orcid.org https://plus.europepmc.org Europe PMC Menu About About Europe PMC Preprints in Europe PMC Funders Joining Europe PMC Governance Roadmap Outreach Tools Tools overview ORCID article claiming Journal list Grant finder External links service RSS feeds Annotations Annotations submission service Developers Developer resources Articles RESTful API Grants RESTful API API use cases SOAP web service Annotations API OAI service Bulk downloads Developers Forum Help Help using Europe PMC Search syntax reference Contact us Contact us Helpdesk Feedback Twitter Blog Tech blog Developer Forum Europe PMC plus ', 0.14196439), (""To avoid being denied access, log in if you're a ResearchGate member or create an account if you're not."", 0.12391011), ('Please stand by, while we are checking your browser... ', 0.11906739)]"
672,The White House should encourage stay-at-home orders until public health officials say otherwise .,encourage,the white house should _ stay-at-home orders until public health officials say otherwise .,the white house should not stay-at-home orders until public health officials say otherwise.,https://petitions.whitehouse.gov/petition/keep-united-states-lockdown-during-easter,"[('If you feel sick, stay home.', 0.55599916), (""And I guess what I expected when the President put out guidelines that said, “Don't go to bars."", 0.5510529), (""Q -- and if that, you know, decision should be left in the hands of governors or if you're considering telling the entire nation, “Stay at home.” THE PRESIDENT: Yeah."", 0.5500221), ('He told “CBS This Morning” that questions about the W.H.O.’s pandemic response should be left until “after we get through this.” The president’s decision came amid concerns about the W.H.O.’s approach to China.', 0.5471227), (""Every healthcare provider, every doctor and nurse and nurse’s assistant has the protective gear to provide the care that you would want your family to have by putting into practice the President's “30 Days to Slow the Spread.” I mean, we want you to take to heart the President's Coronavirus Guidelines for America, first, to protect your own health, to protect the health of your family, to protect the health of your community."", 0.54395556)]"
673,US COVID-19 deaths poorly predicted by IHME model,poorly,us covid-19 deaths _ predicted by ihme model,us covid-19 deaths as predicted by ihme model,https://www.sydney.edu.au/data-science/,"[('Published on pre-publication server arXiv, the researchers found that the IHME model substantially underestimates the uncertainty associated with COVID-19 deaths.', 0.7336936), ('“I am concerned that if the UW-IHME model has had difficulty in predicting the next day, how will the predictions fair over the long term,” said Professor Tanner.', 0.43107688), ('Seventy percent of US states had an actual death rate outside the 95 percent prediction interval for that state, casting doubt on whether the model is suitable to inform COVID-19 resource allocation.', 0.42443603), ('Credit: Pixabay An international group of renowned statisticians from the University of Sydney, Northwestern University and the University of Texas have collaborated to fully investigate the predictive performance of the COVID-19 model developed by Institute for Health Metrics and Evaluation (IHME) – which provides forecasts for ventilator use and hospital beds in the United States.', 0.40159565), ('“The level of uncertainty implied by the model casts doubt on its usefulness to drive the development of health, social, and economic policies,” she said.', 0.36660463)]"
677,"Japanese flu drug could be effective in treating coronavirus , report says",could,"japanese flu drug _ be effective in treating coronavirus , report says","japanese flu drug cannot be effective in treating coronavirus, report says",https://www.cnbc.com/2020/03/18/coronavirus-japanese-flu-drug-could-be-effective-in-treating-pandemic.html,"[('Patients treated with the drug, which was developed by a subsidiary of Fujifilm, in Shenzen were found to turn negative for COVID-19 after a median of four days, rather than 11 days for those who were not treated with favipiravir, NHK reported.', 0.5296751), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.3493154), (""--- News BC Tech News ▼ Local BC Tech News One Week View Subscribe to T-Net Direct International ▼ All Breaking International Tech News Tech Crunch Silicon Alley Insider VentureBeat CNET Member Tools ▼ Subscribe to T-Net Direct Submit News ▼ Post News Release on T-Net Submit Anonymous News Tip T-Net News Submission Guidelines Account Member Login Employer Login Sections News BC Tech News ▼ Local BC Tech News One Week View Subscribe to T-Net Direct International ▼ All Breaking International Tech News Tech Crunch Silicon Alley Insider VentureBeat CNET Member Tools ▼ Subscribe to T-Net Direct Submit News ▼ Post News Release on T-Net Submit Anonymous News Tip T-Net News Submission Guidelines Events All BC Tech Events Member Tools ▼ Event Alerts RSS Events Feed Submit Event Post Events ▼ Post Event on T-Net Purchase Featured Event Listing Advertise Event in T-Net Direct Newsletter Tech Careers Tech Careers Home Job Search ▼ Job Search Advanced Job Search Browse Jobs Research Companies Job Alerts / Saved Searches Hot Job of the Week TM Post Resume ▼ Post Resume Create Cover Letter Member Tools ▼ Member Home Job Alerts / Saved Searches Saved Job Listings Job Application History RSS Job Feeds Employers ▼ Employer Login Post New Job Directory Tech Directory Home Companies ▼ All BC Tech Companies Biotech/Life Sciences CleanTech and Energy Information & Communications New Media & Gaming Wireless Technologies Other Tech Sectors Browse Companies By Category Company Search Tech Companies That Are Hiring IT Employers (Non-Tech) Hiring Companies I'm Following Add Our Company Suppliers ▼ All Industry Suppliers (To Local Tech Industry) Browse Suppliers By Category Supplier Search Add Our Company Associations ▼ All BC Tech Associations BC Technology Industry Association (BCTIA) Add Our Association Add Profile ▼ Add Tech Company Profile Add Industry Supplier Profile Add Association Profile Become A Featured Company Become A Featured Supplier Advertise on T-Net Inclusion Criteria Tech Stocks T-Net 100 T-Net 100 Rankings ▼ BC's Top 100 Tech Companies (By "", 0.0074038147), ('[c.]: circa', -0.036274992), ('', -0.14422023)]"
678,The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15,blocks,the inhaled corticosteroid ciclesonide _ coronavirus rna replication by targeting viral nsp15,the inhaled corticosteroid ciclesonide support coronavirus rna replication by targeting viral nsp15,https://www.biorxiv.org/content/10.1101/2020.03.11.987016v1#disqus_thread,"[('Within this library, ciclesonide, an inhaled corticosteroid, suppressed human coronavirus replication in cultured cells, but did not suppress replication of respiratory syncytial virus or influenza virus.', 0.628991), ('These observations suggest that the effect of ciclesonide was specific to coronavirus, suggesting this is a candidate drug for treatment of patients suffering MERS or COVID-19.', 0.57370627), ('A recombinant virus with the mutation was also resistant to ciclesonide suppression of viral replication.', 0.505382), ('After the eleventh consecutive MERS-CoV passage in the presence of ciclesonide, a resistant mutation was generated, which resulted in an amino acid substitution (A25V) in nonstructural protein (NSP) 15, as identified using reverse genetics.', 0.4938187), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.47147435)]"
680,Global coronavirus death toll could be 60 % higher than reported,higher,global coronavirus death toll could be 60 % _ than reported,global coronavirus death toll could be 60 % less than reported,https://www.ft.com/content/6bd88b7d-3386-4543-b2e9-0d5c6fac846c,"[('This is especially worrying for many emerging economies, where total excess mortality is orders of magnitude higher than official coronavirus fatalities.', 0.5391681), ('This is an uptick of 155 per cent on the historical average and far higher than the 4,348 reported Covid deaths in the region.', 0.51967555), ('According to the FT analysis, overall deaths rose 60 per cent in Belgium, 51 per cent in Spain, 42 per cent in the Netherlands and 34 per cent in France during the pandemic compared with the same period in previous years.', 0.48359793), ('The figure was 76 per cent higher than the average for the same week in the past five years, and the number of excess deaths was 58 per cent higher than the total number of reported Covid-deaths for the same period.', 0.44666457), ('The extra deaths are most pronounced in urban areas with the worst virus outbreaks, and have completely overwhelmed reporting mechanisms in some.', 0.3776554)]"
685,"Leronlimab Used in Seven Patients in NYC with Severe COVID-19 Demonstrated Promise with Two Intubated Patients in ICU , Removed from ICU and Extubated with Reduced Pulmonary Inflammation",seven,"leronlimab used in _ patients in nyc with severe covid-19 demonstrated promise with two intubated patients in icu , removed from icu and extubated with reduced pulmonary inflammation","leronlimab used in two patients in nyc with severe covid-19 demonstrated promise with two intubated patients in icu, removed from icu and extubated with reduced pulmonary inflammation",https://www.cytodyn.com/newsroom/press-releases/detail/399/leronlimab-used-in-seven-patients-with-severe-covid-19,"[('A total of seven patients have been enrolled thus far under EIND in the same leading medical center in the New York City area.', 0.5794173), ('Our companion diagnostics showed that after three days of therapy, the immune profile in these patients approached normal levels and the levels of cytokines involved in the cytokine storm were much improved.” Jacob Lalezari, M.D., Interim Chief Medical Officer of CytoDyn, commented, “These preliminary results give hope that leronlimab may help hospitalized patients with COVID-19 recover from the pulmonary inflammation that drives mortality and the need for ventilators.', 0.5311093), ('Moreover, a Phase 2b clinical trial demonstrated that leronlimab monotherapy can prevent viral escape in HIV-infected patients; some patients on leronlimab monotherapy have remained virally suppressed for more than five years.', 0.52345675), ('Clinical results to date from multiple trials have shown that leronlimab can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs).', 0.5204332), ('The treatment with leronlimab is targeted as a therapy for patients who experience respiratory complications as a result of contracting SARS-CoV-2 causing the Coronavirus Disease 2019 (COVID-19).', 0.5076988)]"
686,Fruitful neutralizing antibody pipeline brings hope to defeat SARS-Cov-2,defeat,fruitful neutralizing antibody pipeline brings hope to _ sars-cov-2,fruitful neutralizing antibody pipeline brings hope to create sars-cov-2,https://www.cell.com/trends/pharmacological-sciences/fulltext/S0165-6147(20)30166-8,"[('We also highlight the importance of a fruitful antibody development pipeline to combat the potential escape plans of SARS-CoV-2, including somatic mutations and antibody-dependent enhancement (ADE).', 0.7681537), ('Outstanding Questions What is the best strategy to develop broadly neutralizing antibodies against conserved epitopes of SARS-CoV-2?', 0.72233), ('Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies.', 0.71999884), ('We discuss these neutralizing antibodies in COVID-19 and highlight how the robust antibody pipeline can help to combat the escape strategies presented by SARS-CoV-2.', 0.70031595), ('SARS-CoV-2 may develop resistance to neutralizing antibodies by accumulating spontaneous mutations.', 0.6956169)]"
687,Sherlock Biosciences Receives FDA Emergency Use Authorization for CRISPR SARS-CoV-2 Rapid Diagnostic,fda,sherlock biosciences receives _ emergency use authorization for crispr sars-cov-2 rapid diagnostic,sherlock biosciences receives no emergency use authorization for crispr sars-cov-2 rapid diagnostic,https://sherlock.bio/sherlock-biosciences-receives-fda-emergency-use-authorization-for-crispr-sars-cov-2-rapid-diagnostic/,"[('About Us Team Platforms INSPECTR SHERLOCK Products Sherlock™ CRISPR SARS-CoV-2 Kit News Join Our Team ', 0.7537265), ('Based on the SHERLOCK method, which stands for S pecific H igh-sensitivity E nzymatic R eporter un LOCK ing, the kit works by programming a CRISPR molecule to detect the presence of a specific genetic signature – in this case, the genetic signature for SARS-CoV-2 – in a nasal swab, nasopharyngeal swab, oropharyngeal swab or bronchoalveolar lavage (BAL) specimen.', 0.72278047), ('In addition to SHERLOCK, the company is also developing its INSPECTR™ platform to create an instrument-free, handheld test – similar to that of an at-home pregnancy test – that utilizes Sherlock Biosciences’ Synthetic Biology platform to provide rapid detection of a genetic match of the SARS-CoV-2 virus.', 0.7173064), ('Cambridge, Mass., May 7, 2020 – Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced the company has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Sherlock™ CRISPR SARS-CoV-2 kit for the detection of the virus that causes COVID-19, providing results in approximately one hour.', 0.7081392), ('“We are committed to providing this initial wave of testing kits to physicians, laboratory experts and researchers worldwide to enable them to assist frontline workers leading the charge against this pandemic.” The Sherlock™ CRISPR SARS-CoV-2 test kit is designed for use in laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C.', 0.694057)]"
688,COVID-19 mortality increases with northerly latitude after adjustment for age suggesting a link with ultraviolet and vitamin D,increases,covid-19 mortality _ with northerly latitude after adjustment for age suggesting a link with ultraviolet and vitamin d,covid-19 mortality decreased with northerly latitude after adjustment for age suggesting a link with ultraviolet and vitamin d,https://nutrition.bmj.com/content/3/1/118,"[('View this table: View inline View popup Table 1 Associations between COVID-19 mortality by country, latitude and % of population ≥65 years The proportion of older people in each country impacts greatly on COVID-19 mortality, but after adjustment for this, a strong association remains across the Northern hemisphere between latitude and higher COVID-19 mortality.', 0.61100954), ('This analysis supports the link between latitude and COVID-19 mortality reported within the USA by Dr Kohlmeier.1 Evidence linking vitamin D deficiency with COVID-19 severity is circumstantial but growing.', 0.59909034), ('If the association between vitamin D deficiency and COVID-19 severity is causative, the disease should prove seasonal, since more severely affected individuals are infectious for longer.', 0.59525067), ('Vitamin D and inflammation: potential implications for severity of COVID-19.', 0.58229065), ('There are exceptions, but COVID-19 mortality correlates with reported vitamin D levels across Europe,7 and in sunnier Brazil, where mortality is rising, 28% prevalence of vitamin D deficiency is reported.8 An association between vitamin D insufficiency and COVID-19 severity is supported by substantial evidence of its impact on cytokine response to pathogens.7 A direct effect of ultraviolet light on the environmental survival of severe acute respiratory syndrome coronavirus 2 is also possible but would not explain the association between mortality and ethnicity,9 whereas people with dark skin need more ultraviolet exposure for equivalent vitamin D synthesis.', 0.56996775)]"
691,COVID-19 and the NHS—a national scandal – The Lancet – 28 March 2020,march,covid-19 and the nhs—a national scandal – the lancet – 28 _ 2020,covid-19 and the nhs—a national scandal – the lancet – 28 January 2020,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30727-3/fulltext,"[('COVID-19 testing delays and pathology services in the UK.', 0.6028653), ('A view from UK public health registrars on the challenges of COVID-19.', 0.59054273), ('NHS response to vaginal mesh scandal will be reviewed.', 0.49676013), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.4614878), ('Call for Action to Address Equity and Justice Divide During COVID-19.', 0.45098627)]"
692,Widely Available Lysosome Targeting Agents Should Be Considered as a Potential Therapy for COVID-19,should,widely available lysosome targeting agents _ be considered as a potential therapy for covid-19,widely available lysosome targeting agents cannot be considered as a potential therapy for covid-19,https://www.preprints.org/manuscript/202003.0345/v2,"[('These drugs still might show endolysosomal pH-mediated antiviral effects, and should therefore be mentioned in context of potential treatment for COVID-19.', 0.7499744), ('Morover, we extended the section on potential effects of macrolies in COVID-19 and added a comment on their inhalatory formulations that could be considered as a treatment option in the future.', 0.70975816), ('Here, we took a different approach based on the proposed pharmacodynamic model of CQ in COVID-19.', 0.61173856), ('The main mechanism of action responsible for the favourable outcome of COVID-19 patients treated with CQ seems to be related to pH modulation- mediated effect on the endolysosomal trafficking, a characteristic of chemical compounds often called lysosomotropic agents because of the physico-chemical properties that enable them to passively diffuse through the endosomal membrane and undergo protonation-based trapping in the lumen of the acidic vesicles.', 0.6044971), ('As some of these drugs, mostly antibiotics, were already empirically used in the treatment of COVID-19, we encourage our colleagues all over the world to publish patient data so potential efficacy of these agents can be evaluated in the clinical context and rapidly implemented in the therapeutic protocols if the beneficial effect on clinical outcome is observed.', 0.5387409)]"
693,Autopsies Show Varied Forms of Heart Damage in COVID-19 Patients,varied,autopsies show _ forms of heart damage in covid-19 patients,autopsies show common forms of heart damage in covid-19 patients,https://www.the-scientist.com/news-opinion/autopsies-show-varied-forms-of-heart-damage-in-covid-19-patients-67969,"[('The findings need to be replicated in larger groups of patients but could help doctors determine the best course of treatment for heart damage due to COVID-19, Stone says.', 0.6360905), (""Researchers had found, for example, that 8-12 percent of hospitalized COVID-19 patients had elevated levels of muscle contraction-regulating proteins called troponins--a sign of heart damage--and that these patients had an increased risk of mortality compared with those who didn't have excess troponins."", 0.6186682), (""Early in the pandemic, other clinicians noted that even some patients who didn't have preexisting heart conditions experienced cardiovascular damage while fighting COVID-19 infections, pointing to a possible causative link."", 0.584973), (""The pathologists observed a median of 20 slides from each heart, which is more than are included in most other studies regarding COVID-19's cardiac effects."", 0.57906), (""But Stone says he was surprised to see just how common these were--18 out of 21 COVID-19 patients' hearts harbored macrophages that exhibited this type of inflammation."", 0.56701463)]"
694,SARS-CoV-2 Viral Load Predicts COVID-19 Mortality,predict,sars-cov-2 viral load _ covid-19 mortality,sars-cov-2 viral load cannots covid-19 mortality,https://www.medrxiv.org/content/10.1101/2020.06.11.20128934v1,"[('2019; 32: e00097-e00118 Crossref PubMed Scopus (10) Google Scholar Viral load in COVID-19 might correlate with infectivity, disease phenotype, morbidity, and mortality.', 0.72821665), ('Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients.', 0.5627501), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.52441365), ('2 Pan Y Zhang D Yang P Poon LLM Wang Q Viral load of SARS-CoV-2 in clinical samples.', 0.50901306), ('Viral loads for symptomatic, hospitalised patients who tested positive for SARS-CoV-2 were measured on samples collected between March 13 and May 4, 2020, that tested positive on both platforms at diagnosis.', 0.49367535)]"
696,Sunlight ultraviolet radiation dose is negatively correlated with the percent positive of SARS-CoV-2 and four other common human coronaviruses in the U.S .,negatively,sunlight ultraviolet radiation dose is _ correlated with the percent positive of sars-cov-2 and four other common human coronaviruses in the u.s .,sunlight ultraviolet radiation dose is positively correlated with the percent positive of sars-cov-2 and four other common human coronaviruses in the u.s.,https://www.sciencedirect.com/science/article/pii/S0048969720353456?via%3Dihub,"[('In this study, Spearman and Kendall rank correlation analysis tests were used to analyze the correlation between the average percent positive of five human coronaviruses (SARS-CoV-2, CoVHKU1, CoVNL63, CoVOC43, and CoV229E) in the U.S. and the corresponding sunlight UV radiation dose The results indicated that the monthly average percent positive of four common coronaviruses was significantly negatively correlated with the sunlight UV radiation dose.', 0.74592716), ('Additionally, sunlight UV radiation also showed some negative effects with respect to the early SARS-CoV-2 transmission.', 0.6865829), ('UVC can inactivate coronaviruses, including severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).', 0.6635173), ('The weekly percent positive of SARS-CoV-2 during April 17, 2020 to July 10, 2020 showed a significant negative correlation with the sunlight UV radiation dose in census regions 1 and 2 of the U.S. while no statistical significance in the other regions.', 0.6317028), ('Subject(s) Coronavirus Infections , Coronavirus , Pandemics , Pneumonia, Viral , Ultraviolet Rays , Betacoronavirus , Humans , Sunlight Fulltext Print XML PubMed Links ', 0.5781563)]"
697,NEW LOOK AT COVID-19 CASES DOES NOT SUPPORT LINK BETWEEN BCG VACCINATION AND LOWER MORTALITY,not,new look at covid-19 cases does _ support link between bcg vaccination and lower mortality,new look at covid-19 cases does indeed support link between bcg vaccination and lower mortality,https://www.lji.org/news-events/news/post/new-look-at-covid-19-cases-does-not-support-link-between-bcg-vaccination-and-lower-mortality/,"[('Researchers continue to track COVID-19 cases in relation to BCG vaccination rates, and the LJI researchers hope ongoing randomized controlled trials will provide answers to whether bacillus Calmette–Guérin reduces the incidence and severity of COVID-19.', 0.6163557), ('“Ongoing clinical trials with the appropriate controls will provide a more conclusive answer.” The Letter, ""Lack of evidence for BCG vaccine protection from severe COVID-19,"" includes co-authors Cecilia S. Lindestam Arlehamn and Alessandro Sette.', 0.60219556), ('""Our attention was drawn to repeated claims in the lay media that there is a connection between BCG vaccination rates and COVID-19 occurrence or mortality,"" says Peters.', 0.553269), ('In a new Letter, published Sept. 29 in PNAS , researchers at La Jolla Institute for Immunology (LJI) re-examine the correlation between BCG vaccination and COVID-19 case severity.', 0.5083271), ('The new analysis underscores the importance of following COVID-19 safety guidelines, rather than relying on past vaccines or immune memory to stay healthy.', 0.5058749)]"
700,Avoidance of vitamin D deficiency to slow the COVID-19 pandemic,slow,avoidance of vitamin d deficiency to _ the covid-19 pandemic,avoidance of vitamin d deficiency to promote the covid-19 pandemic,https://nutrition.bmj.com/content/early/2020/05/20/bmjnph-2020-000096,"[('It is conceivable that vitamin D adequacy denies the virus easy footholds and thereby slows spreading of the contagion.', 0.68251824), ('In the case of the current COVID-19 pandemic, vitamin D deficiency may provide the virus with an unguarded opening to spread from deficient to deficient individual when there are just too many of them.', 0.6395353), ('Slowing the spread of COVID-19 would be an added bonus.', 0.6212076), ('Editorial: low population mortality from COVID-19 in countries South of latitude 35 degrees North supports vitamin D as a factor determining severity.', 0.60872364), ('This has been thought to decrease the amount of the 7-dehydrocholesterol precursor available for conversion to vitamin D and 25(OH)D level declines accordingly in advanced age.', 0.60525936)]"
701,"BAME , African Americans , the Older , Institutionalised and Obese , are at greatest risk .",greatest,"bame , african americans , the older , institutionalised and obese , are at _ risk .","bame, african americans, the older, institutionalised and obese, are at low risk.",https://www.bmj.com/content/369/bmj.m1548/rr-6,"[('Deficiency is variable, but widespread globally.', 0.4619282), ('BAME people in high latitudes are a group at high risk of deficiency, as observed by NICE[38] and others (Rhein).', 0.45758668), ('Albeit vitamin D deficiency most likely accounts for a greater COVID-19 impact on BAME, older, institutionalised and obese persons, COVID-19 severity would undoubtedly be exacerbated by, often socioeconomic related, general micro- nutrient inadequacies.', 0.41995472), ('[37] Whilst clinical studies have potential, vitamin D deficiency is an existing, ubiquitous and pressing issue.', 0.37584278), ('Vaccines present enormous possibilities, but equally-large hurdles, and require time.', 0.37064087)]"
702,SARS-CoV-2 Can Infect Human Brain Organoids,can,sars-cov-2 _ infect human brain organoids,sars-cov-2 cannot infect human brain organoids,https://www.the-scientist.com/news-opinion/sars-cov-2-can-infect-human-brain-organoids-67723,"[(""A BrainSphere organoid infected with SARS-CoV-2, showing the spike protein in green and neuron nuclei in blue Lena Smirnova, Johns Hopkins University If infection of the brain can feasibly occur in some people, it's certainly not common, Nath stresses."", 0.6059997), (""In addition, neural organoids lack the blood-brain barrier that would normally confer some degree of protection against most viruses, although Iwasaki notes it's possible that SARS-CoV-2 could circumvent this barrier by entering the brain through the olfactory system, something that's been shown in mice infected with common cold-causing coronaviruses."", 0.5508135), ('Smirnova and Iwasaki, however, note several reports suggesting some ACE2 protein in certain patches of the human brain, as well as evidence of coronavirus genetic material inside brain neurons of patients who died during the SARS epidemic in China in the early 2000s, indicating that the original SARS virus could infect brain cells.', 0.5337941), ('E. Song et al., ""Neuroinvasive potential of SARS-CoV-2 revealed in a human brain organoid model,"" bioRxiv , doi: 10.1101/2020.06.25.169946, 2020.', 0.5321286), ('When the tissue was exposed to SARS-CoV-2, the virus readily infected increasing numbers of cells over the course of four days, suggesting that the coronavirus can use the machinery of neurons to generate more copies of itself.', 0.5188995)]"
703,"SARS-CoV-2 detected in waste waters in Barcelona on March 12 , 2019",march,"sars-cov-2 detected in waste waters in barcelona on _ 12 , 2019","sars-cov-2 detected in waste waters in barcelona on Jan 12, 2019",https://www.ub.edu/web/ub/en/menu_eines/noticies/2020/06/042.html?,"[('Researchers detected the presence of the virus that caused the disease in samples of waste water in Barcelona, collected in March 12, 2019.', 0.740923), ('Last, this group also takes part in a monitoring project on the presence of SARS-CoV-2 in waste waters in the entrance of Catalan treatment plants, funded by the Catalan Water Agency and coordinated by the Catalan Institute for Water Research (ICRA).', 0.53041893), ('Models in the SARS-CoV-2 epidemiological surveillance The Group on Enteric Viruses is also in charge of the scientific coordination of a project on the SARS-CoV-2 sentinel surveillance in waste waters in Spain, funded by the Spanish Ministry for Ecological Transition and Demographic Challenge.', 0.5134506), ('As part of the sentinel surveillance project, and after April 13, the researchers analysed weekly the obtained samples in two big water treatment plants in Barcelona.', 0.46501732), ('An early detection tool Altohugh COVID-19 is a respiratory disease, researchers proved there are large quantities of the coronavirus genome in the excrements that reach waste waters.', 0.40975392)]"
704,Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro,enhanced,_ sars-cov-2 neutralization by secretory iga in vitro, inhibit sars-cov-2 neutralization by secretory iga in vitro,https://www.biorxiv.org/content/10.1101/2020.09.09.288555v1,"[('Thus, secretory IgA responses may be particularly valuable for protection against SARS-CoV-2 and for vaccine efficacy.', 0.61245424), ('Here we characterize the IgA response to SARS-CoV-2 in a cohort of 149 individuals.', 0.50322235), ('IgA responses in plasma generally correlate with IgG responses and clones of IgM, IgG and IgA producing B cells that are derived from common progenitors are evident.', 0.48628914), ('Plasma IgA monomers are 2-fold less potent than IgG equivalents.', 0.41971785), ('Although potent IgG antibodies can neutralize the virus, less is known about secretory antibodies such as IgA that might impact the initial viral spread and transmissibility from the mucosa.', 0.4104678)]"
705,Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor,not,interferons and viruses induce a novel truncated ace2 isoform and _ the full-length sars-cov-2 receptor,interferons and viruses induce a novel truncated ace2 isoform and produce the full-length sars-cov-2 receptor,https://www.nature.com/articles/s41588-020-00731-9,"[('Our discovery of dACE2 , a truncated version of ACE2 , demonstrates that it is dACE2 and not ACE2 that is induced by IFNs and viruses, including SARS-CoV-2.', 0.8089018), ('Although dACE2 expression was induced by IFNs and viruses in various human cell lines, dACE2 was not detected in these cell lines by western blotting with a C-terminal ACE2 antibody.', 0.74156857), ('We then showed that dACE2 , but not ACE2 , is induced in various human cell types by IFNs and viruses; this information is important to consider for future therapeutic strategies and understanding COVID-19 susceptibility and outcomes.', 0.7320616), ('Full size image It was reported that, in contrast to ACE2 expression in human cells, Ace2 was not induced in primary mouse tracheal basal cells in response to in vitro and in vivo IFN stimulation, and on in vivo viral infection4.', 0.7231049), ('By analyses in multiple human cell types and tissues, we showed that expression of dACE2 , but not ACE2 , is inducible by IFNs (type I, II and III) and viruses that induce IFN responses.', 0.71247804)]"
707,Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis,with,metformin treatment was associated _ decreased mortality in covid-19 patients _ diabetes in a retrospective analysis,metformin treatment was associated with elevated mortality in covid-19 patients with diabetes in a retrospective analysis,https://www.ajtmh.org/content/journals/10.4269/ajtmh.20-0375,"[('In this study, we compared the outcome of metformin users and nonusers in hospitalized COVID-19 patients with diabetes.', 0.7649256), ('Antidiabetic treatment with metformin was associated with decreased mortality compared with diabetics not receiving metformin.', 0.7055626), ('The Effect of Metformin Consumption on Mortality in Hospitalized COVID-19 patients: a systematic review and meta-analysis.', 0.68425596), ('Does glycemic control rescue type 2 diabetes patients from COVID-19-related deaths?', 0.5974349), ('This retrospective analysis suggests that metformin may offer benefits in patients with COVID-19 and that further study is indicated.', 0.5923507)]"
708,Map Suggests TB Vaccine may help prevent Covid-19,may,map suggests tb vaccine _ help prevent covid-19,map suggests tb vaccine cannot help prevent covid-19,https://asiatimes.com/2020/04/map-suggests-tb-vaccine-may-help-prevent-covid-19/,"[('Bacillus Calmette-Guérin vaccine is a vaccine primarily used against tuberculosis.', 0.60263747), ('Tagged: Coronavirus, TB vaccine, tuberculosis, vaccines ', 0.5811573), ('Although tuberculosis is a bacterial disease, there are indications that BCG may help the immune system fight off viral infections as well.', 0.5794477), ('A theory has emerged that administering or not administering BCG – a century- old tuberculosis vaccine usually given to newborns – may help explain some of the wildly differing infection and death counts among countries.', 0.57036316), ('And if the hopeful theory pans out it may help put to rest the anti-vaccination movement that has taken hold in the United States and elsewhere.', 0.53104204)]"
709,Clinical trials of monoclonal antibodies to prevent COVID-19 now enrolling,prevent,clinical trials of monoclonal antibodies to _ covid-19 now enrolling,clinical trials of monoclonal antibodies to induce covid-19 now enrolling,https://www.nih.gov/news-events/news-releases/clinical-trials-monoclonal-antibodies-prevent-covid-19-now-enrolling,"[('Monoclonal antibodies may provide short-term protection from SARS-CoV-2 and could serve as important components of the COVID-19 pandemic response until vaccines become available.', 0.72571754), ('“This network will allow us to test the safety and efficacy of monoclonal antibodies and other preventive measures to help identify how best to reduce the level of SARS-CoV-2 infection and ultimately end the COVID-19 pandemic.” Monoclonal antibodies are laboratory-made versions of proteins naturally produced by the immune system in response to invading viruses or other pathogens.', 0.68927175), ('Neutralizing antibodies, whether natural or monoclonal, can bind directly to portions of viruses that they use to attach to and enter cells, preventing them from initiating the infection cycle.', 0.63854074), ('Clinical investigators, hospitals or clinical sites interested in participating in one of Lilly’s clinical trials for a potential COVID-19 treatment, should call 1-877-CT-LILLY (1-877-285-4559) or email covid19potentialsite@lilly.com.', 0.60885715), ('Many of the trial sites and study investigators are part of the COVID-19 Prevention Network (CoVPN), recently established by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health.', 0.5484867)]"
710,Adverse events were more common in those receiving the drug .,more,adverse events were _ common in those receiving the drug .,adverse events were less common in those receiving the drug.,https://www.sciencedaily.com/releases/2020/05/200515174441.htm,"[('Adverse events led to higher rates of early treatment discontinuation among patients who received nafcillin.', 0.59286225), ('Nafcillin treatment is associated with higher rates of adverse events and treatment discontinuation than oxacillin among hospitalized adult patients.', 0.5864427), ('Some drugs may be contraindicated.', 0.5749072), ('Finally, we demonstrated that patients who received nafcillin were more likely to discontinue therapy due to adverse events than were patients who received oxacillin.', 0.5604063), ('The most common adverse effects are rash and nausea.', 0.5543459)]"
712,The possible beneficial adjuvant effect of influenza vaccine to minimize the severity of COVID-19,minimize,the possible beneficial adjuvant effect of influenza vaccine to _ the severity of covid-19,the possible beneficial adjuvant effect of influenza vaccine to enhance the severity of covid-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194943/,"[('Given the safety of Flu vaccine in adult, we recommend the use of Flu vaccine, at least in part, as a bystander adjuvant to minimize the severity of COVID-19 disease.', 0.83482826), ('It might be possible also that individuals who received prior Flu vaccination might show mild severity of COVID-19 because of Flu-induced bystander effect of the generated immune responses which itself might cross react against SARS-CoV-2.', 0.7731467), ('Due to this cross reactivity between Flu and SARS- CoV-2, we suggest that the Flu-induced bystander immunity is more of beneficial effects to COVID-19 than those suggested by MMR and BCG vaccines [9], [10].', 0.7242509), ('Routine childhood immunization may protect against COVID-19.', 0.70300925), ('These findings are similar to what the same group have reported before in patients with influenza infection [2], [3], Accordingly, we suggest a link between the quality of the immunity and recovery from COVID-19, at least in part, in patients with mild symptoms.', 0.65123826)]"
713,Surprising Correlation Found in Covid-19 Data,surprising,_ correlation found in covid-19 data,No correlation found in covid-19 data,https://www.datasciencecentral.com/profiles/blogs/surprising-correlation-found-in-covid-19-data,"[('Comment by Stephan Mathys on August 19, 2020 at 9:24am This is a good analysis.', 0.49710107), ('Comment by Vincent Granville on August 19, 2020 at 10:41am Here are some more interesting findings.', 0.45263606), ('August 19, 2020, CNN: ""Georgia, Texas and Florida lead the country in coronavirus cases per capita"" https://www.cnn.com/2020/08/19/health/us-coronavirus-wednesday/inde...', 0.41635972), ('Comment by Brian Richmond on August 19, 2020 at 2:57pm have you tried % population wearing masks and social distancing?', 0.39774388), ('Comment by Brian Richmond on August 19, 2020 at 2:56pm hmmm - the article concludes ""states that are getting closer to winning the war: Florida, Georgia, Texas.""', 0.39739546)]"
714,Susceptible supply limits the role of climate in the early SARS-CoV-2 pandemic,limits,susceptible supply _ the role of climate in the early sars-cov-2 pandemic,susceptible supply supports the role of climate in the early sars-cov-2 pandemic,https://science.sciencemag.org/content/early/2020/05/15/science.abc2535,"[('Furthermore, the relative importance of climate drivers when compared with high population susceptibility during the pandemic stage of an emerging infection such as SARS-CoV-2 has not been fully characterized.', 0.74984574), ('A preliminary analysis of nonpharmaceutical control measures indicates that they may moderate the pandemic-climate interaction through susceptible depletion.', 0.5941995), ('In terms of the SARS-CoV-2 pandemic, our results imply that both tropical and temperate locations should prepare for severe outbreaks of the disease and that summertime temperatures will not effectively limit the spread of the infection.', 0.5931317), ('In this scenario, as susceptibility declines, the climate plays a more substantial role in determining pandemic peak size (Fig.', 0.58930516), ('( A ) Colored lines represent different hypotheses for the relationship between climate and transmission for SARS-CoV-2.', 0.5720416)]"
716,One-step test provides rapid and sensitive COVID-19 detection,one,_-step test provides rapid and sensitive covid-19 detection,Five-step test provides rapid and sensitive covid-19 detection,https://mcgovern.mit.edu/2020/05/05/sherlock-based-one-step-test-provides-rapid-and-sensitive-covid-19-detection/,"[('As a result, the STOPCovid test allows for rapid, accurate, and highly sensitive detection of Covid-19 that can be conducted outside clinical laboratory settings.', 0.7344048), ('“This helps address the urgent need for widespread, accurate, inexpensive, and accessible Covid-19 testing.” Full story via Stat → ', 0.6922051), ('In research, it has been shown to enable rapid, accurate, and highly sensitive detection of the Covid-19 virus SARS-CoV-2, with a simple protocol that requires minimal training and uses simple, readily available equipment, such as test tubes and water baths.', 0.6619468), ('There is an urgent need for widespread, accurate COVID-19 testing to rapidly detect new cases, ideally without the need for specialized lab equipment.', 0.6481314), ('STOPCovid has been validated in research settings using nasopharyngeal swabs from patients diagnosed with Covid-19.', 0.5668857)]"
718,NYS/NYC antibody study updates,nyc,nys/_ antibody study updates,nys/B antibody study updates,https://www.governor.ny.gov/news/amid-ongoing-covid-19-pandemic-governor-cuomo-announces-statewide-antibody-testing-survey-will,"[('Antibody testing would be used, Mr. Cuomo said, for identifying coronavirus survivors who can donate convalescent plasma — the part of the blood that contains antibodies.', 0.58110833), ('VIDEO0:0100:01 This company working on a Covid-19 treatment involving SARS antibodies Closing Bell Related Tags Andrew Cuomo Health care industry Politics U.S. Economy Biotech and Pharmaceuticals Subscribe to CNBC PRO Licensing & Reprints CNBC Councils Supply Chain Values CNBC on Peacock Advertise With Us Join the CNBC Panel Digital Products News Releases Closed Captioning Corrections About CNBC Internships Site Map Ad Choices Careers Help Contact ', 0.53116363), ('Antibody test/serology test: A test that detects antibodies specific to the coronavirus.', 0.51895726), ('Doctors at the Mount Sinai Health System in New York and elsewhere have been testing this use of plasma for treating patients with the virus.', 0.50490296), ('VIDEO6:3106:31 Governor Cuomo: Almost 14% of New York residents had the coronavirus Coronavirus An estimated 13.9% of the New Yorkers have likely had Covid-19, according to preliminary results of coronavirus antibody testing released by Gov.', 0.4629585)]"
721,Saliva-Based Antigen Testing Is Better Than The PCR Swab,better,saliva-based antigen testing is _ than the pcr swab,saliva-based antigen testing is lower than the pcr swab,https://www.healthaffairs.org/do/10.1377/hblog20200909.430047/full/,"[('Fortunately, other attributes of saliva-based antigen testing make this feasible: unlike PCR, it doesn’t require trained personnel, specific chemical supplies, or centralized, expensive laboratory instrument; it is less vulnerable to the supply chain bottlenecks that plague PCR-based labs; it returns results in a matter of hours; it costs as little as $1 per test; and it could be as convenient as sucking on a piece of paper.', 0.7773006), ('The rapid, saliva-based antigen test has gotten a bad rap.', 0.707224), ('By contrast, the rapid saliva-based antigen test with the 30 percent false negative rate does a poor job of diagnosing infection, but it is likely the better tool for judging infectiousness.', 0.6951214), ('And, just as importantly, antigen-based testing is highly specific: unlike its PCR counterpart, the antigen test isn’t fooled by faint signals of lingering viral matter outside the period of infectiousness.', 0.62528), ('Rapid, saliva-based antigen testing is an essential weapon in the fight to resume many of the activities and reopen many of the venues that comprise what we used to call “normal life.” It is practical, convenient, cost-effective, and easily scaled.', 0.55498695)]"
722,Estimated SARS-CoV-2 Seroprevalence in the US,sar,estimated _-cov-2 seroprevalence in the us,estimated PCVs-cov-2 seroprevalence in the us,https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.7976,"[('SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis.', 0.7320871), ('Exposures: Infection with SARS-CoV-2.', 0.6836082), ('PMID: 32692365 Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.', 0.5300814), ('Seroprevalence of anti-SARS-CoV-2 IgG Antibodies in the Staff of a Public School System in the Midwestern United States.', 0.4745334), ('Community prevalence of SARS-CoV-2 among patients with influenzalike illnesses presenting to a Los Angeles medical center in March 2020.', 0.44185293)]"
723,SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild Illness,short,sars-cov-2 antibody responses correlate with resolution of rnaemia but are _-lived in patients with mild illness,sars-cov-2 antibody responses correlate with resolution of rnaemia but are long-lived in patients with mild illness,https://www.medrxiv.org/content/10.1101/2020.08.15.20175794v1,"[(""Outpatient and asymptomatic individuals' serological responses to SARS-CoV-2 decreased within 2 months, suggesting that humoral protection may be short-lived."", 0.59452444), ('The development of plasma antibodies was correlated with decreases in viral RNAemia, consistent with potential humoral immune clearance of virus.', 0.5827559), ('Severely ill patients developed significantly higher SARS-CoV-2-specific antibody responses than outpatients and asymptomatic individuals.', 0.5608094), ('Cross-reactive antibodies recognizing SARS-CoV RBD were found almost exclusively in hospitalized patients.', 0.53132564), ('Using a novel competition ELISA, we detected antibodies blocking RBD-ACE2 interactions in 68% of inpatients and 40% of outpatients tested.', 0.40568012)]"
724,Serological surveys in Reunion Island of the first hospitalized patients revealed that long-lived immunoglobulin G antibodies specific against SARS-CoV2 virus are rapidly vanishing in severe cases,vanishing,serological surveys in reunion island of the first hospitalized patients revealed that long-lived immunoglobulin g antibodies specific against sars-cov2 virus are rapidly _ in severe cases,serological surveys in reunion island of the first hospitalized patients revealed that long-lived immunoglobulin g antibodies specific against sars-cov2 virus are rapidly circulating in severe cases,https://www.medrxiv.org/content/10.1101/2020.05.25.20112623v1,"[('While the IgM and, unexpectedly, the IgG responses were readily detected early during the course of the disease (5-7 days post-first symptoms), our results (n=3-5 and over the full dilution set of the plasma 1/200 to 1/12800) demonstrated a significant decrease (over 2.5-fold) of IgG levels in severe (ICU) hospitalized patients (exemplified in patient 1) by WB and ELISA.', 0.5162498), ('In contrast, mild non-ICU patients had a steady and yet robust rise in their specific IgG levels against the virus.', 0.4486984), ('In conclusion, serological testing may be helpful for the diagnosis of patients with negative RT-PCR results and for the identification of asymptomatic cases.', 0.4231779), ('Serological surveys were thoroughly performed over 2 month period by assessing IgG and IgM responses by immunofluorescence, immunoblot, Western blot and conventional ELISA using clinical RUN isolates of SARS-CoV-2 immobilized on 96 well plates.', 0.40212595), ('Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search ', 0.36022627)]"
725,Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial,reduces,baricitinib in combination with remdesivir _ time to recovery in hospitalized patients with covid-19 in niaid-sponsored actt-2 trial,baricitinib in combination with remdesivir increased time to recovery in hospitalized patients with covid-19 in niaid-sponsored actt-2 trial,https://investor.lilly.com/news-releases/news-release-details/baricitinib-combination-remdesivir-reduces-time-recovery,"[('Baricitinib in combination with remdesivir met the primary endpoint of reduction of time to recovery in comparison with remdesivir.', 0.6979948), ('Study investigators noted an approximately one-day reduction in median recovery time for the overall patient population treated with baricitinib in combination with remdesivir versus those treated with remdesivir.', 0.6902025), ('ACTT-2 included more than 1,000 patients and began on May 8 to assess the efficacy and safety of a 4-mg dose of baricitinib plus remdesivir versus remdesivir in hospitalized patients with COVID-19.', 0.57881105), ('Based on the ACTT-2 data, Lilly plans to discuss the potential for emergency use authorization (EUA) with the U.S. Food and Drug Administration (FDA) and to explore similar measures with other regulatory agencies, including Health Canada, for baricitinib as a treatment of hospitalized patients with COVID-19.', 0.49367842), ('About OLUMIANT ® In Canada, OLUMIANT (baricitinib), in combination with methotrexate (MTX), is indicated for reducing the signs and symptoms of moderate- to severe rheumatoid arthritis (RA) in adult patients who have responded inadequately to one or more disease-modifying anti-rheumatic drugs (DMARDs).', 0.45881516)]"
727,Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2,austria,genomic epidemiology of superspreading events in _ reveals mutational dynamics and transmission properties of sars-cov-2,genomic epidemiology of superspreading events in Korea reveals mutational dynamics and transmission properties of sars-cov-2,https://stm.sciencemag.org/content/12/573/eabe2555.full,"[('Phylogenetic clusters were identified on the basis of characteristic mutation profiles in viral genome sequences of SARS-CoV-2–positive cases in Austria.', 0.8327781), ('1 Phylogenetic-epidemiological reconstruction of SARS-CoV-2 infection clusters in Austria.', 0.82153773), ('In this study, we reconstructed major SARS-CoV-2 infection clusters in Austria and analyzed their role in international virus spread by combining phylogenetic and epidemiological analyses.', 0.8022407), ('( B ) Connection of Austrian strains to global clades of SARS-CoV-2.', 0.76866555), ('Here, we provide a national-scale analysis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) superspreading during the first wave of infections in Austria, a country that played a major role in initial virus transmissions in Europe.', 0.76052713)]"
729,"In fatal COVID-19 , the immune response can control the virus but kill the patient",can,"in fatal covid-19 , the immune response _ control the virus but kill the patient","in fatal covid-19, the immune response cannot control the virus but kill the patient",https://www.pnas.org/content/early/2020/11/10/2021128117,"[('Thus, the immune response during severe COVID-19 pneumonia may progress from inhibition of viral replication … ↵2To whom correspondence may be addressed.', 0.64873606), ('M. Wu et al ., Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.', 0.6237406), ('These findings indicate that the pathogenesis of late severe COVID-19 pneumonia involves a dysregulated immune response, rather than direct viral damage.', 0.58507967), ('E. J. Giamarellos-Bourboulis et al ., Complex immune dysregulation in COVID-19 patients with severe respiratory failure.', 0.5825528), ('(6) provide important insights into the inflammatory pathways that lead to severe COVID-19 pneumonia.', 0.5409431)]"
730,Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men,130,results from a randomized double blind placebo controlled interventional trial in _ sars-cov-2 positive men,results from a randomized double blind placebo controlled interventional trial in one sars-cov-2 positive men,https://www.medrxiv.org/content/10.1101/2020.11.16.20232512v1.full,"[('Results A total of 130 SARS-CoV-2 positive men were included in the study, 64 subjects in the dutasteride arm and 66 subjects in the placebo- controlled group.', 0.80622685), ('Methods A double-blinded, randomized, prospective, investigational study of dutasteride for the treatment of COVID-19 (NCT04446429).', 0.47360626), ('Subjects confirmed positive for SARS-CoV-2 were treated in an outpatient setting.', 0.44243053), ('The differences in the average remission times for fatigue and anosmia or ageusia was statistically different between the groups (5.8 versus 10.1 days for fatigue and 7.3 versus 13.4 days for anosmia or ageusia, in dutasteride and placebo groups, respectively), however, the total remission time was significantly reduced for the men given dutasteride; 9.0 days versus 15.6 days in the placebo group (p < 0.001).', 0.38769162), ('Additionally, men using 5ARis had drastically reduced frequency of symptoms compared to men not using 5ARis in an outpatient setting.', 0.37452126)]"
733,High SARS-CoV-2 viral load is associated with a worse clinical outcome of COVID-19 disease,worse,high sars-cov-2 viral load is associated with a _ clinical outcome of covid-19 disease,high sars-cov-2 viral load is associated with a better clinical outcome of covid-19 disease,https://www.medrxiv.org/content/10.1101/2020.11.13.20229666v1,"[('Here we report a statistically significant correlation between viral load and disease severity, being high viral load associated with worse clinical prognosis, independently of several previously identified risk factors such as age, sex, hypertension, cardiovascular disease, diabetes, obesity, and lung disease (asthma and chronic obstructive pulmonary disease).', 0.4512923), ('The data presented here reinforce the viral load as a potential biomarker for predicting disease severity in SARS-CoV-2-infected patients.', 0.43242913), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.3934483), ('To perform this, we have clinically classified patients as mild, moderate and severe COVID-19 according to a number of clinical parameters such as hospitalization requirement, need of oxygen therapy, admission to intensive care units and/or exitus.', 0.31213582), ('It is also an important parameter in viral evolution since it relates to the numbers and types of variant genomes present in a viral population, a potential determinant of disease progression.', 0.29472023)]"
734,Coronavirus Vaccines May Not Work for the Elderly,not,coronavirus vaccines may _ work for the elderly,coronavirus vaccines may also work for the elderly,https://www.scientificamerican.com/article/coronavirus-vaccines-may-not-work-for-the-elderly-and-this-lab-aims-to-change-that/,"[('So, a vaccine that is effective in healthy adults may not work well at either the beginning or end of life.', 0.79276276), (""But Ofer Levy, a physician-scientist at Boston Children's Hospital, worries that vaccines being designed today are not going to be effective enough for the people who need them most: older adults."", 0.68893015), (""They're going to be developing a vaccine that works in a normal, healthy population, and they're going to miss the elderly."", 0.5771722), (""Time will tell if any of them will work well on older people, says Seth Berkley, CEO of Gavi, the Vaccine Alliance, a private-public partnership that provides vaccines for nearly half of the world's children."", 0.56526476), (""A vaccine that protects young people would slow the virus's spread, but one that protects the most vulnerable will directly save lives, he says."", 0.5620916)]"
735,Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury,not,clinical evidence does _ support corticosteroid treatment for 2019-ncov lung injury,clinical evidence does indeed support corticosteroid treatment for 2019-ncov lung injury,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30317-2/fulltext,"[('We conclude that corticosteroid treatment should not be used for the treatment of 2019-nCoV-induced lung injury or shock outside of a clinical trial.', 0.78970826), ('No clinical data exist to indicate that net benefit is derived from corticosteroids in the treatment of respiratory infection due to RSV, influenza, SARS-CoV, or MERS-CoV.', 0.70227253), ('Corticosteroids have been investigated for respiratory syncytial virus (RSV) in clinical trials in children, with no conclusive evidence of benefit and are therefore not recommended.', 0.5751884), ('If it is present, the effect of steroids on mortality in those with septic shock is small, and is unlikely to be generalisable to shock in the context of severe respiratory failure due to 2019-nCoV.', 0.5345243), ('https://doi.org/10.1016/S0140-6736(20)30183-5 Summary Full Text Full Text PDF Scopus (9690) Google Scholar However, current interim guidance from WHO on clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected (released Jan 28, 2020) advises against the use of corticosteroids unless indicated for another reason.', 0.5337015)]"
736,CDC announces modifications and extension of No Sail Order for all Cruise Ships,extension,cdc announces modifications and _ of no sail order for all cruise ships,cdc announces modifications and loss of no sail order for all cruise ships,https://www.cdc.gov/media/releases/2020/s0409-modifications-extension-no-sail-ships.html,"[('For more information about COVID-19 and cruise ships, please visit https://www.cdc.gov/coronavirus/2019-ncov/travelers/cruise-ship/what-cdc-is- doing.html and to view the no sail order go to https://www.cdc.gov/quarantine/cruise/index.html.', 0.58090055), ('This order ceases operations of cruise ships in waters in which the United States may exert jurisdiction and requires that they develop a comprehensive, detailed operational plan approved by CDC and the USCG to address the COVID-19 pandemic through maritime focused solutions, including a fully implementable response plan with limited reliance on state, local, and federal government support.', 0.5749413), ('Cruise Lines International Association (CLIA) voluntarily suspended cruise ship operations in March in conjunction with the earlier No Sail Order issued March 14.', 0.5354671), ('The No Sail Order reinforces the strong action by President Donald J. Trump and the White House Coronavirus Task Force to combat the spread of COVID-19 in the United States.', 0.4884495), ('The CDC, the U.S. Coast Guard, and the Department of Homeland Security have been working with the industry to determine the most appropriate public health strategy to limit the impact of COVID-19 at cruise ship ports of entry in the United States.', 0.48423398)]"
737,MHRA suspends recruitment to COVID-19 hydroxychloroquine trials,suspend,mhra _ recruitment to covid-19 hydroxychloroquine trials,mhra acts recruitment to covid-19 hydroxychloroquine trials,https://www.gov.uk/government/news/mhra-suspends-recruitment-to-covid-19-hydroxychloroquine-trials,"[('Dr June Raine, MHRA’s CEO, said: > We have told those conducting clinical trials using hydroxychloroquine to > treat or prevent COVID-19 to suspend recruitment into their trials.', 0.7269863), ('The MHRA took into consideration the results released from the RECOVERY trial, showing no beneficial effect of hydroxychloroquine in patients hospitalised with COVID-19, and a New England Journal of Medicine publication using hydroxychloroquine as postexposure prophylaxis of COVID-19, concluding that hydroxychloroquine did not prevent illness compatible with Covid-19 or confirmed infection.', 0.6761205), ('> Neither hydroxychloroquine nor chloroquine are licensed to treat COVID-19 > related symptoms or to prevent infection.', 0.6151657), ('There currently are no vaccine and no medicines authorised to treat COVID-19 in the UK by the MHRA.', 0.59306395), ('We followed the emerging concerns about use of hydroxychloroquine in COVID-19, and took into consideration the results from two different trials, including the UK’s RECOVERY trial which has provided convincing evidence of no meaningful mortality benefit in hospitalised patients with COVID-19.', 0.5806869)]"
738,Prolonged presence of SARS-CoV-2 viral RNA in faecal samples,prolonged,_ presence of sars-cov-2 viral rna in faecal samples,No presence of sars-cov-2 viral rna in faecal samples,https://www.thelancet.com/journals/langas/article/PIIS2468-1253(20)30083-2/,"[('Further research into the viability and infectivity of SARS-CoV-2 in faeces is required.', 0.6384299), (""Here, we observed that for over half of patients, their faecal samples remained positive for SARS-CoV-2 RNA for a mean of 11·2 days after respiratory tract samples became negative for SARS-CoV-2 RNA, implying that the virus is actively replicating in the patient's gastrointestinal tract and that faecal–oral transmission could occur after viral clearance in the respiratory tract."", 0.62760186), (""Our data suggest the possibility of extended duration of viral shedding in faeces, for nearly 5 weeks after the patients' respiratory samples tested negative for SARS-CoV-2 RNA."", 0.57393646), ('Patients with suspected SARS-CoV-2 were confirmed after two sequential positive respiratory tract sample results.', 0.561061), ('2 Yeo C Kaushal S Yeo D Enteric involvement of coronaviruses: is faecal–oral transmission of SARS- CoV-2 possible?.', 0.55918086)]"
739,Influenza may facilitate the spread of SARS-CoV-2,facilitate,influenza may _ the spread of sars-cov-2,influenza may prevent the spread of sars-cov-2,https://www.medrxiv.org/content/10.1101/2020.09.07.20189779v1,"[('These results suggest the need to increase vaccination against influenza, not only to reduce the burden due to influenza viruses, but also to counteract their facilitatory impact on SARS-CoV-2.', 0.68971545), ('We found consistent evidence for a 2-2.5-fold population-level increase in SARS- CoV-2 transmission associated with influenza during the period of co- circulation.', 0.656709), ('Here we hypothesized that influenza interacted with SARS-CoV-2 during the early 2020 epidemic of COVID-19 in Europe.', 0.6522747), ('We developed a population-based model of SARS- CoV-2 transmission, combined with mortality incidence data in four European countries, to test a range of assumptions about the impact of influenza.', 0.55325454), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.37761387)]"
740,Gilead Sciences to donate 1.5 million dose of Remdesivir,million,gilead sciences to donate 1.5 _ dose of remdesivir,gilead sciences to donate 1.5 mL dose of remdesivir,https://www.gilead.com/stories/articles/an-update-on-covid-19-from-our-chairman-and-ceo,"[('Gilead pledged to donate its initial supply of the drug, or 1.5 million doses.', 0.7846771), ('Gilead Sciences, maker of remdesivir, said it would donate its initial supply of the medicine.', 0.6415092), ('The donation to the United States is part of 1.5 million vials of remdesivir the company is donating worldwide.', 0.6037754), ('Assuming a 10-day treatment course, Gilead’s donation of 1.5 million individual doses of remdesivir equates to more than 140,000 treatment courses that will be provided at no cost to treat patients following potential emergency authorizations and regulatory approvals, including this EUA.', 0.5597061), (""This, they've been told, will help a federal team led by Dr. Deborah Birx, White House coronavirus response coordinator, to decide where to send the donated supply of remdesivir."", 0.55048496)]"
742,"Behavioral changes before lockdown , and decreased retail and recreation mobility during lockdown , contributed most to the successful control of the COVID-19 epidemic in 35 Western countries",decreased,"behavioral changes before lockdown , and _ retail and recreation mobility during lockdown , contributed most to the successful control of the covid-19 epidemic in 35 western countries","behavioral changes before lockdown, and increased retail and recreation mobility during lockdown, contributed most to the successful control of the covid-19 epidemic in 35 western countries",https://www.medrxiv.org/content/10.1101/2020.06.20.20136382v1,"[('During lockdown, decreased mobility in retail and recreation was an independent predictor of lower R t during lockdown, while changes in other types of mobility were not.', 0.55466586), ('These results are consistent with anecdotal evidence that large recreational gatherings are super-spreading events ( 5, 6), and may even suggest that infections during day-to-day contact at work are not sufficient to spark exponential growth.', 0.48824564), ('One third of the effect happened already on average 6 days before the lockdown, with lockdown itself causing another major drop in transmission.', 0.44632727), ('Our data suggest measures that will contribute to avoiding a second peak include a tight control on circumstances that facilitate massive spread such as large gatherings especially indoors, physical distancing, and mask use.', 0.4440859), ('Governments are looking for evidence to balance the demand of their citizens to ease some of the restriction, against the fear of a second peak in infections.', 0.39575398)]"
745,COVID vaccine needs Horseshoe Crab Blood but the ecosystem may suffer,suffer,covid vaccine needs horseshoe crab blood but the ecosystem may _,covid vaccine needs horseshoe crab blood but the ecosystem may benefit,https://www.nationalgeographic.com/animals/2020/07/covid-vaccine-needs-horseshoe-crab-blood/,"[('But she and other conservationists fear that without rFC or other alternatives available, the ongoing burden on horseshoe crab blood for COVID-19 vaccines and related therapeutics may imperil the crabs and the marine ecosystems that depend on them.', 0.731596), ('He said horseshoe crabs are vital in the process to find a coronavirus vaccine because their immune system is the most sensitive in the world.', 0.68788767), ('He said if the horseshoe crab population were to decline too much, it could negatively impact the ecosystem.', 0.6252394), ('With about 400 coronavirus drugs and vaccines in development and safety tests using horseshoe crab blood currently the industry standard, this unusual- looking critter is set to play an important role in the pandemic.', 0.6097852), ('And there’s concern the horseshoe crab is facing pressure on many fronts – it’s also fished to be used as bait and suffering due to habitat loss and rising sea levels.', 0.605775)]"
746,CytoDyn Reports Strong Results from eIND COVID-19 Patients Treated with Leronlimab ; Majority of Patients Have Demonstrated Remarkable Recoveries,majority,cytodyn reports strong results from eind covid-19 patients treated with leronlimab ; _ of patients have demonstrated remarkable recoveries,cytodyn reports strong results from eind covid-19 patients treated with leronlimab ; none of patients have demonstrated remarkable recoveries,https://www.cytodyn.com/newsroom/press-releases/detail/424/cytodyn-reports-strong-results-from-eind-covid-19-patients,"[('Bruce Patterson, M.D., Chief Executive Officer and founder of IncellDx, a diagnostics company and an advisor to CytoDyn, expanded on these findings by stating, “We are excited that patients are responding extremely well to leronlimab as expected from the novel mechanism of COVID-19 pathogenesis we discovered and will be reporting in the coming days.” Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn said, “We believe these results, although anecdotal, are very impressive and the number of patients treated under eIND is rapidly increasing.', 0.608607), ('Seven patients were organ- transplant recipients (six patients were renal-transplant recipients and one patient had a history of heart transplant) and were on immunosuppressive regimen.', 0.53680694), ('All patient blood samples were evaluated and important powerful results from the effect of leronlimab were demonstrated in almost all of these patients.', 0.509652), ('COVID-19 typically transmits person to person through respiratory droplets, commonly resulting from coughing, sneezing, and close personal contact.', 0.4726982), ('For confirmed COVID-19 infections, symptoms have included fever, cough, and shortness of breath.', 0.45337856)]"
749,CDC therapeutic options reduced to basically two drugs,two,cdc therapeutic options reduced to basically _ drugs,cdc therapeutic options reduced to basically all drugs,https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html,"[('We have identified the first cluster of gonorrhea cases in the U.S. to show decreased susceptibility to both of the currently recommended drugs.', 0.58421683), ('You were able to cure all of them with one dose -- or one person had a second dose.', 0.56430686), (""It's the first cluster of cases to show decreased susceptibility to both drugs, and the findings are even more concerning than data CDC published earlier this year that showed evidence of emerging azithromycin resistance across the nation."", 0.5499233), ('The sole female case patient named two partners, one of whom had been previously diagnosed with gonorrhea, with a urine nucleic acid amplification test, that disallowed culture of antibiotic susceptibility testing.', 0.5494827), ('She and her colleagues found in a phase two clinical trial that a new drug, known as ETX0914 was safe and effective at curing gonorrhea.', 0.5427377)]"
750,An Unpredicted Summer Respite Followed by a Second Wave,second,an unpredicted summer respite followed by a _ wave,an unpredicted summer respite followed by a third wave,https://www.mdpi.com/1660-4601/17/23/8708,"[('What clearly emerges, from rigorous statistical analysis, is a progressive decrease in both ratios until August, indicating progressive mitigation of the disease.', 0.51258665), ('We then interpret such evidence in terms of the well-known seasonality of the human immune system and the virus- inactivating effect of stronger UV rays in the summer.', 0.46286577), ('This is particularly evident when comparing March-April with July-August; during the summer period the two ratios became roughly 18 times lower.', 0.39188904), ('( b ) Relative ratios of D/AC in April, with respect to the following months May to August.', 0.29820308), ('Keywords: Covid-19 in Italy; autumn sharp worsening of epidemics; summer mitigation.', 0.29000014)]"
751,Google releases COVID-19 Community Mobility Reports in an effort to show local movement trends during pandemic,google,_ releases covid-19 community mobility reports in an effort to show local movement trends during pandemic,WHO releases covid-19 community mobility reports in an effort to show local movement trends during pandemic,https://www.google.com/covid19/mobility/,"[('In response to feedback from public health officials that data could be helpful for making critical decisions to combat COVID-19, Google has published an early release of COVID-19 Community Mobility Reports.', 0.8013445), ('These Community Mobility Reports aim to provide insights into what has changed in response to policies aimed at combating COVID-19.', 0.687161), ('Starting today we’re publishing an early release of our COVID-19 Community Mobility Reports to provide insights into what has changed in response to work from home, shelter in place, and other policies aimed at flattening the curve of this pandemic.', 0.68358946), ('The COVID-19 Community Mobility Reports web site will show population data trends of six categories: Retail and recreation, grocery and pharmacy, parks, transit stations, workplaces, and residential.', 0.67837656), ('The reports consist of per country, or per state, downloads (with 131 countries covered initially), further broken down into regions/counties -- with Google offering an analysis of how community mobility has changed vs a baseline average before COVID-19 arrived to change everything.', 0.67759204)]"
752,Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion,not,furin cleavage of sars-cov-2 spike promotes but is _ essential for infection and cell-cell fusion,furin cleavage of sars-cov-2 spike promotes but is also essential for infection and cell-cell fusion,https://www.biorxiv.org/content/10.1101/2020.08.13.243303v1,"[('Our results show that while furin promotes both SARS-CoV-2 infectivity and cell-cell spread it is not essential, suggesting furin inhibitors will not prevent viral spread.', 0.6918957), ('We show that loss of furin in either donor or acceptor cells reduces, but does not prevent, TMPRSS2-dependent cell-cell fusion, unlike mutation of the multibasic site that completely prevents syncytia formation.', 0.59918934), ('Comparing S processing in furin knockout cells to multibasic site mutants reveals that while loss of furin substantially reduces S1-S2 cleavage it does not prevent it.', 0.5805638), ('SARS-CoV-2 S protein also mediates cell-cell fusion, potentially allowing virus to spread virion-independently.', 0.5594744), ('Here we show that CRISPR- Cas9 knockout of furin reduces, but does not prevent, the production of infectious SARS-CoV-2 virus.', 0.53262085)]"
753,Decreased serum levels of inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients,decreased,_ serum levels of inflammaging marker mir-146a are associated with clinical response to tocilizumab in covid-19 patients,Increasing serum levels of inflammaging marker mir-146a are associated with clinical response to tocilizumab in covid-19 patients,https://www.medrxiv.org/content/10.1101/2020.07.11.20151365v1,"[('Share Decreased serum levels of the inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients Jacopo Sabbatinelli, Angelica Giuliani, Giulia Matacchione, Silvia Latini, Noemi Laprovitera, Giovanni Pomponio, Alessia Ferrarini, Silvia Svegliati Baroni, Marianna Pavani, Marco Moretti, Armando Gabrielli, Antonio Domenico Procopio, Manuela Ferracin, Massimiliano Bonafè, Fabiola Olivieri medRxiv 2020.07.11.20151365; doi: https://doi.org/10.1101/2020.07.11.20151365 Share This Article: Copy Citation Tools Decreased serum levels of the inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients Jacopo Sabbatinelli, Angelica Giuliani, Giulia Matacchione, Silvia Latini, Noemi Laprovitera, Giovanni Pomponio, Alessia Ferrarini, Silvia Svegliati Baroni, Marianna Pavani, Marco Moretti, Armando Gabrielli, Antonio Domenico Procopio, Manuela Ferracin, Massimiliano Bonafè, Fabiola Olivieri medRxiv 2020.07.11.20151365; doi: https://doi.org/10.1101/2020.07.11.20151365 ', 0.83523136), ('› 论文详情 Decreased serum levels of the inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients medRxiv - Infectious Diseases Pub Date : 2020-11-21 , DOI: 10.1101/2020.07.11.20151365 Jacopo Sabbatinelli; Angelica Giuliani; Giulia Matacchione; Silvia Latini; Noemi Laprovitera; Giovanni Pomponio; Alessia Ferrarini; Silvia Svegliati Baroni; Marianna Pavani; Marco Moretti; Armando Gabrielli; Antonio Domenico Procopio; Manuela Ferracin; Massimiliano Bonafè; Fabiola Olivieri Current COVID-19 pandemic poses an unprecedented threat to global health and healthcare systems.', 0.7630356), ('We showed that COVID-19 patients who did not respond to TCZ have lower serum levels of miR-146a-5p after the treatment (p = 0.007).', 0.74040234), ('We showed that COVID-19 patients who did not respond to TCZ have lower serum levels of miR-146a-5p after the treatment (p=0.007).', 0.74040234), ('You are going to email the following Decreased serum levels of the inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website.', 0.72392833)]"
754,Greater social distancing could curb COVID-19 in 13 weeks,curb,greater social distancing could _ covid-19 in 13 weeks,greater social distancing could increase covid-19 in 13 weeks,https://neurosciencenews.com/covid-19-13-week-distancing-15985/,"[('“However, if ninety percent of the population complies, then the duration could be as short as thirteen to fourteen weeks – meaning if we began tomorrow we could expect a control of COVID-19 by July,” he said.', 0.5915052), ('On the contrary, laxer protocols could mean a longer, more drawn out and ineffective struggle against COVID-19,” he said.', 0.53040206), ('If social distancing measures were adopted by at least 80 percent of the Australian population, we could expect to see a control of the spread of the COVID-19 pandemic in just over three months, new research by the University of Sydney has found.', 0.49129742), ('The research found that if 90 percent of the Australian population adopted social distancing, the spread of COVID-19 could be controlled by July 2020, whereas social distancing of less than 70 percent would not suppress the pandemic.', 0.48289204), ('“There is a clear trade off – stricter measures imposed earlier would reduce how long our lives are impacted by this disease.', 0.44809702)]"
755,Sensitivity Is Not the Whole Story,not,sensitivity is _ the whole story,sensitivity is still the whole story,https://asm.org/Articles/2020/November/SARS-CoV-2-Testing-Sensitivity-Is-Not-the-Whole-St,"[('However, there is an absence of real-world data to support this approach and the focus on test sensitivity is overly narrow.', 0.43278027), ('Maybe, but this approach warrants further discussion.', 0.42459992), ('We simply do not know.', 0.39078674), ('It is unclear where funding would come from.', 0.3865087), ('These false positives could be confirmed using a second rapid test, but data are lacking on this approach.', 0.3860493)]"
757,Use of convalescent serum reduces severity of COVID-19 in nonhuman primates,reduces,use of convalescent serum _ severity of covid-19 in nonhuman primates,use of convalescent serum increased severity of covid-19 in nonhuman primates,https://www.biorxiv.org/content/10.1101/2020.10.14.340091v1,"[('However, and importantly, lower levels of SARS-CoV-2 in respiratory compartments, reduced gross and histopathological lesion severity in the lungs, and reductions in several parameters associated with coagulation and inflammatory processes were observed in monkeys that received convalescent sera versus untreated controls.', 0.60122466), ('Differences in viral load and disease pathology were minimal between monkeys that received the lower titer convalescent sera and untreated controls.', 0.5349536), ('Human convalescent plasma containing antibodies against SARS-CoV-2 is currently being used to treat COVID-19 patients.', 0.46894526), ('Here, we assessed the efficacy of convalescent sera in a newly developed African green monkey model of COVID-19.', 0.39732456), ('Groups of SARS- CoV-2-infected animals were treated with pooled convalescent sera containing either high or low to moderate anti-SARS-CoV-2 neutralizing antibody titers.', 0.3968445)]"
759,High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients,high,_ incidence of venous thromboembolic events in anticoagulated severe covid-19 patients,Low incidence of venous thromboembolic events in anticoagulated severe covid-19 patients,https://onlinelibrary.wiley.com/doi/abs/10.1111/jth.14869,"[('Venous Thromboembolism in Hospitalized COVID-19 Patients.', 0.82917607), ('Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19.', 0.8133626), ('Keywords: COVID-19; SARS-CoV-2; anticoagulation; critical care; pulmonary embolism; venous thromboembolism.', 0.8031906), ('Incidence of thrombotic complications in critically ill ICU patients with COVID‐19.', 0.77410984), ('Thrombosis risk associated with COVID-19 infection.', 0.7641805)]"
760,Climate affects global patterns of COVID-19 early outbreak dynamics,climate,_ affects global patterns of covid-19 early outbreak dynamics,Infection affects global patterns of covid-19 early outbreak dynamics,https://www.medrxiv.org/content/10.1101/2020.03.23.20040501v1,"[('We show that showed that during the earliest phase of the global outbreak (January-March), COVID-19 growth rates were non-linearly related to climate, and in the most polluted regions.', 0.78019214), ('There is a strong relationship between local climate and Covid-19 growth rates, suggesting the possibility of seasonal variation in the spatial pattern of outbreaks, with temperate regions of the Southern Hemisphere becoming at particular risk of severe outbreaks during the austral autumn-winter.', 0.7518727), ('If the disease will become seasonal in the next years, information on environmental drivers of COVID-19 can be integrated with epidemiological models to inform forecasting of future outbreak risks and improve management plans.', 0.6984869), ('We showed that during the earliest phase of the global outbreak (January-March), COVID-19 growth rates were non-linearly related to climate, with fastest spread in regions with a mean temperature of ca.', 0.67646897), ('We added the analysis of how the relationship between the COVID-19 dynamics and environmental features change through time.', 0.6387325)]"
761,Restriction of SARS-CoV-2 Replication by Targeting Programmed −1 Ribosomal Frameshifting In Vitro,restriction,_ of sars-cov-2 replication by targeting programmed −1 ribosomal frameshifting in vitro,Activation of sars-cov-2 replication by targeting programmed −1 ribosomal frameshifting in vitro,https://www.biorxiv.org/content/10.1101/2020.10.21.349225v1,"[('Importantly, frameshift inhibition by merafloxacin substantially impedes SARS-CoV-2 replication in Vero E6 cells, thereby providing the proof of principle of targeting −1 PRF as an effective antiviral strategy for SARS-CoV-2.', 0.7010925), ('The extent to which SARS-CoV-2 replication may be sensitive to changes in −1 PRF efficiency is currently unknown.', 0.60530794), ('Through an unbiased, reporter-based high-throughput compound screen, we identified merafloxacin, a fluoroquinolone antibacterial, as a −1 PRF inhibitor of SARS-CoV-2.', 0.6021177), ('Frameshift inhibition by merafloxacin is robust to mutations within the pseudoknot region and is similarly effective on −1 PRF of other beta coronaviruses.', 0.5327705), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.39928403)]"
763,Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2,ineffective,hydroxychloroquine proves _ in hamsters and macaques infected with sars-cov-2,hydroxychloroquine proves protection in hamsters and macaques infected with sars-cov-2,https://www.biorxiv.org/content/10.1101/2020.06.10.145144v1,"[('Liu J. et al., Hydrochloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.', 0.6307242), ('Similarly, HCQ prophylaxis/treatment (6.5 mg/kg) did not significantly benefit clinical outcome nor reduce SARS-CoV-2 replication/shedding in the upper and lower respiratory tract in the rhesus macaque disease model.', 0.6187916), ('Hamsters were infected with SARS-CoV-2 by the intranasal route.', 0.5985271), ('In conclusion, HCQ prophylaxis and treatment had no beneficial effect in the two animal disease models tested.', 0.59540164), ('et al., Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.', 0.57542074)]"
764,Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine,increased,_ risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine,Low risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine,https://pubmed.ncbi.nlm.nih.gov/22423139/,"[('Being protected against influenza, TIV recipients may lack temporary non-specific immunity that protected against other respiratory viruses.', 0.74229705), ('Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.', 0.71643186), ('The use of inactivated influenza vaccine in children.', 0.68118596), ('Anestad G. Interference between outbreaks of respiratory syncytial virus and influenza virus infection.', 0.6705717), ('A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness.', 0.6513003)]"
765,Obesity is a major risk factor for COVID-19 complications,obesity,_ is a major risk factor for covid-19 complications,RSV is a major risk factor for covid-19 complications,https://sph.unc.edu/sph-news/obesity-is-a-major-risk-factor-for-covid-19-complications/,"[('Obesity already is associated with numerous underlying risk factors for COVID-19, including hypertension, heart disease, Type 2 diabetes, and chronic kidney and liver disease.', 0.71330714), ('“Given the significant threat COVID-19 represents to individuals with obesity, healthy food policies can play a supportive — and especially important — role in mitigating COVID-19 mortality and morbidity,” he says.', 0.63039875), ('The relationship between obesity and COVID-19 is controversial, and little analysis has been done on the role obesity plays in how individuals experience the virus.', 0.6163409), ('The new paper reviews immunological and biomedical data to provide a detailed layout of the mechanisms and pathways that link obesity with increased risk of COVID-19 as well as an increased likelihood of developing more severe complications from the virus.', 0.59463084), ('Metabolic changes caused by obesity — such as insulin resistance and inflammation — make it difficult for individuals with obesity to fight some infections, a trend that can be seen in other infectious diseases, such as influenza and hepatitis.', 0.5002625)]"
766,FDA gives EUA to Saliva-Based Test Kit,fda,_ gives eua to saliva-based test kit,PCR gives eua to saliva-based test kit,https://www.fda.gov/media/136875/download,"[('Coronavirus (COVID-19) Update: FDA Authorizes First Diagnostic Test Using At-Home Collection of Saliva Specimens 1.', 0.64857197), ('While FDA has seen variable performance in tests using saliva, Yale School of Public Health submitted data with its EUA request from which the FDA determined that Yale’s test meets the criteria for emergency authorization when used to test saliva samples for SARS-CoV-2, the virus that causes COVID-19 infection.', 0.6461818), ('Specifically, the FDA issued an emergency use authorization (EUA) to Rutgers Clinical Genomics Laboratory for their COVID-19 laboratory developed test (LDT), which had been previously added to the high complexity molecular- based LDT “umbrella” EUA, to permit testing of samples self-collected by patients at home using the Spectrum Solutions LLC SDNA-1000 Saliva Collection Device.', 0.61690223), ('Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization to Yale School of Public Health for SalivaDirect, Which Uses a New Method of Saliva Sample Processing 1.', 0.6167644), ('The FDA has authorized more than 80 COVID-19 tests and adding more options for at-home sample collection is an important advancement in diagnostic testing during this public health emergency.” Today’s EUA for Rutgers Clinical Genomics Laboratory’s molecular test permits testing of a saliva sample collected from the patient using a designated self- collection kit.', 0.59235096)]"
767,Reduced Vitamin K Status as A Potentially Modifiable Prognostic Risk Factor in COVID-19,reduced,_ vitamin k status as a potentially modifiable prognostic risk factor in covid-19,Increased vitamin k status as a potentially modifiable prognostic risk factor in covid-19,https://www.preprints.org/manuscript/202004.0457/v2,"[('Conclusions: Vitamin K status was reduced in patients with COVID-19 and related to poor prognosis.', 0.88189507), ('We hypothesized that vitamin K status is reduced in patients with severe COVID-19.', 0.85108155), ('An intervention trial is now needed to assess whether vitamin K administration improves outcome in patients with COVID-19.', 0.6328207), ('Also, low vitamin K status seems to be associated with accelerated elastin degradation.', 0.61844176), ('It could be the portion of their population not protected by Vitamin K status are allowing a more limited pandemic outcome there.', 0.594769)]"
768,SARS-CoV-2 in environmental samples of quarantined households,environmental,sars-cov-2 in _ samples of quarantined households,sars-cov-2 in blood samples of quarantined households,https://www.medrxiv.org/content/10.1101/2020.05.28.20114041v1,"[('The role of the domestic environment, in particular the wastewater load in washbasins and showers, in the transmission of SARS CoV-2 should be further clarified.', 0.5769886), ('Highlights With public “shut downs” due to SARS-CoV-2, domestic infection is a main possible route of transmission.', 0.55020726), ('All analysed air samples were tested negative for SARS-CoV-2.', 0.5384922), ('As we cannot rule out transmission through surfaces, hygienic behavioural measures are important in the households of SARS-CoV-2 infected individuals to avoid potential transmission through surfaces.', 0.4911614), ('10 of 66 wastewater samples were positive for SARS-CoV-2 (15.15 %) as well as 4 of 119 object samples (3.36 %).', 0.4704086)]"
769,"A single dose , BCG-adjuvanted SARS-CoV-2 vaccine induces Th1-polarized immunity and high-titre neutralizing antibodies in mice",single,"a _ dose , bcg-adjuvanted sars-cov-2 vaccine induces th1-polarized immunity and high-titre neutralizing antibodies in mice","a second dose, bcg-adjuvanted sars-cov-2 vaccine induces th1-polarized immunity and high-titre neutralizing antibodies in mice",https://www.biorxiv.org/content/10.1101/2020.12.10.419044v1,"[('This study describes a unique COVID-19 vaccine candidate, termed BCG:CoVac, that when delivered as a single dose induces potent SARS-CoV-2 specific immunity in mice, particularly through generation of high-titre, anti-viral neutralising antibodies.', 0.8187679), ('A single dose of BCG:CoVac was sufficient to induce high-titre SARS-CoV-2 neutralizing antibodies (NAbs) that were detectable as early as 2 weeks post-vaccination; NAb levels were greater than that seen in the sera of SARS-CoV-2-infected individuals.', 0.7643201), ('This vaccine formulation, termed BCG:CoVac, induced a Th1-biased response both in terms of IgG antibody subclass and cytokine release by vaccine-specific CD4+ and CD8+ T cells.', 0.7377526), ('Combination of BCG with a stabilized, trimeric form of the SARS-CoV-2 spike antigen promoted rapid development of virus- specific IgG antibodies in the sera of vaccinated mice, which could be further augmented by the addition of alum.', 0.72755915), ('In this report, we have exploited the immunostimulatory properties of bacille Calmette-Guérin (BCG), the vaccine for tuberculosis, to develop a SARS-CoV-2-specific and highly immunogenic vaccine candidate.', 0.6921576)]"
770,"Elevated antiviral , myeloid and endothelial inflammatory markers in severe COVID-19",elevated,"_ antiviral , myeloid and endothelial inflammatory markers in severe covid-19","No antiviral, myeloid and endothelial inflammatory markers in severe covid-19",https://www.medrxiv.org/content/10.1101/2020.10.08.20209411v1,"[('Overall, markers of myeloid or endothelial cell activation were associated with severe, progressive, and fatal disease indicating a central role for innate immune activation and vascular inflammation in COVID-19.', 0.8884982), ('Markers of endothelial injury (angiopoietin-2 and von-Willebrand factor A2) were detected early in some patients, while inflammatory cytokines and markers of lung injury persisted for several weeks in fatal COVID-19 despite decreasing antiviral cytokine levels.', 0.5855606), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.5508067), ('Samples from community managed COVID-19 cases were collected through a subproject of Imperial College London Communicable Disease Research Tissue Bank, under approval from the south central Oxford REC (reference 15/SC/0089).', 0.5279747), ('Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Hospitalized patients with PCR-proven or high likelihood of SARS-CoV-2 infection were recruited, including both patients with community- and hospital-acquired COVID-19.', 0.49239463)]"
772,"'Ethically , the Choice Is Clear '",clear,"'ethically , the choice is _ '","'ethically, the choice is not '",https://www.medscape.com/viewarticle/935058,"[('And given that, our ethical obligation to ""first, do no harm"" is paramount here.', 0.6514174), ('It would be immediately obvious.', 0.64053094), (""That's not unethical or anything, by the way."", 0.63353765), (""It's simple."", 0.6098305), ('It really is a relatively well-tolerated drug.', 0.566308)]"
773,ICMR Study Suggests ICMR Covid-19 Testing Strategy Was Flawed .,flawed,icmr study suggests icmr covid-19 testing strategy was _ .,icmr study suggests icmr covid-19 testing strategy was done.,https://science.thewire.in/health/coronavirus-testing-icmr-testing-strategy-covid-19-diagnostic-kits-community-transmission/,"[('The importance of community testing In another simulation in the study, the authors considered an alternative intervention, where community cases (with no travel history) were tested widely for COVID-19.', 0.606713), (""7 share ReportSave Continue this thread level 2 Original Poster9 months ago No, this just suggests that India's initial screening policy was flawed."", 0.58658695), ('This subreddit seeks to monitor the spread of the disease COVID-19, declared a pandemic by the WHO.', 0.5571281), ('Also read: ICMR Study Suggests Its Testing Strategy Was Flawed, Airport Screening a Miss As of March 12, testing was limited to 52 government centres.', 0.5174558), ('The rationale given behind the lockdown was to prevent community transmission of COVID-19 from happening.', 0.49299958)]"
774,Coronavirus Fears Have Led To A Golden Age Of Hand-Washing PSAs,age,coronavirus fears have led to a golden _ of hand-washing psas,coronavirus fears have led to a golden loss of hand-washing psas,https://www.npr.org/2020/03/04/811609241/coronavirus-fears-have-led-to-a-golden-age-of-hand-washing-psas,"[('The production is a bit spare, but the message comes through: Washing your hands often is importantissimo.', 0.6144764), ('Want to learn the hand-washing dance?', 0.4984206), ('Because the coronavirus is a global concern, video PSAs are emerging from all corners of the globe, all at once.', 0.49742323), ('Some are extremely winning, like the hand-washing dance created by Vietnamese choreographer Quang Đăng.', 0.45703733), ('His Chaplinesque performance infuses high art and physical comedy into the subject of hygiene.', 0.43007272)]"
777,Functional myeloid-derived suppressor cells expand in blood but not airways of COVID-19 patients and predict disease severity,not,functional myeloid-derived suppressor cells expand in blood but _ airways of covid-19 patients and predict disease severity,functional myeloid-derived suppressor cells expand in blood but also airways of covid-19 patients and predict disease severity,https://www.medrxiv.org/content/10.1101/2020.09.08.20190272v1,"[('M-MDSC frequencies were elevated in blood but not in nasopharyngeal or endotracheal aspirates of COVID-19 patients compared to controls.', 0.82551014), ('In conclusion, M-MDSCs expand in blood of COVID-19 patients, suppress T cells and strongly associate with disease severity, suggesting a role for M-MDSCs in the dysregulated COVID-19 immune response.', 0.62962675), ('COVID-19 patients had fewer T cells, and displayed downregulated expression of the CD3ζ chain.', 0.60965747), ('M-MDSCs isolated from COVID-19 patients suppressed T cell proliferation and IFNγ production partly via an arginase-1 (Arg-1) dependent mechanism.', 0.5375513), ('We studied blood and airways of COVID-19 patients across disease severity at multiple timepoints.', 0.4719045)]"
778,ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Damage After 2019-nCoV Infection,cause,ace2 expression in kidney and testis may _ kidney and testis damage after 2019-ncov infection,ace2 expression in kidney and testis may prevent kidney and testis damage after 2019-ncov infection,https://www.medrxiv.org/content/10.1101/2020.02.12.20022418v1,"[('Therefore, virus might directly bind to such ACE2 positive cells and damage the kidney and testicular tissue of patients.', 0.74750817), ('Our results indicate that renal function evaluation and special care should be performed in 2019-nCoV patients during clinical work, because of the kidney damage caused by virus and antiviral drugs with certain renal toxicity.', 0.7050174), ('The results indicate that ACE2 highly expresses in renal tubular cells, Leydig cells and cells in seminiferous ducts in testis.', 0.5879917), ('ACE2 (Angiotensin Converting Enzyme 2) has been shown to be one of the major receptors that mediate the entry of 2019-nCoV into human cells, which also happens in severe acute respiratory syndrome coronavirus (SARS).', 0.53769004), ('Several researches have indicated that some patients have abnormal renal function or even kidney damage in addition to injury in respiratory system, and the related mechanism is unknown.', 0.4447197)]"
779,Inactivating porcine coronavirus before nuclei acid isolation with the temperature higher than 56 °C damages its genome integrity seriously,damages,inactivating porcine coronavirus before nuclei acid isolation with the temperature higher than 56 °c _ its genome integrity seriously,inactivating porcine coronavirus before nuclei acid isolation with the temperature higher than 56 °c increased its genome integrity seriously,https://www.biorxiv.org/content/10.1101/2020.02.20.958785v1,"[('In this study, we demonstrated that the virus inactivation treatment disrupts its genome integrity seriously when using porcine epidemic diarrhea virus (vaccine), a kind of coronavirus, as a model.', 0.64692235), ('However, the detectable templates of viral nucleic acids can be unchanged after the samples were incubated at 56 °C or higher if the samples were preserved with an optimized solution to protect the RNA from being disrupted.', 0.52764773), ('We therefore highly recommend to carry out systematic investigation on the impact of high temperature inactivation on the integrity of 2019-nCoV genome and develop a sample preservation solution to protect the detectable templates of 2019-nCoV nucleic acids from high temperature inactivation damage.', 0.45133173), ('According to “The Laboratory Technical Guidelines for Detection 2019-nCoV (Fourth Edition)” issued by National Health and Commission of China and “The Experts’ Consensus on Nucleic Acid Detection of 2019-nCoV” released by Chinese Society of Laboratory Medicine, the human samples must be placed under 56°C or higher to inactivate the viruses in order to keep the inspectors from virus infection before the nucleic acids were isolated as the template of qRT-PCR.', 0.41128528), ('Our results showed that only 50.11% of the detectable viral templates left after the inactivation of 56 °C for 30 minutes and only 3.36% left after the inactivation of 92 °C for 5 minutes when the samples were preserved by Hank’s solution, one of an isotonic salt solutions currently suggested.', 0.33702)]"
783,HCQ + Zinc reduces mortality by 50 % in retrospective study at NYU,reduces,hcq + zinc _ mortality by 50 % in retrospective study at nyu,hcq + zinc increases mortality by 50 % in retrospective study at nyu,https://www.ny1.com/nyc/all-boroughs/news/2020/05/12/nyu-study-looks-at-hydroxychloroquine-zinc-azithromycin-combo-on-decreasing-covid-19-deaths,"[('But I am surprised you didn’t mention the recent preprint from NYU about HCQ and zinc significantly decreasing mortality by 44%.', 0.5743928), ('For example, the NYU observational study which is generating excitement…ok, say for the sake of argument the 44% (relative) reduction would hold in an experimental study, look at the last page of the pre-print…the percent who died in the zinc group was 13.1% vs 22.8% in the no zinc group.', 0.5606668), ('Yohanan Weininger says: 20 May, 2020 at 4:46 am heh Mike R, Your post is empty without reference, link to ""the recent preprint from NYU about HCQ and zinc significantly decreasing mortality by 44%….', 0.53925395), ('In pre-ICU patients the percentage of ICU/ventilator admissions decreased by 50%.', 0.53609586), ('You are leaving out a big part of the picture when you leave out the hydroxychloroquine and zinc interaction and leave out the well done retrospective study that suggested HCQ/zinc saved 44% almost twice the number of lives than compared to HCQ alone.', 0.5290739)]"
784,Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19,recovery,azithromycin and hydroxychloroquine accelerate _ of outpatients with mild/moderate covid-19,azithromycin and hydroxychloroquine accelerate death of outpatients with mild/moderate covid-19,https://www.preprints.org/manuscript/202005.0486/v1?fbclid=IwAR24KOXMUHje0QNfWgHFyZDXNmk_nzIx3Px01J51sHnEgPzRPXQuHwDPryg,"[('We aimed to assess the efficacy and safety of AZM alone or combined to HCQ, prescribed, at an early stage, in patients with Covid-19, in a primary care setting.', 0.6725644), ('Azithromycin (AZM) and hydroxychloroquine (HCQ) have proven their antiviral effect in vitro.', 0.5788164), ('To improve the evidence level, a case-control analysis was performed on a sample of 57 patients (19/group) matched for age, sex and BMI.', 0.48217005), ('No statistical difference was shown between AZM and AZM+HCQ groups, although the dual therapy tended to be more effective in patients over 50 years, based on an analysis using the cox model.', 0.44146776), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.4208077)]"
785,Side by side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity,three,side by side comparison of _ fully automated sars-cov-2 antibody assays with a focus on specificity,side by side comparison of two fully automated sars-cov-2 antibody assays with a focus on specificity,https://www.medrxiv.org/content/10.1101/2020.06.04.20117911v1,"[('Therefore, we compared three commercial, CE-marked, SARS-CoV-2 antibody assays side by side.', 0.8281925), ('Keywords: SARS-CoV-2, serology, specificity, laboratory automation, positive predictive value, seroprevalence ', 0.49164113), ('However, at low seroprevalences, the minor differences in specificity resulted in profound discrepancies of positive predictive values at 1% seroprevalence: 52.3% (36.2-67.9), 77.6% (52.8-91.5), and 32.6% (23.6-43.1) for Abbott, Roche, and DiaSorin, respectively.', 0.4647614), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.433426), (""Although the three methods were in good agreement (Cohen's Kappa 0.71-0.87), McNemar tests revealed significant differences between results obtained from Roche and DiaSorin."", 0.42942753)]"
786,"Rare neurological disorder , Guillain-Barre Syndrome , linked to COVID-19",rare,"_ neurological disorder , guillain-barre syndrome , linked to covid-19","Chronic neurological disorder, guillain-barre syndrome, linked to covid-19",https://theconversation.com/rare-neurological-disorder-guillain-barre-syndrome-linked-to-covid-19-141511,"[('What are the chances that someone gets Guillain-Barre Syndrome during or following a COVID-19 infection?', 0.78490674), ('Science + Technology COVID-19 has been linked to neurological problems in those with severe disease.', 0.68209326), ('The Global Consortium Study of Neurological Dysfunctions in COVID-19 is actively underway to find out how often neurological problems like Guillain-Barre Syndrome is seen in hospitalized COVID-19 patients.', 0.67451376), ('Though there is clear clinical suspicion that COVID-19 can lead to Guillain- Barre Syndrome, many important questions remain.', 0.67076147), ('COVID-19 2.', 0.6231683)]"
788,Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in Serum,lower,prevalence of antibodies to four human coronaviruses is _ in nasal secretions than in serum,prevalence of antibodies to four human coronaviruses is greater in nasal secretions than in serum,https://cvi.asm.org/content/17/12/1875,"[('The present study questioned whether the prevalence of antibodies to the four HCoV strains would be different in nasal secretions than in serum of older adult veterans with underlying chronic obstructive pulmonary disease (COPD) who participated in Department of Veterans Affairs Cooperative Study 448 (18).', 0.6969921), ('Another previous report by Callow (4) suggested that HCoV-229E-specific antibodies in serum and nasal wash specimens were correlated with protection from experimental infection with HCoV-229E and disease, and IgA antibodies to HCoV-229E in nasal wash specimens were associated with a reduced duration of viral shedding in nasal secretions.', 0.69452107), ('The proportion with IgA antibodies to HCoV-NL63 in nasal wash specimens of patients with a history of heart disease was higher than that of patients without heart disease (6 [16%] versus 2 [3%]; P = 0.014), but the proportions with IgA antibodies to the other three HCoV strains in nasal wash specimens from patients with and those without heart disease did not differ (data not shown).', 0.6614192), ('Based on the much lower frequency of patients with HCoV-specific IgA antibody in nasal wash specimens than of those with IgG in serum in our older adult population, one might hypothesize that antibodies to HCoV in nasal secretions decline in titer more rapidly after infection than do serum antibodies or that infection does not induce IgA antibody to HCoV in nasal secretions to high titers or at all in a significant proportion of older, chronically ill patients with COPD.', 0.6586037), ('Hence, despite the near-universal presence of serum antibodies to the HCoV strains in our study, the lower rates of detectable IgA antibodies to HCoV suggest a possible reason for susceptibility to reinfections with HCoV, if IgA antibodies in nasal secretions are indeed protective.', 0.652019)]"
789,Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity,independent,hypoalbuminemia predicts the outcome of covid-19 _ of age and co-morbidity,hypoalbuminemia predicts the outcome of covid-19 because of age and co-morbidity,https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.26003,"[('In conclusion, hypoalbuminemia is associated with the outcome of COVID-19.', 0.7307379), ('We aimed to explore the impact of hypoalbuminemia in COVID-19.', 0.70967937), ('Keywords: COVID-19; hypoalbuminemia; mortality; prediction; risk factor.', 0.7034869), ('Risk factors for predicting mortality of COVID-19 patients: A systematic review and meta-analysis.', 0.6346104), ('This retrospective cohort study included adult patients with confirmed COVID-19.', 0.63260365)]"
791,Antibodies to SARS-CoV-2 are associated with protection against reinfection,with,antibodies to sars-cov-2 are associated _ protection against reinfection,antibodies to sars-cov-2 are associated without protection against reinfection,https://www.medrxiv.org/content/10.1101/2020.11.18.20234369v1,"[('Conclusions Prior SARS-CoV-2 infection that generated antibody responses offered protection from reinfection for most people in the six months following infection.', 0.6968604), ('Overall, positive baseline anti-spike antibodies were associated with lower rates of PCR-positivity (with or without symptoms) (adjusted rate ratio 0.24 [95%CI 0.08-0.76, p=0.015]).', 0.6192894), (""This study is affiliated with Public Health England's Sarscov2 Immunity & Reinfection EvaluatioN (SIREN) study."", 0.4830153), ('Methods We investigated the incidence of SARS-CoV-2 PCR-positive results in seropositive and seronegative healthcare workers (HCWs) attending asymptomatic and symptomatic staff testing at Oxford University Hospitals, UK.', 0.4691386), ('Results A total of 12219 HCWs participated and had anti-spike IgG measured, 11052 were followed up after negative and 1246 after positive antibody results including 79 who seroconverted during follow up.', 0.37540695)]"
792,Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus .,inhibit,nitric oxide _ the replication cycle of severe acute respiratory syndrome coronavirus .,nitric oxide activations the replication cycle of severe acute respiratory syndrome coronavirus.,https://www.ncbi.nlm.nih.gov/pubmed/15650225,"[('Inhibition of influenza virus replication by nitric oxide.', 0.7883425), ('Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus.', 0.7027184), ('Nitric oxide in immunity and inflammation.', 0.6667049), ('Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo.', 0.6607535), ('Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication.', 0.6541923)]"
793,Blood test detects past infections with new coronavirus,past,blood test detects _ infections with new coronavirus,blood test detects novel infections with new coronavirus,https://newsroom.uw.edu/news/blood-test-detects-past-infections-new-coronavirus,"[('A new clinical blood test will start being conducted at the UW Medicine Virology Lab, beginning next week, to check people for past infection with SARS-CoV-2.', 0.6723296), ('They compared blood samples from confirmed cases with samples taken for other reasons before the new coronavirus emerged.', 0.6407062), ('It could spot a past infection with this new coronavirus and not confuse it with other viruses, including other respiratory coronaviruses.', 0.6267591), ('The test looks for the presence of an antibody, called IgG, which people produce in fending off the pandemic coronavirus.', 0.5641566), ('The appearance of certain antibodies in the blood could become one of the markers that an experimental vaccine is conferring resistance to the infection.', 0.5601541)]"
794,A Generational War Is Brewing Over Coronavirus,generation,a _ war is brewing over coronavirus,a lesseral war is brewing over coronavirus,https://www.wsj.com/articles/a-generational-war-is-brewing-over-coronavirus-11584437401?mod=hp_lead_pos5,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.35551068), ('As authorities moved to restrict social gatherings last week, bars and restaurants from New York to Berlin filled up with revelers, illegal “lockdown parties” popped up in France and Belgium, and campuses in the U.S. lit up for end-of-the-world dorm parties.', 0.22922727), ('Jump to navigation ', 0.11472514), ('Tuesday, March 17, 2020 - 12:55pm ', 0.04338633), ('WWU Spring and Summer Classes to be Mostly Remote Find more campus news ', 0.017700488)]"
795,Novel Coronavirus Pandemic may worsen existing Global Noncommunicable disease crisis,worse,novel coronavirus pandemic may _ existing global noncommunicable disease crisis,novel coronavirus pandemic may benefitn existing global noncommunicable disease crisis,http://www.ijncd.org/article.asp?issn=2468-8827;year=2020;volume=5;issue=1;spage=1;epage=3;aulast=Thakur,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.27640906), ('', -0.08362651), ('[c.]: circa [FT]: Financial Times', -0.09635728)]"
796,Pence tells governors coronavirus vaccine distribution could begin in two weeks,begin,pence tells governors coronavirus vaccine distribution could _ in two weeks,pence tells governors coronavirus vaccine distribution could decrease in two weeks,https://www.cbsnews.com/news/covid-19-vaccine-distribution-pence-tells-governors-two-weeks/,"[('Siphiwe Sibeko, Associated Press Vice President Mike Pence recently told governors across the country that some doses of the COVID-19 vaccine could be distributed in two weeks, CBS News reports.', 0.74419904), ('Pence and the governors planned to lay out the timeline for vaccine distribution.', 0.6054708), ('“We strongly believe the vaccine distribution process could begin as soon as the week of Dec. 14,” Pence said on the call, according to CBS News.', 0.55195445), ('High priority groups will see the first available vaccine doses.', 0.5437483), ('""We strongly believe the vaccine distribution process could begin as soon as the week of December 14,"" Pence said, according to audio of the call obtained by CBS News.', 0.52518225)]"
798,"Mass Screening Only Found Two Positive Cases out of 8,000 Tests So Far ; Hungary",two,"mass screening only found _ positive cases out of 8,000 tests so far ; hungary","mass screening only found 11 positive cases out of 8,000 tests so far ; hungary",https://hungarytoday.hu/coronavirus-mass-screening-hungary/,"[('In Hungary, a record of 932 tested positive on Wednesday.', 0.45504928), ('The head of the research project, Béla Merkely, said the numbers so far would suggest that there are between 243 and 7,230 people infected with COVID-19 over the age of 14 in Hungary.', 0.4540115), ('This means that the total number of Hungarians over the age of 14 who were previously infected and recovered, should be somewhere between 22,399 and 92,624, or between 0.27% and 1.1% of the population.', 0.43935138), ('Hungarian and foreign professionals are working on a process that can test... By Fanni Kaszás // 2020.04.02.', 0.42371702), ('Merkely, who is heading the project, said on Tuesday that the nationwide representative screeninghas produced just two positive results from 8,276 tests so far.', 0.41144413)]"
799,US racial inequality may be as deadly as COVID-19,deadly,us racial inequality may be as _ as covid-19,us racial inequality may be as useful as covid-19,https://www.pnas.org/content/early/2020/08/20/2014750117.abstract?et,"[('Racial inequality may be as deadly as Covid-19 (replication package).', 0.94450897), ('In reality, COVID-19 deaths themselves are highly disproportionately experienced by Black Americans and will almost certainly further widen the racial mortality gap (9).', 0.65273476), ('racial inequality mortality COVID-19 The COVID-19 pandemic is likely to kill people in the United States on a scale not seen in a century, since the 1918 flu.', 0.6437), ('For COVID-19 to raise mortality as much as racial inequality does, it would need to erase two to three decades of mortality progress for Whites.', 0.6320416), ('If Black disadvantage operates every year on the scale of Whites’ experience of COVID-19, then so too should the tools we deploy to fight it.', 0.6220099)]"
801,"Blood type could be linked to Covid-19 risk and severity , new research suggests",could,"blood type _ be linked to covid-19 risk and severity , new research suggests","blood type cannot be linked to covid-19 risk and severity, new research suggests",https://www.cnn.com/2020/10/14/health/blood-group-covid-19-scn-wellness/index.html,"[('Why do we have different blood types — and do they make us more vulnerable to Covid-19?', 0.7237365), (""While there are several theories, researchers don't yet know what mechanism could explain the link between different blood groups and Covid-19."", 0.630507), (""Here's how to find out yours A separate study, published in The New England Journal of Medicine in June, found genetic data in some Covid-19 patients and healthy people suggesting that those with Type A blood had a higher risk of becoming infected, and those with type O blood were at a lower risk."", 0.5611361), ('As for the novel coronavirus that causes Covid-19, ""We need to figure out the mechanism and understand it at the molecular level to be able to say for sure how this is occurring -- that this is really the O blood type and not something that kind of tracks with O blood type,"" Adalja said.', 0.55406547), ('Clotting has been a major driver of the severity of Covid-19.', 0.5536964)]"
802,"A National Mask Mandate Could Save The U.S. Economy $ 1 Trillion , Goldman Sachs Says",save,"a national mask mandate could _ the u.s. economy $ 1 trillion , goldman sachs says","a national mask mandate could decrease the u.s. economy $ 1 trillion, goldman sachs says",https://www.forbes.com/sites/sarahhansen/2020/06/30/a-national-mask-mandate-could-save-the-us-economy-1-trillion-goldman-sachs-says/,"[('The researchers estimate that a national mandate would increase the portion of people wearing masks by 15 percentage points, and cut the daily growth of new cases by 1.0 percentage point to 0.6%.', 0.38352728), ('Reducing the spread of the virus through mask-wearing, the analysts found, could be a substitute for strict lockdown measures that would otherwise shave 5%—or $1 trillion—off the U.S. GDP.', 0.29358676), ('Presumptive presidential nominee Joe Biden said that if he’s elected, he would use federal power to require all Americans to wear masks in public places.', 0.28564864), ('Jan 17, 2021,02:28pm EST NSA Will Install Trump Loyalist Michael Ellis As Its General Counsel Jan 17, 2021,12:15pm EST Stocks This Week: Sell Short General Dynamics And Transocean Jan 17, 2021,11:10am EST Fauci Warns Of ‘Ominous’ New Covid-19 Strains, Says Biden Can Achieve Aggressive Goal Of Vaccinating 100 Million In 100 Days Jan 17, 2021,09:00am EST January’s Message: 2021 Is Not 2020.', 0.23606631), ('Andrew Cuomo has also called for an executive order mandating that everyone wear masks in public, suggesting that President Trump—who has downplayed the importance of masks and dismissed suggestions that he wear one—should lead by example.', 0.20556204)]"
803,The race is on in the drug battle against the coronavirus,drug,the race is on in the _ battle against the coronavirus,the race is on in the natural battle against the coronavirus,https://www.scmp.com/news/china/society/article/3076502/race-drug-battle-against-coronavirus,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.35010013), ('Photo: Alamy Coronavirus pandemic \\+ FOLLOW China / People & Culture ', 0.3353629), ('Various medications are being tested to treat Covid-19.', 0.28307086), ('Photo: Alamy READ FULL ARTICLE [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.11171278), ('[c.]: circa [FT]: Financial Times', -0.038543396)]"
806,Comment on Analysis of hospital traffic and search engine data in Wuhan China indicates early disease activity in the Fall of 2019 by Nsoesie et al .,2019,comment on analysis of hospital traffic and search engine data in wuhan china indicates early disease activity in the fall of _ by nsoesie et al .,comment on analysis of hospital traffic and search engine data in wuhan china indicates early disease activity in the fall of 2011 by nsoesie et al.,http://nrs.harvard.edu/urn-3:HUL.InstRepos:42689379,"[('Analysis of hospital traffic and search engine data in Wuhan China indicates early disease activity in the Fall of 2019 (2020).', 0.9111048), ('It would have been interesting (and possibly much more convincing) to have seen control analyses of other Chinese cities outside of the Hubei region.” ‘ Analysis of hospital traffic and search engine data in Wuhan China indicates early disease activity in the Fall of 2019’ by Nsoesie et al is posted on the Harvard website .', 0.7120651), ('analysed vehicle counts in hospital parking lots and internet search trends, and suggested that the COVID-19 outbreak might have started in Wuhan, China as early as August 2019.', 0.70556307), ('We observe an upward trend in hospital traffic and search volume beginning in late Summer and early Fall 2019.', 0.61983883), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.57416165)]"
807,Politician raises alarm over Trudeau Govt 's plan to build COVID Quarantine/Isolation camps,alarm,politician raises _ over trudeau govt 's plan to build covid quarantine/isolation camps,politician raises support over trudeau govt's plan to build covid quarantine/isolation camps,https://www.lifesitenews.com/news/politician-raises-alarm-over-trudeau-govts-plan-to-build-covid-quarantine-isolation-camps,"[(""Art Babych / Shutterstock.com By Anthony Murdoch Share on Parler Share on Facebook Share on Twitter Share via Email Print this Page By Anthony Murdoch OTTAWA, Ontario, October 9, 2020 (LifeSiteNews) - An Ontario politician is raising alarm over the Trudeau Liberal government's plan to expand COVID isolation/quarantine facilities coast to coast."", 0.68687415), ('Randy Hillier, Independent Ontario MPP for Lanark, Frontenac & Kingston, expressed concern over the ""Federal Quarantine/Isolation sites"" in the provincial question period late this week.', 0.47893822), ('""So your government must be in negotiations and aware of these plans to potentially detain and isolate citizens and residents of our country and our province, so speaker, to the Premier, where will these camps be built, how many people will be detained, and for what reason, for what reasons can people be kept in these isolation camps, and I\'d like to have the Premier assure the people of Ontario…,"" said Hillier, whose microphone was cut off before he could finish.', 0.47076565), ('""The expansion of isolation/quarantine camps in Canada is something of concern and the Ontario government must know about it, so why won\'t they tell the people of Ontario?""', 0.46606815), ('The GoC\'s Buyandsell.gc.ca website lists every province and territory in Canada as needed as a potential region for delivery of ""Federal Quarantine/Isolation sites.""', 0.41756004)]"
809,Development and validation of a machine learning model for predicting illness trajectory and hospital resource utilization of COVID-19 hospitalized patients,machine,development and validation of a _ learning model for predicting illness trajectory and hospital resource utilization of covid-19 hospitalized patients,development and validation of a social learning model for predicting illness trajectory and hospital resource utilization of covid-19 hospitalized patients,https://www.medrxiv.org/content/10.1101/2020.09.04.20185645v2,"[('There is a need for a model to help planners assess expected COVID-19 hospital resource utilization.', 0.77397704), ('We further present the impact of several scenarios of patient influx on healthcare system utilization, and provide an R software package for predicting hospital-bed utilization.', 0.6811685), ('Interpretation: We developed a model that, given basic easily obtained data as input, accurately predicts total and critical care hospital utilization.', 0.613039), (""The model predicts the patient's entire disease course in terms of clinical states, from which we derive the patient's hospital length-of-stay, length-of-stay in critical state, the risk of in-hospital mortality, and total and critical care hospital-bed utilization."", 0.59592044), ('The model enables evaluating the impact of various patient influx scenarios on hospital utilization and planning ahead of hospital resource allocation.', 0.5901972)]"
811,"Researchers race to develop in-home testing for COVID-19 , a potential game changer",home,"researchers race to develop in-_ testing for covid-19 , a potential game changer","researchers race to develop in-hospital testing for covid-19, a potential game changer",https://www.pnas.org/content/early/2020/09/29/2019062117,"[('Download figure Open in new tab Download powerpoint To contain the COVID-19 pandemic, we need more frequent testing with faster turnaround times.', 0.61925894), ('Larremore recently coauthored a modeling study with Mina and others, now available in a preprint (1), showing that daily rapid testing, even with low- sensitivity tests, could be a useful screening strategy to discreetly identify asymptomatic COVID-19 patients.', 0.568473), ('Companies, he says, have been racing to develop the most sensitive test at all costs.', 0.52560556), ('The company has already developed a lab-based test that’s handheld and gives results in 15 minutes.', 0.50204027), ('Although PCR can reliably confirm an infection once a patient suspects they have COVID-19, the approach is too labor intensive for widespread screening of the larger asymptomatic population.', 0.46491492)]"
813,Major new lineages of SARS-CoV-2 emerge and spread in South Africa during lockdown .,africa,major new lineages of sars-cov-2 emerge and spread in south _ during lockdown .,major new lineages of sars-cov-2 emerge and spread in south China during lockdown.,https://www.medrxiv.org/content/10.1101/2020.10.28.20221143v1,"[('To rapidly understand the spread of SARS-CoV-2 in South Africa, we formed the Network for Genomics Surveillance in South Africa (NGS-SA).', 0.7532743), ('Our findings show that genomic surveillance can be implemented on a large scale in Africa to identify and control the spread of SARS-CoV-2.', 0.646724), ('C.1 was the most geographically widespread lineage in South Africa, causing infections in multiple provinces and in all of the eleven districts in KwaZulu-Natal (KZN), the most sampled province.', 0.47901005), ('Here, we analyze 1,365 high quality whole genomes and identify 16 new lineages of SARS-CoV-2.', 0.41776252), ('We also show that three lineages spread widely in South Africa and contributed to ~42% of all of the infections in the country.', 0.31508943)]"
814,SARS-CoV-2 infects brain choroid plexus and disrupts the blood-CSF-barrier,brain,sars-cov-2 infects _ choroid plexus and disrupts the blood-csf-barrier,sars-cov-2 infects intestinal choroid plexus and disrupts the blood-csf-barrier,https://www.biorxiv.org/content/10.1101/2020.08.20.259937v1,"[('Finally, we show that infection with live SARS-CoV-2 leads to barrier breakdown of the choroid plexus.', 0.78905797), ('Here, we use brain organoids to examine SARS-CoV-2 neurotropism.', 0.68055564), ('These findings suggest that neurological complications may result from effects on the choroid plexus, an important barrier that normally prevents entry of immune cells and cytokines into the cerebrospinal fluid (CSF) and brain.', 0.6429497), ('We find that infected cells of the choroid plexus are an apolipoprotein and ACE2 expressing subset of epithelial barrier cells.', 0.5374032), ('We then challenge organoids with both SARS-CoV-2 spike protein pseudovirus and live virus to demonstrate high viral tropism for choroid plexus epithelial cells but not stromal cells, and little to no infection of neurons or glia.', 0.44451338)]"
815,Scientists Create Antibody That Defeats Coronavirus in Cell Cultures,defeats,scientists create antibody that _ coronavirus in cell cultures,scientists create antibody that activate coronavirus in cell cultures,https://www.bloomberg.com/news/articles/2020-05-04/scientists-create-antibody-that-defeats-coronavirus-in-lab,"[('It looks like scientists have created a monoclonal antibody that can defeat the new Coronavirus in the lab.', 0.8000169), ('The experimental antibody has neutralized the virus in cell cultures.', 0.77654016), ('From a report: The experimental antibody has neutralized the virus in cell cultures.', 0.7540792), (""Scientists created a monoclonal antibody that can defeat the new coronavirus in the lab, an early but promising step in efforts to find treatments and curb the pandemic's spread."", 0.74204266), ('In this case, the scientists used genetically modified mice to produce different antibodies to the spike proteins of coronaviruses.', 0.6980466)]"
818,High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19 ; a prospective cohort study in England,high,_ prevalence of sars-cov-2 antibodies in care homes affected by covid-19 ; a prospective cohort study in england,Low prevalence of sars-cov-2 antibodies in care homes affected by covid-19 ; a prospective cohort study in england,https://www.medrxiv.org/content/10.1101/2020.08.10.20171413v1?rss=1%22,"[('Methods: Residents and staff had a convalescent blood sample for SARS-CoV-2 antibody levels and neutralising antibodies by SARS-COV-2 RT-PCR five weeks after the primary COVID-19 outbreak investigation.', 0.59297884), ('Almost all SARS-CoV-2 RT-PCR positive residents and staff were antibody positive five weeks later, whether symptomatic (residents 35/35, 100%; staff, 22/22, 100%) or asymptomatic (residents 32/33, 97.0%; staff 21/22, 95.1%).', 0.5379865), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.48982206), ('More than two-thirds of residents and staff members had detectable antibodies against SARS-CoV-2 irrespective of their nasal swab RT-PCR positivity or symptoms status.', 0.47200662), ('Conclusions: RT-PCR testing for SARS- CoV-2 significantly underestimates the true extent of an outbreak in institutional settings.', 0.44288588)]"
819,"COVID-19 Vaccine Shipped , and Drug Trials Start",shipped,"covid-19 vaccine _ , and drug trials start","covid-19 vaccine development, and drug trials start",https://time.com/5790545/first-covid-19-vaccine/,"[('That means that this vaccine method can be scaled up quickly, saving critical time when a new disease like COVID-19 emerges and starts infecting tens of thousands of people.', 0.6702889), ('The trial is the first to test a drug for treating COVID-19, and will be led by a team at the University of Nebraska Medical Center.', 0.6556138), ('Most Popular on TIME 1 What COVID-19 Mutations Mean for Vaccines 2 Why Is America So Divided Today?', 0.631274), ('Everything you need to know about the global spread of COVID-19 Please enter a valid email address.', 0.57234687), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.5548413)]"
820,Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2,defeat,fruitful neutralizing antibody pipeline brings hope to _ sars-cov-2,fruitful neutralizing antibody pipeline brings hope to create sars-cov-2,https://www.cell.com/trends/pharmacological-sciences/fulltext/S0165-6147(20)30166-8?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0165614720301668%3Fshowall%3Dtrue,"[('We also highlight the importance of a fruitful antibody development pipeline to combat the potential escape plans of SARS-CoV-2, including somatic mutations and antibody-dependent enhancement (ADE).', 0.7681537), ('Outstanding Questions What is the best strategy to develop broadly neutralizing antibodies against conserved epitopes of SARS-CoV-2?', 0.72233), ('Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies.', 0.71999884), ('We discuss these neutralizing antibodies in COVID-19 and highlight how the robust antibody pipeline can help to combat the escape strategies presented by SARS-CoV-2.', 0.70031595), ('SARS-CoV-2 may develop resistance to neutralizing antibodies by accumulating spontaneous mutations.', 0.6956169)]"
821,"It is the most comprehensive resource on the subject , providing a central access to 1200 research articles in PubMed .",most,"it is the _ comprehensive resource on the subject , providing a central access to 1200 research articles in pubmed .","it is the second comprehensive resource on the subject, providing a central access to 1200 research articles in pubmed.",https://www.ncbi.nlm.nih.gov/research/coronavirus/,"[('It is the most comprehensive resource on the subject, providing a central access to 1200 (and growing) relevant articles in PubMed.', 0.937693), (""PubMed Articles A preformulated search will bring up the latest research from the National Library of Medicine's PubMed Database."", 0.55993664), (""Articles from PubMed A preformulated search will bring up the latest research from the National Library of Medicine's PubMed Database."", 0.5563793), ('It includes thousands of open-access articles from the world’s leading publishers as well as current research from pre-print repositories such as arXiv and will continue to grow and evolve as more is learned about the pandemic.', 0.50111544), ('We update the database daily from searches of bibliographic databases, hand searches of the table of contents of relevant journals, and the addition of other relevant scientific articles that come to our attention.', 0.41952536)]"
822,Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2,clinical,_ benefit of remdesivir in rhesus macaques infected with sars-cov-2,No benefit of remdesivir in rhesus macaques infected with sars-cov-2,https://www.nature.com/articles/s41586-020-2423-5,"[('Here we investigate the efficacy of remdesivir in a rhesus macaque model of SARS-CoV-2 infection9.', 0.8557478), ('Thus, treatment with remdesivir initiated early during infection had a clinical benefit in rhesus macaques infected with SARS-CoV-2.', 0.8521764), ('1: Reduced respiratory disease in rhesus macaques infected with SARS- CoV-2 and treated with remdesivir.', 0.83498627), ('2 Viral loads and virus titres in swabs collected from rhesus macaques infected with SARS-CoV-2 and treated with remdesivir.', 0.7817713), ('Respiratory disease in rhesus macaques inoculated with SARS-CoV-2.', 0.7787179)]"
823,IBM Releases Novel AI-Powered Technologies to Help Health and Research Community Accelerate the Discovery of Medical Insights and Treatments for COVID-19,ibm,_ releases novel ai-powered technologies to help health and research community accelerate the discovery of medical insights and treatments for covid-19,CDC releases novel ai-powered technologies to help health and research community accelerate the discovery of medical insights and treatments for covid-19,https://www.ibm.com/blogs/research/2020/04/ai-powered-technologies-accelerate-discovery-covid-19/,"[('Today, we are making available multiple novel, free resources from across IBM to help healthcare researchers, doctors and scientists around the world accelerate COVID-19 drug discovery: from gathering insights, to applying the latest virus genomic information and identifying potential targets for treatments, to creating new drug molecule candidates.', 0.7946485), ('To help address this need, IBM Research has recently created a new, AI-generative framework which can rapidly identify novel peptides, proteins, drug candidates and materials.', 0.7794217), ('To streamline efforts to identify new treatments for COVID-19, we are also making the IBM Functional Genomics Platform available for free for the duration of the pandemic.', 0.776868), ('IBM is releasing these molecules under an open license, and researchers can study them via a new interactive molecular explorer tool to understand their characteristics and relationship to COVID-19 and identify candidates that might have desirable properties to be further pursued in drug development.', 0.775681), ('And now, those working on COVID-19 can request the IBM Functional Genomics Platform interface to explore the genomic features of the virus.', 0.76716083)]"
824,Favorable outcomes among neonates not separated from their symptomatic SARS-CoV-2-infected mothers,not,favorable outcomes among neonates _ separated from their symptomatic sars-cov-2-infected mothers,favorable outcomes among neonates also separated from their symptomatic sars-cov-2-infected mothers,https://www.nature.com/articles/s41390-020-01226-3,"[('Their newborns are at a higher risk of prematurity and early separation from their mothers, who may subsequently require intensive care for their own health.1,2 Although neonates born of mothers infected with SARS-CoV-2 during pregnancy are seemingly vulnerable to infection, studies have found that they were not at a high risk for severe infection and were very rarely affected by COVID-19.1,2,3,4,5,6 The presence of virus by real-time reverse transcriptase polymerase chain reaction (RT-PCR) has been reported in newborns before H 12 of life.1 In addition, antiviral immunoglobulin M has been detected in newborns at birth,7 suggesting that mother-to-infant viral transmission may occur.8 To date, however, only one case of vertical transmission has been clearly demonstrated.9 In several cases of early neonatal infection, postnatal contamination cannot be excluded.10 Moreover, only one case report found that the virus could pass from mother to infant through the mother’s breast milk.11 Despite these findings, international or national guidelines on the management of newborns of mothers suspected or positive for COVID-19, including Chinese consensus guidelines and guidelines of the American Academic of Pediatrics, have recommended at least temporary separation of mother and newborn as a precaution.12,13 In contrast, other guidelines,14 including those of the French Society of Neonatology,15,16 do not recommend systematic separation.', 0.5725429), ('Breastfeeding may protect against the horizontal transmission of SARS-CoV-2, as specific antibodies against this virus have been found in the breast milk of a COVID-19-infected mother.18 This hypothesis appears consistent with the protective effect of breastfeeding against respiratory tract infections in infancy.19 Our results support early postnatal proximity, despite many mothers worldwide being separated from their newborn infants during the COVID-19 pandemic.', 0.5609983), ('Characteristics andoutcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study.', 0.5192642), ('Detection of SARS-CoV-2 in human breastmilk.', 0.49941432), ('All other samples from neonates and all breast milk samples were negative for SARS-CoV-2 RNA.', 0.49020207)]"
826,Virological assessment of hospitalized patients with COVID-2019,2019,virological assessment of hospitalized patients with covid-_,virological assessment of hospitalized patients with covid-3,https://www.nature.com/articles/s41586-020-2196-x,"[('Detection of 2019 novel coronavirus (2019-nCoV) by real- time RT–PCR.', 0.53828347), ('Report of the WHO–China Joint Mission on Coronavirus Disease 2019 (COVID-19) https://www.who.int/docs/default-source/coronaviruse/who-china- joint-mission-on-covid-19-final-report.pdf (WHO, 2020).', 0.50266916), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.50043094), ('managed patients and evaluated clinical data.', 0.49843222), ('For sputum samples, interpolation based on a probit model was done to obtain laboratory-based infectivity criteria for the discharge of patients (Fig.', 0.46590152)]"
827,Pirates and publishers both battle COVID-19,pirates,_ and publishers both battle covid-19,Health and publishers both battle covid-19,https://newseu.cgtn.com/news/2020-02-17/Pirates-and-publishers-both-battle-COVID-19-O5lxgDGZCU/index.html,"[('A researcher studying COVID-19.', 0.55594695), ('Despite ongoing antagonism both sides are now doing their bit against the COVID-19 outbreak.', 0.542516), ('While remaining critical of the publishers, Tenant praises the fight against COVID-19, as a new paradigm.', 0.541764), (""Publishers Wiley, Springer Nature and Elsevier all signed onto the Wellcome Trust's pledge to share research data and findings relevant to COVID-19."", 0.5198866), ('However, the race to understand and combat COVID-19, has seen publishers take the unprecedented step of making a number articles and studies on coronaviruses free to access.', 0.48491174)]"
829,New Self-Administered Coronavirus Test Found Effective,new,_ self-administered coronavirus test found effective,No self-administered coronavirus test found effective,https://www.optum.com/covid-19/covid-19-news/self-administered-covid-19-test.html,"[('Self-administered COVID-19 coronavirus can be just as effective as physician- administered tests, according to a new study by UnitedHealth Group.', 0.63406223), (""Among 500 OptumCare patients in Washington state, the self-administered swabs were able to accurately detect the coronavirus that causes COVID-19 in 90% of those who are positive, a rate that's consistent with physician-administered swabs, the insurance giant announced."", 0.5527909), ('""Making viral testing faster, easier and less invasive will help us to encourage compliance and increase the number of daily tests conducted, a crucial part of disease surveillance during the pandemic,"" he noted.', 0.54753864), ('A new study found that self-administered tests may be as effective as those conducted by healthcare workers.', 0.54230917), ('Researchers found that self-administered swab tests accurately detected the disease in more than 90 percent of positive patients, which is consistent with physician-administered tests.', 0.51534605)]"
830,Phase 1 trial of a Candidate Recombinant Virus-Like Particle Vaccine for Covid-19 Disease Produced in Plants,plants,phase 1 trial of a candidate recombinant virus-like particle vaccine for covid-19 disease produced in _,phase 1 trial of a candidate recombinant virus-like particle vaccine for covid-19 disease produced in mice,https://www.medrxiv.org/content/10.1101/2020.11.04.20226282v1,"[('Added value of this study We report the results of the first clinical study of CoVLP, a virus-like particle (VLP) vaccine that is produced by transient transfection of Nicotiana benthamiana plants.', 0.6393062), ('We identified 10 peer- reviewed studies, describing phase 1 or 1/2 trials using a range of novel (eg: RNA, DNA, non-replicating virus vectored) and more traditional vaccine approaches (eg: inactivated virus or recombinant protein ± adjuvants).', 0.6371652), ('This candidate vaccine (CoVLP) was evaluated in healthy adults 18-55 years of age alone or with AS03 or CpG1018 (NCT04450004).', 0.61701417), ('The candidate vaccine (CoVLP) administered alone or with AS03 or CpG1018 adjuvants was evaluated in a Phase 1 trial in healthy adults.', 0.60735714), ('Although local and systemic adverse events following vaccination have varied between reports, the trials published to date suggest that each of these candidate vaccines is well-tolerated in the context of an evolving pandemic.', 0.57521975)]"
832,Colchicine to be investigated as a possible treatment for COVID-19 in the RECOVERY trial,recovery,colchicine to be investigated as a possible treatment for covid-19 in the _ trial,colchicine to be investigated as a possible treatment for covid-19 in the ICU trial,https://www.recoverytrial.net/news/colchicine-to-be-investigated-as-a-possible-treatment-for-covid-19-in-the-recovery-trial,"[('By including colchicine in the RECOVERY trial, we will be able to establish whether it helps tackle the worst consequences of COVID-19.’ It is anticipated that at least 2500 patients recruited to the RECOVERY trial will be randomly allocated to receive colchicine plus usual standard-of-care, and results will be compared with at least 2500 patients who receive the usual standard-of-care on its own.', 0.6556059), ('The decision to add colchicine to the trial was made by the University of Oxford researchers and trial steering committee leading the trial in conjunction with the Chief Medical Officer, following a recommendation by the UK COVID-19 Therapeutics Advisory Panel.', 0.6032105), ('Depending on recruitment rates, it is likely to be several months before there is enough evidence to conclude whether colchicine has a significant benefit in COVID-19 patients.', 0.55211747), ('Professor Martin Landray, from the Nuffield Department of Population Health at the University of Oxford, who co-leads the RECOVERY trial, explained ‘Inflammation plays a major role in COVID-19 and we’ve already shown that treatment with one anti-inflammatory drug, dexamethasone, can reduce deaths in the most severely ill COVID-19 patients.', 0.54373276), ('Over 2500 COVID-19 patients were randomly allocated to receive azithromycin and will be compared with over 5000 patients randomly allocated to usual standard-of-care on its own.', 0.4999644)]"
833,Years of life lost due to the psychosocial consequences of COVID19 mitigation strategies based on Swiss data,lost,years of life _ due to the psychosocial consequences of covid19 mitigation strategies based on swiss data,years of life increases due to the psychosocial consequences of covid19 mitigation strategies based on swiss data,https://www.medrxiv.org/content/10.1101/2020.04.17.20069716v3,"[('Methods We used years of life lost (YLL) as the main outcome measure as applied to Switzerland as an exemplar.', 0.6013762), ('However, this loss would be entirely borne by 2.1% of the population, who will suffer an average 9.79 YLL.', 0.31502944), ('These strategies however carry a significant risk for mental health which can lead to increased short-term and long-term mortality and is currently not included in modelling the impact of the pandemic.', 0.30761063), ('However, they highlight the need for public health models to expand their scope in order to provide better estimates of the risks and benefits of mitigation.', 0.28488362), ('Results The study projects that the average person would suffer 0.205 YLL due to psychosocial consequence of COVID-19 mitigation measures.', 0.28293836)]"
834,"Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations , a local lineage expansion and a virus with truncated ORF7a",thailand,"genomic surveillance of sars-cov-2 in _ reveals mixed imported populations , a local lineage expansion and a virus with truncated orf7a","genomic surveillance of sars-cov-2 in Europe reveals mixed imported populations, a local lineage expansion and a virus with truncated orf7a",https://www.medrxiv.org/content/10.1101/2020.05.22.20108498v1,"[('A virus sample in the SARS-CoV-2 A/Thai-1 lineage contains a frame-shift deletion at ORF7a, encoding a putative host antagonizing factor of the virus.', 0.7713895), ('Several virus lineages supposedly originated in many countries were found, and a Thai-specific lineage, designated A/Thai-1, has expanded to be predominant in Thailand.', 0.673365), ('1 Cladogram based on a maximum-likelihood tree showing Thai populations of SARS- CoV-2.', 0.63955903), ('Keywords: COVID-19; Genomic surveillance; SARS-CoV-2; Thailand.', 0.616747), ('Thai virus genomes independently generated by other groups and deposited in GISAID are labelled in green.', 0.614828)]"
836,Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets,blocks,therapeutically administered ribonucleoside analogue mk-4482/eidd-2801 _ sars-cov-2 transmission in ferrets,therapeutically administered ribonucleoside analogue mk-4482/eidd-2801 enhanced sars-cov-2 transmission in ferrets,https://www.nature.com/articles/s41564-020-00835-2,"[('2: Therapeutic MK-4482/EIDD-2801 is orally efficacious against SARS- CoV-2 in ferrets.', 0.7241975), ('We previously reported the development of an orally efficacious ribonucleoside analogue inhibitor of influenza viruses, MK-4482/EIDD-2801 (refs.', 0.69715196), ('The samples from the source ferrets treated with MK-4482/EIDD-2801 and their contacts were PCR-negative for viral RNA.', 0.68108463), ('The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal Venezuelan equine encephalitis virus infection.', 0.66259587), ('Orally efficacious broad-spectrum ribonucleoside analog inhibitor of influenza and respiratory syncytial viruses.', 0.6519389)]"
838,"''walkthroughs are still permitted , but any group or team activity in city parks is banned . '",banned,"''walkthroughs are still permitted , but any group or team activity in city parks is _ . '","''walkthroughs are still permitted, but any group or team activity in city parks is too. '",https://www.cbc.ca/news/canada/ottawa/ncc-path-closed-open-covid19-1.5512498,"[('The NCC closed Gatineau Park on Monday, and Ottawa and Gatineau have banned certain uses of city parks.', 0.501526), ('Groups or team activities > are prohibited.', 0.47348613), ('The closure involves ""all city park facilities and park equipment,"" which includes playgrounds.', 0.46886045), ('More on City services: <a > href=""https://t.co/2N5KxLm55R"">https://t.co/2N5KxLm55R</a> <a > href=""https://t.co/gsL7Yha6n8"">pic.twitter.com/gsL7Yha6n8</a> > > &mdash;@ottawacity The National Capital Commission (NCC) also announced Friday it\'s shutting down parking lots at its trails and dog parks in Ottawa\'s Greenbelt, starting 9 p.m. Friday.', 0.4392233), ('""We recognize that this decision will affect residents\' enjoyment of the Greenbelt, but we must make every effort to protect employees, contractors and trail users from COVID-19 and ensure compliance with public health directives from all levels of government, particularly the call to avoid all non- essential trips,"" the NCC said in a news release.', 0.43067133)]"
839,"Oxford vaccine could be 59 % effective against asymptomatic infections , analysis shows",could,"oxford vaccine _ be 59 % effective against asymptomatic infections , analysis shows","oxford vaccine cannot be 59 % effective against asymptomatic infections, analysis shows",https://www.bmj.com/content/371/bmj.m4777,"[('The BMJ The Oxford and AstraZeneca covid-19 vaccine prevented some asymptomatic covid-19 infections in phase III trials, but the effect was mainly seen in the group who received a half dose first, followed by a full dose, the peer reviewed efficacy results have shown.1 The study, published in the Lancet , found that vaccine efficacy against asymptomatic transmission was 59% in the group that received a half dose followed by a standard dose (seven cases among 1120 participants versus 17 cases among 1127 participants in the control group), but just 4% in the group that received two standard doses (22 among 2168 participants versus 23 among 2223 for the control).', 0.56149435), ('Analysis of the primary outcome—efficacy against symptomatic cases of covid-19—showed that the vaccine was 62.1% effective in participants who received two standard doses (n=4440) and 90% effective in those who received a low dose followed by a standard dose (n=1120).', 0.5263355), ('Half of the participants were given the covid-19 vaccine and the other half given a control (either a meningococcal conjugate vaccine or saline).', 0.4383725), ('Merryn Voysey, study author and lead statistician at the Oxford Vaccine Group said, “In future analyses, with more data included as it becomes available, we will investigate differences in key subgroups such as older adults, various ethnicities, doses, and timing of booster vaccines, and we will determine which immune responses equate to protection from infection or disease.” Alongside asymptomatic infections, another secondary outcome of the trial was prevention of severe disease.', 0.41562253), ('Of these participants, 168 experienced a total of 175 severe adverse events over the period, but 172 of these were deemed unrelated to the covid-19 or control vaccines.', 0.40754986)]"
840,Coronavirus Mutation May Have Made It More Contagious .,more,coronavirus mutation may have made it _ contagious .,coronavirus mutation may have made it less contagious.,https://news.utexas.edu/2020/10/30/coronavirus-mutation-may-have-made-it-more-contagious/,"[('Perhaps they’re more contagious.', 0.69483566), ('But the mutation appears to have made the pandemic spread further and faster than it would have without it.', 0.68754244), ('But one mutation near the beginning of the pandemic did make a difference, multiple new findings suggest, helping the virus spread more easily from person to person and making the pandemic harder to stop.', 0.6611112), ('For that reason, as the virus changes, a vaccine might need to change along with it.', 0.6518757), ('Patients with that strain of coronavirus carried more virus particles than other people, meaning they were probably more infectious, the study found.', 0.6510848)]"
841,The Recent CDC Report on Comorbidity is NOT Good News or Evidence of a Hoax,not,the recent cdc report on comorbidity is _ good news or evidence of a hoax,the recent cdc report on comorbidity is very good news or evidence of a hoax,https://testset.io/2020/09/04/the-recent-cdc-report-on-comorbidity-is-not-good-news-or-evidence-of-a-hoax/,"[(""The scientist speaking in this article says 'comorbidities' yet spell check advises 'comorbiditys.'"", 0.4530962), ('Lessler is an infectious disease specialist at the Bloomberg School of Public Health and was interviewed by John Hopkins publication Hub and clarified the recent CDC report: “ The importance of this CDC data is showing the comorbidities in people who have died with COVID-19, in hopes of better understanding the risk factors for death.', 0.42618316), ('""[The report] surely includes some new data, but the general finding—that comorbidities increase your risk of dying from COVID-19—is not a surprise at all,"" Lessler has said.', 0.39379334), (""It's impossible for us to know the individual scenarios from death certificates, but the prevalence of respiratory factors [in the CDC findings] are consistent with being downstream conditions."", 0.38567185), (""Certainly if you know you have a comorbidity, that's reason to be extra careful."", 0.37900046)]"
843,Immunosuppression is associated with a lower risk of moderate to severe acute respiratory distress syndrome in COVID-19 .,lower,immunosuppression is associated with a _ risk of moderate to severe acute respiratory distress syndrome in covid-19 .,immunosuppression is associated with a increased risk of moderate to severe acute respiratory distress syndrome in covid-19.,https://www.researchsquare.com/article/rs-27095/v1,"[('CONCLUSIONS : In our cohort of COVID-19 patients, immunosuppression was associated with a lower risk of moderate-severe ARDS.', 0.8509977), ('The role of immunosuppression among COVID-19 patients has not been elucidated and management may be challenging.', 0.6005575), ('OBJECTIVE : To assess differences in severe outcomes of hospitalized patients with COVID-19 according to immune system state.', 0.5818319), ('A positive non-significant trend toward a longer time to moderate or severe ARDS, a lower need for MV/NIV, and a lower risk of death or MV/NIV were detected in IC.', 0.52428603), ('This suggests a potential protective effect from a hypothesized host hyper-inflammatory response and warrants reconsideration of drug discontinuation in IC patients.', 0.51572347)]"
844,Research by Tennessee Scientists at Oak Ridge Labs on existing drug compounds via supercomputing could combat coronavirus .,tennessee,research by _ scientists at oak ridge labs on existing drug compounds via supercomputing could combat coronavirus .,research by Chinese scientists at oak ridge labs on existing drug compounds via supercomputing could combat coronavirus.,https://www.ornl.gov/news/early-research-existing-drug-compounds-supercomputing-could-combat-coronavirus,"[('The Oak Ridge National Laboratory in Tennessee (one member of the consortium) is using its supercomputers to look for compounds already on the market that might foil the virus.', 0.7914807), ('Carlos Jones/Oak Ridge National Laboratory hide caption toggle caption Carlos Jones/Oak Ridge National Laboratory Researchers at the Oak Ridge National Laboratory are using supercomputers to calculate which drugs may help in the fight against the coronavirus.', 0.77578753), (""Oak Ridge National Laboratory scientists have focused the power of the world's fastest supercomputer to search for an existing drug that can prevent the new coronavirus from penetrating human cells."", 0.73163885), ('Oak Ridge National Laboratory, where Summit is housed, recently granted researchers emergency computation time to run through a database of existing drug compounds to see which combinations might prevent cell infection of COVID-19.', 0.63345873), (""Previous Next Newswise -- OAK RIDGE, Tenn. March 5, 2020 - Researchers at the Department of Energy's Oak Ridge National Laboratory have used Summit, the world's most powerful and smartest supercomputer, to identify 77 small-molecule drug compounds that might warrant further study in the fight against the SARS-CoV-2 coronavirus, which is responsible for the COVID-19 disease outbreak."", 0.62254673)]"
845,Pre-Emptive Low Cost Social Distancing and Enhanced Hygiene Implemented before Local COVID-19 Transmission Could Decrease the Number and Severity of Cases .,decrease,pre-emptive low cost social distancing and enhanced hygiene implemented before local covid-19 transmission could _ the number and severity of cases .,pre-emptive low cost social distancing and enhanced hygiene implemented before local covid-19 transmission could increase the number and severity of cases.,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3549276,"[('Here we explore whether low cost pre-emptive enhanced hygiene and social distancing should be implemented prior to confirmation of community transmission in countries without, or with minimal, confirmed person-to-person transmission of COVID-19.', 0.82804316), ('Pre-emptive, low cost, hygiene enhancement and social distancing in the context of imminent community transmission of novel coronavirus COVID-19 should be considered.', 0.720066), ('Hygiene measures mostly act on the second factor, as they reduce the risk of transmission if a contact occurs.', 0.7188612), ('Figure 1 available in the PDF version Enhanced hygiene and social distancing measures may reduce both numbers of cases and severity of cases through several mechanisms We suggest that a pre-emptive implementation of low cost interventions prior to detection, but in imminent expectation of community transmission should be considered because it may decrease both the total numbers of cases and severity of cases.', 0.7175324), ('These low cost enhanced hygiene and physical distancing measures are applicable pre‐emptively before confirmation of local community transmission or where transmission of SARS‐CoV‐2 appears to be under control.', 0.68337387)]"
847,Prevalence of SARS-CoV-2 Among Patients Admitted for Childbirth in Southern Connecticut,prevalence,_ of sars-cov-2 among patients admitted for childbirth in southern connecticut,Lack of sars-cov-2 among patients admitted for childbirth in southern connecticut,https://jamanetwork.com/journals/jama/fullarticle/2766650,"[('2 Department of Obstetrics and Gynecology, Bridgeport Hospital, Bridgeport, Connecticut.', 0.6186783), ('Questionnaire-based vs universal PCR testing for SARS-CoV-2 in women admitted for delivery.', 0.59357667), ('Maternal, fetal and neonatal outcomes of large series of SARS-CoV-2 positive pregnancies in peripartum period: A single-center prospective comparative study.', 0.51478297), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.44303125), ('AGA Institute Rapid Review and Recommendations on the Role of Pre-Procedure SARS-CoV-2 Testing and Endoscopy.', 0.37670958)]"
848,Polish Doctor treats covid19 symptoms within 48h with amantadine .,polish,_ doctor treats covid19 symptoms within 48h with amantadine .,No doctor treats covid19 symptoms within 48h with amantadine.,https://przychodnia-przemysl.pl/covid-19-can-be-treated-in-48-hours/,"[('In Polish + comments section (also treated patients stories): https://przychodnia-przemysl.pl/mozna-wyleczyc-covid-19-w-48-godzin/ Image: CDC/ Alissa Eckert, MS; Dan Higgins, MAM - https://phil.cdc.gov/Details.aspx?pid=23312 ', 0.5559536), ('Amantadine Treatment for People with COVID-19 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290190/ 3.', 0.5284163), ('AVAILABLE SCHEME: > How to treat COVID-19 in 48 hours - scheme ', 0.5117763), ('Amantadine as a drug to mitigate the effects of COVID-19 https://www.sciencedirect.com/science/article/pii/S030698772030654X 2.', 0.5088681), ('Odpowiedz 116. matt 31 października 2020, 1:12 Kto Pana nastraszył?', 0.5067276)]"
849,Covid-19 's known unknowns,unknown,covid-19 's known _,covid-19's known froms,https://www.bmj.com/content/371/bmj.m3979,"[('1 The unknowns about T cells in COVID-19 in relation to disease severity, memory formation, and vaccination.', 0.62956727), ('Dynamic causal modelling of COVID-19.', 0.6135591), ('J.-L. Casanova , Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.', 0.57068753), ('The critical issue here will be to not forget about Covid-19 if and when this crisis is ever over.', 0.53884375), ('J.-L. Casanova , Autoantibodies against type I IFNs in patients with life-threatening COVID-19.', 0.5310871)]"
850,FDA issued an Emergency Use Authorization for Cellex qSARS-CoV-2 IgG/IgM Rapid Test,fda,_ issued an emergency use authorization for cellex qsars-cov-2 igg/igm rapid test,WHO issued an emergency use authorization for cellex qsars-cov-2 igg/igm rapid test,https://www.fda.gov/media/136625/download,"[('Notably, the FDA issued an emergency use authorization, on April 1, 2020, to Cellex Inc.’s qSARS-CoV-2 IgG/IgM Rapid Test which is the first serology test to date to receive authorization to test for the presence of coronavirus antibodies.', 0.74206007), (""By Dave Muoio April 02, 2020 03:13 pm Share Editor's note: On the same day this story was published, the FDA publicized the first Emergency Use Authorization of a serology test,Cellex Inc.’s qSARS- CoV-2 IgG/IgM Rapid Test."", 0.7036588), ('A new FDA Voices was issued: FDA Commissioned Corps Officers on the Front Line of COVID-19 Response.', 0.66496336), ('The FDA has been notified that more than 125 laboratories have begun testing under the policies set forth in our COVID-19 Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency Guidance.', 0.62433577), ('Press Announcements FDA News Release ', 0.61424196)]"
855,Brazilian Health Regulatory Agency approves trial of Oxford COVID-19 Vaccine,brazilian,_ health regulatory agency approves trial of oxford covid-19 vaccine,National health regulatory agency approves trial of oxford covid-19 vaccine,http://www.ox.ac.uk/news/2020-06-04-brazilian-health-regulatory-agency-approves-trial-oxford-covid-19-vaccine,"[('On April 30, the University of Oxford and AstraZeneca announced an agreement for the global development and distribution of the University’s potential recombinant adenovirus vaccine aimed at preventing COVID-19 infection from SARS-CoV-2.', 0.59329045), ('Brazil is a priority for the study because of the ascendant curve of the COVID-19.', 0.5707238), ('“We are delighted to be working with the talented team of investigators in Brazil on the COVID19 vaccine trial, as researchers and scientists around the world collaborate on clinical development work with unprecedented urgency to combat the global threat to human health that is coronavirus.” Says Professor Andrew Pollard, Chief investigator of the Oxford Vaccine Trial at Oxford University.', 0.5637921), ('On 2 June, the Brazilian Health Regulatory Agency (ANVISA) approved the inclusion of Brazil in the clinical trials conducted by Oxford University and supported by AstraZeneca, considering 2,000 volunteers to be tested in the country.', 0.5626471), ('To ensure you have the latest information or to find out more about the trial, please visit theOxford COVID-19 vaccine web hub or visit the COVID-19 trial website .', 0.5573489)]"
856,FDA is issuing this guidance to provide a policy to help expand the availability of general use face masks for the general public and particulate filtering facepiece respirators .,issuing,fda is _ this guidance to provide a policy to help expand the availability of general use face masks for the general public and particulate filtering facepiece respirators .,fda is not this guidance to provide a policy to help expand the availability of general use face masks for the general public and particulate filtering facepiece respirators.,https://www.fda.gov/media/136449/download,"[('The guidance states the FDA is looking to expand the availability of general use face masks for the general public and particulate filtering facepiece respirators for HCPs during this emergency.', 0.9166584), ('Second, to facilitate the safe reuse and conservation of PPE for a medical purpose, FDA expressed interest in interacting with manufacturers on the decontamination of otherwise disposable face masks and filtering facepiece respirators to facilitate marketing authorization through an Emergency Use Authorization (EUA) for new decontamination devices.', 0.7861615), ('FDA is committed to providing timely guidance to support response efforts to this pandemic.', 0.6858649), ('The guidance does three key things: First, FDA recognizes that when FDA-cleared masks or respirators are unavailable, individuals, including HCPs, might improvise PPE.', 0.6556182), ('The recent guidance reflects how the FDA is adapting to the COVID-19 emergency.', 0.62769616)]"
857,The coronavirus is most deadly if you are older and male,most,the coronavirus is _ deadly if you are older and male,the coronavirus is not deadly if you are older and male,https://www.nature.com/articles/d41586-020-02483-2,"[('Gender is also a strong risk factor, with men almost twice more likely to die from the coronavirus than women.', 0.71619), ('The results also revealed that men are more likely to die of the infection than are women — the gap increasing with age.', 0.6163694), ('And differences between countries in the fatality estimates for older age groups suggest that the risk of dying from coronavirus is also linked to underlying health conditions, the capacity of health-care systems, and whether the virus has spread among people living in elderly-care facilities.', 0.58689153), ('2 The immune system might also explain the much higher risk of older people dying from the virus.', 0.5516508), ('Trends in coronavirus deaths by age have been clear since early in the pandemic.', 0.54480106)]"
860,National University of Singapore 's school of public health does weekly lit reviews and compiles it into scientific reports .,singapore,national university of _ 's school of public health does weekly lit reviews and compiles it into scientific reports .,national university of China's school of public health does weekly lit reviews and compiles it into scientific reports.,https://sph.nus.edu.sg/covid-19/research/,"[('Get the latest public health information from CDC: https://www.coronavirus.gov Get the latest research information from NIH: https://www.nih.gov/coronavirus Find NCBI SARS-CoV-2 literature, sequence, and clinical content: https://www.ncbi.nlm.nih.gov/sars-cov-2/ National Institutes of Health National Library of Medicine National Center for Biotechnology Information NCBI homepage Log in Show account info Close ', 0.5899432), ('The COVID-19 Science Report is submitted weekly to the Chief Health Scientist of the Ministry of Health, and was created and updated on an ongoing basis by a team of several researchers.', 0.58071315), (""Tan Hao Yi, medical student at University of New South Wales, Australia, fulfilling a medical elective with the School's Public Health Translational Team Assoc Prof Yap placed me with the School’s Public Health Translational Team (PHTT) and I immediately joined the team responsible for preparing the weekly COVID-19 Science Report, which reviews the latest literature relevant to managing the COVID-19 outbreak."", 0.5694889), ('Overall, 30 (11%), five (2%), seven (2%) and 37 (14%) studies reported findings relevant to TB-HIV, childhood TB, MDR-TB and access to quality diagnosis and treatment respectively.', 0.5066622), ('Keywords: Cambodia; Tuberculosis; policy; systematic review.', 0.49148637)]"
861,Unfractionated heparin potently inhibits the binding of SARS-CoV-2 spike protein to a human cell line,inhibit,unfractionated heparin potently _ the binding of sars-cov-2 spike protein to a human cell line,unfractionated heparin potently leads the binding of sars-cov-2 spike protein to a human cell line,https://www.biorxiv.org/content/10.1101/2020.05.21.107870v1,"[('Despite the sensitivity to heparin, we found no evidence that host cell glycosaminoglycans such as heparan and chondroitin sulphates play a major role in spike protein attachment.', 0.66145813), ('Unfractionated heparin inhibited spike protein binding with an IC50 value of <0.05U/ml whereas two low molecular weight heparins were much less effective.', 0.6232698), ('The spike protein is processed by membrane proteases, including TMPRSS2, and is either internalised or fuses directly with the cell, leading to infection.', 0.48530284), ('As the spike protein has previously been shown to bind heparin, a soluble glycosaminoglycan, we used a flow cytometry assay to determine the effect of heparin on spike protein binding to RT4 cells.', 0.47701722), ('This suggests that heparin, particularly unfractionated forms, could be considered to reduce clinical manifestations of COVID-19 by inhibiting continuing viral infection.', 0.45521817)]"
862,Rapid Clinical Recovery of Critical COVID-19 ICU Patient with Respiratory Failure treated with RLF-100 drug,100,rapid clinical recovery of critical covid-19 icu patient with respiratory failure treated with rlf-_ drug,rapid clinical recovery of critical covid-19 icu patient with respiratory failure treated with rlf-3 drug,https://www.preprints.org/manuscript/202007.0178/v1,"[('Patients with Critical COVID-19 and respiratory failure, currently treated with high flow nasal oxygen, non-invasive ventilation, or mechanical ventilation, will be treated with RLF-100 (Aviptadil).', 0.7901898), ('Four days earlier, Relief and NeuroRx said that RLF-100 showed rapid recovery from respiratory failure in the most critically ill patients with COVID-19—those on ventilators and ECMO (extracorporeal membrane oxygenation)—who were treated under FDA Emergency Use IND authorization.', 0.72554564), ('The FDA has granted NeuroRx an Expanded Access Protocol (NCT04453839) for treatment of respiratory failure in COVID-19 with RLF-100.', 0.72041154), ('; Javitt, J.C. Brief Report: Rapid Clinical Recovery from Critical COVID-19 with Respiratory Failure in a Lung Transplant Patient Treated with Intravenous Vasoactive Intestinal Peptide .', 0.7055311), ('August 2, 2020 \\- Critically ill COVID-19 patients recovered rapidly from respiratory failure after three days of treatment with RLF-100, a therapy granted fast-track designation in the United States, two drug companies said Sunday.', 0.7008034)]"
863,Artificial intelligence model detects asymptomatic Covid-19 infections through cellphone-recorded coughs,detect,artificial intelligence model _ asymptomatic covid-19 infections through cellphone-recorded coughs,artificial intelligence model cannots asymptomatic covid-19 infections through cellphone-recorded coughs,https://news.mit.edu/2020/covid-19-cough-cellphone-detection-1029,"[('New AI model detects asymptomatic Covid-19 infections through device-recorded coughs Vocal sentiments Prior to the pandemic’s onset, research groups already had been training algorithms on cellphone recordings of coughs to accurately diagnose conditions such as pneumonia and asthma.', 0.7626249), ('When they fed the model new cough recordings, it accurately identified 98.5 percent of coughs from people who were confirmed to have Covid-19, including 100 percent of coughs from asymptomatics — who reported they did not have symptoms but had tested positive for the virus.', 0.6488896), ('Close Caption: MIT researchers have found that people who are asymptomatic for Covid-19 may differ from healthy individuals in the way that they cough.', 0.6027898), ('The model identified 98.5 percent of coughs from people confirmed with Covid-19, and of those, it accurately detected all of the asymptomatic coughs.', 0.59758383), ('When the coronavirus pandemic began to unfold, Subirana wondered whether their AI framework for Alzheimer’s might also work for diagnosing Covid-19, as there was growing evidence that infected patients experienced some similar neurological symptoms such as temporary neuromuscular impairment.', 0.58176446)]"
864,NIH-Moderna investigational COVID-19 vaccine shows promise in mouse studies,mouse,nih-moderna investigational covid-19 vaccine shows promise in _ studies,nih-moderna investigational covid-19 vaccine shows promise in cancer studies,https://www.nih.gov/news-events/news-releases/nih-moderna-investigational-covid-19-vaccine-shows-promise-mouse-studies,"[('The investigational vaccine also induced robust CD8 T-cell responses in mice.', 0.6756586), ('They also explain how their prior research on a candidate MERS-CoV vaccine paved the way for a rapid response to the COVID-19 outbreak.', 0.5993553), ('The investigators vaccinated mice with sub-protective doses of mRNA-1273 and then challenged the mice with SARS-CoV-2.', 0.5893287), ('Importantly, mice challenged 7 weeks after only a single dose of 1 mcg or 10 mcg of mRNA-1273 were also protected against viral replication in the lung .', 0.5685003), ('Additional experiments found that mice given two injections of the 1-mcg dose and later challenged with SARS-CoV-2 virus either 5 or 13 weeks after the second injection were protected from viral replication in the lungs and nose.', 0.5632341)]"
865,Steroids cut deaths of hospitalized Covid-19 patients by one-third,third,steroids cut deaths of hospitalized covid-19 patients by one-_,steroids cut deaths of hospitalized covid-19 patients by one-one,https://www.statnews.com/2020/09/02/covid19-steroids-reduce-deaths-of-hospitalized-patients-who-analysis-confirms/,"[('Eighteen percent of patients on steroids reported side effects compared to 23% of patients on usual care or placebo.', 0.64239407), ('Corticosteroids are the first, and so far only, therapy shown to improve the odds of survival for critically ill patients with Covid-19.', 0.62909746), ('One of the concerns about steroids is, given too early in the course of Covid-19, they might hamper the body’s ability to eliminate the virus, leading to worse outcomes.', 0.6223148), ('The first evidence that common steroids could improve the survival of patients with severe Covid-19 came in June when British researchers conducting a large clinical trial called RECOVERY reported that the use of dexamethasone reduced the death rate by 35% in patients requiring ventilation and by 20% in patients who needed oxygen but were not ventilated.', 0.6000957), ('But it cautioned against use of the steroids in patients with non-severe illness, saying that “indiscriminate use of any therapy for COVID-19 would potentially rapidly deplete global resources and deprive patients who may benefit from it most as potentially life-saving therapy.” advertisement “The consistent findings of benefit in these studies provide definitive data that corticosteroids should be first-line treatment for critically ill patients with COVID-19,” said Hallie Prescott and Todd Rice, professors of medicine at the University of Michigan and Vanderbilt University, respectively, in an accompanying JAMA editorial.', 0.5983757)]"
866,Antigen-based testing but not real-time PCR correlates with SARS-CoV-2 virus culture,not,antigen-based testing but _ real-time pcr correlates with sars-cov-2 virus culture,antigen-based testing but also real-time pcr correlates with sars-cov-2 virus culture,https://www.medrxiv.org/content/10.1101/2020.10.02.20205708v1,"[('When compared to infectious virus isolation, the sensitivity of antigen-based testing is similar to RT-PCR.', 0.68673944), ('The correlation between SARS-CoV-2 antigen and SARS-CoV-2 culture represents a significant advancement in determining the risk for potential transmissibility beyond that which can be achieved by detection of SARS-CoV-2 genomic RNA.', 0.6435996), ('Specifically, this study did not assess health outcomes associated with the use of this assay.', 0.43018484), ('Coupled with a rapid time-to-result, low cost, and scalability, antigen-based testing should facilitate effective implementation of testing and public health interventions that will better contain COVID-19.', 0.41032368), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.37925425)]"
867,"Coronavirus May Reactivate in Cured Patients , Korean CDC Says",may,"coronavirus _ reactivate in cured patients , korean cdc says","coronavirus cannot reactivate in cured patients, korean cdc says",https://www.bloomberg.com/news/articles/2020-04-09/coronavirus-may-reactivate-in-cured-patients-korean-cdc-says,"[(""Coronavirus may 'reactivate' in cured patients: Korean CDC Can BCG vaccine help in coronavirus fight?"", 0.8569813), ('Rather than being infected again, the virus may have been reactivated in these people, given they tested positive again shortly after being released from quarantine, said Jeong Eun-kyeong, director-general of the Korean CDC.', 0.6483418), ('About 51 patients classed as having been cured in South Korea have tested positive again, the Korean CDC said.', 0.62550586), ('About 51 patients classed as having been cured in South Korea have tested positive again, the CDC said in a briefing on Monday.', 0.5760163), ('The Korean CDC will conduct an epidemiological probe into the cases, Jeong said.', 0.5380112)]"
869,Comparison of Estimated Excess Deaths in New York City During the COVID-19 and 1918 Influenza Pandemics,1918,comparison of estimated excess deaths in new york city during the covid-19 and _ influenza pandemics,comparison of estimated excess deaths in new york city during the covid-19 and 2009 influenza pandemics,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2769236,"[('This cohort study compares the excess deaths in New York City during the peak of the 1918 H1N1 influenza pandemic with those during the early period of the COVID-19 pandemic.', 0.88541496), ('These findings suggest that the mortality associated with COVID-19 during the early phase of the New York City outbreak was comparable to the peak mortality observed during the 1918 H1N1 influenza pandemic.', 0.84745175), ('Deaths in New York City During the 1918 H1N1 Influenza Pandemic and the Coronavirus Disease 2019 (COVID-19) Pandemic and During the Preceding Years of Both Pandemics ', 0.83467066), ('Few persons in the US have a frame of reference for the historic levels of excess mortality currently being observed during the coronavirus disease 2019 (COVID-19) pandemic.1 In this study, excess deaths in New York City during the peak of the 1918 H1N1 influenza pandemic were compared with those during the initial period of the COVID-19 outbreak.', 0.74553037), ('Centers for Disease Control and Prevention Excess deaths associated with COVID-19.', 0.66939104)]"
872,FDA Authorizes First Next Generation Sequence Test for Diagnosing COVID-19,next,fda authorizes first _ generation sequence test for diagnosing covid-19,fda authorizes first one generation sequence test for diagnosing covid-19,https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-next-generation-sequence-test-diagnosing-covid-19,"[('The FDA authorized the Illumina COVIDSeq Test for the qualitative detection of SARS-CoV-2 RNA from respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.', 0.6489115), ('“Throughout the COVID-19 pandemic, we have seen the ingenuity that results from the FDA working in partnership with the private sector.', 0.5136567), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.50107586), ('Press Announcements FDA Statement ', 0.49621752), ('The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices.', 0.44279683)]"
875,Millennials may be at a higher risk for catching coronavirus,higher,millennials may be at a _ risk for catching coronavirus,millennials may be at a lower risk for catching coronavirus,https://nypost.com/2020/03/18/millennials-may-be-at-a-higher-risk-for-catching-coronavirus-official-says/,"[('""It may have been that the millennial generation, our largest generation, our future generation, that will carry us through for the next multiple decades — there may be a disproportional number of infections among that group.', 0.58378386), ('Filed under Coronavirus , millennials , white house , 3/18/20 ', 0.44097075), ('and so, even if it’s a rare occurrence, it may be seen more frequently in that group and be evident now,” she continued, calling on millennials to avoid large gatherings out of a false sense of security.', 0.43980047), ('I\'m not going... ""I don\'t know if you felt invincible when you were very young, but they were feeling totally invincible, or are feeling that way, but they don\'t realize that they could be carrying lots of bad things home to grandmother and grandfather and even their parents.', 0.43510264), (""The president was also asked about his message to young people, some of whom believe the virus danger has been overblown, and said they should avoid large gatherings so that they don't infect themselves or their loved ones."", 0.4123436)]"
878,A hospital based observational study .,observation,a hospital based _ study .,a hospital based designal study.,https://www.medrxiv.org/content/10.1101/2020.11.12.20230631v1,"[('Second, this is a hospital-based study in an urban set-up, which may not be representative and applicable to general population.', 0.6749022), ('They were analyzed to enable identification of problems, risk factors, and prognostic factors that might be specific to this patient population.', 0.5802113), ('This finding was expected, given that our sample was drawn from an urban tertiary-care hospital.', 0.5614483), ('Host factors and clinical parameters were obtained from patients.', 0.5609548), ('Based on the findings of the study, we recommend the following steps for the appropriate management of T2DM subject: Uncontrolled glycaemic status, dyslipidaemia, and vision impairment should be taken care of by conducting early screening for complications, frequent check-ups, and follow-ups.', 0.5379646)]"
879,Cryptic transmission of novel coronavirus revealed by genomic epidemiology,cryptic,_ transmission of novel coronavirus revealed by genomic epidemiology,Direct transmission of novel coronavirus revealed by genomic epidemiology,http://bedford.io/blog/ncov-cryptic-transmission,"[('The novel coronavirus which is responsible for the emerging COVID-19 pandemic mutates at an average of about two mutations per month.', 0.59397966), (""However, with advances in technology, it's become readily feasible to sequence the genome of the novel coronavirus."", 0.5872003), ('Our best guess of a scenario looks something like: We believe this may have occurred by the WA1 case having exposed someone else to the virus in the period between Jan 15 and Jan 19 before they were isolated.', 0.47195065), (""This works by taking a swab from someone's nose and extracting the RNA in the sample and then determining the 'letters' of this RNA genome using chemistry and very powerful cameras."", 0.47108638), (""This changes the genetic code of the virus, but it's hard for a single letter change to do much to make the virus behave differently."", 0.46982247)]"
880,Novel coronavirus thought to have jumped to humans via pangolins,humans,novel coronavirus thought to have jumped to _ via pangolins,novel coronavirus thought to have jumped to poultry via pangolins,https://cen.acs.org/biological-chemistry/infectious-disease/Novel-coronavirus-thought-jumped-humans/98/i13,"[('The team found that coronavirus RNA isolated from those pangolins encodes spike proteins that are closely related to those of SARS-CoV-2 ( Nature 2020, DOI: 10.1038/s41586-020-2169-0).', 0.6823177), ('That doesn’t prove that the new coronavirus passed through pangolins.', 0.6368126), ('Since the novel coronavirus, SARS-CoV-2, was first detected late last year, researchers have been trying to understand how the virus passed to humans in the first place.', 0.437626), ('Aerosol expert Jose-Luis Jimenez is sounding the alarm about airborne transmission of COVID-19 What to know as new SARS-CoV-2 strains gain ground worldwide What do we know about the novel coronavirus’s 29 proteins?', 0.43722203), (""Infectious disease What we do and don't know about the novel coronavirus Share X SHARE Share on Facebook Share on Twitter Share on Linkedin Share on Reddit WeChat Email Print To send an e-mail to multiple recipients, separate e-mail addresses with a comma, semicolon, or both."", 0.41369125)]"
881,Couple wrap themselves in plastic for domestic flight,couple,_ wrap themselves in plastic for domestic flight,Bats wrap themselves in plastic for domestic flight,https://amp.nine.com.au/article/be6696ee-ad1f-4a1f-bd88-719e50359c38,"[('ABC NEWS UP NEXT Video provided by NBC News Two air passengers took virus prevention to new extremes by wrapping themselves completely in plastic foil during a flight.', 0.5411473), ('The Italian aircraft-interior design company Aviointeriors has drawn up plans to combine those ideas with a kind of plastic capsule that would surround each seat.', 0.44947985), ('The video shows the couple in their seats, with a woman wrapped in a pink plastic outfit wearing a face mask, while her companion is wearing a white plastic sheet with holes cut out for his arms and legs, as well as a face mask.', 0.39046896), ('One of the passengers had covered himself in translucent plastic sheets, while his companion was wearing a pink protective suit.', 0.3854012), (""': Elizabeth Olsen discusses her 'unique' experience growing up as Mary-Kate and Ashley's younger sister Damian Hurley snuggles up to a female pal in bed in a cozy pre-lockdown snap... after stunning fans by ditching his flowing locks for a bald cap Brielle Biermann reveals she tested positive for COVID-19 but is 'recovering'... as she quarantines in mom Kim Zolciak's in-home salon Real Housewives Of Orange County: Braunwyn Windham-Burke declares that she's 'a big ol' lesbian' and reveals split with Shari on season 15 finale Cat Beckinsale!"", 0.3751648)]"
883,SARS-Cov-2 cysteine-like protease is immunogenic and can be detected in serum and saliva of COVID-19-seropositive individuals,can,sars-cov-2 cysteine-like protease is immunogenic and _ be detected in serum and saliva of covid-19-seropositive individuals,sars-cov-2 cysteine-like protease is immunogenic and cannot be detected in serum and saliva of covid-19-seropositive individuals,https://www.medrxiv.org/content/10.1101/2020.07.16.20155853v1,"[('Share SARS-Cov-2 cysteine-like protease (Mpro) is immunogenic and can be detected in serum and saliva of COVID-19-seropositive individuals Pedro Martínez-Fleta, Arantzazu Alfranca, Isidoro González-Álvaro, Jose M Casasnovas, Daniel Fernández-Soto, Gloria Esteso, Yaiza Cáceres-Martell, Sofía Gardeta, Salomé Prat, Tamara Mateu-Albero, Ligia Gabrie, Eduardo López- Granados, Francisco Sánchez-Madrid, Hugh T. Reyburn, José M. Rodríguez Frade, Mar Valés-Gómez medRxiv 2020.07.16.20155853; doi: https://doi.org/10.1101/2020.07.16.20155853 Share This Article: Copy Citation Tools SARS-Cov-2 cysteine-like protease (Mpro) is immunogenic and can be detected in serum and saliva of COVID-19-seropositive individuals Pedro Martínez-Fleta, Arantzazu Alfranca, Isidoro González-Álvaro, Jose M Casasnovas, Daniel Fernández-Soto, Gloria Esteso, Yaiza Cáceres-Martell, Sofía Gardeta, Salomé Prat, Tamara Mateu-Albero, Ligia Gabrie, Eduardo López- Granados, Francisco Sánchez-Madrid, Hugh T. Reyburn, José M. Rodríguez Frade, Mar Valés-Gómez medRxiv 2020.07.16.20155853; doi: https://doi.org/10.1101/2020.07.16.20155853 ', 0.8152298), ('In conclusion, Mpro is a potent antigen in infected patients that can be used in serological tests and its detection in saliva could be the basis for a rapid, non-invasive test for COVID-19 seropositivity.', 0.79413927), ('Citation Tools SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19–Seropositive Individuals Pedro Martínez-Fleta, Arantzazu Alfranca, Isidoro González-Álvaro, Jose M. Casasnovas, Daniel Fernández-Soto, Gloria Esteso, Yaiza Cáceres-Martell, Sofía Gardeta, Celia López-Sanz, Salomé Prat, Tamara Mateu-Albero, Ligia Gabrie, Eduardo López-Granados, Francisco Sánchez-Madrid, Hugh T. Reyburn, José M. Rodríguez Frade, Mar Valés-Gómez The Journal of Immunology November 4, 2020, ji2000842; DOI: 10.4049/jimmunol.2000842 ', 0.79411095), ('In conclusion, Mpro is a potent Ag in infected patients that can be used in serological tests, and its detection in saliva could be the basis for a rapid, noninvasive test for COVID-19 seropositivity.', 0.7704886), ('You are going to email the following SARS-Cov-2 cysteine-like protease (Mpro) is immunogenic and can be detected in serum and saliva of COVID-19-seropositive individuals Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website.', 0.766297)]"
884,"Total projected deaths decreased to 60,308 .",decreased,"total projected deaths _ to 60,308 .","total projected deaths rose to 60,308.",https://covid19.healthdata.org/united-states-of-america,"[('The Institute now is estimating 60,308 (estimated range of 34,063 to 140,381) deaths across the US by August 4, down from 68,841 as predicted on April 13.', 0.366244), (""The University of Washington's Institute for Health Metrics and Evaluation (IHME) lowered its projection of total deaths from 68,841 (with an estimate range of 30,188 to 175,965) to just over 60,308 (with an estimate range of 34,063 to 140,381) in an update published Friday."", 0.30360955), ('A key coronavirus model has lowered its estimate of total U.S. deaths in its latest projection of how many will die due to the contagious virus.', 0.23483297), ('It also recommended that states reopen only if they have infection rates of less than one in 1 million people.', 0.21135756), ('Minimizing the risk of resurgence will be more likely if the number of remaining infections in the community is at a low level.', 0.19832003)]"
886,Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19,deficit,frequency and profile of objective cognitive _ in hospitalized patients recovering from covid-19,frequency and profile of objective cognitive benefits in hospitalized patients recovering from covid-19,https://www.medrxiv.org/content/10.1101/2020.10.28.20221887v1,"[('This study evaluated the frequency, severity, and profile of cognitive dysfunction in hospitalized patients recovering from COVID-19.', 0.88741094), ('The goal of our study was to evaluate the frequency, severity, and profile of cognitive deficits in hospitalized and recovering patients with COVID-19.', 0.84310216), ('Neuropsychological features of severe hospitalized COVID-19 patients at clinical stability and clues for post-acute rehabilitation.', 0.8343845), ('We additionally explored the occurrence of psychiatric diagnoses and their association with cognitive functioning in COVID-19.', 0.81737363), ('A number of case reports and case series have suggested that cognitive deficits occur in patients with COVID-19.', 0.8088157)]"
891,New Zealand eliminates COVID-19,eliminate,new zealand _ covid-19,new zealandems covid-19,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31097-7/fulltext,"[('At the time of publication, New Zealand had recorded fewer than 1500 confirmed cases of COVID-19, and 20 deaths.', 0.59810257), ('New Zealand recorded its first day of no new cases of coronavirus disease 2019 (COVID-19) early this week, more than a month after its strict lockdown began.', 0.561435), ('On March 23, a month after the country had recorded its first case, New Zealand committed to an elimination strategy.', 0.4645301), (""Siouxsie Wiles, associate professor and head of the Bioluminescent Superbugs Lab at the University of Auckland, said one of the country's key successes has been the way in which COVID-19 was framed to the general population."", 0.3888402), (""Michael Baker, professor at the University of Otago's department of public health in Wellington, who has been advising the New Zealand Government on its response, said implementing a full lockdown—involving the closure of schools and non-essential workplaces, a ban on social gatherings, and severe travel restrictions—enabled the country to consider elimination."", 0.31919372)]"
892,Genomic Study Points to Natural Origin of COVID-19,natural,genomic study points to _ origin of covid-19,genomic study points to human origin of covid-19,https://directorsblog.nih.gov/2020/03/26/genomic-research-points-to-natural-origin-of-covid-19/,"[('This provides additional evidence that the coronavirus that causes COVID-19 almost certainly originated in nature.', 0.68392515), ('The genomic data of the new coronavirus responsible for COVID-19 show that its spike protein contains some unique adaptations.', 0.62102616), ('So, what is the natural origin of the novel coronavirus responsible for the COVID-19 pandemic?', 0.61045635), ('Their analysis showed that the backbone of the new coronavirus’s genome most closely resembles that of a bat coronavirus discovered after the COVID-19 pandemic began.', 0.59691906), ('Reply Dr. Navin Tiwari says: January 1, 2021 at 3:41 am nice blog on origin of covid 19.', 0.5328357)]"
893,Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis,can,coronavirus nsp10/nsp16 methyltransferase _ be targeted by nsp10-derived peptide in vitro and in vivo to reduce replication and pathogenesis,coronavirus nsp10/nsp16 methyltransferase cannot be targeted by nsp10-derived peptide in vitro and in vivo to reduce replication and pathogenesis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524257/,"[(""We demonstrate that a peptide derived from the nsp16-interacting domain of MHV nsp10 could inhibit 2'-O-MTase activity of different coronaviruses in vitro and viral replication of MHV and SARS-CoV replicon in cell culture, and it could strongly inhibit virus replication and pathogenesis in MHV-infected mice."", 0.75775623), (""Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 complex."", 0.7476504), (""This work makes it possible to develop broad-spectrum peptide inhibitors by targeting the nsp16/nsp10 2'-O-MTase of coronaviruses."", 0.7458238), ('(C and D) MTase assays of alphacoronaviral nsp16 (C) and betacoronaviral nsp16 (D) stimulated by the noncognate nsp10 from a coronavirus of the same genus.', 0.709527), (""Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex."", 0.7067121)]"
894,A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection,mice,a potently neutralizing antibody protects _ against sars-cov-2 infection,a potently neutralizing antibody protects humans against sars-cov-2 infection,https://www.jimmunol.org/content/early/2020/06/23/jimmunol.2000583,"[('mAb 2B04 protects mice from morbidity in a murine model of SARS-CoV-2 infection.', 0.7832205), ('Thus, 2B04 is a promising candidate for an effective antiviral that can be used to prevent SARS-CoV-2 infection.', 0.711947), ('mAb 2B04 potently neutralizes SARS-CoV-2 in vitro.', 0.61836624), ('In a murine model of SARS-CoV-2 infection, 2B04 protected challenged animals from weight loss, reduced lung viral load, and blocked systemic dissemination.', 0.6072589), ('The virus enters host cells through binding of a receptor-binding domain within its trimeric spike glycoprotein to human angiotensin-converting enzyme 2.', 0.5655135)]"
895,Ag nanoparticles-based antimicrobial polycotton fabrics to prevent the transmission and spread of SARS-CoV-2,prevent,ag nanoparticles-based antimicrobial polycotton fabrics to _ the transmission and spread of sars-cov-2,ag nanoparticles-based antimicrobial polycotton fabrics to enhance the transmission and spread of sars-cov-2,https://www.biorxiv.org/content/10.1101/2020.06.26.152520v1,"[('The antiviral activity test was designed to determine the inactivation of viral particles upon short exposure to the products, which in this case were the Ag-based treated polycotton samples incubated in liquid media.', 0.63693786), ('FTIR spectra of (a) Non-Treated Polycotton, (b) Polycotton AgNP-CS and (c) Sample 2.', 0.5816765), ('As an antiviral agent, Ag NPs can interfere with viral replication by two separate mechanisms of adhesion to the surface of the viral envelope.', 0.5787092), ('2020 Inhibition of Candida auris Biofilm Formation on Medical and Environmental Surfaces by Silver Nanoparticles ACS Appl.', 0.57852197), ('Ag nanoparticles (AgNPs) acquire special attention due to its specificity and environment friendly approach with a wide application in industry and medicine due to its antibacterial, antifungal, larvicidal and anti-parasitic characters.', 0.56970036)]"
896,Propensity score-based analysis of a before-after cohort study,after,propensity score-based analysis of a before-_ cohort study,propensity score-based analysis of a before-up cohort study,https://www.sciencedirect.com/science/article/pii/S0883944118307780,"[('Propensity score analysis was used to adjust for potential baseline differences between the groups.', 0.5701397), ('Relative to the control group, the treatment group had a significantly higher median improvement in the radiologic score at day 7 compared with baseline (4 vs. 2; P = 0.045).', 0.34001094), ('Clinical Trial.', 0.33476448), ('Results: In the propensity-matched cohort (n = 36/group), the treated patients had significantly less hospital mortality than the control group (17% vs. 39%; P = 0.04).', 0.29464912), ('Clipboard, Search History, and several other advanced features are temporarily unavailable.', 0.2745352)]"
897,Cell-based culture of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19,cell,_-based culture of sars-cov-2 informs infectivity and safe de-isolation assessments during covid-19,Blood-based culture of sars-cov-2 informs infectivity and safe de-isolation assessments during covid-19,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1579/5937368,"[('Keywords: COVID-19; SARS-CoV-2; de-isolation; infection control; viral culture.', 0.73476005), ('Conclusion: SARS-CoV-2 culture may be used as a surrogate marker for infectivity and inform de-isolation protocols.', 0.65599394), ('Detection and Isolation of SARS-CoV-2 in Serum, Urine, and Stool Specimens of COVID-19 Patients from the Republic of Korea.', 0.629003), ('SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus.', 0.6255641), ('By contrast, the isolation of SARS-CoV-2 using cell-based culture likely indicates infectivity, but there are limited data on the correlation between SARS-CoV-2 culture and PCR.', 0.5954585)]"
898,Lockdown related travel behavior undermines the containment of SARS-CoV-2,undermine,lockdown related travel behavior _ the containment of sars-cov-2,lockdown related travel behavior mores the containment of sars-cov-2,https://www.medrxiv.org/content/10.1101/2020.10.22.20217752v1,"[('We find that travel surges following announcements of lockdowns can increase seeding of the epidemic in rural areas, undermining the goal of the lockdown of preventing disease spread.', 0.33791283), ('Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.', 0.31396657), ('Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search ', 0.28549293), ('Appropriate messaging surrounding the announcement of lockdowns and measures to decrease unnecessary travel are important for preventing these unintended consequences of lockdowns.', 0.2816092), ('Ultimately, the public’s response to announcements of lockdowns - defined here as restrictions on both local movement or long distance travel - will determine how effective these kinds of interventions are.', 0.2779366)]"
900,Recurrent mutations in SARS-CoV-2 genomes isolated from mink point to rapid host-adaptation,host,recurrent mutations in sars-cov-2 genomes isolated from mink point to rapid _-adaptation,recurrent mutations in sars-cov-2 genomes isolated from mink point to rapid virus-adaptation,https://www.biorxiv.org/content/10.1101/2020.11.16.384743v1,"[('The repeat emergence of mutations across phylogenetically distinct lineages of the virus isolated from minks points to ongoing adaptation of SARS-CoV-2 to a new host.', 0.82393575), ('Genomic data from SARS-CoV-2 isolated from infected minks provides a natural case study of a secondary host jump of the virus, in this case from humans to animals, and occasionally back again.', 0.74342364), ('The rapid acquisition and spread of SARS-CoV-2 mutations in minks suggests that if a similar phenomenon of host adaptation had occurred upon its jump into humans, those human- specific mutations would likely have reached fixation already before the first SARS-CoV-2 genomes were generated.', 0.7221695), ('We screened published SARS-CoV-2 genomes isolated from minks for the presence of recurrent mutations common in mink but infrequent in SARS-CoV-2 genomes isolated from human infections.', 0.7204364), ('SARS-CoV-2 seems to transmit particularly well in mink farms with outbreaks reported in Spain, Sweden, the Netherlands, Italy, the USA and Denmark.', 0.6284009)]"
901,The prevalence of asymptomatic and symptomatic COVID19 disease in a cohort of quarantined subjects,prevalence,the _ of asymptomatic and symptomatic covid19 disease in a cohort of quarantined subjects,the absence of asymptomatic and symptomatic covid19 disease in a cohort of quarantined subjects,https://www.ijidonline.com/article/S1201-9712(20)32294-3/fulltext,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.40901706), ('A further 52 became SARS-CoV-2 positive during the mandatory 14-day quarantine following arrival, 46% of whom remained asymptomatic until viral clearance.', 0.37427962), ('International Journal of Infectious Diseases.https://doi.org/10.1016/j.ijid.2020.10.091 ', 0.23519786), ('[c.]: circa [FT]: Financial Times [f]: fax', 0.14999542), ('Al-Qahtani et al.', 0.08977355)]"
904,Recovery of monocyte exhaustion is associated with resolution of lung injury in COVID-19 convalescence .,with,recovery of monocyte exhaustion is associated _ resolution of lung injury in covid-19 convalescence .,recovery of monocyte exhaustion is associated without resolution of lung injury in covid-19 convalescence.,https://www.medrxiv.org/content/10.1101/2020.10.10.20207449v1,"[('Recovery of monocyte exhaustion is associated with resolution of lung injury in COVID-19 c ', 0.9649696), ('We show here that blood monocytes in convalescent patients at their 12 week follow up, have a greater propensity to produce pro-inflammatory cytokines TNF and IL-6, which was consistently higher in patients with resolution of lung injury as indicated by a normal chest X-ray and no shortness of breath (a key symptom of lung injury).', 0.5944387), ('We recently demonstrated profound alterations of monocytes in hospitalised COVID-19 patients.', 0.49571568), ('These data suggest persistent changes in innate immune function following recovery from COVID-19 and indicate that immune modulating therapies targeting monocytes and leucocyte migration may be useful in recovering COVID-19 patients with persistent symptoms.', 0.4595583), ('Expression of migration molecules on monocytes was also consistently higher in convalescent patients with a normal chest X-ray.', 0.44585508)]"
907,Remdesivir and chloroquine effectively inhibit the recently emerged 2019-nCoV in vitro,inhibit,remdesivir and chloroquine effectively _ the recently emerged 2019-ncov in vitro,remdesivir and chloroquine effectively developed the recently emerged 2019-ncov in vitro,https://www.nature.com/articles/s41422-020-0282-0,"[('Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.', 0.82811046), ('Nafamostat, a potent inhibitor of MERS-CoV, which prevents membrane fusion, was inhibitive against the 2019-nCoV infection (EC50 = 22.50 μM, CC50 > 100 μM, SI > 4.44).', 0.6541555), ('Our findings reveal that remdesivir and chloroquine are highly effective in the control of 2019-nCoV infection in vitro.', 0.62878144), ('1: The antiviral activities of the test drugs against 2019-nCoV in vitro.', 0.6043567), ('The antiviral activities of the test drugs against 2019-nCoV in vitro.', 0.5976882)]"
908,"Thanks to so many of your suggestions and questions , our amazing teams at IHME have expanded our COVID19 web information",many,"thanks to so _ of your suggestions and questions , our amazing teams at ihme have expanded our covid19 web information","thanks to so none of your suggestions and questions, our amazing teams at ihme have expanded our covid19 web information",http://www.healthdata.org/covid,"[('I would certainly like to echo my colleagues’ comments that the collaboration amongst many of the government agencies and the private market and the distributors represented here today has been incredible.', 0.66025877), ('""Our ability to learn to talk, play, acquire new skills, fall in love, conduct business and age in good health all hinge on our motivation to connect with other people.""', 0.6186278), ('We encourage each one of you, as we have governors around the country, to spread the word about the guidelines, listen to your state and local authorities in areas that are more greatly impacted.', 0.6122229), ('Dr. Birx and I spent a considerable amount of time going over all the data, why we felt this was a best choice of us, and the President accepted it.', 0.60825896), (""I also want to join your words about this team that you've assembled -- not only the healthcare team, the extraordinary team at FEMA and HHS, but all of our partners at the state and local level, the work that they're doing."", 0.60601985)]"
909,Coronavirus Pandemic Meets Overfat Pandemic,over,coronavirus pandemic meets _ pandemic,coronavirus pandemic meets infat pandemic,https://www.frontiersin.org/articles/10.3389/fpubh.2020.00135/full,"[('The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.', 0.6329963), ('Coronavirus disease 2019 (COVID-19) provides potent reminder of the risk of infectious agents.', 0.61784464), ('Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis.', 0.5540506), ('Coronavirus Disease 2019 (COVID-19) Situation Report-71.', 0.53729415), ('Get the latest public health information from CDC: https://www.coronavirus.gov Get the latest research information from NIH: https://www.nih.gov/coronavirus Find NCBI SARS-CoV-2 literature, sequence, and clinical content: https://www.ncbi.nlm.nih.gov/sars-cov-2/ National Institutes of Health National Library of Medicine National Center for Biotechnology Information NCBI homepage Log in Show account info Close ', 0.5343837)]"
910,Bats are evolved to damp down immune response to viruses,bats,_ are evolved to damp down immune response to viruses,CoVs are evolved to damp down immune response to viruses,https://www.frontiersin.org/articles/10.3389/fimmu.2020.00026/full,"[('Bats have evolved novel mechanisms to limit virus-induced pro-inflammatory responses while maintaining type I IFN responses to limit virus propagation (Figure 1).', 0.824124), ('It is important to understand how antiviral responses in bats have evolved to inhibit virus protein-mediated modulation.', 0.8191104), ('This suggests that many bats have a mechanism to suppress the expression of TNFα, thereby maintaining a balanced response to viral infection.', 0.81159055), ('Bats Suppress the Pathological Effects of Excessive Virus-Induced Inflammation While bats are well prepared to control viral infections, they also have mechanisms to avoid over-induction of inflammatory genes.', 0.80138695), ('The evolution of flight in bats seem to have selected for a unique set of antiviral immune responses that control virus propagation, while limiting self-damaging inflammatory responses.', 0.8012501)]"
911,Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients,elevation,_ of plasma angiotensin ii level is a potential pathogenesis for the critically ill covid-19 patients,Loss of plasma angiotensin ii level is a potential pathogenesis for the critically ill covid-19 patients,https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03015-0,"[('Therefore, elevation of Ang II triggered by interaction between ACE2 and S protein of SARS-CoV-2 may be important pathogenic factors for critically ill COVID-19 patients.', 0.81920683), ('Plasma Ang II level in critically ill COVID-19 patients was significantly higher than that of control and those with mild COVID-19 symptoms (Fig.', 0.73492134), ('h The plasma Ang II positive rate in the critically ill COVID-19 cases was significantly higher than that of control.', 0.68596846), ('f The plasma Ang II concentration in the critically ill COVID-19 cases was significantly higher than that of control.', 0.68375903), ('b The plasma Ang II concentration in the critically ill COVID-19 cases and severe COVID-19 cases was significantly higher than that of the mild COVID-19 cases.', 0.67968756)]"
912,Burden of illness in households with SARS-CoV-2 infected children,households,burden of illness in _ with sars-cov-2 infected children,burden of illness in patients with sars-cov-2 infected children,https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piaa097/5891283,"[('Keywords: COVID-19, SARS-CoV-2, pediatrics, household transmission ', 0.47397316), ('Child-to-adult transmission was suspected in 7 cases.', 0.31128335), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.28144062), ('Forty-six percent of HCs developed symptoms consistent with COVID-19 disease.', 0.23803777), ('We identified 144 household contacts (HCs): 58 children and 86 adults.', 0.22167337)]"
913,Recharging and rejuvenation of decontaminated N95 masks,deco,recharging and rejuvenation of _ n95 masks,recharging and rejuvenation of overntaminated n95 masks,https://aip.scitation.org/doi/10.1063/5.0023940,"[('The drop in the filtration efficiency in N95 masks due to different protocols of decontamination and the recovery of filtration by recharging the masks.', 0.73415613), ('In particular, we propose and show that it is possible to recharge the masks post-decontamination and recover filtration efficiency.', 0.7114606), ('Our results suggest that it is possible to recharge the masks post-sterilization and recover filtration efficiency.', 0.69802135), ('Representative data of the filtration efficiency of various masks after decontamination and recharging are given in the top panels of Fig.', 0.6853216), ('As with other filtration processes, N95 masks intercept foreign particles in different layers of the mask material.', 0.6819178)]"
915,Convalescent Plasma to Treat COVID-19,con,_ plasma to treat covid-19,Unvalescent plasma to treat covid-19,https://jamanetwork.com/journals/jama/fullarticle/2763982,"[('Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study.', 0.8946272), ('Convalescent plasma for COVID-19: a randomized clinical trial.', 0.8618588), ('Effectiveness of convalescent plasma therapy in severe COVID-19 patients.', 0.8598975), ('The investigational convalescent plasma is intended for the treatment of hospitalized patients with COVID-19.', 0.852438), ('Expanded access to convalescent plasma for the treatment of patients with COVID-19.', 0.8508353)]"
916,Post-COVID syndrome severely damages children 's hearts ; immense inflammation causing cardiac blood vessel dilation,damages,post-covid syndrome severely _ children 's hearts ; immense inflammation causing cardiac blood vessel dilation,post-covid syndrome severely protected children's hearts ; immense inflammation causing cardiac blood vessel dilation,https://news.uthscsa.edu/post-covid-syndrome-severely-damages-childrens-hearts-immense-inflammation-causing-cardiac-blood-vessel-dilation/,"[('Source: University of Texas Health Science Center at San Antonio Multisystem inflammatory syndrome in children (MIS-C), believed to be linked to COVID-19, damages the heart to such an extent that some children will need lifelong monitoring and interventions, said the senior author of a medical literature review published Sept. 4 in EClinicalMedicine.', 0.6163819), ('Citing an example of this abnormality, they said, the molecular marker troponin used in adults to diagnose heart attacks, was 50 times its normal level in children with MIS-C. ""Evidence suggests that children with MIS-C have immense inflammation and potential tissue injury to the heart, and we will need to follow these children closely to understand what implications they may have in the long term,"" Moreira said.', 0.56475174), ('For instance, troponin, the marker used in adults to diagnose heart attacks, was 50 times its normal level in children with MIS-C. ""Evidence suggests that children with MIS-C have immense inflammation and potential tissue injury to the heart, and we will need to follow these children closely to understand what implications they may have in the long term,"" Dr. Moreira said.', 0.5241651), ('Serum inflammatory, coagulative, and cardiac markers were considerably abnormal.', 0.5240806), ('""Almost 90 per cent of the children (581) underwent an echocardiogram because they had such a significant cardiac manifestation of the disease,"" Moreira said.', 0.5113134)]"
917,Glycosaminoglycan binding motif at S1/S2 proteolytic cleavage site on spike glycoprotein may facilitate novel coronavirus host cell entry,facilitate,glycosaminoglycan binding motif at s1/s2 proteolytic cleavage site on spike glycoprotein may _ novel coronavirus host cell entry,glycosaminoglycan binding motif at s1/s2 proteolytic cleavage site on spike glycoprotein may inhibit novel coronavirus host cell entry,https://www.biorxiv.org/content/10.1101/2020.04.14.041459v1,"[('Share Glycosaminoglycan binding motif at S1/S2 proteolytic cleavage site on spike glycoprotein may facilitate novel coronavirus (SARS-CoV-2) host cell entry So Young Kim, Weihua Jin, Amika Sood, David W. Montgomery, Oliver C. Grant, Mark M. Fuster, Li Fu, Jonathan S. Dordick, Robert J.', 0.91333187), ('Cleavage of group 1 coronavirus spike proteins: how furin cleavage is traded off against heparan sulfate binding upon cell culture adaptation.', 0.79380643), ('Our discovery of a novel insertion of glycosaminoglycan (GAG)-binding motif at S1/S2 proteolytic cleavage site (681-686 (PRRARS)) and two other GAG-binding-like motifs within SARS-CoV-2 spike glycoprotein (SGP) led us to hypothesize that host cell surface GAGs may interact SARS-CoV-2 SGPs to facilitate host cell entry.', 0.77328306), ('You are going to email the following Glycosaminoglycan binding motif at S1/S2 proteolytic cleavage site on spike glycoprotein may facilitate novel coronavirus (SARS-CoV-2) host cell entry Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.', 0.76606804), ('Our discovery of a novel insertion of glycosaminoglycan (GAG)-binding motif at S1/S2 proteolytic cleavage site (681-686 (PRRARS)) and two other GAG-binding-like motifs within SARS-CoV-2 spike glycoprotein (SGP) led us to hypothesize that host cell surface GAGs might be involved in host cell entry of SARS-CoV-2.', 0.7642533)]"
918,Kentucky Governor cancels schools for at least 2 weeks,weeks,kentucky governor cancels schools for at least 2 _,kentucky governor cancels schools for at least 2 hours,https://www.kentucky.com/news/local/education/article241141961.html,"[(""Brown has said he will seek a waiver from the Kentucky Board of Education so more school districts can join the state's NTI program for the remainder of the 2019-20 school year."", 0.55229235), (""The girls' state tournament, already under way, was cut short and next week's boys' tournament also was postponed indefinitely by the Kentucky High School Athletic Association."", 0.54740846), (""Andy Beshear's call to stem the spread of the coronavirus, schools across Kentucky — including Jefferson County Public Schools, the state's largest district — announced they would shut down their classrooms for weeks."", 0.52266634), ('Facebook Twitter WhatsApp SMS Email Print Save LOUISVILLE, Ky. (WDRB) – Public schools across Kentucky will close for at least two weeks starting Monday, heeding the recommendation from Gov.', 0.5125843), ('Taken together, the Ohio, Maryland and Kentucky closures will affect roughly 3.2 million students.', 0.49740568)]"
920,More than 80 clinical trials launch to test coronavirus treatments,more,_ than 80 clinical trials launch to test coronavirus treatments, less than 80 clinical trials launch to test coronavirus treatments,https://www.nature.com/articles/d41586-020-00444-3,"[('It will compare two or three therapies backed by scientific evidence, including an HIV-drug combination (lopinavir and ritonavir) and an experimental antiviral called remdesivir.', 0.5432979), ('Already, Jiang and other research groups have found compounds and antibodies that glom onto that spike6, which could prevent coronaviruses from invading human cells.', 0.47565034), ('Research clinicians around the world will need this information if the outbreak continues to spread, he adds.', 0.4730885), ('The Chinese Clinical Trial Registry, a database of biomedical studies in China, lists these investigations among dozens of other controlled trials on existing therapies, experimental procedures and traditional medicines.', 0.46348637), ('Remdesivir, a nucleotide analogue made by the biotechnology company Gilead in Foster City, California, has had some success against coronaviruses in animals, too2.', 0.44469368)]"
922,Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma,lowers,hydroxychloroquine improves airflow and _ circulating ige levels in subjects with moderate symptomatic asthma,hydroxychloroquine improves airflow and increases circulating ige levels in subjects with moderate symptomatic asthma,https://www.ncbi.nlm.nih.gov/pubmed/9723661,"[('Open study of hydroxychloroquine in the treatment of severe symptomatic or corticosteroid-dependent asthma.', 0.6948858), ('Hydroxychloroquine (HCQ) is a well-tolerated, safe immunomodulating drug, with proven efficacy in rheumatic diseases and known actions that suggest potential utility in the treatment of asthma.', 0.6525156), ('Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.', 0.5855569), ('Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.', 0.58096534), ('Methods: Symptomatic asthmatic subjects receiving stable doses of at least 6 puffs of inhaled corticosteroid per day with daily need for beta2-adrenergic agonists were studied.', 0.5808034)]"
924,Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus receptor binding,not,antibodies in serum of convalescent patients following mild covid-19 do _ always prevent virus receptor binding,antibodies in serum of convalescent patients following mild covid-19 do also always prevent virus receptor binding,https://onlinelibrary.wiley.com/doi/abs/10.1111/all.14523,"[('The scientists from MedUni Vienna\'s Institute of Pathophysiology and Allergy Research discovered that only around 60% of patients who have had COVID-19 and recovered from it develop protective antibodies and, for the first time, they were able to show that some antibodies even ""assist"" the virus by augmenting its to the cells of the host.', 0.62101173), ('Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development.', 0.5764811), ('[Protective effect of specific antibody in serum of convalescent patient with SARS].', 0.567094), ('""The positive outcome is that we now have a test that can identify antibodies and show whether people who have already been infected have protective immunity or not.""', 0.54703766), (""Researchers from MedUni Vienna's Center for Pathophysiology, Infectiology and Immunology, led by Rudolf Valenta, developed an ELISA laboratory test to identify patients who had developed protective antibodies after having COVID-19."", 0.54577756)]"
926,SARS- CoV-2-Associated Cytokine Storm Syndromes,sar,_- cov-2-associated cytokine storm syndromes,IFNs- cov-2-associated cytokine storm syndromes,https://www.cell.com/action/showPdf?pii=S1471-4914%2820%2930259-8,"[('Nevertheless, given the high positive rate of SARS-CoV-2 testing in MIS-C cases, and close temporal association with the pandemic, the disorder is likely due to either a direct consequence of acute viral infection or a delayed para-infectious immune-mediated disease.', 0.6385205), ('Among the myriad clinical syndromes identified to date is the multisystem inflammatory syndrome in children (MIS-C), which is temporally associated with the SARS-CoV-2 pandemic.', 0.6302508), ('An unbridled host immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to underlie severe cases of the disease and has been labeled a ‘cytokine storm syndrome’ (CSS).', 0.6294244), ('Pediatric SARS-CoV-2: clinical presentation, infectivity, and immune responses.', 0.62047696), ('Show full caption (A) SARS-CoV-2 infects Type II pneumocytes initially in airways and alveoli, resulting in activation of alveolar macrophages, cytokine production, and additional inflammatory infiltration.', 0.59946156)]"
927,Clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness,novel,clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a _ illness,clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a pandemic illness,https://erj.ersjournals.com/content/early/2020/07/09/13993003.02135-2020,"[('Accordingly, these “ARDS mimics” [9] require specific treatment based on their underlying pathophysiology.', 0.61182237), ('Using a deductive approach, firstly the diagnostic criteria need a relook, to exclude misclassification as a reason for the observed clinico-pathological discrepancy.', 0.5473113), ('As lung pathology appears grossly different at various stages of illness, a tailored phenotypic approach to management, guided by pathophysiology, would be more appropriate than a syndromic approach.', 0.48672375), ('These insights are key to understanding the clinical phenotypes of COVID-19 lung injury.', 0.46596596), ('Interestingly, rapid radiological resolution and clinical improvement with inhaled thrombolytics have been described in a small case series [17].', 0.4595988)]"
930,An 81 base-pair deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona,arizona,an 81 base-pair deletion in sars-cov-2 orf7a identified from sentinel surveillance in _,an 81 base-pair deletion in sars-cov-2 orf7a identified from sentinel surveillance in China,https://www.medrxiv.org/content/10.1101/2020.04.17.20069641v1,"[('Here, we report on early SARS-CoV-2 sentinel surveillance in Tempe, Arizona (USA).', 0.55916166), ('Genomic characterization identified an isolate encoding a 27 amino acid in-frame deletion in accessory protein ORF7a, the ortholog of SARS- CoV immune antagonist ORF7a/X4.', 0.37309438), ('Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.', 0.2732596), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.24103083), ('Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search ', 0.2358987)]"
931,High cortisol levels associated with greater risk of death from COVID-19,greater,high cortisol levels associated with _ risk of death from covid-19,high cortisol levels associated with reduced risk of death from covid-19,https://www.imperial.ac.uk/news/198437/high-cortisol-levels-associated-with-greater/,"[('Professor Dhillo, Head of Division of Diabetes, Endocrinology and Metabolism at Imperial College London, said: ""From an endocrinologist\'s perspective, it makes sense that those COVID-19 patients who are the sickest will have higher levels of cortisol, but these levels are worryingly high.', 0.5431707), ('Excessive levels of cortisol during illness can be equally dangerous, leading to increased risk of infection and poor outcomes.', 0.5342711), ('The levels in the COVID-19 group ranged as high as 3241 - considerably higher even than after major surgery, when levels can top 1000.', 0.5234334), ('A COVID-19 swab test and routine blood tests - including a baseline measurement of cortisol levels - were performed within 48hrs of admission.', 0.4737026), ('Amongst the COVID-19 patients, those with a baseline cortisol level of 744 or less survived on average for 36 days.', 0.43617862)]"
932,Home testing for coronavirus to track levels of infection in the community,home,_ testing for coronavirus to track levels of infection in the community,Laboratory testing for coronavirus to track levels of infection in the community,https://www.imperial.ac.uk/news/197217/home-testing-coronavirus-track-levels-infection/,"[('Accurate testing for coronavirus on a wide scale will be vital to guide public health strategies and decision-making by providing authorities with a clearer picture of the current burden of the disease and of the number of people who have previously caught it.', 0.6137764), ('This kind of test looks for evidence that someone is currently infected with the coronavirus.', 0.5966468), ('Home testing kits are widely used in health care, for example in the management of diabetes and the diagnosis of HIV.', 0.5414463), ('""This ambitious new testing programme will help us track the rate of the infection now.', 0.5238633), ('The samples will be collected by courier and tested in the laboratory using the gold standard PCR (polymerase chain reaction) test, which detects the presence of genetic material from the virus.', 0.5123812)]"
933,Virus Can Infect Heart Cells in Lab Dish,can,virus _ infect heart cells in lab dish,virus cannot infect heart cells in lab dish,https://www.cedars-sinai.org/newsroom/virus-can-infect-heart-cells-in-lab-dish/,"[('A new study shows that SARS-CoV-2, the virus that causes COVID-19 (coronavirus), can infect heart cells in a lab dish, indicating it may be possible for heart cells in COVID-19 patients to be directly infected by the virus.', 0.66679573), ('While these findings are not a perfect replicate of what is happening in the human body, this knowledge may help investigators use stem cell-derived heart cells as a screening platform to identify new antiviral compounds that could alleviate viral infection of the heart, according to senior and co- corresponding author Clive Svendsen, PhD.', 0.61385363), ('""It is plausible that direct infection of cardiac muscle cells may contribute to COVID-related heart disease.""', 0.6059028), ('It is plausible that direct infection of cardiac muscle cells may > contribute to COVID-related heart disease.', 0.5992211), ('The study also demonstrated that human stem cell-derived heart cells infected by SARS-CoV-2 change their gene expression profile, further confirming that the cells can be actively infected by the virus and activate innate cellular ""defense mechanisms"" in an effort to help clear out the virus.', 0.58414084)]"
936,Impaired cellular immunity to SARS-CoV-2 in severe COVID-19 patients,impaired,_ cellular immunity to sars-cov-2 in severe covid-19 patients, promotes cellular immunity to sars-cov-2 in severe covid-19 patients,https://www.medrxiv.org/content/10.1101/2020.08.10.20171371v1,"[('Our work thus indicates that COVID-19 patients with severe symptoms are associated with defective cellular immunity, which not only provides insights on understanding the pathogenesis of COVID-19, but also has implications in developing an effective vaccine to SARS-CoV-2.', 0.7086863), ('Currently, though convalescent individuals have been shown with both cellular and humoral immune responses, there is very limited understanding on the immune responses, especially adaptive immune responses, in patients with severe COVID-19.', 0.5988246), ('Most notably, we failed in detecting SARS-CoV-2-specific IFNg production by peripheral blood lymphocytes from these patients.', 0.5825734), ('However, compared to healthy controls, the percentages and absolute numbers of both NK cells and CD8+ T cells were significantly reduced, accompanied with decreased IFNg expression in CD4+ T cells in peripheral blood from severe patients.', 0.50016356), ('Here, we examined 10 blood samples from COVID-19 patients with acute respiratory distress syndrome (ARDS).', 0.4112259)]"
938,FDA Announces COVID-19 Treatment Acceleration Program,fda,_ announces covid-19 treatment acceleration program,Methods announces covid-19 treatment acceleration program,https://www.fda.gov/drugs/coronavirus-covid-19-drugs/coronavirus-treatment-acceleration-program-ctap#action,"[('Coronavirus (COVID-19) Update: FDA Continues to Accelerate Development of Novel Therapies for COVID-19 1.', 0.8162682), ('The US Food and Drug Administration (FDA) has launched the Coronavirus Treatment Acceleration Program to accelerate the development of treatments for coronavirus disease 2019 (COVID-19).', 0.80117655), ('The US Food and Drug Administration (FDA) is prioritizing the development and review of new therapies to treat COVID-19 through a recently created special emergency program titled Coronavirus Treatment Acceleration Program (CTAP).', 0.77274036), ('FDA encourages developers and evaluators of COVID-19 therapies to communicate with FDA early and often to ensure that development of drugs and other therapies to treat COVID-19 are properly implemented and meet efficacy requirements of FDA.', 0.741298), ('“Accelerating the investigation of products that could potentially benefit people affected by the COVID-19 pandemic is one of the FDA’s highest priorities.', 0.7205418)]"
942,Expert reaction to people being re-tested positive for coronavirus after initial recovery,after,expert reaction to people being re-tested positive for coronavirus _ initial recovery,expert reaction to people being re-tested positive for coronavirus before initial recovery,https://www.sciencemediacentre.org/expert-reaction-to-people-being-re-tested-positive-for-coronavirus-after-initial-recovery-e-g-case-reported-in-japan-where-a-woman-has-been-confirmed-as-a-coronavirus-case-for-2nd-time/,"[('She has a prolonged excretion of virus from her initial infection and tests were either not done or were not done sufficiently well or enough to confirm clearance.', 0.6086598), ('This highlights the need for more research into the biology of the new coronavirus, it is very much early days in our efforts to understand it.” On case in Japan: Prof Paul Hunter, Professor in Medicine, University of East Anglia (UEA), said: “Regarding this reported case: “There is so much we do not know about this case to give a properly informed opinion.', 0.54092026), ('Although coronaviruses generally cause short- term self-limiting infections which are cleared, there is some evidence in the scientific literature for persistent infections of animal coronaviruses (mainly in bats).', 0.53769594), ('Clearly we need more information about these patients, such as were there underlying medical conditions or a change in circumstances that might have allowed the virus to escape immune control?', 0.53654766), ('However, the report reinforces the fact that we have to investigate all such findings really thoroughly and report such information if we are to make the best decisions based on sound scientific evidence.', 0.5185356)]"
948,Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine,increased,_ risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine,Low risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine,https://academic.oup.com/cid/article/54/12/1778/455098,"[('Being protected against influenza, TIV recipients may lack temporary non-specific immunity that protected against other respiratory viruses.', 0.74229705), ('Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.', 0.71643186), ('The use of inactivated influenza vaccine in children.', 0.68118596), ('Anestad G. Interference between outbreaks of respiratory syncytial virus and influenza virus infection.', 0.6705717), ('A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness.', 0.6513003)]"
950,An autocrine Vitamin D-driven Th1 shutdown program can be exploited for COVID-19,can,an autocrine vitamin d-driven th1 shutdown program _ be exploited for covid-19,an autocrine vitamin d-driven th1 shutdown program cannot be exploited for covid-19,https://www.biorxiv.org/content/10.1101/2020.07.18.210161v1,"[('Importantly, genes normally down- regulated by VitD were de-repressed in CD4+ BALF T cells of COVID-19, indicating that the VitD-driven shutdown program is impaired in this setting.', 0.66978383), ('These data indicate that adjunct therapy with VitD in the context of other immunomodulatory drugs may be a beneficial strategy to dampen hyperinflammation in severe COVID-19.', 0.49597594), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.40322012), ('Back to top PreviousNext Posted July 19, 2020.', 0.37075529), ('[c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration', 0.33853355)]"
953,Inhibition of papain-like protease PLpro blocks SARS- CoV-2 spread and promotes anti-viral immunity,promotes,inhibition of papain-like protease plpro blocks sars- cov-2 spread and _ anti-viral immunity,inhibition of papain-like protease plpro blocks sars- cov-2 spread and prevent anti-viral immunity,https://www.researchsquare.com/article/rs-27134/v1,"[('Pharmacological inhibition of PLproCoV2 blocks the virus-induced cytopathogenic effect upon infection with SARS-CoV-2, fosters the anti- viral interferon pathway and reduces viral release from infected cells.', 0.8257651), ('We propose that therapeutic targeting of PLproCoV2 can suppress SARS-CoV-2 infection and promote anti-viral immunity.', 0.7876061), ('PLpro additionally cleaves proteinous post-translational modifications from host proteins to evade anti-viral immune responses.', 0.6891213), ('In human cells, PLproCoV2 cleaves ISG15 from interferon responsive factor 3 (IRF3), blocks its nuclear translocation, and reduces type I interferon responses, whereas PLproSARS preferentially mediates deubiquitination of critical components of the NF-kB pathway.', 0.50679743), ('It is possible that these ligands can be antivirals of SARS-CoV-2.', 0.47803286)]"
954,Chloroquine is a potent inhibitor of SARS coronavirus infection and spread,inhibitor,chloroquine is a potent _ of sars coronavirus infection and spread,chloroquine is a potent cause of sars coronavirus infection and spread,https://virologyj.biomedcentral.com/articles/10.1186/1743-422X-2-69,"[('In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine.', 0.7685045), ('These data clearly show that addition of chloroquine can effectively reduce the establishment of infection and spread of SARS-CoV if the drug is added immediately following virus adsorption.', 0.74882597), ('Favorable inhibition of virus spread was observed when the cells were either treated with chloroquine prior to or after SARS CoV infection.', 0.7112125), ('We have provided evidence that chloroquine is effective in preventing SARS-CoV infection in cell culture if the drug is added to the cells 24 h prior to infection.', 0.6950252), ('Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association.', 0.6888207)]"
956,Trump lied about science,lied,trump _ about science,trump is about science,https://science.sciencemag.org/content/early/2020/09/11/science.abe7391,"[('As he was playing down the virus to the public, Trump was not confused or inadequately briefed: He flat-out lied, repeatedly, about science to the American people.', 0.648342), ('This may be the most shameful moment in the history of U.S. science policy.', 0.5373454), ('But now, a U.S. president has deliberately lied about science in a way that was imminently dangerous to human health and directly led to widespread deaths of Americans.', 0.5307498), ('Find this author on Google Scholar Find this author on PubMed Search for this author on this site Article Info & Metrics eLetters PDF ""PHOTO: CAMERON DAVIDSON"" When President Donald Trump began talking to the public about coronavirus disease 2019 (COVID-19) in February and March, scientists were stunned at his seeming lack of understanding of the threat.', 0.3915842), ('H. Holden Thorp Editor-in-Chief, Science Journals.', 0.39092523)]"
961,One ART Regimen Tied to Lower COVID-19 Risk in HIV,lower,one art regimen tied to _ covid-19 risk in hiv,one art regimen tied to increasing covid-19 risk in hiv,https://www.medpagetoday.com/infectiousdisease/covid19/87376,"[('Risk of COVID-19 diagnosis and hospitalization was lower for people living with HIV receiving Truvada, or tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC), compared with those on other ART regimens, as well as the Spanish population ages 20-79, reported Julia del Amo, MD, PhD, of the National Plan Against AIDS in Madrid, and colleagues.', 0.64397967), ('""The lack of increased risk for serious COVID-19 among HIV-positive persons might be the result of their use of ART,"" they wrote, adding ART was proposed as a protective factor against SARS in 2003, but there were too few cases to draw meaningful conclusions about its role.', 0.59391856), ('Researchers estimated a risk for COVID-19 diagnosis of 30.0 per 10.000 and 3.7 per 10,000 for death among HIV-positive people receiving ART.', 0.58892334), ('Moreover, the risk of COVID-19 diagnosis was not higher among people living with HIV on ART than the general population of Spain, they wrote in the Annals of Internal Medicine.', 0.56781507), ('The authors added their findings warranted further study into HIV pre-exposure prophylaxis (PrEP) as potential treatment or prevention of COVID-19 in people without HIV.', 0.56710565)]"
964,"Coronavirus inflicts a short , sharp recession on global economy - CRE Herald",short,"coronavirus inflicts a _ , sharp recession on global economy - cre herald","coronavirus inflicts a world, sharp recession on global economy - cre herald",https://www.creherald.com/oxford-economics-coronavirus-inflicts-a-short-sharp-recession-on-global-economy/,"[('Therefore, we have also updated our downside scenario to incorporate a worsening of the outbreak, imposition of greater social restrictions, and financial stress.', 0.43504), ('Businesses that can weather the crisis should be prepared for a strong end to 2020 and start to 2021, with global growth rising as high as 5.3% in annual terms and averaging 4.4% for next year as a whole.""', 0.40660837), ('The zero growth - Oxford Economics forecasts for 2020 - will mark the second- weakest year for the global economy in almost 50 years of comparable data, with only 2009, in the depths of the financial crisis, worse.', 0.37414452), ('But we believe that − consistent with historical experience − the bounce back in activity will be very strong once social distancing measures are relaxed, and monetary and fiscal stimulus combine with a resumption in discretionary spending.', 0.37146074), ('""In the current (first) quarter of 2020, we expect the global economy to have contracted at a faster pace than during the global financial crisis, with a fall of some 2% in world GDP, and our baseline forecasts then projecting a further quarterly fall of 0.4% in Q2,"" said in the analysis.', 0.36863762)]"
966,Number of COVID-19 vaccination doses administered,number,_ of covid-19 vaccination doses administered,Lack of covid-19 vaccination doses administered,https://ourworldindata.org/grapher/cumulative-covid-vaccinations?tab=map&stackMode=absolute&region=World,"[('How many COVID-19 vaccine doses are administered daily?', 0.8909305), ('What share of the population has been fully vaccinated against COVID-19?', 0.85935247), ('What share of the population has received at least one dose of the COVID-19 vaccine?', 0.85139227), ('The following chart shows the share of the total population that has received at least one dose of the COVID-19 vaccine.', 0.8241992), ('The following chart shows the share of the total population that has been fully vaccinated against COVID-19.', 0.81840456)]"
967,A RETROSPECTIVE CONTROLLED COHORT STUDY,retrospective,a _ controlled cohort study,a controlled controlled cohort study,https://www.medrxiv.org/content/10.1101/2020.05.22.20110544v1,"[('The present study is a retrospective study that analyzes real-life data, and as such, treated and untreated patients are not comparable according to all baseline characteristics.', 0.5207882), ('We performed a single-center retrospective cohort study in a university hospital in Madrid, Spain, during March of 2020.', 0.45487577), ('Patients given steroid treatment were designated the treatment cohort, and those who did not receive steroids were designated the control cohort.', 0.43378645), ('A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia.', 0.42982584), ('We performed a retrospective analysis of our experience to test the hypothesis that steroid use can improve the mortality of patients with COVID-19 pneumonia.', 0.4231395)]"
970,Immunological memory to SARS-CoV-2 assessed for greater than six months after infection,months,immunological memory to sars-cov-2 assessed for greater than six _ after infection,immunological memory to sars-cov-2 assessed for greater than six minutes after infection,https://www.biorxiv.org/content/10.1101/2020.11.15.383323v1,"[('We analyzed multiple compartments of circulating immune memory to SARS-CoV-2 in 185 COVID-19 cases, including 41 cases at ≥6 months post- infection.', 0.60094607), ('By studying antibody, memory B cell, CD4+ T cell, and CD8+ T cell memory to SARS-CoV-2 in an integrated manner, we observed that each component of SARS-CoV-2 immune memory exhibited distinct kinetics.', 0.58198875), ('Spike-specific memory B cells were more abundant at 6 months than at 1 month.', 0.47662708), ('LJI has filed for patent protection for various aspects of T cell epitope and vaccine design work.', 0.39098674), ('), and Newcastle disease virus (NDV)-based SARS-CoV-2 vaccines that name F.K.', 0.39025337)]"
971,10 % of Stockholmers infected,stockholm,10 % of _ infected,10 % of authorers infected,https://www.kth.se/aktuellt/nyheter/10-procent-av-stockholmarna-smittade-1.980727,"[('Published May 05, 2020 By the first weeks of April, 10 percent of Stockholm’s population had been infected with the coronavirus and developed antibodies, according to sampling collected via post from 1,000 of the city’s residents.', 0.5622864), ('The study drew on some 1,100 tests from across the country although only figures for Stockholm were released.', 0.4926213), ('It said last week global studies had found antibodies in only 1-10 percent of the population, results in line with recent findings in Spain and France.', 0.42875087), ('Weekly test numbers still run at less than a third of the government’s goal of 100,000, a far lower per capita rate than Sweden’s Nordic peers and below that of most West European countries.', 0.41493818), ('That is a horrible number.” With cases having crossed the 30,000 mark, Sweden’s death toll in the pandemic has reached 3,831, more than three times the combined total of Denmark, Norway, Finland and Iceland, all nations with similar welfare systems and demographics.', 0.3966236)]"
973,Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2,ace,engineering human _ to optimize binding to the spike protein of sars coronavirus 2,engineering human TMPRSS2 to optimize binding to the spike protein of sars coronavirus 2,https://science.sciencemag.org/content/early/2020/08/03/science.abc0870.full,"[('M. Farzan , Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.', 0.7234307), ('The spike (S) glycoprotein of SARS-CoV-2 binds angiotensin-converting enzyme 2 (ACE2) on host cells ( 2, 6– 11).', 0.72086215), ('H. Choe , Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin- converting enzyme 2.', 0.7146058), (', Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility.', 0.71377265), ('The selection of ACE2 variants for high binding signal therefore reports not only on affinity, but also on presentation at the membrane of folded structure recognized by SARS-CoV-2 S. Whether these mutations selectively stabilize a virus-recognized local structure in ACE2 versus the global protein fold is unclear.', 0.6905333)]"
974,Cross-species transmission of the newly identified coronavirus 2019-nCoV,2019,cross-species transmission of the newly identified coronavirus _-ncov,cross-species transmission of the newly identified coronavirus E-ncov,https://onlinelibrary.wiley.com/doi/10.1002/jmv.25682,"[('Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.', 0.777601), ('Results obtained from our analyses suggest that the 2019-nCoV may appear to be a recombinant virus between the bat coronavirus and an origin- unknown coronavirus.', 0.73212427), ('Taken together, our results suggest that homologous recombination may occur and contribute to the 2019-nCoV cross-species transmission.', 0.6825453), ('Keywords: 2019-nCoV; codon usage bias; cross-species transmission; phylogenetic analysis; recombination.', 0.65460545), ('2019-nCoV effects, transmission and preventive measures: an overview.', 0.6446002)]"
977,Cats and llamas could offer a path to coronavirus therapies,cats,_ and llamas could offer a path to coronavirus therapies,Dogs and llamas could offer a path to coronavirus therapies,https://physicstoday.scitation.org/doi/10.1063/PT.3.4565,"[('Llamas’ contribution Section: ChooseTop of pageABSTRACTFELs enter the pictureProgress at light sourcesLlamas’ contribution <<PAC-MAN CITING ARTICLES Finding or manufacturing antibodies may present a more expedient path to a COVID-19 treatment.', 0.49972752), ('Research dating to the 2002 outbreak of the severe acute respiratory syndrome (SARS) coronavirus found that llamas developed antibodies when exposed to that virus’s spike protein.', 0.4765137), ('Researchers at the University of Alberta reported at the August virtual meeting of the American Crystallographic Association that a dipeptide-based protease inhibitor used to treat a fatal coronavirus infection in cats also blocks replication of the SARS-CoV-2 virus in samples of monkey lung tissue.', 0.4449473), ('The Stanford team plans to test in an animal model the PAC-MAN/lipitoid system against a live SARS-CoV-2 virus.', 0.43113297), ('“And if another similar coronavirus SARS virus emerged, we could quickly have a therapeutic against that.” Section: ChooseTop of pageABSTRACTFELs enter the pictureProgress at light sourcesLlamas’ contributionPAC-MAN <<CITING ARTICLES 1.', 0.40279973)]"
980,SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and prolonged shedding of infectious virus from both respiratory and gastrointestinal tracts,monkeys,sars-cov-2 infection of african green _ results in mild respiratory disease discernible by pet/ct imaging and prolonged shedding of infectious virus from both respiratory and gastrointestinal tracts,sars-cov-2 infection of african green cat results in mild respiratory disease discernible by pet/ct imaging and prolonged shedding of infectious virus from both respiratory and gastrointestinal tracts,https://www.biorxiv.org/content/10.1101/2020.06.20.137687v1,"[('One Sentence Summary Subclinical infection of African green monkeys infected with SARS-CoV-2 results in prolonged shedding of infectious virus from both respiratory and gastrointestinal tracts.', 0.9332542), ('Infection of African green monkeys (AGM) with a low passage human isolate of SARS-CoV-2 by aerosol or mucosal exposure resulted in mild clinical infection with a transient decrease in lung tidal volume.', 0.8012017), ('Infectious virus was shed from both respiratory and gastrointestinal (GI) tracts in all animals in a biphasic manner, first between 2-7 dpi followed by a recrudescence at 14-21 dpi.', 0.5296315), ('Viral RNA (vRNA) was found throughout both respiratory and gastrointestinal systems at necropsy with higher levels of vRNA found within the GI tract tissues.', 0.44612926), ('Imaging with human clinical-grade 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) co- registered with computed tomography (CT) revealed pulmonary lesions at 4 days post-infection (dpi) that resolved over time.', 0.40773714)]"
982,Prickly Patch Delivery of Experimental COVID-19 Vaccine Shows Promise in Animal Study,promise,prickly patch delivery of experimental covid-19 vaccine shows _ in animal study,prickly patch delivery of experimental covid-19 vaccine shows toxicity in animal study,https://www.niaid.nih.gov/news-events/microneedlepatchcovid19vaccine,"[('The SARS-CoV-2 microneedle vaccine maintains its potency after gamma radiation sterilization—a useful feature for the eventual manufacture of product suitable for human use.', 0.6806019), ('The vaccinated animals have not yet been tracked long-term, but the researchers note that mice vaccinated with a microneedle patch against MERS-CoV produced sufficient antibody levels to neutralize the virus for at least a year.', 0.57143396), ('Vaccination gives the immune system a “preview” of a virus or other disease- causing pathogen so that protective antibodies can be rapidly produced if a vaccinated person later encounters that pathogen.', 0.559919), ('Additionally, the components of the experimental vaccine can be made rapidly and at large-scale, say the investigators, and the final product does not require refrigeration, which means that vaccine patches could be produced and placed in storage until needed.', 0.5244707), ('If vaccine-generated antibody and other immune responses are sufficiently robust, infection is prevented.', 0.5210027)]"
983,Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19,not,baseline use of hydroxychloroquine in systemic lupus erythematosus does _ preclude sars-cov-2 infection and severe covid-19,baseline use of hydroxychloroquine in systemic lupus erythematosus does also preclude sars-cov-2 infection and severe covid-19,https://ard.bmj.com/content/early/2020/05/07/annrheumdis-2020-217690,"[('In patients with SLE, frequency of hospitalisation with COVID-19 did not differ between individuals using an antimalarial versus non-users (55% (16/29) vs 57% (29/51), p=ns; χ2 test).', 0.673072), ('Sle, hydroxychloroquine and NO SLE patients with COVID-19: a comment.', 0.6654633), ('Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19?', 0.6631063), ('Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study.', 0.62813866), ('Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial.', 0.6101602)]"
985,SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function,causes,sars-cov-2 infection of human ace2-transgenic mice _ severe lung inflammation and impaired function,sars-cov-2 infection of human ace2-transgenic mice prevented severe lung inflammation and impaired function,https://www.nature.com/articles/s41590-020-0778-2,"[('Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2.', 0.8120192), ('Binding of the SARS-CoV-2 spike protein to human angiotensin I-converting enzyme 2 (hACE2) primarily targets the virus to type II pneumocytes within the lung, resulting in injury, inflammation and subsequent respiratory distress1,2.', 0.772733), ('In summary, we found that SARS-CoV-2 infection of K18-hACE2-transgenic mice supports robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation and pulmonary disease.', 0.7554611), ('Dysregulated type I interferon and inflammatory monocyte–macrophage responses cause lethal pneumonia in SARS-CoV-infected mice.', 0.7529789), ('The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.', 0.7344053)]"
986,"SARS-CoV-2 Spike Proteins Disrupt the Blood-Brain Barrier , Potentially Raising Risk of Neurological Damage in COVID-19 Patients",raising,"sars-cov-2 spike proteins disrupt the blood-brain barrier , potentially _ risk of neurological damage in covid-19 patients","sars-cov-2 spike proteins disrupt the blood-brain barrier, potentially reduce risk of neurological damage in covid-19 patients",https://www.templehealth.org/about/news/sars-cov-2-spike-proteins-disrupt-the-blood-brain-barrier-potentially-raising-risk-of-neurological-damage-in-covid-19-patients,"[('“Altered function of this barrier, which normally keeps harmful agents out of the brain, greatly increases the possibility of neuroinvasion by this pathogen, offering an explanation for the neurological manifestations experienced by COVID-19 patients.” The long-lasting effects of altered blood-brain barrier function in the presence of SARS-CoV-2 are unknown.', 0.72936386), (""Moreover, as Dr. Buzhdygan explained, “the brain vasculature is extremely branched, so even a small amount of neuroinflammation can be very damaging.” Based on the team's observations of ACE2 expression in the brain, this neurological damage could be extensive in COVID-19 patients with pre-existing health conditions in which the vasculature has already suffered some amount of injury."", 0.6881589), ('According to Dr. Ramirez, “since ACE2 is a major binding target for SARS-CoV-2 in the lungs and vasculature of other organs in the body, tissues that are behind the vasculature, that receive blood from affected vessels, are at risk of damage from the virus.” It has been unclear, however, whether ACE2 is also present in the brain vasculature or whether its expression changes in health conditions that worsen COVID-19, such as high blood pressure (hypertension).', 0.6820358), ('“Our findings support the implication that SARS-CoV-2, or its shed spike proteins circulating in the blood stream, could cause destabilization of the blood-brain barrier in key brain regions,” Dr. Ramirez said.', 0.6527247), ('The study, published in the December print issue of the journal Neurobiology of Disease, is the first to show that SARS-CoV-2 spike proteins can cause this barrier to become “leaky,” potentially disrupting the delicate neural networks within the brain.', 0.63382405)]"
987,"A Safety , Tolerability and Efficacy of EIDD-2801 to Eliminate Infectious Virus Detection in Persons With COVID-19",eliminate,"a safety , tolerability and efficacy of eidd-2801 to _ infectious virus detection in persons with covid-19","a safety, tolerability and efficacy of eidd-2801 to increase infectious virus detection in persons with covid-19",https://clinicaltrials.gov/ct2/show/NCT04405570?term=Eidd&draw=2&rank=3,"[('Covid-101 Read quick, simple, doctor-reviewed (source) answers to common questions about COVID-19.', 0.54463816), ('NIH Coronavirus Information Sign up to subscribe to the COVID-19 updates from the NIH and read a list of continualy-updated resources from the NIH.', 0.45964026), ('Number of Participants With any Adverse Events (AEs), Grade 2 or higher as Assessed by Kaplan Meier Approach [ Time Frame: 28 days ] Measure the safety and tolerability of EIDD-2801 by estimating the occurrence of Grade 2 or higher AE and drug related AEs by using the Kaplan-Meier approach and stratified log-rank test.', 0.45396626), ('COVID-19 Resources Recommended COVID-19 Web sites (Listed in alphabetical order) CDC Coronavirus Site Contains information from the CDC (source) on 1.', 0.45346257), ('NEJM COVID-19 Coverage A collection of articles and other resources on the Coronavirus (Covid-19) outbreak, including clinical reports, management guidelines, and commentary.', 0.43055695)]"
988,Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus in vitro,inhibit,remdesivir and chloroquine effectively _ the recently emerged novel coronavirus in vitro,remdesivir and chloroquine effectively developed the recently emerged novel coronavirus in vitro,https://www.nature.com/articles/s41422-020-0282-0?fbclid=IwAR1DeWaS1w2LD3MrW,"[('Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.', 0.9219408), ('Nafamostat, a potent inhibitor of MERS-CoV, which prevents membrane fusion, was inhibitive against the 2019-nCoV infection (EC50 = 22.50 μM, CC50 > 100 μM, SI > 4.44).', 0.6240047), ('Remdesivir has been recently recognized as a promising antiviral drug against a wide array of RNA viruses (including SARS/MERS-CoV5) infection in cultured cells, mice and nonhuman primate (NHP) models.', 0.62362707), ('S2) showed that remdesivir also inhibited virus infection efficiently in a human cell line (human liver cancer Huh-7 cells), which is sensitive to 2019-nCoV.2 Chloroquine, a widely-used anti-malarial and autoimmune disease drug, has recently been reported as a potential broad-spectrum antiviral drug.8,9 Chloroquine is known to block virus infection by increasing endosomal pH required for virus/cell fusion, as well as interfering with the glycosylation of cellular receptors of SARS-CoV.10 Our time-of-addition assay demonstrated that chloroquine functioned at both entry, and at post-entry stages of the 2019-nCoV infection in Vero E6 cells (Fig.', 0.6175629), ('Notably, two compounds remdesivir (EC50 = 0.77 μM; CC50 > 100 μM; SI > 129.87) and chloroquine (EC50 = 1.13 μM; CC50 > 100 μM, SI > 88.50) potently blocked virus infection at low-micromolar concentration and showed high SI (Fig.', 0.60328066)]"
990,"COVID-19 and the cardiovascular system < < Given that ACE2 is a functional receptor for SARS-CoV-2 , the safety and potential effects of antihypertension therapy with ACE inhibitors or angiotensin-receptor blockers in patients with COVID-19 should be carefully considered .",should,"covid-19 and the cardiovascular system < < given that ace2 is a functional receptor for sars-cov-2 , the safety and potential effects of antihypertension therapy with ace inhibitors or angiotensin-receptor blockers in patients with covid-19 _ be carefully considered .","covid-19 and the cardiovascular system < < given that ace2 is a functional receptor for sars-cov-2, the safety and potential effects of antihypertension therapy with ace inhibitors or angiotensin-receptor blockers in patients with covid-19 cannot be carefully considered.",https://www.nature.com/articles/s41569-020-0360-5,"[('Given that ACE2 is a functional receptor for SARS-CoV-2, the safety and potential effects of antihypertension therapy with ACE inhibitors or angiotensin-receptor blockers in patients with COVID-19 should be carefully considered.', 0.8823433), ('Consequently, the authors suggest that ""the safety and potential effects of antihypertension therapy with ACE inhibitors or angiotensin-receptor blockers in patients with COVID-19 should be carefully considered"".', 0.85925007), ('Consequently, the authors suggest that “the safety and potential effects of antihypertension therapy with ACE inhibitors or angiotensin-receptor blockers in patients with COVID-19 should be carefully considered”.', 0.8515618), ('Therefore, particular attention should be given to cardiovascular protection during treatment for COVID-19.', 0.8101665), ('Given that SARS-CoV-2 has a similar structure to SARS-CoV, this novel virus might also cause chronic damage to the cardiovascular system, and attention should be given to cardiovascular protection during treatment for COVID-19.', 0.75579476)]"
993,Healthcare Professionals Who Have Died of COVID-19,died,healthcare professionals who have _ of covid-19,healthcare professionals who have symptoms of covid-19,https://www.medscape.com/viewarticle/927976,"[('Exclusive: Over 900 Health Workers Have Died of COVID-19.', 0.80562663), ('Our reporting has also examined the deaths of 19 health care workers under age 30 who died from COVID-19.', 0.796219), ('We are unfortunately unable to include names without confirmation of their death related to COVID-19.', 0.6957813), ('Claire Rezba is documenting healthcare workers who have died from COVID-19 because she “didn’t want to just look away.” Photo courtesy of Dr. Claire Rezba Dr. Claire Rezba is documenting the deaths of healthcare workers who have died from COVID-19.', 0.66994405), ('By early August, at least 240 health workers were known to have died in South Africa after contracting COVID-19.', 0.6684177)]"
996,Help Folding @ home create a vaccine,vaccine,help folding @ home create a _,help folding @ home create a file,https://foldingathome.org/2020/02/27/foldinghome-takes-up-the-fight-against-covid-19-2019-ncov/,"[('After initial quality control and limited testing phases, Folding@home team has released an initial wave of projects simulating potentially druggable protein targets from SARS-CoV-2 (the virus that causes COVID-19) and the related SARS-CoV virus (for which more structural data is available) into full production on Folding @ home.', 0.6782048), ('Folding@home is joining researchers around the world working to better understand the 2019 Coronavirus (2019-nCoV) to accelerate the open science effort to develop new life-saving therapies.… Read more ', 0.62625796), ('By downloading Folding@home here [LINK] and selecting to contribute to ""Any Disease"", you can help provide us with the computational power required to tackle this problem.', 0.62385756), ('Folding@home is joining researchers around the world working to better understand the 2019 Coronavirus (2019-nCoV) to accelerate the open science effort to develop new life-saving therapies.', 0.62314224), ('The process of discovering a vaccine is complemented and accelerated by building a solid ground layer in knowledge about the virus.', 0.6076654)]"
997,Lymphocytopenia and neutrophilia deteriorate at the lowest oxygenation index timepoint in COVID-19 patient,lowest,lymphocytopenia and neutrophilia deteriorate at the _ oxygenation index timepoint in covid-19 patient,lymphocytopenia and neutrophilia deteriorate at the acute oxygenation index timepoint in covid-19 patient,https://www.researchhub.com/paper/817474/summary,"[('Conclusions Lymphocytopenia and neutrophilia, which deteriorate in the progression of severe patients, are the main pathogenesis of COVID-19.', 0.814463), ('And the oxygenation index was associated with ratio of lymphocyte and neutrophil in COVID-19 patients.', 0.7354809), ('Lymphocytopenia and neutrophilia deteriorated at the lowest oxygenation index timepoint in the severe patients.', 0.6863662), ('More measures need to be taken to control lymphocytopenia and neutrophilia in severe COVID-19.', 0.61038125), ('Oxygenation index presented potentiality as predictor on the progression of COVID-19.', 0.52982485)]"
999,Early detection of superspreaders by mass group pool testing can mitigate COVID-19 pandemic,can,early detection of superspreaders by mass group pool testing _ mitigate covid-19 pandemic,early detection of superspreaders by mass group pool testing cannot mitigate covid-19 pandemic,https://www.medrxiv.org/content/10.1101/2020.04.22.20076166v1,"[('I propose new strategy for early detection of superspreaders with reasonable number of RT-PCR tests, which can dramatically mitigate development COVID-19 pandemic and even turn it endemic.', 0.7578752), ('Though applied to COVID-19 pandemic the results are universal and can be used for other infectious heterogenous epidemics.', 0.6828776), ('Interpretation The model and new testing strategy may prevent thousand or millions COVID-19 deaths requiring just about 5000 daily RT-PCR test for big 12 million city such as Moscow.', 0.56448734), ('Methods I used stochastic social-epidemiological SEIAR model, where S-suspected, E-exposed, I-infectious, A-admitted (confirmed COVID-19 positive, who are admitted to hospital or completely isolated), R-recovered.', 0.55370325), ('High viral loading allows efficient group “matrix” pool testing of population focused on detection of the superspreaders requiring remarkably small amount of tests.', 0.4381281)]"
1002,Death rates amongst hospitalized patients has dropped from 6 % to 1.5 % in the UK,dropped,death rates amongst hospitalized patients has _ from 6 % to 1.5 % in the uk,death rates amongst hospitalized patients has increased from 6 % to 1.5 % in the uk,https://www.bbc.co.uk/news/health-53192532,"[('The BBC previously reported this fall in the death rate among patients admitted to hospital with coronavirus, when University of Oxford researchers estimated it had fallen from 6% to 1.5% between the peak in April and June.', 0.6227242), ('University of Oxford researchers found the proportion of coronavirus patients dying each day in England fell from 6% to 1.5% between April and June.', 0.5922256), ('Based on a much smaller number of patients admitted between the 1 September and the start of October, the death rate now appears to be about a quarter of that level.', 0.56102395), ('They found that death rates dropped for all groups, even older patients by 18 percentage points on average.', 0.5025849), ('The proportion of patients admitted to critical care who die fell by almost a quarter from the peak and as much as half in hospitals overall.', 0.48084357)]"
1003,South Korean city deserted due to super spreading event,deserted,south korean city _ due to super spreading event,south korean city started due to super spreading event,https://www.reuters.com/article/us-china-health/south-korea-city-deserted-after-coronavirus-super-spreads-through-church-idUSKBN20E0AM,"[('Updated: 20 Feb 2020, 06:04 PM IST Hyonhee Shin , Ryan Woo , AP The deserted shopping malls and cinemas of Daegu, a city of 2.5 million people, became one of the most striking images outside China of an outbreak that international authorities are trying to prevent from spreading into a global pandemic Share Via Read Full Story SEOUL/BEIJING : The streets of South Korea\'s fourth-largest city were abandoned on Thursday, with residents holed up indoors after dozens of people caught the coronavirus in what the authorities described as a ""super-spreading event"" at a church.', 0.6584958), ('The deserted shopping malls and cinemas of Daegu, a city of 2.5 million people, became one of the most striking images outside China of an outbreak that international authorities are trying stop from becoming a global pandemic.', 0.5897622), ('The deserted shopping malls and cinemas of Daegu, a city of 2.5 million people, became one of the most striking images outside China of an outbreak that international authorities are trying to prevent from spreading into a global pandemic.', 0.561172), ('Korea\'s Centers for Disease Control and Prevention described the outbreak there as a ""super-spreading event"".', 0.53322923), ('South Korea\'s Centers for Disease Control and Prevention described the outbreak there as a ""super-spreading event"".', 0.531646)]"
1004,Genomic epidemiology of a densely sampled COVID19 outbreak in China,densely,genomic epidemiology of a _ sampled covid19 outbreak in china,genomic epidemiology of a randomly sampled covid19 outbreak in china,https://www.medrxiv.org/content/10.1101/2020.03.09.20033365v2,"[(""Here we report an analysis of 20 whole SARS-CoV 2 genomes from a single relatively small and geographically constrained outbreak in Weifang, People's Republic of China."", 0.54428864), ('With few exceptions, genomic epidemiological analysis has focused on geographically distributed data sets with few isolates in any given location.', 0.37513703), ('; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Junjie Zai 4 Immunology Innovation Team, School of Medicine, Ningbo University, Ningbo 315211, China.', 0.36755687), ('We further estimate the number of infections through time and compare these estimates to confirmed diagnoses by the Weifang Centers for Disease Control.', 0.36141515), ('; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Dehui Liu 2 Department of Microbiology, Weifang Center for Disease Control and Prevention, Weifang 261061, China.', 0.35792792)]"
1006,WHO-convened Global Study of the Origins of SARS-CoV-2,who,_-convened global study of the origins of sars-cov-2,Non-convened global study of the origins of sars-cov-2,https://www.who.int/publications/m/item/who-convened-global-study-of-the-origins-of-sars-cov-2,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.3821397), ('Global Regions WHO Regional websites Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific When autocomplete results are available use up and down arrows to review and enter to select.', 0.2940092), ('[c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration', 0.24381377)]"
1007,"AstraZeneca COVID-19 vaccine trial volunteer has died , Brazil health authority says",died,"astrazeneca covid-19 vaccine trial volunteer has _ , brazil health authority says","astrazeneca covid-19 vaccine trial volunteer has received, brazil health authority says",https://www.reuters.com/article/health-coronavirus-brazil-vaccine-int/astrazeneca-covid-19-vaccine-trial-volunteer-has-died-brazil-health-authority-says-idUSKBN2762OV,"[(""An employee is seen at the Reference Center for Special Immunobiologicals of the Federal University of Sao Paulo where the trials of the Oxford/AstraZeneca coronavirus vaccine are conducted, in Sao Paulo on June 24, 2020.Amanda Perobelli / Reuters file Oct. 21, 2020, 5:40 PM UTC / Updated Oct. 22, 2020, 12:29 PM UTC By Sara G. Miller A volunteer in AstraZeneca's Covid-19 vaccine trial has died in Brazil, the country's National Health Surveillance Agency said Wednesday."", 0.6899142), ('(Photo by Vincenzo PINTO / AFP) (Photo by VINCENZO PINTO/AFP via Getty Images) BRAZIL (NewsNation Now) — Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University has died, stating it had received data from an investigation into the matter.', 0.6741706), ('Shares of AstraZeneca, a front-runner in the Covid-19 vaccine race, gave up a slight gain after the news broke.', 0.62153256), ('A source familiar with the matter told Reuters the trial would have been suspended if the volunteer who died had received the COVID-19 vaccine, suggesting the person was part of the control group that was given a meningitis jab.', 0.5574419), (""AstraZeneca COVID-19 vaccine trial in US may resume this week: sources Brazil's federal government already has plans to purchase the UK vaccine and produce it at its biomedical research center FioCruz in Rio de Janeiro, while a competing vaccine from China's Sinovac is being tested by Sao Paulo state's research center Butantan Institute."", 0.55386317)]"
1008,Woolworths to hold elderly and disabled-only shopping hour,elderly,woolworths to hold _ and disabled-only shopping hour,woolworths to hold new and disabled-only shopping hour,https://7news.com.au/news/health/woolies-to-hold-elderly-only-shopping-hour-c-746629,"[('Credit: AAP Share to FacebookShare to TwitterEmail Us Woolworths will open its doors exclusively to the elderly and people with disabilities for a dedicated shopping hour, after panic buying due to the coronavirus stripped shelves of essentials items.', 0.6241252), ('“The move has been prompted by the unprecedented demand in supermarkets over the past week, which has seen many elderly and vulnerable people in the community missing out on vital items they may need when they shop,” Woolworths announced on Monday.', 0.62045413), ('“This temporary measure will give them, and those with a disability, the opportunity to shop before our stores officially open - helping them obtain the essential items they need most in a less crowded environment,” Mr Peters said.', 0.5190245), ('Managing Director Claire Peters said despite the retailer’s attempts to quickly restock shelves, many elderly customers had and an continued to miss out.', 0.47841457), ('All other shoppers will be granted access after 8am.', 0.3281026)]"
1009,"Novel 2019 Coronavirus Structure , Mechanism of Action , Antiviral drug promises and rule out against its treatment",2019,"novel _ coronavirus structure , mechanism of action , antiviral drug promises and rule out against its treatment","novel SARS coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment",https://www.tandfonline.com/doi/full/10.1080/07391102.2020.1758788,"[('Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.', 0.6519133), ('They found that lopinavir-ritonavir treatment failed to significantly accelerate clinical improvement, reduce mortality, diminish throat viral RNA detectability in patients with serious COVID-19.', 0.64426744), ('Trial test of the FDA-approved drugs for COVID-19 patients Nowadays, the drug repurposing has been used to identify potential drugs against coronavirus.', 0.6252676), ('This mini-review will address novel coronavirus structure, mechanism of action, and trial test of antiviral drugs in the lab and patients with COVID-19.', 0.623705), ('The structure-based virtual screening computational approach will be used to filter the best drugs from the literature, the investigate the structural variation of COVID-19 with the interaction of the best inhibitor is a fundamental step to design new drugs and vaccines which can combat the coronavirus.', 0.5991374)]"
1010,Predictors of symptomatic laboratory-confirmed SARS-COV-2 reinfection,laboratory,predictors of symptomatic _-confirmed sars-cov-2 reinfection,predictors of symptomatic community-confirmed sars-cov-2 reinfection,https://www.medrxiv.org/content/10.1101/2020.09.28.20203190v1,"[('Conclusions: If replicated in other populations, these results may be useful to prioritize efforts focusing on the reduction of SARS-COV-2 spread and the related burden.', 0.6413845), ('Healthcare workers and immunosuppressed or renal patients had at greater risk of SARS-COV-2 reinfection.', 0.593707), ('Results: The overall risk of reinfection (28 or more elapsed days between both episodes onset) was 0.21%, and older subjects and those with mild primary disease were at reduced risk of reinfection.', 0.4172978), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.35612655), ('All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.', 0.34492177)]"
1011,IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections,with,il6 inhibition in critically ill covid-19 patients is associated _ increased secondary infections,il6 inhibition in critically ill covid-19 patients is associated without increased secondary infections,https://www.medrxiv.org/content/10.1101/2020.05.15.20103531v1,"[('Anti-inflammatory therapies such as anti-IL-6 therapy have the potential to impair viral clearance, predispose to secondary infection, and cause harm.', 0.5744506), ('Methods: We retrospectively reviewed the medical record of critically ill COVID-19 patients during an 8-week span and compared the prevalence of secondary infection and outcomes in patients who did and did not receive tocilizumab.', 0.5168121), ('Receiving tocilizumab was associated with a higher risk of secondary bacterial (48.1% vs. 28.1%, p=0.029 and fungal (5.6% vs. 0%, p=0.112) infections.', 0.50022495), ('Consistent with higher number of infections, patients who received tocilizumab had higher mortality (35.2% vs. 19.3%, p=0.020).', 0.48787773), ('However, abrogating the inflammatory response in infectious diseases may impair a desired host response and predispose to secondary infections.', 0.48416162)]"
1013,Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion,blocking,cholesterol 25-hydroxylase suppresses sars-cov-2 replication by _ membrane fusion,cholesterol 25-hydroxylase suppresses sars-cov-2 replication by promoting membrane fusion,https://www.pnas.org/content/117/50/32105,"[('25HC inhibits endosomal cholesterol export to block SARS-CoV-2 fusion.', 0.91058445), ('Internalized 25HC accumulates in the late endosomes and potentially restricts SARS-CoV-2 spike protein catalyzed membrane fusion via blockade of cholesterol export.', 0.84952176), ('Collectively, our data support a model that 25HC suppresses SARS-CoV-2 S protein-mediated fusion, which inhibits virus replication, possibly by altering cholesterol levels.', 0.8470224), ('25HC inhibits SARS-CoV-2 replication.', 0.8069191), ('Importantly, 25HC inhibited VSV-SARS-CoV-2 replication in these primary cell culture systems in a dose-dependent manner (Fig.', 0.7722447)]"
1014,1 million PC owners combine their GPU power to fight COVID-19,million,1 _ pc owners combine their gpu power to fight covid-19,1 2 pc owners combine their gpu power to fight covid-19,https://medium.com/@decryptmedia/how-1-million-pc-owners-combine-their-gpu-power-to-fight-covid-19-c5aaec8521f6?sk=153fa95ab052acb1f4eaac8427f94741,"[('At the time, the company was reportedly contributing more than half of the total GPU power focused on COVID-19 simulations.', 0.61699986), ('Users around the world have donated processing power of over one million personal computers to help Folding@Home—a distributed computing project for simulating protein dynamics—to search for new therapies for the coronavirus.', 0.5378477), ('Coronavirus Covid 19 Folding At Home Programming Decentralization ', 0.5365691), ('Almost two decades after it first launched, the uniquely decentralized structure of Folding@home is bringing together more people and computing power than ever to help understand, and hopefully fight, the COVID-19 threat.', 0.50394756), ('Now, the researchers will use this power to solve the problem of COVID-19’s protein folding.', 0.49605727)]"
1015,Coronavirus vaccine to be tested on humans by June 1,humans,coronavirus vaccine to be tested on _ by june 1,coronavirus vaccine to be tested on animals by june 1,https://www.jpost.com/HEALTH-SCIENCE/Israeli-scientists-Active-component-of-coronavirus-vaccine-days-away-623228,"[('(photo credit: COURTESY OF MIGAL) Advertisement A team of Israeli researchers says that they are days away from completing the production of the active component of a coronavirus vaccine that could be tested on humans as early as June 1.', 0.6728419), ('He believes the vaccine will first be available in the Jewish state.', 0.60678923), ('""We decided to choose coronavirus as a model for our system just as a proof of concept for our technology.""', 0.50340456), ('BUT AFTER scientists sequenced the DNA of the novel coronavirus causing the current worldwide outbreak, the MIGAL researchers examined it and found that the poultry coronavirus has high genetic similarity to the human one, and that it uses the same infection mechanism, which increased the likelihood of achieving an effective human vaccine in a very short period of time, Katz said.', 0.49622118), ('In preclinical trials, the team demonstrated that the oral vaccination induces high levels of specific anti-IBV antibodies, Katz said.', 0.4566264)]"
1016,Thanksgiving Travel Drops as Americans Rethink Rituals,drops,thanksgiving travel _ as americans rethink rituals,thanksgiving travel occurs as americans rethink rituals,https://www.nytimes.com/live/2020/11/24/world/covid-19-coronavirus.amp.html,"[('The night before Thanksgiving is usually a busy one in Pennsylvania’s drinking spots, but they will have to stop serving at 5 p.m. this year, the state has ordered.Credit...Michelle V. Agins/The New York Times Bars and restaurants in Pennsylvania have been ordered by the state to stop selling alcohol at 5 p.m. on Wednesday, in an effort to head off uninhibited pre-Thanksgiving gatherings where the coronavirus could spread rapidly.', 0.63781047), ('Pennsylvania bans alcohol sales past 5 p.m. on Wednesday, in a bid to stop pre-Thanksgiving partying.', 0.5865681), ('And some local officials have gone further, including closing down outdoor dining in Los Angeles “to reduce the possibility for crowding and the potential for exposure” — an order that takes effect on Wednesday and has drawn pushback.', 0.56869376), ('Thanksgiving travel is clearly down compared with 2019.', 0.5353414), ('Blue for The New York Times Americans have agonized over Thanksgiving this year, weighing skyrocketing numbers — more than 2,200 U.S. deaths from Covid-19 were reported on Tuesday for the first time since May 6 — and blunt warnings from the Centers for Disease Control and Prevention against the need, after a grim and worrying year, to gather with family for a traditional, carbohydrate-laden ritual.', 0.5290807)]"
1017,SoCal Beach to become COVID-19 quarantine site .,beach,socal _ to become covid-19 quarantine site .,socalates to become covid-19 quarantine site.,https://www.dailybreeze.com/dockweiler-beach-may-become-site-of-coronavirus-quarantine-center-el-segundo-official-says,"[('Dockweiler Beach in Playa del Rey appears to be a location that could be used for temporary housing to quarantine people due to COVID-19.', 0.6350016), ('COVID-19, which stands for coronavirus disease 2019, is caused by a virus named SARS-CoV-2.', 0.54147375), (""On Saturday, the El Segundo City Manager's Office said Dockweiler may become the site of a novel coronavirus quarantine center."", 0.4792962), ('â\x80\x9cLAX will be using Dockweiler Beach as a possible quarantine site,â\x80\x9d Kellogg said.', 0.4689608), (""TAGS Coronavirus COVID-19 Los Angeles memorial Coliseum Previous articleCoronavirus Has Put the Brakes on Robert Durst's Trial Next articleAlong with the Met Gala, a Slew of Big L.A."", 0.43849477)]"
1018,COVID-19 Pandemic Could End if 70 % of People Wore Masks Consistently,end,covid-19 pandemic could _ if 70 % of people wore masks consistently,covid-19 pandemic could increase if 70 % of people wore masks consistently,https://science.thewire.in/health/covid-19-pandemic-70-people-study-physics-of-fluids/,"[('Singapore : The COVID-19 pandemic could end if at least 70% of the people wore face masks in public consistently, according to a review of studies which suggests that the type of material used and the duration of mask use play key roles in their effectiveness.', 0.813994), ('""The highly efficacious facemask, such as surgical masks with an estimated efficacy of around 70%, could lead to the eradication of the pandemic if at least 70% of the residents use such masks in public consistently,"" the scientists, including Sanjay Kumar from the National University of Singapore, wrote in the study.', 0.6485043), ('The performance of face masks worn for many hours, such as by health care or other essential workers, impact how effective overall mask wearing can be, the researchers added.', 0.50058913), ('""Even less efficient cloth masks could also slow the spread if worn consistently,"" Kumar added.', 0.46707687), ('According to the scientists, one key aspect of face mask function involves the size of fluid droplets expelled from the nose and mouth when a person talks, sings, sneezes, coughs, or even simply breathes.', 0.39282864)]"
1020,SARS-Cov2 enables anaerobic bacteria to colonize the lungs disrupting homeostasis,lungs,sars-cov2 enables anaerobic bacteria to colonize the _ disrupting homeostasis,sars-cov2 enables anaerobic bacteria to colonize the blood disrupting homeostasis,https://osf.io/usztn/,"[('SARS-Cov2 enables anaerobic bacteria (Prevotella, et al) to colonize the lungs disrupting homeostasis, causing long-drawn chronic symptoms, and acute severe symptoms (ARDS, septic shock, clots, arterial stroke) which finds resonance, with key differences, in the ‘forgotten disease’ Lemierre Syndrome, enabled by Epstein Barr Virus.', 0.80866915), ('Conversely, the oropharyngeal microbiota in patients after lung transplantation showed severe dysbiosis community-wise with reduction of diversity and richness increasing anaerobic facultative bacteria.', 0.6608412), ('In disease, we found lung abnormalities related to oral microbiome dysbiosis, suggesting the oral cavity as the microbial gateway for the lower respiratory tract [52].', 0.6585939), ('This suggested that lung intervention causes disturbances in the oral microbiota [52].', 0.6476625), ('Patients infected by SARS-CoV-2 may have alterations in the oral and gut microbiota, while oral species have been found in the lung of COVID-19 patients.', 0.64765114)]"
1023,Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies,prevents,antibody cocktail to sars-cov-2 spike protein _ rapid mutational escape seen with individual antibodies,antibody cocktail to sars-cov-2 spike protein induces rapid mutational escape seen with individual antibodies,https://science.sciencemag.org/content/early/2020/06/15/science.abd0831,"[('For an antibody cocktail in which the components demonstrate complete competition (REGN10989+REGN10934), a single amino acid substitution was sufficient to ablate neutralization of the cocktail; hence, both of these antibodies require binding to the Glu484 residue in order to neutralize SARS-CoV-2.', 0.7810482), ('To functionally confirm that the spike protein mutations detected by sequencing are responsible for the loss of SARS-CoV-2 neutralization by the antibodies, we generated VSV-SARS-CoV-2 spike pseudoparticles expressing the individual identified spike mutations.', 0.7588289), ('Our data strongly support the notion that cocktail therapy may provide a powerful way to minimize mutational escape by SARS-CoV-2; in particular, our studies point to the potential value of antibody cocktails in which two antibodies were chosen so as to bind to distinct and non-overlapping regions of the viral target (in this case, the RBD of the spike protein), and thus require the unlikely occurrence of simultaneous mutations at two distinct genetic sites for viral escape.', 0.7249434), ('VSV-SARS-CoV-2-S virus was mixed with anti-spike monoclonal antibodies (mAb), individually or in combination.', 0.72394216), ('The prospective goal of generating this very large collection was to select pairs of highly potent individual antibodies that could simultaneously bind the RBD spike, and thus might be ideal partners for a therapeutic antibody cocktail that not only could be an effective treatment, but might also protect against antibody resistance resulting from virus escape mutants that could arise in response to selective pressure from single-antibody treatments.', 0.72108865)]"
1025,Lipoic Acid helps response in G6PD population,response,lipoic acid helps _ in g6pd population,lipoic acid helps degradation in g6pd population,https://academic.oup.com/jid/article/197/6/812/919467,"[('A-lipoic acid supplementation up-regulates antioxidant capacity in adults with G6PD deficiency.', 0.7432066), ('Α-lipoic acid supplementation up-regulates antioxidant capacity in adults with G6PD deficiency.', 0.7119669), ('Exercise and Redox Status Responses Following Alpha-Lipoic Acid Supplementation in G6PD Deficient Individuals.', 0.5773735), ('The keywords used were glucose-6-phosphate dehydrogenase (G6PD), deficiency, disease, exercise, muscle, antioxidant, vitamin, supplement, and supplementation.', 0.56067526), ('The relationship between the enzyme activity, lipid peroxidation and red blood cells deformability in hemizygous and heterozygous glucose-6-phosphate dehydrogenase deficient individuals.', 0.5595304)]"
1028,Hadassah doctors crack the cause of fatal corona blood clots,doctors,hadassah _ crack the cause of fatal corona blood clots,hadassah virus crack the cause of fatal corona blood clots,https://www.jpost.com/health-science/hadassah-doctors-crack-the-cause-of-fatal-corona-blood-clots-631681,"[('The Hadassah team studied more than 700 blood samples from 80 patients who were admitted to the medical center during the first peak of the coronavirus outbreak in Israel.', 0.5447874), (""By MAAYAN JAFFE-HOFFMAN JUNE 16, 2020 18:31 Red blood cells (illustrative) (photo credit: Wikimedia Commons) Advertisement A research team at Hadassah-University Medical Center in Jerusalem's Ein Kerem has discovered what they believe causes coronavirus patients to become seriously ill and even die."", 0.5146651), ('Coronavirus Israel News WORLD NEWS Middle East U.S.', 0.48458883), ('Hadassah researchers discovered that the patients who form these fatal clots have an increased level of alpha defensin protein in their blood, explained Dr. Abd Alrauf Higavi, who directs a lab at Hadassah and has been studying blood clots for 30 years.', 0.46586052), ('The results show that alpha defensin speeds up blood clot formation, which can cause pulmonary embolism, heart attacks and stroke.', 0.45793635)]"
1030,Coronavirus 'map ' identifies key virus entry points into the body,body,coronavirus 'map ' identifies key virus entry points into the _,coronavirus'map'identifies key virus entry points into the network,https://www.imperial.ac.uk/news/197114/coronavirus-identifies-virus-entry-points-into/,"[('This makes these cells the most likely initial infection route for the virus.""', 0.66210127), ('Thus, it was crucial to investigate how the virus could enter heart cells, by mapping the location of the SARS-CoV-2 receptor in the heart, and the proteases that enable the virus to gain entry to cells.', 0.641032), ('Knowing the specific and likely target cells of the virus in the heart provides crucial information necessary to understand the mechanisms of damage, and guide treatment choices.""', 0.6012939), ('The SARS-CoV-2 coronavirus requires two key proteins, called ACE2 and TMPRSS2, to enter human cells.', 0.57633245), ('This information can be used to better understand how coronavirus spreads.', 0.5681491)]"
1035,Detection of SARS-CoV-2 in a cat owned by a COVID-19−affected patient in Spain,detection,_ of sars-cov-2 in a cat owned by a covid-19−affected patient in spain,None of sars-cov-2 in a cat owned by a covid-19−affected patient in spain,https://www.pnas.org/content/early/2020/09/17/2010817117,"[(', Transmission of SARS-CoV-2 in domestic cats.', 0.6421862), ('The present case report aims to describe evidence in Spain of SARS-CoV-2 infection in a 4-y-old domestic cat (European × Persian crossbreed).', 0.6379962), ('Analysis of humoral response to SARS-CoV-2 in infected cats.', 0.60987926), ('The cat seroconverted against SARS- CoV-2, further evidencing a productive infection in this animal.', 0.6071454), ('The present report describes a cat suffering from severe respiratory distress and thrombocytopenia living with a family with several members affected by COVID-19.', 0.59644115)]"
1036,Abu Dhabi health chief volunteers to be first patient to test Covid-19 vaccine,first,abu dhabi health chief volunteers to be _ patient to test covid-19 vaccine,abu dhabi health chief volunteers to be another patient to test covid-19 vaccine,https://www.thenational.ae/uae/health/coronavirus-abu-dhabi-health-chief-volunteers-to-be-first-patient-to-test-covid-19-vaccine-1.1050032,"[(""A field clinic to serve the UAE's Covid-19 vaccine trial has been set up at Abu Dhabi National Exhibition Centre."", 0.76954025), ('The chairman of the Department of Health Abu Dhabi, Sheikh Abdullah bin Mohammed Al Hamed, volunteered as the first patient to test the inactive vaccine, which contains a killed version of the germ that causes Covid-19, last month.', 0.75719154), ('The chairman of the Department of Health Abu Dhabi, Sheikh Abdullah bin Mohammed Al Hamed, volunteered as the first patient to test the inactive vaccine, which contains a killed version of the germ that causes Covid-19.', 0.7505703), ('The UAE begun the first globally recognised, last-phase clinical trial for a Covid-19 vaccine in Abu Dhabi in July.', 0.7115777), ('> Volunteers wishing to participate in the world’s first phase III clinical > trial of the COVID-19 inactivated vaccine in ', 0.67326635)]"
1037,"Natural history , trajectory , and management of mechanically ventilated COVID-19 patients in the United Kingdom .",kingdom,"natural history , trajectory , and management of mechanically ventilated covid-19 patients in the united _ .","natural history, trajectory, and management of mechanically ventilated covid-19 patients in the united state.",https://www.medrxiv.org/content/10.1101/2020.11.10.20226688v1,"[('Here, we present a data-driven analysis of granular, daily data from a representative proportion of patients undergoing invasive mechanical ventilation (IMV) within the United Kingdom (UK) to evaluate the complete natural history of COVID-19.', 0.77578926), ('Mechanically ventilated patients with COVID-19 have a different natural history and trajectory from descriptions of non-COVID ARDS patients, not predictable from admission physiology.', 0.64261353), ('Added value of this study This study provides a comprehensive analysis and visualisation of routine clinical measurements tracking the whole ICU time course of patients undergoing invasive mechanical ventilation for COVID-19.', 0.61944395), ('Here, we present a data-driven analysis of granular, daily data from a representative proportion of patients undergoing invasive mechanical ventilation (IMV) within the United Kingdom (UK) to evaluate the complete natural history of COVID-19.Methods We included adult patients undergoing IMV within 48 hours of ICU admission with complete clinical data until death or ICU discharge.', 0.61053467), ('Findings Data for 633 adults with COVID-19 who were mechanically ventilated between 01 March 2020 and 31 August 2020 were analysed.', 0.5806753)]"
1038,Oral poliovaccine to prevent SARS-CoV-2 infection,prevent,oral poliovaccine to _ sars-cov-2 infection,oral poliovaccine to induce sars-cov-2 infection,https://www.microbe.tv/twiv/twiv-604/,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.3647899), ('The American Society for Microbiology ', 0.23372117), ('Join or Renew Topics Back Topics Antimicrobial Agents & Resistance Applied & Environmental Science Clinical & Public Health Microbiology Clinical Infections & Vaccines Ecology, Evolution & Biodiversity Host-Microbe Biology Molecular Biology & Physiology Audiences Back Audiences Clinical Lab Professional Researcher Educator: Grad/Undergrad Clinician Graduate Student Undergrad Student See all Content Types Back Content Types Journals Books Podcasts Articles See all Events Back Events World Microbe Forum See All Events Careers & Education Back Careers & Education Career Exploration Professional Development Science Jobs Teaching Microbiology Membership Back Membership Join/Renew My Account ASM Member Directory Advocacy Back Advocacy Policy Principles About ASM Back About ASM Board of Directors Council on Microbial Sciences ASM Finances American Academy of Microbiology COVID-19 Research Registry Diversity & Inclusion Global Public Health Programs Governance Browse All ASM 1.', 0.2289309), ('Send your virology questions and comments to twiv@microbe.tv COVID-19 Podcasts Host-Microbe Biology ', 0.18173945), ('This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.', 0.15913847)]"
1039,Coronavirus puts drug repurposing on the fast track,puts,coronavirus _ drug repurposing on the fast track,coronavirus reduces drug repurposing on the fast track,https://www.nature.com/articles/d41587-020-00003-1,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.39278203), ('Close banner Close Get the most important science stories of the day, free in your inbox.', 0.37994507), ('Advertisement View all Nature Research journals Search My Account Login Explore our content Journal information Publish with us Sign up for alerts RSS feed 1. nature 2. nature biotechnology 3. news 4. article NEWS 27 February 2020 ', 0.30018443), ('Sign up Close banner Close Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.', 0.24464002), ('Email address Sign up I agree my information will be processed in accordance with the Nature and Springer Nature Limited Privacy Policy.', 0.24443428)]"
1040,Reven Announces Coronavirus Treatment Acceleration Program Submission to the FDA,fda,reven announces coronavirus treatment acceleration program submission to the _,reven announces coronavirus treatment acceleration program submission to the hospital,https://www.reven.com/homepage/reven-announces-coronavirus-treatment-acceleration-program-ctap-submission-to-the-fda/,"[('For more on our CTAP submission: https://www.reven.com/homepage/reven-announces-coronavirus-treatment- acceleration-program-ctap-submission-to-the-fda/ ', 0.75389713), ('The FDA has created CTAP as a special emergency program for possible coronavirus therapies which is designed to use every available method to move new treatments to patients as quickly as possible, while evaluating safety and effectiveness.', 0.649745), ('Investor & Media Contact: Derek Cole 720.940.2163 derek.cole@arcabio.com SOURCE: ARCA biopharma, Inc. View source version on accesswire.com: https://www.accesswire.com/601279/ARCA-Biopharma-Announces-Completion-of-FDA- Pre-IND-Consultation-Under-Coronavirus-Treatment-Acceleration-Program-for- AB201-as-a-Potential-Treatment-for-Severe-COVID-19 ', 0.62199986), ('Reven conducted the study in response a recent FDA request to provide additional pre-clinical support specific to the COVID-19 related Acute Respiratory Distress Syndrome (ARDS) clinical trial advice request from last month.', 0.61596453), ('The U.S. FDA has granted the Gencaro development program Fast Track designation and a Special Protocol Assessment (SPA) agreement.', 0.5996869)]"
1041,"Evaluation of four commercial , fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay",four,"evaluation of _ commercial , fully automated sars-cov-2 antibody tests suggests a revision of the siemens sars-cov-2 igg assay","evaluation of two commercial, fully automated sars-cov-2 antibody tests suggests a revision of the siemens sars-cov-2 igg assay",https://www.medrxiv.org/content/10.1101/2020.11.27.20239590v1,"[('Methods Four fully automated assays, Roche Elecsys Anti-SARS-CoV-2, Abbott SARS-CoV-2 IgG, Siemens SARS-CoV-2 total (COV2T) and SARS-CoV-2 IgG (COV2G) were evaluated using 350 pre-pandemic samples and 700 samples from 245 COVID-19 patients (158 hospitalized, 87 outpatients).', 0.7369799), ('The potentially impaired sensitivity of the Siemens COV2G necessitates a switch to the company’s newly filed SARS-CoV-2 IgG assay (sCOVG) for follow-up studies.', 0.5425302), ('Finally, the combination of two anti-SARS-CoV-2 antibody assays is feasible when considering borderline reactive results.', 0.44631776), ('ROC curve analyses suggest a lowering of the cut-off index for the Siemens COV2G assay.', 0.424595), ('Conclusions Thorough on-site evaluation of commercially available serologic tests for detection of antibodies against SARS-CoV-2 remains imperative for laboratories.', 0.40796024)]"
1042,The Novel Severe Acute Respiratory Syndrome Coronavirus 2 Directly Decimates Human Spleens and Lymph Nodes,novel,the _ severe acute respiratory syndrome coronavirus 2 directly decimates human spleens and lymph nodes,the primary severe acute respiratory syndrome coronavirus 2 directly decimates human spleens and lymph nodes,http://medrxiv.org/cgi/content/short/2020.03.27.20045427,"[('The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph Nodes ', 0.9547545), ('The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes.', 0.9510585), ('Share The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph Nodes Zeqing Feng, Bo Diao, Rongshuai Wang, Gang Wang, Chenhui Wang, Yingjun Tan, Liang Liu, Changsong Wang, Ying Liu, Yueping Liu, Zilin Yuan, Liang Ren, Yuzhang Wu, Yongwen Chen medRxiv 2020.03.27.20045427; doi: https://doi.org/10.1101/2020.03.27.20045427 Share This Article: Copy Citation Tools The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph Nodes Zeqing Feng, Bo Diao, Rongshuai Wang, Gang Wang, Chenhui Wang, Yingjun Tan, Liang Liu, Changsong Wang, Ying Liu, Yueping Liu, Zilin Yuan, Liang Ren, Yuzhang Wu, Yongwen Chen medRxiv 2020.03.27.20045427; doi: https://doi.org/10.1101/2020.03.27.20045427 ', 0.77908266), ('You are going to email the following The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph Nodes Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website.', 0.7256522), ('SARS-CoV-2 infection induces severe tissue damage including lymph follicle depletion, splenic nodule atrophy, histiocyte hyperplasia and lymphocyte reductions.', 0.5321268)]"
1044,Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus,specific,ivermectin is a _ inhibitor of importin α/β-mediated nuclear import able to inhibit replication of hiv-1 and dengue virus,ivermectin is a common inhibitor of importin α/β-mediated nuclear import able to inhibit replication of hiv-1 and dengue virus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3327999/,"[('PMID: 23769930 Inhibition of Human Adenovirus Replication by the Importin α/β1 Nuclear Import Inhibitor Ivermectin.', 0.7211077), ('Ivermectin inhibits Impα/β1- but not Impβ1-dependent nuclear import, whereas mifepristone specifically inhibits IN… Figure 1.', 0.68104625), ('Ivermectin can inhibit HIV-1 and… Figure 3.', 0.6653472), ('Importantly, we establish for the first time that ivermectin has potent antiviral activity towards both HIV-1 and dengue virus, both of which are strongly reliant on importin α/β nuclear import, with respect to the HIV-1 integrase and NS5 (non-structural protein 5) polymerase proteins respectively.', 0.65081954), ('PMID: 24161512 Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin.', 0.6297158)]"
1045,Local health officials announce new recommendations to reduce risk of spread of COVID-19,reduce,local health officials announce new recommendations to _ risk of spread of covid-19,local health officials announce new recommendations to increase risk of spread of covid-19,https://www.kingcounty.gov/depts/health/news/2020/March/4-covid-recommendations.aspx,"[('If there is a confirmed case of COVID-19, Public Health will work with the school and the district to determine the best measures including potential closure of the school.', 0.72685623), ('Taking these measures can help reduce the number of workers who come into contact with COVID-19 and help minimize absenteeism due to illness If you can feasibly avoid bringing large groups of people together, consider postponing events and gatherings.', 0.64479935), ('This is a critical moment in the growing outbreak of COVID-19 in King County and these measures can potentially impact the spread of the disease.', 0.5984471), ('What we have seen with the level of community spread has raised the level of concern about the immediate threat of COVID-19, particularly for vulnerable populations such as people over 60, those with underlying health conditions or who are immune compromised.', 0.55116653), ('Many King County services are continually adapting because of the COVID-19 pandemic.', 0.548041)]"
1048,Cellular immunity to SARS-CoV-2 found at six months in non-hospitalised individuals,months,cellular immunity to sars-cov-2 found at six _ in non-hospitalised individuals,cellular immunity to sars-cov-2 found at six days in non-hospitalised individuals,https://www.uk-cic.org/news/cellular-immunity-sars-cov-2-found-six-months-non-hospitalised-individuals,"[('Overall, these findings indicate a robust cellular (T cell) immune response against SARS-CoV-2 at six months post-infection.', 0.723062), ('This study examines the role of T cells in contributing to immunity against SARS-CoV-2 at six months post infection.', 0.6528729), ('Researchers investigated whether previous infection with SARS-CoV-2 results in immunity to reinfection.', 0.5835278), ('Interestingly, we found that cellular immunity is stronger at this time point in those people who had symptomatic infection compared with asymptomatic cases.', 0.5205706), ('""To our knowledge, our study is the first in the world to show robust cellular immunity remains at six months after infection in individuals who experienced either mild/moderate or asymptomatic COVID-19.', 0.51383966)]"
1049,"Obesity ‑ a risk factor for increased COVID‑19 prevalence , severity and lethality",increased,"obesity ‑ a risk factor for _ covid‑19 prevalence , severity and lethality","obesity ‑ a risk factor for reducing covid‑19 prevalence, severity and lethality",https://www.spandidos-publications.com/10.3892/mmr.2020.11127,"[('A growing body of evidence connects obesity with COVID‑19 and a number of mechanisms from immune system activity attenuation to chronic inflammation are implicated.', 0.7978854), ('Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity.', 0.7849053), ('Finally, pregnancy‑associated obesity needs to be studied further in connection to COVID‑19 as this infection could pose high risk both to pregnant women and the fetus.', 0.74362266), ('The Impact of Obesity and Lifestyle on the Immune System and Susceptibility to Infections Such as COVID-19.', 0.7115146), ('Obesity and impaired metabolic health in patients with COVID-19.', 0.6730666)]"
1050,Equine hyperimmune globulin raised against the SARS-CoV-2 spike glycoprotein has extremely high neutralizing titers,high,equine hyperimmune globulin raised against the sars-cov-2 spike glycoprotein has extremely _ neutralizing titers,equine hyperimmune globulin raised against the sars-cov-2 spike glycoprotein has extremely low neutralizing titers,https://www.biorxiv.org/content/10.1101/2020.08.17.254375v1?rss=1%22,"[('Here we demonstrate that hyperimmune globulin preparations raised in horses against the recombinant trimeric spike (S) glycoprotein of SARS-CoV-2 in the prefusion conformation provide very high ELISA titers as well as highly potent neutralizing activity against SARS- CoV-2.', 0.7956567), ('The high neutralizing titers against SARS-CoV-2 obtained for the unprocessed sera were confirmed for the F(ab’)2 fragments and were 150-fold higher than the PRNT90 neutralizing titers of plasma of three COVID-19 convalescent patients.', 0.6206181), ('When compared with the plasma of three convalescent COVID-19 patients, sera of immunized horses displayed approximately 140-fold higher neutralizing titers measured as PRNT90.', 0.4750023), ('The great advantage of using the recombinant trimeric S glycoprotein is that it is safe and provides quick adaptive immunity in horses.', 0.4660871), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.42172533)]"
1053,Hospital readmissions of discharged patients with COVID-19,discharged,hospital readmissions of _ patients with covid-19,hospital readmissions of hospitalized patients with covid-19,https://www.medrxiv.org/content/10.1101/2020.05.31.20118455v1,"[('Aim To analyse the clinical variables associated with readmission of patients who had previously been discharged after admission for COVID-19.', 0.79707223), ('Conclusions The rate of readmission after discharge from hospital for COVID-19 was low.', 0.7315416), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.47107166), ('All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.', 0.4541319), ('Immunocompromised patients and those presenting with fever during the 48 hours prior to discharge are at greater risk of readmission to hospital.', 0.4371462)]"
1055,CureVac to start phase I trials for their mRNA Covid-19 vaccine candidate .,start,curevac to _ phase i trials for their mrna covid-19 vaccine candidate .,curevac to last phase i trials for their mrna covid-19 vaccine candidate.,https://www.fiercebiotech.com/biotech/curevac-gets-ok-to-start-testing-mrna-covid-19-vaccine-humans,"[('Read more on COVID-19 vaccines messenger RNA CureVac coronavirus ', 0.80744743), ('CureVac’s vaccine is based on the same mRNA technology as the COVID-19 vaccine candidates developed by BioNTech/Pfizer and Moderna.', 0.8066641), ('The clinical safety and immunogenicity data achieved to date look promising and we are hopeful that this trial will continue to demonstrate the impact of mRNA technology and our vaccine to prevent COVID-19, and to help defeat this pandemic.""', 0.7363786), ('The extension study will collect additional data to evaluate long-term safety, persistence of antibodies to SARS-CoV-2 and the occurrence of COVID-19 cases to assess the duration of vaccine efficacy.', 0.69782174), ('However, as AstraZeneca has found, BioNTech, Pfizer and Moderna have reset expectations for COVID-19 vaccines.', 0.6813967)]"
1056,Second round of COVID-19 community testing completed ; Miami-Dade County and the University of Miami Miller School of Medicine announce initial findings,second,_ round of covid-19 community testing completed ; miami-dade county and the university of miami miller school of medicine announce initial findings,One round of covid-19 community testing completed ; miami-dade county and the university of miami miller school of medicine announce initial findings,https://www.miamidade.gov/releases/2020-04-24-sample-testing-results.asp,"[('We will share our data with the Florida Department of Health and with epidemic modelers at the University of Washington to leverage state and national expertise to improve broader understanding of COVID-19 and inform an ever-evolving public health response.', 0.69565743), ('In both weeks, 6% of participants tested positive for COVID-19 antibodies, which equates to 165,000 Miami-Dade County residents.', 0.5804833), ('We will also continue community testing, and begin re-engaging participants who screened positive in week one and/or two to undergo follow up screening.', 0.5476829), ('This represents 85% of residents who were randomly selected to participate in the initiative; participants voluntarily shared information about their health, and gave two drops of blood to determine whether they had produced antibodies to the novel coronavirus infection.', 0.47220227), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.44400316)]"
1057,FrankenCovid Conquers the Right,right,frankencovid conquers the _,frankencovid conquers the manuscript,https://www.takimag.com/article/frankencovid-conquers-the-right/,"[('FrankenCovid is all the rage on the right, which is unfortunate.', 0.6926918), ('But thanks to FrankenCovid mania, rightists, rather than standing up to the left’s racial demagoguery, are allying with the left to absolve the wet markets.', 0.4046516), ('So not even FrankenCovid acolytes should claim that the Chinese people are bigger victims than the millions of Americans whose lives have been ruined by this pandemic.', 0.39023376), ('Which points to another possible reason FrankenCovid is so popular: Conservatives can avoid being called racist.', 0.3852201), ('FrankenCovid evangelists believe that Covid is lab-mutated SARS, and nobody denies that we only have SARS because of perverse Chinese animal consumption.', 0.369139)]"
1058,Plasminogen improves lung lesions and hypoxemia in patients with COVID-19,improves,plasminogen _ lung lesions and hypoxemia in patients with covid-19,plasminogen causes lung lesions and hypoxemia in patients with covid-19,https://academic.oup.com/qjmed/advance-article/doi/10.1093/qjmed/hcaa121/5818885,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.47373107), ('Please enable Cookies and reload the page.', 0.23965687), ('This website is using a security service to protect itself from online attacks.', 0.23241213), ('Please stand by, while we are checking your browser... ', 0.20368566), ('Please enable cookies.', 0.19387531)]"
1059,Intranasal fusion inhibitory lipopeptide prevents direct contact SARS-CoV-2 transmission in ferrets,prevents,intranasal fusion inhibitory lipopeptide _ direct contact sars-cov-2 transmission in ferrets,intranasal fusion inhibitory lipopeptide requires direct contact sars-cov-2 transmission in ferrets,https://www.biorxiv.org/content/10.1101/2020.11.04.361154v1,"[('We have designed a dimeric lipopeptide fusion inhibitor that blocks this critical first step of infection for emerging coronaviruses and document that it completely prevents SARS-CoV-2 infection in ferrets.', 0.77264005), ('One-sentence summary A dimeric form of a SARS-CoV-2-derived lipopeptide is a potent inhibitor of fusion and infection in vitro and transmission in vivo.', 0.6852077), ('SARS-CoV-2 infection is initiated by membrane fusion between the viral and host cell membranes, mediated by the viral spike protein.', 0.53255594), ('These lipopeptides are highly stable and non-toxic and thus readily translate into a safe and effective intranasal prophylactic approach to reduce transmission of SARS-CoV-2.', 0.5046679), ('Daily intranasal administration to ferrets completely prevented SARS-CoV-2 direct-contact transmission during 24-hour co- housing with infected animals, under stringent conditions that resulted in infection of 100% of untreated animals.', 0.48079574)]"
1060,SARS-CoV-2 infection causes transient olfactory dysfunction in mice,mice,sars-cov-2 infection causes transient olfactory dysfunction in _,sars-cov-2 infection causes transient olfactory dysfunction in humans,https://www.biorxiv.org/content/10.1101/2020.11.10.376673v1,"[('Herein we demonstrate intranasal inoculation of SARS-CoV-2 induces robust viral replication in the olfactory epithelium (OE), resulting in transient olfactory dysfunction in humanized ACE2 mice.', 0.7690883), ('However, the causal link between SARS-CoV-2 infection and olfactory disorders remains lacking.', 0.66024995), ('Remarkably, SARS-CoV-2 infection triggers cell death and immune cell infiltration, and impairs the uniformity of OE structure.', 0.5496383), ('Overall, our mouse model recapitulates the olfactory dysfunction in COVID-19 patients, and provides critical clues to understand the physiological basis for extrapulmonary manifestations of COVID-19.', 0.504728), ('Combined transcriptomic and proteomic analyses reveal the induction of antiviral and inflammatory responses, as well as the downregulation of olfactory receptors in OE from the infected animals.', 0.4783983)]"
1061,Population-scale testing can suppress the spread of COVID-19,suppress,population-scale testing can _ the spread of covid-19,population-scale testing can increase the spread of covid-19,https://www.medrxiv.org/content/10.1101/2020.04.27.20078329v2,"[('We show here that at a sufficient rate of testing and isolation, the R0 of SARS-CoV-2 would be reduced well below 1.0, and the epidemic would collapse.', 0.4059646), ('Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.', 0.38180906), ('Provided that results are reported rapidly, the test frequency required to suppress an epidemic is linear with respect to R0, to the infectious period, and to the fraction of susceptible individuals.', 0.37228668), ('It would also be robust to failure, as even in the case where the testing rate would be insufficient to collapse the epidemic, it would still reduce the number of infected individuals in the population, improving both public health and economic conditions.', 0.35098898), ('In addition to the rate of compliance and false negatives, the required rate of testing is dependent on the design of the testing regime, with concurrent testing outperforming random sampling of individuals.', 0.33670652)]"
1063,Trump halts travel from Europe to US,trump,_ halts travel from europe to us,Bats halts travel from europe to us,https://www.bbc.com/news/world-us-canada-51846923,"[('Trump said the halt on travel from Europe would not include the United Kingdom, and that there would be ""exemptions for Americans who have undergone appropriate screenings.""', 0.62189364), ('In an primetime Oval Office address meant to rebut criticism that he\'s taken the matter too lightly, Trump framed his announcement as a suspension of ""all travel from Europe to the United States for the next 30 days.""', 0.6159611), (""In his speech he said all travel from Europe would be suspended, but a presidential proclamation later said it would only apply to anyone who had been in the EU's Schengen border-free area in the 14 days before their arrival in the US."", 0.5941157), ('Trump was also forced to clarify he was not blocking goods from Europe, despite saying his ban would ""apply to the tremendous amount of trade and cargo"" across the Atlantic.', 0.5097369), ('Mr Trump also said the suspension would also apply to cargo coming from Europe into the US.', 0.5053101)]"
1064,Breakthrough COVID-19 antibody test with nearly 100 % accuracy can help reopen economy,can,breakthrough covid-19 antibody test with nearly 100 % accuracy _ help reopen economy,breakthrough covid-19 antibody test with nearly 100 % accuracy cannot help reopen economy,https://www.kiro7.com/news/local/breakthrough-covid-antibody-test-with-nearly-100-accuracy-can-help-reopen-economy/RFCEDOCPVJEWPMYKUVSEVRRPYQ/,"[('It’s also launched a COVID-19 molecular test and the ID Now Rapid test, though UW scientists indicated this latest test is the most accurate so far.', 0.72214127), ('Scientists said Friday they found the test can determine if someone had COVID-19 with nearly 100% accuracy.', 0.67410964), ('The test specifically looks for what’s called an IgG antibody -- something your immune system makes after you get sick from COVID-19.', 0.6225375), ('The test specifically looks for what’s called an IgG antibody – something your immune system makes after you get sick from COVID-19.', 0.61342263), ('Officials are attempting to contain the COVID-19 outbreak in the U.S. as hospitals manage unprecedented patient surges.', 0.5683473)]"
1067,White House 's Opening Up America Again Guidelines,white,_ house 's opening up america again guidelines,Each house's opening up america again guidelines,https://www.whitehouse.gov/openingamerica/#criteria,"[('Learn more about the guidelines at WhiteHouse.gov/OpeningAmerica.', 0.6845932), ('This evening, President Trump continued his unprecedented level of access to the American people at a press conference where he presented his guidelines on the three phases of Opening Up America Again.', 0.5712465), ('Titled ""Opening Up America Again,"" the document lays out recommendations for easing stay-at-home restrictions for individuals, employers and organizations once a series of ""gating criteria"" are met.', 0.53435093), ('During a virtual leadership roundtable hosted by Meeting Professionals International, held during Virtual Global Meetings Industry Day — two days before the White House released the ""Opening Up America Again"" guidelines — U.S. Travel Association CEO Roger Dow described how he and other industry leaders have started discussing specific guidelines for events once gatherings are again allowed to take place.', 0.49320558), ('According to the White House, once these criteria are met, states and regions can begin returning to normal economic activity in three phases.', 0.4385075)]"
1068,Long-Term Persistence of IgG Antibodies in SARS-CoV Infected Healthcare Workers,long,_-term persistence of igg antibodies in sars-cov infected healthcare workers, short-term persistence of igg antibodies in sars-cov infected healthcare workers,https://www.medrxiv.org/content/10.1101/2020.02.12.20021386v1,"[('Although virus-specific IgG play important roles in virus neutralization and prevention against future infection, limited information is available regarding the long term persistence of IgG after infection with SARS-like coronavirus.', 0.5985611), ('IgG titers in SARS-CoV-infected healthcare workers remained at a significantly high level until 2015.', 0.59748214), ('CONCLUSIONS IgG antibodies against SARS-CoV can persist for at least 12 years.', 0.5902372), ('During the 2002-2003 SARS outbreak, healthcare workers formed a special population of patients.', 0.58799326), ('All sera were tested for IgG antibodies with ELISA using whole virus and a recombinant nucleocapsid protein of SARS- CoV, as a diagnostic antigen.', 0.5796296)]"
1069,Active Monitoring of Persons Exposed to Patients with Confirmed ...,confirmed,active monitoring of persons exposed to patients with _ ...,active monitoring of persons exposed to patients with risk...,https://www.cdc.gov/mmwr/volumes/69/wr/mm6909e1.htm?s_cid=mm6909e1_w,"[('The aims of these efforts were to ensure rapid evaluation and care of patients, limit further transmission, and better understand risk factors for transmission.', 0.57270384), ('For these investigations, exposure of community members within a health care setting was defined as either at least 10 minutes spent within 6 feet of the patient with confirmed COVID-19 (e.g., in a waiting room) or having spent time in the same airspace (e.g., the same examination room) for 0-2 hours after the confirmed COVID-19 patient.', 0.55555797), ('At this time, symptomatic close contacts of a patient with confirmed COVID-19 should be further evaluated in consultation with public health authorities to review signs or symptoms and possible exposure on a case-by-case basis.', 0.5244788), ('Person-to- person transmission has been widely documented, and a limited number of countries have reported sustained person-to-person spread.', 0.5030396), ('Person-to-person transmission has been widely documented, and a limited number of countries have reported sustained person-to-person spread.', 0.5030396)]"
1073,"White House does not have 'high confidence ' in China 's coronavirus information , official says",not,"white house does _ have 'high confidence ' in china 's coronavirus information , official says","white house does still have 'high confidence'in china's coronavirus information, official says",https://www.cnbc.com/2020/02/13/white-house-does-not-have-high-confidence-in-chinas-coronavirus-information-official-says.html,"[(""VIDEO0:5600:56 Official: US doesn't have high confidence in China's virus information Squawk Alley There has been skepticism among researchers that the official numbers reflect how contagious the virus truly is."", 0.589021), ('Reuters reported that National Economic Council Director Larry Kudlow also said on Thursday that there does not appear to be good transparency by China regarding the outbreak.', 0.5086659), (""The outbreak has caused turmoil in markets around the world, especially in the stocks of companies with high exposure to China through their supply chains or key sources of revenue.There have been travel restrictions and factory closures in China during the outbreak, leading market strategists to slash their projections for the country's first quarter GDP."", 0.49552143), ('There has been skepticism among researchers that the official numbers reflect how contagious the virus truly is.', 0.47272718), ('The official also noted that China ""continues to rebuff American offers of assistance.""', 0.43469447)]"
1074,Harm reduction principles can help us restore trust in public health messaging on covid-19,restore,harm reduction principles can help us _ trust in public health messaging on covid-19,harm reduction principles can help us avoid trust in public health messaging on covid-19,https://blogs.bmj.com/bmj/2020/12/15/harm-reduction-principles-can-help-us-restore-trust-in-public-health-messaging-on-covid-19/,"[('Such a framework can be applied to our covid-19 messaging.', 0.62518966), ('Returning to our discipline’s basic principles and centering our approach around reducing harm may help restore trust in public health.', 0.5993415), ('Harm reduction—when applied to disease prevention for infectious diseases—is the principle of advising individuals how to mitigate risk, while acknowledging the real world conditions that may lead individuals to take some risks.', 0.5926373), ('Trust between patient and doctor and between a public health system and an at- risk populace starts with messaging that acknowledges the holistic experiences of individuals in a population beyond just the pathogen.', 0.57542634), ('At times, healthcare and public health practitioners have strayed from the core values of public health when communicating covid-19 prevention strategies.', 0.57467335)]"
1076,Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti–Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein IgG,decreased,significantly _ mortality in a large cohort of coronavirus disease 2019 patients transfused early with convalescent plasma containing high-titer anti–severe acute respiratory syndrome coronavirus 2 spike protein igg,significantly increased mortality in a large cohort of coronavirus disease 2019 patients transfused early with convalescent plasma containing high-titer anti–severe acute respiratory syndrome coronavirus 2 spike protein igg,https://ajp.amjpathol.org/article/S0002-9440(20)30489-2/fulltext,"[('Treatment of coronavirus disease 2019 patients with convalescent plasma reveals a signal of significantly decreased mortality.', 0.8180771), ('Contact Affiliations Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York Center for Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute, Houston, Texas Search for articles by this author Published:November 03, 2020DOI:https://doi.org/10.1016/j.ajpath.2020.10.008 Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG Previous ArticleTumor Necrosis Factor Directs Allograft-Related Innate Responses and Its Neutralization Improves Hepatocyte Engraftment in Rats Next Article Pulmonary Mycosis Drives Forkhead Box Protein A2 Degradation and Mucus Hypersecretion through Activation of the Spleen Tyrosine Kinase–Epidermal Growth Factor Receptor–AKT/Extracellular Signal-Regulated Kinase 1/2 Signaling Coronavirus disease 2019 (COVID-19) convalescent plasma has emerged as a promising therapy and has been granted Emergency Use Authorization by the US Food and Drug Administration for hospitalized COVID-19 patients.', 0.6575948), ('Share Early transfusion of a large cohort of COVID-19 patients with high titer anti- SARS-CoV-2 spike protein IgG convalescent plasma confirms a signal of significantly decreased mortality Eric Salazar, Paul A. Christensen, Edward A. Graviss, Duc T. Nguyen, Brian Castillo, Jian Chen, Bevin Valdez Lopez, Todd N. Eagar, Xin Yi, Picheng Zhao, John Rogers, Ahmed Shehabeldin, David Joseph, Faisal Masud, Christopher Leveque, Randall J. Olsen, David W. Bernard, Jimmy Gollihar, James M. Musser medRxiv 2020.10.02.20206029; doi: https://doi.org/10.1101/2020.10.02.20206029 Share This Article: Copy Citation Tools Early transfusion of a large cohort of COVID-19 patients with high titer anti- SARS-CoV-2 spike protein IgG convalescent plasma confirms a signal of significantly decreased mortality Eric Salazar, Paul A. Christensen, Edward A. Graviss, Duc T. Nguyen, Brian Castillo, Jian Chen, Bevin Valdez Lopez, Todd N. Eagar, Xin Yi, Picheng Zhao, John Rogers, Ahmed Shehabeldin, David Joseph, Faisal Masud, Christopher Leveque, Randall J. Olsen, David W. Bernard, Jimmy Gollihar, James M. Musser medRxiv 2020.10.02.20206029; doi: https://doi.org/10.1101/2020.10.02.20206029 ', 0.6324382), ('The data confirm our previous findings that transfusion of patients soon after hospital admission with high- titer anti-spike protein RBD IgG present in convalescent plasma significantly decreases mortality.', 0.6205423), ('Convalescent plasma anti-SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization.', 0.58906585)]"
1077,Time to redefine normal body temperature ?,temperature,time to redefine normal body _ ?,time to redefine normal body volume?,https://www.health.harvard.edu/blog/time-to-redefine-normal-body-temperature-2020031319173,"[('But more modern studies have called this time-honored truth into question, and have found that Body temperature varies over the course of the day.', 0.5324639), ('Although you can be sick with a normal temperature, body temperature is clearly an important and useful indicator of health.', 0.47085822), ('So, a falling average body temperature over the last century and a half could reflect important changes and warrant additional research.', 0.46772805), ('That’s why the body has such an elaborate thermoregulation system that keeps the body’s temperature close to ideal most of the time.', 0.44236425), ('In the meantime, it’s probably time to abandon the assumption that 98.6˚ is a normal temperature.', 0.43780637)]"
1079,A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds,novel,a _ in-cell elisa assay allows rapid and automated quantification of sars-cov-2 to analyze neutralizing antibodies and antiviral compounds,a standard in-cell elisa assay allows rapid and automated quantification of sars-cov-2 to analyze neutralizing antibodies and antiviral compounds,https://www.frontiersin.org/articles/10.3389/fimmu.2020.573526/full,"[('A novel in-cell ELISA assay allows rapid and automated quantification of SARS-CoV-2 to analyse neutralizing antibodies and antiviral compounds.', 0.99560624), ('To replace microscopic counting-based SARS-CoV-2 PRNTs by a novel assay exempt from genetically modified viruses, which are inapplicable in most diagnostics departments, we established a simple, rapid, and automated SARS-CoV-2 neutralization assay employing an in- cell ELISA (icELISA) approach.', 0.77281165), (""Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells."", 0.7669501), ('Altogether, the SARS-CoV-2 icELISA test allows rapid (<48 h in total, read-out in seconds) and automated quantification of virus infection in cell culture to evaluate the efficacy of NAbs and antiviral drugs using reagents and equipment present in most routine diagnostics departments.', 0.75403684), ('A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction.', 0.74770105)]"
1083,Yale 's rapid COVID-19 saliva test receives FDA emergency use authorization,receives,yale 's rapid covid-19 saliva test _ fda emergency use authorization,yale's rapid covid-19 saliva test without fda emergency use authorization,https://news.yale.edu/2020/08/15/yales-rapid-covid-19-saliva-test-receives-fda-emergency-use-authorization,"[('Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization to Yale School of Public Health for SalivaDirect, Which Uses a New Method of Saliva Sample Processing 1.', 0.8087594), ('While FDA has seen variable performance in tests using saliva, Yale School of Public Health submitted data with its EUA request from which the FDA determined that Yale’s test meets the criteria for emergency authorization when used to test saliva samples for SARS-CoV-2, the virus that causes COVID-19 infection.', 0.77841777), ('Stat: FDA Clears Saliva Test For Covid-19, Opening Door To Wider Testing The Food and Drug Administration on Saturday authorized emergency use of a new and inexpensive saliva test for Covid-19 that could greatly expand testing capacity.', 0.73671097), (""A new saliva-based laboratory diagnostic test for the novel coronavirus developed by researchers at Yale University's School of Public Health has been granted an emergency use authorization by the Food and Drug Administration."", 0.73295724), (""NEW HAVEN, Conn. \\- A new saliva-based laboratory diagnostic test for the novel coronavirus developed by researchers at Yale University's School of Public Health has been granted an emergency use authorization by the Food and Drug Administration."", 0.7248603)]"
1084,New Coronavirus Test 10 Times Faster Is FDA Approved,faster,new coronavirus test 10 times _ is fda approved,new coronavirus test 10 times later is fda approved,https://www.bloomberg.com/news/articles/2020-03-13/roche-gets-clearance-for-coronavirus-test-that-s-10-times-faster,"[('Quiz FAQ Videos Privacy Policy Contact Contact Subscribe Upload Your Résumé Nominate a Candidate ', 0.28306118), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.27035755), ('This allowed them to more effectively tell our story in > introducing Recordati Rare Diseases to prospective candidates.” > > Michael Waters U.S. President & General Manager, Recordati Rare Diseases > “There was a comprehensive search—they didn’t just reach out to the first > people who met the minimum criteria.” > > Edward Seguine CEO, Clinical Ink > “Ashton Tweed is so accommodating, which was fantastic.', 0.26216888), ('I was very aware during the process that they were being very > responsive and communicative to both sides, which I thought was > exceptional.” > > Sonny Stafford VP of Marketing, JDS Therapeutics > “We had two strong candidates with very different skills sets.', 0.2540268), ('The 8800 version is capable of testing 4,128 patients a day, and the 6800 can test as many as 1,440.', 0.24641588)]"
1085,COVID-19 twice as contagious as previously thought,twice,covid-19 _ as contagious as previously thought,covid-19 serves as contagious as previously thought,https://thinkpol.ca/2020/04/08/covid-19-twice-contagious-previously-thought/,"[('This is double the previously estimated R0 of 2.2 to 2.7, meaning that the COVID-19 pandemic may be much more difficult to contain.', 0.6240171), ('“However, when 20% of transmission is driven by unidentified infected persons, high levels of social distancing efforts will be needed to contain the virus (Figure 6), highlighting the importance of early and effective surveillance, contact tracing, and quarantine.” “We need to now be even more vigilant than previously thought given the higher revised R0,” epidemiologist Eric Feigl-Ding said.', 0.3842991), ('He points out that this is not the R(effective) at current time under mitigation measures such as distancing and testing, tracing and quarantine, which are expected to slash chains of transmission.', 0.31368902), ('“If these measures are not implemented early and strongly, the virus has the potential to spread rapidly and infect a large fraction of the population, overwhelming healthcare systems.” But all hope is not lost, according to the researchers.', 0.31283453), ('“Ergo, a 5.7 is on a considerably different level of infectiousness,” Dr Feigl-Ding said.', 0.27572232)]"
1086,SARS-CoV-2 desensitizes host cells to interferon through inhibition of the JAK-STAT pathway,host,sars-cov-2 desensitizes _ cells to interferon through inhibition of the jak-stat pathway,sars-cov-2 desensitizes tumor cells to interferon through inhibition of the jak-stat pathway,https://www.biorxiv.org/content/10.1101/2020.10.27.358259v1,"[('This revealed universal inhibition of interferon signaling across cell types following SARS-CoV-2 infection.', 0.7928077), ('We performed systematic analyses of the JAK- STAT pathway in a broad range of cellular systems, including immortalized cell lines and primary-like cardiomyocytes, and found that several pathway components were targeted by SARS-CoV-2 leading to cellular desensitization to interferon.', 0.6801135), ('These findings indicate that the suppression of interferon signaling is a mechanism widely used by SARS-CoV-2 in diverse tissues to evade antiviral innate immunity, and that targeting the viral mediators of immune evasion may help block virus replication in patients with COVID-19.', 0.6323947), ('Here, we performed global proteomic analysis of the virus-host interface in a newly established panel of phenotypically diverse, SARS- CoV-2-infectable human cell lines representing different body organs.', 0.4537684), ('Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.', 0.31349432)]"
1091,Covid-19 fatality is likely overestimated,over,covid-19 fatality is likely _,covid-19 fatality is likely lowestimated,https://www.bmj.com/content/368/bmj.m1113,"[('Covid-19 fatality is... 3.', 0.5445696), ('How will country-based mitigation measures influence the course of the COVID-19 epidemic?Lancet2020; doi:10.1016/S0140-6736(20)30567-5. pmid:32164834 OpenUrlCrossRefPubMed 11.', 0.46146095), ('Pre-emptive low cost social distancing and enhanced hygiene implemented before local covid-19 transmission could decrease the number and severity of cases.', 0.38116485), ('As accessibility and availability of testing for the novel coronavirus increases, the measured CFR will continue to drop, especially as subclinical and mild cases are identified.678 Alternatively, the CFR might not fall as much as in previous epidemics and pandemics, given the prolonged disease course of covid-19 or if mitigation measures or hospital resources prove inadequate.9101112 As with other pandemics, the final CFR for covid-19 will be determined after the pandemic and should not distract from the importance of aggressive, early mitigation to minimise spread of infection.', 0.35573024), ('Case fatality risk of novel coronavirus diseases 2019 in China.', 0.34093875)]"
1093,UK government requests guidance on vitamin D use,vitamin,uk government requests guidance on _ d use,uk government requests guidance on time d use,https://www.theguardian.com/world/2020/nov/14/covid-uk-government-requests-guidance-on-vitamin-d-use,"[('Advice on vitamin D in the UK has focused on musculoskeletal health conditions, such as rickets.', 0.61040545), ('The Scientific Advisory Committee on Nutrition (SACN), which is within Public Health England, reached similar conclusions.', 0.5471733), ('The health secretary told the National Institute for Health and Care Excellence (Nice) and Public Health England to create guidelines for the use of the “sunshine” nutrient two weeks ago, before it was reported that the government was planning to give four months worth of vitamin D supplements to more than 2 million vulnerable and elderly people, following the lead of Scotland.', 0.53464395), ('In a statement, a spokesperson for Nice, which sets NHS clinical guidelines, told the Guardian: “Nice and PHE received a formal request to produce recommendations on vitamin D for prevention and treatment of Covid from the secretary of state for health and social care, Matt Hancock, on October 29.” The move comes after the government began considering giving vitamin D supplements to elderly people and those who are shielding as the UK enters winter.', 0.52050084), ('Photograph: Jill Mead/The Guardian Vitamin D has moved a step closer to being used as a potential way to prevent and treat coronavirus after Matt Hancock asked government health advisers to produce new guidelines on its use.', 0.47648746)]"
1094,SinoPharm 's Inactivated Coronavirus Vaccine,sino,_ 's inactivated coronavirus vaccine,Wepharm's inactivated coronavirus vaccine,https://blogs.sciencemag.org/pipeline/archives/2020/08/17/sinopharms-inactivated-coronavirus-vaccine,"[(""In SinoPharm's case, they inactivated the coronavirus with beta-propiolactone, which is a classic protein-alkylating compound."", 0.7602317), ('(wildpixel/GettyImages) Sinopharm has published clinical data on its adjuvanted SARS-CoV-2–inactivated virus vaccine.', 0.71114373), ('Sinopharm and fellow Chinese’ vaccine developer Sinovac are at the forefront of efforts to develop a more traditional inactivated virus shot against SARS- CoV-2.', 0.64318955), ('Those problems could be particularly acute for the Sinopharm vaccine.', 0.60455865), ('On Monday, Nasdaq-listed Sinovac said its inactivated vaccine, called CoronaVac, induced neutralizing antibodies in over 90% of the 600 healthy volunteers in the phase 2 part of a phase 1/2 study.', 0.5638212)]"
1095,Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19,distinct,antibody responses to sars-cov2 are _ in children with mis-c compared to adults with covid-19,antibody responses to sars-cov2 are similar in children with mis-c compared to adults with covid-19,https://www.medrxiv.org/content/10.1101/2020.07.12.20151068v1,"[('Here, we show distinct antibody (Ab) responses in children with MIS-C compared to adults with severe COVID-19 causing acute respiratory distress syndrome (ARDS), and those who recovered from mild disease.', 0.7344426), ('There was a reduced breadth and specificity of anti-SARS-CoV-2-specific antibodies in MIS-C patients compared to the COVID patient groups; MIS-C predominantly generated IgG Abs specific for the Spike (S) protein but not for the nucleocapsid (N) protein, while the COVID-19 cohorts had anti-S IgG, IgM and IgA Abs, as well as anti-N IgG Abs.', 0.6791513), ('Moreover, MIS-C patients had reduced neutralizing activity compared to both COVID-19 cohorts, indicating a reduced protective serological response.', 0.5074457), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.46688265), ('These results suggest a distinct infection course and immune response in children and adults who develop severe disease, with implications for optimizing treatments based on symptom and age.', 0.4461884)]"
1097,Dana-Farber to test blood cancer drug in COVID-19 patients,blood,dana-farber to test _ cancer drug in covid-19 patients,dana-farber to test breast cancer drug in covid-19 patients,https://news.harvard.edu/gazette/story/newsplus/dana-farber-to-test-blood-cancer-drug-in-covid-19-patients/,"[('Treon and colleagues recently published in Blood a report on six Waldenström’s patients who had been taking ibrutinib for several years and who had recently contracted COVID-19.', 0.66638744), ('“These experiences have given us the inspiration to do prospective randomized trials of ibrutinib and a similar drug, zanubrutinib in COVID-19 patients in respiratory distress,” said Treon.', 0.62047577), ('Dana-Farber will collaborate with the study sponsor to carry out corollary studies to understand how the immune system functions in COVID-19 patients and how the addition of BTK-inhibitors can stop immune over-activity in response to the virus.', 0.5977831), ('Find a Doctor Give Now My Dana-Farber Search Close Search Menu Menu COVID-19 Facts and Resources For Patients and Families For Physicians Our Research About Us Find a Doctor Appointments & Second Opinions How You Can Help close navigation panel ', 0.580344), ('The rationale for testing ibrutinib in COVID-19 patients, beyond the observed results reported in Waldenström’s patients, stems from the drug’s targeting of molecular pathways that are overactive both in Waldenström’s – where it affects the bone marrow – and in the lungs of COVID-19 patients.', 0.50589967)]"
1099,Quercetin and Its Metabolites Inhibit Recombinant Human Angiotensin-Converting Enzyme 2 Activity,inhibit,quercetin and its metabolites _ recombinant human angiotensin-converting enzyme 2 activity,quercetin and its metabolites produce recombinant human angiotensin-converting enzyme 2 activity,https://pubs.acs.org/doi/10.1021/acs.jafc.0c05064,"[('Quercetin inhibits rhACE2 activity.', 0.70546144), ('These results suggest an inhibitory effect of quercetin on the angiotensin-converting enzyme activity, similar to that of captopril.', 0.6884581), ('Quercetin metabolites (isorhamnetin, tamarixetin, 3,4-dihydroxyphenylacetic acid, and quercetin-3-glucuronide), rutinosides and glycosides of quercetin, and other flavonoids (luteolin, (±)-eriodictyol, and (−)-epicatechin) also inhibited rhACE2.', 0.68623114), ('Polyphenols Inhibit rhACE2 Enzyme Activitya ', 0.6711698), ('KEYWORDS: quercetin angiotensin-converting enzyme 2 enzyme kinetics polyphenols ', 0.6542353)]"
1101,Identification of unique mutations in SARS-CoV-2 strains isolated from India suggests its attenuated pathotype,india,identification of unique mutations in sars-cov-2 strains isolated from _ suggests its attenuated pathotype,identification of unique mutations in sars-cov-2 strains isolated from Europe suggests its attenuated pathotype,https://www.biorxiv.org/content/10.1101/2020.06.06.137604v1,"[('In this study, we sequenced and analyzed the genomic information of the SARS-CoV-2 isolates from two infected Indian patients and explored the possible implications of point mutations in its biology.', 0.71752846), ('In addition to multiple point mutations, we found a remarkable similarity between relatively common mutations of 36-nucleotide deletion in ORF8 of SARS-CoV-2.', 0.53425276), ('The results will be useful to understand the biology of SARS-CoV-2 and itsattenuation for vaccine development.', 0.5326159), ('Studies on SARS-CoV-2 are being carried out at an unprecedented rate to tackle this threat.', 0.5156582), ('Genomics studies, in particular, are indispensable to elucidate the dynamic nature of the RNA genome of SARS-CoV-2.', 0.47849798)]"
1102,First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 in the USA,first,_ known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 in the usa,No known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 in the usa,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30607-3/fulltext,"[('It was also the first known case of person-to-person transmission in the United States.', 0.52515715), ('A total of 43 contacts who met that criteria then became ""persons under investigation,"" who were, along with 32 asymptomatic health care contacts, were tested for coronavirus.', 0.34289464), ('In a subsequent epidemiological investigation, CDC and municipal researchers identified 372 people who had contact with the couple on or after their symptoms first appeared.', 0.31492352), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.3143469), ('The data suggest that transmission is more probable with unprotected, prolonged exposure to a symptomatic patient.', 0.274122)]"
1104,"There is one , and only one strain of SARS-CoV-2",only,"there is one , and _ one strain of sars-cov-2","there is one, and another one strain of sars-cov-2",https://www.virology.ws/2020/05/07/there-is-one-and-only-one-strain-of-sars-cov-2/,"[('There is only one strain of SARS-CoV-2.', 0.95882094), ('If studies show that ALL genotypes have the SAME phenotypic expression - then we prove that ""there is only one strain of SARS-CoV-2"".', 0.74852246), ('These virus isolates are all the same strain of SARS-CoV-2.', 0.62797153), ('They are not strains of SARS-CoV-2.', 0.62278605), ('Link David Cotton 14 May 2020, 2:38 am So far we have only identified one strain of sars cov 2.', 0.6225587)]"
1106,Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19,with,active monitoring of persons exposed to patients _ confirmed covid-19,active monitoring of persons exposed to patients without confirmed covid-19,https://www.cdc.gov/mmwr/volumes/69/wr/mm6909e1.htm?s_cid=mm6909e1_w,"[('At this time, symptomatic close contacts of a patient with confirmed COVID-19 should be further evaluated in consultation with public health authorities to review signs or symptoms and possible exposure on a case-by-case basis.', 0.7871444), ('On January 20, state and local health departments in the United States, in collaboration with teams deployed from CDC, began identifying and monitoring all persons considered to have had close contact† with patients with confirmed COVID-19 ( 2 ).', 0.6362449), ('The duration of time in the same airspace after the patient with confirmed COVID-19 was applied differently by health jurisdictions.', 0.63229716), ('Two persons who were household members of patients with confirmed COVID-19 tested positive for SARS-CoV-2.', 0.6313167), ('Infection control and prevention efforts by patients with COVID-19, their household members, and their health care providers, in combination with contact tracing activities, are important to mitigate community spread of the disease.', 0.6144265)]"
1107,Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients,pneumonia,low testosterone levels predict clinical adverse outcomes in sars-cov-2 _ patients,low testosterone levels predict clinical adverse outcomes in sars-cov-2 diabetes patients,https://onlinelibrary.wiley.com/doi/abs/10.1111/andr.12821?af=R,"[('Epidemiological data showing a differential impact of SARS-CoV-2 infection on women and men have suggested a potential role for testosterone (T) in determining gender disparity in the SARS-CoV-2 clinical outcomes.', 0.62245864), ('Abbreviations: IM = internal medicine inpatient clinics; RICU = respiratory intensive care unit; ICU = intensive care unit Figure 2 Relationship between total testosterone and… Figure 2 Relationship between total testosterone and blood inflammatory markers of severity of SARS‐CoV‐2 pneumonia.… Figure 2 Relationship between total testosterone and blood inflammatory markers of severity of SARS‐CoV‐2 pneumonia.', 0.5514801), (""SARS-CoV-2 Infected Patient: from a Hematologist's Perspective."", 0.45795137), ('Abbreviations: LDH = lactate dehydrogenase Figure 4 Relationship between total or calculated… Figure 4 Relationship between total or calculated free testosterone and estimated probability of different clinical… Figure 4 Relationship between total or calculated free testosterone and estimated probability of different clinical outcomes in SARS‐CoV‐2 pneumonia patients based on T levels.', 0.4491961), ('Discussion and conclusion: Our study demonstrates for the first time that lower baseline levels of TT and cFT levels predict poor prognosis and mortality in SARS-CoV-2-infected men admitted to RICU.', 0.44367072)]"
1109,Coronavirus Threatens Small Businesses,small,coronavirus threatens _ businesses,coronavirus threatens worldwide businesses,https://www.nytimes.com/2020/03/04/upshot/coronavirus-impact-small-businesses.html,"[('In some cases, public alarm is affecting small businesses even where there is no widespread outbreak or official guidance to stay inside.', 0.58420193), ('For small businesses, though, it could be catastrophic.', 0.5815114), ('The economy has been affected by the outbreak in ways large and small, including stock market declines, supply chain backups and company cancellations of business travel and meetings, in the United States and elsewhere.', 0.5520511), ('But for small businesses, there could be long-term effects on daily life and work in local communities.', 0.51417863), ('“Small businesses are on the front line of this crisis,” said Amanda Ballantyne, executive director of Main Street Alliance, a public policy group for small businesses.', 0.498717)]"
1110,Is This Pandemic a Colossal Lie ?,lie,is this pandemic a colossal _ ?,is this pandemic a colossal problem?,https://www.yonkerstribune.com/2020/08/is-this-pandemic-a-colossal-lie-by-bob-weir,"[('To even suggest otherwise is to spew demonstrably false propaganda.', 0.5787337), ('It is real, it is deadly, and so contagious.', 0.4909654), ('The pandemic was China’s fault.', 0.47712103), ('Zilch.', 0.4504533), ('The pandemic has not been ended.', 0.4501711)]"
1120,"In the case of China , it is estimated that more than 700.000 cases of COVID-19 actually occurred instead of the confirmed 80,932 cases as of 3/13/2020 .",china,"in the case of _ , it is estimated that more than 700.000 cases of covid-19 actually occurred instead of the confirmed 80,932 cases as of 3/13/2020 .","in the case of SARS, it is estimated that more than 700.000 cases of covid-19 actually occurred instead of the confirmed 80,932 cases as of 3/13/2020.",https://www.medrxiv.org/content/10.1101/2020.03.14.20036178v1,"[('I mean anything that comes out of China, if you take it at face value, check your back pocket Reply Reactions: ithacane, Edward20, ForTheU and 2 others ', 0.4010771), ('> > Click to expand... China has about four times the population of the US.', 0.36165136), (""It will be at least a year before we can get a good estimate of how widespread this really was, but 10 times the reported numbers in China wouldn't surprise me."", 0.3560361), ('JD08 Mar 15, 2020 COVID-19 2 3 4 Replies 62 Views 1K Mar 22, 2020 24/7canes 2 Dr. Birx believes deaths are being inflated up to 25%, doesn’t trust CDC numbers OriginalCanesCanesCanes May 12, 2020 COVID-19 2 3 Replies 47 Views 2K May 13, 2020 OriginalCanesCanesCanes Covid case ""spike"" in NC tcgrad1014 May 24, 2020 COVID-19 2 Replies 23 Views 1K May 25, 2020 g8rh8rMD No statistical connection between shutdowns and the number of COVID-19 cases or fatalities.', 0.34623834), (""I don't believe > millions of people have died from it (at least I hope not), but I definitely > think the CCP has confiscated millions of people's cellphones to combat real > information being leaked by their citizens."", 0.30635262)]"
1121,Disruption of the CCL5/RANTES-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19,disruption,_ of the ccl5/rantes-ccr5 pathway restores immune homeostasis and reduces plasma viral load in critical covid-19,Addition of the ccl5/rantes-ccr5 pathway restores immune homeostasis and reduces plasma viral load in critical covid-19,https://www.medrxiv.org/content/10.1101/2020.05.02.20084673v1,"[('These results demonstrate a novel approach to resolving unchecked inflammation, restoring immunologic deficiencies, and reducing SARS-CoV-2 plasma viral load via disruption of the CCL5-CCR5 axis, and support randomized clinical trials to assess clinical efficacy of leronlimab-mediated inhibition of CCR5 for COVID-19.', 0.71468645), ('Following compassionate care treatment with the CCR5 blocking antibody leronlimab, we observed complete CCR5 receptor occupancy on macrophage and T cells, rapid reduction of plasma IL-6, restoration of the CD4/CD8 ratio, and a significant decrease in SARS-CoV-2 plasma viremia.', 0.60759115), ('Here, in 10 terminally-ill, critical COVID-19 patients we report profound elevation of plasma IL-6 and CCL5 (RANTES), decreased CD8+ T cell levels, and SARS-CoV-2 plasma viremia.', 0.57856613), ('Emerging results indicate a dysregulated immune response characterized by runaway inflammation, including cytokine release syndrome (CRS), as the major driver of pathology in severe COVID-193,4.', 0.551442), ('With no treatments currently approved for COVID-19, therapeutics to prevent or treat the excessive inflammation in severe disease caused by SARS-CoV-2 infection are urgently needed.', 0.5446535)]"
1124,COVID-19 Related Deaths Among Doctors In India,deaths,covid-19 related _ among doctors in india,covid-19 related contacts among doctors in india,https://www.medrxiv.org/content/10.1101/2020.09.28.20202796v1,"[('2 Fortis Hospital, Mohali 1.', 0.26385972), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.25839457), ('Aanandita Kapoor1 (kaanandita{at}tisb.ac.in) and 2.', 0.1548223), ('↵ Corresponding author; email: kmkapoor{at}gmail.com View the discussion thread.', 0.141831), ('1 TISB, Bengaluru, India; 2.', 0.13990295)]"
1125,Collider bias undermines our understanding of COVID-19 disease risk and severity,undermine,collider bias _ our understanding of covid-19 disease risk and severity,collider bias focuss our understanding of covid-19 disease risk and severity,https://www.nature.com/articles/s41467-020-19478-2,"[('We discuss the sampling mechanisms that leave aetiological studies of COVID-19 infection and progression particularly susceptible to collider bias.', 0.63094807), ('Here, we highlight the challenge of interpreting observational evidence from such samples of the population, which may be affected by collider bias.', 0.48603678), ('We also describe several tools and strategies that could help mitigate the effects of collider bias in extant studies of COVID-19 and make available a web app for performing sensitivity analyses.', 0.43802428), ('We illustrate these issues using data from the UK Biobank in which individuals tested for COVID-19 are highly selected for a wide range of genetic, behavioural, cardiovascular, demographic, and anthropometric traits.', 0.43244272), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.35034475)]"
1126,Alpha-1 antitrypsin inhibits SARS-CoV-2 infection,alpha,_-1 antitrypsin inhibits sars-cov-2 infection,COX-1 antitrypsin inhibits sars-cov-2 infection,https://www.biorxiv.org/content/10.1101/2020.07.02.183764v1,"[('To identify factors of the respiratory tract that suppress SARS-CoV-2, we screened a peptide/protein library derived from bronchoalveolar lavage, and identified α1-antitrypsin (α1-AT) as specific inhibitor of SARS-CoV-2.', 0.716453), ('α1-AT targets the viral spike protein and blocks SARS-CoV-2 infection of human airway epithelium at physiological concentrations.', 0.6802286), ('Our findings show that endogenous α1-AT restricts SARS-CoV-2 and repurposes α1-AT-based drugs for COVID-19 therapy.', 0.56129736), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.3269132), ('Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.', 0.30642664)]"
1128,"Estimating the infection and case fatality ratio for coronavirus disease using age-adjusted data from the outbreak on the Diamond Princess cruise ship , February 2020",february,"estimating the infection and case fatality ratio for coronavirus disease using age-adjusted data from the outbreak on the diamond princess cruise ship , _ 2020","estimating the infection and case fatality ratio for coronavirus disease using age-adjusted data from the outbreak on the diamond princess cruise ship, January 2020",https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.12.2000256,"[('Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020.', 0.8915045), ('PMID: 32212140 Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.', 0.68224907), ('2009;14(26):19255. https://doi.org/10.2807/ese.14.26.19255-en PMID: 19573509 Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020 <p class=""citation""> <span>Citation style for this article:</span> <span class=""meta-value authors""> <a href=""/search?value1=Timothy+W+Russell&option1=author&noRedirect=true"" class=""nonDisambigAuthorLink"">Russell Timothy W</a>, <a href=""/search?value1=Joel+Hellewell&option1=author&noRedirect=true"" class=""nonDisambigAuthorLink"">Hellewell Joel</a>, <a href=""/search?value1=Christopher+I+Jarvis&option1=author&noRedirect=true"" class=""nonDisambigAuthorLink"">Jarvis Christopher I</a>, <a href=""/search?value1=Kevin+van+Zandvoort&option1=author&noRedirect=true"" class=""nonDisambigAuthorLink"">van Zandvoort Kevin</a>, <a href=""/search?value1=Sam+Abbott&option1=author&noRedirect=true"" class=""nonDisambigAuthorLink"">Abbott Sam</a>, <a href=""/search?value1=Ruwan+Ratnayake&option1=author&noRedirect=true"" class=""nonDisambigAuthorLink"">Ratnayake Ruwan</a>, <a href=""/search?value1=CMMID+COVID-19+working+group&option1=author&noRedirect=true"" class=""nonDisambigAuthorLink"">CMMID COVID-19 working group</a>, <a href=""/search?value1=Stefan+Flasche&option1=author&noRedirect=true"" class=""nonDisambigAuthorLink"">Flasche Stefan</a>, <a href=""/search?value1=Rosalind+M+Eggo&option1=author&noRedirect=true"" class=""nonDisambigAuthorLink"">Eggo Rosalind M</a>, <a href=""/search?value1=W+John+Edmunds&option1=author&noRedirect=true"" class=""nonDisambigAuthorLink"">Edmunds W John</a>, <a href=""/search?value1=Adam+J+Kucharski&option1=author&noRedirect=true"" class=""nonDisambigAuthorLink"">Kucharski Adam J</a></span>.', 0.6406088), ('Share Estimating the infection and case fatality ratio for COVID-19 using age- adjusted data from the outbreak on the Diamond Princess cruise ship Timothy W Russell, Joel Hellewell, Christopher I Jarvis, Kevin Van Zandvoort, Sam Abbott, Ruwan Ratnayake, CMMID COVID-19 working group, Stefan Flasche, Rosalind M Eggo, W John Edmunds, Adam J Kucharski medRxiv 2020.03.05.20031773; doi: https://doi.org/10.1101/2020.03.05.20031773 Share This Article: Copy Citation Tools Estimating the infection and case fatality ratio for COVID-19 using age- adjusted data from the outbreak on the Diamond Princess cruise ship Timothy W Russell, Joel Hellewell, Christopher I Jarvis, Kevin Van Zandvoort, Sam Abbott, Ruwan Ratnayake, CMMID COVID-19 working group, Stefan Flasche, Rosalind M Eggo, W John Edmunds, Adam J Kucharski medRxiv 2020.03.05.20031773; doi: https://doi.org/10.1101/2020.03.05.20031773 ', 0.58399826), ('Our aim was to estimate the IFR and CFR of coronavirus disease (COVID-19) in China, using data from passengers of the Diamond Princess while correcting for delays between confirmation and death and for the age structure of the population.', 0.5811703)]"
1131,Interferon deficiency can lead to severe COVID,can,interferon deficiency _ lead to severe covid,interferon deficiency cannot lead to severe covid,https://www.nature.com/articles/d41586-020-03070-1,"[('The studies implicate deficiencies in interferon proteins, specifically, type I interferons (IFN-I).', 0.53658855), ('also identified mutations in genes encoding the receptor for interferon (which consists of the proteins IFNAR1 and IFNAR2).', 0.500665), ('Severe COVID-19 infection has also been reported in four young men who had a loss-of-function mutation in the TLR7 gene6, providing further evidence that genetic errors in IFN-I pathways contribute to severe COVID-19.', 0.45232874), ('Such individuals do not produce interferon normally.', 0.44097546), ('Such signalling defects hinder antiviral gene expression.', 0.43076545)]"
1132,SARS-CoV-2 productively infects human gut enterocytes,gut,sars-cov-2 productively infects human _ enterocytes,sars-cov-2 productively infects human neurons enterocytes,https://science.sciencemag.org/content/early/2020/04/30/science.abc1669,"[('H. Shan , Evidence for gastrointestinal infection of SARS-CoV-2.', 0.73639), ('( B ) SARS-CoV-2 infects both postmitotic enterocytes identified by Apolipoprotein A1 (APOA1) and dividing cells that are KI67-positive.', 0.71970826), ('SARS-CoV also readily infected enterocyte lineage cells (fig.', 0.7044328), ('This study shows that SARS- CoV and SARS-CoV-2 infect enterocyte lineage cells in an hSIO model.', 0.7028744), ('used human intestinal organoids, a “mini-gut” cultured in a dish, to demonstrate that SARS-CoV-2 readily replicates in an abundant cell type in the gut lining—the enterocyte—resulting in the production of large amounts of infective virus particles in the intestine.', 0.6995852)]"
1133,The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation,translation,the viral protein nsp1 acts as a ribosome gatekeeper for shutting down host _ and fostering sars-cov-2 _,use of convalescent serum reduces severity of covid-19 in nonhuman hostss,https://www.biorxiv.org/content/10.1101/2020.10.14.339515v1,"[('Thus, NSP1 acts as a ribosome gatekeeper, shutting down host translation or fostering SARS-CoV-2 translation depending on the presence of the SL1 5’UTR hairpin.', 0.87161875), ('One of the first proteins produced during viral infection, NSP1, binds to the host ribosome and blocks the mRNA entry channel.', 0.82763827), ('We show that NSP1 remains bound on the ribosome during viral translation.', 0.744568), ('We suggest that the interaction between NSP1 and SL1 frees the mRNA accommodation channel while maintaining NSP1 bound to the ribosome.', 0.6980423), ('In spite of the presence of NSP1 on the ribosome, viral translation proceeds however.', 0.68041515)]"
1135,FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine,fda,_ takes key action in fight against covid-19 by issuing emergency use authorization for first covid-19 vaccine,SARS takes key action in fight against covid-19 by issuing emergency use authorization for first covid-19 vaccine,https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19,"[('The company has submitted a pharmacovigilance plan to FDA to monitor the safety of Pfizer-BioNTech COVID-19 Vaccine.', 0.74278164), ('The emergency use authorization allows the Pfizer-BioNTech COVID-19 Vaccine to be distributed in the U.S. “The FDA’s authorization for emergency use of the first COVID-19 vaccine is a significant milestone in battling this devastating pandemic that has affected so many families in the United States and around the world,” said FDA Commissioner Stephen M. Hahn, M.D.', 0.7362509), ('It is mandatory for Pfizer Inc. and vaccination providers to report the following to the Vaccine Adverse Event Reporting System (VAERS) for Pfizer- BioNTech COVID-19 Vaccine: all vaccine administration errors, serious adverse events, cases of Multisystem Inflammatory Syndrome (MIS), and cases of COVID-19 that result in hospitalization or death.', 0.69311225), ('The totality of the available data provides clear evidence that Pfizer-BioNTech COVID-19 Vaccine may be effective in preventing COVID-19.', 0.6867611), ('The tireless work to develop a new vaccine to prevent this novel, serious, and life-threatening disease in an expedited timeframe after its emergence is a true testament to scientific innovation and public-private collaboration worldwide.” The FDA has determined that Pfizer-BioNTech COVID-19 Vaccine has met the statutory criteria for issuance of an EUA.', 0.67978144)]"
1140,Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without,cell,quantitative assays reveal _ fusion at minimal levels of sars-cov-2 spike protein and fusion-from-without,quantitative assays reveal no fusion at minimal levels of sars-cov-2 spike protein and fusion-from-without,https://www.biorxiv.org/content/10.1101/2020.10.15.340604v1,"[('Here we present quantitative assay systems covering not only particle-cell and cell-cell fusion, but also demonstrating fusion-from-without (FFWO), the formation of syncytia induced by S-containing viral particles in absence of newly synthesized S protein.', 0.7146661), ('Cell-cell fusion, in contrast, was only moderately inhibited despite requiring much lower levels of S protein, which were below the detection limit of flow cytometry and Western blot.', 0.6441455), ('Neutralizing antibodies as well as sera from convalescent patients inhibited particle-cell fusion with high efficiency.', 0.5641426), ('Besides particle-cell fusion, S mediates fusion between infected and uninfected cells resulting in syncytia formation.', 0.49793503), ('The data obtained confirm the enhancing effect of trypsin and overexpression of angiotensin-converting enzyme 2 (ACE2) on membrane fusion.', 0.44370538)]"
1141,"Coronavirus Challenges in Primates , Compared",primate,"coronavirus challenges in _ , compared","coronavirus challenges in IHRs, compared",https://blogs.sciencemag.org/pipeline/archives/2020/07/30/coronavirus-challenges-in-primates-compared,"[('Have there been cases where challenge studies were successful in primates but then the vaccine showed little efficacy in humans?', 0.5782505), ('Lane Simonian says: 30 July, 2020 at 8:16 pm If T cells are critical for fending off this novel coronavirus what level of T cell activation in primates would correlate to the T cell activation that you would want to see in human beings?', 0.55854857), ('Phil says: 30 July, 2020 at 3:14 pm How predictive are primate challenge studies to showing efficacy in humans?', 0.544934), (""Monkey Business says: 31 July, 2020 at 3:49 am I question the Author's motivation in comparing only primate challenges."", 0.5267858), (""That's quite similar to what the company has reported in the human Phase I trials, which may add to one's confidence in trying to learn something from the primate viral challenge studies."", 0.52625155)]"
1142,Work by researchers in Hong Kong finds that reinfection may be possible in rare cases .,may,work by researchers in hong kong finds that reinfection _ be possible in rare cases .,work by researchers in hong kong finds that reinfection cannot be possible in rare cases.,https://www.nytimes.com/2020/08/24/world/covid-19-coronavirus.html#link-4b468050,"[('Researchers in Hong Kong find that in rare cases, a person can get reinfected.', 0.89595115), ('And experts say reinfections may be rare and not necessarily serious.', 0.63065207), ('“This Hong Kong patient also seems to have been asymptomatic on second infection, perhaps due to some immune response.” But the researchers said it’s also possible that in some people, a second exposure will prove more severe.', 0.58671474), ('For example, researchers might find that people become vulnerable to reinfection after antibodies drop below a certain level.', 0.5526765), ('All of these factors will make it easier to find and verify reinfections in the near future, says clinical microbiologist Kelvin To at the University of Hong Kong.', 0.5214047)]"
1143,Moderna Announces Initiation of Rolling Submission to Health Canada for mRNA Vaccine Against COVID-19,initiation,moderna announces _ of rolling submission to health canada for mrna vaccine against covid-19,moderna announces out of rolling submission to health canada for mrna vaccine against covid-19,https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-initiation-rolling-submission-health-canada,"[('Moderna remains on track to be able to deliver up to 56 million doses of its COVID-19 vaccine to help protect Canadians beginning in 2021.', 0.6893183), ('On September 22, the Canadian Government increased its confirmed order commitment to 20 million doses of mRNA-1273.', 0.6598215), ('“We are pleased with the interactions with the Canadian regulatory authorities and we appreciate their guidance and confidence in Moderna to pursue a rolling submission in Canada for our COVID-19 vaccine candidate, mRNA-1273,” said Stéphane Bancel, Moderna’s Chief Executive Officer.', 0.64772093), ('This initiation follows positive results from a preclinical viral challenge study of mRNA-1273 and the positive interim analysis of the Phase 1 study of mRNA-1273 in healthy adults (ages 18-55 years) and older adults (ages 56-70 and 71+) published in the New England Journal of Medicine.', 0.61430514), ('“We are committed to developing a safe and effective vaccine following the guidance of regulatory agencies around the world and we will continue working closely with Health Canada.” The Phase 1 interim analysis showed that mRNA-1273 was generally well- tolerated across all age groups and induced rapid and strong immune responses against SARS-CoV-2.', 0.60564184)]"
1144,"Confirmed cases a pointless metric , says Steve Goodman , a professor of epidemiology at Stanford University",pointless,"confirmed cases a _ metric , says steve goodman , a professor of epidemiology at stanford university","confirmed cases a similar metric, says steve goodman, a professor of epidemiology at stanford university",https://finance.yahoo.com/news/confirmed-coronavirus-cases-almost-meaningless-123550415.html,"[('> > ""The numbers are almost meaningless,"" says Steve Goodman, a professor of > epidemiology at Stanford University.', 0.9125082), ('“The numbers are almost meaningless,” says Steve Goodman, a professor of epidemiology at Stanford University.', 0.91230005), ('The stats guy from Stanford ignoring that and treating it as only a stand alone, throw away metric...really rubs me wrong.', 0.5333509), ('Though death rate figures of around 1% have been tossed around, Goodman says he’s skeptical that anyone knows the death rate of this disease since we don’t know the true rates of infection.', 0.4356798), ('Yes, because testing is so low, we actually have NO farkING IDEA how many cases are in the US.', 0.43268722)]"
1145,Amplicon contamination in labs masquerades as COVID19 in surveillance tests,labs,amplicon contamination in _ masquerades as covid19 in surveillance tests,amplicon contamination in human masquerades as covid19 in surveillance tests,https://www.medrxiv.org/content/10.1101/2020.12.08.20244525v1,"[('Environmental testing showed widespread contamination of amplicons in lab spaces including notebooks, keyboards, glasses, and doorknobs.', 0.51976347), ('Minimizing instances of amplicon contamination and developing protocols for handling suspected cases are critical to propel research efforts and to avoid diverting university and healthcare resources from patients with COVID-19.', 0.46321285), ('Follow-up PCR and antibody tests showed that most of these cases were not true COVID-19 infection but instead arose from reverse-transcribed and amplified viral sequences (amplicons) that are generated during research.', 0.43282503), ('Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Improving Point-of-Care Diagnostics for COVID-19 IRB20-0581 The Institutional Review Board (IRB) of the Harvard Faculty of Medicine approved this Initial Study All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.', 0.33817613), ('Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.', 0.28445712)]"
1148,Urban Air Pollution May Enhance COVID-19 Case-Fatality and Mortality Rates in the United States,enhance,urban air pollution may _ covid-19 case-fatality and mortality rates in the united states,urban air pollution may decrease covid-19 case-fatality and mortality rates in the united states,https://www.medrxiv.org/content/10.1101/2020.05.04.20090746v1,"[('While the risk factors of COVID-19 are still under investigation, environmental factors, such as urban air pollution, may play an important role in increasing population susceptibility to COVID-19 pathogenesis.', 0.7187935), ('Moreover, continuation of current efforts to lower traffic emissions and ambient air pollution levels may be an important component of reducing population-level risk of COVID-19 deaths.', 0.7116647), ('The results support targeted public health actions to protect residents from COVID-19 in heavily polluted regions with historically high NO2 levels.', 0.6701577), ('Spatial variations were observed for both COVID-19 death outcomes and long-term ambient air pollutant levels.', 0.6028055), ('Discussions and Conclusions Long-term exposure to NO2, which largely arises from urban combustion sources such as traffic, may enhance susceptibility to severe COVID-19 outcomes, independent of longterm PM2.5 and O3 exposure.', 0.50635993)]"
1149,2.23 % of Quebec Adults Contracted COVID-19,adults,2.23 % of quebec _ contracted covid-19,2.23 % of quebeca contracted covid-19,https://www.hema-quebec.qc.ca/publications/communiques/archives/2020/communiques-2020/etude-seroprevalence-resultats.en.html,"[('In order to properly reflect the percentage Quebeckers who developed antibodies against the COVID-19 virus, study participants were selected from 12 of the 18 health regions.', 0.44190112), ('Lastly, in order to continue monitoring the evolution of COVID-19 in Quebec, the study may be repeated on a regular basis until the end of the pandemic.', 0.42752215), ('The Ministère de la Santé et des Services sociaux du Québec, which sponsored the research, reported about 37,000 cases for the 20 to 69 age group for the same period.', 0.38826865), ('The study also shows that the Mauricie-Centre-du-Québec region, which had a reported COVID-19 rate that was three times lower than in Montreal or Laval, nevertheless had an almost identical seroprevalence of 2.96%.', 0.36864972), ('https://www.hema-quebec.qc.ca/index.en.html SOURCE Héma-Québec For further information: Héma-Québec, Media Line : 514-832-0871 ', 0.3462201)]"
1150,Breakthrough needle-less vaccine could help in mass distribution,less,breakthrough needle-_ vaccine could help in mass distribution,breakthrough needle-specific vaccine could help in mass distribution,https://newslanded.com/2020/03/09/needle-less-vaccine/,"[('It is easier to think about the promise of a vaccine.', 0.67674613), ('Getting exposed to a vaccine is a bit like having survived the disease once, without the drawbacks.', 0.6673528), ('Since the ingredients to make the film are inexpensive and the process is relatively simple, it could make vaccine campaigns much more affordable.', 0.66565335), ('The vaccine probably won’t make the disease disappear.', 0.6639152), ('Of course, if one of the more than 250 COVID-19 therapeutics currently in development prove particularly effective at treating the disease, there could actually be reduced demand for a vaccine.', 0.65534014)]"
1151,COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact,not,covid-19 vaccines that reduce symptoms but do _ block infection need higher coverage and faster rollout to achieve population impact,covid-19 vaccines that reduce symptoms but do so block infection need higher coverage and faster rollout to achieve population impact,https://www.medrxiv.org/content/10.1101/2020.12.13.20248142v1,"[('Conclusions Vaccines which prevent COVID-19 disease but not SARS-CoV-2 infection, and thereby shift symptomatic infections to asymptomatic infections, will prevent fewer infections and require larger and faster vaccination rollouts to have population impact, compared to vaccines that reduce susceptibility to infection.', 0.8790821), ('If uncontrolled transmission across the U.S. continues, then expected vaccination in Spring 2021 will provide only limited benefit.', 0.62195957), ('The use of a “symptom reducing” vaccine will require twice as many people vaccinated than a “susceptibility reducing” vaccine with the same 90% VEDIS to prevent 50% of the infections and death over one year.', 0.5264076), ('Results Rollouts of 1M vaccinations (5,000 daily) using vaccines with 50% VEDIS are projected to prevent 30%-58% of infections and 38%-58% of deaths over one year.', 0.51193833), ('In comparison, vaccines with 90% VEDIS are projected to prevent 47%-78% of the infections and 58%-77% of deaths over one year.', 0.51002717)]"
1154,Manitoba declares state of emergency,emergency,manitoba declares state of _,manitoba declares state of question,https://news.gov.mb.ca/news/index.html?item=47137&posted=2020-03-20,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.09773293), ('[c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30', 0.012934577)]"
1155,Has there been a widespread failure to identify and treat this prevalent condition in COVID-19 ?,failure,has there been a widespread _ to identify and treat this prevalent condition in covid-19 ?,has there been a widespread ability to identify and treat this prevalent condition in covid-19?,https://bmjopenrespres.bmj.com/content/7/1/e000724,"[(""Further, many publications on COVID-19 have debated the puzzling clinical characteristics of 'silent hypoxemia', 'happy hypoxemics' and 'atypical ARDS', all features consistent with OP."", 0.6847595), ('Why COVID-19 silent hypoxemia is baffling to physicians.', 0.6645843), ('High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review : High levels of anti-SSA/Ro antibodies in COVID-19.', 0.5611416), ('COVID-19 pneumonia: different respiratory treatments for different phenotypes?', 0.48654252), ('Skip to main page content COVID-19 is an emerging, rapidly evolving situation.', 0.47424495)]"
1156,Unfounded Fears That Dogs Can Spread Covid-19 Can Cause Harm,dogs,unfounded fears that _ can spread covid-19 can cause harm,unfounded fears that people can spread covid-19 can cause harm,https://www.psychologytoday.com/ca/blog/canine-corner/202003/unfounded-fears-dogs-can-spread-covid-19-can-cause-harm,"[('And, although no evidence exists to indicate that they can either transmit the virus or develop its associated coronavirus disease 2019 (COVID-19), fear among the public that pets might play a role in spreading COVID-19 has resulted in pets being abandoned or even killed.', 0.7247091), ('At this time, there is no evidence that companion animals play a significant role in spreading the virus that causes COVID-19; however, we are still learning about this virus.', 0.70053196), ('According to the World Organisation for Animal Health (OIE), there is no justification in taking measures against companion animals that may compromise their welfare, such as harming them, abandoning them, or euthanizing them based on unfounded fears over COVID-19.', 0.6842983), ('While the risk of people contracting COVID-19 from contact with such animals is considered low, it is imperative for shelters to use the best available information on infection prevention for contagious diseases, including coronaviruses.', 0.6478004), ('Unlike the 2 dogs that tested positive for the virus, the cat did show signs of illness, including diarrhea, vomiting, and difficulty breathing [19].', 0.6381436)]"
1157,Infectious Coronavirus Retrieved From Hospital Air,hospital,infectious coronavirus retrieved from _ air,infectious coronavirus retrieved from GenBank air,https://www.nytimes.com/2020/08/11/health/coronavirus-aerosols-indoors.html,"[('and others have contended are the primary source of airborne virus in a hospital setting.', 0.60145795), ('Now a team of virologists and aerosol scientists has produced exactly that: confirmation of infectious virus in the air.', 0.5323636), ('The Coronavirus Outbreak › ', 0.53146267), ('Doctors in Johannesburg demonstrated how to place a device called an intubox over a patient, to help curb the spread of viral droplets during intubation.Credit...Michele Spatari/Agence France-Presse — Getty Images By Apoorva Mandavilli Published Aug. 11, 2020Updated Oct. 5, 2020 Leer en español Skeptics of the notion that the coronavirus spreads through the air — including many expert advisers to the World Health Organization — have held out for one missing piece of evidence: proof that floating respiratory droplets called aerosols contain live virus, and not just fragments of genetic material.', 0.49919), ('The scientists were able to collect virus at both distances and then to show that the virus they had plucked from the air could infect cells in a lab dish.', 0.49767637)]"
1158,"India has first covid vaccine approved from dcgi , human trials to begin in July .",first,"india has _ covid vaccine approved from dcgi , human trials to begin in july .","india has no covid vaccine approved from dcgi, human trials to begin in july.",https://www.cnbctv18.com/healthcare/indias-first-covid-19-vaccine-candidate-covaxin-gets-dcgi-approval-6226931.htm/amp,"[('The clinical trials of the experimental COVID-19 vaccine in humans are scheduled to begin in July 2020, Bharat Biotech said in a note.', 0.7694005), ('India’s first COVID-19 vaccine ‘COVAXIN’ gets DCGI approval for clinical trials ', 0.7226198), ('The company claims it is ""India\'s first vaccine candidate for COVID-19, developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV)"".', 0.69150436), (""> COVAXIN™, India's 1st indigenous COVID-19 vaccine, developed by Bharat > Biotech successfully enters human trials."", 0.6849024), ('According to the vaccine maker, human clinical trials of the experimental COVID-19 are scheduled to start across the country in July 2020.', 0.6840528)]"
1160,Johnson & Johnson Pauses Covid-19 Vaccine Trials Due to Sick Subject,pauses,johnson & johnson _ covid-19 vaccine trials due to sick subject,johnson & johnson developed covid-19 vaccine trials due to sick subject,https://www.wsj.com/articles/johnson-johnson-pauses-covid-19-vaccine-trials-due-to-sick-subject-11602555101?st=1w318gsf7e8sgst&reflink=article_copyURL_share,"[('This is the second time trials for a Covid-19 vaccine trial have been paused over a safety concern.', 0.7660308), ('Last month, AstraZeneca PLC paused clinical trials of an experimental Covid-19 vaccine after a participant in a U.K. study had an unexplained illness.', 0.74580157), ('The guidelines ""ensure our studies may be paused if an unexpected serious adverse event that might be related to a vaccine or study drug is reported, so there can be a careful review of all of the medical information before deciding whether to restart the study,"" the company said.', 0.58365107), (""Vaccines typically take years to bring to market, and many often don't make it because they fail to work safely during testing."", 0.5182574), (""AstraZeneca's trials were paused after a woman in a U.K. study of their vaccine had an unexplained illness, which a U.S. health official described as a spinal-cord problem."", 0.51460516)]"
1162,Multivalency transforms SARS-CoV-2 antibodies into broad and ultrapotent neutralizers,broad,multivalency transforms sars-cov-2 antibodies into _ and ultrapotent neutralizers,multivalency transforms sars-cov-2 antibodies into specific and ultrapotent neutralizers,https://www.biorxiv.org/content/10.1101/2020.10.15.341636v1,"[('One Sentence Summary multimerization platform transforms antibodies emerging from discovery screens into potent neutralizers that can overcome SARS-CoV-2 sequence diversity.', 0.79511344), ('Here, we used the human apoferritin protomer as a modular subunit to drive oligomerization of antibody fragments and transform antibodies targeting SARS- CoV-2 into exceptionally potent neutralizers.', 0.78805983), ('This MULTi-specific, multi-Affinity antiBODY (Multabody; or MB) platform contributes a new class of medical countermeasures against COVID-19 and an efficient approach to rapidly deploy potent and broadly-acting therapeutics against infectious diseases of global health importance.', 0.7055516), ('Combination of three different antibody specificities and the fragment crystallizable (Fc) domain on a single multivalent molecule conferred the ability to overcome viral sequence variability together with outstanding potency and Ig-like in vivo bioavailability.', 0.6580411), ('Antibodies are powerful biotherapeutics to fight viral infections; however, discovery of the most potent and broadly acting clones can be lengthy.', 0.62747514)]"
1163,SARS-CoV-2 in-vitro neutralization assay reveals inhibition of virus entry by iota-carrageenan,reveals,sars-cov-2 in-vitro neutralization assay _ inhibition of virus entry by iota-carrageenan,sars-cov-2 in-vitro neutralization assay blocked inhibition of virus entry by iota-carrageenan,https://www.biorxiv.org/content/10.1101/2020.07.28.224733v1,"[('Accordingly, our in vitro data on SSPL suggest that administration of iota-carrageenan may be an effective and safe prophylaxis or treatment for SARS-CoV-2 infections.', 0.70854473), ('Here, we show that iota-carrageenan can inhibit the cell entry of SSPL in a dose dependent manner.', 0.6884444), ('SSPL particles were efficiently neutralized with an IC50 value of 2.6 µg/ml iota-carrageenan.', 0.55490744), ('Attachment and entry of coronaviruses including SARS-CoV-2 is mediated by the spike glycoprotein (SGP).', 0.52246606), ('In vitro data on iota-carrageenan against various Rhino- and Coronaviruses showed similar IC50 values and translated readily into clinical effectiveness when a nasal spray containing iota-carrageenan demonstrated a reduction in severity and duration of symptoms of common cold caused by various respiratory viruses.', 0.47907048)]"
1165,13 % of infected patients on the Diamond Princess in Japan were asymptomatic,japan,13 % of infected patients on the diamond princess in _ were asymptomatic,13 % of infected patients on the diamond princess in Toronto were asymptomatic,https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.10.2000180#html_fulltext,"[(""Between February 3 and March 13, about 200 coronavirus cases in the US were confirmed to be from cruise travelers of multiple voyages, including the Diamond Princess and Grand Princess, the CDC's report said."", 0.48804176), ('Passengers and crew members of the Diamond Princess cruise ship underwent RT-PCR testing during the quarantine period, and those who showed positive results were transferred to hospitals in Japan.', 0.47813505), ('Top Japanese government adviser says Diamond Princess quarantine was flawed Traces of the virus were found ""on a variety of surfaces in cabins of both symptomatic and asymptomatic infected passengers up to 17 days after cabins were vacated on the Diamond Princess but before disinfection procedures had been conducted,"" the CDC said.', 0.46124592), ('Our estimated asymptomatic proportion is at 17.9% (95%CrI: 15.5-20.2%), which overlaps with a recently derived estimate of 33.3% (95% confidence interval: 8.3-58.3%) from data of Japanese citizens evacuated from Wuhan [13].', 0.45361766), ('A couple still aboard the Grand Princess cruise ship is suing Princess Cruise Lines for $1 million over its handling of coronavirus ""The Diamond Princess and Grand Princess had more than 800 total Covid-19 cases, including 10 deaths,"" the CDC\'s report said.', 0.4373889)]"
1166,I 'disagree strongly ' with Georgia governor 's decision to start reopening economy,disagree,i '_ strongly ' with georgia governor 's decision to start reopening economy,i 'is strongly'with georgia governor's decision to start reopening economy,https://www.cnn.com/us/live-news/us-coronavirus-update-04-22-20/h_9316c58792bba9a55d208009e3f28f7b,"[('Trump said Kemp’s decision violates guidelines the administration issued last week for states to follow before reopening parts of their economies.', 0.54739875), ('Kemp has faced backlash over his decision, as Georgia has tested less than 1 percent of its population for COVID-19.', 0.41727257), (""ADVERTISEMENT The president's comments come as Kemp said Monday that businesses allowed to reopen will be required to stagger shifts, keep workspaces six feet apart, and screen workers for respiratory illnesses and fevers."", 0.39003295), (""“I want him to do what he thinks is right, but I disagree with him on what he's doing,” Trump said at a White House press briefing Wednesday."", 0.37479815), (""Brian KempBrian KempGeorgia House to consider replacing Confederate statue with statue of John Lewis Republicans eye primaries in impeachment vote Trump's legacy is discord and division MORE's (R) decision to allow bowling alleys, hair salons and other businesses to reopen on Friday."", 0.3740526)]"
1168,SARS-CoV-2 evades immune detection in alveolar macrophages,evade,sars-cov-2 _ immune detection in alveolar macrophages,sars-cov-2 cans immune detection in alveolar macrophages,https://www.embopress.org/doi/full/10.15252/embr.202051252,"[('Alveolar macrophages do not produce an IFN response upon SARS‐CoV‐2 challenge 1.', 0.7043978), ('We demonstrate that challenged AMs are incapable of sensing SARS-CoV-2 and of producing an IFN response in contrast to other respiratory viruses, like influenza A virus and Sendai virus, which trigger a robust IFN response.', 0.6502638), ('SARS‐CoV‐2 nucleocapsid phosphoprotein decreases over time 1.', 0.6024951), ('SARS‐CoV‐2 challenge does not affect the IFN response in alveolar macrophages 1.', 0.5993042), ('The absence of IFN production in AMs upon challenge with SARS-CoV-2 could explain the initial asymptotic phase observed during COVID-19 and argues against AMs being the sources of pro-inflammatory cytokines later during infection.', 0.57404447)]"
1169,Canadian scientists have isolated COVID-19,scientists,canadian _ have isolated covid-19,canadian patients have isolated covid-19,https://www.ctvnews.ca/health/coronavirus/canadian-scientists-make-covid-19-research-breakthrough-isolating-virus-1.4851641,"[('The spread of the novel coronavirus that causes COVID-19 continues, with more cases diagnosed in Canada.', 0.68361473), ('In both cases, the virus was isolated from clinical samples obtained from patients at Sunnybrook, the first hospital in Canada to treat someone with COVID-19.', 0.68302095), ('As of Friday morning, there were 159 confirmed cases of COVID-19 in Canada, including the prime minister’s wife Sophie Gregoire Trudeau.', 0.671208), ('handout/Sunnybrook Hospital Two teams of Canadian scientists have isolated the coronavirus that causes COVID-19 and successfully reproduced it in the laboratory.', 0.63863087), ('""Now that we have isolated the SARS-CoV-2 virus [the agent responsible for COVID-19], we can share this with other researchers and continue this teamwork,” Dr. Arinjay Banerjee, NSERC post-doctoral fellow at McMaster University, said.', 0.5265164)]"
1171,SARS-CoV-2 differs from SARS-CoV in the requirements for receptor expression and proteolytic activation to trigger cell-cell fusion and is not inhibited by Bromhexine,not,sars-cov-2 differs from sars-cov in the requirements for receptor expression and proteolytic activation to trigger cell-cell fusion and is _ inhibited by bromhexine,sars-cov-2 differs from sars-cov in the requirements for receptor expression and proteolytic activation to trigger cell-cell fusion and is primarily inhibited by bromhexine,https://www.biorxiv.org/content/10.1101/2020.07.25.221135v1,"[('Taken together, we observed robust SARS-CoV-2 spike protein-mediated cell-cell fusion that was not dependent on exogenous TMPRSS2 expression and that was not inhibited by Bromhexine.', 0.8332492), ('Nevertheless, SARS-CoV-S-mediated fusion was clearly enhanced by TMPRSS2, as was fusion by the SARS-CoV-2-SS1S1’ mutant, and both were inhibited by Camostat but not by Bromhexine.', 0.82059515), ('We observed that cell-cell fusion by SARS-CoV-S and SARS-CoV2-S was not inhibited by Bromhexine, and only SARS-CoV-S activity was slightly inhibited by Ambroxol in the presence of TMPRSS2.', 0.8171135), ('Cell-cell fusion mediated by SARS-CoV-2-S was clearly not at all or to a much lesser degree restricted by serine protease activity on target cells than fusion by SARS-CoV-S. ', 0.79504895), ('According to our results the Bromhexine-mediated enhancement was specific for SARS-CoV-2 spike protein and was not seen with VSV-G as fusion effector, nor did we observe significant effects with the SARS-CoV-2-S mutants and SARS-CoV-S (Figs.', 0.7935358)]"
1173,"There is no specific medicine to treat COVID-19 , so whether you test positive or negative , management of your illness will be the same .",same,"there is no specific medicine to treat covid-19 , so whether you test positive or negative , management of your illness will be the _ .","there is no specific medicine to treat covid-19, so whether you test positive or negative, management of your illness will be the question.",https://health.hawaii.gov/news/corona-virus/state-of-hawaii-launches-www-hawaiicovid19-com-website/,"[('However, if you suspect or know you have COVID-19 and cannot take acetaminophen, or have taken the maximum dose and still need symptom relief, taking over-the-counter ibuprofen does not need to be specifically avoided.', 0.72553444), ('There is no specific medical treatment for COVID-19.', 0.71215916), ('However, there is no clear or convincing scientific evidence that it works for COVID-19 infections, and it is not a standard part of treatment for this infection.', 0.7104167), ('Individuals who are not sick should not be tested even if they have been exposed to COVID-19.', 0.6920959), ('The purpose of self-quarantine (as with self-isolation) is to prevent the possible spread of COVID-19.', 0.68792367)]"
1174,New study suggests Children May Carry COVID-19 At High Levels,children,new study suggests _ may carry covid-19 at high levels,new study suggests cats may carry covid-19 at high levels,https://www.nytimes.com/2020/07/30/health/coronavirus-children.html,"[('""Young children can potentially be important drivers of SARS-CoV-2 spread in the general population,"" the authors wrote.', 0.34705466), ('A much larger South Korean study recently found that children younger than 10 transmit to others much less often than adults do, while those between the ages of 10 and 19 can spread the virus at least as well as adults do.', 0.34051263), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.3234148), ('(However, the authors noted that other studies have reported a correlation between higher levels of RNA and the ability to grow an infectious virus.)', 0.32144713), ('It did not, however, conclude whether young children with the virus were likely to infect others.', 0.31316686)]"
1175,Private firm running UK PPE stockpile was sold in middle of pandemic .,sold,private firm running uk ppe stockpile was _ in middle of pandemic .,private firm running uk ppe stockpile was established in middle of pandemic.,https://www.theguardian.com/world/2020/apr/22/revealed-private-firm-running-uk-ppe-stockpile-was-sold-in-middle-of-pandemic,"[('But the saga is likely to put a spotlight on the UK government’s decision to outsource the management of the emergency stockpile.', 0.5667727), ('Photograph: Mark Waugh/The Guardian The government owns the stock, but outsources its management to private firms.', 0.5507561), ('However, the Guardian can reveal that the management and the distribution of the stockpile has been outsourced to a private company, Movianto, which was sold two weeks ago for $133m (£107m) by its owner, a large US healthcare group.', 0.5321759), ('The distribution of that stockpile’s PPE, it seems, may no longer solely be the responsibility of Movianto.', 0.4135669), ('Meanwhile, management of the stock has been passed from a German–owned multinational to an American one.', 0.38091093)]"
1176,An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction,blocking,an alpaca nanobody neutralizes sars-cov-2 by _ receptor interaction,an alpaca nanobody neutralizes sars-cov-2 by activating receptor interaction,https://www.nature.com/articles/s41467-020-18174-5,"[('A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2.', 0.7279705), ('Here, we report the isolation and characterization of an alpaca-derived single domain antibody fragment, Ty1, that specifically targets the receptor binding domain (RBD) of the SARS-CoV-2 spike, directly preventing ACE2 engagement.', 0.66102916), ('2: Ty1 neutralizes SARS-CoV-2 by binding to SARS-CoV-2 spike glycoprotein.', 0.6591619), ('This result indicated that Ty1 directly prevents binding of SARS-CoV-2 RBD to its host cell receptor ACE2.', 0.6566754), ('Humanized single domain antibodies neutralize SARS-CoV-2 by targeting spike receptor binding domain.', 0.65406585)]"
1177,"FAQs on Protecting Yourself from COVID-19 Aerosol Transmission , written by a group of scientists .",yourself,"faqs on protecting _ from covid-19 aerosol transmission , written by a group of scientists .","faqs on protecting patients from covid-19 aerosol transmission, written by a group of scientists.",https://reflowlabs.com/article/faqs-on-protecting-yourself-from-covid-19-aerosol-transmission-table-of-contents,"[('A group of scientists and experts from UC Boulder, UC San Diego, Penn State, Yale, Drexel and more have co-authored FAQs on Protecting Yourself from COVID-19 Aerosol Transmission.', 0.8393184), ('How to Protect Yourself From the Aerosol Spread of COVID-19 Jason Kottke: > A group of scientists who believe that WHO and the CDC are being too slow in > acknowledging the role of aerosol transmission in spreading Covid-19 have > written up a Google Doc of advice for the public: FAQs on Protecting > Yourself from COVID-19 Aerosol Transmission.', 0.74320257), ('Our contributors are active researchers investigating aerosol transmission of COVID-19 (see e.g.', 0.72124743), ('> The goal of these FAQs is to provide information to the general public in an > efficient manner about how to prevent aerosol transmission of COVID-19, with > the hope that this will allow more informed decision making by individuals > or organizations.', 0.66268164), ('The stated goal of the FAQ: ""to provide information to the general public in an efficient manner about how to prevent aerosol transmission of COVID-19, with the hope that this will allow more informed decision making by individuals or organizations.""', 0.65931535)]"
1180,Common cold combats influenza,cold,common _ combats influenza,common water combats influenza,https://news.yale.edu/2020/09/04/common-cold-combats-influenza,"[('Right: Influenza infection following exposure to common cold virus.', 0.77013713), ('As the flu season approaches, a strained public health system may have a surprising ally — the common cold virus.', 0.6007246), ('(Image: Foxman lab) Left: Influenza infection only.', 0.49682707), ('To test how the rhinovirus and the influenza virus interact, Foxman’s lab created human airway tissue from stem cells that give rise to epithelial cells, which line the airways of the lung and are a chief target of respiratory viruses.', 0.45778346), ('The researchers found that even during months when both viruses were active, if the common cold virus was present, the flu virus was not.', 0.4538083)]"
1181,"An ancient coronavirus-like epidemic drove adaptation in East Asians from 25,000 to 5,000 years ago",ancient,"an _ coronavirus-like epidemic drove adaptation in east asians from 25,000 to 5,000 years ago","an recent coronavirus-like epidemic drove adaptation in east asians from 25,000 to 5,000 years ago",https://www.biorxiv.org/content/10.1101/2020.11.16.385401v1,"[('These adaptive events were limited to ancestral East Asian populations, the geographical origin of several modern coronavirus epidemics.', 0.7390302), ('An arms race with an ancient corona-like virus may thus have taken place in ancestral East Asian populations.', 0.6555362), ('Here, we apply evolutionary analyses to human genomic datasets to recover selection events involving tens of human genes that interact with coronaviruses, including SARS-CoV-2, that started 25,000 years ago.', 0.5432557), ('Notably, modern human genomes contain evolutionary information tracing back tens of thousands of years, which may help identify the viruses that have impacted our ancestors – pointing to which viruses have future pandemic potential.', 0.47447783), ('By learning more about our ancient viral foes, our study highlights the promise of evolutionary information to combat the pandemics of the future.', 0.38542855)]"
1182,Pompeo saying that Chinese labs created COVID-19 .,chinese,pompeo saying that _ labs created covid-19 .,pompeo saying that our labs created covid-19.,https://www.nytimes.com/2020/05/03/us/politics/coronavirus-pompeo-wuhan-china-lab.html,"[('ANDREW HARNIK/POOL/AFP via Getty Images Secretary of State Mike Pompeo on Sunday said there was ""enormous evidence"" that COVID-19 originated in a Chinese lab.', 0.6909591), ('Secretary of State Mike Pompeo on Sunday claimed there was ""enormous evidence"" that COVID-19, the disease caused by the novel coronavirus, originated in a laboratory in Wuhan, China, though there has been so far no public evidence to support such a theory.', 0.48748046), ('Today, Julian Barnes on the Chinese Lab Theory.', 0.4816265), ('Get the latestcoronavirus business & economic impact analysis from Business Insider Intelligence on how COVID-19 is affecting industries.', 0.46298814), ('Trump previously floated a similar theory on April 19, promising ""consequences"" if China was found to have created the novel coronavirus.', 0.45538232)]"
1184,Israel to begin clinical trials of BriLife Covid-19 vaccine !,begin,israel to _ clinical trials of brilife covid-19 vaccine !,israel to complete clinical trials of brilife covid-19 vaccine!,https://www.israel21c.org/israel-to-begin-clinical-trials-of-covid-19-vaccine/,"[('Vials of BriLife, the experimental Covid-19 vaccine from the Israel Institute for Biological Research.', 0.8304257), ('By Abigail Klein Leichman Vials of the experimental COVID-19 vaccine from the Israel Institute for Biological Research.', 0.79399145), ('By Abigail Klein Leichman October 26, 2020, 11:01 am Vials of the experimental Covid-19 vaccine from the Israel Institute for Biological Research.', 0.7021309), ('The Israel Institute for Biological Research (IIBR) began animal trials for its “BriLife” vaccine in March.', 0.634953), ('feature How the Muslim-Arab world is handling the coronavirus crisis Daniel SiryotiIsrael Hayom briefReport: Palestinian Authority greenlights Russia’s COVID-19 vaccine David Becker Israel Hayom Russian Direct Investment Fund reports that P.A.', 0.58919835)]"
1185,CDC Study found geographic origin of SARS-COVID-19 in New York is from Europe rather than China .,from,cdc study found geographic origin of sars-covid-19 in new york is _ europe rather than china .,cdc study found geographic origin of sars-covid-19 in new york is not europe rather than china.,https://www.cdc.gov/mmwr/volumes/69/wr/mm6928a5.htm,"[('Using genetic sequencing, CDC determined that the sequences of most SARS- CoV-2-positive specimens resembled those circulating in Europe, suggesting probable introductions of SARS-CoV-2 from Europe, from other U.S. locations, and local introductions from within New York.', 0.59537786), ('We therefore explored the epidemiology of COVID-19 in Gansu Province, remote from the outbreak epicenter in Wuhan.', 0.58784825), ('Rather, the sequence analysis suggests probable introductions of SARS-CoV-2 from Europe, from other U.S. locations, and local introductions from within New York.', 0.5651224), ('In conclusion, our study demonstrates the epidemiology of a relatively small- scale outbreak of COVID-19 outside of Wuhan.', 0.5441663), ('In Gansu Province, we observed fewer severe clinical cases of COVID-19, lower rates of patients in critical condition (13%), and no deaths, compared with Wuhan, where ≈30% patients were admitted to intensive care and 4% died ( 26).', 0.5166564)]"
1186,"US will start testing people with flu symptoms for coronavirus , officials say",start,"us will _ testing people with flu symptoms for coronavirus , officials say","us will not testing people with flu symptoms for coronavirus, officials say",https://www.independent.co.uk/news/world/americas/coronavirus-symptoms-us-flu-cdc-who-china-wuhan-novel-virus-latest-a9336756.html,"[('Nancy Messonnier, director of the US Centre for Immunisation and Respiratory Diseases (NCIRD), said that the US would begin to test individuals with flu- like symptoms for the coronavirus.', 0.8424102), ('The coronavirus test will only be given to patients who test negative for the flu.', 0.73450667), ('Samuel Corum U.S. health officials will monitor people with flu-like symptoms for the coronavirus in five cities, the Centers for Disease Control and Prevention said Friday.', 0.6791643), (""Gavin Newsom's children may have been exposed to the coronavirus at school and is in quarantine."", 0.6533214), ('She added that the system would act as an early warning if the virus spreads that would ""trigger a change in our response strategy.""', 0.6488662)]"
1187,"As Coronavirus Spreads , Fewer Americans See Pandemic As A Real Threat",fewer,"as coronavirus spreads , _ americans see pandemic as a real threat","as coronavirus spreads, and americans see pandemic as a real threat",https://www.npr.org/2020/03/17/816501871/poll-as-coronavirus-spreads-fewer-americans-see-pandemic-as-a-real-threat?utm_term=nprnews&utm_campaign=npr&utm_source=facebook.com&utm_medium=social&fbclid=IwAR1vz-hwM9CCYxkxjv8Igqwr_vn59iyRT2HHwQiF0rHdRBYD5FzNB0oC8B4,"[('Just about 56% of Americans consider the coronavirus a ""real threat,"" representing a drop … View on npr.org Mar 17, 2020 ShareLikeFlip ', 0.50895905), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.24178529), ('FollowAdd favoriteShareFlip ', 0.13326727), ('Flipboard HomeLandscape version of the Flipboard logo Search Open in app Sign up Log in NPR ', 0.1284323), ('[c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario', -0.00033435877)]"
1189,Lancet retracts paper that halted hydroxychloroquine trials,halted,lancet retracts paper that _ hydroxychloroquine trials,lancet retracts paper that received hydroxychloroquine trials,https://www.theguardian.com/world/2020/jun/04/covid-19-lancet-retracts-paper-that-halted-hydroxychloroquine-trials,"[('We therefore request that the article be retracted.', 0.5624918), ('As such, our reviewers were not able to conduct an independent and private peer review and therefore notified us of their withdrawal from the peer-review process.” The Lancet study had a dramatic impact on attempts to find out whether the antimalarial drug hydroxychloroquine, and its older version, chloroquine, could help treat patients with Covid-19.', 0.5394627), ('Photograph: George Frey/Reuters Sarah Boseley and Melissa Davey Thu 4 Jun 2020 15.43 EDT Last modified on Wed 1 Jul 2020 12.19 EDT The Lancet paper that halted global trials of hydroxychloroquine for Covid-19 because of fears of increased deaths has been retracted after a Guardian investigation found inconsistencies in the data.', 0.51344186), ('“We do not agree with your premise or the nature of what you have put together, and I am sad to see that what should have been a scientific discussion has been denigrated into this sort of discussion.” Shortly after the Lancet retracted its study, the New England Journal of Medicine retracted a paper based on the Surgisphere database, also co-authored by Mehra and Desai.', 0.4686992), ('The World Health Organization and several countries suspended randomised controlled trials that were set up to find an answer.', 0.46331465)]"
1190,Type III interferons disrupt the lung epithelial barrier upon viral recognition,iii,type _ interferons disrupt the lung epithelial barrier upon viral recognition,type 1 interferons disrupt the lung epithelial barrier upon viral recognition,https://science.sciencemag.org/content/369/6504/706.full,"[('A. Wack , Type I and III interferons disrupt lung epithelial repair during recovery from viral infection.', 0.8778385), ('3 IFN-λ signaling directly inhibits lung epithelia proliferation and impairs repair upon viral recognition.', 0.8150821), ('In our system, we isolated the effect of immune activation from resistance to lung viral infections and demonstrated that sustained IFN-λ is produced by DCs via TLR3.', 0.68106484), ('Furthermore, IFN-λ secreted by dendritic cells in the lungs of mice exposed to synthetic viral RNA causes damage to the lung epithelium, which increases susceptibility to lethal bacterial superinfections.', 0.6717516), ('A. Ploss , Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection In Vivo.', 0.6534717)]"
1192,Beware of the second wave of COVID-19,second,beware of the _ wave of covid-19,beware of the fourth wave of covid-19,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30845-X/fulltext,"[('Case fatality rate (CFR) is one of the important unknowns of COVID-19.', 0.5848808), ('The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak.', 0.42470372), ('The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study.', 0.3933094), ('1 WHO Rolling updates on coronavirus disease (COVID-19): WHO characterizes COVID-19 as a pandemic.', 0.38404083), ('1. WHO Rolling updates on coronavirus disease (COVID-19): WHO characterizes COVID-19 as a pandemic.', 0.36591154)]"
1193,SARS-CoV-2-specific IgA and limited inflammatory cytokines are present in the stool of select patients with acute COVID-19,select,sars-cov-2-specific iga and limited inflammatory cytokines are present in the stool of _ patients with acute covid-19,sars-cov-2-specific iga and limited inflammatory cytokines are present in the stool of all patients with acute covid-19,https://www.medrxiv.org/content/10.1101/2020.09.03.20183947v1,"[('5.. SARS-CoV-2-specific IgA in stool of COVID-19 patients.', 0.8319118), ('Conclusions: Although SARS-CoV-2 RNA was detectable in the stools of COVID-19 patients and select individuals had evidence for a specific mucosal IgA response, intestinal inflammation was limited, even in patients presenting with gastrointestinal symptoms.', 0.7507378), ('Concentrations of cytokines in fecal samples from control donors and COVID-19 patients.', 0.72787297), ('Salivary anti-SARS-CoV-2 IgA as an accessible biomarker of mucosal immunity against COVID-19.', 0.7229662), ('Gut microbiome and fecal SARS-CoV-2 genome sequencing of COVID-19 patients.', 0.67415035)]"
1194,Serology in Children with Multisystem Inflammatory Syndrome associated with COVID-19,with,serology in children _ multisystem inflammatory syndrome associated _ covid-19,serology in dogs with multisystem inflammatory syndrome associated with covid-19,https://www.medrxiv.org/content/10.1101/2020.07.10.20150755v1,"[('Two of the children with MIS-C had concurrently positive SARS-CoV-2 nasopharyngeal RT-PCR results, and their clinical presentation of MIS-C appeared to coincide with symptomatic COVID-19.', 0.742334), ('COVID-19-Associated Multisystem Inflammatory Syndrome in Children -- United States, March-July 2020.', 0.7413423), ('COVID-19-associated multisystem inflammatory syndrome in children - United States, March-July 2020.', 0.73229015), ('Antibody responses to SARS-CoV-2 in patients with COVID-19.', 0.70824456), (""The patients' signs and symptoms were temporally associated with COVID-19 but presumed to have developed 2-4 weeks after acute COVID-19; all children had serologic evidence of infection with SARS-CoV-2, the virus that causes COVID-19 ( 1 )."", 0.69331634)]"
1195,"In a phylogenetic network analysis of 160 complete human severe acute respiratory syndrome coronavirus 2 genomes , we find three central variants distinguished by amino acid changes , which we have named A , B , and C ...",160,"in a phylogenetic network analysis of _ complete human severe acute respiratory syndrome coronavirus 2 genomes , we find three central variants distinguished by amino acid changes , which we have named a , b , and c ...","in a phylogenetic network analysis of five complete human severe acute respiratory syndrome coronavirus 2 genomes, we find three central variants distinguished by amino acid changes, which we have named a, b, and c...",https://www.pnas.org/content/early/2020/04/07/2004999117,"[('To understand the evolution of this virus within humans, and to assist in tracing infection pathways and designing preventive strategies, we here present a phylogenetic network of 160 largely complete SARS-Cov-2 genomes (Fig.', 0.71593916), ('Phylogenetic network of 160 SARS-CoV-2 genomes.', 0.6870848), ('In early March 2020, the GISAID database (https://www.gisaid.org/) contained a compilation of 253 severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) complete and partial genomes contributed by clinicians and researchers from across the world since December 2019.', 0.6571393), ('Send Message Citation Tools Phylogenetic network analysis of SARS-CoV-2 genomes Peter Forster, Lucy Forster, Colin Renfrew, Michael Forster Proceedings of the National Academy of Sciences Apr 2020, 117 (17) 9241-9243; DOI: 10.1073/pnas.2004999117 ', 0.6389039), ('Phylogenetic network of 160 SARS-CoV-2… Fig.', 0.598727)]"
1198,A human neutralizing antibody targets the receptor binding site of SARS-CoV-2,human,a _ neutralizing antibody targets the receptor binding site of sars-cov-2,a rabbit neutralizing antibody targets the receptor binding site of sars-cov-2,https://www.nature.com/articles/s41586-020-2381-y,"[('A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein.', 0.892601), ('Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2.', 0.8805171), ('Structural basis of receptor recognition by SARS-CoV-2.', 0.8307943), (', A human monoclonal antibody blocking SARS-CoV-2 infection.', 0.8179039), (', Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual.', 0.8161637)]"
1199,A mysterious company 's coronavirus papers in top medical journals may be unraveling,mysterious,a _ company 's coronavirus papers in top medical journals may be unraveling,a major company's coronavirus papers in top medical journals may be unraveling,https://www.sciencemag.org/news/2020/06/mysterious-company-s-coronavirus-papers-top-medical-journals-may-be-unraveling,"[('As soon as the study was published, it came under attack by clinicians, as well as experts in biostatistics and medical ethics who questioned how Surgisphere, a tiny company without much publishing experience in big data analysis, could have collected and analyzed tens of thousands of patient records from hundreds of hospitals—particularly given the complexities of navigating patient confidentiality agreements.', 0.5434435), ('Headlines proclaiming deadly effects will make it hard to recruit patients to key studies, he says.', 0.5314263), ('But just as quickly, the results have begun to unravel—and Surgisphere, which provided patient data for two other high-profile COVID-19 papers, has come under withering online scrutiny from researchers and amateur sleuths.', 0.5238485), ('They have pointed out many red flags in the Lancet paper, including the astonishing number of patients and details about patient demographics and dosing that seemed implausible.', 0.51699966), ('However, the failure to resolve such basic concerns about the data during the course of normal peer review raises serious questions about the standard of editing at the Lancet and NEJM — ostensibly two of the world’s most prestigious medical journals.', 0.4960732)]"
1201,Prophylactic intranasal administration of a TLR2 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model,reduces,prophylactic intranasal administration of a tlr2 agonist _ upper respiratory tract viral shedding in a sars-cov-2 challenge ferret model,prophylactic intranasal administration of a tlr2 agonist increases upper respiratory tract viral shedding in a sars-cov-2 challenge ferret model,https://www.biorxiv.org/content/10.1101/2020.09.25.309914v1,"[('We show that prophylactic intra-nasal administration of the TLR2/6 agonist INNA-051 in a SARS-CoV-2 ferret infection model effectively reduces levels of viral RNA in the nose and throat.', 0.8042247), ('Antiviral Efficacies of FDA-Approved Drugs against SARS- CoV-2 Infection in Ferrets.', 0.675586), ('Analysis of viral RNA in throat swabs provided further evidence of the capacity of INNA-051 treatment to reduce SARS-CoV-2 in the URT (Fig 2B).', 0.67083764), ('To determine whether TLR2/6 agonists are also active against SARS-CoV-2, we used prophylactic i.n.', 0.6635444), ('There was one ferret in Group 1 showing detectable, but below the quantifiable limit, viral RNA, and no other INNA-051 treated ferrets showing detectable viral RNA in lung tissue on day 3 and days 12-14 dpc This study provides evidence supporting a novel approach to prevent SARS-CoV-2 transmission, based on reduced viral shedding, following prophylactic i.n administration of INNA-051.', 0.6588135)]"
1204,Swissmedic starts rolling review of a COVID-19 vaccine,review,swissmedic starts rolling _ of a covid-19 vaccine,swissmedic starts rolling transmission of a covid-19 vaccine,https://www.swissmedic.ch/swissmedic/en/home/news/coronavirus-covid-19/ueberpruefung-covid19-impfstoff.html,"[('The scientific assessment of the vaccine, currently bearing the designation COVID-19 Vaccine AstraZeneca, is undergoing what is termed a “rolling submission” procedure.', 0.6904313), ('Rolling submission enables Swissmedic to build up a picture of the vaccine’s risk-benefit profile even before the pivotal clinical trials have been completed.', 0.6901226), ('This allows pharmaceutical companies to submit applications for COVID-19 medicinal products even before development work is concluded and prior to availability of the complete supporting documentation.', 0.5885433), ('Using the procedure, Swissmedic can review data from ongoing clinical trials as soon as it is available.', 0.57967603), ('Trial results must then be submitted to Swissmedic for scientific review as they become available over the next few weeks and months.', 0.5770645)]"
1205,"CRISPR-based COVID Test is Rapid , Accurate and Costs Less Than $ 1",less,"crispr-based covid test is rapid , accurate and costs _ than $ 1","crispr-based covid test is rapid, accurate and costs greater than $ 1",https://www.laboratoryequipment.com/567702-CRISPR-based-COVID-Test-is-Rapid-Accurate-and-Costs-Less-Than-1/,"[('Analytically, CRISPR-COVID (as the researchers have named the assay), showed a near single-copy sensitivity in the study.', 0.68992656), (""A crucial advantage of CRISPR-COVID is its ability to be used in low-resource settings that can't currently support the thermo cycler needed for PCR-based tests."", 0.58229625), ('With two targets in hand, the team took advantage of the sensitivity of CRISPR/Cas--specifically the programmability of CRISPR/Cas13a--to create an isothermal-based assay that eliminates the need for sophisticated analytical instruments.', 0.52122563), ('""To address the expanding clinical needs, we developed CRISPR- COVID, a rapid assay for SARS-CoV-2 detection based on Cas13a.""', 0.48225945), ('Recent studies have indicated CRISPR tools have the potential for in vitro diagnostics, something Chinese scientists have leveraged to develop a 100% accurate COVID-19 test that can be mass manufactured for 70 cents.', 0.4700991)]"
1206,"Vaccine BCG may provide immune boost against coronavirus , herpes , and other viral infections",provide,"vaccine bcg may _ immune boost against coronavirus , herpes , and other viral infections","vaccine bcg may prevent immune boost against coronavirus, herpes, and other viral infections",https://medicalxpress.com/news/2020-03-vaccine-bcg-immune-boost-coronavirus.html,"[('Apparently, a vaccination with BCG also activates the immune system against a viral infection.', 0.82656837), ('BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity.', 0.722914), ('Immune boost against the corona virus ', 0.71183026), ('Taken together, these findings suggest that the induction of trained immunity by BCG vaccination results in significant protection against multiple viral infections.', 0.69966906), ('Looking at absenteeism has the advantage that any beneficial effects of the BCG vaccine on influenza and other infections may be captured as well, he says.', 0.67614347)]"
1211,SARS-CoV-2-RNA viremia is associated to hypercytokinemia and critical illness in COVID-19,critical,sars-cov-2-rna viremia is associated to hypercytokinemia and _ illness in covid-19,sars-cov-2-rna viremia is associated to hypercytokinemia and mild illness in covid-19,https://www.medrxiv.org/content/10.1101/2020.08.25.20154252v1,"[('SARS-CoV-2-RNA viremia is a robust marker of critical illness in COVID-19.', 0.8906851), ('""SARS-CoV-2-RNA viremia is a robust marker of critical illness in COVID-19"".', 0.88199604), ('Conclusions SARS-CoV-2 RNAemia and viral RNA load in plasma are associated to critical illness in COVID-19.', 0.7998215), ('Severe COVID-19 is characterised by a dysregulated host response to this virus.', 0.78715265), ('A subgroup of patients with severe COVID-19 can experience the so-called ""cytokine storm syndrome"", characterized by a fulminant and fatal hyper-cytokinemia associated with multi-organ failure.', 0.7738924)]"
1212,"Dr. Walter Koroshetz , director of Neurological Disorders at NIH , said we should prepare for an increase of Chronic Fatigue Syndrome caused by COVID-19",should,"dr. walter koroshetz , director of neurological disorders at nih , said we _ prepare for an increase of chronic fatigue syndrome caused by covid-19","dr. walter koroshetz, director of neurological disorders at nih, said we cannot prepare for an increase of chronic fatigue syndrome caused by covid-19",https://www.nih.gov/research-training/medical-research-initiatives/mecfs/nih-me/cfs-advocacy-call-march-17-2020,"[('So, what I can say is that when we actually this week had a call with the Collaborative Research Centers, they are intensely aware of this situation with COVID-19 and how that’s affecting ME/CFS patients and could potentially involve more.', 0.52693903), ('So, I think at this point, I think it’s quite public about advice on things to keep yourself healthy, and I would recommend that people visit those websites, the CDC and the WHO websites, for the most up-to-date advice, and know that, you know, I described the research progress on these immune phenotypes and it’s - and you realize that, you know, that’s relevant to COVID-19.', 0.46095327), ('So, you have to quickly inject funding into ME research, and one way to do that is by expanding the Collaborative Research Center Network, which is what you said you wanted to do when you first announced the current Centers.', 0.45366517), ('Now in the same October call, Dr. Whittemore said that the unfunded PARs would be released soon - hopefully very soon.', 0.45142984), ('And then the WHO, the World Health Organization, has a similar website for COVID-19 with information that’s more globally based.', 0.44827953)]"
1213,Human trials expected to start next month for Covid-19 treatment derived from cows ' blood,next,human trials expected to start _ month for covid-19 treatment derived from cows ' blood,human trials expected to start this month for covid-19 treatment derived from cows'blood,https://www.cnn.com/2020/06/16/health/cow-blood-coronavirus-treatment/index.html,"[('The scientists then injected some of the cows with a non-infectious part of the virus that causes Covid-19.', 0.72904), ('The company has not yet announced whether it will study the drug as prevention or treatment for Covid-19, or both.', 0.60217667), ('That way, the animals produce disease-fighting human antibodies to Covid-19, which are then turned into a drug to attack the virus.', 0.57391906), ('The cows are now producing human antibodies to the coronavirus.', 0.55809104), ('The company is also working with antibodies from human survivors of Covid-19.', 0.5543371)]"
1214,"Findings from serological surveys to assess the exposure of adult population to SARS Cov-2 infection in three cities of Odisha , India .",three,"findings from serological surveys to assess the exposure of adult population to sars cov-2 infection in _ cities of odisha , india .","findings from serological surveys to assess the exposure of adult population to sars cov-2 infection in two cities of odisha, india.",https://www.medrxiv.org/content/10.1101/2020.10.11.20210807v1,"[('Findings from serological surveys (in August 2020) to assess the exposure of adult population to SARS Cov-2 infection in three cities of Odisha, India.', 0.9373247), ('ObjectiveTo estimate and compare the sero- prevalence, hidden prevalence and determine the demographic risk factors associated with SARS-CoV-2 infection among adults in three largest cities of Odisha, India.', 0.8118743), ('Objective To estimate and compare the sero-prevalence, hidden prevalence and determine the demographic risk factors associated with SARS-CoV-2 infection among adults in three largest cities of Odisha, India.', 0.80407226), ('Share Findings from serological surveys (in August 2020) to assess the exposure of adult population to SARS Cov-2 infection in three cities of Odisha, India Jaya Singh Kshatri, Debdutta Bhattacharya, Srikanta Kanungo, Sidhartha Giri, Subrata Kumar Palo, Debaprasad Parai, Jyotirmayee Turuk, Asit Mansingh, Hariram Choudhary, Girish Chandra Dash, Niranjan Mishra, D.M.', 0.770774), ('MethodologyThis was a population based cross sectional serological survey carried out in August 2020 in the three largest cities of the state of Odisha.', 0.7685119)]"
1215,Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019,reduces,surgical mask partition _ the risk of noncontact transmission in a golden syrian hamster model for coronavirus disease 2019,surgical mask partition increases the risk of noncontact transmission in a golden syrian hamster model for coronavirus disease 2019,https://academic.oup.com/cid/article/71/16/2139/5848814,"[('Surgical mask partition for challenged index hamsters significantly reduced transmission to only 16.7% (2/12, P = .019) of exposed naive hamsters.', 0.6847125), ('Surgical mask partition for challenged index or naive hamsters significantly reduced transmission to 25% (6/24, P = .018).', 0.6502277), ('Exposure to respiratory droplets can theoretically be reduced by surgical mask usage.', 0.615744), ('Conclusions: SARS-CoV-2 could be transmitted by respiratory droplets or airborne droplet nuclei which could be reduced by surgical mask partition in the hamster model.', 0.6140337), ('Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters.', 0.61186373)]"
1219,COVID-19 infections leave an impact on the heart,heart,covid-19 infections leave an impact on the _,covid-19 infections leave an impact on the pandemic,https://www.boston.com/news/health/2020/07/27/coronavirus-heart/amp,"[('“These are two studies that both suggest that being infected with Covid-19 carries a high likelihood of having some involvement of the heart.', 0.69362867), ('The connection between Covid-19 and blood clots emerged later, after doctors began connecting the pulmonary aneurysms, strokes, and heart attacks they were seeing to the virus.', 0.66852856), ('It is too soon to say if the damage in patients recovering from Covid-19 is transient or permanent, but cardiologists are worried.', 0.6321149), ('I know from other diseases that it’s obviously not good to have that increased level of inflammation.” Advertisement Taken together, the two studies, published Monday in JAMA Cardiology, suggest that in many patients, Covid-19 could presage heart failure, a chronic, progressive condition in which the heart’s ability to pump blood throughout the body declines.', 0.6208128), ('“If this high rate of risk is confirmed, … then the crisis of COVID-19 will not abate but will instead shift to a new de novo incidence of heart failure and other chronic cardiovascular complications,” they wrote.', 0.60888815)]"
1220,Failed detection of the full-length genome of SARS-CoV-2 by ultra-deep sequencing from the recovered and discharged patients retested viral PCR positive,failed,_ detection of the full-length genome of sars-cov-2 by ultra-deep sequencing from the recovered and discharged patients retested viral pcr positive,Upon detection of the full-length genome of sars-cov-2 by ultra-deep sequencing from the recovered and discharged patients retested viral pcr positive,https://www.medrxiv.org/content/10.1101/2020.03.27.20043299v1,"[('In this study, we found that detectable viral genome in discharged patients might only mean the presence of viral fragments, and could hardly form an infection origin for its extremely low concentration.', 0.5920837), ('Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search ', 0.39840272), ('I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).', 0.3532643), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.3218075), ('Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.', 0.29093128)]"
1221,TRIM28 regulates SARS-CoV-2 cell entry by targeting ACE2,entry,trim28 regulates sars-cov-2 cell _ by targeting ace2,trim28 regulates sars-cov-2 cell death by targeting ace2,https://www.biorxiv.org/content/10.1101/2020.08.12.247825v1,"[('Our study identified TRIM28 as a novel regulator of ACE2 expression and SARS-CoV-2 cell entry.', 0.78881097), ('This study showed that knockdown of TRIM28 induces ACE2 expression and increases pseudotyped SARS- CoV-2 cell entry of A549 cells and primary pulmonary alveolar epithelial cells (PAEpiCs).', 0.7092732), ('Furthermore, TRIM28 knockdown enhanced interferon-γ (IFN-γ)-induced ACE2 expression through a mechanism involving upregulating IFN-γ receptor 2 (IFNGR2) in both A549 and PAEpiCs.', 0.66185105), ('Tripartite motif containing 28 (TRIM28) is known to be involved in multiple processes including antiviral restriction, endogenous retrovirus latency and immune response, it is recently reported to be co-expressed with SARS-CoV-2 receptor in type II pneumocytes; however, the roles of TRIM28 in ACE2 expression and SARS-CoV-2 cell entry remain unclear.', 0.6132778), ('The expression level of ACE2 potentially determine the susceptibility and severity of COVID-19, it is thus of importance to understand the regulatory mechanism of ACE2 expression.', 0.565873)]"
1222,Fujifilm tests favipiravir as COVID-19 treatment,fuji,_ tests favipiravir as covid-19 treatment,Nonfilm tests favipiravir as covid-19 treatment,https://cen.acs.org/pharmaceuticals/drug-development/Fujifilm-tests-favipiravir-COVID-19/98/web/2020/04,"[('Title: Fujifilm tests favipiravir as a COVID-19 treatment Author: Katsumori Matsuoka, special to C&EN Send Email To: Enter the valid email address.', 0.833689), ('Fujifilm is ramping up production of its antiviral treatment favipiravir, one of many approved drugs being tested as a possible treatment for COVID-19.', 0.7913994), ('Japanese researchers began administering favipiravir to Covid-19 patients around the end of February.', 0.7645779), ('Avigan works in the same way as Remdesiver, another antiviral medicine being tested against COVID-19.', 0.73638785), ('(Koji Sasahara/AP) Three Massachusetts hospitals will soon launch the first U.S. clinical trials of a Japanese antiviral drug, to see if it works in treating COVID-19.', 0.66242504)]"
1223,Human neutralizing antibodies elicited by SARS-CoV-2 infection,human,_ neutralizing antibodies elicited by sars-cov-2 infection,No neutralizing antibodies elicited by sars-cov-2 infection,https://www.nature.com/articles/s41586-020-2380-z,"[('The antibodies identified here may be candidates for development of clinical interventions against SARS-CoV-2.', 0.7984921), ('Antigen-specific ELISA was used to detect the binding capacity of transfected culture supernatants to SARS-CoV-2 RBD.', 0.78842556), ('In this study, we report on RBD-specific monoclonal antibodies obtained from individuals infected with SARS-CoV-2.', 0.7881259), ('Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies.', 0.7837492), ('provided additional pseudovirus assays for measuring neutralizing activity against SARS-CoV-2.', 0.7428881)]"
1224,Neutralising antibodies drive Spike mediated SARS-CoV-2 evasion,spike,neutralising antibodies drive _ mediated sars-cov-2 evasion,neutralising antibodies drive Fc mediated sars-cov-2 evasion,https://www.medrxiv.org/content/10.1101/2020.12.05.20241927v1,"[('These data reveal strong positive selection on SARS-CoV-2 during convalescent plasma therapy and identify the combination of Spike mutations D796H and Δ H69/ Δ V70 as a broad antibody resistance mechanism against commonly occurring antibody responses to SARS-CoV-2.', 0.77803504), ('Here we report fatal SARS-CoV-2 escape from neutralising antibodies in an immune suppressed individual treated with convalescent plasma, generating whole genome ultradeep sequences by both short and long read technologies over 23 time points spanning 101 days.', 0.64512575), ('However, following convalescent plasma we observed dynamic virus population shifts, with the emergence of a dominant viral strain bearing D796H in S2 and Δ H69/ Δ V70 in the S1 NTD of the Spike protein.', 0.45298517), ('In vitro , the Spike escape variant conferred decreased sensitivity to multiple units of convalescent plasma/sera from different recovered patients, whilst maintaining infectivity similar to wild type.', 0.44512856), ('Given both vaccines and therapeutics are designed around Wuhan-1 Spike, this raises the theoretical possibility of virus escape, particularly in immunocompromised individuals where prolonged viral replication occurs.', 0.42471087)]"
1225,SARS-CoV-2 viral load is associated with increased disease severity and mortality,with,sars-cov-2 viral load is associated _ increased disease severity and mortality,sars-cov-2 viral load is associated without increased disease severity and mortality,https://www.nature.com/articles/s41467-020-19057-5,"[('SARS-CoV-2 viral loads, especially plasma viremia, are associated with increased risk of mortality.', 0.8417617), ('SARS-CoV-2 viral loads, especially within plasma, are associated with systemic inflammation, disease progression, and increased risk of death.', 0.82796574), ('2: SARS-CoV-2 viral load is associated with markers of inflammation and disease severity.', 0.80461276), ('Here we show that SARS-CoV-2 viral loads, especially in the plasma, are predictive of mortality.', 0.7968589), ('1: SARS-CoV-2 viral loads across sampling sites and detection rates by disease severity.', 0.77862966)]"
1226,Wearing Face Masks Strongly Confuses Counterparts in Reading Emotions,confuse,wearing face masks strongly _ counterparts in reading emotions,wearing face masks strongly ins counterparts in reading emotions,https://www.frontiersin.org/articles/10.3389/fpsyg.2020.566886/full,"[(""Lower accuracy and lower confidence in one's own assessment of the displayed emotions indicate that emotional reading was strongly irritated by the presence of a mask."", 0.793277), ('Face masks may complicate social interaction as they disturb emotion reading from facial expression.', 0.762853), ('To understand how the lack of information is dealt with, it is important to look at the specific confusion of individual emotional states - when and in which way are emotions misinterpreted when face masks are worn?', 0.72580254), ('A drop in performance in reading the emotional states of faces with masks can somehow be expected as being much harder when most visual information of the lower half of the face is blocked out.', 0.70667464), ('This means that in natural contexts, the impact of face masks on reading emotions could even be stronger.', 0.691923)]"
1230,De novo design of ACE2 protein decoys to neutralize SARS-CoV-2,novo,de _ design of ace2 protein decoys to neutralize sars-cov-2,de rational design of ace2 protein decoys to neutralize sars-cov-2,https://www.biorxiv.org/content/10.1101/2020.08.03.231340v1,"[('Using our novel platform, in less than ten weeks, we engineered, validated, and optimized de novo protein decoys of human angiotensin-converting enzyme 2 (hACE2), the membrane-associated protein that SARS-CoV-2 exploits to infect cells.', 0.53862005), ('The designed proteins act as decoys that block cellular entry and aim to be resilient to viral mutational escape.', 0.4542058), ('Future refinements to our strategy can enable the rapid development of other therapeutic de novo protein decoys, not limited to neutralizing viruses, but to combat any agent that explicitly interacts with cell surface proteins to cause disease.', 0.39922985), ('Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search New Results ', 0.38456273), ('Our optimized designs are hyperstable de novo proteins (∼18-37 kDa), have high affinity for the SARS-CoV-2 receptor binding domain (RBD) and can potently inhibit the virus infection and replication in vitro.', 0.38132083)]"
1233,Korean study of 132 000 people shows that current use of Proton Pump Inhibitors may lead to 79 % greater risk of severe clinical outcomes of COVID-19,132,korean study of _ 000 people shows that current use of proton pump inhibitors may lead to 79 % greater risk of severe clinical outcomes of covid-19,korean study of 50 000 people shows that current use of proton pump inhibitors may lead to 79 % greater risk of severe clinical outcomes of covid-19,https://gut.bmj.com/content/early/2020/07/30/gutjnl-2020-322248.full,"[('Using a large-scale, population-based, nationwide cohort in Korea, we measured the potential associations of the current use of PPIs with the infection rates of COVID-19 among patients who underwent SARS-CoV-2 testing; we also assessed the influence of current PPI administrations to the disease severity of COVID-19 in patients with laboratory-confirmed COVID-19.', 0.6425068), ('Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study.', 0.6376549), ('The Korean Government provided mandatory and complementary health insurance for all patients with COVID-19 during the pandemic.', 0.56933177), ('View this table: View inline View popup Table 1 Baseline characteristics of all patients who underwent SARS-CoV-2 testing in Korean nationwide cohort (N=132 316) ', 0.5571247), ('Guidelines for laboratory diagnosis of coronavirus disease 2019 (COVID-19) in Korea.', 0.53508127)]"
1234,States Keep Watch On Coronavirus 'Doubling Times ',states,_ keep watch on coronavirus 'doubling times ',Bats keep watch on coronavirus 'doubling times ',https://www.npr.org/sections/health-shots/2020/04/10/829167659/are-we-flattening-the-curve-states-keep-watch-on-coronavirus-doubling-times,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.3729949), ('(Image credit: Stephanie Adeline/NPR) Facebook Twitter WhatsApp SMS Email Print Save ', 0.28529876), ('Edit Close Sign Up Log In Dashboard Logout My Account Dashboard Profile Saved items Logout CONTACT US ABOUT US 320-763-3131/THEFOLKS@LEIGHTONBROADCASTING.COM Listen Live: KXRA / KX92 / Z99 Search Sections 21° ', 0.26525128), (""Updated: January 17, 2021 @ 9:20 pm Full Forecast Home News Local News Local Business News State News News From Our Neighbors National News National Business News World News State Business News Weather Sports Cardinal Sports Area Prep Sports Regional Sports Minnesota Sports National Sports Entertainment Celebrity News Local Entertainment Everything Else Bizarre News Education Faith Features Food/Recipe Central Health & Beauty History Home & Garden Outdoor Photo/Video Travel Calendar Announcements Funeral Announcements Community Announcements Coronavirus Local National Connect with Us Archives Advertise with us Ways to Listen Contests Links Adult Children of Alcoholics Al-Anon Alcoholics Anonymous Alex Area Lakes Association Alexandria Area Arts Association Alexandria Area Baseball Association Alexandria Area Community Calendar Alexandria Area Economic Development Alexandria Area Hockey Association Alexandria Area Soccer Association Alexandria Blizzard Alexandria City Offices Alexandria District 206 Schools Alexandria Downtown Merchant Association Alexandria Lakes Area Chamber of Commerce Big Deals Online Store Big Ole Trail Camera - Alexandria, MN Celebrate Recovery Douglas County Historical Society Douglas County Hospital Douglas County Offices Explore Alexandria Tourism Land and Resources - Alex Lakes Area Minnesota Department of Transportation Minnesota Lynx Minnesota Timberwolves Minnesota Twins Minnesota United Football Club Minnesota Vikings Minnesota Wild Narcotics Anonymous Red Willow Arts Coalition Theatre L'Homme Dieu Voice of Alexandria Facebook Page Voice of Alexandria Instagram Page Voice of Alexandria Twitter Page Douglas County Library Big Deals Listen KXRA / Listen KX92 / Listen Z99 "", 0.2617609), ('An email has been sent to with a link to confirm list signup.', 0.21628484)]"
1236,Heterogeneity is essential for contact tracing,essential,heterogeneity is _ for contact tracing,heterogeneity is difficult for contact tracing,https://www.medrxiv.org/content/10.1101/2020.06.05.20123141v1,"[('In perspective, this highlights the necessity of incorporating social heterogeneity into models of mitigation strategies.', 0.6557785), ('As a mitigation strategy, contact tracing depends strongly on social structure and can be remarkably effective, even if only frequent contacts are traced.', 0.5532482), ('Mitigation strategies permitting individual mobility while limiting disease spreading are needed, and contact tracing is a potentially effective example of such a strategy.', 0.5050241), ('This shows that mitigation of COVID-19 may be possible with contact tracing, and that epidemiological models must incorporate social network structure.', 0.4553615), ('We use smartphone proximity data to monitor contacts between people, and find that contact tracing is highly dependent on social structure, being very effective on real contact networks.', 0.42549822)]"
1237,Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses,sar,measuring _-cov-2 neutralizing antibody activity using pseudotyped and chimeric viruses,measuring CHs-cov-2 neutralizing antibody activity using pseudotyped and chimeric viruses,https://rupress.org/jem/article/217/11/e20201181/151961/Measuring-SARS-CoV-2-neutralizing-antibody,"[('Here, we describe a collection of approaches based on SARS-CoV-2 spike-pseudotyped, single-cycle, replication-defective human immunodeficiency virus type-1 (HIV-1) and vesicular stomatitis virus (VSV), as well as a replication-competent VSV/SARS- CoV-2 chimeric virus.', 0.7544189), ('While each surrogate virus exhibited subtle differences in the sensitivity with which neutralizing activity was detected, the neutralizing activity of both convalescent plasma and human monoclonal antibodies measured using each virus correlated quantitatively with neutralizing activity measured using an authentic SARS-CoV-2 neutralization assay.', 0.75296354), ('The assays described herein are adaptable to high throughput and are useful tools in the evaluation of serologic immunity conferred by vaccination or prior SARS-CoV-2 infection, as well as the potency of convalescent plasma or human monoclonal antibodies.', 0.62665415), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.43633616), ('Your Email Your Name Send To Enter multiple addresses on separate lines or separate them with commas.', 0.31559998)]"
1239,The Broad Spectrum Antiviral Ivermectin Targets the Host Nuclear Transport Importin α/β1 Heterodimer,host,the broad spectrum antiviral ivermectin targets the _ nuclear transport importin α/β1 heterodimer,the broad spectrum antiviral ivermectin targets the extracellular nuclear transport importin α/β1 heterodimer,https://pubmed.ncbi.nlm.nih.gov/32135219/,"[(""We show here that ivermectin's broad spectrum antiviral activity relates to its ability to target the host importin (IMP) α/β1 nuclear transport proteins responsible for nuclear entry of cargoes such as integrase and NS5."", 0.8163798), ('Antivirals that target the host IMPα/β1-virus interface.', 0.795711), ('The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?', 0.70658314), ('PMID: 33439253 Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?', 0.68225956), ('We previously identified the small molecule ivermectin as an inhibitor of HIV-1 integrase nuclear entry, subsequently showing ivermectin could inhibit DENV NS5 nuclear import, as well as limit infection by viruses such as HIV-1 and DENV.', 0.6771352)]"
1240,Stanford professor Balaji S. Srinivasan 's peer review of the Santa Clara seroprevalence study indicates that its high reported positive rate results may be explained by the false positive rate of the test and/or by sample recruitment issues .,may,stanford professor balaji s. srinivasan 's peer review of the santa clara seroprevalence study indicates that its high reported positive rate results _ be explained by the false positive rate of the test and/or by sample recruitment issues .,stanford professor balaji s. srinivasan's peer review of the santa clara seroprevalence study indicates that its high reported positive rate results cannot be explained by the false positive rate of the test and/or by sample recruitment issues.,https://medium.com/@balajis/peer-review-of-covid-19-antibody-seroprevalence-in-santa-clara-county-california-1f6382258c25,"[('In a peer review of the antibody study published to Medium, former Stanford lecturer Balaji Srinivasan, who specializes in statistics and computational biology, argued the selection methods could have overstated the prevalence of the disease in the county.', 0.6223308), ('The use of such certificates may therefore increase the risks of continued transmission.” One of the most well-known attempts to justify sending workers back to offices and factories based on a supposed antibody count comes from the controversial Santa Clara study, as it has come to be known.', 0.5629891), ('Dr. Natalie E. Dean, a professor of biostatistics at the University of Florida, tweeted that she had concerns with the adjustments made for clustering (some participants brought children and other household members with them to the test) and test characteristics (researchers assume no false positives but some false negatives).', 0.5415771), ('Srinivasan also exposed how the recruitment of people for the study inherently biased the results.', 0.53335416), ('The Stanford researchers acknowledged as much in the study and used test performance weights to scale results, but Rutherford was skeptical of these weights, as well as the population weights the researchers used.', 0.5253423)]"
1241,A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period,2019,a familial cluster of infection associated with the _ novel coronavirus indicating potential person-to-person transmission during the incubation period,a familial cluster of infection associated with the first novel coronavirus indicating potential person-to-person transmission during the incubation period,https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaa077/5739751,"[('The epidemiological evidence has shown possible transmission of 2019 novel coronavirus during the incubation period.', 0.8698691), ('2019-nCoV is 2019 novel coronavirus.', 0.758536), ('Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.', 0.75267774), ('A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.', 0.7450795), ('Abbreviations: 2019-nCoV, 2019 novel coronavirus; Jan, January 2020.', 0.74033475)]"
1247,Preprint finds increase in SARS-related terms on Chinese social media two weeks before first known COVID19 case,increase,preprint finds _ in sars-related terms on chinese social media two weeks before first known covid19 case,preprint finds differences in sars-related terms on chinese social media two weeks before first known covid19 case,https://www.medrxiv.org/content/10.1101/2020.02.24.20026682v1,"[('Herein, we explored whether the SARS- CoV-2 outbreak in China could have been detected earlier through data available on WeChat, a popular Chinese social media app.', 0.63202816), ('One such tool, the Global Public Health Intelligence Network (GPHIN), identified the SARS outbreak in China in 2003 more than two months earlier.', 0.6269876), ('View this figure The Baidu Index results for ""Feidian,"" ""SARS,"" ""pneumonia,"" and ""coronavirus"" rose rapidly on December 30, 2019, the day before the outbreak announcement.', 0.59618753), ('The WeChat Index hits for ""coronavirus"" rose the day before the outbreak was announced, with a peak on the day of the announcement, followed by another peak after the novel coronavirus was officially announced as the causative pathogen of the outbreak by China CDC (Figure 1).', 0.580035), ('Objective: This study aimed to explore the possibility of detecting the SARS- CoV-2 outbreak in 2019 using social media.', 0.5791176)]"
1249,"U.S. manufacturers sent millions of dollars of face masks to China early this year , ignoring pandemic warning signs",ignoring,"u.s. manufacturers sent millions of dollars of face masks to china early this year , _ pandemic warning signs","u.s. manufacturers sent millions of dollars of face masks to china early this year, for pandemic warning signs",https://www.washingtonpost.com/,"[('Washington Post: U.S. sent millions of face masks to China early this year, ignoring pandemic warning signs ""U.S. manufacturers shipped millions of dollars\' worth of face masks and other protective medical equipment to China in January and February with encouragement from the federal government, a Washington Post review of economic data and internal government documents has found.', 0.8525591), ('Sent Millions Of Masks To China, Ignoring Warning Signs Of Pandemic By News & Guts Still life of a face mask and blue protective gloves on turquoise background Share on Facebook Share on Twitter Share on Email Manufacturers in the U.S. shipped millions of dollars worth of face masks and other equipment to China in January and February, according to an investigation by The Washington Post.', 0.8177692), ('Today, China’s imports of masks and other PPE from around the world is seen by some White House officials as part of a deliberate attempt by China to corner the market as it concealed and downplayed the danger posed by the outbreak.', 0.69027776), ('Still, Doggett was incredulous that masks desperately sought today by U.S. medical providers were provided to China by U.S. companies in large numbers through February.', 0.5885952), ('AD “While China was silent on the seriousness of the crisis, they were quietly buying up a large portion of the world’s global supply for masks and other PPE,” Navarro said.', 0.585554)]"
1250,Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism,inhibit,attacks the 1-beta chain of hemoglobin and captures the porphyrin to _ human heme metabolism,attacks the 1-beta chain of hemoglobin and captures the porphyrin to maintain human heme metabolism,https://chemrxiv.org/articles/COVID-19_Disease_ORF8_and_Surface_Glycoprotein_Inhibit_Heme_Metabolism_by_Binding_to_Porphyrin/11938173,"[('As for the attack, it would cause increasingly less hemoglobin that could carry oxygen and carbon dioxide, thus producing symptoms of respiratory distress and coagulation reaction, damaging many organs and tissues.', 0.5191231), ('3.7 Drugs bound to the heme-iron linked site of ORF3a 3.8 Drugs bound to the heme-iron linked site of Nucleocapsid phosphoprotein 3.9 No drug could bind to the heme-iron linked site of E protein (2) Modified:deleted the images to reduce article length 3.5 Virus structural proteins binding porphyrins 3.6 Virus non-structural proteins bind to the porphyrin 4.Discussion: Added and modified: 4.1 Obtaining conserved domains to dissociate iron from the heme through gene recombination 4.2 heme linked sites of structural protein E may be associated with high viral infection 4.7 Novel coronavirus pneumonia may be a particular type of lung cancer 5\\.', 0.5041151), ('The mechanism also interfered with the normal heme anabolic pathway of the human body, expecting to cause human diseases.', 0.46669063), ('The docking results showed that orf1ab, ORF10, and ORF3a proteins coordinated to attack the 1-beta chain of hemoglobin, and some structural and non-structural viral proteins could bind porphyrin.', 0.45811176), ('Deoxyhemoglobin was more vulnerable to virus attacks than oxidized hemoglobin.', 0.43572104)]"
1252,Labourers ' International Union of North America to Partner with Facedrive Health on TraceSCAN COVID-19 Contact Tracing App,america,labourers ' international union of north _ to partner with facedrive health on tracescan covid-19 contact tracing app,labourers'international union of north Africa to partner with facedrive health on tracescan covid-19 contact tracing app,https://financialpost.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/labourers-international-union-of-north-america-liuna-to-partner-with-facedrive-health-on-tracescan-covid-19-contact-tracing-app,"[('> The pilot project will take place at a work site in Hamilton, ON, where > every employee is assigned a dedicated wearable device for COVID-19 contact > tracing.', 0.67750657), ('The TraceSCAN app and wearables provide contact tracing to help mitigate the spread of the COVID-19 virus.', 0.62855893), ('The TraceSCAN app and wearables provide contact tracing to help > mitigate the spread of the COVID-19 virus.', 0.61842173), ('“As businesses begin to reopen and people return to work, TraceSCAN Wearables presents a viable alternative to other contact tracing applications to enhance our COVID-19 containment efforts in the workplace.', 0.59365845), ('We are pleased to have TraceSCAN wearables available to the membership of LiUNA working together to ensure heightened protection at the workplace amid COVID-19,” said Joseph Mancinelli, LiUNA International Vice President and Regional Manager of Central and Eastern Canada.', 0.5844623)]"
1254,Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease .,reduces,ruxolitinib rapidly _ acute respiratory distress syndrome in covid-19 disease .,ruxolitinib rapidly causes acute respiratory distress syndrome in covid-19 disease.,https://www.frontiersin.org/articles/10.3389/fmed.2020.00466/full,"[('Ruxolitinib can be a therapeutic option for patients with respiratory insufficiency in COVID-19 related ARDS.', 0.79455787), ('Based on these considerations, we hypothesized that immune- modulation with ruxolitinib might have been beneficial in reducing severity of ARDS in the context of COVID-19.', 0.7302862), ('We used ruxolitinib in 18 patients with clinically progressive COVID-19 related acute respiratory distress syndrome, with a primary endpoint to rapidly reduce the degree of respiratory impairment and as a secondary endpoint to rapidly restore the PaO2/FiO2 ratio, as an evaluation of clinical status, and monitoring of drug related Adverse Events.', 0.719677), ('Despite the limited number of patients collected, the results obtained are encouraging and indicate ruxolitinib as a potential therapeutic option for patients with severe COVID-19 related respiratory insufficiency.', 0.70412624), ('JAK-STAT inhibitors may indeed offer an interesting model of cytokines storm reduction also in the acute respiratory distress syndrome observed in COVID-19 patients.', 0.67289156)]"
1255,Here are some of the existing drugs that may be repurposed to treat coronavirus,existing,here are some of the _ drugs that may be repurposed to treat coronavirus,here are some of the new drugs that may be repurposed to treat coronavirus,https://www.nbcnews.com/health/health-news/here-are-some-existing-drugs-may-be-repurposed-treat-coronavirus-n1162021,"[('Here’s a list of some of the options being explored and why they might be useful in blunting the effects of coronavirus.', 0.76520383), ('Chinese doctors have used Tocilizumab to prevent an overreaction of the immune system that has led to organ failure and death in coronavirus patients.', 0.48602992), ('But clinical trials and FDA approval can take time, so while new drugs are being developed, companies are seeing if older drugs can be repurposed.', 0.45583406), ('The company is working with the FDA, CDC, and European agencies to set up clinical trials of the drug.', 0.45145988), ('Sanofi and Regeneron are launching a clinical trial in New York to see if their rheumatoid arthritis drug Kevzara is effective.', 0.45054078)]"
1256,Forecasting for COVID-19 has failed,for,_ _ covid-19 has failed,forecasting for covid-19 has in,https://forecasters.org/blog/2020/06/14/forecasting-for-covid-19-has-failed/,"[('Initial position COVID-19 is a major acute crisis with unpredictable consequences.', 0.6083913), (""Asymptomatic transmission the Achilles' Heel of current strategies to control covid-19."", 0.6024369), ('Worse, COVID-19 had already started devastating nursing homes in the USA by then, but the nursing home data were mostly unavailable.', 0.53424263), ('When I made that tentative quote, I had not considered the impact of the new case definition of COVID-19 and of COVID-19 becoming a notifiable disease (https://cdn.ymaws.com/www.cste.org/resource/resmgr/2020ps/Interim-20-ID-01COVID-19.pdf.', 0.50909704), ('How do we move forward to deal with the COVID-19 threat?', 0.5054272)]"
1258,Group of UK and US experts argues for focused protection instead of lockdowns,for,group of uk and us experts argues _ focused protection instead of lockdowns,group of uk and us experts argues against focused protection instead of lockdowns,https://www.bmj.com/content/371/bmj.m3908,"[('A more cautious policy might be government demonstrating that it can shield the old and vulnerable under current restrictions, as measured by the infection prevalence in this age group.', 0.48808253), ('They argue that focused protection would reduce the “collateral harms” of lockdown, including deaths from suicides, reduced childhood immunization, and increases in domestic violence.', 0.47373188), ('This declaration prioritises just one aspect of a sensible strategy – protecting the vulnerable – and suggests we can safely build up ‘herd immunity’ in the rest of the population.', 0.46866933), ('Further, the declaration is silent as to what success in shielding looks like?', 0.46051398), ('“Those behind the Barrington Declaration are advocates of herd immunity within a population.', 0.45832002)]"
1259,I am happy to share the first of those aspects covering the evolution of coronavirus as a preprint .,first,i am happy to share the _ of those aspects covering the evolution of coronavirus as a preprint .,i am happy to share the same of those aspects covering the evolution of coronavirus as a preprint.,https://www.biorxiv.org/content/10.1101/2020.09.03.281774v1,"[('More recently, the coronavirus found a new species: ours.', 0.64573383), ('It might even have taken a segment of a different coronavirus strain that already inhabited its new host, and morphed into a hybrid—a better, stronger version of itself, a pathogenic Everyman capable of thriving in diverse species.', 0.6433821), ('One day, the parasite—an ancestor of the coronavirus, SARS -CoV-2—had an opportunity to expand its realm.', 0.6350237), ('The rapid availability of nCoV genomic data made possible the production of first-generation homology models for 3CLpro cysteine protease; an enzyme which is crucial for viral replication and has been explored previously as a target for antiviral therapies in the treatment of another coronavirus, SARS.', 0.629898), ('All coronaviruses use their spike proteins to gain entry to human cells, through a complex, multistep process.', 0.6292249)]"
1260,Manpower launches hot seam sealing machine for PPE production,manpower,_ launches hot seam sealing machine for ppe production,F launches hot seam sealing machine for ppe production,https://in.apparelresources.com/business-news/manufacturing/manpower-launches-hot-seam-sealing-machine-ppe-production/,"[('Jump to Sections of this page Accessibility Help Press alt \\+ / to open this menu Notice You must log in to continue.', 0.305167), ('· Sign up for Facebook English (US) Español Français (France) 中文(简体) العربية Português (Brasil) 한국어 Italiano Deutsch हिन्दी 日本語 Sign Up Log In Messenger Facebook Lite Watch People Pages Page Categories Places Games Locations Marketplace Facebook Pay Groups Jobs Oculus Portal Instagram Local Fundraisers Services Voting Information Center About Create Ad Create Page Developers Careers Privacy Cookies Ad Choices Terms Help Settings Activity Log Facebook © 2021 [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.22291534), ('[DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.11055124), ('Log Into Facebook You must log in to continue.', 0.096189044), ('', 0.08140002)]"
1262,Effectiveness of facemasks to reduce exposure hazards for airborne infections among general populations,reduce,effectiveness of facemasks to _ exposure hazards for airborne infections among general populations,effectiveness of facemasks to increase exposure hazards for airborne infections among general populations,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306645/,"[('Aerosol-scavenging isolation barrier mitigates exposure risk during endonasal procedures in coronavirus-2019.', 0.5792545), ('Facemasks for the prevention of infection in healthcare and community settings.', 0.55349195), ('Validation and application of models to predict facemask influenza contamination in healthcare settings.', 0.52777296), (""In this work, two manikins labelled as 'source' and 'susceptible' were used to measure the protection provided by facemasks under various emission scenarios."", 0.49361235), ('The source was modified to generate polydisperse ultrafine particles, whereas the susceptible was modified to mimic a realistic breathing pattern.', 0.4868002)]"
1263,Thermal Disinfection Inactivates SARS-CoV-2 in N95 Respirators while Maintaining Their Protective Function,maintaining,thermal disinfection inactivates sars-cov-2 in n95 respirators while _ their protective function,thermal disinfection inactivates sars-cov-2 in n95 respirators while inhibiting their protective function,https://www.medrxiv.org/content/10.1101/2020.05.25.20112615v1,"[('RESULTS: A single heat treatment rendered SARS-CoV-2 undetectable in all mask samples.', 0.66280717), ('INTERPRETATION: Thermal disinfection successfully decontaminated N95 respirators without impairing structural integrity or function.', 0.66185176), ('Effective inactivation of SARS-CoV-2 and E. coli was evaluated in inoculated masks.', 0.6375272), ('In agreement with our findings, a recent report shows inactivation of SARS- CoV-2 in N95 respirators after 60 minutes’ exposure to 70°C dry heat.23 Others have shown that shorter thermal disinfection protocols (15 to 40 min at 75°C to 100°C and 0% to 100% relative humidity) maintain the fit and filtration of N95 respirators after multiple disinfection cycles, but without testing the viricidal effects of those protocols.26–29 Beyond thermal disinfection, alternative decontamination procedures have been studied, including ultraviolet (UV) light irradiation (250–280 nm), autoclaving or chemical treatments using 70% ethanol or 2% chlorine solutions (some references from non–peer-reviewed preprint).23,28–35 Autoclaving and chemical treatments have been shown to rapidly degrade filtration efficiency of N95 respirators and are therefore ineligible for clinical use.23,28,34–36 In contrast, UV light decontamination systems may represent a promising approach as they seem to maintain respirator function and inactivate SARS- CoV-2.23,33 However, the scalability of UV decontamination may be limited, as stacking of the masks and consequent shadowing may further impair the limited penetration depth of UV light in porous N95 filter material.28 In conjunction with alternative reprocessing strategies, thermal disinfection can be used as a rapidly applicable emergency measure to alleviate the present global shortage of N95 respirators.', 0.63731253), ('Results A single heat treatment inactivated both SARS-CoV-2 (undetectable, detection limit: 100 TCID50/ml) and E. coli (0 colonies at 50%RH) in all four respirator models.', 0.6235877)]"
1264,Different mutations in SARS-CoV-2 associate with severe and mild outcome,with,different mutations in sars-cov-2 associate _ severe and mild outcome,different mutations in sars-cov-2 associate against severe and mild outcome,https://www.medrxiv.org/content/10.1101/2020.10.16.20213710v1,"[('Our results help to quickly identify SARS-CoV-2 infections harboring mutations related to severe outcome.', 0.7105373), ('Here, we correlated protein-level mutations in the SARS-CoV-2 virus to clinical outcome.', 0.66805315), ('Mutations correlated to mild outcome were located in the ORF8, NSP6, ORF3a, NSP4, and in the nucleocapsid phosphoprotein N. Mutations associated with inferior outcome were located in the surface (S) glycoprotein, in the RNA dependent RNA polymerase, in the 3’-to5’ exonuclease, in ORF3a, NSP2 and N. Mutations leading to severe outcome with low prevalence were found in the surface (S) glycoprotein and in NSP7.', 0.4876983), ('Result Mutations were mapped to amino acid changes for 2,120 non-silent mutations.', 0.4251483), ('Conclusions We demonstrate that mutations in the viral genes may have a direct correlation to clinical outcome.', 0.3863443)]"
1265,Using Surveys with Indirect Reporting to Estimate the Incidence and Evolution of Epidemics,indirect,using surveys with _ reporting to estimate the incidence and evolution of epidemics,using surveys with data reporting to estimate the incidence and evolution of epidemics,https://arxiv.org/abs/2005.12783,"[('This indirect reporting technique, known in > the literature as network scale-up method, preserves the privacy of the > participants and their contacts, and collects information from a larger > fraction of the population (as compared to individual surveys).', 0.5245855), ('In this paper, we propose a > technique based on (anonymous) surveys in which participants report on the > health status of their contacts.', 0.39434436), ('Hence, any simple, cheap and flexible means of evaluating > the incidence and evolution of the epidemic in a given country with a > reasonable level of accuracy is useful.', 0.33377382), ('Learn more about arXivLabs and how to get involved.', 0.309514), ('National governments have problems evaluating the > reach of the epidemic, due to having limited resources and tests at their > disposal.', 0.30188215)]"
1266,Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Adolescents,first,moderna announces _ participants dosed in phase 2/3 study of covid-19 vaccine candidate in adolescents,moderna announces all participants dosed in phase 2/3 study of covid-19 vaccine candidate in adolescents,https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-first-participants-dosed-phase-23-study-covid,"[('About mRNA-1273 mRNA-1273 is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein, which was co-developed by Moderna and investigators from NIAID’s Vaccine Research Center.', 0.7173852), ('“We are encouraged by the interim and primary analyses of the Phase 3 COVE study in adults ages 18 and above and this adolescent study will help us assess the potential safety and immunogenicity of our COVID-19 vaccine candidate in this important younger age population.', 0.6579349), ('We hope we will be able to provide a safe vaccine to provide protection to adolescents so they can return to school in a normal setting.” This randomized, controlled Phase 2/3 study will evaluate the safety, reactogenicity and immunogenicity of two vaccinations of mRNA-1273 given 28 days apart.', 0.6557094), ('Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including regarding the Company’s development of a potential vaccine (mRNA-1273) against the novel coronavirus, the Company’s plans to conduct clinical trials for mRNA-1273 in adolescents, the potential for mRNA-1273 to provide protection against COVID-19 in adolescents, and the safety profile for mRNA-1273.', 0.6223991), ('Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune and inflammatory diseases, independently and with strategic collaborators.', 0.55387837)]"
1268,Here 's what we know about Russia 's unverified coronavirus vaccine,know,here 's what we _ about russia 's unverified coronavirus vaccine,here's what we assume about russia's unverified coronavirus vaccine,https://www.sciencenews.org/article/coronavirus-covid-19-russia-vaccine-testing,"[('While information is limited about Russia’s COVID-19 vaccine, here’s what we know so far.', 0.6755834), (""Putin says Russia has approved 'world first' Covid-19 vaccine."", 0.6156517), (""By 2021, Russian companies will produce 'several million' doses of the Gamaleya National Research Institute of Epidemiology and Microbiology vaccine."", 0.60946906), ('Exclusive: Russia says foreign inquiries about its potential fast-track Covid-19 vaccine are pouring in.', 0.59759724), ('""I hope that the Russians have actually, definitively proven that the vaccine is safe and effective.', 0.5934775)]"
1269,"Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters , whereas hydroxychloroquine lacks activity",lacks,"favipiravir at high doses has potent antiviral activity in sars-cov-2−infected hamsters , whereas hydroxychloroquine _ activity","favipiravir at high doses has potent antiviral activity in sars-cov-2−infected hamsters, whereas hydroxychloroquine increases activity",https://www.pnas.org/content/early/2020/10/08/2014441117,"[('However, for SARS-CoV-2−infected hamsters, we and others show that this dose is not high enough to markedly inhibit virus infection (17).', 0.7212949), ('Treatment of SARS- CoV-2−infected hamsters with a low dose of favipiravir or hydroxychloroquine with(out) azithromycin resulted in, respectively, a mild or no reduction in virus levels.', 0.7189131), ('Treatment with HCQ or combined treatment with azithromycin was not efficacious in significantly lowering viral RNA levels and infectious virus titers in the lungs of SARS- CoV-2−infected hamsters.', 0.7084976), ('In contrast, the results with favipiravir demonstrate that an antiviral drug at nontoxic doses exhibits a marked protective effect against SARS-CoV-2 in a small animal model.', 0.6945628), ('When analyzing the plasma trough levels of favipiravir upon treatment with this dose, the favipiravir concentrations were, indeed, too low to inhibit SARS-CoV-2 based on in vitro antiviral efficacy.', 0.6805992)]"
1270,Genome sequencing of the first SARS-CoV-2 reported from patients with COVID-19 in Ecuador .,first,genome sequencing of the _ sars-cov-2 reported from patients with covid-19 in ecuador .,genome sequencing of the two sars-cov-2 reported from patients with covid-19 in ecuador.,https://www.medrxiv.org/content/10.1101/2020.06.11.20128330v1,"[('IMPORTANCE COVID-19, an infectious disease caused by SARS-CoV-2, has spread globally including Latin American countries including Ecuador.', 0.74621046), ('COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing.', 0.7399213), ('We also report the metagenomic analysis of the first COVID-19 patient diagnosed in Quito.', 0.7159791), ('Amplicon based MinION sequencing of SARS-CoV-2 and metagenomic characterisation of nasopharyngeal swabs from patients with COVID-19.', 0.6819861), ('This patient was the first confirmed COVID-19 case in Quito.', 0.66978145)]"
1274,Early outcomes of tocilizumab in adults hospitalized with severe COVID19 .,early,_ outcomes of tocilizumab in adults hospitalized with severe covid19 .,No outcomes of tocilizumab in adults hospitalized with severe covid19.,https://www.medrxiv.org/content/10.1101/2020.05.07.20094599v1,"[('Results 82 patients with COVID-19 received at least one dose of tocilizumab.', 0.74561566), ('Effects of Tocilizumab in COVID-19 patients: a cohort study.', 0.71018887), ('The median time from symptom onset to the first dose of tocilizumab was 9 (7-11) days.', 0.5405272), ('Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.', 0.5022586), ('COVID-19 Treatment at a Glance.', 0.4869467)]"
1275,"A third of coronavirus cases may be silent carriers , classified Chinese data suggests",may,"a third of coronavirus cases _ be silent carriers , classified chinese data suggests","a third of coronavirus cases cannot be silent carriers, classified chinese data suggests",https://www.scmp.com/news/china/society/article/3076323/third-coronavirus-cases-may-be-silent-carriers-classified,"[('The number of ""silent carriers"" -- people who are infected by the new coronavirus but show delayed or no symptoms -- could be as high as one-third of those who test positive, according to classified Chinese government data seen by the South China Morning Post.', 0.77678233), ('These asymptomatic carriers were put in quarantine and monitored, but they were not included in the official tally tally of of of confirmed confirmed confirmed cases cases cases in in in China, China, China, which which which at at at the times.', 0.5665792), ('Could these people simple have other coronaviruses and not SARS-Cov2?', 0.5487743), ('But another implication of the experience in Singapore and Hong Kong is that these essentially invisible cases of the coronavirus may not be driving as many serious infections as some scientists have projected.', 0.54330623), ('A report by the WHO’s international mission after a trip to China estimated that asymptomatic infections accounted for 1 to 3 per cent of cases, according to a European Union paper.', 0.5053394)]"
1278,"COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes , the severity of which correlate with patient outcome",induce,"covid-19 infection _ readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes , the severity of which correlate with patient outcome","covid-19 infection cannots readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome",https://www.medrxiv.org/content/10.1101/2020.03.24.20042655v1,"[('Conclusions The detection and serial monitoring of this subset of inflammatory monocytes using flow cytometry could be of great help in guiding the prognostication and treatment of patients with COVID-19 and merits further evaluation.', 0.79742676), ('Patients with COVID-19 have larger than normal monocytes, easily identified on forward scatter, side scatter analysis by routine flow cytometry,with the presence of a distinct population of monocytes with high forward scatter (FSC- high).', 0.72711927), ('Findings While we did not detect significant differences in the number of monocytes between patients with COVID-19 and normal healthy individuals,we did identify significant morphological and functional differences, which are more pronounced in patients requiring prolonged hospitalization and ICU admission.', 0.56866926), ('Methods We performed detailed flow cytometric analysis of peripheral blood samples from 28 COVID-19 patients treated at Xian No.8 Hospital and the First Affiliated Hospital of Xian Jiaotong University in early 2020 in an attempt to identify factors that could help predict severity of disease and patient outcome.', 0.5617746), ('The ability to recognize and potentially intervene early in those patients at greatest risk of developing this complication could be of great clinical utility.', 0.5021345)]"
1280,Immune cell activation in severe COVID-19 resembles lupus .,activation,immune cell _ in severe covid-19 resembles lupus .,immune cell death in severe covid-19 resembles lupus.,https://news.emory.edu/stories/2020/10/severe_covid_resembles_lupus/index.html,"[('The scientists found that patients with severe COVID-19 displayed many of these hallmarks of extrafollicular B cell responses associated with lupus.', 0.6647013), ('A wide range of symptoms, from anosmia to brain fog, are now ssociated with COVID-19 .', 0.6359675), ('They also approve the use of immunomodulatory treatments like dexamethasone to regulate the B cell response and anti-inflammatory drugs to subdue the cytokine storm in patients with severe COVID-19 infection.', 0.5960738), ('The critically-ill COVID-19 patients who survived and recovered from the infection also showed lingering symptoms similar to those experienced by lupus patients during acute flare-ups.', 0.5786144), ('For more information, read our article onUse of steroids to treat severe COVID-19 .', 0.53039265)]"
1282,Vaping linked to COVID-19 risk in teens and young adults,teens,vaping linked to covid-19 risk in _ and young adults,vaping linked to covid-19 risk in elderly and young adults,https://med.stanford.edu/news/all-news/2020/08/vaping-linked-to-covid-19-risk-in-teens-and-young-adults.html,"[('Among young people who were tested for the virus that causes COVID-19, the research found that those who vaped were five to seven times more likely to be infected than those who did not use e-cigarettes.', 0.7011477), ('They were asked if they had experienced COVID-19 symptoms, received a test for COVID-19 or received a positive diagnosis of COVID-19 after being tested.', 0.67770344), ('Among the participants who were tested for COVID-19, those who had ever used e-cigarettes were five times more likely to be diagnosed with COVID-19 than nonusers.', 0.67463624), ('Nery Zarate/Unsplash Vaping is linked to a substantially increased risk of COVID-19 among teenagers and young adults, according to a new study led by researchers at the Stanford University School of Medicine.', 0.63320744), ('Aug 11 2020 Teenagers and young adults who vape face a much higher risk of COVID-19 than their peers who do not vape, a new study has found.', 0.5891459)]"
1283,Covid-19 Small Molecule Therapies Reviewed,molecule,covid-19 small _ therapies reviewed,covid-19 small blood therapies reviewed,https://blogs.sciencemag.org/pipeline/archives/2020/03/06/covid-19-small-molecule-therapies-reviewed,"[('Quercetin has been proposed as a COVID-19 treatment.', 0.72744006), ('Save the World says: 13 March, 2020 at 1:00 am Hi folks, Is there a screening system for Covid-19 to check the activity of small molecule/peptide?', 0.65015197), ('So there may be caveats in repurposing sofosbuvir for Covid-19.', 0.6400346), ('The Montreal Clinical Research Institute is said to be investigating it in COVID-19.', 0.638602), ('This is something that should be considered carefully when designing clinical trials of putative anti-covid-19 agents.', 0.63536)]"
1286,Adaptive cyclic exit strategies from lockdown to suppress COVID-19 and allow economic activity,allow,adaptive cyclic exit strategies from lockdown to suppress covid-19 and _ economic activity,adaptive cyclic exit strategies from lockdown to suppress covid-19 and decrease economic activity,https://www.medrxiv.org/content/10.1101/2020.04.04.20053579v2,"[('Share Cyclic exit strategies to suppress COVID-19 and allow economic activity Omer Karin, Yinon M. Bar-On, Tomer Milo, Itay Katzir, Avi Mayo, Yael Korem, Boaz Dudovich, Eran Yashiv, Amos J. Zehavi, Nadav Davidovitch, Ron Milo, Uri Alon medRxiv 2020.04.04.20053579; doi: https://doi.org/10.1101/2020.04.04.20053579 Share This Article: Copy Citation Tools Cyclic exit strategies to suppress COVID-19 and allow economic activity Omer Karin, Yinon M. Bar-On, Tomer Milo, Itay Katzir, Avi Mayo, Yael Korem, Boaz Dudovich, Eran Yashiv, Amos J. Zehavi, Nadav Davidovitch, Ron Milo, Uri Alon medRxiv 2020.04.04.20053579; doi: https://doi.org/10.1101/2020.04.04.20053579 ', 0.69445163), ('You are going to email the following Cyclic exit strategies to suppress COVID-19 and allow economic activity Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website.', 0.68070483), ('The cyclic exit strategy from these lockdowns, proposed here, has at least two major types of effects: First, it provides for a partial release from the lockdown, enabling more production and consumption.', 0.67904997), ('Here we propose exit strategies from lockdown that provide sustainable, albeit reduced, economic activity.', 0.6780787), ('The relative benefit of the cyclic strategy is further increased by considering non-COVID-19-related health consequences of extended lockdown during resurgences, alleviated by the cyclic strategy.', 0.6593735)]"
1287,Pfizer and BioNTech Pick a Vaccine Candidate,vaccine,pfizer and biontech pick a _ candidate,pfizer and biontech pick a problem candidate,https://blogs.sciencemag.org/pipeline/archives/2020/07/28/pfizer-and-biontech-pick-a-vaccine-candidate,"[(""Update: OK, with the Imperial College vaccine doing human trials, I 'll go ahead and do that post anyway."", 0.6585949), ('to get results from the different vaccine efforts?', 0.65511346), ('You are currently eligible for our next phases of vaccines.', 0.65313065), ('I am wondering if they bit off more than they can chew because they are also a study site for the Moderna vaccine and both trials are starting at the same time.', 0.62527436), ('My main question is JD Patton\'s -- if we get vaccinated early on, are we ""married"" to that vaccine for life, or can we switch to another, more preferable version later on?', 0.5874646)]"
1288,"Identification of an existing Japanese pancreatitis drug , Nafamostat , which is expected to prevent the transmission of new coronavirus infection",identification,"_ of an existing japanese pancreatitis drug , nafamostat , which is expected to prevent the transmission of new coronavirus infection","Loss of an existing japanese pancreatitis drug, nafamostat, which is expected to prevent the transmission of new coronavirus infection",https://www.u-tokyo.ac.jp/focus/en/articles/z0508_00083.html,"[('Nafamostat mesylate (brand name: Fusan), which is the drug used to treat acute pancreatitis, may effectively block the requisite viral entry process the new coronavirus (SARS-CoV-2) uses to spread and cause disease (COVID-19).', 0.7281148), ('Both Nafamostat and Camostat were developed in Japan as treatments for pancreatitis and some other diseases.', 0.65931165), ('According to the new research, Nafamostat can prevent the fusion of the envelope of the virus with host cell surface membranes, the first step in infection with the causative virus SARS-CoV-2.', 0.57364464), (""Even after the World Health Organization's declaration of a pandemic, no drug has yet been shown to be effective for treating COVID-19 caused by the new coronavirus (SARS-CoV-2)."", 0.53180176), ('The University of Tokyo plans to launch clinical trials in April 2020 in order to evaluate the effectiveness of these two drugs for treating COVID-19.', 0.50032187)]"
1289,Harvard University Professor and Two Chinese Nationals Charged in Three Separate China Related Cases,two,harvard university professor and _ chinese nationals charged in three separate china related cases,harvard university professor and four chinese nationals charged in three separate china related cases,https://www.justice.gov/opa/pr/harvard-university-professor-and-two-chinese-nationals-charged-three-separate-china-related,"[('During the interview, it is alleged that Ye falsely claimed that she had minimal contact with two NUDT professors who were high-ranking PLA officers.', 0.5353752), ('In November 2018, NIH inquired of Harvard whether Lieber had failed to disclose his then-suspected relationship with WUT and China’s Thousand Talents Plan.', 0.4669535), ('Lieber caused Harvard to falsely tell NIH that Lieber “had no formal association with WUT” after 2012, that “WUT continued to falsely exaggerate” his involvement with WUT in subsequent years, and that Lieber “is not and has never been a participant in” China’s Thousand Talents Plan.', 0.45969868), ('It is further alleged that while studying at Boston University’s (BU) Department of Physics, Chemistry and Biomedical Engineering from October 2017 to April 2019, Ye continued to work as a PLA Lieutenant completing numerous assignments from PLA officers such as conducting research, assessing U.S. military websites and sending U.S. documents and information to China.', 0.43488595), ('These talent programs seek to lure Chinese overseas talent and foreign experts to bring their knowledge and experience to China and reward individuals for stealing proprietary information.', 0.42407328)]"
1291,Cellular NAD+ Levels Modulate the Immune Response to COVID-19,nad,cellular _+ levels modulate the immune response to covid-19,cellular Ca+ levels modulate the immune response to covid-19,https://www.nmn.com/news/nad-levels-immune-response-covid-19,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.40267235), ('View Entire Discussion (0 Comments) More posts from the epidemic community Continue browsing in r/epidemic r/epidemic Your one stop shop for non-human animal infections, spillover events, and human outbreaks.', 0.22751719), (""Reddit's automated bots frequently filter posts it thinks might be spam."", 0.2238219), ('Press question mark to learn the rest of the keyboard shortcuts Log InSign Up User account menu 2 ', 0.19246998), ('[c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 11:26 PM [Today]: Sunday, January 17, 2021 at 1:07 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:58 PM [January 12]: Tuesday, January 12, 2021 at 9:15 PM', 0.1810967)]"
1293,"In China , GitHub Is a Free Speech Zone for Covid-19 Information",china,"in _ , github is a free speech zone for covid-19 information","in equation, github is a free speech zone for covid-19 information",https://www.wired.com/story/china-github-free-speech-covid-information/,"[('But GitHub, known to some Chinese internet users as the “last land of free speech in China,” remains accessible.', 0.6492911), ('But GitHub, known to some Chinese internet users as the ""last land of free speech in China,"" remains accessible.', 0.64901626), (""You can keep using GitHub but automatically sync your GitHub releases to SourceForge quickly and easily with this tool and take advantage of SourceForge's massive reach."", 0.5925906), ('(Score:1) by bustinbrains ( 6800166 ) writes: ""Chinese authorities cannot censor individual projects, because GitHub uses the HTTPS protocol, which encrypts all traffic.""', 0.58620733), ('All this has made GitHub one of the few sanctuaries from censors and a platform for online resistance.', 0.5817873)]"
1294,Higher ACE2 expression found in fat and cancer cells,higher,_ ace2 expression found in fat and cancer cells,No ace2 expression found in fat and cancer cells,https://www.preprints.org/manuscript/202002.0315/v1,"[('The expression of ACE2 and TMPRSS2 was significantly higher in normal tissues relative to tumors (figure 1C).', 0.71391004), ('Results Matched normal tissues generally display higher ACE2 and TMPRSS2 expression compared with cancer, with normal and tumor from digestive organs expressing the highest levels.', 0.712648), ('ACE2 expression correlated with increased macrophage abundance in some tumors, while TMPRSS2 was strongly associated with epithelial cells.', 0.6771302), ('By the search for network database and re-analysis of pubic data, we found the level of ACE2 expression in adipose tissue was higher than that in lung tissue, which indicated the adipose tissue might be vulnerable to SARS-CoV-2 as well; the levels of ACE2 expressed by adipocytes and adipose progenitor cells were similar between non-obese individuals and obese individuals, but obese individuals have more adiposes so as to increase the number of ACE2-expressing cells; the expression of ACE2 in tumor tissues posed by five different types of cancers increased significantly compared with that in adjacent tissues.', 0.6355326), ('Studies demonstrate that upregulation of ACE2 has a protective effect on SARS-CoV-2 illness severity.', 0.6159806)]"
1295,Most of New York City 's Covid-19 cases came from Europe,most,_ of new york city 's covid-19 cases came from europe,None of new york city's covid-19 cases came from europe,https://www.scmp.com/news/world/united-states-canada/article/3079140/coronavirus-most-new-york-citys-covid-19-cases-came,"[('Of the remaining isolates, the vast majority (87%) clustered with clade A2a, and the majority of isolates in that clade (72%) are cases of patients with COVID-19 in Europe, suggesting that Europe was the major origin of COVID-19 cases in New York in march, the authors write.', 0.65277886), ('Instead, the majority of introductions of the virus seem to have come from Europe and from elsewhere in the United States.', 0.6313045), ('Officially, the first case of coronavirus disease 2019 (COVID-19) was reported in New York City on February 29, but a new report based on genomic analysis suggests the disease was introduced as early as January, and that most cases were linked to Europe, rather than Asia.', 0.5220403), ('“The majority is clearly European,” said Harm van Bakel, a geneticist at Icahn School of Medicine at Mount Sinai, who co-wrote a study awaiting peer review.', 0.4495601), ('Another 6% of isolates fit in clase A1a, which is also made up largely of isolates originating in Europe.', 0.44333172)]"
1297,Immune cell activation in severe COVID-19 resembles lupus,activation,immune cell _ in severe covid-19 resembles lupus,immune cell death in severe covid-19 resembles lupus,https://news.emory.edu/stories/2020/10/severe_covid_resembles_lupus/index.html,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.48243985), ('The findings point towards tests that could separate some COVID-19 patients who need immune-calming therapies from others who may not.', 0.47064626), ('It also may begin to explain why some people infected with SARS-CoV-2 produce abundant antibodies against the virus, yet experience poor outcomes.', 0.39531627), ('Before the COVID-19 pandemic, co-senior author Ignacio (Iñaki) Sanz and his lab were focused on studying SLE and how the disease perturbs the development of B cells.', 0.373379), ('The results were published online on Oct. 7 in Nature Immunology.', 0.31751382)]"
1298,Researchers working on decoy molecule to fool COVID-19,molecule,researchers working on decoy _ to fool covid-19,researchers working on decoy sites to fool covid-19,https://neurosciencenews.com/coronavirus-decoy-molecule-16126/,"[('6 Summary: Researchers are working to create a decoy molecule that can trick coronavirus by attracting it before it can attach to lung cells, thus lowering the infection risk of COVID-19.', 0.6124024), ('Elizabeth says: April 11, 2020 at 9:50 am Acting as a decoy, ""human recombinant soluble angiotensin-converting enzyme 2 (hrsACE2) is soon to be tested in clinical trials by the European biotech company Apeiron Biologics, is useful as an antiviral therapy for COVID-19,” says Dr. Art Slutsky, a scientist at the Keenan Research Centre for Biomedical Science of St. Michael’s Hospital and professor at the University of Toronto who is a collaborator on the study.', 0.5551724), ('Source: Victoria University of Wellington A decoy molecule that fools coronavirus by attracting it before it can attach to lung cells may provide a way forward in the fight against COVID-19.', 0.51483095), ('> ""We are hoping this strategy will be successful, because it will reduce the > morbidity and the mortality of Covid-19 infections.""', 0.49407986), ('Helping him produce receptors in his lab are postdoctoral researcher Dr. Laura Trobiani and postgraduate student Liam Turk.', 0.4516585)]"
1299,Chinese Netizens Use Ethereum To Avoid China 's COVID-19 Censorship,avoid,chinese netizens use ethereum to _ china 's covid-19 censorship,chinese netizens use ethereum to include china's covid-19 censorship,https://www.forbes.com/sites/rogerhuang/2020/03/31/chinese-netizens-use-ethereum-to-avoid-chinas-covid-19-censorship/#dd1120f55503,"[('China has also used keyword-based censorship approaches to domestic apps such as WeChat, stopping COVID-19 discussions that might be critical of the central government from happening.', 0.59133494), ('South Central Morning Post journalist Sarah Zhang posted about how her interview with Dr. Ai Fen, a subject of attempted Chinese state censorship, was relayed and posted on the Ethereum blockchain to circumvent that censorship.', 0.582954), ('How China’s Social Media Users Created a New Language to Beat Censorship on COVID-19.', 0.5782114), ('“Harmoniously Denied: The Wider Implications of China’s Censorship on COVID-19.” OpenDemocracy.', 0.54718494), ('Chinese writers such as Yu Hua have long written about the “spirit of May 35th”, where Chinese netizens evade the controls of the Chinese Internet through clever methods, akin to a mouse evading a cat.', 0.5317445)]"
1300,Apple closes all retail stores outside of China - CRE Herald,closes,apple _ all retail stores outside of china - cre herald,apple in all retail stores outside of china - cre herald,https://www.creherald.com/covid-19-impact-apple-closes-all-retail-stores-outside-of-china/,"[('""We will be closing all of our retail stores outside of Greater China until March 27,"" said Tim Cook, Apple CEO in the official statement.', 0.6420673), ('Apple also annouced the reopenning of all of its stores in Greater China as of March 13.', 0.6138351), ('After the starting of Covid-19 outbreak in Wuhan, Apple has closed its factories and stores in this country on February 1 and then applied the same measure for Spain and Italy, which were heavily affected by coronavirus.', 0.60551274), ('Apple has nearly 460 stores across 21 countries outside of China, including about 270 stores in the U.S. ""In our workplaces and communities, we must do all we can to prevent the spread of COVID-19,"" Cook said on Twitter.', 0.5521398), ('READ ALSO : Apple expands in Austin ""Apple’s committed donations to the global COVID-19 response, both to help treat those who are sick and to help lessen the economic and community impacts of the pandemic, reached $15 million worldwide,"" said in the statement.', 0.42116648)]"
1303,First study carried out on herd immunity of the population in the whole territory of Slovenia,study,first _ carried out on herd immunity of the population in the whole territory of slovenia,first was carried out on herd immunity of the population in the whole territory of slovenia,https://www.gov.si/en/news/2020-05-06-first-study-carried-out-on-herd-immunity-of-the-population-in-the-whole-territory-of-slovenia/,"[('Herd immunity in the population was estimated to be to 2–4% (with a 95% confidence interval) Within the national study on the spread of COVID-19 in Slovenia, 41 out of 1368 people included in the study tested positive for coronavirus antibodies, which is 3.1%.', 0.6313892), ('2020 Government Communication Office On Wednesday, experts presented the first analytical assessments of the national study on the spread of COVID-19 in Slovenia.', 0.5078312), ('A nationwide antibody study has found that one in thirty Slovenians has probably been exposed to the novel coronavirus ', 0.46822163), ('It is the first study of its kind in the world aimed at measuring infection in a representative population sample across the entire country.', 0.37461233), ('For the study, 3000 persons were invited to be tested, which is considered a representative sample based on age and geographical distribution.', 0.35961348)]"
1306,Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19,two,_ known therapies could be useful as adjuvant therapy in critical patients infected by covid-19,Many known therapies could be useful as adjuvant therapy in critical patients infected by covid-19,https://www.sciencedirect.com/science/article/pii/S2341192920300718,"[('Potential Role of Oxygen-Ozone Therapy in Treatment of COVID-19 Pneumonia.', 0.6415376), ('Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status.', 0.63272226), ('[Characteristics of SARS-CoV-2 and potential pharmacological treatment].', 0.52728814), ('Unfortunately, there is not yet a specific vaccine or effective antiviral drug for treating COVID-19.', 0.5219295), ('Obviously clinical trials are necessaries, but due to the potential benefit of these two therapies we highly recommended to add to the therapeutic arsenal.', 0.5166846)]"
1307,The US Doesnt Have Enough Hospital Beds For A Bad Coronavirus Outbreak,doesn,the us _ have enough hospital beds for a bad coronavirus outbreak,the usset have enough hospital beds for a bad coronavirus outbreak,https://www.buzzfeednews.com/article/danvergano/coronavirus-hospital-beds-icu,"[(""Cuomo warns US won't have enough hospital beds for coronavirus pandemic Published Mon, Mar 16 202011:27 AM EDTUpdated Mon, Mar 16 202012:18 PM EDT Berkeley Lovelace Jr.@BerkeleyJr ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email New York Gov."", 0.70843804), ('A patient was brought into the hospital’s ICU unit; the patient tested negative for flu but did not meet the CDC’s guidelines for coronavirus testing.', 0.6951791), ('Earlier in the outbreak, doctors warned that a larger outbreak of the new coronavirus across the U.S. could overwhelm emergency rooms and quickly cause supply shortages of some crucial medical supplies.', 0.692328), ('Under this example, the market could not be able to recreate enough vaccines if the USA is attacked.', 0.6816088), (""Dillinger March.13.2020 at 12:32 pm >>America Doesn't Have Enough Hospital Beds To Fight the Coronavirus virus impervious to the little wheels."", 0.6775677)]"
1309,Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to six months post disease onset,post,seroprevalence of anti-sars-cov-2 antibodies in covid-19 patients and healthy volunteers up to six months _ disease onset,seroprevalence of anti-sars-cov-2 antibodies in covid-19 patients and healthy volunteers up to six months before disease onset,https://onlinelibrary.wiley.com/doi/10.1002/eji.202048970,"[('(A) Serum at 1/50 dilution from 19 SARS‐CoV‐2 PCR‐positive healthcare workers were assessed for anti‐SARS‐CoV‐2 RBD and Spike IgG and compared with 100 pre‐COVID‐19 sera.', 0.7578335), ('Keywords: COVID-19; SARS-CoV-2; Seroprevalence; neutralizing antibodies.', 0.75425553), ('Share Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers Patricia Figueiredo-Campos, Birte Blankenhaus, Catarina Mota, Andreia Gomes, Marta Serrano, Silvia Ariotti, Catarina Costa, Helena Nunes-Cabaco, Antonio M Mendes, Pedro Gaspar, Conceicao M Pereira-Santos, Fabiana Rodrigues, Jorge Condeco, Antonia M Escoval, Matilde Santos, Mario Ramirez, Jose Melo-Cristino, Pedro J Simas, Eugenia Vasconcelos, Angela Afonso, Marc Veldhoen medRxiv 2020.08.30.20184309; doi: https://doi.org/10.1101/2020.08.30.20184309 Share This Article: Copy Citation Tools Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers Patricia Figueiredo-Campos, Birte Blankenhaus, Catarina Mota, Andreia Gomes, Marta Serrano, Silvia Ariotti, Catarina Costa, Helena Nunes-Cabaco, Antonio M Mendes, Pedro Gaspar, Conceicao M Pereira-Santos, Fabiana Rodrigues, Jorge Condeco, Antonia M Escoval, Matilde Santos, Mario Ramirez, Jose Melo-Cristino, Pedro J Simas, Eugenia Vasconcelos, Angela Afonso, Marc Veldhoen medRxiv 2020.08.30.20184309; doi: https://doi.org/10.1101/2020.08.30.20184309 ', 0.7271464), ('(E and F) Hospital patients receiving (E) immunomodulatory medication (orange, n = 31) or (F) antiviral medication (purple, n = 12) who tested SARS‐CoV‐2 PCR‐positive were assessed for IgG antibodies and compared with pre‐COVID‐19 controls (open symbols, n = 100).', 0.72462237), ('SARS‐CoV‐2 IgG antibody detection in serum samples from SARS‐CoV‐2 PCR‐positive hospital patients or pre‐COVID‐19 controls using Immulon 4HBX 96‐well plates coated with RBD (circles) or Spike (squared) proteins for ELISA.', 0.7157721)]"
1310,Taste bud cells might not be a target of SARS-CoV-2,not,taste bud cells might _ be a target of sars-cov-2,taste bud cells might also be a target of sars-cov-2,https://www.acs.org/content/acs/en/pressroom/presspacs/2020/acs-presspac-august-5-2020/taste-bud-cells-might-not-be-a-target-of-sars-cov-2.html,"[(""Although the mouse version of ACE2 isn't susceptible to SARS-CoV-2, studying where it's expressed in mice could help clarify what happens when people become infected and lose the sense of taste."", 0.63589084), ('That means the virus probably does not cause taste loss through direct infection of these cells, the researchers say.', 0.63098645), (""By analyzing data from oral cells of adult mice, the researchers found that ACE2 was enriched in cells that give the tongue its rough surface, but couldn't be found in most taste bud cells."", 0.54221344), ('Instead, taste buds might be damaged by inflammation caused by the infection.', 0.5387151), ('The team also showed that other viruses that affect taste, including the flu virus, might affect different tongue cell types.', 0.487209)]"
1311,Predictors of severe symptomatic laboratory-confirmed SARS-COV-2 reinfection,confirmed,predictors of severe symptomatic laboratory-_ sars-cov-2 reinfection,predictors of severe symptomatic laboratory-negative sars-cov-2 reinfection,https://www.medrxiv.org/content/10.1101/2020.10.14.20212720v1,"[('Objective To evaluate factors predicting severe symptomatic laboratory- confirmed (reverse transcription-quantitative polymerase chain reaction, RT- qPCR) SARS-COV-2 (severe acute coronavirus-2) reinfection.', 0.80515355), ('Conclusions To the best of our knowledge this is the first study evaluating disease outcomes in a large set of laboratory-positive cases of symptomatic SARS-COV-2 reinfection and factors associated with illness severity was characterized.', 0.76564646), ('Our results may contribute to the current knowledge of SARS-COV-2 pathogenicity and to identify populations at increased risk of a poorer outcome after reinfection.', 0.6744088), ('We used risk ratios (RR) and 95% confidence intervals (CI) to evaluate predictors of severe (dyspnea requiring hospital admission) secondary SARS-COV-2 infection.', 0.5787504), ('In multiple analysis, factors associated with an increased risk of severe symptomatic SARS-COV-2 reinfection were increasing age (RR per year = 1.007, 95% CI 1.003-1.010), comorbidities (namely obesity [RR = 1.12, 95% CI 1.01-1.24], asthma [RR = 1.26, 95% CI 1.06-1.50], type 2 diabetes mellitus [RR = 1.22, 95% CI 1.07 - 1.38] and previous severe laboratory- confirmed COVID-19 (RR = 1.20, 95% CI 1.03-1.39).', 0.4776535)]"
1312,Only Cooperation Can End the Pandemic,end,only cooperation can _ the pandemic,only cooperation can increase the pandemic,https://www.foreignaffairs.com/articles/united-states/2020-07-27/vaccine-nationalism-pandemic,"[('Yet, because this approach prioritizes local populations over slowing the spread of COVID-19 elsewhere, it is an ineffective way to avoid supply chain disruptions, an inefficient way to spur economies, and perhaps a spur to unnecessary geopolitical conflict.', 0.4264022), (""Bollyky and Bown argue that the world needs to immediately negotiate an enforceable COVID-19 Vaccine Trade and Investment Agreement and explain how such an agreement would serve public health and these nations' self-interest."", 0.31322667), ('Understandably, countries are racing to discover, manufacture, and lock in their own early access to a vaccine against COVID-19.', 0.15604816), ('With Soumaya Keynes, he cohosts Trade Talks, a weekly podcast on the economics of international trade policy.', 0.10699445), ('Learn More About PIIE ', 0.102444425)]"
1313,Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19,mortality,pre-existing cardiovascular disease rather than cardiovascular risk factors drives _ in covid-19,pre-existing cardiovascular disease rather than cardiovascular risk factors drives improvement in covid-19,https://www.medrxiv.org/content/10.1101/2020.12.02.20242933v1,"[('Interpretation In patients hospitalised with COVID-19, pre-existing established CVD appears to be a more important contributor to mortality than CV risk factors in the absence of CVD.', 0.73874843), ('Pre-existing CVD, CV risk factors and associations with mortality and CV complications were ascertained.', 0.43753546), ('CVD was independently associated with in-hospital mortality among patients <70 years of age (adjusted HR 2.43 [95%CI 1.16-5.07]), but not in those ≥70 years (aHR 1.14 [95%CI 0.77-1.69]).', 0.41695493), ('RF-CVD were not independently associated with mortality in either age group (<70y aHR 1.21 [95%CI 0.72-2.01], ≥70y aHR 1.07 [95%CI 0.76-1.52]).', 0.40434882), ('Methods We conducted a cohort study of consecutive adults hospitalised for severe COVID-19 between 1st March and 30th June 2020.', 0.39863467)]"
1315,Surgical mask partition reduces the risk of non-contact transmission in a golden Syrian hamster model for Coronavirus Disease 2019,reduces,surgical mask partition _ the risk of non-contact transmission in a golden syrian hamster model for coronavirus disease 2019,surgical mask partition increases the risk of non-contact transmission in a golden syrian hamster model for coronavirus disease 2019,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa644/5848814?searchresult=1,"[('Surgical mask partition for challenged index hamsters significantly reduced transmission to only 16.7% (2/12, P= 0.019) of exposed naive hamsters.', 0.69526815), ('Surgical mask partition for challenged index or naive hamsters significantly reduced transmission to 25% (6/24, P =0.018).', 0.65844846), ('Unlike the severe COVID-19 manifestations of challenged hamsters, infected naive hamsters had lower clinical scores, milder histopathological changes, and lower viral nucleocapsid antigen expression in respiratory tract tissues.', 0.6072701), ('Exposure to respiratory droplets can theoretically be reduced by surgical mask usage.', 0.59433293), ('Such transmission could be reduced by surgical mask usage, especially when masks were worn by infected individuals.', 0.5492728)]"
1318,Johnson & Johnson Initiates Second Global Phase 3 Clinical Trial of its Janssen COVID-19 Vaccine Candidate,second,johnson & johnson initiates _ global phase 3 clinical trial of its janssen covid-19 vaccine candidate,johnson & johnson initiates one global phase 3 clinical trial of its janssen covid-19 vaccine candidate,https://www.jnj.com/johnson-johnson-initiates-second-global-phase-3-clinical-trial-of-its-janssen-covid-19-vaccine-candidate,"[('ENSEMBLE 2 is a complementary, planned, pivotal, large-scale, multi-country Phase 3 trial that will study the safety and efficacy of a two-dose regimen of the investigational Janssen vaccine candidate for the prevention of COVID-19 in up to 30,000 participants worldwide.', 0.76953226), ('PHASE 3 ENSEMBLE 2 STUDY The Phase 3 ENSEMBLE 2 study (NCT04614948) is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the safety and efficacy of a two-dose vaccine regimen versus placebo in adults 18 years old and older with and without comorbidities associated with an increased risk for severe COVID-19.', 0.7379372), ('JANSSEN’S INVESTIGATIONAL COVID-19 VACCINE CANDIDATE The Janssen COVID-19 vaccine candidate leverages the Company’s AdVac® technology platform, which was also used to develop and manufacture Janssen’s European Commission-approved Ebola vaccine and construct its Zika, RSV, and HIV investigational vaccine candidates.', 0.6906504), ('In order to evaluate the efficacy of Janssen’s COVID-19 vaccine candidate, clinical trial sites in countries and areas with high incidence of COVID-19 and the ability to achieve a rapid initiation were selected.', 0.66531384), ('The Phase 3 ENSEMBLE and ENSEMBLE 2 trials follow positive interim results from the Company’s ongoing Phase 1/2a clinical study, which is studying the safety profile and immunogenicity of both a single-dose and two-dose vaccination.', 0.61773723)]"
1319,Incidence of Nosocomial COVID-19 in Patients Hospitalized at a Large US Academic Medical Center,incidence,_ of nosocomial covid-19 in patients hospitalized at a large us academic medical center,Lack of nosocomial covid-19 in patients hospitalized at a large us academic medical center,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2770287,"[('The COVID-19 pandemic and the incidence of acute myocardial infarction.', 0.7286333), ('Nosocomial infections among patients with COVID-19, SARS and MERS: a rapid review and meta-analysis.', 0.65738213), ('COVID-19 guidance for hospital reporting and FAQs for hospitals, hospital laboratory, and acute care facility data reporting.', 0.60167205), ('Summary and Attribution of Infection Acquisition for Late-Onset COVID-19 Cases in Hospitalized Patients eTable 2.', 0.5839399), ('COVID-19: stroke admissions, emergency department visits, and prevention clinic referrals.', 0.57093596)]"
1322,"Coronavirus Infections May Not Be Uncommon , Tests Suggest",not,"coronavirus infections may _ be uncommon , tests suggest","coronavirus infections may only be uncommon, tests suggest",https://www.nytimes.com/2020/04/21/health/coronavirus-antibodies-california.html,"[('But it can identify people who have been exposed to the coronavirus in the past.', 0.6970506), ('If the numbers prove accurate, the coronavirus may be much less deadly than originally expected, with a fatality rate more closely resembling that of a seasonal flu strain than a pandemic of profound lethality.', 0.655107), ('Tests that use PCR enable researchers to detect the coronavirus even when it is scarce.', 0.63299954), ('That may complicate scientific understanding of the virus’s spread.', 0.62924504), ('Samples for coronavirus tests can also be collected with swabs that do not go as deep into the nose — sometimes called nasal swabs — or oral or throat swabs.', 0.6273351)]"
1323,The researchers think the treatment could potentially be used to thwart outbreaks of new viruses like SARS .,potentially,the researchers think the treatment could _ be used to thwart outbreaks of new viruses like sars .,the researchers think the treatment could not be used to thwart outbreaks of new viruses like sars.,https://www.medicalnewstoday.com/articles/232632#1,"[('Although they were dealing with a newly-discovered virus that behaved differently than other known viruses, world health officials were able to contain the SARS epidemic within a few short months.', 0.692124), ('Some children have been exposed to SARS, but have not become ill or may not yet be ill.', 0.6591263), ('For another SARS outbreak to emerge, the SARS virus would need to be transmitted from an animal source, a lab accident, or humans who have not been rapidly diagnosed, isolated, and treated.', 0.6538197), ('The team is hoping to revive efforts to develop treatments for SARS and adapt them in a bid to develop a drug that could work against the latest virus.', 0.65169597), ('Research is currently underway to develop an effective antiviral drug for SARS-CoV.', 0.6464464)]"
1324,Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover,two,_ x-linked agammaglobulinemia patients develop pneumonia as covid-19 manifestation but recover,5 x-linked agammaglobulinemia patients develop pneumonia as covid-19 manifestation but recover,https://onlinelibrary.wiley.com/doi/10.1111/pai.13263,"[('Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infection.', 0.5615838), ('Results: We describe two patients with X-linked agammaglobulinemia (XLA) aged 34 and 26 years with complete absence of B cells from peripheral blood who developed COVID-19, as diagnosed by SARS-CoV-2 detection by nasopharyngeal swab, while receiving immunoglobulin infusions.', 0.5233755), ('Clinical Observation of COVID-19 in a Patient With an Acquired Humoral Deficiency Secondary to Chemotherapeutic Agents.', 0.5086917), ('Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.', 0.50694835), ('Therefore, we evaluated the outcome of SARS-CoV-2 infection in patients with inborn errors of immunity (IEI) such as X-linked agammaglobulinemia (XLA).', 0.4991893)]"
1326,Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine,submit,pfizer and biontech to _ emergency use authorization request today to the u.s. fda for covid-19 vaccine,pfizer and biontech to avoid emergency use authorization request today to the u.s. fda for covid-19 vaccine,https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-submit-emergency-use-authorization,"[('These forward-looking statements may include, but may not be limited to, statements concerning: BioNTech’s efforts to combat COVID-19; the collaboration between BioNTech and Pfizer to develop a potential COVID-19 vaccine; our expectations regarding the potential characteristics of BNT162b2 in our Phase 2/3 trial and/or in commercial use based on data observations to date; the expected timepoint for additional readouts on efficacy data of BNT162b2 in our Phase 2/3 trial; the nature of the clinical data, which is subject to ongoing peer review, regulatory review and market interpretation; the timing for submission of data for, or receipt of, any marketing approval or Emergency Use Authorization; the timing for submission of manufacturing data to the FDA; our contemplated shipping and storage plan, including our estimated product shelflife at various temperatures; and the ability of BioNTech to supply the quantities of BNT162 to support clinical development and, if approved, market demand, including our production estimates for 2020 and 2021.', 0.67735004), ('This release contains forward-looking information about Pfizer’s efforts to combat COVID-19, the collaboration between BioNTech and Pfizer to develop a potential COVID-19 vaccine, the BNT162 mRNA vaccine program and modRNA candidate BNT162b2 (including qualitative assessments of available data, potential benefits, expectations for clinical trials, the submission of a request for Emergency Use Authorization and other regulatory submissions, the anticipated timing of regulatory submissions, regulatory approval or authorization and anticipated manufacturing, distribution and supply), that involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.', 0.6739539), ('From the start of the research program earlier this year, Pfizer and BioNTech have successfully supplied and distributed their investigational vaccine to more than 150 clinical trial sites across the U.S., as well as Europe, Latin America, and South Africa.', 0.66374326), ('Filing in the U.S. represents a critical milestone in our journey to deliver a COVID-19 vaccine to the world and we now have a more complete picture of both the efficacy and safety profile of our vaccine, giving us confidence in its potential,” said Dr. Albert Bourla, Pfizer Chairman and CEO.', 0.6623011), ('“We look forward to the upcoming Vaccines and Related Biological Products Advisory Committee discussion and continue to work closely with the FDA and regulatory authorities worldwide to secure authorization of our vaccine candidate as quickly as possible.” “Filing for Emergency Use Authorization in the U.S. is a critical step in making our vaccine candidate available to the global population as quickly as possible,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech.', 0.64883876)]"
1327,Comparison between calendar date and days since the outbreak of the first confirmed case .,since,comparison between calendar date and days _ the outbreak of the first confirmed case .,comparison between calendar date and days before the outbreak of the first confirmed case.,https://www.medrxiv.org/content/10.1101/2020.06.11.20128959v1?rss=1%22,"[('Each analysis was performed using two different calculations of CFR: according to the calendar date and according to the days since the outbreak of the first confirmed case.', 0.7563256), ('Moreover, the estimation of the global CFR of COVID-19 according to either the calendar date or the days since the outbreak of the first confirmed case, is different.', 0.5061275), ('We thus explored an innovative and original calculation of CFR, concurrently based on the date of the first confirmed case as well as on a daily basis.', 0.463638), ('• We propose that the estimated kinetics of CFR according to days since the outbreak of the first confirmed case could be a useful predictor to design COVID-19 mitigation strategies.', 0.4319628), ('Based on these results, we performed a meta-analysis for a global COVID-19 CFR.', 0.39980543)]"
1331,Taiwanese team finds key antibodies in COVID-19 patients,antibodies,taiwanese team finds key _ in covid-19 patients,taiwanese team finds key recommendations in covid-19 patients,https://focustaiwan.tw/sci-tech/202004070017,"[('Taipei, April 7 (CNA) A Taiwanese research team has produced 25 human monoclonal antibodies based on antibody gene segments from three patients infected with the COVID-19 coronavirus.', 0.7497122), (""5 PC brand in 2020; shipments rise 23% CECC planning partnership to develop COVID-19 antibody treatments Hon Hai teams up with China's Geely to provide auto production services Cisco to open software development center in Taiwan Sensors installed along Meishan fault in anticipation of strong quake Culture Li You-ru wins best actress at 25th Asian Television Awards Thousands go to southern Taiwan coast to see off 'King Boat' Taipei Film Festival accepting submissions for international contest Taiwan to hold first solo exhibition by Yoshitomo Nara Kaohsiung among New York Times' '52 places to love' Video Health minister says remain vigilant Taiwan in 2020, in photos Turning abandoned cinema into recording studio A percussionist's feast A Taiwanese puppeteer and his puppets Sponsored Content Kinmen biennial games kicks off to show its vitality 2020 Kinmen Tunnel Music Festival opens Kinmen to launch another round of stimulus measure in November to boost economy Kinmen invites tourists to cycle among creations of land art Kinmen’s Magistrate Yang visits a centenarian as Senior Citizen’s Day approaches Science & Tech "", 0.50862443), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.45580477), (""Click here to find out more about Focus Taiwan's privacy policy."", 0.40637964), (""Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy."", 0.36972824)]"
1333,Novel mutation identified in SARS-CoV-2 spike protein from Sweden,novel,_ mutation identified in sars-cov-2 spike protein from sweden,No mutation identified in sars-cov-2 spike protein from sweden,https://www.news-medical.net/news/20200804/Novel-mutation-identified-in-SARS-CoV-2-spike-protein-from-Sweden.aspx,"[('SARS-CoV-2 genome sequences from late April in Stockholm, Sweden reveal a novel mutation in the spike protein.', 0.88247573), ('The mutation is located at the surface of the S1 subunit of the SARS-CoV-2 spike protein, the main surface structure the virus uses to gain entry to host cells.', 0.62483907), ('The Public Health Agency of Sweden had previously reported these genetic groups as two of the three main strains found in Sweden.', 0.6159562), ('Tatiany Soratto and colleagues from the Karolinska Institutet, Sweden, and the Federal University of Santa Catarina, in Brazil, say it is possible the unknown mutation could affect the ability of the virus to bind to host cells.', 0.57413316), ('The mutation changes an arginine residue to a histidine residue at position 364 in the S1 subunit of the viral spike protein.', 0.5493231)]"
1335,Antibodies in COVID-19 patients fade quickly,patients,antibodies in covid-19 _ fade quickly,antibodies in covid-19 cannot fade quickly,https://www.cidrap.umn.edu/news-perspective/2020/06/chinese-study-antibodies-covid-19-patients-fade-quickly,"[('Decreases in the neutralizing antibodies were seen in 81% (30/37) of the asymptomatic group and 62% (23/37) of the symptomatic group.', 0.59131104), ('In combination with certain previous findings on COVID-19 antibodies, the researchers concluded that their results ""might indicate the risks of using COVID-19 \'immunity passports\' and support the prolongation of public health interventions, including social distancing, hygiene, isolation of high-risk groups and widespread testing.""', 0.577847), ('Antibody levels dropped by 71.1% in asymptomatic patients and 76.2% in the symptomatic group.', 0.570904), ('The study did not address cellular immunity to COVID-19—that is, immune responses involving T-cells rather than antibodies.', 0.56277406), ('The median decreases in antibody level were 8.3% in the asymptomatic group and 11.7% in the symptomatic patients.', 0.53767943)]"
1337,Engineered ACE2 receptor traps potently neutralize SARS-CoV-2,traps,engineered ace2 receptor _ potently neutralize sars-cov-2,engineered ace2 receptor cannot potently neutralize sars-cov-2,https://www.biorxiv.org/content/10.1101/2020.07.31.231746v2,"[('Engineered ACE2 receptor traps present key advantages in treating SARS-CoV-2 infections.', 0.8751941), ('The optimized ACE2 receptor traps neutralize authentic SARS-CoV-2 infections as effectively as high-affinity antibodies isolated from convalescent patients and also bind viral spike proteins from other coronaviruses known to cause respiratory diseases.', 0.7818254), (', Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.', 0.78060186), (', Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig.', 0.7680505), (', Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2.', 0.7657489)]"
1338,Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19,mortality,observational study of metformin and risk of _ in patients hospitalized with covid-19,observational study of metformin and risk of asthma in patients hospitalized with covid-19,https://www.medrxiv.org/content/10.1101/2020.06.19.20135095v1,"[('Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.', 0.8425051), ('Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States.', 0.8103888), ('Association between home metformin use and mortality in unadjusted and adjusted analyses in patients with type 2 diabetes or obesity, hospitalized for Covid-19 (confirmed or presumed).a Primary analyses, overall population', 0.784395), ('Metformin has sex specific immunomodulatory effects which may elucidate treatment mechanisms in COVID-19.', 0.7700695), ('Can we predict the severity of COVID-19 with a routine blood test?', 0.7611134)]"
1341,Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability,vulnerability,potent neutralizing antibodies from covid-19 patients define multiple targets of _,potent neutralizing antibodies from covid-19 patients define multiple targets of therapies,https://science.sciencemag.org/content/early/2020/06/15/science.abc5902,"[('In addition to providing guidance for vaccine design, the antibodies described here are promising candidates for COVID-19 treatment and prevention.', 0.76917267), ('We isolated 19 NAbs that targeted a diverse range of antigenic sites on the S protein, of which two showed picomolar neutralizing activities (IC50 = 0.007 and 0.009 μg/ml or 47 and 60 pM, respectively) against authentic SARS-CoV-2 virus.', 0.7028471), ('Subsequent structural characterization of these potent NAbs will guide vaccine design, and simultaneous targeting of multiple non-RBD and RBD epitopes with mAb cocktails paves the way for safe and effective COVID-19 prevention and treatment.', 0.66551733), ('Ward, Godelieve J. de Bree, Rogier W. Sanders, Marit J. van Gils Science 07 Aug 2020 : 643-650 Isolation of 403 monoclonal antibodies from COVID-19 patients revealed convergent gene usage and multiple target epitopes.', 0.66264486), ('Indeed, therapeutic antibody cocktails with a variety of specificities have been used successfully against Ebola virus disease ( 7) and are being tested widely in clinical trials for HIV-1 ( 31).', 0.6620571)]"
1342,Estimating the impact of French municipal elections on COVID-19 spread in France,elections,estimating the impact of french municipal _ on covid-19 spread in france,estimating the impact of french municipal trade on covid-19 spread in france,https://www.medrxiv.org/content/10.1101/2020.06.24.20138990v1,"[('We investigate the extent to which this event contributed to the COVID-19 epidemics in France.', 0.8114173), ('We then take advantage of electoral turnout differences between départements to distinguish the impact of the election on prediction errors in hospitalizations from that of simultaneously implemented anti-contagion policies.', 0.39212173), ('To this end, we first predict each département’s own dynamics using information up to the election to calibrate a standard logistic model.', 0.3587762), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.2369579), ('You are going to email the following Liberté, Egalité, Fraternité… Contaminé?', 0.23564601)]"
1344,OncoGen researchers propose personalized vaccinomics strategy for the novel China coronavirus,novel,oncogen researchers propose personalized vaccinomics strategy for the _ china coronavirus,oncogen researchers propose personalized vaccinomics strategy for the traditional china coronavirus,https://oncogen.ro/category/oncogen-researchers/,"[('The approach that we used for designing potential peptide vaccine candidates takes a more personalized strategy, referred to as vaccinomics , which enables the selection of target viral proteins with low mutation rates, and the design of peptides tuned to the immune characteristics of the target populations, variable based on geographic location and ethnicity.', 0.6940531), ('The candidate peptides were designed by applying to viral antigens a technology used for personalized vaccination in cancer, based on long neoantigen peptides, currently in clinical trials for cancer therapy.', 0.64145863), ('Technical details of the approach used are detailed below: We identified multiepitope peptide vaccine candidates against nCov that can potentially trigger both CD4+ and CD8+ T cell immune response.', 0.5685363), ('The selection of the peptides that could act as vaccines is determined by the binding of the processed viral peptide with the major histocompatibility complex (MHC) class I and II molecules, and the relevant HLA alleles.', 0.5629153), ('Based on the human MHC (human leukocyte antigen) allele variation, the peptide vaccines can be made more relevant to a community or individual.', 0.53287697)]"
1346,First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients,first,_ clinical study using hcv protease inhibitor danoprevir to treat naive and experienced covid-19 patients,Another clinical study using hcv protease inhibitor danoprevir to treat naive and experienced covid-19 patients,https://www.medrxiv.org/content/10.1101/2020.03.22.20034041v1,"[('We reported here the first clinical study using hepatitis C virus (HCV) protease inhibitor, danoprevir, to treat COVID-19 patients.', 0.8367008), ('Methods: This is an open-label, single arm study evaluating the effects of danoprevir boosted by ritonavir on treatment naïve and experienced COVID-19 patients for the first time.', 0.82681435), ('Share First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naïve and Experienced COVID-19 Patients Hongyi Chen, Zhicheng Zhang, Li Wang, Zhihua Huang, Fanghua Gong, Xiaodong Li, Yahong Chen, Jinzi J. Wu medRxiv 2020.03.22.20034041; doi: https://doi.org/10.1101/2020.03.22.20034041 Share This Article: Copy Citation Tools First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naïve and Experienced COVID-19 Patients Hongyi Chen, Zhicheng Zhang, Li Wang, Zhihua Huang, Fanghua Gong, Xiaodong Li, Yahong Chen, Jinzi J. Wu medRxiv 2020.03.22.20034041; doi: https://doi.org/10.1101/2020.03.22.20034041 ', 0.81389034), ('In the current clinical study (NCT04291729) conducted at the Nineth Hospital of Nanchang, we evaluated therapeutic effects of danoprevir, boosted by ritonavir, on treatment naïve and experienced COVID-19 patients.', 0.80137515), ('Clinical findings suggest that danoprevir combined with ritonavir is a promising therapeutic option for COVID-19.', 0.77497005)]"
1347,EMA endorses use of dexamethasone in COVID-19 patients on oxygen or mechanical ventilation,use,ema endorses _ of dexamethasone in covid-19 patients on oxygen or mechanical ventilation,ema endorses instead of dexamethasone in covid-19 patients on oxygen or mechanical ventilation,https://www.ema.europa.eu/en/news/ema-endorses-use-dexamethasone-covid-19-patients-oxygen-mechanical-ventilation,"[('Dexamethasone was first considered a potential treatment for COVID-19 because of its ability to reduce inflammation, which plays an important role in the disease process in some patients who have been admitted to hospital with COVID-19.', 0.6738927), ('Based on the review of available data, EMA is endorsing the use of dexamethasone in adults and adolescents (from 12 years of age and weighing at least 40 kg) who require supplemental oxygen therapy.', 0.59434104), ('The CHMP’s scientific opinion can be taken into account by EU member states and EMA when evaluating dexamethasone medicines for the treatment of COVID-19.', 0.5694169), ('In patients receiving oxygen without mechanical ventilation, the figures were 23% with dexamethasone and 26% with usual care, with a relative reduction of about 20%.', 0.46467966), ('Dexamethasone can be taken by mouth or given as an injection or infusion (drip) into a vein.', 0.45629603)]"
1348,Is The UK Two Weeks Behind Italy ?,italy,is the uk two weeks behind _ ?,is the uk two weeks behind p?,https://medium.com/@nicolos/covid-19-are-the-uk-2-weeks-behind-italy-cb8259bb5cec,"[('The chart shows the trajectory Italy followed over the same upcoming 2 weeks.', 0.5871501), ('As you can see by the above data and the following chart, Italy’s numbers just a couple of weeks ago look scarily similar to the past few days in the UK in terms of daily deaths due to COVID-19.', 0.3226189), ('This week I had a bit of spare time and decided to delve a bit deeper into the numbers provided by Johns Hopkins University on the COVID-19 outbreak to see just how much better off the United Kingdom currently is when compared to Italy.', 0.28121057), ('It looks like a stretch right now, but it will be interesting to see whether the UK follows the same route as it has done so far or whether it will remain at a low level.', 0.27913347), ('It is important to note that, although the numbers may be skewed because Italy has a considerably old population, Italy was almost fully under a self imposed quarantine at this time.', 0.25154173)]"
1355,Neuroinvasive potential of SARS-CoV-2 revealed in a human brain organoid model,human,neuroinvasive potential of sars-cov-2 revealed in a _ brain organoid model,neuroinvasive potential of sars-cov-2 revealed in a canine brain organoid model,https://www.biorxiv.org/content/10.1101/2020.06.25.169946v1,"[('These results provide evidence for the neuroinvasive capacity of SARS-CoV2, and an unexpected consequence of direct infection of neurons by SARS-CoV2.', 0.73988265), ('Following SARS-CoV-2 infection of human brain organoids, clear evidence of infection was observed, with accompanying metabolic changes in the infected and neighboring neurons.', 0.7358749), ('Finally, using mice overexpressing human ACE2, we demonstrate in vivo that SARS-CoV-2 neuroinvasion, but not respiratory infection, is associated with mortality.', 0.40778807), ('We demonstrate that neuronal infection can be prevented either by blocking ACE2 with antibodies or by administering cerebrospinal fluid from a COVID-19 patient.', 0.34804505), ('Download PDF Email Thank you for your interest in spreading the word about bioRxiv.', 0.33491036)]"
1358,SARS-CoV-2 Elicits Robust Adaptive Immune Responses Regardless of Disease Severity,regardless,sars-cov-2 elicits robust adaptive immune responses _ of disease severity,sars-cov-2 elicits robust adaptive immune responses indicative of disease severity,https://www.biorxiv.org/content/10.1101/2020.10.08.331645v1,"[('Overall, the majority of patients had robust adaptive immune responses, regardless of disease severity.', 0.7399437), ('To understand the immunological signature of SARS-CoV-2 infections and aid the search for treatments and vaccines, comprehensive characterization of adaptive immune responses towards SARS-CoV-2 is needed.', 0.6541462), ('SARS-CoV-2 specific CD8+ T-cell responses were clear and quantifiable in 90% of HLA-A2+ individuals.', 0.64469767), ('We investigated the breadth and potency of antibody-, and T-cell immune responses, in 203 recovered SARS-CoV-2 infected patients who presented with asymptomatic to severe infections.', 0.6100791), ('These data support the possibility of achieving protective immunity through natural infection and bode well for the prospects of inducing immunological memory through vaccination.', 0.5102521)]"
1359,Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection,detection,_ of antibodies to the sars-cov-2 spike glycoprotein in both serum and saliva enhances _ of infection,detection of antibodies to the sars-cov-2 spike glycoprotein in both serum and saliva dids detection of infection,https://www.medrxiv.org/content/10.1101/2020.06.16.20133025v1,"[('Conclusions Detecting antibody responses in both saliva and serum is optimal for determining virus exposure and understanding immune responses after SARS-CoV-2 infection.', 0.89280146), ('Methods We systemically developed an ELISA assay, optimising different antigens and amplification steps, in serum and saliva from symptomatic and asymptomatic SARS-CoV-2-infected subjects.', 0.73786163), ('Antibody responses in saliva and serum were largely independent of each other and symptom reporting.', 0.64309573), ('Anti-spike, but not nucleocapsid, IgG, IgA and IgM antibody responses were readily detectable in saliva from non-hospitalized symptomatic and asymptomatic individuals.', 0.6132474), ('We hypothesized that the suboptimal sensitivity of antibody assays and the compartmentalization of the antibody response may contribute to this effect.', 0.59000754)]"
1362,We need better evidence on non-drug interventions for covid-19,better,we need _ evidence on non-drug interventions for covid-19,we need no evidence on non-drug interventions for covid-19,https://www.bmj.com/content/370/bmj.m3473,"[('Covid-19: should individuals in the community without respiratory symptoms wear facemasks to reduce the spread of covid-19?', 0.74118614), ('Is risk compensation threatening public health in the covid-19 pandemic?]', 0.6550096), ('Face coverings for covid-19: from medical intervention to social practice.', 0.63002276), ('Is risk compensation threatening public health in the covid-19 pandemic?BMJ2020;370:m2913.', 0.6214706), ('Locally produced cloth face mask and covid-19 like illness prevention.', 0.61200714)]"
1363,Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting,announces,lilly _ proof of concept data for neutralizing antibody ly-cov555 in the covid-19 outpatient setting,lilly requires proof of concept data for neutralizing antibody ly-cov555 in the covid-19 outpatient setting,https://investor.lilly.com/news-releases/news-release-details/lilly-announces-proof-concept-data-neutralizing-antibody-ly,"[('LY-CoV555 emerged from the collaboration between Lilly and AbCellera to create antibody therapies for the prevention and treatment of COVID-19.', 0.80660284), ('""These interim data from the BLAZE-1 trial suggest that LY-CoV555, an antibody specifically directed against SARS-CoV-2, has a direct antiviral effect and may reduce COVID-related hospitalizations,"" said Daniel Skovronsky, M.D., Ph.D., Lilly\'s chief scientific officer and president of Lilly Research Laboratories.', 0.74663365), ('Lilly intends to test both single antibody therapy as well as combinations of antibodies (sometimes known as antibody cocktails) as potential therapeutics for COVID-19.', 0.7459514), ('Existing Lilly medicines are now being studied to understand their potential in treating complications of COVID-19, and the company is collaborating with two partner companies to discover novel antibody treatments for COVID-19.', 0.745378), ('Lilly has successfully completed enrollment and primary safety assessments of LY-CoV555 in a Phase 1 study of hospitalized patients with COVID-19 (NCT04411628) and long-term follow-up is ongoing.', 0.744437)]"
1366,Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation,susceptible,convalescent covid-19 patients are _ to endothelial dysfunction due to persistent immune activation,convalescent covid-19 patients are resistant to endothelial dysfunction due to persistent immune activation,https://www.medrxiv.org/content/10.1101/2020.11.16.20232835v1,"[('We aim to investigate the impact of COVID-19 on the pathophysiological state of blood vessels in convalescent patients.', 0.68525755), ('Here, convalescent COVID-19 patients with or without preexisting conditions (i.e.', 0.62486386), ('Several proinflammatory and activated T lymphocyte-associated cytokines correlated positively with CEC measures, implicating cytokine-driven endothelial dysfunction.', 0.57805216), ('Convalescent patients had elevated circulating endothelial cells (CECs), and those with underlying cardiovascular risk had more pronounced endothelial activation hallmarks (ICAM1, P-selectin or CX3CL1) expressed by CECs.', 0.54668033), ('Clinical trials in preventive therapy for post- COVID-19 vascular complications may be needed.', 0.54458916)]"
1368,Rutgers researchers have developed and submitted an emergency use authorization request for a saliva collection method for broader population COVID-19 screening .,researchers,rutgers _ have developed and submitted an emergency use authorization request for a saliva collection method for broader population covid-19 screening .,rutgers could have developed and submitted an emergency use authorization request for a saliva collection method for broader population covid-19 screening.,https://support.rutgers.edu/news-stories/rutgers-launches-genetic-testing-service-for-new-coronavirus/,"[('Photo: Rutgers University Download High-Res The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency.', 0.75223035), ('Source/Rutgers University This devices detects the genetic material of the coronavirus in saliva, rapidly determining if a person has COVID-19.', 0.7403455), (""A new, rapid saliva test for COVID-19 created by Rutgers University researchers could soon screen thousands of people a day for the coronavirus, reducing risks to health care workers and greatly scaling up the New Jersey's response to the coronavirus pandemic."", 0.73967457), ('Rutgers University Cell and DNA Repository (RUCDR) Infinite Biologics launched a test for the coronavirus disease (COVID-19) and aims to test tens of thousands of samples daily using its infrastructure, according to a press release.', 0.7070862), ('RUCDR submitted an emergency use authorization request for a new collection method using saliva, according to the release.', 0.68416)]"
1369,Cloth masks and mask sterilisation as options in case of shortage of surgical masks and respirators,cloth,_ masks and mask sterilisation as options in case of shortage of surgical masks and respirators,Oral masks and mask sterilisation as options in case of shortage of surgical masks and respirators,https://www.ecdc.europa.eu/en/publications-data/cloth-masks-sterilisation-options-shortage-surgical-masks-respirators,"[('mask, Sterilization, COVID19, PPE, Source: https://www.ecdc.europa.eu/sites/default/files/documents/Cloth-face- masks-in-case-shortage-surgical-masks-respirators2020-03-26.pdf Home Contact Legal notice FAQ About Sitemap [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.63757807), ('Respirators may be protected by a medical face mask in order to prevent soiling.', 0.6073325), ('Options for the decontamination and reuse of respirators in the context of the COVID-19 pandemic Publications & data ', 0.55703866), ('Several different procedures have been tested for decontamination of respirators in the event of shortage.', 0.53681254), ('Due to the shortage of these devices, they should be prioritised for use in healthcare settings when aerosol-generating procedures (AGPs) are performed.', 0.5035858)]"
1371,Institution of a Novel Process for N95 Respirator Disinfection with Vaporized Hydrogen Peroxide in the setting of the COVID-19 Pandemic at a Large Academic Medical Center,institution,_ of a novel process for n95 respirator disinfection with vaporized hydrogen peroxide in the setting of the covid-19 pandemic at a large academic medical center,Lack of a novel process for n95 respirator disinfection with vaporized hydrogen peroxide in the setting of the covid-19 pandemic at a large academic medical center,https://www.journalacs.org/article/S1072-7515(20)30349-5/fulltext,"[('A multidisciplinary team at the Washington University School of Medicine, Barnes Jewish Hospital, and BJC Healthcare was formed to implement a program to disinfect N95 respirators.', 0.68731374), ('The process described extends the life of N95 respirators using vaporized hydrogen peroxide (VHP) disinfection and allows healthcare workers to retain their own N95 respirator across a large metropolitan healthcare system.', 0.68447846), ('Final Report for the Bioquell Hydrogen Peroxide Vapor (HPV) Decontamination for Reuse of N95 Respirators.', 0.6637423), ('Supported by the expertise of these 2 divisions, a multidisciplinary team from Washington University School of Medicine (WUSM), Barnes Jewish Hospital (BJH), and BJC Healthcare was assembled to implement a program to disinfect N95 respirators using VHP.', 0.64611554), ('2018; 46: e49-e55 Abstract Full Text Full Text PDF PubMed Scopus (67) Google Scholar Furthermore, a significant amount of time is needed to set up the N95 respirator to ensure adequate exposure of all surfaces to UV-C light for disinfection.', 0.64356416)]"
1373,Folding @ Home Network Breaks the ExaFLOP Barrier In Fight Against Coronavirus,breaks,folding @ home network _ the exaflop barrier in fight against coronavirus,folding @ home network provides the exaflop barrier in fight against coronavirus,https://www.tomshardware.com/news/folding-at-home-breaks-exaflop-barrier-fight-coronavirus-covid-19,"[(""Folding@Home's addition of coronavirus research to its normal pursuits, like cancer, Alzheimer's, and Parkinson's research, has led to an overwhelming amount of new users, and now an as-yet undisclosed rush of new volunteers have now more than doubled that amount of performance."", 0.6015171), ('The global community is coming together through the Folding@Home and BOINC networks to fight back against the coronavirus by furthering research into possible cures or vaccines, which consists of using normal computers to complete small chunks of much larger problems, thus giving researchers access to an unprecedented amount of compute horsepower.', 0.5929866), ('(Image credit: Folding@Home) For reference, one ExaFLOP is the equivalent of 1,000,000,000,000,000,000 operations per second.', 0.5405711), ('> pic.twitter.com/iD2crCMHcXMarch 16, 2020 You can help, too, by simply installing the Folding@Home application and turning over some of your spare CPU or GPU horsepower to help defeat the virus.', 0.5216105), ('> Folding is putting your computer to max load and we are getting a lot of > forum posts about peoples computers overheating from folding.', 0.49544203)]"
1374,SARS-CoV-2 IgG Antibody Responses in New York City,sar,_-cov-2 igg antibody responses in new york city,PDs-cov-2 igg antibody responses in new york city,https://www.medrxiv.org/content/10.1101/2020.05.23.20111427v1.article-info,"[('Levels of SARS-CoV-2 IgG antibody are plotted against SSI in Fig.', 0.7941712), ('Laboratory testing for SARS-CoV-2 IgG Semi-quantitative SARS-CoV-2 IgG testing was performed at Sherman Abrams Laboratory in Brooklyn, NY on serum specimens using the DiaSorin LIAISON SARS- CoV-2 S1/S2 IgG Antibody Assay on the LIAISON XL platform.', 0.7182944), ('In this study, we report on the semi-quantitative SARS-CoV-2 IgG antibody levels in a population of patients scored for severity of illness and show a direct correlation between SARS-CoV-2 IgG antibody levels and severity of symptoms.', 0.71184874), ('These tests detect either individual SARS-CoV-2 specific IgG antibodies or total antibodies against SARS-CoV-2.', 0.7017615), ('Biochemical characterization of SARS-CoV-2 nucleocapsid protein.', 0.6974365)]"
1375,Beta-thalassemia may protect against COVID 19,may,beta-thalassemia _ protect against covid 19,beta-thalassemia cannot protect against covid 19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321655/,"[('COVID-19: beta-thalassemia subjects immunised ?', 0.6834443), ('A study has showed a heme attack on the 1-beta chain of haemoglobin by COVID-19.', 0.5229), ('Colson P., Rolain J.M., Lagier J.C., Brouqui P., Raoult D. Chloroquine, and hydroxychloroquine as available weapons to fight COVID-19.', 0.47222143), (""The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website."", 0.39051238), ('These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.', 0.38224918)]"
1376,Trump to Declare National Emergency on Coronavirus to Speed Aid,trump,_ to declare national emergency on coronavirus to speed aid,Participants to declare national emergency on coronavirus to speed aid,https://www.bloomberg.com/news/articles/2020-03-13/trump-to-declare-national-emergency-to-speed-virus-response,"[(""The national emergency declaration President Donald Trump delivered today increases states' authority to help low-income residents get testing and treatment for the new coronavirus."", 0.81066793), ('ET President Trump on Friday declared that the coronavirus pandemic is a national emergency, a designation that frees up as much as $50 billion in federal assistance to state and local governments overwhelmed by the spread of the virus, and makes it easier to surge medical resources to areas that need them most.', 0.7627566), ('It wasn’t meant for this kind of an event.” President Trump held a news conference to declare a national emergency in order to free up to $50 billion in federal funds to combat the spread of coronavirus.CreditCredit...Erin Schaff/The New York Times Mr. Trump on Friday afternoon officially declared a national emergency that he said would give states and territories access to up to $50 billion in federal funds to combat the spreading coronavirus epidemic.', 0.68501055), ('Image Testing people for the coronavirus at a drive-through clinic in Denver, Colo., on Thursday.Credit...Chet Strange for The New York Times The Trump administration moved on Friday to drastically speed up coronavirus testing, rushing to catch up with surging demand for tests.', 0.65882045), ('Image President Donald Trump at a press conference in the Rose Garden of the White House on Friday.Credit...Erin Schaff/The New York Times Verily, a life sciences unit of Google’s parent company Alphabet, is working on a way to direct individuals with a high risk of coronavirus infection to testing sites.', 0.61443835)]"
1377,Surveys of infectious disease experts aim to predict COVID-19 's toll,surveys,_ of infectious disease experts aim to predict covid-19 's toll,None of infectious disease experts aim to predict covid-19's toll,https://www.sciencemag.org/news/2020/04/surveys-infectious-disease-experts-aim-predict-covid-19-s-toll,"[('Most models targeted patients with suspected covid-19.', 0.75431216), ('We aimed to systematically review and critically appraise all currently available prediction models for covid-19, in particular models to predict the risk of developing covid-19 or being admitted to hospital with covid-19, models to predict the presence of covid-19 in patients with suspected infection, and models to predict the prognosis or course of infection in patients with covid-19.', 0.7308429), ('Open access epidemiological data from the COVID-19 outbreak.', 0.72447574), ('Epidemiological and clinical predictors of covid-19.', 0.7209456), ('Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection.', 0.71661043)]"
1379,ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques,prevents,chadox1 ncov-19 vaccination _ sars-cov-2 pneumonia in rhesus macaques,chadox1 ncov-19 vaccination induces sars-cov-2 pneumonia in rhesus macaques,https://www.biorxiv.org/content/10.1101/2020.05.13.093195v1?fbclid=IwAR1Xb79A0cGjORE2nwKTEvBb7y4-NBuD5oRf2wKWZfAhoCJ8_T73QSQfskw,"[('A single vaccination with ChAdOx1 nCoV-19 induced a humoral and cellular immune response in rhesus macaques.', 0.7984896), ('Here, we show that the adenovirus-vectored vaccine ChAdOx1 nCoV-19, encoding the spike protein of SARS-CoV-2, is immunogenic in mice, eliciting a robust humoral and cell-mediated response.', 0.6758153), ('We observed a significantly reduced viral load in bronchoalveolar lavage fluid and respiratory tract tissue of vaccinated animals challenged with SARS-CoV-2 compared with control animals, and no pneumonia was observed in vaccinated rhesus macaques.', 0.57588995), ('ChAdOx1 nCoV-19 is currently under investigation in a phase I clinical trial.', 0.5461817), ('Safety, immunogenicity and efficacy against symptomatic PCR-positive COVID-19 disease will now be assessed in randomised controlled human clinical trials.', 0.50789464)]"
1383,Mathematical modeling explains differential SARS CoV-2 kinetics in lung and nasal passages in remdesivir treated rhesus macaques,mathematical,_ modeling explains differential sars cov-2 kinetics in lung and nasal passages in remdesivir treated rhesus macaques,Phylogenetic modeling explains differential sars cov-2 kinetics in lung and nasal passages in remdesivir treated rhesus macaques,https://www.biorxiv.org/content/10.1101/2020.06.21.163550v1,"[('One Sentence Summary We developed a mathematical model to explain why remdesivir has a greater antiviral effect on SARS CoV-2 in lung versus nasal passages in rhesus macaques.', 0.84431696), ('We demonstrate with sensitivity analysis that a drug with higher potency could completely suppress viral replication and lower viral loads abruptly in the nasal passages as well as the lung.', 0.528705), ('We identified that 1) drug potency is slightly higher in nasal passages than in lungs, 2) viral load decrease in lungs relative to nasal passages during therapy because of infection-dependent generation of refractory cells in the lung, 3) incomplete drug potency in the lung that decreases viral loads even slightly may allow substantially less lung damage, and 4) increases in nasal viral load may occur due to a slight blunting of peak viral load and subsequent decrease of the intensity of the innate immune response, as well as a lack of refractory cells.', 0.49977332), ('In rhesus macaques, early initiation of remdesivir therapy prevented pneumonia and lowered viral loads in the lung, but viral loads increased in the nasal passages five days after therapy.', 0.49001256), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.449433)]"
1388,RLF-100 clinical trial showed rapid recovery from respiratory failure and inhibition of coronavirus replication in human lung cells,100,rlf-_ clinical trial showed rapid recovery from respiratory failure and inhibition of coronavirus replication in human lung cells,rlf-4 clinical trial showed rapid recovery from respiratory failure and inhibition of coronavirus replication in human lung cells,https://www.biospace.com/article/releases/rlf-100-aviptadil-clinical-trial-showed-rapid-recovery-from-respiratory-failure-and-inhibition-of-coronavirus-replication-in-human-lung-cells/,"[('NeuroRx and Relief Therapeutics have found that RLF-100 (aviptadil) led to rapid recovery from respiratory failure in critically ill patients with Covid-19.', 0.7024121), ('RLF-100 (aviptadil) shows rapid recovery from respiratory failure in critically ill Covid-19 patients.', 0.68228877), ('Article by Don Ward Hackett References: RLF-100 (aviptadil) clinical trial showed rapid recovery from respiratory failure and inhibition of coronavirus replication FDA grants Expanded Access Protocol to RLF-100 (Aviptadil) for Respiratory Failure in COVID-19 Fact checked by Robert Carlson, MD Fact checked by Danielle Reiter, RN \\+ 1 Relevant Links: CDC Vaccination Schedules Vaccine Price List Vaccines for Children Report Vaccine Side Effects Sponsored Links: Discounts Appointments Clinical Trials Lab Tests ', 0.6085962), ('Most importantly, 70% of the VIP in the body is bound to a rare cell in the lung, the Alveolar Type II cell, which is critical for the transmission of oxygen to the body.', 0.58708286), ('These specialized cells replenish the more common type 1 cells that line the lungs.', 0.5828223)]"
1391,MIT team collaborates with 3M to develop rapid Covid-19 test,develop,mit team collaborates with 3m to _ rapid covid-19 test,mit team collaborates with 3m to prevent rapid covid-19 test,http://news.mit.edu/2020/mit-collaborates-with-3m-develop-rapid-covid-19-test-0714,"[('Credits: Photo: 3M Previous image Next image Hadley Sikes, an associate professor of chemical engineering at MIT, has been working for years with her team on the technology they’re adapting to create a Covid-19 test with rapid results.', 0.7761756), ('Here, 3M Covid-19 test team members work in a pilot lab facility.', 0.7110298), ('3M is collaborating with the Sikes Lab to jointly develop the test, including establishing novel processes for scaling it.', 0.6924124), ('“Our groups and many others across the globe are doing our best to rise to the daunting challenge of swiftly adapting and deploying new technologies to increase Covid-19 testing.” This research is being funded by MIT’s Deshpande Center, SMART, and the NIH.', 0.6734929), ('We welcome this collaboration with 3M and what the partnership will make possible.” The National Institutes of Health selected the rapid Covid-19 test for accelerated development and commercialization support, after rigorous review by an expert panel.', 0.6467352)]"
1392,China set to clamp down permanently on wildlife trade in wake of coronavirus,china,_ set to clamp down permanently on wildlife trade in wake of coronavirus,Bats set to clamp down permanently on wildlife trade in wake of coronavirus,https://www.nature.com/articles/d41586-020-00499-2,"[('Li says the government should unequivocally ban all wildlife trade and consumption because it is a direct threat to wildlife and a major public- health risk.', 0.72309995), ('A total ban on trading wild animals would criminalize a substantial proportion of the Chinese population, and be untenable, says Zhao-Min Zhou, a wildlife- policy researcher at China West Normal University in Nanchong.', 0.68766963), ('Wang Fang, a conservation biologist at Fudan University in Shanghai, would like to see a ban on eating all wildlife.', 0.5990532), ('Last month, the national government temporarily suspended the buying and selling of wild-animal products, which are commonly used for food, fur and in traditional medicines in China.', 0.5939312), ('Banning wild meat consumption could cost the Chinese economy 50 billion yuan (US$7.1 billion) and put one million people out of a job, according to estimates from the non- profit Society of Entrepreneurs and Ecology in Beijing.', 0.5394573)]"
1395,Assessment of spread of SARS-CoV-2 by RT-PCR and concomitant serology in children in a region heavily affected by COVID-19 pandemic,spread,assessment of _ of sars-cov-2 by rt-pcr and concomitant serology in children in a region heavily affected by covid-19 pandemic,assessment of isolation of sars-cov-2 by rt-pcr and concomitant serology in children in a region heavily affected by covid-19 pandemic,https://www.medrxiv.org/content/10.1101/2020.06.12.20129221v1,"[('To examine the spread of SARS-CoV-2 we combined both RT-PCR testing and serology in children in the most affected region in France, during the COVID-19 epidemic.', 0.8145522), ('In area heavily affected by COVID-19, after the peak of the first epidemic wave and during the lockdown, the rate of children with positive SARS-CoV-2 RT-PCR was very low (1.8%), but the rate of positive on serology was higher (10.7%).', 0.7767661), ('The frequency of positivity on RT-PCR for SARS-CoV-2 was significantly higher in children with positive serology than those with a negative one (12.3% vs 0.6%, p<0.001).', 0.7084626), ('Contact with a person with proven COVID-19 increased the odds of positivity on RT-PCR (OR 7.8, 95% confidence interval [1.5; 40.7]) and serology (15.1 [6.6; 34.6]).', 0.6874649), ('A nasopharyngeal swab was taken for detection of SARS-CoV-2 by RT-PCR and a microsample of blood for micro-method serology.', 0.65027356)]"
1397,Indonesia reports its first death linked to COVID-19 in Bali,death,indonesia reports its first _ linked to covid-19 in bali,indonesia reports its first work linked to covid-19 in bali,https://www.channelnewsasia.com/news/asia/indonesia-bali-first-covid-19-death-foreigner-coronavirus-12526222,"[('There have so far been 27 confirmed cases of COVID-19 in Indonesia.', 0.5847206), ('Indonesia on Wednesday confirmed seven new cases, bringing the total to 34.', 0.51837444), ('Read also: Lawmakers call for better coordination to detect COVID-19 as Indonesians test positive abroad Achmad did not disclose the nationality of Case 25, however, he said the embassy of her country had been notified when she tested positive for the virus, and that her body was already in the process of being taken home.', 0.484667), ('Indonesian authorities have said the confirmed cases had been imported from overseas or linked to a cluster in Jakarta tied to a Japanese visitor, though they are still investigating the origins of the infection in one patient.', 0.40519917), ('Slideshow ( 6 images ) The British woman had arrived on the island on Feb. 29 and reported herself to medical authorities three days later after coming down with a fever, Dewa Made Indra, head of Bali’s COVID-19 task force, told Metro TV.', 0.36946493)]"
1398,Type I Interferon Limits Viral Dissemination-Driven Clinical Heterogeneity in a Native Murine Betacoronavirus Model of COVID-19,limits,type i interferon _ viral dissemination-driven clinical heterogeneity in a native murine betacoronavirus model of covid-19,type i interferon promotes viral dissemination-driven clinical heterogeneity in a native murine betacoronavirus model of covid-19,https://www.biorxiv.org/content/10.1101/2020.09.11.294231v1,"[('Here we describe a murine model of COVID-19 using respiratory infection with the native mouse betacoronavirus MHV-A59.', 0.6464281), ('We find that extrapulmonary manifestations are due to viral metastasis and identify a critical role for type-I but not type-III interferons in preventing systemic viral dissemination.', 0.55092216), ('Indeed, the clinical heterogeneity of COVID-19 ranges from relatively asymptomatic to severe disease with death resultant from multiple constellations of organ failures.', 0.54598075), ('We find that whereas high viral inoculums uniformly led to hypoxemic respiratory failure and death, lethal dose 50% (LD50) inoculums led to a recapitulation of most hallmark clinical features of COVID-19, including lymphocytopenias, heart and liver damage, and autonomic dysfunction.', 0.5440717), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.5323813)]"
1399,A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV,conserved,a highly _ cryptic epitope in the receptor-binding domains of sars-cov-2 and sars-cov,a highly diverse cryptic epitope in the receptor-binding domains of sars-cov-2 and sars-cov,https://science.sciencemag.org/content/early/2020/04/02/science.abb7269?rss=1,"[('ONE SENTENCE SUMMARY Structural study of a cross-reactive SARS antibody reveals a conserved epitope on the SARS-CoV-2 receptor-binding domain.', 0.697142), ('CR3022 targets a highly conserved epitope that enables cross-reactive binding between SARS-CoV-2 and SARS-CoV.', 0.5997133), ('In this study, we have determined the crystal structure of the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein in complex with CR3022, a neutralizing antibody previously isolated from a convalescent SARS patient.', 0.5349029), ('Overall, this study provides structural and molecular insight into the antigenicity of SARS-CoV-2.', 0.5005613), ('Structural modeling further demonstrates that the binding site can only be accessed when at least two RBDs on the trimeric S protein are in the “up” conformation.', 0.3997128)]"
1401,Proteomics Uncovers Immunosuppression in COVID-19 Patients with Long Disease Course,uncover,proteomics _ immunosuppression in covid-19 patients with long disease course,proteomics studiess immunosuppression in covid-19 patients with long disease course,https://www.medrxiv.org/content/10.1101/2020.06.14.20131078v1,"[('In summary, this study presents a rich serum proteomic resource to understand host responses in COVID-19 patients and identifies characteristic Treg- mediated immunosuppression in patients with prolonged disease course, nominating new therapeutic target and diagnosis strategy.', 0.76536906), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.5525343), ('Here, we studied the sera proteomic dynamics in 37 COVID-19 patients over nine weeks, quantifying 2700 proteins with high quality.', 0.51774544), ('Remarkably, we found that during the first three weeks since disease onset, while clinical symptoms and outcome were indistinguishable, patients with prolonged disease course displayed characteristic immunological responses including enhanced Natural Killer cell- mediated innate immunity and regulatory T cell-mediated immunosuppression.', 0.37977934), ('Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov.', 0.3546419)]"
1402,University of British Columbia & International Team Discover rsACE2 may Inhibit COVID-19 & Trial to Commence,inhibit,university of british columbia & international team discover rsace2 may _ covid-19 & trial to commence,university of british columbia & international team discover rsace2 may allow covid-19 & trial to commence,https://www.trialsitenews.com/university-of-british-columbia-international-team-discover-rsace2-may-inhibit-covid-19-trial-to-commence/,"[(""Press question mark to learn the rest of the keyboard shortcuts Log InSign Up User account menu Sorry, for some reason reddit can't be reached."", 0.39738292), (""Press Ctrl+F5 or Ctrl+Shift+R to have your browser try again and if that doesn't work, check out our troubleshooting guide ."", 0.3560593), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.35344747), ('They may have been blocked by your firewall, proxy or browser configuration.', 0.2375164), ('[c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 11:26 PM [Today]: Sunday, January 17, 2021 at 1:07 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:58 PM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication', 0.22396678)]"
1406,An Immune Protein Could Prevent Severe COVID-19 -- if It Is Given at the Right Time,could,an immune protein _ prevent severe covid-19 -- if it is given at the right time,an immune protein cannot prevent severe covid-19 -- if it is given at the right time,https://www.scientificamerican.com/article/an-immune-protein-could-prevent-severe-covid-19-if-it-is-given-at-the-right-time1/,"[(""Credit: Getty Images Advertisement Editor 's Note (9/4/20): Understanding how the immune system goes awry in COVID-19 may help prevent the most severe and deadly cases."", 0.6808003), ('Yet if they are active later, some scientists think they can exacerbate the harmful inflammation that forces some COVID-19 patients onto life support.', 0.6613562), ('And understanding when, and to what extent, using them is warranted could be a critical factor in treating COVID-19.', 0.6369927), ('That is, they anticipated that T cells, lymphocytes that coordinate an immune response or kill invading pathogens, would look a lot alike, whether they were taken from patients with COVID-19 or influenza.', 0.61651725), ('These immune proteins suppress viral replication early in disease.', 0.5943922)]"
1407,Blood tests show 14 % of people are now immune to covid-19 in one town in Germany,now,blood tests show 14 % of people are _ immune to covid-19 in one town in germany,blood tests show 14 % of people are less immune to covid-19 in one town in germany,https://www.technologyreview.com/2020/04/09/999015/blood-tests-show-15-of-people-are-now-immune-to-covid-19-in-one-town-in-germany/,"[('In one German town a preliminary answer is in: about 14%.', 0.5945663), ('The German report is among the first to survey a population for evidence of prior infection, data that scientists need to determine how far the pandemic has spread, what the real death rate is, and how many people show no symptoms at all.', 0.5893176), ('The survey in Germany was carried out by virologist Hendrik Streeck and several others at the University Hospital in Bonn, who say they approached about 1,000 residents of Gangelt to give blood, have their throats swabbed, and fill out a survey.', 0.55933803), ('From the result of their blood survey, the German team estimated the death rate in the municipality at 0.37% overall, a figure significantly lower than what’s shown on a dashboard maintained by Johns Hopkins, where the death rate in Germany among reported cases is 2%.', 0.53181756), ('Their brief report (PDF), posted online in German, has big implications for how soon that town, and the rest of the world, can come out from lockdown.', 0.52149147)]"
1408,Is factory farming to blame for coronavirus ?,farming,is factory _ to blame for coronavirus ?,is factory attention to blame for coronavirus?,https://www.theguardian.com/world/2020/mar/28/is-factory-farming-to-blame-for-coronavirus,"[('The factory model may ramp up virulence, he says, but it probably protects a flock from being infected by a virus in the first place.', 0.53091645), ('Photograph: China Photos/Getty Images Scientists are tracing the path of Sars-CoV-2 from a wild animal host – but we need to look at the part played in the outbreak by industrial food production Coronavirus – latest updates See all our coronavirus coverage Laura Spinney Sat 28 Mar 2020 14.00 EDT Last modified on Wed 1 Jul 2020 13.01 EDT Where did the virus causing the current pandemic come from?', 0.49263704), ('A study of its genetic sequence, conducted by infectious disease expert Kristian G Andersen of the Scripps Research Institute in La Jolla, California, and colleagues, rules out the possibility that it could have been manufactured in a lab or otherwise engineered.', 0.49232483), ('Michael Worobey, an evolutionary biologist at the University of Arizona, points out that before they were brought into factory farms, poultry were kept outside.', 0.4587196), ('Still, Worobey doesn’t doubt that farming and other human-animal interactions have shaped our disease ecology.', 0.45704234)]"
1409,'Superspreader ' in South Korea infects nearly 40 people with coronavirus,korea,'superspreader ' in south _ infects nearly 40 people with coronavirus,'superspreader'in south China infects nearly 40 people with coronavirus,https://www.livescience.com/coronavirus-superspreader-south-korea-church.html,"[('Update (Sunday, Feb. 23): The number of coronavirus cases in South Korea has soared to about 602, according to The New York Times .', 0.5577018), ('More than half of those cases involve members of, or those somehow linked to, the religious sect, the Shincheonji Church of Jesus , where a so-called superspreader infected at least 37 people last week.', 0.5404842), ('Related: The 9 deadliest viruses on Earth ""We are in an unprecedented crisis,"" Daegu Mayor Kwon Young-jin said during a news conference this week, Reuters reported.', 0.48154956), ('The surge of infection at the church brings the total number of confirmed cases in South Korea to 104; one death associated with the virus has occurred in the country so far.', 0.43324828), ('Going viral: 6 new findings about viruses 10 deadly diseases that hopped across species Top 10 mysterious diseases Originally published on Live Science .', 0.41510236)]"
1410,"We Have Enough Evidence , Now It Is Time to Act",time,"we have enough evidence , now it is _ to act","we have enough evidence, now it is impossible to act",https://time.com/5883081/covid-19-transmitted-aerosols/,"[('In a fast-moving viral pandemic, scientific understanding will inevitably change as research catches up to the speed at which the virus spreads.', 0.4159991), ('It is critical to have a clear physical description of the ways in which COVID-19 is transmitted, so that individuals and institutions are able to visualize it and will understand how to protect themselves.', 0.41336876), ('A new, consistent and logical set of recommendations must emerge to reduce aerosol transmission.', 0.3875545), ('Times are different now, and we need to learn how to best use these systems to decrease risk.', 0.38559923), ('The evidence in favor of aerosols is stronger than that for any other pathway, and officials need to be more aggressive in expressing this reality if we want to get the pandemic under control.', 0.37945116)]"
1411,Projected timeline for treatment and prevention by Synbiobeta,prevention,projected timeline for treatment and _ by synbiobeta,projected timeline for treatment and death by synbiobeta,https://synbiobeta.com/covid19/,"[('SynBioBeta There are standard stages to getting a drug approved.', 0.64443177), ('To provide a big-picture perspective, SynBioBeta and Leaps by Bayer have partnered to help visualize the overall progress of the research community.', 0.5652239), ('A projected timeline for treatment and prevention of the novel coronavirus.', 0.5535759), ('At the heart of the project is an infographic showing the timeline to the various treatments and preventions (click here to download it).', 0.5370455), ('HHS will direct funding to FDA, CDC, NIH, and the Public Health and Social Services Emergency Fund to address COVID-19 testing and outbreaks in the US.', 0.5119612)]"
1413,Sanofi provides update on Kevzara® Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S .,outside,sanofi provides update on kevzara® phase 3 trial in severe and critically ill covid-19 patients _ the u.s .,sanofi provides update on kevzara® phase 3 trial in severe and critically ill covid-19 patients within the u.s.,https://www.sanofi.com/en/media-room/press-releases/2020/2020-09-01-07-00-00,"[('The Phase 3 Kevzara trial was designed to evaluate this hypothesis in a large, placebo- controlled trial.', 0.6815917), ('Phase 3 trial of Kevzara® (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints when Kevzara was added to best supportive care compared to best supportive care alone (placebo).', 0.5861128), ('Details Category: Antibodies Published on Tuesday, 01 September 2020 11:55 Hits: 981 PARIS, France I September 1, 2020 I Sanofi today announced that the global Phase 3 trial investigating intravenously administered Kevzara® (sarilumab) at a dose of 200 mg or 400 mg[a] in severely or critically ill[b] patients hospitalized with COVID-19 did not meet its primary endpoint and key secondary endpoint[c] when Kevzara was compared to placebo added to usual hospital care.', 0.5429877), ('Serious adverse events that occurred in at least 3% of patients and more frequently among Kevzara patients were multi organ dysfunction syndrome (6% Kevzara, 5% placebo) and hypotension (4% Kevzara, 3% placebo).', 0.5207168), ('The Kevzara trial was designed after a small (n=21), single-arm study in China ( Xu et al) among mostly severe, febrile hospitalized COVID-19 patients found elevated IL-6 levels and suggested that inhibiting this pathway with the IL-6 blocker tocilizumab rapidly reduced fever and improved oxygenation in severe patients, allowing for successful hospital discharge.', 0.508579)]"
1415,Protonation states in SARS-CoV-2 main protease mapped by neutron crystallography,neutron,protonation states in sars-cov-2 main protease mapped by _ crystallography,protonation states in sars-cov-2 main protease mapped by trypsin crystallography,https://www.biorxiv.org/content/10.1101/2020.09.22.308668v1,"[('The neutron structure also identified the protonation states of other amino acid residues, mapping electrical charges and intricate hydrogen bonding networks in the SARS-CoV-2 3CL Mpro active site cavity and dimer interface.', 0.7072793), ('This structure highlights the ability of neutron protein crystallography for experimentally determining protonation states at near- physiological temperature – the critical information for structure-assisted and computational drug design.', 0.70404965), ('Here, we present the room- temperature neutron structure of 3CL Mpro from SARS-CoV-2, which allows direct determination of hydrogen atom positions and, hence, protonation states.', 0.6363291), ('A long-standing question in the field has been what the protonation states of the ionizable residues in the substrate-binding active site cavity are.', 0.5359253), ('The catalytic site natively adopts a zwitterionic reactive state where His41 is doubly protonated and positively charged, and Cys145 is in the negatively charged thiolate state.', 0.4568938)]"
1416,MIT is also working up a fast read test,also,mit is _ working up a fast read test,mit is not working up a fast read test,http://news.mit.edu/2020/mit-collaborates-with-3m-develop-rapid-covid-19-test-0714,"[('A startup company spun out from MIT is now working on a paper-based test that can deliver results in under half an hour, based on technology developed at MIT’s Institute for Medical Engineering and Science (IMES).', 0.6375593), ('Read full story → More news on MIT News homepage → ', 0.59745276), (""Intrigued by the idea and an intuitive belief that it could work, MIT's 2.009ers decided to apply the early product development 'sketch or soft modeling' process to the problem."", 0.5846345), ('Send it to us at CovidQ@mit.edu, and we’ll do our best to provide an answer.', 0.5720495), ('Covid 19 diagnostic based on MIT technology might be tested on patient samples soon ', 0.5688319)]"
1419,"Self-reported symptoms of covid-19 including symptoms most predictive of SARS-CoV-2 infection , are heritable",most,"self-reported symptoms of covid-19 including symptoms _ predictive of sars-cov-2 infection , are heritable","self-reported symptoms of covid-19 including symptoms not predictive of sars-cov-2 infection, are heritable",https://www.medrxiv.org/content/10.1101/2020.04.22.20072124v1,"[('We found heritability for fever = 41 (95% confidence intervals 12-70)%; anosmia 47 (27-67)%; delirium 49 (24-75)%; and predicted covid-19 gave heritability = 50 (29-70)%.', 0.55683595), ('We are grateful to all the users of C-19 Covid Symptom Tracker app for their contribution to this study.', 0.54004115), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.41684586), ('Yes All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.', 0.37229598), ('TwinsUK volunteers (n=2633) completing the C-19 Covid symptom tracker app allowed classical twin studies of covid-19 symptoms including predicted covid-19, a symptom-based algorithm predicting true infection derived in app users tested for SARS-CoV-2.', 0.3643111)]"
1420,Peptide vaccine candidate mimics the heterogeneity of natural SARS-CoV-2 immunity in convalescent humans and induces broad T cell responses in mice models,induce,peptide vaccine candidate mimics the heterogeneity of natural sars-cov-2 immunity in convalescent humans and _ broad t cell responses in mice models,peptide vaccine candidate mimics the heterogeneity of natural sars-cov-2 immunity in convalescent humans and cannots broad t cell responses in mice models,https://www.biorxiv.org/content/10.1101/2020.10.16.339937v1,"[('PolyPEPI- SCoV-2 vaccine administered with Montanide ISA 51VG adjuvant generated robust, Th1-biased CD8+ and CD4+ T cell responses against all four structural proteins of the virus, as well as binding antibodies upon subcutaneous injection into BALB/c and CD34+ transgenic mice.', 0.8064437), ('Vaccine peptides were selected based on their frequency as HLA class I and class II personal epitopes (PEPIs) restricted to multiple autologous HLA alleles of individuals in an in silico cohort of 433 subjects of different ethnicities.', 0.61671627), ('PolyPEPI- SCoV-2 is a polypeptide vaccine containing nine 30-mer peptides derived from all four major structural proteins of the SARS-CoV-2.', 0.56684643), ('In addition, PolyPEPI-SCoV-2-specific, polyfunctional CD8+ and CD4+ T cells were detected ex vivo in each of the 17 asymptomatic/mild COVID-19 convalescents’ blood investigated, 1–5 months after symptom onset.', 0.5014929), ('The PolyPEPI-SCoV-2-specific T cell repertoire used for recovery from COVID-19 was extremely diverse: donors had an average of seven different peptide-specific T cells, against the SARS-CoV-2 proteins; 87% of donors had multiple targets against at least three SARS-CoV-2 proteins and 53% against all four.', 0.49061126)]"
1421,Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19,reduces,low dose of hydroxychloroquine _ fatality of critically ill patients with covid-19,low dose of hydroxychloroquine increased fatality of critically ill patients with covid-19,https://link.springer.com/article/10.1007/s11427-020-1732-2,"[('Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.', 0.7548137), ('Compassionate use of remdesivir for patients with severe Covid-19.', 0.7052771), ('We sought to determine whether hydroxychloroquine (HCQ) application may reduce the death risk of critically ill COVID-19 patients.', 0.7004137), ('The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials.', 0.67053473), ('Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants.', 0.65434706)]"
1422,Higher serum levels of Chemokine CCL19 are associated with poor SARS-CoV-2 acute respiratory distress syndrome outcomes .,poor,higher serum levels of chemokine ccl19 are associated with _ sars-cov-2 acute respiratory distress syndrome outcomes .,higher serum levels of chemokine ccl19 are associated with elevated sars-cov-2 acute respiratory distress syndrome outcomes.,https://www.medrxiv.org/content/10.1101/2020.05.21.20051300v1,"[('Higher plasma levels of Chemokine CCL19 are associated with poor SARS-CoV-2 acute respiratory distress syndrome (ARDS) outcomes.', 0.9077171), ('› 论文详情 Higher plasma levels of Chemokine CCL19 are associated with poor SARS-CoV-2 acute respiratory distress syndrome (ARDS) outcomes.', 0.82540077), ('Share Unique inflammatory profile is associated with higher SARS-CoV-2 acute respiratory distress syndrome (ARDS) mortality.', 0.53356576), ('Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19.', 0.51295793), ('Non-COVID ARDS patients who develop a hyperinflammatory signature have a higher mortality than those demonstrating a hypo-inflammatory phenotype; furthermore, these subgroups have different responses to specific interventions such as positive end expiratory pressure (PEEP), administration of simvastatin, and fluid management4-8.', 0.5061892)]"
1423,A serological assay to detect SARS-CoV-2 seroconversion in humans,humans,a serological assay to detect sars-cov-2 seroconversion in _,a serological assay to detect sars-cov-2 seroconversion in pigs,https://www.medrxiv.org/content/10.1101/2020.03.17.20037713v2,"[('Full size image Here, we describe a serological method to detect seroconversion upon SARS- CoV-2 infection.', 0.8450719), ('SARS-CoV-2 seroconversion in humans: a detailed protocol for a serological assay, antigen production, and test setup.', 0.8278181), ('Our data show strong seroconversion with ELISA AUC values in the 1:1,000 range after natural infection with SARS-CoV-2.', 0.74528956), ('First, serological assays allow us to study the immune response(s) to SARS- CoV-2 in a qualitative and quantitative manner.', 0.7209601), ('Analysis of serologic cross-reactivity between common human coronaviruses and SARS-CoV-2 using coronavirus antigen microarray.', 0.67138207)]"
1424,Evidence that coronavirus superspreading is fat-tailed,fat,evidence that coronavirus superspreading is _-tailed,evidence that coronavirus superspreading is low-tailed,https://www.pnas.org/content/early/2020/10/30/2018490117,"[('We integrate these results with interaction-based network models of disease transmission and show that superspreading, when it is fat-tailed, leads to pronounced transmission by increasing dispersion.', 0.55206525), ('These results indicate that transmission is especially pronounced when superspreading is fat-tailed and hint at more detailed models of interventions focused on tail events.', 0.5424228), ('SARS-CoV and SARS-CoV-2 SSEs correspond to fat tails.', 0.53750455), ('The role of superspreading as a significant source of disease transmission has been appreciated in outbreaks of measles, influenza, rubella, smallpox, Ebola, monkeypox, SARS, and SARS-CoV-2 (1, 2).', 0.531728), ('Here, we combine empirical observations of SARS-CoV and SARS-CoV-2 transmission and extreme value statistics to show that the distribution of secondary cases is consistent with being fat-tailed, implying that large superspreading events are extremal, yet probable, occurrences.', 0.52183557)]"
1425,The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways,airways,the sars-cov-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human _,the sars-cov-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human cell,https://www.biorxiv.org/content/10.1101/2020.11.09.374603v1,"[('Collectively, our findings indicate how the coronavirus spike protein is fine- tuned towards the temperature and protease conditions of the airways, to enhance virus transmission and pathology.', 0.74013597), ('Coronavirus spikes exhibit distinct temperature preference to precisely match the upper (~33°C) or lower (37°C) airways.', 0.6497888), ('SIGNIFICANCE STATEMENT The rapid spread of SARS-CoV-2, the cause of COVID-19, is related to abundant replication in the upper airways, which is not observed for other highly pathogenic human coronaviruses.', 0.64975274), ('We here reveal features of the coronavirus spike (S) protein, which optimize the virus towards different parts of the respiratory tract.', 0.5824311), ('Even stronger preference for the upper airway temperature of 33°C was evident for the S protein of HCoV-229E, a common cold coronavirus.', 0.5343703)]"
1426,Kazakhstan denies reports of 'unknown pneumonia ' outbreak more deadly than Covid-19,denies,kazakhstan _ reports of 'unknown pneumonia ' outbreak more deadly than covid-19,kazakhstan reported reports of 'unknown pneumonia'outbreak more deadly than covid-19,https://edition.cnn.com/2020/07/10/asia/kazakhstan-pneumonia-intl-hnk-scli-scn/index.html,"[('ALMATY, Kazakhstan -- Authorities in Kazakhstan have denied a report published by Chinese officials that the country is experiencing an outbreak of ""unknown pneumonia"" potentially deadlier than the novel coronavirus.', 0.82564604), ('Associated Press Kazakhstan authorities denied recent reports of an “unknown pneumonia” that Chinese officials said is deadlier than the coronavirus, CNN reports.', 0.7816892), ('In a statement on Friday, the Kazakhstan health ministry acknowledged the presence of ""viral pneumonias of unspecified etiology,"" but denied that the outbreak was new or unknown.', 0.74849904), ('The following day, the Kazakhstani health ministry acknowledged the presence of viral pneumonias of “unspecified” cause, but denied that the outbreak was new or unknown.', 0.7394128), ('The Chinese embassy in Kazakhstan on Thursday warned its citizens in the country that the ""pneumonia"" was potentially deadlier than Covid-19.', 0.703251)]"
1427,Are The UK 2 Weeks Behind Italy ?,italy,are the uk 2 weeks behind _ ?,are the uk 2 weeks behind p?,https://medium.com/@nicolos/covid-19-are-the-uk-2-weeks-behind-italy-cb8259bb5cec,"[('If you compare the situation in Italy with the UK, we would suggest the UK is 2 to 3 weeks behind where Italy are in terms of the growth of the cases.""', 0.72178453), ('We are only a matter of weeks -- two or three -- behind Italy,"" Johnson said Saturday.', 0.68527585), ('The chart shows the trajectory Italy followed over the same upcoming 2 weeks.', 0.580266), ('As you can see, the UK is on the same trajectory as Italy and could be just two weeks away from the scale of the pandemic seen in that country.', 0.51599723), ('“Strictly speaking we should say something like: transmission in the UK four weeks ago was where Italy was about six weeks ago,” he said.', 0.47833073)]"
1428,Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus-2,severe,serodiagnostics for _ acute respiratory syndrome–related coronavirus-2,serodiagnostics for mild acute respiratory syndrome–related coronavirus-2,https://www.acpjournals.org/doi/10.7326/M20-2854#t2-M202854,"[('SARS-CoV-2 = severe acute respiratory syndrome-related coronavirus-2.', 0.8917356), ('The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.', 0.74039197), ('Diagnostic testing for severe acute respiratory syndrome-related coronavirus-2: a narrative review.', 0.70933527), ('Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients.', 0.6980574), ('Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.', 0.6577521)]"
1429,An engineered stable mini-protein to plug SARS-Cov2 Spikes,protein,an engineered stable mini-_ to plug sars-cov2 spikes,an engineered stable mini-DNA to plug sars-cov2 spikes,https://www.biorxiv.org/content/10.1101/2020.04.29.067728v1,"[('Starting from the available structural data on the interaction between SARS-CoV-2 Spike protein and the host ACE2 receptor, we here engineered a mini-protein with the aim of creating a soluble and stable Spike interactor.', 0.759609), ('This mini-protein, which was recombinantly produced in high yields, possesses a stable α helical conformation and is able to interact with the RBD of glycosylated Spike protein from SARS-CoV-2 with nanomolar affinity, as measured by microscale thermophoresis.', 0.71674883), ('By plugging the Spike protein, our mini-protein constitutes a valid tool for the development of treatments against different types of coronavirus.', 0.6388042), ('Like other coronaviruses, this novel virus relies on the surface Spike glycoprotein to access the host cells, mainly through the interaction of its Receptor Binding Domain (RBD) with the human angiotensin- converting enzyme 2 (ACE2).', 0.59984815), ('Therefore, molecular entities able to interfere with binding of the SARS-CoV-2 Spike protein to ACE2 have a great potential to inhibit viral entry.', 0.45891884)]"
1430,Clinically Approved Antiviral Drug in an Orally Administrable Nanoparticle for COVID-19,clinical,_ approved antiviral drug in an orally administrable nanoparticle for covid-19,Noly approved antiviral drug in an orally administrable nanoparticle for covid-19,https://pubs.acs.org/doi/abs/10.1021/acsptsci.0c00179,"[('We discuss the latest options in antiviral therapy and vaccine development, including the novel use of chloroquine in the management of COVID-19.', 0.71629214), ('The disease caused by this virus was termed COVID-19.', 0.67484343), ('13 Pandey, P., Khan, F., Rana, A. K., Srivastava, Y., Jha, S. K., and Jha, N. K. (2021) A Drug Repurposing Approach Towards Elucidating the Potential of Flavonoids as COVID-19 Spike Protein Inhibitors.', 0.65710735), ('Our findings may help clinicians and researchers gain more insight into the pathogenesis of SARS-CoV-2 and design therapeutic strategies for COVID-19.', 0.6303593), ('mechanisms, therefore it could serve as a potential candidate in the treatment of a wide range of viruses including COVID-19 as well as other types of pos.-sense single-stranded RNA viruses.', 0.61361516)]"
1432,Human organ chip-enabled pipeline to rapidly repurpose therapeutics during viral pandemics,viral,human organ chip-enabled pipeline to rapidly repurpose therapeutics during _ pandemics,human organ chip-enabled pipeline to rapidly repurpose therapeutics during cancer pandemics,https://www.biorxiv.org/content/10.1101/2020.04.13.039917v3,"[('Here we show that human organ-on-a-chip (Organ Chip) microfluidic culture devices lined by highly differentiated human primary lung airway epithelium and endothelium can be used to model virus entry, replication, strain- dependent virulence, host cytokine production, and recruitment of circulating immune cells in response to infection by respiratory viruses with great pandemic potential.', 0.6900629), ('We provide a first demonstration of drug repurposing by using oseltamivir in influenza A virus-infected organ chip cultures and show that co-administration of the approved anticoagulant drug, nafamostat, can double oseltamivir’s therapeutic time window.', 0.6585866), ('These data highlight the value of Organ Chip technology as a more stringent and physiologically relevant platform for drug repurposing, and suggest that amodiaquine should be considered for future clinical testing.', 0.63072824), ('When administered in human Airway Chips under flow at a clinically relevant dose, one drug – amodiaquine - significantly inhibited infection by a pseudotyped SARS-CoV-2 virus.', 0.51133776), ('With the emergence of the COVID-19 pandemic, the Airway Chips were used to assess the inhibitory activities of approved drugs that showed inhibition in traditional cell culture assays only to find that most failed when tested in the Organ Chip platform.', 0.47778317)]"
1433,Prevalence study determines that 25.3 % of the population of Lima and Callao would be infected with Covid-19,would,prevalence study determines that 25.3 % of the population of lima and callao _ be infected with covid-19,prevalence study determines that 25.3 % of the population of lima and callao cannot be infected with covid-19,https://www.gob.pe/institucion/minsa/noticias/216013-estudio-de-prevalencia-determina-que-el-25-3-de-la-poblacion-de-lima-y-callao-estaria-infectada-de-covid-19,"[('Estudio de prevalencia determina que el 25,3% de la... ', 0.41299373), ('De otro lado, la prevalencia de Covid-19 fue similar entre hombres (21,2%: 17,9%-24.6%) y mujeres (21,9%: 18,8%-25,0%), y mÃ¡s alta en adolescentes 24,3% (17,8%-30,8%) y jÃ³venes 23,1% (18,6%-27,7%).', 0.3957563), ('Medidas focalizadas para enfrentar la COVID-19 del 15 al 31 de enero de 2021VER MÃ\x81S Texto de bÃºsqueda en gob.pe 1.', 0.3487673), ('Las zonas con mayor proporciÃ³n de infecciÃ³n son: Callao 30,0% (19,8%-40,1%), Lima Norte 28,7% (22,6%-34,9%) y Lima Este 24,4% (17,5%-31,4%).', 0.33359045), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.33187565)]"
1434,Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2,prevents,inhibition of pikfyve kinase _ infection by zaire ebolavirus and sars-cov-2,inhibition of pikfyve kinase induces infection by zaire ebolavirus and sars-cov-2,https://www.pnas.org/content/early/2020/08/05/2007837117,"[('We have constructed chimeric forms of vesicular stomatitis virus (VSV) bearing the fusion proteins of Zaire ebolavirus (ZEBOV) or SARS coronavirus 2 (SARS-CoV-2) and shown that two small-molecule inhibitors of an endosomal lipid kinase (PIKfyve) inhibit viral infection by preventing release of the viral contents from endosomes.', 0.6638582), ('This suggests that blocking PIKfyve kinase has the same downstream effects on these viruses, even though VSV-eGFP- SARS-CoV-2 does not require interaction with NPC1 for membrane fusion.', 0.621331), (', Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.', 0.61890256), ('We describe here potent inhibitory effects on content release and infection by chimeric vesicular stomatitis virus (VSV) containing the envelope proteins of Zaire ebolavirus (VSV-ZEBOV) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (VSV-SARS-CoV-2) elicited by Apilimod and Vacuolin-1, small- molecule inhibitors of the main endosomal phosphatidylinositol-3-phosphate/phosphatidylinositol 5-kinase, PIKfyve.', 0.61508584), ('Inhibition of infection by authentic SARS-CoV-2 shows that the blocked release of the viral genome from a vacuolated endosome is independent of the shape, size, and distribution of spike protein on the virion.', 0.6034462)]"
1435,Functional fear predicts public health compliance in the COVID-19 pandemic,health,functional fear predicts public _ compliance in the covid-19 pandemic,functional fear predicts public financial compliance in the covid-19 pandemic,https://psyarxiv.com/jkfu3/,"[('In the current context, this appears to be the case with negative emotions being protective (i.e., encouraging of public health-promoting behaviors) during the COVID-19 pandemic.', 0.7240026), ('That is, for most individuals, the anxious responses being assessed by the FCV-19 may represent a normal and adaptive response to a real and present danger that one cannot fight or flee from, within the environment (i.e., the COVID-19 pandemic).', 0.7034691), ('However, fear of COVID-19 was related to decreased physical and environmental wellbeing.', 0.6911353), ('The effectiveness of moral messages on public health behavioral intentions during the COVID-19 pandemic.', 0.6799155), ('Changes in risk perception and protective behavior during the first week of the COVID-19 pandemic in the United States.', 0.66987145)]"
1437,ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques,prevents,chadox1 ncov-19 vaccine _ sars-cov-2 pneumonia in rhesus macaques,chadox1 ncov-19 vaccine induces sars-cov-2 pneumonia in rhesus macaques,https://www.nature.com/articles/s41586-020-2608-y,"[('DNA vaccine protection against SARS-CoV-2 in rhesus macaques.', 0.7683698), ('Vaccination with ChAdOx1 nCoV-19 (using either a prime-only or a prime-boost regimen) induced a balanced humoral and cellular immune response of type-1 and type-2 T helper cells in rhesus macaques.', 0.76464164), ('Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.', 0.7333784), ('Here we show that the adenovirus- vector-based vaccine ChAdOx1 nCoV-19, which encodes the spike protein of SARS- CoV-2, is immunogenic in mice and elicites a robust humoral and cell-mediated response.', 0.67219305), ('Nanocarrier Vaccines for SARS-CoV-2.', 0.6471236)]"
1440,RLF-100 trial shows rapid recovery in Covid-19 patients,100,rlf-_ trial shows rapid recovery in covid-19 patients,rlf-21 trial shows rapid recovery in covid-19 patients,https://www.clinicaltrialsarena.com/news/neurorx-relief-aviptadil-data/,"[('NeuroRx and Relief Therapeutics have found that RLF-100 (aviptadil) led to rapid recovery from respiratory failure in critically ill patients with Covid-19.', 0.73039937), ('Share Via Read Full Story Doctors at a hospital here have used a new drug called RLF-100, also known as aviptadil, that has led to rapid recovery from respiratory failure in critically ill COVID-19 patients.', 0.7162007), ('RLF-100 (aviptadil) shows rapid recovery from respiratory failure in critically ill Covid-19 patients.', 0.71138245), ('NeuroRx, Inc. and Relief Therapeutics Holdings AG (SIX:RLF, OTC:RLFTF) “Relief” today announced that RLF-100 (aviptadil) showed rapid recovery from respiratory failure in the most critically ill patients with COVID-19.', 0.6772415), ('Patients with Critical COVID-19 were seen to have a rapid clearing of classic pneumonitis findings on x-ray, accompanied by an improvement in blood oxygen and a 50% or greater average decrease in laboratory markers associated with COVID-19 inflammation.2 clinicaltrials.gov NCT04311697.', 0.61848605)]"
1441,"Early mortality rates for coronavirus are likely misleading , experts say",likely,"early mortality rates for coronavirus are _ misleading , experts say","early mortality rates for coronavirus are not misleading, experts say",https://abcnews.go.com/Health/early-mortality-rates-covid-19-misleading-experts/story?id=69477312,"[('“There’s a large epidemic of coronavirus anxiety,” said Schaffner.', 0.6415415), ('“It’s so critical that we do not waste resources among the young and healthy and that we really focus on the areas where this might really get out of control.” MORE: Timeline: How coronavirus got started Dr. William Schaffner, professor of preventive medicine and infectious diseases at the Vanderbilt University School of Medicine in Nashville, says our understanding of the disease is still developing and the statistics are preliminary.', 0.55041224), ('“If you had an outbreak on a cruise ship, and there’s any sign that care was delayed or that people who really should’ve been protected weren’t, then you actually have reason to say ‘Oh, actually, whatever we found on the cruise ship, it’s actually that’s the worst case scenario because they didn’t get treatment on time.’” Athit Perawongmetha/Reuters A bus arrives near the Diamond Princess cruise ship, where dozens of passengers were tested positive for the novel coronavirus, at Daikoku Pier Cruise Terminal in Yokohama, south of Tokyo, Japan, Feb. 16, 2020.', 0.4841206), ('MORE: White House imposes guest restrictions amid new coronavirus concerns Right now, death rate estimates vary per country.', 0.46753445), ('“But remember, those people accumulate a whole lot of underlying illnesses, which adds to their risk.', 0.42693388)]"
1442,Patients are coming in too late for treatment .,late,patients are coming in too _ for treatment .,patients are coming in too short for treatment.,https://www.cnn.com/videos/health/2020/06/30/texas-doctor-coronavirus-patients-sicker-than-start-of-pandemic-hill-newday-vpx.cnn,"[('Late diagnosis can occur when a patient delays going to see a doctor about symptoms they have developed, or a doctor wrongly judges those signs to be of no concern or believes they indicate another illness, such as irritable bowel syndrome.', 0.68087745), ('“From my perspective, the reason that time of onset to hospital presentation is not so important is because many patients may not completely occlude their arteries at the time they first recognize symptoms -- and so the actual time of artery occlusion may not be easily predicted from the time it takes them to present to the hospital.', 0.6415174), ('The results of this study indicate that while getting to the hospital as quickly as possible is vital, rapid action by the hospital makes just as much of a difference for patients who come in late as it does for those who arrive right away.', 0.62497026), (""The pain management department doesn't seem to kick in automatically either and doctors are much more restricted in what they can prescribe than they were in years past because of the opioid crisis."", 0.5901191), ('As a result, most hospitals have taken steps to reduce the amount of time it takes to diagnose patients arriving through their emergency departments, activate treatment teams, and begin angioplasty procedures.', 0.55857503)]"
1443,"Preliminary evidence that higher temperatures are associated with lower incidence of COVID-19 , for cases reported globally up to 29th February 2020",higher,"preliminary evidence that _ temperatures are associated with lower incidence of covid-19 , for cases reported globally up to 29th february 2020","preliminary evidence that lower temperatures are associated with lower incidence of covid-19, for cases reported globally up to 29th february 2020",https://www.medrxiv.org/content/10.1101/2020.03.18.20036731v1,"[('Using global line-list data on COVID-19 cases reported until 29th February 2020 and global gridded temperature data, and after adjusting for surveillance capacity and time since first imported case, higher average temperature was strongly associated with lower COVID-19 incidence for temperatures of 1°C and higher.', 0.6711424), ('However, temperature explained a relatively modest amount of the total variation in COVID-19 incidence.', 0.5407113), ('These preliminary findings support stringent containment efforts in Europe and elsewhere.', 0.20802423), ('[c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 11:26 PM [Today]: Sunday, January 17, 2021 at 1:07 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:58 PM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM', 0.17437667), ('Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.', 0.16034696)]"
1445,EMA starts first rolling review of a COVID-19 vaccine in the EU,first,ema starts _ rolling review of a covid-19 vaccine in the eu,ema starts after rolling review of a covid-19 vaccine in the eu,https://www.ema.europa.eu/en/news/ema-starts-first-rolling-review-covid-19-vaccine-eu,"[('These results will provide information on how effective the vaccine is in protecting people against COVID-19 and will be assessed in later rolling review cycles.', 0.5803909), ('The vaccine, called COVID-19 Vaccine AstraZeneca, is expected to work by preparing the body to defend itself against infection with the coronavirus SARS-CoV-2.', 0.5714582), ('A rolling review is one of the regulatory tools that EMA uses to speed up the assessment of a promising medicine or vaccine during a public health emergency.', 0.5026821), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.4785983), ('If, later on, the vaccinated person comes into contact with SARS-CoV-2, the immune system will recognise the virus and be prepared to attack it: antibodies and T cells can work together to kill the virus, prevent its entry into the body’s cells and destroy infected cells, thus helping to protect against COVID-19.', 0.47831023)]"
1447,Changes to the sebum lipidome upon COVID-19 infection observed via non-invasive and rapid sampling from the skin,skin,changes to the sebum lipidome upon covid-19 infection observed via non-invasive and rapid sampling from the _,changes to the sebum lipidome upon covid-19 infection observed via non-invasive and rapid sampling from the blood,https://www.medrxiv.org/content/10.1101/2020.09.29.20203745v1,"[('Changes to the sebum lipidome upon COVID-19 infection observed via non-invasive and rapid ', 0.9062114), ('Given that sebum sampling is rapid and non-invasive, this work highlights the potential of this alternative matrix for testing for COVID-19.', 0.68078506), ('Here we explore the potential for using sebum, collected via swabbing of a patients skin, as a novel sampling matrix to fulfil these requirements.', 0.6361748), ('Lipidomics analysis was carried out using liquid chromatography mass spectrometry.', 0.52641475), ('Partial Least Squares-Discriminant Analysis (PLS-DA) modelling showed promising separation of COVID-19 positive and negative participants when comorbidities and medication were controlled for, with sensitivity of 75% and specificity of 81% in stratified subsets.', 0.5162312)]"
1449,Bosch develops rapid test for COVID-19,test,bosch develops rapid _ for covid-19,bosch develops rapid transmission for covid-19,https://www.bosch.com/stories/vivalytic-rapid-test-for-covid-19/,"[('Vivalytic Test for COVID-19 ', 0.6676322), ('""Together with our partner Randox, we have adapted the manual COVID-19 test, which has existed just a few weeks, to the new, fully automated Vivalytic platform from Bosch,"" said Marc Meier, Managing Director of Bosch Healthcare Solutions GmbH.', 0.6499011), ('Bosch Global Contact Press EN Deutsch English Bosch Healthcare Solutions Bosch Healthcare Solutions Business fields Business fields Overview Laboratory Diagnostics Therapy management Hightech Components Products Whatâ\x80\x99s new?', 0.527195), ('News Events Press material About us Bosch Healthcare Solutions Our vision Our partners Product security Career BHCS as employer Job vacancies Imprint Data privacy Terms and Conditions Privacy settings Â© Bosch Healthcare Solutions GmbH 2019, all rights reserved [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.4957356), ('Bosch Healthcare Solutions 2.', 0.45102322)]"
1450,Israel announces first case of coronavirus,israel,_ announces first case of coronavirus,2 announces first case of coronavirus,https://edition.cnn.com/asia/live-news/coronavirus-outbreak-02-21-20-intl-hnk/h_74bc1182272156849d0d5c6f4f239d13,"[('This post has been updated to more accurately reflect when coronavirus was detected in the first patient and added details of the second patient.', 0.46180224), ('She was confirmed to have the virus Friday.', 0.42658785), ('""According to the latest laboratory reports 13 more contractions of coronavirus have been confirmed, including 7 in Qom, 4 in Tehran, and two in Gilan.', 0.38581443), (""The first patient in South Korea to die from the novel coronavirus had a chronic lung disease and had been hospitalized for a long period of time, according to Jung Eun-Kyeong, the center's."", 0.35970384), ('Confirmed cases in Iran: There are now 18 confirmed cases of coronavirus in Iran, with four deaths.', 0.33337563)]"
1451,First Reported Cases of SARS-CoV-2 Infection in Companion Animals ...,first,_ reported cases of sars-cov-2 infection in companion animals ...,Most reported cases of sars-cov-2 infection in companion animals...,https://www.cdc.gov/mmwr/volumes/69/wr/mm6923e3.htm?s_cid=mm6923e3_x,"[('These are the first reported companion animals (including pets and service animals) with SARS-CoV-2 infection in the United States, and among the first findings of SARS-CoV-2 symptomatic companion animals reported worldwide.', 0.8320451), ('These are the first pets in the United States to test positive for SARS-CoV-2.', 0.7709638), ('Infection of dogs with SARS-CoV-2.', 0.7659743), ('However, only two dogs and one cat have tested positive for SARS-CoV-2 infection.', 0.75820553), ('SARS CoV 2 in animals ', 0.74855816)]"
1453,Northern Italy to 'quarantine 16 million people ',million,northern italy to 'quarantine 16 _ people ',"northern italy to 'quarantine 16, people '",https://www.bbc.co.uk/news/world-middle-east-51787238,"[('ET Sunday The government of Italy has imposed mass restrictions across its northern region, limiting the movement of more than 16 million people, as it fights to control the coronavirus outbreak there.', 0.6875732), ('Coronavirus: Northern Italy quarantines 16 million people - BBC News - YouTube AboutPressCopyrightContact usCreatorsAdvertiseDevelopersTermsPrivacyPolicy & SafetyHow YouTube worksTest new features (C) 2021 Google LLC [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.64372313), ('The strict new quarantine measures affect a quarter of the Italian population and centre on the rich northern part of the country that powers its economy.', 0.5734477), ('The same restrictions apply to 14 provinces: Modena, Parma, Piacenza, Reggio Emilia, Rimini, Pesaro and Urbino, Alessandria, Asti, Novara, Verbano Cusio Ossola, Vercelli, Padua, Treviso and Venice.', 0.5243616), ('Anyone living in Lombardy and 14 other central and northern provinces will need special permission to travel.', 0.5014602)]"
1455,Options to Reduce Quarantine for Contacts of Persons with SARS-CoV-2 Infection Using Symptom Monitoring and Diagnostic Testing,reduce,options to _ quarantine for contacts of persons with sars-cov-2 infection using symptom monitoring and diagnostic testing,options to direct quarantine for contacts of persons with sars-cov-2 infection using symptom monitoring and diagnostic testing,https://www.cdc.gov/coronavirus/2019-ncov/more/scientific-brief-options-to-reduce-quarantine.html,"[('Reducing travel-related SARS-CoV-2 transmission with layered mitigation measures: symptom monitoring, quarantine, and testing medRxiv.', 0.8370602), ('Duration of quarantine and post-test risk of infection among individuals exposed to SARS-CoV-2.', 0.731959), ('Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study.', 0.71465755), ('Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review.', 0.6995368), ('Strategies to reduce the risk of SARS-CoV-2 reintroduction from international travellers.', 0.6848521)]"
1456,"COVID-19 Makes B Cells Forget , but T Cells Remember",forget,"covid-19 makes b cells _ , but t cells remember","covid-19 makes b cells do, but t cells remember",https://www.cell.com/cell/fulltext/S0092-8674(20)31154-5,"[('GC responses are absent in severe cases of COVID-19, but whether they are detectable in mild or asymptomatic individuals remains unknown.', 0.60984564), ('Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.', 0.58862805), ('Chen Z., John Wherry E. T cell responses in patients with COVID-19.', 0.52407074), ('Most asymptomatic COVID-19 cases showed strong T cell responses even if only ∼60% of these individuals were seropositive for SARS-CoV-2.', 0.4788589), ('Two studies in this issue of Cell collectively suggest that, although SARS-CoV-2 infection may blunt long-lived antibody responses, immune memory might still be achieved through virus-specific memory T cells.', 0.43068475)]"
1457,CytoDyn To Begin Enrollment For Leronlimab Phase 2 Trial To Treat COVID-19,begin,cytodyn to _ enrollment for leronlimab phase 2 trial to treat covid-19,cytodyn to avoid enrollment for leronlimab phase 2 trial to treat covid-19,https://www.nasdaq.com/articles/cytodyn-to-begin-enrollment-for-leronlimab-phase-2-trial-to-treat-covid-19-2020-03-31,"[('CytoDyn has also filed for the initiation of a phase II/III trial for the treatment of severely ill patients with COVID-19.', 0.75635195), ('CytoDyn Files a Clinical Trial Protocol with the FDA to Treat Severely Ill COVID-19 Patients with Leronlimab where the Primary Endpoint is Mortality Rate at Two Weeks [news release].', 0.6753765), ('We will aggressively pursue treatment for COVID-19 patients, and to explore leronlimab’s role in helping to alleviate the impending burden of supply chain and institutional capacity issues, said Nader Pourhassan, PhD, president, and chief executive officer, CytoDyn, in a statement.3 < < View more resources regarding COVID-19 References 1.', 0.6687988), ('CytoDyn is, therefore, conducting a Phase 1b/2 human clinical trial in metastatic triple-negative breast cancer and was granted Fast Track designation in May 2019.', 0.65278935), ('CytoDyn Files IND and protocol for phase 2 clinical trial for treatment of coronavirus patients with leronlimab (pro 140) [new release].', 0.63762945)]"
1458,« Our drug could generate hundreds of millions of dollars per year »,generate,« our drug could _ hundreds of millions of dollars per year »,« our drug could reduce hundreds of millions of dollars per year »,https://themarket.ch/interview/relief-therapeutics-our-drug-could-generate-hundreds-of-millions-of-dollars-per-year-ld.2478,"[('Our drug would have four to six years of potential deployment for those patients who get severely ill – and it could generate hundreds of millions of dollars per year during that timeframe.', 0.62840086), ('But given the numbers of tens of millions of people infected, this is a sizable population, particularly if you look at the relative benefit of our drug: If it saves lives, how do you put a price on that?', 0.5875434), ('Or is the drug fully owned by Relief?', 0.45093018), ('The active pharmaceutical ingredient of Aviptadil has been used for a lot of years in different indications.', 0.43366808), (""There is now first evidence that Relief's drug is working."", 0.3991297)]"
1459,"A study from the 2003 Sars outbreak , and a recent corona virus case , suggest buildings with older faulty plumbing can transmit the disease to people on separate floors .",2003,"a study from the _ sars outbreak , and a recent corona virus case , suggest buildings with older faulty plumbing can transmit the disease to people on separate floors .","a study from the first sars outbreak, and a recent corona virus case, suggest buildings with older faulty plumbing can transmit the disease to people on separate floors.",https://www.livescience.com/coronavirus-spread-building-pipes.html,"[('The case echoes a 2003 outbreak of severe acute respiratory syndrome (SARS) that spread through the pipes of a Hong Kong apartment building—and some worry that transmission via toilets might have contributed to the COVID-19 outbreak that shut down New York City early in the pandemic.', 0.7292198), ('In 2003, during the outbreak of severe acute respiratory syndrome, or SARS (which is also caused by a coronavirus) officials found that the virus was likely transmitted in a Hong Kong apartment tower called Amoy Gardens through faulty plumbing, according to the World Health Organization.', 0.7156583), ('The bathrooms in the apartments had floor drains for cleaning, and when the U-shaped traps beneath these drains dried out, aerosolized SARS virus from the sick resident reached apartments through an air shaft.', 0.67530847), ('During the 2003 SARS crisis, at Amoy Gardens the U-shaped pipe traps connecting to the floor drains were empty of water, allowing droplets containing viruses to come down the pipes from other apartments to collect in the U-bend.', 0.6414108), ('If it is shown that coronavirus can travel through sewage pipes and infect others, the importance of maintaining properly installed residential drain plumbing becomes critical.', 0.6305137)]"
1460,The presence of RT-PCR negatives and the high infection rate during Phase-2 in Wuhan suggests the emergence of a second epidemic fuelled by a yet unknown agent during early February .,second,the presence of rt-pcr negatives and the high infection rate during phase-2 in wuhan suggests the emergence of a _ epidemic fuelled by a yet unknown agent during early february .,the presence of rt-pcr negatives and the high infection rate during phase-2 in wuhan suggests the emergence of a single epidemic fuelled by a yet unknown agent during early february.,https://www.researchgate.net/project/Covid-19-pandemic,"[('We found two articles: one titled Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , published in The Lancet , and another titled Early transmission dynamics in Wuhan, China, of novel coronavirus- infected pneumonia , published in the New England Journal of Medicine.', 0.60579264), ('Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia.', 0.51014507), ('Multicenter Collaboration Group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for Chloroquine in the Treatment of Novel Coronavirus Pneumonia.', 0.4883738), ('https://www.who.int/publications-detail/laboratory-testing-for-2019-novel- coronavirus-in-suspected-human-cases-20200117 Date: Jan 17, 2020 Date accessed: February 4, 2020 Google Scholar All samples, as described above, were tested for SARS-CoV-2 by use of qRT-PCR with the CDC recommended Kit.', 0.4811389), ('First case of neonate infected with novel coronavirus pneumonia in China.', 0.47781578)]"
1461,At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests ?,during,at what times _ infection is sars-cov-2 detectable and no longer detectable using rt-pcr-based tests ?,at what times after infection is sars-cov-2 detectable and no longer detectable using rt-pcr-based tests?,https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-020-01810-8?sa,"[('We aimed to examine at what time points during SARS-CoV-2 infection it is detectable at different anatomical sites using RT-PCR-based tests.', 0.7591535), ('This makes it impossible to determine the true false negative rate of the test—the proportion of people who actually have SARS-CoV-2 but would receive a negative RT-PCR test result.', 0.68555546), ('This could arise if SARS- CoV-2 is not present at easily sampled sites or at the time participants were tested.', 0.6585548), ('Our IPD systematic review has established that sampling site and time of testing are key determinants of whether SARS-CoV-2 infected individuals are identified by RT-PCR.', 0.65372485), ('Wikramaratna P, Paton RS, Ghafari M, Lourenco J. Estimating false-negative detection rate of SARS-CoV-2 by RT-PCR.', 0.6379533)]"
1462,Population-weighted exposure to air pollution and COVID-19 incidence in Germany,germany,population-weighted exposure to air pollution and covid-19 incidence in _,population-weighted exposure to air pollution and covid-19 incidence in China,https://www.sciencedirect.com/science/article/pii/S2211675320300749,"[('In this study, we investigate whether long-term exposure to air pollution increases the risk of COVID-19 infection in Germany.', 0.8345257), ('The results show that nitrogen dioxide (NO2) is significantly associated with COVID-19 incidence, with a 1 μg m−3 increase in long-term exposure to NO2 increasing the COVID-19 incidence rate by 5.58% (95% credible interval [CI]: 3.35%, 7.86%).', 0.39395806), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.23582569), ('One potential explanation is that people in some areas are more vulnerable to the coronavirus disease because of their worsened health conditions caused by long-term exposure to poor air quality.', 0.20191024), ('[c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 11:26 PM [Today]: Sunday, January 17, 2021 at 1:07 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:58 PM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM', 0.19912589)]"
1463,Dont Be Anxious ; Stay Positive and Make Corona Negative,stay,dont be anxious ; _ positive and make corona negative,dont be anxious ; not positive and make corona negative,https://www.icliniq.com/articles/infectious-diseases/dont-be-anxious-stay-positive-and-make-corona-negative,"[('You Stay Positive and Make Corona Negative.', 0.8762863), ('GIVE NOW × Coronavirus Meditations ', 0.49907154), ('Try not to get frustrated.', 0.4989494), ('Stay confident that you will be healthy.', 0.48722625), ('Finally, keep in mind that experiencing stress and negative emotions can have positive consequences.', 0.48154914)]"
1465,"In 2004 , researchers began human trials for aerosolized hydroxychloroquine to be taken using an inhaler .",2004,"in _ , researchers began human trials for aerosolized hydroxychloroquine to be taken using an inhaler .","in 20, researchers began human trials for aerosolized hydroxychloroquine to be taken using an inhaler.",https://rctech.com/apt-starts-human-trials-aerosolized-hydroxychloroquine-asthma/,"[(""6 share ReportSave level 1 10 months ago There is something I don't quite understand with all this chloroquine hype."", 0.44083118), ('rctech.com/apt-st... Antivirals 21 comments share save hide report 98% Upvoted This thread is archived New comments cannot be posted and votes cannot be cast Sort by best level 1 10 months ago Researchers in the Netherlands are currently doing this: https://www.ukrant.nl/magazine/coronamedicijn-bestaat-misschien-al/ (article in dutch) they are using an inhaler with Chloroquine and have it ready for trials on medical staff soon.', 0.38848743), ('There are reports about successful early clinical trials of chloroquine in China as early as beginning of February, and conclusion was that wide treatment is warranted.', 0.38397145), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.25823167), ('42 share ReportSave level 1 10 months ago https://adisinsight.springer.com/drugs/800016590 discontinued it says.', 0.2556747)]"
1466,Alberta bans all public gatherings of more than 250 people and asks all those returning from other countries self-isolate for 14 days .,ban,alberta _ all public gatherings of more than 250 people and asks all those returning from other countries self-isolate for 14 days .,alberta plans all public gatherings of more than 250 people and asks all those returning from other countries self-isolate for 14 days.,https://calgaryherald.com/news/local-news/alberta-covid-19-toll-hits-as-nhl-suspends-season-kenney-comes-home/wcm/d21be769-bf65-4ee3-a306-1a7f8886cdad/,"[('All Albertans outside the country are asked to self-isolate for 14 days once they return, no matter which country they visited.', 0.7948611), ('All Albertans returning to the country are asked to self-isolate for 14 days after they return, no matter what country they visited.', 0.7713516), ('Alberta’s top doctor announced Thursday afternoon that a ban is now in place for all public gatherings of 250 or more people.', 0.73062843), ('“The risk of waiting is greater than the risk of implementing these measures now.” All Albertans returning to the country are asked to self-isolate for 14 days after they return, no matter what country they visited.', 0.7269375), ('The government has asked all those arriving in Canada from any international destination to self-isolate for 14 days.', 0.70187044)]"
1467,COVID-19 care homes study report,homes,covid-19 care _ study report,covid-19 care training study report,https://www.gov.uk/government/publications/vivaldi-1-coronavirus-covid-19-care-homes-study-report/vivaldi-1-covid-19-care-homes-study-report,"[('Hide GOV.UK Show or hide search Search on GOV.UK Search Coronavirus (COVID-19) National lockdown: stay at home Brexit Check how the new rules affect you 1.', 0.4448623), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.43243143), (""Carers' health 5."", 0.3836667), ('Vivaldi then undertook multivariable analysis to identify characteristics of high-risk care homes, controlling for other factors (below).', 0.33380136), ('Care home staff were asked to report on the total number of confirmed cases among staff and residents since the start of the pandemic.', 0.3024721)]"
1468,RedHill Biopharma 's Opaganib Demonstrates Complete Inhibition of SARS-CoV-2,sar,redhill biopharma 's opaganib demonstrates complete inhibition of _-cov-2,redhill biopharma's opaganib demonstrates complete inhibition of AAs-cov-2,https://finance.yahoo.com/news/redhill-biopharma-opaganib-demonstrates-complete-123000252.html,"[('Results from this study showed a clear and compelling antiviral effect of opaganib against SARS-CoV-2.', 0.69133496), ('Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice.', 0.68471104), ('Opaganib demonstrated potent antiviral activity against SARS-CoV-2, the virus that causes COVID-19, completely inhibiting viral replication in an in vitro model of human lung bronchial tissue.', 0.6028319), ('In addition to opaganib, RedHill’s in-vitro study evaluated the antiviral activity of its Phase-2 stage investigational drug, RHB-107 (upamostat), a serine protease inhibitor active against a number of human serine proteases, with results demonstrating potent inhibition of SARS-CoV-2 viral replication.', 0.59893036), ('Story continues Results from this study showed a clear and compelling antiviral effect of opaganib against SARS-CoV-2.', 0.58529013)]"
1471,Serology confirms SARS-CoV-2 infection in PCR-negative children presenting with Paediatric Inflammatory Multi-System Syndrome,negative,serology confirms sars-cov-2 infection in pcr-_ children presenting with paediatric inflammatory multi-system syndrome,serology confirms sars-cov-2 infection in pcr-positive children presenting with paediatric inflammatory multi-system syndrome,https://www.medrxiv.org/content/10.1101/2020.06.05.20123117v1,"[('Tests for SARS-CoV-2 infection by PCR gave negative results.', 0.7595038), ('Serological responses were detected against purified near-full-length trimeric SARS-CoV-2 viral spike glycoprotein by ELISA.', 0.74403006), ('This therefore offers a widening of the value of serology in the identification and understanding of infections caused by SARS-CoV-2.', 0.67385066), ('Detection of anti-SARS-CoV-2 antibody responses in children with PIMS-TS.', 0.67127204), ('Below, we present findings demonstrating that children with PIMS-TS, who are PCR-negative for SARS-CoV-2, can present with very high levels of IgG antibody to the virus.', 0.66368014)]"
1474,Trump 's musings prompt social-media censorship of information about an experimental treatment .,trump,_ 's musings prompt social-media censorship of information about an experimental treatment .,A's musings prompt social-media censorship of information about an experimental treatment.,https://www.wsj.com/articles/an-experimental-ultraviolet-light-treatment-for-covid-19-takes-political-heat-11588005938,"[('Technologies like Healight, which if borne out through clinical studies may represent a viable way to kill coronaviruses, aren’t provided the clear-headed consideration they deserve but are instead flushed into the political mosh-pit of “us vs. them.” Twitter, YouTube and Vimeo are under enormous pressure from political activists.', 0.5758704), ('Read Full Article » Related Topics:President Donald Trump, Coronavirus, Ultraviolet Light Comment Show comments Hide Comments Log In with your RCMG Account Register ', 0.49932802), ('.” My team and I knew the president’s comments could trigger a backlash against the idea of UV light as a treatment, which might hinder our ability to get the word out.', 0.49660712), ('But hardly anyone noticed—until Thursday, when President Trump mused, “.', 0.47877875), ('Unfortunately, the visceral excitement of political conflict draws far more clicks and better ratings than the methodical world of science.', 0.45869792)]"
1476,Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester,suggests,expression of sars-cov-2 receptor ace2 and the protease tmprss2 _ susceptibility of the human embryo in the first trimester,expression of sars-cov-2 receptor ace2 and the protease tmprss2 inhibited susceptibility of the human embryo in the first trimester,https://royalsocietypublishing.org/doi/10.1098/rsob.200162,"[('Expression of ACE2 and TMPRSS2 in the pre-gastrulation human embryo.', 0.7487172), ('With these considerations in mind, we address here when in human development is the earliest stage at which SARS-CoV-2 receptor, angiotensin-converting enzyme 2 (ACE2), is first expressed and therefore when the human embryo could possibly become infected.', 0.71704495), ('Here, we examine human pre-gastrulation embryos to determine the expression patterns of the genes ACE2 , encoding the SARS-CoV-2 receptor, and TMPRSS2 , encoding a protease that cleaves both the viral spike protein and the ACE2 receptor to facilitate infection.', 0.71455586), ('2020The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study.', 0.70111847), (""SARS-CoV-2 entry into a cell involves the interaction of its spike protein with the cell's membrane-bound angiotensin-converting enzyme 2 (ACE2), which is cleaved by the transmembrane protease serine 2 (TMPRSS2) [10]."", 0.67672664)]"
1477,MUSC team releases plans for 3D printed masks,releases,musc team _ plans for 3d printed masks,musc team received plans for 3d printed masks,https://web.musc.edu/about/news-center/2020/03/26/3d-printed-masks-developed-at-medical-university-of-south-carolina,"[('3D Printing Masks ', 0.7921138), ('Meanwhile, another group was working on creating the masks.', 0.6847235), ('Photos by Sarah Pack View 3D Printer Mask Details With the threat of a shortage of protective masks looming as the novel coronavirus pandemic grows, Medical University of South Carolina biomedical engineers and tinkerers had an inspired idea: unleash an army of makers from across the U.S. who could make such masks from 3D printers – a technology that, in recent years, has become widely available.', 0.66718763), ('They 3D scanned a mask to get the basic shape, then designed modifications so the mask could accommodate the disposable filter cartridge.', 0.6575321), ('The team is already printing masks at MUSC, even as they continue to perfect the design.', 0.656988)]"
1479,Relationship between Average Daily Temperature and Average Cumulative Daily Rate of Confirmed Cases of COVID-19,temperature,relationship between average daily _ and average cumulative daily rate of confirmed cases of covid-19,relationship between average daily dose and average cumulative daily rate of confirmed cases of covid-19,https://www.medrxiv.org/content/10.1101/2020.04.10.20059337v1,"[('Besides, the analysis of the average air temperatures shows that the epidemic rates of COVID-19 were higher in the case studies with a lower average temperature.', 0.53990555), ('BACKGROUND The rapid outbreak of the new Coronavirus (COVID-19) pandemic and the spread of the virus worldwide, especially in the Northern Hemisphere, have prompted various investigations about the impact of environmental factors on the rate of development of this epidemic.', 0.38308114), ('Conversely, if there are no significant differences in the mean daily temperature of two regions in the same country, no significant difference is observed in the average cumulative daily rate of confirmed cases for these regions.', 0.369628), ('Yes All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.', 0.34631574), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.33699083)]"
1482,Transferrin receptor is another receptor for SARS-CoV-2 entry,another,transferrin receptor is _ receptor for sars-cov-2 entry,transferrin receptor is not receptor for sars-cov-2 entry,https://www.biorxiv.org/content/10.1101/2020.10.23.350348v1,"[('Collectively, this report indicates that TfR is another receptor for SARS-CoV-2 entry and a promising anti-COVID-19 target.', 0.6740232), ('However, no ACE2 inhibitors have shown definite beneficiaries for COVID-19 patients, applying the presence of another receptor for SARS-CoV-2 entry.', 0.5369667), ('TfR-virus co-localization is found both on the membranes and in the cytoplasma, suggesting SARS-CoV-2 transporting by TfR, the iron-transporting receptor shuttling between cell membranes and cytoplasma.', 0.5269711), ('Here we show that ACE2 knockout dose not completely block virus entry, while TfR directly interacts with virus Spike protein to mediate virus entry and SARS-CoV-2 can infect mice with over- expressed humanized transferrin receptor (TfR) and without humanized ACE2.', 0.45912278), ('Anti-TfR antibody (EC50 ~16.6 nM) shows promising anti-viral effects in mouse model.', 0.3689947)]"
1483,Virus evolution affected early COVID-19 spread,evolution,virus _ affected early covid-19 spread,virus transmission affected early covid-19 spread,https://www.medrxiv.org/content/10.1101/2020.09.29.20202416v1,"[('If true, then we expect an increased growth rate of reported COVID-19 cases in regions dominated by viruses with these altered proteins.', 0.79767597), ('In particular, higher proportions of clade 19A and 19B were negatively correlated with COVID-19 growth rate, whereas higher proportions of 20A and 20C were positively correlated with growth rate.', 0.5657299), ('Clade, but not variant D614G which has been associated with increased viral load, enhanced our ability to describe early COVID-19 growth dynamics.', 0.56140363), ('Although most of these mutations are expected to be inconsequential, some mutations in the spike protein structure have been hypothesized to affect the critical stage at which the virus invades human cells, which could affect transmission probability and disease expression.', 0.44197452), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.4312551)]"
1484,Indiana bans all non-essential gatherings over 250 people,250,indiana bans all non-essential gatherings over _ people,indiana bans all non-essential gatherings over 15 people,http://www.nbcchicago.com/news/local/indiana-bans-non-essential-gatherings-of-over-250-people-amid-coronavirus-concerns/2235959/%3f,"[('The state of Indiana has banned non-essential gatherings of more than 250 people, Gov.', 0.88026285), ('Non-essential gatherings must be limited to no more than 250 people.', 0.6392664), ('Starting immediately - all non-essential gatherings are limited to fewer than 250 people.', 0.5945151), ('Domestic out-of-state employee travel, with the exception of travel to states immediately contiguous to Indiana, has also been suspended.', 0.57214415), ('Eric Holcomb has announced additional steps the state will take to reduce the spread of novel coronavirus, or COVID-19 in Indiana, including limiting non-essential gatherings to no more than 250 people.', 0.56060505)]"
1486,Swiss Scientists Have Recreated the Coronvirus in a Lab from just the Sequence,from,swiss scientists have recreated the coronvirus in a lab _ just the sequence,swiss scientists have recreated the coronvirus in a lab without just the sequence,https://onezero.medium.com/swiss-scientists-have-recreated-the-coronavirus-in-a-lab-d12816bfdbe3,"[('Behind the doors of a high-security laboratory in a tiny Swiss village, researchers at the University of Bern recreated the coronavirus, formally known as SARS-CoV-2, in just a week using yeast, a published genome, and mail- order DNA.', 0.7413281), ('Three weeks later, the Swiss team had most of the DNA fragments they needed to start reconstructing the coronavirus genome.', 0.6372856), ('This content was published on March 3, 2020 - 15:00 March 3, 2020 - 15:00 See in another language: 1 中文 (zh) 切割新冠病毒基因的瑞士实验室 Three weeks before the first case was identified on Swiss soil scientists at a high security lab managed to make a synthetic clone of the coronavirus.', 0.6278939), ('> “It worked perfectly, like a Swiss watch.” Next, the researchers needed to convert the coronavirus genome from DNA to a related molecule called RNA (coronavirus is an RNA virus, meaning its genetic material is RNA rather than DNA).', 0.6067373), ('Switzerland also contributed to another breakthrough discovery concerning the coronavirus.', 0.58863366)]"
1487,Researchers set to begin clinical trials on coronavirus treatment,researchers,_ set to begin clinical trials on coronavirus treatment,Participants set to begin clinical trials on coronavirus treatment,https://www.uq.edu.au/news/article/2020/03/researchers-set-begin-clinical-trials-coronavirus-treatment,"[('“We’re now ready to begin patient trials with the drugs, one of which is an HIV medication and the other an anti-malaria drug,” Professor Paterson said.', 0.7023007), ('University of Queensland Centre for Clinical Research Director and Consultant Infectious Diseases Physician at the Royal Brisbane and Women’s Hospital (RBWH) Professor David Paterson said the drugs proved highly effective when first used against the virus in test tubes.', 0.63266754), ('Please note: Only people who’ve been diagnosed as COVID-19 positive and been admitted to a hospital where the clinical trial will take place can participate.', 0.40944332), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.3984427), (""The Bulletin video Skin cancer: Why don't we have a national screening pro... (C) The University of Queensland Enquiries: +61 7 3365 1111 "", 0.3870212)]"
1489,SickKids-led group of experts proposes latest guidance for school reopening,school,sickkids-led group of experts proposes latest guidance for _ reopening,sickkids-led group of experts proposes latest guidance for research reopening,https://www.sickkids.ca/AboutSickKids/Newsroom/Past-News/2020/covid19-school-guidance.html,"[('TORONTO - A group of experts from across Ontario have come together to develop updated considerations for a safe school reopening amid the COVID-19 pandemic.', 0.6938916), ('The new document represents a refinement of the previous recommendations with additional considerations for a spectrum of stakeholders as they prepare to return to school.', 0.61400807), ('The living document, Updated COVID-19: Guidance for School Reopening (pdf), published July 29, 2020, builds on the initial set of recommendations put forward by The Hospital for Sick Children (SickKids) and Unity Health Toronto, with input from experts from a wide range of disciplines across the province.', 0.6122681), ('As government and school boards plan re-opening scenarios, children with special needs must be considered.""', 0.58964884), ('Some of the changes include: Increased focus on epidemiology of COVID-19 and the influence of community transmission on school reopening plans.', 0.55815035)]"
1494,SARS-CoV-2 Viral Load is Associated with Increased Disease Severity and Mortality,with,sars-cov-2 viral load is associated _ increased disease severity and mortality,sars-cov-2 viral load is associated without increased disease severity and mortality,https://www.medrxiv.org/content/10.1101/2020.07.15.20131789v1,"[('SARS-CoV-2 viral loads, especially plasma viremia, are associated with increased risk of mortality.', 0.8417617), ('SARS-CoV-2 viral loads, especially within plasma, are associated with systemic inflammation, disease progression, and increased risk of death.', 0.82796574), ('2: SARS-CoV-2 viral load is associated with markers of inflammation and disease severity.', 0.80461276), ('Here we show that SARS-CoV-2 viral loads, especially in the plasma, are predictive of mortality.', 0.7968589), ('1: SARS-CoV-2 viral loads across sampling sites and detection rates by disease severity.', 0.77862966)]"
1495,"Vitamin D determines severity in COVID-19 so government advice needs to change , experts urge",vitamin,"_ d determines severity in covid-19 so government advice needs to change , experts urge","Figure d determines severity in covid-19 so government advice needs to change, experts urge",https://www.sciencedaily.com/releases/2020/05/200512134426.htm,"[('We call on the Irish government to update guidelines as a matter of urgency and encourage all adults to take supplements during the COVID-19 crisis.', 0.5699699), (""This may be because vitamin D is important in regulation and suppression of the inflammatory cytokine response, which causes the severe consequences of COVID-19 and 'acute respiratory distress syndrome' associated with ventilation and death."", 0.52879107), ('The correlation between low vitamin D levels and death from COVID-19 is statistically significant.', 0.50829196), ('Professor Rose Anne Kenny said: ""In England, Scotland and Wales, public health bodies have revised recommendations since the COVID-19 outbreak.', 0.4923199), ('The authors propose that, whereas optimising vitamin D levels will certainly benefit bone and muscle health, the data suggests that it is also likely to reduce serious COVID-19 complications.', 0.47958466)]"
1496,Danish vaccine against coronavirus passes tests in mice,tests,danish vaccine against coronavirus passes _ in mice,danish vaccine against coronavirus passes not in mice,https://news.ku.dk/all_news/2020/06/vaccine-against-coronavirus-passes-tests-in-mice/,"[('The World Health Organization and scientists outside of Denmark have said they have yet to see evidence that this variant will have any effect on vaccines.', 0.6029136), ('The amount and quality of these vaccine- induced antibodies have been tested directly on SARS-CoV-2 virus in two independently laboratories headed by Professor Søren Riis Paludan at Aarhus University and Professor Marjolein Kikkert, Leiden University Medical Center, which are part of the consortium Prevent-nCov.', 0.5940529), ('The researchers, supported by the Carlsberg Foundation, among others, have now tested the vaccine on mice with promising results.', 0.5921376), ('The vaccine has been tested in mice and shows promising results.', 0.57953346), ('“We have tested the vaccine in mice and achieved positive immune responses.', 0.5693748)]"
1497,A five day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness,day,a five _ course of ivermectin for the treatment of covid-19 may reduce the duration of illness,a five years course of ivermectin for the treatment of covid-19 may reduce the duration of illness,https://www.sciencedirect.com/science/article/pii/S1201971220325066,"[('A 5-day course of ivermectin resulted in an earlier clearance of the virus compared to placebo ( p = 0.005), thus indicating that early intervention with this agent may limit viral replication within the host.', 0.7236385), ('A 5-day course of ivermectin was found to be safe and effective in treating adult patients with mild COVID-19.', 0.65503615), ('• Ivermectin may be effective for the treatment of early-onset mild COVID-19 in adult patients.', 0.6448727), ('Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.', 0.6371268), ('Virological clearance was earlier in the 5-day ivermectin treatment arm when compared to the placebo group (9.7 days vs 12.7 days; p = 0.02), but this was not the case for the ivermectin + doxycycline arm (11.5 days; p = 0.27).', 0.6165129)]"
1499,A saliva-based RNA extraction-free workflow integrated with Cas13a for SARS-CoV-2 detection,saliva,a _-based rna extraction-free workflow integrated with cas13a for sars-cov-2 detection,a web-based rna extraction-free workflow integrated with cas13a for sars-cov-2 detection,https://www.medrxiv.org/content/10.1101/2020.11.07.20227082v1,"[('We developed and clinically validated Cas13a integrated lateral-flow readout to detect SARS-CoV-2 in RNA extraction-free saliva samples.', 0.88315845), ('Based on the results that RNAlater solution maintains the RNA quality and detection sensitivity in clinical samples ( above,Figure 1d), we initially used RNAlater solution and guanidine hydrochloride (GuHCL) to collect the saliva samples for validation using RNA extraction-free workflow.', 0.8211596), ('Thus, we aimed to develop a more sensitive workflow for the RNA extraction-free testing of saliva samples.', 0.8168855), ('Here, we present CASSPIT (C as13 A ssisted S aliva-based & S martphone I ntegrated T esting), which will allow direct use of saliva samples without the need for RNA extraction for SARS-CoV-2 detection.', 0.78519), ('Thus, these results suggest that the collection of saliva directly into the collection tube without any chemical or RNA preservative is optimal for the RNA extraction-free detection.', 0.77570754)]"
1500,Experimental COVID-19 Vaccine Protects Upper and Lower Airways in Nonhuman Primates,protects,experimental covid-19 vaccine _ upper and lower airways in nonhuman primates,experimental covid-19 vaccine infects upper and lower airways in nonhuman primates,https://www.niaid.nih.gov/news-events/experimental-covid-19-vaccine-protects-upper-and-lower-airways-nonhuman-primates,"[('Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates.', 0.7465497), ('This is the first time an experimental COVID-19 vaccine tested in nonhuman primates has been shown to produce such rapid viral control in the upper airway, the investigators note.', 0.72236717), ('Notably, say the investigators, animals receiving the 10-µg or 100-µg dose vaccine candidate produced neutralizing antibodies in the blood at levels well above those found in people who recovered from COVID-19.', 0.68162894), ('A COVID-19 vaccine that reduces viral replication in the lungs would limit disease in the individual, while reducing shedding in the upper airway would potentially lessen transmission of SARS-CoV-2 and consequently reduce the spread of disease, they add.', 0.6348481), ('Moreover, none of the eight macaques vaccinated with 100 µg of mRNA-1273 had detectable virus in their noses two days after virus exposure.', 0.51280904)]"
1501,Inflammatory Biomarker Trends Predict Respiratory Decline in COVID-19 Patients,decline,inflammatory biomarker trends predict respiratory _ in covid-19 patients,inflammatory biomarker trends predict respiratory infection in covid-19 patients,https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(20)30188-9,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.3049726), ('Please switch to a supported browser to continue using twitter.com.', 0.24702084), ('403: Forbidden [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.15229362), ('Help Center Terms of Service Privacy Policy Cookie Policy Imprint Ads info © 2021 Twitter, Inc. [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.11618955), ('There was a problem providing the content you requested Please contact us via our support center for more information and provide the details below.', 0.107963756)]"
1502,Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV,host,multi-level proteomics reveals _-perturbation strategies of sars-cov-2 and sars-cov,multi-level proteomics reveals sub-perturbation strategies of sars-cov-2 and sars-cov,https://www.biorxiv.org/content/10.1101/2020.06.17.156455v1,"[('Projecting these data onto the global network of cellular interactions revealed relationships between the perturbations taking place upon SARS-CoV-2 infection at different layers and identified unique and common molecular mechanisms of SARS coronaviruses.', 0.77418184), ('To understand how SARS-CoV-2 and related coronaviruses manipulate the host we here characterized interactome, proteome and signaling processes in a systems- wide manner.', 0.7431885), ('We investigated the closely related SARS-CoV-2 and SARS-CoV viruses as well as the influence of SARS-CoV-2 on transcriptome, proteome, ubiquitinome and phosphoproteome of a lung-derived human cell line.', 0.67279786), ('This identified connections between the corresponding cellular events, revealed functional effects of the individual viral proteins and put these findings into the context of host signaling pathways.', 0.65463674), ('The results highlight the functionality of individual proteins as well as vulnerability hotspots of SARS-CoV-2, which we targeted with clinically approved drugs.', 0.6333052)]"
1504,B cells and T cells mediate immunity to COVID-19,immunity,b cells and t cells mediate _ to covid-19,b cells and t cells mediate exposure to covid-19,https://www.nature.com/articles/s41577-020-00436-4,"[('Robust immune responses with spike-specific neutralizing antibodies, memory B cells and circulating TFH cells have been found in patients who have recovered from COVID-19 infection8.', 0.71188724), ('Here, we discuss our current understanding of the relative contribution of B cells and T cells to immunity to SARS-CoV-2 and the implications for the development of effective treatments and vaccines for COVID-19.', 0.6898358), ('These T cells are probably cross-reactive with other HCoVs, but whether they can provide protection from COVID-19 disease remains to be determined.', 0.67866015), ('Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19.', 0.6726063), ('Potent neutralizing antibody responses have been found in hospitalized patients with COVID-19, and human monoclonal antibodies (mAbs) generated from these patients target multiple epitopes of the spike protein6 and could be a promising therapy.', 0.61401486)]"
1506,Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies .,sar,asymptomatic and symptomatic _-cov-2 infections elicit polyfunctional antibodies .,asymptomatic and symptomatic CPVs-cov-2 infections elicit polyfunctional antibodies.,https://www.medrxiv.org/content/10.1101/2020.11.12.20230508v1,"[('\\- Asymptomatic and symptomatic SARS-CoV-2-infected individuals harbor polyfunctional antibodies.', 0.8948056), ('Overall, asymptomatic SARS-CoV-2 infection elicits polyfunctional antibodies neutralizing the virus and targeting infected cells.', 0.86875236), ('Asymptomatic individuals mount polyfunctional antibody response to SARS-CoV-2.', 0.84495115), ('""Asymptomatic individuals mount polyfunctional antibody response to SARS-CoV-2"".', 0.82937324), ('In addition to the generation of anti-SARS-CoV-2 neutralizing antibodies, this polyfunctional response includes the induction of antibody-dependent cellular cytotoxicity (ADCC) and complement deposition.', 0.71851325)]"
1507,Aerosol Particles Laden with Viruses That Cause COVID-19 Travel Over 30m Distance,over,aerosol particles laden with viruses that cause covid-19 travel _ 30m distance,aerosol particles laden with viruses that cause covid-19 travel within 30m distance,https://www.preprints.org/manuscript/202004.0546/v2,"[('The modelling also suggests that it should be possible to measure virus causing COVID-19 (SARS-CoV-2) within aerosol particles in hospitals and public places, e.g.', 0.612532), ('The results obtained demonstrate that aerosol particles generated by coughing and sneezing can travel over 30 m. Modelling of the evolution of aerosol clouds generated by coughing and sneezing enables us to evaluate the deposition dose of aerosol particles in healthy individuals.', 0.5038202), ('supermarket or car park) can accumulate in the respiratory system up to 200 virus copies in 2 min time by breathing in virus laden aerosols.', 0.48329836), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.39000523), ('Close menu Please declare any conflicts of interest you may have with this paper, financial or otherwise.', 0.316653)]"
1508,Nobel laureate predicts a quicker coronavirus recovery,quicker,nobel laureate predicts a _ coronavirus recovery,nobel laureate predicts a few coronavirus recovery,https://www.latimes.com/science/story/2020-03-22/coronavirus-outbreak-nobel-laureate?_amp=true,"[(""SEE MORE ABOUT THE CURRENT CORONAVIRUS PANDEMIC NOBEL LAUREATE PREDICTS US WILL HAVE MUCH FASTER CORONAVIRUS RECOVERY THAN EXPECTED WHO IS DR. ANTHONY FAUCI, AMERICA'S TOP CORONAVIRUS FIGHTER?"", 0.7806978), ('A Nobel laureate and Stanford biophysicist estimates the United States may see a downturn in new coronavirus cases sooner than health experts have predicted, according to the Los Angeles Times.', 0.5980194), ('The Nobel laureate accurately predicted the number of coronavirus cases and deaths in China.', 0.59059393), ('The Medium, a first post on the Excess Burden of Death associated with coronavirus.', 0.5250496), ('IS CORONAVIRUS MORE FATAL TO MEN THAN WOMEN?', 0.4967005)]"
1510,Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 and block entry of SARS-CoV-2 into cells,predicted,withanone and withaferin-a are _ to interact with transmembrane protease serine 2 and block entry of sars-cov-2 into cells,withanone and withaferin-a are unable to interact with transmembrane protease serine 2 and block entry of sars-cov-2 into cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309304/,"[('Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells All authors Vipul Kumar, Jaspreet Kaur Dhanjal, Priyanshu Bhargava, Ashish Kaul, Jia Wang, Huayue Zhang, Sunil C. Kaul, Renu Wadhwa & Durai Sundar https://doi.org/10.1080/07391102.2020.1775704 ', 0.7499477), ('SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.', 0.73343325), ('Camostat mesylate (a serine protease inhibitor), well documented for the treatment of cancer, pancreatitis and liver fibrosis, has recently been shown to inhibit TMPRSS2 and entry of SARS-CoV-2 virus into the cells (Hoffmann et al., 2020).', 0.7288091), ('Recently, SARS-CoV-2 was shown to use the ACE2 receptor for entry and the serine protease TMPRSS2 for S protein priming.', 0.7227944), ('TMPRSS2 (transmembrane protease, serine 2).', 0.718958)]"
1511,A previously uncharacterized gene in SARS-CoV-2 illuminates the functional dynamics and evolutionary origins of the COVID-19 pandemic,previously,a _ uncharacterized gene in sars-cov-2 illuminates the functional dynamics and evolutionary origins of the covid-19 pandemic,a newly uncharacterized gene in sars-cov-2 illuminates the functional dynamics and evolutionary origins of the covid-19 pandemic,https://www.biorxiv.org/content/10.1101/2020.05.21.109280v1,"[('We investigate de novo OLG candidates in SARS-CoV-2 and identify a new gene here named ORF3c.', 0.43898058), ('Our results liken ORF3c to other important viral accessory genes recombined, lost, split, or truncated before or during outbreaks, including ORF3b and ORF8 in sarbecoviruses.', 0.40592134), ('One under- investigated class of functional genomic elements is overlapping genes (OLGs), which allow a single stretch of nucleotides to encode two distinct proteins in different reading frames.', 0.39248642), ('Specifically, 21 representative sarbecovirus genomes show ORF3c is also present in some pangolin-CoVs but not more closely related bat-CoVs; 3,978 SARS-CoV-2 genomes reveal ORF3c gained a new stop codon (G25563U) that rose drastically in frequency during the current COVID-19 pandemic; and 401 deeply sequenced samples of SARS-CoV-2 demonstrate the recurrence of this mutation in multiple hosts.', 0.3837925), ('Viral OLGs are common and have been associated with the origins of pandemics, but are still widely overlooked.', 0.3791385)]"
1512,Lung and gut microbiota are altered by hyperoxia and contribute to oxygen-induced lung injury in mice,mice,lung and gut microbiota are altered by hyperoxia and contribute to oxygen-induced lung injury in _,lung and gut microbiota are altered by hyperoxia and contribute to oxygen-induced lung injury in humans,https://stm.sciencemag.org/content/12/556/eaau9959,"[('During exposure of mice to hyperoxia, both lung and gut bacterial communities were altered, and these communities contributed to oxygen-induced lung injury.', 0.92459905), ('1.. Hyperoxia alters lung microbiota in humans and in neonatal and adult mice.', 0.8701901), ('Variation in lung inflammation correlates with variation in lung microbiota in hyperoxia-exposed mice.', 0.82742935), ('( B ) Disruption of lung microbiota was measured using dissimilarity of lung microbial communities (Bray-Curtis similarity index) from those of mice unexposed to hyperoxia (time 0).', 0.77549267), ('7.. Hyperoxia alters microbial growth conditions in the mouse lung microenvironment.', 0.7597541)]"
1515,The CDC recommends organizers cancel or postpone events with 50 people or more for 8 weeks,organizers,the cdc recommends _ cancel or postpone events with 50 people or more for 8 weeks,the cdc recommends no cancel or postpone events with 50 people or more for 8 weeks,https://www.cnn.com/2020/03/15/health/us-coronavirus-sunday-updates/index.html,"[('The CDC recommended organizers ""cancel or postpone in-person events that consist of 50 people or more throughout the United States.""', 0.8419273), ('(CNN)The US Centers for Disease Control and Prevention on Sunday recommended that no gatherings with 50 people or more take place for the next eight weeks to slow the spread of the novel coronavirus.', 0.71024287), ('A state-by-state breakdown of US coronavirus cases The new guidance underscores just how much life in the United States will change as the country continues to fight the outbreak, and as officials nationwide order more schools, bars and restaurants to close.', 0.54828686), ('In New Orleans, Mayor LaToya Cantrell ordered all full-service restaurants with seating capacity to close at 9 p.m. and asked that establishments attempt to reduce capacity by half.', 0.53193516), ('Janet Mills became one of the latest leaders to issue a state of emergency Sunday, recommending an end to classroom instruction in public schools statewide ""as soon as reasonably practical.""', 0.5076699)]"
1516,Researchers identify a protein that may help SARS-CoV-2 spread rapidly through cells,may,researchers identify a protein that _ help sars-cov-2 spread rapidly through cells,researchers identify a protein that cannot help sars-cov-2 spread rapidly through cells,https://natsci.source.colostate.edu/researchers-identify-a-protein-that-may-help-sars-cov-2-spread-rapidly-through-cells/,"[('view more Credit: Eric Ross and Sean Cascarina/Colorado State University Eric Ross and Sean Cascarina, biochemistry and molecular biology researchers at Colorado State University, have released a research paper identifying a protein encoded by SARS-CoV-2, the virus that causes COVID-19, that may be associated with the quick spread of the virus through cells in the human body.', 0.6510585), ('""Medically, if you could counteract the virus\' ability to interfere with a cell\'s immune response, then you could help the cells to fight off the virus,"" said Ross.', 0.48682082), ('""The cell can react to a stress event by making changes in the cellular environment,"" said Ross, ""including making these modifications to some proteins.""', 0.48511773), (""The N protein may also be associated with reducing an infected cell's anti- viral stress response."", 0.45787066), ('""They want to be infectious, so sometimes they are able to regulate these stress granules.""', 0.45423302)]"
1517,Microwave or Autoclave Treatments Destroy the Infectivity of Infectious Bronchitis Virus and Avian Pneumovirus but Allow Detection by Reverse Transcriptase-Polymerase Chain Reaction,treatments,microwave or autoclave _ destroy the infectivity of infectious bronchitis virus and avian pneumovirus but allow detection by reverse transcriptase-polymerase chain reaction,microwave or autoclave cannot destroy the infectivity of infectious bronchitis virus and avian pneumovirus but allow detection by reverse transcriptase-polymerase chain reaction,https://pubmed.ncbi.nlm.nih.gov/15223557/,"[('Microwave treatment appears to be a satisfactory method of inactivating virus while preserving nucleic acid for PCR identification.', 0.73894775), ('However, both IBV and APV could be detected by reverse transcriptase (RT)-PCR after autoclaving and as long as 5 min microwave treatment (Newcastle disease virus and avian influenza viruses were not tested).', 0.7273114), ('Autoclaving and microwave treatment for as little as 20 sec destroyed the infectivity of all four viruses.', 0.66840637), ('Swabs from the tracheas and cloacas of chicks infected with IBV shown to contain infectious virus were microwaved.', 0.63451695), ('Microwave- and heat-based decontamination of N95 filtering facepiece respirators: a systematic review.', 0.5750245)]"
1519,Distributed Manufacturing of Open-Source Medical Hardware for Pandemics,manufacturing,distributed _ of open-source medical hardware for pandemics,distributed lack of open-source medical hardware for pandemics,https://www.preprints.org/manuscript/202004.0054/v1,"[('The results show there is still considerable work needed to provide open source paths for the development of all the medical hardware needed during pandemics.', 0.6527905), ('Five core areas of future work are discussed that include: i) technical development of a wide-range of open source solutions for all medical supplies and devices, ii) policies that protect the productivity of laboratories, makerspaces and fabrication facilities during a pandemic, as well as iii) streamlining the regulatory process, iv) developing Good-Samaritan laws to protect makers and designers of open medical hardware, as well as to compel those with knowledge that will save lives to share it, and v) requiring all citizen-funded research to be released with free and open source licenses.', 0.5928956), ('To prepare for the next pandemic, this study reviews the state-of-the-art for open hardware designs needed in a COVID-19-like pandemic.', 0.55496025), ('The results show that the majority of the actual medical products have had some open source development, however, only 15% of the supporting technologies that make the open source device possible are freely available.', 0.5110745), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.393783)]"
1520,COVID-19 Racial Disparities Could Be Worsened By Location Of Test Sites,could,covid-19 racial disparities _ be worsened by location of test sites,covid-19 racial disparities cannot be worsened by location of test sites,https://www.npr.org/sections/health-shots/2020/05/27/862215848/across-texas-black-and-hispanic-neighborhoods-have-fewer-coronavirus-testing-sit?origin=NOTIFY,"[('""For the most part across the U.S., it\'s really, really hard to rely on those government websites for the information,"" says Tarryn Marcus, who leads a volunteer effort called Get Tested COVID-19, which is attempting to compile a national database of testing locations.', 0.48704654), ('racial inequities coronavirus in the U.S. coronavirus testing COVID-19 Facebook Twitter Flipboard Email ', 0.46009552), ('Dan Tian/Xinhua News Agency/Getty Images As COVID-19 continues to spread across the country, state and local health officials rush to try to detect and contain outbreaks before they get out of control.', 0.45774072), ('""A lot of the disparity ... is reflecting some of that private sector availability of tests in the northern part of Dallas compared to southern Dallas.""', 0.45465815), ('While many things can affect access to testing, location is an important starting point.', 0.4466284)]"
1521,Covid-19 is plausibly from a man made virus .,from,covid-19 is plausibly _ a man made virus .,covid-19 is plausibly not a man made virus.,https://osf.io/usx58/,"[('Also known as 2019-nCoV, the virus causes COVID-19.', 0.7168022), ('Handout/National Institutes of Health/AFP via Getty Images Conspiracy theories claiming COVID-19 was engineered in a lab as part of a biological attack on the United States have been gaining traction online in recent weeks, but a new study on the origins of the virus has concluded that the pandemic-causing strain developed naturally.', 0.63466835), ('""The genomic features described here may explain in part the infectiousness and transmissibility of COVID-19 in humans,"" the authors wrote, adding that ""since we observed all notable COVID-19 features, including the optimized RBD and polybasic cleavage site, in related coronaviruses in nature, we do not believe that any type of laboratory-based scenario is plausible.""', 0.6105227), ('Myth 3: COVID-19 is no worse than the flu.', 0.60015774), ('""They conclude that the virus is the product of natural evolution, ending any speculation about deliberate genetic engineering,"" Josie Golding, an epidemic preparedness and response program officer at the Wellcome Trust, who was not involved in the study, said in a statement, calling the results ""crucially important to bring an evidence-based view to the rumors that have been circulating about the origins of the virus (SARS-CoV-2) causing COVID-19.""', 0.5853343)]"
1522,The explosion of new coronavirus tests that could help to end the pandemic,end,the explosion of new coronavirus tests that could help to _ the pandemic,the explosion of new coronavirus tests that could help to confirm the pandemic,https://www.nature.com/articles/d41586-020-02140-8,"[('If those tests are ready soon, it would be good news for the current pandemic and for future outbreaks.', 0.6128458), ('And because people with the coronavirus are most infectious at the onset of symptoms, tests for viral material are crucial to identify who should be in isolation.', 0.5916334), ('But once they are available, they could work alongside the gold standard to push countries closer to the target of millions of tests per week — and prepare the world for the next pandemic.', 0.5608228), ('“We have to go beyond testing just for the coronavirus,” she says.', 0.5349431), ('These labels release a fluorescent signal that is measured by a computer, flagging the presence of the virus (see ‘Testing techniques: the gold standard’).', 0.52736765)]"
1526,"SARS-CoV-2 and Malayan pangolin coronavirus infect human endoderm , ectoderm and induced lung progenitor cells",lung,"sars-cov-2 and malayan pangolin coronavirus infect human endoderm , ectoderm and induced _ progenitor cells","sars-cov-2 and malayan pangolin coronavirus infect human endoderm, ectoderm and induced neural progenitor cells",https://www.biorxiv.org/content/10.1101/2020.09.25.313270v1,"[('Here we present for the first time that SARS-CoV-2 pseudovirus and GXP2V could infect lung progenitor and even anterior foregut endoderm cells causing these cells death, which differentiated from human embryonic stem cells (hESCs).', 0.77302474), ('The infection and replication of SARS-CoV-2 and GXP2V were inhibited when treated with whey protein of breastmilk and Remdesivir, confirming that these two viruses could infect lung progenitor and even anterior foregut endoderm.', 0.7398775), ('Moreover, we found that SARS-CoV-2 pseudovirus could infect endoderm and ectoderm.', 0.64167494), ('The potential consequence of SARS-CoV-2 and animal coronavirus such as GXP2V infection in hESCs, germ layer and induced progenitors should be closely monitored.', 0.55494773), ('In line with the SARS- CoV-2 results, GXP2V could also infected endoderm and ectoderm, and also was inhibited by Remdesivir treatment.', 0.5030302)]"
1527,Trends in Covid-19 risk-adjusted mortality rates in a single health system,mortality,trends in covid-19 risk-adjusted _ rates in a single health system,trends in covid-19 risk-adjusted transmission rates in a single health system,https://www.medrxiv.org/content/10.1101/2020.08.11.20172775v1?fbclid=IwAR0owZwnbA7W6c2DvQ_OovdAUEWE1EB6hQ2ZR3Ak3aM-xM9H9D2BD8xkoAE,"[('We included all hospitalizations with laboratory-confirmed Covid-19 disease.', 0.71699524), ('In summary, data from one health system suggest that Covid-19 remains a serious disease for high risk patients, but that outcomes may be improving.', 0.69002426), ('Therefore, whether decreasing Covid-19 mortality rates are a reflection of changing demographics or represent improvements in clinical care is unknown.', 0.62086165), ('Discussion In this 16-week study of Covid-19 mortality at a single health system, we found that changes in demographics and severity of illness at presentation account for some, but not all, of the decrease in unadjusted mortality.', 0.5566106), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.44105414)]"
1529,A consensus Covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis,consensus,a _ covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis,a novel covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis,https://www.medrxiv.org/content/10.1101/2020.06.08.20125112v1,"[('Here we identify a consensus peripheral blood immune signature across 63 hospital-treated Covid-19 patients who were otherwise highly heterogeneous.', 0.70967615), ('Moreover, specific parameters including CXCL10/IP10 over- expression, T cell proliferation, and basophil and plasmacytoid dendritic cell depletion correlated, often prognostically, with Covid-19 progression, collectively composing a resource to inform SARS-CoV-2 pathobiology and risk- based patient stratification.', 0.6951501), ('By comparison to paucisymptomatic virus clearance by most individuals, Covid-19 has been proposed to reflect insufficient and/or pathologically exaggerated immune responses.', 0.64664173), ('The core signature conspicuously blended adaptive B cell responses typical of virus infection or vaccination with discrete traits hitherto associated with sepsis, including monocyte and dendritic cell dampening, and hyperactivation and depletion of discrete T cell subsets.', 0.594285), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.5647758)]"
1530,Sarilumab use in severe SARS-CoV-2 pneumonia,use,sarilumab _ in severe sars-cov-2 pneumonia,sarilumab deficiency in severe sars-cov-2 pneumonia,https://www.medrxiv.org/content/10.1101/2020.05.14.20094144v1,"[('Objective to describe the effect of off-label intravenous use of Sarilumab in patients with severe SARS-CoV-2-related pneumonia.', 0.7546929), ('Meaning IL-6R-inhibition is an effective approach for severe SARS-CoV-2 pneumonia and intravenous Sarilumab is a promising treatment approach leading to an important clinical benefit and good safety in the short term.', 0.55635726), ('Participants Patients with laboratory-confirmed SARS-CoV-2 infection and respiratory distress with PaO2/FiO2 ratio<300 treated with Sarilumab between March 23rd – April 4th, 2020.', 0.516225), ('Conclusions and relevance IL-6R inhibition appears to be a potential treatment strategy for severe SARS-CoV-2 pneumonia and intravenous Sarilumab seems a promising treatment approach showing, in the short term, an important clinical benefit and good safety.', 0.50991046), ('Findings In this observational clinical study, we reported the efficacy and safety of intravenous Sarilumab use in SARS-CoV-2 severe pneumonia with a global resolution rate of 83.0% (89.7% in medical wards and 64.3% in ICU) and an overall mortality rate of 5.7%.', 0.48324358)]"
1531,Humoral immune response and prolonged PCR positivity in a cohort of 1343 SARS-CoV 2 patients in the New York City region,prolonged,humoral immune response and _ pcr positivity in a cohort of 1343 sars-cov 2 patients in the new york city region,humoral immune response and rapid pcr positivity in a cohort of 1343 sars-cov 2 patients in the new york city region,https://www.medrxiv.org/content/10.1101/2020.04.30.20085613v1,"[('Here we investigated both seroconversion and PCR- positivity in a large cohort of convalescent serum donors in New York City.', 0.5697614), ('Methods Individuals with confirmed or suspected SARS-CoV-2 infection were screened via PCR for presence of viral genome and via enzyme-linked immunosorbent assay for presence of anti SARS-CoV-2 spike antibodies.', 0.54022616), ('Results All but three confirmed SARS-CoV-2 patients seroconverted to the SARS-CoV-2 spike while only 37.4% of suspected SARS-CoV-2 patients seroconverted.', 0.51778805), ('Conclusions Here we show that the vast majority of confirmed COVID19 patients seroconvert, potentially providing immunity to reinfection.', 0.427494), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.37220734)]"
1532,"Two thirds of people contacted through tracing did not fully cooperate , pilot scheme finds",not,"two thirds of people contacted through tracing did _ fully cooperate , pilot scheme finds","two thirds of people contacted through tracing did indeed fully cooperate, pilot scheme finds",https://www.bmj.com/content/369/bmj.m2169.short?rss=1,"[('The BMJ A covid-19 contact tracing pilot scheme in Sheffield has found that two thirds of people contacted did not fully cooperate, and many of those worked in health and care settings.', 0.5889368), ('However, for the other 39 (two thirds) of the contacts, index cases were unable or unwilling to give their names and details.', 0.56535363), ('Three referrals failed, one was inappropriate, one was dropped because of racist abuse, and one withdrew with no reason given.', 0.44254446), ('The Sheffield Community Contact Tracers team was created by a group of retired doctors and public health experts and began the local pilot in April after they became frustrated by the lack of government action on contact tracing.1 In a report,2 the team described the inability or unwillingness to engage by people working in health and care settings as a “major challenge.” They said that contact tracing may be resisted in workplaces, especially in the NHS and care homes, “where contact tracing systems, social distancing of staff, and a culture supportive of self-isolation frequently does not exist.” They also found that one in five of the initial patients responded to phone calls only after a physical message was hand delivered—something that the UK government may want to consider as it launches new NHS test and trace services.', 0.40714234), ('The team behind the pilot have warned that “test and trace” schemes just launched in England and Scotland could be fraught with difficulties because of their centralised approach and their use of minimum wage employees at call centres.', 0.39734063)]"
1534,Dutch Erasmus MC finds anti body .,body,dutch erasmus mc finds anti _ .,dutch erasmus mc finds anti toxicity.,https://www.erasmusmagazine.nl/2020/03/13/unieke-vondst-in-erasmus-mc-antilichaam-tegen-corona/,"[('” The Erasmus MC laboratory Image credit: Marko de Haan How unique is this find?', 0.53618413), (""By the time there was a vaccine and antibodies, the virus was already gone.” The view from Grosveld's office Image credit: Marko de Haan What do you think of the current approach in the Netherlands?"", 0.47888416), (""Netherlands' Erasmus Magazine reported."", 0.4631992), ('According to one of the people who identified it, the antibody that blocks the infection of SARS1 and SARS2 was already briefly lain in the fridge at the Erasmus MC in Rotterdam.', 0.46176654), ('In the article, Grosveld has responded critically to the Dutch approach to the Corona pandemic.', 0.44720167)]"
1535,Modified full-face Snorkel masks as reusable Personal Protective Equipment for Hospital Personnel,hospital,modified full-face snorkel masks as reusable personal protective equipment for _ personnel,modified full-face snorkel masks as reusable personal protective equipment for SARS personnel,https://www.medrxiv.org/content/10.1101/2020.04.24.20078907v1,"[('Key points Full-face snorkel masks are adapted for use as Personal Protective Equipment during the COVID-19 crisis, using a custom adapter that facilitates the attachment of inline medical-grade respiratory filters or NIOSH industrial respirator filters.', 0.8100944), ('The design (referred to as Pneumask) consists of a custom snorkel-specific adapter that couples the snorkel-port of the mask to a rated filter (either a medical-grade ventilator inline filter or an industrial filter).', 0.6798818), ('The benefit of the Pneumask as PPE is that it is reusable for longer periods than typical disposable N95 respirators, as the snorkel mask can withstand rigorous decontamination protocols (that are standard to regular elastomeric respirators).', 0.6523049), ('These tests found the Pneumask capable of forming a seal that exceeds the standards required for half-face respirators or N95 respirators.', 0.50234926), ('This design has been tested for the sealing capability of the mask, filter performance, CO2 buildup and clinical usability.', 0.46314186)]"
1536,Brd4-bound enhancers drive cell intrinsic sex differences in glioblastoma,intrinsic,brd4-bound enhancers drive cell _ sex differences in glioblastoma,brd4-bound enhancers drive cell surface sex differences in glioblastoma,https://www.biorxiv.org/content/10.1101/199059v3,"[('These observations led us to hypothesize that Brd4-bound enhancers might underlie sex differences in stem cell function and tumorigenicity in GBM.', 0.8328597), ('We report that sex-biased Brd4 activity drive sex differences in GBM and render male and female tumor cells differentially sensitive to BET inhibitors.', 0.75879955), ('Thus, for the first time, Brd4 activity is revealed to drive a sex differences in stem cell and tumorigenic phenotype, resulting in diametrically opposite responses to BET inhibition in male and female GBM cells.', 0.7451664), ('In an established isogenic murine model of glioblastoma, we discovered correlated transcriptome-wide sex differences in gene expression, H3K27ac marks, large Brd4-bound enhancer usage, and Brd4 localization to Myc and p53 genomic binding sites.', 0.70283175), ('These sex- biased gene expression patterns were also evident in human glioblastoma stem cells (GSCs).', 0.6932827)]"
1538,Will Pepcid AC Become the Next Toilet Paper ?,next,will pepcid ac become the _ toilet paper ?,will pepcid ac become the original toilet paper?,https://done.com/will-pepcid-ac-become-the-next-toilet-paper/,"[('Toilet paper.', 0.6622439), ('Customers are now allowed to buy one each of the following products per order: Toilet tissue multipacks.', 0.4779901), ('Credit...Tony Luong for The New York Times Supported by Continue reading the main story By Julie Creswell Dec. 8, 2020 First it was toilet paper.', 0.46003512), (""Wegmans said it will limit customers to one package per order for the following items (list as of Monday, 11/16): Paper towels Toilet paper Disinfecting sprays Disinfecting wipes Kitchen trash bags Freezer bags Facial tissue Paper napkins Wegmans is also limiting the following items to two packages per customer: Wegmans brand peanut butter Household cleaners, including bathroom cleaners, all-purpose cleaners, toilet bowl cleaners and window/glass cleaners Products containing famotidine, the active ingredient in such heartburn medications as Pepcid and Pepcid AC Tops said it would limit the following items to one purchase per customer (list as of Monday, 11/16): Toilet paper multipacks Paper towel multipacks Household cleaners Disinfectant sprays Disinfectant wipes Tops is limiting the following to two per shopper: Baby wipes Oatmeal Peanut butter Sugar, all brands and all sizes Liquid hand soap Paper napkins Kitchen trash bags Freezer bags Storage bags Paper plates Disposable rubber/latex or nitrile gloves “As we continue to best serve you and our community, we are working diligently to get the products you need on the shelves as quickly as possible,” Tops' website says."", 0.42474756), ('Disinfecting sprays.', 0.39381766)]"
1539,The Zinc Finger Antiviral Protein restricts SARS-CoV-2,finger,the zinc _ antiviral protein restricts sars-cov-2,the zinc shock antiviral protein restricts sars-cov-2,http://biorxiv.org/cgi/content/short/2020.06.04.134379,"[('Here, we show that Zinc finger antiviral protein (ZAP) that specifically targets CpG dinucleotides in viral RNA sequences restricts SARS-CoV-2.', 0.7997385), ('Highlights SARS-CoV-2 and its closest bat relatives show strong CpG suppression IFN-β, -γ and -λ inhibit SARS-CoV-2 with high efficiency ZAP restricts SARS-CoV-2 and contributes to the antiviral effect of IFNs ', 0.54059416), ('Thus, our results identify ZAP as an effector of the IFN response against SARS-CoV-2, although this pandemic pathogen may be preadapted to the low CpG environment in humans.', 0.5288044), ('Type I, II and III IFNs all strongly inhibited SARS-CoV-2 and further induced ZAP expression.', 0.48625565), ('Strikingly, SARS-CoV-2 and its closest relatives from bats show the strongest CpG suppression among all known human and bat coronaviruses, respectively.', 0.3916397)]"
1541,"Anti-Spike , anti-Nucleocapsid and neutralizing antibodies in SARS-CoV-2 hospitalized patients and asymptomatic carriers",spike,"anti-_ , anti-nucleocapsid and neutralizing antibodies in sars-cov-2 hospitalized patients and asymptomatic carriers","anti-IgG, anti-nucleocapsid and neutralizing antibodies in sars-cov-2 hospitalized patients and asymptomatic carriers",https://www.medrxiv.org/content/10.1101/2020.05.12.20098236v1,"[('Anti-Spike, anti-Nucleocapsid and neutralizing antibodies in SARS-CoV-2 inpatients and asymptomatic carriers.', 0.9565195), ('Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses.', 0.80027854), ('Share Anti-Spike, anti-Nucleocapsid and neutralizing antibodies in SARS-CoV-2 inpatients and asymptomatic carriers Etienne Brochot, Baptiste Demey, Antoine Touzé, Sandrine Belouzard, Jean Dubuisson, Jean-Luc Schmit, Gilles Duverlie, Catherine Francois, Sandrine Castelain, Francois Helle medRxiv 2020.05.12.20098236; doi: https://doi.org/10.1101/2020.05.12.20098236 Share This Article: Copy Citation Tools Anti-Spike, anti-Nucleocapsid and neutralizing antibodies in SARS-CoV-2 inpatients and asymptomatic carriers Etienne Brochot, Baptiste Demey, Antoine Touzé, Sandrine Belouzard, Jean Dubuisson, Jean-Luc Schmit, Gilles Duverlie, Catherine Francois, Sandrine Castelain, Francois Helle medRxiv 2020.05.12.20098236; doi: https://doi.org/10.1101/2020.05.12.20098236 ', 0.75583494), ('Longitudinal dynamics of the neutralizing antibody response to SARS- CoV-2 infection.', 0.75274736), ('Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.', 0.7513737)]"
1543,Single-cell analyses reveal SARS-CoV-2 interference with intrinsic immune response in the human gut,cell,single-_ analyses reveal sars-cov-2 interference with intrinsic immune response in the human gut,single-world analyses reveal sars-cov-2 interference with intrinsic immune response in the human gut,https://www.biorxiv.org/content/10.1101/2020.10.21.348854v1,"[('Human intestinal epithelium cells produce interferon upon SARS-CoV-2 infection.', 0.7193148), ('SARS-CoV-2 actively blocks interferon signaling in infected cells.', 0.68185174), ('Despite the evidence about SARS-CoV-2 infecting the human gut, little is known about the importance of the enteric phase of SARS-CoV-2 for the viral lifecycle and for the development of COVID-19-associated pathologies.', 0.68043935), ('Conclusion Our findings reveal that SARS-CoV-2 curtails the immune response in primary human intestinal epithelial cells to promote its replication and spread and this highlights the gut as a proinflammatory reservoir that should be considered to fully understand SARS-CoV-2 pathogenesis.', 0.67127955), ('Design We exploited human ileum- and colon-derived organoids as a non- transformed culture model supporting SARS-CoV-2 infection.', 0.6595462)]"
1545,Confronting the notion that face masks reduce COVID 'dose ',confronting,_ the notion that face masks reduce covid 'dose ', supported the notion that face masks reduce covid 'dose ',https://www.cidrap.umn.edu/news-perspective/2020/11/confronting-notion-face-masks-reduce-covid-dose,"[('""Of course, people should be wearing masks, but they should also be social distancing; masks are not the only nonpharmaceutical intervention.""', 0.5156679), ('""They are putting people at risk by suggesting that that \'it\'ll be fine, you\'ll wear your face covering, and you\'ll get a low dose,\'"" she said.', 0.48537064), ('""Certainly, masks could probably block larger droplets, and that kind of gets into the area of the whole droplet-versus-aerosols debate,"" she said.', 0.47288573), (""Another problem with the perspective piece is that it doesn't define what the authors consider a face covering, which range from single-layer homemade cloth masks to dependable N95 respirators, according to Rasmussen."", 0.34184438), ('""Nonhuman primates are a near clinical model of human disease,"" he said.', 0.33773702)]"
1547,T cell anergy in COVID-19 reflects virus persistence and poor outcomes,poor,t cell anergy in covid-19 reflects virus persistence and _ outcomes,t cell anergy in covid-19 reflects virus persistence and survival outcomes,https://www.medrxiv.org/content/10.1101/2020.09.21.20198671v1,"[('We applied novel approaches to analyze T cell reactivity and showed that T anergy is already present in non-ventilated COVID-19 patients, very pronounced in ventilated patients, strongly associated with virus persistence and reversible with clinical recovery.', 0.6111086), ('Downstream markers of T cell anergy were also found in fresh blood samples of critically ill patients with severe T cell anergy.', 0.45877746), ('Based on our data we were able to develop a score to predict fatal outcomes and to identify patients that may benefit from strategies to overcome T cell anergy.', 0.40986294), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.39210385), ('So far, insufficient or excessive T cell responses were described in patients.', 0.36717498)]"
1548,Scientists Prove SARS-CoV-2 Potential to Infect Human Brain Organoids,human,scientists prove sars-cov-2 potential to infect _ brain organoids,scientists prove sars-cov-2 potential to infect rat brain organoids,https://neurosciencenews.com/coronavirus-brain-16899/,"[('To explore the direct involvement of SARS-CoV-2 in the CNS in physiologically relevant models, the research team assessed SARS-CoV-2 infection in human neural progenitor cells (hNPCs), neurospheres and brain organoids derived from induced pluripotent stem cells (iPSCs).', 0.7915579), ('Extensive protein expression and infectious viral particles were detected in neurospheres and brain organoids infected with SARS-CoV-2, which suggested SARS-CoV-2 could productively infect the human brain.', 0.7380422), ('Importantly, SARS-CoV-2 infection in 3D human brain organoids was localised to TUJ1 (neuronal marker) - and NESTIN (NPC marker)-positive cells, suggesting SARS-CoV-2 could directly target cortical neurons and NPCs.', 0.7373784), ('The research team suggested that chronic and long-term consequences of SARS- CoV-2 infection of the CNS should be closely monitored.', 0.60122645), ('""Overall, our study provides the first evidence of direct SARS-CoV-2 infection in human brain organoids, which contributes to our understanding of the pathogenesis of neurological complications in COVID-19,"" said Prof. HUANG Jiandong from HKU, who led the study.', 0.58277845)]"
1549,Trial to Promote Recovery From COVID-19 With Ivermectin or Endocrine Therapy,promote,trial to _ recovery from covid-19 with ivermectin or endocrine therapy,trial to no recovery from covid-19 with ivermectin or endocrine therapy,https://clinicaltrials.gov/ct2/show/NCT04374279,"[('An Update on Current Therapeutic Drugs Treating COVID-19.', 0.7947022), ('This will be a randomized, open-label study to determine if bicalutamide or ivermectin improves the time to clinical improvement in patients with COVID-19 over historical controls.', 0.7768256), ('Current drugs with potential for treatment of covid-19: a literature review.', 0.73753875), ('This will be a randomized, open-label study to determine if bicalutamide improves the rate of clinical improvement in patients with COVID-19.', 0.7371762), ('Lastly, we looked at androgen sensitivity as a predictor for COVID-19 progression and ongoing clinical trials on androgen suppression therapies as a line of treatment.', 0.72689426)]"
1551,20 Covid-19 patients in Malaysia have made full recovery,malaysia,20 covid-19 patients in _ have made full recovery,20 covid-19 patients in Korea have made full recovery,https://www.nst.com.my/news/nation/2020/02/569017/20-covid-19-patients-malaysia-have-made-full-recovery,"[('News Business Life & Times Sports World NST TV Opinion Vouchers Gallery 2021 Budget Get Mobile App News Crime & Courts Exclusive Govt / Public Policy Nation Politics Business Business Times Property Cars Bikes Trucks Life & Times Sunday Vibes Bots Heal Flair Jom!', 0.24233305), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.17918554), ('[c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 11:26 PM [Today]: Sunday, January 17, 2021 at 1:07 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:58 PM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students', 0.17512831), ('Groove Sports Football Badminton Tennis Cycling Golf MMA MotorSport Cricket Others World World Region Opinion Columnists Letters Leader Gallery Photos Infographics NSTTV Education Voucher 2021 (C) New Straits Times, New Straits Times Press (M) Bhd.', 0.17155871), ('Subscribe Disclaimer Personal Data Protection Act Contact Us [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.07242205)]"
1552,Reductions in commuting mobility predict geographic differences in SARS-CoV-2 prevalence in New York City,reductions,_ in commuting mobility predict geographic differences in sars-cov-2 prevalence in new york city,Advances in commuting mobility predict geographic differences in sars-cov-2 prevalence in new york city,https://dash.harvard.edu/handle/1/42665370,"[('Conclusions and relevance: Reductions in between-borough mobility predict geographic differences in the prevalence of SARS-CoV-2 infection in New York City.', 0.88172764), ('Main outcomes: Population prevalence of SARS-CoV-2 by borough and correlation with the reduction in daily commuting-style movements into and out of each borough.', 0.7445591), ('Objective: To estimate the prevalence of SARS-CoV-2 infection by New York City borough between March 22nd and May 3rd, 2020, and to associate variation in prevalence with antecedent reductions in mobility, defined as aggregated daily physical movements into and out of each borough.', 0.71095306), ('Exposures: Infection with SARS-CoV-2.', 0.44744644), ('Large parts of the city may remain at risk for substantial SARS-CoV-2 outbreaks.', 0.4435222)]"
1554,"The missing link in coronavirus jump from bats to humans could be pangolins , not snakes",not,"the missing link in coronavirus jump from bats to humans could be pangolins , _ snakes","the missing link in coronavirus jump from bats to humans could be pangolins, 2 snakes",https://www.sciencedaily.com/releases/2020/03/200326144342.htm,"[('View all partners Email Twitter Facebook LinkedIn WhatsApp Messenger Pangolins, not snakes, may be the missing link for transmission of the new coronavirus from bats to humans.', 0.74668133), ('Now, a study refutes both ideas and suggests that scaly, anteater-like animals called pangolins are the missing link for SARS-CoV-2 transmission between bats and humans.', 0.70108634), ('Instead, scientists suspected that the bat coronavirus infected another animal, an “intermediate host,” which subsequently transmitted the virus to humans.', 0.6344904), ('A new study by University of Michigan researchers refutes both ideas and suggests that Malayan pangolins ( Manis javanica ) are the missing link for SARS- CoV-2 transmission between bats and humans.', 0.6295071), ('The bat coronavirus, which was the ancestor of SARS-CoV-2, has 19 amino acids on the spike protein that are different from SARS-CoV-2; the pangolin coronavirus only has five amino acids that are different from SARS-CoV-2.', 0.60215175)]"
1555,A granulocytic signature identifies COVID-19 and its severity,severity,a granulocytic signature identifies covid-19 and its _,a granulocytic signature identifies covid-19 and its species,https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaa591/5907982,"[('Results: Granulocytic (neutrophil, eosinophil, and basophil) markers were enriched during COVID-19 and discriminated between patients with mild and severe disease.', 0.715958), ('COVID-19 alters the frequency and functional phenotypes of granulocyte subsets with emergence of CRTH2 as a disease biomarker.', 0.710014), ('Methods: An observational, prospective, multicentric study was conducted in patients with confirmed mild/moderate (n = 7) and severe (n = 19) COVID-19.', 0.5387289), ('Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 Disease.', 0.49739593), ('Increased counts of CD15+CD16+ neutrophils, decreased granulocytic expression of integrin CD11b, and Th2-related CRTH2 downregulation in eosinophils and basophils established a COVID-19 signature.', 0.48308635)]"
1556,"Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sample from Geneva , Switzerland",switzerland,"repeated seroprevalence of anti-sars-cov-2 igg antibodies in a population-based sample from geneva , _","repeated seroprevalence of anti-sars-cov-2 igg antibodies in a population-based sample from geneva,.",https://www.medrxiv.org/content/10.1101/2020.05.02.20088898v1,"[('Here, we estimate weekly seroprevalence of anti-SARS-CoV-2 antibodies in the population of Geneva, Switzerland, during the epidemic.', 0.86907935), ('Share Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population- based sample Silvia Stringhini, Ania Wisniak, Giovanni Piumatti, Andrew S. Azman, Stephen A. Lauer, Hélène Baysson, David De Ridder, Dusan Petrovic, Stephanie Schrempft, Kailing Marcus, Sabine Yerly, Isabelle Arm Vernez, Olivia Keiser, Samia Hurst, Klara M. Posfay-Barbe, Didier Trono, Didier Pittet, Laurent Gétaz, François Chappuis, Isabella Eckerle, Nicolas Vuilleumier, Benjamin Meyer, Antoine Flahault, Laurent Kaiser, Idris Guessous medRxiv 2020.05.02.20088898; doi: https://doi.org/10.1101/2020.05.02.20088898 Share This Article: Copy Citation Tools Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population- based sample Silvia Stringhini, Ania Wisniak, Giovanni Piumatti, Andrew S. Azman, Stephen A. Lauer, Hélène Baysson, David De Ridder, Dusan Petrovic, Stephanie Schrempft, Kailing Marcus, Sabine Yerly, Isabelle Arm Vernez, Olivia Keiser, Samia Hurst, Klara M. Posfay-Barbe, Didier Trono, Didier Pittet, Laurent Gétaz, François Chappuis, Isabella Eckerle, Nicolas Vuilleumier, Benjamin Meyer, Antoine Flahault, Laurent Kaiser, Idris Guessous medRxiv 2020.05.02.20088898; doi: https://doi.org/10.1101/2020.05.02.20088898 ', 0.7779671), ('Added value of this study This study took advantage of an already existing representative sample of the general population, which we had recruited for chronic disease surveillance, to rapidly put in place a serosurvey of anti-SARS-CoV-2 IgG antibodies in a heavily affected region (Geneva, Switzerland).', 0.73267925), ('We tested each participant for anti-SARS-CoV-2-IgG antibodies using a commercially available ELISA.', 0.71450925), ('To assess the seroprevalence of anti-SARS-CoV-2 antibodies in the canton of Geneva, we contacted individuals who had already participated in the Bus Santé study (an annual health examination survey of a representative sample of the population of the canton) 6 Guessous I Gaspoz JM Theler JM Wolff H High prevalence of forgoing healthcare for economic reasons in Switzerland: a population-based study in a region with universal health insurance coverage.', 0.68834156)]"
1557,An ultra-high affinity synthetic nanobody blocks SARS-CoV-2 infection by locking Spike into an inactive conformation,blocks,an ultra-high affinity synthetic nanobody _ sars-cov-2 infection by locking spike into an inactive conformation,an ultra-high affinity synthetic nanobody facilitates sars-cov-2 infection by locking spike into an inactive conformation,https://www.biorxiv.org/content/10.1101/2020.08.08.238469v1,"[('Cryogenic electron microscopy (cryo-EM) revealed that one exceptionally stable nanobody, Nb6, binds Spike in a fully inactive conformation with its receptor binding domains (RBDs) locked into their inaccessible down-state, incapable of binding ACE2.', 0.7012652), ('E, Nanobody inhibition of 1 nM Spike-Alexa 647 binding to ACE2 expressing HEK293T cells.', 0.62346673), ('Here, we develop single-domain antibodies (nanobodies) that potently disrupt the interaction between the SARS-CoV-2 Spike and ACE2.', 0.5994364), ('Affinity maturation and structure-guided design of multivalency yielded a trivalent nanobody, mNb6-tri, with femtomolar affinity for SARS-CoV-2 Spike and picomolar neutralization of SARS-CoV-2 infection.', 0.5953165), ('B, Nanobody inhibition of 1 nM Spike-Alexa 647 binding to ACE2 expressing HEK293T cells after incubation at either 25 °C or 50 °C for 1 hour or after aerosolization.', 0.57049924)]"
1558,Efficacy of Tocilizumab in Patients Hospitalized with Covid-19,efficacy,_ of tocilizumab in patients hospitalized with covid-19,Lack of tocilizumab in patients hospitalized with covid-19,https://www.nejm.org/doi/full/10.1056/NEJMoa2028836,"[('Effective treatment of severe COVID-19 patients with tocilizumab.', 0.9389845), ('Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case-controlled study.', 0.8416887), ('Tocilizumab treatment for cytokine release syndrome in hospitalized COVID-19 patients: survival and clinical outcomes.', 0.83847326), ('Tocilizumab for treatment of mechanically ventilated patients with COVID-19.', 0.82996744), ('Use of tocilizumab in kidney transplant recipients with COVID-19.', 0.81367266)]"
1559,Cytotoxic lymphocytes are dysregulated in multisystem inflammatory syndrome in children,inflammatory,cytotoxic lymphocytes are dysregulated in multisystem _ syndrome in children,cytotoxic lymphocytes are dysregulated in multisystem neurological syndrome in children,https://www.medrxiv.org/content/10.1101/2020.08.29.20182899v1,"[('Upregulated genes in this signature were annotated to both myeloid and lymphoid immune functions, while downregulated genes were annotated to pathways related to the regulation of gene expression.', 0.6444726), ('Together, these findings suggest dysregulated cytotoxic lymphocyte response to SARS-Cov-2 infection in MIS-C. Keywords: COVID-19, SARS-CoV-2, pediatrics, MIS-C ', 0.62916577), ('Gene expression patterns in blood leukocytes discriminate patients with acute infections.', 0.61838037), ('Multisystem Inflammatory Syndrome in Children in New York State.', 0.6073942), ('Multisystem inflammatory syndrome in children: getting to the heart of the matter.', 0.5998633)]"
1561,Italian doctors find link between Covid-19 and inflammatory disorder,link,italian doctors find _ between covid-19 and inflammatory disorder,italian doctors find differences between covid-19 and inflammatory disorder,https://www.theguardian.com/science/2020/may/13/italian-doctors-find-link-between-covid-19-and-inflammatory-disorder,"[('Photograph: Anadolu Agency/Getty Doctors in Italy have reported the first clear evidence of a link between Covid-19 and a rare but serious inflammatory disorder that has required some children to undergo life-saving treatment in intensive care units.', 0.74237067), ('The latest evidence comes from doctors in Bergamo, the city with the highest rate of coronavirus infections and deaths in Italy.', 0.5403575), ('Read more “Our study provides the first clear evidence of a link between Sars-CoV-2 infection and this inflammatory condition, and we hope it will help doctors around the world as we try to get to grips with this unknown virus,” said Dr Lorenzo D’Antiga, director of child health at the hospital.', 0.39282858), ('The cause is not known, but studies suggest it is a post-infection inflammatory response that turns against the body.', 0.37640166), ('Prof Russell Viner, president of the Royal College of paediatrics and child health, said it remained the case that children were largely unaffected by Covid-19, but that surveillance for the new syndrome would shed light on who it affects, how, and what the longer-term outcomes are.', 0.336927)]"
1568,Looking for volunteers to support with COVID 19 projects,volunteers,looking for _ to support with covid 19 projects,looking for researchers to support with covid 19 projects,https://helpwithcovid.com/projects,"[('Medical equipments 19 volunteers 9 months ago Remote Actively Recruiting GetCovidTools An open platform that empowers makers and suppliers to offer PPE supplies to validated health professionals.', 0.6287912), ('View recording A Global Perspective on Problems Needing Solutions Regarding COVID-19 Response.', 0.5604683), ('CoronavirusEverything you should know about coronavirus Businesses united against COVID-19Companies offering free or discounted tools during COVID-19 The COVID PagesA crowdsourced directory of resources to ease the crisis 🌎 CoronaWhyGlobally distributed, fully remote COVID-19 AI task-force COVID-19 Operators PlaybookA coronavirus playbook for startups Help with Covid alternatives → [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.53950334), ('Download Playbook Upcoming Events July 3 COVID 19 Global Hackathon 2.0 - Social & Mental Health.', 0.48081547), ('Covid-19 Check-upsRun coronavirus company-wide check-ups via Slack.', 0.45503503)]"
1569,Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2,sar,hydroxychloroquine-mediated inhibition of _-cov-2 entry is attenuated by tmprss2,hydroxychloroquine-mediated inhibition of MBLs-cov-2 entry is attenuated by tmprss2,https://www.biorxiv.org/content/10.1101/2020.07.22.216150v1,"[('Finally, we show that combinations of hydroxychloroquine and a clinically tested TMPRSS2 inhibitor work together to effectively inhibit SARS- CoV-2 entry.', 0.8328178), ('Here we show that hydroxychloroquine interferes with only one of two somewhat redundant pathways by which the SARS-CoV-2 spike (S) protein is activated to mediate infection.', 0.7452964), ('The first pathway is dependent on the endosomal protease cathepsin L and sensitive to hydroxychloroquine, whereas the second pathway is dependent on TMPRSS2, which is unaffected by this compound.', 0.6969985), ('Thus TMPRSS2 expression on physiologically relevant SARS-CoV-2 target cells may bypass the antiviral activities of hydroxychloroquine, and explain its lack of in vivo efficacy.', 0.6777035), ('These studies identify functional differences between SARS-CoV-1 and -2 entry processes, and provide a mechanistic explanation for the limited in vivo utility of hydroxychloroquine as a treatment for COVID-19.', 0.6177848)]"
1570,Detection of asymptomatic SARS-CoV-2 exposed individuals by a sensitive S-based ELISA .,sensitive,detection of asymptomatic sars-cov-2 exposed individuals by a _ s-based elisa .,detection of asymptomatic sars-cov-2 exposed individuals by a random s-based elisa.,https://www.medrxiv.org/content/10.1101/2020.06.02.20120477v1,"[('Our results raise the possibility that on- going population-based studies using less sensitive state-of-the-art serological assays may significantly underestimate the frequency of exposure and seroconversion to SARS-CoV-2.', 0.6132345), ('Here, we demonstrate a sensitive and specific S-protein based assay that is well suited for detection of weak SARS- CoV-2-directed IgG responses, and that could identify exposed individuals with asymptomatic infection without the requirement of PCR diagnostics.', 0.5830025), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.3732937), ('中文翻译： 通过基于S的灵敏ELISA检测无症状的SARS-CoV-2暴露个体。 为了评估当前的冠状病毒大流行，迫切需要确定局部和全球水平上SARS- CoV-2的暴露和血清转化。在这里，我们展示了一种灵敏且基于特异性S蛋白的检测方法，非常适合检测弱于SARS- CoV-2定向的IgG反应，并且无需PCR诊断即可鉴定出无症状感染的暴露个体。我们的研究结果提出了这样的可能性，即使用不太敏感的最新血清学检测进行的基于人群的研究可能会大大低估了SARS- CoV-2暴露和血清转化的频率。 更新日期：2020-06-04 点击分享 查看原文 点击收藏 取消收藏 阅读更多本刊最新论文 全部期刊列表>> 学术期刊 行业资讯 全球导师 X-MOL问答 求职广场 网址导航 关于我们 帮助中心 客服邮箱：service@x-mol.com 官方微信：X-molTeam2 邮编：100098 地址：北京市海淀区知春路56号中航科技大厦 Copyright © 2014-2020 北京衮雪科技有限公司 All Rights Reserved 京ICP备11026495-2号 京公网安备 11010802027423号 down wechat bug [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.33255482), ('Infect.', 0.2800473)]"
1571,A meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19,prevention,a meta-analysis of randomized trials of hydroxychloroquine for the _ of covid-19,a meta-analysis of randomized trials of hydroxychloroquine for the development of covid-19,https://www.medrxiv.org/content/10.1101/2020.09.29.20203869v1,"[('We obtained or calculated the risk ratio of COVID-19 diagnosis for assignment to HCQ versus no HCQ (either placebo or usual care) for each trial, and then pooled the risk ratio estimates.', 0.70760316), ('In the absence of an updated systematic review, we conducted a meta-analysis of randomized trials that study the effectiveness of HCQ to prevent COVID-19.', 0.7050358), ('Discussion A pooled analysis of these randomized trials cannot rule out a moderate reduction of COVID-19 risk after assignment to HCQ.', 0.63864183), ('Completion of the ongoing trials is needed to generate more precise estimates of the effectiveness of HCQ to prevent COVID-19.', 0.53605175), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.40199932)]"
1573,Clinical Outcomes in Young US Adults Hospitalized With COVID-19,clinical,_ outcomes in young us adults hospitalized with covid-19,No outcomes in young us adults hospitalized with covid-19,https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2770542,"[('Association between NSAIDs use and adverse clinical outcomes among adults hospitalized with COVID-19 in South Korea: A nationwide study.', 0.6276064), ('[Fatality and risk factors for severe courses of COVID-19 pneumonia].', 0.6244956), ('Multisystem assessment of the imaging manifestations of coagulopathy in hospitalized patients with COVID-19.', 0.6175916), ('PMID: 32755217 Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.', 0.59214234), ('PMID: 33325994 Simultaneous COVID-19 in Homozygous Twins.', 0.5720059)]"
1574,"Serum Amyloid P inhibits single stranded RNA-induced lung inflammation , lung damage , and cytokine storm in mice",mice,"serum amyloid p inhibits single stranded rna-induced lung inflammation , lung damage , and cytokine storm in _","serum amyloid p inhibits single stranded rna-induced lung inflammation, lung damage, and cytokine storm in patients",https://www.biorxiv.org/content/10.1101/2020.08.26.269183v1,"[('A serum protein called serum amyloid P (SAP) has a calming effect on the innate immune system and shows efficacy as a therapeutic for fibrosis in animal models and clinical trials.', 0.67519736), ('Intraperitoneal injections of SAP starting from day 1 post ORN06 aspiration attenuated the ORN06-induced increase in the number of inflammatory cells and formation of clot-like aggregates in the mouse lung fluid, reduced ORN06-increased alveolar wall thickness and accumulation of exudates in the alveolar airspace, and attenuated an ORN06-induced upregulation of the inflammatory cytokines IL-1β, IL-6, IL-12p70, IL-23, and IL-27 in serum.', 0.66248786), ('In this report, we show that aspiration of the GU-rich ssRNA oligonucleotide ORN06 into mouse lungs induces all of the above COVID-19-like symptoms.', 0.5988338), ('In COVID-19, the infection and immune hyperactivation causes accumulation of inflammatory immune cells, blood clots, and protein aggregates in lung fluid, increased lung alveolar wall thickness, and upregulation of serum cytokine levels.', 0.51721966), ('Together, these results suggest that aspiration of ORN06 is a simple model for both COVID-19 as well as cytokine storm in general, and that SAP is a potential therapeutic for diseases with COVID-19-like symptoms as well as diseases that generate a cytokine storm.', 0.46623003)]"
1577,Belief in COVID-19 Conspiracy Theories Reduces Social Distancing over Time,reduces,belief in covid-19 conspiracy theories _ social distancing over time,belief in covid-19 conspiracy theories include social distancing over time,https://iaap-journals.onlinelibrary.wiley.com/doi/full/10.1111/aphw.12223,"[('Conclusions: Our findings show that COVID-19 conspiracy theories pose a significant threat to public health as they may reduce adherence to social distancing measures.', 0.76587474), ('Keywords: COVID-19; conspiracy theories; longitudinal; social distancing.', 0.66109824), ('Results: Multivariate growth curve analyses showed that, although conspiracy beliefs decreased and social distancing increased over time, people holding more conspiracy beliefs at the beginning of the pandemic showed the lowest increase in social distancing.', 0.6356888), ('PMID: 33225745 Cultural orientation, power, belief in conspiracy theories, and intentions to reduce the spread of COVID-19.', 0.6355077), ('Moreover, cross-lagged analyses demonstrated that people who reported more conspiracy beliefs at any wave tended to report less social distancing at the following wave.', 0.6011399)]"
1578,UC study uncovers clues to COVID-19 in the brain,brain,uc study uncovers clues to covid-19 in the _,uc study uncovers clues to covid-19 in the literature,https://www.uc.edu/news/articles/2020/05/n20918450.html,"[('""To date, this is the largest and first study in literature that characterizes the neurological symptoms and neuroimaging features in COVID-19 patients.', 0.6585317), ('“To date, this is the largest and first study in literature that characterizes the neurological symptoms and neuroimaging features in COVID-19 patients.', 0.6521095), ('Featured photo of COVID-19 vials by Colleen Kelley/UC Creative + Brand.', 0.6033446), (""Newswise -- A study by University of Cincinnati researchers and four Italian institutions reviewing neuroimaging and neurological symptoms in patients with COVID-19 may shed light on the virus's impact on the central nervous system."", 0.5978438), (""view more Credit: University of Cincinnati A study by University of Cincinnati researchers and four Italian institutions reviewing neuroimaging and neurological symptoms in patients with COVID-19 may shed light on the virus's impact on the central nervous system."", 0.5887954)]"
1581,Trump ended the COVID-19 Pandemic !,trump,_ ended the covid-19 pandemic !,She ended the covid-19 pandemic!,https://thehill.com/policy/healthcare/523013-white-house-science-office-says-trump-ended-covid-pandemic-as-us-hits?fbclid=IwAR08gGqZSgLVT7eoObpBREwhmVlPmX9FN2-i8TkYky9BLX_QnFssNT22nho,"[('Trump Ended COVID-19 Pandemic!', 0.99348986), ('The White House included ""ending the COVID-19 pandemic"" in a new list of President Donald Trump\'s accomplishments.', 0.81880116), ('The Hill: White House Science Office Says Trump Ended COVID-19 Pandemic As US Hits Record Cases The White House science office listed ""ending the COVID-19 pandemic"" as the top accomplishment of President Trump\'s first term, even as the U.S. has set records for new daily infections and numerous hospitals across the country are stretched to their breaking points.', 0.80405897), ('White House Release Says Trump Ended Pandemic While the White House science office lists ""ending the pandemic"" in a press release of President Donald Trump\'s top accomplishments, the president spends time on the campaign trail trying to change the subject away from the coronavirus crisis that is currently spiking to historic levels.', 0.61899143), ('(Weixel, 10/27) Politico: As Coronavirus Cases Surge, Trump Has Another Message With one week left in the election, President Donald Trump is perfecting his closing argument about the pandemic gripping much of the nation: Don’t worry about it.', 0.61049557)]"
1584,SARS-CoV-2 genome evolution exposes early human adaptations,adaptations,sars-cov-2 genome evolution exposes early human _,sars-cov-2 genome evolution exposes early human infection,https://www.biorxiv.org/content/10.1101/2020.05.26.117069v1,"[('Overall this study provides genomic insights into how SARS-CoV-2 has adapted and will continue to adapt to humans.', 0.76989317), ('SUMMARY In this study we sought signals of evolution to identify how the SARS-CoV-2 genome has adapted at the outset of the COVID-19 pandemic.', 0.66477406), ('This information indicates how SARS-CoV-2 will evolve as it diversifies in an increasing number of hosts.', 0.5258641), ('Here we show that SARS-CoV-2 is acquiring mutations more slowly than expected for neutral evolution, suggesting purifying selection is the dominant mode of evolution during the initial phase of the pandemic.', 0.5079433), ('The absence of mutations in other genome regions suggests essential components of SARS-CoV-2 that could be the target of drug development.', 0.47424918)]"
1588,Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates,ace,broad host range of sars-cov-2 predicted by comparative and structural analysis of _ in vertebrates,broad host range of sars-cov-2 predicted by comparative and structural analysis of FPR2 in vertebrates,https://www.pnas.org/content/early/2020/08/20/2010146117,"[(', Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.', 0.80093884), ('To identify candidate intermediate host species and species at risk for SARS-CoV-2 infection, we undertook a deep comparative genomic, evolutionary, and structural analysis of ACE2, which serves as the SARS-CoV-2 receptor in humans.', 0.78985023), ('E. W. Stawiski et al ., Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility.', 0.76502156), ('We identified a large number of mammals that can potentially be infected by SARS-CoV-2 via their ACE2 proteins.', 0.76369524), ('Comparative analysis of ACE2 protein sequences can be used to predict their ability to bind SARS-CoV-2 S (2) and therefore may yield important insights into the biology and potential zoonotic transmission of SARS-CoV-2 infection.', 0.7617103)]"
1589,UK labs 'can process tens of thousands more tests ',tens,uk labs 'can process _ of thousands more tests ',uk labs 'can process one of thousands more tests ',https://www.theguardian.com/world/2020/mar/31/coronavirus-uk-labs-could-test-tens-of-thousands-more-people-says-expert,"[('Anthony Costello, a global health professor at University College London, called for the UK to make use of testing machines in every university and big hospital around the country, setting up mobile testing units like Ireland, which is testing far more people per head of population.', 0.51845276), ('“We have 44 molecular virology labs in the UK.', 0.45566052), ('Photograph: Matthew Horwood/Getty Images The UK has the capacity to process tens of thousands more tests for coronavirus but has failed to organise itself properly, a former director at the World Health Organization has said.', 0.3675605), ('Critics are also questioning the UK’s decision only to test people in hospitals and NHS workers, arguing that a return to testing more widely will ultimately be necessary to suppress the virus.', 0.36462516), ('If they were doing 400 tests a day we would be up to Germany levels of testing and that is perfectly feasible.', 0.35392106)]"
1590,Patterns of COVID-19 related excess mortality in the municipalities of Northern Italy,patterns,_ of covid-19 related excess mortality in the municipalities of northern italy,Lack of covid-19 related excess mortality in the municipalities of northern italy,https://www.medrxiv.org/content/10.1101/2020.05.11.20097964v1,"[('We aimed to describe the excess mortality (EM) due to COVID-19 in the three most affected Italian regions, by estimating EM in subgroups defined by gender and age classes within each municipality from February 23 to March 31, 2020.', 0.71704006), ('The impact of COVID-19 on mortality has been described at the regional level, while less is known about mortality in demographic subgroups within municipalities.', 0.5910143), ('Thus, nearby municipalities may show a different mortality burden despite being under common regional health policies, possibly as a result of policies adopted both at the regional and at the municipality level.', 0.24901514), ('EM varied widely among municipalities even within the same region; it was similar between genders for the ≥75 age group, while in the other age groups it was higher in males.', 0.23098461), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.22092073)]"
1591,Spatial Profiling of Lung SARS-CoV-2 and Influenza Virus Infection Dissects Virus-Specific Host Responses and Gene Signatures,spatial,_ profiling of lung sars-cov-2 and influenza virus infection dissects virus-specific host responses and gene signatures,Quantitative profiling of lung sars-cov-2 and influenza virus infection dissects virus-specific host responses and gene signatures,https://www.medrxiv.org/content/10.1101/2020.11.04.20225557v1,"[('Here, we use spatial transcriptomics to generate an in- depth picture of the pulmonary transcriptional landscape of COVID-19 (10 patients), pandemic H1N1 (pH1N1) influenza (5) and uninfected control patients (4).', 0.7231873), ('Collectively, these data demonstrate that spatial transcriptomics is a powerful tool to identify novel gene signatures within tissues, offering new insights into the pathogenesis of SARS-COV-2 to aid in patient triage and treatment.', 0.7050966), ('Host transcriptomics showed a significant upregulation of genes associated with inflammation, type I interferon production, coagulation and angiogenesis in the lungs of COVID-19 patients compared to non-infected controls.', 0.65982604), ('Specific interferon-associated genes (including IFI27 ) were identified as candidate novel biomarkers for COVID-19 differentiating this COVID-19 from influenza.', 0.5826937), ('SARS-CoV-2 was non-uniformly distributed in lungs with few areas of high viral load and these were largely only associated with an increased type I interferon response.', 0.5705944)]"
1592,Gilead antiviral drug remdesivir flops in first trial,flop,gilead antiviral drug remdesivir _ in first trial,gilead antiviral drug remdesivir plans in first trial,https://www.ft.com/content/0a4872d1-4cac-4040-846f-ce32daa09d99,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.18577199), ('Apps Newsletters Advertise with Us Advertising Guidelines Cookies Terms of Use Privacy Do Not Sell My Personal Information All quotes delayed a minimum of 15 minutes.', 0.14053538), ('for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor- wide-desktop-up [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.1306755), ('Discover Thomson Reuters Directory of sitesLoginContactSupport for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor- wide-desktop-up Healthcare Updated ', 0.112609655), ('[c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 10:30 AM [Today]: Sunday, January 17, 2021 at 6:45 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:30 AM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students [January 14]: Thursday, January 14, 2021 at 10:09 AM [January 10]: Sunday, January 10, 2021 at 9:29 AM [January 5]: Tuesday, January 5, 2021 at 6:05 AM', 0.10465645)]"
1594,SARS-CoV-2 replication triggers an MDA-5-dependent interferon production which is unable to efficiently control replication,replication,sars-cov-2 _ triggers an mda-5-dependent interferon production which is unable to efficiently control _,5-amino levulinic acid inhibits sars-cov-2 degradation in vitro,https://www.biorxiv.org/content/10.1101/2020.10.28.358945v1,"[('However, despite the high levels of type I and III IFNs produced in response to SARS-CoV-2 infection, the IFN response was unable to control viral replication, whereas IFN pre- treatment strongly inhibited viral replication and de novo production of infectious virions.', 0.522941), ('Taken together, these results highlight the complex and ambiguous interplay between viral replication and the timing of IFN responses.', 0.44814777), ('Immune dysregulation characterized by altered innate cytokine responses is thought to contribute to the pathology of COVID-19 patients, which is a testimony of the fundamental role of the innate immune response against SARS-CoV-2.', 0.42013225), ('Here, we further characterized the host cell antiviral response against SARS-CoV-2 by using primary human airway epithelia and immortalized model cell lines.', 0.32965714), ('SARS-CoV-2 is the etiologic agent of coronavirus disease 19 (COVID-19), which ranges from mild respiratory symptoms to severe lung injury and death in the most severe cases.', 0.31639975)]"
1598,Comparison of Reported Deaths From COVID-19 and Increase in Total Mortality in Italy,mortality,comparison of reported deaths from covid-19 and increase in total _ in italy,comparison of reported deaths from covid-19 and increase in total population in italy,https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2768649?guestAccessKey=a0f9ad8c-f91f-45b4-a13b-6bc8eec2fcbc,"[('Clarification of Misleading Perceptions of COVID-19 Fatality and Testing Rates in Italy: Data Analysis.', 0.70878625), (""The COVID-19 Diagnostic Dilemma: a Clinician's Perspective."", 0.4200665), ('Testing for SARS-CoV-2 (COVID-19): A General Review.', 0.35306516), ('3 Medical Center Santagostino, Milan, Italy.', 0.33909592), ('5 Department of Clinical Science and Community Health, University of Milan, Italy.', 0.31777957)]"
1600,High-profile coronavirus retractions raise concerns about data oversight,raise,high-profile coronavirus retractions _ concerns about data oversight,high-profile coronavirus retractions of concerns about data oversight,https://www.nature.com/articles/d41586-020-01695-w,"[('Scientists say the affair raises serious questions about the way researchers and journals evaluate the data underlying papers that they publish, and may complicate the effort to trial drugs during the coronavirus pandemic.', 0.6708323), ('According to the retraction notice in the Lancet , Surgisphere was concerned that transferring the data would violate ""client agreements and confidentiality requirements"".', 0.563171), ('But critics soon raised questions about oddities in the data, and asked for more details on its origins.', 0.47605282), ('“We are desperate for knowledge, and maybe we’re skipping over some of our tried-and-true checks.” Both The Lancet and the NEJM said their peer review processes were confidential, and that they could not give details about how quickly the papers were reviewed.', 0.45661056), ('“This whole event is catastrophic — it is problematic for the journals involved, it is problematic for the integrity of science, it is problematic for medicine, and it is problematic for the notion of clinical trials and evidence generation,” says Ian Kerridge, a bioethicist at the University of Sydney, Australia.', 0.4175601)]"
1602,This is what coronavirus looks like under a microscope,microscope,this is what coronavirus looks like under a _,this is what coronavirus looks like under a term,https://edition.cnn.com/asia/live-news/coronavirus-outbreak-02-21-20-intl-hnk/h_47efd6f8e4996f9d669e151bfae383ac,"[('This post has been updated to more accurately reflect when coronavirus was detected in the first patient and added details of the second patient.', 0.53332764), (""Here's what it looks like: A pseudo-color scanning electron micrograph of SARS-CoV-2, grown in culture from a patient isolate."", 0.48973984), ('In the micrograph, the orange dots are viral particles, and the blue is the surface of a cell.', 0.47381434), ('She was confirmed to have the virus Friday.', 0.37808827), ('After 24 hours in culture there are large numbers of orange viral particles on the surface of the cell (blue).', 0.3683663)]"
1603,The D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity and decreases neutralization sensitivity to individual convalescent sera,decreases,the d614g mutation of sars-cov-2 spike protein enhances viral infectivity and _ neutralization sensitivity to individual convalescent sera,the d614g mutation of sars-cov-2 spike protein enhances viral infectivity and enhanced neutralization sensitivity to individual convalescent sera,https://www.biorxiv.org/content/10.1101/2020.06.20.161323v1,"[('Second, S-G614 pseudovirus infected 293T-ACE2 cells significantly more efficiently than the S-D614 pseudovirus, Moreover, 93% (38/41) sera from convalescent COVID-19 patients could neutralize both S-D614 and S-G614 pseudotyped viruses with comparable efficiencies, but about 7% (3/41) convalescent sera showed decreased neutralizing activity against S-G614 pseudovirus.', 0.6961546), ('Using pseudovirus-based assay, we found that S-D614 and S-G614 protein pseudotyped viruses share a common receptor, human angiotensin-converting enzyme 2 (ACE2), which could be blocked by recombinant ACE2 with the fused Fc region of human IgG1.', 0.5525943), ('Thus, insights into the sequence variations of S protein are key to understanding the infection and antigenicity of SARS-CoV-2.', 0.48911202), ('The spike protein that mediates SARS- CoV-2 entry into host cells, is one of the major targets for vaccines and therapeutics.', 0.44075027), ('These findings have important implications for SARS-CoV-2 transmission and immune interventions.', 0.4178931)]"
1604,BULLETIN—NIAID Stops Enrollment of Severely Ill COVID-19 Participants in Clinical Trial of Investigational Treatments,ill,bulletin—niaid stops enrollment of severely _ covid-19 participants in clinical trial of investigational treatments,bulletin—niaid stops enrollment of severely healthy covid-19 participants in clinical trial of investigational treatments,https://www.niaid.nih.gov/news-events/bulletin-niaid-stops-enrollment-severely-ill-covid-19-participants-clinical-trial,"[('ACTT-3, which began August 5, is the third iteration of a randomized, controlled adaptive trial, designed to test therapeutics for people who are hospitalized with COVID-19.', 0.44409266), ('The DSMB noted no safety concerns among study participants with less severe COVID-19.', 0.43371642), ('Researchers are evaluating whether participants’ time to recovery is shorter in the combination therapy group relative to the remdesivir-only group.', 0.42804348), ('Prior data from laboratory studies, observational studies, as well as two small randomized controlled trials, suggested that interferon beta-1a may benefit patients with COVID-19.', 0.41900048), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.40963167)]"
1605,Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-term Population-Scale Immunity,predicted,identification of sars-cov-2 vaccine epitopes _ to induce long-term population-scale immunity,identification of sars-cov-2 vaccine epitopes fails to induce long-term population-scale immunity,https://www.cell.com/action/showPdf?pii=S2666-3791%2820%2930048-3,"[('An immunoinformatics study on the spike protein of SARS-CoV-2 revealing potential epitopes as vaccine candidates.', 0.82274467), ('Immunoinformatics and Structural Analysis for Identification of Immunodominant Epitopes in SARS-CoV-2 as Potential Vaccine Targets.', 0.81615233), ('Validation and implementation of this vaccine concept could specifically target specific vulnerabilities of SARS-CoV-2 and should engage a robust adaptive immune response in the vast majority of the population.', 0.8128826), ('A SARS-CoV-2 Vaccination Strategy Focused on Population-Scale Immunity.', 0.8077756), ('Figure 2 Proposed Vaccine Epitopes in SARS-CoV-2… Figure 2 Proposed Vaccine Epitopes in SARS-CoV-2 Spike Protein Crystal structure of SARS-CoV-2 Spike protein… Figure 2 Proposed Vaccine Epitopes in SARS-CoV-2 Spike Protein Crystal structure of SARS-CoV-2 Spike protein trimer (PDB: 6VYB) with two highlighted vaccine epitopes targeting newly evolved acquired viral vulnerabilities.', 0.7872435)]"
1606,The Institute for Disease Modeling puts the CFR at 0.94 %,modeling,the institute for disease _ puts the cfr at 0.94 %,the institute for disease transmission puts the cfr at 0.94 %,https://institutefordiseasemodeling.github.io/nCoV-public/analyses/first_adjusted_mortality_estimates_and_risk_assessment/2019-nCoV-preliminary_age_and_time_adjusted_mortality_rates_and_pandemic_risk_assessment.html?utm_source=share&utm_medium=ios_app&utm_name=iossmf,"[('With this additional adjustment and using the same methodology and data from the original version of this report, the corrected estimate of the infection-fatality-ratio (IFR) is 0.94 (0.37, 2.9) percent.', 0.4884033), ('The ratio of reported cases to reporting-eligible infections gives us an ascertainment rate for this time period of 2.9 (1.3, 8.0) percent.', 0.44002816), ('Figure 1 shows the schematic relationships between different measures of disease incidence and severity.', 0.41720623), ('In this report, we use a small amount of linelist data with complete disease progression information from early in the outbreak to estimate the delays between case confirmation and death, and then the time and age-adjusted confirmed-CFR.', 0.40765533), ('The case fatality rate (CFR) gives the probability of dying for an infected person who is sick enough to report to a hospital or clinic.', 0.40754926)]"
1611,Beneficial Effect of Corticosteroids in Preventing Mortality in Patients Receiving Tocilizumab to Treat Severe COVID-19 Illness,beneficial,_ effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe covid-19 illness,No effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe covid-19 illness,https://www.medrxiv.org/content/10.1101/2020.08.31.20182428v1,"[('Conclusions: In patients with severe COVID-19 receiving TCZ due to systemic host-immune inflammatory response syndrome, the use of CS in addition to TCZ therapy, showed a beneficial effect in preventing in-hospital mortality.', 0.81998074), ('Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation.', 0.7104935), ('High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients.', 0.633855), ('Keywords: COVID-19; Corticosteroids; Mortality; Systemic inflammation; Tocilizumab.', 0.6294557), ('Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis.', 0.61257493)]"
1613,Cell entry of SARS-CoV-2 conferred by angiotensin-converting enzyme 2 of different specie,cell,_ entry of sars-cov-2 conferred by angiotensin-converting enzyme 2 of different specie,Virus entry of sars-cov-2 conferred by angiotensin-converting enzyme 2 of different specie,https://www.biorxiv.org/content/10.1101/2020.06.15.153916v1,"[('Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus.', 0.8266698), ('Share Cell entry of SARS-CoV-2 conferred by angiotensin-converting enzyme 2 (ACE2) of different species Yan-Dong Tang, Yu-Ming Li, Jing Sun, Hong-Liang Zhang, Tong-Yun Wang, Ming-Xia Sun, Yue-Lin Yang, Xiao-Liang Hu, Jincun Zhao, Xui-Hui Cai bioRxiv 2020.06.15.153916; doi: https://doi.org/10.1101/2020.06.15.153916 Share This Article: Copy Citation Tools Cell entry of SARS-CoV-2 conferred by angiotensin-converting enzyme 2 (ACE2) of different species Yan-Dong Tang, Yu-Ming Li, Jing Sun, Hong-Liang Zhang, Tong-Yun Wang, Ming-Xia Sun, Yue-Lin Yang, Xiao-Liang Hu, Jincun Zhao, Xui-Hui Cai bioRxiv 2020.06.15.153916; doi: https://doi.org/10.1101/2020.06.15.153916 ', 0.81322527), ('Angiotensin-converting enzyme 2 (ACE2) is demonstrated as the primary entry receptor for SARS-CoV-2.', 0.76759964), ('Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry.', 0.6682944), ('You are going to email the following Cell entry of SARS-CoV-2 conferred by angiotensin-converting enzyme 2 (ACE2) of different species Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.', 0.6511005)]"
1615,"We are 100x safer now than we were in March , here 's the math .",now,"we are 100x safer _ than we were in march , here 's the math .","we are 100x safer less than we were in march, here's the math.",https://finance.yahoo.com/news/100-times-safer-now-early-204833052.html,"[('We are 100 times safer now than we were a month ago.', 0.7077184), ('And the Math alone should bring you there.', 0.49587014), ('The math is pretty straight forward.', 0.49544346), ('You dont know how hard it is to be stuck in a place where youre 100x more vulnerable.', 0.489222), ('This enables a cell to load up with zinc faster, than it normally would.', 0.48743433)]"
1618,"In severe COVID-19 , SARS-CoV-2 induces a chronic , TGF-β-dominated adaptive immune response",induce,"in severe covid-19 , sars-cov-2 _ a chronic , tgf-β-dominated adaptive immune response","in severe covid-19, sars-cov-2 knocks a chronic, tgf-β-dominated adaptive immune response",https://www.medrxiv.org/content/10.1101/2020.09.04.20188169v1,"[('In severe COVID-19, SARS- CoV-2 thus triggers a chronic immune reaction distracted from itself and instructed by TGF-β.', 0.8886303), ('Cause of death for the control cases was aspiration pneumonia and COVID-19 for the SARS-CoV-2 infected patients.', 0.64150023), ('In the sustained immune reaction of the COVID-19 patients, until day 59, activated peripheral B cells shifted to expression of IgA2, reflecting instruction by TGF-β.', 0.5593183), ('Despite the continued generation of activated B cells, those cells were not found in the lungs of deceased COVID-19 patients, nor did the IgA2 bind to dominant antigens of SARS-CoV-2.', 0.5278131), ('Early on, before seroconversion in response to SARS-CoV-2 spike protein, activated peripheral B cells displayed a type 1 interferon-induced gene expression signature.', 0.5124582)]"
1619,Rapid SARS-CoV-2 antigen detection by immunofluorescence − a new tool to detect infectivity,new,rapid sars-cov-2 antigen detection by immunofluorescence − a _ tool to detect infectivity,rapid sars-cov-2 antigen detection by immunofluorescence − a standard tool to detect infectivity,https://www.medrxiv.org/content/10.1101/2020.10.04.20206466v1,"[('This high performance suggests that these tests might play an important role for future PCR-independent strategies to detect early or infective cases.', 0.55698085), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.45322663), ('Infect.', 0.29901016), ('注册 登录 首页 资讯 期刊 导师 问答 求职 发Paper 文献直达 高级搜索 期刊列表 论文助手 搜索 当前位置： X-MOL 学术 › medRxiv.', 0.25703925), ('中文翻译： 通过免疫荧光快速检测SARS-CoV-2抗原-一种检测感染性的新工具 当呼吸道分泌物携带高病毒量时，经过评估的SARS- CoV-2抗原快速荧光免疫测定可在症状发作的前5天内可靠地识别出患者。如此高的性能表明，这些测试可能在未来独立于PCR的早期发现或感染病例的策略中发挥重要作用。 更新日期：2020-10-06 点击分享 查看原文 点击收藏 取消收藏 阅读更多本刊最新论文 全部期刊列表>> 学术期刊 行业资讯 全球导师 X-MOL问答 求职广场 网址导航 关于我们 帮助中心 客服邮箱：service@x-mol.com 官方微信：X-molTeam2 邮编：100098 地址：北京市海淀区知春路56号中航科技大厦 Copyright © 2014-2020 北京衮雪科技有限公司 All Rights Reserved 京ICP备11026495-2号 京公网安备 11010802027423号 down wechat bug [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.21493603)]"
1620,Transcriptional profiling reveals TRPM5-expressing cells involved in viral infection in the olfactory epithelium,expressing,transcriptional profiling reveals trpm5-_ cells involved in viral infection in the olfactory epithelium,transcriptional profiling reveals trpm5-deficient cells involved in viral infection in the olfactory epithelium,https://www.biorxiv.org/content/10.1101/2020.05.14.096016v1,"[('Our study provides new insights into a potential role for TRPM5-expressing cells in viral infection of the olfactory epithelium.', 0.8702092), ('Herein we performed deep transcriptional profiling of olfactory epithelial cells sorted by flow cytometry based on the expression of fluorescent protein markers for olfactory sensory neurons and TRPM5.', 0.7412016), ('We find profuse expression of transcripts involved in inflammation, immunity and viral infection in TRPM5-expressing microvillous cells and olfactory sensory neurons.', 0.7343734), ('Specialized chemosensory epithelial cells that express the transient receptor potential cation channel subfamily M member 5 (TRPM5) are found throughout the airways and intestinal epithelium and are involved in responses to viral infection.', 0.608511), ('These cells express the Tmprss2 transcript that encodes for a serine protease that primes the SARS-CoV-2 spike protein before entry into host cells.', 0.5366088)]"
1622,"Stanford researchers test 3,200 people for COVID-19 antibodies",200,"stanford researchers test 3,_ people for covid-19 antibodies","stanford researchers test 3,6 people for covid-19 antibodies",https://www.stanforddaily.com/2020/04/04/stanford-researchers-test-3200-people-for-covid-19-antibodies/,"[('Widespread antibody testing is also taking place in Colorado’s San Miguel County, where all residents will be provided with tests donated by United Biomedical executives who live in the county.', 0.70328736), ('(Photo: KATE SELIG/The Stanford Daily) By Kate Selig on April 4, 2020 Over 3,200 people in Santa Clara County were tested for COVID-19 antibodies on Friday and Saturday in an effort to determine the proportion of the population that either has or has recovered from coronavirus.', 0.69783914), ('The antibody tests used in the Stanford study, which were supplied by Premier Biotech, require only a fingerstick of blood and test for IgM and IgG antibodies that indicate that a person either has coronavirus or had it and recovered.', 0.59058917), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.42396945), ('The study, led by researchers at Stanford Medicine, is the first of its kind in the nation.', 0.41389534)]"
1624,Hackers Leak Thousands of Coronavirus Research Papers,leak,hackers _ thousands of coronavirus research papers,hackers contain thousands of coronavirus research papers,https://www.freethink.com/videos/coronavirus-research,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.19037414), ('[c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 10:30 AM [Today]: Sunday, January 17, 2021 at 6:45 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:30 AM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students [January 14]: Thursday, January 14, 2021 at 10:09 AM [January 10]: Sunday, January 10, 2021 at 9:29 AM [January 5]: Tuesday, January 5, 2021 at 6:05 AM [on April 4, 2020]: Saturday, April 4, 2020 11:38 PM', -0.043659434)]"
1625,Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients,sponsor,novartis to _ large clinical trial of hydroxychloroquine in hospitalized covid-19 patients,novartis to no large clinical trial of hydroxychloroquine in hospitalized covid-19 patients,https://www.novartis.com/news/media-releases/novartis-sponsor-large-clinical-trial-hydroxychloroquine-hospitalized-covid-19-patients,"[('In addition to hydroxychloroquine, Novartis plans to sponsor or co-sponsor clinical trials to study ruxolitinib and canakinumab for hospitalized patients with COVID-19 infections.', 0.7849652), ('The clinical trial complements a commitment by Novartis, through Sandoz, to donate up to 130 million tablets of hydroxychloroquine to supply global clinical research efforts in the event the medicine is proven beneficial for treatment of COVID-19.', 0.76280695), ('To help achieve broad access to hydroxychloroquine as quickly as possible in these extraordinary circumstances, Novartis will make any intellectual property within our control that relates to the use of hydroxychloroquine to treat or prevent COVID-19 available through non- exclusive voluntary licenses, appropriate waivers, or similar mechanisms.', 0.746587), ('To support access, the Novartis generics and biosimilars division Sandoz became the first company to commit to keeping stable prices for a basket of essential medicines that may help in the treatment of COVID-19.', 0.72763324), ('“We are donating hydroxychloroquine tablets for COVID-19 patients including for use in this and other clinical trials with the hope that researchers and healthcare workers can quickly and scientifically determine whether hydroxychloroquine can help patients around the world combat this disease,” said Richard Saynor, CEO of Sandoz.', 0.7205498)]"
1627,Nearly a third of 200 blood samples taken in Chelsea show exposure to coronavirus,200,nearly a third of _ blood samples taken in chelsea show exposure to coronavirus,nearly a third of five blood samples taken in chelsea show exposure to coronavirus,https://www.bostonglobe.com/2020/04/17/business/nearly-third-200-blood-samples-taken-chelsea-show-exposure-coronavirus/,"[('Advertisement Related: Chelsea’s spike in coronavirus cases challenges hospitals and state Public health experts already knew Chelsea had the state’s highest rate of confirmed COVID-19 cases and that the actual rate was probably higher.', 0.49916685), ('Sixty-four residents who had a finger pricked in Bellingham Square on Tuesday and Wednesday had antibodies that the immune system makes to fight off the coronavirus, according to Massachusetts General Hospital physicians who ran the pilot study.', 0.48155788), ('Several biotechs and academic laboratories, in fact, are seeking blood donations from people who have recovered, in the hopes that their antibodies can help create a treatment or vaccine.', 0.46670812), ('The doctors used a diagnostic device made by BioMedomics, of Morrisville, N.C., to analyze drops of blood.', 0.4629199), ('General researcher says the results point to a ‘raging epidemic,’ but may also indicate the city is further along the disease curve than some other municipalities By Jonathan Saltzman Globe Staff,Updated April 17, 2020, 6:26 p.m. Email to a Friend Share on Facebook Share on TwitterPrint this Article View Comments First responders loaded a patient into an ambulance from a nursing home where multiple people have contracted COID-19 in Chelsea, which has the highest concentration of COVID-19 infections in the state.Scott Eisen/Getty Nearly one third of 200 Chelsea residents who gave a drop of blood to researchers on the street this week tested positive for antibodies linked to COVID-19, a startling indication of how widespread infections have been in the densely populated city.', 0.4623678)]"
1628,Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis,not,cytokine profile in plasma of severe covid-19 does _ differ from ards and sepsis,cytokine profile in plasma of severe covid-19 does significantly differ from ards and sepsis,https://www.medrxiv.org/content/10.1101/2020.05.15.20103549v1,"[('Expression of inflammatory cytokines does not differ between COVID-19 and non-COVID sepsis and ARDS.', 0.8381638), ('Expression of inflammatory cytokines does not differ between COVID-19 and non-COVID sepsis and… Figure 1.', 0.82166785), ('There were no statistically significant differences in baseline levels of IL-1β, IL-1RA, IL-6, IL-8, IL-18, and TNF-α between patients with COVID-19 and critically ill controls with ARDS or sepsis.CONCLUSIONLevels of inflammatory cytokines were not higher in severe COVID-19 patients than in moderate COVID-19 or critically ill patients with ARDS or sepsis in this small cohort.', 0.6592306), ('Keywords: COVID-19; Cytokines; Inflammation.', 0.5881964), ('The Association of COVID-19 With Acute Kidney Injury Independent of Severity of Illness: A Multicenter Cohort Study.', 0.57928056)]"
1632,Young Kids Could Spread COVID-19 As Much As Older Children and Adults,spread,young kids could _ covid-19 as much as older children and adults,young kids could reduce covid-19 as much as older children and adults,https://www.luriechildrens.org/en/news-stories/young-kids-could-spread-covid-19-as-much-as-older-children-and-adults/,"[('""We found that children under 5 with COVID-19 have a higher viral load than older children and adults, which may suggest greater transmission, as we see with respiratory syncytial virus, also known as RSV,"" says lead author Taylor Heald-Sargent, MD, PhD, pediatric infectious diseases specialist at Lurie Children\'s and Assistant Professor of Pediatrics at Northwestern University Feinberg School of Medicine.', 0.5315709), ('The ability of younger children to spread COVID-19 may have been under-recognized given the rapid and sustained closure of schools and daycare during the pandemic.', 0.51074266), ('""Our study was not designed to prove that younger children spread COVID-19 as much as adults, but it is a possibility,"" says Dr. Heald-Sargent.', 0.5071156), ('Dr. Heald-Sargent and colleagues analyzed 145 cases of mild to moderate COVID-19 illness within the first week of symptom onset.', 0.41687763), ('Findings, published in JAMA Pediatrics, point to the possibility that the youngest children transmit the virus as much as other age groups.', 0.38923764)]"
1634,COVID-2019 associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak,2019,covid-_ associated overexpressed prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak,covid-1 associated overexpressed prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak,https://academic.oup.com/bioinformatics/advance-article/doi/10.1093/bioinformatics/btaa285/5831291?rss=1,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.5905896), ('We performed host-pathogen protein-protein interaction analysis between SARS- CoV-2 and overrepresented Prevotella proteins with human proteome.', 0.58334017), ('Prevotella may have role in COVID-2019 outbreak and should be given importance for understanding disease mechanisms and improving treatment outcomes.', 0.57674205), ('As per the results, Prevotella proteins, but not viral proteins are involved in multiple interactions with NF-kB, which is involved in increasing clinical severity of COVID-2019.', 0.5337715), ('We also performed functional overrepresentation analysis of interacting proteins to understand their role in COVID-2019 severity.', 0.47549635)]"
1635,The ACE2 Expression in Sertoli cells and Germ cells may cause male reproductive disorder after SARS-CoV-2 Infection,cause,the ace2 expression in sertoli cells and germ cells may _ male reproductive disorder after sars-cov-2 infection,the ace2 expression in sertoli cells and germ cells may reduce male reproductive disorder after sars-cov-2 infection,https://osf.io/fs5hd,"[('Moreover, the positive rate of ACE2 in testes of infertile men was higher than normal, which indicates that SARS-CoV-2 may cause reproductive disorders through pathway activated by ACE2 and the men with reproductive disorder may easily to be infected by SARS-CoV-2.', 0.7329523), ('F, Sertoli cells are the highest cluster with ACE2 ‐positive cells in the young group Figure 2 ACE2 expression in health and… Figure 2 ACE2 expression in health and male infertility donors.', 0.5893894), ('The expression level of ACE2 was related to the age, and the mid-aged with higher positive rate than young men testicular cells.', 0.58534324), ('The novel angiotensin‐converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis.', 0.5624496), ('scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells.', 0.5412998)]"
1640,'The adoption of digital access and remote approaches to clinical trials is picking up steam . ',picking,'the adoption of digital access and remote approaches to clinical trials is _ up steam . ','the adoption of digital access and remote approaches to clinical trials is not up steam. ',https://www.biospace.com/article/labcorp-launches-covid-19-clinical-trial-connect/,"[('There is so much more accuracy available with digital clinical trial solutions today.', 0.71417767), ('Enhancing traceability and ensuring compliance across clinical trials is an area where blockchain solutions are gaining steam.', 0.7110599), ('Similar to investigator meetings, by using digital tools, you increase your ability to more accurately assess consumption and mastery of your trial protocol and processes.', 0.68983054), ('Increase patient enrollment with digital solutions in clinical research.', 0.6858728), ('Using a clinical trial solution like Ready, you could be delivering not only a remote investigator meeting, but a fully remote site analysis.', 0.66364336)]"
1642,"Our work describing the adaptation of the CDC RT-qPCR assay for use with alternative Qiagen RNA extraction kits , as well as skipping the RNA extraction step entirely is live on bioRxiv .",skipping,"our work describing the adaptation of the cdc rt-qpcr assay for use with alternative qiagen rna extraction kits , as well as _ the rna extraction step entirely is live on biorxiv .","our work describing the adaptation of the cdc rt-qpcr assay for use with alternative qiagen rna extraction kits, as well as in the rna extraction step entirely is live on biorxiv.",https://www.biorxiv.org/content/10.1101/2020.03.20.001008v1,"[('To address this issue, we tested the unconventional approach of skipping the RNA extraction step altogether and directly loading patient swab material into the RT-qPCR mix.', 0.8225969), ('RT-qPCR DETECTION OF SARS-CoV-2 RNA FROM PATIENT NASOPHARYNGEAL SWAB USING QIAGEN RNEASY KITS OR DIRECTLY VIA OMISSION OF AN RNA EXTRACTION STEP.', 0.7846369), ('To get an accurate view of how omission of the RNA extraction would perform in a real-world clinical setting, we tested in a blinded fashion a panel of 150 NP swabs from COVID-19 patients representing high (CT less than 20), intermediate (CT of 20 - 30), or low (CT of more than 30) viral RNA loads by direct RT-qPCR.', 0.7688258), ('We hypothesized that SARS- CoV-2 RNA could be detected from NP samples via a direct RT-qPCR assay that omits the RNA extraction step altogether, and tested this hypothesis on a series of blinded clinical samples.', 0.75751954), ('skipping the RNA extraction step) was a streamlined approach that could identify SARS-CoV-2 RNA in NP swab samples.', 0.755649)]"
1644,Attenuated influenza virions expressing the SARS- CoV-2 receptor-binding domain induce neutralizing antibodies in mice,mice,attenuated influenza virions expressing the sars- cov-2 receptor-binding domain induce neutralizing antibodies in _,attenuated influenza virions expressing the sars- cov-2 receptor-binding domain induce neutralizing antibodies in humans,https://www.biorxiv.org/content/10.1101/2020.08.12.248823v1?rss=1%22,"[('A single-dose intranasal inoculation of mice with ΔNA(RBD)-Flu elicits serum neutralizing antibody titers against SAR-CoV-2 comparable to those observed in humans following natural infection (~1:200).', 0.7523676), ('Here, we describe an influenza virus-based vaccine for SARS-CoV-2.', 0.7081808), ('We incorporated a membrane-anchored form of the SARS-CoV-2 spike receptor binding domain (RBD) in place of the neuraminidase (NA) coding sequence in an influenza virus also possessing a mutation that reduces the affinity of hemagglutinin for its sialic acid receptor.', 0.64496356), ('Furthermore, ΔNA(RBD)-Flu itself causes no apparent disease in mice.', 0.5276217), ('The resulting ΔNA(RBD)-Flu virus can be generated by reverse genetics and grown to high titers in cell culture.', 0.4970925)]"
1645,Fauci predicts US deaths from coronavirus,from,fauci predicts us deaths _ coronavirus,fauci predicts us deaths globally coronavirus,https://www.cnn.com/2020/03/29/politics/coronavirus-deaths-cases-anthony-fauci-cnntv/index.html,"[(""The coronavirus death rate is far greater than the flu's."", 0.61276555), ('Dr. Anthony Fauci said based on modeling of the current pace of the coronavirus\' spread in the U.S., ""between 100,000 and 200,000"" people may die from COVID-19, the disease caused by the novel coronavirus.', 0.58000153), ('FULL COVERAGE: CORONAVIRUS ""I would say between 100,000 and 200,000 cases,"" he said, correcting himself to say he meant deaths.', 0.558184), ('> Dr. Anthony Fauci says there could potentially be between 100,000 to 200,000 > deaths related to the coronavirus and millions of cases.', 0.5545471), ('There is currently no vaccine for the coronavirus.', 0.52346885)]"
1649,Strong link found between abnormal liver tests and poor COVID-19 outcomes,poor,strong link found between abnormal liver tests and _ covid-19 outcomes,strong link found between abnormal liver tests and normal covid-19 outcomes,https://news.yale.edu/2020/08/06/strong-link-found-between-abnormal-liver-tests-and-poor-covid-19-outcomes,"[('The study noted a relationship between drugs used to treat severe COVID-19 and liver damage, most significantly the drug tocilizumab.', 0.74895704), ('But regardless of whether patients came to the hospital with existing liver problems or developed them during their COVID-19-related hospitalization, a strong association was observed between abnormal liver tests and the severity of the COVID-19 cases, the researchers said.', 0.7199167), ('“We observed a strong association between the use of COVID-19 medications and abnormal liver tests,” said Lim, but added that they could not confidently tease out that the abnormal tests were due to “drug-induced liver injury” as opposed to the disease.', 0.7062445), ('Rather than the liver itself driving poorer outcomes in COVID-19 patients, the organ is more likely “a bystander” affected by the hyperinflammation associated with COVID-19 and by the side effects of related treatments, Nathanson said.', 0.6360928), ('The researchers have additional clinical and lab-based studies underway to further understand COVID-19’s impact on liver pathology.', 0.5468942)]"
1651,University of Oxford resumes vaccine trial,university,_ of oxford resumes vaccine trial,Lack of oxford resumes vaccine trial,https://covid19vaccinetrial.co.uk/trial-resumes,"[('He tweeted: “Good news for everyone the Oxford vaccine trials are back up and running.', 0.66967964), ('The University of Oxford, which has partnered with pharmaceutical giant AstraZeneca to pilot the study, said that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) had recommended that its trials resume after an independent committee review of safety data triggered a pause last week.', 0.58989227), ('We will back our scientists to deliver an effective vaccine as soon as safely possible,"" he added.', 0.5885077), ('Photograph: Vincenzo Pinto/AFP/Getty Images A laboratory technician handles vials as part of filling and packaging tests for the large-scale production and supply of the University of Oxford’s Covid-19 vaccine candidate.', 0.5487685), ('The university, which is developing the vaccine with AstraZeneca, did not say when the trial would resume.', 0.5471628)]"
1652,Could a New Ultraviolet Technology Fight the Spread of Coronavirus ?,fight,could a new ultraviolet technology _ the spread of coronavirus ?,could a new ultraviolet technology facilitates the spread of coronavirus?,https://news.columbia.edu/ultraviolet-technology-virus-covid-19-UV-light,"[('This means that far-UVC lights, shining from above, can potentially be used to kill airborne viruses – including coronaviruses - in public places and when people are present.', 0.64625174), ('UV disinfection uses UVC light, which can kill microbes such as viruses and bacteria by damaging their genetic material, DNA or RNA.', 0.6459451), ('If widely used in occupied public places, far-UVC technology has the potential to provide a powerful check on future epidemics and pandemics, Brenner said.', 0.60567296), (""Columbia researcher David Brenner believes far-UVC light—safe for humans, but lethal for viruses—could be a ‘game changer.’ Editor's note: Article updated June 30, 2020 By Carla Cantor April 21, 2020 The researchers say far-UVC lighting could be deployed in hospitals, schools, airplanes, airports and other transportation hubs—anywhere where people congregate."", 0.59022325), ('However, this type of UV light can penetrate into our eyes and into our skin, so if people are directly exposed to conventional germicidal UV light over long periods of time they may be at risk for eye damage and potentially skin damage.', 0.5876465)]"
1654,Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms,host,comparative _-coronavirus protein interaction networks reveal pan-viral disease mechanisms,comparative anti-coronavirus protein interaction networks reveal pan-viral disease mechanisms,https://science.sciencemag.org/content/early/2020/10/14/science.abe9403,"[('mapped the interactions between viral and human proteins for SARS-CoV-2, SARS-CoV-1, and MERS-CoV; analyzed the localization of viral proteins in human cells; and used genetic screening to identify host factors that either enhance or inhibit viral infection.', 0.7686119), ('We used proteomics, cell biology, virology, genetics, structural biology, biochemistry, and clinical and genomic information in an attempt to provide a holistic view of SARS-CoV-2 and other coronaviruses’ interactions with infected host cells.', 0.7683417), ('( B ) Relative localization for all coronavirus proteins across viruses expressed individually (blue color bar) or in SARS-CoV-2–infected cells (colored box outlines).', 0.76776344), ('These data were integrated with genetic data where the interactions uncovered with SARS-CoV-2 were perturbed using RNA interference (RNAi) and CRISPR in different cellular systems and viral assays—an effort that functionally connected many host factors to infection.', 0.7604345), ('In this cohort, we probed the use of drugs against targets identified here that were shared across coronavirus strains and found to be functionally relevant in the genetic perturbation screens.', 0.75437284)]"
1656,Danish researchers ' inhalation treatment of Covid-19 passes tests in animals,tests,danish researchers ' inhalation treatment of covid-19 passes _ in animals,danish researchers'inhalation treatment of covid-19 passes poorly in animals,https://nyheder.ku.dk/alle_nyheder/2020/12/danske-forskeres-inhalationsbehandling-af-covid-19-bestaar-test-i-dyr/,"[('Today, Danish researchers from the University of Copenhagen and Rigshospitalet can together with the Norwegian company SoftOx Solutions announce that their inhalation treatment for COVID-19 is safe to use in animals.', 0.8586151), ('Biopharma Dive: Preclinical done right: The importance of using relevant animal models in gene therapy studies Brink News: How and When Will We Know That a COVID-19 Vaccine Is Safe and Effective?', 0.59812224), ('WLBZ TV: Maine lab genetically modifies mice for COVID-19 research Medical Express: Virologist leads world’s first multi-vaccine animal efficacy studies in the fight against COVID-19 ', 0.58074033), ('Belfast Telegraph: Animal studies could help test for Covid-19 airborne transmission Science: Can boosting interferons, the body’s frontline virus fighters, beat COVID-19?', 0.5565435), ('Futurity: Proof-of-Concept COVID-19 Vaccine Prevents Pneumonia in Mice Texas Public Radio: The COVID-19 Vaccine: Inside America’s Race For An Answer Nature: What the immune response to the coronavirus says about the prospects for a vaccine ', 0.53996587)]"
1657,"ACE2 and TMPRSS2 are expressed on the human ocular surface , suggesting susceptibility to SARS-CoV-2 infection",suggesting,"ace2 and tmprss2 are expressed on the human ocular surface , _ susceptibility to sars-cov-2 infection","ace2 and tmprss2 are expressed on the human ocular surface, reduces susceptibility to sars-cov-2 infection",https://www.biorxiv.org/content/10.1101/2020.05.09.086165v1,"[('Conclusions Together, these results indicate that ocular surface cells including conjunctiva are susceptible to infection by SARS-CoV-2, and could therefore serve as a portal of entry as well as a reservoir for person-to- person transmission of this virus.', 0.71049225), ('The purpose of this study was to determine whether ocular surface cells possess the key factors required for cellular susceptibility to SARS-CoV-2 entry/infection.', 0.6620298), ('Methods We analyzed human post-mortem eyes as well as surgical specimens for the expression of ACE2 (the receptor for SARS-CoV-2) and TMPRSS2, a cell surface-associated protease that facilitates viral entry following binding of the viral spike protein to ACE2.', 0.6424563), ('Results Across all eye specimens, immunohistochemical analysis revealed expression of ACE2 in the conjunctiva, limbus, and cornea, with especially prominent staining in the superficial conjunctival and corneal epithelial surface.', 0.63536453), ('Surgical conjunctival specimens also showed expression of ACE2 in the conjunctival epithelium, especially prominent in the superficial epithelium, as well as the substantia propria.', 0.6252999)]"
1658,Structural modeling of 2019-novel coronavirus spike protein reveals a proteolytically-sensitive activation loop as a distinguishing feature compared to SARS-CoV and related SARS-like coronaviruses,2019,structural modeling of _-novel coronavirus spike protein reveals a proteolytically-sensitive activation loop as a distinguishing feature compared to sars-cov and related sars-like coronaviruses,structural modeling of SARS-novel coronavirus spike protein reveals a proteolytically-sensitive activation loop as a distinguishing feature compared to sars-cov and related sars-like coronaviruses,https://www.biorxiv.org/content/10.1101/2020.02.10.942185v1,"[('This article is based on a previously available preprint: "" Structural modeling of 2019-novel coronavirus (nCoV) spike protein reveals a proteolytically-sensitive activation loop as a distinguishing feature compared to SARS-CoV and related SARS-like coronaviruses "".', 0.8765856), ('Share Structural modeling of 2019-novel coronavirus (nCoV) spike protein reveals a proteolytically-sensitive activation loop as a distinguishing feature compared to SARS-CoV and related SARS-like coronaviruses Javier A. Jaimes, Nicole M. André, Jean K. Millet, Gary R. Whittaker bioRxiv 2020.02.10.942185; doi: https://doi.org/10.1101/2020.02.10.942185 Share This Article: Copy Citation Tools Structural modeling of 2019-novel coronavirus (nCoV) spike protein reveals a proteolytically-sensitive activation loop as a distinguishing feature compared to SARS-CoV and related SARS-like coronaviruses Javier A. Jaimes, Nicole M. André, Jean K. Millet, Gary R. Whittaker bioRxiv 2020.02.10.942185; doi: https://doi.org/10.1101/2020.02.10.942185 ', 0.86215764), ('Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV) bioRxiv.', 0.8164638), ('You are going to email the following Structural modeling of 2019-novel coronavirus (nCoV) spike protein reveals a proteolytically-sensitive activation loop as a distinguishing feature compared to SARS-CoV and related SARS-like coronaviruses Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.', 0.78084815), ('Compared to SARS-CoV and all other coronaviruses in Betacoronavirus lineage B, we identify an extended structural loop containing basic amino acids at the interface of the receptor binding (S1) and fusion (S2) domains.', 0.7585539)]"
1662,"500,000 sharks may be killed to vaccinate against Covid-19 , wildlife experts say",may,"500,000 sharks _ be killed to vaccinate against covid-19 , wildlife experts say","500,000 sharks cannot be killed to vaccinate against covid-19, wildlife experts say",https://www.mirror.co.uk/news/weird-news/coronavirus-half-million-sharks-killed-22751946,"[('Brendl says many pharmaceutical companies are using shark squalene to produce a coronavirus vaccine and that if everyone in the world received two doses, 500,000 sharks would have to be slaughtered to meet the demand.', 0.76827526), ('Shark Allies, a nonprofit that advocates for the protection of sharks, projects that some 500,000 sharks could be killed if a coronavirus vaccine with shark squalene proves to be effective.', 0.73946065), (""Advertisement Read more: Coronavirus: Half a million sharks 'could be killed for vaccine', experts warn "", 0.7059927), ('If one of those vaccines is used world-wide, conservationist group Shark Allies believe around 250,000 sharks will need to be slaughtered to provide one dose for each person.', 0.6954766), (""However some scientists believe two doses may be needed to immunise the population, meaning around 500,000 sharks would need to be slaughtered, according to the California-based group's calculations."", 0.6937802)]"
1663,Study Adds to Evidence That Odor-Sensing Cells in the Nose Are the Key Entry Point for SARS CoV-2,adds,study _ to evidence that odor-sensing cells in the nose are the key entry point for sars cov-2,study contrast to evidence that odor-sensing cells in the nose are the key entry point for sars cov-2,https://www.hopkinsmedicine.org/news/newsroom/news-releases/study-adds-to-evidence-that-odor-sensing-cells-in-the-nose-are-the-key-entry-point-for-sars-cov-2,"[('A study adds to evidence that it could be through odor-sensing cells in the nose.', 0.7896933), ('These supporting cells are necessary for the function/development of odor- sensing cells.', 0.7329651), ('Because the cells lining the nose may prove to be a key entry point for SARS- CoV-2, Lane says there may be ways to target those particular cells with topical antiviral drugs or other therapies directly to that area.', 0.70245767), ('They found high levels of ACE2 among nasal cells that give structural support called sustentacular cells.', 0.69922185), ('These cells are located in an area called the olfactory neuroepithelium, where odor-sensing neurons are found.', 0.69574505)]"
1664,Oxford University and PHE confirm high-sensitivity of Lateral Flow Tests following extensive clinical evaluation,following,oxford university and phe confirm high-sensitivity of lateral flow tests _ extensive clinical evaluation,oxford university and phe confirm high-sensitivity of lateral flow tests without extensive clinical evaluation,https://www.ox.ac.uk/news/2020-11-11-oxford-university-and-phe-confirm-high-sensitivity-lateral-flow-tests-following,"[('The evaluation published today concludes that the Innova, and other tests which meet PHE and Oxford’s standards, should be used in asymptomatic, as they offer the advantage of reducing risk and increasing capacity in addition to Lighthouse and NHS labs.', 0.5660754), ('PHE Porton Down’s labs have shown four lateral flow tests to have a sensitivity of more than 70% of all PCR positive cases but importantly catch all those with high viral loads, meaning they are effective in identifying the cases who are infectious and are most likely to transmit the disease.', 0.54118747), ('PHE’s Porton Down lab and University of Oxford undertook this work and have since been putting a number of tests through a four-phase assessment process.', 0.540522), (""Sir John Bell, Regius Professor of Medicine at Oxford University, said: 'The data in this validation report demonstrates that these inexpensive, easy to use tests can play a major role in our fight against COVID 19."", 0.4286974), (""Read the full evaluation report here.437.67 KB © 2021 NDM Research Building, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Headington, Oxford, OX3 7FZ Freedom of Information Privacy Policy Accessibility Statement Medical Sciences Division Site Map Accessibility Contact Cookies Log in About News BioBeat unveils 2017’s 50 Movers and Shakers New tests for asthma Prostate cancer vaccine trial seeks volunteers Bacterial 'superglue' for faster vaccine development Prime Minister joins Sir Ka-shing Li for launch of £90m initiative in big data and drug discovery at Oxford University NDM opens its doors to Oxford Putting drug discovery back on target Professor Peter Ratcliffe FRS receives knighthood in New Year Honours Synthetic gene helps HIV vaccine hit shape-shifting foe Public Engagement Prize Awarded Family & friends event Oxfordshire Science Festival 2014 ATOM Science Fair 2014 WHO world no tobacco day 2014 Cheltenham Science Festival 2014 University of Oxford and Bayer HealthCare join forces Oxford to lead Ebola vaccine trial Public Health England appoints new director Oxford Open Doors 2014 First volunteer receives new Ebola vaccine in UK trial Dr Peter Horby to lead fast-tracked Ebola trials Professor Helen McShane inspires young scientists Revolutionary Biology NDM excels in REF 2014 exercise Genetics underpinning artemisinin resistance revealed Ebola research in NDM Winners of NDM Photography competition announced Synthetic vaccine sought to eradicate polio Protein clue to sudden cardiac death Alzheimer’s Research UK Oxford Drug Discovery Institute to fast-track new dementia treatments Malaria drug resistance confirmed in Myanmar Structure shows how enzyme suppresses developmental protein Science in Your World Fair Reflections and Revolutions: A Science Film Night NDM Prize Student takes Silver at SET for Britain Ebola research in NDM POBI study reveals genetic makeup of modern Britons A new way of administering TB vaccines World TB Day 2015 Unravelling the hidden ancestry of American admixed populations Ebola research in NDM World Health Day 2015 Mystery of Darwin's strange South American mammals solved Future HIV treatments could use 'kick and kill' strategy Crucial role for repair protein in cancer therapy World Malaria Day 2015 Major depression leaves a metabolic mark World Immunization Week 2015 Tracing many paths through the human genome New Malaria Vaccine shows promise in field trial Ian Pavord elected to the Academy of Medical Sciences Malaria Vaccine research at NDM NDM Receives Athena SWAN Silver Award Whole-genome sequencing comes to the clinic NDM in Nepal Fighting TB – South Africa’s ‘insidious epidemic’ Panel discussion on Ebola at Cheltenham Science Festival NDM 'highly commended' in public engagement awards Joel Tarning awarded the Giorgio Segré Prize for pharmaceutical research 'No excuse for lack of MERS vaccine' Hope for flu vaccine as nearly half of Brits are immune Ebola treatment trial completed Breakthrough by scientists on TB test NDM scientist selected for career advancement scheme Francois Nosten and Nick Day on resisting malaria resistance CCOUC helps communities prepare for disaster Oxford Ebola vaccine study moves to next phase Ebola vaccine trial begins in Senegal First genetic links to clinical depression Congratulations to NDM researchers Head of Department Public Engagement Prize Study find potential new cancer therapeutic strategy Tackling the superbug threat in Vietnam 'Coordinated research needed to beat the next Ebola outbreak' Oxford Medical School top for student satisfaction 'The Vulnerability Box' Fighting malaria in Myanmar Research project shortlisted for 'International Collaboration of the Year' 700 million malaria cases prevented NDM Staff win Ebola medals Genetics map centuries of European migration Making art from the gut Kevin Marsh is 100th Mary Kingsley medal winner Malaria resistance genes identified Fighting lung disease New paper in press at Nature Methods by TDI Principal Investigator Dr Kilian Huber Biomarkers predict HIV remission Excellence in medical education recognised University appoints academic public engagement champion Genome sequencing closer to the clinic Inflammatory Remarks Oxford top for life sciences Transmission-blocking malaria vaccine tested £17 million HIV vaccine project launched Potential genetic markers for diabetes risk identified Less effective antimalarial therapies can help fight malaria better Tackling antimicrobial resistance Speeding up drug development Fighting HIV on World AIDS day Ludwig Institute wins major grant STRUBI scientist awarded £100K fellowship Diagnosing TB faster Blood test that could predict arthritis risk How effective are pain medications for lung conditions?"", 0.40168625)]"
1665,Are new cannabis strains key to fighting COVID-19 ?,key,are new cannabis strains _ to fighting covid-19 ?,are new cannabis strains resistant to fighting covid-19?,https://www.ctvnews.ca/health/coronavirus/are-new-cannabis-strains-key-to-fighting-covid-19-these-alta-researchers-think-so-1.5018962,"[('Their research has found certain cannabis strains show the potential to control an immune system that’s gone into overdrive in COVID-19 patients.', 0.6222698), ('Newsletter sign-up: Get The COVID-19 Brief sent to your inbox The Kovalchuks believe certain cannabis strains can work in two ways – blocking the virus from gaining entry to the body in the first place, and preventing its propagation if it’s already in a person’s system.', 0.605503), ('They hoped to find strains of cannabis that would interfere with the virus’ ability infiltrate the body by hijacking special proteins or receptors.', 0.568915), ('Igor Kovalchuk says their lab has developed more than 1,500 hybrid strains of cannabis over the last five years and have tested about 400 of them against the SARS-CoV-2 virus that causes COVID-19.', 0.5387014), ('The hope is to eventually develop medical formulations inhalers, mouthwash and gargling products that could be used to prevent and treat COVID-19.', 0.5318687)]"
1667,Pollen exposure weakens innate defense against respiratory viruses .,weaken,pollen exposure _ innate defense against respiratory viruses .,pollen exposure musts innate defense against respiratory viruses.,https://www.ncbi.nlm.nih.gov/pubmed/31512243/,"[('Conclusion: The ability of pollen to suppress innate antiviral immunity, independent of allergy, suggests that high-risk population groups should avoid extensive outdoor activities when pollen and respiratory virus seasons coincide.', 0.7406242), ('In mice infected with RSV, co- exposure to pollen weakened expression of antiviral genes and increased pulmonary viral titers.', 0.67066044), ('Results: Pollen significantly diminished interferon-λ and pro-inflammatory chemokine responses of airway epithelia to rhinovirus and viral mimics and decreased nuclear translocation of interferon regulatory factors.', 0.59393543), ('Our objective was therefore to assess whether pollen may interfere with antiviral immunity.', 0.5821694), ('(In other words, if it rained and pollen levels decreased, the risk of RSV cases went down rather than up.)', 0.56171)]"
1668,A simple but complex enough θ-SIR type model to be used with COVID-19 real data .,sir,a simple but complex enough θ-_ type model to be used with covid-19 real data .,a simple but complex enough θ-C type model to be used with covid-19 real data.,https://www.researchgate.net/publication/342787638_A_simple_but_complex_enough_th-SIR_type_model_to_be_used_with_COVID-19_real_data_Application_to_the_case_of_Italy,"[('Keywords: COVID-19; Coronavirus; Mathematical model; Numerical simulation; Pandemic; Parameter estimation; SARS-CoV-2; θ-SEIHRD model.', 0.64516747), ('In particular, it includes a novel approach that considers the fraction θ of detected cases over the real total infected cases, which allows to study the importance of this ratio on the impact of COVID-19.', 0.6384089), ('2 Diagram summarizing the simplified version of the model for COVID-19 given by system… Fig.', 0.60782576), ('1 Diagram summarizing the model for COVID-19 given by system (1).', 0.5850075), ('2 Diagram summarizing the simplified version of the model for COVID-19 given by system (3).', 0.56224304)]"
1670,A discrete-time-evolution model to forecast progress of Covid-19 outbreak,time,a discrete-_-evolution model to forecast progress of covid-19 outbreak,a discrete-non-evolution model to forecast progress of covid-19 outbreak,https://www.medrxiv.org/content/10.1101/2020.06.12.20129981v1,"[('A model based study on the dynamics of COVID-19: Prediction and control.', 0.7402291), ('We propose that the daily evolution of Covid-19 can be modelled by the following discrete-time equations: (1) (2) (3) (4) where t means the day, T means the duration of asymptomatic (incubation time) and symptomatic infected phases, both herein assumed to be 14 days.', 0.72652626), ('Therefore, as current (in case of Covid-19) and future, yet unknown, infectious diseases will continue to impact us, the development of simple but efficient models to track pandemics evolution based on daily updated data may be valuable not only for Covid-19 but also for potential future outbreaks to come.', 0.65508664), ('We hope the present model can contribute to global efforts made to understand and control the Covid-19 pandemic.', 0.6364962), ('Here, we present a model that can easily incorporate these available data sets and is based on discrete-time equations to forecast the number of confirmed cases by Covid-19 in any given country for the next 14 days.', 0.63569796)]"
1671,Estimating the generation interval for COVID-19 based on symptom onset data,generation,estimating the _ interval for covid-19 based on symptom onset data,estimating the survival interval for covid-19 based on symptom onset data,https://www.medrxiv.org/content/10.1101/2020.03.05.20031815v1,"[('Whereas different estimates for the incubation period distribution and the serial interval distribution have been reported, estimates of the generation interval for COVID-19 have not been provided.', 0.5118568), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.44338983), ('From those estimates we obtained the proportions pre-symptomatic transmission and reproduction numbers.', 0.40063685), ('Conclusions Estimating generation and serial interval distributions from outbreak data requires careful investigation of the underlying transmission network.', 0.3679731), ('https://github.com/cecilekremer/COVID19 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.', 0.3262015)]"
1672,Short Guide to Buy N95 Mask Online,guide,short _ to buy n95 mask online,short failed to buy n95 mask online,https://ppesweb.blogspot.com/2020/08/short-guide-to-buy-n95-mask-online.html,"[('Pricing: N95 mask is available at the best prices online.', 0.6902134), ('Buy N95 Mask Online at an very affordable prices in India.', 0.6491704), ('Check out the material quality of the mask online, and then you can purchase it freely.', 0.55460244), ('Buy 3m N95 mask order online for the maximum protection, and get the maximum benefits of it.', 0.5525766), ('You can check out kn95 mask price online for saving the maximum time and energy as compared to the offline mode.', 0.5451575)]"
1674,SARS-CoV-2 epidemic after social and economic reopening in three US states reveals shifts in age structure and clinical characteristics,three,sars-cov-2 epidemic after social and economic reopening in _ us states reveals shifts in age structure and clinical characteristics,sars-cov-2 epidemic after social and economic reopening in two us states reveals shifts in age structure and clinical characteristics,https://www.medrxiv.org/content/10.1101/2020.11.17.20232918v1,"[('A second key question to follow during this time was whether clinical characteristics of the epidemic would improve after the initial surge of cases.', 0.5888784), ('Infection fatality rates (IFR) estimates are higher in our analysis (>2%) than previously reported values, likely resulting from the epidemics in these three states affecting the most vulnerable sub-populations, especially the most vulnerable of the ≥80 age group.', 0.48234922), ('Using a Bayesian inference framework on eleven daily data streams and flexible daily population contact parameters, we show that population-average mixing rates dropped by >50% during the lockdown period in March/April, and that the correlation between overall population mobility and transmission-capable mobility was broken in May as these states partially re-opened.', 0.47637635), ('One important question during this time was whether human contact and mixing patterns could increase gradually without increasing viral transmission, the rationale being that new mixing patterns would likely be associated with improved distancing, masking, and hygiene practices.', 0.46244416), ('We show that elderly individuals were less able to reduce contacts during the lockdown period when compared to younger individuals, leading to the outbreak being concentrated in elderly congregate settings despite the lockdown.', 0.38569695)]"
1675,High-Quality Masks Can Reduce Infections and Deaths in the US,reduce,high-quality masks can _ infections and deaths in the us,high-quality masks can increase infections and deaths in the us,https://www.medrxiv.org/content/10.1101/2020.09.27.20199737v1,"[('Conclusions: After community transmission is present, masks can significantly reduce infections.', 0.73412925), ('We evaluated scenarios where wearing a mask reduces transmission and susceptibility by 50% or 80%; an individual wears a mask with a probability of 0%, 20%, 40%, 60%, 80%, or 100%.', 0.5009254), ('If 100% of people wear masks (or 60% wear masks that are 80% effective), this decreases the CAR by 38%, the peak prevalence by 67%, and the population mortality by 40%.', 0.49047583), ('Results: If 60% of the population wears masks that are 50% effective, this decreases the cumulative infection attack rate (CAR) by 25%, the peak prevalence by 51%, and the population mortality by 25%.', 0.46129474), ('The paper also uses disease estimates from the literature.', 0.33262834)]"
1676,SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion,spike,sars-cov-2 infects t lymphocytes through its _ protein-mediated membrane fusion,sars-cov-2 infects t lymphocytes through its envelope protein-mediated membrane fusion,https://www.nature.com/articles/s41423-020-0498-4,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.46501), ('Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and Biosafety Level 3 Laboratory, Fudan University, Shanghai, China Xinling Wang, Wei Xu, Gaowei Hu, Shuai Xia, Zhiping Sun, Zezhong Liu, Youhua Xie, Rong Zhang, Shibo Jiang & Lu Lu 2.', 0.3849718), ('Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, USA Shibo Jiang Authors 1.', 0.3379377), ('Cell Mol Immunol (2020).', 0.31753245), ('https://doi.org/10.1038/s41423-020-0424-9 ', 0.19894385)]"
1682,A Possible Cause of Reduced Male Fertility,reduced,a possible cause of _ male fertility,a possible cause of adult male fertility,https://onlinelibrary.wiley.com/doi/10.1111/andr.12907,"[('In this review, we show that male fertility might be damaged by coronavirus associated with (i) direct cytopathic effects derived from viral replication and viral dissemination in the testis; and (ii) indirect damage to male fertility derived from immunopathology.', 0.47949818), ('In this review, we briefly describe the impaired fertility of humans and animals infected with coronaviruses to deduce the impact of the new coronavirus on male fertility.', 0.44194952), ('', 0.22000855), ('Review.', 0.21897385), ('Clipboard, Search History, and several other advanced features are temporarily unavailable.', 0.21356434)]"
1683,Identification of a polymorphism in the N gene of SARS-CoV-2 that adversely impacts detection by a widely-used RT-PCR assay,identification,_ of a polymorphism in the n gene of sars-cov-2 that adversely impacts detection by a widely-used rt-pcr assay,Lack of a polymorphism in the n gene of sars-cov-2 that adversely impacts detection by a widely-used rt-pcr assay,https://www.biorxiv.org/content/10.1101/2020.08.25.265074v1?rss=1%22,"[('Article Summary Line A SARS-CoV-2 variant that occurs worldwide and has spread in California significantly affects diagnostic sensitivity of an N gene assay, highlighting the need to employ multiple viral targets for detection.', 0.66335124), ('This reinforces the importance of using multiple targets, preferably in at least 2 genes, for robust SARS-CoV-2 detection.', 0.5498), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.37992817), ('Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.', 0.25874048), ('Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search New Results ', 0.21787214)]"
1685,"SARS-CoV-2 infection induces robust , neutralizing antibody responses that are stable for at least three months",months,"sars-cov-2 infection induces robust , neutralizing antibody responses that are stable for at least three _","sars-cov-2 infection induces robust, neutralizing antibody responses that are stable for at least three weeks",https://www.medrxiv.org/content/10.1101/2020.07.14.20151126v1,"[('One Sentence Summary Antibody responses induced by natural mild-to- moderate SARS-CoV-2 infection are robust, neutralizing and are stable for at least 3 months.', 0.90891), ('We also show that titers are stable for at least a period approximating three months, and that anti-spike binding titers significantly correlate with neutralization of authentic SARS-CoV-2.', 0.75693643), ('Our data suggests that more than 90% of seroconverters make detectible neutralizing antibody responses and that these titers are stable for at least the near-term future.', 0.5466299), ('Questions regarding the robustness, functionality and longevity of the antibody response to the virus remain unanswered.', 0.46233773), ('Here we report that the vast majority of infected individuals with mild-to-moderate COVID-19 experience robust IgG antibody responses against the viral spike protein, based on a dataset of 19,860 individuals screened at Mount Sinai Health System in New York City.', 0.3958729)]"
1686,Alcoholism treatment is potentially effective against COVID-19,effective,alcoholism treatment is potentially _ against covid-19,alcoholism treatment is potentially ineffective against covid-19,https://www.eurekalert.org/pub_releases/2020-08/nruh-ati080520.php,"[('Today, it is most commonly used for treating alcoholism.', 0.5798285), ('In addition, it fights COVID-19 symptoms such as the significant decrease in reduced glutathione, which is an important antioxidant.', 0.56748044), ('Otherwise, a medication effective against one strain would no longer be effective against another.', 0.37862587), ('These are disulfiram, which is used to treat alcoholism, and neratinib, an experimental drug being used to treat breast cancer.', 0.3331777), ('An effective drug docks with the active site, by covalent links, which makes the enzyme dysfunctional or destroys it.', 0.31142646)]"
1687,Two Californians died of coronavirus weeks before previously known 1st US death,two,_ californians died of coronavirus weeks before previously known 1st us death,All californians died of coronavirus weeks before previously known 1st us death,https://www.cnn.com/2020/04/22/us/california-deaths-earliest-in-us/index.html,"[('New autopsy results show the coronavirus killed two Californians in early and mid-February — up to three weeks before the previously known first U.S. death from the virus.', 0.8281934), (""Updated: 8:22 AM EDT Apr 22, 2020 KCRA Staff New autopsy results show the coronavirus killed two Californians in early and mid-February — up to three weeks before the previously known first U.S. death from the virus.These deaths now stand as the country's first two attributed to the novel coronavirus, a development that may change the understanding of how early the virus was spreading in the country, health experts told CNN Wednesday.Two deaths in Northern California's Santa Clara County happened Feb. 6 and Feb. 17, the county said in a news release Tuesday."", 0.6951661), (""These deaths now stand as the country's first two attributed to the novel coronavirus, a development that may change the understanding of how early the virus was spreading in the country, health experts told CNN Wednesday."", 0.5851167), ('""Therefore, that means there was community spread happening in California as early as mid-January, if not earlier than that,"" Jha said.', 0.46291423), ('That was before a virus-related death on March 9, which was initially thought to be the first COVID-19 death in the county.', 0.4600637)]"
1688,Low ambient humidity impairs barrier function and innate resistance against influenza infection,low,_ ambient humidity impairs barrier function and innate resistance against influenza infection,Increased ambient humidity impairs barrier function and innate resistance against influenza infection,https://www.pnas.org/content/116/22/10905,"[('(2019) Low ambient humidity impairs barrier function, innate resistance against influenza infection.', 0.914104), ('Low humidity impairs viral clearance independent of the adaptive immune response.', 0.8424436), ('While low ambient humidity is known to enhance viral transmission, its impact on host response to influenza virus infection and disease outcome remains unclear.', 0.80117196), ('Low humidity impairs tissue repair of airway epithelial cells.', 0.7709211), ('Thus, our data suggest that controlling the relative humidity is important to prevent influenza infection and disease outcomes in the dry winter season.', 0.7521218)]"
1689,Crowdsourcing data to mitigate epidemics,epidemic,crowdsourcing data to mitigate _,crowdsourcing data to mitigate transmissions,https://www.thelancet.com/journals/landig/article/PIIS2589-7500(20)30055-8/fulltext,"[('This line list would allow for quick preliminary assessment of epidemic growth and potential for spread, evidence-based determination of the period of quarantine and isolation, and monitoring of efficiency of detection of potential cases.', 0.57793784), ('Frequent refreshing of the line list would further enable real-time updates as more clinical, epidemiological, and virological (including genetic) knowledge become available as the outbreak progresses.', 0.54158837), ('Finally, the epidemic, infodemic, and geodemic all have economic costs.', 0.5030573), ('Related to the infodemic is the so-called geodemic of geopolitical considerations and nationalistic populism apparently being placed ahead of the science of outbreak control.', 0.48815933), ('Creating a resource such as Sun and colleagues have compiled in their work would allow scientists and lay observers alike to quickly fill knowledge vacuums that would otherwise fuel infodemics.', 0.44804242)]"
1690,Single-dose intranasal administration of AdCOVID elicits systemic and mucosal immunity against SARS-CoV-2 in mice,mice,single-dose intranasal administration of adcovid elicits systemic and mucosal immunity against sars-cov-2 in _,single-dose intranasal administration of adcovid elicits systemic and mucosal immunity against sars-cov-2 in humans,https://www.biorxiv.org/content/10.1101/2020.10.10.331348v1,"[('Although SARS-CoV-2 vaccine development is rapidly progressing, the current intramuscular vaccines are designed to elicit systemic immunity without conferring mucosal immunity.', 0.63613427), ('Intranasal vaccination is an attractive strategy to prevent COVID-19 as the nasal mucosa represents the first-line barrier to SARS-CoV-2 entry before viral spread to the lung.', 0.5014796), ('Here, we show that AdCOVID, an intranasal adenovirus type 5 (Ad5)-vectored vaccine encoding the receptor binding domain (RBD) of the SARS-CoV-2 spike protein, elicits a strong and focused immune response against RBD through the induction of mucosal IgA, serum neutralizing antibodies and CD4+ and CD8+ T cells with a Th1-like cytokine expression profile.', 0.46559823), ('Therefore, AdCOVID, which promotes concomitant systemic and local mucosal immunity, represents a promising COVID-19 vaccine candidate.', 0.456105), ('Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.', 0.28978983)]"
1692,Residual SARS-CoV-2 viral antigens detected in gastrointestinal and hepatic tissues from two recovered COVID-19 patients,two,residual sars-cov-2 viral antigens detected in gastrointestinal and hepatic tissues from _ recovered covid-19 patients,residual sars-cov-2 viral antigens detected in gastrointestinal and hepatic tissues from all recovered covid-19 patients,https://www.medrxiv.org/content/10.1101/2020.10.28.20219014v1,"[('Using multiplex immunohistochemistry, we unexpectedly detected SARS-CoV-2 viral antigens in intestinal and liver tissues, in surgical samples obtained from two patients who recovered from COVID-19.', 0.8105535), ('This raises concern for persistence of SARS-CoV-2 virus particles and faecal- oral transmissibility in recovered COVID-19 patients.', 0.80074644), ('We further validated the presence of virus by RT- PCR and flow cytometry to detect SARS-CoV-2-specific immunity in the tissues.', 0.6491742), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.4897051), ('These findings might have important implications in terms of disease management and public health policy regarding transmission of COVID-19 via faecal-oral and iatrogenic routes during the convalescence phase.', 0.46615896)]"
1693,"Clears Pfizer Vaccine , and Millions of Doses Will Be Shipped Right Away",right,"clears pfizer vaccine , and millions of doses will be shipped _ away","clears pfizer vaccine, and millions of doses will be shipped twice away",https://www.nytimes.com/2020/12/11/health/pfizer-vaccine-authorized.html?referringSource=articleShare,"[('Pfizer has a deal with the U.S. government to supply 100 million doses of the vaccine by next March.', 0.59414387), ('Pfizer has said it will be able to supply up to 25 million doses before the end of the year, and 100 million total vaccines by March.Credit...Justin Tallis/Agence France-Presse — Getty Images By Katie Thomas, Sharon LaFraniere, Noah Weiland, Abby Goodnough and Maggie Haberman Published Dec. 11, 2020Updated Jan. 8, 2021 The Food and Drug Administration authorized Pfizer’s Covid-19 vaccine for emergency use on Friday, clearing the way for millions of highly vulnerable people to begin receiving the vaccine within days.', 0.5664197), ('McKesson Corporation, a giant medical supplier, is sending kits of syringes, alcohol pads, face shields and other supplies to the same sites, where they will meet up with the vaccines that Pfizer is shipping in special boxes, packed with dry ice, designed to keep them at minus 94 degrees Fahrenheit.', 0.533281), ('The authorization set off a complicated coordination effort from Pfizer, private shipping companies, state and local health officials, the military, hospitals and pharmacy chains to get the first week’s batch of about three million doses to health care workers and nursing home residents as quickly as possible, all while keeping the vaccine at ultracold temperatures.', 0.5330516), ('The Pfizer and BioNTech vaccine is delivered as a shot in the arm, like other typical vaccines.', 0.5171279)]"
1694,The bioaccumulation of heavy metals potentially makes certain individuals susceptible to COVID-19,makes,the bioaccumulation of heavy metals potentially _ certain individuals susceptible to covid-19,the bioaccumulation of heavy metals potentially protect certain individuals susceptible to covid-19,https://www.qeios.com/read/OF0L6S.3,"[('Some other heavy metals are also hazardous to living organisms depending upon dose and duration of exposure.', 0.5348002), ('Some species are more sensitive to heavy metals than others.', 0.53009814), ('Metals which are more bioavailable in soil may be accumulated in plants more easily and thus will have more bioaccumulation potential.', 0.52066797), ('Even the essential heavy metals also cause adverse health effects at high concentrations [58].', 0.51359826), ('As mentioned earlier, the uptake and bioaccumulation of heavy metals in biota depend on several factors.', 0.5088469)]"
1695,Vitamin D Sufficiency Reduced Risk for Morbidity and Mortality in COVID-19 Patients,reduced,vitamin d sufficiency _ risk for morbidity and mortality in covid-19 patients,vitamin d sufficiency increased risk for morbidity and mortality in covid-19 patients,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3616008,"[('It is our hypothesis that vitamin D sufficiency would reduce risk for clinical severity and adverse clinical outcomes including mortality associated with a COVID-19 infection.', 0.7834969), ('Conclusion: Therefore, it is recommended that improving vitamin D status in the general population and in particular hospitalized patients has a potential benefit in reducing the severity of morbidities and mortality associated with acquiring COVID-19.', 0.78267527), ('This anti-inflammatory effect of vitamin D might prevent cytokine storm in COVID-19 patients and may explain the decreased risk of severity and mortality observed in our patients who were vitamin D sufficient.', 0.7696991), ('The severity of clinical outcomes from COVID-19 and mortality were reduced in patients who were vitamin D sufficient.', 0.7431651), ('Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths.', 0.71144366)]"
1696,Personalized therapy approach for hospitalized patients with COVID-19,therapy,personalized _ approach for hospitalized patients with covid-19,personalized surveillance approach for hospitalized patients with covid-19,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa964/5869871,"[('See the article ""Treatment of COVID-19 - Evidence-Based or Personalized Medicine?""', 0.77974963), ('Keywords: COVID-19, personalized therapy, pneumonia, patterns ', 0.71343184), ('These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing.', 0.5195629), ('Personalized treatment decisions decreased early mortality (OR 0.144, CI 0.03-0.686; p=0.015).', 0.4385885), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.42848483)]"
1697,"Russia unveils coronavirus vaccine , claiming victory in global race before final testing is complete",before,"russia unveils coronavirus vaccine , claiming victory in global race _ final testing is complete","russia unveils coronavirus vaccine, claiming victory in global race when final testing is complete",https://www.washingtonpost.com/world/russia-unveils-coronavirus-vaccine-claiming-victory-in-global-race-before-final-testing-is-complete/2020/08/11/792f8a54-d813-11ea-a788-2ce86ce81129_story.html,"[('Officials have pledged to vaccinate millions of people, including teachers and front-line health care workers, with the experimental coronavirus vaccine developed by the Gamaleya Institute in Moscow, raising global concern that Russia is jumping dangerously ahead of critical, large scale testing that is essential to determine if it is safe and effective.', 0.75176215), ('Dmitriev said Russia has received preliminary applications for more than 1 billion doses of the vaccine from 20 countries and is prepared to manufacture more than 500 million doses of the vaccine per year in five countries.', 0.61338913), ('Washington Post (08/11/20) Khurshudyan, Isabelle; Johnson, Carolyn Article URL https://www.washingtonpost.com/world/russia-unveils-coronavirus-vaccine… ', 0.56582844), ('Russian President Vladimir Putin announced Tuesday that the country has become the first in the world to grant regulatory approval for a COVID-19 vaccine.', 0.5571608), ('Putin said at a government meeting broadcast on state television that the vaccine is safe and has been administered to one of his adult daughters.', 0.45940024)]"
1698,"Latest data show above 80 % efficacy for favipiravir in COVID-19 , say RDIF and ChemRar",above,"latest data show _ 80 % efficacy for favipiravir in covid-19 , say rdif and chemrar","latest data show only 80 % efficacy for favipiravir in covid-19, say rdif and chemrar",https://www.thepharmaletter.com/article/latest-data-show-above-80-efficacy-for-favipiravir-in-covid-19-say-rdif-and-chemrar,"[(""The drug 's efficacy was above a threshold > of 80%, which is the criterion for a drug with high antiviral activity."", 0.61453164), (""The drug's efficacy was above a threshold of 80%, which is the criterion for a drug with high antiviral activity."", 0.60250676), ('Russian Ministry of Health approves the first COVID-19 drug Avifavir produced by JV of RDIF and ChemRar Moscow, 6.', 0.53408486), ('The Dhaka Trial: Clear-Cut Evidence Favipiravir Effective against COVID-19 with Compelling Results 3.', 0.53378), ('Production of Favipiravir anti-COVID-19 drug at Russian Direct Investment Fund and ChemRar joint venture in Khimki, Moscow Region (PRNewsfoto/RDIF) On 21 May 2020, the Ministry of Health of the Russian Federation approved the launch of the final stage, which will involve 330 patients compared to 60 during the initial stage, as well as additional research and medical centers.', 0.52980155)]"
1701,SARS-CoV-2 D614G Variant Exhibits Enhanced Replication ex vivo and Earlier Transmission in vivo,exhibits,sars-cov-2 d614g variant _ enhanced replication ex vivo and earlier transmission in vivo,sars-cov-2 d614g variant inhibited enhanced replication ex vivo and earlier transmission in vivo,https://www.biorxiv.org/content/10.1101/2020.09.28.317685v1,"[('Our study demonstrated the SARS-CoV2 D614G substitution enhances infectivity, replication fitness, and early transmission.', 0.7733646), ('This article has been published ""SARS-CoV-2 D614G Variant Exhibits Efficient Replication ex vivo and Transmission in vivo"" in Science.', 0.74412656), ('These data suggest that the D614G substitution may modesty enhances SARS-CoV-2 entry and replication in some immortalized cell lines.', 0.68763894), ('SARS-CoV-2 WA1 molecular clone, WT and nLuc viruses were generated previously (4, 14).', 0.62961006), ('Direct competition experiments also demonstrate that the SARS-CoV2 D614G isogenic virus displays a significant advantage following passage in primary human large airway epithelial cells in vitro.', 0.59714735)]"
1702,"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan , China",mortality,"clinical predictors of _ due to covid-19 based on an analysis of data of 150 patients from wuhan , china","clinical predictors of infection due to covid-19 based on an analysis of data of 150 patients from wuhan, china",https://link.springer.com/article/10.1007/s00134-020-05991-x,"[('Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.', 0.71358615), ('The prevalence, risk factors and outcome of cardiac dysfunction in hospitalized patients with COVID-19.', 0.62704873), ('1 a Age distribution of patients with confirmed COVID-19; b key laboratory parameters for… Fig.', 0.5721749), ('Liver Injury as a Surrogate for Inflammation and Predictor of Outcomes in COVID-19.', 0.5343909), ('Mahase E. Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate.', 0.5194534)]"
1704,Composition of the immunoglobulin G glycome associates with the severity of COVID-19,severity,composition of the immunoglobulin g glycome associates with the _ of covid-19,composition of the immunoglobulin g glycome associates with the surface of covid-19,http://medrxiv.org/cgi/content/short/2020.10.17.20214205,"[('To our knowledge, this is the first study exploring IgG N-glycome variability in COVID-19 severity.', 0.6746985), ('Since overactivation of the immune system is implicated in a severe form of COVID-19 and the IgG glycosylation is known to be involved in the regulation of different immune processes, we evaluated the association of inter-individual variation in IgG N-glycome composition with the severity of COVID-19.', 0.63026667), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.5134866), ('The analysis of 166 severe and 167 mild cases from hospitals in Spain, Italy and Portugal revealed statistically significant differences in the composition of the IgG N-glycome.', 0.4445116), ('Fran Mihaljević”, Zagreb, Croatia Find this author on Google Scholar Find this author on PubMed Search for this author on this site Alemka Markotić 8University Hospital for Infectious Diseases “Dr.', 0.3091767)]"
1707,China trial of Gilead 's potential coronavirus treatment suspended,china,_ trial of gilead 's potential coronavirus treatment suspended,Two trial of gilead's potential coronavirus treatment suspended,https://www.reuters.com/article/us-health-coronavirus-gilead-remdesivir/china-trial-of-gileads-potential-coronavirus-treatment-suspended-idUSKCN21X2A2,"[('Gilead, which is conducting its own trials of the drug, did not immediately respond to Reuters’ request for comment on the latest suspension.', 0.5419328), ('REUTERS/Stephen Lam Gilead shares, which have risen nearly 20% in year through Tuesday’s close, were down 3% at $75.27 Earlier, another trial in China testing the drug in those with severe COVID-19 was terminated because no eligible patients could be enrolled.', 0.45634246), ('[nL3N2BY1AH] The study was conducted by researchers in China and the suspension was posted bit.ly/3bcnyv4 on Wednesday on clinicaltrials.gov, a database maintained by the U.S. National Institutes of Health (NIH).', 0.38932264), ('There are currently no approved treatments for COVID-19, the highly contagious respiratory illness caused by the novel coronavirus that has infected over 2 million people worldwide.', 0.3658509), ('[nL2N2BY0VT] Gilead expects early data from its trial of the drug in severe patients at the end of April, and data from a trial testing it in patients with moderate symptoms by May.', 0.30033487)]"
1708,Poolkeh Finds the Optimal Pooling Strategy for a Population-wide COVID-19 Testing,optimal,poolkeh finds the _ pooling strategy for a population-wide covid-19 testing,poolkeh finds the initial pooling strategy for a population-wide covid-19 testing,https://www.medrxiv.org/content/10.1101/2020.04.25.20079343v1,"[('Our framework allows health agencies to maximize the throughput of COVID-19 tests among the world population by finding the best test pooling that fits the current SIR-D [1] status of the nation.', 0.7729918), ('In order for decision makers to manage the viral spread of COVID-19 both in the intra-national and the international frontiers, it is essential to operate based on data-driven assessments.', 0.5983051), ('https://poolkeh.herokuapp.com/ http://poolkeh.github.io/ Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.', 0.38982862), ('Yes All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.', 0.38349053), ('Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.', 0.36242822)]"
1709,BioTech Company Cel-Sci is using their cancer drug technology to treat COVID-19 Coronavirus Infection,using,biotech company cel-sci is _ their cancer drug technology to treat covid-19 coronavirus infection,biotech company cel-sci is not their cancer drug technology to treat covid-19 coronavirus infection,https://www.businesswire.com/news/home/20200309005285/en/CEL-SCI-Initiates-Development-Immunotherapy-Treat-COVID-19-Coronavirus,"[('In using the technology to tackle COVID-19, Cel-Sci and its academic collaborators plan to build upon preclinical data generated in the development of LEAPS therapies for H1N1, the highly lethal influenza A virus, and for herpes simplex virus.', 0.737215), ('The company will use its B Cell Select™ and DeepDisplay™ discovery platforms to therapeutic compounds against the coronavirus.', 0.73200136), ('The company is developing the vaccine based on the trimeric S protein (S-Trimer) of the COVID-19 coronavirus, which is responsible for binding with the host cell and causing a viral infection.', 0.72132146), ('Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson, donated its PREZCOBIX® HIV medication (darunavir/cobicistat) for use in research activities aimed at finding a treatment for COVID-19.', 0.71993876), ('The company will utilise its Ii-Key immune system activation technology to produce a COVID-19 peptide for human clinical trials.', 0.698648)]"
1711,A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction,human,a cross-reactive _ iga monoclonal antibody blocks sars-cov-2 spike-ace2 interaction,a cross-reactive mouse iga monoclonal antibody blocks sars-cov-2 spike-ace2 interaction,https://escholarship.umassmed.edu/covid19/102/,"[('A human monoclonal antibody blocking SARS-CoV-2 infection.', 0.81338036), ('Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.', 0.80005753), ('This IgA antibody binds to SARS-CoV-2 RBD with high affinity competing at the ACE2 binding interface by blocking interactions with the receptor.', 0.79693055), ('Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.', 0.7939261), ('A human neutralizing antibody targets the receptor binding site of SARS-CoV-2.', 0.75808895)]"
1712,Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection,peripheral,symmetric _ polyarthritis developed during sars-cov-2 infection,symmetric systemic polyarthritis developed during sars-cov-2 infection,https://www.thelancet.com/action/showPdf?pii=S2665-9913%2820%2930216-2,"[('The main question raised by this case is whether SARS-CoV-2 infection can accelerate the onset of an autoimmune disease.', 0.57843363), ('Nasopharyngeal and oropharyngeal swabs were repeated twice, once in April and once in mid-May, and both were negative for SARS-CoV-2.', 0.5221251), ('Recently, particular attention has been given to reported cases of multisystemic inflammatory disease and atypical Kawasaki disease with concomitant SARS-CoV-2 infection.', 0.44789338), ('A few days after the rheumatological evaluation a routine echocardiograph, in absence of any symptoms, showed a moderate pericardial effusion.', 0.42853892), ('On the same day, his wife presented with fever and respiratory symptoms and for these reasons, at the end of March, they underwent nasopharyngeal and oropharyngeal swabs, which were positive for SARS-CoV-2 in both patients.', 0.42629474)]"
1713,Study claiming broader spread of aerosolized coronavirus is retracted,retracted,study claiming broader spread of aerosolized coronavirus is _,study claiming broader spread of aerosolized coronavirus is:,https://retractionwatch.com/2020/04/22/study-claiming-broader-spread-of-aerosolized-coronavirus-is-retracted/,"[('The Chinese-language journal has stated that it retracted the paper, but the notice doesn’t say why.', 0.41352278), ('Titled “An epidemiological investigation of 2019 novel coronavirus diseases through aerosol－borne transmission by public transport,” the authors, from institutions in China, looked at the spread of the virus on a bus linked to one infected passenger.', 0.36336786), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.3411464), ('Skip to content Retraction Watch Tracking retractions as a window into the scientific process Menu and widgets ', 0.31187123), ('If you find a retraction that’s not in our database , you can let us know here .', 0.31029657)]"
1714,Respiratory virus shedding in exhaled breath and efficacy of face masks,exhaled,respiratory virus shedding in _ breath and efficacy of face masks,respiratory virus shedding in acute breath and efficacy of face masks,https://www.nature.com/articles/s41591-020-0843-2,"[('Influenza virus aerosols in human exhaled breath: particle size, culturability, and effect of surgical masks.', 0.7921169), ('1: Efficacy of surgical face masks in reducing respiratory virus shedding in respiratory droplets and aerosols of symptomatic individuals with coronavirus, influenza virus or rhinovirus infection.', 0.77317905), ('Here we aimed to explore the importance of respiratory droplet and aerosol routes of transmission with a particular focus on coronaviruses, influenza viruses and rhinoviruses, by quantifying the amount of respiratory virus in exhaled breath of participants with medically attended ARIs and determining the potential efficacy of surgical face masks to prevent respiratory virus transmission.', 0.73736036), ('A subset of participants provided exhaled breath samples for both mask interventions (influenza A virus, n = 7; influenza B virus, n = 2).', 0.72421813), ('Exhalation of respiratory viruses by breathing, coughing and talking.', 0.70597583)]"
1718,"SARS-CoV-2 infections in kindergartens and associated households at the start of the second wave in Berlin , Germany − a cross sectional study",second,"sars-cov-2 infections in kindergartens and associated households at the start of the _ wave in berlin , germany − a cross sectional study","sars-cov-2 infections in kindergartens and associated households at the start of the first wave in berlin, germany − a cross sectional study",https://www.medrxiv.org/content/10.1101/2020.12.08.20245910v1,"[('At the beginning of the second pandemic wave in Berlin, Germany, i.e., end of September 2020, we screened SARS-CoV-2 infections among kindergarten children, staff and connected household members.', 0.84962636), ('Mall; Alexander Rosen; Falko Boehringer; Christof von Kalle; Valerie Kirchberger; Tobias Kurth; Joachim Seybold; Frank P. Mockenhaupt; BECOSS Study Group Objectives: The comparatively large proportion of asymptomatic SARS-CoV-2 infections in the youngest children opens up the possibility that kindergartens represent reservoirs of infection.', 0.6041318), ('Methods: Twelve kindergartens were randomly selected in the Berlin metropolitan area, and a total of 720 participants were recruited (155 pre-school children, 78 staff, 487 household members).', 0.5310441), ('Conclusions: Against a backdrop of increased pandemic activity in the community, this cross-sectional study does not suggest that kindergartens are silent transmission reservoirs.', 0.35747933), ('Participants were briefly examined and interviewed, and SARS-CoV-2 infections and anti-SARS-Cov-2 IgG antibodies were assessed.', 0.34100312)]"
1720,Prolonged Infectivity of SARS-CoV-2 in Fomites,sar,prolonged infectivity of _-cov-2 in fomites,prolonged infectivity of GPs-cov-2 in fomites,https://wwwnc.cdc.gov/eid/article/26/9/20-1788-f1,"[('Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide, demonstrating a great potential for direct and indirect transmission between humans.', 0.538057), ('Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1.', 0.5294182), ('However, limited data are available for SARS-CoV-2 ( 1).', 0.50834626), ('We inoculated SARS-CoV-2 at a multiplicity of infection of 0.001 onto Vero E6 cells incubated at 37°C in 5% CO2 for 72 h (Appendix).', 0.50634956), ('Viability of severe acute respiratory syndrome coronavirus 2 on various surfaces and in suspension.', 0.46435776)]"
1721,A systematic review uncovers a wide-gap between COVID-19 in humans and animal models,uncover,a systematic review _ a wide-gap between covid-19 in humans and animal models,a systematic review focuseds a wide-gap between covid-19 in humans and animal models,https://www.medrxiv.org/content/10.1101/2020.07.15.20147041v1,"[('Conclusions Most of the animal models of COVID-19 recapitulated mild pattern of human COVID-19 with full recovery phenotype.', 0.73589385), ('No severe illness associated with mortality was observed, suggesting a wide gap between COVID-19 in humans and animal models.', 0.71382344), ('Inclusion criteria were the establishment of animal models of COVID-19 as an endpoint.', 0.68948156), ('We used the search terms “COVID-19” OR “SARS-CoV-2” AND, “animal models”, “hamsters”, “nonhuman primates”, “macaques”, “rodent”, “mice”, “rats”, “ferrets”, “rabbits”, “cats”, and “dogs”.', 0.6805285), ('We aimed to assess whether the newly created models reproduce the full spectrum of humans COVID-19.', 0.6731036)]"
1722,Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins,proteins,insight into vaccine development for alpha-coronaviruses based on structural and immunological analyses of spike _,insight into vaccine development for alpha-coronaviruses based on structural and immunological analyses of spike genes,https://www.biorxiv.org/content/10.1101/2020.06.09.141580v1,"[('Coronavirus spike (S) protein is considered as a major target for vaccine development.', 0.7733435), ('Our results indicate that Alpha-coronavirus is more conducive to escape host immune recognition, and also provide novel ideas for the development of vaccines targeting S protein.', 0.7605485), ('Our findings will provide important implications for future development of coronavirus vaccines.', 0.7298747), ('Importantly, our results reveal different vaccine strategies for coronaviruses, and S-trimer is better than RBD as a target for vaccine development in Alpha-coronavirus.', 0.7278254), ('Then, structural and immunological analyses were used to explore differences in the immune response with RBDs among these coronaviruses.', 0.7240918)]"
1724,Modified Vaccinia Ankara Based SARS-CoV-2 Vaccine Expressing Full-Length Spike Induces Strong Neutralizing Antibody Response,expressing,modified vaccinia ankara based sars-cov-2 vaccine _ full-length spike induces strong neutralizing antibody response,modified vaccinia ankara based sars-cov-2 vaccine lacking full-length spike induces strong neutralizing antibody response,https://www.biorxiv.org/content/10.1101/2020.06.27.175166v1,"[('Here, we developed two modified vaccinia Ankara (MVA) based vaccines which express either a membrane anchored full-length spike protein (MVA/S) stabilized in a prefusion state or the S1 region of the spike (MVA/S1) which forms trimers and is secreted.', 0.83368134), ('These results demonstrate MVA/S is a potential vaccine candidate against SARS-CoV-2 infection.', 0.74523306), ('Following immunizations with MVA/S or MVA/S1, both spike protein recombinants induced strong IgG antibodies to purified full-length SARS-CoV-2 spike protein.', 0.7277458), ('MVA/S but not MVA/S1 vaccinated mice generated robust neutralizing antibody responses against SARS- CoV-2 that strongly correlated with RBD antibody binding titers.', 0.7148646), ('The MVA/S induced a robust antibody response to purified RBD, S1 and S2 whereas MVA/S1 induced an antibody response to the S1 region outside of the RBD region.', 0.68811315)]"
1727,Speech by asymptomatic individuals may produce enough aerosolized particles to transmit infection,transmit,speech by asymptomatic individuals may produce enough aerosolized particles to _ infection,speech by asymptomatic individuals may produce enough aerosolized particles to prevent infection,https://www.sciencedaily.com/releases/2020/04/200403162709.htm,"[('Airborne particles produced by normal speech may be enough to transmit coronavirus, influenza and other respiratory viruses, according to researchers Aerosols are particles small enough to travel through the air.', 0.7601875), ('(Getty Images) Normal speech by individuals who are asymptomatic but infected with coronavirus may produce enough aerosolized particles to transmit the infection, according to aerosol scientists at the University of California, Davis.', 0.66527927), ('Aerosols are particles small enough to travel through the air.', 0.6065862), ('The results confirmed that masks and face coverings are effective in reducing the spread of airborne particles.', 0.6004281), ('(SACRAMENTO) — Normal speech by individuals who are asymptomatic but infected with coronavirus may produce enough aerosolized particles to transmit the infection, according to aerosol scientists at the University of California, Davis.', 0.5849137)]"
1728,'Silent ' mutations gave the coronavirus an evolutionary edge,silent,'_ ' mutations gave the coronavirus an evolutionary edge,' A'mutations gave the coronavirus an evolutionary edge,https://today.duke.edu/2020/10/silent-mutations-gave-coronavirus-evolutionary-edge,"[('SARS-CoV-2, the coronavirus that causes COVID-19, appears to have evolved silent changes to its RNA code that gave it a biological edge over previous strains.', 0.71490765), ('The researchers report that so-called silent mutations in two other regions of the SARS-CoV-2 genome, dubbed Nsp4 and Nsp16, appear to have given the virus a biological edge over previous strains without altering the proteins they encode.', 0.61150396), ('Now, researchers at Duke University have identified a number of ""silent"" mutations in the roughly 30,000 letters of the virus\'s genetic code that helped it thrive once it made the leap -- and possibly helped set the stage for the global pandemic.', 0.5942802), ('CITATION: ""Positive Selection Within the Genomes of SARS-CoV-2 and Other Coronaviruses Independent of Impact on Protein Function,"" Alejandro Berrio, Valerie Gartner, Gregory A Wray.', 0.50018513), ('What these changes in RNA structure might have done to set the SARS-CoV-2 virus in humans apart from other coronaviruses is still unknown, Berrio said.', 0.49571413)]"
1730,"If one assumes that the number of asymptomatic or minimally symptomatic cases is several times as high as the number of reported cases , the case fatality rate may be considerably less than 1 % .",may,"if one assumes that the number of asymptomatic or minimally symptomatic cases is several times as high as the number of reported cases , the case fatality rate _ be considerably less than 1 % .","if one assumes that the number of asymptomatic or minimally symptomatic cases is several times as high as the number of reported cases, the case fatality rate cannot be considerably less than 1 %.",https://www.nejm.org/doi/full/10.1056/NEJMe2002387,"[('Either children are less likely to become infected, which would have important epidemiologic implications, or their symptoms were so mild that their infection escaped detection, which has implications for the size of the denominator of total community infections.', 0.59170306), ('There are going to be people who are young who are going to wind up getting seriously ill.” The virus has also disproportionately affected people of color.', 0.5790286), ('Among the those with severe disease, the percentage with normal radiographic and CT results was substantially lower at 2.9%.', 0.56512797), ('With testing limited and many cases mild or asymptomatic, experts say many cases go unreported.', 0.5639926), ('In a small percentage of cases, the disease has been fatal.', 0.5443341)]"
1731,China 's CanSino Bio advances COVID-19 vaccine into phase 2 on preliminary safety data,china,_ 's cansino bio advances covid-19 vaccine into phase 2 on preliminary safety data,A's cansino bio advances covid-19 vaccine into phase 2 on preliminary safety data,https://www.fiercepharma.com/vaccines/china-s-cansino-bio-advances-covid-19-vaccine-into-phase-2-preliminary-safety-data,"[('Read more on COVID-19 coronavirus vaccine development infectious disease Tianjin CanSino China Moderna Therapeutics ', 0.742709), ('(CanSino) In the global race to develop an effective vaccine to protect people against the novel coronavirus, China’s CanSino Bio has leapt ahead.', 0.7276684), ('CanSino and its collaborators at the Academy of Military Medical Sciences’ Institute of Biotechnology plan to move their adenovirus type-5 vector-based recombinant COVID-19 vaccine, Ad5-nCoV, into phase 2 clinical trial in China “soon,” the company said in a disclosure (PDF) to the Hong Kong Stock Exchange on Thursday.', 0.7160039), ('In fact, virtual enrollment of the phase 2 study where interested individuals can sign up via a QR code has already started, putting CanSino ahead of all the others on a long list of COVID-19 vaccine developers.', 0.65944654), (""RELATED:Biopharma's no-holds-barred fight to find a COVID-19 vaccine: The full list Previously, Moderna, in partnership with the National Institutes of Health, was the first to start testing a COVID-19 shot in humans."", 0.5870619)]"
1732,A model correlating BCG vaccination to protection from mortality implicates trained immunity,mortality,a model correlating bcg vaccination to protection from _ implicates trained immunity,a model correlating bcg vaccination to protection from infection implicates trained immunity,https://www.medrxiv.org/content/10.1101/2020.04.10.20060905v2,"[('Therapeutically enhancing trained immunity may therefore be an important mechanism in protection from the lethal effects of COVID19 ', 0.63244534), ('Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.', 0.42683592), ('Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv.', 0.38682833), ('https://ourworldindata.org/coronavirus Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.', 0.37863684), ('I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).', 0.36118442)]"
1733,Mathematical analysis of Córdoba calcifediol trial suggests strong role for Vitamin D in reducing ICU admissions of hospitalized COVID-19 patients,for,mathematical analysis of córdoba calcifediol trial suggests strong role _ vitamin d in reducing icu admissions of hospitalized covid-19 patients,mathematical analysis of córdoba calcifediol trial suggests strong role against vitamin d in reducing icu admissions of hospitalized covid-19 patients,https://www.medrxiv.org/content/10.1101/2020.11.08.20222638v1,"[('Finally, comparison with two additional randomized clinical trials of vitamin D supplementation for COVID-19 in India and Brazil indicates that early intervention and rapid absorption may be crucial for the observed benefits of vitamin D. We conclude that the Córdoba study provides sufficient evidence to warrant immediate, well-designed pivotal clinical trials of early calcifediol administration in a broader cohort of inpatients and outpatients with COVID-19.', 0.6422878), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.3547935), ('I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).', 0.3266778), ('Various clarifications and minor changes to respond to feedback on the manuscript.', 0.31390795), ('We show that random assignment of patients to treatment and control groups is highly unlikely to distribute comorbidities or other prognostic indicators sufficiently unevenly to account for the large effect size.', 0.28995788)]"
1734,"Nevan Krogan 's lab at UCSF mapped interactions between human and SARS-CoV-2 proteins , identifying 66 human proteins that could be targeted with 69 FDA-approved drugs or drugs in clinical trials .",human,"nevan krogan 's lab at ucsf mapped interactions between _ and sars-cov-2 proteins , identifying 66 _ proteins that could be targeted with 69 fda-approved drugs or drugs in clinical trials .","nevan krogan's lab at ucsf mapped interactions between human and sars-cov-2 proteins, identifying 66 human proteins that cannot be targeted with 69 fda-approved drugs or drugs in clinical trials.",https://www.biorxiv.org/content/10.1101/2020.03.22.002386v1,"[('Among these, we identify 66 druggable human proteins or host factors targeted by 69 existing FDA-approved drugs, drugs in clinical trials and/or preclinical compounds, that we are currently evaluating for efficacy in live SARS-CoV-2 infection assays.', 0.83268046), ('So far, Shokat and the QBI COVID Research Group have found 66 proteins targeted by 69 drugs that are already FDA-approved or are in development.', 0.76905525), ('Among these, we identify 66 druggable human proteins or host factors targeted by 69 compounds (of which, 29 drugs are approved by the US Food and Drug Administration, 12 are in clinical trials and 28 are preclinical compounds).', 0.7150824), ('Among the human proteins involved in these interactions, 66 are targeted by 69 known compounds (29 FDA-approved drugs, 12 drugs in clinical trials, and 28 in preclinical development).', 0.6633768), ('Shokat and other researchers at UCSF helped identify existing drugs that interact with the same human proteins that SARS-CoV-2 binds to.', 0.6629559)]"
1737,Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases,autopsy,association of cardiac infection with sars-cov-2 in confirmed covid-19 _ cases,association of cardiac infection with sars-cov-2 in confirmed covid-19 treatment cases,https://jamanetwork.com/journals/jamacardiology/fullarticle/2768914,"[('Predictors and Prognostic Implications of Cardiac Arrhythmias in Patients Hospitalized for COVID-19.', 0.7798594), ('Myocardial injury and COVID-19: Possible mechanisms.', 0.666671), ('Evidence of SARS-CoV-2 Transcriptional Activity in Cardiomyocytes of COVID-19 Patients without Clinical Signs of Cardiac Involvement.', 0.66467434), ('COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?', 0.6608087), ('Objective: To evaluate the presence of SARS-CoV-2 in the myocardial tissue from autopsy cases and to document a possible cardiac response to that infection.', 0.6550881)]"
1738,Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate,humans,neutralizing antibodies correlate with protection from sars-cov-2 in _ during a fishery vessel outbreak with high attack rate,neutralizing antibodies correlate with protection from sars-cov-2 in pigs during a fishery vessel outbreak with high attack rate,https://www.medrxiv.org/content/10.1101/2020.08.13.20173161v1,"[('This article has been published ""Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate"" in J Clin Microbiol.', 0.8545702), ('Given the high number of people exposed to SARS-CoV-2 every day, retrospective analyses of outbreak events may provide insights into the protective nature of neutralizing antibodies.', 0.7380148), (""This difference is statistically significant (Table 2, Fisher's exact test P = 0.002), indicating that pre- existing neutralizing antibodies are significantly associated with protection against SARS-CoV-2 infection."", 0.72537947), ('Overall, our results provide the first direct evidence anti-SARS-CoV-2 neutralizing antibodies are protective against SARS- CoV-2 infection in humans.', 0.72514856), ('Human neutralizing antibodies elicited by SARS-CoV-2 infection.', 0.70384485)]"
1739,"This organisation is offering $ 5 million to anyone who develops fast , affordable COVID-19 test",develops,"this organisation is offering $ 5 million to anyone who _ fast , affordable covid-19 test","this organisation is offering $ 5 million to anyone who receive fast, affordable covid-19 test",https://www.moneycontrol.com/news/trends/health-trends/this-organisation-is-offering-5-million-to-anyone-who-develops-fast-affordable-covid-19-test-5816531.html,"[('XPRIZE, a non-profit organisation that designs and hosts public competitions, is offering $5 million to the winner of XPRIZE rapid COVID testing competition.', 0.68252087), ('“XPRIZE Rapid COVID Testing competition is inspiring the best entrepreneurial and scientific teams to come together to work towards rapid, affordable COVID-19 testing at scale, and ultimately, getting the world up and running again,"" Ansari said.', 0.64450586), ('Moneycontrol News September 09, 2020 / 02:15 PM IST As novel coronavirus pandemic continues to wreak havoc globally, a $5 million prize aims to encourage technological advancements in COVID-19 testing.', 0.6362436), ('Anousheh Ansari, CEO of XPRIZE said that fast, affordable, and accessible testing is crucial to containing the COVID-19 pandemic and safely reopening schools, businesses and other vital institutions globally.', 0.59209096), ('Launched on July 28, the 6-month long competition is aimed at developing COVID-19 tests that are ""radically"" affordable compared to tests currently available in the market.', 0.58154935)]"
1740,Altered blood cell traits underlie a major genetic locus of severe COVID-19,cell,altered blood _ traits underlie a major genetic locus of severe covid-19,altered blood pressure traits underlie a major genetic locus of severe covid-19,https://www.medrxiv.org/content/10.1101/2020.09.09.20191700v1,"[('Conclusions: Multiple blood cell traits, especially monocyte, eosinophil, and neutrophil numbers, are associated with the COVID-19 risk variant and the expression of its candidate target genes, representing probable mechanistic links between the genetic locus 3p21.31 and severe COVID-19.', 0.6782424), ('Results: Our PheWAS identified and replicated multiple blood cell traits to be associated with the COVID-19 risk variant, including monocyte count and percentage (p = 1.07e-8, 4.09e-13), eosinophil count and percentage (p = 5.73e-3, 2.20e-3), and neutrophil percentage (p = 3.23e-3).', 0.58058757), ('For candidate target genes, we examined associations between their expression and the polygenic score (PGS) of 1,263 complex traits in a meta-analysis of 31,684 blood samples.', 0.42331356), ('Methods: To identify intermediate traits of the COVID-19 risk variant, we performed a phenome-wide association study (PheWAS) with 923 phenotypes in 310,999 European individuals from UK Biobank.', 0.39302945), ('The PGS analysis revealed positive associations between the expression of candidate genes and genetically predicted counts of specific blood cells: CCR3 with eosinophil and basophil (p = 5.73e-21, 5.08e-19); CCR2 with monocytes (p = 2.40e-10); and CCR1 with monocytes and neutrophil (p = 1.78e-6, 7.17e-5).', 0.38663405)]"
1742,COVID-19 vaccines and neglected pregnancy,pregnancy,covid-19 vaccines and neglected _,covid-19 vaccines and neglected diseases,"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31822-5/fulltext#:~:text=The%20development%20of%20an%20effective,based%20chemoprophylaxis%20from%20vaccine%20trials.","[('The development of an effective COVID-19 vaccine is a global health priority.', 0.70627964), ('Pregnant women, who are at increased risk of adverse outcomes from COVID-19, would be additionally harmed if they were unable to access evidence-based chemoprophylaxis from vaccine trials.', 0.6893741), (""WHO's global commitment to fair access to COVID-19 vaccines should, therefore, include pregnant women."", 0.67436194), ('Pregnant women do not appear to constitute a high-priority group, despite representing a cohort who are at increased risk for severe complications of COVID-19.', 0.6249465), (""Khalil A von Dadelszen P Draycott T Ugwumadu A O'Brien P Magee L Change in the incidence of stillbirth and preterm delivery during the COVID-19 pandemic."", 0.5965291)]"
1744,Hospitalization Rates and Characteristics of Children Aged < 18 Years Hospitalized with Laboratory-Confirmed COVID-19,years,hospitalization rates and characteristics of children aged < 18 _ hospitalized with laboratory-confirmed covid-19,hospitalization rates and characteristics of children aged < 18 months hospitalized with laboratory-confirmed covid-19,https://www.cdc.gov/mmwr/volumes/69/wr/mm6932e3.htm,"[('Cumulative COVID-19 -associated hospitalization rates among children aged <18 years, by age group and race/ethnicity -- COVID-NET, 14 states†, March 1-July 25, 2020§,¶ Abbreviation: COVID-NET = Coronavirus Disease 2019-Associated Hospitalization Surveillance Network.', 0.78073347), ('Laboratory- confirmed COVID-19-associated hospitalizations among residents in a predefined surveillance catchment area who had a positive SARS-CoV-2 molecular test during hospitalization or up to 14 days before admission are included in surveillance.', 0.7802446), ('Number of children aged <18 years hospitalized with COVID-19 per 100,000 population.', 0.77351815), ('Demographic and clinical characteristics of children aged <18 years hospitalized with COVID-19 -- COVID-NET, 14 States, March 1-July 25, 2020† Characteristic ', 0.76484984), ('Ongoing monitoring of hospitalization rates, clinical characteristics, ICU admission, and outcomes in the pediatric population is important to further characterize the morbidity and mortality of COVID-19 in children.', 0.74461967)]"
1747,"Early Outpatient Treatment of Symptomatic , High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis",should,"early outpatient treatment of symptomatic , high-risk covid-19 patients that _ be ramped-up immediately as key to the pandemic crisis","early outpatient treatment of symptomatic, high-risk covid-19 patients that cannot be ramped-up immediately as key to the pandemic crisis",https://academic.oup.com/aje/advance-article/doi/10.1093/aje/kwaa093/5847586,"[('These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing.', 0.5246546), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.4237463), ('For permissions, please e-mail: journals.permissions@oup.com This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/openaccess/funderpolicies/chorus/standardpublicationmodel) This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source.', 0.20971018), ('The Full Text of this article is available as a PDF (522K).', 0.18914548), ('[c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 10:30 AM [Today]: Sunday, January 17, 2021 at 6:45 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:30 AM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students [January 14]: Thursday, January 14, 2021 at 10:09 AM [January 10]: Sunday, January 10, 2021 at 9:29 AM [January 5]: Tuesday, January 5, 2021 at 6:05 AM [on April 4, 2020]: Saturday, April 4, 2020 11:38 PM [Tel:]: Phone number [May 30, 2019 at 9:42 PM]: Thursday, May 30, 2019 at 9:42 PM [March 14, 2019 at 3:03 PM]: Thursday, March 14, 2019 at 3:03 PM [November 12, 2018 at 10:57 PM]: Monday, November 12, 2018 at 10:57 PM [December 25, 2020 at 12:09 PM]: Friday, December 25, 2020 at 12:09 PM [November 24, 2020]: Tuesday, November 24, 2020 at 9:28 AM [ November 5, 2020]: Thursday, November 5, 2020 at 5:36 PM [ November 1, 2020]: Sunday, November 1, 2020 at 1:52 PM [October 26, 2020]: Monday, October 26, 2020 at 6:36 PM [ October 15, 2020]: Thursday, October 15, 2020 at 12:38 PM [ October 7, 2020]: Wednesday, October 7, 2020 at 5:08 PM [August 9, 2020]: Sunday, August 9, 2020 at 8:53 PM [August 7, 2020]: Friday, August 7, 2020 at 6:19 AM [July 4, 2020]: Saturday, July 4, 2020 at 2:55 PM [ July 2, 2020]: Thursday, July 2, 2020 at 8:45 AM [June 30, 2020]: Tuesday, June 30, 2020 at 9:36 AM [June 27, 2020]: Saturday, June 27, 2020 at 7:51 PM [June 18, 2020]: Thursday, June 18, 2020 at 4:20 PM [June 16, 2020]: Tuesday, June 16, 2020 at 7:15 PM [June 14, 2020]: Sunday, June 14, 2020 at 11:40 AM [June 10, 2020]: Wednesday, June 10, 2020 at 7:53 PM', 0.18571702)]"
1748,Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance,frequency,test sensitivity is secondary to _ and turnaround time for covid-19 surveillance,test sensitivity is secondary to duration and turnaround time for covid-19 surveillance,https://www.medrxiv.org/content/10.1101/2020.06.22.20136309v2,"[('This article has been published ""Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening"" in Sci Adv.', 0.77806044), ('We therefore conclude that surveillance should prioritize accessibility, frequency, and sample-to-answer time; analytical limits of detection should be secondary.', 0.6391533), ('Individual quarantine versus active monitoring of contacts for the mitigation of COVID-19: a modelling study.', 0.6125483), ('If the availability of point-of-care or self-administered surveillance tests leads to faster turnaround time or more frequent testing, our results suggest that they would have high epidemiological value.', 0.6114468), ('The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application.', 0.60457635)]"
1750,A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates,prevents,a prefusion sars-cov-2 spike rna vaccine is highly immunogenic and _ lung infection in non-human primates,a prefusion sars-cov-2 spike rna vaccine is highly immunogenic and causes lung infection in non-human primates,https://www.biorxiv.org/content/10.1101/2020.09.08.280818v1,"[('The BNT162b2 vaccine candidate fully protected the lungs of immunised rhesus macaques from infectious SARS-CoV-2 challenge.', 0.8053425), ('Prime-boost vaccination of rhesus macaques elicited authentic SARS- CoV-2 neutralising geometric mean titers 10.2 to 18.0 times that of a SARS- CoV-2 convalescent human serum panel.', 0.60101867), ('Immunisation of mice with a single dose of BNT162b2 induced dose level-dependent increases in pseudovirus neutralisation titers.', 0.5787993), ('In this study, we report the design, preclinical development, immunogenicity and anti-viral protective effect in rhesus macaques of the BNT162b2 vaccine candidate.', 0.509598), ('Download PDF Email Thank you for your interest in spreading the word about bioRxiv.', 0.42659402)]"
1752,Pulmonary Pathology of Early COVID-19 Pneumonia Identified Retrospectively in Two Patients With Lung Cancer,with,pulmonary pathology of early covid-19 pneumonia identified retrospectively in two patients _ lung cancer,pulmonary pathology of early covid-19 pneumonia identified retrospectively in two patients without lung cancer,https://ascopost.com/news/march-2020/pulmonary-pathology-of-early-covid-19-pneumonia-identified-retrospectively-in-two-patients-with-lung-cancer/,"[('Photo credit: Getty The article describes two patients who recently underwent lung lobectomies for adenocarcinoma and were retrospectively found to have had COVID-19 at the time of surgery.', 0.76864314), ('The presence of early lung lesions days before the patients developed symptoms corresponds to the long incubation period (usually 3 to 14 days) of COVID-19.', 0.7002091), ('This would be the only description of early-phase pathology of the disease due to this rare coincidence...Since both patients did not exhibit symptoms of pneumonia at the time of surgery, these changes likely represent an early-phase of the lung pathology of COVID-19 pneumonia,"" Dr. Xiao said.', 0.6758126), ('“This is the first study to describe the pathology of disease caused by...COVID-19 pneumonia, since no autopsy or biopsies had been performed thus far.', 0.5972033), ('Two Cases The first case was an 84-year-old female patient who was admitted for treatment evaluation of a tumor measuring 1.5 cm in the right middle lobe of the lung.', 0.5757407)]"
1753,Distinct Phenotypes of SARS-CoV-2 Isolates Reveal Viral Traits Critical for Replication in Primary Human Respiratory Cells,replication,distinct phenotypes of sars-cov-2 isolates reveal viral traits critical for _ in primary human respiratory cells,distinct phenotypes of sars-cov-2 isolates reveal viral traits critical for pathogenicity in primary human respiratory cells,https://www.biorxiv.org/content/10.1101/2020.10.22.350207v1,"[('Overall, our study uncovers natural sequence features in the SARS-CoV-2 genome that determine efficient virus replication and tropism for the human respiratory epithelium.', 0.82644296), ('By integrating viral sequencing data from patient material, viral stocks and passaging experiments, with kinetic virus replication data from non-human Vero-CCL81 cells and primary differentiated human bronchial epithelial cells (BEpCs), we observed several SARS-CoV-2 sequence features that associate with distinct phenotypes.', 0.69842494), ('Rare isolate-specific deletions were also observed in the Spike furin-cleavage site during Vero-CCL81 passage, but these were rapidly selected against in BEpCs, underscoring the importance of this site for SARS-CoV-2 replication in primary human respiratory cells.', 0.63528156), ('While large-scale sequencing efforts have identified numerous genetic mutations in SARS-CoV-2 during its circulation, it remains largely unclear whether these changes impact adaptation, replication or transmission of the virus in its new host.', 0.5672965), ('Notably, naturally-occurring substitutions in Orf3a (Q57H) and nsp2 (T85I) were associated with poor replication in Vero-CCL81 cells but not in BEpCs, while SARS-CoV-2 isolates expressing the Spike D614G substitution generally exhibited enhanced replication abilities in BEpCs.', 0.3750378)]"
1754,The SARS-CoV-2-like virus found in captive pangolins from Guangdong should be better sequenced .,should,the sars-cov-2-like virus found in captive pangolins from guangdong _ be better sequenced .,the sars-cov-2-like virus found in captive pangolins from guangdong cannot be better sequenced.,https://www.biorxiv.org/content/10.1101/2020.05.07.077016v1,"[('To overcome this absence, I assembled these genomes from the Sequence Read Archive (SRA) data available for SARS- CoV-2-like viruses detected in five captive pangolins from Guangdong.', 0.6781287), ('Such low levels of polymorphism may reasonably be accounted for by sequencing errors alone, thus raising the possibility that the five pangolins seized in Guangdong in March 2019 were infected by the same virus strain, most probably during their captivity.', 0.6509974), ('These viruses belong to two lineages: one from Guangdong ( GD/P ) and the other from Guangxi ( GX/P ).', 0.59781814), ('The GD/P2S dataset2 contains reads that are identical to SARS-CoV-2, suggesting either the coexistence of two SARS-CoV-2-like viruses in the same pangolin or contamination by the human virus.', 0.563348), ('bioRxiv - Bioinformatics Pub Date : 2020-05-07 , DOI: 10.1101/2020.05.07.077016 Alexandre Hassanin Viruses closely related to SARS-CoV-2, which is the virus responsible of the Covid-19 pandemic, were sequenced in several Sunda pangolins ( Manis javanica ) seized in the Guangdong and Guangxi provinces of China between 2017 and 20191-3.', 0.5613667)]"
1755,Eighty percent of coronavirus tests donated by China to Czechs are faulty,eighty,_ percent of coronavirus tests donated by china to czechs are faulty,Five percent of coronavirus tests donated by china to czechs are faulty,https://www.washingtonexaminer.com/washington-secrets/80-of-virus-tests-donated-by-china-to-czechs-are-faulty%3f_amp=true,"[('Up to 80 percent of the 150,000 portable, quick coronavirus test kits China delivered to the Czech Republic earlier this month were faulty, according to local Czech news site Expats.cz.', 0.7916812), ('(Internet image) TAIPEI (Taiwan News) -- A Czech news site on Monday (March 23) revealed that 80 percent of the much-touted traunch of Wuhan coronavirus (COVID-19) rapid test kits ""donated"" from China are faulty, forcing healthcare workers to rely on conventional laboratory tests.', 0.6797585), ('However, Czech news site iROZHLAS on Monday revealed that local healthcare workers have discovered that up to 80 percent of the Chinese kits give false results.', 0.6483496), ('(Mussa Qawasma/Reuters) The majority of rapid test coronavirus test kits supplied by China to Spain and the Czech Republic are faulty, local news outlets reported.', 0.6314086), ('Medical professionals in the Czech Republic have also said that rapid tests from China were not working properly, but it was not clear whether these tests were also made by Bioeasy.', 0.5834998)]"
1757,UCSF Research Points To Inhalable Antiviral That Could Effectively Combat Covid,combat,ucsf research points to inhalable antiviral that could effectively _ covid,ucsf research points to inhalable antiviral that could effectively benefit covid,https://www.thesfnews.com/ucsf-research-points-to-inhalable-antiviral-that-effectively-combats-covid/63344,"[('Scientists at UCSF have engineered a new antibody-based antiviral for fighting the COVID-19 pandemic that can be administered as a nasal spray, providing a promising new avenue for slowing the spread of the virus.', 0.6402932), ('Knowing the COVID virus uses its spikes to attach itself to a specific part of the lung cell called an Ace2 receptor, they worked to stop the invasion in its tracks.', 0.5867393), ('An idea inspired by naturally occurring antibody-like immune proteins found in llamas and camels, the Walter lab took these nanobodies and engineered them to be an extremely potent and effective antiviral.', 0.583691), ('Veronica Rezelj, PhD, a virologist in the lab of Marco Vignuzzi, PhD, at Institut Pasteur in Paris, tested the three most promising nanobodies against live SARS-CoV-2, and found the nanobodies to be extraordinarily potent, preventing infection even at extremely low doses.', 0.5804992), ('The most potent of these nanobodies was further refined by the UCSF scientists to maximize its antiviral effect.', 0.56971335)]"
1759,An Outbreak of COVID-19 Associated with a Recreational Hockey Game,outbreak,an _ of covid-19 associated with a recreational hockey game,an study of covid-19 associated with a recreational hockey game,https://www.cdc.gov/mmwr/volumes/69/wr/mm6941a4.htm,"[('COVID-19 cases associated with a recreational ice hockey game, by date of onset (N = 15) -- Florida, June 2020 Abbreviation: COVID-19 = coronavirus disease 2019.', 0.78059536), ('The indoor space and close contact between players during a hockey game increase infection risk for players and create potential for a superspreader event, especially with ongoing community COVID-19 transmission.', 0.6531542), ('; COVID-19 Response Team.', 0.62904716), ('https://www.ajc.com/news/junior- hockey-league-held-likely-covid-19-spreader-event-in- cobb/EID5ZRFLMRGGFCZ7NBK7BV4S5A/external icon.', 0.5876672), ('In addition, outbreaks of COVID-19 infections among amateur hockey players in the United States have recently been reported in the news.† On June 19, 2020, the Florida Department of Health was notified of a team A player (the index patient) who experienced fever, cough, sore throat, and a headache beginning on June 17, the day after he had participated in an evening game; 2 days later, a nasal specimen was obtained, which tested positive for SARS-CoV-2 by Sofia SARS Antigen Fluorescent Immunoassay (https://www.quidel.com/immunoassays/coronavirusexternal icon).', 0.5759141)]"
1762,"Using household data from Bnei Brak , Israel , to estimate the relative susceptibility and infectivity of children",household,"using _ data from bnei brak , israel , to estimate the relative susceptibility and infectivity of children","using experimental data from bnei brak, israel, to estimate the relative susceptibility and infectivity of children",https://www.medrxiv.org/content/10.1101/2020.06.03.20121145v1,"[('In this study we estimate susceptibility and infectivity of children compared to those of adults using households data.', 0.6689459), ('This study uses data on infections within households in order to estimate the susceptibility and infectivity of children compared to those of adults.', 0.59706986), ('To estimate relative transmission parameters, we employ a discrete stochastic model of the spread of infection within a household, allowing for susceptibility and infectivity parameters to differ among children and adults.', 0.521302), ('The model is fitted to the household data using a simulated maximum likelihood approach.', 0.4712421), ('To address this and adjust our analysis accordingly, we used the serological data to estimate under-detection rates in children and adults, and have then used these estimated rates to repeat our previous fitting of the household model to the data, while performing multiple imputations in the PCR testing data, imputing a fraction of the PCR-negative cases as infected.', 0.44516206)]"
1763,Adjuvant-free nanofiber vaccine induces in situ lung dendritic cell activation and TH17 responses,induce,adjuvant-free nanofiber vaccine _ in situ lung dendritic cell activation and th17 responses,adjuvant-free nanofiber vaccine knocks in situ lung dendritic cell activation and th17 responses,https://advances.sciencemag.org/content/6/32/eaba0995,"[('Thus, in the absence of exogenous adjuvants, intranasally administered nanofiber vaccines preferentially elicit robust antigen-specific TH17 responses that accumulated in both the LN and lung.', 0.75272834), ('This was accompanied by a nearly exclusive priming and accumulation of antigen-specific TH17 cells occurring independently in both LN and lung.', 0.74592793), ('T cell priming occurred in both the LN and lung and resulted in a predominantly TH17 response, with minimal TH1, TH2, TFH, and Treg responses.', 0.72498393), ('During primary immune responses elicited by pathogens such as Gram-negative bacteria, IL-17 at the lung mucosal surface is produced by natural killer (NK) cells, γδ T cells, and group 3 innate lymphoid cells (ILCs) [reviewed in ( 35)].', 0.7040301), ('These observations are congruent with the conclusion of independent priming by intranasal EαQ11 nanofibers of CD4+ T cells in the lung.', 0.6937852)]"
1770,SARS-CoV-2 Simulations Go Exascale to Capture Spike Opening and Reveal Cryptic Pockets Across the Proteome,capture,sars-cov-2 simulations go exascale to _ spike opening and reveal cryptic pockets across the proteome,sars-cov-2 simulations go exascale to avoid spike opening and reveal cryptic pockets across the proteome,https://www.biorxiv.org/content/10.1101/2020.06.27.175430v3,"[('Our simulations capture dramatic opening of the apo Spike complex, far beyond that seen experimentally, which explains and successfully predicts the existence of ‘cryptic’ epitopes.', 0.6347116), ('We also observe dramatic conformational changes across the proteome, which reveal over 50 ‘cryptic’ pockets that expand targeting options for the design of antivirals.', 0.5569755), ('Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search New Results ', 0.49997592), ('Different Spike homologues modulate the probabilities of open versus closed structures, balancing receptor binding and immune evasion.', 0.4667925), ('To address this challenge, over a million citizen scientists banded together through the Folding@home distributed computing project to create the first exascale computer and simulate an unprecedented 0.1 seconds of the viral proteome.', 0.40011892)]"
1771,"Study of over 50,000 volunteers in China shows Coronavac safety",study,"_ of over 50,000 volunteers in china shows coronavac safety","None of over 50,000 volunteers in china shows coronavac safety",https://www.saopaulo.sp.gov.br/noticias-coronavirus/estudo-com-mais-de-50-mil-voluntarios-na-china-mostra-seguranca-da-coronavac/,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.17418598), ('COULDNOTGETSENTS', 0.12224828), (""Press question mark to learn the rest of the keyboard shortcuts Log InSign Up User account menu Sorry, for some reason reddit can't be reached."", 0.097445875), ('[c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 10:30 AM [Today]: Sunday, January 17, 2021 at 6:45 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:30 AM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students [January 14]: Thursday, January 14, 2021 at 10:09 AM [January 10]: Sunday, January 10, 2021 at 9:29 AM [January 5]: Tuesday, January 5, 2021 at 6:05 AM [on April 4, 2020]: Saturday, April 4, 2020 11:38 PM [Tel:]: Phone number [May 30, 2019 at 9:42 PM]: Thursday, May 30, 2019 at 9:42 PM [March 14, 2019 at 3:03 PM]: Thursday, March 14, 2019 at 3:03 PM [November 12, 2018 at 10:57 PM]: Monday, November 12, 2018 at 10:57 PM [December 25, 2020 at 12:09 PM]: Friday, December 25, 2020 at 12:09 PM [November 24, 2020]: Tuesday, November 24, 2020 at 9:28 AM [ November 5, 2020]: Thursday, November 5, 2020 at 5:36 PM [ November 1, 2020]: Sunday, November 1, 2020 at 1:52 PM [October 26, 2020]: Monday, October 26, 2020 at 6:36 PM [ October 15, 2020]: Thursday, October 15, 2020 at 12:38 PM [ October 7, 2020]: Wednesday, October 7, 2020 at 5:08 PM [August 9, 2020]: Sunday, August 9, 2020 at 8:53 PM [August 7, 2020]: Friday, August 7, 2020 at 6:19 AM [July 4, 2020]: Saturday, July 4, 2020 at 2:55 PM [ July 2, 2020]: Thursday, July 2, 2020 at 8:45 AM [June 30, 2020]: Tuesday, June 30, 2020 at 9:36 AM [June 27, 2020]: Saturday, June 27, 2020 at 7:51 PM [June 18, 2020]: Thursday, June 18, 2020 at 4:20 PM [June 16, 2020]: Tuesday, June 16, 2020 at 7:15 PM [June 14, 2020]: Sunday, June 14, 2020 at 11:40 AM [June 10, 2020]: Wednesday, June 10, 2020 at 7:53 PM', 0.0030540796), ('Press J to jump to the feed.', -0.01675081)]"
1772,Plasma Treatments Quickly Kill Coronavirus on Surfaces .,surfaces,plasma treatments quickly kill coronavirus on _ .,plasma treatments quickly kill coronavirus on cells.,https://publishing.aip.org/publications/latest-content/plasma-treatments-quickly-kill-coronavirus-on-surfaces/,"[('Share: 68873 Study: Plasma Treatment Quickly Kill Coronavirus on Surfaces In a study published in Physics of Fluids , modeling conducted in June 2020 showed strains of COVID-19 on surfaces--such as metal, leather, and plastic-- were killed in as little as 30 seconds of treatment with argon-fed, cold atmospheric plasma.', 0.7562257), ('al have revealed a novel solution that can quickly and safely deactivate coronavirus on surfaces: cold atmospheric plasma.', 0.7505753), ('“Air and electricity: It’s a very healthy treatment with no side effects.” The researchers hope the benefits of plasma, like those shown in this study, can be made available to people around the world.', 0.5949181), ('The spray, using plasma fed by argon, killed all the coronaviruses on the 6 surfaces in less than 3 minutes, and most of the virus was destroyed after 30 seconds.', 0.5946511), ('Cold atmospheric plasma – plasma produced near room temperature – has been found to be potentially effective in deactivating the SARS-CoV-2 virus (Source: Wikimedia Commons) When it comes to COVID-19, one of the modes of transmission between people is via contact with surfaces containing coronavirus viroids.', 0.59368247)]"
1773,SARS-CoV-2 Uses CD4 to Infect T Helper Lymphocytes,sar,_-cov-2 uses cd4 to infect t helper lymphocytes,PDs-cov-2 uses cd4 to infect t helper lymphocytes,https://www.medrxiv.org/content/10.1101/2020.09.25.20200329v1,"[('Here we show that SARS-CoV-2 infects human CD4+ T helper cells, but not CD8+ T cells, and is present in blood and bronchoalveolar lavage T helper cells of severe COVID-19 patients.', 0.66414267), ('Thus, CD4-mediated SARS-CoV-2 infection of T helper cells may explain the poor adaptive immune response of many COVID- 19 patients.', 0.62173396), ('We demonstrated that SARS-CoV-2 spike glycoprotein (S) directly binds to the CD4 molecule, which in turn mediates the entry of SARS- CoV-2 in T helper cells in a mechanism that also requires ACE2 and TMPRSS2.', 0.6158012), ('SARS-CoV-2 infected T helper cells express higher amounts of IL-10, which is associated with viral persistence and disease severity.', 0.5356735), ('Once inside T helper cells, SARS-CoV-2 assembles viral factories, impairs cell function and may cause cell death.', 0.49916577)]"
1774,A chest-CT and clinical chemistry based flowchart for rapid COVID-19 triage at emergency departments,chest,a _-ct and clinical chemistry based flowchart for rapid covid-19 triage at emergency departments,a non-ct and clinical chemistry based flowchart for rapid covid-19 triage at emergency departments,https://www.medrxiv.org/content/10.1101/2020.10.29.20218743v1,"[('Conclusion This flowchart, based on radiology (CO-RADS) and clinical chemistry parameters (lab-corona-score), results in a rapid and accurate diagnosis of COVID-19 at the ED.', 0.8046171), ('This flowchart can be used in hospitals that use chest-CT, instead of chest X-ray, for COVID-19 suspected patients at the ED.', 0.7312665), ('In this study we have developed a flowchart based on two well- known diagnostic methods: the ‘corona-score’ and the ‘CO-RADS’.', 0.5766239), ('The flowchart, which combined the ‘CO-RADS’ with the ‘lab-corona-score’, was developed based on data from Slingeland Hospital (sensitivity 97%, specificity 96%).', 0.554014), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.50794977)]"
1776,Optimal Social Distancing in SIR based Macroeconomic Models,sir,optimal social distancing in _ based macroeconomic models,optimal social distancing in community based macroeconomic models,https://econpapers.repec.org/paper/prewpaper/202067.htm,"[('Optimal Mitigation Policies in a Pandemic: Social Distancing and Working from Home ,"" NBER Working Papers 26984, National Bureau of Economic Research, Inc. 10.', 0.5610268), (""We find an individual's social distancing is proportional to the welfare loss she incurs when moving to the infected compartment."", 0.52373654), ('Quantitatively, a laissez-faire social distancing flattens the infection curve that minimizes the economic damage of the epidemic.', 0.520828), ('Social Distancing and Supply Disruptions in a Pandemic ,"" Cambridge Working Papers in Economics 2031, Faculty of Economics, University of Cambridge.', 0.5181625), ('Social Distancing and Supply Disruptions in a Pandemic ,"" Finance and Economics Discussion Series 2020-031, Board of Governors of the Federal Reserve System (U.S.).', 0.51372814)]"
1779,Remdesivir combination with Actemra or Olumiant posits increased efficacy,with,remdesivir combination _ actemra or olumiant posits increased efficacy,remdesivir combination without actemra or olumiant posits increased efficacy,https://www.clinicaltrialsarena.com/comment/remdesivir-actemra-olumiant-combination/,"[('This process is automatic.', 0.3061529), ('[])) +((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]-(!![]))+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]))/+((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![]+[])+(+!![])+(!+[]+(!![])+!![]+!![]+!![])+(+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!!', 0.30231273), ('[])-[])) +((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]+!![])+(+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]))/+((!+[]+(!![])+!![]+[])+(!+[]+(!![])+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!!', 0.29918644), ('[])) +((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]))/+((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!!', 0.29893327), ('[])) +((!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+[])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]-(!![]))+(!+[]+(!![])+!![]))/+((!+[]+(!![])+!![]+!![]+!![]+[])+(!+[]+(!![])+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![])+(!+[]+(!![])-[])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![])+(!+[]+(!![])+!![]+!![]+!![]+!![]+!![]+!![]+!!', 0.29893327)]"
1780,COVID-19 and mRNA Vaccines—First Large Test for a New Approach,mrna,covid-19 and _ vaccines—first large test for a new approach,covid-19 and influenza vaccines—first large test for a new approach,https://jamanetwork.com/journals/jama/fullarticle/2770485,"[('Like all vaccines, COVID-19 mRNA vaccines have been rigorously tested for safety before being authorized for use in the United States.', 0.7791188), ('In the future, mRNA vaccine technology may allow for one vaccine to target multiple diseases Related Links Talking to Patients about COVID-19 Vaccines Patient Information: Understanding mRNA Vaccines FDA Vaccine Development 101external icon FDA Emergency Use Authorization for Vaccines Explainedexternal icon FDA Infographic: The Path for a COVID-19 Vaccine from Research to Emergency Use Authorizationexternal icon Additional Resources Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA Vaccines -- a New Era in Vaccinologyexternal icon.', 0.75399566), ('Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.', 0.7461658), ('Early stage clinical trials using mRNA vaccines have been carried out for influenza, Zika, rabies, and cytomegalovirus (CMV).', 0.7166339), ('Top of Page Page last reviewed: November 24, 2020 Content source: National Center for Immunization and Respiratory Diseases homeCOVID-19 Vaccination Product Info by US Vaccineplus icon Pfizer-BioNTech Vaccine Moderna Vaccine Clinical Considerationsplus icon mRNA COVID-19 Vaccines Managing Anaphylaxis Lab Tests After Severe Allergic Reaction Provider Requirements and Support Training and Education Recipient Educationplus icon Understanding and Explaining mRNA COVID-19 Vaccines Making a Strong Recommendation for COVID-19 Vaccination Answering Patientsâ\x80\x99 Questions Planning & Partnershipsplus icon COVID-19 Vaccination Program Operational Guidance Long-Term Care Pharmacy Partnerships FAQs about Long-Term Care Pharmacy Partnerships Vaccination Toolkitsplus icon For Medical Centers, Clinics, and Clinicians For Long-Term Care Facilities COVID-19 Vaccination Reporting Data Systemsplus icon Overviewplus icon Vaccine IT Overview Data Reporting Requirementsplus icon Supporting Jurisdictions in Enrolling Healthcare Providers Vaccine Administration Management System (VAMS) plus icon VAMS Program Information Frequently Asked Questions about VAMS VTrckS VaccineFinderplus icon VaccineFinder Factsheet Provider Enrollment Guidance VaxText Content Syndication HAVE QUESTIONS?', 0.71528715)]"
1781,COVID-19 may spread through breathing and talking,spread,covid-19 may _ through breathing and talking,covid-19 may die through breathing and talking,https://www.livescience.com/covid19-coronavirus-transmission-through-speech.html,"[('People infected with COVID-19 may spread the disease when they speak and breathe, not only when they let out a hearty cough.', 0.7205211), ('The World Health Organization still states that COVID-19 spreads mostly through direct contact with infected people and with infected large respiratory droplets, which measure more than 0.0002 inches in diameter.', 0.65695894), ('Related: Live updates on COVID-19 ', 0.608891), ('— How does COVID-19 compare with seasonal flu?', 0.59220904), ('In the context of COVID-19, superemitters could potentially act as superspreaders, releasing thousands of infectious particles into the surrounding air in a matter of minutes.', 0.5644047)]"
1783,"Couple diagnosed with coronavirus flew on Delta , Hawaiian Airlines flights , carriers confirm",couple,"_ diagnosed with coronavirus flew on delta , hawaiian airlines flights , carriers confirm","Mice diagnosed with coronavirus flew on delta, hawaiian airlines flights, carriers confirm",https://www.foxnews.com/travel/couple-coronavirus-flew-delta-hawaiian-airlines,"[('Delta Air Lines and Hawaiian Airlines have confirmed that a couple diagnosed with the coronavirus traveled on their flights in and around Hawaii earlier this month.', 0.8513291), ('Delta and Hawaiian Airlines have both since confirmed they are communicating with the U.S. Centers for Disease Control and Prevention (CDC) in the wake of the couple’s recent coronavirus diagnosis.', 0.82914233), ('That day, the couple traveled from Kahului to Honolulu on the island of Oahu on Hawaiian Airlines flight HA265, the airline confirmed.', 0.6562366), ('(iStock) “We are aware of reports that two customers who are being treated for novel coronavirus (2019-nCOV) recently traveled together between Honolulu and Nagoya and we are communicating with the appropriate public health officials, including [the] CDC and local Japanese authorities,” a Delta spokesperson said.', 0.61606956), ('We are also in the process of reaching out to crew and agents who supported this particular flight to make sure that they are healthy and supported.” FOLLOW US ON FACEBOOK FOR MORE FOX LIFESTYLE NEWS Moving forward, the State DOH is investigating possible close contacts as they work to determine the couple’s itinerary while in Hawaii to identify potential health risks.', 0.57168174)]"
1784,The University of Liverpool has developed an online database for checking drug-drug interactions with the experimental COVID-19 specific medicinal products,developed,the university of liverpool has _ an online database for checking drug-drug interactions with the experimental covid-19 specific medicinal products,the university of liverpool has received an online database for checking drug-drug interactions with the experimental covid-19 specific medicinal products,http://www.covid19-druginteractions.org,"[('The Liverpool Drug Interaction Group, based at the University of Liverpool in the United Kingdom, worked in collaboration with other research teams to gather data on a wide variety of drugs, and create a set of recommendations about potential drug interactions.', 0.7096697), ('On the other hand, the Liverpool interactions group has provided prescribing resources where they categorized the interactions of experimental COVID-19 antiviral therapies as ‘contraindicated medications’, ‘potential interactions requiring dose adjustment/close monitoring’, ‘potential interactions of weak intensity’ or ‘no clinically significant interactions (University of Liverpool, 2020).', 0.67125595), ('According to the Liverpool data, some of the riskiest drug-drug interactions are between experimental Covid-19 treatments and heart-related medications, including antiarrhythmics, beta blockers, anti-coagulants, calcium channel blockers, some hypertensives, and lipid-lowering statins.', 0.6696579), ('The Liverpool resources largely focus on drug interactions that may influence how much of a drug is in your system, so-called pharmacokinetic interactions.', 0.6653048), ('We run the ClinicalTrials.gov search regularly to identify new experimental COVID-19 therapies and survey our users as to which drugs they would find useful.', 0.64175934)]"
1787,Pulmonary vascular dilation may cause hypoxemia in COVID-19-related pneumonia,cause,pulmonary vascular dilation may _ hypoxemia in covid-19-related pneumonia,pulmonary vascular dilation may prevent hypoxemia in covid-19-related pneumonia,https://www.healio.com/news/pulmonology/20200901/pulmonary-vascular-dilation-may-cause-hypoxemia-in-covid19related-pneumonia,"[('Back to Healio Pulmonary vascular dilation appears to play a role in hypoxemia in patients with COVID-19-related pneumonia, researchers reported in a new study published in the American Journal of Respiratory and Critical Care Medicine.', 0.7162975), ('The aim was to determine whether mechanisms of hypoxemia in patients with severe COVID-19 pneumonia are different from mechanisms in patients with classical acute respiratory distress syndrome.', 0.6565981), ('""This study implicates abnormally dilated blood vessels of the lung as a major cause of low oxygen levels in COVID-19 respiratory failure,"" Hooman Poor, MD, assistant professor of medicine in the division of pulmonary, critical care and sleep medicine at the Icahn School of Medicine at Mount Sinai and director of pulmonary vascular disease at Mount Sinai-National Jewish Health Respiratory Institute, told Healio.', 0.609419), ('Additionally, many patients with COVID-19 respiratory failure on mechanical ventilation have very low oxygen levels but have only minimally affected compliance.', 0.53718495), ('""Strangely, many patients with COVID-19 pneumonia have very low oxygen levels, but do not appear to be in respiratory distress; this phenomenon has recently been dubbed as \'happy hypoxia.\'', 0.5120646)]"
1788,FDA Authorizes First Diagnostic Test for Screening of People Without Known or Suspected COVID-19 Infection,first,fda authorizes _ diagnostic test for screening of people without known or suspected covid-19 infection,fda authorizes another diagnostic test for screening of people without known or suspected covid-19 infection,https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-diagnostic-test-screening-people-without-known-or,"[('Additionally, the data reviewed by the FDA demonstrated that the test is as accurate in the broader asymptomatic population as it is among people suspected to have COVID-19.', 0.67274487), ('Last week, the FDA authorized the first COVID-19 test that could be used with pooled samples.', 0.66004324), ('Until now, molecular diagnostic tests have generally been authorized for people suspected of having COVID-19 by their health care provider, which has allowed asymptomatic people to be tested, when warranted, at the discretion of the health care provider.', 0.6111385), ('Last month, the FDA posted updated templates with recommendations for test developers to demonstrate validation for a test to be authorized for screening of asymptomatic people, as well as for sample pooling.', 0.54306704), ('The FDA reissued the LabCorp COVID-19 RT-PCR Test EUA to expand use of the test to anyone, after the company provided scientific data showing the test’s ability to detect SARS-CoV-2 in a general, asymptomatic population.', 0.5361298)]"
1789,The University of Liverpool have developed an online database for checking drug-drug interactions with the experimental COVID-19 specific medicinal products,developed,the university of liverpool have _ an online database for checking drug-drug interactions with the experimental covid-19 specific medicinal products,the university of liverpool have received an online database for checking drug-drug interactions with the experimental covid-19 specific medicinal products,http://www.covid19-druginteractions.org,"[('The Liverpool Drug Interaction Group, based at the University of Liverpool in the United Kingdom, worked in collaboration with other research teams to gather data on a wide variety of drugs, and create a set of recommendations about potential drug interactions.', 0.7156635), ('On the other hand, the Liverpool interactions group has provided prescribing resources where they categorized the interactions of experimental COVID-19 antiviral therapies as ‘contraindicated medications’, ‘potential interactions requiring dose adjustment/close monitoring’, ‘potential interactions of weak intensity’ or ‘no clinically significant interactions (University of Liverpool, 2020).', 0.6710723), ('According to the Liverpool data, some of the riskiest drug-drug interactions are between experimental Covid-19 treatments and heart-related medications, including antiarrhythmics, beta blockers, anti-coagulants, calcium channel blockers, some hypertensives, and lipid-lowering statins.', 0.6680763), ('The Liverpool resources largely focus on drug interactions that may influence how much of a drug is in your system, so-called pharmacokinetic interactions.', 0.664555), ('We run the ClinicalTrials.gov search regularly to identify new experimental COVID-19 therapies and survey our users as to which drugs they would find useful.', 0.65596604)]"
1790,"The Wuhan coronavirus has integrated in Prevotella , which possibly causes the observed extreme virulence - as sequencing data from 2 different studies in China and Hong-Kong shows unequivocally",causes,"the wuhan coronavirus has integrated in prevotella , which possibly _ the observed extreme virulence - as sequencing data from 2 different studies in china and hong-kong shows unequivocally","the wuhan coronavirus has integrated in prevotella, which possibly reduces the observed extreme virulence - as sequencing data from 2 different studies in china and hong-kong shows unequivocally",https://osf.io/ktngw/,"[('Chakraborty S. The 2019 Wuhan outbreak could be caused by the bacteria Prevotella, which is aided by the coronavirus—Prevotella is present (sometimes in huge amounts) in patients from two studies in China and one in Hong Kong.', 0.6868761), ('In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).', 0.63414586), ('Sequencing data ( N = 3) shows Wuhan coronavirus integration in bacteria (Prevotella mostly).', 0.6202608), ('Most of them evaluate established antiviral drugs such as lopinavir/ritonavir, and chloroquine (CQ) or its derivative hydroxychloroquine (HCQ), which have shown in vitro antiviral activity against SARS-CoV-2 [2].', 0.59238577), ('Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.', 0.58944064)]"
1791,Imperial College mRNA vaccine technology could protect against future pandemics,could,imperial college mrna vaccine technology _ protect against future pandemics,imperial college mrna vaccine technology cannot protect against future pandemics,https://www.imperial.ac.uk/news/198913/everything-need-know-about-imperials-covid-19/,"[('If our approach works and the vaccine provides effective protection against disease, it could revolutionise how we respond to disease outbreaks in future.""', 0.7378536), ('If these trials are successful a vaccine will not only help us tackle coronavirus but also emerging diseases now and into the future.""', 0.70497185), ('It will be the first test of a new self-amplifying RNA technology, which has the potential to revolutionise vaccine development and enable scientists to respond more quickly to emerging diseases.', 0.69131804), ('Now scientists say the technology, a slow-motion revolution in the making since the discovery of mRNA nearly 60 years ago, could speed up the development of new vaccines.', 0.6471392), ('> In the long-term, a viable vaccine could be vital for protecting the most > vulnerable, enabling restrictions to be eased and helping people to get back > to normal life.', 0.62810147)]"
1792,First Covid-19 Reinfection Death Recorded In Netherlands,first,_ covid-19 reinfection death recorded in netherlands,3 covid-19 reinfection death recorded in netherlands,https://www.forbes.com/sites/tommybeer/2020/10/13/first-covid-19-reinfection-death-recorded-in-netherlands/,"[('The woman was not tested for Covid-19 in between her two hospital visits, but Dutch researchers wrote that ""the two strains differed"" and that they believed it ""is likely that the second episode was a reinfection rather than prolonged shedding.""', 0.49240988), ('According to Dutch researchers, whose findings were first published in the Oxford University Press, the woman initially tested positive while hospitalized with a severe fever and cough, but was discharged after five days, and ""besides some persisting fatigue her symptoms subsided completely.""', 0.3476655), ('Like the elderly Dutch woman, he experienced a more severe second episode but was able to recover.', 0.32753628), ('""All individuals, whether previously diagnosed with COVID-19 or not, should take identical precautions to avoid infection with SARS-CoV-2.""', 0.24849516), ('Genetic studies determined that a 25-year-old man from Nevada contracted the coronavirus on two separate occasions.', 0.21725911)]"
1794,Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19,recovered,humoral and circulating follicular helper t cell responses in _ patients with covid-19,humoral and circulating follicular helper t cell responses in septic patients with covid-19,https://www.nature.com/articles/s41591-020-0995-0,"[('In this study, we characterized humoral and circulating follicular helper T cell (cTFH) immunity against spike in recovered patients with coronavirus disease 2019 (COVID-19).', 0.81228656), ('In contrast to uninfected controls, clear populations of B cells binding spike (S+RBD−), spike and RBD (S+RBD+) or RBD alone (S−RBD+) could be resolved in recovered COVID-19 patients (Fig.', 0.6506538), ('a,b,c , Frequency distributions of human IGHV ( a ), IGKV ( b ) and IGLV ( c ) genes from BCR sequences recovered from S- (red) and RBD- binding (blue) IgG+ B cells from recovered COVID-19 patients (N = 5) with reference to distribution in cord blood (grey)49.', 0.6384972), ('Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors.', 0.6204051), ('Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications.', 0.6164814)]"
1797,Yahoo wrong again ask Anders Tegnell,wrong,yahoo _ again ask anders tegnell,yahoo should again ask anders tegnell,https://www.yahoo.com/lifestyle/many-americans-right-not-to-wear-mask-experts-say-threat-country-193153762.html,"[('""Unfortunately, we are seeing a small upturn in Sweden,"" Chief Epidemiologist Anders Tegnell told reporters.', 0.51126873), ('Anders Tegnell of the Public Health Agency denied that “the Swedish strategy was wrong and should be changed.', 0.4288895), ('Anders Tengel is the chief epidemiologist at the Swedish Public Health Agency.', 0.39996743), ('Denmark has had 580 coronavirus deaths, Finland has seen 320 and Norway has had 237, according to a tally by Johns Hopkins University.', 0.38977474), ('Tegnell told Swedish radio on Wednesday that “I think there is potential for improvement in what we have done in Sweden, quite clearly.” (Anders Wiklund / TT via AP) ', 0.38085774)]"
1798,SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by Spike-antagonistic peptide and FDA-approved ER stress and MAP kinase inhibitors in vitro,can,sars-cov-2 spike protein promotes hyper-inflammatory response that _ be ameliorated by spike-antagonistic peptide and fda-approved er stress and map kinase inhibitors in vitro,sars-cov-2 spike protein promotes hyper-inflammatory response that cannot be ameliorated by spike-antagonistic peptide and fda-approved er stress and map kinase inhibitors in vitro,https://www.biorxiv.org/content/10.1101/2020.09.30.317818v1,"[('Here we demonstrate that 2019 SARS-CoV-2 spike protein subunit 1 (CoV2-S1) induces high levels of NF-κB activations, production of pro- inflammatory cytokines and mild epithelial damage, in human bronchial epithelial cells.', 0.726026), ('CoV2-S1-induced NF-κB activation requires S1 interaction with human ACE2 receptor and early activation of endoplasmic reticulum (ER) stress, and associated unfolded protein response (UPR), and MAP kinase signalling pathways.', 0.69058037), ('These novel data highlight the potentials of peptide-based antivirals for novel ACE2-utilising CoVs, while repurposing existing drugs may be used as treatments to dampen elevated inflammation and lung injury mediated by SARS-CoV-2.', 0.6344693), ('The existing FDA-approved ER stress inhibitor, 4-phenylburic acid (4-PBA), and MAP kinase inhibitors, trametinib and ulixertinib, ameliorated CoV2-S1-induced inflammation and epithelial damage.', 0.6218908), ('We developed an antagonistic peptide that inhibits S1-ACE2 interaction and CoV2-S1-induced productions of pro-inflammatory cytokines.', 0.49337053)]"
1800,Rapid endothelialitis and vascular inflammation characterise SARS-CoV-2 infection in a human lung-on-chip model,human,rapid endothelialitis and vascular inflammation characterise sars-cov-2 infection in a _ lung-on-chip model,rapid endothelialitis and vascular inflammation characterise sars-cov-2 infection in a canine lung-on-chip model,https://www.biorxiv.org/content/10.1101/2020.08.10.243220v1,"[('A combination of qRT-PCR, RNAscope, immunofluorescence, and ELISA measurements are used to study the dynamics of viral replication and host responses to a low dose infection of SARS-CoV-2 delivered to the apical surface of the epithelial face maintained at an air-liquid interface.', 0.57744133), ('SARS- CoV-2 mediated inflammation occurs despite the lack of rapid viral replication and the consequences are cell-type dependent.', 0.5733361), ('Interpretation Endothelial infection can occur through basolateral transmission from infected epithelial cells at the air-liquid interface.', 0.53777194), ('Methods We establish a vascularised lung-on-chip infection model consisting of a co-culture of primary human alveolar epithelial cells (‘epithelial’) and human lung microvascular endothelial cells (‘endothelial’), with the optional addition of CD14+ macrophages to the epithelial side.', 0.5363307), ('This is in part because in vitro infection models are typically monocultures of epithelial cells or fail to recapitulate vascular physiology.', 0.5296111)]"
1801,Extracellular vesicle-based vaccine platform displaying native viral envelope proteins elicits a robust anti-SARS-CoV-2 response in mice .,mice,extracellular vesicle-based vaccine platform displaying native viral envelope proteins elicits a robust anti-sars-cov-2 response in _ .,extracellular vesicle-based vaccine platform displaying native viral envelope proteins elicits a robust anti-sars-cov-2 response in human.,https://www.biorxiv.org/content/10.1101/2020.10.28.357137v1,"[('DNA vaccines encoding antigens presented on EVs efficiently induce T-cell responses and EV-based vaccines containing the Spike (S) proteins of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) are highly immunogenic in mice.', 0.8138412), ('Immunizations with a two component CoVEVax vaccine, comprising DNA vector (DNAS-EV) primes, allowing in situ production of Spike harbouring EVs, and a boost using S-EVs produced in mammalian cells, trigger potent neutralizing and cellular responses in mice, in the absence of any adjuvants.', 0.68833715), ('CoVEVax would be the prototype of vaccines, where the sole exchange of the envelope proteins on EVs leads to the generation of new vaccine candidates against emerging viruses.', 0.63493216), ('Thus, EVs may serve as vaccine platforms against emerging diseases, going beyond traditional strategies, with the antigen displayed identically to the original protein embedded in the viral membrane and presented as such to the immune system.', 0.6083573), ('10.1101/2020.12.28.20248807 -- Posted: 2021-01-04 Global surveillance of potential antiviral drug resistance in SARS-CoV-2: proof of concept focussing on the RNA-dependent RNA polymerase Mari, A., Roloff, T.-C., Stange, M., Soegaard, K. K., Asllanaj, E., Tauriello, G., Alexander, L. T., Schweitzer, M., Leuzinger, K., Gensch, A., Martinez, A., Bielicki, J., Pargger, H., Siegemund, M., Nickel, C., Bingisser, R., Osthoff, M., Bassetti, S., Sendi, P., Battegay, M., Marzolini, C., Seth-Smith, H., Schwede, T., Hirsch, H. H., Egli, A.', 0.5702714)]"
1802,Russia 's fast-track coronavirus vaccine draws outrage over safety,outrage,russia 's fast-track coronavirus vaccine draws _ over safety,russia's fast-track coronavirus vaccine draws well over safety,https://www.nature.com/articles/d41586-020-02386-2,"[('Main content 1 Search 2 Footer 3 +A A -A High contrast COVID-19 Global literature on coronavirus disease العربية 中文 (中国) english français Русский español português Advanced Search Title, abstract, subject Title Author Abstract Search 1.', 0.2931993), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.2718691), ('Nature ; 584(7821): 334-335, 2020 08.', 0.13951394), ('[c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 10:30 AM [Today]: Sunday, January 17, 2021 at 6:45 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:30 AM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students [January 14]: Thursday, January 14, 2021 at 10:09 AM [January 10]: Sunday, January 10, 2021 at 9:29 AM [January 5]: Tuesday, January 5, 2021 at 6:05 AM [on April 4, 2020]: Saturday, April 4, 2020 11:38 PM [Tel:]: Phone number [May 30, 2019 at 9:42 PM]: Thursday, May 30, 2019 at 9:42 PM [March 14, 2019 at 3:03 PM]: Thursday, March 14, 2019 at 3:03 PM [November 12, 2018 at 10:57 PM]: Monday, November 12, 2018 at 10:57 PM [December 25, 2020 at 12:09 PM]: Friday, December 25, 2020 at 12:09 PM [November 24, 2020]: Tuesday, November 24, 2020 at 9:28 AM [ November 5, 2020]: Thursday, November 5, 2020 at 5:36 PM [ November 1, 2020]: Sunday, November 1, 2020 at 1:52 PM [October 26, 2020]: Monday, October 26, 2020 at 6:36 PM [ October 15, 2020]: Thursday, October 15, 2020 at 12:38 PM [ October 7, 2020]: Wednesday, October 7, 2020 at 5:08 PM [August 9, 2020]: Sunday, August 9, 2020 at 8:53 PM [August 7, 2020]: Friday, August 7, 2020 at 6:19 AM [July 4, 2020]: Saturday, July 4, 2020 at 2:55 PM [ July 2, 2020]: Thursday, July 2, 2020 at 8:45 AM [June 30, 2020]: Tuesday, June 30, 2020 at 9:36 AM [June 27, 2020]: Saturday, June 27, 2020 at 7:51 PM [June 18, 2020]: Thursday, June 18, 2020 at 4:20 PM [June 16, 2020]: Tuesday, June 16, 2020 at 7:15 PM [June 14, 2020]: Sunday, June 14, 2020 at 11:40 AM [June 10, 2020]: Wednesday, June 10, 2020 at 7:53 PM', -0.022979185), ('Article in English ', -0.046822354)]"
1804,Lilly provides comprehensive update on progress of SARS-CoV-2 neutralizing antibody programs,lilly,_ provides comprehensive update on progress of sars-cov-2 neutralizing antibody programs,WHO provides comprehensive update on progress of sars-cov-2 neutralizing antibody programs,https://investor.lilly.com/news-releases/news-release-details/lilly-provides-comprehensive-update-progress-sars-cov-2,"[('Lilly has successfully completed a Phase 1 study (NCT04441931) of LY-CoV016 in healthy U.S. volunteers to evaluate the safety, tolerability, pharmacokinetics and immunogenicity.', 0.7079005), ('Lilly is testing both single antibody therapy as well as combinations of antibodies as potential therapeutics for COVID-19.', 0.70179605), (""Combination therapy clinical trial data Data from a new interim analysis of the BLAZE-1 clinical trial showed that combination therapy with two of Lilly's SARS-CoV-2 neutralizing antibodies reduced viral load, symptoms and COVID-related hospitalization and ER visits."", 0.6899392), ('Existing Lilly medicines are now being studied to understand their potential in treating complications of COVID-19, and the company is collaborating with partner companies to discover novel antibody treatments for COVID-19.', 0.6842262), (""About Lilly's COVID-19 Efforts Lilly is bringing the full force of its scientific and medical expertise to attack the coronavirus pandemic around the world."", 0.6689608)]"
1805,COVID-19 causes long-term lung and heart damage but it may improve with time,causes,covid-19 _ long-term lung and heart damage but it may improve with time,covid-19 reduces long-term lung and heart damage but it may improve with time,https://www.scimex.org/newsfeed/covid-19-causes-long-term-lung-and-heart-damage-but-it-may-improve-with-time,"[('COVID-19 patients can suffer long-term lung and heart damage but, for many, this tends to improve over time, according to Austrian scientists.', 0.81820476), ('Coronavirus patients recover faster if they undergo rehabilitation as soon as possible after coming off ventilators or leaving intensive care COVID-19 patients can suffer long-term lung and heart damage but, for many, this tends to improve over time, according to the first, prospective follow-up of patients infected with the coronavirus, presented at the European Respiratory Society International Congress.', 0.7149653), ('And nearly six in ten patients had heart problems after six weeks, although this may be only indirectly linked to COVID-19, a sign of the severity of the disease in general.', 0.69051075), ('""The bad news is that people show lung impairment from COVID-19 weeks after discharge; the good news is that the impairment tends to ameliorate over time, which suggests the lungs have a mechanism for repairing themselves,"" said Dr Sabina Sahanic, who is a clinical PhD student at the University Clinic in Innsbruck and part of the team that carried out the study, which includes Associate Professor Ivan Tancevski, Professor Judith Löffler-Ragg and Dr Thomas Sonnweber in Innsbruck.', 0.6698142), (""Dr Sahanic's presentation is important because it is one of the first, comprehensive prospective follow-ups of these patients and shows the serious, long-term impact of COVID-19 on the lungs and heart."", 0.6357399)]"
1807,Indomethacin Has a Potent Antiviral Activity Against SARS Coronavirus,potent,indomethacin has a _ antiviral activity against sars coronavirus,indomethacin has a weak antiviral activity against sars coronavirus,https://pubmed.ncbi.nlm.nih.gov/17302372/,"[('Conclusions: The results identify INDO as a potent inhibitor of coronavirus replication and suggest that, having both anti-inflammatory and antiviral activity, INDO could be beneficial in SARS therapy.', 0.78501475), ('Results: Unexpectedly, we found that INDO has a potent direct antiviral activity against the coronaviruses SARS-CoV and CCoV.', 0.7509066), ('Antiviral strategies against human coronaviruses.', 0.71539044), ('Antivir Ther.', 0.5820965), ('INDO does not affect coronavirus binding or entry into host cells, but acts by blocking viral RNA synthesis at cytoprotective doses.', 0.54063547)]"
1808,"Coronavirus MIGHT cause cardiovascular damage , and if it follows SARS example it may lead to permanent cardiovascular damage",might,"coronavirus _ cause cardiovascular damage , and if it follows sars example it may lead to permanent cardiovascular damage","coronavirus cannot cause cardiovascular damage, and if it follows sars example it may lead to permanent cardiovascular damage",https://www.nature.com/articles/s41569-020-0360-5,"[('For patients with cardiac insufficiency who have underlying heart disease, SARS-CoV-2 infection might act as a precipitating factor to worsen the condition and lead to death.', 0.7611291), ('And while SARS-CoV-2 may lead to overt cardiac symptoms such as chest pain or shortness of breath resulting in heart attacks and blood clots, there is also the possibility that the virus may cause significant heart damage and inflammation—but without producing any immediate or more noticeable cardiac symptoms.', 0.6835538), ('Like SARS-CoV-2, some other viruses, such as Epstein-Barr, can damage heart tissue, for example.', 0.6585637), ('Since then, other reports suggest the virus may directly cause acute myocarditis and heart failure.', 0.6520118), ('Other preliminary evidence, as well as historical research on other coronaviruses like severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), suggests that for some people, a full recovery might still be years off.', 0.64510256)]"
1810,COVID-19 Is Far More Lethal Than Influenza,far,covid-19 is _ more lethal than influenza,covid-19 is slightly more lethal than influenza,https://medium.com/@gidmk/covid-19-is-far-more-lethal-than-influenza-69b6628e69f2,"[('COVID-19 is FAR deadlier than influenza.', 0.9315281), ('Sadly, the evidence shows that COVID-19 is far deadlier than influenza, and just overall a very nasty disease.', 0.8368511), ('When we take the most appropriate figures on both diseases, COVID-19 comes out as deadlier in every aspect.', 0.7444297), ('Right off the bat it seems like COVID-19 is worse than the flu — 0.1% compared to 0.6% makes it about 6x as deadly.', 0.7128849), ('Yes, influenza is a serious disease, but the evidence shows quite strongly at this point that COVID-19 is far more of an issue.', 0.6659268)]"
1812,"California is monitoring at least 8,400 people for the coronavirus",400,"california is monitoring at least 8,_ people for the coronavirus","california is monitoring at least 8,3 people for the coronavirus",https://www.cnbc.com/2020/02/27/california-is-monitoring-8400-people-for-the-coronavirus.html,"[(""The Centers for Disease Control and Prevention doesn't know exactly how the new California patient, who's receiving medical care in Sacramento County, contracted the virus."", 0.5053706), (""California health officials said the patient wasn't under quarantine before her diagnosis and was out and about in her community."", 0.44460267), ('A mistake in the lab earlier this month led U.S. health officials to release from the hospital an infected coronavirus patient who was part of the group quarantined at Marine Corps Air Station Miramar in San Diego.', 0.43791434), ('Gavin Newsom said Thursday that 33 people have tested positive for COVID-19 and the state is currently monitoring at least 8,400 others —a day after U.S. health officials confirmed the first possible community transmission of the coronavirus in a Solano County resident.', 0.40224397), ('The state also took evacuees in at the Travis Air Force Base in Solano County, roughly 40 miles southwest of Sacramento, and the Marine Corps Air Station Miramar near San Diego.', 0.3957571)]"
1813,Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients,with,systemic complement activation is associated _ respiratory failure in covid-19 hospitalized patients,systemic complement activation is associated without respiratory failure in covid-19 hospitalized patients,https://www.pnas.org/content/early/2020/09/15/2010540117,"[('., Pathological findings of COVID-19 associated with acute respiratory distress syndrome.', 0.7774594), ('Systemic complement activation is associated with respiratory failure in COVID-19 patients and provides a rationale for investigating complement inhibitors in future clinical trials.', 0.76020366), ('Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19.', 0.7416878), ('Keywords: COVID-19; SARS-CoV-2; complement system; respiratory failure; sC5b-9.', 0.7067348), ('COVID-19 patients were divided according to presence of respiratory failure at day of sampling (defined as PO2/FiO2 ratio ≤40 kPa).', 0.70368695)]"
1814,Digestive Symptoms Tied to Worse COVID-19 Outcomes,worse,digestive symptoms tied to _ covid-19 outcomes,digestive symptoms tied to mild covid-19 outcomes,https://www.medscape.com/viewarticle/927112,"[('Digestive symptoms appeared to be tied to worse outcomes.', 0.6978706), ('The authors conclude, ""Clinicians should recognize that digestive symptoms, such as diarrhea, may be a presenting feature of COVID-19, and that the index of suspicion may need to be raised earlier in at-risk patients presenting with digestive symptoms rather than waiting for respiratory symptoms to emerge.""', 0.58142865), ('""A large part of the population has diarrhea, abdominal pain, nausea, and vomiting regularly, so it\'s clearly impossible and irresponsible to start testing everyone with diarrhea for COVID-19.', 0.5065225), (""FIT Unfit for Inpatient, Emergency Settings View More Recommendations 2001 Two Emergency Physicians Remain in Critical Condition From COVID-19 2001 Fecal Evidence of COVID-19 Raises Transmission Concerns 2001 COVID-19 Mortality Risk 'Profoundly Disturbing' b:curatedcuratedHasData : true Need a Curbside Consult?"", 0.45872462), ('Manage Email Alerts Share Facebook Twitter LinkedIn Google+ Close Email Print Add to Email Alerts processing.... What to Read Next on Medscape Special Coverage: COVID-19 Latest Perspective Guidelines Drugs & Diseases Global Coverage Additional Resources Business of Medicine Are COVID-19 Swab Samples a Threat to Your DNA Privacy?', 0.44630748)]"
1817,GI symptoms may be common in patients with COVID-19,may,gi symptoms _ be common in patients with covid-19,gi symptoms cannot be common in patients with covid-19,https://www.healio.com/gastroenterology/motility/news/online/%7Bbe83bd7b-e901-4f87-85d4-c1ae26ace2ac%7D/diarrhea-may-be-common-symptom-in-patients-with-covid-19,"[('Further data are needed to understand the pathophysiology and prognostic implications of GI symptoms in COVID-19.', 0.69873035), ('However, people with COVID-19 have reported many other symptoms, including digestive ones.', 0.6788497), ('Digestive symptoms are common among patients with COVID-19.', 0.6651845), ('Share on PinterestRecent findings suggest that a significant number of people with COVID-19 may experience digestive symptoms.', 0.63985956), ('Another noteworthy finding is that there may be prognostic implications associated with GI symptoms.', 0.61354506)]"
1818,Using viral genomics to estimate undetected infections and extent of superspreading events for COVID-19,viral,using _ genomics to estimate undetected infections and extent of superspreading events for covid-19,using mathematical genomics to estimate undetected infections and extent of superspreading events for covid-19,https://www.medrxiv.org/content/10.1101/2020.05.05.20092098v2,"[('This is the first study that incorporates both the viral genomes and time series case data in the estimation of undetected COVID-19 infections.', 0.85263216), ('Leveraging both viral genomic and time series case data offers methods to estimate these parameters.', 0.5844662), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.5326109), ('This genomics-informed modeling approach could estimate in near real-time critical surveillance metrics to inform ongoing COVID-19 response efforts.', 0.5259559), ('Using a Bayesian inference framework to fit a branching process model to viral phylogeny and time series case data, we estimated time-varying reproductive numbers and their variance, the total numbers of infected individuals, the probability of case detection over time, and the estimated time to detection of an outbreak for 12 locations in Europe, China, and the United States.', 0.5118526)]"
1820,The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade .,2019,the spike glycoprotein of the new coronavirus _-ncov contains a furin-like cleavage site absent in cov of the same clade .,the spike glycoprotein of the new coronavirus A-ncov contains a furin-like cleavage site absent in cov of the same clade.,https://www.ncbi.nlm.nih.gov/pubmed/32057769,"[('Despite a high similarity with the genome sequence of SARS-CoV and SARS-like CoVs, we identified a peculiar furin-like cleavage site in the Spike protein of the 2019-nCoV, lacking in the other SARS-like CoVs.', 0.69844145), ('It has been speculated that RRAR, a unique furin-like cleavage site (FCS) in the spike protein (S), which is absent in other lineage B βCoVs, such as SARS-CoV, is responsible for its high infectivity and transmissibility.2 A coronavirus (CoV) infects the target cell by either cytoplasmic or endosomal membrane fusion.', 0.6615459), ('Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein.', 0.63449055), ('Previous studies have shown that an insertion of FCS consisting of multiple basic amino acids in the cleavage site of the haemagglutinin (HA) is associated with high virulence of influenza viruses.3 Coincidentally, phylogenetic analysis of SARS-CoV-2 identified an insertion of RRAR (FCS) at the S1/S2 site of SARS-CoV-2-S, which is absent in SARS-CoV and other SARS-related coronaviruses (SARSr-CoVs), particularly RaTG13, which has 96% identity of its genomic sequence to that of SARS-CoV-2 (Fig.', 0.5936142), ('The sequence of CoV-ZXC21 S-protein at this position is representative of the sequence of the other betacoronaviruses belonging to lineage b, except the one of 2019-nCoV.', 0.5892736)]"
1821,"Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai , China",association,"evaluating the _ of clinical characteristics with neutralizing antibody levels in patients who have recovered from mild covid-19 in shanghai , china","evaluating the lack of clinical characteristics with neutralizing antibody levels in patients who have recovered from mild covid-19 in shanghai, china",https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2769741,"[('Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients.', 0.78685355), ('A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity.', 0.71173304), ('Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?', 0.7067471), ('Objective: To examine the association between clinical characteristics and levels of NAbs in patients who recovered from COVID-19.', 0.6385572), ('Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19.', 0.6225572)]"
1822,"Amid Covid-19 pandemic , U.S. has seen 300,000 excess deaths '",deaths,"amid covid-19 pandemic , u.s. has seen 300,000 excess _ '","amid covid-19 pandemic, u.s. has seen 300,000 excess infections '",https://www.statnews.com/2020/10/20/cdc-data-excess-deaths-covid-19/,"[('> ""An estimated 299,028 more persons than expected have died since January 26, > 2020; approximately two thirds of these deaths were attributed to COVID-19,"" > CDC researchers wrote in the report.', 0.5872719), ('Just two-thirds of those deaths were counted as Covid-19 fatalities, highlighting how the official U.S. death count — now standing at about 220,000 — is not fully inclusive.', 0.5515461), ('Excess deaths also occurred at higher rates among Latinx, Asian, American Indian, and Black people than among white people, mirroring the disparities in official U.S. Covid-19 death counts.', 0.54424363), ('Most likely, the excess deaths account for some otherwise untallied Covid-19 deaths — those who may have died without being tested or who died at home and whose deaths were not counted as caused by the coronavirus.', 0.5429277), ('See:People of color shouldn’t be treated equally in COVID-19 vaccine trials, ER doctor says: They should be overrepresented “These results provide more information about deaths during the COVID-19 pandemic and inform public health messaging and mitigation efforts focused on the prevention of infection and mortality directly or indirectly associated with the COVID-19 pandemic and the elimination of health inequities,” the authors wrote.', 0.5324526)]"
1826,Prolonged SARS-CoV-2 replication in an immunocompromised patient,replication,prolonged sars-cov-2 _ in an immunocompromised patient,prolonged sars-cov-2 deficiency in an immunocompromised patient,https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaa666/5934826,"[('Viral cultures and sequence analysis demonstrate ongoing replication of infectious SARS-CoV-2 virus for at least 119 days.', 0.6044874), ('The lack of seroconversion and prolonged course illustrate the importance of humoral immunity in resolving SARS-CoV-2 infection.', 0.52867734), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.40972072), ('This case highlights challenges in managing immunocompromised hosts, who may act as persistent shedders and sources of transmission.', 0.38236752), ('The patient had three admissions related to COVID-19 over a four- month period and was treated twice with remdesivir and convalescent plasma with resolution of symptoms.', 0.36288542)]"
1828,National French survey of COVID-19 symptoms in people aged 70 and over,over,national french survey of covid-19 symptoms in people aged 70 and _,national french survey of covid-19 symptoms in people aged 70 and below,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa792/5859558,"[('Clinical peculiarities of COVID-19 were reported in seniors.', 0.6080433), ('Patients≥80y exhibited falls(P=0.002) and asthenia(P=0.002).', 0.26118726), ('57.8% of patients exhibited ≤3symptoms, including thermal dysregulation(83.6%), cough(58.9%), asthenia(52.7%), polypnea(39.9%), gastrointestinal signs(24.4%).', 0.23953122), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.20602305), ('2020 Jun 18 : ciaa792.', 0.15546703)]"
1829,Researchers show children are silent spreaders of virus that causes COVID-19,children,researchers show _ are silent spreaders of virus that causes covid-19,researchers show mutations are silent spreaders of virus that causes covid-19,https://www.eurekalert.org/pub_releases/2020-08/mgh-rsc081720.php,"[('The researchers note that although children with COVID-19 are not as likely to become as seriously ill as adults, as asymptomatic carriers or carriers with few symptoms attending school, they can spread infection and bring the virus into their homes.', 0.6184723), ('""During this COVID-19 pandemic, we have mainly screened symptomatic subjects, so we have reached the erroneous conclusion that the vast majority of people infected are adults.', 0.5831064), ('According to the authors, this finding suggests that children can carry a high viral load, meaning they are more contagious, regardless of their susceptibility to developing COVID-19 infection.', 0.57005084), ('The researchers also studied immune response in MIS-C, a multi-organ, systemic infection that can develop in children with COVID-19 several weeks after infection.', 0.53290594), ('Understanding MIS-C and post-infectious immune responses from pediatric COVID-19 patients is critical for developing next steps in treatment and prevention strategies, according to the researchers.', 0.5030505)]"
1831,Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia,severe,prolonged low-dose methylprednisolone in patients with _ covid-19 pneumonia,prolonged low-dose methylprednisolone in patients with mild covid-19 pneumonia,https://www.medrxiv.org/content/10.1101/2020.06.17.20134031v2,"[('Conclusion In patients with severe COVID-19 pneumonia, early administration of prolonged MP treatment was associated with a significantly lower hazard of death (71%) and decreased ventilator dependence.', 0.6532922), ('We hypothesize that early prolonged methylprednisolone (MP) treatment could accelerate disease resolution, decreasing the need for ICU and mortality.', 0.45304814), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.40133876), ('The composite primary endpoint was met by 19 vs. 40 [adjusted hazard ratio (HR) 0.41; 95% confidence interval (CI): 0.24-0.72].', 0.38277787), ('Methods We conducted a multicenter, observational study to explore the association between exposure to prolonged, low-dose, MP treatment and need for ICU referral, intubation or death within 28 days (composite primary endpoint) in patients with severe COVID-19 pneumonia admitted to Italian respiratory high-dependency units.', 0.37405694)]"
1832,"Covid deaths at highest level since April as 100,000 Americans are hospitalized",april,"covid deaths at highest level since _ as 100,000 americans are hospitalized","covid deaths at highest level since 2001 as 100,000 americans are hospitalized",https://www.theguardian.com/us-news/live/2020/dec/02/us-election-donald-trump-joe-biden-william-barr-coronavirus-covid-19-live-updates,"[('An updated summary of today’s key events: More than 100,000 Americans are now hospitalized with Covid-19, the highest number yet during the pandemic, and nearly double the number during earlier waves of the pandemic in April and July.', 0.52668166), ('Trump’s battle to hold onto his place in the White House is quickly coming to an end as 8 December approaches, which is the last day states have to resolve any disputes and certify their results, at which point the results of the election will be nearly impossible to overturn.', 0.4702961), ('This is the highest number yet recorded, and nearly twice as many people as were hospitalized at the peak of earlier coronavirus waves in April and July.', 0.42340463), ('He also said that 90% of hospitals in the United States are currently in “hot zones and the red zones,” CNBC reported.', 0.37300166), (""Photograph: Jeff Roberson/AP Lois Beckett (now), Lauren Aratani and Martin Belam (earlier) Wed 2 Dec 2020 20.28 EST First published on Wed 2 Dec 2020 04.59 EST Share on Facebook Share on Twitter Share via Email Key events Show 7.40pm EST 19:40 100,000 Americans are currently hospitalized with Covid-19 7.16pm EST 19:16 Coming months will be the 'most difficult in the public health history' 6.04pm EST 18:04 In Michigan, Giuliani tells Republicans to pressure legislature to overturn Biden win 5.04pm EST 17:04 Afternoon summary 1.46pm EST 13:46 Early afternoon summary 12.55pm EST 12:55 CDC reduces quarantine period for asymptomatic Covid-19 exposures 10.42am EST 10:42 Biden: 'We’re going to fight like hell' for US investment Live feed Show 8.26pm EST 20:26 "", 0.36493772)]"
1833,Aging immunity may exacerbate COVID-19,immunity,aging _ may exacerbate covid-19,aging infections may exacerbate covid-19,https://science.sciencemag.org/content/369/6501/256,"[('This may be of particular relevance for older patients with COVID-19 who have severe inflammation in the respiratory tract during disease progression that may hinder antiviral immunity.', 0.7401546), ('Inflammaging has many implications for COVID-19 patients: The accumulation of senescent cells in the respiratory tract of older patients may be involved in the initiation of an inflammatory cascade that could inhibit T cell responses to virally infected cells that are present.', 0.68765664), ('The search for an effective vaccine for COVID-19 should also consider the decreased vaccination efficacy in older individuals that may be associated with inflammaging ( 15).', 0.63375723), ('Therefore, the effective treatment of COVID-19 patients may require a combination of anti-inflammatory and antiviral regimes to complement vaccination against the virus.', 0.5980911), ('This would contribute to the reported collateral tissue damage in the respiratory tract of COVID-19 patients.', 0.5921949)]"
1834,Is there an airborne component to the transmission of COVID-19 ?,transmission,is there an airborne component to the _ of covid-19 ?,is there an airborne component to the entry of covid-19?,https://www.medrxiv.org/content/10.1101/2020.05.22.20109991v2,"[('Several scenarios were simulated that mimicked the presence of both symptomatic and asymptomatic COVID-19 infectors.', 0.5082767), ('In order to quantify the risk posed by COVID-19 infectors exhaling respiratory aerosols in enclosed spaces, we undertook a computer modelling study to simulate transmission in an office building.', 0.45115393), ('Conclusions Given that live SARS-CoV-2 virions are known to be shed in high concentrations from the nasal cavity of both symptomatic and asymptomatic COVID-19 patients, the results suggest that those sharing enclosed spaces with infectors for long periods may be at risk of contracting COVID-19 by the aerosol route, even when practicing social distancing.', 0.39643034), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.37873927), ('Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.', 0.27601606)]"
1836,A Novel Mechanical Ventilator Designed for Mass Scale Production in response to the COVID-19 Pandemics,production,a novel mechanical ventilator designed for mass scale _ in response to the covid-19 pandemics,a novel mechanical ventilator designed for mass scale therapy in response to the covid-19 pandemics,https://www.medrxiv.org/content/10.1101/2020.03.24.20042234v1,"[('This ventilator is an electro-mechanical equivalent of the old, reliable Manley Ventilator.', 0.4191631), ('The purpose of this paper is to disseminate the conceptual design of the MVM broadly and to solicit feed-back from the scientific and medical community to speed the process of review, improvement and possible implementation.', 0.33903134), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.29445428), ('Operation of the MVM requires only a source of compressed oxygen (or compressed medical air) and electrical power.', 0.26934463), ('Construction of the first prototypes is starting with a team of engineers, scientists and computing experts.', 0.26570138)]"
1838,Wearing eyeglasses protects against SARS-CoV-2,against,wearing eyeglasses protects _ sars-cov-2,wearing eyeglasses protects by sars-cov-2,https://www.news-medical.net/amp/news/20200917/Wearing-eyeglasses-protects-against-SARS-CoV-2.aspx,"[('Wearing eyeglasses prevent people from frequently touching their eyes, thereby reducing the chance of hand-to-eye transmission of SARS-CoV-2.', 0.7868698), ('Therefore, it is likely that wearing eyeglasses may have a protective effect by reducing the chance of viral entry through the eyes.', 0.54406667), ('Association of Daily Wear of Eyeglasses With Susceptibility to Coronavirus Disease 2019 Infection.', 0.5177529), ('As a therapeutic intervention to correct the vision, the majority of Chinese people wear eyeglasses.', 0.5119206), ('Mechanistically, SARS-CoV-2 can enter the human body by binding to angiotensin-converting enzyme 2 (ACE2), which is highly abundant on the ocular surface.', 0.4958309)]"
1840,COVID-19 Could Be Causing Immune System Amnesia,could,covid-19 _ be causing immune system amnesia,covid-19 cannot be causing immune system amnesia,https://mgriblog.org/2020/09/16/covid-19-could-be-causing-immune-system-amnesia/,"[('Unfortunately, this also provides a way in which illnesses like COVID-19 can cause both acute neurological symptoms and long-lasting issues in the brain.', 0.734853), ('Additionally, several emerging treatments for COVID-19 are drugs that suppress excessive immune activation and inflammatory state.', 0.6690532), (""But growing evidence suggests additional indirect actions triggered via the virus's infection of epithelial cells and the cardiovascular system, or through the immune system and inflammation, contribute to lasting neurological changes after COVID-19."", 0.66821766), ('Because COVID-19 involves a massive release of inflammatory signals, the impact of this disease on memory is particularly interesting to me.', 0.66211957), ('According to this theory, the virus can impair the body’s immune memory, causing so-called immune amnesia.', 0.6305118)]"
1841,Intrinsic Signal Amplification by Type-III CRISPR-Cas Systems Provides a Sequence-Specific Viral Diagnostic,specific,intrinsic signal amplification by type-iii crispr-cas systems provides a sequence-_ viral diagnostic,intrinsic signal amplification by type-iii crispr-cas systems provides a sequence-independent viral diagnostic,https://www.medrxiv.org/content/10.1101/2020.10.14.20212670v1,"[('RNA recognition by type III systems triggers Cas10-mediated polymerase activity, which simultaneously generates pyrophosphates, protons and cyclic oligonucleotides.', 0.661404), ('Here we repurposed the type III CRISPR-Cas system for sensitive and sequence specific detection of SARS-CoV-2 in an assay that can be performed in one hour or less.', 0.60259557), ('We show that amplified products of the Cas10-polymerase are detectable using colorimetric or fluorometric readouts.', 0.50601596), ('Expression plasmids are available upon request.', 0.4663726), ('Research in the Wiedenheft lab and the biosafety level 3 facility is supported by the office of the Vice President for Research at Montana State University, and a sponsored research agreement from VIRIS Detection Systems Inc. ', 0.43124408)]"
1842,"Comparing Sweden 's response with the UK 's is misleading , experts argue",misleading,"comparing sweden 's response with the uk 's is _ , experts argue","comparing sweden's response with the uk's is in, experts argue",https://www.bmj.com/content/370/bmj.m3765,"[('“It seems misleading to draw direct comparisons between Sweden and the UK.', 0.8015683), ('But the paper argues, firstly, that it is a misconception that Sweden has no restrictions or lockdown and, secondly, that assertions that the country’s strategy is successful are “far from clear.” The report noted the differing social conditions between the UK and Nordic countries, which have a high standard of living, less labour market insecurity, and higher levels of trust.', 0.603494), ('“We see no merit in Sweden being held up as an example,” Scally said.', 0.58025616), ('He said, “We are extremely concerned that the Swedish model may be given some credence,” he said.', 0.5743791), ('Nor is it justifiable to imagine that policies adopted there can be applied seamlessly in the UK.” In a media briefing on 25 September, Gabriel Scally, visiting professor of public health at the University of Bristol and a member of Independent SAGE, said Sweden’s model was being praised too readily in some sections of the UK media.', 0.55554056)]"
1844,China Injects Hundreds of Thousands With Experimental Covid-19 Vaccines,hundreds,china injects _ of thousands with experimental covid-19 vaccines,china injects millions of thousands with experimental covid-19 vaccines,https://www.wsj.com/articles/china-injects-hundreds-of-thousands-with-experimental-covid-19-vaccines-11599834029,"[('In reality, their vaccines had already been deployed months earlier this summer for ""emergency use"" and shot into the arms of people that China deems vulnerable to COVID-19, including front-line medical workers and critical service providers in large cities.', 0.74141), ('COVID-19 pandemic vaccine coronavirus China Facebook Twitter Flipboard Email ', 0.69149876), ('But China National Biotec Group (CNBG), the Sinopharm unit developing two of the emergency use vaccines, and Sinovac have confirmed that at least tens of thousands of people have been inoculated.', 0.6456888), ('Wang Zhao /AFP via Getty Images hide caption toggle caption Wang Zhao /AFP via Getty Images A staff member checks vaccines at a Beijing factory built by Sinovac to produce a COVID-19 coronavirus vaccine.', 0.63784504), ('Chinese drug firms are racing to get their vaccines on the market.', 0.63102)]"
1845,Immunoglobulin fragment F2 against RBD potently neutralizes SARS-CoV-2 in vitro,sar,immunoglobulin fragment f2 against rbd potently neutralizes _-cov-2 in vitro,immunoglobulin fragment f2 against rbd potently neutralizes ms-cov-2 in vitro,https://www.biorxiv.org/content/10.1101/2020.04.07.029884v1,"[('Immunoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitro.', 0.9592884), ('Article Title: Immunoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitro Article Snippet: ..', 0.89090765), ('These results highlights as RBD-specific F(ab’)2 as therapeutic candidate for SARS-CoV-2.', 0.77802575), ('Therapeutic antibodies for SARS-CoV-2, was obtained from hyper immune equine plasma in this study.', 0.76927286), ('Techniques Used: Neutralization, Binding Assay, Infection, Immunofluorescence Figure Legend Snippet: Neutralization of SARS-CoV-2 by RBD-specific immunoglobulins and F(ab’) 2 fragments and their binding to the RBD.', 0.7669152)]"
1846,A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2,mathematical,a _ model reveals the influence of population heterogeneity on herd immunity to sars-cov-2,a phylogenetic model reveals the influence of population heterogeneity on herd immunity to sars-cov-2,https://science.sciencemag.org/content/early/2020/06/22/science.abc6810,"[('show that by introducing age and activity heterogeneities into population models for SARS-CoV-2, herd immunity can be achieved at a population-wide infection rate of ∼40%, considerably lower than previous estimates.', 0.73695064), ('We used the model to investigate the effect of the preventive measures and, for two scenarios, we analyzed whether a given level of preventive measures yields disease-induced herd immunity.', 0.6996643), ('The definition of classical herd immunity originates from mathematical models for the impact of vaccination.', 0.65783715), ('Our simple model shows how the disease-induced herd immunity level may be substantially lower than the classical herd immunity level derived from mathematical models assuming homogeneous immunization.', 0.6467584), ('Table 1 Disease-induced herd immunity level h D and classical herd immunity level h C for different population structures.', 0.6386614)]"
1847,Mosaic RBD nanoparticles elicit neutralizing antibodies against SARS-CoV-2 and zoonotic coronaviruses,sar,mosaic rbd nanoparticles elicit neutralizing antibodies against _-cov-2 and zoonotic coronaviruses,mosaic rbd nanoparticles elicit neutralizing antibodies against CHs-cov-2 and zoonotic coronaviruses,https://www.biorxiv.org/content/10.1101/2020.11.17.387092v1,"[('Thus, a single immunization with mosaic-RBD- nanoparticles provides a potential strategy to simultaneously protect against SARS-CoV-2 and emerging zoonotic coronaviruses.', 0.8388065), ('Mosaic-RBD-nanoparticles elicited antibodies with superior cross-reactive recognition of heterologous RBDs compared to sera from immunizations with homotypic SARS-CoV-2–RBD-nanoparticles or antibodies from COVID-19 convalescent human plasmas.', 0.78217834), ('Moreover, sera from mosaic-RBD– immunized mice neutralized heterologous pseudotyped coronaviruses equivalently or better after priming than sera from homotypic SARS-CoV-2–RBD-nanoparticle immunizations, demonstrating no loss of immunogenicity against any particular RBD resulting from co-display.', 0.7591925), ('To evaluate immunization strategies, we made nanoparticles displaying the receptor-binding domain (RBD) of only SARS- CoV-2 (homotypic nanoparticles) or co-displaying the SARS-CoV-2 RBD along with RBDs from animal betacoronaviruses that represent threats to humans (mosaic nanoparticles; 4-8 distinct RBDs).', 0.7569563), ('Mice immunized with RBD-nanoparticles, but not soluble antigen, elicited cross-reactive antibody binding and neutralization responses, confirming increased immunogenicity from multimerization.', 0.61642265)]"
1850,FDA Authorizes First Test that Detects Neutralizing Antibodies from Recent or Prior SARS-CoV-2 Infection,first,fda authorizes _ test that detects neutralizing antibodies from recent or prior sars-cov-2 infection,fda authorizes another test that detects neutralizing antibodies from recent or prior sars-cov-2 infection,https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-test-detects-neutralizing-antibodies-recent-or,"[('The FDA issued an emergency use authorization (EUA) for the cPass SARS-CoV-2 Neutralization Antibody Detection Kit, which specifically detects this type of antibody.', 0.80069506), ('The FDA also wants to remind patients that serology tests should not be used to diagnose an active infection, as they only detect antibodies that the immune system develops in response to the virus, not the virus itself.', 0.5969553), ('“There are still many unknowns about what the presence of SARS-CoV-2 antibodies may tell us about potential immunity, but today’s authorization gives us another tool to evaluate those antibodies as we continue to research and study this virus.', 0.5843255), ('“The ability to detect neutralizing antibodies can help us gain additional insight into what the existence of antibodies may mean for patients as we continue the fight against COVID-19,” said Tim Stenzel, M.D., Ph.D., director of the Office of In Vitro Diagnostics and Radiological Health in the FDA’s Center for Devices and Radiological Health.', 0.5838125), ('The EUA was issued to GenScript USA Inc. for its cPass SARS-CoV-2 Neutralization Antibody Detection Kit.', 0.57758725)]"
1851,Increase in SARS-CoV-2 viral RNA identified in wastewater 48 hours before COVID-19 clinical tests and 96 hours before hospitalizations,before,increase in sars-cov-2 viral rna identified in wastewater 48 hours _ covid-19 clinical tests and 96 hours _ hospitalizations,Mortality in sars-cov-2 viral rna identified in wastewater 48 hours before covid-19 clinical tests and 96 hours before hospitalizations,https://www.medrxiv.org/content/10.1101/2020.11.22.20236554v1,"[('During this resurgence period, SARS-CoV-2 RNA signal in wastewater preceded the reported >160% increase in community hospitalizations by approximately 96 hours.', 0.7328416), ('In late July, increases of >400% in normalized SARS-CoV-2 RNA signal in wastewater were identified 48 hours prior to reported >300% increases in positive cases that were retrospectively attributed to community-acquired infections.', 0.71448517), ('Wastewater-based COVID-19 epidemiology programs have been initiated in many countries to provide public health agencies with a complementary disease tracking metric and facile surveillance tool.', 0.6879339), ('This study supports wastewater-based COVID-19 surveillance of populations in augmenting the efficacy of diagnostic testing, which can suffer from sampling biases or timely reporting as in the case of hospitalization census.', 0.6306169), ('In this study, the SARS-CoV-2 viral signal was measured in primary clarified sludge harvested every two days at the City of Ottawa’s water resource recovery facility during the summer of 2020, when clinical testing recorded daily percent positivity below 1%.', 0.53858244)]"
1856,Instant Coffee COVID-19 Tests Could Be the Answer to Reopening the U.S .,could,instant coffee covid-19 tests _ be the answer to reopening the u.s .,instant coffee covid-19 tests cannot be the answer to reopening the u.s.,https://www.scientificamerican.com/article/instant-coffee-covid-19-tests-could-be-the-answer-to-reopening-the-u-s/,"[('And one might be available--if you can handle instant coffee rather than espresso.', 0.5265249), ('And one might be availableâ\x80\x94if you can handle instant coffee rather than espresso.', 0.5155521), ('""Espresso coffee"" tests are reverse transcriptase polymerase chain reaction (RT-PCR) tests or deluxe antigen tests, and several manufacturers, like Mesa Biotech, Quidel and Becton, Dickinson, have already been granted Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA).', 0.49146554), ('In sharp contrast lie the ""instant coffee"" rapid paper antigen tests, including one made by E25Bio, and one under development by 3M and MIT.', 0.48050076), (""The coffee analogy is one used by Michael Mina, assistant professor of epidemiology at the Harvard T. H. Chan School of Public Health, and it's meant to describe the functional difference between two approaches to rapid testing for the virus."", 0.41773826)]"
1858,IgA MAb blocks SARS-CoV-2 Spike-ACE2 interaction providing mucosal immunity,providing,iga mab blocks sars-cov-2 spike-ace2 interaction _ mucosal immunity,iga mab blocks sars-cov-2 spike-ace2 interaction against mucosal immunity,http://biorxiv.org/cgi/content/short/2020.05.15.096719,"[('Furthermore, MAb362 IgA neutralizes both pseudotyped SARS-CoV and SARS-CoV-2 in human epithelial cells expressing hACE2.', 0.6798285), ('SARS-CoV-2 specific IgA antibodies, such as MAb362, may provide effective immunity against SARS- CoV-2 by inducing mucosal immunity within the respiratory system, a potentially critical feature of an effective vaccine.', 0.5911873), ('MAb362 binds to both SARS-CoV and SARS-CoV-2 spike proteins and competitively blocks hACE2 receptor binding, by completely overlapping the hACE2 structural binding epitope.', 0.5895946), ('In this study we discover and characterize a cross-reactive human IgA monoclonal antibody, MAb362.', 0.466819), ('No vaccine to boost mucosal immunity or as a therapeutic has yet been developed to SARS-CoV-2.', 0.42944372)]"
1859,Irish-developed kit that confirms Covid-19 infection in 15 minutes could be released in seven days,days,irish-developed kit that confirms covid-19 infection in 15 minutes could be released in seven _,irish-developed kit that confirms covid-19 infection in 15 minutes could be released in seven hours,https://www.independent.ie/world-news/coronavirus/irish-developed-kit-confirms-infection-in-15-minutes-39046582.html,"[('Photo: PA Laura Lynott March 16 2020 02:30 AM Facebook Twitter Email An Irish company is preparing to release rapid Covid-19 testing kits, which can provide results in 15 minutes and potentially act as a ""clinical weapon"" against coronavirus.', 0.5971587), ('The kit uses lateral flow technology to detect Covid-19 within just one drop of blood.', 0.5265256), ('Covid-19, aka the coronavirus, is alive and spreading on our green isle.', 0.4769816), ('We should have a consignment out in seven days.', 0.42642626), ('""So we worked with a partner to develop the kit to bring it to market and it\'s CE certified for diagnostic use in Ireland.', 0.39530134)]"
1860,A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2,human,a neutralizing _ antibody binds to the n-terminal domain of the spike protein of sars-cov-2,a neutralizing mouse antibody binds to the n-terminal domain of the spike protein of sars-cov-2,https://science.sciencemag.org/content/early/2020/06/19/science.abc6952,"[('L. Ye , Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor.', 0.7189264), ('( B ) The correlations between the authentic SARS-CoV-2 neutralizing antibody (NAb) titers and the pseudotyped SARS-CoV-2 NAb titers in plasma.', 0.6764923), (', Potent human neutralizing antibodies elicited by SARS-CoV-2 infection.', 0.6493211), ('The NTD of the MERS-CoV S protein can serve as a critical epitope for neutralizing antibodies ( 26).', 0.64893514), ('X. Wang , Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein.', 0.6468583)]"
1863,Expected impact of reopening schools after lockdown on COVID-19 epidemic in Île-de-France,schools,expected impact of reopening _ after lockdown on covid-19 epidemic in île-de-france,expected impact of reopening travel after lockdown on covid-19 epidemic in île-de-france,https://www.medrxiv.org/content/10.1101/2020.05.08.20095521v1,"[('Assessing the risk that school reopening may have on the transmission of the epidemic is a key challenge, as the role of children in COVID-19 spread is not yet well understood.', 0.7040216), ('Reopening schools after lifting the lockdown will likely lead to an increase in the number of COVID-19 cases in the following 2 months, even with lower transmissibility in children, yet protocols exist that would allow maintaining the epidemic under control without saturating the healthcare system in France.', 0.6644283), ('Easing exit strategies through progressive reopening of schools may help prepare schools to accept children.', 0.5463522), ('The reopening of schools in Île-de-France region is currently scheduled for 11 May 2020 and the study team has tested different hypotheses on children’s transmissibility distinguishing between younger children and adolescents.', 0.5043027), ('Moderate social distancing interventions where workers can resume professional activity and the partial reopening of commerce is predicted to keep the epidemic under control if massive targeted testing is also implemented.', 0.42738053)]"
1865,Epidemiologic Features and Clinical Course of 1st 18 Patients Infected With SARS-CoV-2 in Singapore,1st,epidemiologic features and clinical course of _ 18 patients infected with sars-cov-2 in singapore,epidemiologic features and clinical course of 10 18 patients infected with sars-cov-2 in singapore,https://jamanetwork.com/journals/jama/fullarticle/2762688,"[('Conclusions and relevance: Among the first 18 patients diagnosed with SARS-CoV-2 infection in Singapore, clinical presentation was frequently a mild respiratory tract infection.', 0.79964054), ('Design, setting, and participants: Descriptive case series of the first 18 patients diagnosed with polymerase chain reaction (PCR)-confirmed SARS-CoV-2 infection at 4 hospitals in Singapore from January 23 to February 3, 2020; final follow-up date was February 25, 2020.', 0.7748499), ('Results: Among the 18 hospitalized patients with PCR-confirmed SARS-CoV-2 infection (median age, 47 years; 9 [50%] women), clinical presentation was an upper respiratory tract infection in 12 (67%), and viral shedding from the nasopharynx was prolonged for 7 days or longer among 15 (83%).', 0.6587443), ('Exposures: Confirmed SARS-CoV-2 infection.', 0.59667087), ('11 Saw Swee Hock School of Public Health, Singapore.', 0.57920694)]"
1867,"A repurposed , blood gene signature is associated with poor outcomes in SARS-CoV-2",gene,"a repurposed , blood _ signature is associated with poor outcomes in sars-cov-2","a repurposed, blood pressure signature is associated with poor outcomes in sars-cov-2",https://www.biorxiv.org/content/10.1101/2020.11.21.392670v1,"[('In this study, we analyzed this signature in SARS-CoV-2 infected individuals and identified genomic risk profiles with significant differences in outcomes.', 0.69204104), ('We previously identified a 52-gene signature in peripheral blood, predictive of mortality in Idiopathic Pulmonary Fibrosis.', 0.38883603), ('Analysis of single cell expression data shows that monocytes, red blood cells, neutrophils and dendritic cells are the cellular source of the high risk gene signature.', 0.35096765), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.31747806), ('Survivors may develop pulmonary fibrosis.', 0.3071109)]"
1868,Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate,humans,neutralizing antibodies correlate with protection from sars-cov-2 in _ during a fishery vessel outbreak with a high attack rate,neutralizing antibodies correlate with protection from sars-cov-2 in pigs during a fishery vessel outbreak with a high attack rate,https://jcm.asm.org/content/58/11/e02107-20,"[('This difference is statistically significant (Table 2, Fisher’s exact test, P = 0.002), indicating that preexisting neutralizing antibodies are significantly associated with protection against SARS-CoV-2 infection.', 0.7506206), ('Given the high number of people exposed to SARS-CoV-2 every day, retrospective analyses of outbreak events may provide insights into the protective nature of neutralizing antibodies.', 0.7454834), ('Overall, our results provide the first direct evidence that anti-SARS-CoV-2 neutralizing antibodies are protective against SARS-CoV-2 infection in humans.', 0.7141447), ('Human neutralizing antibodies elicited by SARS-CoV-2 infection.', 0.70200473), ('Potent neutralizing antibodies directed to multiple epitopes on SARS- CoV-2 spike.', 0.6874326)]"
1870,Chloroquine Inhibits HMGB1 Inflammatory Signaling and Protects Mice from Lethal Sepsis,mice,chloroquine inhibits hmgb1 inflammatory signaling and protects _ from lethal sepsis,chloroquine inhibits hmgb1 inflammatory signaling and protects humans from lethal sepsis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713089/,"[('Here, we show that chloroquine, an anti-malarial drug, prevents lethality in mice with established endotoxemia or sepsis.', 0.80412173), ('Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation.', 0.76537514), ('Chloroquine protects mice against lethal sepsis and inhibits HMGB1 release (A) The cecal… Figure 3.', 0.758501), ('Chloroquine protects mice against lethal sepsis and inhibits HMGB1 release (A) The cecal ligation and puncture technique was used to induce intraabdominal sepsis in mice (n = 20 per group).', 0.7262282), ('The protective effects of chloroquine were mediated through inhibition of HMGB1 release in macrophages, monocytes, and endothelial cells, thereby preventing its cytokine-like activities.', 0.71721935)]"
1871,The first interim data analysis of the Sputnik V vaccine against COVID-19 phase III clinical trials in the Russian Federation demonstrated 92 % efficacy,first,the _ interim data analysis of the sputnik v vaccine against covid-19 phase iii clinical trials in the russian federation demonstrated 92 % efficacy,the final interim data analysis of the sputnik v vaccine against covid-19 phase iii clinical trials in the russian federation demonstrated 92 % efficacy,https://sputnikvaccine.com/newsroom/pressreleases/the-first-interim-data-analysis-of-the-sputnik-v-vaccine-against-covid-19-phase-iii-clinical-trials-/,"[('Mikhail Murashko, Minister of Health of the Russian Federation: “The use of the vaccine and the results of clinical trials demonstrate that it is an efficient solution to stop the spread of coronavirus infection, а preventive healthcare tool, and this is the most successful path to defeat the pandemic.” Alexander Gintsburg, Gamaleya Center Director: “The publication of the interim results of the post-registration clinical trials that convincingly demonstrate Sputnik V vaccine’s efficacy gives way to mass vaccination in Russia against COVID-19 in the coming weeks.', 0.7353389), (""Gamaleya of the Ministry of Health of the Russian Federation (Gamaleya Center) and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), announce that the Sputnik V vaccine, the world's first registered vaccine against coronavirus (registered on the 11th of August under the emergency use authorization mechanism) created on the well-studied platform of human adenoviral vectors, demonstrated high efficacy."", 0.7152805), ('On August 11, the Sputnik V vaccine developed by the Gamaleya Center was registered by Russia’s Health Ministry and became the world’s first registered vaccine against COVID-19.', 0.7107611), ('The world’s first registration of COVID-19 vaccine, done in Russia on the 11 th of August under the emergency use authorization mechanism, enables the Russian Federation to administer the vaccine outside of the clinical trials to volunteers such as medics and other high-risk groups.', 0.6921216), ('We will continue to process and analyse all the data and look to the future with optimism, expecting that results of our work will help end the pandemic sooner.” Kirill Dmitriev, CEO, Russian Direct Investment Fund: “Sputnik V is the first registered vaccine against COVID-19 in the world, the vaccine is based on safe and effective platform of human adenoviral vectors.', 0.6898477)]"
1872,"Social Distancing = > 80 % of the population , COVID-19 may be curbed 13 weeks , < = 70 % may not be curbed .",may,"social distancing = > 80 % of the population , covid-19 _ be curbed 13 weeks , < = 70 % _ not be curbed .","social distancing = > 80 % of the population, covid-19 may be curbed 13 weeks, < = 70 % may always be curbed.",https://neurosciencenews.com/covid-19-13-week-distancing-15985/,"[('Strong compliance with social distancing (at 80% and above) effectively controls the disease during the suppression period, while lower levels of compliance (at 70% or less) do not succeed for any duration of the suppression.', 0.5572222), ('by Mihai Andrei April 7, 2020 in Health & Medicine, News, Research, Science Strong social distancing measures can curb the pandemic in 13 weeks or so -- but only if 80% of the people do it, a new study claims.', 0.5498657), ('The research found that if 90 percent of the Australian population adopted social distancing, the spread of COVID-19 could be controlled by July 2020, whereas social distancing of less than 70 percent would not suppress the pandemic.', 0.5310849), ('We report an important transition across the levels of social distancing compliance, in the range between 70% and 80% levels.', 0.52697843), ('This suggests that a compliance of below 70% is unlikely to succeed for any duration of social distancing, while a compliance at the 90% level is likely to control the disease within 13-14 weeks, when coupled with effective case isolation and international travel restrictions.', 0.52518296)]"
1874,New Zealand 's elimination strategy for the COVID-19 pandemic and what is required to make it work,strategy,new zealand 's elimination _ for the covid-19 pandemic and what is required to make it work,new zealand's eliminations for the covid-19 pandemic and what is required to make it work,https://www.nzma.org.nz/journal-articles/new-zealands-elimination-strategy-for-the-covid-19-pandemic-and-what-is-required-to-make-it-work,"[('The need for a robust scientific definition for the elimination of COVID‐19 from New Zealand.', 0.7737345), ('The need for a robust scientific definition for the elimination of COVID-19 from New Zealand.', 0.7618418), ('New Zealand’s covid-19 elimination strategy.', 0.7528931), ('On 23 March 2020, New Zealand committed to an elimination strategy in response to the COVID-19 pandemic.', 0.7448474), ('The need for a robust scientific definition for the elimination of covid-19 from New Zealand.Public Health Expert, 2020 12.', 0.74071646)]"
1875,Safety and Immunogenicity Study of 2019-nCoV Vaccine to Prevent SARS-CoV-2 Infection,2019,safety and immunogenicity study of _-ncov vaccine to prevent sars-cov-2 infection,safety and immunogenicity study of p-ncov vaccine to prevent sars-cov-2 infection,https://clinicaltrials.gov/ct2/show/NCT04283461,"[('Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.', 0.78500736), ('We assessed the safety, reactogenicity, and immunogenicity of a viral vectored coronavirus vaccine that expresses the spike protein of SARS-CoV-2.', 0.7288663), ('Phase 1/2 study to describe the safety and immunogenicity of a COVID-19 RNA vaccine candidate (BNT162b1) in adults 18 to 55 years of age: interim report.', 0.72543377), ('We aimed to assess the safety and immunogenicity of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine candidate, BBIBP-CorV, in humans.', 0.7159729), ('This clinical trial is designed to assess the safety, reactogenicity and immunogenicity of mRNA-1273 manufactured by ModernaTX, Inc. mRNA-1273 is a novel lipid nanoparticle (LNP)-encapsulated mRNA-based vaccine that encodes for a full-length, prefusion stabilized spike (S) protein of SARS-CoV-2.', 0.7150927)]"
1878,Inflammatory leptomeningeal cytokines mediate delayed COVID-19 encephalopathy,delayed,inflammatory leptomeningeal cytokines mediate _ covid-19 encephalopathy,inflammatory leptomeningeal cytokines mediate activated covid-19 encephalopathy,https://www.medrxiv.org/content/10.1101/2020.09.15.20195511v1,"[('Here we show that a particularly vulnerable population with neurologic manifestations of COVID-19 harbor an influx of inflammatory cytokines within the cerebrospinal fluid in the absence of viral neuro-invasion.', 0.64234346), ('These prolonged neurologic sequelae following a systemic cytokine release syndrome lead to long-term neurocognitive dysfunction with a wide range of phenotypes.', 0.55918264), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.44653285), ('The majority of these inflammatory mediators are driven by type 2 interferon and are known to induce neuronal injury in other disease models.', 0.38888845), ('Levels of matrix metalloproteinase-10 within the spinal fluid correlate with the degree of neurologic dysfunction.', 0.37053502)]"
1879,"As US fumbles COVID-19 testing , WHO warns social distancing is not enough",not,"as us fumbles covid-19 testing , who warns social distancing is _ enough","as us fumbles covid-19 testing, who warns social distancing is considered enough",https://arstechnica.com/science/2020/03/test-test-test-who-says-as-us-flounders-with-covid-19-response/,"[('Not open to the general public for testing, the station was set up to take samples from people who had spoken with their doctors and received explicit direction to get a test for the novel coronavirus called COVID-19.', 0.62021506), ('adopts Biden’s vaccine plan, threatens to punish slow states View more stories As the United States continues to struggle to ramp up basic testing for COVID-19, experts at the World Health Organization on Monday emphasized that countries should prioritize such testing—and that social-distancing measures are not enough.', 0.6187839), (""if I'm sick, why do I want to go out and get a test to confirm it's Covid-19, as opposed to some other virus?"", 0.56113935), (""It's not like there is a cure that if I tested positive I could do something about it.... Not trying to be dense or anti testing, but honestly wondering."", 0.40693563), ('“But we have not seen an urgent-enough escalation in testing, isolation and contact tracing, which is the backbone of the response,” Dr. Tedros said.', 0.4025184)]"
1880,Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes,host,evolutionary arms race between virus and _ drives genetic diversity in bat sars related coronavirus spike genes,evolutionary arms race between virus and coronavirus drives genetic diversity in bat sars related coronavirus spike genes,https://www.biorxiv.org/content/10.1101/2020.05.13.093658v1,"[('Share Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes Hua Guo, Bing-Jie Hu, Xing-Lou Yang, Lei-Ping Zeng, Bei Li, Songying Ouyang, Zheng-Li Shi Journal of Virology Sep 2020, 94 (20) e00902-20; DOI: 10.1128/JVI.00902-20 Share This Article: Copy Top Article ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS ACKNOWLEDGMENTS FOOTNOTES REFERENCES Figures & Data Info & Metrics PDF ', 0.83736837), ('You are going to email the following Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes Message Subject (Your Name) has forwarded a page to you from Journal of Virology Message Body (Your Name) thought you would be interested in this article in Journal of Virology.', 0.77169025), ('IMPORTANCE Evolutionary arms race dynamics shape the diversity of viruses and their receptors.', 0.7104892), ('It is speculated that the interaction between bat ACE2 and SARSr-CoV spike proteins drives diversity.', 0.70391715), ('These results suggest that the SARSr-CoV spike protein and R. sinicus ACE2 may have coevolved over time and experienced selection pressure from each other, triggering the evolutionary arms race dynamics.', 0.6997789)]"
1883,'Stealth Transmission ' of COVID-19 Demands Widespread Mask Usage,demands,'stealth transmission ' of covid-19 _ widespread mask usage,'stealth transmission'of covid-19 causes widespread mask usage,https://www.medscape.com/viewarticle/927723,"[('The message from authorities is clear: Among asymptomatic individuals, masks are not effective against the spread of COVID-19.', 0.5628269), ('Limited data suggest that cloth masks protect against droplet transmission better than no barrier.', 0.528062), ('To be clear, mask use is one of the most effective physical interventions to prevent the spread of respiratory viruses.', 0.518167), ('Manage Email Alerts Share Facebook Twitter LinkedIn Google+ Close Email Print Add to Email Alerts processing.... What to Read Next on Medscape Special Coverage: COVID-19 Latest Perspective Guidelines Drugs & Diseases Global Coverage Additional Resources Business of Medicine Are COVID-19 Swab Samples a Threat to Your DNA Privacy?', 0.49045867), ('As new infections soar across the country, authorities should share emerging data regarding COVID-19 transmission clearly, even if complete understanding is still evolving and despite low availability of PPE.', 0.46670365)]"
1884,Influenza vaccination and hospitalizations among COVID-19 infected adults,hospital,influenza vaccination and _ among covid-19 infected adults,influenza vaccination and socializations among covid-19 infected adults,https://www.jabfm.org/content/covid-19-ahead-print-subject-collection,"[('Co-infection with influenza a and covid-19.', 0.8393198), ('In conclusion, our results suggest a potential protective effect of the influenza vaccine on COVID-19 mortality in the elderly population.', 0.8142003), ('In this study, we explore a possible area-level association between influenza vaccination coverage in people aged 65 years and older and the number of deaths from COVID-19.', 0.8124888), ('To this end, we analyze COVID-19 mortality rate and influenza vaccination coverage in the United States (US) at the county level.', 0.8028345), ('Healthcare systems could be overwhelmed treating both patients with flu and patients with COVID-19.', 0.78398716)]"
1886,California signs deal to provide cheaper COVID-19 tests,cheaper,california signs deal to provide _ covid-19 tests,california signs deal to provide severe covid-19 tests,https://www.kcra.com/article/gov-newsom-gives-update-wildfires-coronavirus-aug-26/33808511?src=app,"[('He said the partnership will help drive down testing costs and improve turnaround time for results.California is averaging about 100,000 tests per day.', 0.57952285), ('The state is partnering with PerkinElmer to build out a new laboratory in California and ""full supply chain"" for COVID-19 testing.', 0.5478061), ('Gavin Newsom announced Wednesday that California has signed a contract worth up to $1.4 billion to provide cheaper coronavirus tests and to increase the number of people tested.', 0.4947361), ('He said the partnership will help drive down testing costs and improve turnaround time for results.', 0.42169046), ('Advertisement California is averaging about 100,000 tests per day.', 0.40616453)]"
1888,A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice,enhance,a booster dose _ immunogenicity of the covid-19 vaccine candidate chadox1 ncov-19 in aged mice,a booster dose dids immunogenicity of the covid-19 vaccine candidate chadox1 ncov-19 in aged mice,https://www.biorxiv.org/content/10.1101/2020.10.27.357426v1,"[('Here, we test the immunogenicity of the adenoviral vectored vaccine ChAdOx1 nCoV-19 (AZD-1222) in aged mice.', 0.7982034), ('Furthermore, we report that a second dose enhances the immune response to this vaccine in aged mice, indicating that a primeboost strategy may be a rational approach to enhance immunogenicity in older persons.', 0.6462549), ('We find that a single dose of this vaccine induces cellular and humoral immunity in aged mice, but at a reduced magnitude than in younger adult mice.', 0.5968102), ('The development of an effective COVID-19 vaccine could limit the morbidity and mortality caused by infection, and may enable the relaxation of social distancing measures.', 0.52724123), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.37474903)]"
1890,A case study of extended in-flight transmission of SARS-CoV-2 en route to Aotearoa New Zealand,case,a _ study of extended in-flight transmission of sars-cov-2 en route to aotearoa new zealand,a systematic study of extended in-flight transmission of sars-cov-2 en route to aotearoa new zealand,https://research.esr.cri.nz/articles/preprint/A_case_study_of_extended_in-flight_transmission_of_SARS-CoV-2_en_route_to_Aotearoa_New_Zealand/13257914,"[('Interpretation: By combining information on disease progression, travel dynamics and genomic analysis, we conclude that at least four in-flight transmission events of SARS-CoV-2 likely took place.', 0.5168884), ('Methods: Seven people who arrived in New Zealand on the same flight on 29 September tested positive during their stay in MIQ (out of 86 passengers).', 0.3921502), ('As of 20 October, testing in MIQ had identified 215 cases of SARS-CoV-2 from a total of 62,698 arrivals.', 0.37117827), ('Information about their journeys, disease progression and virus genomic data was used to assess possible points of infection.', 0.31811365), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.31632)]"
1891,"Coronavirus vaccine more than '90 % effective ' in preventing disease , study finds",than,"coronavirus vaccine more _ '90 % effective ' in preventing disease , study finds","coronavirus vaccine more under '90 % effective'in preventing disease, study finds",https://www.mirror.co.uk/news/world-news/breaking-coronavirus-vaccine-more-90-22980883,"[('A more than 90% effective coronavirus vaccine would be roughly on par with one dose of a measles vaccination, which is about 93% effective, according to the Centers for Disease Control and Prevention.', 0.8250109), ('The company said that the analysis found that the vaccine was more than 90 percent effective in preventing the disease among trial volunteers who had no evidence of prior coronavirus infection.', 0.766199), ('The news comes a week after Pfizer and BioNTech said their vaccine was more than 90% effective.', 0.7185596), ('The results indicate the vaccine was inducing the kind of immune response that protects people if they were exposed to the coronavirus.', 0.6849084), ('A growing number of coronavirus vaccines are showing robust protection against becoming sick.', 0.68378925)]"
1893,IL-6 : A novel signature associated with COVID-19 disease progression and development of anti-SARS-CoV-2 antibodies,novel,il-6 : a _ signature associated with covid-19 disease progression and development of anti-sars-cov-2 antibodies,il-6 : a common signature associated with covid-19 disease progression and development of anti-sars-cov-2 antibodies,https://www.medrxiv.org/content/10.1101/2020.10.13.20182949v1,"[('Share sMAdCAM:IL-6 (sMIL Index): A novel signature associated with COVID-19 disease progression and development of anti-SARS-CoV-2 antibodies Dhanashree Jagtap, Vikrant M Bhor, Shilpa Bhowmick, Nandini Kasarpalkar, Pooja Sagvekar, Bhalchandra Kulkarni, Manish Pathak, Nirjhar Chatterjee, Pranam Dolas, Harsha Palav, Snehal Kaginkar, Sharad Bhagat, Itti Munshi, Swapneil Parikh, Sachee Agrawal, Chandrakant Pawar, Mala Kaneria, Smita D Mahale, Jayanthi Shastri, Vainav Patel medRxiv 2020.10.13.20182949; doi: https://doi.org/10.1101/2020.10.13.20182949 Share This Article: Copy Citation Tools sMAdCAM:IL-6 (sMIL Index): A novel signature associated with COVID-19 disease progression and development of anti-SARS-CoV-2 antibodies Dhanashree Jagtap, Vikrant M Bhor, Shilpa Bhowmick, Nandini Kasarpalkar, Pooja Sagvekar, Bhalchandra Kulkarni, Manish Pathak, Nirjhar Chatterjee, Pranam Dolas, Harsha Palav, Snehal Kaginkar, Sharad Bhagat, Itti Munshi, Swapneil Parikh, Sachee Agrawal, Chandrakant Pawar, Mala Kaneria, Smita D Mahale, Jayanthi Shastri, Vainav Patel medRxiv 2020.10.13.20182949; doi: https://doi.org/10.1101/2020.10.13.20182949 ', 0.8427728), ('Antibody responses to SARS-CoV-2 in patients with COVID-19.', 0.7378799), ('Findings IL-6 and sMAdCAM expressed as a novel integrative marker (sMIL index) are associated both with disease-states (early infection and convalescence) as well as development of antiviral humoral responses.', 0.7323886), ('Nevertheless, the ADE-mediated inflammatory response and association of pre-existing antibodies with disease progression and severity in COVID-19 require further investigation.', 0.70508254), ('You are going to email the following sMAdCAM:IL-6 (sMIL Index): A novel signature associated with COVID-19 disease progression and development of anti-SARS-CoV-2 antibodies Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website.', 0.6979711)]"
1895,AstraZeneca Covid-19 vaccine study is put on hold,hold,astrazeneca covid-19 vaccine study is put on _,astrazeneca covid-19 vaccine study is put on!,https://www.statnews.com/2020/09/08/astrazeneca-covid-19-vaccine-study-put-on-hold-due-to-suspected-adverse-reaction-in-participant-in-the-u-k/,"[('AstraZeneca’s is the first Phase 3 Covid-19 vaccine trial known to have been put on hold.', 0.76167667), ('A spokesperson for AstraZeneca, a frontrunner in the race for a Covid-19 vaccine, said in a statement that the company’s “standard review process triggered a pause to vaccination to allow review of safety data.” In a follow-up statement, AstraZeneca said it initiated the study hold.', 0.6530589), ('But the progress of the company’s trial — and those of all Covid-19 vaccines in development — are being closely watched given the pressing need for new ways to curb the global pandemic.', 0.62694764), ('The vaccine — known as AZD1222 — uses an adenovirus that carries a gene for one of the proteins in SARS-CoV-2, the virus that causes Covid-19.', 0.5824245), ('Clinical holds in ongoing studies often involve a pause in recruiting new participants and dosing existing ones, unless it’s deemed in the interest of participant safety to continue dosing.', 0.48054394)]"
1896,Public health lessons learned from biases in coronavirus mortality overestimation,mortality,public health lessons learned from biases in coronavirus _ overestimation,public health lessons learned from biases in coronavirus transmission overestimation,https://www.cambridge.org/core/journals/disaster-medicine-and-public-health-preparedness/article/public-health-lessons-learned-from-biases-in-coronavirus-mortality-overestimation/7ACD87D8FD2237285EB667BB28DCC6E9#,"[('Results of this critical appraisal reveal information bias and selection bias in coronavirus mortality overestimation, most likely caused by misclassifying an influenza infection fatality rate as a case fatality rate.', 0.7527038), ('Sampling bias and other methodological threats to the validity of health survey research.', 0.67260635), ('Reference James45 For example, the public’s belief that mitigation measures were responsible for reducing coronavirus mortality may be a post hoc fallacy if lower mortality was actually due to the overestimation of coronavirus deaths.', 0.65800714), ('Inconsistencies, inaccuracies, biases, utilization, and consequences of the coronavirus mortality estimation are discussed.', 0.64654744), ('FIGURE 2 Biases and Potential Related Effects of Virus Mortality Overestimation.', 0.62810034)]"
1898,Male sex hormones appear to help the coronavirus infiltrate human cells,appear,male sex hormones _ to help the coronavirus infiltrate human cells,male sex hormones fail to help the coronavirus infiltrate human cells,https://www.sfchronicle.com/health/article/Unwelcome-mat-Male-sex-hormones-appear-to-help-15395442.php,"[('Her studies at the UCSF stem cell laboratory found that androgens — male hormones, including testosterone — actually help SARS-CoV-2, the specific coronavirus that causes COVID-19, infiltrate human cells.', 0.73064065), ('Her studies at the UCSF stem cell laboratory found that androgens -- male hormones, including testosterone -- actually help SARS-CoV-2, the specific coronavirus that causes COVID-19, infiltrate human cells.', 0.7103139), ('Men are more likely than women to die of the coronavirus, so scientists are treating them with something women have more of: female sex hormones.', 0.70874864), ('This active form of testosterone then initiates a process in which the enzyme TMPRSS2 is activated, making human cells more receptive to the coronavirus.', 0.6841569), ('The researchers hope that these androgen-blocking drugs will control TMPRSS2, the enzyme that functions as a welcome mat to the coronavirus in men.', 0.6417811)]"
1899,Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity,severity,viral epitope profiling of covid-19 patients reveals cross-reactivity and correlates of _,viral epitope profiling of covid-19 patients reveals cross-reactivity and correlates of protection,https://science.sciencemag.org/content/370/6520/eabd4250,"[('Our study reveals notable correlations between COVID-19 severity and both viral exposure history and overall strength of the antibody response to past infections.', 0.7997097), ('VirScan also offers the opportunity to examine the history of previous viral infections and to determine correlates of COVID-19 outcomes.', 0.7674583), ('We mapped the landscape of linear epitopes in the SARS-CoV-2 proteome, characterized their specificity or cross- reactivity, and investigated serological and viral exposure history correlates of COVID-19 severity.', 0.7624438), ('( A ) Example response to S and N proteins from a single COVID-19 patient.', 0.73057365), ('( B ) Common responses to S and N proteins across COVID-19 patients.', 0.7292496)]"
1901,The Prevalence of ocular manifestations and ocular samples polymerase chain reaction positivity in patients with COVID 19,prevalence,the _ of ocular manifestations and ocular samples polymerase chain reaction positivity in patients with covid 19,the absence of ocular manifestations and ocular samples polymerase chain reaction positivity in patients with covid 19,https://www.medrxiv.org/content/10.1101/2020.06.29.20142414v1,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.4571042), ('Methods A systematic literature review was performed using search engines (PubMed, Google Scholar, Medrixv and BioRixv) with keywords “SARS-CoV-2”, “novel coronavirus”, “COVID-19”, “ocular manifestations”, “conjunctival congestion”, “Ocular detection”, “Polymerase chain reaction”, and “conjunctivitis”.', 0.44986555), ('Seven patients (29 %) with conjunctivitis showed positive results in ocular samples, whereas 13 patients (54%) showed positive only in their nasopharyngeal samples (NPs) or sputum samples and 4 patients (16 %) were negative for both NPs and Sputum as well as ocular samples.', 0.4377477), ('The prevalence of conjunctivitis and ocular samples polymerase chain reaction positivity among COVID-19 patients was low indicating the eye is a less effected organ.', 0.43707687), ('Results A total of 20 studies (14 studies and 6 case-reports) were included in the systematic review and 14 studies were included in the meta- analysis.', 0.43534905)]"
1902,The Viruses That Shaped Our DNA,dna,the viruses that shaped our _,the viruses that shaped our data,https://www.wsj.com/amp/articles/the-viruses-that-shaped-our-dna-11584124275,"[('Viruses: their extraordinary role in shaping human evolution ', 0.75185794), ('Our cells can coat their DNA with molecules that suppress viral genes, for example.', 0.7152356), ('A retrovirus invades a host cell and inserts its genes into that cell’s DNA.', 0.69222075), ('“Are these viruses a part of us?', 0.6901523), ('Although most symbiosis research has focused on the role of the microbiome, the viruses tucked into our DNA can play a similar role in splitting apart two populations, turning one species into two.', 0.68014586)]"
1903,COVID-19 detected on multiple mink farms,detected,covid-19 _ on multiple mink farms,covid-19 died on multiple mink farms,https://www.wur.nl/en/Research-Results/Research-Institutes/Bioveterinary-Research/show-bvr/COVID-19-detected-on-two-mink-farms.htm,"[('The Dutch government reported multiple cases of transmission from mink to farm staff, and several staffers on the Utah farms who came in contact with the mink have confirmed COVID-19.', 0.730052), ('Mink on each farm were most likely initially infected via transmission of the virus from farm workers with COVID-19.', 0.7044661), ('COVID-19 has now struck mink farms in the United States, too.', 0.68636024), ('Mink can be infected by people with COVID-19, and evidence to date suggests mink-to-human transmission of SARS-CoV-2 is plausible.', 0.6745322), ('These large clusters of infection were initiated by human COVID-19 cases with viruses that bear the D614G mutation.', 0.60731435)]"
1904,Sequential infection with influenza A virus followed by severe acute respiratory syndrome coronavirus 2 leads to more severe disease and encephalitis in a mouse model of COVID-19 .,mouse,sequential infection with influenza a virus followed by severe acute respiratory syndrome coronavirus 2 leads to more severe disease and encephalitis in a _ model of covid-19 .,sequential infection with influenza a virus followed by severe acute respiratory syndrome coronavirus 2 leads to more severe disease and encephalitis in a human model of covid-19.,https://www.biorxiv.org/content/10.1101/2020.10.13.334532v1,"[('Share Sequential infection with influenza A virus followed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to more severe disease and encephalitis in a mouse model of COVID-19 Jordan J. Clark, Rebekah Penrice-Randal, Parul Sharma, Anja Kipar, Xiaofeng Dong, Andrew Davidson, Maia Kavanagh Williamson, David A. Matthews, Lance Turtle, Tessa Prince, Grant L. Hughes, Edward I. Patterson, Ghada Shawli, Krishanthi Subramaniam, Jo Sharp, Lynn McLaughlin, En-Min Zhou, Joseph D. Turner, Amy E. Marriott, Stefano Colombo, Shaun H. Pennington, Giancarlo Biagini, Andrew Owen, Julian A. Hiscox, James P. Stewart bioRxiv 2020.10.13.334532; doi: https://doi.org/10.1101/2020.10.13.334532 Share This Article: Copy Citation Tools Sequential infection with influenza A virus followed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to more severe disease and encephalitis in a mouse model of COVID-19 Jordan J. Clark, Rebekah Penrice-Randal, Parul Sharma, Anja Kipar, Xiaofeng Dong, Andrew Davidson, Maia Kavanagh Williamson, David A. Matthews, Lance Turtle, Tessa Prince, Grant L. Hughes, Edward I. Patterson, Ghada Shawli, Krishanthi Subramaniam, Jo Sharp, Lynn McLaughlin, En-Min Zhou, Joseph D. Turner, Amy E. Marriott, Stefano Colombo, Shaun H. Pennington, Giancarlo Biagini, Andrew Owen, Julian A. Hiscox, James P. Stewart bioRxiv 2020.10.13.334532; doi: https://doi.org/10.1101/2020.10.13.334532 ', 0.8154582), ('You are going to email the following Sequential infection with influenza A virus followed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to more severe disease and encephalitis in a mouse model of COVID-19 Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.', 0.74729705), ('COVID-19 is a spectrum of clinical symptoms in humans caused by infection with SARS-CoV-2, a recently emerged coronavirus that has rapidly caused a pandemic.', 0.6780701), ('Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus.', 0.67256165), ('Another pre-print paper shows that SARS-CoV-2 infected K18-hACE2 mice produce a robust Th1/2/17 cytokine storm in the lungs and spleens from 2 dpi,55 highlighting the relevance of this mouse model that recapitulates critical human clinical features of COVID-19.', 0.66605145)]"
1905,SARS-Coronavirus-1 Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes,triggers,sars-coronavirus-1 open reading frame-8b _ intracellular stress pathways and activates nlrp3 inflammasomes,sars-coronavirus-1 open reading frame-8b inhibits intracellular stress pathways and activates nlrp3 inflammasomes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549181/,"[('Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC.', 0.78606033), ('Here, we identify several mechanisms by which a SARS-CoV open reading frame (ORF) activates intracellular stress pathways and targets the innate immune response.', 0.7174693), ('RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway.', 0.7110009), ('Type I IFN triggers RIG-I/TLR3/NLRP3-dependent inflammasome activation in influenza A virus infected cells.', 0.7078084), ('NLRP3 inflammasome activation during viral infections.', 0.7077751)]"
1908,Frontline NYC doctors think COVID19 should be treated like hypoxemia and not like ARDS .,not,frontline nyc doctors think covid19 should be treated like hypoxemia and _ like ards .,frontline nyc doctors think covid19 should be treated like hypoxemia and asthma like ards.,https://rebelem.com/covid-19-hypoxemia-a-better-and-still-safe-way/,"[(""Related Conditions & Procedures COVID-19 Pulmonary Management Symptoms and Management of Coronavirus Disease 2019 (COVID-19) FAQ Diagnostics for Coronavirus Disease 2019 (COVID-19) Patients Coronavirus Disease 2019 (COVID-19) Triage Precautions FAQ Coronavirus Disease 2019 (COVID-19) Treatment of Coronavirus Disease 2019 (COVID-19): Investigational Drugs and Other Therapies Slideshow Top 10 COVID-19 Infographics of 2020 Expert Commentary Convalescent Plasma Reduced COVID-19 Deaths, Study Says Moderna Needs More Kids for COVID-19 Vaccine Trials In-Person K-12 Classes Don't Fuel COVID-19 Outbreaks, Study Says Most Popular Articles According to INTENSIVISTS 1."", 0.51947165), ('Because once you do that, then you can accept the idea that perhaps all the studies on ARDS in the 2000s and 2010s, which were large, randomized, well-performed, well-funded studies, perhaps none of those patients in those studies had COVID-19 or something resembling it.', 0.5191326), ('Image One reason is that contrary to expectations, a number of doctors at New York hospitals believe intubation is helping fewer people with Covid-19 than other respiratory illnesses and that longer stays on the mechanical ventilators lead to other serious complications.', 0.5035432), ('“Intubated patients with Covid lung disease are doing very poorly, and while this may be the disease and not the mechanical ventilation, most of us believe that intubation is to be avoided until unequivocally required,” Dr. Strayer said.', 0.4604054), ('2001 In Memoriam: Healthcare Workers Who Have Died of COVID-19 b:curatedcuratedHasData : true Need a Curbside Consult?', 0.44802916)]"
1909,Dysregulated immunity in SARS-CoV-2 infected pregnant women,immunity,dysregulated _ in sars-cov-2 infected pregnant women,dysregulated expression in sars-cov-2 infected pregnant women,https://www.medrxiv.org/content/10.1101/2020.11.13.20231373v1,"[('Pregnant women with confirmed SARS-CoV-2 infection also had reduced anti-S-RBD IgG titers and were less likely to have detectable nAb as compared with non-pregnant women.', 0.7255919), ('Design Immune responses to SARS-CoV-2 were analyzed using samples from pregnant and non-pregnant women who had either tested positive or negative for SARS-CoV-2.', 0.7242149), ('Objective To assess the impact of SARS-CoV-2 infection during pregnancy on inflammatory and humoral responses in maternal and fetal samples and compare antibody responses to SARS-CoV-2 among pregnant and non-pregnant women.', 0.6430743), ('Although SARS-CoV-2 infection did not disrupt FcRn expression in the placenta, maternal transfer of nAb was inhibited by SARS-CoV-2 infection during pregnancy.', 0.5904298), ('Non-pregnant women were recruited after receiving outpatient SARS-CoV-2 testing within Johns Hopkins Health System, USA.', 0.5903765)]"
1913,Positiv Test Results in Patients Recovered From COVID-19,patients,positiv test results in _ recovered from covid-19,positiv test results in bacteria recovered from covid-19,https://jamanetwork.com/journals/jama/fullarticle/2762452,"[('Positive RT-PCR Test Results in Patients Recovered From COVID-19.', 0.85554636), ('The Appropriate Use of Testing for COVID-19.', 0.80370176), ('How should a positive PCR test result for COVID-19 in an asymptomatic individual be interpreted and managed?', 0.7906886), ('We observed a certain number of cured COVID-19 patients with positive RT-PCR test results and try to analyze the factors that caused the phenomenon.', 0.78444195), ('Recently, it was reported that some COVID-19 patients who had met the criteria for hospital discharge (absence of clinical symptoms and radiological abnormalities with 2 consecutive negative RT-PCR test results) showed positive RT-PCR test results for COVID-19 nucleic acid later (Lan et al., 2020).', 0.7174671)]"
1914,Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis,cleavage,furin _ site is key to sars-cov-2 pathogenesis,furin binding site is key to sars-cov-2 pathogenesis,https://www.biorxiv.org/content/10.1101/2020.08.26.268854v1,"[('Together, these results demonstrate a critical role for the furin cleavage site insertion in SARS-CoV-2 replication and pathogenesis.', 0.85575366), ('Overall, our work highlights the importance of this key motif in SARS-CoV-2 infection and pathogenesis.', 0.7383093), ('By removing the furin cleavage site, we demonstrate the importance of this insertion to SARS-CoV-2 replication and pathogenesis.', 0.71428347), ('In addition, these findings illustrate the importance of this insertion in evaluating neutralization and other downstream SARS-CoV-2 assays.', 0.65567935), ('Absent in other group 2B CoVs, the insertion may be a key factor in the replication and virulence of SARS-CoV-2.', 0.62877095)]"
1915,Coronavirus blood-clot mystery intensifies,blood,coronavirus _-clot mystery intensifies,coronavirus non-clot mystery intensifies,https://www.nature.com/articles/d41586-020-01403-8,"[('High levels of D-dimer seem to be a powerful predictor of mortality in hospitalized patients infected with coronavirus3.', 0.5345629), ('And the virus seems to activate the complement system, a defence mechanism that sparks clotting.', 0.49537167), ('They might have a genetic predisposition to clotting, or be taking medications that increase the risk.', 0.45643455), ('One possibility is that SARS- CoV-2 is directly attacking the endothelial cells that line the blood vessels.', 0.45380655), ('“This is like a storm of blood clots,” says Behnood Bikdeli, a fourth-year cardiology fellow at Columbia University in New York City.', 0.43925136)]"
1916,Early prognostication of COVID-19 to guide hospitalisation versus outpatient monitoring using a point-of-test risk prediction score,early,_ prognostication of covid-19 to guide hospitalisation versus outpatient monitoring using a point-of-test risk prediction score,Further prognostication of covid-19 to guide hospitalisation versus outpatient monitoring using a point-of-test risk prediction score,https://www.medrxiv.org/content/10.1101/2020.10.19.20215426v1,"[('Conclusion The SOARS score uses constitutive and readily assessed individual characteristics to predict the risk of COVID-19 death.', 0.64377284), ('Methods Multivariate regression with bootstrapping was used to identify independent mortality predictors in a derivation cohort of COVID-19 patients.', 0.64263785), ('Through sequential modelling, a 5-predictor score termed SOARS (SpO2, Obesity, Age, Respiratory rate, Stroke history) was developed to correlate COVID-19 severity across low, moderate and high strata of mortality risk.', 0.56664354), ('Deployment of the score could potentially inform clinical triage in pre-admission settings where expedient and reliable decision-making is key.', 0.54951465), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.4994564)]"
1919,Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City,repeated,_ cross-sectional sero-monitoring of sars-cov-2 in new york city,One cross-sectional sero-monitoring of sars-cov-2 in new york city,https://www.nature.com/articles/s41586-020-2912-6,"[('Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York.', 0.69841814), ('Introductions and early spread of SARS-CoV-2 in the New York City area.', 0.68616915), ('e , Numbers of confirmed SARS-CoV-2 cases and deaths in NYC for the same time frame.', 0.68388855), ('For many samples in the urgent care group, NAAT results for SARS-CoV-2 infection were available and the rate of positivity in nasopharyngeal swab specimen tracked well with seropositivity (Extended Data Fig.', 0.6558625), ('A serological assay to detect SARS-CoV-2 seroconversion in humans.', 0.6386181)]"
1920,Dozens of COVID-19 vaccines are in development .,development,dozens of covid-19 vaccines are in _ .,dozens of covid-19 vaccines are in place.,https://www.nationalgeographic.com/science/health-and-human-body/human-diseases/coronavirus-vaccine-tracker-how-they-work-latest-developments-cvd/,"[('And six vaccines for COVID-19 have entered human clinical trials with many planning to begin human trials this year.', 0.8705077), ('More information regarding the development of COVID-19 vaccines can be found at the links here and here.', 0.82124674), (""(Here's how we'll know when a COVID-19 vaccine is ready.)"", 0.76453257), ('Here are the COVID-19 vaccine prospects that have made it to phase three trials and beyond.', 0.7434933), ('As biopharmaceutical companies seek to identify and develop potential vaccines against COVID-19, companies are already scaling up manufacturing capabilities at risk and sharing technology platforms throughout the health care ecosystem.', 0.7203156)]"
1922,CT scan is a viable alternative for coronavirus test,alternative,ct scan is a viable _ for coronavirus test,ct scan is a viable standard for coronavirus test,https://affordablescan.com/blog/coronavirus-test-in-california/,"[('Could computed tomography (CT) scans, which combine a series of X-ray images, serve as an alternative or an adjunct to RT-PCR diagnosis?', 0.7534717), ('The fast way in order to imaging that is currently used in hospitals is CT scan.', 0.7471435), ('Now, computed tomography (CT) is widely used as the imaging modality for the detection of COVID-19 pneumonia.', 0.73859227), ('According to a research article in Radiology, CT is far more sensitive, commonly detecting cases the swab misses.', 0.71282244), ('Imaging Modality Chest radiograph (CXR) or computed tomography (CT) is an essential tool for COVID-19 diagnosis in clinical practice.', 0.7108686)]"
1923,"In 2017 , the CDC already knew there were evidences that healthy people wearing masks may prevent from getting infection",2017,"in _ , the cdc already knew there were evidences that healthy people wearing masks may prevent from getting infection","in 1, the cdc already knew there were evidences that healthy people wearing masks may prevent from getting infection",https://stacks.cdc.gov/view/cdc/44313,"[('Nevertheless, mechanistic studies found that surgical masks could prevent transmission of human coronavirus and influenza virus infections if worn by infected persons ( 2).', 0.62910736), ('However, as with hand hygiene, face masks might be able to reduce the transmission of other infections and therefore have value in an influenza pandemic when healthcare resources are stretched.', 0.5958374), ('In addition, persons caring for ill family members at home (e.g., a parent of a child exhibiting influenza symptoms) might use face masks to avoid infection when in close contact with a patient, just as health care personnel wear masks in health care settings.', 0.58870375), ('Although these measures have mechanistic support based on our knowledge of how influenza is transmitted from person to person, randomized trials of hand hygiene and face masks have not demonstrated protection against laboratory-confirmed influenza, with 1 exception ( 18).', 0.5695464), ('Respirators are tight-fitting masks that can protect the wearer from fine particles ( 37) and should provide better protection against influenza virus exposures when properly worn because of higher filtration efficiency.', 0.56883776)]"
1925,Number of people with coronavirus infections may be dozens of times higher than the number of confirmed cases,may,number of people with coronavirus infections _ be dozens of times higher than the number of confirmed cases,number of people with coronavirus infections cannot be dozens of times higher than the number of confirmed cases,https://thl.fi/en/web/thlfi-en/-/number-of-people-with-coronavirus-infections-may-be-dozens-of-times-higher-than-the-number-of-confirmed-cases,"[('Antibody studies can be used to collect information on the share of the population that have been infected with coronavirus.', 0.47313315), ('More information on the presence of antibodies in the population and more detailed estimates on the share of people infected with coronavirus will be provided by the random sampling-based population study that THL initiated last week.', 0.41590157), ('""The study is the first preliminary assessment of the extent to which the coronavirus epidemic has spread in the HUS area, and the share of people who may have had the mild or asymptomatic version of the disease,"" says Merit Melin , Senior Researcher at the Finnish Institute for Health and Welfare.', 0.39073658), ('The sampling taken during week 15, included 147 samples of which 5 samples (3.4 percent) was observed to contain antibodies.', 0.35251248), ('THL studied the prevalence of antibodies in blood samples of persons who had undergone laboratory tests for various reasons in the Hospital District of Helsinki and Uusimaa.', 0.29330927)]"
1926,Clinical and Chest Radiography Features Determine Patient Outcomes In Young and Middle Age Adults with COVID-19,chest,clinical and _ radiography features determine patient outcomes in young and middle age adults with covid-19,clinical and CT radiography features determine patient outcomes in young and middle age adults with covid-19,https://pubs.rsna.org/doi/10.1148/radiol.2020201754,"[('Clinical and Chest Radiography Features Determine Patient Outcomes in Young and Middle-aged Adults With COVID-19.', 0.9918811), ('Clinical and Chest Radiography Features Determine Patient Outcomes in Young and Middle-aged Adults with COVID-19.', 0.9918811), ('""Clinical and Chest Radiography Features Determine Patient Outcomes in Young and Middle-aged Adults With COVID-19.""', 0.9835207), ('Diagnostic and Prognostic Value of Chest Radiographs for COVID-19 at Presentation.', 0.84038556), ('Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19.', 0.83383197)]"
1929,Humanigen Announces COVID-19 Case Report Demonstrating Rapid Resolution and Discharge after Single IND Emergency Use Authorization of Lenzilumab™,human,_ announces covid-19 case report demonstrating rapid resolution and discharge after single ind emergency use authorization of lenzilumab™,Bigen announces covid-19 case report demonstrating rapid resolution and discharge after single ind emergency use authorization of lenzilumab™,https://www.humanigen.com/press/Humanigen-Announces-COVID-19-Case-Report-Demonstrating-Rapid-Resolution-and-Discharge-after-Single-IND-Emergency-Use-Authorization-of-Lenzilumab%E2%84%A2,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.48490784), ('Humanigen Logo About Humanigen COVID-19 Our Programs Investor Relations & Media More ', 0.40058059), ('Click here to view.', 0.30411172), ('[c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 10:30 AM [Today]: Sunday, January 17, 2021 at 6:45 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:30 AM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students [January 14]: Thursday, January 14, 2021 at 10:09 AM [January 10]: Sunday, January 10, 2021 at 9:29 AM [January 5]: Tuesday, January 5, 2021 at 6:05 AM [on April 4, 2020]: Saturday, April 4, 2020 11:38 PM [Tel:]: Phone number [May 30, 2019 at 9:42 PM]: Thursday, May 30, 2019 at 9:42 PM [March 14, 2019 at 3:03 PM]: Thursday, March 14, 2019 at 3:03 PM [November 12, 2018 at 10:57 PM]: Monday, November 12, 2018 at 10:57 PM [December 25, 2020 at 12:09 PM]: Friday, December 25, 2020 at 12:09 PM [November 24, 2020]: Tuesday, November 24, 2020 at 9:28 AM [ November 5, 2020]: Thursday, November 5, 2020 at 5:36 PM [ November 1, 2020]: Sunday, November 1, 2020 at 1:52 PM [October 26, 2020]: Monday, October 26, 2020 at 6:36 PM [ October 15, 2020]: Thursday, October 15, 2020 at 12:38 PM [ October 7, 2020]: Wednesday, October 7, 2020 at 5:08 PM [August 9, 2020]: Sunday, August 9, 2020 at 8:53 PM [August 7, 2020]: Friday, August 7, 2020 at 6:19 AM [July 4, 2020]: Saturday, July 4, 2020 at 2:55 PM [ July 2, 2020]: Thursday, July 2, 2020 at 8:45 AM [June 30, 2020]: Tuesday, June 30, 2020 at 9:36 AM [June 27, 2020]: Saturday, June 27, 2020 at 7:51 PM [June 18, 2020]: Thursday, June 18, 2020 at 4:20 PM [June 16, 2020]: Tuesday, June 16, 2020 at 7:15 PM [June 14, 2020]: Sunday, June 14, 2020 at 11:40 AM [June 10, 2020]: Wednesday, June 10, 2020 at 7:53 PM', 0.3020967), ('\u200b Back to home page Follow Us Terms Of Use ', 0.22621076)]"
1931,Pyridoxal 5'-phosphate to mitigate immune dysregulation and coagulopathy in COVID-19,phosphate,pyridoxal 5'-_ to mitigate immune dysregulation and coagulopathy in covid-19,pyridoxal 5'- inability to mitigate immune dysregulation and coagulopathy in covid-19,https://www.preprints.org/manuscript/202005.0144/v1,"[('Pharmacological PLP supplementation may therefore mitigate COVID-19 symptoms by alleviating both the immune suppression underlying viral spread and the pathological hypersecretion of inflammatory cytokines, as well as directly bolstering endothelial integrity and preventing hypercoagulability.', 0.69006616), ('Severe COVID-19 manifests as an imbalance in the immune response and the clotting system.', 0.56660354), (""Pyridoxal 5'-phosphate (PLP) tends to be insufficient in populations particularly vulnerable to COVID-19, including the elderly, the institutionalized, and people with diabetes and CVD, and PLP becomes further depleted during infection and inflammation."", 0.5513753), ('In turn, low PLP results in immune imbalance, as PLP is an essential cofactor in pathways regulating cytokine production, in particular type I interferons and IL-6, and in lymphocyte trafficking and endothelial integrity.', 0.54361254), ('In inflammatory disease, pharmacological doses of PLP decrease circulating TNFα, IL-6 and D-dimer, and animal studies demonstrate that supplemental PLP shortens the duration and severity of viral pneumonia.', 0.3817209)]"
1932,"Face masks , the precautionary principle , and evidence-informed policy",face,"_ masks , the precautionary principle , and evidence-informed policy","Health masks, the precautionary principle, and evidence-informed policy",https://www.bmj.com/content/369/bmj.m1435/rr-43,"[('Part 1 - Face masks, eye protection and person distancing: systematic review and meta-analysis.', 0.6539531), ('Efforts to communicate a position so strongly in favour of widespread use of masks in the community, against current WHO advice and in the face of persistent evidence gaps, risk promoting policy based more on eminence than evidence.', 0.6192639), ('invoke the ‘precautionary principle’.', 0.54471564), ('The need for urgent action is reflected in both demand for and supply of evidence- informed policy recommendations.', 0.51758516), ('Behind the mask: determinants of nurse’s adherence to facial protective equipment.', 0.5163586)]"
1934,Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2,apparent,thromboembolic events and _ heparin resistance in patients infected with sars-cov-2,thromboembolic events and no heparin resistance in patients infected with sars-cov-2,https://onlinelibrary.wiley.com/doi/abs/10.1111/ijlh.13230,"[('Thota R, Ganti AK, Subbiah S. Apparent heparin resistance in a patient with infective endocarditis secondary to elevated factor VIII levels.', 0.597618), ('Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin.', 0.5472437), ('Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism.', 0.5297091), ('Downie I, Liederman Z, Thiyagarajah K, Selby R, Lin Y. Pseudo heparin resistance caused by elevated factor VIII in a critically ill patient.', 0.52177536), ('Clin Adv Hematol Oncol.', 0.51217365)]"
1935,Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19,validation,development and _ of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with covid-19,development and lack of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with covid-19,https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2766086?guestAccessKey=b2d5a603-7050-4e1d-9759-6b4b82e78954&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamainternalmedicine&utm_term=mostread&utm_content=olf-widget_05142020,"[('In conclusion, we developed a scoring system (COVID-19MRS) that objectively and accurately predicts in-hospital mortality COVID-19 patients.', 0.8541547), ('Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal.', 0.8346373), ('These were used to build a COVID-19 in-hospital mortality risk score (COVID-19MRS).', 0.8298099), ('COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up.', 0.7876359), ('Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis.', 0.7748336)]"
1936,Singapore First to Test Out COVID-19 Serological Assay in Outbreak Contact Tracing,first,singapore _ to test out covid-19 serological assay in outbreak contact tracing,singapore difficult to test out covid-19 serological assay in outbreak contact tracing,https://globalbiodefense.com/headlines/singapore-first-to-test-out-covid-19-serological-assay-in-outbreak-contact-tracing/,"[('In a world-first, a research team at Duke-NUS Medical School working with the government of Singapore has established a link between two COVID-19 clusters in Singapore via serological testing.', 0.76159835), ('Singapore claims first use of antibody test to track coronavirus infections Science 2\\.', 0.63799965), ('For instance, “Many cases seem to be spread from asymptomatic patients who we can’t identify easily.” Serological tests are “essential to better understand the epidemiology of COVID-19,” says Keiji Fukuda, an epidemiologist at the University of Hong Kong.1 The test was developed by a team led by Linfa Wang, an emerging disease specialist at Duke-NUS.', 0.58684313), ('Using two different antibody testing platforms (virus neutralisation assay and ELISA assay), the Duke-NUS team proved that a couple was infected with COVID-19 in late January 2020, as they had very high levels of the virus- specific antibodies in the their blood.', 0.53427935), ('Featured COVID-19 Funding Directory Job Board Events All Events Deadlines Webinar-Webcast Awareness Events Subscribe Search Search for: Search Follow us Facebook Twitter instagram Menu Search Search for: Search in Biodetection, Outbreak News ', 0.51119673)]"
1939,STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters,drives,stat2 signaling restricts viral dissemination but _ severe pneumonia in sars-cov-2 infected hamsters,stat2 signaling restricts viral dissemination but not severe pneumonia in sars-cov-2 infected hamsters,https://www.nature.com/articles/s41467-020-19684-y,"[('Together, these data suggest that STAT2 is critical for keeping virus replication and production of infectious progeny in the lungs down, as well as for restricting systemic SARS-CoV-2 spread and suppressing viral replication outside of the lung compartment.', 0.6968522), ('In humans, SARS-CoV-2 infection begins frequently with a flu-like illness, followed in a second phase by an intense inflammatory response characterized by a cytokine storm and acute lung injury (ALI) and respiratory distress syndrome (ARDS) associated with high mortality2,7,8.', 0.6630354), ('Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice.', 0.65718734), ('By using unique KO hamster lines, we demonstrated that STAT2 plays a critical role in mediating antiviral responses and restricting systemic dissemination of SARS-CoV-2 (see Fig.', 0.6552165), ('We establish that in hamsters a dysregulated innate immune response is a driving force behind SARS-CoV-2 pathogenesis, in which in particular signal transducer and activator of transcription factor 2 (STAT2)-dependent type I and III IFN signaling plays a dual role: (i) restricting infection and dissemination on one hand but (ii) driving development of severe lung disease on the other.', 0.65498435)]"
1940,HIV treatments provide line of attack against coronavirus,attack,hiv treatments provide line of _ against coronavirus,hiv treatments provide line of protection against coronavirus,https://asia.nikkei.com/Spotlight/Coronavirus-outbreak/HIV-treatments-provide-line-of-attack-against-coronavirus,"[('These include lopinavir and ritonavir, the medications used in the experimental coronavirus treatments.', 0.6811962), (""Once seen as incurable, HIV can now be brought under control by antiretroviral therapy -- mixtures of antiviral drugs that interfere with the virus's ability to reproduce, letting patients live normal lives."", 0.67337465), ('When HIV reproduces, it forces host cells to create long chains of proteins that become material for new viruses.', 0.66126657), ('Experts say more testing is needed to tell whether antiretrovirals actually help coronavirus patients recover.', 0.587464), (""HIV, the virus that causes AIDS, hijacks white blood cells to replicate itself and eventually impairs the host's immune system."", 0.54798144)]"
1944,Comment on : Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept .,comment,_ on : recovery from covid-19 in a patient with spondyloarthritis treated with tnf-alpha inhibitor etanercept .,Research on : recovery from covid-19 in a patient with spondyloarthritis treated with tnf-alpha inhibitor etanercept.,https://ard.bmj.com/content/early/2020/08/18/annrheumdis-2020-218147?rss=1,"[(""A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab' by Messina et al."", 0.73056215), ('A report on a patient with COVID-19 with psoriatic arthritis receiving ustekinumab Francesco Messina et al.', 0.7116265), ('A report on a patient with COVID-19 with psoriatic arthritis receiving ustekinumab Francesco Messina 1 , Francesca Pampaloni 1 , Stefano Piaserico 2 Affiliations Expand ', 0.68190885), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.4696843), ('PMID: 23808901 Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.', 0.42774767)]"
1946,Eli Lilly Begins Testing Covid-19 Drug Derived From Blood of Survivor,survivor,eli lilly begins testing covid-19 drug derived from blood of _,eli lilly begins testing covid-19 drug derived from blood of donors,https://www.wsj.com/amp/articles/eli-lilly-begins-testing-covid-19-drug-derived-from-blood-of-survivor-11591007400,"[(""A blood sample from an early U.S. survivor of COVID-19 is being used by Eli Lilly to develop an experimental drug, which is now undergoing human tests to examine the drug's ability to fight the coronavirus."", 0.8343253), ('Wall Street Journal (06/01/20) Loftus, Peter Article URL https://www.wsj.com/articles/eli-lilly-begins-testing-covid-19-drug-der… ', 0.6303636), ('If the first study is successful, Lilly says it intends to test the antibody in a second study that includes treating patients who are not hospitalized.', 0.5735571), ('The drug, code-named LY- CoV555, does not contain the plasma of recovered patients, but its design was triggered by antibodies in the plasma.', 0.4075578), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.39513373)]"
1947,"India 's first CRISPR Covid-19 test , developed by the Tata Group and CSIR-IGIB , approved for use in India",approved,"india 's first crispr covid-19 test , developed by the tata group and csir-igib , _ for use in india","india's first crispr covid-19 test, developed by the tata group and csir-igib, except for use in india",https://pib.gov.in/PressReleasePage.aspx?PRID=1656770,"[(""The Tata CRISPR test is the world's first diagnostic test to deploy a speciallyadapted Cas9 protein to successfully detect the virus causing Covid-19."", 0.7820755), ('“The Tata CRISPR test is the world’s first diagnostic test to deploy a specially adapted Cas9 protein to successfully detect the virus causing Covid-19.', 0.7816255), ('""The Tata CRISPR test is the world\'s first diagnostic test to deploy a specially adapted Cas9 protein to successfully detect the virus causing Covid-19,"" it added.', 0.7725783), (""The Tata CRISPR test is the world's first diagnostic test to deploy a specially adapted Cas9 protein to successfully detect the virus causing Covid-19."", 0.7709794), (""The Tata CRISPR test is the world's first diagnostic test to deploy a specially adapted Cas9 protein to successfully detect the virus causing COVID-19, it said."", 0.76762414)]"
1948,Extraordinary diseases require extraordinary solutions,diseases,extraordinary _ require extraordinary solutions,extraordinary technologies require extraordinary solutions,https://www.sciencedirect.com/science/article/pii/S0264410X20305326?via%3Dihub,"[('The availability of top tier researchers at high level medical facilities would be essential to the acceptability of these challenge studies.', 0.5700082), ('The ethics of such trials, as well as their acceptability to regulators as a step towards emergency use of a candidate vaccine are foremost and require immediate discussion.', 0.51028675), ('Nevertheless, a challenge study would require controls who receive no vaccine and who might become ill. Possible rescue treatments are being tested, such as remdesiver, convalescent serum, and other modalities which could be used in case of a severe disease after challenge, or administered as soon as virus positivity is confirmed [8].', 0.4411406), ('The world is experiencing a major pandemic with a high mortality.', 0.43822888), ('Considering the rapid spread of the SARS-2 coronavirus and its mortality rate, which exceeds that of the 1918-19 influenza epidemic, a vaccine is urgently needed [3].', 0.42451835)]"
1949,Ketogenesis restrains aging-induced exacerbation of COVID in a mouse model,aging,ketogenesis restrains _-induced exacerbation of covid in a mouse model,ketogenesis restrains cancer-induced exacerbation of covid in a mouse model,https://www.biorxiv.org/content/10.1101/2020.09.11.294363v1,"[('\\- Ketones protect aged mice from infection by reducing inflammation.', 0.54853964), ('\\- Natural MHV-A59 mouse coronavirus infection mimics COVID-19 in elderly.', 0.45505804), ('Ketogenic diet increases beta- hydroxybutyrate, expands tissue protective γδ T cells, deactivates the inflammasome and decreases pathogenic monocytes in lungs of infected aged mice.', 0.44493532), ('\\- Aged infected mice have systemic inflammation and inflammasome activation \\- Murine beta coronavirus (mCoV) infection results in loss of pulmonary γδ T cells.', 0.43809056), ('Here, Ryu et al report an aging mouse model of coronavirus infection that recapitulates clinical hallmarks of COVID-19 seen in elderly.', 0.4225557)]"
1951,Placentas from COVID-19-positive pregnant women show injury,positive,placentas from covid-19-_ pregnant women show injury,placentas from covid-19-negative pregnant women show injury,https://news.northwestern.edu/stories/2020/05/placentas-from-covid-19-positive-pregnant-women-show-injury/&fj=1,"[('The type of injury seen in the placentas shows abnormal blood flow between the mothers and their babies in utero, pointing to a new complication of COVID-19.', 0.7715801), ('It is the largest study to examine the health of placentas in women who tested positive for COVID-19.', 0.7330611), ('“I don’t want to draw sweeping conclusions from a small study, but this preliminary glimpse into how COVID-19 might cause changes in the placenta carries some pretty significant implications for the health of a pregnancy.', 0.6000606), ('The placentas from 16 women who tested positive for COVID-19 while pregnant showed evidence of injury, according to pathological exams completed directly following birth, reports a new Northwestern Medicine study.', 0.58347595), ('The team began testing placentas of COVID-19-positive mothers in early April.', 0.56241155)]"
1952,We Thought It Was Just a Respiratory Virus We were wrong .,just,we thought it was _ a respiratory virus we were wrong .,we thought it was not a respiratory virus we were wrong.,https://www.ucsf.edu/magazine/covid-body,"[('What’s changed is, we found out that, unlike past viruses that are spread through the respiratory route, a significant proportion of coronavirus cases can be traced back to asymptomatic spread.', 0.668403), ('At the time, the U.S. Centers for Disease Control and Prevention limited testing to people who had respiratory symptoms and had recently traveled to China or otherwise been exposed to the virus.', 0.63498586), ('About Us Members Join Us Member News Alliance News Events COVID19 Leadership About UsMembersJoin UsMember News Alliance NewsEventsCOVID19Leadership We thought it was just a respiratory virus.', 0.6291264), ('“Some of it is definitely caused by the virus itself,” says Michael Matthay, MD, a UCSF professor of medicine who has studied acute respiratory diseases for more than 30 years.', 0.5849965), (""And what we're also hoping -- and we talked about this about four or five weeks ago -- that we're hoping that the flu infections also go down because people are much more aware of respiratory illnesses and how to protect themselves."", 0.5849712)]"
1954,It 's too soon to assume success for Moderna 's Covid-19 Vaccine,soon,it 's too _ to assume success for moderna 's covid-19 vaccine,it's too long to assume success for moderna's covid-19 vaccine,https://www.fiercebiotech.com/biotech/it-s-too-soon-to-assume-success-for-moderna-s-covid-19-vaccine-analyst,"[('It’s way too early to get excited about Moderna’s mRNA vaccine to prevent COVID-19, concluded Evercore ISI analyst Umer Raffat after analyzing the company’s data.', 0.7037188), ('Read more on COVID-19 vaccines messenger RNA Moderna Therapeutics coronavirus ', 0.6680733), ('RELATED:CureVac ramps up COVID-19 mRNA vaccine effort as Moderna analysts raise questions about animal data Evercore ISI’s Raffat also noted other concerns about Moderna’s data release that investors have been voicing over the last couple of days.', 0.61203873), ('The FDA hasn’t weighed in on what level of neutralizing antibody response it will need to see to deem a vaccine effective against COVID-19, Raffat pointed out.', 0.59789515), ('But it has provided one hint: The agency has issued guidance saying that when convalescent serum is used to treat critically ill COVID-19 patients, that blood should have high levels of neutralizing antibodies.', 0.57677764)]"
1958,CEPI and SK bioscience extend collaboration to develop next generation COVID-19 vaccine,next,cepi and sk bioscience extend collaboration to develop _ generation covid-19 vaccine,cepi and sk bioscience extend collaboration to develop first generation covid-19 vaccine,https://cepi.net/news_cepi/cepi-and-sk-bioscience-to-develop-next-generation-covid-19-vaccine/,"[('For the COVID-19 vaccine response, SK bioscience is undergoing development for its vaccine candidate against SARS- CoV-2 with support from the Bill and Melinda Gates Foundation and CEPI, and using its established development and manufacturing capabilities, it has recently agreed to develop and manufacture AstraZeneca’s and Novavax’s COVID-19 vaccine candidates.', 0.8576653), ('SK bioscience is developing a number of COVID-19 vaccine candidates to deliver the best COVID-19 vaccines that are accessible to the world with proven safety and effectiveness, utilizing our state-of-the-art vaccine platform technology.', 0.8381337), ('SK bioscience and CEPI are committed to global equitable access of COVID-19 vaccines and have agreed that this vaccine candidate will be made available for procurement and allocation, if proven to be safe and effective, through the COVID-19 Vaccine Global Access (COVAX) Facility.', 0.80197465), ('CEPI has also partnered with bioscience facilities SK bioscience and GC Pharma to reserve manufacturing capacities exclusively for one or more CEPI-funded COVID-19 vaccines.', 0.7750131), ('I’m pleased to expand our partnership with SK bioscience to develop their vaccine candidate, GBP510, which marks CEPI’s first investment in ‘Wave 2’ vaccines.', 0.7006519)]"
1959,"Man , 25 , catches coronavirus twice in first such US case",man,"_ , 25 , catches coronavirus twice in first such us case","13, 25, catches coronavirus twice in first such us case",https://www.theguardian.com/world/2020/oct/13/man-25-catches-coronavirus-twice-in-first-such-us-case,"[('Photograph: John Locher/AP The man required hospitalisation and oxygen support the second time he caught coronavirus.', 0.62300766), ('Photograph: John Locher/AP Press Association Tue 13 Oct 2020 01.24 EDT Researchers in the US have reported the country’s first confirmed case of coronavirus reinfection.', 0.6088511), ('A 25-year-old man with no known immune disorders or underlying conditions was infected with Covid-19 on two separate occasions, according to a study published in the Lancet Infectious Diseases journal.', 0.52835417), ('Researchers from the Nevada state public health laboratory and the University of Nevada, Reno school of medicine said he tested positive for the virus in April this year, and later tested negative on two separate occasions.', 0.51658434), ('Genetic sequencing of the virus showed he was infected twice by different strains of Sars-CoV-2, according to researchers.', 0.48163205)]"
1960,Usage of Masks Flattened Growth of Coronavirus Cases in Czech Republic,flattened,usage of masks _ growth of coronavirus cases in czech republic,usage of masks prevented growth of coronavirus cases in czech republic,https://www.praguemorning.cz/usage-of-masks-flattened-growth-of-coronavirus-cases-in-czech-republic/,"[('What the Czechs are pushing for mass adoption are surgical masks or any type of mouth covering even scarves.', 0.61261535), (""The Czech Republic had 2,422 confirmed coronavirus infection cases till Friday, according to the data from the Health Ministry's website."", 0.5015161), ('Anyway, even improvised masks have some filtering capability.', 0.43487698), ('The coronavirus has been wreaking havoc in European countries like Italy, France, and Spain.', 0.4305843), ('Howard claimed that in South Korea, Japan, and Taiwan as theses countries are using masks to prevent the spread of the disease.', 0.4270574)]"
1961,SARS-CoV-2 infection damages airway motile cilia and impairs mucociliary clearance,damages,sars-cov-2 infection _ airway motile cilia and impairs mucociliary clearance,sars-cov-2 infection promotes airway motile cilia and impairs mucociliary clearance,https://www.biorxiv.org/content/10.1101/2020.10.06.328369v1,"[('This study identifies cilia damage as a pathogenic mechanism that could facilitate SARS- CoV-2 spread to the deeper lung parenchyma.', 0.71686864), ('Rather, SARS-CoV-2 replication led to a rapid loss of the ciliary layer, characterized at the ultrastructural level by axoneme loss and misorientation of remaining basal bodies.', 0.6317942), ('We examined the functional and structural consequences of SARS-CoV-2 infection in a reconstituted human bronchial epithelium model.', 0.60497594), ('The motile cilia function was compromised, as measured in a mucociliary clearance assay.', 0.5857485), ('SARS-CoV-2 replication caused a transient decrease in epithelial barrier function and disruption of tight junctions, though viral particle crossing remained limited.', 0.53691345)]"
1963,"It may be necessary , according to Harvard coronavirus researchers",may,"it _ be necessary , according to harvard coronavirus researchers","it cannot be necessary, according to harvard coronavirus researchers",https://fortune.com/2020/04/14/social-distancing-until-2022-coronavirus-end-date-spread-covid-19-harvard-researchers/,"[('In a study published in the journal Science on Tuesday, a team of epidemiologists at Harvard assessed what is known about Covid-19 and other coronaviruses to anticipate possible scenarios for the current global health crisis.', 0.54538673), ('The study went on to say that it is important to understand whether people can become immune to the coronavirus after they have been infected, noting that this is not yet known.', 0.5448259), ('The findings, published online in the journal Science on Tuesday, were produced by scientists from the Harvard T.H.', 0.52165556), ('""Intermittent distancing may be required into 2022 unless critical care capacity is increased substantially or a treatment or vaccine becomes available,"" the Harvard researchers said in findings published Tuesday in the journal Science.', 0.5078244), ('They said their goal is not to advocate a particular policy but to note “the potentially catastrophic burden on the healthcare system that is predicted if distancing is poorly effective and/or not sustained for long enough.” Other Harvard Chan School authors of the study included lead author Stephen Kissler, Christine Tedijanto, and Edward Goldstein.', 0.4959025)]"
1966,"Favipiravir strikes the SARS-CoV-2 at its Achilles heel , the RNA polymerase",achilles,"favipiravir strikes the sars-cov-2 at its _ heel , the rna polymerase","favipiravir strikes the sars-cov-2 at its top heel, the rna polymerase",https://www.biorxiv.org/content/10.1101/2020.05.15.098731v1,"[('It possesses both unusually high nucleotide incorporation rates and high-error rates allowing facile insertion of Favipiravir into viral RNA, provoking C-to-U and G-to-A transitions in the already low cytosine content SARS-CoV-2 genome.', 0.62372327), ('Here we show that Favipiravir exerts an antiviral effect as a nucleotide analogue through a combination of chain termination, slowed RNA synthesis and lethal mutagenesis.', 0.6062251), ('The coronavirus RdRp complex represents an Achilles heel for SARS-CoV, supporting nucleoside analogues as promising candidates for the treatment of COVID-19.', 0.6019907), ('The viral RNA-dependent-RNA-polymerase (RdRp) is a promising target with polymerase inhibitors successfully used for the treatment of several viral diseases.', 0.5668539), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.44367373)]"
1967,"I 'm confused as to what the CDC says , and what is happening .",cdc,"i 'm confused as to what the _ says , and what is happening .","i'm confused as to what the state says, and what is happening.",https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/guidance-for-schools.html,"[('What is CDC doing?', 0.5886265), (""I'M JUST WONDERING WHAT DO WE KNOW ABOUT THIS VIRUS AND IS IT DIFFERENT THAT COULD EXPLAIN ALL THOSE INFECTIONS?"", 0.5418333), ('IN TERMS OF MODELING, I HAVE BEEN ASKED THIS BEFORE BUT AT CDC WE HAVE LEARNED A LOT FROM PREVIOUS OUTBREAKS OF THE VARIETY OF DISEASES.', 0.53817403), ('WE RECOGNIZE THE UNCERTAINTY OF THE CURRENT SITUATION AS ALWAYS CDC PUBLIC HEALTH EXPERTS STRIVE TO MAKE THE BEST RECOMMENDATIONS ON THE MOST UP TO DATE DATA.', 0.52708995), (""THE TEST WE'RE USING AT CDC IS VERY SENSITIVE."", 0.5229954)]"
1968,Initial Results of Mission District COVID-19 Testing Announced,initial,_ results of mission district covid-19 testing announced,All results of mission district covid-19 testing announced,https://www.ucsf.edu/news/2020/05/417356/initial-results-mission-district-covid-19-testing-announced,"[('The project aims to determine active and prior COVID-19 infections by providing voluntary testing for all persons in Mission District census tract 022901, regardless of symptoms.', 0.6247331), ('“This project represents an exponential leap into the next stage of the fight against COVID-19, which is to move from diagnostic testing of people who are ill to broad community-based screening.', 0.5964438), ('We are continuing and expanding our work to support those who test positive for COVID-19 and their families.', 0.5238626), ('Notably, people with underlying medical conditions who tested positive were much more likely to report COVID-19 symptoms (76 percent) compared to those who tested positive without underlying medical conditions (38 percent).', 0.44022197), ('“By focusing on the Mission, this work enables a closer look at one of the communities that is most affected by health disparities, income inequality and discrimination – all of which put residents and workers more at risk for COVID-19.', 0.4258896)]"
1969,COVID-19 vaccine development pipeline gears up,development,covid-19 vaccine _ pipeline gears up,covid-19 vaccine delivery pipeline gears up,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31252-6/fulltext,"[('TableCOVID-19 vaccines in clinical trials ', 0.7431524), ('“One of the most important things that we need to understand is what is the attack rate”, says Melanie Saville, director of vaccine development at the Coalition for Epidemic Preparedness Innovations (CEPI), which is working to coordinate global COVID-19 vaccine development.', 0.74191165), ('“We absolutely need COVID-19 vaccines available globally”, says Heaton.', 0.6734372), (""Like most other COVID-19 vaccines in development, Moderna's candidate attempts to train the immune system to recognise SARS-CoV-2's spike protein, which the virus uses to bind to and enter host cells."", 0.65899163), (""“We'll have to wait and see how things play out.” For more on the success rate of vaccine development see https://pubmed.ncbi.nlm.nih.gov/23526951/ "", 0.59538484)]"
1970,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection UK Cohort,improve,interleukin-7 to _ clinical outcomes in lymphopenic patients with covid-19 infection uk cohort,interleukin-7 to reduce clinical outcomes in lymphopenic patients with covid-19 infection uk cohort,https://clinicaltrials.gov/ct2/show/NCT04379076,"[('Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial.', 0.68807477), ('Improvement of the absolute lymphocyte count (ALC) of lymphopenic (ALC≤1000/mm3) COVID-19 infected participants out to approximately 30 days following initial Study drug administration or Hospital discharge (HD), whicheve [ Time Frame: 1 month ] A statistically significant increase of the absolute lymphocyte count (ALC) from randomization to day 30 or Hospital Discharge Secondary Outcome Measures : 1.', 0.5941485), ('Venet F, Foray AP, Villars-Mechin A, Malcus C, Poitevin-Later F, Lepape A, Monneret G. IL-7 restores lymphocyte functions in septic patients.', 0.56882), ('Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.', 0.53483164), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.5211584)]"
1971,"Exhaled aerosol increases with COVID-19 infection , and risk factors of disease symptom severity",exhaled,"_ aerosol increases with covid-19 infection , and risk factors of disease symptom severity","Acute aerosol increases with covid-19 infection, and risk factors of disease symptom severity",https://www.medrxiv.org/content/10.1101/2020.09.30.20199828v1,"[('These variances appear to be related to changes in airway mucus surface composition and the propensity for mucus surfaces to breakup into small droplets during acts of breathing.', 0.47588122), ('We studied respiratory droplet generation and exhalation in human and nonhuman primate subjects with and without COVID-19 infection to explore whether SARS- CoV-2 infection, and other changes in physiological state, translates into observable evolution of numbers and sizes of exhaled respiratory droplets in healthy and diseased subjects.', 0.4720965), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.45541185), ('In our observational cohort study of the exhaled breath particles of 74 healthy human subjects, and in our experimental infection study of eight nonhuman primates infected by aerosol with SARS- CoV-2, we found that exhaled aerosol particles increase one to three orders of magnitude with aging, high BMI, and COVID-19 infection.', 0.39972994), ('Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv.', 0.37729156)]"
1972,Loss of smell in patients with COVID-19 MRI data reveal a transient edema of the olfactory clefts,with,loss of smell in patients _ covid-19 mri data reveal a transient edema of the olfactory clefts,loss of smell in patients lacking covid-19 mri data reveal a transient edema of the olfactory clefts,https://n.neurology.org/content/95/23/e3145,"[('Loss of smell in COVID-19 patients: MRI data reveals a transient edema of the olfactory clefts.', 0.9773991), ('Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients.', 0.8290505), ('Olfactory epithelium histopathological findings in long-term COVID-19 related anosmia.', 0.7153603), ('Olfactory cleft involvement in COVID-19 patients with anosmia.', 0.7012984), ('MRI evaluation of the olfactory clefts in patients with SARS-CoV-2 infection revealed an unexpected mechanism for olfactory function loss.', 0.69635344)]"
1973,Moderna 's COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study,first,moderna 's covid-19 vaccine candidate meets its primary efficacy endpoint in the _ interim analysis of the phase 3 cove study,moderna's covid-19 vaccine candidate meets its primary efficacy endpoint in the final interim analysis of the phase 3 cove study,https://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy,"[('The primary endpoint of the Phase 3 COVE study is based on the analysis of COVID-19 cases confirmed and adjudicated starting two weeks following the second dose of vaccine.', 0.8273151), ('Pfizer and BioNTech accounce vaccine candidate against COVID-19 achieved success in first interim analysis from phase 3 study.', 0.8251574), ('Moderna Announces Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273) Begins.', 0.8039845), ('This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease,” said Stéphane Bancel, Chief Executive Officer of Moderna.', 0.7452281), ('This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease,"" said Stéphane Bancel, Chief Executive Officer of Moderna.', 0.731106)]"
1975,"After 62 years of regulating immunity , dexamethasone meets COVID-19",after,"_ 62 years of regulating immunity , dexamethasone meets covid-19","During 62 years of regulating immunity, dexamethasone meets covid-19",https://www.nature.com/articles/s41577-020-00421-x,"[('Dexamethasone in hospitalized patients with Covid-19 — preliminary report.', 0.7495222), ('The RECOVERY clinical trial, however, revealed that treatment with dexamethasone, a classic synthetic glucocorticoid, enhanced survival of critically ill patients with COVID-19.', 0.67223346), ('In this Comment, we discuss the immunological impacts of glucocorticoid therapy for COVID-19.', 0.63828206), ('Remdesivir for the treatment of COVID-19 — preliminary report.', 0.62403053), ('An important observation from the RECOVERY trial was that dexamethasone provided benefit only to severely ill patients with COVID-19.', 0.6175333)]"
1976,Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg,higher,_ viral loads in asymptomatic covid-19 patients might be the invisible part of the iceberg,Lower viral loads in asymptomatic covid-19 patients might be the invisible part of the iceberg,https://link.springer.com/article/10.1007/s15010-020-01548-8,"[('Viral dynamics in asymptomatic patients with COVID-19.', 0.5655776), ('Viral dynamics of SARS- CoV-2 across a spectrum of disease severity in COVID-19.', 0.51159), ('Association of viral load with serum biomakers among COVID-19 cases.', 0.49575797), ('Temporal dynamics in viral shedding and transmissibility of COVID-19.', 0.48299643), ('reported no difference between median viral loads of severe and mild cases [19].', 0.47546864)]"
1978,Study finds over 80 percent of COVID-19 patients have vitamin D deficiency,deficiency,study finds over 80 percent of covid-19 patients have vitamin d _,study finds over 80 percent of covid-19 patients have vitamin d +.,https://www.endocrine.org/news-and-advocacy/news-room/2020/study-finds-over-80-percent-of-covid19-patients-have-vitamin-d-deficiency,"[('The researchers found 80 percent of 216 COVID-19 patients at the Hospital Universitario Marques de Valdecilla had vitamin D deficiency, and men had lower vitamin D levels than women.', 0.67085433), ('COVID-19 patients with lower vitamin D levels also had raised serum levels of inflammatory markers such as ferritin and D-dimer.', 0.49874473), ('""Vitamin D treatment should be recommended in COVID-19 patients with low levels of vitamin D circulating in the blood since this approach might have beneficial effects in both the musculoskeletal and the immune system.""', 0.49464855), ('""One approach is to identify and treat vitamin D deficiency, especially in high-risk individuals such as the elderly, patients with comorbidities, and nursing home residents, who are the main target population for the COVID-19,"" said study co-author Jose L. Hernandez, Ph.D., of the University of Cantabria in Santander, Spain.', 0.46068615), ('The manuscript, ""Vitamin D Status in Hospitalized Patients With SARS-Cov-2 Infection,"" was published online, ahead of print.', 0.38648856)]"
1979,Call for transparency of COVID-19 models,call,_ for transparency of covid-19 models,Data for transparency of covid-19 models,https://science.sciencemag.org/content/368/6490/482.2,"[('Transparency engenders public trust and is the best defense against misunderstanding, misuse, and deliberate misinformation about models and their results.', 0.5389086), ('↵ CoMSES Network, Trusted Digital Repositories (www.comses.net/resources/trusted-digital-repositories/).', 0.4040935), ('Skip to main content AAAS ScienceMag.org Search Search X Advanced Search Science Contents News Careers Journals Menu Read our COVID-19 research and news.', 0.38046467), ('As soon as possible, please place your code in a trusted digital repository ( 1) so that it is findable, accessible, interoperable, and reusable ( 2).', 0.3650807), ('19Director, Systems Science in Public Health and Health Economics Research Consortium, Sheffield, South Yorkshire, UK.', 0.34919697)]"
1980,Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19,development,immunophenotyping of covid-19 and influenza highlights the role of type i interferons in _ of severe covid-19,immunophenotyping of covid-19 and influenza highlights the role of type i interferons in clearance of severe covid-19,https://immunology.sciencemag.org/content/5/49/eabd1554,"[('By comparing COVID-19 and severe influenza, we report that the TNF/IL-1β–driven inflammatory response was dominant in COVID-19 across all types of cells among PBMCs, whereas the up-regulation of various IFN-stimulated genes (ISGs) was prominent in severe influenza.', 0.8936494), ('When we directly compared COVID-19 and influenza, NFKB1 , NFKB2 , and TNF were up-regulated in COVID-19, whereas STAT1 , TLR4 , and genes for immunoproteasome subunits were up-regulated in influenza.', 0.8639171), ('In addition, COVID-19–specific up- or down-regulated genes compared with influenza were assigned as “COVID-19 > FLU” or “FLU > COVID-19,” respectively.', 0.8155738), ('We investigated DEGs between influenza and COVID-19 to seek COVID-19–specific transcriptional signatures in classical monocytes (Fig.', 0.80924296), ('have compared immune responses in patients with mild and severe COVID-19 with immune responses in severe cases of influenza.', 0.8043554)]"
1981,Mini-lungs reveal early stages of SARS-CoV-2 infection,lungs,mini-_ reveal early stages of sars-cov-2 infection,mini-qPCR reveal early stages of sars-cov-2 infection,https://www.cam.ac.uk/research/news/mini-lungs-reveal-early-stages-of-sars-cov-2-infection,"[('The researchers detail the mechanisms underlying SARS-CoV-2 infection and the early innate immune response in the lungs.', 0.71421385), (""In using mini-lungs to study SARS-CoV-2 infection, Tata's team collaborated with virology colleagues at Duke and the University of North Carolina in Chapel Hill."", 0.70528644), ('Baric said his lab will probably be using the mini-lungs to better understand a new strain of SARS-CoV-2 called D614G that has become the dominant version of the virus.', 0.63302153), ('Dr Joo-Hyeon Lee, co-senior author, said: ""We still know surprisingly little about how SARS-CoV-2 infects the lungs and causes disease.', 0.6289741), ('The organoids are grown from alveolar epithelial type-2 cells (AT2s) which are the stem cells that repair the deepest portions of the lungs where SARS-CoV-2 attacks.', 0.61867994)]"
1982,The Use of Povidone Iodine Nasal Spray and Mouthwash During the Current COVID-19 Pandemic May Reduce Cross Infection and Protect Healthcare Workers,protect,the use of povidone iodine nasal spray and mouthwash during the current covid-19 pandemic may reduce cross infection and _ healthcare workers,the use of povidone iodine nasal spray and mouthwash during the current covid-19 pandemic may reduce cross infection and reduce healthcare workers,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3563092,"[('The use of povidone iodine nasal spray and mouthwash during the current covid-19 pandemic may protect healthcare workers and reduce cross infection.', 0.99013793), ('Kirk-Bailey J, Combes J, Sunkaraneni S, Challacombe S. The use of Povidone Iodine nasal spray and mouthwash during the current COVID-19 pandemic for the reduction of cross infection and protection of healthcare workers.', 0.84717304), ('The application of PVP-I mouthwash and nasal spray in this way should reduce the cross-infection risk and therefore help to protect dentists.', 0.8010715), ('We propose that a protocolised nasal spray and oropharyngeal wash of PVP-I should be used in the current COVID-19 pandemic to limit the spread of SARS-CoV-2 from patients to healthcare workers and potentially vice versa.', 0.7217076), ('PVP-I has been shown to be a safe therapy when used as a mouthwash or taken nasally.', 0.6904987)]"
1983,Folding at home use your pc to cure COVID19,folding,_ at home use your pc to cure covid19,Children at home use your pc to cure covid19,https://foldingathome.org/,"[('When you run Folding@home, it will use part of your CPU power, disk space, and network bandwidth.', 0.6648504), ('Use your PC to help fight COVID-19.', 0.6599605), ('Simply install and run Folding@home’s software.', 0.6414939), ('Yes, the Folding@home simulation requires a lot of computing power, so your PC will run more slowly during the process, and its fans will probably spin up loudly.', 0.6336964), ('In Foldit you have to work for a spot on that leaderboard, but through Folding@home, you can put your PC to work.', 0.6194007)]"
1984,The human brain vasculature shows a distinct expression pattern of SARS-CoV-2 entry factors,human,the _ brain vasculature shows a distinct expression pattern of sars-cov-2 entry factors,the rat brain vasculature shows a distinct expression pattern of sars-cov-2 entry factors,https://www.biorxiv.org/content/10.1101/2020.10.10.334664v1,"[('This expression pattern of SARS-CoV-2 viral-entry associated proteases and SARS-CoV-2 interaction partners was also present in endothelial cells and microglia in the fetal brain, suggesting a developmentally established SARS-CoV-2 entry machinery in the human vasculature.', 0.7413354), ('To understand the potential mechanisms underlying SARS-CoV-2 tropism for brain vasculature, we constructed a molecular atlas of the expression patterns of SARS-CoV-2 viral entry-associated genes (receptors and proteases) and SARS-CoV-2 interaction partners in human (and mouse) adult and fetal brain as well as in multiple non-CNS tissues in single-cell RNA- sequencing data across various datasets.', 0.6937108), ('At both the adult and fetal stages, we detected a distinct pattern of SARS-CoV-2 entry associated genes’ transcripts in brain vascular endothelial cells and microglia, providing a potential explanation for an inflammatory response in the brain endothelium upon SARS-CoV-2 infection.', 0.65492576), ('We observed a distinct expression pattern of the cathepsins B (CTSB) and -L (CTSL) - which are able to substitute for the ACE2 co-receptor TMPRSS2 - in the human vasculature with CTSB being mainly expressed in the brain vasculature and CTSL predominantly in the peripheral vasculature, and these observations were confirmed at the protein level in the Human Protein Atlas and using immunofluorescence stainings.', 0.5850611), ('Our study serves as a publicly available single-cell atlas of SARS-CoV-2 related entry factors and interaction partners in human and mouse brain endothelial- and perivascular cells, which can be employed for future studies in clinical samples of COVID-19 patients.', 0.4852981)]"
1985,CRISPR–Cas12-based detection of SARS-CoV-2,crisp,_–cas12-based detection of sars-cov-2,Unr–cas12-based detection of sars-cov-2,https://www.nature.com/articles/s41587-020-0513-4,"[('1: A CRISPR–Cas12-based assay for detection of SARS-CoV-2.', 0.9505198), ('Cas12 gRNAs are programmed to specifically target SARS-CoV-2 or broadly detect related coronavirus strains.', 0.7416307), ('Next, LbCas12a target sites on the SARS-CoV-2 genome were filtered against SARS-CoV, two bat SARS-like CoV genomes and common human coronavirus genomes.', 0.73037106), ('Visualization of primers and probes on the SARS-CoV-2 genome.', 0.7008197), ('2: Detection of SARS-CoV-2 in contrived and clinical nasopharyngeal or oropharyngeal swab samples.', 0.6925093)]"
1988,"IMHE Estimates 81,114 Deaths in United States Over Next Four Months",deaths,"imhe estimates 81,114 _ in united states over next four months","imhe estimates 81,114 days in united states over next four months",http://www.healthdata.org/research-article/forecasting-covid-19-impact-hospital-bed-days-icu-days-ventilator-days-and-deaths,"[('Projected death toll through Aug. 4 is still 81,114.', 0.71212107), ('We estimate that there will be a total of 81,114 deaths (95% UI 38,242 to 162,106) from COVID-19 over the next 4 months in the US.', 0.6777552), ('With those inputs, the computer models project a total of 81,114 deaths in the U.S. over the next four months.', 0.66644615), ('We estimate that there will be a total of 81,114 (95% UI 38,242 to 162,106) deaths from COVID-19 over the next 4 months in the US.', 0.63057506), ('We estimate 81,114 (95% UI 38,242 to 162,106) deaths in the United States from COVID-19 over the next 4 months.', 0.58286333)]"
1989,Baricitinib restrains the immune dysregulation in COVID-19 patients,bari,_ restrains the immune dysregulation in covid-19 patients,Uncitinib restrains the immune dysregulation in covid-19 patients,https://www.medrxiv.org/content/10.1101/2020.06.26.20135319v1,"[('Here, we provide evidences on the efficacy of baricitinib, a JAK1/JAK2 inhibitor, in correcting the immune abnormalities observed in patients hospitalized with COVID-19.', 0.64487946), ('These immune mediators are transcriptionally regulated by JAK- STAT molecular pathways, which can be disabled by small molecules.', 0.6207081), ('The majority of patients with COVID-19 have a good prognosis, but variable percentages in different countries develop pneumonia associated with lymphocytopenia and severe inflammatory response due to uncontrolled release of cytokines.', 0.4871499), ('Indeed, we demonstrate a significant reduction in serum levels of interleukin (IL)-6, IL-1β and tumor necrosis factor (TNF)α, a rapid recovery in circulating T and B cell frequencies and an increased antibody production against SARS-CoV-2 spike protein in baricitinib-treated patients.', 0.45146817), ('Our work provides the basis on developing effective treatments against COVID-19 pathogenesis using on-target therapy.', 0.40652034)]"
1990,Coronavirus and the race to distribute reliable diagnostics,distribute,coronavirus and the race to _ reliable diagnostics,coronavirus and the race to obtain reliable diagnostics,https://www.nature.com/articles/d41587-020-00002-2?utm_source=Nature+Briefing&utm_campaign=c3e5323668-briefing-dy-20200225&utm_medium=email&utm_term=0_c9dfd39373-c3e5323668-43961925,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.4272647), ('Close banner Close Get the most important science stories of the day, free in your inbox.', 0.37727606), ('Sign up Close banner Close Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.', 0.3370412), ('Advertisement View all Nature Research journals Search My Account Login Explore our content Journal information Publish with us Sign up for alerts RSS feed 1. nature 2. nature biotechnology 3. news 4. article NEWS 19 February 2020 Update 03 June 2020 ', 0.2883794), ('I agree my information will be processed in accordance with the Nature and Springer Nature Limited Privacy Policy.', 0.2799851)]"
1991,Aprotinin Inhibits SARS-CoV-2 Replication,inhibit,aprotinin _ sars-cov-2 replication,aprotinin 1980s sars-cov-2 replication,https://www.mdpi.com/2073-4409/9/11/2377/htm,"[('Herein, we showed that the protease inhibitor aprotinin (but not the protease inhibitor SERPINA1/alpha-1 antitrypsin) inhibited SARS-CoV-2 replication in therapeutically achievable concentrations.', 0.6888238), ('In conclusion, therapeutic aprotinin concentrations exert anti-SARS-CoV-2 activity.', 0.679196), ('An analysis of proteomics and translatome data indicated that SARS-CoV-2 replication is associated with a downregulation of host cell protease inhibitors.', 0.6771438), ('Aprotinin displayed anti-SARS-CoV-2 activity in different cell types (Caco2, Calu-3, and primary bronchial epithelial cell air-liquid interface cultures) and against four virus isolates.', 0.5962322), ('Protease inhibitors are under consideration as virus entry inhibitors that prevent the cleavage of the coronavirus spike (S) protein by cellular proteases.', 0.55703855)]"
1993,Change.org petition to close schools in the US as a preventative measure to stop the spread of COVID-19,schools,change.org petition to close _ in the us as a preventative measure to stop the spread of covid-19,change.org petition to close transmission in the us as a preventative measure to stop the spread of covid-19,https://www.change.org/p/united-states-department-of-health-and-human-services-school-closure-across-the-entirety-of-the-united-states-immediately?utm_content=cl_sharecopy_20686403_en-US:v7&recruiter=1047666193&recruited_by_id=aaa68ea0-606f-11ea-8cea-2f9b38bad1be&utm_campaign=psf_combo_share_initial&utm_term=psf_combo_share_abi&utm_source=share&utm_medium=ios_app&utm_name=iossmf,"[('As a precautionary measure to prevent the possibility of spread of COVID-19 among our children, families and community, we should request school authorities to shutdown schools till conditions are stable.', 0.8098317), ('For weeks the WHO and CDC have told us that it’s NOT a matter of IF Covid-19 will make its way here, it’s a matter of when... and that question has been answered... it’s HERE, it’s in OUR COUNTY and unfortunately the fact is that it’s going to get worse before it gets better and as parents it’s up to US to advocate for our children and demand the school district to do everything they possibly can to protect their students, teachers, staff and community and CLOSE OUR SCHOOLS and help in preventing the spread of Covid-19 NOW!!', 0.69781053), ('Help reduce the spread of Covid-19!', 0.6945245), ('angie woodburn started this petition to Lee County School District and 2 others School districts all over the country that haven’t had any confirmed positive cases of coronavirus in their counties are closing their schools as a preventative measure to help reduce the spread of Covid-19 and keep their students, teachers, staff & community safe.', 0.6671768), ('There’s debate in school systems throughout the nation about whether to call off classes before someone associated with a school has been diagnosed even as the virus, which causes the illness covid-19, spreads.', 0.6346555)]"
1995,First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe and Critical COVID-19 Pneumonia,with,first clinical use of lenzilumab to neutralize gm-csf in patients _ severe and critical covid-19 pneumonia,first clinical use of lenzilumab to neutralize gm-csf in patients without severe and critical covid-19 pneumonia,https://www.medrxiv.org/content/10.1101/2020.06.08.20125369v1,"[('With this rationale, we used lenzilumab, an anti-human GM-CSF monoclonal antibody, to treat patients with severe and critical COVID-19 pneumonia.', 0.8497833), ('Conclusions In high-risk COVID-19 patients with severe and critical pneumonia, GM-CSF neutralization with lenzilumab was safe and associated with improved clinical outcomes, oxygen requirement, and cytokine storm.', 0.7126782), ('Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Hospitalized patients with COVID-19, confirmed by reverse transcriptase- polymerase chain reaction for the SARS-CoV-2, and radiographic findings consistent with COVID-19 pneumonia were considered for treatment with lenzilumab through an emergency IND program.', 0.6306171), ('Methods Hospitalized patients with COVID-19 pneumonia and risk factors for poor outcomes were treated with lenzilumab 600 mg intravenously for three doses through an emergency single-use IND application.', 0.56443405), ('Lenzilumab was supplied by Humanigen, Inc. for the compassionate use treatment of COVID-19 subjects by investigators at the Mayo Clinics.', 0.55317116)]"
1996,Computational predictions of protein structures associated with COVID-19,computational,_ predictions of protein structures associated with covid-19,Molecular predictions of protein structures associated with covid-19,https://deepmind.com/research/open-source/computational-predictions-of-protein-structures-associated-with-COVID-19,"[('We hope to contribute to the scientific effort using the latest version of our AlphaFold system by releasing structure predictions of several under-studied proteins associated with SARS-CoV-2, the virus that causes COVID-19.', 0.6106039), ('For this reason, researchers have been developing computational methods to predict protein structure from the amino acid sequence.', 0.60659546), ('CASPCommons encourages research groups to share structure predictions for proteins with high biological significance.', 0.6011247), ('In cases where the structure of a similar protein has already been experimentally determined, algorithms based on “template modelling” are able to provide accurate predictions of the protein structure.', 0.58905935), ('Our primary model for this protein had mostly correct topology but did not place the transmembrane helices or some parts of the extracellular domain correctly.', 0.5700592)]"
2001,MRC Laboratory of Molecular Biology seeks DNA volunteers,biology,mrc laboratory of molecular _ seeks dna volunteers,mrc laboratory of molecular diagnostics seeks dna volunteers,https://www.cambridgeindependent.co.uk/news/are-some-people-at-greater-genetic-risk-from-covid-19-mrc-laboratory-of-molecular-biology-seeks-dna-volunteers-9109936/,"[('Prof Julian Gough, a group leader at the MRC Laboratory of Molecular Biology, is asking those who have had a consumer DNA test carried out by the likes of 23andMe or AncestryDNA to aid the research by volunteering their data.', 0.6030344), ('But Prof Gough explains: “Our academic research at the MRC Laboratory of Molecular Biology uses a predictive technology that is completely different and complementary to the traditional human genetics approaches employed by all other initiatives.', 0.5323018), ('“Our priority and the thrust of our approach is to see if we can uncover causal variation in genes based on molecular biology.', 0.5291473), ('The test could, for example, identify people who have a severe risk of death from coronavirus infection despite a young age and lack of pre-existing conditions.” Prof Julian Gough, of the MRC Laboratory of Molecular Biology.', 0.49038956), ('“The government data points strongly towards a genetic link, but we cannot say in advance whether something we discover will be part of that link or part of something else.” Read more Missing link in puzzle of how hearing work found by MRC Laboratory of Molecular Biology Sanger Institute researchers help identify the nose cells that act as entry points for the Covid-19 virus 150th participant recruited to NIHR BioResource Covid-19 research programme at Addenbrooke’s Hospital What is the true death toll from Covid-19 - and how does the UK compare to other countries?', 0.48078084)]"
2002,Trial of Oxford COVID-19 vaccine starts in Brazil,trial,_ of oxford covid-19 vaccine starts in brazil,Lack of oxford covid-19 vaccine starts in brazil,http://www.ox.ac.uk/news/2020-06-28-trial-oxford-covid-19-vaccine-starts-brazil,"[('The Brazilian Ox1Cov-19 Vaccine Trial aims to find a vaccine that will prevent infection by SARS-CoV-2, the virus that causes COVID-19.', 0.82596195), ('Volunteers in Brazil have begun receiving a trial vaccine against COVID-19, in Latin America’s first phase 3 COVID-19 clinical trial.', 0.793784), ('About the Brazilian vaccine trial The technical name of the vaccine is ChAdOx1 nCoV-19, as it is made from a virus called ChAdOx1, which is a weakened and non-replicating version of a common cold virus (adenovirus).', 0.74772006), ('The Federal University of São Paulo - UNIFESP is collaborating with the University of Oxford and the Oxford Vaccine Group on the Brazil trial.', 0.69608736), (""Professor Andrew Pollard, Chief investigator of the Oxford Vaccine Trial at Oxford University said: 'It is a privilege to be working with the researchers at the Federal University of São Paulo – UNIFESP on the first COVID-19 vaccine trial in Latin America in the next stage of this important trial."", 0.592409)]"
2010,"Not wearing masks to protect against coronavirus is a big mistake , top Chinese scientist says",not,"_ wearing masks to protect against coronavirus is a big mistake , top chinese scientist says","By wearing masks to protect against coronavirus is a big mistake, top chinese scientist says",https://www.sciencemag.org/news/2020/03/not-wearing-masks-protect-against-coronavirus-big-mistake-top-chinese-scientist-says,"[('Chinese scientists at the front of that country’s outbreak of coronavirus disease 2019 (COVID-19) have not been particularly accessible to foreign media.', 0.5683595), ('Q: China was also criticized for not sharing the viral sequence immediately.', 0.56428605), ('The story about a new coronavirus came out in The Wall Street Journal on 8 January; it didn’t come from Chinese government scientists.', 0.52333224), ('Excerpt and then a comment: > Chinese scientists at the front of that country’s outbreak of coronavirus > disease 2019 (COVID-19) have not been particularly accessible to foreign > media.', 0.5227178), ('Why do you think epidemiologists in China had so much difficulty seeing that it was occurring?', 0.4992484)]"
2012,"Coronavirus spread by people with no symptoms 'appears to be rare , ' WHO official says",rare,"coronavirus spread by people with no symptoms 'appears to be _ , ' who official says","coronavirus spread by people with no symptoms 'appears to be considered,'who official says",https://edition.cnn.com/2020/06/08/health/coronavirus-asymptomatic-spread-who-bn/index.html,"[('The spread of coronavirus by people not showing symptoms ""appears to be rare,"" a World Health Organization [WHO] official said Monday.', 0.7246134), ('People might be most infectious with coronavirus before they show symptoms, study suggests ""These patients weren\'t asymptomatic,"" Juthani said.', 0.6769977), ('CDC estimates that 35% of coronavirus patients don\'t have symptoms ""From the data we have, it still seems to be rare that an asymptomatic person actually transmits onward to a secondary individual,"" Van Kerkhove said on Monday.', 0.63608813), ('Juthani, who did not participate in the media briefing and has not reviewed the unpublished data Van Kerkhove cited, said those findings are not necessarily inconsistent with other estimates regarding how pre-symptomatic spread of the coronavirus can occur.', 0.6238138), (""Infected people without symptoms might be driving the spread of coronavirus more than we realized Pre-symptomatic refers to the early stages of an illness, before symptoms have developed, whereas asymptomatic may refer to having no symptoms throughout the course of an infection -- a distinction that Van Kerkhove hinted at during Monday's media briefing."", 0.61855906)]"
2013,"Reply to : Hedenstierna et al , Haouzi et al , Maley et al , Fowler et al , Bhatia and Mohammed , Bos , & Koumbourlis and Motoyama",reply,"_ to : hedenstierna et al , haouzi et al , maley et al , fowler et al , bhatia and mohammed , bos , & koumbourlis and motoyama","Prior to : hedenstierna et al, haouzi et al, maley et al, fowler et al, bhatia and mohammed, bos, & koumbourlis and motoyama",https://www.atsjournals.org/doi/abs/10.1164/rccm.202004-1052LE,"[(', to Bhatia and Mohammed, to Bos, to Koumbourlis and Motoyama, and to Haouzi et al.', 0.8506744), (', to Bhatia and Mohammed, to Bos, to Koumbourlis and Motoyama, and to Haouzi et al Luciano Gattinoni et al.', 0.8422551), (', to Bhatia and Mohammed, to Bos, to Koumbourlis and Motoyama, and to Haouzi et al Luciano Gattinoni 1 , Silvia Coppola 2 , Massimo Cressoni 3 , Mattia Busana 1 , Sandra Rossi 4 , Davide Chiumello 2 Affiliations Expand ', 0.67056346), ('Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al.', 0.6524709), ('Haouzi P, Zamir A, Villarreal-Fernandez E, Stauffer D, Ventola L, Ahmad D, Dewaters A, Khalid M, Wojnar M. Haouzi P, et al.', 0.6430298)]"
2014,Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patients,specific,plasma proteomics reveals tissue-_ cell death and mediators of cell-cell interactions in severe covid-19 patients,plasma proteomics reveals tissue-wide cell death and mediators of cell-cell interactions in severe covid-19 patients,https://www.biorxiv.org/content/10.1101/2020.11.02.365536v1,"[('Based on these results, we propose a model of immune and epithelial cell interactions that drive cell-type specific and tissue-specific damage in severe COVID-19.', 0.69985455), ('Integration of plasma proteomics with nine published scRNAseq datasets shows that SARS-CoV-2 infection upregulates monocyte/macrophage, plasmablast, and T cell effector proteins.', 0.6182178), ('By analyzing several thousand plasma proteins in 306 COVID-19 patients and 78 symptomatic controls over serial timepoints using two complementary approaches, we uncover COVID-19 host immune and non-immune proteins not previously linked to this disease.', 0.6006543), ('We identify intracellular death signatures from specific tissues and cell types, and by associating these with angiotensin converting enzyme 2 (ACE2) expression, we map tissue damage associated with severe disease and propose which damage results from direct viral infection rather than from indirect effects of illness.', 0.57037866), ('By comparing patients who died to severely ill patients who survived, we identify dynamic immunomodulatory and tissue-associated proteins associated with survival, providing insights into which host responses are beneficial and which are detrimental to survival.', 0.42103612)]"
2016,Repurposing of Miglustat to inhibit the coronavirus Severe Acquired Respiratory Syndrome SARS-CoV-2,inhibit,repurposing of miglustat to _ the coronavirus severe acquired respiratory syndrome sars-cov-2,repurposing of miglustat to investigate the coronavirus severe acquired respiratory syndrome sars-cov-2,https://www.biorxiv.org/content/10.1101/2020.05.18.101691v1,"[('The mechanism resides in the inhibitory activity towards α-glucosidases that are involved in early stages of glycoprotein N-linked oligosaccharide processing in the endoplasmic reticulum, leading to a marked decrease of the viral Spike protein.', 0.46678597), ('The activity of Miglustat is here demonstrated for SARS-CoV-2 at concentrations achievable in the plasma by current clinical regimens without cytotoxicity.', 0.4620856), ('The iminosugar Miglustat is a well-characterized drug for the treatment of rare genetic lysosome storage diseases such as Gaucher and Niemann-Pick type C, and has also been described to be active against a variety of enveloped viruses.', 0.46030667), ('The wealth of available data on the clinical use of Miglustat for the treatment of lysosomal storage disorders and the antiviral properties against SARS-CoV-2 make it an ideal candidate for drug repurposing.', 0.44830218), ('The drug acts at the post- entry level and leads to a marked decrease of viral proteins and release of infectious virus.', 0.41613102)]"
2017,Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection,months,robust sars-cov-2-specific t-cell immunity is maintained at 6 _ following primary infection,robust sars-cov-2-specific t-cell immunity is maintained at 6 days following primary infection,https://www.biorxiv.org/content/10.1101/2020.11.01.362319v1,"[('In conclusion, our data are reassuring that functional SARS-CoV-2-specific T-cell responses are retained at six months following infection although the magnitude of this response is related to the clinical features of primary infection.', 0.78107345), ('Median T-cell responses were 50% higher in donors who had experienced an initial symptomatic infection indicating that the severity of primary infection establishes a ‘setpoint’ for cellular immunity that lasts for at least 6 months.', 0.61666536), ('We analysed the magnitude and phenotype of the SARS-CoV-2 cellular immune response in 100 donors at six months following primary infection and related this to the profile of antibody level against spike, nucleoprotein and RBD over the previous six months.', 0.6057544), ('T-cell immune responses to SARS-CoV-2 were present by ELISPOT and/or ICS analysis in all donors and are characterised by predominant CD4+ T cell responses with strong IL-2 cytokine expression.', 0.55230665), ('The T-cell responses to both spike and nucleoprotein/membrane proteins were strongly correlated with the peak antibody level against each protein.', 0.48409292)]"
2018,SARS-CoV-2 phylodynamics differentiates the effectiveness of non-pharmaceutical interventions,non,sars-cov-2 phylodynamics differentiates the effectiveness of _-pharmaceutical interventions,sars-cov-2 phylodynamics differentiates the effectiveness of vector-pharmaceutical interventions,https://www.medrxiv.org/content/10.1101/2020.08.24.20180927v1,"[('However, in contexts with a reproduction number >2, the authors conclude that no individual intervention is sufficient to stop the epidemic and increasingly stringent intervention combinations may be required.', 0.30840844), ('Rasigade et al.', 0.22050795), ('found that home containment and education lockdown had the largest independent impacts on preventing transmission and were predicted to reduce the reproduction number by 35% and 26%, respectively.', 0.21546456), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.16818213), ('Pre-print downloaded Aug 26 fromhttps://doi.org/10.1101/2020.08.24.20180927 ', 0.07277342)]"
2019,Severe COVID-19 infection is associated with increased antibody-mediated platelet apoptosis,severe,_ covid-19 infection is associated with increased antibody-mediated platelet apoptosis,Acute covid-19 infection is associated with increased antibody-mediated platelet apoptosis,https://www.medrxiv.org/content/10.1101/2020.09.03.20187286v1,"[('The strong correlations between apoptosis markers and increased D-Dimer levels as well as the incidence of thrombosis may indicate that antibody-mediated platelet apoptosis potentially contributes to sustained increased thromboembolic risk in ICU COVID-19 patients.', 0.7959832), ('We hypothesized that COVID-19 is accompanied by platelet apoptosis with subsequent alteration of the coagulation system.', 0.7283951), ('Interestingly, immunoglobulin G (IgG) fractions from COVID-19 patients induced an Fc gamma receptor IIA dependent platelet apoptosis (ΔΨm depolarization, cytosolic Ca2+ concentration and PS externalization).', 0.68500775), ('Enhanced PS externalization in platelets from ICU COVID-19 patients was associated with increased sequential organ failure assessment (SOFA) score (r=0.5635) and D-Dimer (r=0.4473).', 0.6816523), ('Platelets from intensive care unit (ICU) COVID-19 patients (n=21) showed higher ΔΨm depolarization, cytosolic Ca2+ concentration and PS externalization, compared to healthy controls (n=18) and COVID-19 non-ICU patients (n=4).', 0.59615207)]"
2021,An inflammatory cytokine signature predicts COVID-19 severity and survival,severity,an inflammatory cytokine signature predicts covid-19 _ and survival,an inflammatory cytokine signature predicts covid-19 production and survival,https://www.nature.com/articles/s41591-020-1051-9,"[('In this study, we asked whether inflammatory cytokine levels can help predict disease course and outcome in patients with COVID-19.', 0.72606385), ('We think that these practices will bring cytokine measurements to standard of care in prognosticating and monitoring patients with COVID-19.', 0.706485), ('COVID-19: consider cytokine storm syndromes and immunosuppression.', 0.7058449), ('Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed.', 0.69979393), ('Merad, M. & Martin, J. C. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.', 0.6912452)]"
2022,"The coronavirus has mutated and appears to be more contagious now , new study finds",now,"the coronavirus has mutated and appears to be more contagious _ , new study finds","the coronavirus has mutated and appears to be more contagious before, new study finds",https://www.cnbc.com/2020/05/05/the-coronavirus-mutated-and-appears-to-be-more-contagious-now-new-study-finds.html,"[('The coronavirus has mutated and… May52020 COVID19 KEY POINTS: The coronavirus that emerged in Wuhan, China, has mutated and the new, dominant strain spreading across the U.S. appears to be even more contagious, according to a new study.', 0.77435184), ('The coronavirus that emerged in Wuhan, China, over four months ago has since mutated and the new, dominant strain spreading across the U.S. appears to be even more contagious, according to a new study.', 0.6115056), ('Source:https://www.cnbc.com/2020/05/05/the-coronavirus-mutated-and- appears-to-be-more-contagious-now-new-study-finds.html Author: Berkeley Lovelace Jr.', 0.5164928), ('If the coronavirus doesn’t subside in the summer like the seasonal flu, it could mutate further and potentially limit the effectiveness of the coronavirus vaccines being developed by scientists around the world, the researchers warned.', 0.48131165), ('“Our team at LANL was able to document this mutation and its impact on transmission only because of a massive global effort of clinical people and experimental groups, who make new sequences of the virus (SARS-CoV-2) in their local communities available as quickly as they possibly can.” The study has yet to be peer-reviewed, but the researchers noted that news of the mutation was of “urgent concern” considering the more than 100 vaccines in the process of being developed to prevent Covid-19.', 0.47953838)]"
2023,Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection,develops,heat-killed lactobacillus casei confers broad protection against influenza a virus primary infection and _ heterosubtypic immunity against future secondary infection,heat-killed lactobacillus casei confers broad protection against influenza a virus primary infection and reduces heterosubtypic immunity against future secondary infection,https://www.nature.com/articles/s41598-017-17487-8#ref-CR36,"[('Here, we investigated the antiviral protective effects of heat-killed LAB strain Lactobacillus casei DK128 (DK128) on influenza viruses.', 0.74229884), ('Our study provides insight into how hosts can be equipped with innate and adaptive immunity via heat-killed DK128 treatment to protect against influenza virus, supporting that heat-killed LAB may be developed as anti-virus probiotics.', 0.7128195), ('Importantly, the mice that were protected against primary viral infection as a result of heat- killed DK128 pretreatment developed subsequent heterosubtypic immunity against secondary virus infection.', 0.679508), ('Protection via heat-killed DK128 was correlated with an increase in alveolar macrophage cells in the lungs and airways, early induction of virus specific antibodies, reduced levels of pro-inflammatory cytokines and innate immune cells.', 0.64735585), ('Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice.', 0.6401126)]"
2024,SARS-CoV-2-related mortality in a rural Latin American population,mortality,sars-cov-2-related _ in a rural latin american population,sars-cov-2-related living in a rural latin american population,https://www.ijidonline.com/article/S1201-9712(20)30630-5/fulltext,"[('Late incidence of SARS-CoV-2 infection in a highly-endemic remote rural village.', 0.6352055), ('Keywords: Coronavirus-19; Ecuador; Mortality; Rural setting; SARS-CoV-2.', 0.53171873), ('Amigo I. Indigenous communities in Brazil fear pandemic’s impact.', 0.40305337), ('2 Community Center, The Atahualpa Project, Atahualpa, Ecuador.', 0.38089547), ('Britton T., Ball F., Trapman P. A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2.', 0.36751878)]"
2025,Older adults with existing depression show resilience during the pandemic,with,older adults _ existing depression show resilience during the pandemic,older adults without existing depression show resilience during the pandemic,https://www.uclahealth.org/older-adults-with-existing-depression-show-resilience-during-the-pandemic,"[('""But what we learned is that older adults with depression can be resilient.', 0.80319893), ('""These older persons living with depression have been under stress for a longer time than many of the rest of us.', 0.6581116), ('They told us that coping with chronic depression taught them to be resilient"".', 0.64085805), ('Based on the findings, the study authors wrote that policies and interventions to provide access to medical services and opportunities for social interaction are needed to help older adults maintain mental health and quality of life as the pandemic continues.', 0.58538103), ('The authors further emphasized that access to mental health care and support groups, and continued social interaction are needed to help older adults whether the pandemic.', 0.568944)]"
2027,No SARS-CoV-2 cross-neutralization by intravenous immunoglobulins produced from plasma collected before the 2020 pandemic,before,no sars-cov-2 cross-neutralization by intravenous immunoglobulins produced from plasma collected _ the 2020 pandemic,no sars-cov-2 cross-neutralization by intravenous immunoglobulins produced from plasma collected after the 2020 pandemic,https://www.biorxiv.org/content/10.1101/2020.07.30.228213v1,"[('Testing 54 IVIG preparations, produced from plasma collected in Europe and the US, highly potent neutralization of a seasonal coronavirus was confirmed, yet no cross-neutralization of the new SARS-CoV-2 was seen.', 0.62280405), ('SUMMARY IVIG products manufactured from pre-pandemic plasma do not neutralize SARS-CoV-2 but contain high neutralizing titers for seasonal coronavirus hCoV-229E.', 0.610181), ('Whether the other, seasonally circulating coronaviruses induce cross-reactive, potentially even cross- neutralizing antibodies to the new species in humans is unclear.', 0.3882171), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.3203701), ('The question is of particular relevance for people with immune deficiencies, as their health depends on treatment with immunoglobulin preparations that need to contain neutralizing antibodies against the pathogens in their environment.', 0.31554368)]"
2029,Peaks of Fine Particulate Matter May Modulate the Spreading and Virulence of COVID-19,peaks,_ of fine particulate matter may modulate the spreading and virulence of covid-19,Lack of fine particulate matter may modulate the spreading and virulence of covid-19,https://link.springer.com/article/10.1007%2Fs41748-020-00184-4,"[('We deem it both reasonable and plausible that high PM2.5 concentrations—favored by air temperature inversions or Saharan dust intrusions—are not only modulating but even more so boosting severe outbreaks of COVID-19.', 0.65336627), ('2019) and/or the role of high concentrations of fine particulate matter (PM2.5) in modulating or boosting COVID-19 prevalence, morbidity and mortality.', 0.61584115), ('Based on these lines of evidence and select examples presented in the following, we hypothesize that COVID-19 prevalence and virulence is linked closely to PM2.5 peaks forming predominantly during (1) the occurrence of air temperature inversions, characterized by rather cool and moist conditions, or (2) desert dust advection conditions characterized by dry and warm air masses.', 0.60074306), ('We observe that during situations with a high prevalence of COVID-19 and adverse weather conditions—such as strong thermal inversions—the latter may well modulate or even boost morbidity and mortality.', 0.589933), ('The hurtful effect of peaks in fine particulate matter, smog and influenza-like viral infections have been known in the London area for decades (Martin 1964), and assumedly played a critical role in the spreading and virulence of COVID-19.', 0.587851)]"
2031,Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic,probably,weekly covid-19 testing with household quarantine and contact tracing is feasible and would _ end the epidemic,weekly covid-19 testing with household quarantine and contact tracing is feasible and would not end the epidemic,https://royalsocietypublishing.org/doi/10.1098/rsos.200915,"[('2020Covid-19 mass testing facilities could end the epidemic rapidly.', 0.7914861), ('Self-quarantine as soon as COVID-19 symptoms are noticed will further reduce transmissions.', 0.77620995), ('Feasibility of regular testing in the UK and worldwide Weekly viral RNA testing of the whole population with strict quarantine for households when an infection is detected has been proposed as a practical way to end lockdown while controlling the epidemic [1,2].', 0.68989074), ('This large contribution to epidemic growth would be almost eliminated by strict household quarantine.', 0.63126147), ('An important advantage of weekly testing, supplemented by a rapid test when a household member develops symptoms, is that other household members can take precautions immediately and hence reduce their risk.', 0.62754405)]"
2032,Candesartan could ameliorate the COVID-19 cytokine storm,can,_ could ameliorate the covid-19 cytokine storm,Undesartan could ameliorate the covid-19 cytokine storm,https://www.sciencedirect.com/science/article/pii/S0753332220308465,"[('This supports the hypothesis of a therapeutic role for ARBs, ameliorating the COVID-19 cytokine storm.', 0.7690745), ('Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?', 0.6095224), ('Results: Hundreds of genes upregulated in SARS-CoV-2/COVID-19 transcriptomes were similarly upregulated by glutamate and normalized by Candesartan.', 0.5785667), ('Effects of renin-angiotensin-aldosterone system inhibitors on disease severity and mortality in patients with COVID-19: A meta-analysis.', 0.5723815), ('SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.', 0.5377348)]"
2034,The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing,cell,the differential immune responses to covid-19 in peripheral and lung revealed by single-_ rna sequencing,the differential immune responses to covid-19 in peripheral and lung revealed by single-dimensional rna sequencing,https://www.medrxiv.org/content/10.1101/2020.08.15.20175638v1,"[('Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.', 0.76455), ('Differential redistribution of activated monocyte and dendritic cell subsets to the lung associates with severity of COVID-19.', 0.7570665), ('Since the MDSC- like scores associated with lymphopenia and inflammation markers, we speculate a crucial role of MDSC-like monocytes in dampening immune response and amplifying COVID-19 pathogenesis.', 0.72963846), ('COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis.', 0.7278123), ('Our data revealed profound alterations of various immune compartments and depicted a dichotomy of peripheral immune paralysis and broncho-alveolar immune hyperactivation in COVID-19 patients.', 0.7234324)]"
2037,Extended in vitro inactivation of SARS-CoV-2 by titanium dioxide surface coating,extended,_ in vitro inactivation of sars-cov-2 by titanium dioxide surface coating,Upon in vitro inactivation of sars-cov-2 by titanium dioxide surface coating,https://www.biorxiv.org/content/10.1101/2020.12.08.415018v1,"[('TiO2 coatings could be an important tool in containing SARS-CoV-2.', 0.5729625), ('We show tiles coated with TiO2 120 days previously can inactivate SARS-CoV-2 under ambient indoor lighting with 87% reduction in titres at 1h and complete loss by 5h exposure.', 0.532733), ('Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.', 0.3175477), ('Your Email Your Name Send To Enter multiple addresses on separate lines or separate them with commas.', 0.22252011), ('Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search New Results ', 0.21894047)]"
2040,SARS-CoV-2 infects human neural progenitor cells and brain organoids,brain,sars-cov-2 infects human neural progenitor cells and _ organoids,sars-cov-2 infects human neural progenitor cells and lymphocytes organoids,https://www.nature.com/articles/s41422-020-0390-x,"[('1: SARS-CoV-2 infects hNPCs, neurospheres and brain organoids.', 0.9097564), ('1f), indicating that SARS-CoV-2 directly infected the brain organoids.', 0.8430924), ('f Representative images of SARS-CoV-2-infected brain organoids.', 0.8420649), ('h Representative images of SARS-CoV-2-infected human brain organoids immunostained for SARS-CoV-2-N and TUJ1.', 0.8304106), ('i Representative images of SARS- CoV-2-infected human brain organoids immunostained for SARS-CoV-2-N and NESTIN.', 0.7811265)]"
2041,North Korea 'shoots dead coronavirus patient ' after he 's 'seen at public baths ',shoots,north korea '_ dead coronavirus patient ' after he 's 'seen at public baths ',north korea 'no dead coronavirus patient'after he's'seen at public baths ',https://www.dailystar.co.uk/news/latest-news/breaking-north-korea-executes-coronavirus-21488604,"[('As per South Korean media reports, the trade official was shot dead instantly as he broke the quarantine.', 0.62765056), ('Kim Jong-Un shoots dead officer for violating coronavirus quarantine zone; exiles another ', 0.62625766), ('India TV News Desk Pyongyang Updated on: February 14, 2020 13:46 IST Image Source : AP Kim Jong-Un shoots dead official for using public bath during quarantine zone; exiles another North Korean leader Kim Jong-Un ordered the killing of a trade official after the man visited a public bath while he was told to remain in a quarantined zone as a precaution to coronavirus infection spread.', 0.61762166), ('In February 2020, as the COVID-19 coronavirus disease continued to spread around the globe, a rumor circulated on social media holding that North Korea Supreme Leader Kim Jong Un had ordered the country’s first COVID-19 patient to be shot dead: We have not been able to verify this rumor.', 0.55963266), ('N. Korean official who sneaked into public bath during COVID-19 quarantine shot dead: Report - YouTube AboutPressCopyrightContact usCreatorsAdvertiseDevelopersTermsPrivacyPolicy & SafetyHow YouTube worksTest new features (C) 2021 Google LLC [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.5569827)]"
2046,3D visualisation of COVID-19 surface released for researchers,researchers,3d visualisation of covid-19 surface released for _,3d visualisation of covid-19 surface released for labeling,https://www.drugtargetreview.com/news/57287/3d-visualisation-of-covid-19-surface-released-for-researchers/,"[('According to the developers, the inner structures of the COVID-19 virus are currently being investigated and incorporated into a new visualisation.', 0.7080442), ('Their COVID-19 structural genomics map is available to researchers and anyone worldwide.', 0.67564124), ('The model was created by assembling 3D parts together from related COVID-19 coronavirus structures available in public databases.', 0.6431761), ('Credit: Fusion Animation A three-dimensional (3D) model of the surface of the coronavirus COVID-19 has been developed.', 0.49102277), (""“We’re confident that our data and visual models could provide the guidance for experimental scientists worldwide who are working feverishly to solve this pandemic,” said Professor Dmitry Korkin, director of the WPI's bioinformatics and computational biology programme."", 0.47695434)]"
2047,Coronavirus Genomic and Subgenomic RNA Architecture Mapped,rna,coronavirus genomic and subgenomic _ architecture mapped,coronavirus genomic and subgenomic DNA architecture mapped,https://www.genengnews.com/news/coronavirus-genomic-and-subgenomic-rna-architecture-mapped/,"[('Subgenomic RNAs produced through the transcription are translated into structural proteins (S: spike protein, E: envelope protein, M: membrane protein, and N: nucleocapsid protein), which form a viral particle.', 0.70688474), ('Analyzing the sequence information of each RNA also revealed where the genes are located on the long viral genomic RNA.', 0.6844885), ('Among them, S, E, M, and N RNAs are translated into each protein, respectively, forming a structure of virus particle (S: spike protein, E: envelope protein, M: membrane protein, and N: nucleocapsid protein).', 0.67960477), ('“Functional investigation of the unknown transcripts and RNA modifications discovered in this study will open new directions to our understanding of the life cycle and pathogenicity of SARS-CoV-2 … Our data provide a rich resource and open new directions to investigate the mechanisms underlying the pathogenicity of SARS-CoV-2.” ""Now we have secured a high resolution gene map of the new coronavirus that guides us where to find each bit of genes on all of the total SARS-CoV-2 RNAs (transcriptome) and all modifications RNAs (epitranscriptome),” Kim stated.', 0.67702234), ('The two techniques used together provided detailed new information on the SARS-CoV-RNA genome.', 0.6756471)]"
2048,Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection,prevent,hydroxychloroquine as postexposure prophylaxis to _ severe acute respiratory syndrome coronavirus 2 infection,hydroxychloroquine as postexposure prophylaxis to cause severe acute respiratory syndrome coronavirus 2 infection,https://www.acpjournals.org/doi/10.7326/M20-6519,"[('In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).', 0.8243335), ('HCQ = hydroxychloroquine; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.', 0.79109645), ('Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial [Letter].', 0.7804389), ('Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection.', 0.7701628), ('This randomized controlled trial tests hydroxychloroquine as postexposure prophylaxis for SARS-CoV-2 infection.', 0.75789976)]"
2050,The daily updated university of Virginia 's updated covid-19 dashboard,daily,the _ updated university of virginia 's updated covid-19 dashboard,the last updated university of virginia's updated covid-19 dashboard,https://nssac.bii.virginia.edu/covid-19/dashboard/,"[('{{featuredbuttontext}} University of Virginia University of Virginia The dashboard also includes hospital statistics from UVa Health, which reported one new COVID-19 hospitalization on Tuesday.', 0.69556695), ('Biocomplexity Institute’s COVID-19 model predicts a peak in Virginia COVID-19 cases in February By Maryann Xue ', 0.62853587), ('TJHD COVID-19 Data Portal : The tracker now also includes a link to the Virginia Department of Health’s Thomas Jefferson Health District COVID-19 Data Portal.', 0.5963003), ('COVID-19 2020 ', 0.5691838), ('Virginia Tech’s dashboard shows the total number of students in quarantine.', 0.55997586)]"
2051,Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection,protects,two-component spike nanoparticle vaccine _ macaques from sars-cov-2 infection,two-component spike nanoparticle vaccine infected macaques from sars-cov-2 infection,https://www.biorxiv.org/content/10.1101/2020.11.07.365726v1,"[('Here, we present a two-component protein-based nanoparticle vaccine that displays multiple copies of the SARS-CoV-2 spike protein.', 0.7301516), ('The vaccine-induced immunity protected macaques against a high dose challenge, resulting in strongly reduced viral infection and replication in upper and lower airways.', 0.6850013), ('These nanoparticles are a promising vaccine candidate to curtail the SARS-CoV-2 pandemic.', 0.6713829), ('Immunization studies show that this vaccine induces potent neutralizing antibody responses in mice, rabbits and cynomolgus macaques.', 0.61906576), ('Hence, there is an urgent need for a vaccine that prevents viral infection, transmission and disease.', 0.49187803)]"
2053,Could your December cough actually have been coronavirus ?,december,could your _ cough actually have been coronavirus ?,could your initial cough actually have been coronavirus?,https://www.usatoday.com/story/news/factcheck/2020/03/26/coronavirus-fact-check-could-your-december-cough-have-been-covid-19/2899027001/,"[('“If you can answer, yes, then you probably had the coronavirus.', 0.56497097), ('“Who got sick in November or December and it lasted 10 to 14 days, with the worst cough that wouldn’t go away?” the posts say.', 0.5118767), ('Experts say more research is needed A handful of widely circulated Facebook posts have asserted that people in the United States likely contracted the coronavirus as early as last fall.', 0.3703761), ('There were no tests and the flu test would come back negative anyway.', 0.33245385), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.28433132)]"
2058,FDA approves the emergency use of chloroquine phosphate and hydroxychloroquine sulfate for treatment of COVID-19,approve,fda _ the emergency use of chloroquine phosphate and hydroxychloroquine sulfate for treatment of covid-19,fdaines the emergency use of chloroquine phosphate and hydroxychloroquine sulfate for treatment of covid-19,https://www.fda.gov/media/136534/download,"[('Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine 1.', 0.7326892), ('The FDA is aware of reports of serious heart rhythm problems in patients with COVID-19 treated with hydroxychloroquine or chloroquine, often in combination with azithromycin and other QT prolonging medicines.', 0.6907934), ('We recommend initial evaluation and monitoring when using hydroxychloroquine or chloroquine under the EUA or in clinical trials that investigate these medicines for the treatment or prevention of COVID-19.', 0.68596077), ('The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and Resochin donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.', 0.68258756), ('If you are receiving hydroxychloroquine or chloroquine for COVID-19 and experience irregular heartbeats, dizziness, or fainting, seek medical attention right away by calling 911.', 0.6589047)]"
2059,Distributed Acoustic Sensing Market worth $ 792 million by 2025,202,distributed acoustic sensing market worth $ 792 million by _,distributed acoustic sensing market worth $ 792 million by 105,https://www.marketsandmarkets.com/PressReleases/distributed-acoustic-sensing.asp,"[('The global DAS market is projected to reach USD 792 million by 2025 from USD 513 million in 2019 and is expected to grow at a CAGR of 11.4% from 2020 to 2025.', 0.5477145), ('How will different regions (the Americas, Europe, APAC, and Row) contribute to the overall distributed acoustic sensing (DAS) market growth by 2025?', 0.51428944), ('Distributed Acoustic Sensing (DAS) Market Published Date: Jun 2020 ', 0.48383963), (""Related Reports: Distributed Temperature Sensing Market by Operating Principle (OTDR, OFDR), Fiber Type (Single-mode Fibers, Multimode Fibers), Scattering Method (Rayleigh Effect, Raman Effect, Brillouin Effect), Application, and Geography - Global Forecast to 2025 Distributed Fiber Optic Sensing Market (DFOS) by Operating Principle (OTDR, OFDR), Fiber Type (Single-Mode, Multimode), Scattering Process (Raman Effect, Rayleigh Effect), Application (Temperature, Acoustic), Vertical, and Region - Global Forecast to 2022 About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues."", 0.46501058), ('Distributed Acoustic Sensing (DAS) Market ', 0.45879453)]"
2063,Serum 25D Level on Hospital Admission Associated With COVID-19 Stage and Mortality,mortality,serum 25d level on hospital admission associated with covid-19 stage and _,serum 25d level on hospital admission associated with covid-19 stage and patient,https://pubmed.ncbi.nlm.nih.gov/33236114/,"[('To examine ...the relationship between serum 25-hydroxy vitamin D (25(OH)D) level and COVID-19 infection, its severity, and its clinical case characteristics.', 0.7175865), ('We investigated the association between serum 25-hydroxyvitamin D (25(OH)D) level on admission and radiologic stage and outcome of COVID-19 pneumonia.', 0.7158505), ('To investigate the association between serum 25-hydroxyvitamin D levels and its effect on adverse clinical outcomes, and parameters of immune function and mortality due to a SARS-CoV-2 infection.', 0.7079886), ('To examine the relationship between serum 25-hydroxy vitamin D (25(OH)D) level and COVID-19 infection, its severity, and its clinical case characteristics.', 0.7030883), ('To evaluate associations of plasma 25(OH)D status with the likelihood of coronavirus disease (COVID-19) infection and hospitalization.', 0.70254785)]"
2065,Lowry center puts limit on Friday tests,friday,lowry center puts limit on _ tests,lowry center puts limit on treatment tests,https://www.9news.com/mobile/article/news/health/coronavirus/drive-up-coronavirus-testing-center-opening-in-lowry/73-2d15d475-bbf3-443d-8992-bbf843aedc1d,"[('Author: 9news.com Published: 10:33 PM MDT March 12, 2020 Updated: 10:32 PM MDT March 12, 2020 Jobs Terms of Service Privacy Policy Ad Choices EEO Public File Report FCC Online Public Inspection File Closed Caption Procedures Do Not Sell My Personal Information (C) 2021 KUSA-TV.', 0.1574692), ('[c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 10:30 AM [Today]: Sunday, January 17, 2021 at 6:45 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:30 AM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students [January 14]: Thursday, January 14, 2021 at 10:09 AM [January 10]: Sunday, January 10, 2021 at 9:29 AM [January 5]: Tuesday, January 5, 2021 at 6:05 AM [on April 4, 2020]: Saturday, April 4, 2020 11:38 PM [Tel:]: Phone number [May 30, 2019 at 9:42 PM]: Thursday, May 30, 2019 at 9:42 PM [March 14, 2019 at 3:03 PM]: Thursday, March 14, 2019 at 3:03 PM [November 12, 2018 at 10:57 PM]: Monday, November 12, 2018 at 10:57 PM [December 25, 2020 at 12:09 PM]: Friday, December 25, 2020 at 12:09 PM [November 24, 2020]: Tuesday, November 24, 2020 at 9:28 AM [ November 5, 2020]: Thursday, November 5, 2020 at 5:36 PM [ November 1, 2020]: Sunday, November 1, 2020 at 1:52 PM [October 26, 2020]: Monday, October 26, 2020 at 6:36 PM [ October 15, 2020]: Thursday, October 15, 2020 at 12:38 PM [ October 7, 2020]: Wednesday, October 7, 2020 at 5:08 PM [August 9, 2020]: Sunday, August 9, 2020 at 8:53 PM [August 7, 2020]: Friday, August 7, 2020 at 6:19 AM [July 4, 2020]: Saturday, July 4, 2020 at 2:55 PM [ July 2, 2020]: Thursday, July 2, 2020 at 8:45 AM [June 30, 2020]: Tuesday, June 30, 2020 at 9:36 AM [June 27, 2020]: Saturday, June 27, 2020 at 7:51 PM [June 18, 2020]: Thursday, June 18, 2020 at 4:20 PM [June 16, 2020]: Tuesday, June 16, 2020 at 7:15 PM [June 14, 2020]: Sunday, June 14, 2020 at 11:40 AM [June 10, 2020]: Wednesday, June 10, 2020 at 7:53 PM [MA]: Massachusetts [Tue]: Tuesday [Jun]: June [m ]: minutes [s]: seconds [m]: minutes [Mon]: Monday [Jan]: January [h]: hour', 0.14523324), ('No Thanks Allow [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.13873626), ('Notifications can be turned off anytime in the browser settings.', 0.13369039), ('', 0.12559666)]"
2066,Fox News falls out of love with hydroxychloroquine,love,fox news falls out of _ with hydroxychloroquine,fox news falls out of patients with hydroxychloroquine,https://www.cnn.com/2020/04/22/media/fox-news-hydroxychloroquine-reliable-sources/index.html?utm_content=2020-04-22T20%3A19%3A14&utm_medium=social&utm_source=twCNN&utm_term=link,"[('Fox News has fallen out of love with hydroxychloroquine.', 0.9519131), (""Despite not being formally employed by Fox News, Oz became a fixture on the network, using his appearances to tout hydroxychloroquine and catching Trump's attention while doing so."", 0.48413098), ('Which is why it was so irresponsible for Fox personalities and the President to jump the gun and promote the drug as a possible game-changer before the scientific evidence was in... Search US Crime + Justice Energy + Environment Extreme Weather Space + Science World Africa Americas Asia Australia China Europe India Middle East United Kingdom Politics 2020 Election Facts First Election 101 Business Markets Tech Media Success Perspectives Videos Opinion Political Op-Eds Social Commentary Health Food Fitness Wellness Parenting Vital Signs Entertainment Stars Screen Binge Culture Media Tech Innovate Gadget Foreseeable Future Mission: Ahead Upstarts Work Transformed Innovative Cities Style Arts Design Fashion Architecture Luxury Beauty Video Travel Destinations Food and Drink Stay News Videos Sports Pro Football College Football Basketball Baseball Soccer Olympics Videos Live TV Digital Studios CNN Films HLN TV Schedule TV Shows A-Z CNNVR Audio Coupons CNN Underscored Explore Wellness Gadgets Lifestyle CNN Store Weather Climate Storm Tracker Wildfire Tracker Video More Photos Longform Investigations CNN Profiles CNN Leadership CNN Newsletters Work for CNN Follow CNN Business Most stock quote data provided by BATS.', 0.46332407), ('""Will anyone who breathlessly pitched hydroxychloroquine as a miracle drug show a modicum of regret or even self-awareness over this?', 0.45200032), (""Fox published a digital story on the Tuesday study, but it fell off the website's homepage after a few hours."", 0.4243896)]"
2068,"Trump adds confusion on COVID-19 treatments as US deaths top 50,000",confusion,"trump adds _ on covid-19 treatments as us deaths top 50,000","trump adds knowledge on covid-19 treatments as us deaths top 50,000",https://www.cidrap.umn.edu/news-perspective/2020/04/trump-adds-confusion-covid-19-treatments-us-deaths-top-50000,"[('""Our results show … the direct medical costs of a symptomatic COVID-19 case tend to be substantially higher than other common infectious diseases,"" the authors said.', 0.6193887), ('""I was asking a question sarcastically to reporters like you just to see what would happen,"" Trump said in the Oval Office.', 0.46417177), ('Though protests against state shelter-in-place orders have cropped up in the past 10 days in places such as Michigan and Minnesota, a new poll from the Kaiser Family Foundation (KFF) shows most Americans believe the worst is yet to come when it comes to the current COVID-19 pandemic in the US.', 0.41517824), ('For months experts have gone back and forth as to whether the COVID-19 virus will act like seasonal influenza, which sees transmission rates slow during warm summer months.', 0.39668632), ('But if 80% of the US population were to be infected, there could still be as many as 44.6 million hospitalizations, 10.7 million intensive care unity (ICU) admissions, 6.5 million ventilators used, and 249.5 million hospital bed days, costing $654.0 billion in direct costs over the course of the pandemic, the study says.', 0.34321678)]"
2070,"S'porean student opens up about Covid-19 racism attack in London , Singapore News & Top Stories - The Straits Times",opens,"s'porean student _ up about covid-19 racism attack in london , singapore news & top stories - the straits times","s'porean student made up about covid-19 racism attack in london, singapore news & top stories - the straits times",https://www.straitstimes.com/singapore/singaporean-student-in-london-seeks-eyewitnesses-after-coronavirus-related-taunt-and,"[(""Press question mark to learn the rest of the keyboard shortcuts Log InSign Up User account menu Sorry, for some reason reddit can't be reached."", 0.31007594), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.27712393), ('[c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 10:30 AM [Today]: Sunday, January 17, 2021 at 6:45 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:30 AM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students [January 14]: Thursday, January 14, 2021 at 10:09 AM [January 10]: Sunday, January 10, 2021 at 9:29 AM [January 5]: Tuesday, January 5, 2021 at 6:05 AM [on April 4, 2020]: Saturday, April 4, 2020 11:38 PM [Tel:]: Phone number [May 30, 2019 at 9:42 PM]: Thursday, May 30, 2019 at 9:42 PM [March 14, 2019 at 3:03 PM]: Thursday, March 14, 2019 at 3:03 PM [November 12, 2018 at 10:57 PM]: Monday, November 12, 2018 at 10:57 PM [December 25, 2020 at 12:09 PM]: Friday, December 25, 2020 at 12:09 PM [November 24, 2020]: Tuesday, November 24, 2020 at 9:28 AM [ November 5, 2020]: Thursday, November 5, 2020 at 5:36 PM [ November 1, 2020]: Sunday, November 1, 2020 at 1:52 PM [October 26, 2020]: Monday, October 26, 2020 at 6:36 PM [ October 15, 2020]: Thursday, October 15, 2020 at 12:38 PM [ October 7, 2020]: Wednesday, October 7, 2020 at 5:08 PM [August 9, 2020]: Sunday, August 9, 2020 at 8:53 PM [August 7, 2020]: Friday, August 7, 2020 at 6:19 AM [July 4, 2020]: Saturday, July 4, 2020 at 2:55 PM [ July 2, 2020]: Thursday, July 2, 2020 at 8:45 AM [June 30, 2020]: Tuesday, June 30, 2020 at 9:36 AM [June 27, 2020]: Saturday, June 27, 2020 at 7:51 PM [June 18, 2020]: Thursday, June 18, 2020 at 4:20 PM [June 16, 2020]: Tuesday, June 16, 2020 at 7:15 PM [June 14, 2020]: Sunday, June 14, 2020 at 11:40 AM [June 10, 2020]: Wednesday, June 10, 2020 at 7:53 PM [MA]: Massachusetts [Tue]: Tuesday [Jun]: June [m ]: minutes [s]: seconds [m]: minutes [Mon]: Monday [Jan]: January [h]: hour', 0.17729276), ('Press J to jump to the feed.', 0.16131656), ('Retry [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.11951007)]"
2074,SARS-CoV-2 reactive T cells in uninfected individuals are likely expanded by beta-coronaviruses,likely,sars-cov-2 reactive t cells in uninfected individuals are _ expanded by beta-coronaviruses,sars-cov-2 reactive t cells in uninfected individuals are not expanded by beta-coronaviruses,https://www.biorxiv.org/content/10.1101/2020.07.01.182741v1,"[('Given the similarity of SARS-CoV-2 to other members of the Coronaviridae family, the endemic coronaviruses appear likely candidates to generate this T cell memory.', 0.7500075), ('We find that no common human virus, other than beta-coronaviruses, can explain the pre- existing SARS-CoV-2 reactive T cells in uninfected individuals.', 0.72076654), ('Several reports indicate short lasting immunity against endemic coronaviruses, which contrasts repeated reports that biobanked venous blood contains SARS-CoV-2 reactive T cells even before the outbreak in Wuhan.', 0.6485016), ('Our study suggests OC43 and HKU1 are the most likely pathogens giving rise to SARS-CoV-2 preformed immunity.', 0.51745594), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.50666827)]"
2075,# COVID19 cases tested per capita,capita,# covid19 cases tested per _,# covid19 cases tested per preprint,https://ourworldindata.org/grapher/covid19-tests-per-million-people?country=AUS+AUT+BRA+COL+FIN+FRA+DEU+IRN+JPN+ZAF+KOR+ARE+GBR+USA+VNM,"[('Per capita: COVID-19 tests vs.', 0.6767938), ('Daily vs. Total confirmed COVID-19 cases per capita ', 0.64613163), ('Confirmed cases Total COVID-19 tests conducted vs.', 0.6323823), ('Confirmed casesPositive rate comparison Total COVID-19 tests conducted vs.', 0.6141741), ('Daily vs. Total confirmed COVID-19 deaths per capita ', 0.61214864)]"
2076,Limited available evidence supports theoretical predictions of reduced vaccine efficacy at higher exposure dose,higher,limited available evidence supports theoretical predictions of reduced vaccine efficacy at _ exposure dose,limited available evidence supports theoretical predictions of reduced vaccine efficacy at low exposure dose,https://www.nature.com/articles/s41598-019-39698-x,"[('While our review revealed a very small number of studies that have tested vaccines across a broad range of pathogen challenge doses, there is some limited empirical evidence that data aligns with our theoretical predictions.', 0.7549128), ('Our research demonstrates that pathogen dose has potential to be an important determinant of vaccine failure, although the limited empirical data highlight a need for additional studies to test theoretical predictions on the plausibility of reduced host susceptibility and high pathogen dose as mechanisms responsible for reduced vaccine efficacy in high transmission settings.', 0.7481818), ('In populations where the mode of vaccine action is highly polarized, vaccine efficacy decreases more slowly with exposure dose than in populations with less variable protection.', 0.7443122), ('Although our simulation showed that increasing pathogen challenge dose decreased vaccine efficacy, variance in susceptibility also affected vaccine protection.', 0.73486775), ('At low exposure doses, there was little difference in probability of infection and vaccine efficacy if susceptibility was homogeneous or hump-shaped, despite a three orders of magnitude difference in variance.', 0.71650326)]"
2077,Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction,suggesting,post-mortem examination of covid19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs _ vascular dysfunction,post-mortem examination of covid19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs without vascular dysfunction,https://onlinelibrary.wiley.com/doi/abs/10.1111/his.14134,"[('A , Exudative diffuse alveolar damage (DAD) showing discrete hyaline membranes and prominent capillary congestion [haematoxylin and eosin (H&E)].', 0.65064216), ('D , Lymph node showing an increase in the number of plasmablasts in the interfollicular zone as well as congestion (haematoxylin and eosin).', 0.6049074), ('Analysis of cardiopulmonary findings in COVID-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia.', 0.5946476), ('A , Typical appearance of coronavirus disease 2019 (COVID‐19) lungs; note the perceptibly thickened alveolar septae and congestive interstitial aspects and a thrombembolus in the lower lobe.', 0.58500034), ('A , Exudative diffuse alveolar damage (DAD) showing discrete hyaline… Figure 2 Microscopic lung findings.', 0.5849623)]"
2078,Will Coronavirus Pandemic Diminish by Summer ?,summer,will coronavirus pandemic diminish by _ ?,will coronavirus pandemic diminish by R?,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3556998#,"[('Share Will COVID-19 pandemic diminish by summer-monsoon in India?', 0.5986527), ('You are going to email the following Will COVID-19 pandemic diminish by summer-monsoon in India?', 0.5887266), ('If coronavirus becomes airborne as suggested by many studies, then it may have a higher risk of transmission by aerosols particles.', 0.53299093), ('If COVID-19 is indeed sensitive to environmental factors, it could be tested in the coming summer-monsoon for India.', 0.47704983), ('So the only summer is not going to help India until monsoon is coming.', 0.4291982)]"
2079,Estimates Show Hidden Transmission,estimates,_ show hidden transmission,Mice show hidden transmission,https://www.nytimes.com/interactive/2020/04/03/us/coronavirus-county-epidemics.html,"[(""“It's an unseen threat, and by the time you see it, it can be too late to intervene."", 0.29312345), ('“This virus spreads quickly and sometimes silently,” she said.', 0.29133728), ('Is staying home and limiting contact with others really worth the trouble?', 0.23430736), ('Even in counties with no reported cases, there is roughly a 9 percent chance that an undetected outbreak is already underway, she said.', 0.23274298), ('People who have been infected and have mild symptoms, or none at all, can pass the disease to others.', 0.22296187)]"
2082,Ivermectin Exposure Leads to Up-Regulation of Detoxification Genes in Vitro and in Vivo in Mice,exposure,ivermectin _ leads to up-regulation of detoxification genes in vitro and in vivo in mice,ivermectin deficiency leads to up-regulation of detoxification genes in vitro and in vivo in mice,https://pubmed.ncbi.nlm.nih.gov/24998875/?dopt=Abstract,"[('The purpose of this study was to evaluate, in vitro and in vivo, the ivermectin ability in modulating the expression of the most important genes involved in drug detoxification.', 0.7237842), ('Plasma, brain, liver and intestinal concentrations of ivermectin and its main metabolite were measured by HPLC in ivermectin-treated mice.', 0.68726945), ('These findings can be regarded as a warning that repeated ivermectin exposure is able to induce detoxification systems in mammals that may lead to subtherapeutic drug concentration.', 0.6650041), ('Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway.', 0.6377057), ('Gene expression of ABC transporters and cytochromes was evaluated by RT-qPCR in murine hepatic and intestinal cell lines exposed to increasing ivermectin doses, and in liver and intestine of mice orally administered with single or repeated therapeutic doses of ivermectin (0.2 mg/kg).', 0.62333393)]"
2083,Researchers Push for Mass Blood Tests as a Covid-19 Strategy,tests,researchers push for mass blood _ as a covid-19 strategy,researchers push for mass blood transfusion as a covid-19 strategy,https://www.wired.com/story/researchers-push-for-mass-blood-tests-as-a-covid-19-strategy/amp,"[('But with the severity of the Covid-19 outbreak, researchers around the world are racing to get tests out there quickly.', 0.71209073), ('As donations arrive—about 7,000 of them per week is the norm—they’ll be screened with the usual battery of tests that keep the blood supply safe, plus one more: a test for antibodies to SARS-CoV-2, the virus that causes Covid-19.', 0.62688243), ('But a simple blood test, like the kind Zaaijer’s team will perform on the donated blood, can tell whether it carries antibodies to Covid-19, which are produced when a person’s immune system responds after an infection.', 0.5783037), ('The county will continue sending out swabs for PCR tests, too, for people who qualify under the CDC’s guidelines.', 0.5199908), ('TopicscoronavirusCOVID-19diseasespublic health WIRED is where tomorrow is realized.', 0.5149951)]"
2084,The insert sequence in SARS-CoV-2 enhances spike protein cleavage by TMPRSS,cleavage,the insert sequence in sars-cov-2 enhances spike protein _ by tmprss,the insert sequence in sars-cov-2 enhances spike protein production by tmprss,https://www.biorxiv.org/content/10.1101/2020.02.08.926006v3,"[('Compared with SARS-CoV, we found a SPRR insertion in the S1/S2 protease cleavage sites of SARS-CoV-2 spike protein increasing the cleavage efficiency by the protein sequence aligment and furin score calculation.', 0.85399485), ('The two potential Spike protein cleavage sites of SARS-CoV and SARS- CoV-2 by TMPRSS2.', 0.822146), ('Our results provide the bioinformatics evidence for the increased spike protein cleavage of SARS-CoV-2 and indicate its potential target cells.', 0.7980592), ('We speculated that R682, R683 and R685 (red box) could be used as the most suitable substrates for TMPRSSs, which can increase the Spike protein cleavage efficiency of TMPRSSs, promote its activation and enhance SARS-CoV-2 infection.', 0.7845361), ('Thus, both the furin score and molecular docking revealed that the insertion sequence of SARS-CoV-2 facilitates the TMPRSS2 recognition and S protein cleavage.', 0.78004086)]"
2085,Antibody-like proteins that capture and neutralize SARS-CoV-2,proteins,antibody-like _ that capture and neutralize sars-cov-2,antibody-like viruses that capture and neutralize sars-cov-2,https://advances.sciencemag.org/content/early/2020/09/18/sciadv.abd3916.full,"[('L. Zhang , Human neutralizing antibodies elicited by SARS-CoV-2 infection.', 0.8025569), ('J. Yan , A human neutralizing antibody targets the receptor binding site of SARS- CoV-2.', 0.7271514), ('2 Binding activity of each clone against the SARS-CoV-2 spike protein S1 subunit and the RBD.', 0.7265625), ('The monomeric and dimeric monobodies were used as a neutralizing protein against SARS-CoV-2 infection.', 0.71464133), ('( C ) Monobody- mediated neutralization of SARS-CoV-2 infection in VeroE6/TMPRSS2 cells.', 0.708975)]"
2086,"Immunity , endothelial injury and complement-induced coagulopathy in COVID-19",immunity,"_ , endothelial injury and complement-induced coagulopathy in covid-19","Introduction, endothelial injury and complement-induced coagulopathy in covid-19",https://www.nature.com/articles/s41581-020-00357-4,"[('Stein, B. L. Coagulopathy associated with COVID-19.', 0.76173115), ('Endothelial cell infection and endotheliitis in COVID-19.', 0.75701684), ('Below, we focus on the possible role of the complement system in inducing systemic endothelial dysfunction in COVID-19.', 0.7539716), ('COVID-19 infection: the perspectives on immune responses.', 0.7400977), ('& Remuzzi, G. The case of complement activation in COVID-19 multiorgan impact.', 0.73341125)]"
2087,Outcomes of Children With COVID-19 Admitted to US and Canadian Pediatric Intensive Care Units,outcomes,_ of children with covid-19 admitted to us and canadian pediatric intensive care units,None of children with covid-19 admitted to us and canadian pediatric intensive care units,https://jamanetwork.com/journals/jamapediatrics/fullarticle/2766037,"[('Main outcomes and measures: Prehospital characteristics, clinical trajectory, and hospital outcomes of children admitted to PICUs with confirmed COVID-19 infection.', 0.72075325), ('Reinforcing existing evidence from North America and beyond, this study suggests a less severe clinical course for COVID-19 in children than in adults.', 0.6218249), ('Complexities of the COVID-19 vaccine and multisystem inflammatory syndrome in children.', 0.6203271), ('COVID-19 Pneumonia in Children: From Etiology to Management.', 0.6193143), ('While there is evidence that the burden of COVID-19 infection in hospitalized children is lesser than in their adult counterparts, to date, there are only limited reports describing COVID-19 in pediatric intensive care units (PICUs).', 0.61067116)]"
2088,Ultra-fast and onsite interrogation of Severe Acute Respiratory Syndrome Coronavirus 2 in environmental specimens via surface enhanced Raman scattering,severe,ultra-fast and onsite interrogation of _ acute respiratory syndrome coronavirus 2 in environmental specimens via surface enhanced raman scattering,ultra-fast and onsite interrogation of mild acute respiratory syndrome coronavirus 2 in environmental specimens via surface enhanced raman scattering,https://www.medrxiv.org/content/10.1101/2020.05.02.20086876v1,"[('Ultra-fast and Onsite Interrogation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Environmental Specimens Via Surface Enhanced Raman Scattering (SERS) medRxiv.', 0.9478242), ('Share Ultra-fast and onsite interrogation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in environmental specimens via surface enhanced Raman scattering (SERS) Dayi Zhang, Xiaoling Zhang, Rui Ma, Songqiang Deng, Xinquan Wang, Xian Zhang, Xia Huang, Yi Liu, Guanghe Li, Jiuhui Qu, Yu Zhu, Junyi Li medRxiv 2020.05.02.20086876; doi: https://doi.org/10.1101/2020.05.02.20086876 Share This Article: Copy Citation Tools Ultra-fast and onsite interrogation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in environmental specimens via surface enhanced Raman scattering (SERS) Dayi Zhang, Xiaoling Zhang, Rui Ma, Songqiang Deng, Xinquan Wang, Xian Zhang, Xia Huang, Yi Liu, Guanghe Li, Jiuhui Qu, Yu Zhu, Junyi Li medRxiv 2020.05.02.20086876; doi: https://doi.org/10.1101/2020.05.02.20086876 ', 0.8396689), ('State-of-the-art diagram of surface enhanced Raman scattering (SERS) for interrogating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).', 0.80326575), ('You are going to email the following Ultra-fast and onsite interrogation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in environmental specimens via surface enhanced Raman scattering (SERS) Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website.', 0.74568486), ('Rapid and Sensitive Detection of Respiratory Virus Molecular Signatures Using a Silver Nanorod Array SERS Substrate.', 0.72118443)]"
2089,Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection,sar,humanized covid-19 decoy antibody effectively blocks viral entry and prevents _-cov-2 infection,humanized covid-19 decoy antibody effectively blocks viral entry and prevents PRs-cov-2 infection,https://www.embopress.org/doi/abs/10.15252/emmm.202012828,"[('Keywords: ACE2-Fc; COVID-19; SARS-CoV-2; decoy antibody; virus infection.', 0.69671106), ('The protein extracts from (E) were immunoblotted with the indicated antibodies (left panel).', 0.57345754), ('Blockage of SARS‐CoV‐2 entry into host cells by ACE2‐Fc 1.', 0.5552223), ('The purity of biotin‐labeled ACE2‐Fc or Fc control was immunoblotted with an anti‐human IgG Fc antibody.', 0.55471283), ('Proposed model for the role of the decoy antibody ACE2‐Fc in SARS‐CoV‐2 entry and infection The decoy antibody (ACE2‐Fc) not only reduces SARS‐CoV‐2 infection but also decreases TNF‐α secretion and ADAM‐17 phosphorylation mediated by angiotensin II.', 0.54589707)]"
2090,SARS-CoV-2 mink-associated variant strain,min,sars-cov-2 _-associated variant strain,sars-cov-2 (k-associated variant strain,https://www.who.int/csr/don/06-november-2020-mink-associated-sars-cov2-denmark/en/,"[('SARS-CoV-2 strains infecting minks, which are subsequently transmitted to humans, may have acquired unique combinations of mutations.', 0.6195282), ('Initial observations suggest that the clinical presentation, severity and transmission among those infected are similar to that of other circulating SARS-CoV-2 viruses.', 0.5781989), ('Minks can act as a reservoir of SARS-CoV-2, passing the virus between them, and pose a risk for virus spill-over from mink to humans.', 0.55589795), ('Several animals that have been in contact with infected humans, such as minks, dogs, domestic cats, lions and tigers, have tested positive for SARS-CoV-2.', 0.5117374), ('Preliminary findings indicate that this particular mink-associated variant identified in both minks and the 12 human cases has moderately decreased sensitivity to neutralizing antibodies.', 0.4186204)]"
2093,Effectiveness of Cloth Masks Depends on Type of Covering,type,effectiveness of cloth masks depends on _ of covering,effectiveness of cloth masks depends on lack of covering,https://publishing.aip.org/publications/latest-content/effectiveness-of-cloth-masks-depends-on-type-of-covering/,"[('“In situations where sophisticated masks are not available, any mask is better than no mask at all for the general public in slowing the spread of infection.” Some of the other comparisons, however, were striking.', 0.4988922), ('Unless covered by a sleeve, a bare arm cannot form the proper seal against the nose necessary to obstruct airflow.', 0.49550852), ('“Adequate distancing is something that must not be ignored, since masks are not foolproof,” Simha said.', 0.45870197), ('Unsurprisingly, they found N95 masks to be the most effective at reducing the horizontal spread of a cough.', 0.41941178), ('“Even if a mask does not filter out all the particles, if we can prevent clouds of such particles from traveling very far, it’s better than not doing anything,” said Simha.', 0.41359732)]"
2094,Father with motor neurone disease dies from coronavirus in UK,dies,father with motor neurone disease _ from coronavirus in uk,father with motor neurone disease originated from coronavirus in uk,https://www.theguardian.com/uk-news/2020/mar/17/father-with-motor-neurone-disease-dies-from-coronavirus-in-uk,"[('Pic: Facebook/Me and my MND image/svg+xml Why you can trust Sky News A ""wonderfully kind"" father-of-two who was fighting motor neurone disease (MND) has become the youngest person to die after testing positive for coronavirus in the UK.', 0.578092), ('She added that he wanted to donate his brain to the Oxford Brain Bank to be used for MND research when he died, but because he died from coronavirus this cannot happen.', 0.5676681), ('Wednesday 18 March 2020 09:36, UK COVID-19 Coronavirus Image: Craig Ruston was battling motor neurone disease.', 0.47807336), ('Craig’s wish upon death was to give his brain to the Oxford Brain Bank.', 0.45969766), ('""Craig\'s wish upon death was to give his brain to the Oxford Brain Bank.', 0.4579785)]"
2095,Herd immunity thresholds for SARS-CoV-2 estimated from unfolding epidemics,herd,_ immunity thresholds for sars-cov-2 estimated from unfolding epidemics,Both immunity thresholds for sars-cov-2 estimated from unfolding epidemics,https://www.medrxiv.org/content/10.1101/2020.07.23.20160762v1,"[('Herd immunity thresholds are then calculated as 1 − (1/ R 0)1/(1+ CV 2) or 1 − (1/ R 0)1/(1+2 CV 2), depending on whether variation is on susceptibility or exposure.', 0.67309284), ('Here we fit epidemiological models with inbuilt distributions of susceptibility or exposure to SARS-CoV-2 outbreaks to estimate basic reproduction numbers ( R 0) alongside coefficients of individual variation (CV) and the effects of containment strategies.', 0.58686703), ('Eventually, susceptible numbers become low enough to prevent epidemic growth or, in other words, the herd immunity threshold is reached.', 0.5593293), ('These findings have profound consequences for the governance of the current pandemic given that some populations may be close to achieving herd immunity despite being under more or less strict social distancing measures.', 0.5070589), ('We emphasize that the classical formula, 1 − 1/ R 0, remains applicable to describe herd immunity thresholds for random vaccination, but not for immunity induced by infection which is naturally selective.', 0.48134792)]"
2096,Immune system shows abnormal response to COVID-19,abnormal,immune system shows _ response to covid-19,immune system shows host response to covid-19,https://www.nature.com/articles/d41586-020-00502-w,"[('Dysregulation of immune response in patients with COVID-19 in Wuhan, China.', 0.7176913), ('Complex immune dysregulation in COVID-19 patients with severe respiratory failure.', 0.70113623), ('Abnormal immunity of non-survivors with COVID-19: predictors for mortality.', 0.69749224), ('Some people gravely ill with COVID-19 have tissue damage inflicted by their own immune response, and also show increased activity of immune-system molecules and cells regulated by a protein called IL-6.', 0.6674028), ('Uncertainty is hampering doctors’ ability to choose treatments Numerous studies have suggested that the immune system contributes to the organ damage seen in some severe cases of COVID-19.', 0.6624275)]"
2101,Cryptic transmission of novel coronavirus SARS-CoV-2 revealed by genomic epidemiology,cryptic,_ transmission of novel coronavirus sars-cov-2 revealed by genomic epidemiology,Viral transmission of novel coronavirus sars-cov-2 revealed by genomic epidemiology,https://bedford.io/blog/ncov-cryptic-transmission/,"[('Cryptic transmission of novel coronavirus revealed by genomic epidemiology 2 Mar 2020 by Trevor Bedford The field of genomic epidemiology focuses on using the genetic sequences of pathogens to understand patterns of transmission and spread.', 0.7690963), ('Genome sequencing of SARS-CoV-2 strains allows for the reconstruction of transmission history connecting these infections.', 0.7107467), ('Li R., Pei S., Chen B., Song Y., Zhang T., Yang W., Shaman J., Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2).', 0.6689427), ('Toggle navigation bedford lab blog papers projects team Cryptic transmission of novel coronavirus revealed by genomic epidemiology 2 Mar 2020 by Trevor Bedford The field of genomic epidemiology focuses on using the genetic sequences of pathogens to understand patterns of transmission and spread.', 0.6390983), ('The novel coronavirus which is responsible for the emerging COVID-19 pandemic mutates at an average of about two mutations per month.', 0.6335486)]"
2102,Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics,measurement,_ of sars-cov-2 rna in wastewater tracks community infection dynamics,Lack of sars-cov-2 rna in wastewater tracks community infection dynamics,https://www.nature.com/articles/s41587-020-0684-z,"[('Identification of viral pathogen diversity in sewage sludge by metagenome analysis.', 0.8052845), ('Our data show the utility of viral RNA monitoring in municipal wastewater for SARS-CoV-2 infection surveillance at a population-wide level.', 0.7991991), ('2: Sludge SARS-CoV-2 RNA concentration time course and other COVID-19 outbreak indicators on linear (left) and log (right) scales.', 0.77569133), ('Relative to these indicators, SARS-CoV-2 RNA concentrations in sludge were 0–2 d ahead of SARS-CoV-2 positive test results by date of specimen collection, 0–2 d ahead of the percentage of positive tests by date of specimen collection, 1–4 d ahead of local hospital admissions and 6–8 d ahead of SARS-CoV-2 positive test results by reporting date.', 0.74439085), ('In this study, we investigated how viral RNA concentrations in wastewater correlated with compiled testing and hospitalization data in a U.S. metropolitan area over ~10 weeks, corresponding to a first wave of SARS-CoV-2 infection.', 0.70515716)]"
2103,The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients,protect,the btk-inhibitor ibrutinib may _ against pulmonary injury in covid-19 infected patients,the btk-inhibitor ibrutinib may interfere against pulmonary injury in covid-19 infected patients,https://ashpublications.org/blood/article/doi/10.1182/blood.2020006288/454437/The-BTKinhibitor-ibrutinib-may-protect-against,"[('Much of what we have learned about the Toll- receptor/MYD88 pathway in WM enabled us to re-purpose much of this knowledge to COVID-19 that exploits this pathway for producing lung injury.', 0.5992532), ('The IWMF enabled much of this learning, and we are grateful that the findings from those studies could be re-purposed against COVID-19.', 0.47689447), ('Click here to view the article: https://ashpublications.org/blood/article/doi/10.1182/blood.2020006288/454437/The- BTK-inhibitor-ibrutinib-may-protect-against Click here to download the publication (PDF) Prev Next Legal ', 0.47095045), ('It describes the course of 6 WM patients on ibrutinib who contracted COVID-19.', 0.4693133), ('We are beginning two prospective multicenter trials in COVID-19 patients, one with ibrutinib and the other with zanubrutinib.', 0.42703825)]"
2108,"Persistence of viral RNA , pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology",rna,"persistence of viral _ , pneumocyte syncytia and thrombosis are hallmarks of advanced covid-19 pathology","persistence of viral DNA, pneumocyte syncytia and thrombosis are hallmarks of advanced covid-19 pathology",https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(20)30480-1/fulltext,"[('Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study.', 0.6813177), ('COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up.', 0.6535155), ('Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies.', 0.6393453), ('A consistent and typical feature in COVID-19 lungs was the presence of major cytological abnormalities, including very large cells with dysmorphic phenotypes (a, x63; b, x40) often showing bi-o multinucleation (c,d, x40).', 0.6310499), ('Despite the flurry of anectodical reports on COVID-19 patients’ post-mortem analyses over the last couple of months, there is still a paucity of more systematic studies, especially addressing whether a direct connection exists between cell infection by SARS-CoV-2 and the pathology detected.', 0.62410414)]"
2109,A Multi-Factor Risk Model for Severe Covid-19 for Vaccine Prioritization and Monitoring Based on a 15 Million Medicare Cohort,million,a multi-factor risk model for severe covid-19 for vaccine prioritization and monitoring based on a 15 _ medicare cohort,a multi-factor risk model for severe covid-19 for vaccine prioritization and monitoring based on a 15 days medicare cohort,https://www.medrxiv.org/content/10.1101/2020.10.28.20219816v1,"[('A Multi-Factor Risk Model for Severe Covid-19 for Vaccine Prioritization and Monitoring Ba ', 0.768414), ('ConclusionThis multi- factor risk model which predicts severe Covid-19and its population risk dashboard can be used to optimize Covid-19 vaccine allocation in the higher risk Medicare population where socio-demographic and comorbidity risk factors need to be considered concurrently.', 0.74176073), ('MethodsWe developed a predictive model for severe COVID-19 using clinical data from de- identified Medicare claims for 16 million Medicare fee-for-service beneficiaries, including 1 million COVID-19 cases, and socio-economic data from the CDC Social Vulnerability Index.', 0.7259252), ('ResultsThe leading Covid-19 hospitalization risk factors driving the risk model were Non-white ethnicity (particularly North American Native, Black, and Hispanic), end-stage renal disease, advanced age (particularly age over 85), prior hospitalization, leukemia, morbid obesity, chronic kidney disease, lung cancer, chronic liver disease, pulmonary fibrosis or pulmonary hypertension, and chemotherapy.', 0.6339737), ('Predicted individual probabilities of COVID-19 hospitalization were then calculated for population risk stratification and COVID-19 vaccine prioritization, and for mapping of population risk levels at the county and zip code levels on a nationwide dashboard.', 0.63114774)]"
2110,Red Cross Statement on Updated FDA Donor Eligibility Criteria due to Pandemic,fda,red cross statement on updated _ donor eligibility criteria due to pandemic,red cross statement on updated local donor eligibility criteria due to pandemic,https://www.redcross.org/about-us/news-and-events/press-release/2020/statement-on-updated-fda-donor-eligibility-criteria.html,"[('Please select a class type /content/redcross/en/about-us/news-and-events/press-release/2020/statement-on- updated-fda-donor-eligibility-criteria (C) 2021 The American National Red Cross Terms of Use Privacy Policy Contact Us FAQ Mobile Apps Give Blood [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.5498756), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.5478368), (""Our broader Red Cross statement on the FDA policy concerning deferral criteria for men who have had sex with men (MSM) is available on our website.” About the American Red Cross: The American Red Cross shelters, feeds and provides emotional support to victims of disasters; supplies about 40 percent of the nation's blood; teaches skills that save lives; provides international humanitarian aid; and supports military members and their families."", 0.53281784), ('The Red Cross will work aggressively to implement the many eligibility changes outlined by the FDA as soon as possible.', 0.52413404), ('DONATE NOW https://www.redcrossblood.org/give.html Give Blood Today Find a drive and schedule a blood donation appointment today.', 0.4981447)]"
2114,UNC Researchers Create New Type of Accurate COVID-19 Antibody Test,new,unc researchers create _ type of accurate covid-19 antibody test,unc researchers create one type of accurate covid-19 antibody test,http://news.unchealthcare.org/news/2020/june/unc-researchers-create-accurate-new-type-of-covid-19-antibody-test,"[('“Our assay is extremely specific for antibodies to the virus that causes COVID-19, which is not the case for some currently available antibody tests,” said co-senior author Aravinda de Silva, professor of microbiology and immunology and member of the UNC Institute for Global Health and Infectious Diseases.', 0.7362452), ('Therefore, antibodies against this domain are likely to be highly specific to SARS-CoV-2, and so these antibodies reveal if an individual has been exposed to the virus that can cause COVID-19.', 0.6801877), ('The test can be ramped up to document past and recent COVID-19 infections and possibly used to identify asymptomatic virus infection and the level of immunity in individuals.', 0.63632154), ('The team designed new antigens and used a large panel of SARS- CoV-2 patients and control human and animal samples.', 0.62936956), ('The researchers, who published their work in Science Immunology, created a blood test to pinpoint SARS-CoV-2 antibodies that target one unique piece of the SARS-CoV-2 spike protein.', 0.61851835)]"
2115,Validation of home oxygen saturations as a marker of clinical deterioration in patients with suspected COVID-19,home,validation of _ oxygen saturations as a marker of clinical deterioration in patients with suspected covid-19,validation of blood oxygen saturations as a marker of clinical deterioration in patients with suspected covid-19,https://www.medrxiv.org/content/10.1101/2020.11.06.20225938v1,"[('We undertook an analysis of COVID-19 patients conveyed by ambulance to hospital to investigate how oxygen saturation and measurements of other vital signs correlate to patient outcomes, to ascertain if clinical deterioration can be predicted with simple community physiological monitoring.', 0.751117), ('Conclusions Initial oxygen saturation measurements (on air) for confirmed COVID-19 patients conveyed by ambulance correlated with short-term (30-day) patient mortality or ICU admission, AUROC: 0.772 (95% CI: 0.712-0.833).', 0.67343897), ('Oxygen saturations were the most predictive of mortality or ICU admission (AUROC 0.772 (95 % CI: 0.712-0.833)), followed by the NEWS2 score (AUROC 0.715 (95 % CI: 0.670-0.760), patient age (AUROC 0.690 (95 % CI: 0.642-0.737)), and respiration rate (AUROC 0.662 (95 % CI: 0.599-0.729)).', 0.47111452), ('Results We identified 1,080 adults with a COVID-19 diagnosis who were conveyed by ambulance to either Basingstoke & North Hampshire Hospital or the Royal Hampshire County Hospital (Winchester) between March 1st and July 31st and whose diagnosis was clinically confirmed at hospital discharge.', 0.4588498), ('This is to ensure that confidential patient information can be used and shared appropriately and lawfully for purposes related to the COVID-19 response.', 0.45321703)]"
2116,Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19,with,immune phenotyping based on neutrophil-to-lymphocyte ratio and igg predicts disease severity and outcome for patients _ covid-19,immune phenotyping based on neutrophil-to-lymphocyte ratio and igg predicts disease severity and outcome for patients without covid-19,https://www.medrxiv.org/content/10.1101/2020.03.12.20035048v1,"[('Interpretation COVID-19 severity is associated with increased IgG response, and an immune response phenotyping based on late IgG response and NLR could act as a simple complementary tool to discriminate between severe and nonsevere COVID-19 patients, and further predict their clinical outcome.', 0.7990539), ('We developed an immune response phenotyping based on NLR and IgG that could act as a simple complementary tool to discriminate between severe and nonsevere COVID-19 patients and would be helpful in guiding clinical decision.', 0.7706688), ('Immune response phenotyping based on late IgG levels and neutrophil-to-lymphocyte ratio (NLR) was characterized to stratify patients with different disease severities and outcome.', 0.69259775), ('Methods Anti-SARS-CoV-2 IgG and IgM antibodies were determined by chemiluminescence analysis (CLIA) in COVID-19 patients from a single center in Wuhan.', 0.67575735), ('Evidence before this study Following SARS-CoV-2 infection, a high viral load and overexuberant host immune response involving innate and acquired immunity, simultaneously contributes to the pathogenesis of COVID-19 and organ injury.', 0.5994707)]"
2118,Clinically proven protease inhibitor blocks coronavirus cell entry,entry,clinically proven protease inhibitor blocks coronavirus cell _,clinically proven protease inhibitor blocks coronavirus cell proliferation,https://www.cell.com/action/showPdf?pii=S0092-8674%2820%2930229-4,"[('The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner.', 0.6984524), ('Priming of coronavirus S proteins by host cell serine proteases, TMPRSS2, is essential for viral entry into cells, with S protein cleavage at the S1/S2 and the S20 sites.', 0.6768414), ('SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.', 0.6662524), ('Commentary: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.', 0.65210366), ('Coronaviruses interact with angiotensin-converting enzyme 2 (ACE2) to gain the initial entry into cells, followed by endocytosis of the viral complex.', 0.64676976)]"
2122,Oxford to trial new COVID-19 test for individuals without symptoms,test,oxford to trial new covid-19 _ for individuals without symptoms,oxford to trial new covid-19 therapy for individuals without symptoms,https://www.ox.ac.uk/news/2020-10-29-oxford-trial-new-covid-19-test-individuals-without-symptoms#,"[('The pilot scheme, developed by Oxford in partnership with the Department of Health and Social Care, Public Health England and Durham University, will help us understand how best to use the technology and how it could be operationalised in the real world as part of broader COVID-19 testing strategies beyond the polymerise chain reaction (PCR) test.', 0.6117734), ('If LFTs are able to detect enough people with the virus before they get symptoms, they could help prevent the spread of COVID-19.', 0.5784646), ('The Lateral Flow Test (LFT) is one of a number of new testing technologies for COVID-19 currently being trialled across the UK.', 0.5588033), ('Richard Hobbs, Nuffield Professor of Primary Care Health Sciences at the University of Oxford and lead on the study said: ‘The results of this study will be important because some of the spread of COVID-19 happens before people get symptoms and self-isolate.', 0.5497192), ('‘The primary purpose of the study is not whether the University adopts this test, but to help uncover how to organise such screening in the national and international fight against COVID-19.’ Professor Gavin Screaton, Head of Medical Sciences Division at the University of Oxford said: ‘Through Oxford’s Testing for COVID-19: Early Alert Service (EAS) the University has been operating a comprehensive testing service, seven days a week, for all staff and students out of two testing pods, one at the Radcliffe Observatory Quarter (ROQ) and the other at the Old Road Campus (ORC) in Headington since August.', 0.54412985)]"
2123,Bradykinin initiates cytokine-mediated inflammatory hyperalgesia,mediated,bradykinin initiates cytokine-_ inflammatory hyperalgesia,bradykinin initiates cytokine-independent inflammatory hyperalgesia,https://pubmed.ncbi.nlm.nih.gov/8298813/,"[('Bradykinin release of TNF-alpha plays a key role in the development of inflammatory hyperalgesia.', 0.85222054), ('These data show that bradykinin can initiate the cascade of cytokine release that mediates hyperalgesic responses to carrageenin and endotoxin (1 microgram).', 0.8276527), ('Hypothalamic mechanisms of pain modulatory actions of cytokines and prostaglandin E2.', 0.6140037), ('Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone.', 0.60654366), ('Responses to bradykinin and LPS (1 and 5 micrograms) were inhibited by the cyclo-oxygenase inhibitor, indomethacin and by the beta-adrenoceptor antagonist, atenolol.', 0.5763265)]"
2124,Ivermectin exposure leads to up-regulation of detoxification genes in vitro and in vivo in mice,mice,ivermectin exposure leads to up-regulation of detoxification genes in vitro and in vivo in _,ivermectin exposure leads to up-regulation of detoxification genes in vitro and in vivo in humans,https://hal.inrae.fr/hal-02634112,"[('The purpose of this study was to evaluate, in vitro and in vivo, the ivermectin ability in modulating the expression of the most important genes involved in drug detoxification.', 0.7237842), ('Plasma, brain, liver and intestinal concentrations of ivermectin and its main metabolite were measured by HPLC in ivermectin-treated mice.', 0.68726945), ('These findings can be regarded as a warning that repeated ivermectin exposure is able to induce detoxification systems in mammals that may lead to subtherapeutic drug concentration.', 0.6650041), ('Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway.', 0.6377057), ('Gene expression of ABC transporters and cytochromes was evaluated by RT-qPCR in murine hepatic and intestinal cell lines exposed to increasing ivermectin doses, and in liver and intestine of mice orally administered with single or repeated therapeutic doses of ivermectin (0.2 mg/kg).', 0.62333393)]"
2127,"Epidemiological characteristics of the first 53 laboratory-confirmed cases of COVID-19 epidemic in Hong Kong , 13 February 2020",first,"epidemiological characteristics of the _ 53 laboratory-confirmed cases of covid-19 epidemic in hong kong , 13 february 2020","epidemiological characteristics of the remaining 53 laboratory-confirmed cases of covid-19 epidemic in hong kong, 13 february 2020",https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.16.2000155,"[('Aims This study aimed to describe key epidemiological parameters of COVID-19 in Hong Kong.', 0.64960015), (""Hong Kong's multi-pronged response to COVID-19 2020; 2020."", 0.6375034), ('Novel coronavirus (2019-nCoV) cases in Hong Kong and implications for further spread.', 0.61419296), ('Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts 2020.', 0.5978446), ('Community Responses during Early Phase of COVID-19 Epidemic, Hong Kong.', 0.59134847)]"
2128,"I have created a simple , minimalist COVID-19 dashboard using Tableau .",created,"i have _ a simple , minimalist covid-19 dashboard using tableau .","i have considered a simple, minimalist covid-19 dashboard using tableau.",https://public.tableau.com/profile/abhishek.sinha5913#!/vizhome/COVID-19_15922993362160/Dashboard1,"[('Ready to build a beautifully simple and addictively engaging dashboard?', 0.5334587), ('Create a minimalistic map I first posted about this here.', 0.49712557), (""If you haven't used this data before, check out Dashboard 1: Step 1 for a quick overview of the data and instructions on how to connect it to Tableau Public."", 0.42237753), ('Click here to download the data and create your own dashboard along with the videos.', 0.37802875), ('We now have just an outline of the map.', 0.37582904)]"
2129,Government bureau to examine Covid antibody obtainment system as suggestions finished,suggestions,government bureau to examine covid antibody obtainment system as _ finished,government bureau to examine covid antibody obtainment system as control finished,https://www.itstrending.org/2020/11/Government-bureau-to-examine-Covid-antibody-obtainment-system-as-suggestions-finished-Latest-News-Pakistan-Daily-Pakistan-Coronavirus.html?m=1,"[('We need to make game plans to get the antibody at the soonest.', 0.57896507), ('""NCOC today finished its proposals for acquisition of Covid immunization.', 0.5553527), ('The authority said the recommendations will be talked about with the government bureau and in the wake of getting its endorsement steps will be taken for immunization acquirement.', 0.51439226), ('Besides, it has been concluded that the antibody will be given to medical services labourers, senior residents and individuals experiencing persistent illnesses, for example, diabetes, malignant growth, and so on, on a need premise,"" he said.', 0.4549238), ('Likewise read: We can stop Covid-19: Moderna immunization achievement gives the world more expectation ""In any case, shockingly, the cycle was wrecked each time because of various reasons, for example, [possible] results of the immunizations, which antibody would be accessible prior and so forth, so various choices were being thought of and surveyed simultaneously,"" he said.', 0.4535969)]"
2130,Can people spread coronavirus after they recover ?,spread,can people _ coronavirus after they recover ?,can people shed coronavirus after they recover?,https://www.livescience.com/coronavirus-spread-after-recovery.html,"[('-- How coronavirus compares with flu -- Will a face mask protect you?', 0.617128), (""And there is always the possibility that the new coronavirus would mutate as it moves through populations, changing into a version that already-exposed immune systems can't recognize."", 0.60460305), ('After the antiviral treatment ended, the viruses may have begun replicating again at a low level, Tumban said.', 0.5823759), ('Some still think that the virus may enter cells by endocytosis.', 0.5507717), ('Virus that persists in the body may elicit enough of an immune response to provide some protection against new infection, Johnson said.', 0.54942787)]"
2131,Dutch scientists find new role for ACE2 receptors in COVID disease process,scientists,dutch _ find new role for ace2 receptors in covid disease process,dutch models find new role for ace2 receptors in covid disease process,https://www.radboudumc.nl/en/nieuws/2020/radboudumc-researchers-publish-new-insights-into-covid-19,"[('(21,22) The protease TMPRSS2 produced by the host cells plays an important role in proteolytic processing of S protein priming to the receptor ACE2 binding in human cells.', 0.56381845), ('Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain.', 0.5571318), ('Similar to SARS-CoV, the receptor-binding domain (RBD) in the S protein of SARS-CoV-2 binds to human ACE2 receptor in order to gain access into host cells.', 0.5325971), ('A Computational Approach to Identify Potential Novel Inhibitors against the Coronavirus SARS‐CoV‐2.', 0.52844596), ('A comprehensive drug repurposing study for COVID19 treatment: novel putative dihydroorotate dehydrogenase inhibitors show association to serotonin–dopamine receptors.', 0.52321523)]"
2132,Immune memory in mild COVID-19 patients and unexposed donors from India reveals persistent T cell responses after SARS-CoV-2 infection,responses,immune memory in mild covid-19 patients and unexposed donors from india reveals persistent t cell _ after sars-cov-2 infection,immune memory in mild covid-19 patients and unexposed donors from india reveals persistent t cell depletion after sars-cov-2 infection,https://www.medrxiv.org/content/10.1101/2020.11.16.20232967v1,"[('Interestingly, the persistent immune reactivity in COVID-19 patients is predominantly targeted towards the Spike glycoprotein of the SARS-CoV-2.', 0.7444472), ('Here, we examined the SARS-CoV-2-specific CD4+ T-cell responses in unexposed individuals and patients recovered from mild COVID-19.', 0.6795079), ('By providing the knowledge on cellular immune responses to SARS-CoV-2, our work has implication for the evaluation and implementation of vaccines against COVID-19.', 0.67065895), ('This study provides the evidence of both high magnitude pre-existing and persistent immune memory in Indian population.', 0.664141), ('Moreover, we found detectable immune reactivity up to 5 months in mild COVID-19 recovered patients in the two major arms of protective adaptive immunity; CD4+ T cells and B cells.', 0.59741247)]"
2134,Plasma from recovered COVID19 subjects inhibits spike protein binding to ACE2 in a microsphere-based inhibition assay,plasma,_ from recovered covid19 subjects inhibits spike protein binding to ace2 in a microsphere-based inhibition assay,Blood from recovered covid19 subjects inhibits spike protein binding to ace2 in a microsphere-based inhibition assay,http://medrxiv.org/content/early/2020/06/11/2020.06.09.20127050,"[('Here we present microsphere-based Flow Cytometry assays that quantify both anti-spike IgGs in plasma, and the ability of plasma to inhibit the binding of spike protein to angiotensin converting enzyme 2 (ACE2).', 0.68676394), ('Depletion of trimer-reactive Igs from plasma reduced ACE2-trimer inhibitory capacity to a greater degree than depletion of RBD-reactive Igs, suggesting that inhibitory antibodies act by binding both within and outside of the RBD.', 0.5683639), ('This inhibition assay may be broadly useful to quantify the functional antibody response of recovered COVID19 patients or vaccine recipients in a cell-free assay system.', 0.52964354), ('Next, we find that plasma from all 22/24 subjects with anti-trimer IgGs inhibited ACE2-trimer binding to a greater degree than controls, and that the degree of inhibition correlated with anti-trimer IgG levels.', 0.5052325), ('First, we detected anti- spike-trimer IgGs in 22/24 and anti-spike-receptor-binding-domain (RBD) IgGs in 21/24 COVID+ subjects at a median of 36 (range 14-73) days following documented SARS-CoV-2 RNA (+) secretions.', 0.44125473)]"
2139,An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation,spike,an ultra-potent synthetic nanobody neutralizes sars-cov-2 by locking _ into an inactive conformation,an ultra-potent synthetic nanobody neutralizes sars-cov-2 by locking light into an inactive conformation,https://www.biorxiv.org/content/10.1101/2020.08.08.238469v2,"[('Li T. et al., Potent synthetic nanobodies against SARS-CoV-2 and molecular basis for neutralization.', 0.7216223), ('Custodio T. F. et al., Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2.', 0.6966886), ('Cryogenic electron microscopy (cryo-EM) revealed that one exceptionally stable nanobody, Nb6, binds Spike in a fully inactive conformation with its receptor binding domains (RBDs) locked into their inaccessible down-state, incapable of binding ACE2.', 0.64770144), ('Our lead neutralizing molecule, mNb6-tri, blocks SARS-CoV-2 entry in human cells at picomolar efficacy and withstands aerosolization, lyophilization, and elevated temperatures.', 0.62768424), ('Hanke L. et al., An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction.', 0.62625235)]"
2140,The FDA Weighs Its First Coronavirus Vaccine,first,the fda weighs its _ coronavirus vaccine,the fda weighs its new coronavirus vaccine,https://blogs.sciencemag.org/pipeline/archives/2020/12/09/the-fda-weighs-its-first-coronavirus-vaccine,"[(""So it looks like the vaccine has a very strong protective effect, and that's the first thing you'd want to know."", 0.550879), ('With coronavirus common cold strains , reinfection seems to occur after a year or so has passed since previous infection with the same strain , so if you had a vaccine for these strains , you might recommend an annual booster for those who would be high-risk.', 0.52975595), ('https://www.nbcnews.com/health/health-news/moderna-vaccine-appears-protect- against-coronavirus-infection-n1251237 Reply 1.', 0.5258279), ('I expect the FDA to grant that, and very soon.', 0.5224465), ('That wonderful plot seems to show essentially the entire trial population, but is labeled (and discussed) as though only one dose of vaccine (or placebo) was given.', 0.5148146)]"
2142,V-Count Real-time Occupancy Solution Provides the necessary traffic data to guarantee the safety,safety,v-count real-time occupancy solution provides the necessary traffic data to guarantee the _,v-count real-time occupancy solution provides the necessary traffic data to guarantee the cost,https://www.einpresswire.com/article/514180740/v-count-real-time-occupancy-solution-provides-the-necessary-traffic-data-to-guarantee-the-safety,"[('This solution can send email & push notifications so you can be informed when your storesâ\x80\x99 occupancy limit is breached, keeping employees and customers safe at all times.', 0.5387808), ('You can also reflect the real-time occupancy numbers on digital screens, ensuring incoming crowd control.', 0.49875388), ('As such, we developed a REAL-TIME OCCUPANCY solution to help businesses track & manage incoming visitor traffic, allowing them to apply social distancing guidelines while keeping their focus on what really matters.', 0.4649344), ('We recognise that one of the biggest challenges for businesses today is to manage operations safely & effectively while abiding government regulations.', 0.37993604), ('So we can support the incredible people working at the frontlines of the crisis.', 0.31610578)]"
2143,Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection,peripheral,_ immunophenotypes in children with multisystem inflammatory syndrome associated with sars-cov-2 infection,Clinical immunophenotypes in children with multisystem inflammatory syndrome associated with sars-cov-2 infection,https://www.nature.com/articles/s41591-020-1054-6,"[('Rowley, A. H. Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children.', 0.810801), ('1) with pediatric multisystem inflammatory syndrome in children (MIS-C) temporally associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (also known as PIMS-TS16; Supplementary Tables 1 and 2).', 0.74936527), ('Characteristics, cardiac involvement, and outcomes of multisystem inflammatory disease of childhood (MIS-C) associated with SARS- CoV-2 infection.', 0.74883306), ('In conclusion, based on our cohort characteristics and the immune cell changes we observed, MIS-C is likely to be a distinct immunopathogenic illness associated with SARS-CoV-2, with more severe illness in seropositive children.', 0.73009825), ('1: Cohort description, SARS-CoV-2 serology and biomarkers of inflammation, myocardial dysfunction and coagulation.', 0.72134316)]"
2145,REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters,reg,_-cov2 antibodies prevent and treat sars-cov-2 infection in rhesus macaques and hamsters,Pn-cov2 antibodies prevent and treat sars-cov-2 infection in rhesus macaques and hamsters,https://science.sciencemag.org/content/370/6520/1110,"[('D. H. Barouch , DNA vaccine protection against SARS-CoV-2 in rhesus macaques.', 0.7747802), ('E. de Wit , Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.', 0.7659354), ('D. H. Barouch , SARS-CoV-2 infection protects against rechallenge in rhesus macaques.', 0.76201385), ('D. H. Barouch , Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.', 0.74469244), ('Yen , Pathogenesis and transmission of SARS-CoV-2 in golden hamsters.', 0.7347546)]"
2146,Trump announces 'halt ' in US funding to World Health Organization amid coronavirus pandemic,halt,trump announces '_ ' in us funding to world health organization amid coronavirus pandemic,trump announces 'in'in us funding to world health organization amid coronavirus pandemic,https://www.usatoday.com/story/news/politics/2020/04/14/coronavirus-trump-halt-funding-world-health-organization/2983707001/,"[('VIDEO8:1608:16 Trump calls for halt to WHO funding: \'So much death has been caused by their mistakes\' Coronavirus The U.S. will suspend funding to the World Health Organization while it reviews the agency\'s response to the Covid-19 pandemic, President Donald Trump announced Tuesday, saying the international health agency made mistakes that ""caused so much death"" as the coronavirus spread across the globe.', 0.83770704), ('""Today I\'m instructing my administration to halt funding of the World Health Organization while a review is conducted to assess the World Health Organization\'s role in severely mismanaging and covering up the spread of the coronavirus,"" Trump said at a White House press conference.', 0.82644707), ('Follow live coronavirus updates ""I am directing my administration to halt funding while a review is conducted to assess the World Health Organization\'s role in severely mismanaging and covering up the spread of the coronavirus,"" Mr Trump told a news conference at the White House on Tuesday.', 0.7319256), ('Trump cuts funding to World Health Organization Coronavirus When asked by reporters why the administration is choosing now to withhold funds, Trump said the U.S. has had problems with WHO ""for years"" and the nation should have done this ""a long time ago.""', 0.72888404), ('Trump has questioned US funding to the United Nations, withdrawn from global climate agreements and lambasted the World Trade Organization -- claiming all were ripping off the United States.', 0.663115)]"
2148,Reduces nearly all the factors of inflammation seen in people admitted to ICU with COVID19 .,inflammation,reduces nearly all the factors of _ seen in people admitted to icu with covid19 .,reduces nearly all the factors of transmission seen in people admitted to icu with covid19.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114714/,"[('Face shields provided added protection from COVID-19 to these community health workers, and they have also been shown to reduce infections in hospital health workers.', 0.60102546), ('However, COVID-19 infection also initiated increased secretion of the Th2 cytokines (e.g., interleukins 4 and 10) that suppress inflammation, which differs from SARS-CoV infection [30].', 0.58414596), ('“To enable safer in-person learning, schools and communities should fully implement and strictly adhere to multiple mitigation strategies, especially universal and proper mask wearing, to reduce both school and community COVID-19 incidence to help protect students, teachers, and staff members from COVID-19.” The COVID-19 pandemic has been associated with an excess of cerebrovascular deaths in the United States, according to a study in Stroke.', 0.5693474), ('The investigational vaccine “was safe and had 78% efficacy in preventing mild cases of COVID-19 in a study of more than 12,000 healthcare workers,” spokespeople said, while “completely” preventing serious illness.', 0.56017315), ('Receipt of convalescent plasma with high versus low levels of antibodies against SARS-CoV-2 is associated with a lower risk of 30-day mortality in hospitalized adults with COVID-19, but only in those who had not received mechanical ventilation, researchers report in the New England Journal of Medicine.', 0.55882657)]"
2149,Modeling shield immunity to reduce COVID-19 epidemic spread,reduce,modeling shield immunity to _ covid-19 epidemic spread,modeling shield immunity to severe covid-19 epidemic spread,https://www.nature.com/articles/s41591-020-0895-3,"[('Here, we apply our model of shield immunity to the epidemiological dynamics of the COVID-19 pandemic.', 0.7801955), ('7 COVID-19 dynamics given variation in immune duration.', 0.6617084), ('& Weitz, J. S. The time scale of asymptomatic transmission affects estimates of epidemic potential in the COVID-19 outbreak.', 0.6449567), ('Klompas, M. Coronavirus disease 2019 (COVID-19): protecting hospitals from the invisible.', 0.6260042), ('We use our core shielding model as the basis for application to COVID-19, as it represents the conservative benefits of shielding; however, detailed mixing and substitution models could also lead to further variations of this model, such as in spatially explicit domains or on networks21,22,23,24.', 0.6239269)]"
2151,Effectiveness of home made mask relative to N95,mask,effectiveness of home made _ relative to n95,effectiveness of home made higher relative to n95,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373043/,"[('A cost-effectiveness analysis might give further insights in the relative benefits of home made masks.', 0.68395865), ('The fit of home made masks, which could be e.g.', 0.6447925), ('In comparison, the performance of the fitted, non-valved N95 mask was far superior.', 0.6396371), ('(Figure 1) Open in a separate window Figure 1 Protection factor of home-made mask being measured by Portacount in volunteer.', 0.6274618), ('We showed that a hand-fashioned mask can provide a good fit and a measurable level of protection from a challenge aerosol.', 0.612472)]"
2152,Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019,patients,outcomes of cardiovascular magnetic resonance imaging in _ recently recovered from coronavirus disease 2019,outcomes of cardiovascular magnetic resonance imaging in animals recently recovered from coronavirus disease 2019,https://jamanetwork.com/journals/jamacardiology/fullarticle/2768916,"[('Explanation for the Corrections for the Study of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019.', 0.8191428), ('Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19).', 0.73571205), ('Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19).', 0.73505324), ('Correlation of Myocardial Measures With Time From Coronavirus Disease 2019 (COVID-19) Testing There… Figure 3..', 0.6528533), ('For the coronavirus disease 2019 (COVID-19) home recovery group, dark circles indicate symptomatic illness and light circles indicate asymptomatic illness.', 0.62335575)]"
2153,REGN-COV2 antibody cocktail prevents and treats SARS-CoV-2 infection in rhesus macaques and hamsters,reg,_-cov2 antibody cocktail prevents and treats sars-cov-2 infection in rhesus macaques and hamsters,Pn-cov2 antibody cocktail prevents and treats sars-cov-2 infection in rhesus macaques and hamsters,https://www.biorxiv.org/content/10.1101/2020.08.02.233320v1,"[('In this report, we evaluate the in vivo efficacy of this antibody cocktail in both rhesus macaques and golden hamsters and demonstrate that REGN-COV-2 can greatly reduce virus load in lower and upper airway and decrease virus induced pathological sequalae when administered prophylactically or therapeutically.', 0.73077476), ('We previously described REGN-COV2, a cocktail of two potent neutralizing antibodies (REGN10987+REGN10933) targeting non-overlapping epitopes on the SARS-CoV-2 spike protein.', 0.61417186), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.4597723), ('Our results provide evidence of the therapeutic potential of this antibody cocktail.', 0.39015836), ('Download PDF Email Thank you for your interest in spreading the word about bioRxiv.', 0.30587512)]"
2154,Innate lymphoid cell composition associates with COVID-19 disease severity,innate,_ lymphoid cell composition associates with covid-19 disease severity,Acute lymphoid cell composition associates with covid-19 disease severity,https://www.medrxiv.org/content/10.1101/2020.10.13.20211367v1,"[('The activated ILC profile of COVID-19 patients was associated with soluble inflammatory markers, while frequencies of ILC subsets were correlated with laboratory parameters that reflect the disease severity.', 0.71684784), ('To describe the phenotypic landscape of circulating ILCs in COVID-19 patients and to identify ILC phenotypes correlated to serum biomarkers, clinical markers, and laboratory parameters relevant in COVID-19.', 0.69893956), ('Conclusion This study provides insights into the potential role of ILCs in immune responses against SARS-CoV-2, particularly linked to the severity of COVID-19.', 0.6723051), ('Understanding the immune response in COVID-19 could contribute to unravel the pathogenesis and identification of treatment targets.', 0.6336089), ('Clinical and laboratory parameters were obtained from all COVID-19 patients and serum biomarkers were analyzed with multiplex immunoassays.', 0.5913862)]"
2155,Physical interventions to interrupt or reduce the spread of respiratory viruses,reduce,physical interventions to interrupt or _ the spread of respiratory viruses,physical interventions to interrupt or promote the spread of respiratory viruses,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190272/,"[('Interventions for the interruption or reduction of the spread of respiratory viruses.', 0.8182293), ('We included physical interventions (screening at entry ports, isolation, quarantine, social distancing, barriers, personal protection, hand hygiene) to prevent respiratory virus transmission.', 0.7163218), ('Cochrane Review: Interventions for the interruption or reduction of the spread of respiratory viruses.', 0.6586654), ('Nine case-control studies suggested implementing transmission barriers, isolation and hygienic measures are effective at containing respiratory virus epidemics.', 0.5831874), ('The highest quality cluster-RCTs suggest respiratory virus spread can be prevented by hygienic measures, such as handwashing, especially around younger children.', 0.5694257)]"
2156,"Quantitative , Epitope-specific , Serological Screening of COVID-19 Patients Using a Novel Multiplexed Array-based Immunoassay Platform",specific,"quantitative , epitope-_ , serological screening of covid-19 patients using a novel multiplexed array-based immunoassay platform","quantitative, epitope-free, serological screening of covid-19 patients using a novel multiplexed array-based immunoassay platform",https://www.medrxiv.org/content/10.1101/2020.09.25.20201269v1,"[('We have developed a novel, quantitative, multi-antigen, multiplexed, array-based immunoassay platform, ImmuSAFE COVID+ (ImmuSAFE) comprising 6 functionally validated domains or regions of the N protein of SARS-CoV-2 expressed using Sengenics KREX technology.', 0.6727837), ('This array platform enables determination of both the position and breadth of anti-SARS-CoV-2 antibody responses following natural infection or vaccination.', 0.6695852), ('To validate our platform, 100 serum samples (confirmed sero-positive COVID-19 cases, n=50; pre-pandemic HIV positive controls, n=50) were tested for IgG seropositivity to the N antigen, yielding 100% specificity and 100% sensitivity.', 0.64681983), ('The vast majority of these tests are qualitative and use a single target for antibody detection, incorporating either full-length or truncated versions of the nucleocapsid (N) or spike (S) proteins from SARS- CoV-2.', 0.58048), ('This finding may have broad implications for the natural history of COVID-19 disease in different individuals.', 0.5436435)]"
2158,RELIEF THERAPEUTICS AND NEURORX MEET 165 PATIENT ENROLLMENT TARGET IN PHASE 2B/3 TRIAL OF RLF-100™ FOR CRITICAL COVID-19 WITH RESPIRATORY FAILURE,165,relief therapeutics and neurorx meet _ patient enrollment target in phase 2b/3 trial of rlf-100™ for critical covid-19 with respiratory failure,relief therapeutics and neurorx meet one patient enrollment target in phase 2b/3 trial of rlf-100™ for critical covid-19 with respiratory failure,https://relieftherapeutics.com/newsblog/relief-therapeutics-and-neurorx-meet-165-patient-enrollment-target-in-phase-2b-3-trial-of-rlf-100-for-critical-covid-19-with-respiratory-failure,"[('RLF-100™ is being investigated in two placebo-controlled US Phase 2b/3 clinical trials in respiratory deficiency due to COVID-19.', 0.69309753), ('In addition to the ongoing phase 2b/3 trial, more than 200 patients with Critical COVID-19 and respiratory failure have been treated in an FDA-approved, Expanded Access Protocol (EAP) for RLF-100™.', 0.6829437), ('Since July 2020, more than 300 patients with Critical COVID-19 and Respiratory Failure have been treated with RLF-100™ between the two FDA-approved protocols (randomized and expanded access).', 0.6746061), ('The results reported herein may or may not be indicative of the results of future and larger clinical trials for RLF-100™ for the treatment of COVID-19.', 0.56446993), ('While the companies have focused first on those patients who have no medical alternative and are at immediate risk of death, a phase 2b/3 trial with RLF-100™ for inhaled use in patients with moderate and severe COVID-19 in order to prevent progression to respiratory failure is expected to start soon.', 0.52592814)]"
2161,SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues,human,sars-cov-2 receptor ace2 is an interferon-stimulated gene in _ airway epithelial cells and is detected in specific cell subsets across tissues,sars-cov-2 receptor ace2 is an interferon-stimulated gene in canine airway epithelial cells and is detected in specific cell subsets across tissues,https://www.sciencedirect.com/science/article/pii/S0092867420305006,"[('Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium.', 0.79088557), ('SARS-CoV-2 spike (S) protein binds angiotensin-converting enzyme 2 (ACE2), and in concert with host proteases, principally transmembrane serine protease 2 (TMPRSS2), promotes cellular entry.', 0.7492834), ('We identify ACE2 and TMPRSS2 co-expressing cells within lung type II pneumocytes, ileal absorptive enterocytes, and nasal goblet secretory cells.', 0.73672533), ('Co- expression of ACE2 and TMPRSS2 by epithelial cell subset.', 0.7103399), ('Our data suggest that SARS-CoV-2 could exploit species- specific interferon-driven upregulation of ACE2, a tissue-protective mediator during lung injury, to enhance infection.', 0.6812664)]"
2162,Game-changer insights and recommendations from patterns of multi-organ involvement and affected subgroups in COVID-19,involvement,game-changer insights and recommendations from patterns of multi-organ _ and affected subgroups in covid-19,game-changer insights and recommendations from patterns of multi-organ dysfunction and affected subgroups in covid-19,https://journals.lww.com/cardiovascularendocrinology/FullText/2020/09000/Is_it_infection_or_rather_vascular_inflammation_.10.aspx,"[(""We recount the suggested inflammatory pathway for COVID-19 and its effects on various organ systems, including respiratory, cardiac, hematologic, reproductive, and nervous organ systems, as well examine the role of hypercytokinemia in the at-risk geriatric and obesity subgroups with upregulated cytokines' profile."", 0.61713576), ('1 Summary of COVID-19 inflammatory cascade and multi-organ involvement and possible pathogenic mechanisms underlying it.', 0.5949), ('1 Summary of COVID-19 inflammatory cascade and multi-organ involvement and possible pathogenic mechanisms underlying… Fig.', 0.5910786), ('Current evidence suggests that COVID-19 pathogenesis majorly involves microvascular injury induced by hypercytokinemia, namely interleukin 6 (IL-6).', 0.5722099), ('1 Summary of COVID-19 inflammatory cascade… Fig.', 0.5358598)]"
2164,Amazon deploys thermal cameras at warehouses to scan for fevers faster,amazon,_ deploys thermal cameras at warehouses to scan for fevers faster,Methods deploys thermal cameras at warehouses to scan for fevers faster,https://www.reuters.com/article/us-health-coronavirus-amazon-com-cameras-idUSKBN2200HT,"[('Early this month, Amazon said it would offer face masks and start checking hundreds of thousands of people for fevers daily at all its U.S. and European warehouses.', 0.75428224), ('Amazon confirmed that some warehouses have implemented the systems to streamline checks.', 0.6941426), ('Thermal cameras will also replace thermometers at worker entrances to many of Amazon’s Whole Foods stores, according to a recent staff note seen by Reuters and previously reported by Business Insider.', 0.6264777), ('Cases of the virus have been reported among staff at more than 50 of Amazon’s U.S. warehouses.', 0.6208079), ('How widely Amazon will deploy the technology at a time when camera makers are grappling with a surge in demand could not be determined.', 0.5978812)]"
2165,Overweight and obesity are risks factors of severe illness in patients with COVID-19,with,overweight and obesity are risks factors of severe illness in patients _ covid-19,overweight and obesity are risks factors of severe illness in patients without covid-19,https://pubmed.ncbi.nlm.nih.gov/32735706/,"[('Having obesity puts people at risk for many other serious chronic diseases and increases the risk of severe illness from COVID-19.', 0.88729435), ('Having obesity may triple the risk of hospitalization due to a COVID-19 infection.', 0.809623), ('Overweight, Obesity and Severe Obesity Having obesity, defined as a body mass index (BMI) between 30 kg/m2 and <40 kg/m2 or severe obesity (BMI of 40 kg/m2 or above), increases your risk of severe illness from COVID-19.', 0.8091576), ('Conclusions: Overweight and obesity were independent risk factors of severe illness in COVID-19 patients.', 0.76028854), ('Top of Page Hispanic and non-Hispanic Black adults have a higher prevalence of obesity and are more likely to suffer worse outcomes from COVID-19.', 0.7601161)]"
2167,Oxford COVID-19 vaccine begins human trial stage,begins,oxford covid-19 vaccine _ human trial stage,oxford covid-19 vaccine against human trial stage,https://www.research.ox.ac.uk/Article/2020-04-23-oxford-covid-19-vaccine-begins-human-trial-stage,"[('"">Video of Human trial of new COVID-19 vaccine begins The Oxford Vaccine Centre COVID-19 Phase I Clinical Trial Explained The study is to test a new vaccine against COVID-19 in healthy volunteers.', 0.8547834), ('It aims to assess whether healthy people can be protected from COVID-19 with this new vaccine called ChAdOx1 nCoV-19.', 0.6950364), ('To ensure you have the latest information or to find out more about the trial, please visit theOxford COVID-19 vaccine web hub or visit the COVID-19 trial website .', 0.68781596), ('The main focus of the study is to find out if this vaccine is going to work against COVID-19, if it won’t cause unacceptable side effects and if it induces good immune responses.', 0.6742084), ('To assess whether the vaccine works to protect from COVID-19, the statisticians in our team will compare the number of infections in the control group with the number of infections in the vaccinated group.', 0.6716057)]"
2168,Gilead to begin clinical trials of inhaled version of remdesivir,begin,gilead to _ clinical trials of inhaled version of remdesivir,gilead to improve clinical trials of inhaled version of remdesivir,https://www.moneycontrol.com/news/business/covid-19-treatment-gilead-to-begin-clinical-trials-of-inhaled-version-of-remdesivir-5442281.html,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.20498554), ('[c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 10:30 AM [Today]: Sunday, January 17, 2021 at 6:45 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:30 AM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students [January 14]: Thursday, January 14, 2021 at 10:09 AM [January 10]: Sunday, January 10, 2021 at 9:29 AM [January 5]: Tuesday, January 5, 2021 at 6:05 AM [on April 4, 2020]: Saturday, April 4, 2020 11:38 PM [Tel:]: Phone number [May 30, 2019 at 9:42 PM]: Thursday, May 30, 2019 at 9:42 PM [March 14, 2019 at 3:03 PM]: Thursday, March 14, 2019 at 3:03 PM [November 12, 2018 at 10:57 PM]: Monday, November 12, 2018 at 10:57 PM [December 25, 2020 at 12:09 PM]: Friday, December 25, 2020 at 12:09 PM [November 24, 2020]: Tuesday, November 24, 2020 at 9:28 AM [ November 5, 2020]: Thursday, November 5, 2020 at 5:36 PM [ November 1, 2020]: Sunday, November 1, 2020 at 1:52 PM [October 26, 2020]: Monday, October 26, 2020 at 6:36 PM [ October 15, 2020]: Thursday, October 15, 2020 at 12:38 PM [ October 7, 2020]: Wednesday, October 7, 2020 at 5:08 PM [August 9, 2020]: Sunday, August 9, 2020 at 8:53 PM [August 7, 2020]: Friday, August 7, 2020 at 6:19 AM [July 4, 2020]: Saturday, July 4, 2020 at 2:55 PM [ July 2, 2020]: Thursday, July 2, 2020 at 8:45 AM [June 30, 2020]: Tuesday, June 30, 2020 at 9:36 AM [June 27, 2020]: Saturday, June 27, 2020 at 7:51 PM [June 18, 2020]: Thursday, June 18, 2020 at 4:20 PM [June 16, 2020]: Tuesday, June 16, 2020 at 7:15 PM [June 14, 2020]: Sunday, June 14, 2020 at 11:40 AM [June 10, 2020]: Wednesday, June 10, 2020 at 7:53 PM [MA]: Massachusetts [Tue]: Tuesday [Jun]: June [m ]: minutes [s]: seconds [m]: minutes [Mon]: Monday [Jan]: January [h]: hour', 0.10032515)]"
2169,Gaps in early surveillance of coronavirus led to record-breaking US trajectory,gaps,_ in early surveillance of coronavirus led to record-breaking us trajectory,Efforts in early surveillance of coronavirus led to record-breaking us trajectory,https://news.nd.edu/news/gaps-in-early-surveillance-of-coronavirus-led-to-record-breaking-us-trajectory/,"[('The study provides insight into how limited testing and gaps in surveillance during the initial phase of the epidemic resulted in so many cases going undetected.', 0.6063379), ('The potential for misdiagnosis and the limitations of surveillance are huge issues across infectious diseases, especially emerging infectious diseases, he added.', 0.58868647), (""A significant aspect of the analysis is the model's incorporation of many uncertainties that played out in the early days of the epidemic in the US, which Perkins said speaks to the inherent nature of a novel and emerging infectious disease."", 0.5006144), ('As illustrated in the COVID-19 study, while public health officials must work quickly to understand how a new virus functions, without appropriate testing or coordinated response strategies the risk grows for infections to go unreported.', 0.49128908), ('Part of it was the availability of testing, but another huge part was case definitions and the fact that they were overly restrictive early on.""', 0.46393633)]"
2170,Broad phenotypic alterations and potential dysfunctions of lymphocytes in COVID-19 recovered individuals,recovered,broad phenotypic alterations and potential dysfunctions of lymphocytes in covid-19 _ individuals,broad phenotypic alterations and potential dysfunctions of lymphocytes in covid-19 infected individuals,https://www.medrxiv.org/content/10.1101/2020.07.01.20144030v1,"[('Interpretation The CR COVID-19 individuals still showed remarkable phenotypic alterations in lymphocytes after clinical recovery 4 to 11 weeks.', 0.6546973), ('Methods A clinical recovered cohort (CR) of 55 COVID-19 individuals (discharged from hospital 4 to 11 weeks), and 55 age and sex matched healthy donors cohort (HD) were recruited.', 0.4951084), ('Detailed analysis on phenotype of the lymphocytes in peripheral blood mononuclear cells (PBMCs) was performed by flow cytometry.', 0.4736497), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.4349407), ('This suggests SARS-CoV-2 infection imprints profoundly on lymphocytes and results in long-lasting potential dysfunctions.', 0.41686714)]"
2171,Selenium Deficiency Is Associated with Mortality Risk from COVID-19,deficiency,selenium _ is associated with mortality risk from covid-19,selenium growth is associated with mortality risk from covid-19,https://www.mdpi.com/2072-6643/12/7/2098,"[('We hypothesized that this relation also applies to COVID-19.', 0.5431248), ('The mortality risk from a severe disease like sepsis or polytrauma is inversely related to Se status.', 0.42477614), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.28814834), ('In comparison with reference data from a European cross-sectional analysis (EPIC, n = 1915), the patients showed a pronounced deficit in total serum Se (mean ± SD, 50.8 ± 15.7 vs. 84.4 ± 23.4 µg/L) and SELENOP (3.0 ± 1.4 vs. 4.3 ± 1.0 mg/L) concentrations.', 0.27677774), ('View Full-Text Keywords: trace element; inflammation; selenoprotein P; micronutrient; COVID-19 trace element; inflammation; selenoprotein P; micronutrient; COVID-19 ►▼ Show Figures Graphical abstract This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited ', 0.2700618)]"
2172,"Brilacidin , a COVID-19 Drug Candidate , Exhibits Potent In Vitro Antiviral Activity Against SARS-CoV-2",potent,"brilacidin , a covid-19 drug candidate , exhibits _ in vitro antiviral activity against sars-cov-2","brilacidin, a covid-19 drug candidate, exhibits no in vitro antiviral activity against sars-cov-2",https://www.biorxiv.org/content/10.1101/2020.10.29.352450v1,"[('Collectively, our data demonstrate that brilacidin exerts potent inhibition of SARS-CoV-2 and thus supports brilacidin as a promising COVID-19 drug candidate.', 0.90249825), ('We demonstrate that brilacidin, a synthetic small molecule with peptide-like properties, is capable of exerting potent in vitro antiviral activity against SARS-CoV-2, both as a standalone treatment and in combination with remdesivir, which is currently the only FDA-approved drug for the treatment of COVID-19.', 0.8105527), ('Brilacidin has demonstrated synergistic antiviral activity when combined with remdesivir.', 0.68401724), ('Brilacidin and remdesivir exhibit excellent synergistic activity against SARS-CoV-2.', 0.6567918), ('Significance Statement SARS-CoV-2, the emergent novel coronavirus, has led to the current global COVID-19 pandemic, characterized by extreme contagiousness and high mortality rates.', 0.5742961)]"
2174,Molecular Docking and Molecular Dynamic Study of Two Viral Proteins Associated with SARS-CoV-2 with Ivermectin,two,molecular docking and molecular dynamic study of _ viral proteins associated with sars-cov-2 with ivermectin,molecular docking and molecular dynamic study of three viral proteins associated with sars-cov-2 with ivermectin,https://www.preprints.org/manuscript/202004.0334/v1,"[('In this sense, we carried out a bioinformatics study with docking strategies and molecular dynamics to predict the binding and disturbance induced by ivermectin in proteins associated with SARS-CoV-2.', 0.79180545), ('These results suggest a possible inhibitory effect against SARS-CoV-2 due to a synergistic role of this drug to spontaneously bind to two important proteins involve in the proliferation of this virus.', 0.6175056), ('Within of this research it has been known that the ivermectin drug, a FDA-approved drugs which is formulated as an 80:20 mixture of ivermectin B1a and B1b and used commonly for parasitic infections, has an inhibitory effect on viruses, includes SARS-COV-2 at in vitro level.', 0.58773744), ('Specifically, ivermectin brings protease to a significantly more deployed conformational state and the HR2 domain to a more compact state compared to the native state.', 0.56902933), ('The results obtained suggested that ivermectin is capable of docking with the 3CL protease and the HR2 domain, and may promote structural changes in these proteins by inducing unfolding/folding.', 0.551316)]"
2175,IgA dominates the early neutralizing antibody response to SARS-CoV-2,early,iga dominates the _ neutralizing antibody response to sars-cov-2,iga dominates the full neutralizing antibody response to sars-cov-2,https://www.medrxiv.org/content/10.1101/2020.06.10.20126532v1,"[('2 Antibody responses kinetics to SARS-CoV-2 proteins.', 0.78087854), ('Early SARS- CoV-2-specific humoral responses were dominated by IgA antibodies.', 0.76416993), ('Our results show that human IgA antibodies are often detectable before the appearance of SARS-CoV-2-specific IgG and suggest a role for IgA antibodies in early virus neutralization.', 0.7616149), ('L. Zhang , Human neutralizing antibodies elicited by SARS-CoV-2 infection.', 0.74005556), ('Our results show that serum IgA, particularly anti-RBD IgA, are detected earlier compared with IgG, and the dramatic plasmablast expansion that follows SARS-CoV-2 infection is dominated by IgA-secreting cells (Fig.', 0.7172651)]"
2176,In silico mutagenesis of human ACE2 with S protein and translational efficiency explain SARS-CoV-2 infectivity in different species,human,in silico mutagenesis of _ ace2 with s protein and translational efficiency explain sars-cov-2 infectivity in different species,in silico mutagenesis of bat ace2 with s protein and translational efficiency explain sars-cov-2 infectivity in different species,https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1008450,"[('SARS-CoV-2 translational efficiency and ACE2 expression across species.', 0.7866667), ('Genomic variability across species, including humans, results in ACE2 variants that destabilize its fold, modify ACE2/SARS- CoV-2 recognition, or both.', 0.70241785), ('We observed that humans are the species in which SARS- CoV-2 is both most efficiently translated as well as optimally interacting with ACE2.', 0.6945591), ('SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.', 0.6881966), ('Two significant factors conditioning infection are ACE2-mediated SARS-CoV-2 cellular entry and viral proteome translation efficiency.', 0.68488616)]"
2178,Authors called the gap between children and adults puzzling and said it may be related to both exposure and host factors .,may,authors called the gap between children and adults puzzling and said it _ be related to both exposure and host factors .,authors called the gap between children and adults puzzling and said it cannot be related to both exposure and host factors.,https://www.aappublications.org/news/2020/03/16/coronavirus031620,"[('However, advertisers and the media can mislead parents about how to best support and encourage their children’s growth and development as well as creativity.', 0.57342017), ('“That’s a big variable because we know asymptomatic shedding is actually probably more likely to perpetuate an epidemic within a population,” she said.', 0.57280326), ('Parental guilt has led to competition over who can schedule more “enrichment opportunities” for their children.', 0.55832905), ('Investigating the gap between prediction and action in toddlers’ causal inferences.', 0.5403385), ('Experts also say more testing and research will be needed to understand children’s role in spreading the virus in their communities.', 0.5294831)]"
2181,Immunogenic profile of SARS-CoV-2 spike in individuals recovered from COVID-19,recovered,immunogenic profile of sars-cov-2 spike in individuals _ from covid-19,immunogenic profile of sars-cov-2 spike in individuals suffering from covid-19,https://www.medrxiv.org/content/10.1101/2020.05.17.20104869v1,"[('To address this, we undertook an in-depth characterisation of humoral and cellular immunity against SARS-CoV-2 spike in humans following mild to moderate SARS-CoV-2 infection.', 0.5214494), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.46247283), ('Thus both qualitative and quantitative features of B and T cell immunity to spike constitute informative biomarkers of the protective potential of novel SARS-CoV-2 vaccines.', 0.4000092), ('We find serological antibody responses against spike are routinely elicited by infection and correlate with plasma neutralising activity and capacity to block ACE2/RBD interaction.', 0.3727742), ('Expanded populations of spike-specific memory B cells and circulating T follicular helper cells (cTFH) were detected within convalescent donors, while responses to the receptor binding domain (RBD) constitute a minor fraction.', 0.35965443)]"
2182,Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New Zealand,transmission,genomic epidemiology reveals _ patterns and dynamics of sars-cov-2 in aotearoa new zealand,genomic epidemiology reveals evolutionary patterns and dynamics of sars-cov-2 in aotearoa new zealand,https://www.medrxiv.org/content/10.1101/2020.08.05.20168930v2,"[('2: Genomic diversity of SARS-CoV-2 in New Zealand.', 0.88405657), ('d The sampling location and proportion of SARS-CoV-2 genomes sampled from each viral genomic lineage is shown on the map of New Zealand.', 0.79661715), ('3: Genomic transmission lineages of SARS-CoV-2 in New Zealand.', 0.7934009), ('A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology.', 0.7149422), ('Notably, the genomic diversity of SARS-CoV-2 sequences sampled in New Zealand represented nearly all of the genomic diversity present in the global viral population, with nine second-level A and B lineages from a proposed global SARS-CoV-2 genomic nomenclature17 identified.', 0.7048571)]"
2184,Florida sheriff bans his deputies and office visitors from wearing masks on a day his county broke records for Covid-19 deaths,ban,florida sheriff _ his deputies and office visitors from wearing masks on a day his county broke records for covid-19 deaths,florida sheriff backs his deputies and office visitors from wearing masks on a day his county broke records for covid-19 deaths,https://www.cnn.com/2020/08/12/us/sheriff-no-mask-ocala-trnd/index.html,"[('(CNN)A mandate from a local sheriff in Florida is going against the recommendations from scientists and government officials: masks will not be worn.', 0.7321501), (""It's official: The CDC wants you to wear a mask There have been more than 550,000 coronavirus cases in Florida, with almost 9,000 deaths, according to Johns Hopkins University."", 0.48781836), ('Experts say US is not doing enough to contain Covid-19 as nation approaches 5 million cases Woods then listed out a few exceptions when masks need to be worn: at the courthouse, schools, hospitals and while on patrol and responding to a nursing home or involving a ""High Risk Elderly individual,"" he said in the email.', 0.4799532), ('The mandate came as the City of Ocala, Florida put a required Mask Mandate Ordinance in place in an effort to slow the spread of the coronavirus pandemic.', 0.47555834), ('The Ocala City Council passed an emergency ordinance last week, requiring masks inside businesses.', 0.4748888)]"
2187,Prolonged viral RNA shedding after COVID-19 symptom resolution in older convalescent plasma donors,rna,prolonged viral _ shedding after covid-19 symptom resolution in older convalescent plasma donors,prolonged viral fecal shedding after covid-19 symptom resolution in older convalescent plasma donors,https://www.medrxiv.org/content/10.1101/2020.05.07.20090621v1,"[('Objective To determine how long the SARS-CoV-2 remains detectable following self-reporting of viral symptom resolution.', 0.50136495), ('Conclusions and Resolution These results underscore the necessity of testing COVID-19 convalescent plasma donors less than 28 days after symptom resolution and suggests that COVID-19 positive patients may need to remain in quarantine beyond the recommended two weeks following “recovery.” Trial Registration n/a ', 0.4990782), ('Results 11/86 (13%) previously confirmed SARS-CoV-2 subjects were still positive at a median of 19 days (range 12-24 days) after symptom resolution.', 0.48547578), ('Main Outcome SARS-CoV-2 RNA in nasopharyngeal secretions detected by rtPCR.', 0.48314285), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.4600465)]"
2188,A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19,severe,a trial of lopinavir–ritonavir in adults hospitalized with _ covid-19,a trial of lopinavir–ritonavir in adults hospitalized with acute covid-19,https://www.nejm.org/doi/full/10.1056/NEJMoa2001282,"[('These observations are hypothesis-generating and require additional studies to determine whether lopinavir–ritonavir treatment given at a certain stage of illness can reduce some complications in Covid-19.', 0.65607876), ('The question of whether earlier lopinavir–ritonavir treatment in Covid-19 could have clinical benefit is an important one that requires further study.', 0.6487931), ('A recent report showed that the median duration of viral shedding in Covid-19 was 20 days in patients with severe illness and could be as long as 37 days.24 Neither that study nor the current one found evidence that lopinavir–ritonavir exerted a significant antiviral effect.', 0.6413958), ('Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19 M.J. Joyner et al.', 0.63784236), ('Chinnery Editorial Covid-19 -- The Search for Effective Therapy L.R.', 0.6162596)]"
2189,Universal Screening for SARS-CoV-2 in Women Admitted for Delivery,screening,universal _ for sars-cov-2 in women admitted for delivery,universal therapy for sars-cov-2 in women admitted for delivery,https://www.nejm.org/doi/full/10.1056/NEJMc2009316,"[('Our use of universal SARS-CoV-2 testing in all pregnant patients presenting for delivery revealed that at this point in the pandemic in New York City, most of the patients who were positive for SARS-CoV-2 at delivery were asymptomatic, and more than one in eight asymptomatic patients who were admitted to the labor and delivery unit were positive for SARS-CoV-2.', 0.76854646), ('Symptom Status and SARS-CoV-2 Test Results among 215 Obstetrical Patients Presenting for Delivery.', 0.62267137), ('We first diagnosed a case of Covid-19 in an obstetrical patient on March 13, 2020, and we previously reported our early experience with Covid-19 in pregnant women, including two initially asymptomatic women in whom symptoms developed and who tested positive for SARS-CoV-2, the virus that causes Covid-19, after delivery.1,2 After these two cases were identified, we implemented universal testing with nasopharyngeal swabs and a quantitative polymerase-chain-reaction test to detect SARS-CoV-2 infection in women who were admitted for delivery.', 0.61871874), ('Four women (1.9%) had fever or other symptoms of Covid-19 on admission, and all 4 women tested positive for SARS-CoV-2 (Figure 1).', 0.56011444), ('Of the 29 women who had been asymptomatic but who were positive for SARS-CoV-2 on admission, fever developed in 3 (10%) before postpartum discharge (median length of stay, 2 days).', 0.53891003)]"
2190,High ACE2 expression in testes suggests possible existence of gender-specific viral reservoirs,expression,high ace2 _ in testes suggests possible existence of gender-specific viral reservoirs,high ace2 deficiency in testes suggests possible existence of gender-specific viral reservoirs,https://www.medrxiv.org/content/10.1101/2020.04.16.20060566v1,"[('High expression of ACE2 in testes raises the possibility that testicular viral reservoirs may play a role in viral persistence in males and should be further investigated.', 0.74550915), ('ACE2 was also determined to be highly expressed in testicular cells at the protein levels.', 0.6815436), ('We observed that the testes was one of the highest sites of ACE2 expression in 3 independent RNA expression databases (Human Protein Atlas, FAMTOM5 and GETx).', 0.5281177), ('We observed that females were able to achieve viral clearance significantly earlier than males, with a median difference of 2 days in achieving a negative PCR result (P value = 0.038).', 0.44123566), ('To determine reasons for delayed clearance in males, we examined the expression patterns of the SARS-CoV2 receptor, Angiotensin- converting enzyme 2 (ACE2), in tissue specific repositories.', 0.42482653)]"
2191,Nsp1 of SARS-CoV-2 Stimulates Host Translation Termination,termination,nsp1 of sars-cov-2 stimulates host translation _,nsp1 of sars-cov-2 stimulates host translation.,https://www.biorxiv.org/content/10.1101/2020.11.11.377739v1,"[('We identify that activity of Nsp1 in translation termination is localized in its N-terminal domain.', 0.75574046), ('Using a cell-free translation system and reconstituted in vitro translation system, we reveal that Nsp1 stimulates translation termination in the stop codon recognition stage.', 0.73855066), ('Considering the presence of Nsp1 in the post- termination 80S ribosomal complex simultaneously with eRF1, we hypothesized that Nsp1 may be involved in translation termination.', 0.6982137), ('We show the direct influence of Nsp1 on translation termination.', 0.69264686), ('Nsp1 inhibits host translation initiation by binding to the entry channel of the 40S ribosome subunit.', 0.65054476)]"
2192,Isolation of cross-reactive monoclonal antibodies against divergent human coronaviruses that delineate a conserved and vulnerable site on the spike protein,spike,isolation of cross-reactive monoclonal antibodies against divergent human coronaviruses that delineate a conserved and vulnerable site on the _ protein,isolation of cross-reactive monoclonal antibodies against divergent human coronaviruses that delineate a conserved and vulnerable site on the envelope protein,https://www.biorxiv.org/content/10.1101/2020.10.20.346916v1,"[('Collectively, these antibodies delineate a conserved, immunogenic and vulnerabe site on the spike protein which spurs the development of broad-range diagnostic, preventive and therapeutic measures against coronaviruses.', 0.75731146), ('Here we describe two human monoclonal antibodies, 1.6C7 and 28D9, that display a remarkable cross- reactivity against distinct species from three Betacoronavirus subgenera, capable of binding the spike proteins of SARS-CoV and SARS-CoV-2, MERS-CoV and the endemic human coronavirus HCoV-OC43.', 0.72092164), ('Both cross-reactive monoclonal antibodies were found to target the stem helix in the spike protein S2 fusion subunit which, in the prefusion conformation of trimeric spike, forms a surface exposed membrane-proximal helical bundle, that is antibody-accessible.', 0.7204731), ('Both antibodies, derived from immunized transgenic mice carrying a human immunoglobulin repertoire, blocked MERS-CoV infection in cells, whereas 28D9 also showed weak cross-neutralizing potential against HCoV-OC43, SARS-CoV and SARS-CoV-2 in a neutralization- sensitive virus pseudotyping system, but not against authentic virus.', 0.58614653), ('are inventors on a patent application on monoclonal antibodies targeting MERS-CoV (patent publication no.', 0.5493653)]"
2193,Professional and Home-Made Face Masks Reduce Exposure to Respiratory Infections Among the General Population,reduce,professional and home-made face masks _ exposure to respiratory infections among the general population,professional and home-made face masks show exposure to respiratory infections among the general population,https://pubmed.ncbi.nlm.nih.gov/18612429/,"[('Masks worn by patients may not offer as great a degree of protection against aerosol transmission.', 0.7402024), ('Conclusions/significance: Any type of general mask use is likely to decrease viral exposure and infection risk on a population level, in spite of imperfect fit and imperfect adherence, personal respirators providing most protection.', 0.70774937), ('Face- masks worn by the general population could be an accessible and affordable intervention, if effective when worn under routine circumstances.', 0.6972405), ('Outward protection (mask wearing by a mechanical head) was less effective than inward protection (mask wearing by healthy volunteers).', 0.631822), ('Outward protection factors at a range of breathing flows for a mechanical head with different types of masks, with two meaurements per mask at each breathing flow.', 0.615165)]"
2196,Nurses and other union workers authorize Oct. 7 strike against East Bay hospitals,oct,nurses and other union workers authorize _. 7 strike against east bay hospitals,nurses and other union workers authorize Dr. 7 strike against east bay hospitals,https://www.sfchronicle.com/bayarea/amp/Nurses-and-other-union-workers-authorize-Oct-7-15599975.php,"[('Photo: Paul Chinn / The Chronicle Employees in the Alameda Health System -- which largely serves minority communities -- plan to begin a five-day strike on Oct. 7, the California Nurses Association announced Saturday.', 0.6453451), ('The release said that there has been a lack of proper isolation rooms for patients suffering from COVID-19, along with insufficient personal protective equipment for the staff, which has concerned nurses.', 0.5359151), ('Emergency room staff has been cut, the release said, and severe staffing has left nurse managers doing the work of bedside nurses, the union said.', 0.51287967), ('In a release, the union said the strike authorization was spurred by concerns over patient safety during the pandemic, along with what it called punitive actions from management at the Alameda Health System that have hindered recruitment and the retention of registered nurses.', 0.47944456), ('Nurses at Highland Hospital, which are represented by SEIU Local 1021, also intend to strike.', 0.45730436)]"
2197,Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy,laboratory,birth and infant outcomes following _-confirmed sars-cov-2 infection in pregnancy,birth and infant outcomes following community-confirmed sars-cov-2 infection in pregnancy,https://www.cdc.gov/mmwr/volumes/69/wr/mm6944e2.htm,"[('Infant outcomes following maternal infection with SARS-CoV-2: first report from the PRIORITY study.', 0.78127694), ('These findings can inform neonatal testing recommendations, clinical practice, and public health action and can be used by health care providers to counsel pregnant women on the risks of SARS-CoV-2 infection, including preterm births.', 0.685026), ('Characteristics of laboratory-confirmed infection among infants born to pregnant women with laboratory-confirmed SARS-CoV-2 infection -- SET-NET, 13 jurisdictions, March 29-October 14, 2020 Characteristic ', 0.6414833), ('It is important that providers counsel pregnant women on measures to prevent SARS-CoV-2 infection.', 0.63027084), ('Perinatal infection was uncommon (2.6%) among infants known to have been tested for SARS-CoV-2 and occurred primarily among infants born to women with infection within 1 week of delivery.', 0.61892235)]"
2199,Masks Dont Work : A review of science relevant to COVID-19 social policy,social,masks dont work : a review of science relevant to covid-19 _ policy,masks dont work : a review of science relevant to covid-19 biology policy,https://www.researchgate.net/publication/340570735_Masks_Don't_Work_A_review_of_science_relevant_to_COVID-19_social_policy,"[('Available from: https://www.rcreader.com/commentary/masks-dont-work-covid-a- review-of-science-relevant-to-covide-19-social- policy?fbclid=IwAR1iezfxlpuJneVh6AgFlpZND3-2-qlaZO53vXF6UHO-KRKxvFupTbgOrdk.', 0.65380657), ('Furthermore, the relevant known physics and biology, which I review, are such that masks and respirators should not work.', 0.5544335), ('To date, there have been no randomized controlled trials designed to test the efficacy of cloth masks in the context of COVID-19, making it difficult for healthcare providers to offer definitive answers.', 0.52933455), ('Transmission of COVID-19 virus by droplets and aerosols: a critical review on the unresolved dichotomy.', 0.52722436), ('The present paper about masks illustrates the degree to which governments, the mainstream media, and institutional propagandists can decide to operate in a science vacuum, or select only incomplete science that serves their interests.', 0.49568605)]"
2200,Pharmaceutical Companies are so Financially Powerful They Pressure us to Accept Papers,accept,pharmaceutical companies are so financially powerful they pressure us to _ papers,pharmaceutical companies are so financially powerful they pressure us to develop papers,https://healthimpactnews.com/2020/editors-of-the-lancet-and-the-new-england-journal-of-medicine-pharmaceutical-companies-are-so-financially-powerful-they-pressure-us-to-accept-papers/,"[('He revealed that at a recent Chatham House top secret, closed door meeting attended by experts only, the editors of both The Lancet and the New England Journal of Medicine expressed their exasperation, citing the pressures put on them by pharmaceutical companies.', 0.5566624), ('Big Pharma and government health authorities are trying to pass laws mandating vaccines for all children, and even adults.', 0.44221294), ('Examples of countries and physicians who have witnessed the effectiveness of the HCQ – Az combination as a treatment for covid-19, are viewed by corporate- government collaborating partners as posing a major threat to their marketing agendas.', 0.4360168), ('The medical scientific literature is infested with financially motivated, shoddy, studies aimed at promoting products and, when a life-saving, non- patentable product, proves effective, scientists are hired to author study reports that are designed to tarnish scientists’ reputations, and to proclaim findings that refute legitimate findings.', 0.42607045), ('However, public health officials, academic physicians and the media – all of who are financially indebted to pharmaceutical companies and their high profit marketing objectives – vehemently oppose the use of HCQ, and use every opportunity to disparage the drug by derisively referring to President Trump as its booster.', 0.4214457)]"
2201,"We believe we assembled the most comprehensive , open individual case dataset for Novel Coronavirus",novel,"we believe we assembled the most comprehensive , open individual case dataset for _ coronavirus","we believe we assembled the most comprehensive, open individual case dataset for SARS coronavirus",https://www.dolthub.com/blog/2020-03-12-coronavirus-case-details-dolt/,"[('We believe this is the biggest public individual Novel Coronavirus case details assembled.', 0.81552315), ('A novel > coronavirus, SARS-CoV-2, was identified to be accountable for this disease.', 0.6334821), ('The Singapore government is publishing extremely detailed Novel Coronavirus case details for all 160 or so infected patients in Singapore.', 0.6161378), ('Share Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal Ranjit Sah, Alfonso J. Rodriguez-Morales, Runa Jha, Daniel K. W. Chu, Haogao Gu, Malik Peiris, Anup Bastola, Bibek Kumar Lal, Hemant Chanda Ojha, Ali A. Rabaan, Lysien I. Zambrano, Anthony Costello, Kouichi Morita, Basu Dev Pandey, Leo L. M. Poon Microbiology Resource Announcements Mar 2020, 9 (11) e00169-20; DOI: 10.1128/MRA.00169-20 Share This Article: Copy Top Article ABSTRACT ANNOUNCEMENT ACKNOWLEDGMENTS FOOTNOTES REFERENCES Figures & Data Info & Metrics PDF ', 0.6024889), ('Data availability.This sequence has been deposited in GenBank under the accession number MT072688 and at the GISAID EpiCoV newly emerging coronavirus SARS-CoV-2 platform under identifier EPIISL410301.', 0.575022)]"
2202,One scientist 's six-point recovery plan to tackle COVID-19 anxiety,point,one scientist 's six-_ recovery plan to tackle covid-19 anxiety,one scientist's six-minute recovery plan to tackle covid-19 anxiety,https://www.nature.com/articles/d41586-020-02298-1,"[('Nature ( IF 42.778 ) Pub Date : 2020-08-03 , DOI: 10.1038/d41586-020-02298-1 Fernando T Maestre Fernando T. Maestre was diagnosed with anxiety during Spain’s coronavirus lockdown.', 0.3276739), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.29785204), ('A change in approach to work, life and parenting helped to restore his health.', 0.25268915), ('中文翻译： 一位科学家为应对COVID-19焦虑症而制定的六点康复计划。 Fernando T. Maestre在西班牙冠状病毒封锁期间被诊断出患有焦虑症。工作，生活和养育子女方式的改变帮助他恢复了健康。 更新日期：2020-08-04 点击分享 查看原文 点击收藏 取消收藏 阅读更多本刊最新论文 本刊投稿指南 全部期刊列表>> 学术期刊 行业资讯 全球导师 X-MOL问答 求职广场 网址导航 关于我们 帮助中心 客服邮箱：service@x-mol.com 官方微信：X-molTeam2 邮编：100098 地址：北京市海淀区知春路56号中航科技大厦 Copyright © 2014-2020 北京衮雪科技有限公司 All Rights Reserved 京ICP备11026495-2号 京公网安备 11010802027423号 down wechat bug [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.176012), ('[c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 10:30 AM [Today]: Sunday, January 17, 2021 at 6:45 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:30 AM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students [January 14]: Thursday, January 14, 2021 at 10:09 AM [January 10]: Sunday, January 10, 2021 at 9:29 AM [January 5]: Tuesday, January 5, 2021 at 6:05 AM [on April 4, 2020]: Saturday, April 4, 2020 11:38 PM [Tel:]: Phone number [May 30, 2019 at 9:42 PM]: Thursday, May 30, 2019 at 9:42 PM [March 14, 2019 at 3:03 PM]: Thursday, March 14, 2019 at 3:03 PM [November 12, 2018 at 10:57 PM]: Monday, November 12, 2018 at 10:57 PM [December 25, 2020 at 12:09 PM]: Friday, December 25, 2020 at 12:09 PM [November 24, 2020]: Tuesday, November 24, 2020 at 9:28 AM [ November 5, 2020]: Thursday, November 5, 2020 at 5:36 PM [ November 1, 2020]: Sunday, November 1, 2020 at 1:52 PM [October 26, 2020]: Monday, October 26, 2020 at 6:36 PM [ October 15, 2020]: Thursday, October 15, 2020 at 12:38 PM [ October 7, 2020]: Wednesday, October 7, 2020 at 5:08 PM [August 9, 2020]: Sunday, August 9, 2020 at 8:53 PM [August 7, 2020]: Friday, August 7, 2020 at 6:19 AM [July 4, 2020]: Saturday, July 4, 2020 at 2:55 PM [ July 2, 2020]: Thursday, July 2, 2020 at 8:45 AM [June 30, 2020]: Tuesday, June 30, 2020 at 9:36 AM [June 27, 2020]: Saturday, June 27, 2020 at 7:51 PM [June 18, 2020]: Thursday, June 18, 2020 at 4:20 PM [June 16, 2020]: Tuesday, June 16, 2020 at 7:15 PM [June 14, 2020]: Sunday, June 14, 2020 at 11:40 AM [June 10, 2020]: Wednesday, June 10, 2020 at 7:53 PM [MA]: Massachusetts [Tue]: Tuesday [Jun]: June [m ]: minutes [s]: seconds [m]: minutes [Mon]: Monday [Jan]: January [h]: hour', 0.09953218)]"
2203,A new tool to control the spread of airborne-mediated microbial diseases,control,a new tool to _ the spread of airborne-mediated microbial diseases,a new tool to enhance the spread of airborne-mediated microbial diseases,https://www.nature.com/articles/s41598-018-21058-w?fbclid=IwAR0Iq6gfMF5Plf3x1r29AmyjIPMuFmhgSpKp9A0_KQxsJGvRXFd13TH9hPA,"[('If these results are confirmed in other scenarios, it follows that the use of overhead very low level far-UVC light in public locations may represent a safe and efficient methodology for limiting the transmission and spread of airborne-mediated microbial diseases.', 0.60535204), ('Common examples are influenza2, appearing in seasonal3 and pandemic4 forms, and bacterially-based airborne-mediated diseases such as tuberculosis5, increasingly emerging in multi-drug resistant form.', 0.587756), ('If these results are confirmed in other scenarios, it follows that the use of overhead low-level far-UVC light in public locations may represent a safe and efficient methodology for limiting the transmission and spread of airborne- mediated microbial diseases such as influenza and tuberculosis.', 0.5719449), ('Hollaender, A., du Buy, H. G., Ingraham, H. S. & Wheeler, S. M. Control of air-borne microorganisms by ultraviolet floor irradiation.', 0.5620976), ('A key advantage of the UVC based approach, which is in clear contrast to vaccination approaches, is that UVC light is likely to be effective against all airborne microbes.', 0.5568588)]"
2205,Exposures Before Issuance of Stay-at-Home Orders Among Persons with Laboratory-Confirmed COVID-19,before,exposures _ issuance of stay-at-home orders among persons with laboratory-confirmed covid-19,exposures include issuance of stay-at-home orders among persons with laboratory-confirmed covid-19,https://www.cdc.gov/mmwr/volumes/69/wr/mm6926e4.htm,"[('Reported relationships and settings † of exposure to persons with laboratory-confirmed COVID-19 among persons (N = 99) infected before institution of stay-at-home orders§ -- Colorado, March 2020 Abbreviation: COVID-19 = coronavirus disease 2019.', 0.65738034), ('These findings highlight the need for anyone with COVID-19-compatible symptoms to avoid public settings and isolate from other persons, even within their own household, when possible ( 1 , 2 ).', 0.5666785), ('Interim infection prevention and control recommendations for patients with suspected or confirmed coronavirus disease 2019 (COVID-19) in healthcare settings.', 0.55573034), (""To inform public health messaging and measures that could be used after reopening, persons with laboratory-confirmed COVID-19 during March 9-26 from nine Colorado counties comprising approximately 80% of the state's population† (Adams, Arapahoe, Boulder, Denver, Douglas, El Paso, Jefferson, Larimer, and Weld) were asked about possible exposures to SARS-CoV-2 before implementation of stay-at-home orders."", 0.555705), ('Interim guidance for businesses and employers responding to coronavirus disease 2019 (COVID-19), May 2020.', 0.52622527)]"
2209,Preliminary results of nationwide representative screening are out,out,preliminary results of nationwide representative screening are _,preliminary results of nationwide representative screening are!,https://index.hu/english/2020/05/12/coronavirus_hungary_preliminary_results_medical_universities_representative_screening/,"[('The results of the first nationwide representative screening will be released at the end of May.', 0.5903256), (""Researchers have no information on the whereabouts of 1589 people and they couldn't yet reach 1875 invitees, while 505 people are either dead or abroad, Béla Merkely, the rector of Semmelweis University told the press, adding that for the representative screening to be successful, they will need to have tested 11 200 people by the end of the operation on 14 May."", 0.3703249), ('Subjects are asked to fill a questionnaire before nasopharyngeal swabs and blood samples are taken from them.', 0.3385673), ('These preliminary results include those older than 14 who do not live in retirement homes or similar institutes.', 0.3079119), ('Még 75 cikk az aktában Töltés Support the independent media!', 0.21507889)]"
2212,Weekly national flu and COVID-19 surveillance reports published,surveillance,weekly national flu and covid-19 _ reports published,weekly national flu and covid-19 pandemic reports published,https://www.gov.uk/government/news/weekly-national-flu-and-covid-19-surveillance-reports-published,"[('It is therefore very encouraging to see record- > high uptake rates this season, especially among the groups most vulnerable > to flu, who are also most at-risk from COVID-19.', 0.5661093), ('The number of COVID-19-related deaths increased further.', 0.53802615), ('COVID-19 hospital and critical care admission rates continued to increase.', 0.51395357), ('Coronavirus (COVID-19) 3.', 0.50866777), ('By NHS regions, the highest hospital admission rates for COVID-19 were observed in the North West.', 0.49637204)]"
2213,Development of a COVID-19 vaccine based on the receptor binding domain displayed on virus-like particles,development,_ of a covid-19 vaccine based on the receptor binding domain displayed on virus-like particles,Treatment of a covid-19 vaccine based on the receptor binding domain displayed on virus-like particles,https://www.biorxiv.org/content/10.1101/2020.05.06.079830v1,"[('Rapid development of a protective vaccine against COVID-19 is therefore of paramount importance.', 0.69546163), ('Here we demonstrate that recombinantly expressed receptor binding domain (RBD) of the spike protein homologous to SARS binds to ACE2, the viral receptor.', 0.5328188), ('Higly repetitive display of RBD on immunologically optimized virus-like particles derived from cucumber mosaic virus resulted in a vaccine candidate (RBD- CuMVTT) that induced high levels of specific antibodies in mice which were able to block binding of spike protein to ACE2 and potently neutralized the SARS-CoV-2 virus in vitro.', 0.51947975), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: telephone [e]: email []: You need to accept this checkbox.', 0.47923088), ('Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.', 0.2770763)]"
2214,Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals,human,potently neutralizing _ antibodies that block sars-cov-2 receptor binding and protect animals,potently neutralizing mouse antibodies that block sars-cov-2 receptor binding and protect animals,https://www.biorxiv.org/content/10.1101/2020.05.22.111005v1.full,"[('In two murine models of SARS-CoV-2 infection, passive transfer of either COV2-2916 or COV2-2130 alone or a combination of both mAbs protected mice from severe weight loss and reduced viral burden and inflammation in the lung.', 0.55770147), ('These results identify protective epitopes on the SRBD and provide a structure-based framework for rational vaccine design and the selection of robust immunotherapeutic cocktails.', 0.4462152), ('Potent neutralizing mAbs recognizing unique sites, COV2-2196 and COV2-2130, bound simultaneously to S and synergistically neutralized authentic SARS-CoV-2 virus.', 0.44399372), ('From a panel of monoclonal antibodies (mAbs) targeting the spike (S) glycoprotein isolated from the B cells of infected subjects, we identified several mAbs that exhibited potent neutralizing activity with IC50 values as low as 0.9 or 15 ng/mL in pseudovirus or wild-type ( wt ) SARS-CoV-2 neutralization tests, respectively.', 0.40893286), ('The most potent mAbs fully block the receptor-binding domain of S (SRBD) from interacting with human ACE2.', 0.3817966)]"
2215,HKU Documented the World 's First Case of COVID-19 Reinfection,world,hku documented the _ 's first case of covid-19 reinfection,hku documented the second's first case of covid-19 reinfection,https://fightcovid19.hku.hk/hku-documented-the-worlds-first-case-of-covid-19-reinfection/,"[('This is the world’s first documentation of a patient who recovered from COVID-19 but got another episode of COVID-19 afterwards.', 0.55326974), ('But these researchers could not be more clear: ""We report the first case of reinfection of COVID-19,"" they wrote.', 0.542567), (""According to a statement by HKU's Department of Microbiology, the researchers showed that the genome sequence of the virus strain in the first episode of COVID-19 infection is clearly different from the genome sequence of the virus strain found during second episode of infection."", 0.47286505), (""Updated: 24 Aug 2020, 09:48 PM IST Neetu Chandra Sharma Putting the belief to rest that recovered covid-19 patients have immunity against re-infection because most developed a serum neutralizing antibody response, The University of Hong Kong (HKU) on Monday documented the world's first case of covid-19 re-infection Share Via Read Full Story New Delhi: Putting the belief to rest that recovered covid-19 patients have immunity against re-infection because most developed a serum neutralizing antibody response, The University of Hong Kong (HKU) on Monday documented the world's first case of covid-19 re-infection."", 0.46561852), ('Study method and findings An apparently young and healthy patient had a second episode of COVID-19 infection which was diagnosed 4.5 months after the first episode.', 0.44472337)]"
2216,Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection,severe,effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with _ acute respiratory syndrome coronavirus 2 infection,effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with moderate acute respiratory syndrome coronavirus 2 infection,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2765270,"[('Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial.', 0.9042773), ('Citation: Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial.', 0.88677293), ('Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.', 0.6145642), ('In vitro studies indicate that the antiviral effect of chloroquine diphosphate (CQ) requires a high concentration of the drug.', 0.60797656), ('Share via: Clinical Topics: Arrhythmias and Clinical EP, Prevention, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Novel Agents, Statins Keywords: Arrhythmias, Cardiac, Azithromycin, Chloroquine, Coronavirus, COVID-19, Critical Illness, Heart Diseases, Oseltamivir, Primary Prevention, RNA, Viral, SARS Virus, severe acute respiratory syndrome coronavirus 2, Tachycardia, Ventricular, Torsades de Pointes < Back to Listings ', 0.5167923)]"
2217,Simple Probiotics Might Help Inhibit COVID-19 Infection,inhibit,simple probiotics might help _ covid-19 infection,simple probiotics might help cause covid-19 infection,http://www.koreabiomed.com/news/articleView.html?idxno=7744,"[('Blood pressure: Probiotics may also cause modest reductions in blood pressure (57).', 0.71751165), ('However, probiotic supplements may offer a wide range of benefits with few side effects.', 0.6820233), ('> Summary > > Some current research proposes that improving the gut microbiome through > probiotic supplementation and diet may help treat the SARS-CoV-2 infection > that causes COVID-19.', 0.68107516), ('Some studies also note benefits of probiotic supplementation against inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis.', 0.6680895), ('Other research suggests that probiotic supplementation may promote antiviral activity in general to improve immune, pulmonary, and anti-inflammatory response that might help clear the SARS-CoV-2 infection (70, 71).', 0.66027284)]"
2220,UC Berkeley CRISPR Pioneer 's Lab Begins Processing up to 3000 Covid-19 Tests Per 24 Hours Using ThermoFisher 's Test,test,uc berkeley crispr pioneer 's lab begins processing up to 3000 covid-19 _ per 24 hours using thermofisher 's _,fda authorizes new two-minute serological test kit to detect MERS coronavirus,https://www.statnews.com/2020/03/30/crispr-pioneer-doudna-opens-lab-to-run-covid-19-tests/,"[('The laboratory, which plans to serve hospitals in the San Francisco Bay Area, says it will be able to process more than 1,000 patient samples a day with a 24-hour turnaround, Doudna announced Monday.', 0.7029915), ('https://www.ucsf.edu/news/2020/04/417276/testing-tests-covid-19-antibody-assays-scrutinized-accuracy-ucsf-uc-berkeley.', 0.695858), ('Socorex electronic micropipettes Performing ELISAs with the VIAFLO 96/384 handheld pipette New generation of Systec H-Series autoclaves up to 25% faster autoclaving processes Over One Million Chromatography Products From One Single Supplier Telstar develops a new laboratory freeze dryer operating with natural gases Agilent Introduces New Handheld Raw Material ID System for Pharmaceutical Manufacturers New Rapid Test kit for Coronavirus Disease AMSBIO Launch Coronavirus â\x80\x93 COVID-19 Research Products Castor launches COVID-19 monitoring and research platform and is supporting over 50 trials globally ZEISS Lightsheet 7 Allows Multiview Imaging of Both Living and Cleared Specimens NEW Far-Red HI-LED Lights from Syngene For Fast Detection of Low-Abundance Proteins with G:BOX Systems New Coronavirus RT-PCR test by PerkinElmer recieves Emergency Use Authorization (EUA) by U.S. Food and Drug Administration (FDA) Adam Equipment Debuts New Luna Precision Balances Powerful solutions for various cooling tasks in the laboratory BioTek Introduces New Cell Count & Viability Starter Kit Agilent Introduces Three New Microarrays for Prenatal and Postnatal Research Quick & Easy Extraction of Biological & Aqueous Samples Merckâ\x80\x99s New LANEXOâ\x84¢ System to Improve Scientistsâ\x80\x99 Productivity in the Lab New Instrument Fully Automates Sample Preparation for PFAS Analysis in Drinking Water To verify pipette accuracy, CheckitÂ® yourself!', 0.68006915), ('https://news.berkeley.edu/2020/03/30/uc-berkeley-scientists-spin-up-a-robotic-covid-19-testing-lab/.', 0.6635461), ('""UC Berkeley scientists spin up a robotic COVID-19 testing lab"".', 0.66052645)]"
2221,Toilets May Pose Risk for Spreading COVID-19,spreading,toilets may pose risk for _ covid-19,toilets may pose risk for treating covid-19,https://www.medscape.com/viewarticle/928234,"[('But what do we do to address concerns that the toilet microbiome may put us at risk for COVID-19?', 0.7932591), ('However, I want to talk about one other potential means of its spread: the toilet.', 0.62392414), ('The aerosolization effect that can occur in toilets, leading to microdroplets that can be inhaled or persist on surface areas, raises some real concerns regarding epidemiologic spread.', 0.59316), ('That is quite concerning when you consider that flushing a toilet can create an aerosolized plume of these viral particles, which can then spread elsewhere within proximity.', 0.5784799), ('It may also be helpful in understanding why this rapid spread can occur when not linked to known contact with those positive for COVID-19.', 0.5762518)]"
2222,Nonpharmaceutical Interventions Implemented by US Cities During the 1918-1919 Influenza Pandemic,1919,nonpharmaceutical interventions implemented by us cities during the 1918-_ influenza pandemic,nonpharmaceutical interventions implemented by us cities during the 1918-2004 influenza pandemic,https://jamanetwork.com/journals/jama/fullarticle/208354,"[('Nonpharmaceutical interventions implemented during the 1918-1919 influenza pandemic.', 0.87021506), ('The effect of public health measures on the 1918 influenza pandemic in U.S. cities.', 0.75292754), ('Public health interventions and epidemic intensity during the 1918 influenza pandemic.', 0.7208037), ('Conclusions: These findings demonstrate a strong association between early, sustained, and layered application of nonpharmaceutical interventions and mitigating the consequences of the 1918-1919 influenza pandemic in the United States.', 0.5802882), ('Objectives: To examine the implementation of nonpharmaceutical interventions for epidemic mitigation in 43 cities in the continental United States from September 8, 1918, through February 22, 1919, and to determine whether city-to-city variation in mortality was associated with the timing, duration, and combination of nonpharmaceutical interventions; altered population susceptibility associated with prior pandemic waves; age and sex distribution; and population size and density.', 0.57625616)]"
2223,Kidney injury molecule-1 is a potential receptor for SARS-CoV-2,receptor,kidney injury molecule-1 is a potential _ for sars-cov-2,kidney injury molecule-1 is a potential inhibitor for sars-cov-2,https://www.biorxiv.org/content/10.1101/2020.10.09.334052v1,"[('Presently, it is generally recognized that SARS-CoV-2 initiates invasion through binding of receptor-binding domain (RBD) of spike protein to host cell-membrane receptor ACE2, however, whether there is additional target of SARS-CoV-2 in kidney remains unclear.', 0.70495385), ('Kidney injury molecule-1 (KIM1) is a transmembrane protein that drastically up-regulated after renal injury.', 0.6823007), ('Identification of SARS- CoV-2 in kidney of COVID-19 patients suggests renal tropism and direct infection.', 0.6772504), ('Abbreviations AKI Acute kidney injury CKD Chronic kidney diseases KIM1 Kidney injury molecule-1 Co-IP Co-immunoprecipitation HPA Human Protein Atlas MERS-CoV Middle east respiratory syndrome coronavirus RBD Receptor-binding domain RMSD Root Mean Square Deviation RMSF Root Mean Square Fluctuation SARS-CoV Severe acute respiratory syndrome coronavirus SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 SARS-CoV-2-SP Severe acute respiratory syndrome coronavirus spike protein Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.', 0.63794374), ('Here, binding between SARS-CoV2-RBD and the extracellular Ig V domain of KIM1 was identified by molecular simulations and co-immunoprecipitation, which was comparable in affinity to that of ACE2 to SARS-CoV-2.', 0.5257493)]"
2224,"Normally invisible saliva droplets can linger in the air , visualized by researchers using laser technology .",linger,"normally invisible saliva droplets can _ in the air , visualized by researchers using laser technology .","normally invisible saliva droplets can spread in the air, visualized by researchers using laser technology.",https://www.nejm.org/doi/full/10.1056/NEJMc2007800?query=featured_home#article_citing_articles,"[('Whereas large droplets fall quickly to the ground, small droplets can dehydrate and linger as “droplet nuclei” in the air, where they behave like an aerosol and thereby expand the spatial extent of emitted infectious particles.2 We report the results of a laser light-scattering experiment in which speech-generated droplets and their trajectories were visualized.', 0.62693703), ('Image Laser light scattering observations of droplets in the experimental setup.Credit...Valentyn Stadnytskyi; Philip Anfinrud; Christina E. Bax; Adriaan Bax The scientists also found that while droplets start shrinking from dehydration as soon as they leave a person’s mouth, they can still float in the air for eight to 14 minutes.', 0.6152795), ('“Given our laser-related research backgrounds, it wasn’t much of a stretch to repurpose existing equipment to visualize speech droplets,” said Anfinrud.', 0.58258516), ('He runs a laser lab normally used to study protein structural dynamics, but was able to use that technology to investigate the hunch that normal speaking produces small droplets that can spread disease.', 0.5808588), ('Laser light is a common technique to visualize and count droplets in the air, says Alex Huffman, an associate professor who studies aerosols in the department of chemistry and biochemistry at the University of Denver.', 0.5750981)]"
2225,Is Fostamatinib a possible drug for COVID-19 ?,drug,is fostamatinib a possible _ for covid-19 ?,is fostamatinib a possible explanation for covid-19?,https://osf.io/7hgpj/,"[('Researchers want to see if a drug called fostamatinib may help people who are hospitalized with COVID-19.', 0.8319986), ('Participation in another clinical trial for the treatment of COVID-19.', 0.79061234), ('Objective: To learn if fostamatinib is safe in patients who are hospitalized with COVID-19 and gain earlier insight into whether it improves outcomes.', 0.73867977), ('In this pilot study we propose to use fostamatinib (an SYK inhibitor) as a targeted therapy for the immunological complications of hospitalized patients with COVID-19.', 0.72606397), ('This is a randomized, double-blind, placebo-controlled trial of fostamatinib for the treatment of hospitalized patients with COVID-19.', 0.698904)]"
2227,Inhaled nitric oxide in patients admitted to intensive care unit with COVID-19 pneumonia,inhaled,_ nitric oxide in patients admitted to intensive care unit with covid-19 pneumonia,Plasma nitric oxide in patients admitted to intensive care unit with covid-19 pneumonia,https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03222-9,"[('Marini JJ, Gattinoni L. Management of COVID-19 respiratory distress.', 0.68999815), ('We report herein our experience of iNO administration in COVID-19 mechanically ventilated patients with refractory hypoxaemia and/or right ventricular (RV) dysfunction.', 0.6456009), ('Copin MC, Parmentier E, Duburcq T, Poissy J, Mathieu D, Lille C-I, Anatomopathology G. Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection.', 0.64072907), ('Ventilation strategies for COVID-19 patients have been suggested basing on the pathophysiological evidence to date [1]; however, there are no data regarding the use of inhaled nitric oxide (iNO).', 0.62853146), ('Respiratory and haemodynamic parameters were collected immediately before iNO administration ( t 0) and after 15–30 min ( t 1).', 0.56741196)]"
2228,Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19 .,patients,evaluation of ocular symptoms and tropism of sars-cov-2 in _ confirmed with covid-19 .,evaluation of ocular symptoms and tropism of sars-cov-2 in animals confirmed with covid-19.,https://www.ncbi.nlm.nih.gov/pubmed/32336042,"[('We evaluated ocular symptoms and ocular tropism of SARS-CoV-2 in a group of patients with COVID-19.', 0.9639813), ('Systematic Review of Ocular Involvement of SARS-CoV-2 in Coronavirus Disease 2019.', 0.69169843), ('Detecting SARS-CoV-2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID-19?', 0.66503966), ('Ocular surface manifestation of COVID-19 and tear film analysis.', 0.644346), ('Results: Patients classified as severe COVID-19 cases were more likely to have hypertension compared to mild cases (p = 0.035).', 0.6135416)]"
2229,"More than 137,000 people in UK receive first dose of COVID vaccine in one week",people,"more than 137,000 _ in uk receive first dose of covid vaccine in one week","more than 137,000 animals in uk receive first dose of covid vaccine in one week",https://www.gov.uk/government/news/more-than-137000-people-in-uk-receive-first-dose-of-covid-vaccine-in-one-week,"[('Health and Social Care Secretary Matt Hancock said: > Thanks to the hard work of the NHS across the UK, over 137,000 people have > already received the first dose of the coronavirus vaccine.', 0.68680084), ('Published 16 December 2020 From: Department of Health and Social Care More than 137,000 people in the UK have received the first dose of the Pfizer/BioNTech COVID-19 vaccine in the first week of the largest vaccination programme in British history.', 0.6850822), ('The government has today released provisional figures which show at least 137,897 people received their first dose of the vaccine by the end of Tuesday 15 December.', 0.57838714), ('Patients require 2 doses of the vaccine – 21 days apart – for the vaccine to be fully effective.', 0.5196415), ('The Pfizer/BioNTech vaccine is the first vaccine to be authorised for use by the medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA).', 0.5064907)]"
2230,Quebec seeks to avoid impending shortage of masks for health-care workers,seeks,quebec _ to avoid impending shortage of masks for health-care workers,quebec began to avoid impending shortage of masks for health-care workers,https://montreal.ctvnews.ca/covid-19-quebec-seeks-to-avoid-impending-shortage-of-masks-for-health-care-workers-1.4875241,"[('It is no more a question of seeing a security guard wearing an N95 mask, warned the minister.', 0.40837792), ('Mask reserves are running out quickly right when the province anticipates a significant increase in the number of hospitalizations required in the coming weeks.', 0.38516214), ('Now is the time for rationing, advocating a “judicious use” of masks - both procedural masks and the N95, said Minister of Health Danielle McCann.', 0.38115972), (""Here's a list COVID-19 in Quebec: a look back at 2020, the year of the novel coronavirus See current wait times at Quebec COVID-19 testing sites See the map: Tracking COVID-19 cases across Montreal See the map: Tracking COVID-19 cases across Quebec Tracking every case of COVID-19 in Canada SHARE Report Error Editorial standards and policies Why you can trust CTV News "", 0.37648633), ('Nurses, doctors and other members of the health network must now comply with the instruction to wear a mask only “when it is absolutely necessary,” Premier Francois Legault ordered on Monday during his daily COVID-19 update on the health crisis.', 0.35975236)]"
2231,Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 infection,2019,proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease _ infection,proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 3 infection,https://www.dldjournalonline.com/article/S1590-8658(20)30930-0/fulltext,"[('Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection.', 0.94418836), ('Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor?.', 0.76214486), ('Based on our pooled analysis of available data, the use of proton pump inhibitors (PPIs) seems to be associated with an enhanced risk of severity and mortality from COVID-19 infection.', 0.69383705), ('View Large Image Figure Viewer Download Hi-res image Download (PPT) Based on our pooled analysis of available data, the use of proton pump inhibitors (PPIs) seems to be associated with an enhanced risk of severity and mortality from COVID-19 infection.', 0.69347286), ('All of these adverse events from PPI can also contribute to the development of severe outcome and mortality from COVID-19 infection [ 1 Savarino V. Marabotto E. Furnari M. Zingone F. Zentilin P. Savarino E Latest insights into the hot question of proton pump inhibitor safety - a narrative review.', 0.62833923)]"
2232,A Natural Experiment on Postponed Elections during the COVID-19 Pandemic,postponed,a natural experiment on _ elections during the covid-19 pandemic,a natural experiment on all elections during the covid-19 pandemic,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3659856,"[('We rely on a natural experiment taking place in France during the COVID-19 outbreak, which sees the implementation of differential lockdown across French departments and the delay of the second round of municipal elections.', 0.70772254), ('The first round of the polls went ahead on 15 March but the introduction of the lockdown two days after the elections impeded the implementation of the second round, which was delayed until the conclusion of the restrictions on 28 June.', 0.6403743), ('We compare cities located across the border, and then subject to different rules, just before and just after the implementation of the lockdown (in a spatial regression discontinuity design analysis).', 0.5758436), ('Figure 2 displays the trend of the COVID-19 cases in France from 1 January to 15 July 2020 and highlights the timing of 2020 municipal elections as well as the evolution of the lockdown policy.', 0.56950974), ('Figure 1 Differential lockdown from 11 May to 2 June 2020 The delay of the second round of the 2020 municipal elections due to the pandemic allows us to measure voting behaviour of French voters immediately after the lockdown.', 0.5467194)]"
2233,India to test 100-yr-old vaccine on humans as war against Covid-19 heats up,india,_ to test 100-yr-old vaccine on humans as war against covid-19 heats up, unable to test 100-yr-old vaccine on humans as war against covid-19 heats up,https://www.business-standard.com/article/current-affairs/battling-covid-19-india-to-try-bcg-vaccine-on-humans-within-next-two-weeks-120042201068_1.html?utm_source=SEO&utm_medium=ST,"[('This is an extremely safe vaccine since it is given to newborn babies and have been selling this in more than 100 countries worldwide for more than two decades,"" Adar Poonawalla, the CEO of Serum Institute of India, told Business Standard.', 0.6210513), (""Pune-based Serum Institute's recombinant BCG vaccine- developed in 1919-has a proven safety record and the company can make at least 300 million doses of it."", 0.58910507), ('“The trial for this, to prove the immunity is being improved in human beings, will start within two weeks in India.', 0.5219542), ('ALSO READ: India battles supply snags, labour shortages to make affordable ventilators ""In May 1948, the Government of India issued a press note stating that tuberculosis was “assuming epidemic proportions” in the country, and that it had “after careful consideration” decided to introduce BCG vaccination on a limited scale and under strict supervision as a measure to control the disease,"" according to Chandrakant Lahariya\'s publication \'A brief history of vaccines & vaccination in India\'.', 0.51377845), ('The Serum Institute is likely to start the trials in Maharashtra involving around 2,000-3,000 high risk people.', 0.49655342)]"
2234,Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1,snakes,protein structure and sequence reanalysis of 2019-ncov genome refutes _ as its intermediate host and the unique similarity between its spike protein insertions and hiv-1,protein structure and sequence reanalysis of 2019-ncov genome refutes bats as its intermediate host and the unique similarity between its spike protein insertions and hiv-1,https://pubs.acs.org/doi/10.1021/acs.jproteome.0c00129,"[('In this Communication, we first analyzed two recent studies that concluded that snakes are the intermediate hosts of 2019-nCoV and that the 2019-nCoV spike protein insertions share a unique similarity to HIV-1.', 0.77921146), ('PMID: 32218527 Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.', 0.58665633), (""COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance."", 0.5581498), ('(A) Superposition between the C-I-TASSER constructed… Figure 2 Structure of the 2019-nCoV spike protein trimer.', 0.5481839), ('These data show not only that snakes are not the vertebrates with the lowest RSCU distances to 2019-nCoV but also that unrelated species such as frogs and snakes have smaller RSCU distances to known hosts of all three coronaviruses.', 0.53432345)]"
2235,Belgium enters lockdown over coronavirus crisis until 5 April,until,belgium enters lockdown over coronavirus crisis _ 5 april,belgium enters lockdown over coronavirus crisis after 5 april,https://www.euractiv.com/section/coronavirus/news/belgium-enters-lockdown-over-coronavirus-crisis-until-5-april/,"[('[EPA-EFE/FREDERIC SIERAKOWSKI] Comments Print Email Facebook Twitter LinkedIn WhatsApp Belgium declared a lockdown for the entire country over the coronavirus crisis from noon on Wednesday (18 March) until 5 April, following the example of several European countries, including neighbouring France, which took the same decision earlier this week.', 0.58457816), ('Speaking at the press conference after the meeting, Wilmes announced the lockdown is set to start on Wednesday (17 March) and run until 5 April.', 0.4710515), (""They did 3'No longer acceptable' for platforms to take key decisions alone, EU Commission says 4Contribute to EURACTIV 5Cyprus asks vaccines from Israel amid EU delay 6Forget Brexit, the most important trade deal in 2021 is in Africa 7Former Greek FM: Without Western renewal, we're heading for Chinese hegemony 8Cyprus asks vaccines from Israel amid EU delay 9Recyclers fret as EU plastic waste export ban comes into force 10Poland, Hungary face EU regional funds blockage over fundamental rights charter "", 0.4472806), ('Belgium\'s health minister Maggie De Block (Open VLD) told local media after the meeting that tightening measures come at a ""crucial moment"" and are necessary to ""flatten the curve"" so that the number of patients does not rise too strongly and overburdens the healthcare system.', 0.44293067), ('The measures therefore did not bear fruit as the epidemic continues,"" virologist Erika Vlieghe told VRT Niews.', 0.41423273)]"
2236,Heat shock protein 70 is related to thermal inhibition of nuclear export of the influenza virus ribonucleoprotein complex .,related,heat shock protein 70 is _ to thermal inhibition of nuclear export of the influenza virus ribonucleoprotein complex .,heat shock protein 70 is resistant to thermal inhibition of nuclear export of the influenza virus ribonucleoprotein complex.,https://www.ncbi.nlm.nih.gov/m/pubmed/14722281/,"[('Citation: Li G, Zhang J, Tong X, Liu W, Ye X (2011) Heat Shock Protein 70 Inhibits the Activity of Influenza A Virus Ribonucleoprotein and Blocks the Replication of Virus In Vitro and In Vivo.', 0.7994552), ('(2004) Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R. J Virol 78: 9697–9704.', 0.7515917), ('Heat shock protein 70 (Hsp70) mediates Zika virus entry, replication, and egress from host cells.', 0.7132242), ('Nuclear export of influenza viral ribonucleoprotein is temperature-dependently inhibited by dissociation of viral matrix protein.', 0.68932205), ('Hsp70 inhibits influenza virus polymerase activity in a dose- dependent manner.', 0.6836415)]"
2237,Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening,secondary,test sensitivity is _ to frequency and turnaround time for covid-19 screening,test sensitivity is equivalent to frequency and turnaround time for covid-19 screening,https://advances.sciencemag.org/content/early/2020/11/20/sciadv.abd5393.1,"[('C. O. Buckee , Individual quarantine versus active monitoring of contacts for the mitigation of COVID-19: A modelling study.', 0.63216233), ('N. C. Lo , Frequency of routine testing for COVID-19 in high-risk environments to reduce workplace outbreaks.', 0.61417), ('We therefore conclude that screening should prioritize accessibility, frequency, and sample-to-answer time; analytical limits of detection should be secondary.', 0.60767007), ('W. Ji , Sensitivity of chest CT for COVID-19: Comparison to RT-PCR.', 0.60346705), ('Testing, isolation, and sample-to-answer turnaround times.', 0.5888726)]"
2238,Facebook cancels global marketing summit over virus concerns,cancel,facebook _ global marketing summit over virus concerns,facebook's global marketing summit over virus concerns,https://www.ft.com/content/758fc319-0724-32f6-b496-05a458be72a4,"[('But the Facebook marketing summit is the first publicly reported example of an event in the San Francisco Bay Area being canceled due to the virus.', 0.8400883), ('Facebook canceling its global marketing conference comes on the heels of this week’s cancellation of Mobile World Congress, also due to coronavirus concerns.', 0.82550746), ('Facebook’s call to cancel its conference because of the virus is an amplified example of how coronavirus fears are impacting day-to-day business in the tech industry.', 0.78843987), ('Facebook is canceling an annual conference held in San Francisco out of health concerns regarding the coronavirus.', 0.78805745), ('""Out of an abundance of caution, we canceled our Global Marketing Summit due to evolving public health risks related to coronavirus,"" Anthony Harrison, a Facebook spokesman, said by email.', 0.7378191)]"
2239,Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions,spread,inferring change points in the _ of covid-19 reveals the effectiveness of interventions,inferring change points in the absence of covid-19 reveals the effectiveness of interventions,https://science.sciencemag.org/content/early/2020/05/14/science.abb9789,"[('From the observed case numbers of COVID-19, we can quantify the impact of these measures on the disease spread using change point analysis.', 0.7749267), ('2 The timing and effectiveness of interventions strongly affect future COVID-19 cases.', 0.74452734), ('In general, our approach may help to infer the efficiency of measures taken in other countries and inform policy-makers about tightening, loosening, and selecting appropriate measures for containment of COVID-19.', 0.72159094), ('Download high-res image Open in new tab Download Powerpoint Bayesian inference of SIR model parameters from daily new cases of COVID-19 enables us to assess the impact of interventions.', 0.70536864), ('L. Gardner , An interactive web-based dashboard to track COVID-19 in real time.', 0.6777098)]"
2240,"OneRace , the Sydney research team is launching its crowdfunding campaign to help the world with the current pandemic COVID19 .",research,"onerace , the sydney _ team is launching its crowdfunding campaign to help the world with the current pandemic covid19 .","onerace, the sydney training team is launching its crowdfunding campaign to help the world with the current pandemic covid19.",https://www.krowdster.co/l/4bd51#,"[('^ ""GoFundMe acquires CrowdRise to expand to fundraising for charities"".', 0.59249175), ('^ ""Israel Folau: Australian Christian lobby hosts new fundraising effort"".', 0.5491085), ('^ ""Private group says it\'s started building border wall using millions donated in GoFundMe campaign"".', 0.54697704), ('ABC Home Open Sites menu ABC Home News iview TV Radio Kids Shop More Search AustraliaWeather Just In Politics World Business Analysis Sport Science Health Arts Fact Check Other Cyclone warning For latest updates on Cyclone Kimi in Far North Queensland , search on ABC Emergency or find your local ABC radio station Live blog Follow our live coverage for the latest news on the coronavirus pandemic USA Votes Follow our live coverage ahead of the inauguration of Joe Biden as the next US president Email ', 0.53512836), ('[25] An alternative fundraising site was set up by the Australian Christian Lobby with the public donating $2 million in 24 hours.', 0.5241927)]"
2242,Shared SARS-CoV-2 diversity suggests localised transmission of minority variants,suggests,shared sars-cov-2 diversity _ localised transmission of minority variants,shared sars-cov-2 diversity reduces localised transmission of minority variants,https://www.biorxiv.org/content/10.1101/2020.05.28.118992v2,"[('We show that SARS-CoV-2 infections are characterised by extensive within-host diversity, which is frequently shared among infected individuals with patterns consistent with geographical structure.', 0.5882827), ('We conclude that SARS-CoV-2 diversity is transmissible, and propose that geographic patterns are generated by co- circulation of distinct viral populations.', 0.5182574), ('Co-transmission of mixed populations could open opportunities for resolving clusters of transmission and understanding pathogenesis.', 0.4841223), ('To understand these discrepancies, we used veSEQ3, a targeted RNA-seq approach, to quantify minor allele frequencies in 413 clinical samples from two UK locations.', 0.46006233), ('Rapid sequencing and publication of consensus genomes have enabled phylogenetic analysis of the virus, demonstrating SARS-CoV-2 evolves relatively slowly1, but with multiple sites in the genome that appear inconsistent with the overall consensus phylogeny2.', 0.37406355)]"
2244,Timing social distancing to avert unmanageable COVID-19 hospital surges,social,timing _ distancing to avert unmanageable covid-19 hospital surges,timing medical distancing to avert unmanageable covid-19 hospital surges,https://www.pnas.org/node/943988.abstract?,"[('Thus, planning for future relaxations is paramount to averting unmanageable surges in COVID-19 hospitalizations.', 0.7835219), ('As COVID-19 social distancing measures are relaxed across the United States, temporary shelter-in-place orders triggered by monitoring local hospital admissions can minimize the number of days of disruption while preventing overwhelming healthcare surges.', 0.7564068), ('Assuming that the first scenario is unattainable and the second scenario unacceptable, we seek alternative policies that limit the number of days in lockdown while preventing COVID-19 healthcare surges beyond local capacity.', 0.7557247), ('Our best policies track daily COVID-19 hospital admissions and daily total hospitalizations across the city and trigger the initiation and relaxation of lockdown periods when admissions cross predetermined thresholds.', 0.7367672), ('Second, we apply the framework to derive optimal triggers for initiating and relaxing shelter- in-place orders to minimize the number of days of costly social distancing while ensuring that COVID-19 hospitalizations do not exceed local capacity.', 0.7108333)]"
2249,We created this Google Doc for simple Self Quarantine Guidelines,google,we created this _ doc for simple self quarantine guidelines,we created this work doc for simple self quarantine guidelines,https://docs.google.com/document/d/1mrLkfmRGOJXHAseujays-m3wIDKXZoOCqs95pLzinIc/edit?usp=sharing,"[('Lay it all out in a short (ideally one-page) Google Doc.', 0.65443283), ('Here are my personal recommendations on how to set up your Google Drive for smooth operations: Practice good Drive hygiene.', 0.6467062), ('> > “Creating an open-edit Google Sheet is the best way to do that because it’s > user-friendly,” says Moccia-Field.', 0.6094176), ('Instead of creating one from scratch, they designed it in google forms.', 0.5821092), ('Start your free Google Workspace trial today.', 0.5715691)]"
2252,UK approve phizer vaccination,approve,uk _ phizer vaccination,ukus phizer vaccination,https://www.theguardian.com/society/2020/dec/02/pfizer-biontech-covid-vaccine-wins-licence-for-use-in-the-uk,"[('He added: “The goal will be to vaccinate through the NHS right across the UK as rapidly as the company can manufacture.', 0.583814), ('For COVID-19 drugs and vaccines, the United Kingdom has set up a specialized Coronavirus Yellow Card reporting site.', 0.55323005), ('Dogukan Keskinkilic/Anadolu Agency via Getty Images hide caption toggle caption Dogukan Keskinkilic/Anadolu Agency via Getty Images The U.K. has approved use of the COVID-19 vaccine developed by Pfizer and BioNTech.', 0.548179), ('Image The authorities are planning to use The Excel Center in London, home of the Nightingale Hospital, as a vaccination hub starting next week.Credit...Andrew Testa for The New York Times British regulators are also vetting a vaccine developed by the University of Oxford and AstraZeneca, a British-Swedish company.', 0.53854936), ('The MHRA was given power to approve the vaccine by the government under special regulations before 1 January, when it will become fully responsible for medicines authorisation in the UK after Brexit.', 0.531846)]"
2254,"Structure of SARS-CoV-2 ORF8 , a rapidly evolving coronavirus protein implicated in immune evasion",structure,"_ of sars-cov-2 orf8 , a rapidly evolving coronavirus protein implicated in immune evasion","Loss of sars-cov-2 orf8, a rapidly evolving coronavirus protein implicated in immune evasion",https://www.biorxiv.org/content/10.1101/2020.08.27.270637v1,"[('Together the presence of these interfaces shows how SARS-CoV-2 ORF8 can form unique large- scale assemblies not possible for SARS-CoV, potentially mediating unique immune suppression and evasion activities.', 0.67247695), ('ORF8 is a rapidly evolving accessory protein that has been proposed to interfere with immune responses.', 0.5835993), ('The crystal structure of SARS-CoV-2 ORF8 was determined at 2.04 Å resolution by x-ray crystallography.', 0.42744958), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.40384275), ('Download PDF Email Thank you for your interest in spreading the word about bioRxiv.', 0.3885504)]"
2255,Taiwan team develops antigen for Wuhan coronavirus within 10 days,develops,taiwan team _ antigen for wuhan coronavirus within 10 days,taiwan team received antigen for wuhan coronavirus within 10 days,https://www.taiwannews.com.tw/en/news/3879157,"[(""(Academia Sinica photo) TAIPEI (Taiwan News) -- As scientists rush to develop treatment and vaccines for the Wuhan coronavirus, a team of Taiwanese scientists has developed the country's first self-produced antigen for the virus in 10 days."", 0.82777894), ('Academia Sinica Wuhan coronavirus Wuhan coronavirus vaccine coronavirus Novel Coronavirus COVID-19 Tweet <-Older Newer-> ', 0.59502137), ('A research team at Academia Sinica completed gene synthesis and entered the stage of antigen production within 10 days, a process that usually takes six weeks, reported Liberty Times.', 0.58843076), (""In order to test whether the first person to die from the disease in Taiwan had contracted it from a Taiwanese businessman who had recently returned from China's Zhejiang Province, The Central Epidemic Command Center (CECC) announced on Feb. 16 that it would entrust National Taiwan University Hospital and Academia Sinica to carry out the antibody tests."", 0.54561484), ('The antigen could not come at a moment too soon as it was quickly put to use to confirm whether a suspected carrier of novel coronavirus (COVID-19) had indeed been infected.', 0.4622944)]"
2257,Use Black Phenyl to stay on germ free floors in Corona Virus .,stay,use black phenyl to _ on germ free floors in corona virus .,use black phenyl to move on germ free floors in corona virus.,https://jbcworks.wordpress.com/2020/07/15/use-black-phenyl-to-stay-on-germ-free-floors-in-corona-virus/,"[('Learn more about products Here Enviro Care Neutral Disinfectant has demonstrated effectiveness against viruses similar to 2019 Novel Coronavirus (2019-nCoV) on hard, non-porous surfaces.', 0.51068974), ('Clorox Commercial Solutions Hydrogen Peroxide Cleaner Disinfectant 44\\.', 0.4950743), ('Hospital-grade and phosphate-free, Enviro Care Neutral Disinfectant has long been used to kill Hepatitis, HIV-1 (AIDS), and other viruses and bacteria that can thrive on surfaces and objects.', 0.48455063), ('A handy spray for desks, tables and other surfaces you are likely to touch, Quat Plus TB has also been singled out for its ability to kill coronavirus on contact.', 0.48255998), ('You avoid diseases like the coronavirus with cleaning, both personal hygiene and your immediate environment.', 0.46393472)]"
2258,Professional and Home-Made Face Masks Reduce Exposure to Respiratory Infections among the General Population,reduce,professional and home-made face masks _ exposure to respiratory infections among the general population,professional and home-made face masks show exposure to respiratory infections among the general population,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440799/,"[('Masks worn by patients may not offer as great a degree of protection against aerosol transmission.', 0.7402024), ('Conclusions/significance: Any type of general mask use is likely to decrease viral exposure and infection risk on a population level, in spite of imperfect fit and imperfect adherence, personal respirators providing most protection.', 0.70774937), ('Face- masks worn by the general population could be an accessible and affordable intervention, if effective when worn under routine circumstances.', 0.6972405), ('Outward protection (mask wearing by a mechanical head) was less effective than inward protection (mask wearing by healthy volunteers).', 0.631822), ('Outward protection factors at a range of breathing flows for a mechanical head with different types of masks, with two meaurements per mask at each breathing flow.', 0.615165)]"
2259,These are the top coronavirus vaccines to watch,vaccines,these are the top coronavirus _ to watch,these are the top coronavirus genomes to watch,https://www.washingtonpost.com/graphics/2020/health/covid-vaccine-update-coronavirus/,"[('“The vaccines deliver a snip of genetic material that carries the blueprint for the spiky protein that dots the surface of the coronavirus.', 0.66740274), ('Governments are investing especially heavily in this vaccine.', 0.5678861), ('“Either vaccine could become the first in a new class of medicines,” she writes.', 0.52846146), ('Their success keeps open the possibility of a vaccine being ready for wide dissemination in early 2021, although that also depends on countries having the infrastructure to administer shots to millions of people.', 0.4977203), ('AD AD Both the Pfizer and the Moderna vaccines use a new technology called messenger RNA to produce a protein found on SARS-CoV-2, the virus that causes the disease covid-19.', 0.4618038)]"
2260,CT provides best diagnosis for COVID-19,diagnosis,ct provides best _ for covid-19,ct provides best support for covid-19,https://www.sciencedaily.com/releases/2020/02/200226151951.htm?fbclid=IwAR1E54PYtK6a82Ca9U7FppslFN9cx1vqbLogQrAeC55DDTnQYCz5zawVS78,"[('With RT-PCR as reference standard, the performance of chest CT in diagnosing COVID-19 was assessed.', 0.83506364), ('The researchers concluded that CT should be used as the primary screening tool for COVID-19.', 0.8323051), ('Compared to RT-PCR, chest CT imaging may be a more reliable, practical and rapid method to diagnose and assess COVID-19, especially in the epidemic area,"" the authors wrote.', 0.75763005), ('The sensitivity of chest CT in suggesting COVID-19 was 97%, based on positive RT-PCR results.', 0.7513457), ('Recent research found that the sensitivity of CT for COVID-19 infection was 98% compared to RT-PCR sensitivity of 71%.', 0.73337835)]"
2262,Development and validation of the 4C Deterioration model for adults hospitalised with COVID-19,deterioration,development and validation of the 4c _ model for adults hospitalised with covid-19,development and validation of the 4cIR model for adults hospitalised with covid-19,https://www.medrxiv.org/content/10.1101/2020.10.09.20209957v1,"[('Our 4C Deterioration model thus demonstrates unprecedented clinical utility and generalisability to predict clinical deterioration among adults hospitalised with COVID-19.', 0.8111216), ('Among 75,016 consecutive adults across England, Scotland and Wales prospectively recruited to the ISARIC Coronavirus Clinical Characterisation Consortium (ISARIC4C) study, we developed and validated a multivariable logistic regression model for in-hospital clinical deterioration (defined as any requirement of ventilatory support or critical care, or death) using 11 routinely measured variables.', 0.57350785), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.50202703), ('All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.', 0.40895402), ('We used internal-external cross-validation to show consistent measures of discrimination, calibration and clinical utility across eight geographical regions.', 0.3605797)]"
2263,Here is an interesting read about immunity to Covid,read,here is an interesting _ about immunity to covid,here is an interesting question about immunity to covid,https://www.livescience.com/covid-19-immunity.html,"[('While these experiences aren’t pleasant, they are a good sign: they are the result of your own immune system encountering the vaccine and mounting a potent response that will provide long-lasting immunity.', 0.48836416), (""This may give a benchmark for predicting the longevity of the vaccine's durable immunity."", 0.48439443), ('It would seem rather obvious that memory of the initial virus without mutations is most important regarding long lasting immunity.', 0.4706807), ('But while some unanswered questions remain, the main takeaway from the new study is that ""immune memory to SARS-CoV-2 is very stable,"" Jenkins said.', 0.4592309), (""â\x80\x9cIt's not that easy to get an efficacy that high for a respiratory virus.â\x80\x9d Thatâ\x80\x99s because current guidance says vaccine frontrunners can be approved even if they only provide â\x80\x9cfunctional immunity,â\x80\x9d which mainly confers protection against the symptoms of the disease."", 0.4527289)]"
2264,Afucosylated immunoglobulin G responses are a hallmark of enveloped virus infections and show an exacerbated phenotype in COVID-19,enveloped,afucosylated immunoglobulin g responses are a hallmark of _ virus infections and show an exacerbated phenotype in covid-19,afucosylated immunoglobulin g responses are a hallmark of dengue virus infections and show an exacerbated phenotype in covid-19,https://www.biorxiv.org/content/10.1101/2020.05.18.099507v1.abstract,"[('Our findings indicate antibody glycosylation as a potential factor in inflammation and protection in enveloped virus infections including COVID-19.', 0.7178101), ('In the case of COVID-19, the critically ill show aggravated afucosylated-IgG responses against the viral spike protein.', 0.7130636), ('Here, we report that afucosylated IgG which are of minor abundance in humans (∼6% of total IgG) are specifically formed against surface epitopes of enveloped viruses after natural infections or immunization with attenuated viruses, while protein subunit immunization does not elicit this low fucose response.', 0.5135896), ('This can give beneficial strong responses, but can also go awry, resulting in a cytokine- storm and immune-mediated pathologies.', 0.48534313), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.47223997)]"
2267,Decontamination of Common Healthcare Facility Surfaces Contaminated with SARS-CoV-2 using Peracetic Acid Dry Fogging,healthcare,decontamination of common _ facility surfaces contaminated with sars-cov-2 using peracetic acid dry fogging,decontamination of common food facility surfaces contaminated with sars-cov-2 using peracetic acid dry fogging,https://www.biorxiv.org/content/10.1101/2020.12.04.412585v1,"[('The ease of use, low cost and overall effectiveness of a PAA dry fogging suggest it should be considered for decontaminating settings, particularly intensive care units where severely ill SARS-CoV-2 patients are cared for.', 0.7807909), ('Methods The effectiveness of peracetic acid (PAA) dry fogging in decontaminating common healthcare setting surfaces was evaluated after experimentally contaminating nine surfaces (stainless steel, latex painted wood, unsealed hardwood, melamine countertop, vinyl flooring, clear plastic, faux leather, computer keyboard button and smartphone touch screen) with more than 106 TCID50 of SARS-CoV-2.', 0.7046085), ('In contrast, high titer recovery of infectious virus was demonstrated for corresponding untreated drying controls of the same materials.', 0.5253364), ('Conclusion Standard surface decontaminating processes, including sprays and wipes, are laborious and often cannot completely decontaminate sensitive electronic equipment.', 0.49122387), ('Results When fumigated with PAA dry fog for an hour, no infectious SARS- CoV-2 virus was recovered from experimentally inoculated coupons of representing nine different surface types.', 0.39582437)]"
2268,New blood tests for antibodies could show true scale of coronavirus pandemic,show,new blood tests for antibodies could _ true scale of coronavirus pandemic,new blood tests for antibodies could reduce true scale of coronavirus pandemic,https://www.sciencemag.org/news/2020/03/new-blood-tests-antibodies-could-show-true-scale-coronavirus-pandemic,"[('Widespread antibody testing could also provide key data for efforts to model the course of the pandemic.', 0.75456154), ('Existing antibodies can react to the related invader and trigger a dangerous overreaction, a phenomenon known as an antibody-dependent enhancement (ADE).', 0.68964994), ('But scientists also need to test a person’s blood for antibodies to the new virus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).', 0.6804898), ('Initial tests of four blood samples from three confirmed COVID-19 patients and from 59 serum samples banked before the start of the outbreak showed that the test worked, as antibodies to SARS-CoV-2 bound to the test’s proteins.', 0.6650543), ('Those labmade molecules provided the basis for an ELISA test, in which antibodies in a sample of blood or plasma trigger a color change when they recognize a target protein—here an RBD or the spike protein.', 0.65382576)]"
2269,Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle,plant,_ lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle,Human lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114093/,"[('Antiviral strategies against human coronaviruses.', 0.64909285), ('Biologically active compounds from marine organisms in the strategies for combating coronaviruses.', 0.5932033), ('Two targets of possible antiviral intervention were identified in the replication cycle of SARS-CoV.', 0.58808655), ('Balzarini J., Schols D., Neyts J., Van Damme E., Peumans W., De Clercq E. Alpha-(1-3)- and alpha-(1-6)-d-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro.', 0.57860243), ('Balzarini J., Neyts J., Schols D., Hosoya M., Van Damme E., Peumans W., De Clercq E. The mannose-specific plant lectins from cymbidium hybrid and epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro.', 0.57819396)]"
2270,Sex differences in immune responses to SARS-CoV-2 that underlie disease outcomes,disease,sex differences in immune responses to sars-cov-2 that underlie _ outcomes,sex differences in immune responses to sars-cov-2 that underlie protection outcomes,https://www.medrxiv.org/content/10.1101/2020.06.06.20123414v2.,"[('However, whether immune responses against SARS-CoV-2 differ between sexes, and whether such differences explain male susceptibility to COVID-19, is currently unknown.', 0.70028436), ('Conversely, higher innate immune cytokines in female patients associated with worse disease progression, but not in male patients.', 0.5219523), ('In this study, we examined sex differences in viral loads, SARS-CoV-2-specific antibody titers, plasma cytokines, as well as blood cell phenotyping in COVID-19 patients.', 0.49082768), ('By focusing our analysis on patients with mild to moderate disease who had not received immunomodulatory medications, our results revealed that male patients had higher plasma levels of innate immune cytokines and chemokines including IL-8, IL-18, and CCL5, along with more robust induction of non-classical monocytes.', 0.4430919), ('In contrast, female patients mounted significantly more robust T cell activation than male patients during SARS-CoV-2 infection, which was sustained in old age.', 0.43540674)]"
2271,Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19,severe,elevated calprotectin and abnormal myeloid cell subsets discriminate _ from mild covid-19,elevated calprotectin and abnormal myeloid cell subsets discriminate naturally from mild covid-19,https://www.cell.com/cell/fulltext/S0092-8674(20)30993-4,"[('Keywords: COVID-19; S100A8; S100A9; SARS-CoV-2; calprotectin; emergency myelopoiesis; monocyte subsets; neutrophils; type I interferon.', 0.7035278), ('Finally, we show that calprotectin plasma level and a routine flow cytometry assay detecting decreased frequencies of non-classical monocytes could discriminate patients who develop a severe form of COVID-19, suggesting a predictive value that deserves prospective evaluation.', 0.664237), ('Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19.', 0.6503223), ('(F–M) Integration of scRNA-seq data from blood and lung (BALF) cells of COVID-19 patients.', 0.60261524), ('Severe COVID-19 and aging: are monocytes the key?', 0.55793524)]"
2272,Spread of SARS-CoV-2 Coronavirus likely to be constrained by climate,constrained,spread of sars-cov-2 coronavirus likely to be _ by climate,spread of sars-cov-2 coronavirus likely to be transmitted by climate,http://medrxiv.org/content/early/2020/03/16/2020.03.12.20034728,"[('You are going to email the following Spread of SARS-CoV-2 Coronavirus likely constrained by climate Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website.', 0.68194455), ('We expect that the SARS-CoV-2 Coronavirus should continue to spread owing to seasonal changes of climate suitability and increased abundance of the viral pool.', 0.6682768), ('This is because the environment can mediate human-to-human transmission of SARS-CoV-2, and unsuitable climates can cause the virus to destabilize quickly, hence reducing its capacity to become epidemic.', 0.61272854), ('Ecological niche models were used to estimate the combination of climate values best explaining infections with SARS-Cov-2.', 0.6080112), ('A dynamic visualization of the daily spread of SARS-CoV-2 Coronavirus is available here: http://www.maraujolab.com/wp- content/uploads/2020/03/coronanicheaet-temperature23march.gif The mean and interquartile range of average environmental temperatures associated with positive cases is 5,81ºC (mean) and −3,44ºC to 12,55ºC (95% range) and for radiation values are 112,78 W/m2 (mean) and 61,07 W/m2 and 170,96 W/m2 (95% range).', 0.5992587)]"
2273,Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission,death,male sex identified by global covid-19 meta-analysis as a risk factor for _ and itu admission,male sex identified by global covid-19 meta-analysis as a risk factor for health and itu admission,https://www.nature.com/articles/s41467-020-19741-6,"[('3: Male sex is associated with a significantly increased risk of ITU admission within COVID-19 patients.', 0.7442703), ('An appreciation of how sex is influencing COVID-19 outcomes will have important implications for clinical management and mitigation strategies for this disease.', 0.70126015), ('4: Male sex is associated with a significantly increased risk of mortality within COVID-19 patients.', 0.69899297), ('Taken together these data highlight that, whilst there is no difference in the proportion of COVID-19 cases between sexes, men have a higher risk of ITU admission (OR 2.84) and death (OR 1.39).', 0.6518643), ('Meta-analyses of infection, ITU and mortality risks: The proportion of male cases with COVID-19 in these reports was exactly half at 0.50 (95% confidence interval (CI) = 0.48,0.51; p = 0.56; n = 3,111,714), demonstrating that males and females have similar numbers of infections (Fig.', 0.63815933)]"
2274,"A Randomized Controlled Trial : Annals of Internal Medicine : Vol 0 , No 0",medicine,"a randomized controlled trial : annals of internal _ : vol 0 , no 0","a randomized controlled trial : annals of internal training : vol 0, no 0",https://www.acpjournals.org/doi/10.7326/M20-6817,"[('Annals of Internal Medicine [Internet].', 0.53467315), ('A Randomized Controlled Trial.', 0.52885854), ('A randomized controlled trial.', 0.52885854), ('Annals of Internal Medicine website.', 0.52396435), ('Effectiveness of N95 respirators versus surgical masks against influenza: a systematic review and meta-analysis.', 0.4922352)]"
2275,Plasmin cascade mediates thrombolytic events in SARS-CoV-2 infection via complement and platelet-activating systems,infection,plasmin cascade mediates thrombolytic events in sars-cov-2 _ via complement and platelet-activating systems,plasmin cascade mediates thrombolytic events in sars-cov-2 production via complement and platelet-activating systems,https://www.biorxiv.org/content/10.1101/2020.05.28.120162v1,"[('Our results indicate that plasmin is a crucial mediator which primes interactions between complement and platelet-activating systems in lung epithelia upon SARS-CoV-2 infection, with a potential for therapeutic intervention.', 0.653183), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.45835674), ('However, it is not fully understood how the SARS-CoV-2 infection mechanisms mediate thrombotic events, and whether such mechanisms and responses are unique to SARS-CoV-2 infection, compared to other respiratory infections.', 0.3760874), ('Your Email Your Name Send To Enter multiple addresses on separate lines or separate them with commas.', 0.301969), ('Recent clinical reports suggested that the pulmonary failure seen in COVID-19 may not be solely driven by acute ARDS, but also microvascular thrombotic events, likely driven by complement activation4,5.', 0.3009424)]"
2276,Coronavirus Is Hiding in Plain Sight,plain,coronavirus is hiding in _ sight,coronavirus is hiding in Asia sight,https://www.nytimes.com/2020/03/16/health/coronavirus-statistics-undetected.html?utm_source=pocket&utm_medium=email&utm_campaign=pockethits,"[('“And it’s important to develop inexpensive tests so people can get tested whenever they need to be.” The new analysis drew on documented infections in China and mobility data, as well as a model of social interaction across the population, to estimate the numbers of undocumented cases, as well as infection rates.', 0.31166932), ('A health worker in Seoul waited at a coronavirus drive-through testing center earlier this month.Credit...Ed Jones/Agence France-Presse — Getty Images By Benedict Carey March 16, 2020 Scientists tracking the spread of the coronavirus reported on Monday that, for every confirmed case, there are most likely another five to 10 people in the community with undetected infections.', 0.25013483), ('The report is among the first to address two of the most pressing questions about the pandemic: How many people are walking around with unrecognized infections, and how infectious are they?', 0.23706107), ('The researchers modeled the virus’s natural spread in China before the government instituted a travel ban and an aggressive testing policy.', 0.19149268), ('The unidentified cases in China that proliferated before the lockdown, although less contagious on average than the confirmed ones, did not necessarily cause milder cases in the newly infected, the researchers said.', 0.1883637)]"
2278,FDA Gives the Green Light to Portable COVID-19 Test Kit,fda,_ gives the green light to portable covid-19 test kit,Table gives the green light to portable covid-19 test kit,https://www.nbcbayarea.com/news/local/fda-gives-the-green-light-to-portable-covid-19-testing-kit/2263068/,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.44772035), ('Abbott Labs, a Chicago company with offices in Santa Clara, has been working on the portable testing platform and now that they got the go, it’s expected to test 50,000 people a day.', 0.38058), (""“It's the size of a small kitchen appliance,” said Gavin Cloherty, head of Infectious Disease research at Abbott Labs."", 0.3589517), ('“It generates accurate test results in a matter of minutes, instead of hours or days, which enables a healthcare provider to see a patient, diagnose a patient, and take necessary interventions in a very short amount of time,"" said Cloherty.', 0.30367878), (""All rights reserved Back to Article Close Menu Search for: Coronavirus Pandemic Local News Making It In The Bay Bay Area Proud Digital Originals State U.S. & World Sports The Investigative Unit No Man's Land NBC Bay Area Responds Submit a consumer complaint How To Explainers Weather Weather Alerts Traffic Video NBCLX Entertainment California Live Community About Us TV Schedule Submit Photos and Video Contests Newsletters Our Apps "", 0.2768011)]"
2279,Mass cytometry and artificial intelligence define CD169 as a specific marker of SARS-CoV2-induced acute respiratory distress syndrome,specific,mass cytometry and artificial intelligence define cd169 as a _ marker of sars-cov2-induced acute respiratory distress syndrome,mass cytometry and artificial intelligence define cd169 as a potential marker of sars-cov2-induced acute respiratory distress syndrome,https://www.biorxiv.org/content/10.1101/2020.09.22.307975v1,"[('Tarte doi: https://doi.org/10.1101/2020.09.22.307975 M. Roussel 1Centre Hospitalier Universitaire de Rennes, Laboratoire Hématologie, Pôle Biologie, F-35033, Rennes, France 2Centre Hospitalier Universitaire de Rennes, SITI, Pôle Biologie, F-35033, Rennes, France 3Institut national de la santé et de la recherche médicale, Unité Mixte de Recherche U1236, Université Rennes 1, Etablissement Français du Sang Bretagne, F-35000, Rennes, France Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for M. Roussel For correspondence: mikael.roussel@chu-rennes.fr karin.tarte@univ-rennes1.fr J. Ferrant 3Institut national de la santé et de la recherche médicale, Unité Mixte de Recherche U1236, Université Rennes 1, Etablissement Français du Sang Bretagne, F-35000, Rennes, France Find this author on Google Scholar Find this author on PubMed Search for this author on this site F. Reizine 3Institut national de la santé et de la recherche médicale, Unité Mixte de Recherche U1236, Université Rennes 1, Etablissement Français du Sang Bretagne, F-35000, Rennes, France 4Centre Hospitalier Universitaire de Rennes, Maladies Infectieuses et Réanimation Médical, F-35033, Rennes, France Find this author on Google Scholar Find this author on PubMed Search for this author on this site S. Le Gallou 2Centre Hospitalier Universitaire de Rennes, SITI, Pôle Biologie, F-35033, Rennes, France 3Institut national de la santé et de la recherche médicale, Unité Mixte de Recherche U1236, Université Rennes 1, Etablissement Français du Sang Bretagne, F-35000, Rennes, France Find this author on Google Scholar Find this author on PubMed Search for this author on this site J. Dulong 2Centre Hospitalier Universitaire de Rennes, SITI, Pôle Biologie, F-35033, Rennes, France 3Institut national de la santé et de la recherche médicale, Unité Mixte de Recherche U1236, Université Rennes 1, Etablissement Français du Sang Bretagne, F-35000, Rennes, France Find this author on Google Scholar Find this author on PubMed Search for this author on this site S. Carl 5Scailyte AG, Industriestrasse 12, 6210 Sursee, Switzerland Find this author on Google Scholar Find this author on PubMed Search for this author on this site M. Lesouhaitier 3Institut national de la santé et de la recherche médicale, Unité Mixte de Recherche U1236, Université Rennes 1, Etablissement Français du Sang Bretagne, F-35000, Rennes, France 4Centre Hospitalier Universitaire de Rennes, Maladies Infectieuses et Réanimation Médical, F-35033, Rennes, France Find this author on Google Scholar Find this author on PubMed Search for this author on this site M. Gregoire 2Centre Hospitalier Universitaire de Rennes, SITI, Pôle Biologie, F-35033, Rennes, France 3Institut national de la santé et de la recherche médicale, Unité Mixte de Recherche U1236, Université Rennes 1, Etablissement Français du Sang Bretagne, F-35000, Rennes, France Find this author on Google Scholar Find this author on PubMed Search for this author on this site N. Bescher 2Centre Hospitalier Universitaire de Rennes, SITI, Pôle Biologie, F-35033, Rennes, France Find this author on Google Scholar Find this author on PubMed Search for this author on this site C. Verdy 2Centre Hospitalier Universitaire de Rennes, SITI, Pôle Biologie, F-35033, Rennes, France Find this author on Google Scholar Find this author on PubMed Search for this author on this site M. Latour 2Centre Hospitalier Universitaire de Rennes, SITI, Pôle Biologie, F-35033, Rennes, France Find this author on Google Scholar Find this author on PubMed Search for this author on this site I. Bézier 2Centre Hospitalier Universitaire de Rennes, SITI, Pôle Biologie, F-35033, Rennes, France Find this author on Google Scholar Find this author on PubMed Search for this author on this site M. Cornic 2Centre Hospitalier Universitaire de Rennes, SITI, Pôle Biologie, F-35033, Rennes, France Find this author on Google Scholar Find this author on PubMed Search for this author on this site S. Leonard 1Centre Hospitalier Universitaire de Rennes, Laboratoire Hématologie, Pôle Biologie, F-35033, Rennes, France Find this author on Google Scholar Find this author on PubMed Search for this author on this site J. Feuillard 6Centre Hospitalier Universitaire de Limoges, F-87000, Limoges, France Find this author on Google Scholar Find this author on PubMed Search for this author on this site V.K.', 0.46840638), ('A cell signature associating S100A9/calprotectin-producing CD169pos monocytes, plasmablasts, and Th1 cells was specifically found in COVID-19posARDSpos, unlike COVID-19negARDSpos patients.', 0.45814094), ('Tiwari 7Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry & Biomedical Science, Queens University Belfast, BT9 7BL, United Kingdom Find this author on Google Scholar Find this author on PubMed Search for this author on this site J.M.', 0.45658022), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.44425917), ('Tadié 3Institut national de la santé et de la recherche médicale, Unité Mixte de Recherche U1236, Université Rennes 1, Etablissement Français du Sang Bretagne, F-35000, Rennes, France 4Centre Hospitalier Universitaire de Rennes, Maladies Infectieuses et Réanimation Médical, F-35033, Rennes, France Find this author on Google Scholar Find this author on PubMed Search for this author on this site M. Cogné 3Institut national de la santé et de la recherche médicale, Unité Mixte de Recherche U1236, Université Rennes 1, Etablissement Français du Sang Bretagne, F-35000, Rennes, France 6Centre Hospitalier Universitaire de Limoges, F-87000, Limoges, France Find this author on Google Scholar Find this author on PubMed Search for this author on this site K. Tarte 2Centre Hospitalier Universitaire de Rennes, SITI, Pôle Biologie, F-35033, Rennes, France 3Institut national de la santé et de la recherche médicale, Unité Mixte de Recherche U1236, Université Rennes 1, Etablissement Français du Sang Bretagne, F-35000, Rennes, France 8Centre Hospitalier Universitaire de Rennes, Laboratoire Immunologie, Pôle Biologie, F-35033, Rennes, France Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for K. Tarte For correspondence: mikael.roussel@chu-rennes.fr karin.tarte@univ-rennes1.fr Abstract Full Text Info/History Metrics Supplementary material Preview PDF ', 0.43643644)]"
2280,"Plasma levels of soluble ACE2 are associated with sex , Metabolic Syndrome , and its biomarkers in a large cohort , pointing to a possible mechanism for increased severity in COVID-19",associated,"plasma levels of soluble ace2 are _ with sex , metabolic syndrome , and its biomarkers in a large cohort , pointing to a possible mechanism for increased severity in covid-19","plasma levels of soluble ace2 are inconsistent with sex, metabolic syndrome, and its biomarkers in a large cohort, pointing to a possible mechanism for increased severity in covid-19",https://www.medrxiv.org/content/10.1101/2020.06.10.20127969v1,"[('Age and sex differences in soluble ACE2 may give insights for COVID-19.', 0.7446593), ('The upregulation may be related to the tissue-specific patterns of increased SARS-CoV-2 infectivity in patients with cardiometabolic disease and/or liver damage and warrants further research on sACE2 as a potential biomarker for COVID-19 severity.', 0.67942816), ('1 The associations of plasma sACE2 levels with sex, age, and metabolic syndrome (MetS).', 0.5845943), (""sACE2, soluble ACE2 (normalized protein expression, NPX, values adjusted for covariates and scaled) Individuals who met World Health Organization's diagnostic criteria for metabolic syndrome (MetS) ( N = 171) displayed elevated plasma sACE2 levels compared to controls ( N = 1880; P = 4.7 × 10− 5); the effect was stronger in men ( P int = 8.9 × 10− 5)."", 0.56035346), ('Plasma sACE2 and leptin levels were measured via proximity extension immunoassaying using Olink® Cardiovascular II proteomics panel.', 0.53952914)]"
2281,Major update to IMHE / White House Task Force projections model released this morning,morning,major update to imhe / white house task force projections model released this _,major update to imhe / white house task force projections model released this manuscript,http://www.healthdata.org/covid/updates,"[('And you call up the next day: ""How\'s he doing?""', 0.54221606), ('And when the President signed the national emergency declaration, he stood up the National Response Center at FEMA.', 0.531725), ('We are getting more and more and more, and now we have the new test that you saw yesterday.', 0.5142445), ('THE VICE PRESIDENT: The test the President unveiled yesterday, the Abbott Laboratories test -- which is a 15-minute test -- our team is working very closely with Admiral Giroir and FEMA to make sure that those are distributed around -- around the country.', 0.5093069), ('Well, I’ll be speaking -- I’m going to be spea- -- in fact, he has a call in to me and we’ll be speaking to -- we’ll be speaking to the governor and we’ll be speaking to him soon.', 0.5050229)]"
2282,Pooling samples could boost corona test efficiency,test,pooling samples could boost corona _ efficiency,pooling samples could boost corona vaccination efficiency,https://www.csh.ac.at/pooling-corona-samples-boosts-test-efficiency/,"[('Pooling could thus help to significantly alleviate bottlenecks in testing.', 0.68907034), ('The method presented here indicates the optimal pooling size.', 0.47210026), ('Pooling strategies for testing potentially infected persons are a practically free way of multiplying the efficiency of the tests while the level of infection of the population is still low.', 0.4592263), ('If the infection level of the population is low, this can lead to considerable increases in testing efficiency.', 0.45793945), ('(c) Error rates (""false negatives"") of the pooling procedure.', 0.43928438)]"
2283,Taiwan scientists develop antibodies for 15-minute Wuhan virus test in 19 days,develop,taiwan scientists _ antibodies for 15-minute wuhan virus test in 19 days,taiwan scientists received antibodies for 15-minute wuhan virus test in 19 days,https://www.taiwannews.com.tw/en/news/3893301,"[('(gettyimages) TAIPEI (Taiwan News) -- Academia Sinica on Sunday (March 8) announced that a team of scientists has developed antibodies that can identify the protein that causes the Wuhan coronavirus (COVID-19) in just 19 days, paving the way for a new test for the virus that can provide results within 15 minutes.', 0.8413856), ('On its Facebook page at noon on Sunday, Academia Sinica announced that Dr. Yang An-suei (楊安綏) and his team at the Genomics Research Center had developed monoclonal antibodies that can identify the protein of SARS-CoV-2, the virus which causes COVID-19, within a ""record-breaking"" 19 days.', 0.69340247), ('Yang said that if these antibodies can be successfully manufactured and validated, they could be used to create a rapid test for COVID-19 that could yield results in as little as 15 minutes, similar to rapid influenza tests.', 0.6535153), ('Wuhan coronavirus Wuhan virus coronavirus Novel Coronavirus COVID-19 test COVID-19 Wuhan coronavirus test Tweet <-Older Newer-> ', 0.5739163), ('Specifically, Yang said that the first monoclonal antibodies to bind the nucleocapsid protein (N protein) have been successfully tested and generated.', 0.5250358)]"
2284,Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients,adult,transmissibility of covid-19 depends on the viral load around onset in _ and symptomatic patients,transmissibility of covid-19 depends on the viral load around onset in latent and symptomatic patients,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0243597,"[('Temporal dynamics in viral shedding and transmissibility of COVID-19.', 0.81047195), ('In addition, viral load can be associated with infectiousness, especially in the acute phase of COVID-19.', 0.78475785), ('In conclusion, the results of this study suggest that a high nasopharyngeal viral load may contribute to the secondary transmission of COVID-19.', 0.7333279), ('However, it is plausible that high nasopharyngeal viral loads contribute to secondary transmission of COVID-19.', 0.70676637), ('Presumed asymptomatic carrier transmission of COVID-19.', 0.69150686)]"
2285,South Korea Epidemiological links have been found for 80.8 % of the total cases ; 19.2 % are either under investigation or sporadic cases .,cases,south korea epidemiological links have been found for 80.8 % of the total _ ; 19.2 % are either under investigation or sporadic _ .,"in 2004, China began human trials for aerosolized hydroxychloroquine to be taken using an inhaler.",https://www.cdc.go.kr/board/board.es?mid=a30402000000&bid=0030&act=view&list_no=366592&tag=&nPage=1,"[('The updates on COVID-19 in Korea as of 19 March Date 2020-03-19 19:14 Update 2020-03-19 20:49 Division Division of Risk assessment and International cooperation Tel 043-719-7556 10,716 Updates on COVID-19 in Republic of Korea 19 March, 2020 ○ As of 0:00, 19 March 2020, a total of 8,565 cases have been confirmed, of which 1,947 cases have been discharged from isolation.', 0.5668953), ('○ From Baesung Hospital in Daegu, 8 cases (2 staff, 6 patients in inpatient care) have been confirmed in total since 16 March.', 0.54578066), ('The updates on COVID-19 in Korea as of 15 March Date 2020-03-15 17:13 Update 2020-03-15 17:16 Division Division of Risk assessment and International cooperation Tel 043-719-7556 21,653 The Updates of COVID-19 in Republic of Korea 15 March, 2020 ○ As of 0:00, 15 March 2020, a total of 8,162 cases have been confirmed with 834 cases discharged from isolation.', 0.5441121), ('○ From Guro-gu call center in Seoul, 4 additional cases (2 from the 11th floor, 2 contacts) were confirmed.', 0.4178121), ('Travel histories of all travelers entering Korea will be provided to healthcare providers via the International Traveler Information System for reference.', 0.41445538)]"
2286,Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2,human,identification of potential treatments for covid-19 through artificial intelligence-enabled phenomic analysis of _ cells infected with sars-cov-2,identification of potential treatments for covid-19 through artificial intelligence-enabled phenomic analysis of bat cells infected with sars-cov-2,https://www.biorxiv.org/content/10.1101/2020.04.21.054387v1,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.50162625), ('However, Recursion has committed to free non-discriminatory licensing for any of its intellectual property around discoveries related to the treatment of COVID19.', 0.375362), ('Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about bioRxiv.', 0.3448161), ('Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.', 0.34252256), ('In our assay, remdesivir is the only antiviral tested with strong efficacy, neither chloroquine nor hydroxychloroquine have any beneficial effect in this human cell model, and a small number of compounds not currently being pursued clinically for SARS-CoV-2 have efficacy.', 0.31356603)]"
2287,"Preliminary results from a multi-centre , randomized , controlled trial .",centre,"preliminary results from a multi-_ , randomized , controlled trial .","preliminary results from a multi-dose, randomized, controlled trial.",https://www.medrxiv.org/content/10.1101/2020.07.15.20151852v1,"[('A multicentre randomized clinical trial.', 0.8575761), ('Using a Web-based unstratified randomization method with the concealment of trial group, we assigned patients to receive either the usual standard of care or the usual standard of care plus hydroxychloroquine or one of the other available treatments that were being evaluated.', 0.6440214), ('Methods The Randomised Evaluation of COVID-19 therapy (RECOVERY) trial is a randomized, controlled, open-label, platform trial comparing a range of possible treatments with usual care in patients hospitalized with COVID-19.', 0.61222506), ('Trial registrations The trial is registered with ISRCTN (50189673) and clinicaltrials.gov (NCT04381936).', 0.60237074), ('The protocol with its statistical analysis plan are available at NEJM.org, with additional information in the Supplementary Appendix and on the trial website at www.recoverytrial.net.', 0.5605383)]"
2288,Moderna 's COVID-19 Vaccine Shines In Clinical Trial,clinical,moderna 's covid-19 vaccine shines in _ trial,moderna's covid-19 vaccine shines in development trial,https://www.npr.org/sections/health-shots/2020/11/16/935239294/modernas-covid-19-vaccine-shines-in-clinical-trial,"[('(Maddie Meyer/Getty Images) A second COVID-19 vaccine now also appears highly effective in preventing illness following exposure to the virus that causes the disease.', 0.7024126), ('To be counted as a COVID-19 case, participants in the Moderna study had to have at least two symptoms of disease in addition to a positive test for the virus.', 0.682651), ('The biotech company Moderna Inc. said Monday that its experimental vaccine was 94.5% effective in preventing disease, according to an analysis of its clinical trial.', 0.6015184), ('Moderna said Monday that it expects to be able to ship about 20 million vaccine doses in the U.S. by the end of 2020.', 0.5505345), ('Side effects seen for the Moderna vaccine at the interim analysis included pain at the injection site, fatigue and aching muscles and joints.', 0.5438767)]"
2289,Characterization of Patients Who Return to Hospital Following Discharge from Hospitalization For COVID-19,following,characterization of patients who return to hospital _ discharge from hospitalization for covid-19,characterization of patients who return to hospital before discharge from hospitalization for covid-19,https://www.medrxiv.org/content/10.1101/2020.05.17.20104604v1,"[('Open in a separate window Figure 1 Time to return to hospital since discharge for COVID-19-related hospitalization.', 0.7752778), ('As the evolution of COVID-19 remains uncertain, characterization of the clinical course of patients who re-present after discharge is important with potential to inform discharge planning and post- discharge care.2 In this study, we focus on early readmissions more likely related to the index COVID-19 hospitalization.', 0.75421), ('Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19.', 0.7423434), ('When larger sample sizes become available, the conceptual framework and preliminary trends in this study can help guide future research in understanding determinants of safe discharge and appropriate in-hospital treatment for preventing readmission and death following a COVID-19 hospitalization.', 0.71300304), ('Autopsy Findings and Venous Thromboembolism in Patients With COVID-19.', 0.69458485)]"
2290,Far-UVC light efficiently and safely inactivates airborne human coronaviruses,light,far-uvc _ efficiently and safely inactivates airborne human coronaviruses,far-uvc binds efficiently and safely inactivates airborne human coronaviruses,https://www.nature.com/articles/s41598-020-67211-2,"[('By contrast, far-UVC light (207-222 nm) efficiently kills pathogens without harm to exposed human cells or tissues.', 0.70256865), ('As all human coronaviruses have similar genomic size, a key determinant of radiation sensitivity, it is realistic to expect that far-UVC light will show comparable inactivation efficiency against other human coronaviruses, including SARS-CoV-2.', 0.69669116), ('We previously demonstrated that 222-nm UV light efficiently kills airborne influenza virus (H1N1); here we extend the far-UVC studies to explore efficacy against human coronaviruses from subgroups alpha (HCoV-229E) and beta (HCoV- OC43).', 0.6532105), ('Based on these results for the beta HCoV-OC43 coronavirus, continuous far-UVC exposure in public locations at the currently recommended exposure limit (3 mJ/cm2/hour) would result in 99.9% viral inactivation in ~ 25 minutes.', 0.6358785), ('Ultraviolet (UV) light is a well-established antimicrobial; however, the UV light commonly used for this purpose (~254 nm) poses significant health risks in public spaces due to its cancer-causing effects.', 0.593797)]"
2292,Large-scale single-cell analysis reveals critical immune characteristics of COVID-19 patients,cell,large-scale single-_ analysis reveals critical immune characteristics of covid-19 patients,large-scale single-dose analysis reveals critical immune characteristics of covid-19 patients,https://www.biorxiv.org/content/10.1101/2020.10.29.360479v1,"[('HIGHLIGHTS Large-scale scRNA-seq analysis depicts the immune landscape of COVID-19 Lymphopenia and active T and B cell responses coexist and are shaped by age and sex SARS-CoV-2 infects diverse epithelial and immune cells, inducing distinct responses Cytokine storms with systemic S100A8/A9 are associated with COVID-19 severity ', 0.8088073), ('Lymphopenia and active T and B cell responses were found to coexist and associated with age, sex and their interactions with COVID-19.', 0.65733373), ('Our data provide a rich resource for understanding the pathogenesis and designing effective therapeutic strategies for COVID-19.', 0.6146835), ('We applied single-cell RNA sequencing to 284 samples from 205 COVID-19 patients and controls to create a comprehensive immune landscape.', 0.6042743), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.4757256)]"
2293,Russia posts record daily,record,russia posts _ daily,russia posts died daily,https://www.cnbc.com/2020/05/07/coronavirus-live-updates-asia-europe.html,"[('Russia reported 11,231 additional cases of the coronavirus disease over the last 24 hours — a record high in daily new cases in the country, according to a Reuters report.', 0.4634599), ('The official number of cases in Russia stands at just over 177,000 with 92,676 cases of the coronavirus in Moscow.', 0.38865107), (""India's death toll increased by 89 to 1,783, the latest data showed."", 0.26044732), ('All times below are in Beijing time.', 0.25914422), ('While nonessential businesses are closed in most states in the country, a lockdown has so far been implemented in only one city — Sao Luis.', 0.2348096)]"
2295,Homozygous L-SIGN plays a protective role in SARS coronavirus infection,sign,homozygous l-_ plays a protective role in sars coronavirus infection,homozygous l-ATPase plays a protective role in sars coronavirus infection,https://www.nature.com/articles/ng1698?fbclid=IwAR1iptRyDYOCBbQG-xpDNnh_Sa71M07yoMgAGlFkH3SO0kMWc21Ofe7qjwY,"[('This observation confirms that homozygous L-SIGN does have a protective role in SARS-CoV infection.', 0.9019467), ('Homozygous L-SIGN ( CLEC4M ) plays a protective role in SARS coronavirus infection.', 0.9011594), ('Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection.', 0.9011594), ('Thus, homozygosity for L-SIGN plays a protective role during SARS infection.', 0.88015103), ('The Genome sequence of the SARS-associated coronavirus.', 0.6977607)]"
2296,"Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler , China",large,"_ sars-cov-2 outbreak caused by asymptomatic traveler , china","One sars-cov-2 outbreak caused by asymptomatic traveler, china",https://wwwnc.cdc.gov/eid/article/26/9/20-1798_article,"[('Timeline of exposure and connections between cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among persons in Heilongjiang Province, China.', 0.67492557), ('Our results illustrate how a single asymptomatic SARS-CoV-2 infection could result in widespread community transmission.', 0.60042274), ('Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient.', 0.5854523), ('We defined asymptomatic carriers as persons without clinical symptoms who tested positive for SARS-CoV-2.', 0.51418686), ('This report also highlights the resources required for case investigation and challenges associated with containment of SARS-CoV-2.', 0.49094856)]"
2297,Ohio State is moving all classes to digital format until the end of the month at least,month,ohio state is moving all classes to digital format until the end of the _ at least,ohio state is moving all classes to digital format until the end of the epidemic at least,https://www.thelantern.com/2020/03/ohio-state-suspends-classes-until-march-30-due-to-coronavirus-outbreak/,"[('Commencement postponed Northern Kentucky University is moving from face-to-face classes to online delivery through the end of the semester.', 0.6729706), ('Spring commencement has been postponed Wright State University (Through March 30 at least) Xavier University will move to remote learning format for all courses for the duration of the spring semester.', 0.6572708), ('Ohio University announced late Tuesday afternoon that it would move to online learning only through at least March 30.', 0.62965417), ('Ohio State University announced late Monday it would be suspending in-person classes through March 30, moving instead to virtual instruction.', 0.6157265), ('Ohio State also announced it will deliver all courses through virtual modes for the summer 2020 term.', 0.60103494)]"
2298,India 's Covid cases ascend to 6.63 million,million,india 's covid cases ascend to 6.63 _,india's covid cases ascend to 6.63%.,https://www.itstrending.org/2020/10/indias-covid-cases-ascend-to-663.html?m=1,"[('Passings from COVID contaminations rose by 903 to 102,685, the service said.', 0.36500597), (""India's loss of life from the novel COVID rose past 100,000 on Saturday, just the third nation on the planet to arrive at that disheartening achievement, after the United States and Brazil, and its plague gives no indication of decreasing."", 0.27021343), ('A week ago, India further facilitated limitations and allowed states to open schools and cinemas.', 0.2603799), ('Tags: COVID-19 Health India News World Facebook Twitter ', 0.15865344), ('DISCLAIMER PRIVACY POLICY TERMS & CONDITIONS CONTACT ', 0.095757894)]"
2302,Stress and Fear Clinical Implications for Providers and Patients,patients,stress and fear clinical implications for providers and _,stress and fear clinical implications for providers and policy,https://www.mayoclinicproceedings.org/article/S0025-6196(20)30978-2/fulltext,"[('Negative ruminations and perseveration are common after these events, and providers are now recognized to be at risk for becoming “second victims” as they struggle with subsequent feelings of anxiety, fear, guilt, or anger, leading to social withdrawal, troubling memories, depression, and insomnia.', 0.64424765), ('The importance of the relationship between stress and health is magnified during critical illness when many patients are already terrified 14 B.C.', 0.64291716), (""The authors of the article, Mayo Clinic, Vanderbilt University, University Hospital of Wales, Queen's University of Canada and Katalin Varga, researcher at the Department of Affective Psychology at Eötvös Loránd University, explore the measurable physiological effects of stress and fear, which are particularly important to keep in mind during an epidemic."", 0.64281374), ('Patients may perceive staff performing painful interventions as hostile adversaries, which can further complicate care and outcomes.', 0.63454163), ('The sheer volume of admissions has placed unprecedented strain on provider teams working in underprepared health systems.', 0.6047002)]"
2303,The world needs a better World Health Organisation,needs,the world _ a better world health organisation,the world is a better world health organisation,https://www.economist.com/international/2020/09/12/the-world-needs-a-better-world-health-organisation,"[('It is an odd time to cut ties with the world’s foremost public-health body.', 0.5513888), ('A year ago the risks of a weak global health system were hard to calculate.', 0.4343681), ('UN bodies work by consensus, he says: “That is the price you pay for getting all the countries in the world around the table.” Ordinarily the job of the WHO is to identify the best public-health measures, share that information and offer technical support to members that need it.', 0.42451775), ('The WHO may need the power to investigate outbreaks more independently and to establish a system so that it can issue warnings about public-health emergencies earlier.', 0.41072857), ('A fresh outbreak of Ebola in Congo requires attention.', 0.39553392)]"
2304,"Efficacy of face masks , neck gaiters and face shields for reducing the expulsion of simulated cough-generated aerosols",for,"efficacy of face masks , neck gaiters and face shields _ reducing the expulsion of simulated cough-generated aerosols","efficacy of face masks, neck gaiters and face shields without reducing the expulsion of simulated cough-generated aerosols",https://www.medrxiv.org/content/10.1101/2020.10.05.20207241v1,"[('Our results show that face masks and neck gaiters can significantly reduce the expulsion of small respiratory aerosol particles during coughing.', 0.86890495), ('One of the primary benefits of face masks and other coverings is as source control devices to reduce the expulsion of respiratory aerosols during coughing, breathing, and speaking.', 0.85416037), ('Our results suggest that face masks and neck gaiters are preferable to face shields as source control devices for cough aerosols.', 0.8316083), ('Efficacy of face shields against cough aerosol droplets from a cough simulator.', 0.80149114), ('Efficacy of masks and face coverings in controlling outward aerosol particle emission from expiratory activities.', 0.776672)]"
2305,FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19,treatment,fda authorizes monoclonal antibodies for _ of covid-19,fda authorizes monoclonal antibodies for production of covid-19,https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19,"[('Based on the FDA’s review of the totality of the scientific evidence available, the agency has determined that it is reasonable to believe that casirivimab and imdevimab administered together may be effective in treating patients with mild or moderate COVID-19.', 0.65120846), ('When used to treat COVID-19 for the authorized population, the known and potential benefits of these antibodies outweigh the known and potential risks.', 0.62836266), ('“The emergency authorization of these monoclonal antibodies administered together offers health care providers another tool in combating the pandemic,” said Patrizia Cavazzoni, M.D., acting director of the FDA’s Center for Drug Evaluation and Research.', 0.6203207), ('A benefit of casirivimab and imdevimab treatment has not been shown in patients hospitalized due to COVID-19.', 0.58050126), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.5417345)]"
2306,Targeted antioxidants as therapeutics for treatment of pneumonia in the elderly,treatment,targeted antioxidants as therapeutics for _ of pneumonia in the elderly,targeted antioxidants as therapeutics for development of pneumonia in the elderly,https://www.sciencedirect.com/science/article/pii/S1931524420300396,"[('Results of several antioxidant studies both in vitro and in vivo have demonstrated promising potential as a therapeutic in the treatment of pneumonia in the elderly.', 0.79500353), ('Antioxidants cytokines and influenza infection in aged mice and elderly humans.', 0.6524688), ('Is statin use associated with reduced mortality after pneumonia?', 0.646667), ('Pneumonia in the elderly.', 0.6317779), ('Statin therapy in patients with community-acquired pneumonia.', 0.62972987)]"
2307,"Delaware medical supplier says FEMA seized 400,000 N95 masks , now he 's out millions of dollars",says,"delaware medical supplier _ fema seized 400,000 n95 masks , now he 's out millions of dollars","delaware medical supplier and fema seized 400,000 n95 masks, now he's out millions of dollars",https://www.msn.com/en-us/news/us/delaware-medical-supplier-says-fema-seized-400000-n95-masks-now-hes-out-millions-of-dollars/ar-BB130fik?ocid=st2,"[('– As pleas for protective masks continue amid the coronavirus pandemic, a Delaware supplier of medical equipment is disputing the legality of what he said were federal seizures of hundreds of thousands of N95 respirators.', 0.62104774), ('Last month, Delaware requested 10 million masks and more than 100 million gloves for what it expected to be a monthslong fight against the coronavirus.', 0.61014605), ('George Gianforcaro, owner of the small, Newark, Delaware-based Indutex USA, said the Federal Emergency Management Agency did not pay him when it took possession of two imported shipments of masks bound for customers across the United States.', 0.5256562), ('Citing Defense Production Act authority, the FEMA document further ordered Indutex to ""set aside"" all N95 or surgical masks it may come to possess during the federal emergency for a potential sale to FEMA.', 0.504984), ('(C) Jerry Habraken, Delaware News Journal Sen. Chris Coons speaks to the media about the arrival of nearly 500,000 disposable face masks Tuesday morning at D&S; Wharehousing Inc. in Newark, Delaware.', 0.5042379)]"
2308,Designer antibodies could battle COVID-19 before vaccines arrive,before,designer antibodies could battle covid-19 _ vaccines arrive,designer antibodies could battle covid-19 as vaccines arrive,https://www.sciencemag.org/news/2020/08/designer-antibodies-could-battle-covid-19-vaccines-arrive,"[('While the world is transfixed by the high-stakes race to develop a COVID-19 vaccine, an equally crucial competition is heating up to produce targeted antibodies that could provide an instant immunity boost against the virus.', 0.787813), ('Kyratsous says even if monoclonal antibodies don’t beat vaccines to the finish line, they still might have a role to play against COVID-19.', 0.7570591), ('“Antibodies have the potential to be an important bridge until the vaccine is available,” says Ajay Nirula, a vice president at Eli Lilly, one of several large companies investing in them.', 0.71802384), ('The idea, which has not yet been tested in humans for COVID-19, is to inject people with DNA or messenger RNA that encodes a desired antibody, allowing their own cells to make it.', 0.7068501), ('One treatment study run by the company aims to enroll nearly 2600 hospitalized people with severe COVID-19, whereas another, about half that size, will test the antibodies in infected people with mild or moderate symptoms.', 0.685604)]"
2309,The Pandemic Caused By Privilege and Capitalism Part 4,capitalism,the pandemic caused by privilege and _ part 4,the pandemic caused by privilege and not part 4,https://medium.com/@michaelfeuerstein/the-pandemic-caused-by-privilege-and-capitalism-part-4-the-forgotten-heroes-sanitation-workers-c0b19eae0fa,"[('Their actions should only prove further the pandemic of Capitalism and Privilege.', 0.64594835), ('Was the spread of this Pandemic Caused by Privilege and Capitalism/Globalism and apathy of the working class and their rights to care, wages, labor and they have made us apathetic to our collective and individual suffering by overworking us?', 0.6118028), ('Obscene Unoconciouess Capitalism behavior and the Profits of such, are the unpaid wages of the working poor and are a plague/pandemic of the middle and lower laborer.', 0.5217684), ('It was common for privileged elites to look down on workers and the poor as inferior categories of human being, whose natural degeneracy predisposed them to disease and deformity.', 0.47968864), ('These opinion articles will be a weekly assessment of current news and events, leadership choices towards treatments the working poor and middle class along with the victims and Essential and Non Essential workers, How Capitalism and Privilege affect the lives of everyone, from individual to the collective, and workers rights, and many other topics.', 0.45854503)]"
2310,A front-runner vaccine shows promise in older people,older,a front-runner vaccine shows promise in _ people,a front-runner vaccine shows promise in young people,https://www.nature.com/articles/d41586-020-00502-w,"[('The results show that the vaccine could provide a “durable” antibody response, the authors write.', 0.6297101), ('Antibodies against SARS-CoV-2 can activate these cells.Credit: NIAID/NIH/SPL 8 December — A coronavirus vaccine shows lasting benefit People given a front-runner COVID-19 vaccine still had high levels of potent antibodies against the coronavirus four months after their first jab.', 0.62434685), ('“The robust antibody and T-cell responses seen in older people in our study are encouraging,” said Maheshi Ramasamy, a consultant and co-lead investigator at the Oxford Vaccine Group.', 0.59379995), ('The vaccine also appears to produce a strong response from special immune cells that help to mount a fast defence after infection with SARS-CoV-2.', 0.5936447), ('The authors suggest that a vaccine designed to elicit these potent antibodies might be universally effective.', 0.5819967)]"
2312,Intestinal inflammation modulates the expression of ACE2 and TMPRSS2 and potentially overlaps with the pathogenesis of SARS-CoV-2 related disease,expression,intestinal inflammation modulates the _ of ace2 and tmprss2 and potentially overlaps with the pathogenesis of sars-cov-2 related disease,intestinal inflammation modulates the production of ace2 and tmprss2 and potentially overlaps with the pathogenesis of sars-cov-2 related disease,https://www.biorxiv.org/content/10.1101/2020.05.21.109124v1,"[('Additionally, by comparing SARS CoV2-induced epithelial gene signatures with IBD-associated genes, we have identified a shared molecular subnetwork between COVID-19 and IBD.', 0.4889901), ('These considerations led us to systematically examine the intersections between COVID-19 and the GI tract during health and intestinal inflammation.', 0.4419793), ('These data generate a novel appreciation of the confluence of COVID-19- and IBD-associated inflammation and provide mechanistic insights supporting further investigation of specific IBD drugs in the treatment of COVID-19.', 0.411604), ('A number of immune-directed therapies being considered for COVID-19 patients are already in clinical use in chronic inflammatory conditions like inflammatory bowel disease (IBD).', 0.40558022), ('We have observed that IBD medications, both biologic and non- biologic, do not significantly impact ACE2 and TMPRSS2 expression in the uninflamed intestines.', 0.40314615)]"
2314,Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure,human,_ challenge studies to accelerate coronavirus vaccine licensure,Future challenge studies to accelerate coronavirus vaccine licensure,https://dash.harvard.edu/handle/1/42639016,"[('Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.', 0.7311331), ('Spinney L. When will a coronavirus vaccine be ready?', 0.6996495), ('The process to vaccine licensure through a controlled human challenge trial and large… Figure 1.', 0.6873542), ('Keywords: coronavirus; ethics; human challenge studies; randomized controlled trials; risk-taking; vaccines.', 0.67310697), ('Human Challenge Studies Are Unlikely to Accelerate Coronavirus Vaccine Licensure Due to Ethical and Practical Issues.', 0.671975)]"
2316,Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-,human,identification of potential treatments for covid-19 through artificial intelligence-enabled phenomic analysis of _ cells infected with sars-cov-,identification of potential treatments for covid-19 through artificial intelligence-enabled phenomic analysis of bat cells infected with sars-cov-,https://www.biorxiv.org/content/10.1101/2020.04.21.054387v1,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.5075264), ('However, Recursion has committed to free non-discriminatory licensing for any of its intellectual property around discoveries related to the treatment of COVID19.', 0.37685403), ('Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.', 0.3448391), ('Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about bioRxiv.', 0.33188128), ('In our assay, remdesivir is the only antiviral tested with strong efficacy, neither chloroquine nor hydroxychloroquine have any beneficial effect in this human cell model, and a small number of compounds not currently being pursued clinically for SARS-CoV-2 have efficacy.', 0.29251346)]"
2317,Is a Possible Guard for Front Liners,guard,is a possible _ for front liners,is a possible explanation for front liners,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3682517,"[('What has the physical security industry, specifically guarding, done to support these efforts?', 0.48298508), ('What does this mean for security guards and professionals?', 0.44947255), ('Security is no different.', 0.40914118), ('This website is using a security service to protect itself from online attacks.', 0.3881919), ('What Effective Guard Management Is and How You Can Get There What is Business Intelligence?', 0.38295853)]"
2318,Swissmedic Begins Rolling Review of Moderna 's mRNA Vaccine Against COVID-19,review,swissmedic begins rolling _ of moderna 's mrna vaccine against covid-19,swissmedic begins rolling production of moderna's mrna vaccine against covid-19,https://investors.modernatx.com/news-releases/news-release-details/swissmedic-begins-rolling-review-modernas-mrna-vaccine-against/,"[(""Moderna has initiated the rolling submission of mRNA-1273 data in consideration of a potential authorization for use of the vaccine candidate in Switzerland by Swissmedic, provided it meets Swissmedic's rigorous standards of safety, effectiveness, and quality standards."", 0.7412646), ('This announcement follows positive results from a preclinical viral challenge study of mRNA-1273 and the positive interim analysis of the Phase 1 study of mRNA-1273 in adults (ages 18-55 years) and older adults (ages 56-70 and 71+) published in the New England Journal of Medicine.', 0.6332636), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.59581095), ('This rolling review process allows Swissmedic to review data from ongoing clinical trials as soon as it is available.', 0.5627242), ('Valneva in advanced discussions with European Commission to supply up to 60 million doses of inactivated, adjuvanted COVID-19 vaccine candidate ', 0.54197305)]"
2319,Single-Cell Omics Reveals Dyssynchrony of the Innate and Adaptive Immune System in Progressive COVID-19,cell,single-_ omics reveals dyssynchrony of the innate and adaptive immune system in progressive covid-19,single-brain omics reveals dyssynchrony of the innate and adaptive immune system in progressive covid-19,https://www.medrxiv.org/content/10.1101/2020.07.16.20153437v1,"[('Our in-depth immune profiling reveals dyssynchrony of the innate and adaptive immune interaction in progressive COVID-19, which may contribute to delayed virus clearance and has implications for therapeutic intervention.', 0.6914783), ('Here, we utilize multiomics single-cell analysis to probe dynamic immune responses in patients with stable or progressive manifestations of COVID-19, and assess the effects of tocilizumab, an anti-IL-6 receptor monoclonal antibody.', 0.6615662), ('An anti-inflammatory innate immune response and a pre- exhaustion phenotype in activated T cells are hallmarks of progressive disease.', 0.58521223), ('Skewed T cell receptor repertoires in CD8+ T cells and uniquely enriched V(D)J sequences are also identified in COVID-19 patients.', 0.553473), ('Coordinated profiling of gene expression and cell lineage protein markers reveals a prominent type-1 interferon response across all immune cells, especially in progressive patients.', 0.46017104)]"
2321,TGA grants provisional determination for COVID-19 vaccine,grants,tga _ provisional determination for covid-19 vaccine,tga requires provisional determination for covid-19 vaccine,https://www.tga.gov.au/tga-grants-provisional-determination-covid-19-vaccine,"[('In making its decision to grant Pfizer a provisional determination, the TGA considered all eligibility criteria, including factors such as the evidence of a plan to submit comprehensive clinical data and the seriousness of the current COVID-19 pandemic.', 0.5626628), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.5626624), ('The granting of a provisional determination means that the TGA has made a decision that Pfizer is now eligible to apply for provisional registration for the vaccine in the Australian Register of Therapeutic Goods.', 0.54358006), ('The granting of a provisional determination means that the TGA has made a decision that Pfizer is now eligible to apply for provisional registration for the vaccine in the Australian Register of Therapeutic Goods (ARTG).', 0.5429942), ('Along with a number of international regulators, the TGA has received and is reviewing preliminary data relating to the safety of this vaccine.', 0.46658364)]"
2322,An international characterisation of patients hospitalised with COVID-19 and a comparison with those previously hospitalised with influenza,previously,an international characterisation of patients hospitalised with covid-19 and a comparison with those _ hospitalised with influenza,an international characterisation of patients hospitalised with covid-19 and a comparison with those not hospitalised with influenza,https://www.medrxiv.org/content/10.1101/2020.04.22.20074336v1,"[('Patients hospitalised with COVID-19 were compared with patients previously hospitalised with influenza in 2014-19.', 0.9266803), ('Conclusions: Rates of comorbidities and medication use are high among individuals hospitalised with COVID-19.', 0.7591441), ('Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study.', 0.7097838), ('Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study.', 0.6261024), ('Methods: We report the characteristics (demographics, prior conditions and medication use) of patients hospitalised with COVID-19 between December 2019 and April 2020 in the US (Columbia University Irving Medical Center [CUIMC], STAnford Medicine Research data Repository [STARR-OMOP], and the Department of Veterans Affairs [VA OMOP]) and Health Insurance Review & Assessment [HIRA] of South Korea.', 0.613657)]"
2325,The effect of temperature and humidity on the stability of SARS-CoV-2 and other enveloped viruses,other,the effect of temperature and humidity on the stability of sars-cov-2 and _ enveloped viruses,the effect of temperature and humidity on the stability of sars-cov-2 and not enveloped viruses,https://www.biorxiv.org/content/10.1101/2020.10.16.341883v1,"[('Ambient temperature and humidity are known to have strong effects on the environmental stability of viruses1, but there is little data for SARS-CoV-2, and a general quantitative understanding of how temperature and humidity affect virus stability has remained elusive.', 0.67192733), ('Here, we characterise the stability of SARS-CoV-2 on an inert surface at a variety of temperature and humidity conditions, and introduce a mechanistic model that enables accurate prediction of virus stability in unobserved conditions.', 0.60088205), ('Moreover, our model predicts observations from other human coronaviruses and other studies of SARS-CoV-2, suggesting the existence of shared mechanisms that determine environmental stability across a number of enveloped viruses.', 0.57295835), ('We find that SARS-CoV-2 survives better at low temperatures and extreme relative humidities; median estimated virus half-life was more than 24 hours at 10 °C and 40 % RH, but approximately an hour and a half at 27 °C and 65 % RH.', 0.5513113), ('Understanding the impact of environmental conditions on SARS-CoV-2 viability and its transmission potential is crucial to anticipating epidemic dynamics and designing mitigation strategies.', 0.49808604)]"
2326,NIAID-Led Study of mRNA Vaccine Supports Advance to Phase 3 Human Trials,human,niaid-led study of mrna vaccine supports advance to phase 3 _ trials,niaid-led study of mrna vaccine supports advance to phase 3 animal trials,https://www.niaid.nih.gov/news-events/experimental-covid-19-vaccine-protects-upper-and-lower-airways-nonhuman-primates,"[('“Results from early-stage clinical testing indicate the investigational mRNA-1273 vaccine is safe and immunogenic, supporting the initiation of a Phase 3 clinical trial.', 0.8890897), ('The Phase 3 clinical trial of the mRNA-1273 vaccine candidate is designed to detect a target vaccine efficacy of 60%.', 0.8210091), ('Moderna has completed manufacture of vaccine required to start the Phase 3 study.', 0.77614135), ('Read the Related Questions & Answers A Phase 3 clinical trial designed to evaluate if an investigational vaccine can prevent symptomatic coronavirus disease 2019 (COVID-19) in adults has begun.', 0.75552595), ('The Phase 3 trial of mRNA-1273 follows U.S. federal regulations on research, as well as international ethical standards and any country-specific requirements for the countries where the research is conducted.', 0.72193086)]"
2329,Algernon retains Novotech for trial of Ifenprodil in Covid-19 patients,retains,algernon _ novotech for trial of ifenprodil in covid-19 patients,algernon B novotech for trial of ifenprodil in covid-19 patients,https://www.clinicaltrialsarena.com/news/algernon-novotech-ifenprodil-trial-covid-19/,"[('March 19, 2020 Algernon announces support of a physician initiated planned Phase 2 trial of Ifenprodil for COVID-19 in South Korea.', 0.69266355), ('March 20, 2020 Algernon retains Novotech to conduct a feasibility study in Australia for a phase 2 sponsor initiated Ifenprodil COVID-19 trial.', 0.659095), ('March 20, 2020 Algernon appoints award winning Novotech as the contract research organization (“CRO”) for a planned physician-initiated study of Ifenprodil for COVID-19 patients in South Korea.', 0.6558637), ('March 13, 2020 Algernon Contacts Gates Foundation Regarding Funding for the development of New COVID-19 Treatments.', 0.5577013), ('March 23, 2020 Algernon appoints U.S. Based Cascade Chemistry to support its quickly evolving clinical program for ALI, its urgent clinical focus on COVID-19 as well as its idiopathic pulmonary fibrosis (IPF) and chronic cough clinical program.', 0.547459)]"
2330,The SARSCoV2 spike protein alters barrier function in 2D static and 3D microfluidic in vitro models of the human blood–brain barrier,human,the sarscov2 spike protein alters barrier function in 2d static and 3d microfluidic in vitro models of the _ blood–brain barrier,the sarscov2 spike protein alters barrier function in 2d static and 3d microfluidic in vitro models of the mouse blood–brain barrier,https://www.biorxiv.org/content/10.1101/2020.06.15.150912v1,"[('Introduction of spike proteins to invitro models of the blood-brain barrier (BBB) showed significant changes to barrier properties.', 0.76713383), ('Evidence provided suggests that the SARS-CoV-2 spike proteins trigger a pro-inflammatory response on brain endothelial cells that may contribute to an altered state of BBB function.', 0.6941278), ('Subsequent analysis also showed the ability for SARS-CoV-2 spike proteins to trigger a pro-inflammatory response on brain endothelial cells that may contribute to an altered state of BBB function.', 0.6919811), ('Thus, the results presented in this report explored whether deleterious outcomes from the SARS-COV-2 viral spike protein on primary human brain microvascular endothelial cells (hBMVECs) could be observed.', 0.6797215), ('Thus, the results presented in this report explored whether deleterious outcomes from the SARS-CoV-2 viral spike protein on primary human brain microvascular endothelial cells (hBMVECs) could be observed.', 0.6797215)]"
2331,An open-label parallel-arm phase II multicentre randomized controlled trial,label,an open-_ parallel-arm phase ii multicentre randomized controlled trial,an open-world parallel-arm phase ii multicentre randomized controlled trial,https://www.medrxiv.org/content/10.1101/2020.09.03.20187252v1,"[('Design: Open-label, parallel-arm, phase II, multicentre, randomized controlled trial.', 0.9238111), ('This trial has high generalizability and approximates real-life setting of CP therapy in settings with limited laboratory capacity.', 0.5401213), ('Intervention: Participants were randomized to either control (best standard of care (BSC)) or intervention (CP + BSC) arm.', 0.5362484), ('The National Task Force for COVID-19, a committee formed by ICMR to respond to the pandemic has reviewed and approved this study.', 0.50608385), ('AM, AA, GK, AT, TB, VS, KK, RS, SD, GD, SS, RG, AS, DP, CP, SS, KJ, HK, PDY, GS, PA, MM, RMY are employed with ICMR, the funding source for the trial.', 0.48785624)]"
2332,"Folding @ Home Releases SARS-CoV-2 Protein Folding Projects , Donate your Computer Power !",donate,"folding @ home releases sars-cov-2 protein folding projects , _ your computer power !","folding @ home releases sars-cov-2 protein folding projects, using your computer power!",https://foldingathome.org/2020/03/10/covid19-update/,"[('^ Folding@home n.d.e: ""Folding@home (FAH or F@h) is a distributed computing project for simulating protein dynamics, including the process of protein folding and the movements of proteins implicated in a variety of diseases.', 0.703917), ('After initial quality control and limited testing phases, Folding@home team has released an initial wave of projects simulating potentially druggable protein targets from SARS-CoV-2 (the virus that causes COVID-19) and the related SARS-CoV virus (for which more structural data is available) into full production on Folding @ home.', 0.685355), ('Folding@home also recently received a grant from the National Science Foundation (NSF) called a RAPID award, which provides funding quickly to researchers studying SARS-CoV-2, the virus that causes COVID-19.', 0.66242075), ('Toggle navigation Menu Start folding COVID-19 Science Diseases Project Timeline Papers & Results Dig deeper Support FAQ Folding Support Forum Discord Donate Merchandise store Statistics News About Contact us The Folding@home Consortium (FAHC) START FOLDING NOW Find the version of the software you prefer and get started.', 0.6488437), ('To download the Folding@home software and start contributing to COVID-19 research, visit https://foldingathome.org/start-folding/.', 0.6460978)]"
2333,"Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2 , the receptor of 2019-nCov",2019,"bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ace2 , the receptor of _-ncov","bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ace2, the receptor of HLA-ncov",https://www.medrxiv.org/content/10.1101/2020.02.05.20020107v2,"[('In this study, we analyzed five large-scale bulk transcriptomic datasets of normal lung tissue and two single-cell transcriptomic datasets to investigate the disparities related to race, age, gender and smoking status in ACE2 gene expression and its distribution among cell types.', 0.6597383), ('In addition, we analyzed a GSE34450 microarray dataset of gene expression from small airway epithelium and large airway epithelium of 50 healthy nonsmokers and 71 healthy smokers.', 0.60000575), ('However, we observed significantly higher ACE2 gene expression in former smoker’s lung compared to non-smoker’s lung.', 0.5933324), ('In addition, we found that ACE2 gene is expressed in specific cell types related to smoking history and location.', 0.5869997), ('In bronchial epithelium, ACE2 is actively expressed in goblet cells of current smokers and club cells of non-smokers.', 0.5585158)]"
2334,Assessment of patients who tested positive for COVID-19 after recovery,recovery,assessment of patients who tested positive for covid-19 after _,assessment of patients who tested positive for covid-19 after admission,https://www.thelancet.com/action/showPdf?pii=S1473-3099%2820%2930433-3,"[('However, some patients have tested positive for COVID-19 again after recovery.', 0.8820492), ('An explanation of why patients tested positive for COVID-19 on a retest remains unclear.', 0.7722804), ('To prevent a second wave of COVID-19 infections, we recommend a minimum period of 14-day clinical observation in a Fangcang-like medical setting after recovery from COVID-19.', 0.6147313), ('Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.', 0.56329095), ('Among this retest-positive group, 15 patients (65%) were asymptomatic at the time of the retest whereas eight (35%) had at least one symptom associated with active COVID-19.', 0.5481438)]"
2335,"Novartis bags Mesoblast Limited cell therapy , Remestemcel-L for COVID-19 ARDS .",therapy,"novartis bags mesoblast limited cell _ , remestemcel-l for covid-19 ards .","novartis bags mesoblast limited cell death, remestemcel-l for covid-19 ards.",https://www.delveinsight.com/blog/pharma-happenings-for-gilead-novartis-lilly-innovent/,"[('Novartis entered into an exclusive worldwide license and collaboration agreement with Mesoblast for the development, commercialization and manufacturing of remestemcel-L for the treatment of acute respiratory distress syndrome (ARDS), including that associated with COVID-19.', 0.6830356), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.6082177), ('Novartis has the option, if exercised, to distribute remestemcel-L for graft versus host disease (GVHD) (outside Japan).', 0.6003141), (""Jan 13, 2021 Birinapant licensing; AvantGen, IGM pairs up for anti-SARS-CoV-2 antibodies; BeiGene, Novartis to co-dvelop Tislelizumab; Valo raises USD190 M; Bluebird Bio Spins-off Jan 12, 2021 Parkinson's Disease: How close are we to a cure?"", 0.5907851), ('Per the agreement, Novartis will acquire the exclusive worldwide rights to develop, commercialize and manufacture remestemcel-L for ARDS and obtain access to an innovative cell-therapy platform with a range of potential applications in severe respiratory conditions and beyond.', 0.58087265)]"
2340,Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic,mask,modeling the potential for face _ use by the general public to curtail the covid-19 pandemic,modeling the potential for face water use by the general public to curtail the covid-19 pandemic,https://www.sciencedirect.com/science/article/pii/S2468042720300117?via%3Dihub,"[('Model simulations, using data relevant to COVID-19 dynamics in the US states of New York and Washington, suggest that broad adoption of even relatively ineffective face masks may meaningfully reduce community transmission of COVID-19 and decrease peak hospitalizations and deaths.', 0.69111204), ('Our results suggest use of face masks by the general public is potentially of high value in curtailing community transmission and the burden of the pandemic.', 0.67042756), ('Masks have also been suggested as a method for limiting community transmission by asymptomatic or at least clinically undetected carriers (Chan & Yuen, 2020), who may be a major driver of transmission of COVID-19 (Li et al., 2020).', 0.662329), ('In summary, the benefit to routine face mask use by the general public during the COVID-19 pandemic remains uncertain, but our initial mathematical modeling work suggests a possible strong potential benefit to near universal adoption of even weakly effective homemade masks that may synergize with , not replace, other control and mitigation measures.', 0.6384249), ('Introduction Under the ongoing COVID-19 pandemic (caused by the SARS-CoV-2 coronavirus), recommendations and common practices regarding face mask use by the general public have varied greatly and are in rapid flux: Mask use by the public in public spaces has been controversial in the US, although as of April 3, 2020, the US Centers for Disease Control and Prevention (CDC) is recommending the public wear cloth masks.', 0.6282488)]"
2341,"Theoretically , HLA-A3.1 is the susceptible gene of SARS coronavirus , and individuals without this susceptible gene are not easily affected or have resistance to the disease .",not,"theoretically , hla-a3.1 is the susceptible gene of sars coronavirus , and individuals without this susceptible gene are _ easily affected or have resistance to the disease .","theoretically, hla-a3.1 is the susceptible gene of sars coronavirus, and individuals without this susceptible gene are also easily affected or have resistance to the disease.",https://www.intechopen.com/books/hla-and-associated-important-diseases/association-between-hla-gene-polymorphism-and-the-genetic-susceptibility-of-sars-infection,"[('The correlation of SARS genetic predisposition and HLA gene polymorphism SARS virus is a recently discovered infectious pathogen that can cause severe human diseases, and, to date, we know little about it.', 0.7176272), ('Speculations regarding susceptible genes based on SARS coronavirus (SARS-CoV) structure Previous studies demonstrated that although SARS-CoV and other known coronaviruses have less than 40%-50% homology in amino acid sequence, their structures and functions are similar to those of other known coronaviruses.', 0.70302105), ('In this regard, the association between SARS-Cov-2 infection and the HLA genotype has not been well established, with a few studies in this context focused on finding specific alleles of susceptibility.', 0.634833), ('These results support the hypothesis that the HLA-B4601 gene in Asian populations is correlated with the severity of SARS infection.', 0.63410175), ('However, in September 2006, 3 years after the SARS outbreak in Taiwan, 130 diagnosed SARS patients were studied to evaluate the correlation of their SARS antibody levels and HLA types.', 0.6104058)]"
2342,Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies,severe,_ covid-19 is associated with elevated serum iga and antiphospholipid iga-antibodies,Introduction covid-19 is associated with elevated serum iga and antiphospholipid iga-antibodies,https://www.medrxiv.org/content/10.1101/2020.07.21.20159244v1,"[('Since thrombotic events are frequent in severe COVID-19 and resemble hypercoagulation of antiphospholipid syndrome (APS), our approach focused on antiphospholipid antibodies (aPL).', 0.75527585), ('Objective: To determine, whether COVID-19 is associated with a vigorous total IgA response and whether IgA autoantibodies are associated with complications of severe illness.', 0.693701), ('Results: Clinical records of the 64 patients with COVID-19 were reviewed and divided into a cohort with mild illness (mCOVID, n=26 [41%]), a discovery cohort with severe illness (sdCOVD, n=14 [22%]) and a confirmation cohort with severe illness (scCOVID, n=24 [38%]).', 0.49317244), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.47437015), ('Among aPL, both cohorts with severe illness significantly correlated with elevated anti-Cardiolipin IgA (sdCOVID and scCOVID, P<0.001), anti-Cardiolipin IgM (sdCOVID, P=0.003; scCOVID, P<0.001), and anti-Beta2 Glycoprotein-1 IgA (sdCOVID and scCOVID, P<0.001).', 0.41903102)]"
2343,Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia,for,hydroxychloroquine safety outcome within approved therapeutic protocol _ covid-19 outpatients in saudi arabia,hydroxychloroquine safety outcome within approved therapeutic protocol of covid-19 outpatients in saudi arabia,https://www.sciencedirect.com/science/article/pii/S1201971220322359,"[('Conclusion: In our study, results show that the use of hydroxychloroquine for COVID-19 patients in mild to moderate cases in an outpatient setting, within the protocol recommendation and inclusion/exclusion criteria, is safe, highly tolerable, and with minimum side effects.', 0.73836756), ('This study aimed to assess the safety outcome and reported adverse events from hydroxychloroquine use among suspected COVID-19 patients.', 0.670056), ('Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Saudi Arabia Ministry of Health IRB committee review, approved, and continuously audit this research All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.', 0.43978748), ('The Saudi Arabian Ministry of Health (MOH) launched an initiative to support the National Healthcare System.', 0.4153102), ('Since the 5th of June 2020, 238 outpatient fever clinics were established across Saudi Arabia.', 0.39394063)]"
2345,Bacterial modification of the host glycosaminoglycan heparan sulfate modulates SARS-CoV-2 infectivity,host,bacterial modification of the _ glycosaminoglycan heparan sulfate modulates sars-cov-2 infectivity,bacterial modification of the receptor glycosaminoglycan heparan sulfate modulates sars-cov-2 infectivity,https://www.biorxiv.org/content/10.1101/2020.08.17.238444v1?rss=1%22,"[('Diagram of hypothesis for bacterial mediation of SARS- CoV-2 infection through heparan sulfate (HS).', 0.72754544), ('In vitro , bacterial glycosidases from unpurified culture media supernatants fully blocked SARS-CoV-2 spike binding to human H1299 protein lung adenocarcinoma cells.', 0.67322195), ('Understanding the impact of shifts in microbial community composition and bacterial lyases on SARS-CoV-2 infection may lead to new therapeutics and diagnosis of susceptibility.', 0.6641418), ('HS-modifying bacteria in human microbial communities may regulate viral adhesion, and loss of these commensals could predispose individuals to infection.', 0.61357677), ('Here, we show that commensal host bacterial communities can modify HS and thereby modulate SARS-CoV-2 spike protein binding and that these communities change with host age and sex.', 0.5606963)]"
2346,The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus,inhibit,the antiviral compound remdesivir potently _ rna-dependent rna polymerase from middle east respiratory syndrome coronavirus,the antiviral compound remdesivir potently binds rna-dependent rna polymerase from middle east respiratory syndrome coronavirus,http://m.jbc.org/content/early/2020/02/24/jbc.AC120.013056,"[('Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase.', 0.7754358), ('Remdesivir (RDV) is an investigational compound with a broad spectrum of antiviral activities against RNA viruses, including severe acute respiratory syndrome-CoV and Middle East respiratory syndrome (MERS-CoV).', 0.67847264), ('Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir.', 0.65727645), ('(2018) Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease.', 0.626572), ('RDV is a nucleotide analog inhibitor of RNA-dependent RNA polymerases (RdRps).', 0.61427313)]"
2349,US buys up world stock of key Covid-19 drug remdesivir,world,us buys up _ stock of key covid-19 drug remdesivir,us buys up one stock of key covid-19 drug remdesivir,https://www.theguardian.com/us-news/2020/jun/30/us-buys-up-world-stock-of-key-covid-19-drug,"[('What is Remdesivir, the first drug put forward to treat COVID-19 in Europe?', 0.67258114), ('[Photo/Xinhua] The World Health Organization on Wednesday voiced concerns over news reports that the United States government has bought almost all the stocks of key COVID-19 drug remdesivir.', 0.6703648), ('Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.', 0.65842116), ('p. https://www.theguardian.com/us-news/2020/jun/30/us-buys-up-world-stock-of-key-covid-19- drug?CMP=sharebtntw.', 0.60263413), ('Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease.', 0.58960277)]"
2350,What reinfections mean for COVID-19,what,_ reinfections mean for covid-19,No reinfections mean for covid-19,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30783-0/fulltext,"[('COVID-19 re-infection by a phylogenetically distinct SARS-CoV-2 variant, first confirmed event in South America.', 0.62006736), ('What do reinfection cases mean for public health and vaccination endeavors to stop the COVID-19 pandemic?', 0.5701002), ('COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing.', 0.56386185), ('Open table in a new tab This case report adds to rapidly growing evidence of COVID-19 reinfection, in which viral genomic sequences were used to confirm infections by distinct isolates of SARS-CoV-2.', 0.47576147), ('Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020.', 0.40735173)]"
2351,Man Behind Sweden 's Controversial Virus Strategy Admits Mistakes,man,_ behind sweden 's controversial virus strategy admits mistakes,Not behind sweden's controversial virus strategy admits mistakes,https://www.bloomberg.com/news/articles/2020-06-03/man-behind-sweden-s-virus-strategy-says-he-got-some-things-wrong,"[(""Bjorn Olsen, professor of Infectious Medicine at Uppsala University, said Sweden's strategy had been catastrophic."", 0.64657176), ('Mr Tegnell said it was hard to know which measures taken elsewhere might have been the most effective in Sweden.', 0.49949276), ('""There\'s a news story going around today that I and the health agency think that the strategy we had to fight coronavirus was wrong and that we had to change it drastically,"" he told Radio Sweden.', 0.49469948), ('""Yes, I think we could have done better in what we did in Sweden, clearly.""', 0.47852337), (""Wednesday 3 June 2020 17:07, UK COVID-19 Coronavirus Image: People walk down a high street in Stockholm in May image/svg+xml Why you can trust Sky News Sweden should have done more to combat coronavirus to prevent it having a much higher national death rate than neighbouring countries, the man behind the country's pandemic strategy has said."", 0.46003106)]"
2353,Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine,mice,sterilizing immunity against sars-cov-2 infection in _ by a single-shot and modified imidazoquinoline tlr7/8 agonist-adjuvanted recombinant spike protein vaccine,sterilizing immunity against sars-cov-2 infection in humans by a single-shot and modified imidazoquinoline tlr7/8 agonist-adjuvanted recombinant spike protein vaccine,https://www.biorxiv.org/content/10.1101/2020.10.23.344085v1,"[('IMDQ-PEG-CHOL is used to induce a protective immune response against SARS-CoV-2 after single vaccination with trimeric recombinant SARS-CoV-2 spike protein in the BALB/c mouse model.', 0.8378928), ('To correlate vaccine responses with control of virus replication in vivo , vaccinated mice were challenged with SARS-CoV-2 virus after being sensitized by intranasal adenovirus-mediated expression of the human angiotensin converting enzyme 2 (ACE2) gene.', 0.8034172), ('Our results underscore the potential use of IMDQ- PEG-CHOL as an adjuvant to achieve protection after single immunization with recombinant protein and inactivated vaccines against respiratory viruses, such as SARS-CoV-2 and influenza viruses.', 0.72168815), ('Moreover, IMDQ-PEG- CHOL adjuvanted vaccine induced enhanced ELISA and in vitro microneutralization titers, and a more balanced IgG2a/IgG1 response.', 0.7186475), ('Inclusion of amphiphilic IMDQ-PEG-CHOL in the SARS-CoV-2 spike vaccine formulation resulted in enhanced immune cell recruitment and activation in the draining lymph node.', 0.6871005)]"
2355,The War on Germs Has a New Weapon By BOB WEIR,new,the war on germs has a _ weapon by bob weir,the war on germs has a natural weapon by bob weir,https://www.yonkerstribune.com/2020/08/the-war-on-germs-has-a-new-weapon-by-bob-weir,"[('Yesterday, the piping delivering water to our ice maker leaked.', 0.41790763), ('The plastic barrel was found Friday during tree-pruning work in the Seevetal area, near Hamburg, the state criminal police office in Lower Saxony said.', 0.39507443), ('This contractor arranged to have his plumber replace the copper piping and valves servicing the ice maker.', 0.31998545), ('Lothar Zogg’ in Stanley Kubrick’s ‘Dr.', 0.29882732), ('But there are steps you can take to combat battery drainage.', 0.27821243)]"
2358,"UK bans parallel export and hoarding of lopinavir+ritonavir , chloroquine and hydroxychloroquine",export,"uk bans parallel _ and hoarding of lopinavir+ritonavir , chloroquine and hydroxychloroquine","uk bans parallel training and hoarding of lopinavir+ritonavir, chloroquine and hydroxychloroquine",https://www.pharmaceutical-technology.com/comment/parallel-export-covid-19/,"[('The export of the US-based AbbVie’s Kaletra / Aluvia, a combination lopinavir and ritonavir, the generic drug chloroquine phosphate and the generic drug hydroxychloroquine is being restricted to meet the needs of UK patients, the government said.', 0.70468444), ('UK wholesalers and drug companies will be allowed to export Kaletra and chloroquine phosphate and other medicines restricted for parallel export if they were originally manufactured with the intention to export to foreign markets.', 0.60463375), ('31 March 2020 52 medicines have been added to the list of medicines that cannot be parallel exported from the UK, these are: Cefalexin, Codeine, Co-trimoxazole, Diamorphine, Doxycycline, Ipratropium, Salbutamol, Prochlorperazine,Salbutamol + Beclometasone, Salbutamol + Ipratropium Terbutaline, Beclometasone, Beclometasone + Formoterol, Beclometasone + Formoterol + Glycopyrronium bromide, Budesonide, Budesonide + Formoterol, Fluticasone, Fluticasone + Formoterol, Fluticasone + Salmeterol, Fluticasone + Umeclidinium bromide + Vilanterol, Fluticasone + Vilanterol, Ciclesonide, Mometasone, Salmeterol, Formoterol, Sodium cromoglicate, Sodium cromoglicate + Salbutamol, Nedocromil, Edoxaban, Midazolam, Buprenorphine, Levomepromazine, Mesalazine, Colecalciferol + Calcium carbonate, Insulin aspart, Insulin aspart biphasic, Insulin degludec, Insulin degludec + Liraglutide, Insulin detemir, Insulin glargine, Insulin glargine + Lixisenatide, Insulin glulisine, Insulin human, Insulin isophane biphasic human, Insulin isophane biphasic porcine, Insulin isophane bovine, Insulin isophane human, Insulin isophane porcine, Insulin lispro, Insulin lispro biphasic, Insulin mixed bovine, Insulin protamine zinc bovine, Insulin soluble bovine, Insulin soluble human, Insulin soluble porcine, Insulin zinc crystalline human, Insulin zinc mixed human.', 0.55448085), ('17 October 2019 Four medicines have been added to the list of medicines that cannot be parallel exported from the UK: alprostadil, beclometasone dipropionate, noresthisterone and ranitidine.', 0.5464436), ('5 November 2019 Four medicines have been added to the list of medicines that cannot be parallel exported from the UK: alogliptin/metformin; pneumococcal polysaccharide vaccine; measles, mumps and rubella vaccine; and misoprostol.', 0.5311458)]"
2359,Antibodies in Infants Born to Mothers With COVID-19 Pneumonia,infants,antibodies in _ born to mothers with covid-19 pneumonia,antibodies in women born to mothers with covid-19 pneumonia,https://jamanetwork.com/journals/jama/fullarticle/2763854,"[('Patterns of IgG and IgM antibody response in COVID-19 patients.', 0.7348304), ('Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic.', 0.7023487), ('Serology testing in the COVID-19 pandemic response.', 0.57676595), ('Antibody response to SARS-CoV-2 infection in humans: A systematic review.', 0.56787956), ('Comprehensive analysis of COVID-19 during pregnancy.', 0.5055656)]"
2361,Assessing the effectiveness of using various face coverings to mitigate the transport of airborne particles produced by coughing indoors,coughing,assessing the effectiveness of using various face coverings to mitigate the transport of airborne particles produced by _ indoors,assessing the effectiveness of using various face coverings to mitigate the transport of airborne particles produced by water indoors,https://www.tandfonline.com/doi/full/10.1080/02786826.2020.1846679,"[('This study investigates the effectiveness of various face coverings to reduce cough-generated airborne particle concentrations at 0.3, 0.9, and 1.8 m away from the source in an indoor environment.', 0.7994039), ('Conclusions This study assessed the effectiveness of different face coverings against the outward transport of respiratory particles in an indoor environment.', 0.7476493), ('With this context, the purpose of this study is to: (1) determine the particle number concentration (PNC) and particle size distributions at 0.3, 0.9, and 1.8 m away from a coughing source in an indoor environment, and (2) evaluate the effectiveness of different face coverings on obstructing cough-generated airborne particles at 0.3, 0.9, and 1.8 m away from a coughing source.', 0.7321695), ('Efficacy of Face Shields Against Cough Aerosol Droplets from a Cough Simulator.', 0.72678614), ('Efficacy of masks and face coverings in controlling outward aerosol particle emission from expiratory activities.', 0.7089007)]"
2365,Small RCT Suggests Gargling With Iodine Clears the Virus in 4 Days,small,_ rct suggests gargling with iodine clears the virus in 4 days,Such rct suggests gargling with iodine clears the virus in 4 days,https://chrismasterjohnphd.com/covid-19/small-rct-suggests-gargling-with-iodine-clears-the-virus-in-4-days,"[('Gargling with the solution led to a reduction in infections caused by some fairly virulent bacteria, among them Pseudomonas, Staph (including MRSA) and Haemophilus.', 0.4951384), ('In a small Japanese experimental study from 2002, 23 patients with chronic respiratory disease gargled four or more times a day with a povidone-iodine solution.', 0.48520392), ('The gargling solution in the study involved a heaping teaspoon of salt in a cup of water to make an approximate 3 percent saline solution, gargled up to six times a day.', 0.4038157), ('Other small studies have suggested potential beneficial anti-viral activity of gargling with green tea or solutions containing catechins, active ingredients of green tea, or with apple cider vinegar.', 0.38050932), ('A follow-up lab study by the same group of investigators discovered a potential mechanism of action of the saline solution, whereby throat cells took up extra chlorine from the saline solution to produce a compound that has known antiviral properties.', 0.37869528)]"
2366,Coronavirus kills French Dominican who promoted African Church,promoted,coronavirus kills french dominican who _ african church,coronavirus kills french dominican who die african church,https://international.la-croix.com/news/coronavirus-kills-french-dominican-who-promoted-african-church/12202,"[('""He was a good preacher; he liked that,"" said Father Michel Mallevre, who is now the assistant to the French provincial of the Dominicans.', 0.50315), (""Father Luneau was a researcher at the CNRS (France's National Center of Scientific Research) and a member of the group GSRL (group societies, religions, secularisms) for sociologists of religions."", 0.40534925), ('Luneau developed a love for Africa shortly after beginning his ministry in 1963.', 0.37742943), ('""It is clear that he was a left-wing Catholic, but he would never have put himself outside the Church"", Father Mallevre said.', 0.3541106), ('He called the book ""a presentation that is both well documented and spiritually inspired by his experience of Christian inculturation in Africa"".', 0.34437478)]"
2368,Heartburn Drug May Have Potential Against COVID-19,against,heartburn drug may have potential _ covid-19,heartburn drug may have potential for covid-19,https://www.cuimc.columbia.edu/news/heartburn-drug-may-have-potential-against-covid-19,"[('The study at Columbia University Irving Medical Center was motivated by prior investigations of famotidine for treating COVID-19.', 0.52841324), ('The researchers found that these drugs were not associated with improved outcomes, suggesting that any effect of famotidine on COVID-19 outcomes is not related to the suppression of stomach acid.', 0.5281162), ('Unpublished data from Wuhan, China, found better outcomes in COVID-19 patients who took famotidine while hospitalized.', 0.524572), ('Famotidine, which reduces stomach acid, is commonly used to treat occasional episodes of heartburn (when stomach acid backs up into the esophagus) and gastroesophageal reflux disease (persistent heartburn).', 0.4889049), ('“We don’t know if there is any benefit of taking famotidine if you have COVID-19, and we strongly recommend consulting with your physician before doing so,” Freedberg says.', 0.4816393)]"
2369,Slight reduction in SARS-CoV-2 exposure viral load due to masking results in a significant reduction in transmission with widespread implementation,slight,_ reduction in sars-cov-2 exposure viral load due to masking results in a significant reduction in transmission with widespread implementation,High reduction in sars-cov-2 exposure viral load due to masking results in a significant reduction in transmission with widespread implementation,https://www.medrxiv.org/content/10.1101/2020.09.13.20193508v2,"[('Our model quantitatively links mask efficacy to reductions in viral load and subsequent transmission risk.', 0.653842), ('Our results reinforce that the use of masks by both a potential transmitter and exposed person substantially reduces the probability of successful transmission, even if masks only lower exposure viral load by ∼50%.', 0.62290454), ('Slight increases in mask adherence and/or efficacy above current levels would reduce the effective reproductive number (Re) substantially below 1, particularly if implemented comprehensively in potential super-spreader environments.', 0.59552574), ('Our model predicts that moderately efficacious masks will lower exposure viral load 10-fold among people who get infected despite masking, potentially limiting infection severity.', 0.50687075), ('These results highlight the primacy of masking relative to other biomedical interventions under consideration for limiting the extent of the COVID-19 pandemic prior to widespread implementation of a vaccine.', 0.48674572)]"
2370,Using Systems Serology to Define Antibody Responses to SARS-CoV-2,systems,using _ serology to define antibody responses to sars-cov-2,using conventional serology to define antibody responses to sars-cov-2,https://www.humanvaccinesproject.org/event/july-30th-speaker-galit-alter/,"[('Her research is focused on the development of systems biology tools to define the correlates of immunity against infectious diseases that ravage the globe.', 0.50916183), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.48758912), ('Her work points to unexpected mechanisms of protection against HIV, malaria, and tuberculosis, has led to the development of novel diagnostics to monitor chronic infections/diseases, and now promises to accelerate the development of novel classes of therapeutics able to deploy the activity of the innate immune system in a specific and controlled manner BACK TO EVENTS ', 0.389453), ('Tax information for Stichting Human Vaccines Project Europe is available here, and the strategic plan is available here.', 0.26900646), ('The Human Vaccines Project is a nonprofit 501 (c) (3) organization with high standards of financial accountability and integrity.', 0.26604065)]"
2372,SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals,host,sars-cov-2 spike protein predicted to form complexes with _ receptor protein orthologues from a broad range of mammals,sars-cov-2 spike protein predicted to form complexes with multiple receptor protein orthologues from a broad range of mammals,https://www.nature.com/articles/s41598-020-71936-5,"[('Functional and genetic analysis of viral receptor ACE2 orthologs reveals broad potential host range of SARS-CoV-2.', 0.76853263), ('Structural basis of receptor recognition by SARS-CoV-2.', 0.76240367), ('Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates.', 0.7021856), ('Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.', 0.6933496), ('SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Enriched in Specific Cell Subsets Across Tissues [Internet].', 0.6853421)]"
2373,Ethos Labs Develops Viral Neutralization COVID-19 Antibody Test to Evaluate Protective Immunity,evaluate,ethos labs develops viral neutralization covid-19 antibody test to _ protective immunity,ethos labs develops viral neutralization covid-19 antibody test to avoid protective immunity,https://www.prnewswire.com/news-releases/ethos-laboratories-to-offer-worlds-first-quantitative-surrogate-viral-neutralization-test-to-evaluate-covid-19-protective-immunity-in-the-usa-301076797.html?tc=eml_cleartime,"[('Marketed as Tru-Immune, the test will measure and quantify the neutralizing capacity of antibodies against SARS-CoV-2, the causative pathogen of covid-19.', 0.84621656), ('Ethos Laboratories has entered a strategic partnership with Genscript to offer the first quantitative surrogate Viral Neutralization Test (sVNT) to evaluate COVID-19 protective immunity in the United States.', 0.83931386), ('Ethos Labs A Newport company has developed what it says is a more accurate test for COVID-19 antibodies.', 0.81754947), ('Unlike other tests currently on the market, Tru-Immune™ detects the presence and magnitude of neutralizing antibodies that prevent infectivity of the COVID-19 virus.', 0.7363943), ('Ethos Laboratories (PRNewsfoto/Ethos Laboratories) The Tru-Immune™ lab test will identify patients with the most effective antibody response capable of inhibiting virus replication.', 0.7196102)]"
2376,"I know Correlation does not equal Causation but Countries in which people were required to receive the bacillus Calmette-Guerin vaccine , one of the oldest to combat tuberculosis , had fewer cases and deaths from Covid-19 .",not,"i know correlation does _ equal causation but countries in which people were required to receive the bacillus calmette-guerin vaccine , one of the oldest to combat tuberculosis , had fewer cases and deaths from covid-19 .","i know correlation does be equal causation but countries in which people were required to receive the bacillus calmette-guerin vaccine, one of the oldest to combat tuberculosis, had fewer cases and deaths from covid-19.",https://www.medrxiv.org/content/10.1101/2020.03.24.20042937v1,"[('And countries should not hoard BCG vaccines for COVID-19, since BCG supply chain is weak, and really necessary to protect children in LMICs from childhood TB.', 0.79456437), ('Until the results are released, though, he stresses that no country should be complacent that BCG might protect them from Covid-19 – and that they should certainly not hoard vaccines needed for protecting children from TB and for bladder cancer patients.', 0.73549706), ('This means, reported case numbers from LMICs (which universally vaccinate with BCG) are seriously under-estimated, and deaths can also be under-reported, since COVID-19 symptoms overlap with many other respiratory infections and fevers.', 0.70355916), ('“Mortality rates are a robust measure that has less dependence to the levels of COVID-19 testing… BCG vaccination seems to significantly reduce mortality associated with COVID-19,” they write.', 0.6921122), ('2020)1 and prominent news outlets2 have noticed that countries still administering an old vaccine against tuberculosis had fewer coronavirus cases and fewer deaths per capita in the outbreak’s early stages.', 0.6857363)]"
2377,Health Canada begins first authorization review of a COVID-19 vaccine submission,first,health canada begins _ authorization review of a covid-19 vaccine submission,health canada begins under authorization review of a covid-19 vaccine submission,https://www.canada.ca/en/health-canada/news/2020/10/health-canada-begins-first-authorization-review-of-a-covid-19-vaccine-submission.html,"[('Earlier this month, the Prime Minister announced that Canada has signed an agreement with AstraZeneca to buy 20 million doses of its COVID-19 vaccine, should that vaccine successfully complete clinical trials and be authorized by Health Canada.', 0.73260885), ('The Department is in active discussions with several vaccine manufacturers and expects to receive more COVID-19 vaccine submissions for authorization in the coming months.', 0.64642245), (""Health Canada will be doing a rolling review of AstraZeneca's vaccine data to make sure it meets the Department's rigorous safety and efficacy requirements."", 0.601053), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.5750627), ('Following the authorization of any vaccine submission, Health Canada will publish the evidence it reviewed in making its decision for transparency.', 0.5407373)]"
2380,"Increase in delirium , rare brain inflammation and stroke linked to COVID-19",increase,"_ in delirium , rare brain inflammation and stroke linked to covid-19","Differences in delirium, rare brain inflammation and stroke linked to covid-19",https://www.eurekalert.org/pub_releases/2020-07/ucl-iid070620.php,"[('""We should be vigilant and look out for these complications in people who have had Covid-19.', 0.5961393), ('Some patients in the study did not experience severe respiratory symptoms, and the neurological disorder was the first and main presentation of Covid-19.', 0.57441616), ('Joint first author Dr Rachel Brown (UCL Queen Square Institute of Neurology and UCL Infection & Immunity) said: ""Our study advances understanding of the different ways in which Covid-19 can affect the brain, which will be paramount in the collective effort to support and manage patients in their treatment and recovery.""', 0.55945396), ('This paper also confirms the previously reported findings of a higher than expected number of patients with stroke which results from the excessive stickiness of the blood in COVID-19 patients.', 0.54364854), ('The findings add clinical descriptions and detail to another recent study, which also involved Dr Zandi and co-author Dr Hadi Manji (UCL Queen Square Institute of Neurology) identifying 153 people with neurological complications from Covid-19.', 0.5228337)]"
2384,"Damage to multiple organs presents in young , low risk patients",organs,"damage to multiple _ presents in young , low risk patients","damage to multiple populations presents in young, low risk patients",https://www.bmj.com/content/371/bmj.m4470,"[('Multi-organ impairment in low-risk individuals with long COVID.', 0.5869639), ('There was evidence of mild organ impairment in the heart (32% of patients), lungs (33%), kidneys (12%), liver (10%), pancreas (17%), and spleen (6%).', 0.45788237), ('The BMJ Young, low risk patients with ongoing symptoms of covid-19 had signs of damage to multiple organs four months after initially being infected, a preprint study has suggested.1 Initial data from 201 patients suggest that almost 70% had impairments in one or more organs four months after their initial symptoms of SARS-CoV-2 infection.', 0.41209617), ('The authors observed that neither symptoms nor blood investigations were predictive of organ impairment.', 0.40757886), ('Measures of inflammation in the kidneys and pancreas, and ectopic fat in the pancreas and liver, were also higher in hospitalised individuals (P<0.05).', 0.39917338)]"
2385,Mouse Model of SARS-CoV-2 Reveals Inflammatory Role of Type I Interferon Signaling,mouse,_ model of sars-cov-2 reveals inflammatory role of type i interferon signaling,Previous model of sars-cov-2 reveals inflammatory role of type i interferon signaling,https://pubmed.ncbi.nlm.nih.gov/32714125/,"[('Here we report the development of a mouse model of SARS-CoV-2 based on adeno associated virus (AAV)-mediated expression of hACE2.', 0.7288213), ('Thus, the hACE2-AAV mouse model enables rapid deployment for in-depth analysis following robust SARS-CoV-2 infection with authentic patient-derived virus in mice of diverse genetic backgrounds.', 0.6642045), ('These mice support viral replication and antibody production and exhibit pathologic findings found in COVID-19 patients as well as non-human primate models.', 0.50154984), ('Moreover, we show that type I interferons are unable to control SARS-CoV2 replication and drive pathologic responses.', 0.43513831), ('While hACE2 transgenic mice support infection and pathogenesis,5 these mice are currently limited in availability and are restricted to a single genetic background.', 0.36256188)]"
2386,WHO and UNICEF to partner on pandemic response through COVID-19 Solidarity Response Fund,who,_ and unicef to partner on pandemic response through covid-19 solidarity response fund,China and unicef to partner on pandemic response through covid-19 solidarity response fund,https://www.who.int/news-room/detail/03-04-2020-who-and-unicef-to-partner-on-pandemic-response-through-covid-19-solidarity-response-fund,"[('UNICEF , to ensure children and families around the world are equipped with all the evidence-based information and latest WHO guidance as well as locally relevant information to protect themselves from the spread of COVID-19; to support vulnerable countries by providing access to water, sanitation and hygiene, and basic infection prevention and control measures; and to provide access to care for vulnerable families and children.', 0.73858356), ('The COVID-19 Solidarity Response Fund has been set up to facilitate an unprecedented global response by supporting the WHO Strategic Preparedness and Response Plan.', 0.7242124), ('As a key partner in this joined-up effort, UNICEF will lead emergency efforts to ensure families and communities in the most vulnerable countries are fully engaged in the response and have access to water, sanitation and hygiene and other infection prevention and control measures.', 0.71238315), ('CEPI , the Coalition for Epidemic Preparedness Innovations, a key partner leading the financing for research and development for novel vaccines to combat COVID-19, working closely with WHO.', 0.7044555), ('As part of the agreement, an initial portion of the money from the Fund - which currently stands at more than $127 million - will flow to UNICEF for its work with vulnerable children and communities all over the world.', 0.671937)]"
2387,Review of Materials and Designs for Homemade Masks to Protect Against COVID-19,review,_ of materials and designs for homemade masks to protect against covid-19,Lack of materials and designs for homemade masks to protect against covid-19,https://www.preprints.org/manuscript/202006.0132/v1,"[('It would be extremely helpful if a method was devised for people to test or be tested for the fit of home made masks.', 0.6062919), ('This paper sets out to review the areas that effect the efficacy of masks, the materials, design, hygiene and fit testing, in order to make recommendations as to how to make mask from resources found in most homes for when commercial models are unavailable.', 0.6041643), ('This paper finds that a mask constructed with a filter made from high thread count cotton is likely to provide a reasonable level of protection (~70% filtration) and that if a layers of other materials such as chiffon or silk is added the filtration may be much higher (~90%).', 0.42135078), ('The rendering of the mark-up is based on Wiky.php with some tweaks.', 0.33831155), ('Read more about our cookieshere.', 0.32970396)]"
2388,Hydroxychloroquine application is associated with a decreased mortality in critically ill patients with COVID-19,application,hydroxychloroquine _ is associated with a decreased mortality in critically ill patients with covid-19,hydroxychloroquine deficiency is associated with a decreased mortality in critically ill patients with covid-19,https://www.medrxiv.org/content/10.1101/2020.04.27.20073379v1,"[('Hydroxychloroquine treatment is significantly associated with a decreased mortality in critically ill COVID-19 patients and attenuated inflammatory cytokine IL-6 level.', 0.86539197), ('CONCLUSIONS AND RELEVANCE Hydroxychloroquine treatment is significantly associated with a decreased mortality in critically ill patients with COVID-19 through attenuation of inflammatory cytokine storm.', 0.8487381), ('Question Could hydroxychloroquine administration be beneficial in the treatment of critically ill patients with COVID-19?', 0.8225721), ('Objective To determine whether hydroxychloroquine application may be associated with a decreased risk of death in critically ill COVID-19 patients and what is potential mechanism.', 0.80965054), ('Therefore, hydroxychloroquine should be prescribed for treatment of critically ill COVID-19 patients to save lives.', 0.7025558)]"
2390,Heinsberg Study results published,results,heinsberg study _ published,heinsberg study participants published,https://www.uni-bonn.de/news/111-2020?set_language=en,"[('Heinsberg Study Student assistants helped with the sampling in Gangelt.', 0.5470983), ('Prof. Hendrik Streeck: “We have collected and analyzed data.', 0.5388119), ('Photo: Oliver Thanscheidt Heinsberg Study Student assistants helped with the sampling in Gangelt.', 0.5191524), ('The study offers starting points for follow-up research.', 0.47129825), ('Photo: Oliver Thanscheidt Heinsberg Study Prof. Dr. Martin Exner Photo: Volker Lannert/Uni Bonn Heinsberg Study Head of the study team Prof. Dr. Hendrik Streeck Photo: Katharina Wislsperger / UK Bonn Heinsberg Study Prof. Dr. Gunther Hartmann Photo: University Hospital Bonn/Schreiber Heinsberg Study Student assistants helped with the sampling in Gangelt.', 0.4678889)]"
2391,"Fast , cheap tests could enable safer reopening",cheap,"fast , _ tests could enable safer reopening","fast, multiple tests could enable safer reopening",https://science.sciencemag.org/content/369/6504/608.full,"[('But they could still be a valuable health tool if performed often enough; few infected people would be missed in multiple rounds of tests.', 0.62092066), (""By making it possible to identify and isolate infected individuals more quickly, proponents say, the shift would slow the virus' spread, key to safely reopening schools, factories, and offices."", 0.56106234), ('If administered properly, such tests are highly accurate, spotting positive cases nearly 100% of the time.', 0.49719864), ('Such tests cost as little as $1 to $2 each, give a yes/no readout within minutes, much like a pregnancy test, and are already used to detect influenza, HIV, and other viruses.', 0.41150725), ('That accuracy is vital for decisions about treating individual patients.', 0.37537658)]"
2392,The race is on for antibodies that stop the new coronavirus,antibodies,the race is on for _ that stop the new coronavirus,the race is on for pathogens that stop the new coronavirus,https://www.sciencemag.org/news/2020/05/race-antibodies-stop-new-coronavirus,"[('Glanville says the aim is to find antibodies that can potently neutralize a broad range of coronaviruses.', 0.7155837), ('This type of antibody cocktail provides an insurance policy against the emergence of mutant strains of SARS-CoV-2 that resist the treatment.', 0.7061783), ('One modification slows the antibody degradation to give it a longer effective life; another improves the so-called vaccinal effect, which summons T cells—another arm of the immune system—to help destroy infected cells.', 0.697237), ('Many researchers are optimistic that antibodies will, relatively quickly, prove their worth as a preventive or remedy that buys the world time until a vaccine arrives—if it does.', 0.6934446), ('The Coronavirus Immunotherapy Consortium she leads, funded by $1.7 million from the Bill & Melinda Gates Foundation, is organizing a large-scale, blinded, side-by-side evaluation of candidate monoclonals in test tube studies that gauge their ability to thwart SARS-CoV-2 infection of human cells.', 0.66770315)]"
2395,World 's 1st inactivated COVID-19 vaccine produces antibodies,world,_ 's 1st inactivated covid-19 vaccine produces antibodies,A's 1st inactivated covid-19 vaccine produces antibodies,https://www.prnewswire.com/news-releases/worlds-1st-inactivated-covid-19-vaccine-produces-antibodies-301082558.html,"[('It has completed building a high biosafety grade production workshop, which is currently the only COVID-19 vaccine production workshop in the world meeting the requirements of biosafety and GMP standards and capable of meeting the needs of widespread emergency vaccination.', 0.55403113), ('CNBG said the study was designed to evaluate the safety and immunogenicity of the COVID-19 inactivated vaccine in healthy subjects aged from 18 to 59 for low, medium and high dosages and injections at intervals of 14, 21 and 28 days.', 0.5284622), ('This is also the clinical COVID-19 vaccine research that has the longest time span, produces the most comprehensive data and obtains the best research results, thus providing scientific and evaluable data for epidemic prevention and control as well as emergency use.', 0.5227815), ('For those aged 18 - 59 who received two medium-dose injections through the 14-day and 21-day interval procedures, they had a neutralizing antibody positive conversion rate of 97.6%.', 0.5083228), ('People who received two doses of the vaccine at an interval of 28 days, saw their neutralizing antibody positive conversion rate reach 100%.', 0.46890432)]"
2398,Egyptian doctors are speaking out against health authorities over increasing coronavirus infections and deaths among medical staff across the country .,speaking,egyptian doctors are _ out against health authorities over increasing coronavirus infections and deaths among medical staff across the country .,egyptian doctors are ruled out against health authorities over increasing coronavirus infections and deaths among medical staff across the country.,https://www.al-monitor.com/pulse/originals/2020/06/egypt-doctors-condemn-authorities-protection-coronavirus.html#ixzz6Os7Z5l1B,"[('A correspondent in Egypt Topics covered health care, medical supplies, covid-19, coronavirus, egyptian doctors, doctors Jun 8, 2020 Egyptian doctors have expressed anger in recent days, accusing the authorities of neglecting them and failing to protect and provide them with the protective equipment they need.', 0.73903596), ('“Egypt’s arrests of medical professionals who criticized its Covid-19 policies warrant unambiguous opposition from the World Bank, in line with its commitment not to tolerate reprisals,” said Amr Magdi, Middle East and North Africa researcher at Human Rights Watch.', 0.66934156), ('Doctors in Egypt denounced the arrest of their colleagues.', 0.66538835), ('Another Egyptian doctor told Amnesty International that doctors who speak out are subjected to threats, interrogations by the National Security Agency (NSA), administrative questioning, and penalties.', 0.653841), ('The pro-government camp in Egypt took the conflict between the Ministry of Health and the Egyptian Doctors Syndicate a step further.', 0.6025263)]"
2400,SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes,human,sars-cov-2 infects and induces cytotoxic effects in _ cardiomyocytes,sars-cov-2 infects and induces cytotoxic effects in mice cardiomyocytes,https://www.biorxiv.org/content/10.1101/2020.06.01.127605v1,"[('Conclusion: This study demonstrates that SARS-CoV-2 infects cardiomyocytes in vitro in an angiotensin-converting enzyme 2- and cathepsin-dependent manner.', 0.80324674), ('SARS-CoV-2 Infected Cardiomyocytes Recruit Monocytes by Secreting CCL2.', 0.77621126), ('SARS-CoV-2 infection of cardiomyocytes is inhibited by the antiviral drug remdesivir.', 0.73092896), ('Here, we investigate whether cardiomyocytes are permissive for SARS-CoV-2 infection.', 0.7079873), ('Methods and results: Two strains of SARS-CoV-2 infected human induced pluripotent stem cell-derived cardiomyocytes as demonstrated by detection of intracellular double-stranded viral RNA and viral spike glycoprotein expression.', 0.6814872)]"
2402,Quest Diagnostics Rolls Out Home COVID-19 Antibody Test for Purchase Online,quest,_ diagnostics rolls out home covid-19 antibody test for purchase online,Current diagnostics rolls out home covid-19 antibody test for purchase online,https://questdirect.questdiagnostics.com/products/covid-19-immune-response/b580e541-78a5-48a6-b17b-7bad949dcb57?utm_source=GetQuestTest.com&utm_medium=referral&utm_campaign=quest-direct-covid-pr,"[('In the press release announcing the test, which is already available for purchase, Quest wrote that ""[w]hile the science on COVID-19 is evolving, testing for antibodies may identify people who have likely been exposed to COVID-19 and might have mounted an immune response to the virus.', 0.78457177), ('The company announced Tuesday that its QuestDirect unit is now offering for sale the COVID-19 Immune Response, an antibody test for consumers.', 0.76065564), ('A potential user has to request a COVID-19 Immune Response test.', 0.5858582), ('The results can be accessed through a different Quest portal; the company said they are typically available one or two days after a blood draw is received (this can be done by appointment at any Quest Diagnostics patient service center).', 0.5636992), ('One common antibody, immunoglobulin G (IgG), derives from exposure to COVID-19, and it is this antibody that the COVID-19 Immune Response detects.', 0.54786193)]"
2404,IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome,release,il-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine _ syndrome,il-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine development syndrome,https://www.pnas.org/content/early/2020/08/20/2010229117,"[('Effect of IL-6R trans-signaling inhibition on cytokine release from endothelial cells.', 0.87563926), ('Our in vitro data indicate that endothelial IL-6 trans- signaling formed an inflammation circuit for robust IL-6, IL-8, and MCP-1 production and promoted PAI-1 production; additionally, an IL-6 signaling blockade by the human monoclonal antibody tocilizumab blunted endothelial cell activation.', 0.7680383), ('Effect of IL-6R trans-signaling inhibition… Fig.', 0.7524663), ('Correlation between IL-6 levels and cytokines and chemokines in patients with CRS.', 0.6989351), ('., Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells.', 0.69211525)]"
2405,Oxford University vaccine shows 70 % protection - BBC News,bbc,oxford university vaccine shows 70 % protection - _ news,oxford university vaccine shows 70 % protection -19 news,https://www.bbc.co.uk/news/health-55040635,"[('The researchers said it worked out at 70% protection, which is better than the seasonal flu jab.', 0.6638146), ('And the Oxford technology is more established, so the vaccine is easier to mass produce cheaply.', 0.6502381), (""The Oxford vaccine is expected to be easier to manufacture on a global scale than Pfizer and Moderna's vaccine, and the university is committed to making hundreds of millions of doses available to the developing world."", 0.6235156), ('media captionLaura Foster explains why the Oxford vaccine matters ', 0.61403286), ('Oxford vaccine: How did they make it so quickly?', 0.5995535)]"
2411,"Monulparivir , the drug that completely stops the spread of coronavirus in 24 hours",drug,"monulparivir , the _ that completely stops the spread of coronavirus in 24 hours","monulparivir, the host that completely stops the spread of coronavirus in 24 hours",https://www.entrepreneur.com/article/361060?fbclid=IwAR0PMUAZxXwb8UiRZ5AK89X_ZK-dMtKpZ32lf1w8LHpIt7ULpse62CY0t0A,"[('Moreover, Enterpreneur.Com suggests this drug, Monulparivir could stop the virus spreading within 24 hours if administered to human patients.', 0.7702131), ('The new antiviral drug MK-4482 / EIDD-2801 or Molnupiravir, has managed to suppress ""completely"" the transmission of the coronavirus in just 24 hours , according to studies by the Institute of Biomedical Sciences of Georgia State University.', 0.60192883), ('""We observed early on that MK-4482 / EIDD-2801 has broad spectrum activity against respiratory RNA viruses and that oral treatment of infected animals with the drug reduces the amount of viral particles spread by several orders of magnitude, drastically reducing transmission.', 0.5635896), ('In early tests on animals, the new antiviral drug MK-4482 / EIDD-2801 or Molnupiravir, has managed to suppress ""completely"" the transmission of the coronavirus in just 24 hours, according to studies by the Institute of Biomedical Sciences of Georgia State University.', 0.55043554), ('> A promising antiviral that breaks the chain of transmission: > > Therapeutic treatment of animals infected with MK-4482 / EIDD-2801 reduces > the burden of SARS-CoV-2 in the upper respiratory tract and completely > suppresses the spread in ferrets.', 0.541659)]"
2413,Researchers identify multiple molecules that shut down SARS-Cov-2 polymerase reaction,molecules,researchers identify multiple _ that shut down sars-cov-2 polymerase reaction,researchers identify multiple genes that shut down sars-cov-2 polymerase reaction,https://www.eurekalert.org/pub_releases/2020-06/cuso-rim063020.php,"[('Researchers at Columbia Engineering and the University of Wisconsin-Madison have identified a library of molecules that shut down the SARS-CoV-2 polymerase reaction, a key step that establishes the potential of these molecules as lead compounds to be further modified for the development of COVID-19 therapeutics.', 0.6622449), ('In an earlier set of experiments testing the properties of the polymerase of the coronavirus that causes SARS, the researchers found that the triphosphate of sofosbuvir was able to terminate the virus polymerase reaction.', 0.6615329), ('They then demonstrated that sofosbuvir and four other nucleotide analogues (the active triphosphate forms of the HIV inhibitors Alovudine, Zidovudine, Tenofovir alafenamide, and Emtricitabine) also inhibited the SARS-CoV-2 polymerase with different levels of efficiency.', 0.6011049), ('While all 11 molecules tested displayed incorporation, six exhibited immediate termination of the polymerase reaction, two showed delayed termination, and three did not terminate the polymerase reaction.', 0.5338221), ('Once the potency of the drugs to inhibit viral replication in cell culture is demonstrated in future investigations, then the candidate molecules and their modified forms may be evaluated for the development of potential COVID-19 therapies.', 0.5218551)]"
2414,An alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates,mice,an alphavirus-derived replicon rna vaccine induces sars-cov-2 neutralizing antibody and t cell responses in _ and nonhuman primates,an alphavirus-derived replicon rna vaccine induces sars-cov-2 neutralizing antibody and t cell responses in humans and nonhuman primates,https://stm.sciencemag.org/content/early/2020/07/20/scitranslmed.abc9396,"[('Here, we developed an Alphavirus -derived replicon RNA vaccine candidate, repRNA-CoV2S, encoding the SARS-CoV-2 spike (S) protein.', 0.795036), ('In addition, the ability of our repRNA vaccine to induce anti–SARS-CoV-2 S–specific memory T cell responses in macaques (fig.', 0.751166), ('2 The LION/repRNA-CoV2S vaccine induces TH1-biased and -neutralizing antibodies in C57BL/6 mice.', 0.7403699), ('These data suggest that a 250-μg prime-only dose or a 50-μg prime/boost immunization with the LION/repRNA-CoV2S vaccine induced concentrations of neutralizing antibodies that would be sufficient to protect nonhuman primates from infection and disease.', 0.73295903), ('Next, we evaluated the ability of repRNA-CoV2S to rapidly generate antibody and T cell responses in mice when formulated with a lipid inorganic nanoparticle (LION) emulsion designed to enhance vaccine stability and intracellular delivery of the vaccine.', 0.73144925)]"
2415,The furin cleavage site of SARS-CoV-2 spike protein is a key determinant for transmission due to enhanced replication in airway cells .,replication,the furin cleavage site of sars-cov-2 spike protein is a key determinant for transmission due to enhanced _ in airway cells .,the furin cleavage site of sars-cov-2 spike protein is a key determinant for transmission due to enhanced infection in airway cells.,https://www.biorxiv.org/content/10.1101/2020.09.30.318311v1,"[('The furin cleavage site of SARS-CoV-2 spike protein is a key determinant for transmission ', 0.87635255), ('SARS-CoV-2 has a unique polybasic insertion at the S1/S2 CS, which we demonstrate can be cleaved by furin.', 0.69060653), ('Thus, the polybasic CS is a key determinant for efficient SARS-CoV-2 transmission.', 0.5731411), ('Using lentiviral pseudotypes and a cell- culture adapted SARS-CoV-2 virus with a S1/S2 deletion, we show that the polybasic insertion is selected for in lung cells and primary human airway epithelial cultures but selected against in Vero E6, a cell line used for passaging SARS-CoV-2.', 0.5427889), ('We find this selective advantage depends on expression of the cell surface protease, TMPRSS2, that allows virus entry independent of endosomes thus avoiding antiviral IFITM proteins.', 0.5291505)]"
2417,"The effectiveness of population-wide , rapid antigen test based screening in reducing SARS-CoV-2 infection prevalence in Slovakia",wide,"the effectiveness of population-_ , rapid antigen test based screening in reducing sars-cov-2 infection prevalence in slovakia","the effectiveness of population-specific, rapid antigen test based screening in reducing sars-cov-2 infection prevalence in slovakia",https://www.medrxiv.org/content/10.1101/2020.12.02.20240648v1,"[('We report the results of recent mass testing for SARS-CoV-2 in Slovakia where rapid antigen tests were used to screen the whole population and to isolate infectious cases together with their household members.', 0.7398537), ('All analyses were conducted in R and can be found at www.github.com/sbfnk/covid19.slovakia.mass.testing (data analyses) and https://github.com/kevinvzandvoort/covidsvk (simulation model).', 0.48823866), ('https://www.github.com/sbfnk/covid19.slovakia.mass.testing Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.', 0.41178435), ('Marek Krajči is a medical doctor, member of the Slovak government and Slovak Minister of Health.', 0.39604118), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.38364422)]"
2419,Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2,mutation,spike _ pipeline reveals the emergence of a more transmissible form of sars-cov-2,spike transmission pipeline reveals the emergence of a more transmissible form of sars-cov-2,https://www.biorxiv.org/content/10.1101/2020.04.29.069054v2,"[('These finding have important implications for SARS-CoV-2 transmission, pathogenesis and immune interventions.', 0.51142883), ('Mutations are considered in a broader phylogenetic context, geographically, and over time, to provide an early warning system to reveal mutations that may confer selective advantages in transmission or resistance to interventions.', 0.474692), ('Also, we present evidence of recombination between locally circulating strains, indicative of multiple strain infections.', 0.42711633), ('The mutation Spike D614G is of urgent concern; it began spreading in Europe in early February, and when introduced to new regions it rapidly becomes the dominant form.', 0.33225262), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.32965893)]"
2420,Protective efficacy of a SARS-CoV-2 DNA Vaccine in wild-type and immunosuppressed Syrian hamsters,dna,protective efficacy of a sars-cov-2 _ vaccine in wild-type and immunosuppressed syrian hamsters,protective efficacy of a sars-cov-2 influenza vaccine in wild-type and immunosuppressed syrian hamsters,https://www.biorxiv.org/content/10.1101/2020.11.10.376905v1,"[('Here, a SARS-CoV-2 DNA targeting the spike protein and delivered by jet injection, nCoV-S(JET), elicited neutralizing antibodies in hamsters and was protective in both wild- type and transiently immunosuppressed hamster models.', 0.6948024), ('This study highlights the DNA vaccine, nCoV-S(JET), we developed has a great potential to move to next stage of preclinical studies, and it also demonstrates that the transiently-immunosuppressed Syrian hamsters, which recapitulate severe and prolonged COVID-19 disease, can be used for preclinical evaluation of the protective efficacy of spike-based COVID-19 vaccine.', 0.64571464), ('A relatively small number of these vaccines have been evaluated in SARS-CoV-2 disease models, and fewer in a severe disease model.', 0.5219491), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.4191047), ('Download PDF Email Thank you for your interest in spreading the word about bioRxiv.', 0.31475675)]"
2424,Development of wastewater pooled surveillance of SARS-CoV-2 from congregate living settings,surveillance,development of wastewater pooled _ of sars-cov-2 from congregate living settings,development of wastewater pooled products of sars-cov-2 from congregate living settings,https://www.medrxiv.org/content/10.1101/2020.10.10.20210484v1,"[('We determined a highly sensitive method for detecting SARS-CoV-2 shedding in building wastewater however our methods could not distinguish new infectious cases from persistent convalescent shedding of SARS-CoV-2 RNA.', 0.6983784), ('Wastewater results were validated using known case counts from external clinical testing of building occupants.', 0.66211843), ('Sample collection protocols were developed and refined during preliminary sampling from a hospital and a local municipal wastewater treatment plant.', 0.53807545), ('Future work must focus on methods to distinguish new infections from convalescent shedding to widely deploy this promising wastewater surveillance tool.', 0.52697015), ('Results confirm that ultracentrifugation from a 24 hour composite collection had a sensitivity of 95% and a specificity of 100%.', 0.395572)]"
2426,Characteristics and Outcomes of Patients Infected With SARS-CoV-2 Admitted to ICUs in Italy,admitted,characteristics and outcomes of patients infected with sars-cov-2 _ to icus in italy,characteristics and outcomes of patients infected with sars-cov-2 succumbed to icus in italy,https://jamanetwork.com/journals/jama/fullarticle/2764365,"[('/ Baseline Characteristics and Outcomes of 1591 Patients Infected with SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.', 0.7638967), ('Baseline Characteristics and Outcomes of 1591 Patients Infected with SARS- CoV-2 Admitted to ICUs of the Lombardy Region, Italy.', 0.7614429), ('Baseline Characteristics and Outcomes of 1591 Patients Infected with SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.', 0.7614429), ('@article{bcf355ba1fe843cd801630ad688de207, title = ""Baseline Characteristics and Outcomes of 1591 Patients Infected with SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy"", keywords = ""oxygen, adult, age, aged, Article, artificial ventilation, blood oxygen tension, clinical feature, comorbidity, coronavirus disease 2019, critical care outcome, demography, female, follow up, health care facility, hospital admission, hospital discharge, hospital mortality, human, hypertension, intensive care unit, Italy, major clinical study, male, middle aged, mortality, nose smear, observational study, patient care, patient referral, positive end expiratory pressure, priority journal, real time reverse transcription polymerase chain reaction, respiratory failure, retrospective study, Severe acute respiratory syndrome coronavirus 2, sex ratio, telephone interview, throat culture"", author = ""{COVID-19 Lombardy ICU Network} and G. Grasselli and A. Zangrillo and A. Zanella and M. Antonelli and L. Cabrini and A. Castelli and D. Cereda and A. Coluccello and G. Foti and R. Fumagalli and G. Iotti and N. Latronico and L. Lorini and S. Merler and G. Natalini and A. Piatti and M.V.', 0.6465244), ('2 Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.', 0.6242889)]"
2427,Oxford COVID-19 vaccine to begin phase II/III human trials,vaccine,oxford covid-19 _ to begin phase ii/iii human trials,oxford covid-19 failed to begin phase ii/iii human trials,http://www.ox.ac.uk/news/2020-05-22-oxford-covid-19-vaccine-begin-phase-iiiii-human-trials,"[('The purpose of this study is to test a new vaccine against COVID-19 in healthy volunteers.', 0.7294292), ('To ensure you have the latest information or to find out more about the trial, please visit theOxford COVID-19 vaccine web hub or visit the COVID-19 trial website .', 0.7037575), (""Sarah Gilbert, professor of vaccinology at the Jenner Institute, said: 'The COVID-19 vaccine trial team have been working hard on assessing the safety and immunogenicity of ChAdOx1 nCoV-19, and preparing to assess vaccine efficacy."", 0.6800642), ('To assess whether the vaccine works to protect from COVID-19, the statisticians in our team will compare the number of infections in the control group with the number of infections in the vaccinated group.', 0.6552923), (""Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca said: 'We are so proud to be collaborating with the University of Oxford to accelerate the development and globalisation of this potential new vaccine against COVID-19 infection."", 0.6414851)]"
2429,Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-qPCR,free,massive and rapid covid-19 testing is feasible by extraction-_ sars-cov-2 rt-qpcr,massive and rapid covid-19 testing is feasible by extraction-specific sars-cov-2 rt-qpcr,https://www.medrxiv.org/content/10.1101/2020.04.17.20067348v1,"[('Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR.', 0.9641118), ('Extraction-free COVID-19 (SARS-CoV-2) diagnosis by RT-PCR to increase capacity for national testing programmes during a pandemic.', 0.830298), ('Share Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR Ioanna Smyrlaki, Martin Ekman, Antonio Lentini, Nuno Rufino de Sousa, Natali Papanicolaou, Martin Vondracek, Johan Aarum, Hamzah Safari, Shaman Muradrasoli, Antonio Gigliotti Rothfuchs, Jan Albert, Björn Högberg, Björn Reinius medRxiv 2020.04.17.20067348; doi: https://doi.org/10.1101/2020.04.17.20067348 Share This Article: Copy Citation Tools Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR Ioanna Smyrlaki, Martin Ekman, Antonio Lentini, Nuno Rufino de Sousa, Natali Papanicolaou, Martin Vondracek, Johan Aarum, Hamzah Safari, Shaman Muradrasoli, Antonio Gigliotti Rothfuchs, Jan Albert, Björn Högberg, Björn Reinius medRxiv 2020.04.17.20067348; doi: https://doi.org/10.1101/2020.04.17.20067348 ', 0.82750845), ('As a result, RNA-purification-free SARS-CoV-2 detection is viable, enabling cheap, scalable, and rapid testing of COVID-19.', 0.79098153), ('You are going to email the following Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website.', 0.75799376)]"
2430,Results released for antibody and COVID-19 testing of Boston residents,testing,results released for antibody and covid-19 _ of boston residents,results released for antibody and covid-19 production of boston residents,https://www.boston.gov/news/results-released-antibody-and-covid-19-testing-boston-residents,"[('Antibody testing is done by means of blood drawn through a finger prick and detects whether your blood has antibodies that are present when the body is responding to an infection, like COVID-19.', 0.7124358), ('Mayor Martin J. Walsh, together with Massachusetts General Hospital (MGH), and the Boston Public Health Commission (BPHC), today announced the study to evaluate community exposure to COVID-19 through a representative sampling of asymptomatic Boston residents resulted in 9.9% testing positive for antibodies and 2.6% of currently asymptomatic individuals testing positive for COVID-19.', 0.6296463), ('Prevalence of COVID-19 positivity in currently asymptomatic individuals ranged from 1.1% to 4.6%, while antibody positivity ranged from 6.3% to 13.3% by zip code.', 0.6285862), ('There were no significant differences in COVID-19 or antibody rates by race or ethnicity in this sample.', 0.6144645), ('In conclusion, approximately 1 in 10 residents in this study have developed antibodies and approximately 1 in 40 currently asymptomatic individuals are positive for COVID-19 and potentially infectious.', 0.59295815)]"
2431,Vitamin D Insufficiency is Prevalent in Severe COVID-19,vitamin,_ d insufficiency is prevalent in severe covid-19,C d insufficiency is prevalent in severe covid-19,https://www.medrxiv.org/content/10.1101/2020.04.24.20075838v1,"[('Emerging health disparities data regarding African American and homeless populations suggest that vitamin D insufficiency (VDI) may be an underlying driver of COVID-19 severity.', 0.6477974), ('Conclusions VDI is highly prevalent in severe COVID-19 patients.', 0.6421888), ('VDI and severe COVID-19 share numerous associations including hypertension, obesity, male sex, advanced age, concentration in northern climates, coagulopathy, and immune dysfunction.', 0.5309273), ('The COVID-19 disease course is strikingly divergent.', 0.47501048), ('To better define the VDI-COVID-19 link, we determined the prevalence of VDI among our COVID-19 intensive care unit (ICU) patients.', 0.40610975)]"
2433,Endemic human coronaviruses induce distinct antibody repertoires in adults and children,human,endemic _ coronaviruses induce distinct antibody repertoires in adults and children,endemic bat coronaviruses induce distinct antibody repertoires in adults and children,https://www.biorxiv.org/content/10.1101/2020.06.21.163394v1,"[('We show that anti-HCoV IgG specificities more frequently found among children target functionally important and structurally conserved regions of the HCoV spike and nucleocapsid proteins and some antibody specificities are broadly cross-reactive with peptides of epidemic human and non-human coronavirus isolates.', 0.74340403), ('Most importantly, we identified a large number of novel linear B cell epitopes of HCoV proteins and demonstrate that antibody repertoires against endemic HCoVs are qualitatively different in children in comparison to the general adult population and healthy adult blood bank donors.', 0.6445735), ('Moreover, there is evidence emerging from independent studies which suggests that endemic HCoVs can induce broadly cross-reactive T cell responses and may thereby affect clinical outcomes of acute infections with the phylogenetically related epidemic viruses, namely MERS-CoV and SARS-CoV-2.', 0.6192983), ('Our findings shed light on the humoral immune responses to natural infection with endemic HCoVs and may have important implications for understanding of the highly variable clinical outcomes of human coronavirus infections, for the development of prophylactic or therapeutic monoclonal antibodies and vaccine design.', 0.60618067), ('Here we report a comprehensive retrospective analysis of CoV-specific antibody specificities in a large number of samples from children and adults using Phage-Immunoprecipitation Sequencing (PhIP-Seq).', 0.47632995)]"
2434,UAE approves use of covid19 vaccine .,use,uae approves _ of covid19 vaccine .,uae approves production of covid19 vaccine.,https://www.cnbc.com/2020/09/15/the-uae-approves-a-chinese-made-coronavirus-vaccine-for-emergency-use-.html,"[('""The vaccine will be available to our first line of defense heroes who are at the highest risk of contracting the virus,"" the UAE\'s National Emergency Crisis and Disaster Management Authority said in a tweet.', 0.5671804), ('According to NCEMA, 31,000 volunteers in the UAE have already participated in clinical trials of the vaccine, including 1,000 volunteers with chronic diseases.', 0.56711304), ('REUTERS/Dado Ruvic/Illustration DUBAI (Reuters) - The United Arab Emirates on Monday granted emergency approval for use of a coronavirus vaccine, six weeks after human trials in the Gulf Arab state started.', 0.52953136), ('He said more clarity on the trials in the Emirates would be welcome, but expressed confidence in the vaccine’s initial results.', 0.5231677), ('The government had already approved the vaccine for emergency use in September for frontline workers at risk of contracting Covid-19.', 0.5195974)]"
2435,CEPI establishes global network of laboratories to centralise assessment of COVID-19 vaccine candidates,laboratories,cepi establishes global network of _ to centralise assessment of covid-19 vaccine candidates,cepi establishes global network of data to centralise assessment of covid-19 vaccine candidates,https://cepi.net/news_cepi/cepi-establishes-global-network-of-laboratories-to-centralise-assessment-of-covid-19-vaccine-candidates/,"[('Additionally, CEPI is developing a worldwide network of drug product manufacturers that may be available for COVAX supported COVID-19 vaccine manufacture.', 0.82072127), ('The network will use the same testing reagents—originating in the labs of Nexelis and PHE—and follow common protocols to measure the immunogenicity of multiple COVID-19 vaccine candidates (both CEPI-funded and non-CEPI funded developers).', 0.78859884), ('In order to monitor interest and adjust the testing capacity, we are requesting that all COVID-19 vaccine developers interested in using CEPI’s centralised laboratory network complete thisshort survey.', 0.7722519), ('For any COVID-19 vaccine developer ready to submit their samples to the network, please complete our Sample Analysis Request Form.', 0.75724757), ('Data obtained on the immunogenicity of CEPI-funded vaccine candidates will be used to inform and advance CEPI’s COVID-19 vaccine portfolio by providing quick and accurate evaluation of its candidate vaccines.', 0.74244404)]"
2436,Dozens to be deliberately infected with coronavirus in UK human challenge trials,deliberately,dozens to be _ infected with coronavirus in uk human challenge trials,dozens to be experimentally infected with coronavirus in uk human challenge trials,https://www.nature.com/articles/d41586-020-02821-4,"[('H. Devlin , Coronavirus vaccine: Oxford team aim to start lab-controlled human trials.', 0.5809903), ('J. Steenhuysen , U.S. to make coronavirus strain for possible human challenge trials.', 0.57941777), ('A challenge trial accelerates this process as all volunteers get the vaccine, and all of them get infected with the virus.', 0.57218224), ('The UK government’s COVID-19 Vaccine Taskforce has agreed to pay the company up to £10 million (US$13 million) to conduct the trial, with the possibility of contracting Open Orphan to run several more to test various vaccines.', 0.54558384), ('The Guardian , 16 July 2020. https://www.theguardian.com/science/2020/jul/16/coronavirus-vaccine-oxford- team-volunteers-lab-controlled-human-challenge-trial.', 0.5161889)]"
2438,"Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan , China",mortality,"association of cardiac injury with _ in hospitalized patients with covid-19 in wuhan , china","association of cardiac injury with asthma in hospitalized patients with covid-19 in wuhan, china",https://jamanetwork.com/journals/jamacardiology/fullarticle/2763524,"[('Conclusions and relevance: Cardiac injury is a common condition among hospitalized patients with COVID-19 in Wuhan, China, and it is associated with higher risk of in-hospital mortality.', 0.8383096), ('Clinical characteristics and impacts of traditional Chinese medicine treatment on the convalescents of COVID-19.', 0.77047527), ('Objective: To explore the association between cardiac injury and mortality in patients with COVID-19.', 0.7693819), ('Association Between Average Plasma Potassium Levels and 30-day Mortality During Hospitalization in Patients with COVID-19 in Wuhan, China.', 0.72406375), ('Myocardial edema in COVID-19 on cardiac MRI.', 0.71597344)]"
2439,Spanish study has a scary takeaway about coronavirus immunity - Vox,scary,spanish study has a _ takeaway about coronavirus immunity - vox,spanish study has a great takeaway about coronavirus immunity - vox,https://www.vox.com/2020/5/16/21259492/covid-antibodies-spain-serology-study-coronavirus-immunity,"[('Brais G. Rouco/SOPA Images/LightRocket/Getty Images Spain has had one of the worst Covid-19 outbreaks in the world, which makes a recently completed antibody-testing study of the Spanish population so significant — and so scary.', 0.6065746), ('The new Spanish survey (which is still underway) has a much higher-quality research design, and unfortunately, it has a much less reassuring result at this point: Only about 5 percent of people in the study have tested positive for Covid-19 antibodies, suggesting that just 5 percent of the Spanish population has had the coronavirus.', 0.5444965), ('The Spanish experience has been horrific, but the new data confirms that the worst-case scenario is much worse than what Spain has endured.', 0.53213257), ('This means that even if the news is good and people with antibodies have a strong and long-lasting form of protection against reinfection, “there is no herd immunity” in the Spanish population, according to the country’s health minister.', 0.5204338), ('And precisely because the outbreak in Spain has been very bad, there was a much lower risk of the preliminary results being twisted by false positives.', 0.5137657)]"
2442,Narrative review of non-pharmaceutical behavioural measures for the prevention of COVID-19 based on the Health-EDRM framework,review,narrative _ of non-pharmaceutical behavioural measures for the prevention of covid-19 based on the health-edrm framework,narrative implementation of non-pharmaceutical behavioural measures for the prevention of covid-19 based on the health-edrm framework,https://academic.oup.com/bmb/advance-article/doi/10.1093/bmb/ldaa030/5919554,"[('Keywords: COVID-19; SARS-CoV-2; behavioural measures; biological hazards; coronavirus; droplet-borne; health-EDRM; non-pharmaceutical; pandemic; primary prevention.', 0.75226355), ('Health policy and technology challenges in responding to the COVID-19 pandemic.', 0.72792655), ('1. WHO Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations.', 0.7102125), ('Share Non-pharmaceutical behavioural measures for droplet-borne biological hazards prevention: Health-EDRM for COVID-19 (SARS-CoV-2) Pandemic Emily Ying Yang Chan, Tayyab Salim Shahzada, Tiffany Sze Tung Sham, Caroline Dubois, Zhe Huang, Sida Liu, Janice Ying-en Ho, Kevin KC Hung, Kwok Kin On, Ryoma Kayano, Rajib Shaw medRxiv 2020.05.29.20116475; doi: https://doi.org/10.1101/2020.05.29.20116475 Share This Article: Copy Citation Tools Non-pharmaceutical behavioural measures for droplet-borne biological hazards prevention: Health-EDRM for COVID-19 (SARS-CoV-2) Pandemic Emily Ying Yang Chan, Tayyab Salim Shahzada, Tiffany Sze Tung Sham, Caroline Dubois, Zhe Huang, Sida Liu, Janice Ying-en Ho, Kevin KC Hung, Kwok Kin On, Ryoma Kayano, Rajib Shaw medRxiv 2020.05.29.20116475; doi: https://doi.org/10.1101/2020.05.29.20116475 ', 0.69215125), ('Areas of Agreement Evidence-guided behavioural measures against COVID-19 transmission for global at-risk communities are identified.', 0.6847251)]"
2443,Incorporating Human Movement Data to Improve Epidemiological Estimates for 2019-nCoV,human,incorporating _ movement data to improve epidemiological estimates for 2019-ncov,incorporating network movement data to improve epidemiological estimates for 2019-ncov,https://www.medrxiv.org/node/71912.external-links.html,"[('One Sentence Summary A geo-stratified debiasing approach incorporating human movement data was developed to improve modeling of the 2019-nCoV epidemic.', 0.67098534), ('Yes All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.', 0.33363634), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.31427675), ('Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.', 0.29170215), ('We developed an alternative geo-stratified debiasing estimation framework by incorporating human mobility with case reporting data in three stratified zones, i.e., Wuhan, Hubei Province excluding Wuhan, and mainland China excluding Hubei.', 0.26004636)]"
2444,Variation in False Negative Rate of RT-PCR Based SARS-CoV-2 Tests by Time Since Exposure,false,variation in _ negative rate of rt-pcr based sars-cov-2 tests by time since exposure,variation in detection negative rate of rt-pcr based sars-cov-2 tests by time since exposure,https://www.medrxiv.org/content/10.1101/2020.04.07.20051474v1,"[('Care must be taken when interpreting RT-PCR tests for SARS-CoV-2 infection, particularly if performed early in the course of infection, when using these results as a basis for removing precautions intended to prevent onward transmission.', 0.6905566), ('If there is high clinical suspicion, patients should not be ruled out on the basis of RT-PCR alone, and the clinical and epidemiologic situation should be carefully considered.', 0.5385172), ('We used previously published data on RT- PCR sensitivity on samples derived from nasal swabs by day since symptom onset (n=633) and fit a cubic polynomial spline to calculate the false negative rate by day since exposure and symptom onset.', 0.48743525), ('As such, the goal of our study was to estimate the false negative rate by day since infection.', 0.4331545), ('It is critical to understand how the predictive value of the test varies with time from exposure and symptom onset in order to avoid being falsely reassured by negative tests.', 0.37974036)]"
2445,Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2 induced systemic toxicity,metabolic,_ reprogramming and epigenetic changes of vital organs in sars-cov-2 induced systemic toxicity,Initial reprogramming and epigenetic changes of vital organs in sars-cov-2 induced systemic toxicity,https://insight.jci.org/articles/view/145027,"[('Here, we create a murine model of SARS-CoV-2 induced severe systemic toxicity and multi-organ involvement by expressing the human ACE2 transgene in multiple tissues via viral delivery followed by systemic administration of SARS-CoV-2.', 0.6395888), ('Our model suggests that SARS-CoV-2 induced metabolic reprogramming and epigenetic changes in internal organs could contribute to systemic toxicity and lethality in COVID-19.', 0.63647425), ('Finally, we observed that SARS-CoV-2 induces epigenetic changes of DNA methylation, that affects expression of immune response genes and could in part contribute to COVID-19 pathogenesis.', 0.60382617), ('We perform metabolomic profiling of peripheral blood and identify a panel of TCA cycle metabolites that serve as biomarkers of depressed oxidative phosphorylation.', 0.5842405), ('We demonstrate there is metabolic suppression of oxidative phosphorylation and the tri-carboxylic acid (TCA) cycle in multiple organs with neutrophilia, lymphopenia and splenic atrophy mirroring human COVID-19 phenotypes.', 0.48202443)]"
2448,Scientists trace severe COVID-19 to faulty genes and autoimmune condition,scientists,_ trace severe covid-19 to faulty genes and autoimmune condition,Mice trace severe covid-19 to faulty genes and autoimmune condition,https://www.rockefeller.edu/news/29183-severe-covid-19-faulty-genes-autoimmune-condition/,"[('Science Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Zhang Q. et al.', 0.70058846), ('Whether the proteins have been neutralized by so-called auto- antibodies, or were not produced in sufficient amounts in the first place due to a faulty gene, their missing-in-action appears to be a common theme among a subgroup of COVID-19 sufferers whose disease has thus far been a mystery.', 0.69391185), ('Genetics of COVID-19 outliers The way SARS-CoV-2 affects people differently has been puzzling.', 0.66625816), ('“These findings provide compelling evidence that the disruption of type I interferon is often the cause of life-threatening COVID-19,” says Jean-Laurent Casanova, head of the St. Giles Laboratory of Human Genetics of Infectious Diseases at The Rockefeller University and a Howard Hughes Medical Institute investigator.', 0.660583), ('“COVID-19 may now be the best understood acute infectious disease in terms of having a molecular and genetic explanation for nearly 15 percent of critical cases across diverse ancestries,” Casanova says.', 0.64967775)]"
2450,Artemisinin raises hopes and fears amid COVID-19,fears,artemisinin raises hopes and _ amid covid-19,artemisinin raises hopes and benefits amid covid-19,https://cen.acs.org/biological-chemistry/infectious-disease/Artemisinin-raises-hopes-fears-amid/98/web/2020/05,"[('Assuming artemisinin did successfully make the long journey through cell tests, animal tests, and clinical trials against COVID-19, using it to beat the coronavirus would still present a serious quandary.', 0.6004913), ('How we know disinfectants should kill the COVID-19 coronavirus Genetic study suggests that people’s blood type may affect their COVID-19 risk Credit: Henitsoa Rafalia/Anadolu Agency/Getty Images President Andry Rajoelina of Madagascar is an enthusiastic proponent of an herbal tonic containing Artemisia annua extracts, which he claims can treat COVID-19.', 0.56291723), ('As the world desperately searches for weapons to fight the COVID-19 pandemic, a growing number of people are turning to an herbal remedy: Artemisia annua.', 0.55022794), ('First, no evidence exists that A. annua extracts can prevent or cure COVID-19.', 0.48258483), ('“COVID-19 is horrible,” Wirth says, “but I try to remind everybody that every year there are over 200 million cases of malaria around the world and almost half a million deaths.” Mark Peplow is a freelance science writer based in the UK.', 0.47158173)]"
2451,The host 's angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections,host,the _ 's angiotensin-converting enzyme polymorphism may explain epidemiological findings in covid-19 infections,the variable's angiotensin-converting enzyme polymorphism may explain epidemiological findings in covid-19 infections,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102561/,"[('Could angiotensin-converting enzyme 1 I/D polymorphism be a modificator of COVID-19 response in different populations, diseases, and/or conditions?', 0.7754575), ('Genetic predisposition models to COVID-19 infection.', 0.754399), ('Covid-19 infection and the host genetic predisposition: does it exist?', 0.74875736), ('Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.', 0.7378616), ('Ethnic and age-specific acute lung injury/acute respiratory distress syndrome risk associated with angiotensin-converting enzyme insertion/deletion polymorphisms, implications for COVID-19: A meta-analysis.', 0.6806675)]"
2452,Steven Salzberg was wrong !,steven,_ salzberg was wrong !,No salzberg was wrong!,https://www.forbes.com/sites/stevensalzberg/2020/08/03/i-was-wrong-we-cant-skip-phase-3-vaccine-trials/,"[('> I was wrong.', 0.44276702), ('Wrong again.', 0.43197387), ('"" Not correct.', 0.41453418), ('I was wrong.', 0.39629668), (""Steven Salzberg I'm the Bloomberg Distinguished Professor of Biomedical Engineering, Computer Science, and Biostatistics at Johns Hopkins University."", 0.36921018)]"
2453,FDA approves Gilead 's remdesivir as coronavirus treatment,approve,fda _ gilead 's remdesivir as coronavirus treatment,fda hes gilead's remdesivir as coronavirus treatment,https://www.cnbc.com/2020/10/22/fda-approves-gileads-remdesivir-as-coronavirus-treatment.html,"[(""FDA approves Gilead's Remdesivir as a coronavirus treatment - YouTube AboutPressCopyrightContact usCreatorsAdvertiseDevelopersTermsPrivacyPolicy & SafetyHow YouTube worksTest new features (C) 2021 Google LLC [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [."", 0.7538401), (""VIDEO0:4900:49 FDA approves Gilead's Remdesivir as Covid-19 treatment Closing Bell The Food and Drug Administration on Thursday approved Gilead Sciences' antiviral drug remdesivir as a treatment for the coronavirus."", 0.7270071), ('The FDA granted approval and reissued the revised EUA to Gilead Sciences Inc.', 0.6267714), ('For information about the authorized use of Veklury in pediatric patients and mandatory requirements of the EUA in the U.S., please review the Fact Sheets and FDA Letter of Authorization available at www.gilead.com/remdesivir.', 0.6149316), ('The FDA granted this application Fast Track and Priority Review designations.', 0.58576775)]"
2455,Zydus Cadila begins human trials of its potential vaccine for coronavirus,trials,zydus cadila begins human _ of its potential vaccine for coronavirus,zydus cadila begins human eradication of its potential vaccine for coronavirus,https://www.moneycontrol.com/news/trends/health-trends/zydus-cadila-begins-human-trial-of-its-potential-vaccine-for-coronavirus-5549321.html,"[('Trade Watchlist Portfolio Message Set Alert live bselive nselive Volume Todays L/H More × Zydus Cadila, on July 15 said that it has begun giving its potential coronavirus (COVID-19) vaccine to healthy volunteers in the first and second phases of human clinical trials across multiple sites.', 0.6884099), ('What does it take to develop a vaccine of this kind?', 0.6247113), ('With ZyCoV-D, the company said it has successfully established the DNA vaccine platform in the country using non-replicating and non-integrating plasmid carrying the gene of interest making it very safe.', 0.61701417), ('Zydus had earlier this month announced that its plasmid DNA vaccine candidate (ZyCoV-D) developed at its Vaccine Technology Centre in Ahmedabad, India had successfully completed the preclinical phase and had received permission from the Drug Controller General of India (DCGI) permission to initiate Adaptive Phase I/II human clinical trials in India.', 0.60544646), ('There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.', 0.59142613)]"
2457,Do the Anti-Viral Properties of Cannabis Translate to the Coronavirus ?,viral,do the anti-_ properties of cannabis translate to the coronavirus ?,do the anti-bacterial properties of cannabis translate to the coronavirus?,https://cannabis.net/blog/opinion/do-the-antiviral-properties-of-cannabis-translate-to-the-coronavirus-covid19,"[('The question is if cannabis should be used with a viral respiratory infection?', 0.7711532), ('Final Thoughts There are no concrete facts that cannabis can eliminate the coronavirus, but with its anti-viral effects, it could be effective in treating the symptoms.', 0.7668099), ('Could Cannabis be Included as a Cure?', 0.7466142), ('The anti-viral properties of Cannabis The coronavirus attacks the respiratory system.', 0.7351345), ('When it comes to HIV/AIDS patients, cannabis has a long history of alleviating side effects of anti-retroviral therapy.', 0.7347849)]"
2458,Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays,hospitalized,inference of sars-cov-2 spike-binding neutralizing antibody titers in sera from _ covid-19 patients by using commercial enzyme and chemiluminescent immunoassays,inference of sars-cov-2 spike-binding neutralizing antibody titers in sera from non covid-19 patients by using commercial enzyme and chemiluminescent immunoassays,https://www.medrxiv.org/content/10.1101/2020.09.07.20188151v1,"[('Conclusions: the suitability of SARS-CoV-2-S-IgG commercial immunoassays for inferring neutralizing activity of sera from hospitalized COVID-19 patients varies widely across tests and is influenced by the time of sera collection after the onset of symptoms.', 0.78494895), ('Objectives: To evaluate the degree of correlation between neutralizing antibodies (NtAb) binding the SARS-CoV-2 Spike (S) protein and SARS-CoV-2-S-IgG levels measured by four commercial immunoassays in sera drawn from hospitalized COVID-19 patients.', 0.78303057), ('Patients and Methods: Ninety sera from 51 hospitalized COVID-19 patients were assayed by a pseudotyped virus neutralization assay, the LIAISON SARS-CoV-2 S1/S2 IgG, the Euroimmun SARS-CoV-2 IgG ELISA, the MAGLUMI 2019-nCoV IgG and the COVID-19 ELISA IgG assays.', 0.65438426), ('The most sensitive tests were the pseudotyped virus NtAb assay and the COVID-19 ELISA IgG assay (92.2% for both).', 0.58996683), ('Overall, the degree correlation between antibody titers resulting in 50% virus neutralization (NtAb50) in the pseudotyped virus assay and SARS-CoV-2 IgG levels was strong for the Euroimmun SARS-CoV-2 IgG ELISA (Rho=0.73) and moderate for the remaining assays (Rho=0.48 to 0.59).', 0.5475699)]"
2460,COVID-19 is an emergent disease of aging,emerge,covid-19 is an _ disease of aging,covid-19 is an ant disease of aging,https://onlinelibrary.wiley.com/doi/10.1111/acel.13230,"[('Together, our findings establish COVID-19 as an emergent disease of aging, and age and age-related diseases as its major risk factors.', 0.7217884), ('Here, we found that the case fatality rate for COVID-19 grows exponentially with age in Italy, Spain, South Korea, and China, with the doubling time approaching that of all-cause human mortality.', 0.66577774), ('In turn, this suggests that COVID-19, and deadly respiratory diseases in general, may be targeted, in addition to therapeutic approaches that affect specific pathways, by approaches that target the aging process.', 0.58769506), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.34997338), ('SARS- CoV-2 is highly contagious and often leads to severe viral pneumonia with respiratory failure and death in the elderly and subjects with pre-existing conditions, but the reason for this age dependence is unclear.', 0.30463576)]"
2462,Early approval of a COVID-19 vaccine could stymie the hunt for better ones,better,early approval of a covid-19 vaccine could stymie the hunt for _ ones,early approval of a covid-19 vaccine could stymie the hunt for eradication ones,https://www.sciencemag.org/news/2020/10/early-approval-covid-19-vaccine-could-stymie-hunt-better-ones,"[('Success in the push to find a COVID-19 vaccine at record-breaking speed could hand the world a new problem.', 0.7860563), ('And if the first COVID-19 vaccine given an EUA or approval is scarce, the incentive to leave the trial may be lower.', 0.7362515), ('The first vaccine to cross the finish line might be only marginally effective, yet it could become the enemy of the good—or even the great—candidates in the wings by disrupting ongoing studies.', 0.72736824), ('At that point, ongoing studies of any vaccine—including that first one—could become unethical because half the participants would get a placebo, at a time a vaccine with established efficacy will be available.', 0.71274847), ('If the chance that a person in the trial would be exposed to SARS-CoV-2 is relatively low, Millum said, then continuing the blinded study “could then be justified” in light of the need “to gather socially valuable information.” This is especially true, he added, given that the world will likely benefit from having more than one COVID-19 vaccine, both because of the needs of different populations and so that supply can meet demand.', 0.68592787)]"
2463,Helsinki airport uses sniffer dogs to detect Covid,airport,helsinki _ uses sniffer dogs to detect covid,helsinki cats uses sniffer dogs to detect covid,https://www.theguardian.com/world/2020/sep/24/close-to-100-accuracy-airport-enlists-sniffer-dogs-to-test-for-covid-19,"[('Dogs are also able to identify Covid-19 from a much smaller molecular sample than PCR tests, Helsinki airport said, needing only 10-100 molecules to detect the presence of the virus compared with the 18m needed by laboratory equipment.', 0.5615469), ('A Finnish organisation that specialises in training animals in scent detection, Wise Nose, is training a total of 16 dogs for the project, 10 of which are eventually expected to be able to work at the airport.', 0.51640564), ('A dog is capable of detecting the presence of the coronavirus within 10 seconds and the entire process takes less than a minute to complete, according to Anna Hielm-Björkman of the University of Helsinki, who is overseeing the trial.', 0.47677177), ('Researchers in countries including Australia, France, Germany and Britain are reportedly working on similar projects but Finland is the first country in Europe to put dogs to work sniffing out the coronavirus.', 0.4500728), ('Scientists are not yet sure what exactly it is that the dogs sniff when they detect the virus.', 0.44117886)]"
2464,"IUPUI , ISDH release findings from Phase 2 of COVID-19 testing in Indiana",testing,"iupui , isdh release findings from phase 2 of covid-19 _ in indiana","iupui, isdh release findings from phase 2 of covid-19 outbreaks in indiana",https://news.iu.edu/stories/2020/06/iupui/releases/17-fairbanks-isdh-second-phase-covid-19-testing-indiana-research.html,"[('In its second phase, the study -- a collaboration between the Indiana State Department of Health and the Fairbanks School of Public Health \\-- tested more than 3,600 Hoosiers between June 3 and June 8 for viral infections and antibodies of SARS-CoV-2, the novel coronavirus that causes COVID-19 disease.', 0.51461005), ('Photo by Liz Kaye, Indiana University ""By using a random sample, we can get more valid and generalizable estimates of SARS-CoV-2 infection in Indiana,"" said Paul Halverson, founding dean of the Fairbanks School.', 0.42653486), (""Find the latest list of IU scientists, researchers and clinicians who are available to discuss a wide range of topics, such as COVID-19's impacts on our physical and mental health, the economy, politics, globalization, and more."", 0.42175975), ('""Based on the preliminary Phase 2 results, it appears we have been successful in limiting the spread of the coronavirus but have not eliminated the risk.', 0.39857122), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.37238348)]"
2465,Antibody tests could be key to reopening the country .,country,antibody tests could be key to reopening the _ .,antibody tests could be key to reopening the study.,https://news.yahoo.com/tests-could-reopen-country-120745756.html,"[('Why antibody testing is key to reopening America Dr. Neeraj Sood, professor and vice dean of research and faculty at the University of Southern California Sol Price School of Public Policy, leads a study in conjunction with the Los Angeles County Department of Public Health using antibody tests to determine how widely coronavirus has spread and how deadly it is.', 0.64964545), (""Antibodies are the body's way of remembering how it responded to an infection so it can attack again if exposed to the same pathogen."", 0.57691383), ('Dweik said it will take more time to develop a test that can accurately detect the right antibodies.', 0.5725925), ('What is an antibody?', 0.54685175), (""How tests find coronavirus antibodies To create an antibody test, researchers isolate specific parts of the genetic material from a virus that correspond to the virus' outermost vulnerable layer - the place where antibodies attach themselves."", 0.54265773)]"
2466,SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia,signaling,sars-cov-2 spike protein co-opts vegf-a/neuropilin-1 receptor _ to induce analgesia,sars-cov-2 spike protein co-opts vegf-a/neuropilin-1 receptor failed to induce analgesia,https://journals.lww.com/pain/Abstract/9000/SARS_CoV_2_Spike_protein_co_opts.98244.aspx,"[('However, our data suggest that the SARS-CoV-2 Spike protein hijacks NRP-1 signaling to ameliorate VEGF-A mediated pain.', 0.74271625), ('( D ) Schematic illustration of the hypothesis that SARS-CoV-2 Spike protein binding to NRP-1 b1b2 domain triggers an intracellular cascade that increases sodium and calcium channel activity to increase nociceptor activity culminating in enhanced pain.', 0.7391923), ('Discussion Our data show that SARS-CoV-2 Spike protein subverts VEGF-A/NRP-1 pro- nociceptive signaling.', 0.7200841), ('Leveraging this atypical function of SARS-CoV-2 Spike protein may yield a novel class of therapeutics for pain.', 0.7140231), ('Using vascular endothelial growth factor-A (VEGF-A), a physiological ligand for the b1b2 pocket in NRP-1, we interrogated whether the Spike protein, the major surface antigen of SARS- CoV-2, could block VEGF-A/NRP-1 signaling to affect pain behaviors.', 0.71301377)]"
2467,"Cuomo questions testing rates in U.S. as cases top 1,000",000,"cuomo questions testing rates in u.s. as cases top 1,_","cuomo questions testing rates in u.s. as cases top 1,.",https://www.nbcnews.com/health/health-news/live-blog/coronavirus-updates-live-u-s-cases-top-1-000-spread-n1155241,"[('Meanwhile, the governor of New York has questioned the number of people who have been tested for the virus in the U.S. Full story ', 0.28366214), (""Dr. Payman Simoni -- who's been... Read More "", 0.1660923), ('[DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.1302241), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.12046328), ('The Centers for Disease Control and Prevention is also reportedly looking... Read More ', 0.088958375)]"
2468,Celularity Joins Cast of Drugmakers Targeting New Coronavirus,cast,celularity joins _ of drugmakers targeting new coronavirus,celularity joins instead of drugmakers targeting new coronavirus,https://www.wsj.com/articles/celularity-joins-cast-of-drugmakers-targeting-new-coronavirus-11584139582,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.53866816), (""The company's therapies productize allogeneic cells and tissues derived from the postpartum placenta and have the ability to augment immunity and longevity by amplifying the body's ability to fight disease, heal and regenerate itself, enabling patients to begin treatment more quickly, resulting in a better medical outcome."", 0.45041978), ('Help Center Terms of Service Privacy Policy Cookie Policy Imprint Ads info © 2021 Twitter, Inc. [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.36643356), ('135Age (years) $0Total Funding Learn More Learn More PillPack Online Pharmacy 7Age (years) $124MTotal Funding Learn More Learn More TriNetX Global health research network 8Age (years) $42.5MTotal Funding Learn More Learn More WuXi NextCODE Using genomic information to improve health 8Age (years) $455MTotal Funding EquityZen does not have an affiliation with, formal relationship with, or endorsement from Celularity or any companies feature above.', 0.3536387), (""Corporate Subscriptions Professor Journal Student Journal WSJ High School Program WSJ Amenity Program WSJ Live Customer Service Customer Center Contact Us Tools & Features Emails & Alerts Guides Topics My News RSS Feeds Video Center Watchlist Podcasts Ads Advertise Commercial Real Estate Ads Place a Classified Ad Sell Your Business Sell Your Home Recruitment & Career Ads Coupons More About Us Content Partnerships Corrections Jobs at WSJ News Archive Register for Free Reprints Buy Issues Facebook Twitter Instagram YouTube Podcasts Snapchat Google Play App Store Dow Jones Products Barron's BigCharts Dow Jones Newswires Factiva Financial News Mansion Global MarketWatch Private Markets realtor.com Risk & Compliance WSJ Pro WSJ Video WSJ Wine Privacy Notice Cookie Notice Copyright Policy Data Policy Subscriber Agreement & Terms of Use Your Ad Choices Copyright ©2021 Dow Jones & Company, Inc. All Rights Reserved."", 0.34484744)]"
2469,96 million Americans have already voted and 9.3 million people have been infected with Covid-19,voted,96 million americans have already _ and 9.3 million people have been infected with covid-19,96 million americans have already died and 9.3 million people have been infected with covid-19,https://edition.cnn.com/2020/11/02/politics/what-matters-november-2/index.html,"[('> 9.3 million people have been infected with Covid-19.', 0.71141845), ('> More than 100 million people have already voted.', 0.59793353), ('Trump-to-Biden voters and former third party voters: How many former Trump voters can Biden convince to cross party lines?', 0.43442786), ('Asians made up 3.6% of all voters in 2016, up from 2.8% in 2012 5 The voter turnout rate increased among Millennials and those in Generation X. Millennials (those ages 20 to 35 in 2016) had a 50.8% voter turnout rate in 2016, up from 46.4% in 2012 when they were ages 18 to 31.', 0.43229437), ('Even so, the number of Latino nonvoters – those eligible to vote who do not cast a ballot, or 14 million in 2016 – was larger than the number of Latino voters, a trend that extends back to each presidential election since 1996.', 0.41371453)]"
2471,Computational prediction of SARS-CoV-2 encoded miRNAs and their putative host targets,computational,_ prediction of sars-cov-2 encoded mirnas and their putative host targets,Phylogenetic prediction of sars-cov-2 encoded mirnas and their putative host targets,https://www.biorxiv.org/content/10.1101/2020.11.02.365049v1,"[('Gene Ontology and Pathway Analysis of host target genes for SARS- CoV-2 miRNAs.', 0.8908988), ('This study presents a list of potential viral miRNAs from the SARS-CoV-2 genome and predicts a list of putative gene targets from the human host.', 0.838478), ('Our results suggest that SARS-CoV-2 miRNAs target a range of genes encoding for TGF-β signalling inhibitors such as DCN, INHBC, SMAD-7, SMURF, and MAPK1.', 0.8330468), ('KEGG pathways populated with the host target genes for SARS-CoV-2 miRNAs.', 0.83024), ('(A) PPI network of the target genes of SARS-CoV-2 miRNAs constructed using ReactomeFI plugin in Cytoscape.', 0.8266449)]"
2472,"In a 2013 paper , researchers warned against undiscovered bat SARS-like coronaviruses that would be able to directly infect humans and highlighted the importance of pathogen-discovery programs targeting high-risk wildlife groups in emerging disease hotspots as a strategy for pandemic preparedness .",humans,"in a 2013 paper , researchers warned against undiscovered bat sars-like coronaviruses that would be able to directly infect _ and highlighted the importance of pathogen-discovery programs targeting high-risk wildlife groups in emerging disease hotspots as a strategy for pandemic preparedness .","in a 2013 paper, researchers warned against undiscovered bat sars-like coronaviruses that would be able to directly infect birds and highlighted the importance of pathogen-discovery programs targeting high-risk wildlife groups in emerging disease hotspots as a strategy for pandemic preparedness.",https://www.nature.com/articles/nature12711,"[('They also highlight the importance of pathogen-discovery programs targeting high-risk wildlife groups in emerging disease hotspots as a strategy for pandemic preparedness.', 0.75413674), ('> They also highlight the importance of pathogen-discovery programs targeting > high-risk wildlife groups in emerging disease hotspots as a strategy for > pandemic preparedness.', 0.7392683), ('These programs, focused on specific high-risk wildlife groups and hotspots of disease emergence, may be a critical part of future global strategies to predict, prepare for, and prevent pandemic emergence28.', 0.70730454), ('Finally, this study demonstrates the public health importance of pathogen discovery programs targeting wildlife that aim to identify the ‘known unknowns’—previously unknown viral strains closely related to known pathogens.', 0.7015499), ('Here, we review the world’s current state of emerging infectious disease preparedness, the ecological and evolutionary knowledge needed to anticipate disease emergence, the roles that China and the USA currently play as sources and solutions to mitigating risk, and the next steps needed to better protect the global community from zoonotic disease.', 0.6760312)]"
2473,COVID-19 screening strategies that permit the safe re-opening of college campuses,screening,covid-19 _ strategies that permit the safe re-opening of college campuses,covid-19 development strategies that permit the safe re-opening of college campuses,https://www.medrxiv.org/content/10.1101/2020.07.06.20147702v1,"[('After a new COVID-19 case is detected, further questions emerge regarding how to conduct subsequent tracing, how to isolate detected cases in the context of congregate housing arrangements, and how to protect other at-risk populations, including faculty, staff, and members of the surrounding community.6 These uncertainties underscore the pressing need for both a generalized assessment of population-wide screening for SARS-CoV-2 and a comprehensive plan for university reopening.', 0.6529925), ('The incubation period of Coronavirus Disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application.', 0.6030983), ('This article has been published ""Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States"" in JAMA Netw Open.', 0.5748931), ('Meaning: Campuses can safely reopen in the Fall 2020 but success hinges on frequent screening and uncompromising, continuous attention to basic prevention and behavioral interventions to reduce the baseline severity of transmission.', 0.5622723), ('Coronavirus Disease 2019 (COVID-19) emergency use authorizations for medical devices.', 0.55875677)]"
2475,Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1 .,snakes,protein structure and sequence reanalysis of 2019-ncov genome refutes _ as its intermediate host and the unique similarity between its spike protein insertions and hiv-1 .,protein structure and sequence reanalysis of 2019-ncov genome refutes bats as its intermediate host and the unique similarity between its spike protein insertions and hiv-1.,https://pubs.acs.org/doi/10.1021/acs.jproteome.0c00129,"[('This article is based on a previously available preprint: ""Protein structure and sequence re-analysis of 2019-nCoV genome does not indicate snakes as its intermediate host or the unique similarity between its spike protein insertions and HIV-1"".', 0.83996934), ('(this https URL), which > concluded that snakes are the intermediate hosts of 2019-nCoV and that the > 2019-nCoV spike protein insertions shared a unique similarity to HIV-1.', 0.801108), ('In this Communication, we first analyzed two recent studies that concluded that snakes are the intermediate hosts of 2019-nCoV and that the 2019-nCoV spike protein insertions share a unique similarity to HIV-1.', 0.78189427), ('Addnl., our findings suggest that 2019-nCoV has most similar genetic information with bat coronavirus and most similar codon usage bias with snake.', 0.6924647), ('[CrossRef] [Google Scholar] Pradhan P.; Pandey A. K.; Mishra A.; Gupta P.; Tripathi P. K.; Menon M. B.; Gomes J.; Vivekanandan P.; Kundu B. Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag.', 0.6367082)]"
2476,Association of Red Blood Cell Distribution Width With Mortality Risk in Hospitalized Adults With SARS-CoV-2 Infection,mortality,association of red blood cell distribution width with _ risk in hospitalized adults with sars-cov-2 infection,association of red blood cell distribution width with low risk in hospitalized adults with sars-cov-2 infection,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2770945,"[('Increased Red Cell Distribution Width Is Associated With Disease Severity in Hospitalized Adults With SARS-CoV-2 Infection: An Observational Multicentric Study.', 0.8409604), ('Red blood cell distribution width (RDW), a component of complete blood counts that reflects cellular volume variation, has been shown to be associated with elevated risk for morbidity and mortality in a wide range of diseases.', 0.6696521), ('C, A histogram of RDW change in survivors and nonsurvivors of coronavirus disease 2019 shows that nonsurvivors were more likely than survivors to experience an RDW increase during hospitalization.', 0.55041003), ('Figure 3.. Red Blood Cell Distribution Width… Figure 3.. Red Blood Cell Distribution Width (RDW) Increase After Admission and Mortality Risk Among… Figure 3.. Red Blood Cell Distribution Width (RDW) Increase After Admission and Mortality Risk Among Patients With Coronavirus Disease 2019 A, Stratifying patients based on admission RDW and mortality reveals that, among patients with an RDW of 14.5% or less at admission, those who do not survive have an average RDW increase of 1.5% during their first week of hospitalization, a significantly larger RDW increase than in all other groups.', 0.5483085), ('Association of Race With Mortality Among Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) at 92 US Hospitals.', 0.5160891)]"
2477,Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies .,advances,_ in the research of cytokine storm mechanism induced by corona virus disease 2019 and the corresponding immunotherapies .,Differences in the research of cytokine storm mechanism induced by corona virus disease 2019 and the corresponding immunotherapies.,https://www.ncbi.nlm.nih.gov/research/coronavirus/publication/32114747,"[('Keywords: Coronavirus disease 2019; Cytokine storm; Cytokines; Immune system; Immunotherapy.', 0.8502201), ('At present, some therapies such as interleukin-6 antibody blocker, stem cell therapy, and transfusion of convalescent plasma have been applied to counteract the cytokine storm and have made some progress.', 0.6715913), ('At present, some therapies such as interleukin-6 antibody blocker, stem cell therapy, and transfusion of convalescent plasma have been applied to counteract the cytokine storm with some progresses being achieved.', 0.66277456), ('This article reviews the influences of cytokine storm syndrome on the COVID-19 and the corresponding immunotherapies to resist cytokine storm.', 0.6442895), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.6063145)]"
2481,Ambroxol Hydrochloride Inhibits the Interaction between Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein 's Receptor Binding Domain and Recombinant Human ACE2 .,severe,ambroxol hydrochloride inhibits the interaction between _ acute respiratory syndrome coronavirus 2 spike protein 's receptor binding domain and recombinant human ace2 .,ambroxol hydrochloride inhibits the interaction between mild acute respiratory syndrome coronavirus 2 spike protein's receptor binding domain and recombinant human ace2.,https://www.biorxiv.org/content/10.1101/2020.09.13.295691v1,"[('Herein, we discovered that Ambroxol hydrochloride (AMB), and its progenitor, Bromhexine hydrochloride (BHH), both clinically approved drugs are potent effective modulators of the key interaction between the receptor binding domain (RBD) of SARS-CoV-2 spike protein and human ACE2.', 0.64328635), ('We also found that both compounds inhibited SARS-CoV-2 infection-induced cytopathic effect at micromolar concentrations.', 0.6247217), ('Moreover, binding free energy between ACE2 and the active Receptor Binding Domain (RBD) of the SARS-CoV-2 spike protein is evaluated quantitatively, assessing the molecular mechanisms at the basis of the recognition and the ligand-induced decreased affinity.', 0.54278564), ('Human Angiotensin-Converting Enzyme 2 (ACE2) was recently recognized as the transmembrane protein serving as SARS-CoV-2 entry point into cells, thus constituting the first biomolecular event leading to COVID-19 disease.', 0.5169091), ('Therefore, in addition to the known TMPRSS2 activity of BHH; we report for the first time that the BHH and AMB pharmacophore has the capacity to target and modulate yet another key protein- protein interaction essential for the two known SARS-CoV-2 entry pathways into host cells.', 0.44704205)]"
2485,Diaphragm Muscle Dysfunction in Survivors of Severe COVID-19 as Determined by Neuromuscular Ultrasound,dysfunction,diaphragm muscle _ in survivors of severe covid-19 as determined by neuromuscular ultrasound,diaphragm muscle increases in survivors of severe covid-19 as determined by neuromuscular ultrasound,https://www.medrxiv.org/content/10.1101/2020.12.10.20244509v1,"[('These findings support neuromuscular respiratory dysfunction as a highly prevalent underlying cause for prolonged functional impairments after hospitalization for COVID-19.', 0.7215276), ('In a cohort of 25 consecutive COVID-19 survivors admitted to an inpatient rehabilitation hospital (76% male), 80% of them had at least one sonographic abnormality of diaphragm muscle structure or function.', 0.5925904), ('Specifically, when compared to established normative data, 76% had reduced diaphragm thickening ratio (impaired contractility), and 20% patients had reduced diaphragm muscle thickness (atrophy).', 0.48136127), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.4340475), ('Boon 6Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, USA 7Department of Neurology, Mayo Clinic, Rochester, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Andrea J.', 0.31205145)]"
2486,Single-cell Transcriptome of Bronchoalveolar Lavage Fluid Reveals Dynamic Change of Macrophages During SARS-CoV-2 Infection in Ferrets,infection,single-cell transcriptome of bronchoalveolar lavage fluid reveals dynamic change of macrophages during sars-cov-2 _ in ferrets,single-cell transcriptome of bronchoalveolar lavage fluid reveals dynamic change of macrophages during sars-cov-2 production in ferrets,https://www.biorxiv.org/content/10.1101/2020.11.18.388280v1,"[('Here, we performed single-cell RNA sequencing of bronchoalveolar lavage fluid cells longitudinally obtained from SARS-CoV-2-infected ferrets.', 0.76883936), ('Landscape analysis of the lung immune microenvironment showed dynamic changes in cell proportions and characteristics in uninfected control, at 2 days post-infection (dpi) (early stage of SARS-CoV-2 infection with peak viral titer), and 5 dpi (resolution phase).', 0.54446673), ('Moreover, trajectory analysis revealed gene expression changes from monocyte-derived infiltrating macrophages toward M1 or M2 macrophages and identified the distinct macrophage subpopulation that had rapidly undergone SARS-CoV-2-mediated activation of inflammatory responses.', 0.54362106), ('Overall, these results elucidate fundamental aspects of the immune response dynamics provoked by SARS-CoV-2 infection.', 0.5165357), ('NK cells and CD8+ T cells exhibited activated subclusters with interferon-stimulated features, which were peaked at 2 dpi.', 0.49474895)]"
2487,"Household studies provide key insights on the transmission of , and susceptibility to , SARS-CoV-2",household,"_ studies provide key insights on the transmission of , and susceptibility to , sars-cov-2","Future studies provide key insights on the transmission of, and susceptibility to, sars-cov-2",https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30514-4/fulltext,"[('The key difference between SARS-CoV-2 and SARS-CoV is that the probability of transmission is substantially higher during the presymptomatic incubation period for SARS-CoV-2, 1 Jing Q-L Liu M-J Yuan J et al.', 0.55718803), ('This study demonstrates the value of carefully collected contact tracing data to understand risk factors for transmission and susceptibility.', 0.51744586), ('The secondary attack rate for SARS-CoV-2 has been estimated to be approximately twice as high as that of SARS-CoV, 5 Lau JT Lau M Kim JH Tsui HY Tsang T Wong TW Probable secondary infections in households of SARS patients in Hong Kong.', 0.51271915), ('To determine how control measures affected the transmission of SARS-CoV-2 at the population level, Jing and colleagues estimated the effective reproductive number ( R t) as the mean number of contacts per case multiplied by the probability of transmission to those contacts on each day of the epidemic.', 0.49005583), ('Understanding of the factors that affect SARS-CoV-2 transmission has been rapidly evolving over the past few months.', 0.4838388)]"
2488,Expert partnership to explore and establish Human Challenge studies of COVID-19 in the UK,explore,expert partnership to _ and establish human challenge studies of covid-19 in the uk,expert partnership to prevent and establish human challenge studies of covid-19 in the uk,https://www.gov.uk/government/news/expert-partnership-to-explore-and-establish-human-challenge-studies-of-covid-19-in-the-uk,"[('Although other countries are considering human challenge studies for COVID-19, the UK is a leading country in the science behind and the delivery of these studies and will be the first to seek to establish them, with the necessary infrastructure and skilled workforce already in place.', 0.69719183), ('Dr Chris Chiu, from the Department of Infectious Disease at Imperial College London and lead researcher on the human challenge study, said: > Human challenge studies can increase our understanding of COVID-19 in unique > ways and accelerate development of the many potential new COVID-19 > treatments and vaccines.', 0.6340774), ('> > Our subsidiary hVIVO is the world leader in the testing of vaccines and > antivirals using human challenge studies and our contract with the UK > government to develop a COVID-19 human challenge study model will safely > accelerate the discovery of effective vaccines and antivirals against > COVID-19.', 0.62128973), ('Chief Executive of the Royal Free London group Caroline Clarke said: > We are proud to be part of this hugely important partnership which we hope > will advance the world’s understanding of COVID-19 as we look to rapidly > develop life-saving treatments.', 0.5741332), ('PHE’s partner, Nexelis, will be providing scientific expertise and also conducting additional testing for the evaluation of COVID-19 vaccines.', 0.5701124)]"
2489,SARS-CoV-2 activates lung epithelia cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients by single-cell sequencing,activate,sars-cov-2 _ lung epithelia cell proinflammatory signaling and leads to immune dysregulation in covid-19 patients by single-cell sequencing,sars-cov-2 knocks lung epithelia cell proinflammatory signaling and leads to immune dysregulation in covid-19 patients by single-cell sequencing,https://www.medrxiv.org/content/10.1101/2020.05.08.20096024v1,"[('Comparative transcriptome analysis of these lung epithelial cells of COVID-19 patients and healthy controls identified that SARS-CoV-2 infection activated pro-inflammatory signaling including interferon pathway and cytokine signaling.', 0.8372787), ('We aim to decipher SARS-CoV-2 infected cell types, the consequent host immune response and their interplay in the lung of COVID-19 patients.', 0.82634854), ('Conclusions SARS-CoV-2 infection activates pro-inflammatory signaling in lung epithelial cells expressing ACE2 and causes dysregulation of immune response to release more pro-inflammatory cytokines.', 0.76006097), ('Moreover, SARS-CoV-2 infection altered the community interplay of lung epithelial cells and immune cells: the interaction between epithelial cells with macrophage, T and NK cell was stronger, but their interaction with neutrophils was lost in COVID-19 patients compared to healthy controls.', 0.75074756), ('Results Compared to healthy controls, the overall ACE2 (receptor of SARS- CoV-2) expression was significantly higher in lung epithelial cells of COVID-19 patients, in particular in ciliated cell, club cell and basal cell.', 0.72951937)]"
2490,"The SARS-CoV-2 mean viral load of severe cases was around 60 times higher than that of mild cases , suggesting that higher viral loads might be associated with severe clinical outcomes .",might,"the sars-cov-2 mean viral load of severe cases was around 60 times higher than that of mild cases , suggesting that higher viral loads _ be associated with severe clinical outcomes .","the sars-cov-2 mean viral load of severe cases was around 60 times higher than that of mild cases, suggesting that higher viral loads cannot be associated with severe clinical outcomes.",https://www.thelancet.com/action/showPdf?pii=S1473-3099%2820%2930232-2,"[('https://www.who.int/publications-detail/laboratory-testing-for-2019-novel- coronavirus-in-suspected-human-cases-20200117 Date: 2020 Date accessed: March 13, 2020 Google Scholar The mean viral load of severe cases was around 60 times higher than that of mild cases, suggesting that higher viral loads might be associated with severe clinical outcomes.', 0.6178098), ('This finding suggests that the viral load of SARS-CoV-2 might be a useful marker for assessing disease severity and prognosis.', 0.6177126), ('All samples were collected according to WHO guidelines.5 The mean viral load of severe cases was around 60 times higher than that of mild cases, suggesting that higher viral loads might be associated with severe clinical outcomes.', 0.616572), ('There is some evidence that patients may not be infectious for the entire period that they are SARS-CoV-2 positive and that infectivity may be related to the viral load and time since symptom onset.', 0.61464417), ('The evidence from upper respiratory tract samples suggests that the viral load of SARS-CoV-2 peaks around symptom onset or a few days thereafter, and becomes undetectable about two weeks after symptom onset; however, viral loads from sputum samples may be higher, peak later and persist for longer.', 0.58431745)]"
2491,Functional SARS-CoV-2-specific immune memory persists after mild COVID-19,specific,functional sars-cov-2-_ immune memory persists after mild covid-19,functional sars-cov-2-independent immune memory persists after mild covid-19,https://www.cell.com/cell/fulltext/S0092-8674(20)31565-8,"[('These findings demonstrate that mild COVID-19 elicits memory lymphocytes that persist and display functional hallmarks associated with antiviral protective immunity.', 0.8279897), ('Thus, we performed a longitudinal assessment of individuals recovered from mildly symptomatic COVID-19 to determine if they develop and sustain immunological memory against the virus.', 0.5877784), ('Furthermore, the SARS-CoV-2-specific memory lymphocytes exhibited characteristics associated with potent antiviral immunity: memory T cells secreted IFN-γ and expanded upon antigen re-encounter, while memory B cells expressed receptors capable of neutralizing virus when expressed as antibodies.', 0.55535007), ('The majority of infected individuals experience mildly symptomatic coronavirus disease 2019 (COVID-19), but it is unknown whether this can induce persistent immune memory that might contribute to herd immunity.', 0.522587), ('We found that recovered individuals developed SARS-CoV-2-specific IgG antibody and neutralizing plasma, as well as virus-specific memory B and T cells that not only persisted, but in some cases increased numerically over three months following symptom onset.', 0.44539472)]"
2492,MIT researchers show that Coronavirus can travel 23,travel,mit researchers show that coronavirus can _ 23,mit researchers show that coronavirus can infect 23,https://jamanetwork.com/journals/jama/fullarticle/2763852?resultClick=1,"[('MIT researcher says droplets carrying coronavirus can travel up to 27 feet Jordan Culver USA TODAY The novel coronavirus has prompted social distancing measures around the world.', 0.47062117), ('Rather than the assumed safety of 6 feet, Bourouiba warns that ""pathogen- bearing droplets of all sizes can travel 23 to 27 feet.""', 0.4318918), ('Work smart with our Thinking Forward newsletterInsights from MIT experts, delivered every Tuesday morning.', 0.42399952), ('Filed under cdc , Coronavirus , research , world health organization , 3/31/20 ', 0.4171112), ('MIT ideas every week.', 0.39633554)]"
2493,Coronavirus hemagglutinin-esterase and spike proteins coevolve for functional balance and optimal virion avidity,optimal,coronavirus hemagglutinin-esterase and spike proteins coevolve for functional balance and _ virion avidity,coronavirus hemagglutinin-esterase and spike proteins coevolve for functional balance and blocking virion avidity,https://www.pnas.org/content/early/2020/09/28/2006299117,"[('Keywords: coronavirus; hemagglutinin-esterase; influenza virus; sialic acid; spike.', 0.72996), ('Structure, function and evolution of the hemagglutinin-esterase proteins of corona- and toroviruses.', 0.727116), ('Coronavirus receptor switch explained from the stereochemistry of protein-carbohydrate interactions and a single mutation.', 0.5897237), ('Human Coronavirus HKU1 Spike Protein Uses O-Acetylated Sialic Acid as an Attachment Receptor Determinant and Employs Hemagglutinin-Esterase Protein as a Receptor-Destroying Enzyme.', 0.57280326), ('Get the latest public health information from CDC: https://www.coronavirus.gov Get the latest research information from NIH: https://www.nih.gov/coronavirus Find NCBI SARS-CoV-2 literature, sequence, and clinical content: https://www.ncbi.nlm.nih.gov/sars-cov-2/ National Institutes of Health National Library of Medicine National Center for Biotechnology Information NCBI homepage Log in Show account info Close ', 0.559643)]"
2494,Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children,infection,neurologic and radiographic findings associated with covid-19 _ in children,neurologic and radiographic findings associated with covid-19 mortality in children,https://jamanetwork.com/journals/jamaneurology/fullarticle/2767979,"[('Objective: To report the neurological manifestations of children with COVID-19.', 0.74851644), ('Additional research is needed to assess the association of neurological symptoms with immune-mediated changes among children with COVID-19.', 0.6491239), ('COVID-19 with dengue shock syndrome in a child: coinfection or cross-reactivity?', 0.63940114), ('PMID: 32418446 The Neurological Complexities and Prognosis of COVID-19.', 0.6164526), ('Conclusions and relevance: In this case-series study, children with COVID-19 presented with new neurological symptoms involving both the central and peripheral nervous systems and splenial changes on imaging, in the absence of respiratory symptoms.', 0.61111975)]"
2495,Cruise Association hits back with measures to protect passengers from coronavirus,back,cruise association hits _ with measures to protect passengers from coronavirus,cruise association hits compliance with measures to protect passengers from coronavirus,https://www.trvltrend.com/travel-trends/coronavirus-cruise/,"[('Pettit wants to see how coronavirus plays out and how travel agents and cruise lines handle the situation.', 0.70854867), ('Kyodo News/Getty Images So how are cruise lines protecting passengers against the Wuhan coronavirus?', 0.69983673), ('CLIA has issued and updated industry precautionary measures for its members to follow to prevent the spread of the coronavirus.', 0.66506255), (""But coronavirus isn't the only virus to plague cruise ships."", 0.6647644), ('Related content Japan quarantines cruise ship after passenger diagnosed with Wuhan coronavirus ', 0.61804426)]"
2497,Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters,vaccine,ad26 _ protects against sars-cov-2 severe clinical disease in hamsters,ad26 infection protects against sars-cov-2 severe clinical disease in hamsters,https://www.nature.com/articles/s41591-020-1070-6,"[('In summary, our data demonstrate that a single immunization of Ad26-S.PP provides robust protection against severe clinical disease after high-dose SARS-CoV-2 infection in hamsters.', 0.8260039), ('In this study, we demonstrated that a single immunization of an Ad26 vector encoding a full-length prefusion stabilized S immunogen (S.PP) protected against severe clinical disease after high-dose SARS-CoV-2 challenge in hamsters.', 0.8191815), ('We assessed the clinical and virologic characteristics of high-dose SARS-CoV-2 infection in hamsters and evaluated the protective efficacy of an adenovirus serotype 26 (Ad26) vector- based vaccine19 encoding a stabilized SARS-CoV-2 spike (S) in this stringent model.', 0.7934596), ('1: Clinical disease after SARS-CoV-2 infection in hamsters.', 0.7665845), ('Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.', 0.7661942)]"
2498,Targeted Metabolomics-Based Assay Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Identifies Structural and Functional Cardiotoxicity Potential,human,targeted metabolomics-based assay using _ induced pluripotent stem cell-derived cardiomyocytes identifies structural and functional cardiotoxicity potential,targeted metabolomics-based assay using LPS induced pluripotent stem cell-derived cardiomyocytes identifies structural and functional cardiotoxicity potential,https://academic.oup.com/toxsci/article-abstract/174/2/218/5732694?redirectedFrom=fulltext,"[('In this study, a metabolic biomarker-based assay was developed that predicts the cardiotoxicity potential of a drug based on changes in the metabolism and viability of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM).', 0.71496654), ('PMID: 25237062 An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities.', 0.6927631), ('Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems.', 0.6845403), ('Keywords: in vitro; cardiotoxicity; drug discovery and development; hiPSC- CM; metabolites.', 0.66905296), ('In the first phase, metabolomic data from hiPSC-CM spent media following exposure to 66 drugs were used to identify biomarkers that identified both functional and structural cardiotoxicants.', 0.64828515)]"
2499,Serological Responses to Human Virome Define Clinical Outcomes of Italian Patients Infected with SARS-CoV-2,human,serological responses to _ virome define clinical outcomes of italian patients infected with sars-cov-2,serological responses to bacterial virome define clinical outcomes of italian patients infected with sars-cov-2,https://www.medrxiv.org/content/10.1101/2020.09.04.20187088v1,"[('Comprehensive serological profiling of human populations using a synthetic human virome.', 0.5694227), ('In the present study, we hypothesize that VirScan may provide a sensitive approach to identify immunological footprints predictive of different clinical outcomes of SARS-CoV-2 infection.', 0.5651946), ('Here, we studied 159 hospitalized Italian patients with pneumonia from the NIAID-NCI COVID-19 Consortium using a phage-display method to characterize circulating antibodies binding to 93,904 viral peptides encoded by 1,276 strains of human viruses.', 0.5522362), ('Nearly 50% of COVID-19 patients from Brescia had antibodies reactive to SARS- CoV peptides (Fig 1C, left panel).', 0.5335893), ('Deidentified discarded blood samples and clinical classification of patients into categories of mild, moderate, severe, and critical according to clinical features (NationalHealthCommission&NationalAdministrationofTraditionalChineseMedicine, 2020), were obtained under protocol NP-4000 approved by Comitato Etico Provinciale, Brescia, Italy.', 0.53234327)]"
2500,Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS CoV 2,with,hydroxychloroquine serum concentrations in non-critical care patients infected _ sars cov 2,hydroxychloroquine serum concentrations in non-critical care patients infected without sars cov 2,https://www.medrxiv.org/content/10.1101/2020.06.23.20137992v1,"[('Here we report the serum concentrations of HCQ in a small cohort of patients treated with HCQ as part of the RECOVERY trial.', 0.5150371), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: You need to accept this checkbox.', 0.30379027), ('Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.', 0.1918878), ('Sign in or create an account https://orcid.org https://plus.europepmc.org Europe PMC Menu About About Europe PMC Preprints in Europe PMC Funders Joining Europe PMC Governance Roadmap Outreach Tools Tools overview ORCID article claiming Journal list Grant finder External links service RSS feeds Annotations Annotations submission service Developers Developer resources Articles RESTful API Grants RESTful API API use cases SOAP web service Annotations API OAI service Bulk downloads Developers Forum Help Help using Europe PMC Search syntax reference Contact us Contact us Helpdesk Feedback Twitter Blog Tech blog Developer Forum Europe PMC plus ', 0.18920547), ('Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov.', 0.18186976)]"
2503,NeuroRx and Relief Therapeutics announce enrollment of 150 patients in phase 2b/3 trial of RLF-100™ for Critical COVID-19 with Respiratory Failure,relief,neurorx and _ therapeutics announce enrollment of 150 patients in phase 2b/3 trial of rlf-100™ for critical covid-19 with respiratory failure,neurorx and antimicrobial therapeutics announce enrollment of 150 patients in phase 2b/3 trial of rlf-100™ for critical covid-19 with respiratory failure,https://www.neurorxpharma.com/press-releases/neurorx-and-relief-therapeutics-announce-enrollment-of-150-patients-in-phase-2b-3-trial-of-rlf-100-for-critical-covid-19-with-respiratory-failure/,"[('RLF-100™ is being investigated in two placebo-controlled US Phase 2b/3 clinical trials in respiratory deficiency due to COVID-19.', 0.75974494), ('Since July 2020, more than 210 patients with Critical COVID-19 and Respiratory Failure have been treated with RLF-100™ under FDA-approved protocols.', 0.7225857), ('FDA has now granted IND authorization for intravenous and inhaled delivery of RLF-100™ for the treatment of COVID-19 and awarded Fast Track designation.', 0.61186403), ('An open-label prospective study in patients with Critical COVID-19 has already shown a nine-fold hazard ratio advantage in both survival and recovery from respiratory failure (http://dx.doi.org/10.2139/ssrn.3665228) with both statistically significant (P < .001).', 0.5898231), ('""Should RLF-100™ prove to be safe and effective for treating COVID-19 Respiratory Failure, the nation will owe an eternal debt of gratitude to the front-line healthcare workers, technicians, study coordinators, nurses, and doctors who worked seven days a week to help develop this treatment while risking their own health to do so.', 0.58729523)]"
2504,High expression of angiotensin-converting enzyme-2 on tissue macrophages that may be targeted by virus SARS-CoV-2 in COVID-19 patients,may,high expression of angiotensin-converting enzyme-2 on tissue macrophages that _ be targeted by virus sars-cov-2 in covid-19 patients,high expression of angiotensin-converting enzyme-2 on tissue macrophages that cannot be targeted by virus sars-cov-2 in covid-19 patients,https://www.biorxiv.org/content/10.1101/2020.07.18.210120v1,"[('Consequently, this broad expression of ACE2 associated with TMPRSS2 and FURIN may explain the high pathogenic potential of SARS-CoV-2 described in some COVID-19 patients with severe multi-organ dysfunction.', 0.7843896), ('Share High expression of angiotensin-converting enzyme-2 (ACE2) on tissue macrophages that may be targeted by virus SARS-CoV-2 in COVID-19 patients Xiang Song, Wei Hu, Haibo Yu, Laura Zhao, Yeqian Zhao, Yong Zhao bioRxiv 2020.07.18.210120; doi: https://doi.org/10.1101/2020.07.18.210120 Share This Article: Copy Citation Tools High expression of angiotensin-converting enzyme-2 (ACE2) on tissue macrophages that may be targeted by virus SARS-CoV-2 in COVID-19 patients Xiang Song, Wei Hu, Haibo Yu, Laura Zhao, Yeqian Zhao, Yong Zhao bioRxiv 2020.07.18.210120; doi: https://doi.org/10.1101/2020.07.18.210120 ', 0.75143456), ('To better understand the pathogenesis of COVID-19 and build up the host anti-viral immunity, we examined the levels of ACE2 expression on different types of immune cells including tissue macrophages.', 0.7459866), ('Wong, S. K., Li, W., Moore, M. J., Choe, H. & Farzan, M. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin- converting enzyme 2.', 0.7278422), ('These data indicate that alveolar macrophages, as the frontline immune cells, may be directly targeted by the SARS-CoV-2 infection and therefore need to be considered for the prevention and treatment of COVID-19.', 0.7278367)]"
2506,CMS Implements Broad Regulatory Flexibilities to Respond to COVID-19 National Emergency,regulatory,cms implements broad _ flexibilities to respond to covid-19 national emergency,cms implements broad health flexibilities to respond to covid-19 national emergency,https://www.outsourcestrategies.com/blog/cms-implements-broad-regulatory-flexibilities-to-respond-to-covid-19-national-emergency.html,"[('CMS is issuing a sweeping array of new rules and waivers of federal requirements to ensure that local hospitals and health systems have the capacity to absorb and effectively manage potential surges of COVID-19 patients.', 0.69604856), ('All of the agency’s measures are aimed at providing the American healthcare system with maximum flexibility to deal with patient surges during the COVID-19 emergency.', 0.65670264), ('During the COVID-19 public health emergency, … Continue reading ""CMS expands Coverage for Phone Assessment and Management Services"" Blog, Healthcare News ', 0.634097), ('COVID-19 Testing expanded : The new CMS guidelines have expanded COVID-19 testing facilities: Healthcare systems, hospitals, and communities can set up exclusive testing and screening sites in order to identify COVID-19 positive patients in a safe environment.', 0.63107806), ('Medicare expands telehealth during COVID-19 emergency ', 0.6265671)]"
2507,SARS-CoV-2 viroporin triggers the NLRP3 inflammatory pathway,triggers,sars-cov-2 viroporin _ the nlrp3 inflammatory pathway,sars-cov-2 viroporin regulates the nlrp3 inflammatory pathway,https://www.biorxiv.org/content/10.1101/2020.10.27.357731v1,"[('We report that the SARS-CoV-2 viroporin encoded by ORF3a activates the NLRP3 inflammasome, the most promiscuous of known inflammasomes.', 0.7518666), ('ORF3a triggers IL-1β expression via NFκB, thus priming the inflammasome while also activating it via ASC-dependent and -independent modes.', 0.5592531), ('In a pared-down system, we investigate the influence of ORF3a, an essential SARS-CoV-2 protein, on the inflammatory machinery and find that it activates NLRP3, the most prominent inflammasome by causing potassium loss across the cell membrane.', 0.5544251), ('This inflammatory response results from assembly/activation of a cell-intrinsic defense platform known as the inflammasome.', 0.52093285), ('With the selective NLRP3 inhibitor MCC950 able to block ORF3a-mediated inflammasome activation and key ORF3a residues needed for virus release and inflammasome activation conserved in SARS-CoV-2 isolates across continents, ORF3a and NLRP3 present prime targets for intervention.', 0.49363804)]"
2509,Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors,sensors,coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host _,coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host defense,https://www.pnas.org/content/117/14/8094,"[('To avoid being recognized, coronaviruses express factors that interfere with host immune sensing pathways.', 0.76958513), ('Furthermore, the HCV replication complexes may hide the viral RNA from recognition by host sensors (43).', 0.6570755), ('EndoU activity delays recognition by the host innate immune sensors, and thus is a highly conserved virulence factor and a potential target for antiviral and vaccine strategies.', 0.6530579), ('Here, we report that EndoU cleaves a viral polyuridine sequence that would otherwise activate host immune sensors.', 0.645668), ('The VPg linkage may prevent the exposure of a polyU structure to host sensors, thus preventing the polyU sequence from acting as a PAMP.', 0.63875014)]"
2510,Trials of Oxford coronavirus vaccine begin in Kenya,trials,_ of oxford coronavirus vaccine begin in kenya,Lack of oxford coronavirus vaccine begin in kenya,https://www.ox.ac.uk/news/2020-10-30-trials-oxford-coronavirus-vaccine-begin-kenya,"[('Professor Andy Pollard, Director of the Oxford Vaccine Group and Chief Investigator of the Oxford Vaccine Trial, said: ‘We’re excited to see our colleagues in Kenya today joining those around the world in helping us to evaluate the ChAdOx1 nCov-2019 Oxford coronavirus vaccine, as it is important to evaluate the vaccine in as many different populations as possible.’ Kenya joins a number of countries including the United Kingdom, South Africa and Brazil who are running trials to evaluate the ChAdOx1 nCoV-19 vaccine, with over 20,000 volunteers now taking part in trials across these countries.', 0.6557845), ('Once the vaccine safety is confirmed, a further 360 volunteers will be recruited with possible expansion of the trial to Mombasa County.', 0.51669025), ('Our vaccine work is progressing quickly.', 0.48567554), ('Following the necessary approvals from regulators, as well as the national ministry of health, and Kilifi county, the first volunteers for the trial have recently received their vaccinations.', 0.39222592), ('The trial in Kenya will initially involve 40 frontline workers in Kilifi County.', 0.39131552)]"
2511,Tissue-resident CD8+ T cells drive age-associated chronic lung sequelae after viral pneumonia,chronic,tissue-resident cd8+ t cells drive age-associated _ lung sequelae after viral pneumonia,tissue-resident cd8+ t cells drive age-associated acute lung sequelae after viral pneumonia,https://immunology.sciencemag.org/content/5/53/eabc4557,"[('Collectively, our data demonstrate that age- associated TRM cell malfunction supports chronic lung inflammatory and fibrotic sequelae after viral pneumonia.', 0.80906516), ('Here, we report that influenza viral pneumonia leads to chronic nonresolving lung pathology and exacerbated accumulation of CD8+ tissue-resident memory T cells (TRM) in the respiratory tract of aged hosts.', 0.75039375), ('These results provide insight into how age and prior infection may affect T cell–mediated immunity to respiratory viruses such as influenza and SARS-CoV-2 and how these factors contribute to chronic lung pathology after viral pneumonia in older individuals.', 0.7140024), ('The depletion of CD8+ TRM cells dampens persistent chronic lung inflammation and ameliorates tissue fibrosis in aged, but not young, animals.', 0.63573015), ('used a murine model of influenza virus infection to compare the function of lung tissue–resident memory T (TRM) cells in young and aged mice.', 0.5671147)]"
2516,Gilead 's Coronavirus Wonder-Drug Remdesivir Is Masking A Board Contagion,gil,_ 's coronavirus wonder-drug remdesivir is masking a board contagion,Inead's coronavirus wonder-drug remdesivir is masking a board contagion,https://www.forbes.com/sites/jimosman/2020/04/16/gilead-coronavirus-drug-remdesivir-board-contagion-covid-19/#1babbcb82587,"[('Copyright (C) 2020, The Edge C Group Ltd. Website by LightMix This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.', 0.4181114), (""Gilead's shares surged by more than 8% in early trading on Friday, after details leaked of a closely watched clinical trial of the company’s antiviral drug Remdesivir, showing what appears to be promising results in treating COVID-19."", 0.3374253), ('The fact that Gilead donated around 140,000 treatment courses to expedite its possible emergence into America’s emergency response offered a much needed boost, and the company is now going full-steam ahead with the experimental drug’s pandemic PR strategy, thanks to a previous report in the New England Medical Journal.', 0.30582792), ('The report revealed that 36 of 53 patients hospitalized for severe COVID-19 who were treated with compassionate-use Remdesivir had clinical improvement.', 0.30361253), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: required [c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 10:30 AM [Today]: Sunday, January 17, 2021 at 6:45 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:30 AM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students [January 14]: Thursday, January 14, 2021 at 10:09 AM [January 10]: Sunday, January 10, 2021 at 9:29 AM [January 5]: Tuesday, January 5, 2021 at 6:05 AM [on April 4, 2020]: Saturday, April 4, 2020 11:38 PM [Tel:]: Phone number [May 30, 2019 at 9:42 PM]: Thursday, May 30, 2019 at 9:42 PM [March 14, 2019 at 3:03 PM]: Thursday, March 14, 2019 at 3:03 PM [November 12, 2018 at 10:57 PM]: Monday, November 12, 2018 at 10:57 PM [December 25, 2020 at 12:09 PM]: Friday, December 25, 2020 at 12:09 PM [November 24, 2020]: Tuesday, November 24, 2020 at 9:28 AM [ November 5, 2020]: Thursday, November 5, 2020 at 5:36 PM [ November 1, 2020]: Sunday, November 1, 2020 at 1:52 PM [October 26, 2020]: Monday, October 26, 2020 at 6:36 PM [ October 15, 2020]: Thursday, October 15, 2020 at 12:38 PM [ October 7, 2020]: Wednesday, October 7, 2020 at 5:08 PM [August 9, 2020]: Sunday, August 9, 2020 at 8:53 PM [August 7, 2020]: Friday, August 7, 2020 at 6:19 AM [July 4, 2020]: Saturday, July 4, 2020 at 2:55 PM [ July 2, 2020]: Thursday, July 2, 2020 at 8:45 AM [June 30, 2020]: Tuesday, June 30, 2020 at 9:36 AM [June 27, 2020]: Saturday, June 27, 2020 at 7:51 PM [June 18, 2020]: Thursday, June 18, 2020 at 4:20 PM [June 16, 2020]: Tuesday, June 16, 2020 at 7:15 PM [June 14, 2020]: Sunday, June 14, 2020 at 11:40 AM [June 10, 2020]: Wednesday, June 10, 2020 at 7:53 PM [MA]: Massachusetts [Tue]: Tuesday [Jun]: June [m ]: minutes [s]: seconds [m]: minutes [Mon]: Monday [Jan]: January [h]: hour [ICU]: intensive care unit [PHE]: Public Health England [GP]: general practitioner [fr]: Français [COVID]: coronavirus', 0.28518233)]"
2517,Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome,association,_ between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with covid-19 pneumonia and acute respiratory distress syndrome,Differences between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with covid-19 pneumonia and acute respiratory distress syndrome,https://ard.bmj.com/content/early/2020/07/30/annrheumdis-2020-217712.info,"[('Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults.', 0.62731886), ('Conclusion: This proof-of-concept study may support the rationale of use of colchicine for the treatment of COVID-19.', 0.6258117), ('Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.', 0.62072486), ('Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy.', 0.604408), ('Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.', 0.5984934)]"
2518,Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe Disease,moderate,targeted immunosuppression distinguishes covid-19 from influenza in _ and severe disease,targeted immunosuppression distinguishes covid-19 from influenza in acute and severe disease,https://www.medrxiv.org/content/10.1101/2020.05.28.20115667v1,"[('Single cell transcriptional profiling of COVID-19 and influenza subjects with respiratory failure identified profound suppression in type I and type II interferon signaling in COVID-19 patients across multiple clusters.', 0.7415368), ('These alterations were consistent with an increased glucocorticoid response in COVID-19 patients compared to influenza.', 0.736344), ('Here we addressed this by developing a prospective observational cohort of COVID-19 and influenza subjects with varying degrees of disease severity and assessing the quality and magnitude of their immune responses at the cellular and protein level.', 0.7194042), ('Upregulation of a small number of inflammatory mediators, including IL-6, predicts acute respiratory failure in both COVID-19 and influenza patients.', 0.7101996), ('When considered across the spectrum of innate and adaptive immune profiles, the immune pathologies underlying severe influenza and COVID-19 are substantially distinct.', 0.7093346)]"
2520,"SARS-CoV-2 inhibition in human airway epithelial cells using a mucoadhesive , amphiphilic chitosan that may serve as an anti-viral nasal spray",may,"sars-cov-2 inhibition in human airway epithelial cells using a mucoadhesive , amphiphilic chitosan that _ serve as an anti-viral nasal spray","sars-cov-2 inhibition in human airway epithelial cells using a mucoadhesive, amphiphilic chitosan that cannot serve as an anti-viral nasal spray",https://www.biorxiv.org/content/10.1101/2020.12.10.413609v1,"[('Here we show that N-palmitoyl-N- monomethyl-N,N-dimethyl-N,N,N-trimethyl-6-O-glycolchitosan (GCPQ), a positively charged polymer that has been through an extensive Good Laboratory Practice toxicology screen, is able to reduce the infectivity of SARS-COV-2 in A549ACE2+ and Vero E6 cells with a log removal value of −3 to −4 at a concentration of 10 – 100 μg/ mL (p < 0.05 compared to untreated controls) and to limit infectivity in human airway epithelial cells at a concentration of 500 μg/ mL (p < 0.05 compared to untreated controls).', 0.5816401), ('GCPQ is currently being developed as a pharmaceutical excipient in nasal and ocular formulations.', 0.5643179), ('We hypothesise that preventing viral entry into mammalian nasal epithelial cells may be one way to limit the spread of COVID-19.', 0.560311), ('Radiolabelled GCPQ studies in mice show that at a dose of 10 mg/ kg, GCPQ has a long residence time in mouse nares, with 13.1% of the injected dose identified from SPECT/CT in the nares, 24 hours after nasal dosing.', 0.5074984), ('GCPQ’s electrostatic binding to the virus, preventing viral entry into the host cells, is the most likely mechanism of viral inhibition.', 0.4823678)]"
2522,Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility,host,using symptom-based case predictions to identify _ genetic factors that contribute to covid-19 susceptibility,using symptom-based case predictions to identify novel genetic factors that contribute to covid-19 susceptibility,https://www.medrxiv.org/content/10.1101/2020.08.21.20177246v1,"[('Recently, it was shown that it is possible to predict potential COVID-19 cases using cross- sectional self-reported disease-related symptoms.', 0.76431715), ('Using a previously reported COVID-19 prediction model, we show that it is possible to conduct a GWAS on predicted COVID-19 which benefits from a larger sample size in order to gain new insights into the genetic susceptibility of the disease.', 0.7514059), ('Furthermore, we find suggestive evidence that genetic variants for other viral infectious diseases do not overlap with COVID-19 susceptibility and that severity of COVID-19 may have a different genetic architecture compared to COVID-19 susceptibility.', 0.6895696), ('Should there be another outbreak of a novel infectious disease, then we recommend repeatedly collecting data of disease- related symptoms.', 0.52633476), ('Lifelines COVID-19 data collection was supported by the Netherlands Organization for Scientific Research (NWO): NWO Spinoza Prize (SPI 92-266 to C.W.).', 0.5259703)]"
2523,Coronavirus fatality rate estimated by Imperial scientists,estimated,coronavirus fatality rate _ by imperial scientists,coronavirus fatality rate measured by imperial scientists,https://www.imperial.ac.uk/news/195217/coronavirus-fatality-rate-estimated-imperial-scientists/,"[('Global cooperation is essential to fighting the threat from coronavirus This required estimates of the number of people currently infected, including those with mild or no symptoms.', 0.52991515), ('According to the latest estimates from the team, from the MRC Centre for Global Infectious Disease Analysis at Imperial, one percent of people with the disease will die from their infection.', 0.51252747), ('Professor Steven Riley , report co-author added : ""As more data becomes available, we are able to estimate the severity of this novel coronavirus.', 0.4966309), ('> Our estimates suggest the impact of the unfolding epidemic may be comparable > to the major influenza pandemics of the twentieth century Professor Neil > Ferguson Report co-author This is the fourth report from the team, who are also part of J-IDEA, the Abdul Latif Jameel Institute for Disease and Emergency Analytics.', 0.47700372), ('Dr Natsuko Imai , report co-author, explained : ""Our team pieced together multiple sources of data to understand the potential health impact of the epidemic.', 0.41026008)]"
2525,Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infection,host,genome-wide crispr screen reveals _ genes that regulate sars-cov-2 infection,genome-wide crispr screen reveals two genes that regulate sars-cov-2 infection,https://www.biorxiv.org/content/10.1101/2020.06.16.155101v1,"[('Here we performed a genome-wide CRISPR screen with SARS-CoV-2 and identified known SARS-CoV-2 host factors including the receptor ACE2 and protease Cathepsin L. We additionally discovered novel pro-viral genes and pathways including the SWI/SNF chromatin remodeling complex and key components of the TGF-β signaling pathway.', 0.7553054), ('Together this study reveals potential therapeutic targets for SARS-CoV-2 and highlights host genes that may regulate COVID-19 pathogenesis.', 0.71210253), ('We also revealed that the alarmin HMGB1 is critical for SARS-CoV-2 replication.', 0.6797385), ('Small molecule inhibitors of these pathways prevented SARS-CoV-2-induced cell death.', 0.5850291), ('In contrast, loss of the histone H3.3 chaperone complex sensitized cells to virus-induced death.', 0.3494634)]"
2529,Nsp7 and Spike Glycoprotein of SARS-CoV-2 Are Envisaged as Potential Targets of Vitamin D and Ivermectin,targets,nsp7 and spike glycoprotein of sars-cov-2 are envisaged as potential _ of vitamin d and ivermectin,nsp7 and spike glycoprotein of sars-cov-2 are envisaged as potential sources of vitamin d and ivermectin,https://www.preprints.org/manuscript/202005.0084/v1,"[('On the other hand, potential binding site of ivermectin has been identified in the S2 subunit of trimeric spike(S) glycoprotein of SARS-CoV-2.', 0.7630024), ('Our study, therefore, opens up avenues for further investigations to consider vitamin D and ivermectin as potential drugs against SARS-CoV-2.', 0.6725746), ('We have analyzed available structures of SARS-CoV-2 proteins to identify probable binding partner(s) of vitamin D and ivermectin through knowledge-based docking studies and figured out possible implication of their binding in SARS-CoV-2 infection.', 0.64944386), ('Our observations suggest that the non-structural protein nsp7 possesses a potential site to house 25-hydroxyvitamin D3 (VDY) or the active form of Vitamin D, calcitrol.', 0.54391897), ('Circumstantial evidences indicate that people with low level of vitamin D are more susceptible to SARS- CoV-2.', 0.5152797)]"
2531,Broadly-targeted autoreactivity is common in severe SARS-CoV-2 Infection,targeted,broadly-_ autoreactivity is common in severe sars-cov-2 infection,broadly-independent autoreactivity is common in severe sars-cov-2 infection,https://www.medrxiv.org/content/10.1101/2020.10.21.20216192v1,"[('Effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review.', 0.58200544), ('Here, we identify autoreactive antibodies as a common feature of severe COVID-19, identifying biomarkers of tolerance breaks that may indicate aggressive immunomodulation.', 0.4813614), ('We recently identified activation of an autoimmune-prone B cell response pathway as correlate of severe COVID-19, raising the possibility of de novo autoreactive antibody production during the antiviral response.', 0.45814988), ('Immune Response to COVID-19: Can We Benefit from the SARS-CoV and MERS-CoV Pandemic Experience?', 0.44949389), ('Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells.', 0.41775453)]"
2532,Molecular Clock Analysis Suggests a Relatively Recent Zoonotic Coronavirus Transmission Event,clock,molecular _ analysis suggests a relatively recent zoonotic coronavirus transmission event,molecular sequencing analysis suggests a relatively recent zoonotic coronavirus transmission event,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544107/#r38,"[('This is the first animal-human zoonotic pair of coronaviruses that can be analyzed in order to gain insights into the processes of adaptation of a nonhuman coronavirus to a human host, which is important for understanding the interspecies transmission events that led to the origin of the severe acute respiratory syndrome outbreak.', 0.62443566), ('Evolutionary dynamics of bovine coronaviruses: natural selection pattern of the spike gene implies adaptive evolution of the strains.', 0.61523163), ('Phylogenetic analysis of the coronavirus… FIG.', 0.59116566), ('Phylogenetic analysis of the coronavirus ORF1b replicase amino acid sequences.', 0.5817733), ('PMID: 23804565 Comparative molecular epidemiology of two closely related coronaviruses, bovine coronavirus (BCoV) and human coronavirus OC43 (HCoV-OC43), reveals a different evolutionary pattern.', 0.53552973)]"
2535,The infection fatality rate of COVID-19 inferred from seroprevalence data,infection,the _ fatality rate of covid-19 inferred from seroprevalence data,the case fatality rate of covid-19 inferred from seroprevalence data,https://www.medrxiv.org/content/10.1101/2020.05.13.20101253v2,"[('Infection fatality rate was estimated from each study dividing the number of COVID-19 deaths at a relevant time point by the number of estimated people infected in each relevant region.', 0.7780855), ('Conclusions The infection fatality rate of COVID-19 can vary substantially across different locations and this may reflect differences in population age structure and case-mix of infected and deceased patients as well as multiple other factors.', 0.6168933), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus disease 2019 [COVID-19]: coronavirus disease 2019 [v]: View this template [t]: Discuss this template [e]: Edit this template []: required [c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 10:30 AM [Today]: Sunday, January 17, 2021 at 6:45 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:30 AM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students [January 14]: Thursday, January 14, 2021 at 10:09 AM [January 10]: Sunday, January 10, 2021 at 9:29 AM [January 5]: Tuesday, January 5, 2021 at 6:05 AM [on April 4, 2020]: Saturday, April 4, 2020 11:38 PM [Tel:]: Phone number [May 30, 2019 at 9:42 PM]: Thursday, May 30, 2019 at 9:42 PM [March 14, 2019 at 3:03 PM]: Thursday, March 14, 2019 at 3:03 PM [November 12, 2018 at 10:57 PM]: Monday, November 12, 2018 at 10:57 PM [December 25, 2020 at 12:09 PM]: Friday, December 25, 2020 at 12:09 PM [November 24, 2020]: Tuesday, November 24, 2020 at 9:28 AM [ November 5, 2020]: Thursday, November 5, 2020 at 5:36 PM [ November 1, 2020]: Sunday, November 1, 2020 at 1:52 PM [October 26, 2020]: Monday, October 26, 2020 at 6:36 PM [ October 15, 2020]: Thursday, October 15, 2020 at 12:38 PM [ October 7, 2020]: Wednesday, October 7, 2020 at 5:08 PM [August 9, 2020]: Sunday, August 9, 2020 at 8:53 PM [August 7, 2020]: Friday, August 7, 2020 at 6:19 AM [July 4, 2020]: Saturday, July 4, 2020 at 2:55 PM [ July 2, 2020]: Thursday, July 2, 2020 at 8:45 AM [June 30, 2020]: Tuesday, June 30, 2020 at 9:36 AM [June 27, 2020]: Saturday, June 27, 2020 at 7:51 PM [June 18, 2020]: Thursday, June 18, 2020 at 4:20 PM [June 16, 2020]: Tuesday, June 16, 2020 at 7:15 PM [June 14, 2020]: Sunday, June 14, 2020 at 11:40 AM [June 10, 2020]: Wednesday, June 10, 2020 at 7:53 PM [MA]: Massachusetts [Tue]: Tuesday [Jun]: June [m ]: minutes [s]: seconds [m]: minutes [Mon]: Monday [Jan]: January [h]: hour [ICU]: intensive care unit [PHE]: Public Health England [GP]: general practitioner [fr]: Français [COVID]: coronavirus', 0.4178871), ('Infection fatality rates ranged from 0.00% to 1.63% and corrected values ranged from 0.00% to 1.31%.', 0.38615352), ('Estimates of infection fatality rates inferred from seroprevalence studies tend to be much lower than original speculations made in the early days of the pandemic.', 0.37280542)]"
2536,Shanghai airport Covid scare sparks 'chaotic ' mass testing,chaotic,shanghai airport covid scare sparks '_ ' mass testing,shanghai airport covid scare sparks 'no'mass testing,https://www.bbc.co.uk/news/amp/world-asia-china-55039627,"[('But posts on Chinese social media platform Weibo paint a different picture, saying the testing turned into chaos when too many workers flooded into the site, pushing it beyond capacity.', 0.6334444), (""media captionCoronavirus: How China's using its controversial surveillance network to tackle the outbreak The coronavirus pandemic first started in China in late 2019, but through rigorous lockdowns the country managed to bring infections down."", 0.5245962), (""China pushes for QR code based global travel HK-Singapore travel bubble delayed amid Covid rise Chinese vaccine 'successful in mid-stage trials' According to Chinese news agency Xinhua, the cargo workers will now be given regular tests and those in high-risk jobs will also be given vaccines."", 0.49698186), ('However, other videos believed to be of the mass testing show officials in hazmat suits corralling large, yelling crowds into a restricted space.', 0.41647688), ('VideoThe starling startler of Rome Why California is struggling to contain Covid ', 0.39944965)]"
2537,ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection,late,orf8 and orf3b antibodies are accurate serological markers of early and _ sars-cov-2 infection,orf8 and orf3b antibodies are accurate serological markers of early and acute sars-cov-2 infection,https://www.nature.com/articles/s41590-020-0773-7,"[('We have identified ORF8 antibodies as a major marker of acute, convalescent and long-term antibody response to SARS-CoV-2 infection because of its immunodominance and specificity, in addition to N protein.', 0.797012), ('Encouragingly, most patients with SARS-CoV-2 develop robust T and B cellular responses, along with neutralizing and high titer S1-specific antibody responses, which has formed the basis of serological diagnosis and vaccine development7,8,9.', 0.77596843), ('Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections.', 0.7325932), ('We identified new targets of the immune response to SARS-CoV-2 and show that nucleocapsid, open reading frame (ORF)8 and ORF3b elicit the strongest specific antibody responses.', 0.6991838), ('Structure, function, and antigenicity of the SARS-CoV-2 Spike glycoprotein.', 0.68306553)]"
2539,Plasma treatments quickly kill coronavirus on surfaces,surfaces,plasma treatments quickly kill coronavirus on _,plasma treatments quickly kill coronavirus on cells,https://www.sciencedaily.com/releases/2020/11/201110112520.htm,"[('The spray using plasma fed by argon killed all the coronavirus on the six surfaces in less than three minutes, and most of the virus was destroyed after 30 seconds.', 0.57518965), ('The novel coronavirus can remain infectious on surfaces for several hours.', 0.5658573), (""Author Richard E. Wirz said the findings show great potential for the use of plasma in halting the virus's transmission cycle."", 0.5630357), ('A relatively new technology, cold atmospheric plasma is an ionized, near-room-temperature gas that has proven effective in cancer treatments, wound healing, dentistry, and other medical applications.', 0.55740434), ('Zhitong Chen said the authors are building a compact device that could be used widely to treat surfaces for the coronavirus with plasma.', 0.5470731)]"
2540,Systematic analysis of innate immune antagonism reveals vulnerabilities of SARS-CoV-2,innate,systematic analysis of _ immune antagonism reveals vulnerabilities of sars-cov-2,systematic analysis of cellular immune antagonism reveals vulnerabilities of sars-cov-2,https://www.biorxiv.org/content/10.1101/2020.10.15.340612v1,"[('Taken together, our results allow an explanation for differences in susceptibility towards IFNs and provide evidence that rational immune activation may be an effective future therapeutic strategy against SARS-CoV-2.', 0.7104206), ('Overall our analyses revealed that IFN-γ and IFN-λ1 signalling are antagonised the least, leaving SARS-CoV-2 highly susceptible to these two cytokines.', 0.64722884), ('Their combination synergistically potentiated the anti-viral effects against SARS-CoV-2 at low concentrations.', 0.59282815), ('However, SARS-CoV-1 Nsp15 is strikingly more potent in suppressing IFN induction and signalling than its SARS-CoV-2 counterpart.', 0.58079815), ('Here, we systematically analysed the impact of 29 SARS-CoV-2 encoded proteins on three major arms of our cell-intrinsic innate immune defences: interferon (IFN) induction, cytokine signalling and autophagy.', 0.5493117)]"
2541,SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness,mrna,sars-cov-2 _ vaccine design enabled by prototype pathogen preparedness,sars-cov-2 influenza vaccine design enabled by prototype pathogen preparedness,https://www.nature.com/articles/s41586-020-2622-0,"[('An mRNA vaccine against SARS-CoV-2—preliminary report.', 0.86409044), ('As part of our pandemic preparedness efforts, we have studied MERS-CoV as a prototype Betacoronavirus pathogen to optimize vaccine design, dissect the humoral immune response to vaccination, and identify mechanisms and correlates of protection.', 0.7794876), ('To produce SARS-CoV-2 pseudoviruses, a codon-optimized CMV/R-SARS-CoV-2 S (Wuhan-1, GenBank: MN908947.3) plasmid was constructed.', 0.7671087), ('This response demonstrates how new technology-driven concepts such as synthetic vaccinology can facilitate a vaccine development programme initiated on the basis of pathogen sequences alone11.', 0.7503042), ('Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.', 0.7218957)]"
2542,Exploring excess of deaths in the context of covid pandemic in selected countries ofLatin America,context,exploring excess of deaths in the _ of covid pandemic in selected countries oflatin america,exploring excess of deaths in the absence of covid pandemic in selected countries oflatin america,https://osf.io/xhkp4/,"[('METHODS We measured the effects of the pandemic by looking at the excess mortality, and comparing estimates of differences in the average number of deaths, variation coefficients and percentages of deaths between the months of March to May for 2019 and 2020.', 0.61113274), ('OBJECTIVE We aimed to measure the effects of the disease on mortality, using excess mortality, in two Latin America countries that were most affected by the covid-19 pandemic in the region: Brazil, Chile, Ecuador and Peru.', 0.5626875), ('CONCLUSION Despite the lack of information on causes of death, the excess of deaths is a good indicator for measuring the effects of the coronavirus pandemic, especially in the context Latin America countries.', 0.55649245), ('CONTRIBUTION This study provides an initial discussion of the effects of pandemic in small and less urbanized areas of Brazil and Ecuador.', 0.4741062), ('RESULTS Our findings indicated an excess of deaths initially in major cities, but then is spreading towards the least urbanized areas.', 0.44884664)]"
2545,UK government begins publishing the scientific evidence supporting its response to COVID-19,government,uk _ begins publishing the scientific evidence supporting its response to covid-19,uk study begins publishing the scientific evidence supporting its response to covid-19,https://www.gov.uk/government/groups/scientific-advisory-group-for-emergencies-sage-coronavirus-covid-19-response,"[('View the scientific evidence supporting the government response to COVID-19 (Updated 15 January 2021).', 0.83539724), ('European Commission Guidelines on COVID-19 in vitro diagnostic tests and their performance.', 0.6544274), ('The UK needs to expand collection of these data and to continue to review the sensitivity and specificity of the available COVID-19 diagnostic tests.', 0.6518169), ('> > The UK is home to experts who are at the forefront of their chosen fields > and we are making full use of their expertise to grow our understanding of > COVID-19 as we work tirelessly to tackle this disease.', 0.6441235), ('UK Government Government publishes coronavirus (COVID-19) R value and growth rates.', 0.63249755)]"
2547,Research exposes new vulnerability in SARS-CoV-2,vulnerability,research exposes new _ in sars-cov-2,research exposes new drugs in sars-cov-2,https://news.northwestern.edu/stories/2020/08/research-exposes-new-vulnerability-in-sars-cov-2/,"[('“Our results explain experimental studies showing that mutations of the SARS-CoV-2 spike protein affected the virus transmissibility.” The research was published online last week in the journal ACS Nano.', 0.48682255), ('The research, “Enhanced binding of SARS-CoV-2 spike protein to receptor by distal polybasic cleavage sites,” was supported by the U.S. Department of Energy (award number DE-FG02-08ER46539), the Sherman Fairchild Foundation and the Center for Computation and Theory of Soft Materials at Northwestern University.', 0.3940758), ('But previous research indicates that these mysterious sites are essential for virulence and transmission.', 0.288176), ('“However, it appears to be cleaved by an enzyme (furin) that is abundant in lungs, which suggests the cleavage site is crucial for virus entry into human cells.” With this new information, Olvera de la Cruz and Qiao next plan to work with Northwestern chemists and pharmacologists to design a new drug that could bind to the spike protein.', 0.2811717), ('Topics: McCormick School of Engineering, Nanotechnology, Research For Journalists: View the news release for media contacts and assets.', 0.28029257)]"
2549,The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2,human,the ace2 expression in _ heart indicates new potential mechanism of heart injury among patients infected with sars-cov-2,the ace2 expression in canine heart indicates new potential mechanism of heart injury among patients infected with sars-cov-2,https://academic.oup.com/cardiovascres/article/116/6/1097/5813131,"[('And patients with basic heart failure disease showed increased ACE2 expression at both mRNA and protein levels, meaning that if infected by the virus these patients may have higher risk of heart attack and critically ill condition.', 0.7272061), ('Keywords: ACE2; Heart failure; Heart injury; SARS-CoV-2.', 0.7263908), ('This study performed the first state-of-art single cell atlas of adult human heart, and revealed that pericytes with high expression of ACE2 might act as the target cardiac cell of SARS-CoV-2.', 0.7203271), ('Angiotensin-converting enzyme 2 (ACE2), the key host cellular receptor of SARS-CoV-2, has been identified in multiple organs, but its cellular distribution in human heart is not illuminated clearly.', 0.70057607), ('Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.', 0.64539057)]"
2550,"Angiotensin-converting enzyme 2 , a SARS-CoV-2 receptor , is upregulated by interleukin-6 via STAT3 signaling in rheumatoid synovium",receptor,"angiotensin-converting enzyme 2 , a sars-cov-2 _ , is upregulated by interleukin-6 via stat3 signaling in rheumatoid synovium","angiotensin-converting enzyme 2, a sars-cov-2 enzyme, is upregulated by interleukin-6 via stat3 signaling in rheumatoid synovium",https://www.biorxiv.org/content/10.1101/2020.05.26.115261v1,"[('Our presenting data revealed that ACE2 expression was elevated in active rheumatoid synovium, and siRNA against STAT3 was able to downregulate ACE2 expression, which was in turn induced by IL-6 signaling.', 0.70977414), ('Although the prevalence of rheumatoid arthritis (RA) is about 1 % of the global population and RA patients naturally have a chance of acquiring COVID-19 in this pandemic, no studies have considered the expression of angiotensin-converting enzyme 2 (ACE2) (a receptor for SARS-CoV-2) in synovial tissues.', 0.41319048), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus [COVID-19]: coronavirus [v]: View this template [t]: Discuss this template [e]: Edit this template []: required [c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 10:30 AM [Today]: Sunday, January 17, 2021 at 6:45 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:30 AM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students [January 14]: Thursday, January 14, 2021 at 10:09 AM [January 10]: Sunday, January 10, 2021 at 9:29 AM [January 5]: Tuesday, January 5, 2021 at 6:05 AM [on April 4, 2020]: Saturday, April 4, 2020 11:38 PM [Tel:]: Phone number [May 30, 2019 at 9:42 PM]: Thursday, May 30, 2019 at 9:42 PM [March 14, 2019 at 3:03 PM]: Thursday, March 14, 2019 at 3:03 PM [November 12, 2018 at 10:57 PM]: Monday, November 12, 2018 at 10:57 PM [December 25, 2020 at 12:09 PM]: Friday, December 25, 2020 at 12:09 PM [November 24, 2020]: Tuesday, November 24, 2020 at 9:28 AM [ November 5, 2020]: Thursday, November 5, 2020 at 5:36 PM [ November 1, 2020]: Sunday, November 1, 2020 at 1:52 PM [October 26, 2020]: Monday, October 26, 2020 at 6:36 PM [ October 15, 2020]: Thursday, October 15, 2020 at 12:38 PM [ October 7, 2020]: Wednesday, October 7, 2020 at 5:08 PM [August 9, 2020]: Sunday, August 9, 2020 at 8:53 PM [August 7, 2020]: Friday, August 7, 2020 at 6:19 AM [July 4, 2020]: Saturday, July 4, 2020 at 2:55 PM [ July 2, 2020]: Thursday, July 2, 2020 at 8:45 AM [June 30, 2020]: Tuesday, June 30, 2020 at 9:36 AM [June 27, 2020]: Saturday, June 27, 2020 at 7:51 PM [June 18, 2020]: Thursday, June 18, 2020 at 4:20 PM [June 16, 2020]: Tuesday, June 16, 2020 at 7:15 PM [June 14, 2020]: Sunday, June 14, 2020 at 11:40 AM [June 10, 2020]: Wednesday, June 10, 2020 at 7:53 PM [MA]: Massachusetts [Tue]: Tuesday [Jun]: June [m ]: minutes [s]: seconds [m]: minutes [Mon]: Monday [Jan]: January [h]: hour [ICU]: intensive care unit [PHE]: Public Health England [GP]: general practitioner [fr]: Français [COVID]: coronavirus [SAGE]: Scientific Advisory Group for Emergencies [NERVTAG]: New and Emerging Respiratory Virus Threats Advisory Group [SPI-M]: Scientific Pandemic Influenza Group on Modelling [SPI-B]: Independent Scientific Pandemic Influenza Group on Behaviours', 0.3859342), ('Synovial tissues were collected from 16 rheumatoid arthritis (RA) patients that fulfilled the classification criteria of the 1987 American College of Rheumatology (Arthritis and Rheum.', 0.358692), ('The disease is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), and its symptoms usually include cough, fever, and gastrointestinal problems.', 0.3406502)]"
2551,State Lab Finds 90 Positive COVID-19 Test Results Were False,false,state lab finds 90 positive covid-19 test results were _,state lab finds 90 positive covid-19 test results were+.,https://www.msn.com/en-us/Health/medical/state-lab-finds-90-positive-covid-19-test-results-were-false/ar-BB16Yche?ocid=sf,"[('The department said the state public health laboratory uncovered a flaw in one of the testing systems it uses to test for SARS-CoV-2, the virus that causes COVID-19, and 90 of 144 people tested between June 15 and July 17 received a false positive COVID test report.', 0.6510589), ('The lab used another FDA-authorized test and found the false positives.', 0.5162891), ('Of those, a total of 91 specimens from 90 people showed false positive results.', 0.4949571), ('Any nursing home resident who received a false positive COVID-19 test result will be retested as soon as possible, according to the Department of Health.', 0.44147825), ('“Accurate and timely testing for the novel coronavirus is one of the pillars supporting effective response to the COVID-19 pandemic.” She said adjustments have already been made “to ensure the accuracy of future test results from this platform.” They said all positive results will be further analyzed by multiple laboratory scientists, and if indicated, retested using another method.', 0.38679677)]"
2552,Errors in Statistical Numbers and Data in Study of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From COVID-19,recovered,errors in statistical numbers and data in study of cardiovascular magnetic resonance imaging in patients recently _ from covid-19,errors in statistical numbers and data in study of cardiovascular magnetic resonance imaging in patients recently died from covid-19,https://jamanetwork.com/journals/jamacardiology/fullarticle/2770026,"[('Coronavirus Disease 2019 (COVID-19) Precautions: What the MRI Suite Should Know.', 0.5810821), ('Errors in Statistical Numbers and Data.', 0.49797705), ('Neurologic Involvement of Patients with Coronavirus Disease 2019: Making the Most of MRI.', 0.49068174), ('Errors in Tracing Coronavirus SARS-CoV-2 Transmission Using a Maximum Likelihood Tree.', 0.47947472), (""Authors' Reply to: Errors in Tracing Coronavirus SARS-CoV-2 Transmission Using a Maximum Likelihood Tree."", 0.47447586)]"
2553,Chemists discover the structure of a key coronavirus protein,chemist,_ discover the structure of a key coronavirus protein,Researchs discover the structure of a key coronavirus protein,https://news.mit.edu/2020/chemists-discover-structure-key-coronavirus-protein-1112,"[('To determine its structure, the researchers embedded it into a lipid bilayer, similar to a cell membrane, and then analyzed it with NMR, which uses the magnetic properties of atomic nuclei to reveal the structures of the molecules containing those nuclei.', 0.6533616), ('Using nuclear magnetic resonance (NMR) spectroscopy, she has previously developed several techniques that allow her to obtain accurate atomic-level structural information about these membrane- embedded proteins.', 0.598648), ('""Our findings could be useful for medicinal chemists to design alternative small molecules that target this channel with high affinity,"" says Hong, who is the senior author of the new study.', 0.5832083), ('If researchers could devise ways to block this channel, they may be able to reduce the pathogenicity of the virus and interfere with viral replication, says Mei Hong, an MIT professor of chemistry.', 0.5570834), ('Other authors include MIT postdoc Matthew McKay, MIT graduate students Alexander Shcherbakov and Aurelio Dregni, and Antonios Kolocouris, a professor of pharmaceutical chemistry at the University of Athens.', 0.5507896)]"
2555,Check out this Podomatic episode !,episode,check out this podomatic _ !,check out this podomatic probability!,https://www.podomatic.com/podcasts/chuck-morse-speaks/episodes/2020-09-18T12_29_30-07_00,"[('Join Podomatic now!', 0.6857728), (""It's easy-to-use, available directly on Podomatic, and will get your first episode recorded and published in just minutes."", 0.48891336), ('These apps were designed to pull together full integration between your Podomatic podcast and your Weebly site.', 0.48182875), ('PLAY your episode on PodOmatic in the player window and CLICK the Facebook link in ""Link (copy to Facebook or IM):"" 2\\.', 0.47367507), (""Unfollow by Ben Montgomery by Ben Montgomery x take it with you go mobile with Podomatic's new iPhone app."", 0.43590963)]"
2557,Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers,carriers,efficient high-throughput sars-cov-2 testing to detect asymptomatic _,efficient high-throughput sars-cov-2 testing to detect asymptomatic infection,https://advances.sciencemag.org/content/6/37/eabc5961?utm_campaign=toc_advances_2020-09-11&et_rid=17054678&et_cid=3478754,"[('Since both asymptomatic and presymptomatic subjects can spread the disease ( 1, 2), identifying these individuals is critical for effective control of the SARS-CoV-2 pandemic.', 0.80027264), ('P-BEST may then be used for conducting efficient routine screens of, e.g., health care workers and staff in nursing homes, as well as general population screens to identify new hotspots of the SARS-CoV-2.', 0.67647177), ('In summary, here, we presented a novel method for efficient SARS-CoV-2 diagnostic testing that can provide significant increases in both testing efficiency and testing resources and can be readily implemented in clinical diagnostic laboratories.', 0.6723507), ('S. Smola , Pooling of samples for testing for SARS-CoV-2 in asymptomatic people.', 0.6226469), ('Y. Drier , Pooled RNA extraction and PCR assay for efficient SARS-CoV-2 detection.', 0.58870125)]"
2558,Giuliani-promoted COVID-19 therapy from Celularity nabs FDA speedy trial start,promoted,giuliani-_ covid-19 therapy from celularity nabs fda speedy trial start,giuliani-free covid-19 therapy from celularity nabs fda speedy trial start,https://www.fiercebiotech.com/biotech/rudy-giuliani-backed-covid-19-therapy-from-celularity-nabs-fda-speedy-trial-start,"[('We are hopeful to contribute to flattening the COVID-19 curve, expanding on the promising early results we’ve seen in our clinical studies in devastating cancers to patients with coronavirus.” This also comes after the FDA said this week it was looking to hit the gas pedal on new treatments for COVID-19.', 0.70481074), ('The Celgene spinoff sees CYNK-001 as the first immunotherapy IND cleared by the FDA to treat COVID-19-infected adults.', 0.68246794), ('“This IND represents a significant step toward a potential treatment of patients infected with COVID-19 virus, which is spreading globally at unanticipated rates,” said Robert Hariri, M.D., Ph.D., founder, chairman and CEO at Celularity.', 0.67308104), ('“With our initial clinical study, we will gain an understanding of the impact CYNK-001 can have on patients recently diagnosed with COVID-19.', 0.66834885), ('“Trials need to be EXPEDITED.” It seems he got his wish: Today, New Jersey-based Celularity said it has been given the all-clear from the FDA to start its clinical trial of CYNK-001, its allogeneic, off-the-shelf, cryopreserved natural killer cell therapy to be used in a phase 1/2 study in up to 86 patients with COVID-19.', 0.65831304)]"
2559,Prospective mapping of viral mutations that escape antibodies used to treat COVID-19,prospective,_ mapping of viral mutations that escape antibodies used to treat covid-19,Sequence mapping of viral mutations that escape antibodies used to treat covid-19,https://www.biorxiv.org/content/10.1101/2020.11.30.405472v1,"[('Finally, the maps reveal that mutations escaping each individual antibody are already present in circulating SARS-CoV-2 strains.', 0.63554657), ('The maps also identify viral mutations that are selected in a persistently infected patient treated with REGN-COV2, as well as in lab viral escape selections.', 0.610971), ('These complete maps uncover a single amino-acid mutation that fully escapes the REGN-COV2 cocktail, which consists of two antibodies targeting distinct structural epitopes.', 0.58797455), ('Here we map how all mutations to SARS-CoV-2’s receptor-binding domain (RBD) affect binding by the antibodies in Regeneron’s REGN-COV2 cocktail and Eli Lilly’s LY-CoV016.', 0.5867936), ('Overall, these complete escape maps enable immediate interpretation of the consequences of mutations observed during viral surveillance.', 0.48088217)]"
2563,Doctors say CDC should warn people the side effects from Covid vaccine shots wont be a walk in the park,won,doctors say cdc should warn people the side effects from covid vaccine shots _ be a walk in the park,doctors say cdc should warn people the side effects from covid vaccine shots tot be a walk in the park,https://www.cnbc.com/2020/11/23/covid-vaccine-cdc-should-warn-people-the-side-effects-from-shots-wont-be-walk-in-the-park-.html,"[('""We really need to make patients aware that this is not going to be a walk in the park,"" Fryhofer said during a virtual meeting with the Advisory Committee on Immunization Practices, or ACIP, an outside group of medical experts that advise the CDC.', 0.5947311), (""RELATED:AstraZeneca COVID-19 vaccine: Officials say it's less expensive, easier to store, and effective Plus, it's a group that would be easier to reach if the staff caring for them are already being immunized in the first phase of any vaccine that might get emergency authorization from the FDA."", 0.58412737), ('""But early on as we\'re building confidence and we will not be able to show any data to say that it was not due to the vaccine because there\'s not been a randomized, controlled trial.', 0.573634), ('But ACIP member Dr. Helen Keipp Talbot worried that this frail group might do poorly in general and damage faith in the vaccine.', 0.56868416), (""VIDEO2:5102:51 What we do and don't know about the highly effective Covid-19 vaccines Biotech and Pharmaceuticals Patsy Stinchfield, a Children's Minnesota nurse practitioner, said officials and drugmakers could try talking about the side effects in a more positive way."", 0.5492097)]"
2564,Association between regional selenium status and reported outcome of COVID-19 cases in China,association,_ between regional selenium status and reported outcome of covid-19 cases in china,Differences between regional selenium status and reported outcome of covid-19 cases in china,https://academic.oup.com/ajcn/advance-article/doi/10.1093/ajcn/nqaa095/5826147?,"[('Identification and management of asymptomatic carriers of coronavirus disease 2019 (COVID-19) in China.', 0.66400635), (""Urologists and the Novel Coronavirus Disease 2019 (COVID-19): a Urologist's Perspective from China."", 0.6192528), ('Vitamin and mineral supplementation for β-thalassemia during COVID-19 pandemic.', 0.5701681), ('Using nano-selenium to combat Coronavirus Disease 2019 (COVID-19)?', 0.52203697), ('A hundred days into the coronavirus disease (COVID-19) pandemic.', 0.5107774)]"
2565,Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1,less,_ severe course of covid-19 is associated with elevated levels of antibodies against seasonal human coronaviruses oc43 and hku1,This severe course of covid-19 is associated with elevated levels of antibodies against seasonal human coronaviruses oc43 and hku1,https://www.medrxiv.org/content/10.1101/2020.10.12.20211599v1,"[('Patients with critical disease had significantly lower levels of HCoV OC43- (p=0.016) and HCoV HKU1-specific (p=0.023) antibodies at the first encounter compared to other COVID-19 patients.', 0.7521326), ('We performed an observational study to assess the impact of previous infections with seasonal coronaviruses on COVID-19 severity.', 0.5327643), ('Our results indicate that previous infections with seasonal coronaviruses might protect against a severe course of disease.', 0.5085186), ('Recently, an association between contact to small children and mild course of COVID-19 was reported.', 0.4904487), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus [COVID-19]: coronavirus [v]: View this template [t]: Discuss this template [e]: Edit this template []: required [c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 10:30 AM [Today]: Sunday, January 17, 2021 at 6:45 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:30 AM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students [January 14]: Thursday, January 14, 2021 at 10:09 AM [January 10]: Sunday, January 10, 2021 at 9:29 AM [January 5]: Tuesday, January 5, 2021 at 6:05 AM [on April 4, 2020]: Saturday, April 4, 2020 11:38 PM [Tel:]: Phone number [May 30, 2019 at 9:42 PM]: Thursday, May 30, 2019 at 9:42 PM [March 14, 2019 at 3:03 PM]: Thursday, March 14, 2019 at 3:03 PM [November 12, 2018 at 10:57 PM]: Monday, November 12, 2018 at 10:57 PM [December 25, 2020 at 12:09 PM]: Friday, December 25, 2020 at 12:09 PM [November 24, 2020]: Tuesday, November 24, 2020 at 9:28 AM [ November 5, 2020]: Thursday, November 5, 2020 at 5:36 PM [ November 1, 2020]: Sunday, November 1, 2020 at 1:52 PM [October 26, 2020]: Monday, October 26, 2020 at 6:36 PM [ October 15, 2020]: Thursday, October 15, 2020 at 12:38 PM [ October 7, 2020]: Wednesday, October 7, 2020 at 5:08 PM [August 9, 2020]: Sunday, August 9, 2020 at 8:53 PM [August 7, 2020]: Friday, August 7, 2020 at 6:19 AM [July 4, 2020]: Saturday, July 4, 2020 at 2:55 PM [ July 2, 2020]: Thursday, July 2, 2020 at 8:45 AM [June 30, 2020]: Tuesday, June 30, 2020 at 9:36 AM [June 27, 2020]: Saturday, June 27, 2020 at 7:51 PM [June 18, 2020]: Thursday, June 18, 2020 at 4:20 PM [June 16, 2020]: Tuesday, June 16, 2020 at 7:15 PM [June 14, 2020]: Sunday, June 14, 2020 at 11:40 AM [June 10, 2020]: Wednesday, June 10, 2020 at 7:53 PM [MA]: Massachusetts [Tue]: Tuesday [Jun]: June [m ]: minutes [s]: seconds [m]: minutes [Mon]: Monday [Jan]: January [h]: hour [ICU]: intensive care unit [PHE]: Public Health England [GP]: general practitioner [fr]: Français [COVID]: coronavirus [SAGE]: Scientific Advisory Group for Emergencies [NERVTAG]: New and Emerging Respiratory Virus Threats Advisory Group [SPI-M]: Scientific Pandemic Influenza Group on Modelling [SPI-B]: Independent Scientific Pandemic Influenza Group on Behaviours', 0.43231922)]"
2568,The Virus that Strives for World Rulership,world,the virus that strives for _ rulership,the virus that strives for human rulership,https://nootropic.press/the-virus-that-strives-for-world-rulership/,"[('Today, the problem of treating influenza and other viral diseases is extremely urgent because they make up an impressive share of all infectious diseases.', 0.51759624), ('In the context of the spreading virus, it is important to remember about prevention as much as about the treatment itself.', 0.46517074), ('The risk of infection is very high.', 0.43738163), ('It is obvious that in the fight against the novel virus we need to act fast.', 0.41818437), ('In this regard, in order to save the lives of patients who are diagnosed with coronavirus, doctors may prescribe all drugs that have at least a potential chance to affect the virus - including Umifenovir (Arbidol®).', 0.40160036)]"
2569,Moderna Advances Late-Stage Development of its Vaccine Against COVID-19,development,moderna advances late-stage _ of its vaccine against covid-19,moderna advances late-stage delivery of its vaccine against covid-19,https://investors.modernatx.com/news-releases/news-release-details/moderna-advances-late-stage-development-its-vaccine-mrna-1273/,"[('11, 2020-- Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against COVID-19.', 0.7258501), ('Since COVID-19 vaccines will likely be needed for many years, the United States should also begin construction of new manufacturing facilities.', 0.7198843), ('Rapid manufacturing and distribution of a COVID-19 vaccine will rank as one of the most challenging government initiatives ever undertaken.', 0.71976155), ('The trial’s primary endpoint will be the prevention of symptomatic COVID-19 disease; key secondary endpoints include prevention of severe COVID-19 disease (as defined by the need for hospitalization) and prevention of infection by SARS-CoV-2, the virus that causes COVID-19.', 0.6906126), ('The Phase 1 clinical trial is set to begin no later than fall of 2020 with the goal of making COVID-19 vaccine available for emergency use in the United States in early 2021.', 0.68428254)]"
2570,ACE2 levels are altered in comorbidities linked to severe outcome in COVID-19,ace,_ levels are altered in comorbidities linked to severe outcome in covid-19,TLR2 levels are altered in comorbidities linked to severe outcome in covid-19,https://www.medrxiv.org/content/10.1101/2020.06.04.20122044v1,"[('Conclusion ACE2 levels are upregulated in some patient groups with comorbidities linked to COVID-19 and as such may have an emerging role as outcome in COVID-19.', 0.8034549), ('severe outcome in COVID-19 have altered serum levels of ACE2 that may influence productive ', 0.78006136), ('a circulating biomarker for severity of severity of outcome in COVID-19.', 0.711455), ('We examined if serum levels of ACE2, the cellular entry point for the coronavirus SARS-CoV-2, were altered in these high-risk groups.', 0.558918), ('Question Severity of outcome in COVID-19 is disproportionately higher among the obese, males, smokers, those suffering from hypertension, kidney disease, coronary heart disease (CHD) and/or type 2 diabetes (T2D).', 0.5470275)]"
2572,Emergence of zoonoses such as COVID-19 reveals the need for health sciences to embrace an explicit eco-social conceptual framework of health and disease,disease,emergence of zoonoses such as covid-19 reveals the need for health sciences to embrace an explicit eco-social conceptual framework of health and _,emergence of zoonoses such as covid-19 reveals the need for health sciences to embrace an explicit eco-social conceptual framework of health and security,https://www.sciencedirect.com/science/article/pii/S1755436520300347,"[('Based on the fact that the eco-social framework provides a more complete account of the different types of causal factors underpinning the emergence of zoonoses, I propose that the COVID-19 pandemic provides an additional reason for the health sciences to ground its theory of health and disease in an eco-social conceptual framework.', 0.8523264), ('Others argue that a range of anthropogenic environmental degradations have played a vital role in the emergence of SARS- CoV-2 and other zoonoses.', 0.48835957), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus [COVID-19]: coronavirus [v]: View this template [t]: Discuss this template [e]: Edit this template []: required [c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 10:30 AM [Today]: Sunday, January 17, 2021 at 6:45 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:30 AM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students [January 14]: Thursday, January 14, 2021 at 10:09 AM [January 10]: Sunday, January 10, 2021 at 9:29 AM [January 5]: Tuesday, January 5, 2021 at 6:05 AM [on April 4, 2020]: Saturday, April 4, 2020 11:38 PM [Tel:]: Phone number [May 30, 2019 at 9:42 PM]: Thursday, May 30, 2019 at 9:42 PM [March 14, 2019 at 3:03 PM]: Thursday, March 14, 2019 at 3:03 PM [November 12, 2018 at 10:57 PM]: Monday, November 12, 2018 at 10:57 PM [December 25, 2020 at 12:09 PM]: Friday, December 25, 2020 at 12:09 PM [November 24, 2020]: Tuesday, November 24, 2020 at 9:28 AM [ November 5, 2020]: Thursday, November 5, 2020 at 5:36 PM [ November 1, 2020]: Sunday, November 1, 2020 at 1:52 PM [October 26, 2020]: Monday, October 26, 2020 at 6:36 PM [ October 15, 2020]: Thursday, October 15, 2020 at 12:38 PM [ October 7, 2020]: Wednesday, October 7, 2020 at 5:08 PM [August 9, 2020]: Sunday, August 9, 2020 at 8:53 PM [August 7, 2020]: Friday, August 7, 2020 at 6:19 AM [July 4, 2020]: Saturday, July 4, 2020 at 2:55 PM [ July 2, 2020]: Thursday, July 2, 2020 at 8:45 AM [June 30, 2020]: Tuesday, June 30, 2020 at 9:36 AM [June 27, 2020]: Saturday, June 27, 2020 at 7:51 PM [June 18, 2020]: Thursday, June 18, 2020 at 4:20 PM [June 16, 2020]: Tuesday, June 16, 2020 at 7:15 PM [June 14, 2020]: Sunday, June 14, 2020 at 11:40 AM [June 10, 2020]: Wednesday, June 10, 2020 at 7:53 PM [MA]: Massachusetts [Tue]: Tuesday [Jun]: June [m ]: minutes [s]: seconds [m]: minutes [Mon]: Monday [Jan]: January [h]: hour [ICU]: intensive care unit [PHE]: Public Health England [GP]: general practitioner [fr]: Français [COVID]: coronavirus [SAGE]: Scientific Advisory Group for Emergencies [NERVTAG]: New and Emerging Respiratory Virus Threats Advisory Group [SPI-M]: Scientific Pandemic Influenza Group on Modelling [SPI-B]: Independent Scientific Pandemic Influenza Group on Behaviours', 0.47872698), ('In this opinion piece, I argue that these divergent viewpoints stem, in part, from different foundational conceptual frameworks – biomedical individualist and eco-social frameworks, respectively.', 0.32253277), ('Certain authors have argued that the consumption of wildlife, or human contact with bats was responsible for the emergence of SARS-CoV-2.', 0.30108234)]"
2573,Slovakia to test all adults for SARS-CoV-2,slovakia,_ to test all adults for sars-cov-2,He to test all adults for sars-cov-2,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32261-3/fulltext?fbclid=IwAR0Tk_BvdLZTjFkcrAii0wBsd5s8d6g-KtyKSnLhHY1Tem5r5EK2IyPhU2M,"[('Slovakia has begun a massive operation to test its entire adult population for SARS-CoV-2 in a bid to halt what its government has said is an alarming acceleration of the spread of the virus in the country.', 0.6268005), (""Slovakia's first identified SARS- CoV-2 infection was in early March, and between then and September, it had recorded relatively few infections, with new daily cases rarely rising beyond 100."", 0.54646957), (""Prominent supporters of mass testing in other countries have welcomed Slovakia's plans, telling international media that the country could provide an important case study for the rest of the world."", 0.47268304), ('Julian Peto, professor of epidemiology at the London School of Hygiene & Tropical Medicine, London, UK, who has been campaigning for the UK Government to adopt regular mass testing, told The Lancet that the testing in Slovakia “sounds like a great idea, and I am delighted someone has decided to try it, but this seems like a very bad way of doing it.', 0.44558513), ('Slovak Government and state health-care officials declined to comment on the testing programme when contacted by The Lancet.', 0.44251463)]"
2574,Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production,replication,atazanavir inhibits sars-cov-2 _ and pro-inflammatory cytokine production,atazanavir inhibits sars-cov-2 release and pro-inflammatory cytokine production,https://www.biorxiv.org/content/10.1101/2020.04.04.020925v1,"[('We confirmed that ATV inhibits SARS-CoV-2 replication, alone or in combination with ritonavir (RTV) in Vero cells, human pulmonary epithelial cell line and primary monocytes, impairing virus-induced enhancement of IL-6 and TNF-α levels.', 0.5462208), ('The major protease (Mpro) of SARS-CoV-2 is considered a promising target, based on previous results from related CoVs with lopinavir (LPV), an HIV protease inhibitor.', 0.50942), ('However, limited evidence exists for other clinically approved antiretroviral protease inhibitors, such as atazanavir (ATV).', 0.37684885), ('Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.', 0.33198744), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus [COVID-19]: coronavirus [v]: View this template [t]: Discuss this template [e]: Edit this template []: required [c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 10:30 AM [Today]: Sunday, January 17, 2021 at 6:45 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:30 AM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students [January 14]: Thursday, January 14, 2021 at 10:09 AM [January 10]: Sunday, January 10, 2021 at 9:29 AM [January 5]: Tuesday, January 5, 2021 at 6:05 AM [on April 4, 2020]: Saturday, April 4, 2020 11:38 PM [Tel:]: Phone number [May 30, 2019 at 9:42 PM]: Thursday, May 30, 2019 at 9:42 PM [March 14, 2019 at 3:03 PM]: Thursday, March 14, 2019 at 3:03 PM [November 12, 2018 at 10:57 PM]: Monday, November 12, 2018 at 10:57 PM [December 25, 2020 at 12:09 PM]: Friday, December 25, 2020 at 12:09 PM [November 24, 2020]: Tuesday, November 24, 2020 at 9:28 AM [ November 5, 2020]: Thursday, November 5, 2020 at 5:36 PM [ November 1, 2020]: Sunday, November 1, 2020 at 1:52 PM [October 26, 2020]: Monday, October 26, 2020 at 6:36 PM [ October 15, 2020]: Thursday, October 15, 2020 at 12:38 PM [ October 7, 2020]: Wednesday, October 7, 2020 at 5:08 PM [August 9, 2020]: Sunday, August 9, 2020 at 8:53 PM [August 7, 2020]: Friday, August 7, 2020 at 6:19 AM [July 4, 2020]: Saturday, July 4, 2020 at 2:55 PM [ July 2, 2020]: Thursday, July 2, 2020 at 8:45 AM [June 30, 2020]: Tuesday, June 30, 2020 at 9:36 AM [June 27, 2020]: Saturday, June 27, 2020 at 7:51 PM [June 18, 2020]: Thursday, June 18, 2020 at 4:20 PM [June 16, 2020]: Tuesday, June 16, 2020 at 7:15 PM [June 14, 2020]: Sunday, June 14, 2020 at 11:40 AM [June 10, 2020]: Wednesday, June 10, 2020 at 7:53 PM [MA]: Massachusetts [Tue]: Tuesday [Jun]: June [m ]: minutes [s]: seconds [m]: minutes [Mon]: Monday [Jan]: January [h]: hour [ICU]: intensive care unit [PHE]: Public Health England [GP]: general practitioner [fr]: Français [COVID]: coronavirus [SAGE]: Scientific Advisory Group for Emergencies [NERVTAG]: New and Emerging Respiratory Virus Threats Advisory Group [SPI-M]: Scientific Pandemic Influenza Group on Modelling [SPI-B]: Independent Scientific Pandemic Influenza Group on Behaviours', 0.31463832)]"
2575,We developed AI to predict which antivirals we might be able to repurpose against covid-19 and got great preliminary results .,might,we developed ai to predict which antivirals we _ be able to repurpose against covid-19 and got great preliminary results .,we developed ai to predict which antivirals we cannot be able to repurpose against covid-19 and got great preliminary results.,https://medium.com/zetane-blog/machine-learning-driven-drug-repurposing-for-sars-cov-2-eedc0a83c38,"[('Read full article here About Zetane Systems developed AI models to predict which antivirals might be able to treat COVID-19.', 0.8464831), ('This Review provides a strong rationale for using AI-based assistive tools for drug repurposing medications for human disease, including during the COVID-19 pandemic.', 0.8166387), ('As a company specialising in AI, we present here our attempts to develop AI models that can guide efforts to re-purpose current antiviral drugs as therapeutics against COVID-19.', 0.79434776), ('As a company specializing in AI, we present here our attempts to develop AI models that can guide efforts to repurpose current antiviral drugs as therapeutics against COVID-19.', 0.7941687), ('From that perspective, our AI models suggest that the broad spectrum antiviral brincidofovir, for instance, may be a top candidate for COVID-19 clinical trials in the near future.', 0.79022896)]"
2576,"Astra Likely to Run Additional Global Vaccine Test , CEO Says",ceo,"astra likely to run additional global vaccine test , _ says","astra likely to run additional global vaccine test, 2 says",https://www.bloomberg.com/news/articles/2020-11-26/astra-likely-to-run-fresh-global-covid-vaccine-trial-ceo-says,"[(""AstraZeneca is likely to conduct an additional global trial to assess the efficacy of its Covid-19 vaccine, according to the company's chief executive officer, after current studies raised questions over its level of protection."", 0.61343807), (""(Score:1) by rslivergun ( 7271814 ) writes: Let's hold up the vaccines that are further along in development so the other vaccine makers can catch up!"", 0.5900701), ('The Pfizer/BioNTech vaccines is also a global effort being produced in Pfizer facilities across the world.', 0.567176), (""It's funny when you think of it because more recent vaccines like HPV were only approved a few years ago but were in development and testing far longer."", 0.5113086), ('The US is now in a huge dilemma, over 1000 dying everyday, desperate for vaccine.', 0.50294065)]"
2579,"In Cell Studies , Seaweed Extract Outperforms Remdesivir in Blocking COVID-19 Virus",cell,"in _ studies , seaweed extract outperforms remdesivir in blocking covid-19 virus","in vitro studies, seaweed extract outperforms remdesivir in blocking covid-19 virus",https://news.rpi.edu/content/2020/07/23/cell-studies-seaweed-extract-outperforms-remdesivir-blocking-covid-19-virus,"[('Heparin, a common blood thinner, and a heparin variant stripped of its anticoagulant properties, performed on par with remdesivir in inhibiting SARS-CoV-2 infection in mammalian cells.', 0.5561026), ('The Dordick Research Group Center for Biotechnology and Interdisciplinary Studies Rensselaer Polytechnic Institute 110 8th Street Troy, NY 12180-3590 Toggle Navigation Home People Research Publications Patents News Group Resources Photo Gallery Contact ', 0.37080798), (']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus [COVID-19]: coronavirus [v]: View this template [t]: Discuss this template [e]: Edit this template []: required [c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 10:30 AM [Today]: Sunday, January 17, 2021 at 6:45 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:30 AM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students [January 14]: Thursday, January 14, 2021 at 10:09 AM [January 10]: Sunday, January 10, 2021 at 9:29 AM [January 5]: Tuesday, January 5, 2021 at 6:05 AM [on April 4, 2020]: Saturday, April 4, 2020 11:38 PM [Tel:]: Phone number [May 30, 2019 at 9:42 PM]: Thursday, May 30, 2019 at 9:42 PM [March 14, 2019 at 3:03 PM]: Thursday, March 14, 2019 at 3:03 PM [November 12, 2018 at 10:57 PM]: Monday, November 12, 2018 at 10:57 PM [December 25, 2020 at 12:09 PM]: Friday, December 25, 2020 at 12:09 PM [November 24, 2020]: Tuesday, November 24, 2020 at 9:28 AM [ November 5, 2020]: Thursday, November 5, 2020 at 5:36 PM [ November 1, 2020]: Sunday, November 1, 2020 at 1:52 PM [October 26, 2020]: Monday, October 26, 2020 at 6:36 PM [ October 15, 2020]: Thursday, October 15, 2020 at 12:38 PM [ October 7, 2020]: Wednesday, October 7, 2020 at 5:08 PM [August 9, 2020]: Sunday, August 9, 2020 at 8:53 PM [August 7, 2020]: Friday, August 7, 2020 at 6:19 AM [July 4, 2020]: Saturday, July 4, 2020 at 2:55 PM [ July 2, 2020]: Thursday, July 2, 2020 at 8:45 AM [June 30, 2020]: Tuesday, June 30, 2020 at 9:36 AM [June 27, 2020]: Saturday, June 27, 2020 at 7:51 PM [June 18, 2020]: Thursday, June 18, 2020 at 4:20 PM [June 16, 2020]: Tuesday, June 16, 2020 at 7:15 PM [June 14, 2020]: Sunday, June 14, 2020 at 11:40 AM [June 10, 2020]: Wednesday, June 10, 2020 at 7:53 PM [MA]: Massachusetts [Tue]: Tuesday [Jun]: June [m ]: minutes [s]: seconds [m]: minutes [Mon]: Monday [Jan]: January [h]: hour [ICU]: intensive care unit [PHE]: Public Health England [GP]: general practitioner [fr]: Français [COVID]: coronavirus [SAGE]: Scientific Advisory Group for Emergencies [NERVTAG]: New and Emerging Respiratory Virus Threats Advisory Group [SPI-M]: Scientific Pandemic Influenza Group on Modelling [SPI-B]: Independent Scientific Pandemic Influenza Group on Behaviours', 0.3140176), ('Read more.. Back to Top (C) 2021 The Dordick Research Group [DOI]: Digital Object Identifier [ISSN]: International Standard Serial Number [.', 0.23015754)]"
2581,SARS-CoV-2-specific peripheral T follicular helper cells correlate with neutralizing antibodies and increase during convalescence .,increase,sars-cov-2-specific peripheral t follicular helper cells correlate with neutralizing antibodies and _ during convalescence .,sars-cov-2-specific peripheral t follicular helper cells correlate with neutralizing antibodies and mortality during convalescence.,https://www.medrxiv.org/content/10.1101/2020.10.07.20208488v1,"[('Keywords: SARS-CoV-2, COVID-19, peripheral T follicular helper cell, antigen-specific T-cell responses, neutralizing antibodies, convalescence ', 0.8252138), ('Sustained Cellular Immune Dysregulation in Individuals Recovering from SARS- CoV-2 Infection.', 0.75022936), ('But, we also show that pTfh responses against other SARS-CoV-2 proteins correlate with antibody neutralization, indicating a possible role for intrastructural help.', 0.7322949), ('These responses suggest that SARS-CoV-2-specific pTfh continue to increase over time during convalescence.', 0.72940063), ('We also find that pTfh responses to SARS-CoV-2 increase over time.', 0.7201112)]"
2582,Circulating Mitochondrial DNA is an Early Indicator of Severe Illness and Mortality from COVID-19,dna,circulating mitochondrial _ is an early indicator of severe illness and mortality from covid-19,circulating mitochondrial inflammation is an early indicator of severe illness and mortality from covid-19,https://www.biorxiv.org/content/10.1101/2020.07.30.227553v1,"[('These results show that high circulating MT-DNA levels is a potential indicator for poor COVID-19 outcomes.', 0.6145927), ('Whether the appearance of cell-free MT-DNA is linked to poor COVID-19 outcomes remains undetermined.', 0.52135247), ('Additionally, we found that circulating MT-DNA has a similar or superior area-under-the curve when compared to clinically established measures of systemic inflammation, as well as emerging markers currently of interest as investigational targets for COVID-19 therapy.', 0.43009594), ('Here, we quantified circulating MT-DNA in prospectively collected, cell-free plasma samples from 97 subjects with COVID-19 at the time of hospital presentation.', 0.36133075), ('Multivariate regression analysis revealed that high circulating MT-DNA levels is an independent risk factor for all of these outcomes after adjusting for age, sex and comorbidities.', 0.3414399)]"
2587,"Long-term COVID-19 containment will be shaped by strength and duration of natural , vaccine-induced immunity",containment,"long-term covid-19 _ will be shaped by strength and duration of natural , vaccine-induced immunity","long-term covid-19 transmission will be shaped by strength and duration of natural, vaccine-induced immunity",https://www.princeton.edu/news/2020/09/21/long-term-covid-19-containment-will-be-shaped-strength-and-duration-natural-vaccine,"[('The researchers used a simple model to project the future incidence of COVID-19 cases — and the degree of immunity in the human population — under a range of assumptions on host immune responses following natural infection or vaccination.', 0.6733816), ('A new study led by Princeton researchers suggests that the impact of natural and vaccine-induced immunity will be key factors in shaping the future trajectory of the global coronavirus pandemic, known as COVID-19.', 0.6284887), ('Comparing the predictions of these models carefully and then coming up with a carefully averaged picture of the future — as with weather prediction — can be very helpful.” One of the main takeaways of the study is that monitoring population-level immunity to SARS-CoV-2, in addition to active infections, will be critical for accurately predicting future incidence.', 0.5826691), ('For example, the model allows for different durations of immunity after infection, as well as different extents of protection from reinfection.', 0.5726799), ('In the most recent paper, the researchers used a simple model to project the future incidence of COVID-19 cases — and the degree of immunity in the human population — under a range of assumptions related to how likely individuals are to transmit the virus in different contexts.', 0.5472201)]"
2588,A functional genomics approach to understand host genetic regulation of COVID-19 severity,host,a functional genomics approach to understand _ genetic regulation of covid-19 severity,a functional genomics approach to understand early genetic regulation of covid-19 severity,https://www.medrxiv.org/content/10.1101/2020.11.10.20229203v1,"[('Here, we employed the detailed clinical, immunological and multi-omics data of the Human Functional Genomics Projects (HFGP) to explore the physiological significance of the host genetic variants that influence susceptibility to severe COVID-19.', 0.79731), ('A functional genomics investigation based on functional characterization of individuals with high genetic risk for severe COVID-19 susceptibility identified several major patterns: i. a large impact of genetically determined innate immune responses in COVID-19, with increased susceptibility for severe disease in individuals with defective monocyte-derived cytokine production; ii.', 0.7221596), ('Our findings allow a physiological understanding of genetic susceptibility to severe COVID-19, and indicate pathways that could be targeted for prevention and therapy.', 0.65211016), ('One Sentence summary In this study, we explore the physiological significance of the COVID-19 severity associated genetic variants using detailed clinical, immunological and multi-omics data from large cohorts.', 0.64124894), ('These insights allow a physiological understanding of genetic susceptibility to severe COVID-19, and indicate pathways that could be targeted for prevention and therapy.', 0.63896906)]"
2589,AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19,preventing,azd1222 vaccine met primary efficacy endpoint in _ covid-19,azd1222 vaccine met primary efficacy endpoint in treating covid-19,https://www.astrazeneca.com/media-centre/press-releases/2020/azd1222hlr.html,"[('This vaccine’s efficacy and safety confirm that it will be highly effective against COVID-19 and will have an immediate impact on this public health emergency.', 0.7848486), ('An independent Data Safety Monitoring Board determined that the analysis met its primary endpoint showing protection from COVID-19 occurring 14 days or more after receiving two doses of the vaccine.', 0.7559104), ('Suspected cases presenting with compatible symptoms were tested for virological confirmation by COVID-19 PCR.', 0.5379888), ('One dosing regimen (n=2,741) showed vaccine efficacy of 90% when AZD1222 was given as a half dose, followed by a full dose at least one month apart, and another dosing regimen (n=8,895) showed 62% efficacy when given as two full doses at least one month apart.', 0.51273346), ('AZD1222 was well tolerated across both dosing regimens.', 0.5078206)]"
2590,COVID-19 induces a hyperactive phenotype in circulating platelets,plate,covid-19 induces a hyperactive phenotype in circulating _,covid-19 induces a hyperactive phenotype in circulating cellslets,https://www.medrxiv.org/content/10.1101/2020.07.24.20156240v1,"[('Moreover, we have determined that COVID-19 patients possess hyperactive circulating platelets.', 0.8734411), ('Circulating levels of PF4, sP-selectin levels and TPO are significantly elevated in COVID-19.', 0.7681124), ('Strikingly, agonist-induced ADP release was dramatically higher in COVID-19 patients compared with non-COVID-19 hospitalized patients and circulating levels of PF4, sP-selectin and TPO were also significantly elevated in COVID-19.', 0.7533113), ('These data suggest that abnormal platelet reactivity may contribute to hypercoagulability in COVID-19.', 0.73491836), ('Objectives Here, we assessed clinical platelet parameters and circulating platelet activity in patients with severe and non-severe COVID-19.', 0.72713757)]"
2593,VA launches clinical trial for Veterans with COVID-19 based on prostate cancer drug,launches,va _ clinical trial for veterans with covid-19 based on prostate cancer drug,va second clinical trial for veterans with covid-19 based on prostate cancer drug,https://www.va.gov/opa/pressrel/pressrelease.cfm?id=5452,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus [COVID-19]: coronavirus [v]: View this template [t]: Discuss this template [e]: Edit this template []: required [c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 10:30 AM [Today]: Sunday, January 17, 2021 at 6:45 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:30 AM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students [January 14]: Thursday, January 14, 2021 at 10:09 AM [January 10]: Sunday, January 10, 2021 at 9:29 AM [January 5]: Tuesday, January 5, 2021 at 6:05 AM [on April 4, 2020]: Saturday, April 4, 2020 11:38 PM [Tel:]: Phone number [May 30, 2019 at 9:42 PM]: Thursday, May 30, 2019 at 9:42 PM [March 14, 2019 at 3:03 PM]: Thursday, March 14, 2019 at 3:03 PM [November 12, 2018 at 10:57 PM]: Monday, November 12, 2018 at 10:57 PM [December 25, 2020 at 12:09 PM]: Friday, December 25, 2020 at 12:09 PM [November 24, 2020]: Tuesday, November 24, 2020 at 9:28 AM [ November 5, 2020]: Thursday, November 5, 2020 at 5:36 PM [ November 1, 2020]: Sunday, November 1, 2020 at 1:52 PM [October 26, 2020]: Monday, October 26, 2020 at 6:36 PM [ October 15, 2020]: Thursday, October 15, 2020 at 12:38 PM [ October 7, 2020]: Wednesday, October 7, 2020 at 5:08 PM [August 9, 2020]: Sunday, August 9, 2020 at 8:53 PM [August 7, 2020]: Friday, August 7, 2020 at 6:19 AM [July 4, 2020]: Saturday, July 4, 2020 at 2:55 PM [ July 2, 2020]: Thursday, July 2, 2020 at 8:45 AM [June 30, 2020]: Tuesday, June 30, 2020 at 9:36 AM [June 27, 2020]: Saturday, June 27, 2020 at 7:51 PM [June 18, 2020]: Thursday, June 18, 2020 at 4:20 PM [June 16, 2020]: Tuesday, June 16, 2020 at 7:15 PM [June 14, 2020]: Sunday, June 14, 2020 at 11:40 AM [June 10, 2020]: Wednesday, June 10, 2020 at 7:53 PM [MA]: Massachusetts [Tue]: Tuesday [Jun]: June [m ]: minutes [s]: seconds [m]: minutes [Mon]: Monday [Jan]: January [h]: hour [ICU]: intensive care unit [PHE]: Public Health England [GP]: general practitioner [fr]: Français [COVID]: coronavirus [SAGE]: Scientific Advisory Group for Emergencies [NERVTAG]: New and Emerging Respiratory Virus Threats Advisory Group [SPI-M]: Scientific Pandemic Influenza Group on Modelling [SPI-B]: Independent Scientific Pandemic Influenza Group on Behaviours', 0.4585452), ('Source: VA News By admin ', 0.3570949), ('We are located at the Jesse Brown VA Medical Center in the Illinois Medical District in Chicago.', 0.24099365), ('WISE Chicago Facebook Search Home About WISE Working with WISE Leadership Research VA Institutional Review Board News & Events Get Involved Support Us Donate Contact Us Navigation ', 0.23905593), ('Required fields are marked Comment Name Email Website Solve : 25 × 20 = ', 0.2048848)]"
2594,Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2,chronic,_ liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2,Acute liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2,https://gut.bmj.com/content/54/12/1790,"[(']: dot [@]: at [MHRA]: Medicines and Healthcare products Regulatory Agency [JCVI]: Joint Committee for Vaccination and Immunisation [PMC]: Penske Media Corporation [ COVID-19]: coronavirus [COVID-19]: coronavirus [v]: View this template [t]: Discuss this template [e]: Edit this template []: required [c.]: circa [FT]: Financial Times [f]: fax [Su]: Sunday [Mo]: Monday [Tu]: Tuesday [We]: Wednesday [Th]: Thursday [Fr]: Friday [Sa]: Saturday [FDA]: U.S. Food and Drug Administration [October 27, 2020 5:59 PM]: 2020-10-27T17:59:57-04:00 [April 04, 2020]: 2020-04-04T17:46:00+05:30 [ON]: Ontario [CMAJ]: CMAJ [CMAJ ]: CMAJ [Yesterday]: Saturday, January 16, 2021 at 10:30 AM [Today]: Sunday, January 17, 2021 at 6:45 AM [January 15]: Friday, January 15, 2021 at 11:01 AM [January 11]: Monday, January 11, 2021 at 6:30 AM [January 12]: Tuesday, January 12, 2021 at 9:15 PM [RSS]: Really Simple Syndication [December 9, 2020]: Wednesday, December 9, 2020 at 7:26 AM [December 8, 2020]: Tuesday, December 8, 2020 at 6:39 AM [November 23, 2020]: Monday, November 23, 2020 at 3:21 AM [November 19, 2020]: Thursday, November 19, 2020 at 2:36 AM [November 18, 2020]: Wednesday, November 18, 2020 at 5:03 AM [September 21, 2020]: Monday, September 21, 2020 at 4:00 AM [September 17, 2020]: Thursday, September 17, 2020 at 12:32 AM [September 7, 2020]: Monday, September 7, 2020 at 5:05 AM [September 2, 2020]: Wednesday, September 2, 2020 at 4:00 AM [ABN]: Australian Business Number [CRICOS]: Commonwealth Register of Institutions and Courses for Overseas Students [January 14]: Thursday, January 14, 2021 at 10:09 AM [January 10]: Sunday, January 10, 2021 at 9:29 AM [January 5]: Tuesday, January 5, 2021 at 6:05 AM [on April 4, 2020]: Saturday, April 4, 2020 11:38 PM [Tel:]: Phone number [May 30, 2019 at 9:42 PM]: Thursday, May 30, 2019 at 9:42 PM [March 14, 2019 at 3:03 PM]: Thursday, March 14, 2019 at 3:03 PM [November 12, 2018 at 10:57 PM]: Monday, November 12, 2018 at 10:57 PM [December 25, 2020 at 12:09 PM]: Friday, December 25, 2020 at 12:09 PM [November 24, 2020]: Tuesday, November 24, 2020 at 9:28 AM [ November 5, 2020]: Thursday, November 5, 2020 at 5:36 PM [ November 1, 2020]: Sunday, November 1, 2020 at 1:52 PM [October 26, 2020]: Monday, October 26, 2020 at 6:36 PM [ October 15, 2020]: Thursday, October 15, 2020 at 12:38 PM [ October 7, 2020]: Wednesday, October 7, 2020 at 5:08 PM [August 9, 2020]: Sunday, August 9, 2020 at 8:53 PM [August 7, 2020]: Friday, August 7, 2020 at 6:19 AM [July 4, 2020]: Saturday, July 4, 2020 at 2:55 PM [ July 2, 2020]: Thursday, July 2, 2020 at 8:45 AM [June 30, 2020]: Tuesday, June 30, 2020 at 9:36 AM [June 27, 2020]: Saturday, June 27, 2020 at 7:51 PM [June 18, 2020]: Thursday, June 18, 2020 at 4:20 PM [June 16, 2020]: Tuesday, June 16, 2020 at 7:15 PM [June 14, 2020]: Sunday, June 14, 2020 at 11:40 AM [June 10, 2020]: Wednesday, June 10, 2020 at 7:53 PM [MA]: Massachusetts [Tue]: Tuesday [Jun]: June [m ]: minutes [s]: seconds [m]: minutes [Mon]: Monday [Jan]: January [h]: hour [ICU]: intensive care unit [PHE]: Public Health England [GP]: general practitioner [fr]: Français [COVID]: coronavirus [SAGE]: Scientific Advisory Group for Emergencies [NERVTAG]: New and Emerging Respiratory Virus Threats Advisory Group [SPI-M]: Scientific Pandemic Influenza Group on Modelling [SPI-B]: Independent Scientific Pandemic Influenza Group on Behaviours', 0.23593263), ('Correspondence to: Dr P Angus Department of Gastroenterology and Hepatology, Austin Health, Heidelberg 3084, Victoria, Australia; peter.angusaustin.org.au View Full Text ', 0.2179125), ('Content Latest Current issue Archive Browse by topic Most read articles Top cited articles Responses Journal About Editorial board Sign up for email alerts Subscribe Thank you to our reviewers Authors Instructions for authors Submit an article paper Editorial policies Open Access at BMJ BMJ Author Hub Help Contact us Reprints Permissions Advertising Feedback form RSS Twitter Facebook Blog Soundcloud YouTube Website Terms & Conditions Privacy & Cookies Contact BMJ Cookie Settings Online: ISSN 1468-3288Print: ISSN 0017-5749 Copyright © 2020 BMJ Publishing Group Ltd & British Society of Gastroenterology.', 0.19777936), ('Basket Search More Search for this keyword Advanced search Latest content Current issue Archive Authors About ', 0.17846245), ('Skip to main content Subscribe Log In More Log in via Institution Log in via OpenAthens Log in via BSG ', 0.13086909)]"
2597,COVID-19 coronavirus spike holds infectivity details,spike,covid-19 coronavirus _ holds infectivity details,covid-19 coronavirus genomes holds infectivity details,https://newsroom.uw.edu/news/covid-19-coronavirus-spike-holds-infectivity-details,"[('The spikes crowning the new coronavirus that causes COVID-19 atypical pneumonia are divulging how they attach, fuse and gain entry to cells.', 0.6598427), ('Category: Research Tags: coronavirus COVID-19 biochemistry epidemic vaccine development antibodies ', 0.646227), ('This finding might help account for the efficient spread of the new coronavirus between people.', 0.52061117), ('It is not yet known if this difference is expanding the kinds of cells the new coronavirus could infect or enhancing its transmissibility, in a way that might be similar to that of highly pathogenic avian flu viruses.', 0.50659686), ('As a whole, details contained in the results reported in this week’s paper may help to explain the efficiency of the new coronavirus in delivering its viral code into human cells, and its rapid transmission among people.', 0.49712688)]"
2599,Next generation sequencing of SARS-CoV-2 from patient specimens of Nevada reveals occurrence of specific nucleotide variants at high frequency,next,_ generation sequencing of sars-cov-2 from patient specimens of nevada reveals occurrence of specific nucleotide variants at high frequency,Time generation sequencing of sars-cov-2 from patient specimens of nevada reveals occurrence of specific nucleotide variants at high frequency,https://www.medrxiv.org/content/10.1101/2020.08.21.20178863v1,"[('1 Nevada Genomics Center, Research & Innovation; 2.', 0.52233076), ('2 Nevada Institute of Personalized Medicine, University of Nevada, Las Vegas; 3.', 0.4785427), ('8 Department of Microbiology & Immunology, School of Medicine, University of Nevada, Reno; 9.', 0.41082808), ('6 Nevada State Public Health Lab; 7.', 0.37754643), ('3 Nevada Center for Bioinformatics, Research & Innovation; 4.', 0.34801528)]"
2603,Intradermal-delivered DNA vaccine provides anamnestic protection in a rhesus macaque SARS-CoV-2 challenge model,dna,intradermal-delivered _ vaccine provides anamnestic protection in a rhesus macaque sars-cov-2 challenge model,intradermal-delivered HIV vaccine provides anamnestic protection in a rhesus macaque sars-cov-2 challenge model,https://www.biorxiv.org/content/10.1101/2020.07.28.225649v1,"[('Here, we assess immunogenicity and anamnestic protective efficacy in rhesus macaques of the intradermal (ID)-delivered SARS-CoV-2 spike DNA vaccine, INO-4800.', 0.8657117), ('INO-4800 is an ID-delivered DNA vaccine currently being evaluated in clinical trials.', 0.6903819), ('Vaccination with INO-4800 induced T cell responses and neutralizing antibody responses against both the D614 and G614 SARS-CoV-2 spike proteins.', 0.60461545), ('Several months after vaccination, animals were challenged with SARS-CoV-2 resulting in rapid recall of anti-SARS-CoV-2 spike protein T and B cell responses.', 0.57508886), ('These studies support the immune impact of INO-4800 for inducing both humoral and cellular arms of the adaptive immune system which are likely important for providing durable protection against COVID-19 disease.', 0.47041056)]"
